Neighbor	O
clustering	O
provides	O
a	O
more	O
comprehensive	O
view	O
of	O
the	O
molecular	O
responses	O
of	O
streptococci	O
during	O
pharyngeal	O
cell	O
adherence	O
.	O

We	O
used	O
this	O
approach	O
to	O
analyze	O
microarray	O
expression	O
data	O
from	O
group	O
A	O
streptococci	O
(	O
Streptococcus	O
pyogenes	O
)	O
during	O
adherence	O
to	O
human	O
pharyngeal	O
cells	O
,	O
the	O
first	O
overt	O
infection	O
step	O
[	O
7	O
]	O
.	O

This	O
analysis	O
identified	O
79	O
genes	O
(	O
4	O
%	O
of	O
the	O
genome	O
)	O
exhibiting	O
statistically	O
significant	O
fold	O
changes	O
in	O
expression	O
(	O
PF	O
value	O
<	O
0	O
.	O
05	O
)	O
during	O
adherence	O
from	O
1	O
,	O
769	O
open	O
reading	O
frames	O
represented	O
on	O
the	O
array	O
(	O
Table	O
1	O
)	O
.	O

We	O
refer	O
to	O
such	O
genes	O
as	O
"	O
differentially	O
expressed	O
.	O
"	O
We	O
present	O
the	O
entire	O
dataset	O
from	O
all	O
experiments	O
as	O
Table	O
S1	O
.	O

Genes	O
demonstrating	O
upregulation	O
(	O
n	O
=	O
45	O
)	O
and	O
downregulation	O
(	O
n	O
=	O
34	O
)	O
included	O
virulence	O
factors	O
,	O
prophage	O
-	O
encoded	O
transcripts	O
,	O
metabolic	O
genes	O
,	O
and	O
transcriptional	O
regulators	O
(	O
Table	O
2	O
)	O
.	O

The	O
initial	O
statistical	O
analysis	O
identified	O
four	O
differentially	O
expressed	O
virulence	O
genes	O
(	O
Tables	O
1	O
and	O
2	O
)	O
.	O

Although	O
few	O
studies	O
have	O
examined	O
gene	O
expression	O
patterns	O
during	O
adherence	O
,	O
SpeB	S-Biological_Molecule
production	O
(	O
as	O
detected	O
by	O
Western	O
blot	O
analysis	O
)	O
decreases	O
during	O
co	O
-	O
culture	O
with	O
human	O
peripheral	O
blood	O
mononuclear	O
cells	O
[	O
30	O
]	O
and	O
in	O
a	O
mouse	O
infection	O
model	O
[	O
31	O
]	O
.	O

We	O
also	O
identified	O
the	O
adherence	O
-	O
mediated	O
upregulation	O
of	O
four	O
transcriptional	O
regulators	O
(	O
Table	O
1	O
)	O
,	O
suggestive	O
of	O
an	O
adaptive	O
response	O
to	O
host	O
cell	O
contact	O
that	O
is	O
dynamic	O
and	O
complex	O
.	O

Our	O
initial	O
analysis	O
revealed	O
the	O
differential	O
expression	O
of	O
a	O
wide	O
range	O
of	O
functionally	O
diverse	O
genes	O
and	O
provided	O
insight	O
into	O
the	O
adaptive	O
response	O
of	O
streptococci	O
to	O
host	O
cell	O
contact	O
.	O

If	O
transcription	O
is	O
internally	O
disrupted	O
by	O
such	O
a	O
terminator	O
,	O
the	O
abundance	O
of	O
the	O
sagA	S-Biological_Molecule
transcript	O
may	O
be	O
much	O
greater	O
than	O
the	O
polycistronic	O
message	O
;	O
such	O
disproportionate	O
transcript	O
levels	O
would	O
affect	O
log2	O
-	O
fold	O
change	O
values	O
and	O
impact	O
the	O
statistical	O
significance	O
of	O
individual	O
genes	O
within	O
these	O
types	O
of	O
clusters	O
.	O

Importantly	O
,	O
because	O
functional	O
gene	O
data	O
are	O
not	O
incorporated	O
into	O
its	O
algorithms	O
,	O
GenomeCrawler	O
is	O
not	O
biased	O
toward	O
identifying	O
"	O
expected	O
"	O
clusters	O
.	O

Based	O
on	O
the	O
Type	O
I	O
cluster	O
results	O
,	O
we	O
speculated	O
that	O
genes	O
contained	O
in	O
Type	O
II	O
clusters	O
might	O
be	O
related	O
by	O
function	O
or	O
regulation	O
.	O

We	O
note	O
,	O
however	O
,	O
that	O
despite	O
the	O
statistical	O
framework	O
with	O
which	O
groupings	O
are	O
assigned	O
,	O
experimental	O
evidence	O
is	O
necessary	O
to	O
confirm	O
functional	O
or	O
regulatory	O
relatedness	O
.	O

A	O
total	O
of	O
18	O
(	O
90	O
%	O
)	O
of	O
20	O
Type	O
II	O
clusters	O
(	O
Table	O
3	O
and	O
Figure	O
S3	O
)	O
may	O
not	O
have	O
been	O
identified	O
without	O
neighbor	O
clustering	O
:	O
eight	O
(	O
44	O
.	O
4	O
%	O
)	O
of	O
18	O
gained	O
additional	O
gene	O
members	O
;	O
the	O
remaining	O
ten	O
comprised	O
genes	O
that	O
demonstrated	O
significant	O
differential	O
expression	O
only	O
after	O
applying	O
GenomeCrawler	O
.	O

Together	O
with	O
the	O
identification	O
of	O
this	O
cluster	O
by	O
GenomeCrawler	O
,	O
these	O
results	O
prompted	O
us	O
to	O
study	O
this	O
cluster	O
and	O
the	O
contributions	O
of	O
the	O
gene	O
products	O
to	O
pharyngeal	O
cell	O
adherence	O
.	O

Experimental	O
confirmation	O
of	O
each	O
candidate	O
is	O
beyond	O
the	O
scope	O
of	O
this	O
study	O
,	O
but	O
Northern	O
blot	O
and	O
RT	O
-	O
PCR	O
analyses	O
could	O
provide	O
such	O
information	O
.	O

Analysis	O
of	O
Previously	O
Published	O
Array	O
Data	O

We	O
applied	O
the	O
statistical	O
analysis	O
and	O
the	O
GenomeCrawler	O
algorithms	O
to	O
data	O
from	O
a	O
recently	O
published	O
streptococcal	O
microarray	O
study	O
that	O
is	O
relevant	O
for	O
comparison	O
to	O
our	O
own	O
data	O
(	O
same	O
streptococcal	O
strain	O
,	O
similar	O
array	O
platform	O
)	O
[	O
57	O
]	O
.	O

Neighbor	O
clustering	O
was	O
able	O
to	O
extend	O
the	O
results	O
by	O
identifying	O
more	O
differentially	O
expressed	O
genes	O
and	O
reconstructing	O
more	O
intact	O
biological	O
pathways	O
.	O

Finally	O
,	O
because	O
of	O
the	O
common	O
architecture	O
of	O
bacterial	O
chromosomes	O
,	O
the	O
neighbor	O
clustering	O
algorithms	O
may	O
be	O
applicable	O
to	O
microarray	O
datasets	O
from	O
other	O
prokaryotes	O
.	O

The	O
long	O
(	O
FimA	S-Biological_Molecule
)	O
fimbriae	O
have	O
been	O
extensively	O
studied	O
.	O

Expression	O
of	O
the	O
fimA	S-Biological_Molecule
gene	O
is	O
tightly	O
controlled	O
by	O
a	O
two	O
-	O
component	O
system	O
(	O
FimS	S-Biological_Molecule
/	O
FimR	S-Biological_Molecule
)	O
through	O
a	O
cascade	O
regulation	O
.	O

Coadhesion	O
and	O
biofilm	O
development	O
between	O
P	O
.	O
gingivalis	O
and	O
Streptococcus	O
gordonii	O
require	O
the	O
interaction	O
of	O
Mfa1	S-Biological_Molecule
with	O
streptococcal	O
protein	O
SspB	S-Biological_Molecule
(	O
Park	O
et	O
al	O
.	O
,	O
2005	O
)	O
.	O

Mfa1	S-Biological_Molecule
expression	O
appears	O
to	O
fluctuate	O
under	O
various	O
growth	O
conditions	O
(	O
Masuda	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

In	O
a	O
nutrient	O
-	O
limited	O
medium	O
,	O
expression	O
of	O
FimA	S-Biological_Molecule
and	O
Mfa1	S-Biological_Molecule
are	O
inhibited	O
in	O
P	O
.	O
gingivalis	O
,	O
whereas	O
such	O
differences	O
are	O
not	O
found	O
in	O
gingipain	O
expression	O
.	O

Results	O

Role	O
of	O
FimR	S-Biological_Molecule
in	O
mfa1	S-Biological_Molecule
expression	O
The	O
fimA	S-Biological_Molecule
gene	O
is	O
the	O
only	O
gene	O
known	O
to	O
be	O
tightly	O
controlled	O
by	O
the	O
FimS	S-Biological_Molecule
/	O
FimR	S-Biological_Molecule
system	O
.	O

Expression	O
of	O
fimA	S-Biological_Molecule
and	O
mfa1	S-Biological_Molecule
in	O
the	O
fimR	S-Biological_Molecule
-	O
mutant	O
was	O
determined	O
using	O
real	O
-	O
time	O
PCR	O
analysis	O
.	O

Statistically	O
significant	O
differences	O
of	O
the	O
level	O
of	O
gene	O
expression	O
in	O
33277	O
and	O
the	O
fimR	S-Biological_Molecule
-	O
mutant	O
were	O
calculated	O
by	O
a	O
Student	O
'	O
s	O
t	O
-	O
test	O
.	O

The	O
striking	O
finding	O
is	O
that	O
expression	O
of	O
the	O
mfa1	S-Biological_Molecule
gene	O
was	O
also	O
repressed	O
threefold	O
in	O
the	O
fimR	S-Biological_Molecule
-	O
mutant	O
,	O
although	O
not	O
to	O
the	O
degree	O
observed	O
with	O
the	O
fimA	S-Biological_Molecule
expression	O
.	O

This	O
analysis	O
revealed	O
that	O
the	O
expression	O
of	O
the	O
fimA	S-Biological_Molecule
and	O
mfa1	S-Biological_Molecule
genes	O
was	O
consistent	O
at	O
the	O
mRNA	O
level	O
and	O
protein	O
level	O
(	O
Fig	O
.	O
1b	O
)	O
.	O

Similarly	O
,	O
there	O
was	O
no	O
apparent	O
change	O
in	O
RgpA	S-Biological_Molecule
production	O
in	O
the	O
fimR	S-Biological_Molecule
-	O
mutant	O
,	O
which	O
was	O
detected	O
by	O
anti	O
-	O
RgpA	S-Biological_Molecule
serum	O
.	O

Cold	O
competitor	O
chase	O
experiments	O
with	O
a	O
100	O
-	O
fold	O
excess	O
of	O
unlabeled	O
DNA	O
probe	O
as	O
a	O
specific	O
competitor	O
were	O
also	O
used	O
to	O
demonstrate	O
the	O
specificity	O
of	O
rFimR	S-Biological_Molecule
binding	O
.	O

Retarded	O
mfa1	S-Biological_Molecule
promoter	O
-	O
rFimR	S-Biological_Molecule
complex	O
was	O
detected	O
with	O
as	O
little	O
as	O
10	O
pmol	O
muL	O
-	O
1	O
rFimR	S-Biological_Molecule
(	O
Fig	O
.	O
3	O
)	O
.	O

Expression	O
of	O
minor	B-Biological_Molecule
fimbriae	E-Biological_Molecule
(	O
mfa1	S-Biological_Molecule
)	O
in	O
a	O
fimR	S-Biological_Molecule
mutanthas	O
been	O
investigated	O
.	O

The	O
previous	O
study	O
suggested	O
that	O
regulation	O
of	O
fimA	S-Biological_Molecule
expression	O
by	O
FimR	S-Biological_Molecule
is	O
through	O
a	O
regulation	O
cascade	O
involving	O
interaction	O
of	O
FimR	S-Biological_Molecule
and	O
the	O
promoter	O
region	O
of	O
the	O
first	O
gene	O
in	O
the	O
fimA	S-Biological_Molecule
cluster	O
(	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

However	O
,	O
no	O
apparent	O
difference	O
was	O
found	O
in	O
DNA	O
-	O
binding	O
affinity	O
between	O
rFimRs	S-Biological_Molecule
with	O
or	O
without	O
acetyl	O
phosphate	O
treatment	O
.	O

Phosphorylation	O
of	O
CovR	S-Biological_Molecule
,	O
a	O
global	O
response	O
regulator	O
,	O
had	O
no	O
effect	O
on	O
its	O
DNA	O
-	O
binding	O
affinity	O
.	O

The	O
transcriptional	O
site	O
revealed	O
here	O
is	O
confirmed	O
by	O
RT	O
-	O
PCR	O
analysis	O
.	O

In	O
E	O
.	O
coli	O
,	O
two	O
promoters	O
direct	O
transcription	O
of	O
acs	O
encoding	O
,	O
an	O
acetate	O
-	O
scavenging	O
enzyme	O
required	O
for	O
fitness	O
during	O
periods	O
of	O
carbon	O
starvation	O
-	O
the	O
distal	O
acsP1	S-Biological_Molecule
and	O
the	O
proximal	O
acsP2	S-Biological_Molecule
(	O
Beatty	O
et	O
al	O
.	O
,	O
2003	O
)	O
.	O

The	O
hypothesis	O
is	O
currently	O
under	O
investigation	O
.	O

In	O
conclusion	O
,	O
P	O
.	O
gingivalis	O
fimbriae	O
play	O
a	O
predominant	O
role	O
in	O
the	O
attachment	O
of	O
the	O
organism	O
to	O
a	O
variety	O
of	O
oral	O
surfaces	O
(	O
Lamont	O
&	O
Jenkinson	O
,	O
2000	O
;	O
Amano	O
et	O
al	O
.	O
,	O
2004	O
)	O
,	O
although	O
other	O
surface	O
proteins	O
,	O
such	O
as	O
gingipains	O
,	O
may	O
also	O
be	O
involved	O
in	O
the	O
bacterial	O
colonization	O
(	O
Tokuda	O
et	O
al	O
.	O
,	O
1996	O
;	O
Chen	O
et	O
al	O
.	O
,	O
2001	O
)	O
.	O

Indeed	O
,	O
M	O
.	O
tuberculosis	O
has	O
retained	O
many	O
secrets	O
of	O
its	O
so	O
successful	O
pathogenic	O
lifecycle	O
.	O

One	O
of	O
them	O
is	O
the	O
"	O
Bacille	O
de	O
Calmette	O
et	O
Guerin	O
"	O
(	O
BCG	O
)	O
,	O
which	O
was	O
originally	O
derived	O
in	O
1921	O
from	O
a	O
virulent	O
Mycobacterium	O
bovis	O
strain	O
by	O
230	O
passages	O
on	O
potato	O
-	O
glycerol	O
-	O
ox	O
bile	O
medium	O
[	O
1	O
]	O
.	O

This	O
technique	O
has	O
previously	O
permitted	O
single	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
of	O
a	O
PA	O
-	O
824	O
drug	O
resistant	O
mutant	O
strain	O
of	O
H37Rv	O
to	O
be	O
detected	O
[	O
13	O
]	O
.	O

This	O
approach	O
was	O
combined	O
with	O
gene	O
"	O
knock	O
-	O
in	O
"	O
strategies	O
,	O
to	O
complement	O
selected	O
lesions	O
,	O
that	O
allowed	O
recombinant	O
H37Ra	O
strains	O
to	O
be	O
engineered	O
,	O
whose	O
virulence	O
and	O
immunogenicity	O
were	O
then	O
evaluated	O
in	O
in	O
vitro	O
,	O
ex	O
vivo	O
and	O
animal	O
models	O
.	O

By	O
this	O
combined	O
approach	O
we	O
identified	O
13	O
non	O
-	O
synonymous	O
SNPs	O
that	O
differed	O
between	O
the	O
H37Ra	O
and	O
H37Rv	O
strains	O
used	O
(	O
Table	O
S1	O
)	O
.	O

For	O
the	O
other	O
13	O
genes	O
we	O
found	O
no	O
indication	O
that	O
would	O
identify	O
them	O
as	O
potential	O
virulence	O
genes	O
,	O
as	O
none	O
of	O
them	O
belong	O
to	O
the	O
5	O
%	O
of	O
genes	O
that	O
were	O
previously	O
determined	O
by	O
transposon	O
site	O
hybridization	O
(	O
TraSH	O
)	O
as	O
being	O
essential	O
for	O
in	O
vivo	O
growth	O
of	O
M	O
.	O
tuberculosis	O
[	O
16	O
]	O
.	O

Clones	O
spanning	O
the	O
different	O
genomic	O
regions	O
of	O
non	O
-	O
synonymous	O
SNPs	O
were	O
selected	O
from	O
an	O
ordered	O
H37Rv	O
library	O
of	O
integrating	O
shuttle	O
cosmids	O
[	O
7	O
,	O
19	O
]	O
and	O
individually	O
electroporated	O
into	O
H37Ra	O
,	O
where	O
they	O
inserted	O
stably	O
into	O
the	O
attB	O
site	O
.	O

As	O
depicted	O
in	O
Figure	O
S2	O
,	O
hybridization	O
of	O
SpeI	S-Biological_Molecule
-	O
digested	O
genomic	O
DNA	O
with	O
a	O
32P	O
labeled	O
phoP	S-Biological_Molecule
probe	O
resulted	O
in	O
two	O
bands	O
of	O
different	O
sizes	O
,	O
one	O
corresponding	O
to	O
the	O
SpeI	S-Biological_Molecule
fragment	O
harboring	O
the	O
H37Ra	O
phoP	S-Biological_Molecule
gene	O
(	O
50	O
kb	O
)	O
,	O
and	O
the	O
other	O
to	O
the	O
larger	O
SpeI	S-Biological_Molecule
fragment	O
created	O
by	O
integration	O
of	O
the	O
I36	O
cosmid	O
into	O
the	O
genome	O
of	O
H37Ra	O
at	O
the	O
attB	O
site	O
.	O

Changes	O
in	O
the	O
regulatory	O
potential	O
of	O
a	O
pathogen	O
are	O
often	O
accompanied	O
by	O
altered	O
virulence	O
.	O

Exactly	O
the	O
same	O
trend	O
was	O
observed	O
when	O
a	O
highly	O
sensitive	O
T	O
cell	O
hybridoma	O
assay	O
was	O
used	O
to	O
investigate	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
secretion	O
.	O

Figure	O
4A	O
shows	O
that	O
infection	O
of	O
BM	O
-	O
DC	O
with	O
H37Ra	O
or	O
H37Ra	O
:	O
:	O
rpsL	S-Biological_Molecule
induced	O
no	O
stimulation	O
of	O
the	O
hybridoma	O
as	O
judged	O
by	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
production	O
,	O
while	O
H37Ra	O
:	O
:	O
phoP	S-Biological_Molecule
or	O
H37Rv	O
triggered	O
high	O
amounts	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
production	O
in	O
this	O
very	O
sensitive	O
and	O
specific	O
test	O
.	O

In	O
the	O
bacterial	O
world	O
the	O
PhoP	S-Biological_Molecule
/	O
PhoR	S-Biological_Molecule
like	O
two	O
-	O
component	O
systems	O
are	O
widely	O
distributed	O
and	O
fulfill	O
a	O
large	O
variety	O
of	O
functions	O
including	O
sensing	O
phosphate	O
and	O
magnesium	O
[	O
32	O
,	O
33	O
]	O
,	O
or	O
regulating	O
virulence	O
genes	O
[	O
34	O
]	O
.	O

Finally	O
,	O
microarray	O
-	O
based	O
trancriptome	O
analysis	O
using	O
the	O
wild	O
-	O
type	O
versus	O
a	O
phoP	S-Biological_Molecule
ko	O
mutant	O
of	O
H37Rv	O
has	O
provided	O
an	O
overview	O
of	O
the	O
transcriptional	O
regulation	O
linked	O
to	O
PhoP	S-Biological_Molecule
[	O
21	O
]	O
.	O

In	O
contrast	O
,	O
in	O
another	O
transcriptome	O
analysis	O
,	O
Mostowy	O
and	O
colleagues	O
[	O
11	O
]	O
found	O
several	O
genes	O
of	O
the	O
RD1	O
region	O
,	O
including	O
that	O
encoding	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
,	O
among	O
the	O
genes	O
that	O
were	O
at	O
least	O
2	O
.	O
5	O
-	O
fold	O
lower	O
expressed	O
in	O
H37Ra	O
than	O
in	O
H37Rv	O
.	O

This	O
strain	O
was	O
previously	O
used	O
to	O
vaccinate	O
mice	O
and	O
guinea	O
pigs	O
and	O
conferred	O
good	O
protection	O
against	O
a	O
challenge	O
with	O
virulent	O
M	O
.	O
tuberculosis	O
[	O
25	O
]	O
.	O

Comparative	O
analysis	O
of	O
the	O
Photorhabdus	O
luminescens	O
and	O
the	O
Yersinia	O
enterocolitica	O
genomes	O
:	O
uncovering	O
candidate	O
genes	O
involved	O
in	O
insect	O
pathogenicity	O

Background	O

However	O
,	O
bacteria	O
of	O
the	O
species	O
P	O
.	O
luminescens	O
are	O
exclusively	O
known	O
to	O
be	O
associated	O
with	O
nematodes	O
and	O
insects	O
.	O

To	O
uncover	O
candidate	O
genes	O
which	O
are	O
involved	O
in	O
insect	O
pathogenicity	O
,	O
a	O
total	O
of	O
424	O
(	O
P	O
.	O
luminescens	O
)	O
and	O
386	O
(	O
Y	O
.	O
enterocolitica	O
)	O
genes	O
and	O
proteins	O
predicted	O
to	O
belong	O
to	O
one	O
of	O
the	O
functional	O
categories	O
described	O
in	O
the	O
text	O
were	O
analysed	O
for	O
their	O
presence	O
or	O
absence	O
in	O
both	O
organisms	O
,	O
and	O
for	O
their	O
degree	O
of	O
similarity	O
.	O

The	O
role	O
of	O
PhoP	S-Biological_Molecule
/	O
PhoQ	S-Biological_Molecule
in	O
regulating	O
virulence	O
gene	O
expression	O
has	O
been	O
characterized	O
mainly	O
in	O
Salmonella	O
species	O
,	O
but	O
has	O
also	O
been	O
shown	O
,	O
in	O
addition	O
to	O
three	O
other	O
TCSs	O
,	O
to	O
be	O
important	O
for	O
virulence	O
of	O
Y	O
.	O
pseudotuberculosis	O
[	O
29	O
,	O
30	O
]	O
.	O

The	O
only	O
TCS	O
of	O
P	O
.	O
luminescens	O
absent	O
in	O
Y	O
.	O
enterocolitica	O
is	O
TctE	S-Biological_Molecule
/	O
TctD	S-Biological_Molecule
(	O
Fig	O
.	O
2	O
,	O
marked	O
in	O
blue	O
)	O
,	O
which	O
,	O
however	O
,	O
is	O
found	O
in	O
the	O
genomes	O
of	O
Y	O
.	O
intermedia	O
and	O
Y	O
.	O
frederiksenii	O
.	O

In	O
comparison	O
to	O
P	O
.	O
luminescens	O
,	O
Y	O
.	O
enterocolitica	O
uses	O
an	O
expanded	O
set	O
of	O
TCSs	O
,	O
possibly	O
to	O
adapt	O
to	O
its	O
various	O
hosts	O
(	O
Fig	O
.	O
1	O
)	O
.	O

The	O
DeltaluxS	S-Biological_Molecule
mutant	O
also	O
showed	O
decreased	O
expression	O
of	O
virulence	O
factors	O
such	O
as	O
the	O
cytotoxic	O
protein	O
CcdB	S-Biological_Molecule
,	O
the	O
hemolysin	O
secretion	O
protein	O
HlyD	S-Biological_Molecule
(	O
Plu0635	S-Biological_Molecule
)	O
,	O
and	O
the	O
toxin	O
ABC	O
transporter	O
subunits	O
RtxD	S-Biological_Molecule
/	O
RtxB	S-Biological_Molecule
.	O

Therefore	O
,	O
the	O
potential	O
PAS	B-Biological_Molecule
_	I-Biological_Molecule
4	E-Biological_Molecule
/	O
LuxR	S-Biological_Molecule
-	O
like	O
receptors	O
of	O
P	O
.	O
luminescens	O
,	O
Y	O
.	O
enterocolitica	O
,	O
and	O
S	O
.	O
glossinidius	O
might	O
sense	O
JH	O
or	O
other	O
eukaryotic	O
hormones	O
of	O
the	O
insect	O
to	O
adapt	O
their	O
gene	O
expression	O
to	O
the	O
insect	O
host	O
.	O

The	O
difference	O
in	O
the	O
number	O
of	O
the	O
uncommon	O
LuxR	S-Biological_Molecule
-	O
like	O
receptors	O
(	O
35	O
in	O
P	O
.	O
luminescens	O
,	O
nine	O
in	O
Y	O
.	O
enterocolitica	O
)	O
gives	O
rise	O
to	O
speculations	O
that	O
the	O
insect	O
host	O
spectrum	O
is	O
constricted	O
for	O
Y	O
.	O
enterocolitica	O
compared	O
with	O
P	O
.	O
luminescens	O
.	O

This	O
hypothesis	O
is	O
underlined	O
by	O
the	O
fact	O
that	O
not	O
more	O
than	O
five	O
PAS	B-Biological_Molecule
_	I-Biological_Molecule
4	E-Biological_Molecule
/	O
LuxR	S-Biological_Molecule
-	O
like	O
receptors	O
are	O
present	O
in	O
S	O
.	O
glossinidius	O
for	O
which	O
only	O
one	O
insect	O
host	O
has	O
been	O
reported	O
.	O

Therefore	O
,	O
UspA	S-Biological_Molecule
might	O
have	O
a	O
global	O
importance	O
in	O
P	O
.	O
luminescens	O
notifying	O
stress	O
and	O
transmitting	O
signals	O
for	O
HexA	S-Biological_Molecule
[	O
18	O
]	O
.	O

A	O
GroEL	S-Biological_Molecule
homologue	O
is	O
present	O
in	O
P	O
.	O
luminescens	O
(	O
Plu4134	S-Biological_Molecule
)	O
which	O
the	O
P	O
.	O
luminescens	O
UspG	S-Biological_Molecule
homologues	O
might	O
interact	O
with	O
.	O

Cyclic	O
diguanylate	O
(	O
c	O
-	O
di	O
-	O
GMP	O
)	O
is	O
a	O
bacterial	O
second	O
messenger	O
that	O
activates	O
biofilm	O
formation	O
while	O
inhibiting	O
motility	O
,	O
thus	O
regulating	O
the	O
switch	O
between	O
a	O
planktonic	O
and	O
a	O
sessile	O
lifestyle	O
.	O

Similar	O
islands	O
in	O
which	O
regulatory	O
genes	O
are	O
followed	O
by	O
three	O
tca	O
genes	O
,	O
phage	O
-	O
related	O
genes	O
and	O
one	O
or	O
two	O
tccC	S-Biological_Molecule
genes	O
,	O
are	O
present	O
in	O
the	O
genomes	O
of	O
Y	O
.	O
pseudotuberculosis	O
IP32953	O
and	O
Y	O
.	O
pestis	O
KIM	O
.	O

The	O
genome	O
sequence	O
of	O
P	O
.	O
luminescens	O
exhibits	O
more	O
toxin	O
genes	O
than	O
found	O
in	O
any	O
other	O
bacterial	O
genome	O
sequenced	O
yet	O
,	O
including	O
the	O
genome	O
of	O
Y	O
.	O
enterocolitica	O
.	O

Examples	O
identified	O
are	O
Txp40	S-Biological_Molecule
,	O
a	O
40	O
kD	O
insecticidal	O
toxin	O
[	O
69	O
]	O
,	O
the	O
nematicidal	O
toxin	O
(	O
Xnp2	S-Biological_Molecule
)	O
first	O
described	O
in	O
X	O
.	O
bovienii	O
(	O
accession	O
number	O
AJ296651	O
.	O
1	O
)	O
,	O
galA	S-Biological_Molecule
(	O
plu0840	S-Biological_Molecule
)	O
similar	O
to	O
the	O
enterotoxin	O
Ast	O
of	O
Aeromonas	O
hydrophila	O
which	O
is	O
involved	O
in	O
carbohydrate	O
transport	O
and	O
metabolism	O
[	O
70	O
]	O
,	O
and	O
two	O
dermonecrotizing	O
toxin	O
-	O
(	O
dnt	O
-	O
)	O
like	O
factors	O
(	O
plu2400	S-Biological_Molecule
and	O
plu2420	S-Biological_Molecule
)	O
.	O

Examples	O
are	O
SopB	S-Biological_Molecule
,	O
a	O
host	O
cell	O
invasion	O
factor	O
translocated	O
via	O
the	O
type	O
-	O
III	O
secretion	O
system	O
that	O
is	O
present	O
in	O
the	O
emerging	O
human	O
pathogen	O
P	O
.	O
asymbiotica	O
,	O
but	O
not	O
in	O
the	O
insect	O
pathogen	O
P	O
.	O
luminescens	O
[	O
14	O
]	O
,	O
a	O
putative	O
effector	O
protein	O
(	O
YE2447	S-Biological_Molecule
)	O
with	O
proteolytic	O
activity	O
,	O
and	O
a	O
homologue	O
of	O
SrfA	S-Biological_Molecule
which	O
is	O
negatively	O
regulated	O
by	O
PhoP	S-Biological_Molecule
in	O
S	O
.	O
typhimurium	O
[	O
75	O
]	O
.	O

Colonization	O
and	O
penetration	O
of	O
epithelial	O
cells	O
,	O
and	O
interaction	O
with	O
immune	O
cells	O
,	O
are	O
key	O
steps	O
during	O
the	O
host	O
infection	O
by	O
pathogens	O
.	O

Many	O
of	O
the	O
pathogen	O
-	O
receptor	O
molecules	O
such	O
as	O
Toll	O
-	O
like	O
receptors	O
or	O
integrins	O
are	O
conserved	O
between	O
invertebrates	O
and	O
mammalians	O
[	O
79	O
]	O
.	O

Unique	O
for	O
the	O
human	O
pathogen	O
in	O
comparison	O
to	O
P	O
.	O
luminescens	O
are	O
the	O
two	O
fimbrial	O
gene	O
cluster	O
ye2664	S-Biological_Molecule
-	O
2668	S-Biological_Molecule
and	O
ye2692	S-Biological_Molecule
-	O
2700	S-Biological_Molecule
,	O
both	O
of	O
yet	O
hypothetical	O
function	O
.	O

P	O
.	O
luminescens	O
produces	O
proteins	O
similar	O
to	O
monooxygenases	O
,	O
dioxygenases	O
and	O
hydroxylases	O
that	O
have	O
been	O
suggested	O
to	O
play	O
a	O
role	O
in	O
rapid	O
elimination	O
of	O
insect	O
polyphenols	O
or	O
in	O
the	O
detoxification	O
of	O
reactive	O
oxygen	O
species	O
generated	O
by	O
the	O
invaded	O
host	O
[	O
24	O
]	O
.	O

Examples	O
are	O
the	O
product	O
of	O
plu4258	S-Biological_Molecule
,	O
adjacent	O
to	O
a	O
gene	O
encoding	O
glutathione	O
transferase	O
(	O
plu4259	S-Biological_Molecule
)	O
,	O
a	O
putative	O
steroid	O
monooxygenase	O
(	O
Plu4232	S-Biological_Molecule
)	O
,	O
and	O
a	O
glycine	O
oxidase	O
(	O
Plu2242	S-Biological_Molecule
)	O
,	O
all	O
of	O
which	O
have	O
no	O
counterparts	O
in	O
Y	O
.	O
enterocolitica	O
.	O

Secretion	O
and	O
exoenzymes	O

The	O
typical	O
effector	O
proteins	O
of	O
Y	O
.	O
enterocolitica	O
are	O
also	O
present	O
in	O
P	O
.	O
luminescens	O
.	O

Due	O
to	O
its	O
absence	O
in	O
Y	O
.	O
enterocolitica	O
,	O
Ymt	S-Biological_Molecule
is	O
another	O
example	O
for	O
the	O
high	O
diversity	O
of	O
genetic	O
determinants	O
that	O
are	O
used	O
by	O
closely	O
related	O
bacterial	O
pathogens	O
to	O
interact	O
with	O
their	O
insect	O
hosts	O
.	O

We	O
speculate	O
that	O
these	O
Y	O
.	O
enterocolitica	O
proteases	O
could	O
be	O
involved	O
in	O
the	O
infection	O
process	O
in	O
mammals	O
,	O
whereas	O
the	O
P	O
.	O
luminescens	O
proteases	O
are	O
rather	O
used	O
for	O
nutrient	O
bioconversion	O
than	O
for	O
the	O
infection	O
process	O
.	O

While	O
many	O
specific	O
virulence	O
factors	O
,	O
which	O
enable	O
the	O
microbes	O
to	O
overcome	O
the	O
various	O
physical	O
and	O
biochemical	O
barriers	O
of	O
the	O
infected	O
hosts	O
,	O
have	O
been	O
investigated	O
in	O
detail	O
,	O
little	O
attention	O
has	O
been	O
given	O
to	O
the	O
metabolic	O
requirements	O
and	O
substrate	O
availability	O
of	O
bacteria	O
in	O
vivo	O
.	O

Beside	O
S	O
.	O
typhimurium	O
,	O
all	O
these	O
genetic	O
determinants	O
were	O
found	O
only	O
in	O
few	O
other	O
bacteria	O
,	O
namely	O
the	O
human	O
pathogens	O
Listeria	O
monocytogenes	O
,	O
and	O
Clostridium	O
perfringens	O
[	O
101	O
]	O
.	O

Moreover	O
,	O
several	O
genes	O
induced	O
at	O
lower	O
temperature	O
such	O
as	O
inv	S-Biological_Molecule
,	O
yst	S-Biological_Molecule
or	O
yplA	S-Biological_Molecule
affect	O
the	O
virulence	O
properties	O
of	O
Y	O
.	O
enterocolitica	O
in	O
mice	O
[	O
87	O
]	O
.	O

However	O
,	O
low	O
temperature	O
-	O
dependent	O
expression	O
of	O
the	O
genes	O
in	O
Table	O
1	O
suggests	O
that	O
they	O
also	O
play	O
a	O
role	O
during	O
the	O
insect	O
stage	O
of	O
Y	O
.	O
enterocolitica	O
,	O
or	O
that	O
they	O
have	O
evolved	O
from	O
bacteria	O
-	O
insect	O
interaction	O
and	O
then	O
adapted	O
to	O
pathogenicity	O
towards	O
mammals	O
.	O

It	O
was	O
assumed	O
that	O
there	O
are	O
parallels	O
in	O
the	O
regulation	O
of	O
pathogenicity	O
in	O
mammals	O
and	O
insect	O
pathogens	O
[	O
41	O
,	O
123	O
]	O
.	O

Moreover	O
,	O
P	O
.	O
luminescens	O
is	O
pathogenic	O
to	O
a	O
variety	O
of	O
insect	O
larvae	O
,	O
and	O
a	O
dose	O
of	O
<	O
5	O
colony	O
-	O
forming	O
units	O
directly	O
injected	O
into	O
the	O
blood	O
system	O
is	O
sufficient	O
to	O
kill	O
within	O
48	O
-	O
72	O
h	O
[	O
124	O
]	O
.	O

One	O
such	O
mechanism	O
is	O
based	O
upon	O
modification	O
of	O
phospholipids	O
in	O
the	O
cytoplasmic	O
membrane	O
by	O
introducing	O
a	O
positively	O
charged	O
lysyl	O
group	O
into	O
anionic	O
phosphatidylglycerol	O
by	O
the	O
MprF	S-Biological_Molecule
protein	O
,	O
thereby	O
neutralizing	O
the	O
net	O
charge	O
of	O
the	O
membrane	O
surface	O
[	O
11	O
,	O
12	O
]	O
.	O

Mechanisms	O
involved	O
in	O
the	O
regulation	O
of	O
these	O
resistance	O
factors	O
are	O
not	O
yet	O
well	O
understood	O
in	O
Gram	O
-	O
positive	O
bacteria	O
.	O

Accordingly	O
,	O
the	O
WT	O
and	O
complemented	O
mutant	O
strains	O
showed	O
no	O
significant	O
decrease	O
in	O
CFU	O
following	O
LL	B-Biological_Molecule
-	I-Biological_Molecule
37	E-Biological_Molecule
exposure	O
,	O
whereas	O
the	O
number	O
of	O
graRS	S-Biological_Molecule
mutant	O
bacteria	O
recovered	O
was	O
only	O
25	O
%	O
of	O
the	O
original	O
inoculum	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

Introduction	O

The	O
strains	O
of	O
emm1	S-Biological_Molecule
genotype	O
,	O
among	O
more	O
than	O
100	O
emm	S-Biological_Molecule
genes	O
encoding	O
the	O
serotype	O
-	O
determinant	O
M	B-Biological_Molecule
protein	E-Biological_Molecule
,	O
are	O
the	O
predominant	O
cause	O
of	O
severe	O
GAS	O
infections	O
in	O
Japan	O
[	O
7	O
]	O
.	O

These	O
findings	O
led	O
us	O
to	O
postulate	O
that	O
invasive	O
GAS	O
infections	O
hampered	O
host	O
innate	O
immune	O
defense	O
,	O
especially	O
on	O
PMN	O
,	O
providing	O
the	O
front	O
-	O
line	O
defense	O
against	O
GAS	O
infection	O
by	O
quick	O
recruitment	O
to	O
infection	O
site	O
and	O
clearance	O
of	O
bacteria	O
following	O
phagocytosis	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
.	O

However	O
,	O
restricted	O
availability	O
of	O
clinical	O
isolates	O
with	O
the	O
same	O
serotypes	O
fail	O
to	O
elucidate	O
direct	O
relationship	O
between	O
definitive	O
genetic	O
changes	O
in	O
clinically	O
isolated	O
severe	O
invasive	O
GAS	O
and	O
the	O
lack	O
of	O
PMN	O
at	O
the	O
site	O
of	O
bacterial	O
growth	O
.	O

As	O
non	O
-	O
opsonized	O
GAS	O
was	O
resistant	O
to	O
the	O
phagocytosis	O
by	O
PMN	O
[	O
14	O
]	O
,	O
we	O
opsonized	O
GAS	O
with	O
human	O
plasma	O
in	O
advance	O
to	O
the	O
assay	O
.	O

However	O
,	O
as	O
shown	O
in	O
Figure	O
1B	O
,	O
in	O
vitro	O
killing	O
assay	O
revealed	O
that	O
PMN	O
killed	O
non	O
-	O
invasive	O
GAS	O
,	O
resulting	O
in	O
15	O
-	O
42	O
%	O
of	O
initial	O
number	O
of	O
bacteria	O
,	O
but	O
not	O
invasive	O
GAS	O
(	O
p	O
=	O
0	O
.	O
019	O
)	O
.	O

In	O
an	O
acute	O
bacterial	O
infection	O
,	O
PMN	O
were	O
quickly	O
recruited	O
at	O
the	O
site	O
of	O
infectious	O
foci	O
according	O
to	O
the	O
gradient	O
of	O
chemoattractants	O
.	O

As	O
shown	O
in	O
Figure	O
2A	O
and	O
2B	O
,	O
a	O
substantial	O
number	O
of	O
PMN	O
,	O
consisted	O
largely	O
of	O
viable	O
cells	O
,	O
was	O
detected	O
in	O
the	O
lower	O
wells	O
consisted	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
and	O
non	O
-	O
invasive	O
GAS	O
,	O
as	O
a	O
control	O
.	O

To	O
confirm	O
that	O
SLO	S-Biological_Molecule
activity	O
is	O
increased	O
in	O
invasive	O
GAS	O
strain	O
,	O
we	O
measured	O
SLO	S-Biological_Molecule
hemolytic	O
activity	O
of	O
GAS	O
strains	O
used	O
in	O
this	O
study	O
.	O

However	O
,	O
as	O
shown	O
in	O
Figure	O
5B	O
,	O
the	O
csrS	S-Biological_Molecule
genes	O
of	O
all	O
clinically	O
isolated	O
severe	O
invasive	O
GAS	O
had	O
a	O
deletion	O
,	O
a	O
point	O
mutation	O
,	O
or	O
an	O
insertion	O
,	O
thereby	O
,	O
resulting	O
in	O
the	O
creation	O
of	O
translational	O
stop	O
codons	O
(	O
NIH147	O
,	O
NIH226	O
,	O
NIH230	O
,	O
and	O
NIH269	O
)	O
or	O
in	O
a	O
mutation	O
in	O
the	O
presumed	O
kinase	O
domain	O
(	O
NIH200	O
)	O
.	O

Extracellular	B-Biological_Molecule
deoxyribonuclease	E-Biological_Molecule
(	O
DNase	S-Biological_Molecule
)	O
is	O
a	O
virulence	O
factor	O
that	O
protects	O
emm1	S-Biological_Molecule
type	O
GAS	O
against	O
neutrophil	O
killing	O
by	O
degrading	O
the	O
DNA	O
framework	O
of	O
neutrophil	O
extracelluar	O
traps	O
(	O
NETs	O
)	O
[	O
25	O
]	O
,	O
[	O
26	O
]	O
.	O

PMN	O
-	O
binding	O
GAS	O
may	O
make	O
a	O
small	O
interface	O
containing	O
a	O
high	O
concentration	O
of	O
SLO	S-Biological_Molecule
between	O
bacteria	O
and	O
PMN	O
,	O
which	O
resembles	O
to	O
killing	O
mechanism	O
of	O
killer	O
cells	O
to	O
target	O
cells	O
[	O
30	O
]	O
.	O

Consistently	O
,	O
the	O
high	O
mortality	O
and	O
histopathological	O
findings	O
which	O
lacks	O
PMN	O
infiltration	O
in	O
mice	O
tissues	O
infected	O
with	O
csrS	S-Biological_Molecule
-	O
mutated	O
GAS	O
(	O
Figure	O
7	O
)	O
are	O
similar	O
to	O
those	O
seen	O
in	O
clinical	O
invasive	O
GAS	O
infections	O
[	O
32	O
]	O
.	O

Thus	O
,	O
these	O
results	O
suggest	O
that	O
the	O
ability	O
of	O
incompetence	O
for	O
PMN	O
functions	O
by	O
individual	O
GAS	O
strain	O
may	O
determine	O
the	O
induction	O
and	O
clinical	O
outcome	O
of	O
invasive	O
diseases	O
.	O

To	O
date	O
,	O
extracellular	O
DNA	O
has	O
been	O
shown	O
to	O
function	O
as	O
a	O
structural	O
support	O
to	O
maintain	O
Pseudomonas	O
aeruginosa	O
biofilm	O
architecture	O
.	O

Thus	O
,	O
the	O
presence	O
of	O
extracellular	O
DNA	O
in	O
the	O
biofilm	O
matrix	O
contributes	O
to	O
cation	O
gradients	O
,	O
genomic	O
DNA	O
release	O
and	O
inducible	O
antibiotic	O
resistance	O
.	O

Although	O
the	O
basis	O
of	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
is	O
not	O
fully	O
understood	O
,	O
it	O
is	O
likely	O
that	O
multiple	O
mechanisms	O
operate	O
simultaneously	O
in	O
biofilms	O
to	O
contribute	O
to	O
antibiotic	O
resistance	O
.	O

Other	O
resistance	O
mechanisms	O
include	O
the	O
presence	O
of	O
subpopulations	O
of	O
multidrug	O
tolerant	O
persister	O
cells	O
[	O
27	O
]	O
-	O
[	O
29	O
]	O
,	O
drug	O
indifference	O
of	O
slow	O
-	O
growing	O
,	O
nutrient	O
-	O
limited	O
cells	O
[	O
30	O
]	O
,	O
and	O
unique	O
resistance	O
mechanisms	O
specifically	O
associated	O
with	O
biofilms	O
[	O
31	O
]	O
,	O
[	O
32	O
]	O
.	O

The	O
extracellular	O
matrix	O
of	O
P	O
.	O
aeruginosa	O
biofilms	O
includes	O
extracellular	O
DNA	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
,	O
multiple	O
bacterial	O
exopolysaccharides	O
and	O
host	O
proteins	O
[	O
4	O
]	O
,	O
[	O
52	O
]	O
.	O

Genomic	O
DNA	O
has	O
been	O
shown	O
to	O
localize	O
to	O
the	O
biofilm	O
surface	O
,	O
surrounding	O
the	O
mushroom	O
-	O
shaped	O
microcolonies	O
[	O
51	O
]	O
.	O

DNA	O
has	O
cation	O
chelating	O
activity	O

PA3553	S-Biological_Molecule
:	O
:	O
lux	S-Biological_Molecule
expression	O
was	O
strongly	O
induced	O
(	O
up	O
to	O
10	O
-	O
fold	O
)	O
by	O
sub	O
-	O
inhibitory	O
concentrations	O
of	O
low	O
molecular	O
weight	O
salmon	O
sperm	O
DNA	O
(	O
Fig	O
4A	O
)	O
.	O

P	O
.	O
aeruginosa	O
genomic	O
DNA	O
inhibited	O
growth	O
at	O
similar	O
concentrations	O
as	O
salmon	O
sperm	O
DNA	O
.	O

Double	O
staining	O
of	O
P	O
.	O
aeruginosa	O
with	O
syto9	O
(	O
stains	O
viable	O
cells	O
green	O
)	O
and	O
the	O
extracellular	O
DNA	O
stain	O
DDAO	O
(	O
red	O
)	O
[	O
51	O
]	O
was	O
used	O
to	O
visualize	O
DNA	O
as	O
a	O
loose	O
lattice	O
in	O
biofilms	O
formed	O
on	O
polystyrene	O
pegs	O
after	O
24	O
h	O
(	O
Fig	O
5A	O
)	O
.	O

These	O
localization	O
patterns	O
of	O
extracellular	O
DNA	O
are	O
suggestive	O
of	O
DNA	O
gradients	O
within	O
biofilms	O
.	O

Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
P	O
.	O
aeruginosa	O
can	O
sense	O
the	O
presence	O
of	O
Mg2	O
+	O
,	O
Ca2	O
+	O
or	O
Mn2	O
+	O
and	O
that	O
chelation	O
of	O
these	O
same	O
cations	O
by	O
DNA	O
results	O
in	O
induction	O
of	O
the	O
PA3552	S-Biological_Molecule
-	O
PA3559	S-Biological_Molecule
LPS	O
modification	O
operon	O
.	O

Biofilms	O
were	O
cultivated	O
on	O
96	O
-	O
well	O
format	O
,	O
polystyrene	O
pegs	O
submerged	O
in	O
BM2	O
defined	O
media	O
,	O
with	O
or	O
without	O
sub	O
-	O
inhibitory	O
concentrations	O
of	O
extracellular	O
DNA	O
(	O
0	O
.	O
75	O
%	O
(	O
w	O
/	O
v	O
)	O
)	O
,	O
and	O
challenged	O
with	O
antibiotics	O
.	O

The	O
CAP	O
resistance	O
phenotype	O
of	O
biofilms	O
grown	O
in	O
limiting	O
magnesium	O
(	O
20	O
microM	O
)	O
was	O
similar	O
to	O
biofilms	O
grown	O
in	O
DNA	O
,	O
confirming	O
that	O
DNA	O
imposes	O
a	O
magnesium	O
limitation	O
stress	O
(	O
Table	O
2	O
)	O
.	O

We	O
have	O
identified	O
a	O
novel	O
mechanism	O
of	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
in	O
which	O
the	O
presence	O
of	O
DNA	O
in	O
the	O
extracellular	O
matrix	O
of	O
biofilms	O
creates	O
a	O
localized	O
cation	O
-	O
limited	O
environment	O
that	O
is	O
detected	O
by	O
P	O
.	O
aeruginosa	O
leading	O
to	O
the	O
induction	O
of	O
LPS	O
modification	O
genes	O
and	O
resistance	O
to	O
antimicrobials	O
.	O

It	O
is	O
also	O
known	O
that	O
CF	O
airway	O
fluid	O
contains	O
high	O
levels	O
of	O
neutrophil	O
defensins	O
[	O
77	O
]	O
and	O
that	O
sub	O
-	O
lethal	O
doses	O
of	O
CAPs	O
induce	O
PA3553	S-Biological_Molecule
gene	O
expression	O
,	O
although	O
independently	O
of	O
PhoPQ	S-Biological_Molecule
and	O
PmrAB	S-Biological_Molecule
[	O
45	O
]	O
.	O

The	O
two	O
-	O
component	O
regulatory	O
system	O
VicRK	S-Biological_Molecule
or	O
YycFG	S-Biological_Molecule
is	O
specific	O
for	O
Gram	O
-	O
positive	O
bacteria	O
.	O

It	O
is	O
believed	O
that	O
the	O
immunity	O
is	O
mediated	O
by	O
mucosal	O
antibodies	O
specific	O
to	O
SeM	S-Biological_Molecule
and	O
other	O
protective	O
antigens	O
.	O

Three	O
putative	O
DeltavicK	S-Biological_Molecule
strains	O
,	O
which	O
were	O
spectinomycin	O
-	O
resistant	O
and	O
chloramphenicol	O
-	O
sensitive	O
,	O
were	O
obtained	O
.	O

The	O
growth	O
factors	O
,	O
the	O
ratio	O
of	O
cfu	O
in	O
the	O
sample	O
at	O
4	O
h	O
over	O
cfu	O
at	O
time	O
zero	O
,	O
were	O
250	O
and	O
66	O
for	O
the	O
wild	O
type	O
and	O
DeltavicK	S-Biological_Molecule
strains	O
,	O
respectively	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

Thus	O
,	O
the	O
DeltavicK	S-Biological_Molecule
mutant	O
has	O
significantly	O
reduced	O
ability	O
to	O
grow	O
in	O
rabbit	O
blood	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
.	O

Group	O
of	O
8	O
mice	O
were	O
subcutaneously	O
inoculated	O
with	O
1	O
.	O
1	O
x	O
108	O
cfu	O
wild	O
-	O
type	O
or	O
DeltavicK	S-Biological_Molecule
mutant	O
strains	O
.	O

Seven	O
of	O
the	O
8	O
mice	O
infected	O
with	O
the	O
wild	O
-	O
type	O
S	O
.	O
equi	O
strain	O
died	O
,	O
whereas	O
7	O
of	O
the	O
8	O
mice	O
inoculated	O
with	O
DeltavicK	S-Biological_Molecule
survived	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

Similarly	O
,	O
these	O
4	O
mice	O
with	O
higher	O
IgA	S-Biological_Molecule
levels	O
also	O
had	O
higher	O
levels	O
of	O
SeM	S-Biological_Molecule
-	O
specific	O
systemic	O
IgG	S-Biological_Molecule
(	O
Fig	O
.	O
5B	O
)	O
.	O

S	O
.	O
equi	O
DeltavicK	S-Biological_Molecule
mutant	O
does	O
not	O
grow	O
as	O
well	O
as	O
the	O
wild	O
-	O
type	O
strain	O
in	O
both	O
THY	O
and	O
blood	O
,	O
suggesting	O
that	O
the	O
vicK	S-Biological_Molecule
deletion	O
causes	O
defect	O
in	O
growth	O
,	O
a	O
plausible	O
reason	O
that	O
likely	O
contributes	O
to	O
the	O
attenuation	O
of	O
S	O
.	O
equi	O
virulence	O
in	O
the	O
mouse	O
infection	O
models	O
.	O

The	O
DeltavicK	S-Biological_Molecule
mutant	O
appears	O
to	O
possess	O
the	O
properties	O
of	O
a	O
potential	O
live	O
vaccine	O
.	O

To	O
cause	O
a	O
systemic	O
infection	O
,	O
Salmonella	O
must	O
respond	O
to	O
many	O
environmental	O
cues	O
during	O
mouse	O
infection	O
and	O
express	O
specific	O
subsets	O
of	O
genes	O
in	O
a	O
temporal	O
and	O
spatial	O
manner	O
,	O
but	O
the	O
regulatory	O
pathways	O
are	O
poorly	O
established	O
.	O

These	O
results	O
,	O
as	O
well	O
as	O
publicly	O
available	O
transcriptional	O
profiles	O
,	O
were	O
analyzed	O
using	O
both	O
network	O
inference	O
and	O
cluster	O
analysis	O
algorithms	O
.	O

We	O
tested	O
the	O
regulatory	O
model	O
by	O
expressing	O
a	O
subset	O
of	O
the	O
regulators	O
in	O
trans	O
and	O
monitoring	O
transcription	O
of	O
7	O
known	O
virulence	O
factors	O
located	O
within	O
Salmonella	O
pathogenicity	O
island	O
2	O
(	O
SPI	O
-	O
2	O
)	O
.	O

In	O
addition	O
to	O
fluid	O
and	O
electrolyte	O
loss	O
,	O
non	O
-	O
typhoidal	O
Salmonella	O
often	O
results	O
in	O
septicemia	O
in	O
children	O
and	O
in	O
HIV	O
infected	O
adults	O
in	O
developing	O
countries	O
with	O
a	O
fatality	O
rate	O
of	O
25	O
%	O
or	O
greater	O
[	O
2	O
]	O
.	O

Secretion	O
can	O
take	O
place	O
from	O
extracellular	O
bacteria	O
that	O
are	O
juxtaposed	O
to	O
the	O
surface	O
of	O
the	O
cell	O
or	O
from	O
intracellular	O
bacteria	O
located	O
in	O
vacuoles	O
.	O

We	O
have	O
used	O
SEBINI	O
(	O
Software	O
Environment	O
for	O
Biological	O
Network	O
Inference	O
;	O
[	O
18	O
]	O
)	O
to	O
directly	O
compare	O
multiple	O
network	O
algorithms	O
.	O

The	O
network	O
inference	O
algorithm	O
that	O
we	O
have	O
used	O
is	O
the	O
context	O
likelihood	O
of	O
relatedness	O
(	O
CLR	O
)	O
to	O
analyze	O
the	O
gene	O
expression	O
profiles	O
[	O
19	O
]	O
.	O

CLR	O
is	O
an	O
extension	O
of	O
the	O
relevance	O
network	O
class	O
of	O
machine	O
learning	O
algorithms	O
[	O
20	O
]	O
and	O
provides	O
the	O
highest	O
precision	O
of	O
several	O
algorithms	O
tested	O
[	O
19	O
]	O
.	O

At	O
a	O
60	O
%	O
true	O
positive	O
rate	O
,	O
CLR	O
identified	O
1	O
,	O
079	O
regulatory	O
interactions	O
in	O
E	O
.	O
coli	O
,	O
of	O
which	O
338	O
were	O
in	O
previously	O
known	O
networks	O
and	O
741	O
were	O
novel	O
predictions	O
(	O
ibid	O
)	O
.	O

Mutations	O
that	O
resulted	O
in	O
either	O
no	O
deaths	O
,	O
one	O
death	O
,	O
or	O
delayed	O
death	O
of	O
infected	O
mice	O
were	O
retested	O
with	O
groups	O
of	O
5	O
mice	O
at	O
the	O
same	O
dose	O
(	O
Figure	O
1A	O
)	O
.	O

BALB	O
/	O
c	O
mice	O
infection	O
to	O
eliminate	O
other	O
regulators	O
required	O
only	O
for	O
gastrointestinal	O
infection	O
or	O
persistence	O
but	O
most	O
of	O
these	O
strains	O
were	O
avirulent	O
in	O
another	O
strain	O
of	O
mice	O
(	O
129X1	O
/	O
SvJ	O
)	O
and	O
by	O
other	O
route	O
(	O
intragastric	O
)	O
of	O
infection	O
(	O
see	O
Table	O
S1	O
)	O
.	O

Therefore	O
the	O
regulators	O
investigated	O
in	O
this	O
study	O
might	O
be	O
considered	O
the	O
most	O
central	O
regulators	O
for	O
virulence	O
.	O

The	O
differences	O
between	O
our	O
results	O
and	O
others	O
are	O
most	O
likely	O
related	O
to	O
the	O
different	O
strains	O
of	O
Salmonella	O
used	O
in	O
the	O
studies	O
[	O
34	O
]	O
.	O

Mutations	O
of	O
himD	S-Biological_Molecule
,	O
rpoE	S-Biological_Molecule
,	O
crp	S-Biological_Molecule
,	O
or	O
hfq	S-Biological_Molecule
drastically	O
reduce	O
the	O
number	O
of	O
viable	O
bacteria	O
that	O
can	O
be	O
recovered	O
from	O
macrophages	O
even	O
at	O
short	O
times	O
(	O
Figure	O
2	O
)	O
.	O

We	O
observed	O
that	O
the	O
results	O
determined	O
by	O
these	O
two	O
methods	O
matched	O
closely	O
(	O
Figure	O
S2	O
)	O
and	O
that	O
the	O
level	O
of	O
transcription	O
of	O
ssaG	S-Biological_Molecule
was	O
highest	O
when	O
Salmonella	O
was	O
grown	O
in	O
minimal	O
acidic	O
media	O
.	O

Because	O
the	O
type	O
III	O
secretion	O
system	O
and	O
associated	O
virulence	O
factors	O
encoded	O
within	O
SPI	O
-	O
2	O
were	O
most	O
highly	O
expressed	O
in	O
acidic	O
minimal	O
media	O
we	O
therefore	O
focused	O
on	O
growth	O
in	O
this	O
media	O
and	O
used	O
qRT	O
-	O
PCR	O
to	O
measure	O
transcript	O
levels	O
.	O

Six	O
promoters	O
have	O
been	O
identified	O
for	O
the	O
type	O
III	O
secretion	O
system	O
encoded	O
within	O
SPI	O
-	O
2	O
(	O
see	O
Figure	O
4	O
;	O
[	O
52	O
]	O
)	O
.	O

We	O
monitored	O
transcription	O
of	O
seven	O
genes	O
within	O
SPI	O
-	O
2	O
,	O
covering	O
each	O
operon	O
at	O
least	O
once	O
,	O
and	O
used	O
gyrB	S-Biological_Molecule
transcript	O
as	O
an	O
internal	O
control	O
.	O

The	O
three	O
exceptions	O
were	O
spvR	S-Biological_Molecule
,	O
fruR	S-Biological_Molecule
,	O
and	O
rpoS	S-Biological_Molecule
.	O

A	O
recent	O
study	O
with	O
E	O
.	O
coli	O
shows	O
that	O
the	O
CLR	O
algorithm	O
was	O
the	O
most	O
accurate	O
in	O
computing	O
the	O
correct	O
network	O
for	O
experimentally	O
verified	O
regulatory	O
interactions	O
[	O
19	O
]	O
.	O

Some	O
of	O
the	O
14	O
regulators	O
in	O
this	O
study	O
have	O
been	O
previously	O
shown	O
to	O
directly	O
regulate	O
ssrA	S-Biological_Molecule
/	O
ssrB	S-Biological_Molecule
;	O
OmpR	S-Biological_Molecule
binding	O
to	O
PssrA	S-Biological_Molecule
/	O
ssrB	S-Biological_Molecule
[	O
60	O
]	O
,	O
[	O
61	O
]	O
;	O
SlyA	S-Biological_Molecule
binding	O
to	O
PssrA	S-Biological_Molecule
[	O
62	O
]	O
;	O
PhoP	S-Biological_Molecule
binding	O
to	O
PssrB	S-Biological_Molecule
[	O
45	O
]	O
.	O

As	O
shown	O
in	O
Figure	O
7D	O
,	O
slyA	S-Biological_Molecule
is	O
capable	O
of	O
activating	O
expression	O
of	O
SPI	O
-	O
2	O
genes	O
independently	O
of	O
ssrB	S-Biological_Molecule
,	O
ompR	S-Biological_Molecule
/	O
envZ	S-Biological_Molecule
,	O
phoP	S-Biological_Molecule
/	O
phoQ	S-Biological_Molecule
,	O
csrA	S-Biological_Molecule
and	O
himD	S-Biological_Molecule
(	O
ihf	S-Biological_Molecule
)	O
,	O
although	O
the	O
effects	O
are	O
not	O
as	O
strong	O
as	O
ssrB	S-Biological_Molecule
.	O

A	O
feedforward	O
loop	O
can	O
act	O
as	O
an	O
electronic	O
"	O
AND	O
-	O
gate	O
"	O
preventing	O
expression	O
except	O
when	O
two	O
or	O
more	O
signals	O
are	O
sensed	O
as	O
we	O
see	O
for	O
slyA	S-Biological_Molecule
(	O
upstream	O
)	O
and	O
ssrB	S-Biological_Molecule
(	O
downstream	O
)	O
;	O
fruR	S-Biological_Molecule
(	O
upstream	O
)	O
and	O
crp	S-Biological_Molecule
(	O
downstream	O
)	O
.	O

Mutations	O
in	O
rpoE	S-Biological_Molecule
,	O
smpB	S-Biological_Molecule
,	O
rpoS	S-Biological_Molecule
,	O
and	O
hfq	S-Biological_Molecule
showed	O
only	O
small	O
decreases	O
in	O
SPI	O
-	O
2	O
gene	O
transcription	O
during	O
growth	O
in	O
minimal	O
acidic	O
media	O
but	O
some	O
of	O
them	O
showed	O
large	O
defects	O
in	O
survival	O
assays	O
performed	O
in	O
murine	O
macrophages	O
.	O

Figure	O
6B	O
shows	O
that	O
there	O
is	O
a	O
close	O
relationship	O
between	O
these	O
two	O
regulators	O
and	O
that	O
they	O
can	O
both	O
affect	O
each	O
other	O
through	O
the	O
ompR	S-Biological_Molecule
/	O
envZ	S-Biological_Molecule
two	O
-	O
component	O
regulator	O
.	O

Similarly	O
SsrB	S-Biological_Molecule
binds	O
upstream	O
of	O
ssrA	S-Biological_Molecule
in	O
a	O
region	O
of	O
the	O
promoter	O
typical	O
of	O
response	O
regulators	O
but	O
has	O
no	O
obvious	O
recognition	O
site	O
and	O
binds	O
within	O
the	O
operons	O
that	O
encode	O
structural	O
components	O
of	O
the	O
type	O
III	O
secretion	O
system	O
[	O
52	O
]	O
,	O
[	O
81	O
]	O
.	O

Four	O
nucleoid	O
-	O
like	O
proteins	O
in	O
enteric	O
bacteria	O
,	O
H	B-Biological_Molecule
-	I-Biological_Molecule
NS	E-Biological_Molecule
,	O
StpA	S-Biological_Molecule
,	O
Hha	S-Biological_Molecule
,	O
and	O
YdgT	S-Biological_Molecule
have	O
a	O
predilection	O
for	O
binding	O
to	O
A	O
+	O
T	O
rich	O
sequences	O
and	O
repress	O
transcription	O
of	O
SPI	O
-	O
2	O
genes	O
(	O
rev	O
.	O
in	O
[	O
14	O
]	O
)	O
.	O

The	O
remaining	O
90	O
%	O
of	O
the	O
infected	O
individuals	O
are	O
asymptomatic	O
,	O
and	O
are	O
generally	O
believed	O
to	O
harbor	O
latent	O
bacilli	O
that	O
can	O
reactivate	O
to	O
cause	O
tuberculous	O
diseases	O
,	O
sometimes	O
decades	O
after	O
the	O
initial	O
infection	O
.	O

An	O
intracellular	O
pathogen	O
,	O
M	O
.	O
tuberculosis	O
must	O
possess	O
a	O
finely	O
tuned	O
signaling	O
network	O
to	O
sense	O
and	O
transduce	O
complex	O
environmental	O
signals	O
,	O
ensuring	O
survival	O
of	O
the	O
bacilli	O
within	O
host	O
cells	O
.	O

Deletion	O
of	O
rv2623	S-Biological_Molecule
is	O
not	O
likely	O
to	O
affect	O
transcription	O
of	O
neighboring	O
genes	O
,	O
given	O
the	O
sequence	O
-	O
confirmed	O
precise	O
excision	O
of	O
the	O
rv2623	S-Biological_Molecule
coding	O
region	O
and	O
the	O
gene	O
organization	O
at	O
the	O
rv2623	S-Biological_Molecule
locus	O
(	O
the	O
downstream	O
rv2624c	S-Biological_Molecule
is	O
transcribed	O
in	O
the	O
direction	O
opposite	O
to	O
that	O
of	O
rv2623	S-Biological_Molecule
)	O
(	O
Figure	O
1B	O
)	O
.	O

Consequently	O
,	O
we	O
examined	O
the	O
virulence	O
of	O
Deltarv2623	S-Biological_Molecule
in	O
the	O
relatively	O
susceptible	O
C3H	O
/	O
HeJ	O
mouse	O
strain	O
[	O
24	O
]	O
.	O

The	O
results	O
showed	O
that	O
the	O
mutant	O
strain	O
was	O
no	O
more	O
susceptible	O
to	O
growth	O
inhibition	O
than	O
was	O
wild	O
type	O
Erdman	O
under	O
all	O
of	O
the	O
stress	O
conditions	O
tested	O
(	O
Figure	O
S2	O
)	O
.	O

We	O
began	O
a	O
biochemical	O
characterization	O
of	O
Rv2623	S-Biological_Molecule
in	O
order	O
to	O
gain	O
insight	O
into	O
the	O
relationship	O
between	O
the	O
molecular	O
structure	O
/	O
function	O
of	O
this	O
USP	O
and	O
it	O
'	O
s	O
growth	O
-	O
regulatory	O
properties	O
.	O

Gel	O
filtration	O
analysis	O
of	O
native	O
His6	O
-	O
Rv2623	S-Biological_Molecule
revealed	O
that	O
the	O
purified	O
protein	O
exists	O
primarily	O
as	O
a	O
single	O
species	O
with	O
an	O
apparent	O
molecular	O
mass	O
of	O
61	O
+	O
/	O
-	O
1	O
kDa	O
;	O
suggesting	O
that	O
Rv2623	S-Biological_Molecule
is	O
a	O
dimer	O
under	O
native	O
conditions	O
(	O
Figure	O
S3	O
)	O
,	O
an	O
observation	O
that	O
was	O
later	O
confirmed	O
using	O
nano	O
electrospray	O
ionization	O
(	O
nano	O
ESI	O
)	O
mass	O
spectrometry	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
crystal	O
structure	O
of	O
M	O
.	O
tuberculosis	O
Rv2623	S-Biological_Molecule
:	O
Dimer	O
assembly	O
and	O
ATP	O
-	O
binding	O
capacity	O

To	O
examine	O
the	O
biochemical	O
mechanisms	O
responsible	O
for	O
Rv2623	S-Biological_Molecule
function	O
,	O
we	O
determined	O
the	O
crystal	O
structure	O
of	O
wild	O
-	O
type	O
Rv2623	S-Biological_Molecule
at	O
a	O
resolution	O
of	O
2	O
.	O
9	O
A	O
.	O

The	O
structure	O
reveals	O
a	O
compact	O
,	O
2	O
-	O
fold	O
symmetric	O
dimer	O
.	O

The	O
growth	O
-	O
regulating	O
property	O
of	O
M	O
.	O
tuberculosis	O
Rv2623	S-Biological_Molecule
is	O
dependent	O
on	O
its	O
ability	O
to	O
bind	O
ATP	O

Furthermore	O
,	O
this	O
growth	O
attenuation	O
is	O
not	O
observed	O
in	O
M	O
.	O
tuberculosis	O
strains	O
overexpressing	O
the	O
G117A	O
or	O
the	O
D15E	O
mutant	O
Rv2623	S-Biological_Molecule
(	O
Figure	O
8B	O
)	O
.	O

However	O
,	O
DosR	S-Biological_Molecule
deficiency	O
has	O
also	O
been	O
reported	O
to	O
have	O
no	O
effect	O
on	O
M	O
.	O
tuberculosis	O
virulence	O
or	O
to	O
lead	O
to	O
an	O
attenuated	O
phenotype	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
.	O

Insufficiency	O
of	O
the	O
chaperone	O
-	O
like	O
alpha	B-Biological_Molecule
-	I-Biological_Molecule
crystallin	E-Biological_Molecule
encoded	O
by	O
M	O
.	O
tuberculosis	O
hspX	S-Biological_Molecule
(	O
acr	S-Biological_Molecule
)	O
has	O
also	O
been	O
shown	O
to	O
be	O
associated	O
with	O
hypervirulence	O
in	O
a	O
BALB	O
/	O
c	O
mouse	O
model	O
of	O
tuberculosis	O
[	O
40	O
]	O
.	O

Results	O
of	O
the	O
complementation	O
studies	O
indicate	O
that	O
the	O
phenotype	O
is	O
Rv2623	S-Biological_Molecule
-	O
specific	O
.	O

The	O
unique	O
nucleotide	O
-	O
binding	O
pocket	O
of	O
this	O
protein	O
family	O
is	O
structurally	O
distinct	O
from	O
those	O
commonly	O
encountered	O
in	O
ATP	O
-	O
binding	O
proteins	O
[	O
26	O
]	O
,	O
[	O
47	O
]	O
,	O
[	O
48	O
]	O
.	O

The	O
latent	O
state	O
allows	O
persistence	O
in	O
infected	O
individuals	O
of	O
tubercle	O
bacilli	O
that	O
can	O
reactivate	O
to	O
cause	O
active	O
disease	O
and	O
to	O
disseminate	O
when	O
the	O
immune	O
status	O
of	O
the	O
host	O
is	O
compromised	O
.	O

Mechanistically	O
,	O
results	O
of	O
the	O
mutagenesis	O
studies	O
have	O
shown	O
that	O
Rv2623	S-Biological_Molecule
regulates	O
growth	O
through	O
ATP	O
-	O
dependent	O
function	O
.	O

A	O
Novel	O
Signaling	O
Network	O
Essential	O
for	O
Regulating	O
Pseudomonas	O
aeruginosa	O
Biofilm	O
Development	O

In	O
addition	O
,	O
P	O
.	O
aeruginosa	O
causes	O
a	O
variety	O
of	O
diseases	O
in	O
individuals	O
predisposed	O
to	O
infections	O
as	O
the	O
result	O
of	O
severe	O
burns	O
,	O
wounds	O
,	O
urinary	O
tract	O
or	O
corneal	O
injury	O
,	O
or	O
immunocompromised	O
status	O
[	O
5	O
]	O
-	O
[	O
8	O
]	O
.	O

RetS	S-Biological_Molecule
belongs	O
to	O
the	O
family	O
of	O
two	O
-	O
component	O
regulatory	O
systems	O
(	O
TCS	O
)	O
which	O
translate	O
external	O
signals	O
into	O
adaptive	O
responses	O
by	O
a	O
variety	O
of	O
mechanisms	O
,	O
including	O
control	O
of	O
gene	O
expression	O
and	O
methylation	O
of	O
target	O
proteins	O
.	O

The	O
formation	O
of	O
biofilms	O
has	O
been	O
proposed	O
to	O
be	O
controlled	O
in	O
response	O
to	O
environmental	O
signals	O
[	O
39	O
]	O
.	O

Additional	O
stage	O
-	O
specific	O
events	O
were	O
detected	O
for	O
biofilms	O
differing	O
in	O
age	O
.	O

In	O
both	O
modes	O
of	O
growth	O
,	O
26	O
proteins	O
were	O
constitutively	O
phosphorylated	O
.	O

This	O
is	O
the	O
first	O
description	O
of	O
the	O
dynamic	O
changes	O
of	O
the	O
phosphoproteome	O
occurring	O
during	O
biofilm	O
development	O
.	O

We	O
thus	O
identified	O
48	O
proteins	O
that	O
were	O
differentially	O
phosphorylated	O
at	O
one	O
or	O
more	O
biofilm	O
developmental	O
stage	O
including	O
elongation	O
factors	O
,	O
ribosomal	O
proteins	O
,	O
several	O
enzymes	O
including	O
reductases	O
and	O
GMP	O
synthase	O
,	O
sigma	O
factor	O
RpoD	S-Biological_Molecule
(	O
Suppl	O
.	O
Table	O
S1	O
)	O
and	O
11	O
regulatory	O
proteins	O
(	O
Table	O
1	O
)	O
.	O

Neither	O
the	O
cognate	O
sensory	O
protein	O
PA5512	S-Biological_Molecule
nor	O
the	O
response	O
regulator	O
PA4196	S-Biological_Molecule
were	O
identified	O
in	O
this	O
study	O
.	O

We	O
therefore	O
analyzed	O
GacS	S-Biological_Molecule
,	O
PA4101	S-Biological_Molecule
,	O
and	O
PA4197	S-Biological_Molecule
mutant	O
biofilm	O
phosphorylation	O
patterns	O
for	O
the	O
presence	O
/	O
absence	O
of	O
these	O
regulators	O
.	O

As	O
differential	O
and	O
sequential	O
phosphorylation	O
of	O
regulatory	O
proteins	O
was	O
detected	O
over	O
the	O
course	O
of	O
P	O
.	O
aeruginosa	O
biofilm	O
development	O
,	O
we	O
asked	O
whether	O
inactivation	O
of	O
these	O
regulatory	O
proteins	O
would	O
alter	O
or	O
affect	O
the	O
stage	O
-	O
specific	O
progression	O
of	O
biofilm	O
formation	O
.	O

Complementation	O
restored	O
biofilm	O
formation	O
to	O
wild	O
type	O
levels	O
(	O
Fig	O
.	O
2C	O
,	O
Table	O
2	O
)	O
.	O

However	O
,	O
when	O
placed	O
in	O
a	O
PAO1	O
background	O
(	O
PAO1	O
/	O
pJN5511	O
)	O
,	O
overexpression	O
of	O
PA5511	S-Biological_Molecule
resulted	O
in	O
biofilms	O
composed	O
of	O
large	O
microcolonies	O
exceeding	O
250	O
microm	O
in	O
diameter	O
(	O
compared	O
to	O
an	O
average	O
cluster	O
diameter	O
of	O
150	O
microm	O
in	O
P	O
.	O
aeruginosa	O
PAO1	O
,	O
Fig	O
.	O
2A	O
,	O
D	O
)	O
.	O

The	O
cognate	O
sensor	O
(	O
MifS	S-Biological_Molecule
,	O
PA5512	S-Biological_Molecule
)	O
is	O
a	O
typical	O
sensor	O
kinase	O
harboring	O
both	O
a	O
His	O
kinase	O
A	O
and	O
a	O
His	O
kinase	O
-	O
like	O
ATPase	O
domain	O
[	O
53	O
]	O
.	O

TCS	O
mutant	O
biofilms	O
are	O
arrested	O
in	O
the	O
transition	O
to	O
later	O
biofilm	O
developmental	O
stages	O

Inactivation	O
of	O
gacS	S-Biological_Molecule
resulted	O
in	O
the	O
formation	O
of	O
biofilms	O
following	O
144	O
hr	O
of	O
growth	O
that	O
were	O
similar	O
in	O
appearance	O
to	O
24	O
-	O
hr	O
-	O
old	O
wild	O
type	O
biofilms	O
.	O

The	O
phosphoproteomes	O
were	O
analyzed	O
using	O
two	O
approaches	O
,	O
(	O
i	O
)	O
immunoblot	O
analysis	O
of	O
whole	O
biofilm	O
cell	O
extracts	O
and	O
(	O
ii	O
)	O
LC	O
-	O
MS	O
/	O
MS	O
analysis	O
in	O
conjunction	O
with	O
cICAT	O
labeling	O
following	O
MOAC	O
purification	O
.	O

In	O
contrast	O
,	O
no	O
reduction	O
of	O
the	O
wild	O
type	O
biofilm	O
architecture	O
was	O
observed	O
(	O
Fig	O
.	O
5	O
,	O
Table	O
3	O
)	O
.	O

Mutation	O
in	O
these	O
regulatory	O
pathways	O
did	O
not	O
affect	O
initial	O
attachment	O
,	O
motility	O
,	O
or	O
Pel	S-Biological_Molecule
and	O
Psl	S-Biological_Molecule
polysaccharide	O
production	O
,	O
but	O
instead	O
arrested	O
biofilm	O
development	O
in	O
the	O
transition	O
from	O
reversible	O
to	O
irreversible	O
attachment	O
[	O
8	O
hr	O
to	O
24	O
hr	O
,	O
BfiRS	S-Biological_Molecule
(	O
PA4196	S-Biological_Molecule
-	O
4197	S-Biological_Molecule
)	O
]	O
,	O
from	O
initial	O
attachment	O
to	O
the	O
maturation	O
-	O
1	O
stage	O
[	O
(	O
24	O
hr	O
to	O
72	O
hr	O
,	O
BfmRS	S-Biological_Molecule
(	O
PA4101	S-Biological_Molecule
-	O
4102	S-Biological_Molecule
)	O
]	O
,	O
and	O
following	O
the	O
maturation	O
-	O
1	O
stage	O
[	O
72	O
hr	O
to	O
144	O
hr	O
,	O
MifRS	S-Biological_Molecule
(	O
PA5511	S-Biological_Molecule
-	O
5512	S-Biological_Molecule
)	O
]	O
(	O
Fig	O
.	O
6	O
)	O
.	O

Thus	O
,	O
it	O
is	O
likely	O
that	O
inactivation	O
of	O
one	O
TCS	O
system	O
(	O
in	O
)	O
directly	O
results	O
in	O
altered	O
or	O
arrested	O
phosphorylation	O
patterns	O
and	O
thus	O
,	O
lack	O
of	O
phosphorylation	O
of	O
downstream	O
TCS	O
systems	O
(	O
as	O
observed	O
here	O
)	O
.	O

MifR	S-Biological_Molecule
homologues	O
harboring	O
a	O
sigma	O
-	O
54	O
binding	O
domain	O
are	O
present	O
in	O
both	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacteria	O
including	O
M	O
.	O
xanthus	O
(	O
Suppl	O
.	O
Table	O
S3	O
)	O
.	O

This	O
family	O
of	O
regulators	O
control	O
transcription	O
from	O
-	O
12	O
,	O
-	O
24	O
promoters	O
recognized	O
by	O
RNA	B-Biological_Molecule
polymerase	E-Biological_Molecule
that	O
utilizes	O
the	O
alternative	O
sigma	O
54	O
factor	O
encoded	O
by	O
rpoN	S-Biological_Molecule
and	O
its	O
analogs	O
.	O

Activation	O
of	O
BfiR	S-Biological_Molecule
coincides	O
with	O
BfiS	S-Biological_Molecule
phosphorylation	O
following	O
8	O
hours	O
of	O
surface	O
attached	O
growth	O
and	O
dephosphorylation	O
of	O
RpoD	S-Biological_Molecule
(	O
Table	O
1	O
)	O
.	O

GacS	S-Biological_Molecule
acts	O
as	O
a	O
suppressor	O
of	O
RetS	S-Biological_Molecule
(	O
and	O
vice	O
versa	O
)	O
with	O
RetS	S-Biological_Molecule
regulating	O
the	O
suppressor	O
activity	O
of	O
the	O
membrane	O
-	O
bound	O
sensor	O
GacS	S-Biological_Molecule
by	O
directly	O
modulating	O
its	O
phosphorylation	O
state	O
[	O
38	O
]	O
.	O

The	O
finding	O
is	O
consistent	O
with	O
our	O
observation	O
of	O
GacS	S-Biological_Molecule
playing	O
a	O
dual	O
role	O
in	O
biofilm	O
formation	O
,	O
with	O
phosphorylation	O
acting	O
as	O
a	O
switch	O
in	O
the	O
function	O
of	O
GacS	S-Biological_Molecule
(	O
Fig	O
.	O
3	O
,	O
Table	O
2	O
)	O
:	O
GacS	S-Biological_Molecule
participates	O
in	O
the	O
planktonic	O
/	O
biofilm	O
switch	O
in	O
its	O
non	O
-	O
phosphorylated	O
state	O
,	O
but	O
limits	O
/	O
regulates	O
the	O
rate	O
of	O
biomass	O
accumulation	O
and	O
biofilm	O
development	O
when	O
phosphorylated	O
.	O

Class	O
II	O
chaperones	O
bind	O
to	O
translocon	O
proteins	O
that	O
make	O
up	O
the	O
secretion	O
pore	O
in	O
the	O
host	O
target	O
membrane	O
and	O
class	O
III	O
chaperones	O
bind	O
the	O
extracellular	O
filament	O
proteins	O
(	O
or	O
flagellin	O
rod	O
in	O
the	O
orthologous	O
flagellar	O
system	O
)	O
that	O
polymerize	O
into	O
a	O
helical	O
structure	O
following	O
secretion	O
from	O
the	O
bacterial	O
cell	O
.	O

Despite	O
being	O
genetically	O
disconnected	O
from	O
SPI	O
-	O
2	O
,	O
SrcA	S-Biological_Molecule
is	O
integrated	O
functionally	O
with	O
this	O
system	O
by	O
binding	O
to	O
the	O
T3SS	O
ATPase	O
,	O
SsaN	S-Biological_Molecule
,	O
and	O
providing	O
chaperone	O
activity	O
towards	O
two	O
important	O
effectors	O
,	O
SseL	S-Biological_Molecule
(	O
STM2287	S-Biological_Molecule
)	O
and	O
PipB2	S-Biological_Molecule
(	O
STM2780	S-Biological_Molecule
)	O
,	O
necessary	O
for	O
immune	O
escape	O
and	O
cell	O
-	O
to	O
-	O
cell	O
transmission	O
.	O

Results	O

The	O
srcA	S-Biological_Molecule
gene	O
is	O
not	O
located	O
in	O
the	O
vicinity	O
of	O
the	O
T3SS	O
encoded	O
by	O
SPI	O
-	O
2	O
(	O
STM1378	S-Biological_Molecule
-	O
STM1425	S-Biological_Molecule
)	O
,	O
but	O
is	O
713	O
genes	O
downstream	O
on	O
the	O
chromosome	O
(	O
STM	O
numbers	O
are	O
based	O
on	O
the	O
LT2	O
genome	O
and	O
ordered	O
sequentially	O
on	O
the	O
chromosome	O
beginning	O
at	O
STM0001	O
,	O
thrL	S-Biological_Molecule
)	O
.	O

In	O
comparative	O
genomics	O
analyses	O
,	O
srcA	S-Biological_Molecule
was	O
found	O
in	O
all	O
virulent	O
strains	O
of	O
Salmonella	O
enterica	O
containing	O
SPI	O
-	O
2	O
,	O
but	O
was	O
absent	O
from	O
the	O
cold	O
-	O
blooded	O
animal	O
commensal	O
,	O
S	O
.	O
bongori	O
,	O
which	O
lacks	O
SPI	O
-	O
2	O
(	O
Table	O
S1	O
)	O
.	O

Sequence	O
analysis	O
showed	O
59	O
%	O
amino	O
acid	O
identity	O
between	O
SrcA	S-Biological_Molecule
and	O
CesT	S-Biological_Molecule
,	O
a	O
secretion	O
chaperone	O
in	O
enteropathogenic	O
E	O
.	O
coli	O
(	O
EPEC	O
)	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

SrcA	S-Biological_Molecule
crystallized	O
in	O
space	O
group	O
C2	O
with	O
two	O
molecules	O
related	O
by	O
a	O
2	O
-	O
fold	O
symmetry	O
axis	O
in	O
each	O
asymmetric	O
unit	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

The	O
larger	O
domain	O
mediates	O
dimerization	O
and	O
is	O
comprised	O
of	O
a	O
twisted	O
anti	O
-	O
parallel	O
beta	O
-	O
sheet	O
(	O
beta1	O
-	O
beta2	O
-	O
beta3	O
-	O
beta5	O
-	O
beta4	O
)	O
flanked	O
by	O
alpha	O
-	O
helices	O
alpha2	O
and	O
alpha3	O
.	O

In	O
SrcA	S-Biological_Molecule
,	O
both	O
extended	O
and	O
closely	O
packed	O
conformations	O
are	O
observed	O
in	O
separate	O
subunits	O
of	O
the	O
same	O
dimer	O
within	O
the	O
asymmetric	O
unit	O
.	O

SsaN	S-Biological_Molecule
contains	O
conserved	O
amino	O
acid	O
residues	O
characteristic	O
of	O
Walker	O
-	O
A	O
and	O
Walker	O
-	O
B	O
motifs	O
of	O
P	O
-	O
loop	O
nucleoside	B-Biological_Molecule
triphosphate	I-Biological_Molecule
hydrolases	E-Biological_Molecule
,	O
as	O
well	O
as	O
a	O
number	O
of	O
residues	O
shown	O
to	O
contribute	O
to	O
ATP	O
binding	O
or	O
ring	O
stacking	O
with	O
the	O
adenine	O
base	O
of	O
ATP	O
in	O
the	O
E	O
.	O
coli	O
orthologue	O
,	O
EscN	S-Biological_Molecule
,	O
(	O
Q412	O
,	O
E191	O
,	O
R366	O
)	O
(	O
Fig	O
.	O
S1	O
)	O
.	O

Peptides	O
originating	O
from	O
wild	O
type	O
cells	O
contained	O
heavy	O
atom	O
-	O
substituted	O
lysine	O
and	O
arginine	O
such	O
that	O
putative	O
SrcA	S-Biological_Molecule
cargo	O
proteins	O
would	O
generate	O
low	O
heavy	O
:	O
light	O
SILAC	O
peptide	O
ratios	O
from	O
the	O
complex	O
mixtures	O
(	O
Fig	O
.	O
5A	O
)	O
.	O

To	O
further	O
show	O
a	O
role	O
for	O
SrcA	S-Biological_Molecule
in	O
chaperoning	O
PipB2	S-Biological_Molecule
,	O
we	O
set	O
up	O
experiments	O
to	O
test	O
whether	O
deleting	O
srcA	S-Biological_Molecule
would	O
phenocopy	O
DeltapipB2	O
cells	O
for	O
PipB2	S-Biological_Molecule
-	O
dependent	O
centrifugal	O
displacement	O
of	O
the	O
Salmonella	O
containing	O
vacuole	O
(	O
SCV	O
)	O
in	O
epithelial	O
cells	O
,	O
an	O
event	O
linked	O
to	O
cell	O
-	O
to	O
-	O
cell	O
transfer	O
during	O
infection	O
in	O
vitro	O
[	O
29	O
]	O
.	O

Typhimurium	O
that	O
is	O
integrated	O
functionally	O
with	O
the	O
T3SS	O
encoded	O
by	O
SPI	O
-	O
2	O
,	O
a	O
system	O
well	O
described	O
for	O
its	O
role	O
in	O
immune	O
subversion	O
and	O
intracellular	O
infection	O
during	O
host	O
colonization	O
.	O

Consistent	O
with	O
other	O
class	O
I	O
secretion	O
chaperones	O
,	O
SrcA	S-Biological_Molecule
has	O
extensive	O
electronegative	O
charge	O
distributed	O
over	O
the	O
surface	O
of	O
the	O
molecule	O
.	O

Thus	O
,	O
it	O
is	O
likely	O
that	O
other	O
surface	O
charged	O
residues	O
of	O
SrcA	S-Biological_Molecule
are	O
involved	O
in	O
these	O
functions	O
or	O
that	O
SrcA	S-Biological_Molecule
targets	O
effector	O
cargo	O
to	O
the	O
secretion	O
apparatus	O
through	O
a	O
mechanism	O
distinct	O
from	O
CesT	S-Biological_Molecule
.	O

The	O
interface	O
for	O
the	O
SrcA	S-Biological_Molecule
homodimer	O
is	O
extensive	O
and	O
is	O
more	O
in	O
keeping	O
with	O
the	O
structural	O
features	O
of	O
single	O
-	O
effector	O
class	O
IA	O
chaperones	O
(	O
approximately1100	O
-	O
1300	O
A2	O
)	O
compared	O
to	O
the	O
reduced	O
dimer	O
interface	O
of	O
Spa15	S-Biological_Molecule
,	O
a	O
multi	O
-	O
cargo	O
class	O
IB	O
chaperone	O
from	O
Shigella	O
[	O
31	O
]	O
.	O

These	O
data	O
suggest	O
that	O
type	O
III	O
chaperones	O
might	O
have	O
an	O
as	O
yet	O
undefined	O
role	O
in	O
assembly	O
of	O
the	O
ATPase	O
homohexamer	O
that	O
gives	O
rise	O
to	O
efficient	O
effector	O
translocation	O
.	O

The	O
expression	O
of	O
srcA	S-Biological_Molecule
is	O
coordinated	O
with	O
T3SS	O
transcriptional	O
activity	O
via	O
the	O
SsrA	S-Biological_Molecule
-	O
SsrB	S-Biological_Molecule
two	O
-	O
component	O
regulatory	O
system	O
encoded	O
in	O
SPI	O
-	O
2	O
.	O

Y	O
.	O
pestis	O
exhibits	O
a	O
distinct	O
life	O
stage	O
in	O
the	O
flea	O
,	O
where	O
it	O
grows	O
in	O
the	O
form	O
of	O
a	O
cohesive	O
biofilm	O
that	O
promotes	O
transmission	O
.	O

Y	O
.	O
pestis	O
from	O
infected	O
fleas	O
were	O
more	O
resistant	O
to	O
phagocytosis	O
by	O
macrophages	O
than	O
in	O
vitro	O
-	O
grown	O
bacteria	O
,	O
in	O
part	O
attributable	O
to	O
a	O
cluster	O
of	O
insecticidal	O
-	O
like	O
toxin	O
genes	O
that	O
were	O
highly	O
expressed	O
only	O
in	O
the	O
flea	O
.	O

One	O
,	O
the	O
yersinia	B-Biological_Molecule
murine	I-Biological_Molecule
toxin	E-Biological_Molecule
(	O
ymt	S-Biological_Molecule
)	O
gene	O
,	O
encodes	O
a	O
phospholipase	B-Biological_Molecule
D	E-Biological_Molecule
that	O
is	O
required	O
for	O
survival	O
in	O
the	O
flea	O
midgut	O
[	O
2	O
]	O
.	O

Notably	O
,	O
several	O
genes	O
with	O
known	O
or	O
predicted	O
roles	O
in	O
protection	O
against	O
the	O
mammalian	O
innate	O
immune	O
system	O
and	O
in	O
pathogenesis	O
were	O
upregulated	O
in	O
the	O
flea	O
,	O
suggesting	O
that	O
transit	O
through	O
the	O
insect	O
vector	O
preinduces	O
a	O
phenotype	O
that	O
enhances	O
Y	O
.	O
pestis	O
survival	O
and	O
dissemination	O
in	O
the	O
mammal	O
after	O
flea	O
-	O
borne	O
transmission	O
.	O

During	O
the	O
first	O
week	O
after	O
being	O
ingested	O
in	O
an	O
infectious	O
blood	O
meal	O
,	O
Y	O
.	O
pestis	O
grows	O
rapidly	O
in	O
the	O
flea	O
midgut	O
to	O
form	O
large	O
bacterial	O
aggregates	O
.	O

Y	O
.	O
pestis	O
KIM6	O
+	O
,	O
which	O
lacks	O
the	O
70	O
-	O
kb	O
virulence	O
plasmid	O
that	O
is	O
not	O
required	O
for	O
flea	O
infection	O
or	O
blockage	O
[	O
3	O
]	O
was	O
used	O
for	O
this	O
analysis	O
.	O

The	O
Y	O
.	O
pestis	O
in	O
vivo	O
biofilm	O
transcriptome	O
was	O
compared	O
to	O
the	O
transcriptomes	O
of	O
in	O
vitro	O
biofilm	O
and	O
planktonic	O
cultures	O
grown	O
at	O
21degreesC	O
,	O
the	O
same	O
temperature	O
at	O
which	O
the	O
fleas	O
were	O
maintained	O
.	O

The	O
central	O
role	O
of	O
the	O
L	O
-	O
glutamate	O
family	O
of	O
amino	O
acids	O
may	O
also	O
confer	O
this	O
advantage	O
in	O
the	O
flea	O
gut	O
,	O
because	O
Glu	O
and	O
Pro	O
are	O
osmoprotectants	O
.	O

In	O
contrast	O
to	O
the	O
amino	O
acids	O
,	O
hexoses	O
do	O
not	O
appear	O
to	O
be	O
an	O
important	O
energy	O
source	O
during	O
infection	O
of	O
the	O
flea	O
.	O

However	O
,	O
Y	O
.	O
pestis	O
is	O
constitutively	O
nonmotile	O
,	O
and	O
synthesis	O
of	O
the	O
Hms	O
-	O
dependent	O
biofilm	O
ECM	O
is	O
regulated	O
post	O
-	O
translationally	O
[	O
26	O
]	O
.	O

The	O
transcriptional	O
profile	O
of	O
Y	O
.	O
pestis	O
in	O
blocked	O
fleas	O
showed	O
greater	O
similarity	O
to	O
the	O
transcriptional	O
profile	O
reported	O
for	O
E	O
.	O
coli	O
in	O
mature	O
,	O
four	O
-	O
day	O
-	O
old	O
in	O
vitro	O
biofilms	O
[	O
23	O
]	O
.	O

The	O
cupA	S-Biological_Molecule
fimbrial	O
locus	O
and	O
tibA	S-Biological_Molecule
are	O
important	O
for	O
surface	O
adherence	O
and	O
for	O
biofilm	O
formation	O
in	O
P	O
.	O
aeruginosa	O
and	O
E	O
.	O
coli	O
,	O
respectively	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
.	O

Because	O
homologs	O
of	O
the	O
yidE	S-Biological_Molecule
,	O
cpxP	S-Biological_Molecule
,	O
tibA	S-Biological_Molecule
(	O
yapL	S-Biological_Molecule
)	O
,	O
cupA	B-Biological_Molecule
fimbriae	E-Biological_Molecule
,	O
and	O
pspABC	S-Biological_Molecule
genes	O
were	O
upregulated	O
in	O
the	O
flea	O
and	O
have	O
been	O
shown	O
to	O
be	O
involved	O
in	O
biofilm	O
formation	O
in	O
other	O
bacteria	O
[	O
23	O
]	O
,	O
[	O
27	O
]	O
,	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
,	O
we	O
made	O
a	O
series	O
of	O
Y	O
.	O
pestis	O
strains	O
containing	O
deletions	O
of	O
these	O
loci	O
.	O

In	O
addition	O
to	O
the	O
known	O
temperature	O
-	O
induced	O
virulence	O
factors	O
,	O
iron	O
acquisition	O
systems	O
,	O
including	O
the	O
ybt	O
and	O
yfe	O
operons	O
that	O
are	O
required	O
for	O
virulence	O
;	O
and	O
oxidative	O
and	O
nitrosative	O
stress	O
response	O
genes	O
,	O
including	O
the	O
hmp	B-Biological_Molecule
virulence	I-Biological_Molecule
factor	E-Biological_Molecule
,	O
are	O
highly	O
upregulated	O
in	O
the	O
rat	O
bubo	O
,	O
but	O
not	O
the	O
flea	O
.	O

Induction	O
of	O
a	O
phagocytosis	O
-	O
resistant	O
phenotype	O
in	O
the	O
flea	O

Bacteria	O
from	O
fleas	O
showed	O
significantly	O
lower	O
levels	O
of	O
phagocytosis	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

These	O
observations	O
,	O
and	O
the	O
fact	O
that	O
the	O
Yersinia	O
Tc	O
proteins	O
have	O
toxicity	O
to	O
certain	O
eukaryotic	O
cell	O
lines	O
in	O
vitro	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
,	O
prompted	O
us	O
to	O
investigate	O
a	O
possible	O
post	O
-	O
transmission	O
antiphagocytic	O
role	O
for	O
these	O
proteins	O
in	O
the	O
mammalian	O
host	O
.	O

Our	O
results	O
indicate	O
that	O
Y	O
.	O
pestis	O
entering	O
the	O
mammal	O
from	O
an	O
infective	O
flea	O
is	O
relatively	O
resistant	O
to	O
macrophages	O
,	O
as	O
well	O
as	O
PMNs	O
[	O
7	O
]	O
;	O
a	O
vector	O
-	O
specific	O
phenotype	O
that	O
is	O
not	O
related	O
to	O
the	O
T3SS	O
or	O
capsule	O
.	O

Coming	O
from	O
the	O
flea	O
,	O
Y	O
.	O
pestis	O
is	O
also	O
associated	O
with	O
the	O
biofilm	O
ECM	O
,	O
identical	O
or	O
closely	O
related	O
to	O
the	O
poly	O
-	O
beta	O
-	O
1	O
,	O
6	O
-	O
N	O
-	O
acetyl	O
glucosamine	O
ECM	O
of	O
staphylococcal	O
biofilms	O
,	O
which	O
has	O
been	O
shown	O
to	O
provide	O
protection	O
from	O
innate	O
immune	O
components	O
[	O
55	O
]	O
,	O
[	O
56	O
]	O
.	O

Transcriptome	O
Analysis	O
of	O
the	O
Brucella	O
abortus	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
Two	O
-	O
Component	O
Regulatory	O
System	O

Although	O
genome	O
sequencing	O
has	O
revealed	O
21	O
putative	O
two	O
-	O
component	O
regulatory	O
systems	O
in	O
the	O
Brucella	O
genus	O
,	O
the	O
best	O
characterized	O
one	O
implicated	O
in	O
virulence	O
is	O
the	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
system	O
.	O

BvrR	S-Biological_Molecule
/	O
bvrS	S-Biological_Molecule
mutants	O
are	O
avirulent	O
in	O
mice	O
,	O
have	O
increased	O
susceptibility	O
to	O
killing	O
by	O
nonimmune	O
serum	O
,	O
show	O
reduced	O
invasiveness	O
to	O
epithelial	O
cells	O
and	O
macrophages	O
,	O
and	O
are	O
incapable	O
of	O
inhibiting	O
lysosome	O
fusion	O
and	O
of	O
intracellular	O
replication	O
[	O
4	O
]	O
.	O

As	O
demonstrated	O
for	O
other	O
two	O
-	O
component	O
systems	O
,	O
multiple	O
genes	O
are	O
expected	O
to	O
be	O
under	O
the	O
control	O
of	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
[	O
1	O
]	O
.	O

Our	O
results	O
link	O
the	O
regulation	O
of	O
carbon	O
and	O
nitrogen	O
metabolism	O
to	O
the	O
expression	O
of	O
cell	O
envelope	O
components	O
and	O
suggest	O
the	O
existence	O
of	O
a	O
complex	O
regulatory	O
network	O
with	O
the	O
interplay	O
of	O
several	O
transcriptional	O
regulators	O
.	O

Results	O
and	O
Discussion	O

Brucella	O
mutants	O
in	O
the	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
two	O
-	O
component	O
regulatory	O
system	O
are	O
pleiotropic	O
[	O
3	O
]	O
-	O
[	O
6	O
]	O
.	O

A	O
change	O
in	O
gene	O
expression	O
was	O
considered	O
both	O
statistically	O
and	O
biologically	O
significant	O
if	O
the	O
p	O
-	O
value	O
was	O
less	O
than	O
0	O
.	O
01	O
.	O

Comparative	O
genome	O
analysis	O
revealed	O
that	O
in	O
addition	O
to	O
the	O
bvrR	S-Biological_Molecule
/	O
bvrS	S-Biological_Molecule
genes	O
,	O
the	O
genome	O
structure	O
around	O
these	O
genes	O
is	O
essentially	O
the	O
same	O
for	O
all	O
the	O
alpha	O
-	O
proteobacteria	O
[	O
5	O
]	O
.	O

Notably	O
,	O
seven	O
transcriptional	O
regulators	O
genes	O
were	O
also	O
differentially	O
expressed	O
in	O
the	O
bvrR	S-Biological_Molecule
mutant	O
compared	O
to	O
parental	O
strain	O
:	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
0237	E-Biological_Molecule
,	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
0891	E-Biological_Molecule
(	O
exoR	S-Biological_Molecule
)	O
,	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
1397	E-Biological_Molecule
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
0118	E-Biological_Molecule
(	O
vjbR	S-Biological_Molecule
)	O
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
0762	E-Biological_Molecule
(	O
ompR	S-Biological_Molecule
)	O
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
1127	E-Biological_Molecule
and	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
1152	E-Biological_Molecule
.	O

As	O
we	O
have	O
show	O
in	O
this	O
study	O
,	O
the	O
expression	O
of	O
at	O
least	O
three	O
flagellar	O
genes	O
(	O
fliM	S-Biological_Molecule
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
0124	I-Biological_Molecule
/	I-Biological_Molecule
5	E-Biological_Molecule
;	O
flgJ	S-Biological_Molecule
,	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
0260	E-Biological_Molecule
;	O
motB	S-Biological_Molecule
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
1103	E-Biological_Molecule
)	O
were	O
increased	O
also	O
in	O
the	O
bvrR	S-Biological_Molecule
mutant	O
(	O
Figure	O
2	O
)	O
.	O

It	O
has	O
been	O
described	O
in	O
S	O
.	O
meliloti	O
that	O
exoR	S-Biological_Molecule
gene	O
encodes	O
a	O
global	O
regulator	O
of	O
transcription	O
and	O
that	O
ExoR	S-Biological_Molecule
interacts	O
genetically	O
with	O
both	O
ExoS	S-Biological_Molecule
and	O
ChvI	S-Biological_Molecule
and	O
inhibits	O
ExoS	S-Biological_Molecule
/	O
ChvI	S-Biological_Molecule
activity	O
[	O
29	O
]	O
,	O
[	O
30	O
]	O
.	O

Virulence	O
and	O
the	O
adaptation	O
to	O
intracellular	O
growth	O

Most	O
of	O
the	O
genes	O
candidate	O
to	O
be	O
regulated	O
by	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
identified	O
in	O
our	O
microarray	O
experiments	O
can	O
be	O
involved	O
with	O
the	O
changes	O
needed	O
for	O
intracellular	O
survival	O
of	O
Brucella	O
.	O

The	O
amount	O
of	O
bacterial	O
RNA	O
was	O
not	O
enough	O
to	O
perform	O
microarray	O
hybridizations	O
.	O

The	O
secreted	O
Mac	S-Biological_Molecule
protein	O
made	O
by	O
group	O
A	O
Streptococcus	O
(	O
GAS	O
)	O
inhibits	O
opsonophagocytosis	O
of	O
GAS	S-Biological_Molecule
by	O
human	O
polymorphonuclear	O
leukocytes	O
(	O
PMNs	O
)	O
.	O

The	O
gene	O
was	O
cloned	O
and	O
recombinant	O
SeMac	S-Biological_Molecule
was	O
overexpressed	O
in	O
Escherichia	O
coli	O
and	O
purified	O
to	O
homogeneity	O
.	O

Horses	O
recovered	O
from	O
strangles	O
acquire	O
immunity	O
against	O
S	O
.	O
equi	O
reinfection	O
[	O
3	O
]	O
.	O

The	O
immunity	O
is	O
primarily	O
mediated	O
by	O
protective	O
antibodies	O
[	O
4	O
]	O
,	O
which	O
opsonize	O
and	O
thus	O
enhance	O
phagocytosis	O
of	O
S	O
.	O
equi	O
by	O
horse	O
PMNs	O
.	O

There	O
are	O
two	O
kinds	O
of	O
Mac	S-Biological_Molecule
produced	O
by	O
GAS	O
isolates	O
[	O
7	O
]	O
,	O
which	O
use	O
different	O
mechanisms	O
to	O
block	O
the	O
interaction	O
between	O
IgG	S-Biological_Molecule
and	O
Fc	B-Biological_Molecule
receptor	E-Biological_Molecule
on	O
the	O
surface	O
of	O
PMNs	O
.	O

No	O
SeMac	S-Biological_Molecule
was	O
detected	O
in	O
all	O
the	O
samples	O
(	O
data	O
not	O
shown	O
)	O
,	O
suggesting	O
that	O
SeMac	S-Biological_Molecule
is	O
not	O
produced	O
in	O
vitro	O
.	O

The	O
results	O
indicate	O
that	O
SeMac	S-Biological_Molecule
is	O
a	O
cysteine	B-Biological_Molecule
endopeptidase	E-Biological_Molecule
,	O
which	O
uses	O
Cys102	O
,	O
His272	O
and	O
Asp294	O
as	O
its	O
catalytic	O
triad	O
to	O
cleave	O
human	O
IgG	S-Biological_Molecule
.	O

SeMac	S-Biological_Molecule
indeed	O
inhibits	O
the	O
opsonophagocytosis	O
of	O
GAS	O
by	O
human	O
PMNs	O
(	O
Fig	O
.	O
5B	O
)	O
.	O

The	O
residues	O
of	O
Cys102	O
and	O
His272	O
are	O
essential	O
and	O
Asp294	O
important	O
for	O
the	O
enzymatic	O
activity	O
of	O
SeMac	S-Biological_Molecule
.	O

Although	O
both	O
SeMac	S-Biological_Molecule
and	O
GAS	O
Mac	S-Biological_Molecule
efficiently	O
cleave	O
human	O
IgG	S-Biological_Molecule
,	O
they	O
cannot	O
cleave	O
the	O
majority	O
of	O
total	O
horse	O
IgG	S-Biological_Molecule
.	O

This	O
suggests	O
that	O
SeMac	S-Biological_Molecule
has	O
other	O
unknown	O
function	O
.	O
Introduction	O

Free	O
-	O
living	O
organisms	O
often	O
encounter	O
wide	O
variations	O
in	O
the	O
pH	O
of	O
their	O
surroundings	O
.	O

While	O
growth	O
in	O
acidic	O
conditions	O
has	O
been	O
shown	O
to	O
promote	O
changes	O
in	O
the	O
gene	O
expression	O
profiles	O
of	O
several	O
bacterial	O
species	O
(	O
Tucker	O
et	O
al	O
.	O
,	O
2002	O
;	O
McGowan	O
et	O
al	O
.	O
,	O
2003	O
;	O
Weinrick	O
et	O
al	O
.	O
,	O
2004	O
;	O
Leaphart	O
et	O
al	O
.	O
,	O
2006	O
)	O
,	O
less	O
is	O
known	O
about	O
the	O
identity	O
of	O
the	O
molecule	O
(	O
s	O
)	O
that	O
sense	O
extracytoplasmic	O
fluctuations	O
in	O
pH	O
and	O
the	O
mechanisms	O
by	O
which	O
such	O
sensors	O
promote	O
changes	O
in	O
gene	O
expression	O
.	O

The	O
expression	O
of	O
these	O
genes	O
has	O
been	O
shown	O
to	O
be	O
dispensable	O
for	O
the	O
acid	O
tolerance	O
response	O
(	O
Bearson	O
et	O
al	O
.	O
,	O
1998	O
)	O
which	O
suggests	O
that	O
there	O
are	O
still	O
uncharacterized	O
cellular	O
function	O
(	O
s	O
)	O
that	O
Salmonella	O
needs	O
to	O
regulate	O
in	O
acidic	O
environments	O
.	O

Results	O

Moreover	O
,	O
a	O
mutant	O
expressing	O
a	O
derivative	O
of	O
the	O
PmrA	S-Biological_Molecule
protein	O
that	O
cannot	O
be	O
phosphorylated	O
due	O
to	O
substitution	O
of	O
the	O
putative	O
phosphorylation	O
residue	O
aspartate	O
51	O
by	O
alanine	O
(	O
Kato	O
and	O
Groisman	O
,	O
2004	O
)	O
completely	O
failed	O
to	O
promote	O
transcription	O
of	O
PmrA	S-Biological_Molecule
-	O
activated	O
genes	O
in	O
response	O
to	O
pH	O
5	O
.	O
8	O
,	O
in	O
a	O
similar	O
fashion	O
to	O
the	O
pmrA	S-Biological_Molecule
strain	O
(	O
A	O
.	O
Kato	O
and	O
E	O
.	O
A	O
.	O
Groisman	O
,	O
unpubl	O
.	O
results	O
)	O
.	O

From	O
these	O
results	O
we	O
conclude	O
that	O
Salmonella	O
harbours	O
a	O
signalling	O
pathway	O
that	O
responds	O
to	O
mild	O
acid	O
pH	O
by	O
activating	O
the	O
PmrA	S-Biological_Molecule
protein	O
through	O
phosphorylation	O
.	O

The	O
acid	O
-	O
promoted	O
expression	O
of	O
the	O
PmrD	S-Biological_Molecule
protein	O
was	O
phoPQ	S-Biological_Molecule
-	O
dependent	O
,	O
which	O
is	O
in	O
agreement	O
with	O
the	O
fact	O
that	O
PhoP	S-Biological_Molecule
is	O
the	O
only	O
known	O
direct	O
transcriptional	O
activator	O
of	O
pmrD	S-Biological_Molecule
(	O
Kox	O
et	O
al	O
.	O
,	O
2000	O
)	O
.	O

While	O
this	O
mutation	O
severely	O
diminished	O
the	O
ability	O
of	O
Salmonella	O
to	O
respond	O
to	O
mild	O
acid	O
pH	O
,	O
there	O
still	O
was	O
some	O
residual	O
pbgP	S-Biological_Molecule
expression	O
(	O
Fig	O
.	O
6B	O
)	O
suggesting	O
that	O
other	O
residues	O
might	O
also	O
be	O
required	O
for	O
pH	O
sensing	O
.	O

For	O
example	O
,	O
the	O
eukaryotic	O
G	O
-	O
protein	O
coupled	O
receptor	O
OGR1	S-Biological_Molecule
is	O
inactive	O
at	O
pH	O
7	O
.	O
8	O
and	O
fully	O
active	O
at	O
pH	O
6	O
.	O
8	O
suggesting	O
that	O
the	O
pH	O
sensing	O
mechanism	O
involves	O
protonation	O
of	O
several	O
extracytoplasmic	O
histidines	O
(	O
Ludwig	O
et	O
al	O
.	O
,	O
2003	O
)	O
,	O
which	O
is	O
in	O
agreement	O
with	O
the	O
pKa	O
of	O
free	O
histidine	O
of	O
approximately6	O
.	O

Finally	O
,	O
while	O
a	O
role	O
for	O
the	O
PmrA	S-Biological_Molecule
-	O
dependent	O
LPS	O
modifications	O
in	O
the	O
previously	O
described	O
acid	O
tolerance	O
response	O
is	O
unlikely	O
because	O
survival	O
to	O
acid	O
stress	O
(	O
pH	O
approximately3	O
)	O
was	O
not	O
reduced	O
in	O
cells	O
deficient	O
in	O
pmrA	S-Biological_Molecule
(	O
data	O
not	O
shown	O
and	O
Bearson	O
et	O
al	O
.	O
,	O
1998	O
)	O
,	O
some	O
of	O
the	O
PmrA	S-Biological_Molecule
-	O
regulated	O
genes	O
to	O
which	O
no	O
function	O
has	O
been	O
ascribed	O
yet	O
could	O
mediate	O
other	O
cellular	O
responses	O
to	O
acid	O
pH	O
.	O

Since	O
Salmonella	O
is	O
acquired	O
usually	O
by	O
oral	O
ingestion	O
of	O
contaminated	O
materials	O
,	O
a	O
key	O
step	O
in	O
the	O
infection	O
process	O
is	O
passage	O
across	O
the	O
intestinal	O
epithelium	O
by	O
invasion	O
of	O
M	O
cells	O
in	O
Peyer	O
'	O
s	O
patches	O
(	O
1	O
)	O
.	O

The	O
effector	O
proteins	O
mediate	O
actin	O
cytoskeleton	O
rearrangement	O
,	O
in	O
the	O
form	O
of	O
large	O
membrane	O
ruffles	O
,	O
which	O
engulf	O
the	O
bacteria	O
into	O
the	O
host	O
cell	O
(	O
4	O
,	O
5	O
)	O
.	O

Using	O
two	O
-	O
hybrid	O
analysis	O
,	O
it	O
has	O
been	O
shown	O
that	O
HilE	S-Biological_Molecule
interacts	O
with	O
HilD	S-Biological_Molecule
,	O
which	O
suggests	O
that	O
HilE	S-Biological_Molecule
represses	O
hilA	S-Biological_Molecule
expression	O
by	O
inhibiting	O
the	O
activity	O
of	O
HilD	S-Biological_Molecule
through	O
a	O
protein	O
-	O
protein	O
interaction	O
(	O
19	O
,	O
20	O
)	O
.	O

SL1344	O
was	O
used	O
as	O
the	O
control	O
strain	O
,	O
and	O
the	O
invasiveness	O
of	O
this	O
strain	O
was	O
arbitrarily	O
set	O
at	O
100	O
%	O
.	O

When	O
the	O
Salmonella	O
bacteria	O
were	O
grown	O
in	O
static	O
cultures	O
to	O
the	O
exponential	O
phase	O
(	O
SPI1	O
-	O
inducing	O
condition	O
)	O
,	O
the	O
invasiveness	O
of	O
SR1304	O
for	O
both	O
epithelial	O
cell	O
lines	O
was	O
reduced	O
by	O
about	O
3	O
-	O
fold	O
,	O
compared	O
to	O
that	O
of	O
SL1344	O
(	O
Figure	O
1A	O
and	O
B	O
)	O
.	O

The	O
expression	O
levels	O
of	O
hilA	S-Biological_Molecule
,	O
invF	S-Biological_Molecule
and	O
hilD	S-Biological_Molecule
,	O
but	O
not	O
of	O
hilC	S-Biological_Molecule
,	O
are	O
decreased	O
in	O
the	O
mlc	S-Biological_Molecule
mutant	O

SR1304	O
exhibited	O
a	O
>	O
10	O
-	O
fold	O
reduction	O
in	O
hilA	S-Biological_Molecule
and	O
HilA	S-Biological_Molecule
-	O
dependent	O
invF	S-Biological_Molecule
(	O
invFA	S-Biological_Molecule
)	O
expression	O
,	O
and	O
about	O
a	O
3	O
-	O
fold	O
reduction	O
in	O
hilD	S-Biological_Molecule
and	O
HilC	S-Biological_Molecule
/	O
D	S-Biological_Molecule
-	O
dependent	O
invF	S-Biological_Molecule
(	O
invFD	S-Biological_Molecule
)	O
expression	O
,	O
compared	O
to	O
SL1344	O
.	O

Baxter	O
et	O
al	O
.	O

To	O
study	O
the	O
effect	O
of	O
Mlc	S-Biological_Molecule
on	O
hilE	S-Biological_Molecule
expression	O
,	O
we	O
measured	O
the	O
expression	O
of	O
hilE	S-Biological_Molecule
-	O
lacZY	S-Biological_Molecule
on	O
the	O
low	O
-	O
copy	O
plasmid	O
pMAB69	O
,	O
which	O
contains	O
the	O
hilE	S-Biological_Molecule
promoter	O
region	O
from	O
-	O
886	O
to	O
+	O
121	O
,	O
relative	O
to	O
the	O
translation	O
start	O
site	O
.	O

The	O
hilE	S-Biological_Molecule
P3	O
promoter	O
is	O
repressed	O
by	O
Mlc	S-Biological_Molecule

Transcription	O
from	O
the	O
P3	O
promoter	O
was	O
increased	O
substantially	O
by	O
mlc	S-Biological_Molecule
mutation	O
(	O
Figure	O
4B	O
,	O
lane	O
2	O
)	O
.	O

The	O
Mlc	S-Biological_Molecule
-	O
His6	O
protein	O
was	O
produced	O
in	O
E	O
.	O
coli	O
and	O
purified	O
to	O
>	O
90	O
%	O
homogeneity	O
by	O
Ni2	O
+	O
affinity	O
chromatography	O
.	O

The	O
activity	O
of	O
the	O
purified	O
Mlc	S-Biological_Molecule
-	O
His6	O
protein	O
was	O
verified	O
with	O
the	O
control	O
gel	O
mobility	O
shift	O
experiment	O
employing	O
the	O
Salmonella	O
ptsG	O
DNA	O
fragment	O
that	O
contains	O
the	O
known	O
Mlc	S-Biological_Molecule
-	O
binding	O
site	O
(	O
data	O
not	O
shown	O
)	O
.	O

When	O
the	O
labeled	O
hilE	S-Biological_Molecule
promoter	O
DNA	O
was	O
incubated	O
with	O
2	O
-	O
fold	O
dilutions	O
of	O
the	O
purified	O
Mlc	S-Biological_Molecule
-	O
His6	O
protein	O
(	O
100	O
-	O
800nM	O
)	O
in	O
the	O
presence	O
of	O
the	O
non	O
-	O
specific	O
DNA	O
competitor	O
poly	O
dI	O
-	O
dC	O
,	O
the	O
concentration	O
-	O
dependent	O
formation	O
of	O
protein	O
-	O
DNA	O
complexes	O
was	O
observed	O
(	O
Figure	O
5A	O
)	O
.	O

Inspection	O
of	O
the	O
DNA	O
sequences	O
at	O
these	O
sites	O
showed	O
high	O
-	O
level	O
homology	O
with	O
the	O
known	O
consensus	O
Mlc	S-Biological_Molecule
-	O
binding	O
sequence	O
,	O
which	O
has	O
the	O
conserved	O
TT	O
-	O
9bp	O
-	O
AA	O
motif	O
and	O
an	O
AT	O
-	O
rich	O
region	O
at	O
positions	O
+	O
/	O
-	O
7	O
to	O
+	O
/	O
-	O
11	O
,	O
showing	O
imperfect	O
dyad	O
symmetry	O
(	O
38	O
)	O
(	O
Figure	O
5C	O
)	O
.	O

It	O
is	O
unusual	O
that	O
the	O
5	O
'	O
-	O
untranslated	O
region	O
(	O
UTR	O
)	O
of	O
mRNA	O
is	O
more	O
than	O
300nt	O
in	O
bacteria	O
(	O
42	O
)	O
.	O

The	O
UTR	O
of	O
the	O
hilA	S-Biological_Molecule
gene	O
is	O
also	O
up	O
to	O
350nt	O
in	O
length	O
,	O
and	O
is	O
suggested	O
to	O
be	O
involved	O
in	O
the	O
complex	O
regulation	O
of	O
hilA	S-Biological_Molecule
in	O
response	O
to	O
environmental	O
signals	O
(	O
8	O
,	O
12	O
)	O
.	O

Therefore	O
,	O
we	O
cannot	O
rule	O
out	O
the	O
possibility	O
that	O
additional	O
cis	O
-	O
or	O
trans	O
-	O
acting	O
regulatory	O
elements	O
,	O
which	O
have	O
not	O
yet	O
been	O
characterized	O
,	O
are	O
involved	O
in	O
hilE	S-Biological_Molecule
expression	O
.	O

The	O
addition	O
of	O
excess	O
glucose	O
to	O
the	O
culture	O
medium	O
results	O
in	O
the	O
reduction	O
of	O
cell	O
association	O
by	O
S	O
.	O

We	O
speculate	O
that	O
the	O
nutrient	O
-	O
rich	O
LB	O
broth	O
may	O
mask	O
the	O
effect	O
of	O
the	O
sugar	O
on	O
hilE	S-Biological_Molecule
expression	O
because	O
the	O
effect	O
of	O
sugar	O
addition	O
on	O
hilA	S-Biological_Molecule
expression	O
was	O
more	O
distinct	O
in	O
DLB	O
than	O
LB	O
(	O
45	O
)	O
.	O

It	O
has	O
been	O
suggested	O
that	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
PhoR	S-Biological_Molecule
-	O
PhoB	S-Biological_Molecule
leads	O
to	O
increased	O
hilE	S-Biological_Molecule
P2	O
expression	O
and	O
subsequent	O
repression	O
of	O
hilA	S-Biological_Molecule
and	O
invasion	O
genes	O
(	O
7	O
,	O
18	O
)	O
.	O

Typhimurium	O
uses	O
bile	O
or	O
SCFAs	O
including	O
acetate	O
,	O
propionate	O
and	O
butyrate	O
,	O
as	O
environmental	O
signals	O
to	O
modulate	O
its	O
invasion	O
of	O
the	O
gastrointestinal	O
tract	O
(	O
50	O
-	O
52	O
)	O
.	O

Further	O
bioinformatics	O
analysis	O
revealed	O
a	O
unique	O
two	O
-	O
component	O
signal	O
transduction	O
system	O
(	O
TCSTS	O
)	O
located	O
in	O
the	O
candidate	O
89K	O
PAI	O
,	O
which	O
is	O
orthologous	O
to	O
the	O
SalK	S-Biological_Molecule
/	O
SalR	S-Biological_Molecule
regulatory	O
system	O
of	O
Streptococcus	O
salivarius	O
.	O

Notably	O
,	O
the	O
average	O
GC	O
content	O
of	O
salKR	S-Biological_Molecule
,	O
29	O
.	O
9	O
%	O
,	O
is	O
much	O
less	O
than	O
that	O
of	O
both	O
89K	O
and	O
the	O
whole	O
genome	O
of	O
05ZYH33	O
(	O
36	O
.	O
8	O
%	O
and	O
41	O
.	O
1	O
%	O
,	O
respectively	O
)	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

The	O
results	O
of	O
bioinformatics	O
analysis	O
indicated	O
that	O
the	O
response	O
regulator	O
,	O
SalR	S-Biological_Molecule
,	O
contains	O
199	O
amino	O
acids	O
(	O
aa	O
)	O
with	O
the	O
three	O
N	O
-	O
terminal	O
invariant	O
aa	O
residues	O
(	O
D30	O
,	O
D54	O
and	O
K107	O
)	O
of	O
the	O
receiver	O
domain	O
of	O
response	O
regulators	O
from	O
Gram	O
-	O
positive	O
bacteria	O
[	O
25	O
]	O
.	O

One	O
candidate	O
mutant	O
in	O
which	O
salKR	S-Biological_Molecule
failed	O
to	O
be	O
amplified	O
was	O
obtained	O
.	O

In	O
wild	O
type	O
strain	O
05ZYH33	O
,	O
the	O
internal	O
fragment	O
of	O
salKR	S-Biological_Molecule
probe	O
hybridized	O
with	O
a	O
single	O
4	O
.	O
0	O
kb	O
Cla	O
I	O
fragment	O
(	O
Fig	O
.	O
3C	O
,	O
lane	O
1	O
)	O
,	O
whereas	O
the	O
SpcR	S-Biological_Molecule
and	O
pUC18	O
probes	O
did	O
not	O
hybridized	O
with	O
the	O
genomic	O
DNA	O
(	O
Fig	O
.	O
3B	O
and	O
3D	O
,	O
lane	O
1	O
)	O
.	O

RT	O
-	O
PCR	O
experiments	O
later	O
also	O
showed	O
that	O
neither	O
salK	S-Biological_Molecule
nor	O
salR	S-Biological_Molecule
could	O
be	O
transcribed	O
in	O
DeltasalKR	S-Biological_Molecule
(	O
data	O
not	O
shown	O
)	O
,	O
which	O
further	O
confirmed	O
that	O
salKR	S-Biological_Molecule
had	O
been	O
deleted	O
from	O
the	O
bacterial	O
chromosome	O
.	O

Given	O
the	O
multiple	O
roles	O
of	O
TCSTS	O
in	O
bacteria	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
salKR	S-Biological_Molecule
deletion	O
on	O
the	O
general	O
biological	O
characteristics	O
of	O
SS2	O
prior	O
to	O
in	O
vivo	O
work	O
.	O

As	O
shown	O
in	O
Figure	O
5	O
,	O
all	O
six	O
SPF	O
-	O
piglets	O
inoculated	O
intravenously	O
with	O
WT	O
developed	O
most	O
of	O
the	O
typical	O
disease	O
symptoms	O
,	O
including	O
high	O
fever	O
,	O
limping	O
,	O
swollen	O
joints	O
,	O
shivering	O
,	O
CNS	O
failure	O
and	O
respiratory	O
failure	O
within	O
24	O
hrs	O
.	O

To	O
gain	O
further	O
insights	O
into	O
the	O
network	O
/	O
circuit	O
mediated	O
by	O
SalK	S-Biological_Molecule
/	O
SalR	S-Biological_Molecule
,	O
whole	O
-	O
genome	O
DNA	O
microarray	O
was	O
applied	O
to	O
reveal	O
the	O
differential	O
transcription	O
profiles	O
between	O
DeltasalKR	S-Biological_Molecule
and	O
WT	O
[	O
13	O
]	O
,	O
[	O
19	O
]	O
.	O

Genes	O
encoding	O
proteins	O
of	O
unknown	O
function	O

Bioinformatics	O
analysis	O
revealed	O
that	O
the	O
GC	O
content	O
of	O
salKR	S-Biological_Molecule
is	O
far	O
less	O
than	O
that	O
of	O
89K	O
island	O
and	O
the	O
whole	O
genome	O
,	O
implying	O
that	O
this	O
TCSTS	O
is	O
of	O
foreign	O
origin	O
which	O
may	O
have	O
been	O
acquired	O
through	O
horizontal	O
gene	O
transfer	O
.	O

Secondly	O
,	O
some	O
of	O
the	O
TCSTSs	O
of	O
S	O
.	O
pneumoniae	O
were	O
suggested	O
to	O
be	O
involved	O
in	O
key	O
processes	O
of	O
pathogenesis	O
,	O
such	O
as	O
autolysis	O
and	O
cell	O
-	O
cell	O
signaling	O
[	O
52	O
]	O
,	O
SalK	S-Biological_Molecule
/	O
SalR	S-Biological_Molecule
might	O
regulate	O
similar	O
processes	O
in	O
Chinese	O
SS2	O
virulent	O
isolates	O
.	O

SsrB	S-Biological_Molecule
-	O
regulated	O
translocated	O
effectors	O
protect	O
S	O
.	O

We	O
tested	O
the	O
hypothesis	O
that	O
RpoE	S-Biological_Molecule
is	O
involved	O
in	O
expression	O
of	O
genes	O
that	O
use	O
the	O
SsrB	S-Biological_Molecule
response	O
regulator	O
for	O
activation	O
.	O

There	O
was	O
no	O
change	O
in	O
the	O
levels	O
of	O
SsrB	S-Biological_Molecule
-	O
FLAG	O
between	O
wild	O
type	O
and	O
DeltarpoE	S-Biological_Molecule
cells	O
(	O
Figure	O
3	O
)	O
,	O
indicating	O
that	O
the	O
effects	O
of	O
RpoE	S-Biological_Molecule
on	O
the	O
four	O
classes	O
of	O
virulence	O
gene	O
promoters	O
examined	O
here	O
was	O
not	O
mediated	O
through	O
changes	O
to	O
SsrB	S-Biological_Molecule
protein	O
levels	O
.	O

We	O
predict	O
that	O
RpoE	S-Biological_Molecule
confers	O
a	O
similar	O
fine	O
-	O
tuning	O
effect	O
on	O
Salmonella	O
virulence	O
gene	O
expression	O
that	O
is	O
required	O
for	O
optimal	O
within	O
-	O
host	O
fitness	O
during	O
infection	O
.	O

Future	O
work	O
will	O
be	O
required	O
to	O
resolve	O
these	O
possibilities	O
.	O

Although	O
when	O
considered	O
individually	O
,	O
each	O
promoter	O
was	O
modestly	O
affected	O
by	O
deletion	O
of	O
rpoE	S-Biological_Molecule
,	O
the	O
cumulative	O
effects	O
of	O
mild	O
rewired	O
inputs	O
on	O
multiple	O
virulence	O
promoters	O
has	O
been	O
shown	O
to	O
severely	O
compromise	O
in	O
-	O
host	O
fitness	O
and	O
virulence	O
ability	O
[	O
25	O
]	O
.	O

Nematodes	O
exposed	O
to	O
PA14	O
grown	O
on	O
nematode	O
growth	O
media	O
(	O
NGM	O
)	O
,	O
succumb	O
to	O
"	O
slow	O
killing	O
"	O
.	O

The	O
TB	O
strain	O
belongs	O
to	O
an	O
abundant	O
clonal	O
complex	O
in	O
the	O
P	O
.	O
aeruginosa	O
population	O
[	O
15	O
]	O
.	O

C	O
.	O
elegans	O
infection	O
using	O
this	O
mutant	O
in	O
the	O
liquid	O
assay	O
resulted	O
in	O
only	O
40	O
%	O
killing	O
at	O
24	O
h	O
,	O
whereas	O
95	O
%	O
killing	O
was	O
observed	O
with	O
the	O
parental	O
PA14	O
strain	O
(	O
data	O
not	O
shown	O
)	O
.	O

A	O
signature	O
tagged	O
mutagenesis	O
(	O
STM	O
)	O
library	O
was	O
previously	O
generated	O
in	O
the	O
virulent	O
P	O
.	O
aeruginosa	O
CF	O
isolate	O
,	O
TB	O
,	O
using	O
the	O
plasposon	O
vector	O
pTnModOGm	O
[	O
20	O
]	O
,	O
[	O
35	O
]	O
.	O

Genomic	O
DNA	O
was	O
recovered	O
from	O
the	O
12	O
group	O
1A	O
isolates	O
.	O

The	O
genes	O
identified	O
are	O
shown	O
in	O
Table	O
1	O
.	O

This	O
vector	O
contains	O
the	O
phiCTX	O
attachment	O
site	O
allowing	O
integration	O
of	O
exogenous	O
DNA	O
fragments	O
at	O
the	O
attB	O
site	O
within	O
the	O
genome	O
of	O
P	O
.	O
aeruginosa	O
.	O

This	O
construct	O
was	O
introduced	O
into	O
the	O
cheB2	S-Biological_Molecule
mutant	O
,	O
TB0173s	O
,	O
generating	O
the	O
TB0173sp2B2	O
strain	O
.	O

We	O
thus	O
investigated	O
the	O
fate	O
of	O
a	O
cheB1	S-Biological_Molecule
mutant	O
in	O
a	O
similar	O
assay	O
.	O

However	O
,	O
the	O
TB1459i	O
strain	O
(	O
cheB1	S-Biological_Molecule
mutant	O
)	O
was	O
no	O
longer	O
able	O
to	O
move	O
towards	O
the	O
attractant	O
,	O
and	O
thus	O
showed	O
a	O
defect	O
in	O
this	O
chemotaxis	O
assay	O
(	O
Figure	O
S4	O
)	O
.	O

Infection	O
with	O
the	O
wild	O
type	O
resulted	O
in	O
50	O
%	O
dead	O
animals	O
(	O
5	O
of	O
10	O
)	O
by	O
day	O
5	O
compared	O
to	O
10	O
%	O
deaths	O
for	O
the	O
TB0173s	O
cheB2	S-Biological_Molecule
mutant	O
(	O
1	O
of	O
10	O
;	O
P	O
=	O
0	O
.	O
036	O
,	O
Fisher	O
'	O
s	O
exact	O
test	O
)	O
.	O

This	O
method	O
was	O
automated	O
using	O
the	O
COPAS	O
Biosort	O
worm	O
sorting	O
system	O
,	O
which	O
greatly	O
reduced	O
the	O
time	O
required	O
to	O
perform	O
the	O
assay	O
.	O

Moreover	O
,	O
it	O
shows	O
more	O
severe	O
motility	O
defect	O
than	O
the	O
cheB2	S-Biological_Molecule
mutant	O
.	O

The	O
bacterial	O
pathogen	O
may	O
lose	O
its	O
ability	O
to	O
perceive	O
its	O
niche	O
due	O
to	O
the	O
absence	O
of	O
chemotaxis	O
[	O
62	O
]	O
.	O

As	O
previously	O
mentioned	O
,	O
even	O
though	O
the	O
cheB2	S-Biological_Molecule
mutant	O
is	O
impaired	O
in	O
motility	O
,	O
it	O
is	O
likely	O
that	O
the	O
cheB2	S-Biological_Molecule
defect	O
in	O
virulence	O
is	O
not	O
linked	O
to	O
this	O
phenotype	O
but	O
to	O
additional	O
traits	O
of	O
virulence	O
and	O
attachment	O
that	O
have	O
not	O
yet	O
been	O
determined	O
.	O

In	O
addition	O
,	O
the	O
Imd	S-Biological_Molecule
pathway	O
plays	O
a	O
predominant	O
role	O
in	O
the	O
regulation	O
of	O
AMPs	O
in	O
the	O
alimentary	O
tract	O
and	O
tracheal	O
epithelia	O
[	O
7	O
]	O
.	O

In	O
addition	O
,	O
the	O
response	O
to	O
non	O
-	O
pathogenic	O
microorganisms	O
does	O
not	O
necessarily	O
reflect	O
a	O
natural	O
host	O
reaction	O
to	O
a	O
real	O
pathogen	O
.	O

Recently	O
we	O
have	O
developed	O
the	O
use	O
of	O
natural	O
oral	O
infection	O
to	O
dissect	O
host	O
responses	O
of	O
Drosophila	O
after	O
challenge	O
with	O
bacteria	O
demonstrated	O
to	O
be	O
infectious	O
for	O
this	O
insect	O
.	O

P	O
.	O
entomophila	O
Secretes	O
an	O
Abundant	O
Protease	O
A	O
common	O
strategy	O
used	O
by	O
bacterial	O
pathogens	O
is	O
to	O
secrete	O
toxins	O
and	O
other	O
virulence	O
factors	O
that	O
damage	O
host	O
tissues	O
.	O

The	O
protein	O
profile	O
for	O
wild	O
-	O
type	O
P	O
.	O
entomophila	O
supernantant	O
(	O
Figure	O
1C	O
,	O
lane	O
2	O
)	O
shows	O
a	O
major	O
protein	O
band	O
at	O
51	O
kDa	O
and	O
several	O
minor	O
bands	O
.	O

To	O
test	O
a	O
possible	O
role	O
of	O
prtR	S-Biological_Molecule
in	O
the	O
regulation	O
of	O
aprA	S-Biological_Molecule
expression	O
,	O
we	O
analyzed	O
the	O
proteins	O
present	O
in	O
the	O
supernatant	O
of	O
prtR	S-Biological_Molecule
mutants	O
.	O

These	O
data	O
confirmed	O
that	O
the	O
protease	O
AprA	S-Biological_Molecule
itself	O
contributes	O
to	O
P	O
.	O
entomophila	O
virulence	O
.	O

Figure	O
4A	O
shows	O
that	O
over	O
-	O
expressing	O
imd	O
12	O
h	O
prior	O
to	O
infection	O
protected	O
flies	O
from	O
a	O
P	O
.	O
entomophila	O
infection	O
,	O
whereas	O
over	O
-	O
expressing	O
imd	O
6	O
h	O
before	O
contributed	O
only	O
modestly	O
to	O
survival	O
of	O
the	O
flies	O
.	O

Local	O
,	O
but	O
Not	O
Systemic	O
Immunity	O
,	O
Contributes	O
to	O
Resistance	O
against	O
Oral	O
Infection	O
with	O
P	O
.	O
entomophila	O

To	O
investigate	O
a	O
possible	O
in	O
vivo	O
role	O
of	O
AprA	S-Biological_Molecule
in	O
the	O
protection	O
against	O
AMPs	O
synthesized	O
in	O
the	O
gut	O
,	O
we	O
compared	O
survival	O
to	O
P	O
.	O
entomophila	O
in	O
imd	S-Biological_Molecule
-	O
deficient	O
flies	O
over	O
-	O
expressing	O
Attacin	B-Biological_Molecule
A	E-Biological_Molecule
or	O
Diptericin	S-Biological_Molecule
ubiquitously	O
under	O
the	O
control	O
of	O
the	O
daughterless	O
Gal4	S-Biological_Molecule
driver	O
(	O
daGal4	S-Biological_Molecule
)	O
using	O
the	O
UAS	O
-	O
Gal4	S-Biological_Molecule
system	O
(	O
referred	O
to	O
as	O
imd	O
;	O
da	O
>	O
AMP	O
,	O
Figure	O
S3B	O
)	O
.	O

Altogether	O
,	O
our	O
results	O
provide	O
an	O
in	O
vivo	O
demonstration	O
that	O
AprA	S-Biological_Molecule
functions	O
in	O
the	O
protection	O
of	O
P	O
.	O
entomophila	O
against	O
Drosophila	O
AMPs	O
.	O

Our	O
analysis	O
reveals	O
that	O
P	O
.	O
entomophila	O
virulence	O
is	O
multi	O
-	O
factorial	O
,	O
as	O
one	O
might	O
expect	O
,	O
but	O
can	O
be	O
decrypted	O
through	O
genetic	O
analysis	O
of	O
the	O
two	O
interacting	O
partners	O
.	O

To	O
explore	O
the	O
potential	O
implication	O
of	O
AMPs	O
in	O
the	O
Imd	S-Biological_Molecule
immune	O
defense	O
against	O
oral	O
infection	O
by	O
P	O
.	O
entomophila	O
,	O
we	O
compared	O
survival	O
of	O
flies	O
expressing	O
only	O
a	O
single	O
AMP	O
.	O

Thus	O
,	O
our	O
approach	O
focusing	O
on	O
both	O
host	O
and	O
pathogen	O
is	O
the	O
first	O
to	O
clearly	O
demonstrate	O
a	O
key	O
role	O
of	O
the	O
AprA	S-Biological_Molecule
metalloprotease	O
in	O
the	O
protection	O
against	O
AMPs	O
in	O
vivo	O
.	O

This	O
conclusion	O
is	O
based	O
on	O
our	O
observations	O
that	O
(	O
i	O
)	O
aprA	S-Biological_Molecule
mutants	O
show	O
attenuated	O
virulence	O
,	O
(	O
ii	O
)	O
aprA	S-Biological_Molecule
mutants	O
survive	O
less	O
well	O
than	O
wild	O
-	O
type	O
P	O
.	O
entomophila	O
in	O
Drosophila	O
and	O
are	O
more	O
sensitive	O
to	O
Imd	S-Biological_Molecule
-	O
mediated	O
defense	O
,	O
and	O
(	O
iii	O
)	O
AprA	S-Biological_Molecule
provides	O
specific	O
protection	O
in	O
vivo	O
against	O
Diptericin	S-Biological_Molecule
.	O

Altogether	O
,	O
our	O
study	O
reveals	O
that	O
local	O
AMP	O
expression	O
plays	O
an	O
important	O
role	O
in	O
defense	O
against	O
oral	O
pathogens	O
and	O
that	O
entomopathogens	O
such	O
as	O
P	O
.	O
entomophila	O
can	O
counteract	O
this	O
effect	O
by	O
expressing	O
aprA	S-Biological_Molecule
.	O

These	O
behaviors	O
are	O
contingent	O
on	O
sophisticated	O
sensory	O
systems	O
that	O
maximize	O
fitness	O
in	O
the	O
complex	O
and	O
highly	O
dynamic	O
environments	O
where	O
physical	O
,	O
chemical	O
,	O
and	O
biological	O
parameters	O
change	O
on	O
many	O
different	O
time	O
scales	O
.	O

Modern	O
genetic	O
and	O
molecular	O
studies	O
have	O
largely	O
focused	O
on	O
a	O
limited	O
repertoire	O
of	O
behaviors	O
of	O
a	O
few	O
model	O
organisms	O
in	O
the	O
non	O
-	O
native	O
context	O
of	O
the	O
laboratory	O
.	O

The	O
identification	O
of	O
the	O
molecular	O
components	O
and	O
their	O
organization	O
into	O
the	O
two	O
dominant	O
modules	O
-	O
the	O
chemotaxis	O
network	O
and	O
the	O
flagellum	O
/	O
basal	O
body	O
/	O
motor	O
system	O
-	O
took	O
the	O
better	O
part	O
of	O
40	O
years	O
and	O
the	O
work	O
of	O
dozens	O
of	O
laboratories	O
.	O

These	O
efforts	O
have	O
culminated	O
in	O
a	O
level	O
of	O
understanding	O
nearly	O
unmatched	O
in	O
any	O
other	O
domain	O
of	O
molecular	O
biology	O
.	O

The	O
comprehensive	O
nature	O
of	O
our	O
methodology	O
is	O
reflected	O
by	O
the	O
identification	O
of	O
nearly	O
all	O
of	O
the	O
known	O
structural	O
and	O
regulatory	O
components	O
of	O
flagellar	O
-	O
mediated	O
chemotaxis	O
.	O

The	O
amplification	O
of	O
transposon	O
insertion	O
sites	O
from	O
a	O
small	O
sample	O
of	O
these	O
mutants	O
showed	O
that	O
the	O
nonmotile	O
phenotype	O
is	O
the	O
result	O
of	O
a	O
single	O
gene	O
disruption	O
in	O
each	O
mutant	O
.	O

To	O
obtain	O
a	O
genome	O
-	O
wide	O
catalog	O
of	O
loci	O
involved	O
in	O
swimming	O
motility	O
,	O
we	O
applied	O
our	O
microarray	O
-	O
based	O
genetic	O
footprinting	O
assay	O
to	O
the	O
population	O
of	O
mutants	O
at	O
the	O
end	O
of	O
the	O
enrichments	O
.	O

Based	O
on	O
the	O
hybridization	O
results	O
,	O
insertional	O
mutations	O
in	O
these	O
genes	O
should	O
not	O
measurably	O
impair	O
motility	O
.	O

Identifying	O
Flagellar	O
Components	O
through	O
Bacteriophage	O
chi	O
Selection	O

Figure	O
2B	O
shows	O
the	O
distribution	O
of	O
z	O
-	O
scores	O
after	O
library	O
selection	O
upon	O
exposure	O
to	O
bacteriophage	O
chi	O
,	O
and	O
the	O
complete	O
microarray	O
results	O
for	O
duplicate	O
selections	O
can	O
be	O
found	O
in	O
Datasets	O
S5	O
and	O
S6	O
.	O

Genetic	O
Basis	O
of	O
Swarming	O
Motility	O

After	O
twenty	O
rounds	O
of	O
daily	O
successive	O
transfers	O
(	O
Figure	O
3A	O
)	O
,	O
more	O
than	O
90	O
%	O
of	O
the	O
population	O
exhibited	O
a	O
defect	O
in	O
swarming	O
(	O
Figure	O
S5	O
)	O
.	O

Interrogation	O
of	O
genes	O
with	O
high	O
z	O
-	O
scores	O
in	O
the	O
enrichment	O
for	O
mutants	O
incapable	O
of	O
swarming	O
identified	O
two	O
additional	O
genes	O
that	O
impact	O
surface	O
motility	O
:	O
hns	S-Biological_Molecule
,	O
encoding	O
a	O
global	O
transcriptional	O
regulator	O
,	O
and	O
yfiR	S-Biological_Molecule
,	O
encoding	O
a	O
predicted	O
periplasmic	O
protein	O
of	O
unknown	O
function	O
.	O

These	O
findings	O
suggested	O
that	O
mutations	O
in	O
LPS	O
and	O
OPG	O
biosynthetic	O
genes	O
may	O
compromise	O
motility	O
.	O

To	O
investigate	O
this	O
possibility	O
,	O
we	O
introduced	O
flhDC	S-Biological_Molecule
-	O
lacZ	S-Biological_Molecule
translational	O
fusions	O
in	O
the	O
deletion	O
strains	O
and	O
performed	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
galactosidase	E-Biological_Molecule
assays	O
.	O

The	O
pathway	O
also	O
includes	O
a	O
recently	O
identified	O
outer	O
membrane	O
lipoprotein	O
(	O
RcsF	S-Biological_Molecule
)	O
that	O
is	O
known	O
to	O
activate	O
the	O
Rcs	O
system	O
[	O
37	O
]	O
.	O

However	O
,	O
since	O
functional	O
flagella	O
are	O
a	O
prerequisite	O
for	O
chi	O
-	O
phage	O
infection	O
,	O
we	O
sought	O
to	O
determine	O
whether	O
defects	O
in	O
LPS	O
and	O
OPG	O
affect	O
chi	O
-	O
phage	O
infection	O
directly	O
or	O
whether	O
the	O
observed	O
selection	O
results	O
are	O
primarily	O
due	O
to	O
reduced	O
flagellar	O
expression	O
.	O

To	O
test	O
whether	O
such	O
a	O
direct	O
role	O
exists	O
,	O
we	O
interrogated	O
our	O
collection	O
of	O
LPS	O
and	O
OPG	O
mutants	O
for	O
swarming	O
proficiency	O
.	O

In	O
a	O
genome	O
-	O
wide	O
effort	O
to	O
identify	O
suppressors	O
of	O
swimming	O
defects	O
,	O
additional	O
libraries	O
of	O
transposon	O
insertional	O
mutants	O
were	O
created	O
in	O
genetic	O
backgrounds	O
containing	O
gene	O
deletions	O
of	O
interest	O
.	O

Further	O
studies	O
are	O
underway	O
to	O
explore	O
the	O
functional	O
relationship	O
between	O
yhjH	S-Biological_Molecule
and	O
these	O
suppressor	O
mutations	O
.	O

It	O
is	O
hypothesized	O
that	O
YcgR	S-Biological_Molecule
undergoes	O
a	O
conformational	O
change	O
upon	O
binding	O
to	O
c	O
-	O
di	O
-	O
GMP	O
,	O
and	O
that	O
the	O
YcgR	S-Biological_Molecule
-	O
c	O
-	O
di	O
-	O
GMP	O
complex	O
impairs	O
motility	O
through	O
a	O
protein	O
-	O
protein	O
interaction	O
with	O
the	O
flagellar	O
motor	O
[	O
57	O
]	O
.	O

Such	O
an	O
interaction	O
may	O
explain	O
the	O
observed	O
rotational	O
bias	O
of	O
flagella	O
in	O
DeltayhjH	S-Biological_Molecule
mutants	O
(	O
Figure	O
6B	O
)	O
and	O
is	O
in	O
agreement	O
with	O
our	O
finding	O
that	O
mutations	O
in	O
ycgR	S-Biological_Molecule
strongly	O
suppress	O
the	O
motility	O
defects	O
of	O
DeltayhjH	S-Biological_Molecule
mutants	O
(	O
Figure	O
6F	O
)	O
.	O

Involvement	O
of	O
Type	O
1	O
Fimbriae	O
in	O
Swimming	O
Motility	O

This	O
observation	O
is	O
confirmed	O
by	O
comparing	O
the	O
motility	O
of	O
the	O
fimS	S-Biological_Molecule
mutant	O
to	O
phase	O
ON	O
fimB	S-Biological_Molecule
-	O
fimE	S-Biological_Molecule
-	O
double	O
mutants	O
(	O
Figure	O
S11B	O
)	O
.	O

We	O
found	O
that	O
swarming	O
was	O
not	O
impaired	O
in	O
either	O
the	O
fimS	S-Biological_Molecule
mutant	O
or	O
the	O
mutants	O
with	O
fimbria	O
locked	O
in	O
phase	O
ON	O
,	O
indicating	O
that	O
fimbria	O
expression	O
does	O
not	O
interfere	O
with	O
swarming	O
motility	O
(	O
Figure	O
S11C	O
)	O
.	O

We	O
focused	O
on	O
inhibition	O
of	O
motility	O
by	O
high	O
osmolarity	O
(	O
0	O
.	O
5	O
M	O
NaCl	O
)	O
,	O
since	O
previous	O
evidence	O
suggested	O
that	O
this	O
environmental	O
condition	O
signals	O
to	O
the	O
flhDC	S-Biological_Molecule
regulatory	O
region	O
[	O
66	O
]	O
.	O

A	O
comparison	O
of	O
two	O
strains	O
of	O
the	O
hospital	O
pathogen	O
Enterococcus	O
faecalis	O
suggests	O
that	O
mediators	O
of	O
virulence	O
differ	O
between	O
strains	O
and	O
that	O
virulence	O
does	O
not	O
depend	O
on	O
mobile	O
gene	O
elements	O

However	O
,	O
many	O
,	O
if	O
not	O
most	O
,	O
strains	O
of	O
these	O
species	O
are	O
harmless	O
commensals	O
,	O
with	O
some	O
enterococci	O
being	O
marketed	O
in	O
Europe	O
to	O
alleviate	O
symptoms	O
of	O
irritable	O
bowel	O
syndrome	O
and	O
recurrent	O
chronic	O
sinusitis	O
or	O
bronchitis	O
(	O
Cylactin	O
(	O
R	O
)	O
and	O
Fargo688	O
(	O
R	O
)	O
(	O
E	O
.	O
faecium	O
)	O
and	O
Symbioflor	O
1	O
(	O
E	O
.	O
faecalis	O
)	O
)	O
.	O

[	O
10	O
]	O
estimated	O
the	O
size	O
of	O
the	O
OG1RF	O
genome	O
as	O
2	O
,	O
825	O
kb	O
and	O
created	O
a	O
restriction	O
map	O
of	O
the	O
chromosome	O
.	O

The	O
lack	O
of	O
resistance	O
to	O
common	O
antibiotics	O
facilitates	O
the	O
selection	O
of	O
plasmids	O
,	O
transposons	O
,	O
and	O
allelic	O
replacement	O
markers	O
introduced	O
into	O
the	O
strain	O
.	O

Also	O
present	O
is	O
Ace	S-Biological_Molecule
,	O
a	O
member	O
of	O
the	O
MSCRAMM	O
(	O
microbial	O
surface	O
component	O
recognizing	O
adhesive	O
matrix	O
molecules	O
)	O
family	O
.	O

The	O
unique	O
regions	O
were	O
then	O
characterized	O
further	O
.	O

The	O
CRISPR	O
(	O
comprised	O
of	O
regularly	O
interspaced	O
short	O
palindromic	O
repeats	O
)	O
loci	O
encoded	O
by	O
some	O
bacterial	O
strains	O
is	O
a	O
recently	O
described	O
system	O
that	O
protects	O
cells	O
from	O
infection	O
with	O
bacteriophage	O
[	O
25	O
-	O
27	O
]	O
.	O

This	O
indicates	O
that	O
the	O
location	O
of	O
the	O
CRISPR1	O
locus	O
appears	O
to	O
be	O
conserved	O
(	O
between	O
EF0672	S-Biological_Molecule
and	O
EF0673	S-Biological_Molecule
when	O
compared	O
with	O
the	O
V583	O
genome	O
)	O
.	O

Loss	O
of	O
the	O
fsr	O
regulatory	O
components	O
results	O
in	O
a	O
gelatinase	O
-	O
negative	O
phenotype	O
under	O
routine	O
test	O
conditions	O
despite	O
the	O
fact	O
that	O
these	O
strains	O
still	O
carry	O
the	O
gelE	S-Biological_Molecule
gene	O
[	O
23	O
,	O
29	O
]	O
.	O

We	O
found	O
two	O
other	O
MSCRAMM	O
proteins	O
that	O
show	O
polymorphisms	O
in	O
the	O
number	O
of	O
their	O
B	O
repeats	O
.	O

OG1RF	B-Biological_Molecule
_	I-Biological_Molecule
0186	E-Biological_Molecule
(	O
corresponding	O
to	O
EF2505	S-Biological_Molecule
of	O
V583	O
)	O
has	O
four	O
repeats	O
compared	O
to	O
seven	O
in	O
V583	O
,	O
and	O
OG1RF	B-Biological_Molecule
_	I-Biological_Molecule
0165	E-Biological_Molecule
(	O
corresponding	O
to	O
EF2224	S-Biological_Molecule
of	O
V583	O
)	O
has	O
eight	O
repeats	O
compared	O
to	O
five	O
in	O
V583	O
.	O

However	O
,	O
because	O
the	O
Symbioflor	O
1	O
genome	O
sequence	O
is	O
not	O
currently	O
available	O
,	O
it	O
was	O
not	O
possible	O
to	O
compare	O
their	O
respective	O
sequences	O
in	O
more	O
detail	O
.	O

OG1RF	B-Biological_Molecule
_	I-Biological_Molecule
0193	E-Biological_Molecule
shares	O
82	O
%	O
similarity	O
with	O
VanRG	S-Biological_Molecule
and	O
81	O
%	O
similarity	O
with	O
VanRG2	S-Biological_Molecule
.	O

Similarly	O
,	O
OG1RF	B-Biological_Molecule
_	I-Biological_Molecule
0192	E-Biological_Molecule
shares	O
68	O
%	O
similarity	O
with	O
VanSG	S-Biological_Molecule
and	O
VanSG2	S-Biological_Molecule
.	O

To	O
investigate	O
whether	O
the	O
iol	O
operon	O
was	O
'	O
inserted	O
into	O
'	O
or	O
'	O
removed	O
from	O
'	O
a	O
putative	O
ancestral	O
strain	O
,	O
the	O
sequences	O
surrounding	O
the	O
iol	O
genes	O
were	O
examined	O
.	O

However	O
,	O
the	O
approximately	O
49	O
kb	O
fragment	O
lacks	O
an	O
excisase	O
gene	O
and	O
the	O
probable	O
lantibiotic	O
ABC	O
transporter	O
genes	O
present	O
in	O
Tn5386	S-Biological_Molecule
.	O

To	O
investigate	O
the	O
possibility	O
that	O
directly	O
or	O
indirectly	O
the	O
com	O
operon	O
might	O
be	O
responsible	O
for	O
this	O
phenotype	O
,	O
we	O
also	O
evaluated	O
transformability	O
by	O
electroporation	O
.	O

When	O
compared	O
with	O
OG1RF	O
,	O
transposon	O
mutants	O
[	O
12	O
]	O
in	O
the	O
OG1RF	O
equivalent	O
of	O
EF2045	S-Biological_Molecule
(	O
encoding	O
the	O
comGB	O
homologue	O
)	O
and	O
in	O
the	O
OG1RF	O
equivalent	O
of	O
EF1986	S-Biological_Molecule
(	O
encoding	O
the	O
comGF	O
homologue	O
)	O
showed	O
similar	O
levels	O
of	O
transformability	O
by	O
electroporation	O
(	O
data	O
not	O
shown	O
)	O
,	O
implying	O
that	O
the	O
difference	O
in	O
electroporation	O
efficiency	O
observed	O
between	O
OG1RF	O
and	O
V583	O
is	O
not	O
related	O
to	O
this	O
locus	O
.	O

[	O
53	O
]	O
compared	O
nine	O
strains	O
,	O
including	O
OG1RF	O
to	O
V583	O
,	O
using	O
comparative	O
genomic	O
hybridization	O
.	O

A	O
Naturally	O
Occurring	O
Mutation	O
in	O
ropB	S-Biological_Molecule
Suppresses	O
SpeB	S-Biological_Molecule
Expression	O
and	O
Reduces	O
M1T1	O
Group	O
A	O
Streptococcal	O
Systemic	O
Virulence	O

This	O
resurgence	O
has	O
been	O
paralleled	O
by	O
the	O
emergence	O
of	O
a	O
globally	O
disseminated	O
GAS	O
cone	O
belonging	O
to	O
serotype	O
M1T1	O
[	O
3	O
]	O
-	O
[	O
5	O
]	O
.	O

In	O
this	O
study	O
we	O
examined	O
the	O
effect	O
of	O
a	O
natural	O
mutation	O
in	O
the	O
gene	O
encoding	O
the	O
regulator	O
RopB	S-Biological_Molecule
(	O
also	O
known	O
as	O
Rgg	S-Biological_Molecule
[	O
22	O
]	O
)	O
identified	O
in	O
a	O
SpeB	S-Biological_Molecule
-	O
negative	O
GAS	O
clinical	O
isolate	O
.	O

While	O
such	O
global	O
differences	O
in	O
virulence	O
effects	O
could	O
in	O
part	O
result	O
from	O
the	O
differing	O
animal	O
models	O
used	O
,	O
it	O
may	O
also	O
reflect	O
strain	O
-	O
specific	O
variation	O
in	O
the	O
RopB	S-Biological_Molecule
regulon	O
.	O

It	O
is	O
in	O
the	O
light	O
of	O
the	O
current	O
uncertainty	O
surrounding	O
RopB	S-Biological_Molecule
and	O
its	O
role	O
in	O
virulence	O
that	O
we	O
sought	O
to	O
investigate	O
the	O
role	O
of	O
this	O
transcriptional	O
regulator	O
in	O
the	O
serotype	O
M1T1	O
GAS	O
background	O
that	O
is	O
the	O
leading	O
agent	O
of	O
severe	O
human	O
infection	O
.	O

Further	O
sequencing	O
was	O
performed	O
on	O
the	O
previously	O
described	O
regulators	O
luxS	S-Biological_Molecule
,	O
rofA	S-Biological_Molecule
,	O
ropA	S-Biological_Molecule
and	O
ropB	S-Biological_Molecule
[	O
24	O
]	O
,	O
[	O
39	O
]	O
-	O
[	O
41	O
]	O
.	O

While	O
the	O
inoculum	O
was	O
100	O
%	O
SpeB	S-Biological_Molecule
-	O
positive	O
,	O
bacterial	O
populations	O
recovered	O
from	O
the	O
lesions	O
of	O
individual	O
mice	O
were	O
found	O
to	O
be	O
2	O
%	O
,	O
4	O
%	O
,	O
6	O
%	O
,	O
8	O
%	O
,	O
and	O
24	O
%	O
SpeB	S-Biological_Molecule
-	O
negative	O
.	O

This	O
finding	O
reveals	O
that	O
when	O
SpeB	S-Biological_Molecule
-	O
negative	O
colonies	O
are	O
selected	O
for	O
in	O
vivo	O
,	O
this	O
selection	O
is	O
predominantly	O
a	O
phenomenon	O
associated	O
with	O
CovR	S-Biological_Molecule
/	O
S	S-Biological_Molecule
inactivation	O
.	O

RopB	S-Biological_Molecule
is	O
required	O
for	O
virulence	O
in	O
systemic	O
infection	O

We	O
have	O
shown	O
that	O
in	O
M1T1	O
GAS	O
,	O
when	O
the	O
covR	S-Biological_Molecule
/	O
S	S-Biological_Molecule
locus	O
is	O
intact	O
and	O
DNase	O
Sda1	S-Biological_Molecule
activity	O
is	O
unaffected	O
,	O
ropB	S-Biological_Molecule
point	O
mutation	O
results	O
in	O
reduced	O
virulence	O
in	O
vivo	O
,	O
despite	O
inactivation	O
of	O
SpeB	S-Biological_Molecule
activity	O
.	O

Restoration	O
of	O
full	O
-	O
length	O
RopB	S-Biological_Molecule
in	O
5628R	O
+	O
resulted	O
in	O
gaining	O
SpeB	S-Biological_Molecule
expression	O
,	O
but	O
did	O
not	O
result	O
in	O
changes	O
in	O
hemolysis	O
,	O
DNase	O
activity	O
or	O
resistance	O
to	O
killing	O
by	O
neutrophils	O
.	O

Global	O
Systems	O
-	O
Level	O
Analysis	O
of	O
Hfq	S-Biological_Molecule
and	O
SmpB	S-Biological_Molecule
Deletion	O
Mutants	O
in	O
Salmonella	O
:	O
Implications	O
for	O
Virulence	O
and	O
Global	O
Protein	O
Translation	O

Samples	O
were	O
analyzed	O
from	O
bacteria	O
grown	O
under	O
four	O
different	O
conditions	O
;	O
two	O
laboratory	O
conditions	O
and	O
two	O
that	O
are	O
thought	O
to	O
mimic	O
the	O
intracellular	O
environment	O
.	O

Post	O
-	O
transcriptional	O
regulation	O
of	O
gene	O
expression	O
by	O
small	O
noncoding	O
RNAs	O
(	O
sRNAs	O
)	O
is	O
widespread	O
in	O
both	O
prokaryotes	O
and	O
eukaryotes	O
and	O
has	O
only	O
recently	O
been	O
recognized	O
as	O
playing	O
a	O
prominent	O
role	O
in	O
the	O
regulation	O
of	O
cellular	O
processes	O
.	O

The	O
RNA	O
-	O
binding	O
protein	O
Hfq	S-Biological_Molecule
was	O
initially	O
shown	O
to	O
be	O
the	O
host	O
factor	O
required	O
for	O
replication	O
of	O
Qbeta	O
RNA	O
bacteriophage	O
[	O
5	O
]	O
and	O
is	O
a	O
member	O
of	O
the	O
Sm	O
protein	O
family	O
of	O
RNA	O
binding	O
proteins	O
that	O
also	O
include	O
eukaryotic	O
proteins	O
required	O
for	O
mRNA	O
splicing	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
.	O

Hfq	S-Biological_Molecule
is	O
a	O
highly	O
conserved	O
protein	O
encoded	O
within	O
many	O
bacterial	O
genomes	O
and	O
at	O
least	O
one	O
archaeon	O
genome	O
[	O
7	O
]	O
,	O
[	O
8	O
]	O
.	O

In	O
bacteria	O
,	O
Hfq	S-Biological_Molecule
functions	O
as	O
a	O
post	O
-	O
transcriptional	O
regulator	O
that	O
modulates	O
the	O
stability	O
and	O
translation	O
of	O
mRNAs	O
chiefly	O
by	O
facilitating	O
sRNA	O
-	O
mRNA	O
interactions	O
[	O
1	O
]	O
,	O
[	O
4	O
]	O
,	O
[	O
9	O
]	O
.	O

tmRNA	S-Biological_Molecule
is	O
found	O
in	O
a	O
wide	O
range	O
of	O
bacteria	O
and	O
in	O
the	O
mitochondria	O
of	O
some	O
eukaryotes	O
and	O
uniquely	O
exhibits	O
properties	O
of	O
both	O
tRNA	O
and	O
mRNA	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
.	O

Recent	O
reports	O
suggest	O
that	O
both	O
Hfq	S-Biological_Molecule
and	O
SmpB	S-Biological_Molecule
play	O
essential	O
roles	O
in	O
bacterial	O
pathogenesis	O
.	O

Identifying	O
what	O
proteins	O
are	O
actually	O
regulated	O
by	O
Hfq	S-Biological_Molecule
and	O
SmpB	S-Biological_Molecule
is	O
an	O
important	O
step	O
in	O
understanding	O
the	O
impact	O
of	O
post	O
-	O
transcriptional	O
gene	O
regulation	O
in	O
Enterobacteria	O
and	O
more	O
specifically	O
how	O
Hfq	S-Biological_Molecule
and	O
SmpB	S-Biological_Molecule
control	O
Salmonella	O
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
/	O
translational	O
level	O
and	O
the	O
role	O
that	O
this	O
may	O
play	O
in	O
Salmonella	O
pathogenesis	O
.	O

To	O
directly	O
assess	O
the	O
role	O
of	O
Hfq	S-Biological_Molecule
and	O
SmpB	S-Biological_Molecule
in	O
Salmonella	O
Typhimurium	O
pathogenesis	O
,	O
BALB	O
/	O
c	O
mice	O
were	O
infected	O
intraperitoneally	O
with	O
200	O
cfu	O
of	O
either	O
Deltahfq	S-Biological_Molecule
mutant	O
strain	O
,	O
DeltasmpB	S-Biological_Molecule
mutant	O
strain	O
or	O
wildtype	O
strain	O
and	O
monitored	O
for	O
21	O
days	O
(	O
Figure	O
1	O
)	O
.	O

Mice	O
infected	O
with	O
wildtype	O
strain	O
exhibited	O
typical	O
symptoms	O
of	O
infection	O
and	O
died	O
at	O
around	O
six	O
days	O
.	O

Considering	O
the	O
reported	O
pleitropic	O
nature	O
of	O
deletion	O
of	O
hfq	S-Biological_Molecule
on	O
the	O
biology	O
of	O
Salmonella	O
Typhimurium	O
it	O
is	O
likely	O
that	O
a	O
proportion	O
of	O
the	O
changes	O
in	O
protein	O
abundances	O
maybe	O
a	O
non	O
-	O
specific	O
and	O
/	O
or	O
secondary	O
consequence	O
of	O
hfq	S-Biological_Molecule
deletion	O
.	O

That	O
is	O
,	O
not	O
every	O
deregulated	O
protein	O
in	O
the	O
hfq	S-Biological_Molecule
mutant	O
strain	O
is	O
necessarily	O
directly	O
regulated	O
by	O
Hfq	S-Biological_Molecule
.	O

The	O
"	O
Cellular	O
Processes	O
"	O
functional	O
category	O
represented	O
the	O
category	O
with	O
most	O
genes	O
impacted	O
by	O
Hfq	S-Biological_Molecule
(	O
approximately63	O
%	O
)	O
.	O

However	O
under	O
SPI	O
-	O
1	O
inducing	O
conditions	O
(	O
LB	O
Log	O
)	O
regulation	O
of	O
SPI	O
-	O
1	O
proteins	O
by	O
Hfq	S-Biological_Molecule
was	O
generally	O
consistent	O
with	O
the	O
literature	O
.	O

The	O
result	O
for	O
hfq	S-Biological_Molecule
transcriptional	O
analysis	O
is	O
in	O
general	O
agreement	O
with	O
previous	O
studies	O
for	O
Salmonella	O
[	O
10	O
]	O
and	O
Pseudomonas	O
aeruginosa	O
[	O
33	O
]	O
where	O
approximately20	O
%	O
and	O
approximately15	O
%	O
of	O
all	O
genes	O
,	O
respectively	O
,	O
were	O
regulated	O
by	O
Hfq	S-Biological_Molecule
,	O
but	O
slightly	O
higher	O
than	O
the	O
number	O
of	O
Hfq	S-Biological_Molecule
-	O
dependent	O
genes	O
reported	O
for	O
E	O
.	O
coli	O
[	O
27	O
]	O
and	O
Vibrio	O
cholerae	O
[	O
21	O
]	O
,	O
approximately6	O
%	O
each	O
.	O

The	O
proteins	O
affected	O
represent	O
a	O
broad	O
spectrum	O
of	O
Salmonella	O
proteins	O
required	O
for	O
many	O
biological	O
processes	O
including	O
general	O
metabolism	O
,	O
the	O
translational	O
machinery	O
,	O
stress	O
response	O
,	O
and	O
virulence	O
-	O
assocaited	O
processes	O
as	O
described	O
next	O
.	O

Other	O
metabolic	O
processes	O
regulated	O
by	O
Hfq	S-Biological_Molecule
include	O
Fatty	O
acid	O
metabolism	O
(	O
FadA	S-Biological_Molecule
,	O
FadB	S-Biological_Molecule
,	O
FabA	S-Biological_Molecule
,	O
FabZ	S-Biological_Molecule
,	O
fbab	S-Biological_Molecule
,	O
AccB	S-Biological_Molecule
,	O
Acs	S-Biological_Molecule
,	O
FabG	S-Biological_Molecule
,	O
FabF	S-Biological_Molecule
,	O
FabI	S-Biological_Molecule
,	O
FabB	S-Biological_Molecule
)	O
;	O
Arginine	O
catabolism	O
(	O
AstABCD	S-Biological_Molecule
)	O
;	O
and	O
Propanoite	O
catabolism	O
(	O
PrpBCDE	S-Biological_Molecule
)	O
.	O

Several	O
ribosomal	O
proteins	O
including	O
RpsM	S-Biological_Molecule
,	O
RpsG	S-Biological_Molecule
,	O
RpmD	S-Biological_Molecule
,	O
and	O
RplN	S-Biological_Molecule
exhibited	O
a	O
marked	O
reduction	O
in	O
both	O
protein	O
and	O
mRNA	O
levels	O
in	O
the	O
Deltahfq	S-Biological_Molecule
mutant	O
strain	O
compared	O
to	O
the	O
wildtype	O
under	O
LB	O
Stat	O
growth	O
condition	O
.	O

The	O
OxyR	S-Biological_Molecule
-	O
regulated	O
gene	O
dps	S-Biological_Molecule
was	O
demonstrated	O
to	O
contribute	O
to	O
Salmonella	O
oxidative	O
stress	O
resistance	O
,	O
survival	O
in	O
macrophages	O
,	O
and	O
virulence	O
in	O
mice	O
[	O
38	O
]	O
.	O

Recent	O
studies	O
have	O
shown	O
the	O
periplasmic	O
Cu	O
,	O
Zn	O
-	O
superoxide	O
dismutase	O
sodC	S-Biological_Molecule
to	O
contribute	O
to	O
Salmonella	O
virulence	O
in	O
mice	O
[	O
39	O
]	O
,	O
[	O
40	O
]	O
.	O

Microarray	O
analysis	O
showed	O
no	O
effect	O
on	O
transcription	O
of	O
these	O
genes	O
.	O

The	O
cob	O
operon	O
is	O
required	O
for	O
the	O
de	O
novo	O
biosynthesis	O
of	O
vitamin	O
B12	O
in	O
Salmonella	O
Typhimurium	O
.	O

Results	O
from	O
our	O
proteomics	O
analysis	O
revealed	O
that	O
Hfq	S-Biological_Molecule
regulates	O
the	O
cob	O
-	O
pdu	O
operon	O
in	O
AMM	O
-	O
2	O
(	O
Figure	O
4A	O
)	O
and	O
stationary	O
phase	O
(	O
Figure	O
4D	O
)	O
growth	O
conditions	O
,	O
with	O
several	O
products	O
of	O
the	O
cob	O
-	O
pdu	O
operon	O
exhibiting	O
increased	O
expression	O
compared	O
to	O
wild	O
type	O
.	O

Among	O
these	O
were	O
PduA	S-Biological_Molecule
,	O
PduB	S-Biological_Molecule
,	O
PduG	S-Biological_Molecule
,	O
PduL	S-Biological_Molecule
,	O
PduM	S-Biological_Molecule
and	O
PduT	S-Biological_Molecule
as	O
well	O
as	O
CobT	S-Biological_Molecule
,	O
CbiH	S-Biological_Molecule
,	O
CbiF	S-Biological_Molecule
,	O
CbiC	S-Biological_Molecule
,	O
and	O
CbiL	S-Biological_Molecule
.	O

From	O
our	O
global	O
proteomics	O
analysis	O
we	O
were	O
able	O
to	O
observe	O
gene	O
products	O
for	O
8	O
of	O
the	O
13	O
conserved	O
RpoS	S-Biological_Molecule
-	O
regulated	O
genes	O
,	O
of	O
which	O
only	O
a	O
single	O
protein	O
,	O
YciF	S-Biological_Molecule
,	O
was	O
regulated	O
by	O
SmpB	S-Biological_Molecule
.	O

In	O
order	O
to	O
accurately	O
characterize	O
global	O
control	O
of	O
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
level	O
it	O
is	O
essential	O
to	O
measure	O
global	O
changes	O
in	O
both	O
transcript	O
and	O
protein	O
levels	O
.	O

Using	O
a	O
sample	O
-	O
matched	O
procedure	O
our	O
strategy	O
simultaneously	O
measures	O
changes	O
in	O
global	O
transcript	O
and	O
protein	O
abundance	O
levels	O
allowing	O
for	O
a	O
clear	O
distinction	O
between	O
the	O
transcriptional	O
and	O
post	O
-	O
transcriptional	O
effects	O
of	O
Hfq	S-Biological_Molecule
or	O
SmpB	S-Biological_Molecule
.	O

The	O
result	O
of	O
this	O
work	O
was	O
very	O
surprising	O
namely	O
that	O
Hfq	S-Biological_Molecule
bound	O
to	O
20	O
%	O
of	O
all	O
Salmonella	O
mRNA	O
transcripts	O
and	O
at	O
least	O
64	O
small	O
RNA	O
molecules	O
.	O

During	O
growth	O
in	O
rich	O
media	O
approximately	O
14	O
%	O
of	O
all	O
proteins	O
observed	O
showed	O
differences	O
in	O
abundance	O
where	O
as	O
in	O
acidic	O
minimal	O
media	O
the	O
result	O
was	O
approximately21	O
%	O
.	O

The	O
published	O
genome	O
sequence	O
of	O
Photorhabdus	O
luminescens	O
TT01	O
strain	O
indicates	O
that	O
virulence	O
genes	O
are	O
encoded	O
within	O
a	O
number	O
of	O
pathogenicity	O
islands	O
located	O
on	O
the	O
bacterial	O
chromosome	O
[	O
4	O
,	O
5	O
]	O
.	O

P	O
.	O
luminescens	O
produces	O
a	O
signaling	O
molecule	O
AI	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
to	O
resist	O
reactive	O
oxygen	O
species	O
[	O
8	O
]	O
and	O
phenylpropanoid	O
chemical	O
ST	O
to	O
inhibit	O
the	O
activity	O
of	O
antimicrobial	O
enzyme	O
PO	O
and	O
formation	O
of	O
melanotic	O
nodules	O
[	O
9	O
]	O
,	O
but	O
the	O
strategy	O
used	O
by	O
X	O
.	O
nematophila	O
appears	O
to	O
be	O
that	O
of	O
suppression	O
of	O
transcripts	O
involved	O
in	O
the	O
insect	O
immune	O
response	O
[	O
10	O
-	O
12	O
]	O
.	O

We	O
used	O
selective	O
capture	O
of	O
transcribed	O
sequences	O
(	O
SCOTS	O
)	O
technique	O
to	O
study	O
in	O
vivo	O
gene	O
expression	O
in	O
Photorhabdus	O
temperata	O
(	O
associated	O
with	O
the	O
nematode	O
Heterorhabditis	O
bacteriophora	O
GPS11	O
)	O
and	O
Xenorhabdus	O
koppenhoeferi	O
(	O
associated	O
with	O
the	O
nematode	O
Steinernema	O
scarabaei	O
AMK001	O
)	O
during	O
infection	O
of	O
the	O
same	O
insect	O
host	O
Rhizotrogus	O
majalis	O
.	O

Isolation	O
of	O
bacterial	O
transcripts	O
induced	O
in	O
Rhizotrogus	O
majalis	O
To	O
isolate	O
bacterial	O
genes	O
induced	O
upon	O
infection	O
,	O
total	O
RNA	O
was	O
isolated	O
from	O
live	O
grubs	O
at	O
24	O
h	O
post	O
injection	O
with	O
P	O
.	O
temperata	O
or	O
X	O
.	O
koppenhoeferi	O
,	O
as	O
well	O
as	O
from	O
48	O
h	O
log	O
-	O
phase	O
bacterial	O
cultures	O
grown	O
in	O
Brain	O
Heart	O
Infusion	O
(	O
BHI	O
)	O
broth	O
that	O
were	O
used	O
to	O
inject	O
R	O
.	O
majalis	O
.	O

The	O
coverage	O
of	O
in	O
vivo	O
enriched	O
libraries	O
was	O
then	O
evaluated	O
using	O
Analytic	O
Rarefaction	O
according	O
to	O
the	O
redundancy	O
of	O
each	O
identical	O
transcript	O
in	O
the	O
sequenced	O
clones	O
.	O

Twenty	O
nine	O
of	O
the	O
40	O
distinct	O
P	O
.	O
temperata	O
transcripts	O
have	O
similar	O
sequences	O
in	O
X	O
.	O
koppenhoeferi	O
genome	O
,	O
thus	O
11	O
were	O
P	O
.	O
temperata	O
specific	O
;	O
30	O
of	O
the	O
39	O
distinct	O
X	O
.	O
koppenhoeferi	O
transcripts	O
share	O
sequence	O
similarity	O
with	O
P	O
.	O
temperata	O
genome	O
,	O
thus	O
9	O
were	O
specific	O
to	O
X	O
.	O
koppenhoeferi	O
(	O
Tables	O
1	O
and	O
2	O
)	O
.	O

As	O
depicted	O
in	O
the	O
conceptual	O
molecular	O
model	O
(	O
Fig	O
.	O
5	O
)	O
,	O
apart	O
from	O
a	O
relatively	O
small	O
number	O
of	O
common	O
strategies	O
used	O
by	O
P	O
.	O
temperata	O
and	O
X	O
.	O
koppenhoeferi	O
to	O
cause	O
infection	O
of	O
R	O
.	O
majalis	O
,	O
most	O
upregulated	O
genes	O
were	O
different	O
between	O
the	O
two	O
bacteria	O
,	O
suggesting	O
vastly	O
different	O
pathways	O
to	O
bring	O
about	O
infection	O
of	O
the	O
same	O
insect	O
host	O
.	O

Flagellum	O
-	O
mediated	O
motility	O
may	O
provide	O
an	O
advantage	O
for	O
infection	O
by	O
attachment	O
to	O
the	O
host	O
surface	O
[	O
19	O
,	O
20	O
]	O
,	O
whereas	O
it	O
has	O
been	O
reported	O
in	O
X	O
.	O
nematophila	O
that	O
the	O
expression	O
of	O
virulence	O
factors	O
is	O
not	O
controlled	O
by	O
the	O
regulation	O
of	O
flagella	O
motility	O
[	O
21	O
]	O
.	O

Gene	O
dacC	S-Biological_Molecule
encoding	O
a	O
peptidoglycan	O
synthesis	O
enzyme	O
D	O
-	O
alanyl	O
-	O
D	O
-	O
alanine	O
carboxypeptidase	O
was	O
induced	O
in	O
X	O
.	O
koppenhoeferi	O
but	O
not	O
in	O
P	O
.	O
temperata	O
,	O
implying	O
that	O
peptidoglycan	O
undergoes	O
structural	O
alterations	O
in	O
X	O
.	O
koppenhoeferi	O
that	O
probably	O
add	O
to	O
its	O
fitness	O
when	O
residing	O
in	O
the	O
host	O
.	O

Facing	O
stimuli	O
,	O
different	O
regulatory	O
genes	O
were	O
upregulated	O
in	O
P	O
.	O
temperata	O
and	O
X	O
.	O
koppenhoeferi	O
,	O
reflecting	O
their	O
unique	O
ability	O
to	O
respond	O
to	O
environmental	O
challenges	O
.	O

Responding	O
to	O
low	O
Mg2	O
+	O
levels	O
,	O
phoP	S-Biological_Molecule
expression	O
is	O
auto	O
-	O
regulated	O
by	O
PhoP	S-Biological_Molecule
and	O
PhoQ	S-Biological_Molecule
proteins	O
and	O
phoQ	S-Biological_Molecule
is	O
constitutive	O
[	O
25	O
]	O
.	O

Besides	O
transcriptional	O
regulatory	O
genes	O
,	O
gene	O
tilS	S-Biological_Molecule
,	O
encoding	O
a	O
putative	O
cell	O
cycle	O
protein	O
[	O
4	O
]	O
,	O
was	O
induced	O
in	O
X	O
.	O
koppenhoeferi	O
.	O

The	O
tca	O
gene	O
family	O
encodes	O
four	O
toxin	O
complexes	O
TcaA	S-Biological_Molecule
,	O
TcaB	S-Biological_Molecule
,	O
TcaC	S-Biological_Molecule
and	O
TcaD	S-Biological_Molecule
[	O
33	O
]	O
,	O
and	O
has	O
been	O
found	O
in	O
several	O
bacterial	O
pathogens	O
including	O
P	O
.	O
luminescens	O
,	O
Yersinia	O
and	O
Xenorhabdus	O
[	O
34	O
]	O
.	O

Further	O
,	O
genes	O
encoding	O
components	O
of	O
different	O
types	O
of	O
secretion	O
machineries	O
were	O
isolated	O
in	O
this	O
study	O
.	O

Notably	O
,	O
in	O
X	O
.	O
koppenhoeferi	O
,	O
virH	S-Biological_Molecule
with	O
sequence	O
similarity	O
to	O
a	O
gene	O
encoding	O
putative	O
toxin	O
secretion	O
transporter	O
in	O
Vibrio	O
cholera	O
,	O
was	O
upregulated	O
during	O
infection	O
of	O
R	O
.	O
majalis	O
.	O

In	O
addition	O
,	O
several	O
other	O
genes	O
encoding	O
proteins	O
with	O
putative	O
virulence	O
functions	O
identified	O
in	O
this	O
study	O
may	O
represent	O
novel	O
toxin	O
candidates	O
involved	O
in	O
insect	O
infection	O
.	O

Gene	O
surA	S-Biological_Molecule
is	O
important	O
for	O
bacterial	O
survival	O
during	O
infection	O
[	O
41	O
,	O
42	O
]	O
to	O
avoid	O
accumulation	O
of	O
non	O
-	O
native	O
protein	O
conformations	O
[	O
42	O
-	O
44	O
]	O
,	O
and	O
uspB	S-Biological_Molecule
gene	O
product	O
is	O
usually	O
accumulated	O
in	O
the	O
stationary	O
phase	O
and	O
probably	O
important	O
for	O
ethanol	O
stress	O
[	O
45	O
]	O
.	O

The	O
glutathione	O
synthetase	O
gene	O
gshB	S-Biological_Molecule
which	O
mediates	O
condensation	O
of	O
gamma	O
-	O
glutamylcysteine	O
and	O
glycine	O
to	O
form	O
glutathione	O
[	O
47	O
,	O
48	O
]	O
was	O
induced	O
in	O
P	O
.	O
temperata	O
,	O
but	O
glutathione	O
reductase	O
gene	O
gor	O
which	O
reduces	O
glutathione	O
disulfide	O
to	O
the	O
sulfhydryl	O
form	O
of	O
glutathione	O
[	O
47	O
,	O
48	O
]	O
was	O
induced	O
in	O
X	O
.	O
koppenhoeferi	O
.	O

Induction	O
of	O
different	O
amino	O
acid	O
biosynthetic	O
genes	O
may	O
suggest	O
the	O
differences	O
in	O
amino	O
acid	O
requirements	O
in	O
the	O
two	O
bacteria	O
during	O
infection	O
.	O

Isolation	O
of	O
P	O
.	O
temperata	O
def	O
,	O
encoding	O
an	O
amino	O
acid	O
tRNA	O
synthesis	O
enzyme	O
N	O
-	O
formylmethionylaminoacyl	O
-	O
tRNA	O
deformylase	O
,	O
may	O
reflect	O
the	O
importance	O
of	O
specific	O
amino	O
acids	O
involved	O
in	O
the	O
translation	O
process	O
during	O
growth	O
in	O
the	O
insect	O
host	O
.	O

Also	O
supported	O
by	O
the	O
pathway	O
analysis	O
,	O
product	O
of	O
glnD	S-Biological_Molecule
identified	O
from	O
P	O
.	O
temperata	O
likely	O
controls	O
the	O
production	O
of	O
siderophore	O
(	O
see	O
Additional	O
file	O
1	O
)	O
.	O

Genes	O
with	O
unknown	O
function	O

Conclusion	O

Our	O
results	O
indicate	O
that	O
,	O
for	O
example	O
,	O
gene	O
apxIVA	S-Biological_Molecule
from	O
an	O
operon	O
coding	O
for	O
RTX	O
toxin	O
ApxIV	S-Biological_Molecule
is	O
highly	O
up	O
-	O
regulated	O
in	O
vivo	O
,	O
and	O
that	O
two	O
genes	O
from	O
the	O
operon	O
coding	O
for	O
type	O
IV	O
fimbriae	O
(	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
0878	E-Biological_Molecule
and	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
0879	E-Biological_Molecule
)	O
were	O
also	O
up	O
-	O
regulated	O
.	O

Actinobacillus	O
pleuropneumoniae	O
is	O
the	O
causative	O
agent	O
of	O
porcine	O
pleuropneumonia	O
,	O
a	O
highly	O
contagious	O
respiratory	O
disease	O
that	O
causes	O
great	O
economic	O
losses	O
worldwide	O
[	O
1	O
]	O
.	O

Fifteen	O
different	O
serotypes	O
can	O
be	O
identified	O
based	O
on	O
differences	O
in	O
capsular	O
polysaccharides	O
.	O

While	O
serotypes	O
1	O
to	O
12	O
and	O
15	O
usually	O
belong	O
to	O
biotype	O
1	O
,	O
which	O
contains	O
strains	O
that	O
are	O
NAD	O
-	O
dependent	O
,	O
serotypes	O
13	O
and	O
14	O
are	O
usually	O
NAD	O
-	O
independent	O
and	O
belong	O
to	O
biotype	O
2	O
[	O
4	O
]	O
.	O

More	O
recently	O
,	O
SCOTS	S-Biological_Molecule
experiments	O
were	O
conducted	O
with	O
A	O
.	O
pleuropneumoniae	O
,	O
at	O
two	O
different	O
stages	O
of	O
infection	O
:	O
at	O
the	O
end	O
of	O
the	O
acute	O
stage	O
,	O
in	O
necrotic	O
lung	O
tissues	O
(	O
7	O
days	O
post	O
-	O
infection	O
)	O
[	O
18	O
]	O
,	O
and	O
in	O
the	O
chronic	O
stage	O
(	O
21	O
days	O
post	O
-	O
infection	O
)	O
[	O
10	O
]	O
.	O

These	O
studies	O
demonstrated	O
the	O
importance	O
of	O
anaerobic	O
metabolism	O
and	O
HlyX	S-Biological_Molecule
-	O
regulated	O
mechanisms	O
during	O
A	O
.	O
pleuropneumoniae	O
infection	O
in	O
the	O
lungs	O
,	O
and	O
led	O
to	O
the	O
identification	O
and	O
characterisation	O
of	O
a	O
maturation	O
autotransporter	O
protease	O
,	O
AasP	S-Biological_Molecule
,	O
responsible	O
for	O
cleavage	O
and	O
release	O
of	O
fragments	O
of	O
OmlA	S-Biological_Molecule
from	O
the	O
cell	O
surface	O
[	O
19	O
]	O
.	O

During	O
the	O
course	O
of	O
our	O
experiments	O
,	O
we	O
were	O
able	O
to	O
collect	O
samples	O
from	O
three	O
different	O
animals	O
from	O
the	O
same	O
herd	O
,	O
before	O
antibiotherapy	O
was	O
undertaken	O
to	O
eradicate	O
the	O
infection	O
.	O

Tissues	O
were	O
homogenized	O
with	O
1	O
.	O
0	O
mm	O
zirconia	O
/	O
silica	O
beads	O
to	O
release	O
but	O
not	O
lyse	O
bacterial	O
cells	O
from	O
the	O
tissue	O
.	O

Approximately	O
20	O
to	O
45	O
mug	O
of	O
total	O
RNA	O
could	O
routinely	O
be	O
extracted	O
from	O
approximately	O
2	O
g	O
of	O
necrotic	O
lung	O
tissue	O
,	O
with	O
no	O
apparent	O
contamination	O
by	O
eukaryotic	O
RNA	O
,	O
as	O
observed	O
on	O
agarose	O
gel	O
when	O
using	O
bacterial	O
RNA	O
extracted	O
from	O
BHI	O
broth	O
and	O
eukaryotic	O
RNA	O
recovered	O
from	O
porcine	O
lung	O
epithelial	O
cells	O
(	O
SJPL	O
cell	O
line	O
)	O
[	O
27	O
]	O
as	O
on	O
-	O
gel	O
controls	O
(	O
data	O
not	O
shown	O
)	O
.	O

This	O
condition	O
was	O
not	O
only	O
chosen	O
for	O
practical	O
reasons	O
,	O
but	O
also	O
to	O
fulfill	O
two	O
precise	O
objectives	O
:	O
first	O
,	O
to	O
allow	O
for	O
the	O
identification	O
of	O
genes	O
that	O
,	O
while	O
important	O
to	O
the	O
infection	O
process	O
,	O
have	O
not	O
been	O
identified	O
previously	O
in	O
vitro	O
in	O
rich	O
medium	O
,	O
and	O
second	O
,	O
to	O
allow	O
comparison	O
of	O
the	O
results	O
obtained	O
in	O
vivo	O
to	O
those	O
obtained	O
in	O
our	O
laboratory	O
in	O
other	O
growth	O
conditions	O
by	O
keeping	O
the	O
same	O
reference	O
[	O
28	O
-	O
30	O
]	O
.	O

Five	O
of	O
these	O
were	O
up	O
-	O
regulated	O
in	O
vivo	O
(	O
sohB	S-Biological_Molecule
,	O
hbpA	S-Biological_Molecule
,	O
kpsF	S-Biological_Molecule
,	O
apxIVA	S-Biological_Molecule
,	O
phoR	S-Biological_Molecule
)	O
and	O
six	O
were	O
down	O
-	O
regulated	O
(	O
nlpI	S-Biological_Molecule
,	O
visC	S-Biological_Molecule
,	O
proQ	S-Biological_Molecule
,	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
1456	E-Biological_Molecule
,	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
1135	E-Biological_Molecule
and	O
nusG	S-Biological_Molecule
)	O
.	O

It	O
is	O
also	O
the	O
only	O
apx	O
gene	O
that	O
was	O
up	O
-	O
regulated	O
in	O
our	O
experiment	O
,	O
but	O
it	O
is	O
worth	O
noting	O
that	O
the	O
apxIBCD	S-Biological_Molecule
and	O
apxIIAB	S-Biological_Molecule
genes	O
,	O
although	O
not	O
differentially	O
expressed	O
,	O
were	O
all	O
actively	O
transcribed	O
in	O
vivo	O
.	O

Finally	O
,	O
the	O
last	O
gene	O
that	O
was	O
up	O
-	O
regulated	O
in	O
our	O
study	O
and	O
identified	O
in	O
another	O
in	O
vivo	O
study	O
is	O
nanE	S-Biological_Molecule
,	O
which	O
codes	O
for	O
a	O
putative	O
N	O
-	O
acetylmannosamine	O
-	O
6	O
-	O
phosphate	O
2	O
-	O
epimerase	O
,	O
an	O
enzyme	O
involved	O
in	O
the	O
use	O
of	O
N	O
-	O
acetylneuraminate	O
and	O
N	O
-	O
acetylmannosamine	O
as	O
carbon	O
sources	O
[	O
35	O
]	O
.	O

It	O
is	O
believed	O
to	O
form	O
a	O
complex	O
with	O
sRNAs	O
and	O
RNAse	B-Biological_Molecule
E	E-Biological_Molecule
,	O
thereby	O
targeting	O
mRNAs	O
that	O
are	O
recognized	O
by	O
sRNAs	O
for	O
degradation	O
.	O

Studies	O
in	O
our	O
laboratory	O
have	O
shown	O
that	O
it	O
is	O
the	O
core	O
oligosaccharide	O
that	O
is	O
responsible	O
for	O
the	O
previously	O
observed	O
LPS	O
-	O
associated	O
adhesion	O
mechanism	O
[	O
54	O
,	O
55	O
]	O
.	O

A	O
few	O
other	O
genes	O
that	O
are	O
involved	O
in	O
anaerobic	O
metabolism	O
were	O
up	O
-	O
regulated	O
.	O

The	O
dmsA	S-Biological_Molecule
gene	O
did	O
show	O
a	O
mean	O
fold	O
change	O
of	O
1	O
.	O
60	O
over	O
two	O
successful	O
hybridizations	O
,	O
but	O
hlyX	S-Biological_Molecule
had	O
a	O
mean	O
fold	O
change	O
of	O
-	O
1	O
.	O
66	O
over	O
three	O
successful	O
hybridizations	O
.	O

However	O
,	O
neither	O
of	O
these	O
changes	O
were	O
deemed	O
statistically	O
significant	O
.	O

Conclusions	O

Mutational	O
analysis	O
of	O
a	O
representative	O
promoter	O
validated	O
this	O
palindrome	O
as	O
the	O
minimal	O
architecture	O
needed	O
for	O
regulatory	O
input	O
by	O
SsrB	S-Biological_Molecule
.	O

Silencing	O
of	O
horizontally	O
-	O
acquired	O
genes	O
by	O
DNA	O
binding	O
proteins	O
like	O
H	B-Biological_Molecule
-	I-Biological_Molecule
NS	E-Biological_Molecule
is	O
one	O
way	O
some	O
incoming	O
genes	O
are	O
initially	O
controlled	O
[	O
2	O
]	O
,	O
[	O
3	O
]	O
,	O
which	O
can	O
then	O
be	O
subject	O
to	O
regulatory	O
evolution	O
by	O
mutating	O
cis	O
-	O
regulatory	O
operator	O
regions	O
to	O
select	O
for	O
optional	O
gene	O
expression	O
.	O

It	O
is	O
generally	O
accepted	O
that	O
SPI	O
-	O
2	O
was	O
acquired	O
by	O
Salmonella	O
enterica	O
after	O
divergence	O
from	O
S	O
.	O
bongori	O
,	O
providing	O
a	O
useful	O
pedigree	O
to	O
study	O
regulatory	O
evolution	O
influenced	O
by	O
SsrB	S-Biological_Molecule
.	O

We	O
recently	O
demonstrated	O
the	O
evolutionary	O
significance	O
of	O
cis	O
-	O
regulatory	O
mutations	O
for	O
pathoadaptation	O
of	O
Salmonella	O
enterica	O
serovar	O
Typhimurium	O
(	O
S	O
.	O
Typhimurium	O
)	O
to	O
an	O
animal	O
host	O
[	O
19	O
]	O
.	O

Transcriptional	O
profiling	O
of	O
an	O
ssrB	S-Biological_Molecule
mutant	O
To	O
begin	O
to	O
understand	O
regulatory	O
evolution	O
and	O
network	O
expansion	O
of	O
the	O
SsrB	S-Biological_Molecule
response	O
regulator	O
,	O
we	O
profiled	O
the	O
transcriptome	O
of	O
an	O
ssrB	S-Biological_Molecule
mutant	O
and	O
compared	O
it	O
to	O
S	O
.	O

This	O
included	O
almost	O
all	O
genes	O
in	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O
as	O
well	O
as	O
effector	O
genes	O
encoded	O
throughout	O
the	O
genome	O
(	O
Dataset	O
S1	O
)	O
.	O

Next	O
,	O
we	O
performed	O
a	O
Clusters	O
of	O
Orthologous	O
Groups	O
(	O
COG	O
)	O
analysis	O
[	O
22	O
]	O
on	O
the	O
118	O
genes	O
that	O
had	O
an	O
ortholog	O
in	O
the	O
annotated	O
genome	O
of	O
S	O
.	O

Typhimurium	O
strain	O
LT2	O
[	O
23	O
]	O
.	O

Among	O
these	O
,	O
45	O
genes	O
lacked	O
a	O
functional	O
COG	O
assignment	O
and	O
the	O
73	O
remaining	O
genes	O
were	O
distributed	O
among	O
86	O
COGs	O
(	O
Figure	O
1	O
)	O
.	O

To	O
expand	O
on	O
this	O
,	O
we	O
used	O
a	O
reciprocal	O
BLAST	O
-	O
based	O
analysis	O
and	O
identified	O
47	O
orthologs	O
in	O
S	O
.	O
bongori	O
among	O
the	O
133	O
genes	O
whose	O
transcription	O
was	O
down	O
-	O
regulated	O
in	O
an	O
ssrB	S-Biological_Molecule
mutant	O
(	O
Table	O
1	O
)	O
.	O

Typhimurium	O
SL1344	O
array	O
containing	O
44	O
,	O
021	O
probes	O
.	O

With	O
this	O
method	O
,	O
we	O
identified	O
256	O
significant	O
interaction	O
peaks	O
distributed	O
throughout	O
the	O
genome	O
that	O
were	O
enriched	O
under	O
SsrB	S-Biological_Molecule
-	O
activating	O
conditions	O
and	O
with	O
interaction	O
scores	O
three	O
standard	O
deviations	O
greater	O
than	O
the	O
mean	O
probe	O
score	O
(	O
Figure	O
2A	O
and	O
Table	O
1	O
)	O
.	O

Typhimurium	O
SL1344	O
genome	O
that	O
encoded	O
at	O
least	O
one	O
gene	O
down	O
-	O
regulated	O
in	O
DeltassrB	S-Biological_Molecule
cells	O
and	O
that	O
possessed	O
an	O
SsrB	S-Biological_Molecule
binding	O
peak	O
in	O
the	O
upstream	O
regulatory	O
region	O
as	O
defined	O
by	O
our	O
ChIP	O
-	O
on	O
-	O
chip	O
analysis	O
.	O

Bait	O
-	O
prey	O
combinations	O
surviving	O
selection	O
on	O
medium	O
lacking	O
histidine	O
were	O
purified	O
,	O
and	O
preys	O
were	O
sequenced	O
and	O
analyzed	O
using	O
the	O
motif	O
-	O
finding	O
program	O
MEME	O
[	O
29	O
]	O
.	O

We	O
identified	O
variations	O
of	O
this	O
motif	O
within	O
footprinted	O
regions	O
of	O
SsrB	S-Biological_Molecule
-	O
regulated	O
promoters	O
[	O
25	O
]	O
,	O
,	O
however	O
sequence	O
degeneracy	O
made	O
it	O
difficult	O
to	O
precisely	O
map	O
the	O
input	O
functions	O
.	O

Typhimurium	O
SPI	O
-	O
2	O
and	O
the	O
Sodalis	O
glossinidius	O
SSR	O
-	O
3	O
region	O

Interestingly	O
,	O
two	O
copies	O
of	O
the	O
palindrome	O
occur	O
upstream	O
of	O
the	O
ssrA	S-Biological_Molecule
-	O
ssrB	S-Biological_Molecule
operon	O
in	O
S	O
.	O

However	O
,	O
if	O
the	O
two	O
half	O
sites	O
were	O
swapped	O
front	O
-	O
to	O
-	O
back	O
so	O
that	O
they	O
maintained	O
tail	O
-	O
to	O
-	O
tail	O
orientation	O
(	O
construct	O
labelled	O
"	O
Reverse	O
"	O
in	O
Figure	O
5	O
)	O
,	O
wild	O
-	O
type	O
promoter	O
activity	O
was	O
restored	O
.	O

This	O
analysis	O
recovered	O
the	O
motifs	O
upstream	O
of	O
ssaB	S-Biological_Molecule
,	O
ssaG	S-Biological_Molecule
,	O
ssaM	S-Biological_Molecule
,	O
and	O
ssaR	S-Biological_Molecule
that	O
were	O
used	O
to	O
generate	O
the	O
PWM	O
.	O

Remarkably	O
,	O
this	O
accounted	O
for	O
17	O
of	O
22	O
SL1344	O
genome	O
-	O
encoded	O
effectors	O
translocated	O
by	O
the	O
SPI	O
-	O
2	O
-	O
encoded	O
T3SS	O
(	O
exceptions	O
are	O
chromosomal	O
steA	S-Biological_Molecule
,	O
gogB	S-Biological_Molecule
,	O
and	O
sseK	S-Biological_Molecule
,	O
and	O
plasmid	O
-	O
encoded	O
spvB	S-Biological_Molecule
and	O
spvC	S-Biological_Molecule
)	O
.	O

For	O
the	O
IGR	O
palindrome	O
upstream	O
of	O
ssaR	S-Biological_Molecule
,	O
we	O
tested	O
both	O
a	O
chromosome	O
-	O
integrated	O
transcriptional	O
fusion	O
and	O
an	O
autonomous	O
episomal	O
reporter	O
.	O

In	O
doing	O
so	O
we	O
believe	O
that	O
the	O
nineteen	O
operons	O
containing	O
differentially	O
expressed	O
genes	O
determined	O
by	O
microarray	O
and	O
containing	O
a	O
ChIP	O
-	O
on	O
-	O
chip	O
peak	O
three	O
standard	O
deviations	O
above	O
the	O
mean	O
captured	O
by	O
this	O
analysis	O
represent	O
the	O
genes	O
directly	O
activated	O
by	O
SsrB	S-Biological_Molecule
(	O
Table	O
2	O
)	O
.	O

The	O
SsrB	S-Biological_Molecule
ortholog	O
in	O
S	O
.	O
glossinidius	O
is	O
approximately30	O
%	O
divergent	O
with	O
SsrB	S-Biological_Molecule
at	O
the	O
protein	O
level	O
,	O
initially	O
leading	O
us	O
to	O
think	O
that	O
they	O
might	O
have	O
different	O
binding	O
site	O
preferences	O
.	O

To	O
the	O
contrary	O
,	O
high	O
local	O
conservation	O
in	O
the	O
promoters	O
evolved	O
in	O
Salmonella	O
and	O
Sodalis	O
was	O
the	O
crux	O
in	O
defining	O
the	O
functional	O
SsrB	S-Biological_Molecule
input	O
among	O
stochastic	O
noise	O
.	O

With	O
the	O
structure	O
of	O
SsrB	S-Biological_Molecule
available	O
[	O
32	O
]	O
and	O
its	O
recognized	O
sequence	O
now	O
identified	O
,	O
future	O
studies	O
will	O
be	O
able	O
to	O
build	O
a	O
picture	O
of	O
how	O
SsrB	S-Biological_Molecule
interacts	O
with	O
both	O
its	O
target	O
DNA	O
,	O
RNA	O
polymerase	O
and	O
potentially	O
other	O
transcription	O
factors	O
including	O
nucleoid	O
associated	O
proteins	O
in	O
order	O
to	O
direct	O
transcription	O
of	O
its	O
regulon	O
.	O

Our	O
findings	O
demonstrate	O
the	O
engagement	O
of	O
unique	O
regulatory	O
modules	O
in	O
niche	O
adaptation	O
,	O
implicate	O
a	O
critical	O
role	O
for	O
bacterial	O
genetic	O
heterogeneity	O
that	O
surpasses	O
transcriptional	O
in	O
vivo	O
adaptation	O
,	O
and	O
portray	O
the	O
dynamics	O
underlying	O
the	O
selection	O
of	O
hypervirulent	O
covS	S-Biological_Molecule
mutants	O
over	O
their	O
parental	O
WT	O
cells	O
.	O

Subsequent	O
studies	O
uncovered	O
that	O
this	O
genetic	O
switch	O
is	O
driven	O
by	O
host	O
innate	O
immune	O
pressure	O
that	O
selects	O
for	O
bacteria	O
with	O
pathoadaptive	O
mutations	O
in	O
the	O
covRS	S-Biological_Molecule
genetic	O
locus	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
.	O

Despite	O
the	O
association	O
between	O
covS	S-Biological_Molecule
mutations	O
and	O
the	O
emergence	O
of	O
the	O
hypervirulent	O
phenotype	O
of	O
M1T1	O
strains	O
,	O
it	O
is	O
unclear	O
whether	O
this	O
increased	O
virulence	O
can	O
be	O
entirely	O
attributed	O
to	O
the	O
modulation	O
of	O
the	O
CovR	S-Biological_Molecule
regulon	O
or	O
if	O
other	O
networks	O
are	O
also	O
perturbed	O
in	O
vivo	O
directly	O
,	O
indirectly	O
,	O
or	O
independently	O
of	O
the	O
CovRS	S-Biological_Molecule
system	O
.	O

Such	O
comprehensive	O
analyses	O
highlighted	O
the	O
behavior	O
of	O
genomic	O
subsystems	O
that	O
may	O
be	O
involved	O
directly	O
or	O
indirectly	O
in	O
S	O
.	O
pyogenes	O
niche	O
adaptation	O
and	O
pathogenesis	O
.	O

The	O
difference	O
in	O
buoyancy	O
can	O
also	O
be	O
attributed	O
to	O
differences	O
in	O
the	O
expression	O
of	O
hyaluronic	O
acid	O
capsule	O
(	O
AP	O
>	O
WT	O
)	O
.	O

Minimal	O
media	O
are	O
not	O
optimal	O
for	O
the	O
expression	O
of	O
GAS	O
proteins	O
,	O
which	O
may	O
explain	O
why	O
GAS	O
failed	O
to	O
grow	O
at	O
many	O
of	O
the	O
PM	O
conditions	O
(	O
Fig	O
.	O
S1	O
)	O
and	O
why	O
fewer	O
phenotypic	O
differences	O
were	O
observed	O
between	O
WT	O
and	O
AP	O
bacteria	O
than	O
transcriptomic	O
differences	O
(	O
see	O
below	O
)	O
.	O

We	O
extracted	O
RNA	O
from	O
these	O
bacteria	O
immediately	O
after	O
their	O
recovery	O
from	O
mouse	O
chambers	O
with	O
no	O
additional	O
culturing	O
and	O
used	O
the	O
extracted	O
RNA	O
for	O
transcriptome	O
profiling	O
as	O
detailed	O
in	O
Materials	O
and	O
Methods	O
.	O

1	O
.	O

Multiple	O
approaches	O
to	O
microarray	O
analysis	O
show	O
statistically	O
significant	O
and	O
biologically	O
relevant	O
differences	O
between	O
the	O
WT	O
and	O
AP	O
populations	O
in	O
vitro	O
and	O
in	O
vivo	O

By	O
clustering	O
normalized	O
expression	O
values	O
from	O
different	O
biological	O
replicates	O
in	O
all	O
data	O
sets	O
,	O
we	O
generated	O
an	O
overall	O
"	O
pathovivogram	O
"	O
that	O
includes	O
276	O
genes	O
in	O
ten	O
coexpression	O
clusters	O
,	O
CCs	O
(	O
Fig	O
.	O
2	O
,	O
Fig	O
.	O
S2	O
,	O
and	O
Table	O
S1	O
)	O
.	O

Moreover	O
,	O
we	O
identified	O
a	O
unique	O
cluster	O
,	O
CC7	O
,	O
that	O
includes	O
genes	O
upregulated	O
both	O
in	O
vivo	O
and	O
as	O
a	O
consequence	O
of	O
the	O
covS	S-Biological_Molecule
mutation	O
(	O
e	O
.	O
g	O
.	O
,	O
those	O
encoding	O
M	B-Biological_Molecule
protein	E-Biological_Molecule
,	O
streptolysin	B-Biological_Molecule
O	E-Biological_Molecule
,	O
and	O
nicotinamide	B-Biological_Molecule
adenine	I-Biological_Molecule
dinucleotide	I-Biological_Molecule
glycohydrolase	E-Biological_Molecule
(	O
NADGH	S-Biological_Molecule
)	O
,	O
Fig	O
.	O
2	O
,	O
CC7	O
)	O
.	O

The	O
patterns	O
in	O
clusters	O
CC1	O
-	O
CC3	O
describe	O
those	O
gene	O
sets	O
whose	O
transcription	O
was	O
turned	O
on	O
(	O
CC1	O
-	O
CC2	O
)	O
or	O
off	O
(	O
CC3	O
)	O
to	O
drive	O
the	O
bacterial	O
adaptation	O
to	O
the	O
host	O
environment	O
,	O
but	O
are	O
not	O
primarily	O
related	O
to	O
bacterial	O
pathogenesis	O
.	O

By	O
contrast	O
,	O
the	O
most	O
dramatic	O
transcriptional	O
reprogramming	O
was	O
that	O
exhibited	O
by	O
the	O
WT	O
bacteria	O
in	O
their	O
attempt	O
to	O
adapt	O
to	O
the	O
in	O
vivo	O
environment	O
(	O
Table	O
2	O
)	O
.	O

However	O
,	O
the	O
fold	O
-	O
change	O
in	O
SpeB	S-Biological_Molecule
operon	O
transcription	O
level	O
largely	O
varied	O
across	O
the	O
four	O
experimental	O
conditions	O
,	O
ranging	O
from	O
a	O
2	O
.	O
2	O
-	O
fold	O
to	O
a	O
30	O
-	O
fold	O
downregulation	O
(	O
Table	O
3	O
)	O
.	O

The	O
next	O
stage	O
in	O
our	O
analysis	O
was	O
to	O
integrate	O
microarray	O
data	O
,	O
moving	O
from	O
the	O
gene	O
/	O
cluster	O
level	O
to	O
the	O
level	O
of	O
biological	O
subsystems	O
.	O

Group	O
A	O
streptococcal	O
sociomicrobiology	O
It	O
is	O
now	O
well	O
established	O
that	O
bacterial	O
populations	O
often	O
consist	O
of	O
heterogeneous	O
communities	O
rather	O
than	O
genetically	O
identical	O
cells	O
with	O
synchronized	O
gene	O
expression	O
profiles	O
[	O
49	O
]	O
,	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
captured	O
dynamic	O
events	O
underlying	O
the	O
phenotypic	O
switch	O
resulting	O
from	O
this	O
population	O
restructuring	O
.	O

SpeB	S-Biological_Molecule
is	O
a	O
major	O
virulence	O
factor	O
in	O
GAS	O
pathogenesis	O
and	O
its	O
expression	O
is	O
regulated	O
by	O
different	O
systems	O
[	O
40	O
]	O
,	O
[	O
56	O
]	O
,	O
[	O
57	O
]	O
,	O
[	O
58	O
]	O
,	O
including	O
the	O
CovRS	S-Biological_Molecule
system	O
[	O
20	O
]	O
,	O
[	O
53	O
]	O
.	O

Whereas	O
SpeB	S-Biological_Molecule
expression	O
may	O
be	O
important	O
in	O
the	O
initial	O
stages	O
of	O
skin	O
infections	O
[	O
29	O
]	O
,	O
[	O
35	O
]	O
,	O
its	O
downregulation	O
has	O
been	O
associated	O
with	O
an	O
invasive	O
and	O
hypervirulent	O
phenotype	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
,	O
[	O
59	O
]	O
.	O

The	O
downregulation	O
of	O
GRAB	S-Biological_Molecule
makes	O
biological	O
sense	O
because	O
this	O
protein	O
binds	O
alpha	B-Biological_Molecule
-	I-Biological_Molecule
2	I-Biological_Molecule
-	I-Biological_Molecule
macroglobulin	E-Biological_Molecule
in	O
blood	O
[	O
60	O
]	O
to	O
protect	O
the	O
bacteria	O
against	O
its	O
own	O
protease	O
,	O
SpeB	S-Biological_Molecule
,	O
and	O
thus	O
the	O
bacteria	O
no	O
longer	O
need	O
to	O
express	O
high	O
levels	O
of	O
GRAB	S-Biological_Molecule
when	O
SpeB	S-Biological_Molecule
is	O
not	O
expressed	O
.	O

However	O
,	O
coexpression	O
analysis	O
alone	O
can	O
miss	O
some	O
biologically	O
relevant	O
genes	O
that	O
could	O
fail	O
the	O
statistical	O
tests	O
for	O
non	O
-	O
biological	O
reasons	O
(	O
e	O
.	O
g	O
.	O
,	O
poorly	O
hybridizing	O
probes	O
,	O
low	O
signal	O
-	O
to	O
-	O
noise	O
ratio	O
,	O
or	O
high	O
variance	O
)	O
and	O
may	O
instead	O
include	O
some	O
irrelevant	O
genes	O
in	O
isolation	O
of	O
their	O
biological	O
networks	O
[	O
41	O
]	O
.	O

In	O
bacteria	O
,	O
biochemical	O
pathways	O
,	O
virulence	O
systems	O
,	O
and	O
multimeric	O
proteins	O
are	O
often	O
encoded	O
next	O
to	O
each	O
other	O
by	O
chromosomally	O
contiguous	O
or	O
clustered	O
genes	O
[	O
64	O
]	O
,	O
[	O
65	O
]	O
.	O

Similarly	O
,	O
the	O
common	O
use	O
of	O
statistical	O
constraints	O
with	O
ratio	O
calculation	O
(	O
e	O
.	O
g	O
.	O
,	O
two	O
-	O
fold	O
ratios	O
and	O
P	O
values	O
<	O
0	O
.	O
05	O
)	O
filters	O
out	O
many	O
biologically	O
relevant	O
genes	O
that	O
are	O
true	O
positives	O
.	O

Having	O
used	O
multiple	O
strategies	O
and	O
integrated	O
the	O
PM	O
data	O
with	O
the	O
in	O
vitro	O
and	O
in	O
vivo	O
microarray	O
data	O
,	O
we	O
propose	O
the	O
following	O
hypotheses	O
about	O
streptococcal	O
niche	O
adaptation	O
and	O
switch	O
to	O
hypervirulence	O
:	O
(	O
1	O
)	O
Exposure	O
to	O
the	O
in	O
vivo	O
environment	O
perturbs	O
a	O
substantial	O
number	O
of	O
GAS	O
genes	O
and	O
regulatory	O
networks	O
.	O

This	O
is	O
why	O
we	O
believe	O
that	O
transcriptional	O
reprogramming	O
by	O
environmental	O
adaptation	O
alone	O
was	O
insufficient	O
to	O
provide	O
WT	O
bacteria	O
with	O
an	O
in	O
vivo	O
survival	O
advantage	O
.	O

We	O
believe	O
that	O
our	O
results	O
offer	O
a	O
proof	O
of	O
principle	O
that	O
in	O
vivo	O
-	O
extracted	O
RNA	O
can	O
provide	O
transcriptional	O
profiles	O
that	O
better	O
reflect	O
the	O
complexity	O
of	O
heterogeneous	O
bacterial	O
communities	O
,	O
and	O
,	O
as	O
shown	O
in	O
this	O
study	O
,	O
can	O
provide	O
a	O
transcriptional	O
snapshot	O
of	O
a	O
bacterial	O
population	O
right	O
before	O
its	O
extinction	O
.	O

The	O
use	O
of	O
in	O
vivo	O
-	O
driven	O
RNA	O
in	O
understanding	O
virulence	O
has	O
been	O
appreciated	O
in	O
streptococcal	O
research	O
[	O
73	O
]	O
,	O
but	O
the	O
technique	O
has	O
not	O
previously	O
been	O
used	O
to	O
explain	O
the	O
switch	O
to	O
hypervirulent	O
,	O
invasive	O
phenotypes	O
or	O
to	O
dissect	O
heterogeneous	O
microbial	O
subpopulations	O
.	O

Conformationally	O
modified	O
RR	O
molecule	O
functions	O
as	O
transcriptional	O
regulator	O
(	O
activator	O
or	O
repressor	O
)	O
by	O
binding	O
with	O
promoter	O
regions	O
of	O
the	O
genes	O
through	O
helix	O
-	O
turn	O
-	O
helix	O
(	O
HTH	O
)	O
motif	O
.	O

HK06	S-Biological_Molecule
/	O
RR06	S-Biological_Molecule
was	O
also	O
important	O
for	O
the	O
ability	O
of	O
pneumococci	O
to	O
adhere	O
to	O
epithelial	O
cells	O
in	O
vitro	O
and	O
to	O
survive	O
and	O
proliferate	O
in	O
an	O
in	O
vivo	O
mouse	O
model	O
[	O
22	O
]	O
.	O

In	O
this	O
strain	O
,	O
the	O
bac	S-Biological_Molecule
gene	O
has	O
unique	O
allele	O
with	O
the	O
closest	O
similarity	O
with	O
676a	O
and	O
676b	O
alleles	O
according	O
to	O
classification	O
of	O
Kong	O
et	O
al	O
.	O

Construction	O
and	O
characterization	O
of	O
mutant	O
strains	O

At	O
the	O
same	O
time	O
the	O
growth	O
curves	O
of	O
mutant	O
strains	O
in	O
THB	O
slightly	O
differed	O
from	O
the	O
growth	O
curve	O
of	O
the	O
strain	O
168	O
/	O
00	O
(	O
data	O
not	O
shown	O
)	O
.	O

Several	O
approaches	O
were	O
used	O
to	O
prepare	O
the	O
cell	O
lysates	O
of	O
the	O
wild	O
-	O
type	O
strain	O
168	O
/	O
00	O
and	O
mutant	O
strains	O
.	O

As	O
result	O
,	O
10	O
min	O
boiling	O
of	O
the	O
cells	O
in	O
2	O
-	O
mercaptoethanol	O
(	O
10	O
%	O
,	O
w	O
/	O
w	O
)	O
was	O
found	O
to	O
be	O
most	O
effective	O
with	O
respect	O
to	O
higher	O
yield	O
and	O
quality	O
of	O
the	O
protein	O
bands	O
observed	O
after	O
SDS	O
-	O
PAGE	O
(	O
data	O
not	O
shown	O
)	O
.	O

4	O
,	O
the	O
mortality	O
rate	O
caused	O
by	O
sak189	S-Biological_Molecule
/	O
sak188	S-Biological_Molecule
double	O
mutant	O
strain	O
significantly	O
differed	O
in	O
comparison	O
with	O
that	O
caused	O
by	O
the	O
wild	O
-	O
type	O
and	O
sak188	S-Biological_Molecule
mutant	O
strains	O
.	O

Compared	O
to	O
the	O
wild	O
-	O
type	O
strain	O
,	O
the	O
differences	O
in	O
virulent	O
properties	O
were	O
statistically	O
significant	O
in	O
case	O
of	O
sak189	S-Biological_Molecule
/	O
sak188	S-Biological_Molecule
double	O
mutant	O
strain	O
(	O
P	O
-	O
value	O
<	O
0	O
.	O
02	O
)	O
,	O
and	O
not	O
significant	O
in	O
case	O
of	O
sak188	S-Biological_Molecule
mutant	O
strain	O
(	O
P	O
-	O
value	O
=	O
0	O
.	O
73	O
)	O
.	O

However	O
,	O
the	O
regulatory	O
mechanism	O
of	O
bac	S-Biological_Molecule
gene	O
expression	O
has	O
not	O
been	O
studied	O
.	O

In	O
S	O
.	O
pneumoniae	O
,	O
inactivation	O
of	O
the	O
response	O
regulator	O
RR06	S-Biological_Molecule
(	O
83	O
%	O
similarity	O
with	O
Sak189	S-Biological_Molecule
)	O
,	O
which	O
binds	O
promoter	O
region	O
of	O
cbpA	S-Biological_Molecule
,	O
repressed	O
transcription	O
of	O
the	O
cbpA	S-Biological_Molecule
gene	O
[	O
22	O
]	O
.	O

This	O
is	O
not	O
surprising	O
given	O
the	O
high	O
similarity	O
in	O
the	O
sequences	O
,	O
functions	O
and	O
relative	O
locations	O
of	O
Sak188	S-Biological_Molecule
/	O
Sak189	S-Biological_Molecule
and	O
HK06	S-Biological_Molecule
/	O
RR06	S-Biological_Molecule
,	O
and	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
antigen	E-Biological_Molecule
and	O
CbpA	S-Biological_Molecule
(	O
Fig	O
.	O
1	O
)	O
.	O

Thus	O
,	O
we	O
can	O
conclude	O
that	O
sak188	S-Biological_Molecule
and	O
bac	S-Biological_Molecule
gene	O
are	O
not	O
in	O
the	O
operon	O
,	O
and	O
repression	O
of	O
bac	S-Biological_Molecule
gene	O
transcription	O
in	O
sak189	S-Biological_Molecule
/	O
sak188	S-Biological_Molecule
double	O
mutant	O
strain	O
is	O
not	O
due	O
to	O
the	O
polar	O
effect	O
.	O

It	O
could	O
be	O
predicted	O
given	O
that	O
inactivation	O
of	O
other	O
S	O
.	O
agalactiae	O
TCSs	O
(	O
CovS	S-Biological_Molecule
/	O
CovR	S-Biological_Molecule
,	O
DltR	S-Biological_Molecule
/	O
DltS	S-Biological_Molecule
,	O
RgfA	S-Biological_Molecule
/	O
RgfC	S-Biological_Molecule
)	O
resulted	O
in	O
the	O
changes	O
of	O
virulent	O
properties	O
,	O
however	O
,	O
in	O
all	O
these	O
studies	O
the	O
mutant	O
strains	O
became	O
less	O
virulent	O
compared	O
to	O
the	O
wild	O
-	O
type	O
strains	O
[	O
8	O
]	O
-	O
[	O
12	O
]	O
.	O

In	O
conclusion	O
,	O
the	O
data	O
presented	O
here	O
characterize	O
the	O
functional	O
role	O
of	O
S	O
.	O
agalactiae	O
Sak188	S-Biological_Molecule
/	O
Sak189	S-Biological_Molecule
two	O
-	O
component	O
system	O
.	O

However	O
,	O
during	O
each	O
phase	O
of	O
the	O
disease	O
,	O
low	O
levels	O
of	O
TGF	O
-	O
beta	O
RII	O
were	O
detected	O
when	O
compared	O
with	O
the	O
hematopoietic	O
cells	O
of	O
normal	O
donors	S-Species
.	O

In	O
contrast	O
,	O
tunicamycin	O
had	O
little	O
effect	O
on	O
the	O
viability	O
and	O
MTT	O
responses	O
of	O
the	O
cells	O
used	O
.	O

We	O
examined	O
the	O
expression	O
of	O
nm23	O
-	O
H1	O
gene	O
product	O
in	O
surgically	O
resected	O
46	O
pairs	O
of	O
primary	O
lung	O
cancers	O
and	O
metastatic	O
lymph	O
nodes	O
by	O
immunohistochemistry	O
.	O

No	O
correlations	O
were	O
found	O
between	O
the	O
nm23	O
-	O
H1	O
gene	O
product	O
expression	O
in	O
lung	O
cancers	O
and	O
the	O
patients	S-Species
survival	O
.	O

Left	O
ventricular	O
weight	O
,	O
body	O
weight	O
,	O
and	O
their	O
ratio	O
were	O
not	O
significantly	O
altered	O
by	O
alinidine	O
treatment	O
.	O

METHODS	O
AND	O
MATERIALS	O
:	O
The	O
prospective	O
trial	O
included	O
287	O
patients	S-Species
with	O
subfoveal	O
neovascularization	O
due	O
to	O
AMD	O
which	O
was	O
verified	O
by	O
fluorescein	O
angiography	O
.	O

In	O
this	O
study	O
we	O
investigated	O
the	O
serum	O
VEGF	O
level	O
(	O
s	O
-	O
VEGF	O
)	O
in	O
patients	S-Species
with	O
renal	O
cell	O
carcinoma	O
(	O
RCC	O
)	O
.	O

The	O
sensitivity	O
and	O
specificity	O
of	O
s	O
-	O
VEGF	O
at	O
the	O
cut	O
-	O
off	O
level	O
of	O
100	O
pg	O
/	O
ml	O
,	O
as	O
determined	O
by	O
the	O
receiver	O
-	O
operating	O
-	O
characteristics	O
curve	O
,	O
were	O
80	O
.	O
0	O
%	O
and	O
72	O
.	O
5	O
%	O
,	O
respectively	O
.	O

METHODS	O
:	O
The	O
effect	O
of	O
insulin	O
on	O
VEGF	O
expression	O
in	O
vivo	O
was	O
examined	O
by	O
in	O
situ	O
hybridization	O
studies	O
of	O
rat	S-Species
retinal	O
VEGF	O
transcripts	O
.	O

Intensive	O
insulin	O
therapy	O
may	O
cause	O
a	O
transient	O
worsening	O
of	O
retinopathy	O
in	O
patients	S-Species
with	O
diabetes	O
through	O
increased	O
retinal	O
VEGF	O
gene	O
expression	O
.	O

Both	O
groups	O
received	O
either	O
0	O
.	O
5	O
mg	O
/	O
ml	O
linomide	O
in	O
drinking	O
water	O
or	O
acidified	O
water	O
and	O
were	O
followed	O
until	O
tumor	O
diameter	O
reached	O
3	O
cm	O
or	O
for	O
4	O
weeks	O
.	O

The	O
latent	O
membrane	O
protein	O
LMP1	O
of	O
Epstein	B-Species
-	I-Species
Barr	I-Species
virus	E-Species
(	O
EBV	S-Species
)	O
is	O
often	O
present	O
in	O
EBV	S-Species
-	O
associated	O
malignancies	O
including	O
nasopharyngeal	O
carcinoma	O
and	O
Hodgkin	O
'	O
s	O
lymphoma	O
.	O

Furthermore	O
,	O
LMP1	O
cooperates	O
with	O
a	O
p16	O
-	O
insensitive	O
CDK4	O
(	O
R24C	O
)	O
oncogene	O
in	O
transforming	O
MEF	O
cells	O
.	O

The	O
ras	O
-	O
transformed	O
,	O
ATX	O
-	O
secreting	O
subclones	O
had	O
enhanced	O
motility	O
to	O
ATX	O
as	O
chemoattractant	O
,	O
but	O
there	O
was	O
little	O
difference	O
in	O
the	O
motility	O
responses	O
of	O
NIH3T3	O
cells	O
transfected	O
with	O
atx	O
,	O
an	O
inactive	O
mutant	O
gene	O
,	O
or	O
empty	O
vector	O
.	O

High	O
-	O
affinity	O
binding	O
is	O
reduced	O
in	O
EGFR	O
.	O
TDM	O
/	O
18	O
-	O
26	O
,	O
although	O
the	O
t1	O
/	O
2	O
of	O
receptor	O
internalization	O
is	O
not	O
prolonged	O
.	O

The	O
second	O
most	O
prevalent	O
urological	O
malignancy	O
in	O
middle	O
aged	O
and	O
elderly	O
men	S-Species
is	O
bladder	O
cancer	O
,	O
with	O
90	O
%	O
of	O
the	O
cases	O
being	O
transitional	O
cell	O
carcinomas	O
.	O

In	O
addition	O
,	O
most	O
of	O
these	O
agents	O
require	O
instrumentation	O
of	O
the	O
urinary	O
tract	O
and	O
are	O
delivered	O
at	O
a	O
significant	O
cost	O
and	O
potential	O
morbidity	O
to	O
the	O
patient	S-Species
.	O

The	O
hypothesis	O
that	O
modifications	O
of	O
activity	O
and	O
/	O
or	O
expression	O
of	O
nitric	O
oxide	O
synthase	O
(	O
NOS	O
)	O
isozymes	O
might	O
play	O
a	O
role	O
in	O
these	O
modifications	O
,	O
via	O
enhanced	O
local	O
production	O
of	O
nitric	O
oxide	O
,	O
was	O
tested	O
in	O
this	O
study	O
.	O

Peritoneal	O
NOS	O
activity	O
is	O
increased	O
fivefold	O
in	O
long	O
-	O
term	O
PD	O
patients	S-Species
compared	O
with	O
control	O
subjects	O
.	O

This	O
study	O
uses	O
quantitative	O
histomorphometry	O
and	O
double	O
-	O
immunohistologic	O
detection	O
techniques	O
for	O
the	O
demarcation	O
of	O
proliferating	O
endothelial	O
cells	O
,	O
to	O
show	O
that	O
synchronized	O
hair	O
follicle	O
cycling	O
in	O
adolescent	O
C57BL	B-Species
/	I-Species
6	I-Species
mice	E-Species
is	O
associated	O
with	O
substantial	O
angiogenesis	O
,	O
and	O
that	O
inhibiting	O
angiogenesis	O
in	O
vivo	O
by	O
the	O
intraperitoneal	O
application	O
of	O
a	O
fumagillin	O
derivative	O
retards	O
experimentally	O
induced	O
anagen	O
development	O
in	O
these	O
mice	S-Species
.	O

Thus	O
,	O
angiogenesis	O
is	O
a	O
physiologic	O
event	O
in	O
normal	O
postnatal	O
murine	S-Species
skin	O
,	O
apparently	O
is	O
dictated	O
by	O
the	O
hair	O
follicle	O
,	O
and	O
appears	O
to	O
be	O
required	O
for	O
normal	O
anagen	O
development	O
.	O

After	O
incubation	O
for	O
4	O
days	O
,	O
the	O
medium	O
from	O
the	O
coculture	O
system	O
is	O
collected	O
.	O

A	O
tumor	O
'	O
s	O
ability	O
to	O
successfully	O
metastasize	O
may	O
be	O
dependent	O
on	O
mediators	O
generated	O
in	O
the	O
tumor	O
-	O
host	O
interaction	O
,	O
and	O
may	O
not	O
be	O
just	O
an	O
independent	O
characteristic	O
of	O
the	O
tumor	O
itself	O
.	O

Following	O
proteolysis	O
,	O
it	O
is	O
thought	O
that	O
the	O
intracellular	O
portion	O
of	O
Notch	O
(	O
N	O
(	O
ic	O
)	O
)	O
translocates	O
to	O
the	O
nucleus	O
,	O
where	O
it	O
is	O
involved	O
in	O
regulating	O
gene	O
expression	O
.	O

CONCLUSIONS	O
:	O
These	O
results	O
suggest	O
that	O
CD40	O
expression	O
on	O
lung	O
cancer	O
may	O
play	O
a	O
role	O
in	O
metastatic	O
spread	O
,	O
and	O
also	O
may	O
serve	O
as	O
a	O
prognostic	O
marker	O
and	O
an	O
indicator	O
of	O
advanced	O
disease	O
.	O

Using	O
univariate	O
analysis	O
,	O
the	O
S	O
-	O
100beta	O
level	O
and	O
metastatic	O
profile	O
were	O
found	O
to	O
be	O
statistically	O
significant	O
prognostic	O
factors	O
for	O
survival	O
.	O

TEL	O
,	O
a	O
putative	O
tumor	O
suppressor	O
,	O
modulates	O
cell	O
growth	O
and	O
cell	O
morphology	O
of	O
ras	O
-	O
transformed	O
cells	O
while	O
repressing	O
the	O
transcription	O
of	O
stromelysin	O
-	O
1	O
.	O

Reconstitution	O
of	O
MCF	O
-	O
7	O
cells	O
by	O
stable	O
transfection	O
of	O
CASP	O
-	O
3	O
cDNA	O
restores	O
all	O
these	O
defects	O
and	O
results	O
in	O
an	O
extensive	O
apoptosis	O
after	O
cisplatin	O
treatment	O
.	O

BACKGROUND	O
:	O
Neurotrophins	O
mediate	O
their	O
effects	O
by	O
binding	O
to	O
members	O
of	O
the	O
Trk	O
family	O
of	O
receptor	O
tyrosine	O
kinases	O
and	O
to	O
the	O
low	O
-	O
affinity	O
nerve	O
growth	O
factor	O
receptor	O
p75	O
.	O

Apoptotic	O
signaling	O
by	O
p75	O
was	O
ligand	O
-	O
independent	O
and	O
only	O
partly	O
caspase	O
-	O
dependent	O
.	O

The	O
soluble	O
factors	O
they	O
release	O
in	O
its	O
presence	O
arrest	O
the	O
cycle	O
of	O
endothelial	O
cells	O
(	O
EC	O
)	O
,	O
inhibit	O
in	O
vitro	O
angiogenesis	O
,	O
negatively	O
modulate	O
the	O
production	O
of	O
matrix	O
metalloproteinase	O
-	O
9	O
,	O
and	O
the	O
ability	O
of	O
EC	O
to	O
adhere	O
to	O
vitronectin	O
and	O
up	O
-	O
regulate	O
ICAM	O
-	O
1	O
and	O
VCAM	O
-	O
1	O
expression	O
.	O

We	O
used	O
neutralizing	O
Abs	O
to	O
show	O
that	O
the	O
IFN	O
-	O
inducible	O
protein	O
-	O
10	O
and	O
monokine	O
-	O
induced	O
by	O
IFN	O
-	O
gamma	O
chemokines	O
are	O
pivotal	O
in	O
inducing	O
these	O
effects	O
.	O

[	O
Study	O
of	O
fungus	O
polysaccharides	O
compounds	O
(	O
FPC	O
)	O
in	O
inducing	O
the	O
apoptosis	O
of	O
liver	O
cancer	O
cell	O
Bel	O
-	O
7402	O
]	O
.	O

Effects	O
of	O
morphological	O
patterning	O
on	O
endothelial	O
cell	O
migration	O
.	O

Although	O
there	O
was	O
no	O
significant	O
difference	O
of	O
the	O
H	B-Species
.	I-Species
pylori	E-Species
positivity	O
between	O
the	O
two	O
groups	O
,	O
the	O
rate	O
for	O
both	O
groups	O
was	O
higher	O
than	O
reported	O
in	O
previous	O
studies	O
.	O

Mutation	O
of	O
p53	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
high	O
proliferative	O
activity	O
of	O
tumors	O
in	O
the	O
RSCM	O
group	O
and	O
H	B-Species
.	I-Species
pylori	E-Species
infection	O
may	O
be	O
closely	O
related	O
to	O
carcinogenesis	O
in	O
patients	S-Species
with	O
RSC	O
.	O

Antibodies	O
to	O
PAI	O
-	O
1	O
alter	O
the	O
invasive	O
and	O
migratory	O
properties	O
of	O
human	S-Species
tumour	O
cells	O
in	O
vitro	O
.	O

The	O
non	O
-	O
invasive	O
human	S-Species
melanoma	O
cell	O
line	O
,	O
IF6	O
,	O
which	O
does	O
not	O
express	O
uPA	O
,	O
provided	O
further	O
confirmation	O
of	O
PAI	O
-	O
1	O
and	O
uPA	O
'	O
s	O
role	O
as	O
,	O
upon	O
transfection	O
with	O
uPA	O
,	O
this	O
cell	O
line	O
attained	O
an	O
invasive	O
phenotype	O
,	O
which	O
was	O
again	O
attenuated	O
by	O
MAI	O
-	O
12	O
.	O

HSP27	O
is	O
implicated	O
in	O
protein	O
-	O
protein	O
interactions	O
such	O
as	O
folding	O
,	O
translocation	O
,	O
and	O
prevention	O
of	O
inappropriate	O
protein	O
aggregation	O
.	O

The	O
issue	O
is	O
complicated	O
because	O
both	O
disorders	O
have	O
a	O
propensity	O
for	O
MDS	O
or	O
AML	O
as	O
part	O
of	O
their	O
natural	O
history	O
.	O

To	O
determine	O
if	O
hypoxic	O
activation	O
of	O
these	O
stress	O
activated	O
protein	O
kinases	O
regulated	O
HIF	O
-	O
1alpha	O
and	O
VEGF	O
expression	O
,	O
we	O
assayed	O
JNK1	O
and	O
p38	O
activity	O
in	O
squamous	O
cell	O
carcinoma	O
(	O
SCC	O
)	O
lines	O
grown	O
under	O
normoxic	O
or	O
hypoxic	O
conditions	O
.	O

Overexpression	O
of	O
JNK1	O
or	O
p38	O
was	O
sufficient	O
to	O
induce	O
HIF	O
-	O
1alpha	O
and	O
VEGF	O
expression	O
.	O

Simian	B-Species
virus	I-Species
40	E-Species
large	O
T	O
antigen	O
and	O
two	O
independent	O
T	O
-	O
antigen	O
segments	O
sensitize	O
cells	O
to	O
apoptosis	O
following	O
genotoxic	O
damage	O
.	O

Target	O
FVs	O
are	O
tracked	O
by	O
a	O
joy	O
-	O
stick	O
controlled	O
laser	O
aiming	O
beam	O
until	O
an	O
intravenously	O
-	O
injected	O
high	O
-	O
concentration	O
ICG	O
dye	O
bolus	O
is	O
observed	O
to	O
enter	O
the	O
target	O
vessel	O
,	O
at	O
which	O
time	O
the	O
laser	O
is	O
fired	O
.	O

This	O
suggested	O
that	O
CLA	O
might	O
inhibit	O
angiogenesis	O
in	O
vivo	O
.	O

After	O
7	O
days	O
,	O
the	O
pellets	O
from	O
animals	O
fed	O
the	O
control	O
diet	O
were	O
infiltrated	O
by	O
abundant	O
branching	O
networks	O
of	O
blood	O
vessels	O
with	O
patent	O
lumen	O
-	O
containing	O
RBCs	O
.	O

Molecular	O
characterization	O
of	O
angiogenic	O
properties	O
of	O
human	S-Species
oral	O
squamous	O
cell	O
carcinoma	O
cells	O
.	O

Prolonged	O
culture	O
led	O
to	O
the	O
implantation	O
of	O
cancer	O
cells	O
into	O
the	O
monolayer	O
of	O
the	O
F	O
-	O
2	O
cells	O
,	O
which	O
was	O
mediated	O
mainly	O
by	O
alpha	O
(	O
3	O
)	O
beta	O
(	O
1	O
)	O
-	O
integrin	O
.	O

The	O
size	O
of	O
these	O
A431	O
tumors	O
did	O
not	O
differ	O
significantly	O
from	O
those	O
of	O
control	O
A431	O
tumors	O
raised	O
without	O
F	O
-	O
2	O
cells	O
.	O

Interestingly	O
,	O
Dss1	O
expression	O
was	O
also	O
shown	O
to	O
be	O
elevated	O
in	O
skin	O
papillomas	O
relative	O
to	O
normal	O
skins	O
,	O
and	O
further	O
increased	O
in	O
squamous	O
cell	O
malignancies	O
.	O

Functional	O
studies	O
by	O
ectopically	O
constitutive	O
expression	O
of	O
Dss1	O
in	O
JB6	O
Cl	O
41	O
-	O
5a	O
preneoplastic	O
cells	O
strongly	O
increased	O
focus	O
formation	O
and	O
proliferation	O
of	O
these	O
cells	O
and	O
enhanced	O
efficiency	O
of	O
neoplastic	O
transformation	O
of	O
the	O
cells	O
in	O
soft	O
agar	O
.	O

Downregulation	O
of	O
c	O
-	O
FLIP	O
sensitizes	O
DU145	O
prostate	O
cancer	O
cells	O
to	O
Fas	O
-	O
mediated	O
apoptosis	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
try	O
to	O
understand	O
why	O
DU145	O
cells	O
are	O
resistant	O
to	O
CH	O
-	O
11	O
and	O
determine	O
the	O
signaling	O
pathway	O
utilized	O
by	O
AdGFPFasL	B-Species
(	I-Species
TET	I-Species
)	E-Species
to	O
induce	O
apoptosis	O
in	O
these	O
Fas	O
-	O
resistant	O
cells	O
.	O

Using	O
immunoblot	O
analysis	O
,	O
we	O
show	O
that	O
AdGFPFasL	B-Species
(	I-Species
TET	I-Species
)	E-Species
is	O
capable	O
of	O
initiating	O
the	O
classic	O
Fas	O
-	O
mediated	O
apoptotic	O
pathway	O
in	O
DU145	O
cells	O
,	O
which	O
includes	O
activation	O
of	O
caspases	O
-	O
8	O
,	O
-	O
3	O
,	O
-	O
7	O
,	O
and	O
-	O
9	O
,	O
BID	O
cleavage	O
,	O
cytochrome	O
c	O
release	O
from	O
mitochondria	O
,	O
and	O
PARP	O
cleavage	O
.	O

Topoisomerase	O
I	O
(	O
topo	O
I	O
)	O
is	O
an	O
important	O
target	O
for	O
the	O
treatment	O
of	O
malignant	O
disease	O
,	O
especially	O
colorectal	O
cancer	O
.	O

OBJECTIVE	O
:	O
To	O
investigate	O
the	O
effect	O
of	O
the	O
expression	O
and	O
mutation	O
of	O
c	O
-	O
kit	O
gene	O
and	O
its	O
relationship	O
with	O
clinical	O
pathology	O
and	O
prognosis	O
of	O
gastrointestinal	O
stromal	O
tumor	O
(	O
GIST	O
)	O
.	O

METHODS	O
:	O
Immunohistochemical	O
and	O
PCR	O
-	O
SSCP	O
techniques	O
were	O
used	O
to	O
detect	O
c	O
-	O
kit	O
protein	O
expression	O
and	O
c	O
-	O
kit	O
gene	O
exon	O
11	O
mutation	O
in	O
82	O
patients	S-Species
with	O
GIST	O
.	O

Altogether	O
,	O
these	O
results	O
suggest	O
that	O
the	O
glycolytic	O
pathway	O
may	O
be	O
an	O
important	O
target	O
for	O
therapeutic	O
intervention	O
to	O
sensitize	O
tumor	O
cells	O
to	O
selectively	O
toxic	O
soluble	O
death	O
ligands	O
or	O
death	O
ligand	O
-	O
expressing	O
cells	O
of	O
the	O
immune	O
system	O
by	O
facilitating	O
the	O
activation	O
of	O
initiator	O
caspase	O
-	O
8	O
.	O

This	O
may	O
explain	O
why	O
some	O
patients	S-Species
remain	O
without	O
symptoms	O
or	O
signs	O
of	O
ischemia	O
.	O

This	O
remodeling	O
process	O
seems	O
to	O
be	O
mainly	O
flow	O
-	O
mediated	O
.	O

In	O
addition	O
,	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
and	O
prostaglandin	O
E	O
(	O
2	O
)	O
(	O
PGE	O
(	O
2	O
)	O
)	O
immunoassay	O
were	O
performed	O
to	O
verify	O
whether	O
BV	O
possesses	O
an	O
inhibitory	O
effect	O
on	O
the	O
expression	O
of	O
cyclooxygenase	O
(	O
COX	O
)	O
and	O
PGE	O
(	O
2	O
)	O
synthesis	O
.	O

Expression	O
of	O
COX	O
-	O
2	O
mRNA	O
and	O
synthesis	O
of	O
PGE	O
(	O
2	O
)	O
were	O
inhibited	O
by	O
BV	O
.	O

Injection	O
of	O
indomethacin	O
,	O
a	O
nonselective	O
COX	O
inhibitor	O
,	O
on	O
the	O
day	O
of	O
ovulation	O
and	O
the	O
following	O
day	O
decreased	O
serum	O
levels	O
of	O
progesterone	O
,	O
as	O
did	O
injection	O
of	O
the	O
selective	O
COX	O
-	O
II	O
inhibitor	O
NS	O
-	O
398	O
.	O

None	O
of	O
the	O
inhibitors	O
had	O
any	O
effect	O
on	O
the	O
weight	O
of	O
the	O
superovulated	O
ovaries	O
or	O
on	O
the	O
synthesis	O
of	O
progesterone	O
by	O
cultured	O
luteal	O
cells	O
.	O

By	O
means	O
of	O
intravital	O
microscopy	O
,	O
tumor	O
necrosis	O
factor	O
alpha	O
-	O
stimulated	O
leukocyte	O
-	O
vessel	O
wall	O
interactions	O
were	O
studied	O
in	O
ear	O
skin	O
microvessels	O
of	O
nude	B-Species
mice	E-Species
bearing	O
small	O
human	S-Species
LS174T	O
colon	O
carcinomas	O
and	O
in	O
C57Bl	B-Species
/	I-Species
6	I-Species
mice	E-Species
bearing	O
murine	S-Species
B16F10	O
melanomas	O
.	O

The	O
effects	O
of	O
LMP1	O
on	O
the	O
invasion	O
and	O
migration	O
of	O
CNE1	O
cells	O
were	O
investigated	O
by	O
transwell	O
methods	O
.	O

The	O
increased	O
expression	O
of	O
MMP	O
-	O
9	O
was	O
also	O
shown	O
in	O
CNE1	O
-	O
GL	O
cells	O
by	O
Western	O
blot	O
analysis	O
.	O

The	O
hypothesis	O
was	O
that	O
therapy	O
with	O
NH	O
(	O
2	O
)	O
-	O
terminally	O
truncated	O
form	O
of	O
galectin	O
-	O
3	O
(	O
galectin	O
-	O
3C	O
)	O
will	O
be	O
efficacious	O
for	O
reduction	O
in	O
tumor	O
growth	O
and	O
for	O
inhibition	O
of	O
metastases	O
.	O

The	O
p53	O
and	O
VEGF	O
staining	O
statuses	O
were	O
coincident	O
in	O
only	O
21	O
%	O
of	O
the	O
tumors	O
,	O
and	O
no	O
significant	O
correlation	O
was	O
found	O
between	O
p53	O
and	O
VEGF	O
statuses	O
.	O

Conversely	O
,	O
expression	O
of	O
pAd	O
-	O
T34A	O
caused	O
apoptosis	O
in	O
umbilical	O
vein	O
and	O
dermal	O
microvascular	O
endothelial	O
cells	O
and	O
resulted	O
in	O
caspase	O
-	O
3	O
activity	O
.	O

Cell	O
death	O
induced	O
by	O
survivin	O
targeting	O
exhibited	O
the	O
hallmarks	O
of	O
mitochondrial	O
-	O
dependent	O
apoptosis	O
with	O
release	O
of	O
cytochrome	O
c	O
and	O
loss	O
of	O
mitochondrial	O
transmembrane	O
potential	O
and	O
was	O
suppressed	O
in	O
Apaf	O
-	O
1	O
or	O
caspase	O
-	O
9	O
knockout	O
mouse	S-Species
embryonic	O
fibroblasts	O
.	O

When	O
injected	O
in	O
human	S-Species
breast	O
cancer	O
xenografts	O
,	O
pAd	O
-	O
T34A	O
inhibited	O
growth	O
of	O
established	O
tumors	O
and	O
triggered	O
tumor	O
cell	O
apoptosis	O
in	O
vivo	O
.	O

Following	O
intravenous	O
administration	O
of	O
cationic	O
lipid	O
-	O
DNA	O
complexes	O
(	O
lipoplexes	O
)	O
into	O
mice	S-Species
,	O
transfection	O
(	O
lipofection	O
)	O
occurs	O
predominantly	O
in	O
the	O
lungs	O
.	O

This	O
aggregation	O
process	O
was	O
irreversible	O
and	O
was	O
inversely	O
correlated	O
with	O
the	O
percentage	O
of	O
lung	O
cells	O
that	O
took	O
up	O
lipoplexes	O
and	O
with	O
the	O
efficiency	O
of	O
lipofection	O
.	O

Angiogenic	O
activity	O
of	O
the	O
aqueous	O
humor	O
was	O
quantified	O
by	O
measuring	O
its	O
effect	O
on	O
the	O
migration	O
of	O
capillary	O
endothelial	O
cells	O
.	O

Expression	O
of	O
osteoprotegerin	O
and	O
RANK	O
ligand	O
in	O
breast	O
cancer	O
bone	O
metastasis	O
.	O

MDA	O
-	O
MB	O
-	O
231	O
cells	O
alone	O
or	O
breast	O
cancer	O
samples	O
did	O
not	O
express	O
RANKL	O
mRNA	O
.	O

This	O
review	O
focuses	O
on	O
the	O
application	O
of	O
therapeutic	O
angiogenesis	O
for	O
treating	O
ischemic	O
muscle	O
disease	O
and	O
includes	O
a	O
critical	O
evaluation	O
of	O
the	O
parameters	O
and	O
limitations	O
of	O
current	O
procedures	O
.	O

Vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
is	O
a	O
mitogen	O
that	O
acts	O
exclusively	O
on	O
endothelial	O
cells	O
.	O

The	O
roles	O
of	O
miscrovascularity	O
density	O
(	O
MVD	O
)	O
and	O
VEGF	O
expression	O
in	O
the	O
progression	O
of	O
oral	O
squamous	O
cell	O
carcinoma	O
(	O
OSCC	O
)	O
have	O
been	O
controversial	O
.	O

This	O
chapter	O
focuses	O
on	O
the	O
morphology	O
of	O
blood	O
vessel	O
formation	O
in	O
and	O
around	O
the	O
early	O
central	O
nervous	O
system	O
(	O
CNS	O
,	O
i	O
.	O
e	O
.	O
,	O
brain	O
and	O
spinal	O
cord	O
)	O
of	O
avian	S-Species
embryos	O
.	O

We	O
discuss	O
cell	O
lineages	O
,	O
proliferation	O
and	O
interactions	O
of	O
endothelial	O
cells	O
,	O
pericytes	O
and	O
smooth	O
muscle	O
cells	O
,	O
and	O
macrophages	O
.	O

Due	O
to	O
space	O
limitations	O
,	O
we	O
can	O
not	O
review	O
the	O
molecular	O
control	O
of	O
CNS	O
angiogenesis	O
,	O
but	O
refer	O
the	O
reader	O
to	O
other	O
chapters	O
in	O
this	O
book	O
and	O
to	O
recent	O
publications	O
on	O
the	O
assembly	O
of	O
the	O
vasculature	O
(	O
1	O
,	O
2	O
)	O
.	O

It	O
is	O
proposed	O
that	O
the	O
switch	O
from	O
tumor	O
suppressor	O
to	O
oncogene	O
reflects	O
genetic	O
or	O
epigenetic	O
alterations	O
in	O
signaling	O
pathways	O
in	O
tumor	O
cells	O
that	O
alter	O
the	O
readout	O
from	O
the	O
TGFbeta1	O
pathway	O
.	O

Clinical	O
,	O
laboratory	O
,	O
histopathological	O
,	O
and	O
pharmacological	O
evidence	O
support	O
the	O
notion	O
that	O
the	O
coagulation	O
system	O
,	O
which	O
is	O
activated	O
in	O
most	O
cancer	O
patients	S-Species
,	O
plays	O
an	O
important	O
role	O
in	O
tumor	O
biology	O
.	O

This	O
event	O
is	O
independent	O
of	O
fibrin	O
formation	O
.	O

Thrombin	O
decreases	O
the	O
ability	O
of	O
endothelial	O
cells	O
to	O
attach	O
to	O
basement	O
membrane	O
proteins	O
.	O

These	O
results	O
could	O
explain	O
the	O
angiogenic	O
and	O
tumor	O
-	O
promoting	O
effect	O
of	O
thrombin	O
and	O
provide	O
the	O
basis	O
for	O
development	O
of	O
thrombin	O
receptor	O
mimetics	O
or	O
antagonists	O
for	O
therapeutic	O
application	O
.	O

Little	O
,	O
however	O
,	O
is	O
known	O
about	O
the	O
inhibitory	O
mechanisms	O
.	O

Pak1	O
-	O
DLC1	O
interaction	O
plays	O
an	O
essential	O
role	O
in	O
cell	O
survival	O
,	O
which	O
depends	O
on	O
Pak1	O
'	O
s	O
phosphorylation	O
of	O
DLC1	O
on	O
Ser88	O
.	O

The	O
proportion	O
of	O
SMCs	O
surviving	O
in	O
the	O
implanted	O
region	O
was	O
greater	O
(	O
P	O
less	O
than	O
0	O
.	O
05	O
)	O
in	O
the	O
IGF	O
-	O
1	O
-	O
transfected	O
group	O
than	O
in	O
the	O
vector	O
or	O
cell	O
controls	O
.	O

It	O
suggests	O
that	O
altered	O
PTEN	O
gene	O
contributes	O
to	O
tumorigenesis	O
and	O
progression	O
of	O
gastric	O
carcinomas	O
.	O

Granulocyte	O
-	O
macrophage	O
colony	O
-	O
stimulating	O
factor	O
and	O
interleukin	O
-	O
3	O
enhance	O
the	O
incorporation	O
of	O
cytosine	O
arabinoside	O
into	O
the	O
DNA	O
of	O
leukemic	O
blasts	O
and	O
the	O
cytotoxic	O
effect	O
on	O
clonogenic	O
cells	O
from	O
patients	S-Species
with	O
acute	O
myeloid	O
leukemia	O
.	O

In	O
contrast	O
,	O
MCT	O
3	O
was	O
the	O
predominantly	O
expressed	O
isoform	O
in	O
normal	O
brain	O
.	O

The	O
molecular	O
mechanisms	O
regulating	O
the	O
gene	O
expression	O
under	O
hypoxic	O
conditions	O
could	O
increase	O
the	O
therapeutic	O
window	O
of	O
tumor	O
-	O
specific	O
delivery	O
systems	O
.	O

In	O
this	O
study	O
,	O
to	O
examine	O
hypoxia	O
-	O
specific	O
production	O
of	O
anti	O
-	O
angiogenic	O
therapeutic	O
gene	O
,	O
we	O
constructed	O
5	O
copies	O
of	O
HRE	O
(	O
5xHRE	O
)	O
of	O
human	S-Species
VEGF	O
linked	O
to	O
soluble	O
Tie2	O
(	O
sTie2	O
)	O
driven	O
by	O
minimal	O
SV40	O
promoter	O
(	O
5xHRE	O
/	O
SV40	O
/	O
sTie2	O
)	O
.	O

The	O
increased	O
expressions	O
of	O
these	O
proteins	O
in	O
Galpha	O
(	O
12	O
)	O
QL	O
cells	O
were	O
validated	O
by	O
immunoblot	O
analysis	O
.	O

An	O
immunohistochemical	O
score	O
based	O
on	O
the	O
intensity	O
of	O
immunoreactivity	O
and	O
proportion	O
of	O
immunoreactive	O
cells	O
was	O
established	O
for	O
each	O
MMP	O
and	O
TIMP	O
.	O

Neuroblastoma	O
is	O
derived	O
from	O
SNS	O
precursors	O
.	O

In	O
a	O
subset	O
of	O
neuroblastomas	O
,	O
a	O
spontaneous	O
neuronal	O
to	O
neuroendocrine	O
differentiation	O
occurs	O
in	O
areas	O
adjacent	O
to	O
necrotic	O
zones	O
.	O

This	O
study	O
shows	O
that	O
angiogenin	O
expression	O
is	O
up	O
-	O
regulated	O
in	O
the	O
cytoplasmic	O
and	O
nuclear	O
compartments	O
in	O
in	O
situ	O
carcinoma	O
and	O
invasive	O
carcinoma	O
compared	O
with	O
normal	O
breast	O
tissue	O
and	O
that	O
angiogenin	O
expression	O
in	O
invasive	O
carcinomas	O
is	O
significantly	O
positively	O
associated	O
with	O
high	O
tumour	O
grade	O
(	O
p	O
=	O
0	O
.	O
03	O
)	O
,	O
positive	O
oestrogen	O
receptor	O
(	O
ER	O
)	O
status	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
,	O
HIF	O
-	O
1	O
alpha	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
and	O
DEC	O
1	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
,	O
but	O
not	O
with	O
patient	S-Species
age	O
(	O
p	O
=	O
0	O
.	O
8	O
)	O
,	O
tumour	O
size	O
(	O
p	O
=	O
0	O
.	O
25	O
)	O
,	O
lymph	O
node	O
status	O
(	O
p	O
=	O
0	O
.	O
69	O
)	O
,	O
epidermal	O
growth	O
factor	O
receptor	O
(	O
p	O
=	O
0	O
.	O
56	O
)	O
or	O
microvessel	O
density	O
(	O
p	O
=	O
0	O
.	O
32	O
)	O
.	O

In	O
addition	O
to	O
p16	O
(	O
INK4A	O
)	O
,	O
the	O
INK4A	O
locus	O
encodes	O
a	O
splice	O
variant	O
,	O
termed	O
p12	O
-	O
-	O
specifically	O
expressed	O
in	O
human	S-Species
pancreas	O
-	O
-	O
and	O
ARF	O
,	O
a	O
protein	O
encoded	O
by	O
an	O
alternative	O
reading	O
frame	O
that	O
acts	O
as	O
a	O
tumor	O
suppressor	O
through	O
the	O
p53	O
pathway	O
.	O

These	O
results	O
indicate	O
that	O
the	O
INK4B	O
locus	O
,	O
similarly	O
to	O
INK4A	O
-	O
ARF	O
,	O
harbors	O
two	O
different	O
splicing	O
variants	O
that	O
can	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
both	O
the	O
p53	O
and	O
retinoblastoma	O
pathways	O
,	O
the	O
two	O
major	O
molecular	O
pathways	O
in	O
tumor	O
suppression	O
.	O

These	O
properties	O
make	O
such	O
agents	O
potentially	O
useful	O
as	O
adjunctive	O
therapy	O
in	O
haemophilia	O
.	O

Thalidomide	O
and	O
angiostatin	O
inhibit	O
tumor	O
growth	O
in	O
a	O
murine	S-Species
xenograft	O
model	O
of	O
human	S-Species
cervical	O
cancer	O
.	O

Excessive	O
vascular	O
development	O
and	O
blood	O
vessel	O
remodeling	O
appears	O
in	O
psoriasis	O
,	O
rheumatoid	O
arthritis	O
,	O
diabetic	O
retinopathy	O
and	O
solid	O
tumors	O
formation	O
.	O

We	O
have	O
evaluated	O
the	O
effect	O
of	O
thalidomide	O
on	O
VEGF	O
secretion	O
,	O
cell	O
migration	O
,	O
adhesion	O
as	O
well	O
as	O
in	O
capillary	O
formation	O
of	O
human	S-Species
endothelial	O
cell	O
line	O
EA	O
.	O
hy	O
926	O
.	O

Thalidomide	O
at	O
the	O
concentrations	O
of	O
0	O
.	O
01	O
microM	O
and	O
10	O
microM	O
inhibited	O
VEGF	O
secretion	O
into	O
supernatants	O
,	O
decreased	O
the	O
number	O
of	O
formed	O
capillary	O
tubes	O
and	O
increased	O
cell	O
adhesion	O
to	O
collagen	O
.	O

Regulation	O
of	O
skin	O
microvasculature	O
angiogenesis	O
,	O
cell	O
migration	O
,	O
and	O
permeability	O
by	O
a	O
specific	O
inhibitor	O
of	O
PKCalpha	O
.	O

Low	O
density	O
lipoprotein	O
receptor	O
-	O
related	O
protein	O
-	O
1	O
(	O
LRP	O
-	O
1	O
)	O
is	O
a	O
catabolic	O
receptor	O
for	O
extracellular	O
matrix	O
(	O
ECM	O
)	O
structural	O
proteins	O
and	O
for	O
proteins	O
that	O
bind	O
to	O
ECM	O
.	O

We	O
show	O
that	O
LRP	O
-	O
1	O
deficiency	O
in	O
murine	S-Species
embryonic	O
fibroblasts	O
(	O
MEFs	O
)	O
is	O
associated	O
with	O
increased	O
levels	O
of	O
type	O
III	O
collagen	O
and	O
pigment	O
epithelium	O
-	O
derived	O
factor	O
,	O
which	O
accumulate	O
in	O
the	O
substratum	O
surrounding	O
cells	O
.	O

Here	O
,	O
we	O
show	O
that	O
NCAM	O
-	O
deficient	O
beta	O
cell	O
tumors	O
grew	O
leaky	O
blood	O
vessels	O
with	O
perturbed	O
pericyte	O
-	O
endothelial	O
cell	O
-	O
cell	O
interactions	O
and	O
deficient	O
perivascular	O
deposition	O
of	O
ECM	O
components	O
.	O

The	O
transcription	O
factor	O
NF	O
-	O
kappaB	O
and	O
associated	O
regulatory	O
factors	O
(	O
including	O
IkappaB	O
kinase	O
subunits	O
and	O
the	O
IkappaB	O
family	O
member	O
Bcl	O
-	O
3	O
)	O
are	O
strongly	O
implicated	O
in	O
a	O
variety	O
of	O
hematologic	O
and	O
solid	O
tumor	O
malignancies	O
.	O

The	O
mechanism	O
of	O
this	O
potent	O
collaboration	O
is	O
elucidated	O
in	O
this	O
study	O
of	O
Runx2	O
/	O
MYC	O
mice	O
.	O

The	O
low	O
apoptosis	O
phenotype	O
is	O
dominant	O
in	O
Runx2	O
/	O
MYC	O
tumors	O
,	O
indicating	O
that	O
Runx2	O
confers	O
a	O
potent	O
survival	O
advantage	O
to	O
MYC	O
-	O
expressing	O
tumor	O
cells	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
molecular	O
pathway	O
of	O
the	O
cytotoxic	O
effect	O
of	O
paclitaxel	O
in	O
human	S-Species
cervical	O
cancer	O
cell	O
lines	O
.	O

Interestingly	O
,	O
in	O
CaSki	O
cells	O
,	O
which	O
were	O
more	O
suggestive	O
of	O
a	O
resistant	O
phenotype	O
,	O
paclitaxel	O
induced	O
the	O
activation	O
of	O
mTOR	O
as	O
a	O
downstream	O
target	O
of	O
Akt	O
.	O

Cancer	O
neoangiogenesis	O
is	O
often	O
disordered	O
and	O
abnormal	O
,	O
with	O
evidence	O
of	O
coexisting	O
vascular	O
endothelial	O
dysfunction	O
.	O

GDP	O
and	O
AGE	O
receptors	O
:	O
mechanisms	O
of	O
peritoneal	O
damage	O
.	O

CONCLUSIONS	O
:	O
Our	O
findings	O
suggest	O
that	O
transcriptional	O
repression	O
of	O
HRK	O
is	O
caused	O
by	O
promoter	O
hypermethylation	O
in	O
PCNSL	O
,	O
and	O
that	O
the	O
loss	O
of	O
HRK	O
associated	O
with	O
the	O
methylation	O
profile	O
of	O
other	O
genes	O
is	O
a	O
potential	O
step	O
in	O
the	O
modulation	O
of	O
cellular	O
death	O
by	O
apoptosis	O
during	O
PCNSL	O
tumorigenesis	O
.	O

In	O
vitro	O
studies	O
using	O
monolayer	O
cultures	O
of	O
human	S-Species
tumor	O
cell	O
lines	O
have	O
shown	O
that	O
2	O
-	O
DG	O
selectively	O
inhibits	O
energy	O
-	O
dependent	O
DNA	O
repair	O
and	O
cellular	O
recovery	O
processes	O
in	O
cancer	O
cells	O
.	O

Comet	O
assay	O
revealed	O
a	O
late	O
onset	O
of	O
DNA	O
breaks	O
in	O
the	O
presence	O
of	O
2	O
-	O
DG	O
following	O
irradiation	O
only	O
in	O
spheroids	O
,	O
which	O
corroborated	O
well	O
with	O
the	O
late	O
onset	O
of	O
oxidative	O
stress	O
.	O

No	O
effective	O
medical	O
therapies	O
have	O
been	O
developed	O
sofar	O
to	O
enhance	O
blood	O
flow	O
in	O
the	O
legs	O
of	O
patients	S-Species
with	O
peripheral	O
arterial	O
disease	O
(	O
PAD	O
)	O
.	O

Considering	O
the	O
relatively	O
few	O
number	O
of	O
patients	S-Species
treated	O
by	O
angiogenic	O
therapy	O
,	O
the	O
interpretation	O
of	O
clinical	O
results	O
needs	O
cautiousness	O
.	O

Six	O
edentulous	O
patients	S-Species
(	O
aged	O
60	O
+	O
/	O
-	O
9	O
years	O
)	O
with	O
a	O
severely	O
atrophic	O
mandible	O
underwent	O
bone	O
augmentation	O
with	O
distraction	O
osteogenesis	O
.	O

Two	O
distraction	O
rates	O
(	O
0	O
.	O
5	O
and	O
1	O
mm	O
/	O
day	O
)	O
were	O
compared	O
and	O
for	O
each	O
group	O
three	O
patients	S-Species
were	O
analyzed	O
.	O

Histological	O
analysis	O
demonstrated	O
the	O
presence	O
of	O
blood	O
vessels	O
throughout	O
the	O
soft	O
connective	O
tissue	O
in	O
the	O
distraction	O
gap	O
.	O

It	O
is	O
synthesised	O
and	O
secreted	O
by	O
the	O
ciliary	O
body	O
epithelium	O
(	O
CBE	O
)	O
from	O
the	O
initiation	O
of	O
CBE	O
development	O
in	O
the	O
embryo	O
,	O
and	O
production	O
continues	O
throughout	O
life	O
.	O

METHODS	O
:	O
Immunohistochemistry	O
was	O
used	O
to	O
determine	O
the	O
distribution	O
of	O
opticin	O
in	O
normal	O
human	S-Species
CBE	O
,	O
and	O
in	O
hyperplastic	O
and	O
neoplastic	O
CBE	O
lesions	O
.	O

Our	O
data	O
indicates	O
that	O
this	O
therapeutic	O
approach	O
markedly	O
promotes	O
angiogenesis	O
and	O
granulation	O
tissue	O
formation	O
in	O
comparison	O
with	O
other	O
conditions	O
14	O
days	O
after	O
wounding	O
.	O

Mutant	O
mice	S-Species
lacking	O
both	O
cyclin	O
-	O
dependent	O
kinase	O
(	O
CDK	O
)	O
inhibitors	O
p18	O
(	O
Ink4c	O
)	O
and	O
p27	O
(	O
Kip1	O
)	O
develop	O
a	O
tumor	O
spectrum	O
reminiscent	O
of	O
human	S-Species
multiple	O
endocrine	O
neoplasia	O
(	O
MEN	O
)	O
syndromes	O
.	O

Compared	O
with	O
their	O
corresponding	O
single	B-Species
mutant	I-Species
littermates	E-Species
,	O
the	O
p18	O
(	O
-	O
/	O
-	O
)	O
;	O
Men1	O
(	O
+	O
/	O
-	O
)	O
mice	O
develop	O
tumors	O
at	O
an	O
accelerated	O
rate	O
and	O
with	O
an	O
increased	O
incidence	O
in	O
the	O
pituitary	O
,	O
thyroid	O
,	O
parathyroid	O
,	O
and	O
pancreas	O
.	O

Punica	B-Species
granatum	E-Species
(	O
pomegranate	S-Species
)	O
and	O
its	O
potential	O
for	O
prevention	O
and	O
treatment	O
of	O
inflammation	O
and	O
cancer	O
.	O

Because	O
of	O
this	O
,	O
and	O
the	O
virtual	O
explosion	O
of	O
interest	O
in	O
pomegranate	S-Species
as	O
a	O
medicinal	O
and	O
nutritional	O
product	O
that	O
has	O
followed	O
,	O
this	O
review	O
is	O
accordingly	O
launched	O
.	O

The	O
pomegranate	S-Species
tree	O
,	O
Punica	B-Species
granatum	E-Species
,	O
especially	O
its	O
fruit	O
,	O
possesses	O
a	O
vast	O
ethnomedical	O
history	O
and	O
represents	O
a	O
phytochemical	O
reservoir	O
of	O
heuristic	O
medicinal	O
value	O
.	O

Angiogenesis	O
,	O
a	O
multi	O
-	O
step	O
process	O
which	O
involves	O
endothelial	O
cell	O
proliferation	O
,	O
adhesion	O
,	O
migration	O
,	O
and	O
basement	O
membrane	O
(	O
BM	O
)	O
degradation	O
,	O
is	O
essential	O
for	O
tumor	O
metastasis	O
.	O

Hyperforin	O
(	O
Hyp	O
)	O
,	O
a	O
polyphenol	O
-	O
derivative	O
of	O
St	B-Species
.	E-Species

We	O
tested	O
whether	O
as	O
well	O
as	O
inhibiting	O
leukocyte	O
elastase	O
(	O
LE	O
)	O
activity	O
,	O
Hyp	O
might	O
be	O
effective	O
in	O
containing	O
both	O
polymorphonuclear	O
neutrophil	O
(	O
PMN	O
)	O
leukocyte	O
recruitment	O
and	O
unfavorable	O
eventual	O
tissue	O
responses	O
.	O

Interference	O
with	O
Dll4	O
-	O
Notch	O
signaling	O
may	O
be	O
particularly	O
desirable	O
in	O
tumors	O
that	O
have	O
highly	O
induced	O
Dll4	O
-	O
Notch	O
pathway	O
.	O

Tsg101	O
is	O
upregulated	O
in	O
a	O
subset	O
of	O
invasive	O
human	S-Species
breast	O
cancers	O
and	O
its	O
targeted	O
overexpression	O
in	O
transgenic	B-Species
mice	E-Species
reveals	O
weak	O
oncogenic	O
properties	O
for	O
mammary	O
cancer	O
initiation	O
.	O

Previous	O
studies	O
reported	O
that	O
the	O
Tumor	O
Susceptibility	O
Gene	O
101	O
(	O
TSG101	O
)	O
is	O
upregulated	O
in	O
selected	O
human	S-Species
malignancies	O
,	O
and	O
the	O
expression	O
of	O
exogenous	O
Tsg101	O
was	O
suggested	O
to	O
transform	O
immortalized	O
fibroblasts	O
in	O
culture	O
.	O

To	O
date	O
,	O
the	O
potential	O
oncogenic	O
properties	O
of	O
Tsg101	O
have	O
not	O
been	O
examined	O
in	O
vivo	O
owing	O
to	O
the	O
lack	O
of	O
appropriate	O
model	O
systems	O
.	O

The	O
overexpression	O
of	O
Tsg101	O
resulted	O
in	O
increased	O
phosphorylation	O
of	O
the	O
epidermal	O
growth	O
factor	O
receptor	O
and	O
downstream	O
activation	O
of	O
MAP	O
kinases	O
.	O

Statistically	O
significant	O
relationship	O
between	O
p53	O
expression	O
in	O
primary	O
oral	O
cancers	O
and	O
its	O
expression	O
in	O
lymph	O
node	O
metastases	O
(	O
P	O
<	O
0	O
.	O
02	O
)	O
as	O
well	O
as	O
increased	O
expression	O
of	O
Bcl	O
-	O
xL	O
,	O
Bax	O
,	O
and	O
p53	O
in	O
metastatic	O
sites	O
compared	O
with	O
primary	O
tumors	O
could	O
indicate	O
an	O
association	O
of	O
these	O
proteins	O
with	O
oral	O
cancer	O
progression	O
and	O
development	O
of	O
metastases	O
.	O

Treatment	O
with	O
the	O
combination	O
of	O
1B3	O
and	O
DC101	O
in	O
BxPC	O
-	O
3	O
xenograft	O
-	O
bearing	O
mice	S-Species
resulted	O
in	O
tumor	O
regression	O
in	O
58	O
%	O
of	O
mice	S-Species
compared	O
to	O
that	O
in	O
18	O
%	O
of	O
mice	S-Species
treated	O
with	O
DC101	O
alone	O
.	O

In	O
all	O
patients	S-Species
,	O
a	O
major	O
and	O
consistent	O
induction	O
of	O
p53	O
target	O
genes	O
was	O
seen	O
.	O

Medical	O
therapy	O
to	O
improve	O
symptoms	O
,	O
stabilise	O
the	O
underlying	O
vascular	O
disease	O
and	O
improve	O
lower	O
limb	O
outcomes	O
is	O
an	O
important	O
and	O
effective	O
adjunct	O
to	O
lifestyle	O
modification	O
and	O
surgical	O
or	O
endovascular	O
interventions	O
in	O
patients	S-Species
with	O
IC	O
.	O

Modulating	O
metastasis	O
by	O
a	O
lymphangiogenic	O
switch	O
in	O
prostate	O
cancer	O
.	O

Further	O
,	O
we	O
implemented	O
a	O
noninvasive	O
molecular	O
imaging	O
technique	O
to	O
facilitate	O
the	O
assessment	O
of	O
the	O
metastatic	O
process	O
.	O

Taken	O
together	O
,	O
our	O
studies	O
,	O
based	O
on	O
a	O
molecular	O
imaging	O
approach	O
for	O
semiquantitative	O
detection	O
of	O
micrometastases	O
,	O
point	O
to	O
an	O
important	O
role	O
of	O
tumor	O
lymphatics	O
in	O
the	O
metastatic	O
process	O
of	O
human	S-Species
prostate	O
cancer	O
.	O

A	O
validated	O
assay	O
in	O
human	S-Species
fat	O
tissue	O
is	O
needed	O
to	O
study	O
the	O
role	O
of	O
angiogenesis	O
in	O
human	S-Species
obesity	O
.	O

The	O
response	O
to	O
taxol	O
and	O
heparin	O
-	O
steroid	O
was	O
similar	O
to	O
that	O
of	O
the	O
HPVAM	O
,	O
a	O
validated	O
angiogenesis	O
assay	O
.	O

Having	O
identified	O
the	O
nucleolar	O
localisation	O
sequence	O
in	O
BAG	O
-	O
1L	O
,	O
we	O
showed	O
that	O
mutation	O
of	O
this	O
sequence	O
did	O
not	O
prevent	O
BAG	O
-	O
1L	O
from	O
potentiating	O
VDR	O
activity	O
.	O

Furthermore	O
,	O
there	O
is	O
strong	O
evidence	O
suggesting	O
that	O
aberrant	O
activation	O
of	O
Wnt	O
signaling	O
induces	O
mammary	O
tumors	O
from	O
stem	O
/	O
progenitor	O
cells	O
,	O
and	O
that	O
Wnt	O
exerts	O
its	O
oncogenic	O
effects	O
through	O
LRP5	O
/	O
6	O
-	O
mediated	O
activation	O
of	O
beta	O
-	O
catenin	O
and	O
mTOR	O
pathways	O
.	O

Expression	O
of	O
hCAP	O
-	O
18	O
/	O
LL	O
-	O
37	O
was	O
localized	O
to	O
immune	O
and	O
granulosa	O
cells	O
of	O
normal	O
ovarian	O
tissue	O
.	O

Treatment	O
of	O
ovarian	O
cancer	O
cell	O
lines	O
with	O
recombinant	O
LL	O
-	O
37	O
stimulated	O
proliferation	O
,	O
chemotaxis	O
,	O
invasion	O
and	O
matrix	O
metalloproteinase	O
expression	O
.	O

Tumor	O
microenvironment	O
,	O
a	O
dangerous	O
society	O
leading	O
to	O
cancer	O
metastasis	O
.	O

RESULTS	O
:	O
11	O
eyes	O
of	O
11	O
patients	S-Species
were	O
included	O
in	O
the	O
study	O
,	O
which	O
had	O
a	O
mean	O
follow	O
-	O
up	O
period	O
of	O
11	O
months	O
.	O

The	O
mean	O
BCVA	O
increased	O
from	O
20	O
/	O
76	O
to	O
20	O
/	O
64	O
.	O

Neurosensorial	O
retinal	O
detachment	O
decreased	O
in	O
80	O
%	O
of	O
cases	O
.	O

PURPOSE	O
:	O
Angiogenesis	O
inhibitors	O
have	O
strong	O
therapeutic	O
potential	O
as	O
antitumor	O
agents	O
in	O
suppressing	O
tumor	O
growth	O
and	O
metastatic	O
progression	O
.	O

Treatment	O
involved	O
intravitreal	O
injection	O
of	O
bevacizumab	O
(	O
1	O
.	O
25	O
mg	O
in	O
0	O
.	O
05	O
mL	O
)	O
every	O
6	O
-	O
12	O
weeks	O
.	O

Mitogen	O
-	O
activated	O
protein	O
kinase	O
kinase	O
signaling	O
promotes	O
growth	O
and	O
vascularization	O
of	O
fibrosarcoma	O
.	O

Growth	O
inhibition	O
correlated	O
with	O
decreased	O
cellular	O
proliferation	O
and	O
extensive	O
necrosis	O
,	O
and	O
it	O
was	O
accompanied	O
by	O
a	O
decrease	O
in	O
tumor	O
mean	O
vessel	O
density	O
as	O
well	O
as	O
a	O
reduction	O
in	O
serum	O
expression	O
of	O
angioproliferative	O
cytokines	O
.	O

These	O
results	O
are	O
consistent	O
with	O
our	O
initial	O
hypothesis	O
and	O
lead	O
us	O
to	O
propose	O
that	O
MKK	O
inhibition	O
by	O
LeTx	O
is	O
a	O
broadly	O
effective	O
strategy	O
for	O
targeting	O
neovascularization	O
in	O
fibrosarcomas	O
and	O
other	O
similar	O
proliferative	O
lesions	O
.	O

Finally	O
,	O
annexin	O
II	O
down	O
-	O
regulation	O
was	O
positively	O
associated	O
with	O
lymph	O
node	O
metastasis	O
,	O
suggesting	O
that	O
it	O
may	O
be	O
a	O
prognostic	O
factor	O
in	O
NPC	O
.	O

An	O
important	O
role	O
of	O
proprotein	O
convertases	O
in	O
tumorigenic	O
processes	O
has	O
been	O
suggested	O
by	O
various	O
studies	O
.	O

This	O
study	O
indicates	O
that	O
the	O
simultaneous	O
presence	O
of	O
ITC	O
and	O
VEGFR	O
-	O
1	O
expression	O
at	O
premetastatic	O
sites	O
is	O
clinically	O
significant	O
for	O
disease	O
progression	O
.	O

In	O
addition	O
,	O
ethanol	O
exposure	O
decreased	O
expression	O
of	O
endothelial	O
VEGF	O
receptor	O
-	O
2	O
,	O
as	O
well	O
as	O
VEGF	O
receptor	O
-	O
2	O
phosphorylation	O
in	O
vitro	O
.	O

Adenomatoid	O
tumour	O
of	O
the	O
liver	O
.	O

The	O
mechanism	O
of	O
TP	O
induction	O
is	O
not	O
yet	O
completely	O
clear	O
,	O
but	O
TNF	O
,	O
IL10	O
and	O
other	O
cytokines	O
have	O
been	O
clearly	O
shown	O
to	O
induce	O
its	O
expression	O
.	O

METHOD	O
:	O
Wild	O
-	O
type	O
and	O
phosphatase	O
-	O
inactive	O
(	O
C124A	O
)	O
PTEN	O
plasmids	O
were	O
transfected	O
into	O
ovarian	O
epithelial	O
cancer	O
A2780	O
cells	O
,	O
and	O
their	O
effects	O
on	O
cell	O
apoptosis	O
,	O
cell	O
proliferation	O
,	O
cell	O
migration	O
and	O
cell	O
invasion	O
were	O
analyzed	O
by	O
flow	O
cytometry	O
analysis	O
,	O
TUNEL	O
assay	O
,	O
MTT	O
assay	O
,	O
wound	O
-	O
healing	O
assay	O
and	O
transwell	O
assay	O
.	O

Bone	O
marrow	O
-	O
derived	O
mesenchymal	O
stem	O
cells	O
(	O
BM	O
-	O
MSC	O
)	O
have	O
been	O
demonstrated	O
to	O
be	O
an	O
attractive	O
therapeutic	O
cell	O
source	O
for	O
tissue	O
regeneration	O
and	O
repair	O
.	O

This	O
study	O
investigates	O
HIF	O
-	O
1alpha	O
,	O
c	O
-	O
Myc	O
,	O
pAkt	O
,	O
and	O
aerobic	O
glycolysis	O
in	O
low	O
-	O
passage	O
breast	O
cancer	O
cells	O
under	O
the	O
assumption	O
that	O
these	O
represent	O
the	O
in	O
vivo	O
condition	O
better	O
than	O
established	O
lines	O
.	O

CONCLUSIONS	O
:	O
We	O
have	O
established	O
a	O
model	O
to	O
study	O
the	O
regulation	O
of	O
angiogenesis	O
by	O
human	S-Species
adipose	O
tissue	O
.	O

A	O
feasibility	O
study	O
was	O
carried	O
out	O
to	O
develop	O
the	O
Ahn	O
/	O
Mustoe	O
lapine	S-Species
wound	O
model	O
for	O
systematic	O
investigation	O
of	O
the	O
effects	O
of	O
electrical	O
stimulation	O
on	O
ischemic	O
wound	O
therapy	O
.	O

The	O
early	O
closure	O
of	O
all	O
wounds	O
implies	O
that	O
the	O
rabbit	S-Species
ear	O
model	O
may	O
not	O
be	O
valid	O
for	O
chronic	O
wound	O
studies	O
.	O

Clinically	O
,	O
elderly	O
patients	S-Species
are	O
more	O
vulnerable	O
to	O
acute	O
myocardial	O
infarction	O
(	O
AMI	O
)	O
.	O

The	O
transplantation	O
of	O
old	O
donor	O
-	O
derived	O
MSCs	O
attenuated	O
apoptosis	O
of	O
cardiomyocytes	O
in	O
the	O
peri	O
-	O
infarct	O
region	O
compared	O
with	O
the	O
control	O
group	O
and	O
the	O
effect	O
was	O
elevated	O
in	O
young	O
donor	O
-	O
derived	O
MSCs	O
(	O
P	O
less	O
than	O
0	O
.	O
05	O
)	O
.	O

The	O
heart	O
functions	O
(	O
left	O
ventricle	O
ejection	O
fraction	O
(	O
LVEF	O
)	O
,	O
left	O
ventricle	O
fractional	O
shortening	O
(	O
LVFS	O
)	O
)	O
were	O
improved	O
more	O
significantly	O
in	O
the	O
old	O
donor	O
-	O
derived	O
MSCs	O
group	O
than	O
in	O
the	O
control	O
group	O
and	O
the	O
heart	O
function	O
in	O
the	O
young	O
donor	O
-	O
derived	O
MSCs	O
group	O
further	O
improved	O
(	O
P	O
less	O
than	O
0	O
.	O
05	O
)	O
.	O

No	O
significant	O
correlation	O
was	O
found	O
between	O
COUP	O
-	O
TFII	O
expression	O
and	O
age	O
at	O
surgery	O
,	O
gender	O
,	O
histopathologic	O
differentiation	O
,	O
vessel	O
invasion	O
,	O
carcinoembryonic	O
antigen	O
(	O
CEA	O
)	O
,	O
or	O
nodal	O
involvement	O
.	O

Reduced	O
PTEN	O
expression	O
was	O
inversely	O
correlated	O
to	O
the	O
expression	O
of	O
proliferating	O
cell	O
nuclear	O
antigen	O
and	O
to	O
the	O
activation	O
of	O
Erk1	O
,	O
2	O
,	O
but	O
not	O
of	O
Akt	O
.	O

The	O
semaphorin	O
7A	O
receptor	O
Plexin	O
C1	O
is	O
lost	O
during	O
melanoma	O
metastasis	O
.	O

The	O
transformation	O
of	O
normal	O
melanocytes	O
,	O
or	O
melanocyte	O
stem	O
cells	O
,	O
to	O
melanoma	O
,	O
is	O
a	O
complex	O
process	O
involving	O
multiple	O
mechanisms	O
.	O

Loss	O
of	O
tumor	O
suppressor	O
proteins	O
,	O
which	O
function	O
as	O
brakes	O
on	O
cell	O
growth	O
,	O
migration	O
,	O
or	O
cell	O
survival	O
,	O
was	O
recognized	O
early	O
on	O
as	O
an	O
important	O
mechanism	O
for	O
initiation	O
and	O
progression	O
of	O
melanoma	O
.	O

In	O
this	O
report	O
,	O
we	O
analyzed	O
the	O
expression	O
of	O
Plexin	O
C1	O
using	O
immunohistochemistry	O
on	O
sections	O
of	O
primary	O
and	O
matched	O
metastatic	O
lesions	O
from	O
19	O
subjects	O
and	O
in	O
a	O
large	O
melanoma	O
tumor	O
microarray	O
.	O

In	O
patients	S-Species
with	O
pancreatic	O
carcinoma	O
,	O
the	O
levels	O
of	O
fibrinogen	O
in	O
the	O
group	O
with	O
jaundice	O
were	O
significantly	O
higher	O
than	O
in	O
patients	S-Species
without	O
jaundice	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
group	O
with	O
lymphatic	O
metastasis	O
had	O
higher	O
levels	O
than	O
the	O
group	O
without	O
lymphatic	O
metastasis	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
elevated	O
fibrinogen	O
level	O
may	O
be	O
associated	O
with	O
invasiveness	O
and	O
lymphatic	O
metastasis	O
.	O

Therefore	O
,	O
genetic	O
instability	O
plays	O
an	O
important	O
role	O
in	O
inflammation	O
-	O
associated	O
cancers	O
.	O

Human	S-Species
pituitary	O
tumor	O
transforming	O
gene	O
(	O
PTTG	O
)	O
overexpression	O
correlates	O
with	O
metastasis	O
in	O
multiple	O
tumors	O
,	O
and	O
yet	O
its	O
molecular	O
mechanisms	O
of	O
action	O
remain	O
elusive	O
.	O

We	O
detected	O
PTTG	O
overexpression	O
in	O
66	O
%	O
(	O
111	O
of	O
169	O
)	O
of	O
primary	O
esophageal	O
squamous	O
cell	O
carcinoma	O
(	O
ESCC	O
)	O
tumor	O
tissues	O
by	O
in	O
situ	O
hybridization	O
.	O

Ectopic	O
PTTG	O
overexpression	O
in	O
a	O
representative	O
ESCC	O
cell	O
line	O
,	O
EC9706	O
,	O
increased	O
in	O
vitro	O
cell	O
migration	O
and	O
invasion	O
and	O
promoted	O
in	O
vivo	O
lymph	O
node	O
metastasis	O
.	O

By	O
using	O
mass	O
spectrometric	O
analysis	O
,	O
we	O
identified	O
that	O
PTTG	O
up	O
-	O
regulated	O
S100A4	O
and	O
galectin	O
-	O
1	O
secretion	O
and	O
down	O
-	O
regulated	O
tissue	O
inhibitor	O
of	O
metalloproteinase	O
-	O
2	O
secretion	O
to	O
the	O
culture	O
media	O
.	O

Here	O
,	O
we	O
have	O
tested	O
endocytic	O
Rab	O
GTPases	O
for	O
regulation	O
of	O
VEGFR2	O
trafficking	O
and	O
signaling	O
linked	O
to	O
endothelial	O
cell	O
migration	O
.	O

We	O
recently	O
observed	O
that	O
FOXO3a	O
gene	O
inactivation	O
occurs	O
frequently	O
in	O
carcinogen	O
-	O
induced	O
lung	O
adenocarcinoma	O
(	O
LAC	O
)	O
.	O

Prior	O
to	O
this	O
cellular	O
outcome	O
,	O
FOXO3a	O
is	O
functionally	O
activated	O
and	O
mediates	O
a	O
large	O
-	O
scale	O
transcription	O
program	O
in	O
response	O
to	O
this	O
damage	O
involving	O
a	O
significant	O
modulation	O
of	O
440	O
genes	O
.	O

We	O
hypothesized	O
that	O
Erbb2	O
activation	O
contributes	O
to	O
UV	O
-	O
induced	O
skin	O
tumorigenesis	O
by	O
suppressing	O
cell	O
cycle	O
arrest	O
.	O

We	O
used	O
a	O
cellular	O
model	O
of	O
tumor	O
invasion	O
to	O
investigate	O
the	O
effect	O
of	O
activated	O
platelets	O
on	O
the	O
human	S-Species
ovarian	O
cancer	O
cell	O
line	O
,	O
SKOV3	O
.	O

The	O
effect	O
of	O
platelets	O
on	O
the	O
content	O
of	O
urokinase	O
plasminogen	O
activator	O
(	O
uPA	O
)	O
and	O
VEGF	O
in	O
SKOV3	O
cell	O
conditioned	O
medium	O
was	O
measured	O
using	O
an	O
ELISA	O
assay	O
.	O

Exposure	O
to	O
platelets	O
resulted	O
in	O
significantly	O
increased	O
uPA	O
and	O
VEGF	O
content	O
of	O
SKOV3	O
cell	O
conditioned	O
medium	O
.	O

The	O
formation	O
of	O
new	O
blood	O
vessels	O
through	O
the	O
process	O
of	O
angiogenesis	O
is	O
critical	O
in	O
vascular	O
development	O
and	O
homeostasis	O
.	O

miR	O
-	O
378	O
,	O
miR	O
-	O
296	O
,	O
and	O
the	O
miR	O
-	O
17	O
-	O
92	O
cluster	O
contribute	O
to	O
tumor	O
angiogenesis	O
.	O

We	O
tested	O
this	O
possibility	O
with	O
in	O
vitro	O
assays	O
using	O
human	S-Species
endothelial	O
cells	O
,	O
as	O
well	O
as	O
in	O
a	O
rodent	O
hindlimb	O
ischemia	O
model	O
.	O

Treatment	O
of	O
cultured	O
human	S-Species
endothelial	O
cells	O
with	O
DAPT	O
,	O
a	O
gamma	O
secretase	O
inhibitor	O
,	O
increased	O
cell	O
migration	O
and	O
sprout	O
formation	O
in	O
response	O
to	O
VEGF	O
stimulation	O
with	O
a	O
biphasic	O
dependence	O
on	O
DAPT	O
concentration	O
.	O

Direct	O
intramuscular	O
or	O
intraperitoneal	O
injection	O
of	O
DAPT	O
did	O
not	O
result	O
in	O
the	O
same	O
level	O
of	O
improvement	O
,	O
suggesting	O
that	O
appropriate	O
presentation	O
of	O
DAPT	O
(	O
gel	O
delivery	O
)	O
is	O
important	O
for	O
its	O
activity	O
.	O

The	O
expression	O
of	O
SREBP	O
and	O
Cdc42	O
were	O
determined	O
by	O
Western	O
blot	O
and	O
quantitative	O
real	O
-	O
time	O
PCR	O
.	O

CONCLUSIONS	O
:	O
Our	O
study	O
provides	O
new	O
candidate	O
genes	O
for	O
the	O
esophageal	O
cancer	O
microenvironment	O
.	O

However	O
,	O
the	O
exact	O
mechanisms	O
of	O
ARF	O
action	O
yet	O
remain	O
unclear	O
and	O
require	O
further	O
studies	O
by	O
different	O
specialists	O
at	O
both	O
the	O
molecular	O
genetic	O
and	O
other	O
levels	O
of	O
investigation	O
.	O

Inhibition	O
of	O
p38	O
SAPK	O
reduced	O
CBP	O
HAT	O
activity	O
and	O
its	O
recruitment	O
to	O
the	O
SRF	O
.	O
MRTF	O
-	O
A	O
complex	O
,	O
whereas	O
enforced	O
induction	O
of	O
p38	O
by	O
upstream	O
activators	O
(	O
e	O
.	O
g	O
.	O
MKK3	O
and	O
MKK6	O
)	O
enhanced	O
both	O
CBP	O
HAT	O
and	O
CCN1	O
promoter	O
activities	O
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
signal	O
-	O
controlled	O
activation	O
of	O
SRF	O
,	O
MRTF	O
-	O
A	O
,	O
and	O
CBP	O
provides	O
a	O
novel	O
connection	O
between	O
mechanical	O
stimuli	O
and	O
angiogenic	O
gene	O
expression	O
.	O

In	O
addition	O
,	O
filopodia	O
formation	O
,	O
a	O
feature	O
of	O
motile	O
cells	O
,	O
was	O
inhibited	O
in	O
PECAM	O
-	O
1	O
-	O
null	O
endothelial	O
cells	O
as	O
well	O
as	O
in	O
human	S-Species
endothelial	O
cells	O
treated	O
with	O
either	O
anti	O
-	O
PECAM	O
-	O
1	O
antibody	O
or	O
PECAM	O
-	O
1	O
siRNA	O
.	O

Directed	O
EC	O
migration	O
is	O
a	O
central	O
step	O
in	O
this	O
process	O
and	O
depends	O
on	O
cellular	O
signaling	O
cascades	O
that	O
initiate	O
and	O
control	O
the	O
structural	O
rearrangements	O
.	O

PURPOSE	O
:	O
Antiangiogenic	O
therapy	O
is	O
considered	O
as	O
an	O
effective	O
strategy	O
for	O
controlling	O
the	O
growth	O
and	O
metastasis	O
of	O
tumors	O
.	O

Angiogenesis	O
-	O
-	O
one	O
of	O
the	O
hallmarks	O
of	O
cancer	O
-	O
-	O
has	O
emerged	O
as	O
a	O
valid	O
therapeutic	O
target	O
in	O
oncology	O
.	O

It	O
is	O
interesting	O
that	O
certain	O
components	O
of	O
neutrophil	O
cytotoxic	O
arsenal	O
(	O
ROS	O
,	O
cytokines	O
,	O
specific	O
enzymes	O
)	O
participate	O
both	O
in	O
antitumoral	O
defenses	O
of	O
an	O
organism	O
and	O
protumoral	O
activity	O
.	O

The	O
aims	O
of	O
the	O
present	O
study	O
were	O
to	O
compare	O
,	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
the	O
antiangiogenic	O
and	O
antitumor	O
activities	O
of	O
metronomic	O
irinotecan	O
(	O
CPT	O
-	O
11	O
)	O
,	O
oxaliplatin	O
(	O
L	O
-	O
OHP	O
)	O
and	O
5	O
-	O
fluorouracil	O
(	O
5	O
-	O
FU	O
)	O
in	O
colorectal	O
cancer	O
and	O
to	O
investigate	O
the	O
metronomic	O
combination	O
of	O
these	O
drugs	O
.	O

HT	O
-	O
29	O
human	S-Species
colorectal	O
cancer	O
xenograft	O
model	O
was	O
used	O
and	O
tumour	O
growth	O
,	O
microvessel	O
density	O
and	O
VEGF	O
quantification	O
were	O
performed	O
in	O
tumours	O
after	O
the	O
administration	O
of	O
metronomic	O
CPT	O
-	O
11	O
,	O
L	O
-	O
OHP	O
,	O
5	O
-	O
FU	O
and	O
their	O
simultaneous	O
combination	O
.	O

The	O
metronomic	O
concept	O
might	O
not	O
universally	O
apply	O
to	O
every	O
cytotoxic	O
drug	O
in	O
colorectal	O
cancer	O
and	O
metronomic	O
combination	O
regimens	O
should	O
be	O
used	O
with	O
caution	O
.	O

Notably	O
,	O
a	O
similar	O
vascular	O
phenotype	O
was	O
induced	O
by	O
morpholino	O
-	O
mediated	O
knockdown	O
of	O
the	O
integrin	O
alpha2	O
subunit	O
.	O

TNF	O
-	O
alpha	O
is	O
also	O
an	O
essential	O
component	O
of	O
the	O
immune	O
system	O
and	O
is	O
required	O
for	O
hematopoiesis	O
,	O
for	O
protection	O
from	O
bacterial	O
infection	O
and	O
for	O
immune	O
cell	O
-	O
mediated	O
cytotoxicity	O
.	O

[	O
Effect	O
of	O
osteopontin	O
silencing	O
by	O
lentivirus	S-Species
-	O
mediated	O
delivery	O
of	O
siRNA	O
on	O
glioma	O
cell	O
invasion	O
and	O
apoptosis	O
]	O
.	O

In	O
addition	O
,	O
a	O
reduction	O
in	O
tumor	O
volume	O
of	O
Grm1	O
-	O
mouse	S-Species
-	O
melanocytic	O
-	O
allografts	O
was	O
detected	O
in	O
the	O
presence	O
of	O
small	O
interfering	O
AKT2	O
RNA	O
(	O
siAKT2	O
)	O
.	O

The	O
expression	O
of	O
NP	O
-	O
1	O
,	O
NP	O
-	O
2	O
,	O
and	O
plexin	O
-	O
A1	O
was	O
not	O
altered	O
in	O
human	S-Species
ovarian	O
surface	O
epithelial	O
and	O
ovarian	O
cancer	O
cells	O
.	O

Forced	O
expression	O
of	O
SEMA3B	O
,	O
but	O
not	O
SEMA3F	O
,	O
inhibited	O
viability	O
of	O
ovarian	O
cancer	O
cells	O
.	O

Chronic	O
exposure	O
to	O
tobacco	S-Species
smoke	O
,	O
which	O
contains	O
over	O
60	O
tumor	O
-	O
initiating	O
carcinogens	O
,	O
is	O
the	O
major	O
risk	O
factor	O
for	O
development	O
of	O
lung	O
cancer	O
,	O
accounting	O
for	O
a	O
large	O
portion	O
of	O
cancer	O
-	O
related	O
deaths	O
worldwide	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
effects	O
of	O
doxorubicin	O
in	O
Hct	O
-	O
116	O
human	O
colon	O
carcinoma	O
cells	O
in	O
order	O
to	O
clarify	O
if	O
a	O
time	O
/	O
concentration	O
range	O
for	O
optimal	O
doxorubicin	O
-	O
induced	O
apoptosis	O
exists	O
.	O

In	O
contrast	O
,	O
continuous	O
(	O
24h	O
)	O
treatment	O
with	O
doxorubicin	O
reduced	O
the	O
number	O
of	O
living	O
cells	O
with	O
no	O
parallel	O
raise	O
in	O
the	O
amount	O
of	O
dead	O
cells	O
.	O

In	O
addition	O
,	O
the	O
results	O
of	O
the	O
previously	O
tested	O
transketolase	O
like	O
1	O
protein	O
(	O
TKTL1	O
)	O
expression	O
were	O
correlated	O
to	O
LDH5	O
expression	O
.	O

No	O
significant	O
correlation	O
could	O
be	O
detected	O
with	O
regard	O
to	O
TNM	O
-	O
stage	O
,	O
grading	O
or	O
survival	O
.	O

CONCLUSIONS	O
:	O
LDH5	O
is	O
overexpressed	O
in	O
NSCLC	O
and	O
could	O
hence	O
serve	O
as	O
an	O
additional	O
marker	O
for	O
malignancy	O
.	O

Unlike	O
the	O
majority	O
of	O
somatic	O
cells	O
,	O
in	O
which	O
hTERT	O
and	O
telomerase	O
activity	O
are	O
generally	O
silent	O
,	O
normal	O
lymphocytes	O
show	O
transient	O
physiological	O
hTERT	O
expression	O
and	O
telomerase	O
activity	O
according	O
to	O
their	O
differentiation	O
/	O
activation	O
status	O
.	O

These	O
models	O
may	O
have	O
clinically	O
relevant	O
implications	O
,	O
particularly	O
for	O
the	O
tailoring	O
of	O
therapeutic	O
strategies	O
targeting	O
telomerase	O
.	O

SAHA	O
enhanced	O
acetylation	O
of	O
histone	O
H3	O
in	O
Bim	O
promoter	O
region	O
,	O
while	O
E1A	O
upregulated	O
Egr	O
-	O
1	O
,	O
which	O
was	O
directly	O
involved	O
in	O
Bim	O
transactivation	O
.	O

Using	O
tamoxifen	O
and	O
doxorubicin	O
-	O
sensitive	O
and	O
-	O
resistant	O
breast	O
cancer	O
cell	O
lines	O
as	O
models	O
,	O
we	O
found	O
that	O
doxorubicin	O
-	O
but	O
not	O
tamoxifen	O
-	O
resistance	O
is	O
associated	O
with	O
nuclear	O
accumulation	O
of	O
FOXO3a	O
,	O
consistent	O
with	O
the	O
finding	O
that	O
sustained	O
nuclear	O
FOXO3a	O
is	O
associated	O
with	O
poor	O
prognosis	O
.	O

Ras	O
-	O
association	O
domain	O
family	O
1C	O
protein	O
promotes	O
breast	O
cancer	O
cell	O
migration	O
and	O
attenuates	O
apoptosis	O
.	O

The	O
disintegrin	O
-	O
like	O
and	O
cysteine	O
-	O
rich	O
domains	O
of	O
ADAM	O
-	O
9	O
mediate	O
interactions	O
between	O
melanoma	O
cells	O
and	O
fibroblasts	O
.	O

ADAM	O
-	O
9	O
is	O
expressed	O
in	O
human	S-Species
melanoma	O
at	O
the	O
tumor	O
-	O
stroma	O
border	O
where	O
direct	O
or	O
indirect	O
interactions	O
between	O
tumor	O
cells	O
and	O
fibroblasts	O
occur	O
.	O

In	O
recent	O
years	O
,	O
investigating	O
the	O
metabolic	O
changes	O
within	O
cancer	O
cells	O
has	O
been	O
a	O
rapidly	O
growing	O
area	O
.	O

The	O
down	O
-	O
regulation	O
of	O
MTSS1	O
that	O
may	O
be	O
caused	O
by	O
DNA	O
methylation	O
was	O
also	O
observed	O
in	O
many	O
other	O
types	O
of	O
cancer	O
.	O

Ras	O
p21	O
onco	O
-	O
protein	O
in	O
the	O
sera	O
of	O
mice	S-Species
carrying	O
an	O
experimentally	O
induced	O
tumor	O
and	O
in	O
human	S-Species
cancer	O
patients	S-Species
.	O

However	O
,	O
sVAP	O
-	O
1	O
expression	O
has	O
not	O
been	O
described	O
for	O
gastric	O
cancer	O
.	O

Determining	O
sVAP	O
-	O
1	O
levels	O
may	O
be	O
valuable	O
for	O
predicting	O
prognosis	O
and	O
lymph	O
node	O
metastasis	O
.	O

DNA	O
microarray	O
analysis	O
allows	O
for	O
analysis	O
of	O
drug	O
effects	O
on	O
multiple	O
pathways	O
linked	O
to	O
cancer	O
and	O
can	O
suggest	O
corresponding	O
imaging	O
tracers	O
for	O
further	O
analysis	O
as	O
biomarkers	O
of	O
tumor	O
response	O
.	O

Induction	O
of	O
Id	O
-	O
1	O
by	O
FGF	O
-	O
2	O
involves	O
activity	O
of	O
EGR	O
-	O
1	O
and	O
sensitizes	O
neuroblastoma	O
cells	O
to	O
cell	O
death	O
.	O

Vimentin	O
expression	O
,	O
growth	O
fractions	O
(	O
GF	O
)	O
,	O
and	O
estrogen	O
receptor	O
(	O
ER	O
)	O
levels	O
were	O
determined	O
for	O
90	O
untreated	O
primary	O
breast	O
carcinomas	O
.	O

Thus	O
,	O
vimentin	O
expression	O
may	O
be	O
helpful	O
in	O
identifying	O
a	O
substantial	O
subset	O
of	O
ER	O
-	O
independent	O
breast	O
carcinomas	O
with	O
poor	O
prognostic	O
indicators	O
.	O

[	O
Expression	O
of	O
Merlin	O
protein	O
in	O
non	O
-	O
small	O
cell	O
lung	O
carcinoma	O
and	O
the	O
clinical	O
significance	O
]	O
.	O

Furthermore	O
,	O
in	O
support	O
of	O
these	O
findings	O
,	O
we	O
found	O
that	O
sunitinib	O
induced	O
a	O
reduction	O
in	O
the	O
expression	O
of	O
the	O
antiapoptotic	O
molecule	O
Bcl	O
-	O
2	O
as	O
well	O
as	O
dephosphorylation	O
of	O
the	O
proapoptotic	O
molecule	O
BAD	O
,	O
which	O
results	O
in	O
the	O
activation	O
of	O
BAD	O
in	O
these	O
cells	O
.	O

Lymph	O
node	O
metastasis	O
is	O
one	O
of	O
the	O
most	O
important	O
prognostic	O
factors	O
in	O
various	O
types	O
of	O
cancers	O
,	O
including	O
endometrial	O
cancer	O
.	O

Vascular	O
endothelial	O
growth	O
factor	O
-	O
C	O
(	O
VEGF	O
-	O
C	O
)	O
plays	O
a	O
crucial	O
role	O
in	O
lymphangiogenesis	O
,	O
and	O
is	O
implicated	O
to	O
play	O
an	O
important	O
role	O
in	O
lymph	O
node	O
metastasis	O
.	O

Curcumin	O
also	O
significantly	O
decreased	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
the	O
expression	O
of	O
uPA	O
and	O
NF	O
-	O
kappaB	O
DNA	O
binding	O
activity	O
,	O
respectively	O
.	O

Oncostatin	O
M	O
(	O
OSM	O
)	O
,	O
an	O
IL	O
-	O
6	O
family	O
cytokine	O
responsible	O
for	O
STAT3	O
activation	O
,	O
has	O
been	O
implicated	O
in	O
cancer	O
development	O
,	O
progression	O
,	O
invasion	O
,	O
and	O
metastasis	O
.	O

It	O
is	O
involved	O
in	O
a	O
wide	O
range	O
of	O
developmental	O
and	O
physiological	O
processes	O
,	O
including	O
serum	O
calcium	O
regulation	O
.	O

Pthrp	O
ablation	O
in	O
the	O
mammary	O
epithelium	O
of	O
the	O
PyMT	O
-	O
MMTV	S-Species
breast	O
cancer	O
mouse	S-Species
model	O
caused	O
a	O
delay	O
in	O
primary	O
tumor	O
initiation	O
,	O
inhibited	O
tumor	O
progression	O
,	O
and	O
reduced	O
metastasis	O
to	O
distal	O
sites	O
.	O

Our	O
data	O
identify	O
what	O
we	O
believe	O
to	O
be	O
new	O
functions	O
for	O
PTHrP	O
in	O
several	O
key	O
steps	O
of	O
breast	O
cancer	O
and	O
suggest	O
that	O
PTHrP	O
may	O
constitute	O
a	O
novel	O
target	O
for	O
therapeutic	O
intervention	O
.	O

However	O
,	O
little	O
in	O
vivo	O
experimental	O
data	O
are	O
available	O
about	O
the	O
effects	O
of	O
NF	O
-	O
kappaB	O
inhibition	O
on	O
OSCC	O
metastasis	O
.	O

Furthermore	O
,	O
the	O
expression	O
levels	O
of	O
NF	O
-	O
kappaB	O
-	O
regulated	O
metastasis	O
-	O
related	O
molecules	O
,	O
such	O
as	O
fibronectin	O
,	O
beta1	O
integrin	O
,	O
MMP	O
-	O
1	O
,	O
-	O
2	O
,	O
-	O
9	O
,	O
and	O
-	O
14	O
,	O
and	O
VEGF	O
-	O
C	O
,	O
were	O
upregulated	O
in	O
the	O
highly	O
metastatic	O
cells	O
.	O

Our	O
results	O
suggest	O
that	O
the	O
selective	O
inhibition	O
of	O
NF	O
-	O
kappaB	O
activation	O
by	O
NBD	O
peptide	O
may	O
provide	O
an	O
effective	O
approach	O
for	O
the	O
treatment	O
of	O
highly	O
metastatic	O
OSCC	O
.	O

beta	O
-	O
catenin	O
signaling	O
controls	O
metastasis	O
in	O
Braf	O
-	O
activated	O
Pten	O
-	O
deficient	O
melanomas	O
.	O

However	O
,	O
effective	O
HDAC	O
inhibitors	O
for	O
the	O
treatment	O
of	O
solid	O
tumors	O
remain	O
to	O
be	O
developed	O
.	O

CONCLUSION	O
:	O
The	O
up	O
-	O
regulation	O
of	O
HER2	O
and	O
B	O
(	O
1	O
)	O
R	O
in	O
precursor	O
lesions	O
of	O
gallbladder	O
carcinoma	O
suggests	O
cross	O
-	O
talk	O
between	O
these	O
two	O
receptors	O
that	O
may	O
be	O
of	O
importance	O
in	O
the	O
modulation	O
of	O
cell	O
proliferation	O
in	O
gallbladder	O
carcinogenesis	O
.	O

The	O
eph	O
gene	O
encodes	O
a	O
putative	O
receptor	O
tyrosine	O
kinase	O
for	O
an	O
as	O
yet	O
unknown	O
ligand	O
.	O

We	O
show	O
here	O
that	O
NIH3T3	O
cells	O
acquire	O
tumorigenic	O
ability	O
in	O
nude	B-Species
mice	E-Species
and	O
make	O
colonies	O
in	O
soft	O
agar	O
with	O
a	O
viral	O
LTR	O
(	O
Long	O
Terminal	O
Repeat	O
)	O
-	O
driven	O
artificial	O
expression	O
of	O
the	O
eph	O
gene	O
to	O
a	O
high	O
level	O
.	O

It	O
is	O
concluded	O
that	O
the	O
observed	O
increase	O
in	O
the	O
Na	O
+	O
/	O
K	O
+	O
ratio	O
in	O
ascites	O
tumor	O
cells	O
is	O
connected	O
with	O
their	O
enhanced	O
ability	O
to	O
synthesize	O
lactic	O
acid	O
.	O

Immunohistochemical	O
study	O
with	O
specific	O
antisera	O
was	O
done	O
.	O

Quercetin	O
increased	O
the	O
efficiency	O
of	O
pumping	O
in	O
EAT	O
cells	O
both	O
in	O
the	O
absence	O
and	O
presence	O
of	O
the	O
detergent	O
.	O

The	O
ras	O
-	O
encoded	O
proteins	O
are	O
similar	O
to	O
regulatory	O
G	O
-	O
proteins	O
and	O
are	O
candidates	O
for	O
the	O
unknown	O
G	O
-	O
protein	O
that	O
modulates	O
phosphatidylinositol	O
(	O
PI	O
)	O
turnover	O
.	O

Differences	O
in	O
polyphosphoinositide	O
metabolism	O
have	O
been	O
reported	O
for	O
ras	O
-	O
transformed	O
cells	O
.	O

In	O
extracts	O
of	O
growing	O
and	O
stationary	O
Swiss	O
3T3	O
cells	O
,	O
the	O
total	O
amount	O
of	O
protein	O
kinase	O
C	O
activity	O
was	O
similar	O
,	O
indicating	O
that	O
growth	O
state	O
does	O
not	O
alter	O
the	O
level	O
of	O
enzyme	O
in	O
the	O
cell	O
.	O

DNA	O
of	O
the	O
non	O
-	O
tumorigenic	O
cell	O
hybrids	O
transformed	O
Rat	O
-	O
1	O
cells	O
to	O
anchorage	O
-	O
independent	O
proliferation	O
as	O
expected	O
for	O
the	O
transforming	O
human	S-Species
Ha	O
-	O
ras	O
gene	O
present	O
in	O
the	O
donor	O
DNA	O
.	O

As	O
chicken	S-Species
embryo	O
fibroblasts	O
are	O
devoid	O
of	O
EGF	O
receptors	O
,	O
their	O
activity	O
is	O
not	O
potentiated	O
by	O
EGF	O
.	O

Experiments	O
using	O
the	O
tsA	O
58	O
allele	O
of	O
the	O
SV	B-Species
40	E-Species
-	O
A	O
gene	O
have	O
demonstrated	O
that	O
the	O
SV	B-Species
40	E-Species
large	O
T	O
-	O
antigen	O
is	O
strictly	O
required	O
both	O
for	O
immortalization	O
and	O
induction	O
anchorage	O
independence	O
of	O
cells	O
.	O

It	O
has	O
been	O
suggested	O
that	O
the	O
immortalized	O
phenotype	O
is	O
mediated	O
by	O
an	O
extra	O
cellular	O
factor	O
.	O

The	O
increased	O
transport	O
rate	O
is	O
a	O
consequence	O
of	O
an	O
increased	O
number	O
of	O
transporters	O
in	O
the	O
transformed	O
cells	O
.	O

After	O
48	O
h	O
in	O
culture	O
,	O
DR	O
antigen	O
expression	O
was	O
substantially	O
increased	O
,	O
but	O
no	O
significant	O
changes	O
were	O
observed	O
in	O
methylation	O
of	O
the	O
DR	O
alpha	O
locus	O
or	O
in	O
the	O
amount	O
of	O
DR	O
mRNA	O
which	O
was	O
present	O
.	O

This	O
suggests	O
that	O
expression	O
of	O
DR	O
antigens	O
also	O
can	O
be	O
modulated	O
post	O
-	O
transcriptionally	O
.	O

The	O
increased	O
energy	O
expended	O
by	O
the	O
host	O
to	O
synthesize	O
substrate	O
,	O
which	O
is	O
utilized	O
by	O
the	O
tumor	O
,	O
is	O
a	O
potential	O
cause	O
of	O
cancer	O
cachexia	O
.	O

In	O
these	O
transformants	O
,	O
mitogen	O
depletion	O
elicited	O
an	O
increase	O
in	O
the	O
Rb	O
level	O
comparable	O
to	O
that	O
in	O
normal	O
C2	O
cells	O
;	O
wt	O
SVLT	O
,	O
however	O
,	O
promoted	O
the	O
phosphorylation	O
of	O
a	O
large	O
part	O
of	O
the	O
induced	O
Rb	O
.	O

The	O
region	O
of	O
the	O
LTR	O
identified	O
here	O
as	O
being	O
important	O
in	O
trans	O
activation	O
has	O
recently	O
been	O
shown	O
to	O
be	O
a	O
critical	O
determinant	O
of	O
the	O
leukemogenicity	O
and	O
latency	O
of	O
Moloney	B-Species
murine	I-Species
leukemia	I-Species
virus	E-Species
.	O

Histologically	O
,	O
both	O
2G7	O
-	O
treated	O
and	O
control	O
tumors	O
were	O
identical	O
.	O

Cytokines	O
and	O
growth	O
factors	O
induce	O
tyrosine	O
phosphorylation	O
of	O
signal	O
transducers	O
and	O
activators	O
of	O
transcription	O
(	O
STATs	O
)	O
that	O
directly	O
activate	O
gene	O
expression	O
.	O

Induction	O
of	O
this	O
DNA	O
-	O
binding	O
activity	O
was	O
accompanied	O
by	O
tyrosine	O
phosphorylation	O
of	O
Stat3	O
and	O
correlated	O
with	O
Src	O
transformation	O
.	O

Furthermore	O
,	O
the	O
conditioned	O
medium	O
from	O
these	O
cells	O
enhanced	O
vascular	O
permeability	O
in	O
vivo	O
.	O

Two	O
weeks	O
after	O
injection	O
,	O
there	O
was	O
histological	O
evidence	O
of	O
neovascularization	O
in	O
the	O
tissues	O
surrounding	O
the	O
Matrigel	O
containing	O
AdCMV	O
.	O
VEGF165	O
,	O
whereas	O
no	O
significant	O
angiogenesis	O
was	O
observed	O
in	O
response	O
to	O
AdCMV	O
.	O
beta	O
gal	O
.	O

Furthermore	O
,	O
the	O
Matrigel	O
plugs	O
with	O
AdCMV	O
.	O
VEGF165	O
demonstrated	O
hemoglobin	O
content	O
fourfold	O
higher	O
than	O
the	O
plugs	O
with	O
AdCMV	O
.	O
beta	O
gal	O
.	O

MPs	O
also	O
play	O
a	O
role	O
in	O
tumor	O
angiogenesis	O
.	O

Several	O
reports	O
have	O
indicated	O
that	O
tetracyclines	O
can	O
suppress	O
tumor	O
MPs	O
as	O
well	O
.	O

These	O
RNAs	O
were	O
not	O
detected	O
by	O
Northern	O
(	O
RNA	O
)	O
hybridization	O
in	O
productively	O
infected	O
chicken	S-Species
embryo	O
fibroblasts	O
48	O
h	O
postinfection	O
;	O
however	O
,	O
they	O
were	O
apparent	O
140	O
h	O
postinfection	O
.	O

To	O
address	O
this	O
issue	O
,	O
an	O
activated	O
neu	O
oncogene	O
was	O
introduced	O
into	O
an	O
immortalized	O
nontumorigenic	O
human	S-Species
breast	O
epithelial	O
cell	O
line	O
(	O
184B5	O
)	O
.	O

TC	O
-	O
PTP	O
PTPase	O
expression	O
was	O
only	O
slightly	O
increased	O
in	O
these	O
neu	O
transformed	O
cells	O
,	O
and	O
no	O
expression	O
of	O
CD45	O
PTPase	O
was	O
observed	O
.	O

Both	O
basal	O
(	O
2	O
.	O
3	O
+	O
/	O
-	O
0	O
.	O
2	O
mumol	O
/	O
100	O
g	O
/	O
minute	O
,	O
P	O
=	O
0	O
.	O
061	O
)	O
and	O
insulin	O
-	O
stimulated	O
(	O
8	O
.	O
5	O
+	O
/	O
-	O
1	O
.	O
9	O
mumol	O
/	O
100	O
g	O
/	O
minute	O
,	O
P	O
=	O
0	O
.	O
055	O
)	O
skeletal	O
arm	O
muscle	O
glucose	O
uptake	O
rates	O
were	O
higher	O
in	O
control	O
subjects	O
than	O
in	O
patients	S-Species
.	O

Whole	O
body	O
glucose	O
use	O
was	O
55	O
%	O
lower	O
in	O
patients	S-Species
than	O
in	O
control	B-Species
subjects	E-Species
(	O
17	O
+	O
/	O
-	O
3	O
mumol	O
/	O
kg	O
/	O
minute	O
versus	O
38	O
+	O
/	O
-	O
3	O
mumol	O
/	O
kg	O
/	O
minute	O
,	O
P	O
=	O
0	O
.	O
002	O
)	O
,	O
consistent	O
with	O
insulin	O
resistance	O
in	O
cancer	O
.	O

The	O
principal	O
types	O
of	O
tumors	O
were	O
plasmacytomas	O
secreting	O
immunoglobulin	O
and	O
novel	O
lymphomas	O
that	O
expressed	O
markers	O
such	O
as	O
Sca	O
-	O
1	O
,	O
CD4	O
,	O
Thy	O
-	O
1	O
,	O
CD34	O
and	O
CD45	O
(	O
B220	O
)	O
,	O
consistent	O
with	O
an	O
origin	O
very	O
early	O
in	O
B	O
-	O
lymphoid	O
development	O
.	O

Rearrangement	O
of	O
the	O
c	O
-	O
myc	O
gene	O
was	O
common	O
in	O
the	O
plasmacytomas	O
,	O
implying	O
a	O
synergistic	O
role	O
for	O
myc	O
and	O
bcl	O
-	O
2	O
in	O
their	O
etiology	O
,	O
but	O
was	O
not	O
detected	O
in	O
the	O
lymphomas	O
.	O

Tumorigenic	O
activity	O
of	O
rho	O
genes	O
from	O
Aplysia	B-Species
californica	E-Species
.	O

We	O
have	O
identified	O
several	O
mechanisms	O
by	O
which	O
the	O
angiogenic	O
cytokine	O
vascular	O
permeability	O
factor	O
/	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VPF	O
/	O
VEGF	O
)	O
likely	O
regulates	O
endothelial	O
cells	O
(	O
EC	O
)	O
migration	O
.	O

VPF	O
/	O
VEGF	O
induced	O
dermal	O
microvascular	O
EC	O
expression	O
of	O
mRNAs	O
encoding	O
the	O
alphav	O
and	O
beta3	O
integrin	O
subunits	O
resulting	O
in	O
increased	O
levels	O
of	O
the	O
alphavbeta3	O
heterodimer	O
at	O
the	O
cell	O
surface	O
,	O
and	O
VPF	O
/	O
VEGF	O
also	O
induced	O
mRNA	O
encoding	O
osteopontin	O
(	O
OPN	O
)	O
,	O
an	O
alphavbeta3	O
ligand	O
.	O

Furthermore	O
,	O
in	O
comparison	O
with	O
native	O
OPN	O
,	O
thrombin	O
-	O
cleaved	O
OPN	O
stimulated	O
a	O
greater	O
rate	O
of	O
EC	O
migration	O
in	O
vitro	O
,	O
which	O
was	O
additive	O
to	O
the	O
increased	O
migration	O
associated	O
with	O
induction	O
of	O
alpha	O
v	O
beta	O
3	O
.	O

Disease	O
-	O
free	O
(	O
DFS	O
)	O
and	O
overall	O
(	O
OAS	O
)	O
survival	O
curves	O
were	O
estimated	O
by	O
the	O
Kaplan	O
-	O
Meier	O
method	O
.	O

The	O
fact	O
that	O
viral	O
or	O
other	O
adjunctive	O
vectors	O
were	O
not	O
required	O
further	O
suggests	O
that	O
secreted	O
gene	O
products	O
may	O
have	O
potential	O
therapeutic	O
utility	O
even	O
when	O
the	O
number	O
of	O
successfully	O
transfected	O
cells	O
remains	O
low	O
.	O

In	O
the	O
current	O
report	O
,	O
we	O
tested	O
the	O
sensitivity	O
of	O
the	O
c	O
-	O
myc	O
-	O
overexpressing	O
cells	O
(	O
Rat	O
6	O
/	O
c	O
-	O
myc	O
)	O
to	O
two	O
additional	O
chemicals	O
:	O
5	O
-	O
azacytidine	O
and	O
MnSO4	O
.	O

These	O
chemicals	O
differ	O
from	O
the	O
direct	O
-	O
acting	O
mutagens	O
tested	O
previously	O
.	O

It	O
has	O
been	O
shown	O
previously	O
that	O
the	O
55	O
-	O
kDa	O
polypeptide	O
abrogates	O
p53	O
-	O
mediated	O
transactivation	O
and	O
that	O
mutants	O
defective	O
in	O
p53	O
binding	O
are	O
unable	O
to	O
cooperate	O
with	O
E1A	O
in	O
transformation	O
.	O

We	O
demonstrate	O
directly	O
that	O
the	O
wild	O
-	O
type	O
55	O
-	O
kDa	O
protein	O
is	O
able	O
to	O
block	O
E1A	O
-	O
induced	O
p53	O
-	O
dependent	O
apoptosis	O
,	O
whereas	O
cells	O
infected	O
by	O
mutant	B-Species
pm490	I-Species
/	I-Species
1	I-Species
/	I-Species
5A	E-Species
,	O
which	O
contains	O
alanine	O
residues	O
at	O
all	O
three	O
phosphorylation	O
sites	O
,	O
exhibited	O
extensive	O
DNA	O
fragmentation	O
and	O
classic	O
apoptotic	O
cell	O
death	O
.	O

The	O
E1B	O
-	O
55kDa	O
product	O
has	O
been	O
shown	O
to	O
exhibit	O
intrinsic	O
transcriptional	O
repression	O
activity	O
when	O
localized	O
to	O
promoters	O
,	O
such	O
as	O
by	O
fusion	O
with	O
the	O
GAL4	O
DNA	O
-	O
binding	O
domain	O
,	O
even	O
in	O
the	O
absence	O
of	O
p53	O
.	O

The	O
Wilms	O
tumor	O
suppressor	O
gene	O
WT1	O
induces	O
G1	O
arrest	O
and	O
apoptosis	O
in	O
myeloblastic	O
leukemia	O
M1	O
cells	O
.	O

The	O
only	O
CD8	O
+	O
CD56	O
+	O
postthymic	O
T	O
-	O
cell	O
lymphoma	O
also	O
expressed	O
all	O
three	O
cytolytic	O
markers	O
,	O
two	O
CD8	O
-	O
ALCL	O
expressed	O
TIA1	O
;	O
other	O
postthymic	O
T	O
-	O
cell	O
,	O
T	O
-	O
lymphoblastic	O
,	O
and	O
B	O
-	O
cell	O
lymphomas	O
were	O
consistently	O
negative	O
.	O

PATIENTS	O
AND	O
METHODS	O
:	O
Fifteen	O
patients	S-Species
with	O
MEN	O
II	O
A	O
(	O
aged	O
4	O
-	O
24	O
years	O
)	O
who	O
had	O
undergone	O
prophylactic	O
thyroidectomy	O
since	O
1990	O
were	O
included	O
in	O
the	O
study	O
.	O

Invasion	O
of	O
the	O
uterus	O
by	O
first	O
trimester	O
human	S-Species
placental	O
extravillous	O
trophoblast	O
(	O
EVT	O
)	O
cells	O
depends	O
on	O
mechanisms	O
shared	O
by	O
malignant	O
cells	O
.	O

A	O
long	O
-	O
lived	O
line	O
,	O
RSVT	O
-	O
2	O
,	O
was	O
produced	O
and	O
an	O
immortalized	O
subclone	O
,	O
RSVT2	O
/	O
C	O
,	O
was	O
further	O
derived	O
under	O
a	O
forced	O
crisis	O
regimen	O
.	O

Since	O
both	O
cell	O
lines	O
remained	O
non	O
-	O
tumorigenic	O
in	O
nude	B-Species
mice	E-Species
,	O
these	O
properties	O
indicate	O
that	O
they	O
attained	O
a	O
premalignant	O
phenotype	O
.	O

Interestingly	O
,	O
under	O
normal	O
conditions	O
muscle	O
cells	O
express	O
only	O
a	O
approximately	O
5	O
.	O
5	O
-	O
kb	O
type	O
II	O
HK	O
RNA	O
transcript	O
.	O

Induced	O
over	O
-	O
and	O
under	O
-	O
expression	O
of	O
these	O
genes	O
has	O
been	O
used	O
to	O
demonstrate	O
their	O
affect	O
on	O
some	O
aspects	O
of	O
hematopoiesis	O
and	O
leukemogenesis	O
.	O

13C	O
and	O
1H	O
nuclear	O
magnetic	O
resonance	O
spectroscopy	O
(	O
NMR	O
)	O
was	O
used	O
to	O
investigate	O
the	O
metabolism	O
of	O
L	O
-	O
lactate	O
and	O
D	O
-	O
glucose	O
in	O
C6	O
glioma	O
cells	O
.	O

This	O
resulted	O
in	O
formation	O
of	O
tumors	O
,	O
which	O
were	O
pigmented	O
and	O
of	O
epithelial	O
origin	O
.	O

In	O
3	O
months	O
-	O
old	O
mice	S-Species
,	O
pigmented	O
cells	O
were	O
detected	O
in	O
spleen	O
and	O
inguinal	O
lymph	O
nodes	O
.	O

In	O
spleen	O
,	O
tyrosinase	O
,	O
TRP	O
-	O
1	O
and	O
SV40	S-Species
Tag	O
were	O
expressed	O
and	O
tyrosinase	O
was	O
enzymatically	O
active	O
.	O

These	O
were	O
pigmented	O
,	O
and	O
maintained	O
expression	O
of	O
tyrosinase	O
,	O
TRP	O
-	O
1	O
,	O
cytokeratin	O
and	O
SV40	S-Species
Tag	O
.	O

Effect	O
of	O
U	O
-	O
995	O
,	O
a	O
potent	O
shark	S-Species
cartilage	O
-	O
derived	O
angiogenesis	O
inhibitor	O
,	O
on	O
anti	O
-	O
angiogenesis	O
and	O
anti	O
-	O
tumor	O
activities	O
.	O

The	O
efficacy	O
of	O
the	O
antitumor	O
activity	O
of	O
1	O
'	O
-	O
acetoxychavicol	O
acetate	O
(	O
ACA	O
)	O
,	O
reported	O
to	O
be	O
a	O
suppressor	O
of	O
chemically	O
induced	O
carcinogenesis	O
,	O
was	O
evaluated	O
in	O
Ehrlich	O
ascites	O
tumor	O
cells	O
.	O

Although	O
the	O
importance	O
of	O
VEGF	O
-	O
A	O
has	O
been	O
shown	O
in	O
renal	O
carcinomas	O
,	O
the	O
contribution	O
of	O
these	O
new	O
ligands	O
in	O
kidney	O
tumors	O
is	O
not	O
clear	O
.	O

A	O
significant	O
increase	O
was	O
observed	O
in	O
flt	O
-	O
1	O
(	O
P	O
less	O
than	O
0	O
.	O
001	O
)	O
,	O
KDR	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
,	O
and	O
flt	O
-	O
4	O
(	O
P	O
=	O
0	O
.	O
01	O
)	O
but	O
not	O
VEGF	O
-	O
B	O
(	O
P	O
=	O
0	O
.	O
82	O
)	O
or	O
VEGF	O
-	O
C	O
(	O
P	O
=	O
0	O
.	O
52	O
)	O
expression	O
in	O
clear	O
cell	O
compared	O
with	O
chromophil	O
(	O
papillary	O
)	O
carcinomas	O
.	O

The	O
effect	O
of	O
von	O
Hippel	O
-	O
Lindau	O
(	O
VHL	O
)	O
gene	O
and	O
hypoxia	O
on	O
VEGF	O
-	O
B	O
and	O
VEGF	O
-	O
C	O
expression	O
in	O
the	O
renal	O
carcinoma	O
cell	O
line	O
786	O
-	O
0	O
transfected	O
with	O
wild	O
-	O
type	O
and	O
mutant	O
VHL	O
was	O
determined	O
by	O
growing	O
cells	O
under	O
21	O
%	O
O2	O
-	O
and	O
0	O
.	O
1	O
%	O
O2	O
.	O

Using	O
DsRed	O
-	O
tagged	O
Crk	O
and	O
a	O
fluorescent	O
time	O
-	O
lapse	O
microscope	O
,	O
we	O
showed	O
that	O
Crk	O
was	O
recruited	O
to	O
the	O
nascent	O
focal	O
complex	O
after	O
ephrin	O
-	O
B1	O
stimulation	O
.	O

The	O
necessity	O
of	O
Crk	O
in	O
ephrin	O
-	O
B1	O
-	O
induced	O
membrane	O
ruffling	O
was	O
shown	O
both	O
by	O
the	O
overexpression	O
of	O
dominant	O
negative	O
Crk	O
mutants	O
and	O
by	O
the	O
depletion	O
of	O
Crk	O
by	O
using	O
RNA	O
interference	O
.	O

The	O
dominant	O
negative	O
mutant	O
of	O
Rac1	O
completely	O
inhibited	O
ephrin	O
-	O
B1	O
-	O
induced	O
membrane	O
ruffling	O
and	O
focal	O
complex	O
assembly	O
.	O

These	O
results	O
indicated	O
that	O
Crk	O
plays	O
a	O
critical	O
role	O
in	O
Rac1	O
-	O
induced	O
membrane	O
ruffling	O
and	O
Rap1	O
-	O
mediated	O
nascent	O
focal	O
complex	O
stabilization	O
contributing	O
to	O
ephrin	O
-	O
B1	O
-	O
induced	O
human	S-Species
aortic	O
endothelial	O
cells	O
migration	O
.	O

Postoperative	O
progression	O
of	O
pulmonary	O
metastasis	O
in	O
osteosarcoma	O
.	O

Antiapoptotic	O
effect	O
of	O
coagulation	O
factor	O
VIIa	O
.	O

FVIIa	O
markedly	O
decreased	O
the	O
number	O
of	O
cells	O
with	O
apoptotic	O
morphology	O
and	O
prevented	O
the	O
DNA	O
degradation	O
as	O
measured	O
by	O
means	O
of	O
TdT	O
-	O
mediated	O
dUTP	O
nick	O
end	O
labeling	O
(	O
TUNEL	O
)	O
.	O

Cloning	O
and	O
characterization	O
of	O
the	O
latent	O
membrane	O
protein	O
(	O
LMP	O
)	O
of	O
a	O
specific	O
Epstein	B-Species
-	I-Species
Barr	I-Species
virus	E-Species
variant	O
derived	O
from	O
the	O
nasopharyngeal	O
carcinoma	O
in	O
the	O
Taiwanese	O
population	O
.	O

However	O
,	O
we	O
need	O
to	O
determine	O
whether	O
it	O
happens	O
in	O
breast	O
cancer	O
.	O

METHODS	O
:	O
The	O
expression	O
of	O
DCC	O
and	O
netrin	O
-	O
1	O
in	O
normal	O
endometrial	O
glands	O
and	O
in	O
cancer	O
cell	O
lines	O
was	O
examined	O
by	O
RT	O
-	O
PCR	O
and	O
immunohistochemistry	O
.	O

In	O
addition	O
,	O
all	O
of	O
the	O
endometrial	O
cancer	O
cell	O
lines	O
lost	O
normal	O
DCC	O
expression	O
.	O

BACKGROUND	O
:	O
The	O
MDM2	O
oncoprotein	O
promotes	O
p53	O
degradation	O
via	O
ubiquitin	O
,	O
establishing	O
negative	O
feedback	O
control	O
of	O
p53	O
and	O
consequently	O
affecting	O
cell	O
cycle	O
arrest	O
and	O
apoptosis	O
.	O

Cox	O
proportional	O
hazards	O
multivariate	O
analysis	O
(	O
MVA	O
)	O
was	O
used	O
to	O
determine	O
the	O
relation	O
of	O
MDM2	O
to	O
the	O
endpoints	O
.	O

The	O
ACIS	O
index	O
,	O
using	O
a	O
cutoff	O
point	O
defined	O
by	O
the	O
median	O
value	O
,	O
<	O
or	O
=	O
3	O
%	O
versus	O
>	O
3	O
%	O
,	O
was	O
related	O
to	O
5	O
-	O
year	O
DM	O
rates	O
in	O
univariate	O
analyses	O
(	O
32	O
.	O
6	O
%	O
vs	O
.	O
45	O
.	O
8	O
%	O
;	O
P	O
=	O
0	O
.	O
057	O
)	O
and	O
MVA	O
(	O
P	O
=	O
0	O
.	O
06	O
)	O
.	O

CONCLUSIONS	O
:	O
MDM2	O
expression	O
quantified	O
by	O
image	O
analysis	O
was	O
weakly	O
associated	O
with	O
DM	O
.	O

The	O
present	O
study	O
was	O
therefore	O
designed	O
to	O
evaluate	O
the	O
expression	O
of	O
thrombospondin	O
1	O
and	O
2	O
(	O
TSP	O
-	O
1	O
,	O
TSP	O
-	O
2	O
)	O
,	O
TSP	O
receptors	O
CD36	O
and	O
CD47	O
,	O
and	O
matrix	O
-	O
metalloproteases	O
2	O
and	O
9	O
(	O
MMP	O
-	O
,	O
MMP	O
-	O
9	O
)	O
in	O
a	O
rat	S-Species
prostate	O
cancer	O
model	O
.	O

Bovine	B-Species
papillomavirus	E-Species
E7	O
transformation	O
function	O
correlates	O
with	O
cellular	O
p600	O
protein	O
binding	O
.	O

The	O
E7	O
oncoprotein	O
of	O
bovine	B-Species
papillomavirus	I-Species
type	I-Species
1	E-Species
(	O
BPV	B-Species
-	I-Species
1	E-Species
)	O
is	O
required	O
for	O
the	O
full	O
transformation	O
activity	O
of	O
the	O
virus	O
.	O

To	O
address	O
this	O
question	O
,	O
we	O
used	O
the	O
proteomic	O
approach	O
of	O
tandem	O
affinity	O
purification	O
to	O
identify	O
cellular	O
proteins	O
that	O
are	O
in	O
complex	O
with	O
E7	O
,	O
and	O
identified	O
the	O
600	O
-	O
kDa	O
protein	O
,	O
p600	O
,	O
as	O
a	O
binding	O
partner	O
of	O
E7	O
.	O

Additionally	O
,	O
knockdown	O
of	O
p600	O
reduced	O
transformation	O
of	O
cells	O
expressing	O
both	O
BPV	B-Species
-	I-Species
1	E-Species
E6	O
and	O
E7	O
,	O
as	O
well	O
as	O
E6	O
alone	O
,	O
suggesting	O
that	O
the	O
ability	O
of	O
E7	O
to	O
transformed	O
cells	O
is	O
mediated	O
,	O
at	O
least	O
in	O
part	O
,	O
through	O
its	O
ability	O
to	O
bind	O
p600	O
.	O

Recent	O
evidence	O
suggests	O
the	O
existence	O
of	O
endothelial	O
precursors	O
in	O
adult	O
bone	O
marrow	O
cells	O
,	O
but	O
it	O
is	O
unclear	O
whether	O
those	O
precursors	O
have	O
a	O
role	O
in	O
tumor	O
neovascularization	O
.	O

Furthermore	O
,	O
we	O
show	O
that	O
VEGF	O
-	O
A	O
stimulation	O
of	O
hemopoietic	O
cells	O
does	O
not	O
significantly	O
alter	O
this	O
process	O
.	O

Estimation	O
of	O
lectin	O
binding	O
site	O
and	O
pattern	O
was	O
useful	O
to	O
evaluate	O
the	O
malignant	O
potential	O
of	O
cell	O
proliferation	O
.	O

In	O
conclusion	O
,	O
the	O
decrease	O
in	O
c	O
-	O
Myc	O
expression	O
enhanced	O
the	O
VLB	O
sensitivity	O
,	O
triggering	O
earlier	O
apoptosis	O
through	O
induction	O
of	O
the	O
intrinsic	O
pathway	O
.	O

Recently	O
,	O
it	O
has	O
been	O
shown	O
that	O
expression	O
of	O
human	S-Species
HOX	O
2	O
genes	O
is	O
sequentially	O
activated	O
by	O
RA	O
beginning	O
from	O
Hox	O
2	O
.	O
9	O
at	O
the	O
3	O
'	O
end	O
of	O
the	O
HOX	O
2	O
cluster	O
(	O
A	O
.	O
Simeone	O
,	O
D	O
.	O
Acampora	O
,	O
L	O
.	O
Arcioni	O
,	O
P	O
.	O
W	O
.	O
Andrews	O
,	O
E	O
.	O
Boncinelli	O
,	O
and	O
F	O
.	O
Mavilio	O
,	O
Nature	O
[	O
London	O
]	O
346	O
:	O
763	O
-	O
766	O
,	O
1990	O
)	O
.	O

We	O
conclude	O
that	O
stimulation	O
of	O
a	O
putative	O
growth	O
factor	O
signal	O
pathway	O
,	O
associated	O
with	O
ras	O
-	O
induced	O
proliferation	O
,	O
transiently	O
suppresses	O
the	O
induction	O
of	O
transcription	O
factors	O
functionally	O
involved	O
in	O
cell	O
growth	O
and	O
differentiation	O
.	O

Median	O
overall	O
and	O
progression	O
-	O
free	O
survivals	O
are	O
14	O
.	O
4	O
and	O
4	O
.	O
7	O
months	O
,	O
respectively	O
.	O

Photodynamic	O
therapy	O
with	O
verteporfin	O
for	O
subfoveal	O
choroidal	O
neovascularization	O
secondary	O
to	O
pathologic	O
myopia	O
:	O
long	O
-	O
term	O
study	O
.	O

Clinical	O
evaluations	O
performed	O
at	O
all	O
study	O
visits	O
included	O
measurement	O
of	O
best	O
-	O
corrected	O
Snellen	O
visual	O
acuity	O
,	O
slit	O
-	O
lamp	O
biomicroscopy	O
,	O
and	O
fundus	O
fluorescein	O
angiography	O
.	O

RESULTS	O
:	O
The	O
final	O
visual	O
acuity	O
of	O
the	O
study	O
patients	S-Species
,	O
after	O
a	O
median	O
follow	O
-	O
up	O
of	O
31	O
months	O
,	O
improved	O
by	O
greater	O
than	O
or	O
=	O
1	O
Snellen	O
lines	O
in	O
8	O
patients	S-Species
(	O
13	O
%	O
)	O
,	O
deteriorated	O
in	O
20	O
(	O
32	O
%	O
)	O
,	O
and	O
remained	O
stable	O
in	O
34	O
(	O
55	O
%	O
)	O
.	O

The	O
final	O
mean	O
visual	O
acuity	O
in	O
group	O
A	O
(	O
55	O
years	O
of	O
age	O
or	O
younger	O
)	O
was	O
20	O
/	O
80	O
and	O
significantly	O
(	O
P	O
=	O
0	O
.	O
006	O
)	O
better	O
than	O
that	O
(	O
20	O
/	O
138	O
)	O
in	O
group	O
B	O
(	O
older	O
than	O
55	O
years	O
of	O
age	O
)	O
.	O

CONCLUSION	O
:	O
PDT	O
preserves	O
vision	O
in	O
patients	S-Species
with	O
CNV	O
associated	O
with	O
PM	O
.	O

The	O
cell	O
type	O
specific	O
glycosylation	O
protects	O
Sp1	O
and	O
HIF1alpha	O
from	O
proteosome	O
degradation	O
and	O
plays	O
an	O
important	O
and	O
novel	O
role	O
in	O
the	O
regulation	O
of	O
VEGF	O
in	O
DCN	O
transfected	O
MCE	O
cells	O
.	O

FAS	O
-	O
1377	O
G	O
/	O
A	O
polymorphism	O
and	O
the	O
risk	O
of	O
lymph	O
node	O
metastasis	O
in	O
cervical	O
cancer	O
.	O

LVI	O
is	O
associated	O
with	O
axillary	O
lymph	O
node	O
metastases	O
(	O
ALNM	O
)	O
and	O
a	O
long	O
-	O
term	O
prognostic	O
factor	O
.	O

We	O
conditionally	O
activated	O
N	O
-	O
myc	O
in	O
SH	O
-	O
EP	O
neuroblastoma	O
cells	O
subjected	O
to	O
the	O
trophic	O
stress	O
of	O
serum	O
or	O
nutrient	O
deprivation	O
while	O
changing	O
the	O
expression	O
of	O
Bcl	O
-	O
2	O
,	O
survivin	O
and	O
FLIP	O
(	O
L	O
)	O
,	O
antiapoptotic	O
molecules	O
often	O
overexpressed	O
in	O
poor	O
prognosis	O
neuroblastomas	O
.	O

Survivin	O
partially	O
antagonized	O
the	O
growth	O
suppressive	O
function	O
of	O
N	O
-	O
myc	O
in	O
SH	O
-	O
EP	O
neuroblastoma	O
cells	O
during	O
serum	O
deprivation	O
whereas	O
FLIP	O
(	O
L	O
)	O
did	O
not	O
.	O

Solid	O
tumors	O
express	O
a	O
range	O
of	O
factors	O
required	O
to	O
sustain	O
their	O
growth	O
and	O
promote	O
their	O
dissemination	O
.	O

In	O
human	S-Species
endothelial	O
cells	O
,	O
cediranib	O
inhibited	O
VEGF	O
-	O
E	O
-	O
induced	O
phosphorylation	O
of	O
VEGFR	O
-	O
2	O
and	O
VEGF	O
-	O
C156S	O
-	O
induced	O
phosphorylation	O
of	O
VEGFR	O
-	O
3	O
at	O
concentrations	O
of	O
less	O
than	O
/	O
=	O
1nmol	O
/	O
L	O
and	O
inhibited	O
activation	O
of	O
downstream	O
signaling	O
molecules	O
.	O

Additionally	O
,	O
cediranib	O
blocked	O
VEGF	O
-	O
C156S	O
-	O
induced	O
and	O
VEGF	O
-	O
E	O
-	O
induced	O
proliferation	O
,	O
survival	O
,	O
and	O
migration	O
of	O
lymphatic	O
and	O
blood	O
vascular	O
endothelial	O
cells	O
.	O

The	O
median	O
time	O
to	O
disease	O
progression	O
while	O
on	O
treatment	O
was	O
24	O
weeks	O
.	O

Antibodies	O
developed	O
to	O
human	S-Species
endosialin	O
were	O
used	O
to	O
investigate	O
endosialin	O
expression	O
and	O
function	O
in	O
human	S-Species
prenatal	O
brain	O
pericytes	O
and	O
pericytes	O
residing	O
in	O
tumors	O
.	O

TUNEL	O
assay	O
and	O
microvessel	O
density	O
was	O
assessed	O
to	O
evaluate	O
apoptosis	O
and	O
angiogenesis	O
.	O

Vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
is	O
one	O
of	O
the	O
most	O
critical	O
factors	O
that	O
induce	O
angiogenesis	O
and	O
has	O
thus	O
become	O
an	O
attractive	O
target	O
for	O
antiangiogenesis	O
treatment	O
.	O

However	O
,	O
most	O
current	O
anti	O
-	O
VEGF	O
agents	O
often	O
cause	O
some	O
side	O
effects	O
when	O
given	O
chronically	O
.	O

We	O
have	O
previously	O
shown	O
that	O
IFI16	O
is	O
required	O
for	O
proinflammatory	O
gene	O
stimulation	O
by	O
IFN	O
-	O
gamma	O
through	O
the	O
NF	O
-	O
kappaB	O
complex	O
.	O

To	O
examine	O
whether	O
IFI16	O
induction	O
might	O
be	O
extended	O
to	O
other	O
proinflammatory	O
cytokines	O
such	O
as	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)	O
-	O
alpha	O
,	O
we	O
used	O
the	O
strategy	O
of	O
the	O
RNA	O
interference	O
to	O
knock	O
down	O
IFI16	O
expression	O
,	O
and	O
analyze	O
the	O
capability	O
of	O
TNF	O
-	O
alpha	O
to	O
stimulate	O
intercellular	O
adhesion	O
molecule	O
-	O
1	O
(	O
ICAM	O
-	O
1	O
or	O
CD54	O
)	O
expression	O
in	O
the	O
absence	O
of	O
functional	O
IFI16	O
.	O

RESULTS	O
:	O
Vandetanib	O
treatment	O
had	O
no	O
effect	O
on	O
tumor	O
cell	O
clonogenic	O
cell	O
survival	O
in	O
vitro	O
but	O
doses	O
>	O
or	O
=	O
10	O
nM	O
significantly	O
reduced	O
endothelial	O
cell	O
migration	O
.	O

beta2	O
-	O
glycoprotein	O
I	O
(	O
beta2GPI	O
)	O
is	O
proteolytically	O
cleaved	O
by	O
plasmin	O
in	O
its	O
domain	O
V	O
(	O
nicked	O
beta2GPI	O
)	O
,	O
resulting	O
in	O
binding	O
to	O
plasminogen	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
examined	O
the	O
ability	O
of	O
the	O
purine	O
analogue	O
8	O
-	O
aminoadenosine	O
to	O
acutely	O
reduce	O
glucose	O
consumption	O
by	O
regulating	O
localization	O
and	O
expression	O
of	O
key	O
glucose	O
transporters	O
.	O

Myeloma	O
cells	O
counteracted	O
the	O
metabolic	O
stress	O
by	O
activating	O
autophagy	O
.	O

However	O
,	O
these	O
cells	O
can	O
be	O
sensitized	O
to	O
8	O
-	O
aminoadenosine	O
under	O
glucose	O
-	O
limiting	O
conditions	O
.	O

Vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
-	O
induced	O
receptor	O
phosphorylation	O
is	O
the	O
crucial	O
step	O
for	O
initiating	O
downstream	O
signaling	O
pathways	O
that	O
lead	O
to	O
angiogenesis	O
or	O
related	O
pathophysiological	O
outcomes	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
D2	O
dopamine	O
receptor	O
(	O
D2DR	O
)	O
colocalizes	O
with	O
VEGFR	O
-	O
2	O
at	O
the	O
cell	O
surface	O
.	O

To	O
test	O
this	O
hypothesis	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
iNOS	O
deficiency	O
(	O
by	O
L	O
-	O
NIL	O
)	O
on	O
angiogenesis	O
in	O
a	O
hindlimb	O
ischemia	O
model	O
.	O

In	O
groups	O
1	O
&	O
2	O
,	O
hindlimb	O
ischemia	O
was	O
induced	O
by	O
ligation	O
of	O
femoral	O
artery	O
and	O
they	O
received	O
L	O
-	O
NIL	O
and	O
saline	O
respectively	O
.	O

In	O
this	O
study	O
we	O
separated	O
weakly	O
acidic	O
phenolic	O
components	O
from	O
other	O
neutral	O
,	O
acidic	O
and	O
basic	O
components	O
of	O
tobacco	O
smoke	O
condensate	O
(	O
TSC	O
)	O
and	O
observed	O
that	O
phenolic	O
fraction	O
of	O
TSC	O
significantly	O
increased	O
the	O
number	O
of	O
colonies	O
of	O
promotion	O
-	O
sensitive	O
JB6	O
Cl41	O
cells	O
that	O
showed	O
anchorage	O
-	O
independent	O
growth	O
on	O
soft	O
agar	O
in	O
response	O
to	O
BPDE	O
(	O
an	O
ultimate	O
carcinogen	O
produced	O
by	O
metabolic	O
activation	O
of	O
the	O
PAH	O
benzo	O
[	O
a	O
]	O
pyrene	O
)	O
.	O

Several	O
regulatory	O
and	O
signaling	O
molecules	O
governing	O
angiogenesis	O
are	O
of	O
interest	O
,	O
including	O
growth	O
factors	O
(	O
eg	O
,	O
vascular	O
endothelial	O
growth	O
factor	O
,	O
platelet	O
-	O
derived	O
growth	O
factor	O
,	O
fibroblast	O
growth	O
factor	O
,	O
and	O
epidermal	O
growth	O
factor	O
)	O
,	O
receptor	O
tyrosine	O
kinases	O
,	O
and	O
transcription	O
factors	O
such	O
as	O
hypoxia	O
inducible	O
factor	O
,	O
as	O
well	O
as	O
molecules	O
involved	O
in	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
and	O
phosphoinositide	O
3	O
-	O
kinase	O
(	O
PI3K	O
)	O
signaling	O
.	O

Overexpression	O
of	O
Bax	O
inhibitor	O
-	O
1	O
(	O
BI	O
-	O
1	O
)	O
induces	O
cell	O
transformation	O
in	O
NIH3T3	O
cells	O
.	O

Although	O
many	O
studies	O
have	O
been	O
carried	O
out	O
to	O
investigate	O
the	O
chemopreventive	O
role	O
of	O
flavonoids	O
,	O
less	O
attention	O
has	O
been	O
focused	O
on	O
phenolic	O
acids	O
.	O

It	O
is	O
possible	O
that	O
the	O
suppressive	O
effect	O
of	O
GA	O
on	O
MMP	O
-	O
2	O
/	O
9	O
might	O
involve	O
the	O
inhibition	O
of	O
NF	O
-	O
kappaB	O
activity	O
.	O

The	O
lack	O
of	O
treatment	O
for	O
worried	O
-	O
well	O
patients	S-Species
with	O
high	O
-	O
grade	O
prostatic	O
intraepithelial	O
neoplasia	O
combined	O
with	O
issues	O
of	O
recurrence	O
and	O
hormone	O
resistance	O
in	O
prostate	O
cancer	O
survivors	O
remains	O
a	O
major	O
public	O
health	O
obstacle	O
.	O

p	O
-	O
XSC	O
effectively	O
inhibits	O
AR	O
expression	O
and	O
transcriptional	O
activity	O
in	O
both	O
cell	O
lines	O
.	O

p	O
-	O
XSC	O
also	O
decreases	O
Akt	O
phosphorylation	O
as	O
well	O
as	O
Akt	O
-	O
specific	O
phosphorylation	O
of	O
the	O
AR	O
.	O

Our	O
data	O
suggest	O
that	O
p	O
-	O
XSC	O
inhibits	O
multiple	O
signaling	O
pathways	O
in	O
prostate	O
cancer	O
,	O
likely	O
accounting	O
for	O
the	O
downstream	O
effects	O
on	O
proliferation	O
and	O
apoptosis	O
.	O

Incubation	O
with	O
1	O
micromol	O
/	O
L	O
sanguinarine	O
for	O
4	O
and	O
24h	O
killed	O
more	O
efficiently	O
MG	O
-	O
63	O
cells	O
than	O
SaOS	O
-	O
2	O
cells	O
,	O
while	O
incubation	O
with	O
5	O
micromol	O
/	O
L	O
sanguinarine	O
killed	O
almost	O
100	O
%	O
of	O
both	O
cell	O
populations	O
within	O
24h	O
.	O

This	O
treatment	O
also	O
changed	O
the	O
mitochondrial	O
membrane	O
potential	O
in	O
both	O
MG	O
-	O
63	O
and	O
SaOS	O
-	O
2	O
cells	O
within	O
1h	O
,	O
caused	O
chromatin	O
condensation	O
and	O
the	O
formation	O
of	O
apoptotic	O
bodies	O
.	O

Androgen	O
stimulates	O
glycolysis	O
for	O
de	O
novo	O
lipid	O
synthesis	O
by	O
increasing	O
the	O
activities	O
of	O
hexokinase	O
2	O
and	O
6	O
-	O
phosphofructo	O
-	O
2	O
-	O
kinase	O
/	O
fructose	O
-	O
2	O
,	O
6	O
-	O
bisphosphatase	O
2	O
in	O
prostate	O
cancer	O
cells	O
.	O

Our	O
earlier	O
studies	O
showed	O
that	O
DATS	O
induced	O
apoptosis	O
in	O
human	S-Species
colon	O
cancer	O
HT29	O
and	O
colo	O
205	O
cell	O
lines	O
in	O
vitro	O
.	O

In	O
vitro	O
studies	O
,	O
the	O
results	O
indicated	O
that	O
DATS	O
induced	O
morphological	O
changes	O
and	O
induction	O
of	O
apoptosis	O
in	O
CT26	O
cells	O
.	O

In	O
vivo	O
studies	O
,	O
CT26	O
cancer	O
cells	O
were	O
implanted	O
into	O
BALB	B-Species
/	I-Species
c	I-Species
mice	E-Species
and	O
groups	O
of	O
mice	S-Species
were	O
treated	O
with	O
vehicle	O
,	O
DATS	O
(	O
10	O
and	O
50	O
mg	O
/	O
kg	O
of	O
body	O
weight	O
)	O
.	O

Treatment	O
with	O
vehicle	O
or	O
with	O
10	O
and	O
50	O
mg	O
/	O
kg	O
of	O
DATS	O
resulted	O
in	O
a	O
reduction	O
in	O
tumor	O
volume	O
and	O
weight	O
.	O

Thus	O
,	O
such	O
a	O
resonating	O
cross	O
-	O
talk	O
can	O
amplify	O
Hedgehog	O
signaling	O
,	O
resulting	O
in	O
molecular	O
chatter	O
that	O
overall	O
promotes	O
tumor	O
progression	O
.	O

We	O
examined	O
the	O
paired	O
tumour	O
and	O
normal	O
-	O
tissue	O
specimens	O
of	O
86	O
CRC	O
patients	S-Species
for	O
the	O
occurrence	O
of	O
aberrations	O
in	O
the	O
mutation	O
cluster	O
region	O
(	O
MCR	O
)	O
of	O
the	O
APC	O
gene	O
and	O
exon	O
3	O
of	O
the	O
beta	O
-	O
catenin	O
gene	O
by	O
polymerase	O
chain	O
reaction	O
-	O
single	O
-	O
strand	O
conformation	O
polymorphism	O
(	O
PCR	O
-	O
SSCP	O
)	O
and	O
/	O
or	O
PCR	O
-	O
direct	O
sequencing	O
.	O

The	O
overall	O
mutation	O
rate	O
of	O
the	O
MCR	O
of	O
the	O
APC	O
gene	O
among	O
86	O
CRC	O
cases	O
was	O
12	O
.	O
8	O
per	O
cent	O
(	O
11	O
of	O
86	O
)	O
.	O

Aglycon	O
of	O
rhizochalin	O
from	O
the	O
Rhizochalina	B-Species
incrustata	E-Species
induces	O
apoptosis	O
via	O
activation	O
of	O
AMP	O
-	O
activated	O
protein	O
kinase	O
in	O
HT	O
-	O
29	O
colon	O
cancer	O
cells	O
.	O

Rhizochalin	O
is	O
a	O
two	O
-	O
headed	O
sphingolipid	O
-	O
like	O
compound	O
isolated	O
from	O
the	O
sponge	O
Rhizochalina	B-Species
incrustata	E-Species
.	O

However	O
,	O
the	O
molecular	O
mechanism	O
of	O
these	O
effects	O
is	O
not	O
understood	O
.	O

Notably	O
,	O
AglRhz	O
inhibits	O
insulin	O
-	O
like	O
growth	O
factor	O
(	O
IGF	O
)	O
-	O
1	O
-	O
induced	O
AP	O
-	O
1	O
activity	O
and	O
cell	O
transformation	O
in	O
JB6	O
Cl41	O
cells	O
.	O

CK1delta	O
mutants	O
exhibited	O
a	O
reduced	O
kinase	O
activity	O
compared	O
to	O
wtCK1delta	O
in	O
in	O
vitro	O
kinase	O
assays	O
.	O

Two	O
of	O
them	O
were	O
selected	O
for	O
high	O
or	O
low	O
osteonectin	O
expression	O
and	O
tested	O
in	O
vivo	O
in	O
spontaneous	O
and	O
artificial	O
metastasis	O
assays	O
.	O

High	O
osteonectin	O
expression	O
was	O
correlated	O
with	O
high	O
lung	O
colonization	O
.	O

When	O
10	O
(	O
5	O
)	O
cells	O
were	O
injected	O
i	O
.	O
v	O
.	O
,	O
median	O
colony	O
value	O
was	O
55	O
and	O
20	O
in	O
higher	O
expressor	O
vs	O
.	O
lower	O
expressor	O
respectively	O
(	O
p	O
less	O
than	O
0	O
.	O
005	O
)	O
.	O

We	O
found	O
that	O
the	O
severity	O
of	O
vascular	O
abnormalities	O
correlated	O
positively	O
with	O
the	O
severity	O
of	O
histologic	O
epithelial	O
lesions	O
;	O
this	O
finding	O
is	O
consistent	O
with	O
colposcopic	O
results	O
.	O

Glycolysis	O
and	O
glutaminolysis	O
in	O
perifused	O
Ehrlich	O
ascites	O
tumour	O
cells	O
.	O

Cells	O
were	O
perifused	O
in	O
the	O
presence	O
of	O
5	O
mM	O
glucose	O
,	O
0	O
.	O
5	O
mM	O
glutamine	O
or	O
5	O
mM	O
glucose	O
and	O
0	O
.	O
5	O
mM	O
glutamine	O
.	O

As	O
reported	O
previously	O
(	O
Namba	O
et	O
al	O
.	O
,	O
1985	O
;	O
Namba	O
,	O
1985	O
)	O
,	O
normal	O
human	S-Species
fibroblasts	O
were	O
transformed	O
into	O
immortal	O
cells	O
with	O
abnormal	O
karyotypes	O
by	O
Co	O
-	O
60	O
gamma	O
-	O
ray	O
irradiation	O
.	O

The	O
tumors	O
were	O
also	O
serially	O
transplantable	O
into	O
other	O
mice	S-Species
.	O

These	O
activities	O
provide	O
an	O
explanation	O
for	O
the	O
angiogenic	O
properties	O
of	O
EGF	O
in	O
vivo	O
.	O

It	O
is	O
also	O
clear	O
that	O
diffusible	O
angiogenic	O
stimuli	O
can	O
be	O
released	O
not	O
only	O
from	O
most	O
solid	O
tumors	O
,	O
but	O
also	O
from	O
at	O
least	O
three	O
non	O
-	O
neoplastic	O
cells	O
.	O

Under	O
specific	O
conditions	O
,	O
casein	O
could	O
be	O
used	O
as	O
an	O
exogenous	O
substrate	O
as	O
well	O
.	O

Finally	O
,	O
anti	O
-	O
p53	O
monoclonal	O
antibodies	O
only	O
slightly	O
affected	O
in	O
vitro	O
phosphorylation	O
reactions	O
,	O
whereas	O
a	O
p53	O
molecule	O
from	O
a	O
simian	B-Species
virus	I-Species
40	E-Species
-	O
free	O
,	O
chemically	O
transformed	O
human	S-Species
cell	O
line	O
was	O
not	O
phosphorylated	O
in	O
vitro	O
under	O
any	O
condition	O
tested	O
.	O

Some	O
potentially	O
promising	O
prognostic	O
,	O
diagnostic	O
,	O
and	O
therapeutic	O
modalities	O
for	O
tumor	O
angiogenesis	O
and	O
metastatic	O
disease	O
are	O
also	O
discussed	O
.	O

H4IIEC3	O
(	O
H4	O
)	O
,	O
a	O
differentiated	O
rat	S-Species
hepatoma	O
line	O
and	O
H5	O
,	O
its	O
dedifferentiated	O
subclone	O
,	O
were	O
investigated	O
as	O
proliferating	O
spheroids	O
and	O
as	O
implanted	O
subcutaneous	O
tumors	O
in	O
juvenile	B-Species
rats	E-Species
.	O

Comparison	O
between	O
RNA	O
/	O
DNA	O
sequence	O
of	O
viral	S-Species
oncogenes	O
and	O
normal	O
human	S-Species
genome	O
of	O
non	O
-	O
transformed	O
cells	O
revealed	O
high	O
sequence	O
similarities	O
in	O
specific	O
genomic	O
areas	O
,	O
which	O
were	O
named	O
cellular	O
proto	O
-	O
oncogens	O
.	O

The	O
detection	O
of	O
increased	O
abundance	O
of	O
EGF	O
-	O
R	O
or	O
Her	O
-	O
2	O
/	O
neu	O
proteins	O
in	O
human	S-Species
tumours	O
can	O
provide	O
additional	O
information	O
on	O
the	O
disease	O
-	O
free	O
survival	O
and	O
overall	O
survival	O
for	O
patients	S-Species
with	O
breast	O
,	O
ovarian	O
,	O
endometrial	O
or	O
cervical	O
cancer	O
.	O

Monoclonal	O
antibody	O
targeted	O
therapy	O
directed	O
against	O
EGF	O
-	O
R	O
or	O
Her	O
-	O
2	O
/	O
neu	O
,	O
the	O
use	O
of	O
anti	O
-	O
sense	O
oligonucleotides	O
and	O
oligodeoxynucleotides	O
,	O
and	O
the	O
application	O
of	O
tyrosine	O
kinase	O
and	O
protein	O
C	O
-	O
kinase	O
inhibitors	O
are	O
currently	O
being	O
investigated	O
.	O

Two	O
of	O
the	O
mutations	O
included	O
a	O
G	O
to	O
C	O
substitution	O
at	O
codon	O
12	O
,	O
and	O
a	O
G	O
to	O
A	O
substitution	O
at	O
codon	O
18	O
,	O
resulting	O
in	O
a	O
glycine	O
to	O
arginine	O
,	O
and	O
an	O
alanine	O
to	O
threonine	O
change	O
at	O
these	O
amino	O
acids	O
,	O
respectively	O
.	O

Rat	S-Species
tissues	O
known	O
to	O
express	O
these	O
glucose	O
transporters	O
were	O
used	O
as	O
controls	O
.	O

CONCLUSIONS	O
:	O
Higher	O
expression	O
of	O
the	O
glucose	O
transporter	O
Glut	O
-	O
1	O
by	O
breast	O
cancer	O
cells	O
compared	O
with	O
the	O
healthy	O
breast	O
tissue	O
is	O
common	O
.	O

High	O
density	O
of	O
somatostatin	O
receptors	O
in	O
veins	O
surrounding	O
human	S-Species
cancer	O
tissue	O
:	O
role	O
in	O
tumor	O
-	O
host	O
interaction	O
?	O

In	O
colonic	O
carcinoma	O
specimens	O
,	O
the	O
peritumoral	O
vessels	O
expressed	O
a	O
high	O
density	O
of	O
somatostatin	O
receptors	O
,	O
whereas	O
the	O
neoplastic	O
tissue	O
itself	O
was	O
receptor	O
-	O
negative	O
in	O
many	O
cases	O
.	O

In	O
all	O
cases	O
,	O
the	O
somatostatin	O
receptors	O
were	O
localized	O
in	O
veins	O
,	O
particularly	O
in	O
the	O
smooth	O
-	O
muscle	O
cell	O
layer	O
.	O

Levels	O
of	O
uPA	O
,	O
urokinase	O
-	O
plasminogen	O
activator	O
receptor	O
(	O
uPAR	O
)	O
and	O
plasminogen	O
activator	O
inhibitor	O
-	O
1	O
(	O
PAI	O
-	O
1	O
)	O
were	O
measured	O
semiquantitatively	O
in	O
paraffin	O
sections	O
of	O
tumours	O
from	O
147	O
patients	S-Species
with	O
NSCLC	O
.	O

There	O
was	O
a	O
significant	O
positive	O
relationship	O
between	O
PAI	O
-	O
1	O
levels	O
and	O
T	O
-	O
stage	O
(	O
p	O
=	O
<	O
0	O
.	O
05	O
)	O
in	O
the	O
total	O
group	O
,	O
and	O
survival	O
status	O
(	O
p	O
=	O
<	O
0	O
.	O
05	O
)	O
in	O
the	O
SCC	O
subgroup	O
alone	O
.	O

Potential	O
roles	O
for	O
focal	O
adhesion	O
kinase	O
in	O
development	O
.	O

However	O
,	O
the	O
role	O
of	O
the	O
TSH	O
-	O
R	O
-	O
related	O
cAMP	O
pathway	O
alterations	O
in	O
thyroid	O
transformation	O
remains	O
to	O
be	O
elucidated	O
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
proto	O
-	O
oncogene	O
N	O
-	O
myc	O
promoter	O
was	O
down	O
-	O
regulated	O
by	O
WT1	O
in	O
transient	O
transfection	O
assays	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
incidence	O
of	O
BRCA1	O
promoter	O
region	O
methylation	O
in	O
tumours	O
in	O
which	O
loss	O
of	O
BRCA1	O
has	O
been	O
shown	O
to	O
play	O
a	O
role	O
in	O
pathogenesis	O
(	O
breast	O
and	O
ovarian	O
carcinomas	O
)	O
with	O
the	O
incidence	O
in	O
tumours	O
in	O
which	O
BRCA1	O
is	O
unlikely	O
to	O
play	O
a	O
role	O
in	O
pathogenesis	O
.	O

Promoter	O
region	O
hypermethylation	O
was	O
significantly	O
more	O
common	O
(	O
P	O
<	O
0	O
.	O
008	O
)	O
in	O
breast	O
and	O
ovarian	O
cancer	O
(	O
6	O
/	O
38	O
tumours	O
methylated	O
)	O
than	O
in	O
colon	O
cancer	O
(	O
0	O
/	O
35	O
tumours	O
methylated	O
)	O
or	O
in	O
leukaemias	O
(	O
0	O
/	O
19	O
samples	O
methylated	O
)	O
.	O

We	O
have	O
constructed	O
a	O
recombinant	O
adenovirus	S-Species
that	O
expresses	O
murine	S-Species
endostatin	O
that	O
is	O
biologically	O
active	O
both	O
in	O
vitro	O
,	O
as	O
determined	O
in	O
endothelial	O
cell	O
proliferation	O
assays	O
,	O
and	O
in	O
vivo	O
,	O
by	O
suppression	O
of	O
angiogenesis	O
induced	O
by	O
vascular	O
endothelial	O
growth	O
factor	O
165	O
.	O

Hypermethylation	O
of	O
final	O
sigma	O
is	O
functionally	O
important	O
,	O
because	O
treatment	O
of	O
final	O
sigma	O
-	O
non	O
-	O
expressing	O
breast	O
cancer	O
cell	O
lines	O
with	O
the	O
drug	O
5	O
-	O
aza	O
-	O
2	O
'	O
-	O
deoxycytidine	O
resulted	O
in	O
demethylation	O
of	O
the	O
gene	O
and	O
synthesis	O
of	O
final	O
sigma	O
mRNA	O
.	O

Western	O
blot	O
analysis	O
of	O
involved	O
hematologic	O
tissues	O
of	O
the	O
p190	O
del	O
C	O
transgenics	S-Species
with	O
end	O
-	O
stage	O
disease	O
showed	O
high	O
-	O
level	O
expression	O
of	O
the	O
transgene	O
and	O
tyrosine	O
phosphorylation	O
of	O
Cbl	O
and	O
Hef1	O
/	O
Cas	O
,	O
proteins	O
previously	O
shown	O
to	O
be	O
affected	O
by	O
Bcr	O
/	O
Abl	O
.	O

A	O
summary	O
is	O
made	O
of	O
recent	O
advances	O
in	O
the	O
understanding	O
of	O
IL	O
-	O
18	O
structure	O
,	O
processing	O
,	O
receptor	O
expression	O
and	O
immunoregulatory	O
functions	O
.	O

In	O
this	O
work	O
,	O
we	O
show	O
that	O
an	O
11	O
-	O
amino	O
acid	O
peptide	O
derived	O
from	O
the	O
second	O
immunoglobulin	O
-	O
like	O
domain	O
of	O
Flt	O
-	O
1	O
functions	O
as	O
an	O
angiogenic	O
inhibitor	O
in	O
chick	S-Species
chorioallantoic	O
membrane	O
and	O
inhibited	O
VEGF	O
-	O
induced	O
vascular	O
permeability	O
in	O
Miles	O
'	O
assay	O
without	O
binding	O
to	O
VEGF	O
directly	O
.	O

The	O
two	O
parameters	O
were	O
more	O
frequently	O
observed	O
in	O
the	O
SCC	O
with	O
VEGF	O
/	O
p53	O
coexpression	O
than	O
in	O
those	O
without	O
the	O
coexpression	O
.	O

Furthermore	O
,	O
both	O
PLD1	O
and	O
PLD2	O
transformants	O
,	O
but	O
not	O
vector	O
-	O
transfectants	O
,	O
induced	O
undifferentiated	O
sarcoma	O
when	O
transplanted	O
into	O
nude	B-Species
mice	E-Species
.	O

Both	O
PLD1	O
-	O
and	O
PLD2	O
-	O
mediated	O
cell	O
cycle	O
distributions	O
in	O
stable	O
cell	O
lines	O
revealed	O
an	O
increased	O
fraction	O
of	O
cells	O
in	O
the	O
S	O
phase	O
compared	O
with	O
control	O
cells	O
.	O

In	O
the	O
current	O
article	O
we	O
demonstrate	O
that	O
TnI	O
inhibits	O
both	O
bFGF	O
-	O
stimulated	O
and	O
basal	O
levels	O
of	O
endothelial	O
cell	O
proliferation	O
,	O
and	O
we	O
hypothesize	O
that	O
this	O
inhibition	O
is	O
occurring	O
,	O
at	O
least	O
in	O
part	O
,	O
via	O
an	O
interaction	O
of	O
TnI	O
with	O
the	O
cell	O
-	O
surface	O
bFGF	O
receptor	O
on	O
capillary	O
endothelial	O
cells	O
.	O

Highly	O
specialized	O
cells	O
,	O
the	O
thyrocytes	O
,	O
express	O
a	O
thyroid	O
-	O
specific	O
set	O
of	O
genes	O
for	O
thyroglobulin	O
(	O
Tg	O
)	O
,	O
thyroperoxidase	O
,	O
and	O
the	O
transcription	O
factors	O
TTF	O
-	O
1	O
,	O
TTF	O
-	O
2	O
,	O
and	O
Pax	O
-	O
8	O
.	O

The	O
mechanism	O
underlying	O
the	O
association	O
between	O
high	O
PE	O
and	O
poor	O
clinical	O
outcome	O
is	O
unclear	O
,	O
although	O
it	O
may	O
be	O
related	O
to	O
the	O
possible	O
PE	O
reflection	O
of	O
tumor	O
burden	O
.	O

In	O
this	O
report	O
we	O
studied	O
the	O
effects	O
of	O
SFLLR	O
,	O
an	O
agonist	O
of	O
the	O
activated	O
thrombin	O
receptor	O
and	O
thrombin	O
receptor	O
peptide	O
and	O
non	O
peptide	O
antagonists	O
on	O
angiogenesis	O
in	O
the	O
chick	S-Species
chorioallantoic	O
membrane	O
(	O
CAM	O
)	O
system	O
.	O

RESULTS	O
:	O
Abnormal	O
E	O
-	O
cadherin	O
and	O
beta	O
-	O
catenin	O
staining	O
correlated	O
with	O
depth	O
of	O
tumour	O
invasion	O
in	O
differentiated	O
-	O
type	O
tumours	O
.	O

Multivariate	O
analysis	O
revealed	O
abnormal	O
E	O
-	O
cadherin	O
expression	O
as	O
an	O
independent	O
factor	O
that	O
correlated	O
with	O
submucosal	O
invasion	O
in	O
early	O
gastric	O
cancer	O
.	O

Furthermore	O
,	O
the	O
formation	O
of	O
complexes	O
containing	O
KDR	O
and	O
NRP1	O
markedly	O
increased	O
125I	O
-	O
VEGF165	O
binding	O
to	O
KDR	O
.	O

Invasive	O
carcinomas	O
without	O
spiculated	O
margins	O
are	O
poorly	O
differentiated	O
tumors	O
.	O

Mammographic	O
patterns	O
of	O
microcalcifications	O
depend	O
on	O
their	O
physiopathological	O
process	O
(	O
necrosis	O
,	O
secretion	O
)	O
,	O
and	O
the	O
shape	O
of	O
clusters	O
(	O
round	O
,	O
triangular	O
)	O
typifies	O
their	O
anatomical	O
site	O
of	O
origin	O
(	O
lobular	O
,	O
ductal	O
)	O
.	O

Knowledge	O
of	O
radiopathological	O
correlations	O
in	O
breast	O
diseases	O
helps	O
the	O
radiologists	O
to	O
analyze	O
and	O
characterize	O
breast	O
lesions	O
.	O

Notably	O
,	O
three	O
immortalizing	O
E6	O
mutants	O
that	O
do	O
not	O
induce	O
direct	O
p53	O
degradation	O
but	O
do	O
interact	O
with	O
hADA3	O
induced	O
the	O
abrogation	O
of	O
p53	O
-	O
mediated	O
transactivation	O
and	O
G	O
(	O
1	O
)	O
cell	O
cycle	O
arrest	O
after	O
DNA	O
damage	O
,	O
comparable	O
to	O
wild	O
-	O
type	O
E6	O
.	O

Ultimately	O
,	O
the	O
primary	O
site	O
was	O
established	O
on	O
clinical	O
and	O
radiographic	O
grounds	O
in	O
71	O
cases	O
(	O
95	O
%	O
)	O
.	O

In	O
cell	O
culture	O
,	O
the	O
compound	O
317615	O
2HCl	O
,	O
a	O
potent	O
inhibitor	O
of	O
VEGF	O
-	O
stimulated	O
HUVEC	O
proliferation	O
,	O
was	O
not	O
very	O
effective	O
against	O
MX	O
-	O
1	O
breast	O
cancer	O
cells	O
(	O
IC50	O
=	O
8	O
.	O
1	O
microM	O
)	O
or	O
SKOV	O
-	O
3	O
ovarian	O
carcinoma	O
cells	O
(	O
IC50	O
=	O
9	O
.	O
5	O
microM	O
)	O
.	O

Treatment	O
with	O
317615	O
x	O
2HCl	O
alone	O
increased	O
the	O
lifespan	O
of	O
animals	O
bearing	O
intraperitoneal	O
SKOV	O
-	O
3	O
xenografts	O
by	O
1	O
.	O
9	O
fold	O
compared	O
with	O
untreated	O
control	O
animals	O
.	O

Moreover	O
,	O
renal	O
carcinoma	O
cell	O
lines	O
also	O
released	O
the	O
soluble	O
form	O
of	O
CD154	O
into	O
the	O
supernatant	O
.	O

The	O
effects	O
on	O
aerobic	O
glucose	O
consumption	O
,	O
lactic	O
acid	O
formation	O
,	O
content	O
of	O
total	O
(	O
T	O
-	O
SH	O
)	O
and	O
non	O
-	O
protein	O
thiol	O
groups	O
(	O
NP	O
-	O
SH	O
)	O
,	O
endogenous	O
and	O
exogenous	O
respiration	O
and	O
the	O
level	O
of	O
ATP	O
in	O
tumour	O
cells	O
incubated	O
in	O
vitro	O
were	O
investigated	O
.	O

Enhanced	O
expression	O
of	O
vascular	O
endothelial	O
growth	O
factor	O
by	O
periodontal	O
pathogens	O
in	O
gingival	O
fibroblasts	O
.	O

Aberrant	O
angiogenesis	O
is	O
often	O
associated	O
with	O
lesion	O
formation	O
in	O
chronic	O
periodontitis	O
.	O

Heating	O
and	O
protease	O
treatment	O
of	O
the	O
stimulants	O
reduced	O
the	O
VEGF	O
enhancing	O
levels	O
in	O
Ve	O
and	O
OMP	O
in	O
vitro	O
.	O

RESULTS	O
:	O
The	O
control	O
group	O
showed	O
the	O
highest	O
level	O
of	O
corneal	O
clouding	O
and	O
neovascularization	O
.	O

CONCLUSIONS	O
:	O
Fluconazole	O
plus	O
adjunct	O
high	O
-	O
dose	O
prednisolone	O
treatment	O
was	O
most	O
effective	O
when	O
administered	O
9	O
days	O
after	O
infection	O
.	O

Gross	O
evaluation	O
included	O
shrinkage	O
and	O
stiffness	O
.	O

There	O
was	O
no	O
difference	O
in	O
fat	O
encapsulation	O
,	O
necrosis	O
,	O
hemorrhage	O
,	O
or	O
exudate	O
between	O
prostheses	O
.	O

Both	O
polyester	O
prostheses	O
(	O
PF	O
and	O
PS	O
)	O
have	O
better	O
tissue	O
integration	O
than	O
the	O
PP	O
mesh	O
,	O
as	O
evidenced	O
by	O
the	O
higher	O
amount	O
of	O
connective	O
tissue	O
and	O
lower	O
extent	O
of	O
fibrous	O
encapsulation	O
.	O

Swift	O
elimination	O
of	O
undesirable	O
cells	O
is	O
an	O
important	O
feature	O
in	O
tumour	O
suppression	O
and	O
immunity	O
.	O

The	O
tumour	O
suppressor	O
p53	O
and	O
interferon	O
-	O
alpha	O
and	O
-	O
beta	O
(	O
IFN	O
-	O
alpha	O
/	O
beta	O
)	O
are	O
essential	O
for	O
the	O
induction	O
of	O
apoptosis	O
in	O
cancerous	O
cells	O
and	O
in	O
antiviral	S-Species
immune	O
responses	O
,	O
respectively	O
,	O
but	O
little	O
is	O
known	O
about	O
their	O
interrelationship	O
.	O

Furthermore	O
,	O
slow	O
release	O
administration	O
by	O
subcutaneous	O
injection	O
using	O
an	O
Alzet	O
osmotic	O
pump	O
of	O
a	O
potent	O
and	O
bio	O
-	O
stable	O
T140	O
analog	O
,	O
4F	O
-	O
benzoyl	O
-	O
TN14003	O
,	O
gave	O
a	O
partial	O
,	O
but	O
statistically	O
significant	O
(	O
P	O
<	O
/	O
=	O
0	O
.	O
05	O
(	O
t	O
-	O
test	O
)	O
)	O
reduction	O
in	O
pulmonary	O
metastasis	O
of	O
MDA	O
-	O
MB	O
-	O
231	O
in	O
SCID	B-Species
mice	E-Species
,	O
even	O
though	O
no	O
attempt	O
was	O
made	O
to	O
inhibit	O
other	O
important	O
targets	O
such	O
as	O
CCR7	O
.	O

These	O
angiogenic	O
activities	O
are	O
neutralized	O
by	O
a	O
specific	O
antibody	O
against	O
CCL16	O
.	O

The	O
largely	O
restricted	O
CCL16	O
expression	O
in	O
the	O
liver	O
suggests	O
that	O
this	O
chemokine	O
may	O
play	O
a	O
role	O
in	O
hepatic	O
vascular	O
formation	O
during	O
development	O
and	O
in	O
angiogenesis	O
associated	O
to	O
hepatic	O
diseases	O
.	O

Despite	O
several	O
advances	O
in	O
therapeutic	O
options	O
,	O
the	O
disease	O
remains	O
incurable	O
.	O

Constitutively	O
increased	O
c	O
-	O
src	O
kinase	O
activity	O
reconstituted	O
the	O
increases	O
in	O
migration	O
and	O
u	O
-	O
PA	O
observed	O
with	O
angiotensin	O
system	O
interruption	O
.	O

Loss	O
-	O
of	O
-	O
function	O
effects	O
were	O
also	O
observed	O
in	O
HIF	O
-	O
1alpha	O
-	O
null	O
embryonic	O
stem	O
cells	O
.	O

However	O
,	O
the	O
expression	O
level	O
of	O
E	O
-	O
cadherin	O
had	O
an	O
inverse	O
relationship	O
with	O
both	O
differentiation	O
level	O
of	O
the	O
tumor	O
and	O
lymphatic	O
vessel	O
invasion	O
(	O
p	O
=	O
0	O
.	O
0430	O
and	O
0	O
.	O
0320	O
,	O
respectively	O
)	O
.	O

RESULTS	O
:	O
Approximate	O
1	O
,	O
000	O
protein	O
spots	O
were	O
detected	O
on	O
silver	O
-	O
stained	O
gel	O
by	O
ImageMaster	O
(	O
977	O
+	O
/	O
-	O
113	O
spots	O
in	O
Hep3B	O
,	O
1092	O
+	O
/	O
-	O
40	O
in	O
MHCC97L	O
,	O
and	O
889	O
+	O
/	O
-	O
14	O
in	O
MHCC97H	O
)	O
.	O

In	O
addition	O
,	O
PPARgamma	O
protein	O
was	O
not	O
detected	O
in	O
all	O
of	O
the	O
eight	O
carcinomas	O
in	O
which	O
COX	O
-	O
2	O
protein	O
was	O
detected	O
,	O
suggesting	O
that	O
expression	O
of	O
PPARgamma	O
and	O
COX	O
-	O
2	O
was	O
in	O
a	O
reciprocal	O
relationship	O
.	O

Osteopontin	O
(	O
OPN	O
)	O
is	O
a	O
secreted	O
adhesive	O
glycophosphoprotein	O
expressed	O
by	O
several	O
cell	O
types	O
.	O

It	O
is	O
normally	O
produced	O
in	O
bone	O
,	O
teeth	O
,	O
kidney	O
and	O
epithelial	O
lining	O
tissues	O
and	O
is	O
found	O
in	O
plasma	O
and	O
breast	O
milk	O
.	O

Here	O
we	O
show	O
that	O
GR	O
activation	O
leads	O
to	O
both	O
the	O
rapid	O
induction	O
of	O
MAPK	O
phosphatase	O
-	O
1	O
(	O
MKP	O
-	O
1	O
)	O
mRNA	O
and	O
its	O
sustained	O
expression	O
.	O

It	O
is	O
therefore	O
highly	O
likely	O
that	O
these	O
alterations	O
are	O
an	O
important	O
component	O
in	O
tumor	O
resistance	O
to	O
therapy	O
.	O

Recent	O
in	O
vitro	O
and	O
in	O
vivo	O
evidence	O
suggest	O
that	O
they	O
may	O
also	O
have	O
direct	O
antitumor	O
effects	O
via	O
induction	O
of	O
apoptosis	O
,	O
inhibition	O
of	O
the	O
invasive	O
potential	O
of	O
tumor	O
cell	O
lines	O
in	O
vitro	O
,	O
inhibition	O
of	O
angiogenesis	O
,	O
and	O
reduction	O
in	O
tumor	O
growth	O
indirectly	O
via	O
effects	O
on	O
accessory	O
cells	O
.	O

This	O
is	O
a	O
randomized	O
,	O
open	O
label	O
,	O
prospective	O
study	O
that	O
examined	O
the	O
effect	O
of	O
preventive	O
zoledronic	O
acid	O
treatment	O
on	O
the	O
development	O
of	O
bone	O
metastases	O
in	O
patients	S-Species
with	O
recurrent	O
solid	O
tumors	O
,	O
without	O
bone	O
metastases	O
at	O
the	O
time	O
of	O
randomization	O
.	O

HYPOTHESIS	O
:	O
This	O
study	O
was	O
designed	O
to	O
compare	O
coronary	O
collateral	O
circulation	O
(	O
CCC	O
)	O
in	O
patients	S-Species
with	O
proliferative	O
diabetic	O
retinopathy	O
(	O
PDR	O
)	O
with	O
that	O
in	O
patients	S-Species
without	O
DR	O
.	O

Groups	O
1	O
and	O
2	O
consisted	O
of	O
48	O
patients	S-Species
without	O
DR	O
and	O
42	O
patients	S-Species
with	O
PDR	O
,	O
respectively	O
.	O

We	O
also	O
show	O
that	O
VEGFR1	O
+	O
cells	O
express	O
VLA	O
-	O
4	O
(	O
also	O
known	O
as	O
integrin	O
alpha4beta1	O
)	O
,	O
and	O
that	O
tumour	O
-	O
specific	O
growth	O
factors	O
upregulate	O
fibronectin	O
-	O
-	O
a	O
VLA	O
-	O
4	O
ligand	O
-	O
-	O
in	O
resident	O
fibroblasts	O
,	O
providing	O
a	O
permissive	O
niche	O
for	O
incoming	O
tumour	O
cells	O
.	O

To	O
this	O
end	O
,	O
we	O
generated	O
endothelial	O
cell	O
lines	O
stably	O
expressing	O
vGPCR	O
or	O
key	O
KSHV	S-Species
latently	O
expressed	O
proteins	O
(	O
vCyclin	O
,	O
vFlip	O
,	O
and	O
LANA1	O
)	O
.	O

Here	O
,	O
HGF	O
stimulation	O
of	O
melanocytes	O
was	O
seen	O
to	O
up	O
-	O
regulate	O
c	O
-	O
Met	O
expression	O
.	O

Finally	O
,	O
dominant	O
-	O
negative	O
inhibition	O
of	O
Mitf	O
resulted	O
in	O
profound	O
resistance	O
of	O
melanocytes	O
and	O
melanoma	O
cells	O
to	O
HGF	O
-	O
dependent	O
matrix	O
invasion	O
,	O
suggesting	O
a	O
physiologic	O
role	O
for	O
this	O
pathway	O
in	O
melanocytic	O
development	O
and	O
melanoma	O
.	O

Coexpression	O
of	O
PIM	O
-	O
1KD	O
and	O
PIM	O
-	O
2KD	O
abrogated	O
growth	O
factor	O
-	O
independent	O
growth	O
of	O
Ba	O
/	O
F3	O
transformed	O
by	O
several	O
PTKs	O
,	O
including	O
BCR	O
/	O
ABL	O
.	O

Although	O
angiostatin	O
administered	O
intravenously	O
is	O
cleared	O
from	O
the	O
circulation	O
in	O
a	O
matter	O
of	O
minutes	O
,	O
angiostatin	O
-	O
mimetics	O
that	O
are	O
more	O
stable	O
have	O
potential	O
for	O
clinical	O
application	O
.	O

The	O
development	O
of	O
hepatocellular	O
carcinoma	O
(	O
HCC	O
)	O
presumably	O
occurs	O
in	O
multiple	O
steps	O
and	O
is	O
influenced	O
by	O
numerous	O
factors	O
.	O

In	O
the	O
present	O
study	O
a	O
DNA	O
probe	O
derived	O
from	O
cellular	O
DNA	O
sequences	O
adjacent	O
to	O
the	O
previously	O
characterized	O
HBV	S-Species
insert	O
was	O
used	O
to	O
analyze	O
a	O
set	O
of	O
19	O
matched	O
normal	O
liver	O
and	O
HBV	S-Species
-	O
positive	O
hepatoma	O
samples	O
obtained	O
from	O
the	O
same	O
region	O
of	O
China	O
,	O
near	O
Shanghai	O
.	O

Tumor	O
-	O
specific	O
DNA	O
changes	O
were	O
detected	O
in	O
two	O
additional	O
HCCs	O
,	O
suggesting	O
that	O
the	O
small	O
region	O
of	O
chromosome	O
17p	O
defined	O
by	O
the	O
flanking	O
cell	O
DNA	O
probe	O
is	O
commonly	O
altered	O
in	O
hepatomas	O
.	O

Here	O
we	O
show	O
that	O
angiogenesis	O
is	O
severely	O
impaired	O
in	O
PSMA	O
-	O
null	O
animals	O
and	O
that	O
this	O
angiogenic	O
defect	O
occurs	O
at	O
the	O
level	O
of	O
endothelial	O
cell	O
invasion	O
through	O
the	O
extracellular	O
matrix	O
barrier	O
.	O

The	O
amount	O
of	O
conjugated	O
amine	O
group	O
onto	O
the	O
microspheres	O
was	O
1	O
.	O
93	O
+	O
/	O
-	O
0	O
.	O
01	O
nmol	O
/	O
mg	O
-	O
microspheres	O
,	O
while	O
the	O
amount	O
of	O
heparin	O
was	O
95	O
.	O
8	O
pmol	O
/	O
mg	O
-	O
microspheres	O
.	O

C	O
/	O
EBPbeta	O
and	O
Ki67	O
,	O
a	O
marker	O
of	O
cell	O
proliferation	O
,	O
were	O
also	O
co	O
-	O
expressed	O
in	O
primary	O
GC	O
.	O

G	O
(	O
i	O
)	O
protein	O
,	O
phosphatidylinositol	O
-	O
3	O
kinase	O
(	O
PI3K	O
)	O
,	O
p38	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
,	O
cytosolic	O
phospholipase	O
A	O
(	O
2	O
)	O
and	O
urokinase	O
type	O
plasminogen	O
activator	O
(	O
uPA	O
)	O
are	O
required	O
for	O
LPA	O
-	O
induced	O
cells	O
invasion	O
.	O

Expression	O
of	O
VEGF	O
had	O
a	O
significantly	O
positive	O
correlation	O
with	O
IMVD	O
(	O
r	O
=	O
0	O
.	O
51	O
,	O
P	O
less	O
than	O
0	O
.	O
01	O
)	O
.	O

The	O
cancer	O
cell	O
'	O
s	O
"	O
power	O
plants	O
"	O
as	O
promising	O
therapeutic	O
targets	O
:	O
an	O
overview	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
angiogenesis	O
parameters	O
in	O
low	O
nuclear	O
grade	O
(	O
n	O
=	O
87	O
)	O
vs	O
high	O
nuclear	O
grade	O
CC	O
-	O
RCC	O
(	O
n	O
=	O
63	O
)	O
.	O

Together	O
,	O
these	O
results	O
suggest	O
that	O
Tip30	O
is	O
an	O
intrinsic	O
and	O
negative	O
regulator	O
of	O
MEC	O
proliferation	O
partly	O
through	O
the	O
inhibition	O
of	O
Wisp2	O
and	O
Igf	O
-	O
1	O
expression	O
,	O
and	O
its	O
absence	O
in	O
the	O
mammary	O
gland	O
may	O
predispose	O
MECs	O
to	O
neoplastic	O
transformation	O
.	O

This	O
work	O
is	O
again	O
extremely	O
significant	O
for	O
patients	S-Species
worldwide	O
,	O
as	O
Dvorak	O
'	O
s	O
scientific	O
research	O
is	O
leading	O
his	O
colleagues	O
all	O
over	O
the	O
world	O
to	O
examine	O
how	O
to	O
treat	O
a	O
tumor	O
through	O
its	O
blood	O
supply	O
.	O

MATERIALS	O
AND	O
METHODS	O
:	O
The	O
tissues	O
were	O
stained	O
with	O
monoclonal	O
antibodies	O
to	O
EGFR	O
,	O
TGF	O
-	O
alpha	O
and	O
Ki	O
-	O
67	O
.	O

The	O
results	O
were	O
analysed	O
using	O
quantitative	O
immunohistochemical	O
analysis	O
.	O

CX3CR1	O
-	O
dependent	O
subretinal	O
microglia	O
cell	O
accumulation	O
is	O
associated	O
with	O
cardinal	O
features	O
of	O
age	O
-	O
related	O
macular	O
degeneration	O
.	O

Interestingly	O
,	O
we	O
found	O
that	O
K5CDK4	O
mice	O
show	O
a	O
decreased	O
number	O
of	O
pituitary	O
stem	O
cells	O
,	O
even	O
though	O
CDK4	O
is	O
not	O
expressed	O
in	O
the	O
stem	O
cells	O
but	O
in	O
transit	O
-	O
amplifying	O
(	O
TA	O
)	O
-	O
like	O
cells	O
.	O

Transforming	O
growth	O
factor	O
-	O
beta	O
(	O
TGF	O
-	O
beta	O
)	O
,	O
a	O
major	O
factor	O
in	O
the	O
activation	O
of	O
fibroblasts	O
,	O
increased	O
alpha	O
-	O
SMA	O
and	O
desmin	O
expression	O
and	O
the	O
ability	O
of	O
cell	O
migration	O
and	O
invasion	O
in	O
NIH3T3	O
cells	O
.	O

The	O
increased	O
migration	O
ability	O
and	O
the	O
invasive	O
ability	O
into	O
tumor	O
cluster	O
of	O
TGF	O
-	O
beta	O
-	O
treated	O
NIH3T3	O
cells	O
were	O
dose	O
dependently	O
inhibited	O
by	O
TSP	O
-	O
1	O
.	O

PURPOSE	O
:	O
The	O
staging	O
of	O
colorectal	O
cancer	O
,	O
therapeutic	O
decision	O
making	O
in	O
the	O
management	O
of	O
early	O
and	O
advanced	O
colorectal	O
cancer	O
,	O
and	O
dilemmas	O
posed	O
by	O
drug	O
-	O
related	O
toxicity	O
are	O
discussed	O
.	O

The	O
optimal	O
duration	O
of	O
chemotherapy	O
in	O
patients	S-Species
with	O
early	O
and	O
metastatic	O
colorectal	O
cancer	O
is	O
unclear	O
.	O

However	O
,	O
the	O
role	O
of	O
IL	O
-	O
8	O
in	O
non	O
-	O
Hodgkin	O
'	O
s	O
lymphoma	O
(	O
NHL	O
)	O
has	O
not	O
been	O
fully	O
determined	O
.	O

This	O
study	O
indicated	O
that	O
urine	O
IL	O
-	O
8	O
/	O
Cr	O
levels	O
might	O
be	O
useful	O
as	O
a	O
diagnostic	O
marker	O
of	O
NHL	O
.	O

This	O
chapter	O
provides	O
a	O
new	O
intravital	O
microscopic	O
method	O
for	O
detecting	O
and	O
measuring	O
NO	O
-	O
dependent	O
angiogenesis	O
in	O
a	O
mouse	S-Species
model	O
.	O

Diabetic	O
mice	S-Species
,	O
which	O
typically	O
show	O
impaired	O
postischemic	O
muscular	O
neovascularization	O
and	O
blood	O
perfusion	O
recovery	O
,	O
have	O
these	O
defects	O
corrected	O
by	O
intramuscular	O
gene	O
transfer	O
of	O
a	O
dominant	O
negative	O
mutant	O
form	O
of	O
p75	O
(	O
NTR	O
)	O
.	O

Collectively	O
,	O
our	O
data	O
newly	O
demonstrate	O
the	O
antiangiogenic	O
action	O
of	O
p75	O
(	O
NTR	O
)	O
and	O
open	O
new	O
avenues	O
for	O
the	O
therapeutic	O
use	O
of	O
p75	O
(	O
NTR	O
)	O
inhibition	O
to	O
combat	O
diabetes	O
-	O
induced	O
microvascular	O
liabilities	O
.	O

RESULTS	O
:	O
The	O
cRGD	O
-	O
HL	O
significantly	O
inhibited	O
adhesion	O
and	O
migration	O
of	O
endothelial	O
cells	O
to	O
vitronectin	O
,	O
and	O
tubular	O
structures	O
of	O
endothelial	O
cells	O
.	O

It	O
was	O
thought	O
that	O
potent	O
antiangiogenic	O
effect	O
of	O
cRGD	O
-	O
HL	O
was	O
probably	O
due	O
to	O
the	O
interference	O
of	O
alpha	O
(	O
v	O
)	O
beta	O
(	O
3	O
)	O
-	O
mediated	O
interaction	O
,	O
resulting	O
in	O
the	O
enhanced	O
antitumoral	O
activity	O
against	O
SCC7	O
tumor	O
.	O

CONCLUSION	O
:	O
These	O
results	O
demonstrated	O
that	O
cRGD	O
-	O
modified	O
heparin	O
derivative	O
enhanced	O
anti	O
-	O
angiotherapeutic	O
effects	O
against	O
solid	O
tumor	O
,	O
and	O
therefore	O
,	O
it	O
could	O
be	O
applied	O
to	O
treat	O
various	O
cancers	O
and	O
angiogenic	O
diseases	O
as	O
a	O
potent	O
angiogenesis	O
inhibitor	O
.	O

The	O
mice	S-Species
were	O
treated	O
by	O
intratumoral	O
injection	O
of	O
2	O
x	O
10	O
(	O
9	O
)	O
pfu	O
Ad	O
-	O
mEndostatin	O
.	O

It	O
is	O
concluded	O
that	O
its	O
action	O
is	O
targeted	O
to	O
tumor	O
neovasculature	O
and	O
the	O
mechanism	O
is	O
inhibition	O
of	O
tumor	O
angiogenesis	O
.	O

During	O
normal	O
skin	O
function	O
,	O
p53	O
in	O
the	O
keratinocyte	O
is	O
a	O
transducer	O
of	O
the	O
skin	O
tanning	O
signal	O
and	O
an	O
essential	O
component	O
of	O
what	O
is	O
effectively	O
a	O
keratinocyte	O
-	O
melanocyte	O
signaling	O
cycle	O
that	O
regulates	O
skin	O
pigmentation	O
.	O

In	O
this	O
review	O
,	O
we	O
outline	O
the	O
known	O
mechanisms	O
that	O
impair	O
p53	O
itself	O
and	O
its	O
immediate	O
regulators	O
or	O
target	O
genes	O
during	O
melanomagenesis	O
.	O

BACKGROUND	O
:	O
The	O
management	O
of	O
hormone	O
-	O
refractory	O
prostate	O
cancer	O
(	O
HRPC	O
)	O
still	O
remains	O
as	O
an	O
important	O
challenge	O
of	O
daily	O
oncology	O
practice	O
.	O

All	O
-	O
trans	O
retinoic	O
acid	O
(	O
ATRA	O
)	O
could	O
potently	O
inhibit	O
the	O
growth	O
of	O
prostate	O
cancer	O
cells	O
in	O
vitro	O
and	O
its	O
combination	O
with	O
various	O
anticancer	O
agents	O
results	O
in	O
increased	O
cytotoxicity	O
.	O

METHODS	O
:	O
XTT	O
cell	O
proliferation	O
assay	O
was	O
used	O
for	O
showing	O
cytotoxicity	O
.	O

Its	O
control	O
of	O
growth	O
factor	O
signaling	O
usually	O
involves	O
interactions	O
with	O
the	O
heparan	O
sulfate	O
chains	O
covalently	O
coupled	O
to	O
the	O
protein	O
core	O
'	O
s	O
N	O
-	O
terminus	O
.	O

The	O
patient	S-Species
received	O
a	O
prescription	O
for	O
100	O
mg	O
Ultralan	O
to	O
be	O
taken	O
daily	O
for	O
3	O
days	O
and	O
then	O
tapered	O
in	O
3	O
day	O
steps	O
.	O

Robo4	O
knockdown	O
endothelial	O
cells	O
unexpectedly	O
show	O
up	O
regulation	O
of	O
Rho	O
GTPases	O
.	O

However	O
,	O
MKN	O
-	O
28	O
,	O
MKN	O
-	O
45	O
,	O
MKN	O
-	O
74	O
,	O
and	O
SNU16	O
cells	O
did	O
not	O
express	O
membrane	O
CXCR4	O
.	O

There	O
is	O
accumulating	O
evidence	O
that	O
the	O
tissue	O
damage	O
associated	O
with	O
chronic	O
wounds	O
is	O
initiated	O
and	O
propagated	O
by	O
an	O
inappropriately	O
excessive	O
inflammatory	O
response	O
.	O

In	O
vitro	O
studies	O
also	O
suggest	O
progesterone	O
may	O
play	O
a	O
role	O
in	O
modulating	O
inflammation	O
.	O

Macrophages	O
are	O
essential	O
mediators	O
of	O
inflammation	O
and	O
wound	O
healing	O
.	O

Macrophages	O
can	O
be	O
activated	O
in	O
a	O
classical	O
or	O
alternative	O
manner	O
in	O
parallel	O
with	O
the	O
T	O
(	O
H	O
)	O
1	O
/	O
T	O
(	O
H	O
)	O
2	O
dichotomy	O
,	O
respectively	O
.	O

Effect	O
of	O
platelet	O
-	O
rich	O
plasma	O
and	O
fibrin	O
glue	O
on	O
healing	O
of	O
critical	O
-	O
size	O
calvarial	O
bone	O
defects	O
.	O

Ang	O
-	O
2	O
-	O
deficient	O
tumor	O
vessels	O
had	O
higher	O
pericyte	O
coverage	O
indices	O
.	O

Here	O
,	O
we	O
established	O
lymph	O
node	O
metastasis	O
models	O
by	O
injecting	O
overexpressing	O
VEGF	O
-	O
D	O
Lewis	O
lung	O
carcinoma	O
cells	O
into	O
C57BL	B-Species
/	I-Species
6	I-Species
mice	E-Species
to	O
explore	O
the	O
effect	O
of	O
honokiol	O
on	O
tumor	O
-	O
associated	O
lymphangiogenesis	O
and	O
related	O
lymph	O
node	O
metastasis	O
.	O

The	O
present	O
findings	O
may	O
be	O
of	O
importance	O
to	O
investigate	O
the	O
molecular	O
mechanisms	O
underlying	O
the	O
spread	O
of	O
cancer	O
via	O
the	O
lymphatics	O
and	O
explore	O
the	O
therapeutical	O
strategy	O
of	O
honokiol	O
on	O
antilymphangiogenesis	O
and	O
antimetastasis	O
.	O

The	O
selected	O
peptide	O
was	O
tested	O
for	O
the	O
antitumor	O
activity	O
against	O
mildly	O
aggressive	O
xenografted	O
prostate	O
carcinoma	O
and	O
highly	O
aggressive	O
renal	O
cell	O
carcinoma	O
.	O

To	O
verify	O
that	O
P18	O
acts	O
in	O
the	O
same	O
manner	O
as	O
PEDF	O
,	O
we	O
used	O
immunohistochemistry	O
to	O
measure	O
PEDF	O
targets	O
,	O
vascular	O
endothelial	O
growth	O
factor	O
receptor	O
2	O
,	O
and	O
CD95	O
ligand	O
expression	O
in	O
P18	O
-	O
treated	O
vasculature	O
.	O

RESULTS	O
:	O
P14	O
and	O
P18	O
blocked	O
endothelial	O
cell	O
chemotaxis	O
;	O
P18	O
and	O
P23	O
induced	O
apoptosis	O
.	O

Finally	O
,	O
CD47	O
signaling	O
may	O
suppress	O
angiogenesis	O
because	O
4N1K	O
significantly	O
inhibited	O
endothelial	O
cell	O
migration	O
and	O
tube	O
formation	O
in	O
vitro	O
.	O

Cisplatin	O
reduces	O
endothelial	O
cell	O
migration	O
via	O
regulation	O
of	O
type	O
2	O
-	O
matrix	O
metalloproteinase	O
activity	O
.	O

Expanded	O
polytetrafluoroethylene	O
(	O
ePTFE	O
)	O
vascular	O
grafts	O
were	O
coated	O
with	O
perlecan	O
and	O
tested	O
in	O
an	O
ovine	S-Species
carotid	O
interposition	O
model	O
for	O
a	O
period	O
of	O
6	O
weeks	O
and	O
assessed	O
using	O
light	O
and	O
scanning	O
microscopy	O
.	O

A	O
putative	O
progestin	O
-	O
response	O
element	O
was	O
identified	O
in	O
the	O
human	S-Species
TSP	O
-	O
1	O
promoter	O
,	O
which	O
is	O
consistent	O
with	O
the	O
hypothesis	O
that	O
a	O
progestin	O
-	O
PR	O
complex	O
might	O
directly	O
regulate	O
transcription	O
of	O
the	O
TSP	O
-	O
1	O
gene	O
in	O
human	S-Species
cells	O
.	O

Metastasis	O
from	O
lung	O
adenocarcinoma	O
can	O
occur	O
swiftly	O
to	O
multiple	O
organs	O
within	O
months	O
of	O
diagnosis	O
.	O

Insufficient	O
angiogenesis	O
occurs	O
in	O
diseases	O
such	O
as	O
coronary	O
artery	O
disease	O
,	O
stroke	O
and	O
chronic	O
wounds	O
.	O

Using	O
a	O
human	S-Species
recombinant	O
antibody	O
(	O
scFv	O
)	O
specific	O
for	O
the	O
angiogenesis	O
marker	O
domain	O
B	O
of	O
fibronectin	O
,	O
interleukin	O
2	O
,	O
and	O
an	O
scFv	O
able	O
to	O
neutralize	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
,	O
we	O
expressed	O
various	O
biologically	O
active	O
uteroglobin	O
fusion	O
proteins	O
.	O

Furthermore	O
,	O
compared	O
with	O
similar	O
fusion	O
proteins	O
in	O
which	O
uteroglobin	O
was	O
not	O
used	O
,	O
the	O
use	O
of	O
uteroglobin	O
improved	O
properties	O
of	O
solubility	O
and	O
stability	O
.	O

[	O
Prognostic	O
significance	O
of	O
cellular	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
expression	O
in	O
the	O
course	O
of	O
chronic	O
myeloid	O
leukaemia	O
]	O

Ecotropic	O
viral	O
integration	O
site	O
-	O
1	O
(	O
Evi	O
-	O
1	O
)	O
is	O
a	O
nuclear	O
transcription	O
factor	O
,	O
which	O
is	O
essential	O
for	O
the	O
proliferation	O
/	O
maintenance	O
of	O
hematopoietic	O
stem	O
cells	O
(	O
HSCs	O
)	O
.	O

In	O
particular	O
,	O
the	O
activity	O
of	O
angiogenic	O
factors	O
is	O
crucial	O
for	O
tumor	O
progression	O
.	O

To	O
examine	O
this	O
hypothesis	O
,	O
we	O
used	O
NCI	O
-	O
H1299	O
non	O
-	O
small	O
cell	O
lung	O
cancer	O
(	O
NSCLC	O
)	O
cell	O
line	O
(	O
p53	O
and	O
PTEN	O
null	O
cell	O
)	O
and	O
constructed	O
an	O
ICAM	O
-	O
3	O
-	O
over	O
-	O
expressing	O
stable	O
transfectant	O
,	O
which	O
exhibited	O
increased	O
cell	O
migration	O
and	O
invasion	O
.	O

Taken	O
together	O
,	O
our	O
findings	O
suggest	O
that	O
ICAM	O
-	O
3	O
stimulates	O
cancer	O
cell	O
migration	O
/	O
invasion	O
via	O
ICAM	O
-	O
3	O
/	O
Akt	O
/	O
CREB	O
/	O
MMP	O
pathway	O
regardless	O
of	O
p53	O
and	O
PTEN	O
status	O
,	O
and	O
this	O
reflects	O
the	O
possibility	O
that	O
ICAM	O
-	O
3	O
could	O
be	O
considered	O
as	O
a	O
candidate	O
for	O
anti	O
-	O
cancer	O
drug	O
development	O
and	O
as	O
a	O
cancer	O
diagnostic	O
marker	O
.	O

14	O
-	O
3	O
-	O
3zeta	O
Overexpression	O
and	O
abnormal	O
beta	O
-	O
catenin	O
expression	O
are	O
associated	O
with	O
poor	O
differentiation	O
and	O
progression	O
in	O
stage	O
I	O
non	O
-	O
small	O
cell	O
lung	O
cancer	O
.	O

Specimens	O
of	O
NSCLC	O
and	O
adjacent	O
normal	O
lung	O
tissues	O
were	O
collected	O
from	O
110	O
patients	S-Species
.	O

The	O
expression	O
of	O
14	O
-	O
3	O
-	O
3zeta	O
was	O
upregulated	O
in	O
stage	O
I	O
NSCLC	O
.	O

The	O
p24	O
protein	O
family	O
have	O
multiple	O
functions	O
in	O
protein	O
transport	O
in	O
the	O
early	O
secretory	O
pathway	O
.	O

KISS1	O
and	O
matrix	O
metalloproteinase	O
-	O
9	O
(	O
MMP	O
-	O
9	O
)	O
may	O
play	O
important	O
roles	O
as	O
metastasis	O
suppressor	O
and	O
metastasis	O
promoter	O
genes	O
,	O
respectively	O
,	O
in	O
a	O
variety	O
of	O
malignancies	O
.	O

Targets	O
identified	O
in	O
these	O
novel	O
and	O
diverse	O
FH	O
-	O
deficient	O
models	O
represent	O
excellent	O
potential	O
candidates	O
for	O
further	O
mechanistic	O
investigation	O
and	O
therapeutic	O
metabolic	O
manipulation	O
in	O
tumors	O
.	O

The	O
pro	O
-	O
oncogenic	O
transcription	O
factor	O
STAT3	O
is	O
constitutively	O
activated	O
in	O
a	O
wide	O
variety	O
of	O
tumours	O
that	O
often	O
become	O
addicted	O
to	O
its	O
activity	O
,	O
but	O
no	O
unifying	O
view	O
of	O
a	O
core	O
function	O
determining	O
this	O
widespread	O
STAT3	O
-	O
dependence	O
has	O
yet	O
emerged	O
.	O

Experiments	O
showed	O
that	O
mutant	O
embryos	O
and	O
mutant	O
cells	O
in	O
culture	O
experienced	O
genome	O
instability	O
,	O
as	O
do	O
cells	O
in	O
FA	O
patients	S-Species
.	O

Correlation	O
of	O
lymphatic	O
vessel	O
density	O
and	O
vascular	O
endothelial	O
growth	O
factor	O
with	O
nodal	O
metastasis	O
in	O
papillary	O
thyroid	O
microcarcinoma	O
.	O

Sorafenib	O
treatment	O
led	O
to	O
accumulation	O
of	O
autophagosomes	O
as	O
evidenced	O
by	O
conversion	O
from	O
LC3	O
-	O
I	O
to	O
LC3	O
-	O
II	O
observed	O
by	O
immunoblot	O
in	O
Huh7	O
,	O
HLF	O
and	O
PLC	O
/	O
PRF	O
/	O
5	O
cells	O
.	O

This	O
induction	O
was	O
due	O
to	O
activation	O
of	O
autophagic	O
flux	O
,	O
as	O
there	O
was	O
further	O
increase	O
in	O
LC3	O
-	O
II	O
expression	O
upon	O
treatment	O
with	O
lysosomal	O
inhibitors	O
,	O
clear	O
decline	O
of	O
the	O
autophagy	O
substrate	O
p62	O
,	O
and	O
an	O
mRFP	O
-	O
GFP	O
-	O
LC3	O
fluorescence	O
change	O
in	O
sorafenib	O
-	O
treated	O
hepatoma	O
cells	O
.	O

ARD1	O
is	O
up	O
-	O
regulated	O
in	O
human	S-Species
PCa	O
cell	O
lines	O
and	O
primary	O
tumor	O
biopsies	O
.	O

The	O
role	O
of	O
Hes	O
genes	O
in	O
intestinal	O
development	O
,	O
homeostasis	O
and	O
tumor	O
formation	O
.	O

Dogs	S-Species
with	O
lymphoma	O
had	O
similar	O
glucose	O
tolerance	O
curves	O
when	O
compared	O
with	O
controls	O
.	O

Rise	O
in	O
lactate	O
concentrations	O
over	O
baseline	O
levels	O
in	O
the	O
first	O
30	O
minutes	O
of	O
the	O
glucose	O
tolerance	O
test	O
were	O
significantly	O
higher	O
in	O
dogs	S-Species
with	O
lymphoma	O
(	O
P	O
=	O
0	O
.	O
011	O
)	O
.	O

Infection	O
with	O
retroviruses	S-Species
containing	O
transforming	O
genes	O
of	O
the	O
src	O
and	O
ras	O
oncogene	O
families	O
led	O
to	O
rapid	O
loss	O
of	O
epidermal	O
growth	O
factor	O
dependence	O
,	O
in	O
some	O
cases	O
,	O
accompanied	O
by	O
alterations	O
in	O
cellular	O
morphology	O
.	O

The	O
protein	O
and	O
water	O
component	O
of	O
brain	O
edema	O
were	O
indirectly	O
quantitated	O
.	O

We	O
assessed	O
the	O
effects	O
of	O
these	O
mutations	O
on	O
the	O
ability	O
of	O
the	O
v	O
-	O
fos	O
protein	O
to	O
transform	O
chicken	S-Species
embryo	O
fibroblasts	O
and	O
to	O
stimulate	O
cellular	O
proliferation	O
of	O
chicken	S-Species
neuroretinal	O
cells	O
.	O

The	O
activity	O
of	O
type	O
IV	O
collagenase	O
,	O
which	O
enables	O
tumor	O
cells	O
to	O
degrade	O
collagen	O
type	O
IV	O
found	O
in	O
the	O
subendothelial	O
basement	O
membrane	O
,	O
has	O
been	O
correlated	O
with	O
the	O
metastatic	O
potential	O
in	O
several	O
tumor	O
types	O
,	O
including	O
the	O
rat	S-Species
13762NF	O
mammary	O
adenocarcinoma	O
cell	O
line	O
and	O
its	O
clones	O
.	O

The	O
growth	O
of	O
the	O
cells	O
was	O
not	O
inhibited	O
under	O
these	O
conditions	O
,	O
except	O
after	O
treatment	O
with	O
10	O
microM	O
all	O
-	O
trans	O
-	O
RA	O
in	O
serum	O
-	O
free	O
medium	O
.	O

Two	O
major	O
type	O
IV	O
collagenolytic	O
metalloproteinases	O
exhibiting	O
molecular	O
weights	O
of	O
64	O
,	O
000	O
and	O
88	O
,	O
000	O
,	O
respectively	O
,	O
were	O
detected	O
by	O
this	O
method	O
.	O

The	O
experimental	O
approach	O
includes	O
:	O
estimation	O
of	O
mitochondrial	O
NAD	O
[	O
P	O
]	O
+	O
-	O
dependent	O
malic	O
enzyme	O
activity	O
;	O
respiratory	O
activity	O
of	O
freshly	O
harvested	O
or	O
fasted	O
cells	O
,	O
and	O
of	O
isolated	O
mitochondria	O
;	O
and	O
determination	O
of	O
the	O
metabolites	O
involved	O
in	O
the	O
glycolytic	O
and	O
glutaminolytic	O
pathways	O
.	O

Interestingly	O
,	O
the	O
high	O
glutamine	O
uptake	O
was	O
maintained	O
in	O
the	O
presence	O
of	O
glucose	O
.	O

To	O
assay	O
for	O
the	O
possible	O
presence	O
of	O
transforming	O
genes	O
which	O
were	O
not	O
active	O
in	O
a	O
focus	O
formation	O
assay	O
,	O
two	O
of	O
the	O
epithelial	O
lines	O
were	O
analysed	O
further	O
by	O
co	O
-	O
transfection	O
with	O
a	O
dominant	O
selectable	O
marker	O
,	O
followed	O
by	O
selection	O
and	O
inoculation	O
into	O
nude	B-Species
mice	E-Species
.	O

These	O
results	O
suggest	O
that	O
there	O
is	O
cell	O
type	O
specificity	O
for	O
oncogene	O
activation	O
during	O
in	O
vitro	O
rat	S-Species
bladder	O
transformation	O
initiated	O
by	O
a	O
single	O
carcinogen	O
and	O
that	O
ras	O
gene	O
activation	O
is	O
not	O
a	O
necessary	O
step	O
in	O
urothelial	O
transformation	O
in	O
vitro	O
.	O

Pouch	O
vascular	O
volume	O
and	O
permeability	O
changes	O
were	O
studied	O
by	O
fractional	O
distributions	O
of	O
radiotracers	O
and	O
were	O
analyzed	O
by	O
a	O
variety	O
of	O
statistical	O
methods	O
which	O
explored	O
the	O
vascular	O
parameters	O
,	O
treatment	O
types	O
,	O
elapsed	O
time	O
,	O
presence	O
of	O
the	O
carcinogen	O
,	O
and	O
histopathologic	O
changes	O
.	O

Prior	O
to	O
the	O
appearances	O
of	O
frank	O
neoplasms	O
,	O
volumetric	O
changes	O
in	O
DMBA	O
only	O
and	O
radiation	O
only	O
groups	O
were	O
similar	O
,	O
while	O
volume	O
changes	O
in	O
DMBA	O
+	O
radiation	O
groups	O
increased	O
slowly	O
to	O
a	O
peak	O
later	O
than	O
in	O
other	O
groups	O
and	O
then	O
declined	O
steadily	O
to	O
levels	O
similar	O
to	O
the	O
radiation	O
only	O
group	O
.	O

As	O
in	O
prior	O
studies	O
,	O
there	O
were	O
significant	O
vascular	O
volume	O
differences	O
between	O
DMBA	O
and	O
DMBA	O
+	O
radiation	O
groups	O
of	O
tumor	O
-	O
bearing	O
cheek	O
pouches	O
.	O

We	O
sought	O
to	O
test	O
whether	O
p53	O
could	O
behave	O
in	O
a	O
manner	O
similar	O
to	O
known	O
genes	O
in	O
a	O
biological	O
test	O
system	O
,	O
and	O
we	O
demonstrate	O
here	O
that	O
p53	O
can	O
cooperate	O
with	O
the	O
activated	O
Ha	O
-	O
ras	O
oncogene	O
to	O
transform	O
normal	O
embryonic	O
cells	O
.	O

Transformation	O
of	O
BHK	O
hamster	O
fibroblasts	O
by	O
an	O
env	O
-	O
strain	O
of	O
Rous	B-Species
sarcoma	I-Species
virus	E-Species
(	O
RSV	S-Species
)	O
leads	O
to	O
the	O
appearance	O
at	O
the	O
cell	O
surface	O
of	O
a	O
virus	O
-	O
induced	O
nonvirion	O
antigen	O
(	O
VCSA	O
)	O
,	O
specific	O
for	O
transformation	O
,	O
whose	O
expression	O
is	O
controlled	O
by	O
the	O
transforming	O
src	O
gene	O
.	O

Now	O
,	O
by	O
competition	O
experiments	O
with	O
a	O
panel	O
of	O
different	O
unlabelled	O
cells	O
we	O
show	O
that	O
the	O
VCSA	O
expressed	O
on	O
RSV	S-Species
-	O
transformed	O
hamster	S-Species
fibroblasts	O
is	O
a	O
complex	O
of	O
at	O
least	O
three	O
distinct	O
antigenic	O
specificities	O
:	O
(	O
1	O
)	O
one	O
expressed	O
on	O
all	O
RSV	S-Species
-	O
transformed	O
fibroblasts	O
,	O
regardless	O
their	O
species	O
and	O
the	O
subgroup	O
or	O
strain	O
of	O
the	O
transforming	O
virus	S-Species
;	O
(	O
2	O
)	O
one	O
cross	O
-	O
reacting	O
with	O
a	O
cell	O
-	O
surface	O
antigen	O
(	O
CSA	O
)	O
expressed	O
at	O
various	O
degrees	O
on	O
untransformed	O
avian	S-Species
fibroblasts	O
,	O
but	O
not	O
on	O
mammalian	O
fibroblasts	O
;	O
(	O
3	O
)	O
one	O
species	O
-	O
specific	O
,	O
present	O
only	O
on	O
RSV	S-Species
-	O
transformed	O
hamster	S-Species
fibroblasts	O
.	O

Chromosomal	O
translocations	O
are	O
found	O
to	O
be	O
a	O
characteristic	O
feature	O
of	O
Burkitt	O
lymphomas	O
.	O

Migration	O
of	O
capillary	O
endothelial	O
cells	O
is	O
an	O
important	O
component	O
of	O
angiogenesis	O
in	O
vivo	O
.	O

We	O
have	O
used	O
a	O
quantitative	O
assay	O
in	O
vitro	O
to	O
demonstrate	O
that	O
mast	O
cells	O
release	O
a	O
factor	O
that	O
significantly	O
increases	O
bovine	S-Species
capillary	O
endothelial	O
cell	O
migration	O
.	O

The	O
acquisition	O
of	O
the	O
metastatic	O
phenotype	O
induced	O
by	O
UV	O
-	O
B	O
could	O
not	O
be	O
attributed	O
to	O
abnormalities	O
in	O
the	O
p53	O
or	O
MTS	O
-	O
1	O
(	O
p16INK4	O
)	O
genes	O
.	O

Downregulation	O
of	O
E	O
-	O
cadherin	O
occurred	O
at	O
the	O
level	O
of	O
transcription	O
or	O
of	O
mRNA	O
stability	O
.	O

In	O
examining	O
the	O
metabolic	O
basis	O
for	O
selenoperoxidase	O
-	O
dependent	O
resistance	O
,	O
we	O
found	O
that	O
glucose	O
-	O
replete	O
Se	O
(	O
-	O
)	O
cells	O
reduce	O
t	O
-	O
BuOOH	O
to	O
t	O
-	O
butanol	O
far	O
more	O
slowly	O
than	O
Se	O
(	O
+	O
)	O
cells	O
,	O
the	O
ratio	O
of	O
the	O
first	O
-	O
order	O
rate	O
constants	O
approximating	O
that	O
of	O
the	O
GPX	O
activities	O
(	O
L1210	O
cells	O
)	O
or	O
PHGPX	O
activities	O
(	O
K562	O
cells	O
)	O
.	O

The	O
putative	O
metastasis	O
suppressor	O
genes	O
,	O
NME1	O
(	O
nm23	O
-	O
1	O
)	O
and	O
NME2	O
(	O
nm23	O
-	O
2	O
)	O
,	O
were	O
examined	O
in	O
a	O
model	O
system	O
we	O
developed	O
to	O
approximate	O
the	O
dissemination	O
of	O
melanoma	O
from	O
a	O
primary	O
skin	O
tumor	O
.	O

Similar	O
differences	O
in	O
NME	O
protein	O
levels	O
were	O
observed	O
in	O
tumors	O
induced	O
by	O
the	O
two	O
cell	O
lines	O
in	O
nude	B-Species
mice	E-Species
.	O

The	O
results	O
demonstrated	O
that	O
levels	O
of	O
the	O
c	O
-	O
jun	O
mRNA	O
and	O
protein	O
were	O
unchanged	O
in	O
the	O
revertants	O
when	O
compared	O
to	O
the	O
transformed	O
parental	O
cells	O
,	O
and	O
ectopic	O
overexpression	O
of	O
c	O
-	O
jun	O
failed	O
to	O
retransform	O
the	O
revertants	O
.	O

Marrow	O
cells	O
survived	O
and	O
continued	O
exogenous	O
hemopoiesis	O
for	O
up	O
to	O
six	O
months	O
and	O
were	O
immunohistochemically	O
reactive	O
to	O
basic	O
fibroblast	O
growth	O
factor	O
(	O
bFGF	O
)	O
.	O

Twenty	O
grafts	O
without	O
bone	O
marrow	O
were	O
implanted	O
as	O
controls	O
.	O

Such	O
cases	O
may	O
be	O
considered	O
either	O
examples	O
of	O
a	O
single	O
primary	O
carcinoma	O
with	O
metastasis	O
or	O
as	O
synchronous	O
primary	O
neoplasms	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
authors	O
used	O
molecular	O
techniques	O
to	O
analyze	O
the	O
clonal	O
composition	O
of	O
five	O
cases	O
of	O
concurrent	O
adenocarcinomas	O
of	O
the	O
endometrium	O
and	O
ovary	O
that	O
were	O
clinicopathologically	O
diagnosed	O
as	O
synchronous	O
primary	O
tumors	O
.	O

It	O
is	O
now	O
known	O
that	O
specific	O
types	O
of	O
human	B-Species
papillomaviruses	E-Species
(	O
HPV	S-Species
)	O
are	O
the	O
principal	O
etiologic	O
agents	O
for	O
both	O
cervical	O
cancer	O
and	O
its	O
precursors	O
.	O

It	O
is	O
thought	O
that	O
radiation	O
treatment	O
inhibits	O
neovascularization	O
of	O
recipient	O
and	O
/	O
or	O
graft	O
tissues	O
,	O
and	O
this	O
may	O
account	O
in	O
part	O
for	O
abnormalities	O
in	O
wound	O
healing	O
associated	O
with	O
radiation	O
therapy	O
.	O

Tumour	O
angiogenesis	O
is	O
an	O
important	O
factor	O
for	O
tumour	O
growth	O
and	O
metastasis	O
.	O

A	O
univariate	O
analysis	O
of	O
survival	O
showed	O
that	O
vascular	O
grade	O
was	O
the	O
most	O
significant	O
prognostic	O
factor	O
(	O
P	O
=	O
0	O
.	O
0004	O
)	O
,	O
followed	O
by	O
N	O
-	O
stage	O
(	O
P	O
=	O
0	O
.	O
001	O
)	O
.	O

Group	B-Species
1	I-Species
animals	E-Species
had	O
the	O
left	O
buccal	O
pouches	O
painted	O
three	O
times	O
weekly	O
with	O
7	O
,	O
12	O
-	O
dimethylbenz	O
(	O
a	O
)	O
anthracene	O
(	O
DMBA	O
)	O
for	O
14	O
weeks	O
.	O

Group	B-Species
2	I-Species
animals	E-Species
had	O
the	O
same	O
procedure	O
of	O
DMBA	O
applications	O
but	O
also	O
received	O
alpha	O
tocopherol	O
.	O

Mean	O
tumour	O
volume	O
was	O
significantly	O
lower	O
in	O
the	O
DMBA	O
-	O
vitamin	O
E	O
group	O
compared	O
to	O
the	O
tumour	O
control	O
group	O
.	O

Cells	O
treated	O
with	O
anti	O
-	O
Fas	O
also	O
exhibited	O
increased	O
tyrosine	O
phosphorylation	O
of	O
the	O
c	O
-	O
met	O
growth	O
factor	O
receptor	O
tyrosine	O
kinase	O
.	O

The	O
present	O
studies	O
examine	O
whether	O
lymphocyte	O
stimulation	O
via	O
cells	O
engineered	O
to	O
secrete	O
GM	O
-	O
CSF	O
or	O
IL	O
-	O
2	O
decreases	O
hepatic	O
tumor	O
growth	O
,	O
and	O
whether	O
stimulation	O
of	O
both	O
macrophages	O
and	O
lymphocytes	O
is	O
more	O
effective	O
than	O
either	O
individually	O
.	O

GM	O
-	O
CSF	O
or	O
IL	O
-	O
2	O
vaccines	O
or	O
gammaIFN	O
decreased	O
tumor	O
nodules	O
significantly	O
(	O
GM	O
-	O
CSF	O
13	O
+	O
/	O
-	O
4	O
,	O
IL	O
-	O
2	O
14	O
+	O
/	O
-	O
6	O
vs	O
.	O
control	O
75	O
+	O
/	O
-	O
24	O
,	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

Additional	O
rats	S-Species
underwent	O
partial	O
hepatectomy	O
,	O
an	O
immunosuppressive	O
procedure	O
known	O
to	O
accelerate	O
the	O
growth	O
of	O
hepatic	O
tumor	O
,	O
following	O
tumor	O
challenge	O
.	O

Under	O
normal	O
conditions	O
insulin	O
regulates	O
expression	O
of	O
hexokinase	O
Type	O
II	O
isoenzyme	O
,	O
which	O
is	O
predominantly	O
expressed	O
in	O
muscle	O
.	O

From	O
one	O
of	O
the	O
revertants	O
,	O
we	O
recovered	O
a	O
0	O
.	O
2	O
-	O
kb	O
cDNA	O
,	O
N56	O
,	O
that	O
suppresses	O
the	O
tumor	O
growth	O
of	O
the	O
transformed	O
3Y1	O
cells	O
irrespective	O
of	O
the	O
expression	O
of	O
the	O
E6	O
and	O
E7	O
genes	O
.	O

The	O
nucleotide	O
sequence	O
of	O
the	O
cDNA	O
was	O
shown	O
to	O
be	O
identical	O
to	O
that	O
of	O
the	O
3	O
'	O
untranslated	O
region	O
of	O
a	O
putative	O
mammalian	S-Species
polycomb	O
group	O
gene	O
,	O
mel	O
-	O
18	O
.	O

Significant	O
differences	O
were	O
found	O
between	O
the	O
control	O
and	O
experimental	O
fat	O
pads	O
with	O
regard	O
to	O
weight	O
and	O
length	O
.	O

Experimental	O
flaps	O
were	O
found	O
to	O
be	O
perfused	O
fully	O
with	O
fluorescein	O
and	O
lead	O
oxide	O
;	O
control	O
fat	O
pads	O
were	O
found	O
not	O
to	O
be	O
perfused	O
.	O

Protective	O
function	O
of	O
von	O
Hippel	O
-	O
Lindau	O
protein	O
against	O
impaired	O
protein	O
processing	O
in	O
renal	O
carcinoma	O
cells	O
.	O

The	O
absence	O
of	O
functional	O
von	O
Hippel	O
-	O
Lindau	O
(	O
VHL	O
)	O
tumor	O
suppressor	O
gene	O
leads	O
to	O
the	O
development	O
of	O
neoplasias	O
characteristic	O
of	O
VHL	O
disease	O
,	O
including	O
renal	O
cell	O
carcinoma	O
(	O
RCC	O
)	O
.	O

Here	O
,	O
we	O
compared	O
the	O
sensitivity	O
of	O
RCC	O
cells	O
lacking	O
VHL	O
gene	O
function	O
with	O
that	O
of	O
RCC	O
cells	O
expressing	O
the	O
wild	O
-	O
type	O
VHL	O
gene	O
(	O
wtVHL	O
)	O
after	O
exposure	O
to	O
various	O
stresses	O
.	O

The	O
Cdc6	O
protein	O
is	O
ubiquitinated	O
in	O
vivo	O
for	O
proteolysis	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

Our	O
work	O
describes	O
the	O
first	O
member	O
of	O
the	O
RDH	O
family	O
found	O
in	O
epidermis	O
.	O

Interleukin	O
-	O
1	O
(	O
IL	O
-	O
1	O
)	O
and	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
-	O
alpha	O
)	O
stimulate	O
transcription	O
factors	O
AP	O
-	O
1	O
and	O
NF	O
-	O
kappaB	O
through	O
activation	O
of	O
the	O
MAP	O
kinases	O
JNK	O
and	O
p38	O
and	O
the	O
IkappaB	O
kinase	O
(	O
IKK	O
)	O
,	O
respectively	O
.	O

Thus	O
,	O
TNF	O
-	O
alpha	O
and	O
IL	O
-	O
1	O
signaling	O
is	O
based	O
on	O
oligomerization	O
of	O
TRAF2	O
and	O
TRAF6	O
leading	O
to	O
activation	O
of	O
effector	O
kinases	O
.	O

Recently	O
,	O
lipopolysaccharide	S-Chemical_Compound
(	O
LPS	S-Chemical_Compound
)	O
,	O
a	O
major	O
biologically	O
active	O
agent	O
of	O
Gram	O
-	O
negative	O
bacteria	O
,	O
was	O
shown	O
to	O
mediate	O
cellular	O
activation	O
by	O
a	O
member	O
of	O
the	O
human	O
Toll	O
-	O
like	O
receptor	O
family	O
,	O
Toll	O
-	O
like	O
receptor	O
(	O
TLR	O
)	O
2	O
.	O

These	O
results	O
suggest	O
that	O
the	O
docking	O
of	O
Cdc2	O
-	O
cyclin	O
B1	O
complexes	O
to	O
the	O
COOH	O
terminus	O
of	O
Myt1	O
facilitates	O
the	O
phosphorylation	O
of	O
Cdc2	O
by	O
Myt1	O
and	O
that	O
overproduction	O
of	O
Myt1	O
perturbs	O
cell	O
cycle	O
progression	O
by	O
sequestering	O
Cdc2	O
-	O
cyclin	O
B1	O
complexes	O
in	O
the	O
cytoplasm	O
.	O

The	O
zinc	S-Chemical_Compound
finger	O
protein	O
A20	O
inhibits	O
TNF	O
-	O
induced	O
NF	O
-	O
kappaB	O
-	O
dependent	O
gene	O
expression	O
by	O
interfering	O
with	O
an	O
RIP	O
-	O
or	O
TRAF2	O
-	O
mediated	O
transactivation	O
signal	O
and	O
directly	O
binds	O
to	O
a	O
novel	O
NF	O
-	O
kappaB	O
-	O
inhibiting	O
protein	O
ABIN	O
.	O

These	O
results	O
demonstrate	O
that	O
A20	O
inhibits	O
NF	O
-	O
kappaB	O
-	O
dependent	O
gene	O
expression	O
by	O
interfering	O
with	O
a	O
novel	O
TNF	O
-	O
induced	O
and	O
RIP	O
-	O
or	O
TRAF2	O
-	O
mediated	O
pathway	O
that	O
is	O
different	O
from	O
the	O
NIK	O
-	O
IkappaB	O
kinase	O
pathway	O
and	O
that	O
is	O
specifically	O
involved	O
in	O
the	O
transactivation	O
of	O
NF	O
-	O
kappaB	O
.	O

Via	O
yeast	O
two	O
-	O
hybrid	O
screening	O
,	O
we	O
found	O
that	O
A20	O
binds	O
to	O
a	O
novel	O
protein	O
,	O
ABIN	O
,	O
which	O
mimics	O
the	O
NF	O
-	O
kappaB	O
inhibiting	O
effects	O
of	O
A20	O
upon	O
overexpression	O
,	O
suggesting	O
that	O
the	O
effect	O
of	O
A20	O
is	O
mediated	O
by	O
its	O
interaction	O
with	O
this	O
NF	O
-	O
kappaB	O
inhibiting	O
protein	O
,	O
ABIN	O
.	O

In	O
contrast	O
,	O
MAO	O
B	O
KO	O
mice	O
do	O
not	O
exhibit	O
aggression	O
and	O
only	O
levels	O
of	O
PEA	S-Chemical_Compound
are	O
increased	O
.	O

Both	O
MAO	O
A	O
and	O
B	O
KO	O
mice	O
show	O
increased	O
reactivity	O
to	O
stress	O
.	O

This	O
signalling	O
cascade	O
is	O
conserved	O
in	O
vertebrates	O
,	O
Drosophila	O
and	O
Caenorhabditis	O
elegans	O
.	O

These	O
results	O
raise	O
the	O
possibility	O
that	O
TAK1	O
and	O
NLK	O
are	O
also	O
involved	O
in	O
Wnt	O
signalling	O
in	O
mammalian	O
cells	O
.	O

Antibodies	O
against	O
Esa1p	O
specifically	O
immunoprecipitate	O
NuA4	O
activity	O
whereas	O
the	O
complex	O
purified	O
from	O
a	O
temperature	O
-	O
sensitive	O
esa1	O
mutant	O
loses	O
its	O
acetyltransferase	O
activity	O
at	O
the	O
restrictive	O
temperature	O
.	O

Additionally	O
,	O
we	O
have	O
identified	O
another	O
subunit	O
of	O
the	O
complex	O
as	O
the	O
product	O
of	O
TRA1	O
,	O
an	O
ATM	O
-	O
related	O
essential	O
gene	O
homologous	O
to	O
human	O
TRRAP	O
,	O
an	O
essential	O
cofactor	O
for	O
c	O
-	O
Myc	O
-	O
and	O
E2F	O
-	O
mediated	O
oncogenic	O
transformation	O
.	O

The	O
structures	O
of	O
apo	O
unphosphorylated	O
ERK2	O
,	O
a	O
related	O
MAP	O
kinase	O
,	O
and	O
apo	O
phosphorylated	O
ERK2	O
have	O
also	O
been	O
determined	O
.	O

P38gamma	O
residue	O
phosphoryl	O
-	O
Thr183	S-Chemical_Compound
forms	O
hydrogen	S-Chemical_Compound
bonds	O
with	O
five	O
basic	O
amino	O
acids	O
,	O
and	O
these	O
interactions	O
induce	O
an	O
interdomain	O
rotation	O
.	O

A	O
mutant	O
derivative	O
in	O
which	O
one	O
threonine	S-Chemical_Compound
and	O
two	O
serine	S-Chemical_Compound
residues	O
,	O
which	O
are	O
candidate	O
phosphorylation	O
sites	O
,	O
were	O
replaced	O
by	O
alanine	S-Chemical_Compound
(	O
to	O
mimic	O
constitutive	O
dephosphorylation	O
)	O
is	O
localised	O
in	O
the	O
nucleus	O
throughout	O
the	O
cell	O
cycle	O
.	O

There	O
are	O
two	O
transcripts	O
from	O
the	O
mdm2	O
gene	O
that	O
differ	O
only	O
in	O
their	O
5	O
'	O
leaders	O
:	O
a	O
long	O
form	O
(	O
L	O
-	O
mdm2	O
)	O
and	O
a	O
short	O
form	O
(	O
S	O
-	O
mdm2	O
)	O
that	O
arise	O
from	O
the	O
use	O
of	O
different	O
promoters	O
.	O

Interleukin	O
-	O
10	O
(	O
IL	O
-	O
10	O
)	O
is	O
a	O
pleiotropic	O
cytokine	O
that	O
controls	O
inflammatory	O
processes	O
by	O
suppressing	O
the	O
production	O
of	O
proinflammatory	O
cytokines	O
which	O
are	O
known	O
to	O
be	O
transcriptionally	O
controlled	O
by	O
NF	O
-	O
kappaB	O
.	O

By	O
Eadie	O
-	O
Hofstee	O
transformation	O
the	O
apparent	O
K	O
(	O
m	O
)	O
of	O
hSVCT1	O
for	O
ascorbate	S-Chemical_Compound
was	O
252	O
.	O
0	O
microM	O
and	O
of	O
hSVCT2	O
for	O
ascorbate	S-Chemical_Compound
was	O
21	O
.	O
3	O
microM	O
.	O

Incubation	O
of	O
oocytes	O
expressing	O
either	O
transporter	O
with	O
phorbol	B-Chemical_Compound
12	I-Chemical_Compound
-	I-Chemical_Compound
myristate	I-Chemical_Compound
13	I-Chemical_Compound
-	I-Chemical_Compound
acetate	E-Chemical_Compound
(	O
PMA	S-Chemical_Compound
)	O
inhibited	O
ascorbate	S-Chemical_Compound
transport	O
activity	O
.	O

We	O
disrupted	O
the	O
gene	O
in	O
F9	O
embryonal	O
carcinoma	O
cells	O
.	O

Hereditary	O
multiple	O
exostoses	O
,	O
a	O
dominantly	O
inherited	O
genetic	O
disorder	O
characterized	O
by	O
multiple	O
cartilaginous	O
tumors	O
,	O
is	O
caused	O
by	O
mutations	O
in	O
members	O
of	O
the	O
EXT	O
gene	O
family	O
,	O
EXT1	O
or	O
EXT2	O
.	O

Either	O
degradation	O
of	O
Far1	O
or	O
its	O
nuclear	O
export	O
by	O
Msn5	O
was	O
sufficient	O
for	O
cell	O
growth	O
,	O
suggesting	O
that	O
the	O
two	O
mechanisms	O
are	O
redundant	O
for	O
cell	O
viability	O
.	O

Molecular	O
cloning	O
of	O
globotriaosylceramide	O
/	O
CD77	O
synthase	O
,	O
a	O
glycosyltransferase	O
that	O
initiates	O
the	O
synthesis	O
of	O
globo	O
series	O
glycosphingolipids	S-Chemical_Compound
.	O

E2F	O
family	O
members	O
are	O
differentially	O
regulated	O
by	O
reversible	O
acetylation	O
.	O

Mechanism	O
of	O
reaction	O
of	O
myeloperoxidase	O
with	O
nitrite	S-Chemical_Compound
.	O

Mutations	O
in	O
the	O
gene	O
encoding	O
Bruton	O
'	O
s	O
tyrosine	O
kinase	O
(	O
btk	O
)	O
cause	O
the	O
B	O
cell	O
deficiency	O
diseases	O
X	O
-	O
linked	O
agammaglobulinemia	O
(	O
XLA	O
)	O
in	O
humans	O
and	O
X	O
-	O
linked	O
immunodeficiency	O
(	O
xid	O
)	O
in	O
mice	O
.	O

We	O
now	O
demonstrate	O
that	O
a	O
null	O
mutation	O
in	O
btk	O
known	O
to	O
cause	O
the	O
xid	O
phenotype	O
prevents	O
BCR	O
-	O
induced	O
activation	O
of	O
NF	O
-	O
kappaB	O
.	O

NF	O
-	O
kappaB	O
activation	O
represents	O
a	O
paradigm	O
for	O
controlling	O
the	O
function	O
of	O
a	O
regulatory	O
protein	O
via	O
ubiquitination	O
-	O
dependent	O
proteolysis	O
,	O
as	O
an	O
integral	O
part	O
of	O
a	O
phosphorylationbased	O
signaling	O
cascade	O
.	O

Gene	O
knockout	O
studies	O
have	O
shed	O
light	O
on	O
the	O
very	O
different	O
physiological	O
functions	O
of	O
IKKalpha	O
and	O
IKKbeta	O
.	O

A	O
variety	O
of	O
other	O
signaling	O
events	O
,	O
including	O
phosphorylation	O
of	O
NF	O
-	O
kappaB	O
,	O
hyperphosphorylation	O
of	O
IKK	O
,	O
induction	O
of	O
IkappaB	O
synthesis	O
,	O
and	O
the	O
processing	O
of	O
NF	O
-	O
kappaB	O
precursors	O
,	O
provide	O
additional	O
mechanisms	O
that	O
modulate	O
the	O
level	O
and	O
duration	O
of	O
NF	O
-	O
kappaB	O
activity	O
.	O

p63	O
and	O
p73	O
transactivate	O
differentiation	O
gene	O
promoters	O
in	O
human	O
keratinocytes	O
.	O

We	O
evaluated	O
the	O
expression	O
of	O
p63	O
and	O
p73	O
in	O
differentiating	O
human	O
keratinocytes	O
in	O
vitro	O
.	O

Nuclear	O
PI3K	O
translocation	O
has	O
been	O
demonstrated	O
to	O
be	O
related	O
to	O
an	O
analogous	O
translocation	O
of	O
a	O
PtdIns	B-Chemical_Compound
(	I-Chemical_Compound
3	I-Chemical_Compound
,	I-Chemical_Compound
4	I-Chemical_Compound
,	I-Chemical_Compound
5	I-Chemical_Compound
)	I-Chemical_Compound
P	I-Chemical_Compound
(	I-Chemical_Compound
3	I-Chemical_Compound
)	E-Chemical_Compound
activated	O
PKC	O
,	O
the	O
zeta	O
isozyme	O
.	O

Western	O
blot	O
analysis	O
showed	O
a	O
maximal	O
nuclear	O
translocation	O
after	O
20	O
min	O
of	O
IGF	O
-	O
I	O
stimulation	O
or	O
after	O
30	O
min	O
of	O
PDGF	O
treatment	O
.	O

A	O
human	O
cDNA	O
encoding	O
a	O
70	O
.	O
9	O
-	O
kDa	O
type	O
II	O
membrane	O
protein	O
with	O
sequence	O
similarity	O
to	O
class	O
I	O
alpha1	O
,	O
2	O
-	O
mannosidases	O
was	O
isolated	O
.	O

The	O
enzyme	O
requires	O
calcium	S-Chemical_Compound
for	O
activity	O
and	O
is	O
inhibited	O
by	O
both	O
1	B-Chemical_Compound
-	I-Chemical_Compound
deoxymannojirimycin	E-Chemical_Compound
and	O
kifunensine	S-Chemical_Compound
.	O

We	O
demonstrate	O
specific	O
ubiquitination	O
of	O
I	O
kappa	O
B	O
alpha	O
by	O
Ubc3	O
and	O
Ubc4	O
in	O
a	O
phosphorylation	O
and	O
SCF	O
beta	O
-	O
TRCP	O
dependent	O
manner	O
and	O
that	O
both	O
are	O
capable	O
of	O
associating	O
with	O
the	O
SCF	O
beta	O
-	O
TRCP	O
complex	O
isolated	O
from	O
human	O
cells	O
.	O

Finally	O
,	O
we	O
show	O
that	O
Ubc4	O
is	O
in	O
excess	O
to	O
Ubc3	O
in	O
THP	O
.	O
1	O
cells	O
and	O
19	O
times	O
more	O
efficient	O
in	O
catalyzing	O
the	O
reaction	O
,	O
suggesting	O
that	O
Ubc4	O
is	O
the	O
preferentially	O
used	O
Ubc	O
in	O
this	O
reaction	O
in	O
vivo	O
.	O

Oncogene	O
(	O
2000	O
)	O
19	O
,	O
3529	O
-	O
3536	O

Surprisingly	O
,	O
Met4	O
is	O
a	O
relatively	O
stable	O
protein	O
and	O
its	O
abundance	O
is	O
not	O
influenced	O
by	O
Met30	O
.	O

Thus	O
Rac1	O
controls	O
a	O
second	O
,	O
I	O
kappa	O
B	O
-	O
independent	O
,	O
pathway	O
to	O
NF	O
-	O
kappa	O
B	O
activation	O
and	O
is	O
essential	O
in	O
innate	O
immune	O
cell	O
signaling	O
via	O
TLR2	O
.	O

Finally	O
,	O
the	O
cytokine	O
interferon	O
-	O
gamma	O
(	O
IFN	O
-	O
gamma	O
)	O
induced	O
apoptosis	O
and	O
KILLER	O
/	O
DR5	O
in	O
cell	O
lines	O
with	O
mutant	O
p53	O
,	O
and	O
the	O
induction	O
of	O
KILLER	O
/	O
DR5	O
mRNA	O
by	O
IFN	O
-	O
gamma	O
was	O
delayed	O
in	O
cells	O
lacking	O
wild	O
-	O
type	O
STAT1	O
,	O
a	O
transcription	O
factor	O
implicated	O
in	O
IFN	O
-	O
gamma	O
signaling	O
.	O

These	O
findings	O
suggest	O
that	O
KILLER	O
/	O
DR5	O
may	O
play	O
a	O
role	O
in	O
p53	O
-	O
independent	O
apoptosis	O
induced	O
by	O
specific	O
drugs	O
and	O
warrants	O
further	O
investigation	O
as	O
a	O
novel	O
target	O
for	O
chemotherapy	O
of	O
tumors	O
lacking	O
wild	O
-	O
type	O
p53	O
.	O

Co	O
-	O
expression	O
of	O
wild	O
-	O
type	O
eEF	O
-	O
2K	O
with	O
luciferase	O
resulted	O
in	O
a	O
2	O
-	O
3	O
-	O
fold	O
reduction	O
in	O
luciferase	O
expression	O
.	O

Both	O
the	O
D	O
-	O
type	O
cyclins	O
and	O
their	O
partner	O
kinases	O
CDK4	O
/	O
6	O
have	O
proto	O
-	O
oncogenic	O
properties	O
,	O
and	O
their	O
activity	O
is	O
carefully	O
regulated	O
at	O
multiple	O
levels	O
including	O
negative	O
control	O
by	O
two	O
families	O
of	O
CDK	O
inhibitors	O
.	O

FUTURE	O
PROSPECTS	O
AND	O
PROJECTS	O
:	O
Major	O
advances	O
in	O
the	O
understanding	O
of	O
cell	O
cycle	O
regulation	O
mechanisms	O
provided	O
a	O
better	O
knowledge	O
of	O
the	O
molecular	O
interactions	O
involved	O
in	O
human	O
cancer	O
.	O

In	O
addition	O
,	O
several	O
key	O
inflammatory	O
mediators	O
including	O
IL	O
-	O
1	O
beta	O
,	O
IL	O
-	O
8	O
,	O
and	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
are	O
up	O
-	O
regulated	O
by	O
NTHi	O
.	O

Cooperation	O
of	O
Toll	O
-	O
like	O
receptor	O
2	O
and	O
6	O
for	O
cellular	O
activation	O
by	O
soluble	O
tuberculosis	O
factor	O
and	O
Borrelia	O
burgdorferi	O
outer	O
surface	O
protein	O
A	O
lipoprotein	O
:	O
role	O
of	O
Toll	O
-	O
interacting	O
protein	O
and	O
IL	O
-	O
1	O
receptor	O
signaling	O
molecules	O
in	O
Toll	O
-	O
like	O
receptor	O
2	O
signaling	O
.	O

Expression	O
of	O
TLR2	O
renders	O
HMEC	O
responsive	O
to	O
all	O
these	O
ligands	O
.	O

We	O
further	O
characterized	O
the	O
signaling	O
pathway	O
in	O
response	O
to	O
STF	O
,	O
OspA	O
-	O
L	O
,	O
and	O
PSM	O
in	O
TLR2	O
-	O
transfected	O
HMEC	O
.	O

Inhibition	O
of	O
promyelocytic	O
leukemia	O
(	O
PML	O
)	O
/	O
retinoic	O
acid	O
receptor	O
-	O
alpha	O
and	O
PML	O
expression	O
in	O
acute	O
promyelocytic	O
leukemia	O
cells	O
by	O
anti	O
-	O
PML	O
peptide	B-Chemical_Compound
nucleic	I-Chemical_Compound
acid	E-Chemical_Compound
.	O

In	O
this	O
study	O
,	O
three	O
anti	O
-	O
PML	O
adamantyl	S-Chemical_Compound
-	O
conjugated	O
peptide	B-Chemical_Compound
nucleic	I-Chemical_Compound
acid	E-Chemical_Compound
(	O
PNA	S-Chemical_Compound
)	O
oligomers	O
previously	O
described	O
as	O
in	O
vitro	O
inhibitors	O
of	O
PML	O
/	O
RARalpha	O
translation	O
were	O
combined	O
and	O
used	O
to	O
block	O
PML	O
/	O
RARalpha	O
synthesis	O
in	O
NB4	O
cells	O
.	O

Exposure	O
of	O
cells	O
to	O
high	O
concentrations	O
of	O
sodium	B-Chemical_Compound
chloride	E-Chemical_Compound
also	O
induced	O
phosphorylation	O
of	O
Snf1	O
.	O

Mechanisms	O
controlling	O
differential	O
promoter	O
-	O
occupancy	O
by	O
the	O
yeast	O
forkhead	O
proteins	O
Fkh1p	O
and	O
Fkh2p	O
:	O
implications	O
for	O
regulating	O
the	O
cell	O
cycle	O
and	O
differentiation	O
.	O

If	O
this	O
induction	O
of	O
mdm2	O
were	O
critical	O
for	O
the	O
recovery	O
of	O
low	O
levels	O
of	O
p53	O
following	O
UV	O
exposure	O
,	O
defects	O
in	O
mdm2	O
'	O
s	O
transcription	O
would	O
result	O
in	O
a	O
prolonged	O
increase	O
in	O
p53	O
.	O

Degradation	O
required	O
the	O
ubiquitin	O
protein	O
ligase	O
called	O
the	O
anaphase	O
-	O
promoting	O
complex	O
,	O
the	O
anaphase	O
-	O
promoting	O
complex	O
activating	O
protein	O
Cdc20	O
,	O
and	O
a	O
unique	O
43	O
-	O
aa	O
sequence	O
in	O
Kip1p	O
.	O

Cloning	O
and	O
expression	O
of	O
human	O
core	O
1	O
beta1	O
,	O
3	O
-	O
galactosyltransferase	O
.	O

The	O
4E	O
-	O
BPs	O
inhibit	O
translation	O
in	O
a	O
reversible	O
manner	O
.	O

We	O
suggest	O
that	O
Bub3	O
could	O
serve	O
as	O
a	O
platform	O
for	O
interactions	O
between	O
kinetochore	O
checkpoint	O
proteins	O
,	O
and	O
its	O
association	O
with	O
Mad2	O
,	O
Mad3	O
and	O
Cdc20	O
might	O
be	O
instrumental	O
for	O
checkpoint	O
activation	O
.	O

In	O
293	O
cells	O
,	O
cHSP60	O
-	O
mediated	O
NF	O
-	O
kappaB	O
activation	O
required	O
both	O
TLR4	O
and	O
MD2	O
.	O

In	O
budding	O
yeast	O
,	O
the	O
phosphatase	O
Cdc14	O
,	O
a	O
key	O
regulator	O
of	O
exit	O
from	O
mitosis	O
,	O
is	O
released	O
from	O
its	O
inhibitor	O
Cfi1	O
/	O
Net1	O
in	O
the	O
nucleolus	O
during	O
anaphase	O
.	O

A	O
signaling	O
cascade	O
,	O
known	O
as	O
the	O
mitotic	O
exit	O
network	O
(	O
MEN	O
)	O
,	O
controls	O
this	O
release	O
.	O

We	O
also	O
show	O
that	O
the	O
FEAR	O
network	O
initiates	O
Cdc14	O
release	O
from	O
Cfi1	O
/	O
Net1	O
during	O
early	O
anaphase	O
,	O
and	O
MEN	O
maintains	O
Cdc14	O
in	O
the	O
released	O
state	O
during	O
late	O
anaphase	O
.	O

Novel	O
signal	O
transduction	O
pathway	O
utilized	O
by	O
extracellular	O
HSP70	O
:	O
role	O
of	O
toll	O
-	O
like	O
receptor	O
(	O
TLR	O
)	O
2	O
and	O
TLR4	O
.	O

It	O
is	O
now	O
clear	O
that	O
HSP	O
can	O
and	O
do	O
exit	O
mammalian	O
cells	O
,	O
interact	O
with	O
cells	O
of	O
the	O
immune	O
system	O
,	O
and	O
exert	O
immunoregulatory	O
effects	O
.	O

Recent	O
studies	O
of	O
histone	O
methylation	O
have	O
yielded	O
fundamental	O
new	O
insights	O
pertaining	O
to	O
the	O
role	O
of	O
this	O
modification	O
in	O
gene	O
activation	O
as	O
well	O
as	O
in	O
gene	O
silencing	O
.	O

While	O
a	O
number	O
of	O
methylation	O
sites	O
are	O
known	O
to	O
occur	O
on	O
histones	O
,	O
only	O
limited	O
information	O
exists	O
regarding	O
the	O
relevant	O
enzymes	O
that	O
mediate	O
these	O
methylation	O
events	O
.	O

Using	O
an	O
antiserum	O
directed	O
against	O
Lys36	S-Chemical_Compound
methylation	O
in	O
H3	O
,	O
we	O
show	O
that	O
Set2	O
,	O
via	O
its	O
SET	O
domain	O
,	O
is	O
responsible	O
for	O
methylation	O
at	O
this	O
site	O
in	O
vivo	O
.	O

Tethering	O
of	O
Set2	O
to	O
a	O
heterologous	O
promoter	O
reveals	O
that	O
Set2	O
represses	O
transcription	O
,	O
and	O
part	O
of	O
this	O
repression	O
is	O
mediated	O
through	O
the	O
HMT	O
activity	O
of	O
the	O
SET	O
domain	O
.	O

The	O
terminal	O
components	O
of	O
this	O
cascade	O
,	O
two	O
PGE	O
(	O
2	O
)	O
synthases	O
(	O
PGES	O
)	O
,	O
have	O
very	O
recently	O
been	O
identified	O
as	O
glutathione	S-Chemical_Compound
-	O
dependent	O
proteins	O
.	O

The	O
interaction	O
of	O
MyD88	O
with	O
IRAK	O
triggers	O
IRAK	O
phosphorylation	O
,	O
which	O
is	O
essential	O
for	O
its	O
activation	O
and	O
downstream	O
signaling	O
ability	O
.	O

In	O
contrast	O
,	O
mSin3B	O
recruitment	O
to	O
certain	O
promoters	O
did	O
not	O
require	O
p107	O
or	O
p130	O
,	O
suggesting	O
that	O
recruitment	O
of	O
this	O
corepressor	O
can	O
occur	O
via	O
E2F	O
-	O
dependent	O
and	O
-	O
independent	O
mechanisms	O
.	O

OBJECTIVE	O
:	O
To	O
investigate	O
PML	O
gene	O
and	O
protein	O
expression	O
and	O
localization	O
in	O
leukemia	O
cell	O
lines	O
.	O

METHODS	O
:	O
Cell	O
morphology	O
was	O
assayed	O
by	O
Wright	O
and	O
fluorescence	O
stain	O
,	O
PML	O
mRNA	O
expression	O
by	O
RT	O
-	O
PCR	O
,	O
and	O
PML	O
protein	O
localization	O
by	O
immunofluorescence	O
.	O

Apoptosis	O
was	O
found	O
in	O
each	O
cell	O
line	O
after	O
treatment	O
with	O
quercetin	S-Chemical_Compound
.	O

(	O
3	O
)	O
The	O
expression	O
of	O
PML	O
mRNA	O
had	O
no	O
change	O
in	O
all	O
the	O
three	O
cell	O
lines	O
after	O
treatment	O
with	O
ATRA	S-Chemical_Compound
or	O
quercetin	S-Chemical_Compound
.	O

PML	O
in	O
POD	O
plays	O
a	O
role	O
of	O
apoptosis	O
induction	O
and	O
growth	O
control	O
of	O
leukemia	O
cells	O
.	O

Cdc7	O
-	O
Dbf4	O
kinase	O
complexes	O
,	O
conserved	O
widely	O
in	O
eukaryotes	O
,	O
play	O
essential	O
roles	O
in	O
initiation	O
and	O
progression	O
of	O
the	O
S	O
phase	O
.	O

We	O
have	O
isolated	O
and	O
characterized	O
the	O
promoter	O
region	O
of	O
the	O
human	O
ASK	O
gene	O
encoding	O
Dbf4	O
-	O
related	O
regulatory	O
subunit	O
for	O
human	O
Cdc7	O
kinase	O
.	O

Heat	O
shock	O
proteins	O
play	O
central	O
roles	O
in	O
ensuring	O
the	O
correct	O
folding	O
and	O
maturation	O
of	O
cellular	O
proteins	O
.	O

Furthermore	O
,	O
studies	O
with	O
K562	O
cells	O
reveal	O
that	O
disruption	O
of	O
the	O
interaction	O
with	O
Hsp70	O
slows	O
the	O
protein	O
kinase	O
C	O
beta	O
II	O
-	O
mediated	O
recovery	O
of	O
cells	O
from	O
PMA	O
-	O
induced	O
growth	O
arrest	O
.	O

Last	O
,	O
we	O
show	O
that	O
other	O
members	O
of	O
the	O
AGC	O
superfamily	O
(	O
Akt	O
/	O
protein	O
kinase	O
B	O
and	O
protein	O
kinase	O
A	O
)	O
also	O
bind	O
Hsp70	O
via	O
their	O
unphosphorylated	O
turn	O
motifs	O
.	O

There	O
is	O
evidence	O
that	O
DNA	O
-	O
dependent	O
protein	O
kinase	O
(	O
DNA	O
-	O
PK	O
)	O
mediates	O
CpG	O
signaling	O
.	O

Telomerase	O
activity	O
is	O
closely	O
correlated	O
with	O
cellular	O
proliferative	O
activity	O
in	O
human	O
tissues	O
.	O

Ubiquitin	O
-	O
mediated	O
proteolysis	O
of	O
securin	O
and	O
mitotic	O
cyclins	O
is	O
essential	O
for	O
exit	O
from	O
mitosis	O
.	O

Little	O
is	O
known	O
about	O
the	O
molecular	O
reaction	O
resulting	O
in	O
APC	O
-	O
dependent	O
substrate	O
ubiquitination	O
or	O
the	O
role	O
of	O
individual	O
APC	O
subunits	O
in	O
the	O
reaction	O
.	O

GTPase	O
-	O
activating	O
proteins	O
for	O
Cdc42	O
.	O

A	O
group	O
of	O
proteins	O
called	O
GTPase	O
-	O
activating	O
proteins	O
(	O
GAPs	O
)	O
catalyze	O
the	O
hydrolysis	O
of	O
GTP	S-Chemical_Compound
to	O
GDP	S-Chemical_Compound
,	O
thereby	O
inactivating	O
Cdc42	O
.	O

We	O
identified	O
another	O
putative	O
GAP	O
for	O
Cdc42	O
and	O
named	O
it	O
Rga2	O
(	O
Rho	O
GTPase	O
-	O
activating	O
protein	O
2	O
)	O
.	O

For	O
example	O
,	O
deletion	O
of	O
RGA1	O
,	O
but	O
not	O
RGA2	O
or	O
BEM3	O
,	O
caused	O
hyperinvasive	O
growth	O
.	O

A	O
second	O
C	O
-	O
terminal	O
site	O
,	O
S112	S-Chemical_Compound
,	O
directly	O
affects	O
binding	O
of	O
4E	O
-	O
BP1	O
to	O
eIF4E	O
without	O
influencing	O
phosphorylation	O
of	O
other	O
sites	O
.	O

Furthermore	O
,	O
trans	O
-	O
activation	O
of	O
cyclin	O
D3	O
by	O
ER	O
-	O
E2F1	O
occurs	O
even	O
in	O
the	O
presence	O
of	O
the	O
protein	O
synthesis	O
inhibitor	O
cycloheximide	S-Chemical_Compound
and	O
thus	O
appears	O
direct	O
.	O

In	O
this	O
study	O
,	O
the	O
consequences	O
of	O
LPS	S-Chemical_Compound
-	O
induced	O
PI	O
3	O
-	O
kinase	O
activation	O
on	O
cytokine	O
and	O
chemokine	O
expression	O
and	O
the	O
intracellular	O
mechanisms	O
of	O
inflammatory	O
activation	O
were	O
examined	O
in	O
mouse	O
macrophages	O
.	O

Taken	O
together	O
,	O
our	O
results	O
demonstrate	O
that	O
activation	O
of	O
Toll	O
-	O
like	O
receptor	O
(	O
TLR	O
)	O
-	O
4	O
results	O
in	O
PI	O
3	O
-	O
kinase	O
-	O
MyD88	O
complex	O
formation	O
,	O
and	O
that	O
PI	O
3	O
-	O
kinase	O
activity	O
selectively	O
leads	O
to	O
cytokine	O
induction	O
downstream	O
of	O
TLR4	O
.	O

When	O
E2F1	O
was	O
cotransfected	O
with	O
HBx	O
,	O
E2F1	O
overcame	O
the	O
repressive	O
effect	O
of	O
HBx	O
on	O
the	O
p53	O
promoter	O
through	O
the	O
E2F1	O
site	O
.	O

These	O
disulfide	O
bonds	O
produce	O
a	O
heterogeneous	O
array	O
of	O
oligomers	O
,	O
including	O
some	O
species	O
that	O
can	O
form	O
an	O
active	O
complex	O
with	O
TLR4	O
.	O

Selective	O
inhibition	O
studies	O
with	O
PD98059	S-Chemical_Compound
,	O
SB202190	S-Chemical_Compound
,	O
SP600125	S-Chemical_Compound
,	O
and	O
the	O
dominant	O
negative	O
JNK	O
indicate	O
that	O
activation	O
of	O
JNK	O
but	O
not	O
p38	O
kinase	O
or	O
ERK	O
kinase	O
is	O
required	O
for	O
the	O
phosphorylation	O
and	O
transcriptional	O
activation	O
of	O
ATF2	O
.	O

OBJECTIVE	O
:	O
To	O
investigate	O
the	O
effects	O
of	O
red	O
orpiment	O
on	O
cell	O
morphology	O
,	O
expression	O
of	O
promyelocytic	O
leukemia	O
(	O
PML	O
)	O
mRNA	O
and	O
its	O
protein	O
localization	O
in	O
NB4	O
and	O
HL	O
-	O
60	O
cell	O
lines	O
.	O

In	O
HL	O
-	O
60	O
cells	O
,	O
PML	O
protein	O
underwent	O
a	O
similar	O
progress	O
.	O

Here	O
we	O
report	O
that	O
the	O
noncanonical	O
IkappaB	O
kinase	O
homologs	O
,	O
IkappaB	O
kinase	O
-	O
epsilon	O
(	O
IKKepsilon	O
)	O
and	O
TANK	O
-	O
binding	O
kinase	O
-	O
1	O
(	O
TBK1	O
)	O
,	O
which	O
were	O
previously	O
implicated	O
in	O
NF	O
-	O
kappaB	O
activation	O
,	O
are	O
also	O
essential	O
components	O
of	O
the	O
IRF3	O
signaling	O
pathway	O
.	O

Hog1	O
interacts	O
with	O
the	O
RNA	O
Pol	O
II	O
and	O
with	O
general	O
components	O
of	O
the	O
transcription	O
machinery	O
.	O

p53	O
-	O
independent	O
activation	O
of	O
the	O
hdm2	O
-	O
P2	O
promoter	O
through	O
multiple	O
transcription	O
factor	O
response	O
elements	O
results	O
in	O
elevated	O
hdm2	O
expression	O
in	O
estrogen	O
receptor	O
alpha	O
-	O
positive	O
breast	O
cancer	O
cells	O
.	O

Expression	O
of	O
hdm2	O
,	O
and	O
its	O
mouse	O
orthologue	O
mdm2	O
,	O
is	O
known	O
to	O
be	O
induced	O
by	O
p53	O
,	O
but	O
recent	O
evidence	O
has	O
demonstrated	O
mdm2	O
expression	O
can	O
also	O
be	O
regulated	O
via	O
p53	O
-	O
independent	O
pathways	O
.	O

However	O
the	O
p53	O
independent	O
mechanisms	O
that	O
control	O
transcription	O
of	O
the	O
human	O
hdm2	O
gene	O
have	O
not	O
been	O
studied	O
.	O

We	O
also	O
demonstrate	O
considerable	O
isoform	O
diversity	O
of	O
both	O
hc	O
-	O
Rel	O
and	O
p105	O
.	O

Quantitative	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
normalized	O
to	O
beta	O
-	O
actin	O
revealed	O
expression	O
of	O
the	O
MRP5	O
gene	O
in	O
all	O
samples	O
(	O
LV	O
,	O
38	O
.	O
5	O
+	O
/	O
-	O
12	O
.	O
9	O
;	O
AS	O
,	O
12	O
.	O
7	O
+	O
/	O
-	O
5	O
.	O
6	O
;	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

In	O
addition	O
,	O
we	O
screened	O
genomic	O
DNA	O
from	O
our	O
samples	O
for	O
20	O
single	O
-	O
nucleotide	O
polymorphisms	O
in	O
the	O
MRP5	O
gene	O
.	O

Like	O
TRIF	O
,	O
TRAM	O
activates	O
interferon	O
regulatory	O
factor	O
(	O
IRF	O
)	O
-	O
3	O
,	O
IRF	O
-	O
7	O
,	O
and	O
NF	O
-	O
kappaB	O
-	O
dependent	O
signaling	O
pathways	O
.	O

Dysregulation	O
of	O
the	O
initial	O
,	O
innate	O
immune	O
response	O
to	O
bacterial	O
infection	O
may	O
lead	O
to	O
septic	O
shock	O
and	O
death	O
.	O

In	O
NE	S-Chemical_Compound
-	O
precontracted	O
vessels	O
,	O
MA	S-Chemical_Compound
stimulated	O
a	O
biphasic	O
response	O
in	O
RA	O
and	O
RSV	O
(	O
rapid	O
contraction	O
followed	O
by	O
prolonged	O
relaxation	O
)	O
and	O
dominant	O
relaxation	O
in	O
LIMA	O
(	O
mean	O
+	O
/	O
-	O
SE	O
,	O
%	O
relaxation	O
:	O
55	O
.	O
4	O
+	O
/	O
-	O
3	O
.	O
9	O
,	O
n	O
=	O
30	O
)	O
.	O

Potent	O
and	O
selective	O
inhibition	O
of	O
the	O
AICAR	O
transformylase	O
active	O
site	O
,	O
compared	O
with	O
other	O
folate	S-Chemical_Compound
-	O
dependent	O
enzymes	O
,	O
should	O
therefore	O
be	O
pursued	O
by	O
further	O
design	O
of	O
sulfonyl	S-Chemical_Compound
-	O
containing	O
antifolates	S-Chemical_Compound
.	O

The	O
replication	O
fork	O
block	O
protein	O
Fob1	O
functions	O
as	O
a	O
negative	O
regulator	O
of	O
the	O
FEAR	O
network	O
.	O

We	O
propose	O
that	O
Fob1	O
helps	O
to	O
prevent	O
the	O
dissociation	O
of	O
Cdc14	O
from	O
Cfi1	O
/	O
Net1	O
prior	O
to	O
anaphase	O
and	O
that	O
Spo12	O
activation	O
during	O
early	O
anaphase	O
promotes	O
the	O
release	O
of	O
Cdc14	O
from	O
its	O
inhibitor	O
by	O
antagonizing	O
Fob1	O
function	O
.	O

The	O
p53	O
signaling	O
cascade	O
is	O
complex	O
,	O
and	O
the	O
mechanism	O
by	O
which	O
p53	O
induces	O
apoptosis	O
is	O
cell	O
type	O
-	O
dependent	O
.	O

Using	O
DNA	O
microarray	O
analysis	O
,	O
we	O
have	O
found	O
a	O
striking	O
induction	O
of	O
the	O
proapoptotic	O
gene	O
,	O
SIVA	O
.	O

SIVA	O
up	O
-	O
regulation	O
is	O
sufficient	O
to	O
initiate	O
the	O
apoptotic	O
cascade	O
in	O
neurons	O
.	O

Inactivating	O
Cdc25	O
,	O
mitotic	O
style	O
.	O

Inhibition	O
of	O
nlk	O
using	O
morpholino	O
oligos	O
reveals	O
essential	O
roles	O
in	O
regulating	O
ventrolateral	O
mesoderm	O
formation	O
in	O
conjunction	O
with	O
wnt8	O
,	O
and	O
in	O
patterning	O
of	O
the	O
midbrain	O
,	O
possibly	O
functioning	O
with	O
wnt8b	O
.	O

Here	O
,	O
we	O
show	O
that	O
E2F	O
directly	O
participates	O
in	O
the	O
transcriptional	O
control	O
of	O
Arf	O
in	O
both	O
normal	O
and	O
transformed	O
cells	O
.	O

In	O
quiescent	O
cells	O
,	O
this	O
role	O
is	O
largely	O
fulfilled	O
by	O
E2F3b	O
,	O
an	O
E2F3	O
isoform	O
whose	O
function	O
was	O
previously	O
undetermined	O
.	O

Survivin	O
is	O
a	O
putative	O
oncogene	O
that	O
is	O
aberrantly	O
expressed	O
in	O
cancer	O
cells	O
.	O

The	O
critical	O
function	O
of	O
this	O
deubiquitinating	O
enzyme	O
in	O
the	O
restriction	O
of	O
TLR	O
signals	O
emphasizes	O
the	O
importance	O
of	O
the	O
regulation	O
of	O
ubiquitin	O
conjugation	O
in	O
innate	O
immune	O
cells	O
.	O

We	O
speculate	O
that	O
hexose	O
-	O
6	O
-	O
phosphate	O
dehydrogenase	O
activity	O
and	O
therefore	O
reduced	O
nicotinamide	B-Chemical_Compound
-	I-Chemical_Compound
adenine	I-Chemical_Compound
dinucleotide	I-Chemical_Compound
phosphate	E-Chemical_Compound
supply	O
may	O
be	O
crucial	O
in	O
determining	O
the	O
directionality	O
of	O
11beta	O
-	O
HSD1	O
activity	O
.	O

Genotoxic	O
stress	O
triggers	O
apoptosis	O
through	O
multiple	O
signaling	O
pathways	O
.	O

E2Fs	O
link	O
the	O
control	O
of	O
G1	O
/	O
S	O
and	O
G2	O
/	O
M	O
transcription	O
.	O

Chromatin	O
immunoprecipitation	O
assays	O
identify	O
multiple	O
interactions	O
of	O
E2F	O
proteins	O
that	O
include	O
those	O
previously	O
shown	O
to	O
activate	O
and	O
repress	O
transcription	O
.	O

The	O
transcriptional	O
repressor	O
E2F6	O
has	O
been	O
identified	O
as	O
a	O
component	O
of	O
two	O
distinct	O
polycomb	O
group	O
protein	O
(	O
PcG	O
)	O
-	O
containing	O
complexes	O
,	O
suggesting	O
a	O
mechanism	O
for	O
the	O
recruitment	O
of	O
repressive	O
complexes	O
to	O
target	O
sequences	O
in	O
DNA	O
.	O

Whereas	O
one	O
complex	O
is	O
involved	O
in	O
the	O
repression	O
of	O
classic	O
E2F	O
target	O
genes	O
in	O
G0	O
,	O
a	O
role	O
for	O
E2F6	O
within	O
the	O
cell	O
cycle	O
has	O
yet	O
to	O
be	O
defined	O
.	O

Transcriptional	O
regulation	O
by	O
mitogen	O
-	O
activated	O
protein	O
(	O
MAP	O
)	O
kinase	O
signaling	O
cascades	O
is	O
a	O
major	O
control	O
mechanism	O
for	O
eukaryotic	O
development	O
.	O

Mutations	O
that	O
disrupt	O
the	O
concentration	O
of	O
Ran	O
in	O
the	O
nucleus	O
displaced	O
Mad2p	O
but	O
not	O
Mad1p	O
from	O
the	O
NPC	O
.	O

Axin2	O
is	O
a	O
negative	O
regulator	O
of	O
Wnt	O
/	O
beta	O
-	O
catenin	O
signalling	O
with	O
roles	O
in	O
early	O
development	O
and	O
tumour	O
suppression	O
.	O

Second	O
,	O
E2F1	O
induces	O
stabilisation	O
of	O
axin2	O
mRNAs	O
.	O

These	O
data	O
have	O
important	O
implications	O
for	O
understanding	O
signaling	O
downstream	O
of	O
mTOR	O
and	O
the	O
development	O
of	O
new	O
strategies	O
to	O
impair	O
mTOR	O
signaling	O
.	O

pRB	O
and	O
the	O
p107	O
/	O
p130	O
pair	O
are	O
required	O
for	O
the	O
repression	O
of	O
distinct	O
sets	O
of	O
genes	O
,	O
potentially	O
due	O
to	O
their	O
selective	O
interactions	O
with	O
E2Fs	O
that	O
are	O
engaged	O
at	O
specific	O
promoter	O
elements	O
.	O

Despite	O
these	O
advances	O
,	O
much	O
remains	O
to	O
be	O
learned	O
about	O
the	O
pocket	O
proteins	O
,	O
particularly	O
with	O
regard	O
to	O
their	O
developmental	O
and	O
tumor	O
suppressor	O
functions	O
.	O

Moreover	O
,	O
inactivation	O
of	O
the	O
target	O
genes	O
resulted	O
in	O
a	O
clear	O
increase	O
of	O
cell	O
viability	O
(	O
>	O
80	O
%	O
)	O
in	O
response	O
to	O
E2F1	O
activation	O
compared	O
with	O
controls	O
(	O
approximately	O
30	O
%	O
)	O
.	O

We	O
report	O
a	O
rapid	O
induction	O
of	O
p53	O
and	O
increased	O
expression	O
of	O
p21	O
,	O
concurrent	O
with	O
reduced	O
levels	O
of	O
many	O
cell	O
cycle	O
proteins	O
that	O
regulate	O
G1	O
to	O
S	O
phase	O
cell	O
cycle	O
progression	O
.	O

Pretreatment	O
of	O
cells	O
with	O
cdk	O
inhibitor	O
olomoucine	S-Chemical_Compound
impeded	O
cdk2	O
-	O
cyclin	O
E	O
accumulation	O
,	O
but	O
not	O
the	O
induction	O
of	O
p53	O
.	O

Ectopic	O
expression	O
of	O
E2F8	O
in	O
diploid	O
human	O
fibroblasts	O
reduces	O
expression	O
of	O
E2F	O
-	O
target	O
genes	O
and	O
inhibits	O
cell	O
growth	O
consistent	O
with	O
a	O
role	O
for	O
repressing	O
E2F	O
transcriptional	O
activity	O
.	O

Similar	O
to	O
mammalian	O
MAP	O
kinases	O
,	O
this	O
modification	O
occurs	O
at	O
two	O
amino	O
acids	O
of	O
FUS3	O
,	O
threonine	B-Chemical_Compound
-	I-Chemical_Compound
180	E-Chemical_Compound
and	O
tyrosine	B-Chemical_Compound
-	I-Chemical_Compound
182	E-Chemical_Compound
.	O

Furthermore	O
,	O
an	O
NFATc2	O
chimera	O
protein	O
containing	O
the	O
LxVP	O
motif	O
from	O
NFATc1	O
interacted	O
with	O
CN	O
much	O
more	O
potently	O
than	O
did	O
wild	O
-	O
type	O
NFATc2	O
.	O

In	O
contrast	O
with	O
PxIxITc2	O
,	O
the	O
LxVP	O
peptide	O
not	O
only	O
blocked	O
CN	O
-	O
NFAT	O
binding	O
but	O
also	O
inhibited	O
CN	O
phosphatase	O
activity	O
in	O
vitro	O
.	O

Regulation	O
of	O
the	O
Pur	O
-	O
alpha	O
promoter	O
by	O
E2F	O
-	O
1	O
.	O

Previously	O
,	O
Puralpha	O
protein	O
was	O
found	O
to	O
bind	O
to	O
E2F	O
-	O
1	O
,	O
inhibit	O
E2F	O
-	O
1	O
transcriptional	O
activity	O
,	O
and	O
reverse	O
the	O
effects	O
of	O
ectopic	O
E2F	O
-	O
1	O
expression	O
on	O
cell	O
growth	O
.	O

E2F	O
-	O
1	O
-	O
associated	O
activation	O
of	O
the	O
pPuralpha	O
was	O
inhibited	O
by	O
co	O
-	O
expression	O
of	O
Puralpha	O
,	O
pRb	O
,	O
and	O
an	O
RNA	O
species	O
with	O
specific	O
binding	O
to	O
E2F	O
-	O
1	O
.	O

Chromatin	O
immunoprecipitation	O
(	O
ChIP	O
)	O
assay	O
using	O
primers	O
that	O
flanked	O
the	O
juxtaposed	O
Puralpha	O
and	O
E2F	O
-	O
1	O
binding	O
sites	O
verified	O
the	O
presence	O
of	O
Puralpha	O
and	O
E2F	O
-	O
1	O
on	O
the	O
pPuralpha	O
in	O
vivo	O
.	O

Thus	O
,	O
E2F	O
-	O
1	O
and	O
Puralpha	O
interplay	O
appears	O
to	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
Puralpha	O
expression	O
and	O
the	O
cell	O
cycle	O
.	O

Deletion	O
of	O
a	O
single	O
allele	O
of	O
the	O
Dkk1	O
gene	O
leads	O
to	O
an	O
increase	O
in	O
bone	O
formation	O
and	O
bone	O
mass	O
.	O

Dkk1	O
expression	O
also	O
increased	O
adipocyte	O
differentiation	O
in	O
these	O
cell	O
cultures	O
.	O

The	O
PGN	S-Chemical_Compound
-	O
induced	O
increase	O
in	O
kappaB	O
luciferase	O
activity	O
was	O
inhibited	O
by	O
NS398	S-Chemical_Compound
,	O
AH6809	S-Chemical_Compound
,	O
AH23848	S-Chemical_Compound
,	O
KT5720	S-Chemical_Compound
,	O
a	O
protein	O
kinase	O
C	O
inhibitor	O
(	O
Ro31	B-Chemical_Compound
-	I-Chemical_Compound
8220	E-Chemical_Compound
)	O
,	O
and	O
a	O
p38	O
MAPK	O
inhibitor	O
(	O
SB203580	S-Chemical_Compound
)	O
.	O

In	O
budding	O
yeast	O
,	O
Gin4	O
,	O
a	O
Nim1	O
-	O
related	O
kinase	O
,	O
plays	O
an	O
important	O
role	O
in	O
proper	O
organization	O
of	O
the	O
septin	O
ring	O
at	O
the	O
mother	O
-	O
bud	O
neck	O
,	O
a	O
filamentous	O
structure	O
that	O
is	O
critical	O
for	O
diverse	O
cellular	O
processes	O
including	O
mitotic	O
entry	O
and	O
cytokinesis	O
.	O

Here	O
we	O
showed	O
that	O
a	O
neck	O
-	O
associated	O
Ser	S-Chemical_Compound
/	O
Thr	S-Chemical_Compound
kinase	O
Elm1	O
,	O
which	O
is	O
important	O
for	O
septin	O
assembly	O
,	O
is	O
critical	O
for	O
proper	O
modification	O
of	O
Gin4	O
and	O
its	O
physiological	O
substrate	O
Shs1	O
.	O

Consistent	O
with	O
these	O
observations	O
,	O
acute	O
inhibition	O
of	O
Elm1	O
activity	O
abolished	O
mitotic	O
Gin4	O
phosphorylation	O
and	O
Gin4	O
-	O
dependent	O
Shs1	O
modification	O
in	O
vivo	O
.	O

In	O
this	O
issue	O
of	O
Cell	O
,	O
Inoki	O
et	O
al	O
.	O

(	O
2006	O
)	O
report	O
that	O
the	O
kinases	O
GSK3	O
and	O
AMPK	O
cooperate	O
in	O
the	O
activation	O
of	O
TSC2	O
to	O
inhibit	O
mTOR	O
activity	O
.	O

This	O
phosphorylation	O
event	O
is	O
required	O
for	O
the	O
normal	O
temporal	O
expression	O
of	O
cell	O
-	O
cycle	O
-	O
regulated	O
genes	O
such	O
as	O
CLB2	O
and	O
SWI5	O
in	O
G2	O
/	O
M	O
phases	O
.	O

Activated	O
Mec1	O
phosphorylates	O
the	O
Ddc1	O
and	O
Mec3	O
subunits	O
of	O
the	O
clamp	O
,	O
the	O
Rad24	O
subunit	O
of	O
the	O
loader	O
,	O
and	O
the	O
Rpa1	O
and	O
Rpa2	O
subunits	O
of	O
RPA	O
.	O

Phosphorylation	O
of	O
Rad53	O
,	O
and	O
of	O
human	O
PHAS	O
-	O
1	O
,	O
a	O
nonspecific	O
target	O
,	O
also	O
requires	O
a	O
properly	O
loaded	O
clamp	O
.	O

In	O
this	O
study	O
,	O
we	O
determined	O
the	O
role	O
of	O
PAG608	O
in	O
methamphetamine	S-Chemical_Compound
-	O
induced	O
neurotoxicity	O
.	O

Transient	O
transfection	O
of	O
PAG608	O
antisense	O
cDNA	O
or	O
RNA	O
interference	O
using	O
PAG608	O
small	O
interfering	O
RNA	O
significantly	O
attenuated	O
the	O
dose	O
-	O
dependent	O
decrease	O
in	O
cell	O
viability	O
of	O
CATH	O
.	O
a	O
cells	O
by	O
methamphetamine	S-Chemical_Compound
(	O
1	O
-	O
4	O
mM	O
)	O
exposure	O
.	O

We	O
show	O
that	O
ACE2	O
,	O
whose	O
zinc	S-Chemical_Compound
finger	O
region	O
is	O
nearly	O
identical	O
to	O
that	O
of	O
SWI5	O
,	O
shows	O
patterns	O
of	O
cell	O
cycle	O
-	O
regulated	O
transcription	O
and	O
nuclear	O
localization	O
similar	O
to	O
those	O
seen	O
previously	O
for	O
SWI5	O
.	O

Given	O
that	O
mTOR	O
activity	O
is	O
frequently	O
deregulated	O
in	O
cancer	O
,	O
there	O
is	O
much	O
interest	O
in	O
new	O
strategies	O
for	O
inhibition	O
of	O
this	O
pathway	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
report	O
that	O
widely	O
expressed	O
isoforms	O
of	O
unstudied	O
proteins	O
termed	O
Protor	O
-	O
1	O
(	O
protein	O
observed	O
with	O
Rictor	O
-	O
1	O
)	O
and	O
Protor	O
-	O
2	O
interact	O
with	O
Rictor	O
and	O
are	O
components	O
of	O
mTORC2	O
.	O

E2F	O
-	O
1	O
controls	O
multiple	O
cellular	O
activities	O
through	O
transcriptional	O
regulation	O
of	O
its	O
target	O
genes	O
.	O

Moreover	O
,	O
endogenous	O
E2F	O
-	O
1	O
upregulates	O
PAC1	O
and	O
suppresses	O
ERK	O
activity	O
,	O
leading	O
to	O
cell	O
death	O
in	O
response	O
to	O
4	B-Chemical_Compound
-	I-Chemical_Compound
HPR	E-Chemical_Compound
.	O

Our	O
data	O
provide	O
strong	O
evidence	O
for	O
a	O
distinct	O
checkpoint	O
pathway	O
responding	O
to	O
lack	O
of	O
sister	O
kinetochore	O
tension	O
,	O
in	O
which	O
Ipl1p	O
-	O
dependent	O
phosphorylation	O
of	O
Mad3p	O
is	O
a	O
key	O
step	O
.	O

Differentiation	O
of	O
PC12	O
cells	O
by	O
NGF	O
involves	O
p53	O
,	O
a	O
transcription	O
factor	O
that	O
controls	O
growth	O
arrest	O
and	O
apoptosis	O
.	O

Binding	O
of	O
PRAS40	O
to	O
14	O
-	O
3	O
-	O
3	O
proteins	O
is	O
inhibited	O
by	O
TSC1	O
/	O
2	O
(	O
negative	O
regulators	O
of	O
mTORC1	O
)	O
and	O
stimulated	O
by	O
Rheb	O
in	O
a	O
rapamycin	S-Chemical_Compound
-	O
sensitive	O
manner	O
.	O

Passenger	O
protein	O
homologues	O
in	O
the	O
budding	O
yeast	O
Saccharomyces	O
cerevisiae	O
play	O
a	O
critical	O
role	O
early	O
in	O
mitosis	O
,	O
ensuring	O
proper	O
biorientation	O
of	O
kinetochore	O
-	O
microtubule	O
attachments	O
.	O

Here	O
,	O
we	O
present	O
data	O
that	O
is	O
consistent	O
with	O
there	O
being	O
multiple	O
passenger	O
protein	O
complexes	O
.	O

Neither	O
conditional	O
alleles	O
nor	O
mutants	O
of	O
BIR1	O
that	O
disrupt	O
the	O
interaction	O
between	O
Bir1p	O
and	O
Sli15p	O
resulted	O
in	O
mono	O
-	O
attached	O
kinetochores	O
,	O
suggesting	O
that	O
the	O
Bir1p	O
-	O
Sli15p	O
complex	O
functions	O
in	O
anaphase	O
and	O
independently	O
from	O
Sli15p	O
-	O
Ipl1p	O
complexes	O
.	O

Global	O
analysis	O
shows	O
that	O
all	O
Ace2	O
-	O
only	O
genes	O
are	O
bound	O
by	O
both	O
Ace2	O
and	O
Swi5	O
,	O
and	O
also	O
by	O
Fkh1	O
/	O
2	O
.	O

An	O
important	O
component	O
in	O
the	O
energy	O
and	O
nutrient	O
pathways	O
is	O
mammalian	O
target	O
of	O
rapamycin	O
(	O
mTOR	O
)	O
,	O
a	O
kinase	O
that	O
regulates	O
cell	O
growth	O
,	O
size	O
and	O
survival	O
.	O

These	O
results	O
have	O
important	O
implications	O
for	O
our	O
understanding	O
of	O
how	O
these	O
pathways	O
might	O
be	O
altered	O
in	O
metabolic	O
diseases	O
and	O
cancer	O
.	O

In	O
contrast	O
with	O
the	O
wide	O
,	O
strong	O
expression	O
of	O
krm1	O
mRNA	O
in	O
mature	O
tissues	O
,	O
expression	O
of	O
krm1	O
is	O
diminished	O
in	O
a	O
variety	O
of	O
human	O
tumor	O
cells	O
.	O

Krm	O
is	O
quite	O
significant	O
in	O
these	O
processes	O
as	O
the	O
gatekeeper	O
of	O
the	O
Wnt	O
/	O
beta	O
-	O
catenin	O
signalling	O
pathway	O
.	O

Exposure	O
to	O
chlorambucil	S-Chemical_Compound
,	O
fludarabine	S-Chemical_Compound
,	O
and	O
Nutlin	B-Chemical_Compound
-	I-Chemical_Compound
3	E-Chemical_Compound
induced	O
p53	O
accumulation	O
and	O
variably	O
affected	O
cell	O
cycle	O
progression	O
in	O
SKW6	O
.	O
4	O
lymphoblastoid	O
cells	O
.	O

Genetic	O
studies	O
have	O
shown	O
the	O
tuberous	O
sclerosis	O
tumor	O
suppressors	O
TSC1	O
/	O
2	O
and	O
the	O
REDD1	O
protein	O
to	O
be	O
essential	O
for	O
hypoxia	O
regulation	O
of	O
TORC1	O
activity	O
in	O
Drosophila	O
and	O
in	O
mammalian	O
cells	O
.	O

In	O
vivo	O
,	O
REDD1	O
loss	O
elicits	O
tumorigenesis	O
in	O
a	O
mouse	O
model	O
,	O
and	O
down	O
-	O
regulation	O
of	O
REDD1	O
is	O
observed	O
in	O
a	O
subset	O
of	O
human	O
cancers	O
.	O

The	O
specific	O
induction	O
of	O
PAG608	O
6	O
-	O
48h	O
after	O
L	B-Chemical_Compound
-	I-Chemical_Compound
DOPA	E-Chemical_Compound
injection	O
in	O
the	O
extrapyramidal	O
tracts	O
,	O
pyramidal	O
tracts	O
and	O
corresponding	O
lower	O
motor	O
neurons	O
of	O
the	O
spinal	O
cords	O
suggests	O
its	O
involvement	O
in	O
molecular	O
events	O
in	O
stimulated	O
motor	O
neurons	O
.	O

Several	O
isoforms	O
of	O
p53	O
have	O
been	O
discovered	O
,	O
some	O
of	O
which	O
inhibit	O
p53	O
function	O
.	O

We	O
also	O
characterized	O
the	O
relationship	O
between	O
the	O
expression	O
of	O
p53	O
,	O
p53	O
isoforms	O
,	O
and	O
p53	O
target	O
genes	O
following	O
treatment	O
with	O
the	O
DNA	O
-	O
damaging	O
agent	O
cisplatin	S-Chemical_Compound
.	O

Promyelocytic	O
leukemia	O
(	O
PML	O
)	O
gene	O
expression	O
is	O
a	O
prognostic	O
factor	O
in	O
ampullary	O
cancer	O
patients	O
.	O

BACKGROUND	O
:	O
Promyelocytic	O
leukemia	O
(	O
PML	O
)	O
tumor	O
suppressor	O
gene	O
plays	O
a	O
key	O
role	O
in	O
acute	O
PML	O
pathogenesis	O
but	O
its	O
involvement	O
in	O
pathogenesis	O
and	O
prognosis	O
of	O
solid	O
cancers	O
has	O
not	O
been	O
defined	O
yet	O
.	O

OS	O
in	O
the	O
group	O
of	O
patients	O
without	O
PML	O
expression	O
,	O
with	O
focal	O
expression	O
,	O
and	O
with	O
diffuse	O
expression	O
was	O
40	O
,	O
48	O
,	O
and	O
77	O
months	O
,	O
respectively	O
(	O
P	O
=	O
0	O
.	O
002	O
)	O
.	O

Cellular	O
p27pT157	O
and	O
p27pT198	O
coprecipitated	O
with	O
Cdk4	O
but	O
were	O
not	O
detected	O
in	O
Cdk2	O
complexes	O
.	O

The	O
addition	O
of	O
p27	O
to	O
recombinant	O
cyclin	O
D1	O
and	O
Cdk4	O
led	O
to	O
cyclin	O
D1	O
-	O
Cdk4	O
-	O
p27	O
complex	O
formation	O
in	O
vitro	O
.	O

Aberrant	O
signaling	O
caused	O
by	O
altered	O
Frizzled	O
receptor	O
activity	O
or	O
by	O
mutations	O
in	O
downstream	O
signaling	O
components	O
has	O
been	O
implicated	O
in	O
several	O
adult	O
pathologies	O
.	O

In	O
conclusion	O
,	O
the	O
TCDD	S-Chemical_Compound
-	O
mediated	O
activation	O
of	O
NFATc1	O
is	O
suggested	O
to	O
promote	O
cell	O
migration	O
via	O
ATX	O
/	O
LPA	S-Chemical_Compound
-	O
signaling	O
.	O

Delivery	O
outcomes	O
,	O
fetal	O
status	O
,	O
serum	O
progesterone	S-Chemical_Compound
,	O
and	O
nuclear	O
translocation	O
of	O
the	O
transcription	O
factor	O
nuclear	O
factor	O
kappa	O
B	O
(	O
NFkappaB	O
)	O
were	O
determined	O
.	O

CONCLUSION	O
:	O
E	O
coli	O
-	O
induced	O
preterm	O
delivery	O
in	O
the	O
mouse	O
is	O
completely	O
dependent	O
upon	O
MyD88	O
but	O
not	O
TRIF	O
.	O

These	O
effects	O
were	O
attenuated	O
by	O
ERK	O
,	O
phosphatidylinositol	O
3	O
-	O
kinase	O
(	O
PI3K	O
)	O
,	O
NF	O
-	O
kappaB	O
inhibitors	O
,	O
and	O
IkappaB	O
protease	O
inhibitor	O
.	O

Previously	O
,	O
we	O
have	O
shown	O
that	O
leukemic	O
cells	O
of	O
most	O
ATL	O
patients	O
express	O
CCR4	O
,	O
a	O
chemokine	O
receptor	O
known	O
to	O
be	O
selectively	O
expressed	O
by	O
T	O
cell	O
subsets	O
such	O
as	O
Th2	O
cells	O
,	O
skin	O
-	O
homing	O
memory	O
/	O
effector	O
T	O
cells	O
,	O
and	O
regulatory	O
T	O
cells	O
.	O

Our	O
previous	O
study	O
showed	O
that	O
overexpression	O
of	O
Notch1	O
could	O
inhibit	O
human	O
hepatocellular	O
carcinoma	O
(	O
HCC	O
)	O
cell	O
growth	O
by	O
arresting	O
the	O
cell	O
cycle	O
and	O
inducing	O
apoptosis	O
.	O

The	O
data	O
suggest	O
that	O
enhancement	O
of	O
TRAIL	O
-	O
induced	O
apoptosis	O
by	O
Notch1	O
signaling	O
is	O
dependent	O
upon	O
p53	O
up	O
-	O
regulation	O
.	O

Therefore	O
,	O
therapeutic	O
NF	O
-	O
kappaB	O
inhibitors	O
should	O
be	O
thoroughly	O
studied	O
before	O
their	O
clinical	O
use	O
in	O
treating	O
rheumatoid	O
arthritis	O
,	O
as	O
undesirable	O
genes	O
may	O
be	O
upregulated	O
through	O
unknown	O
mechanisms	O
,	O
possibly	O
resulting	O
in	O
worse	O
symptoms	O
.	O

Methylation	O
of	O
lysine	B-Chemical_Compound
9	E-Chemical_Compound
on	O
histone	O
H3	O
(	O
H3K9	O
)	O
is	O
widely	O
associated	O
with	O
transcriptional	O
silencing	O
,	O
and	O
its	O
disappearance	O
is	O
linked	O
to	O
the	O
activation	O
of	O
several	O
inflammatory	O
genes	O
by	O
NF	O
-	O
kappaB	O
.	O

NF	O
-	O
kappaB	O
essential	O
modulator	O
(	O
NEMO	O
)	O
caused	O
phosphorylation	O
and	O
stabilization	O
of	O
c	O
-	O
Myc	O
protein	O
in	O
the	O
nucleus	O
through	O
direct	O
interaction	O
.	O

Compared	O
to	O
the	O
classical	O
role	O
as	O
an	O
essential	O
subunit	O
for	O
the	O
activity	O
of	O
IKK	O
complex	O
,	O
stabilization	O
of	O
c	O
-	O
Myc	O
by	O
direct	O
interaction	O
is	O
a	O
unique	O
function	O
of	O
NEMO	O
,	O
representing	O
a	O
new	O
mechanism	O
to	O
regulate	O
c	O
-	O
Myc	O
activity	O
.	O

Moreover	O
,	O
nuclear	O
IRS	O
-	O
2	O
is	O
recruited	O
to	O
the	O
cyclin	O
D1	O
promoter	O
both	O
in	O
MCF	O
-	O
7	O
and	O
BT	O
-	O
20	O
cells	O
.	O

Angiotensin	O
II	O
(	O
Ang	O
II	O
)	O
is	O
a	O
major	O
vasoactive	O
peptide	O
of	O
the	O
renin	O
-	O
angiotensin	O
system	O
.	O

Most	O
of	O
the	O
known	O
pathophysiological	O
effects	O
of	O
Ang	O
II	O
are	O
mediated	O
through	O
Ang	O
type1	O
receptors	O
(	O
AT	O
(	O
1	O
)	O
Rs	O
)	O
,	O
and	O
the	O
up	O
-	O
regulation	O
of	O
AT	O
(	O
1	O
)	O
Rs	O
is	O
one	O
of	O
important	O
causes	O
by	O
which	O
Ang	O
II	O
can	O
contribute	O
to	O
cardiovascular	O
diseases	O
.	O

A	O
growing	O
body	O
of	O
evidence	O
has	O
suggested	O
that	O
reactive	B-Chemical_Compound
oxygen	I-Chemical_Compound
species	E-Chemical_Compound
(	O
ROS	S-Chemical_Compound
)	O
and	O
reactive	B-Chemical_Compound
nitrogen	I-Chemical_Compound
species	E-Chemical_Compound
(	O
RNS	S-Chemical_Compound
)	O
play	O
important	O
roles	O
in	O
the	O
regulation	O
of	O
AT	O
(	O
1	O
)	O
R	O
signaling	O
.	O

This	O
prevents	O
p65	O
from	O
binding	O
to	O
p300	O
,	O
impairs	O
p65	O
acetylation	O
,	O
and	O
attenuates	O
p65	O
binding	O
to	O
its	O
cognate	O
promoters	O
.	O

We	O
show	O
,	O
however	O
,	O
that	O
combined	O
inactivation	O
of	O
the	O
enhancer	O
AP	O
-	O
1	O
and	O
NF	O
-	O
kappaB	O
recognition	O
sites	O
leads	O
to	O
an	O
attenuation	O
of	O
the	O
hMCMV	O
-	O
ES	O
in	O
the	O
neonatal	O
murine	O
infection	O
model	O
,	O
not	O
observed	O
when	O
each	O
single	O
element	O
is	O
abolished	O
.	O

However	O
,	O
the	O
mechanisms	O
underlying	O
TGF	O
-	O
beta1	O
suppression	O
of	O
inflammation	O
remain	O
largely	O
unexplored	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrated	O
that	O
TGF	O
-	O
beta1	O
inhibited	O
TNF	O
-	O
alpha	O
-	O
or	O
IL	O
-	O
1	O
-	O
induced	O
RANTES	O
expression	O
in	O
human	O
kidney	O
tubular	O
epithelial	O
cells	O
(	O
HKC	O
-	O
8	O
)	O
.	O

We	O
found	O
that	O
TGF	O
-	O
beta1	O
induced	O
glycogen	O
synthase	O
kinase	O
-	O
3beta	O
(	O
GSK	O
-	O
3beta	O
)	O
phosphorylation	O
on	O
Ser	B-Chemical_Compound
-	I-Chemical_Compound
9	E-Chemical_Compound
in	O
HKC	O
-	O
8	O
cells	O
,	O
leading	O
to	O
its	O
inactivation	O
.	O

The	O
N	O
-	O
terminal	O
region	O
of	O
p65	O
is	O
necessary	O
for	O
both	O
the	O
interaction	O
with	O
Keap1	O
and	O
its	O
transcriptional	O
suppression	O
activity	O
.	O

However	O
,	O
the	O
functional	O
significance	O
of	O
Forkhead	O
Box	O
M1	O
transcription	O
factor	O
in	O
laryngeal	O
squamous	O
cell	O
carcinoma	O
and	O
the	O
correlation	O
between	O
Forkhead	O
Box	O
M1	O
transcription	O
factor	O
and	O
nuclear	O
factor	O
-	O
kappaB	O
remain	O
unclear	O
.	O

We	O
have	O
previously	O
shown	O
that	O
C	O
/	O
EBPalpha	O
or	O
its	O
AML	O
mutants	O
synergize	O
with	O
NF	O
-	O
kappaB	O
p50	O
to	O
activate	O
antiapoptotic	O
genes	O
,	O
including	O
BCL2	O
and	O
FLIP	O
.	O

Although	O
p50	O
homodimers	O
inhibit	O
transcription	O
,	O
C	O
/	O
EBPalpha	O
and	O
p50	O
synergistically	O
activate	O
antiapoptotic	O
genes	O
.	O

The	O
nuclear	O
factor	O
kappa	O
B	O
(	O
NF	O
-	O
kappaB	O
)	O
regulates	O
genes	O
that	O
function	O
in	O
diverse	O
cellular	O
processes	O
like	O
inflammation	O
,	O
immunity	O
and	O
cell	O
survival	O
.	O

Unlike	O
wild	O
-	O
type	O
optineurin	O
,	O
the	O
H486R	O
mutant	O
did	O
not	O
inhibit	O
tumour	O
necrosis	O
factor	O
alpha	O
(	O
TNFalpha	O
)	O
-	O
induced	O
NF	O
-	O
kappaB	O
activation	O
.	O

Identification	O
of	O
CD44	O
as	O
a	O
downstream	O
target	O
of	O
noncanonical	O
NF	O
-	O
kappaB	O
pathway	O
activated	O
by	O
human	O
T	O
-	O
cell	O
leukemia	O
virus	O
type	O
1	O
-	O
encoded	O
Tax	O
protein	O
.	O

Coimmunoprecipitation	O
experiments	O
in	O
cells	O
overexpressing	O
IL	O
-	O
33	O
or	O
endogenously	O
expressing	O
IL	O
-	O
33	O
revealed	O
rhIL	O
-	O
1beta	O
-	O
stimulated	O
association	O
between	O
IL	O
-	O
33	O
and	O
p65	O
,	O
whereas	O
binding	O
to	O
the	O
p50	O
subunit	O
was	O
constitutive	O
.	O

A	O
novel	O
kinase	O
inhibitor	O
of	O
FADD	O
phosphorylation	O
chemosensitizes	O
through	O
the	O
inhibition	O
of	O
NF	O
-	O
kappaB	O
.	O

It	O
has	O
also	O
been	O
implicated	O
in	O
a	O
number	O
of	O
nonapoptotic	O
activities	O
including	O
embryogenesis	O
,	O
cell	O
-	O
cycle	O
progression	O
,	O
cell	O
proliferation	O
,	O
and	O
tumorigenesis	O
.	O

Further	O
,	O
key	O
acidic	O
residues	O
Glu	B-Chemical_Compound
(	I-Chemical_Compound
6	I-Chemical_Compound
)	E-Chemical_Compound
,	O
Asp	B-Chemical_Compound
(	I-Chemical_Compound
8	I-Chemical_Compound
)	E-Chemical_Compound
,	O
and	O
Glu	B-Chemical_Compound
(	I-Chemical_Compound
16	I-Chemical_Compound
)	E-Chemical_Compound
,	O
believed	O
critical	O
for	O
Pyrin	O
/	O
Pyrin	O
domain	O
interaction	O
,	O
are	O
important	O
for	O
inflammasome	O
inhibition	O
.	O

PPARgamma	O
and	O
NF	O
-	O
kappaB	O
regulate	O
the	O
gene	O
promoter	O
activity	O
of	O
their	O
shared	O
repressor	O
,	O
TNIP1	O
.	O

Human	O
TNFAIP3	O
interacting	O
protein	O
1	O
(	O
TNIP1	O
)	O
has	O
diverse	O
functions	O
including	O
support	O
of	O
HIV	O
replication	O
through	O
its	O
interaction	O
with	O
viral	O
Nef	O
and	O
matrix	O
proteins	O
,	O
reduction	O
of	O
TNFalpha	O
-	O
induced	O
signaling	O
through	O
its	O
interaction	O
with	O
NF	O
-	O
kappaB	O
pathway	O
proteins	O
,	O
and	O
corepression	O
of	O
agonist	O
-	O
bound	O
retinoic	O
acid	O
receptors	O
and	O
peroxisome	O
proliferator	O
-	O
activated	O
receptors	O
(	O
PPAR	O
)	O
.	O

Attempts	O
to	O
elucidate	O
whether	O
interactions	O
between	O
Sp1	O
/	O
Sp3	O
/	O
c	O
-	O
Krox	O
and	O
p65	O
are	O
necessary	O
to	O
mediate	O
the	O
NF	O
-	O
kappaB	O
inhibitory	O
effect	O
on	O
COL1A1	O
in	O
ANF	O
and	O
SF	O
were	O
carried	O
out	O
;	O
in	O
this	O
regard	O
,	O
immunoprecipitation	O
assays	O
revealed	O
that	O
they	O
interact	O
,	O
and	O
this	O
was	O
validated	O
by	O
re	O
-	O
ChIP	O
.	O

These	O
results	O
identify	O
a	O
role	O
for	O
Erg	O
as	O
a	O
gatekeeper	O
controlling	O
vascular	O
inflammation	O
,	O
thus	O
providing	O
an	O
important	O
barrier	O
to	O
protect	O
against	O
inappropriate	O
endothelial	O
activation	O
.	O

Experimental	O
comparison	O
with	O
such	O
stabilized	O
mutants	O
helps	O
provide	O
evidence	O
that	O
much	O
of	O
the	O
system	O
control	O
depends	O
on	O
the	O
"	O
fuzziness	O
"	O
of	O
IkappaBalpha	O
.	O

Suppression	O
of	O
the	O
interferon	O
and	O
NF	O
-	O
kappaB	O
responses	O
by	O
severe	O
fever	O
with	O
thrombocytopenia	O
syndrome	O
virus	O
.	O

Although	O
the	O
viral	O
pathogenesis	O
remains	O
largely	O
unknown	O
,	O
hemopoietic	O
cells	O
appear	O
to	O
be	O
targeted	O
by	O
the	O
virus	O
.	O

Association	O
of	O
initiation	O
factor	O
eIF	O
-	O
4E	O
in	O
a	O
cap	O
binding	O
protein	O
complex	O
(	O
eIF	O
-	O
4F	O
)	O
is	O
critical	O
for	O
and	O
enhances	O
phosphorylation	O
by	O
protein	O
kinase	O
C	O
.	O

With	O
purified	O
eIF	O
-	O
4E	O
,	O
using	O
the	O
same	O
conditions	O
,	O
up	O
to	O
0	O
.	O
1	O
mol	O
of	O
phosphate	S-Chemical_Compound
can	O
be	O
incorporated	O
.	O

We	O
report	O
here	O
the	O
isolation	O
of	O
cDNA	O
clones	O
coding	O
for	O
the	O
beta	O
-	O
subunit	O
of	O
prolyl	O
4	O
-	O
hydroxylase	O
from	O
a	O
human	O
hepatoma	O
lambda	O
gt11	O
library	O
and	O
a	O
corresponding	O
human	O
placenta	O
library	O
.	O

Southern	O
blot	O
analyses	O
of	O
human	O
genomic	O
DNA	O
with	O
a	O
cDNA	O
probe	O
for	O
the	O
beta	O
-	O
subunit	O
indicated	O
the	O
presence	O
of	O
only	O
one	O
gene	O
containing	O
these	O
sequences	O
.	O

This	O
enzyme	O
also	O
converted	O
GlcA	B-Chemical_Compound
(	I-Chemical_Compound
2	I-Chemical_Compound
-	I-Chemical_Compound
SO4	I-Chemical_Compound
)	I-Chemical_Compound
-	I-Chemical_Compound
[	I-Chemical_Compound
3H	I-Chemical_Compound
]	I-Chemical_Compound
ATalR	I-Chemical_Compound
(	I-Chemical_Compound
6	I-Chemical_Compound
-	I-Chemical_Compound
SO4	I-Chemical_Compound
)	E-Chemical_Compound
to	O
a	O
mixture	O
of	O
GlcA	B-Chemical_Compound
-	I-Chemical_Compound
[	I-Chemical_Compound
3H	I-Chemical_Compound
]	I-Chemical_Compound
ATalR	I-Chemical_Compound
(	I-Chemical_Compound
6	I-Chemical_Compound
-	I-Chemical_Compound
SO4	I-Chemical_Compound
)	E-Chemical_Compound
and	O
[	B-Chemical_Compound
3H	I-Chemical_Compound
]	I-Chemical_Compound
ATalR	I-Chemical_Compound
(	I-Chemical_Compound
6	I-Chemical_Compound
-	I-Chemical_Compound
SO4	I-Chemical_Compound
)	E-Chemical_Compound
.	O

The	O
glucurono	O
-	O
2	O
-	O
sulfatase	O
exhibited	O
a	O
pH	O
optimum	O
of	O
4	O
.	O

This	O
nim1	O
-	O
dependent	O
inhibition	O
of	O
the	O
wee1	O
protein	O
kinase	O
can	O
be	O
reversed	O
readily	O
in	O
vitro	O
by	O
treatment	O
with	O
a	O
protein	O
phosphatase	O
.	O

These	O
experiments	O
provide	O
direct	O
biochemical	O
evidence	O
that	O
the	O
wee1	O
protein	O
is	O
subject	O
to	O
negative	O
regulation	O
by	O
phosphorylation	O
and	O
indicate	O
that	O
the	O
nim1	O
protein	O
acts	O
as	O
an	O
inhibitory	O
,	O
wee1	O
-	O
specific	O
kinase	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
a	O
second	O
subunit	O
of	O
the	O
interleukin	O
1	O
receptor	O
complex	O
.	O

A	O
monoclonal	O
antibody	O
(	O
mAb	O
)	O
was	O
isolated	O
that	O
blocked	O
the	O
binding	O
and	O
bioactivity	O
of	O
both	O
human	O
and	O
murine	O
interleukin	O
1	O
beta	O
(	O
IL	O
-	O
1	O
beta	O
)	O
on	O
murine	O
IL	O
-	O
1	O
receptor	O
-	O
bearing	O
cells	O
.	O

In	O
mammalian	O
cells	O
expressing	O
natural	O
or	O
recombinant	O
Type	O
I	O
IL	O
-	O
1R	O
and	O
IL	O
-	O
1R	O
AcP	O
,	O
the	O
accessory	O
protein	O
forms	O
a	O
complex	O
with	O
the	O
Type	O
I	O
IL	O
-	O
1R	O
and	O
either	O
IL	O
-	O
1	O
alpha	O
or	O
IL	O
-	O
1	O
beta	O
but	O
not	O
IL	O
-	O
1ra	O
.	O

In	O
addition	O
,	O
PI	O
3	O
-	O
kinase	O
activity	O
immunoprecipitated	O
from	O
cell	O
lysates	O
with	O
anti	O
-	O
p85	O
antibody	O
was	O
stimulated	O
2	O
-	O
4	O
-	O
fold	O
by	O
GST	O
-	O
Cdc42	O
-	O
GTP	O
gamma	O
S	O
.	O

Two	O
extended	O
regions	O
of	O
significant	O
sequence	O
homology	O
with	O
hormone	O
-	O
sensitive	O
lipase	O
and	O
with	O
lipase	O
2	O
from	O
Moraxella	O
TA144	O
were	O
identified	O
,	O
whereas	O
similarity	O
to	O
carboxyl	O
esterases	O
was	O
restricted	O
to	O
the	O
region	O
encompassing	O
the	O
putative	O
active	O
site	O
,	O
indicating	O
that	O
DAC	O
should	O
be	O
classified	O
as	O
esterase	O
.	O

Normal	O
progression	O
through	O
G1	O
is	O
promoted	O
by	O
the	O
activity	O
of	O
the	O
cyclin	O
-	O
dependent	O
protein	O
kinases	O
CDK4	O
and	O
CDK6	O
(	O
ref	O
.	O
2	O
)	O
,	O
which	O
are	O
inhibited	O
by	O
the	O
protein	O
p16INK4	O
.	O

These	O
proteins	O
were	O
released	O
from	O
this	O
complex	O
capable	O
,	O
in	O
the	O
case	O
of	O
tubulin	O
,	O
of	O
forming	O
heterodimers	O
.	O

Replacement	O
of	O
these	O
phosphorylation	O
sites	O
with	O
Ala	S-Chemical_Compound
residues	O
caused	O
a	O
marked	O
decrease	O
in	O
Myc	O
-	O
stimulated	O
reporter	O
gene	O
expression	O
.	O

Deletion	O
analysis	O
of	O
the	O
SWI4	O
promoter	O
has	O
defined	O
a	O
140	O
-	O
bp	O
region	O
which	O
is	O
absolutely	O
required	O
for	O
transcription	O
and	O
can	O
function	O
as	O
a	O
cell	O
cycle	O
-	O
regulated	O
upstream	O
activating	O
sequence	O
(	O
UAS	O
)	O
.	O

The	O
SWI4	O
UAS	O
contains	O
three	O
potential	O
MluI	O
cell	O
cycle	O
boxes	O
(	O
MCBs	O
)	O
,	O
which	O
are	O
known	O
cell	O
cycle	O
-	O
regulated	O
promoter	O
elements	O
.	O

It	O
also	O
suggests	O
that	O
there	O
is	O
another	O
pathway	O
which	O
can	O
activate	O
SWI4	O
transcription	O
in	O
the	O
absence	O
of	O
SWI6	O
.	O

The	O
second	O
activator	O
may	O
also	O
target	O
MCB	O
elements	O
,	O
since	O
SWI4	O
transcription	O
drops	O
dramatically	O
when	O
they	O
are	O
deleted	O
.	O

PLD1	O
likely	O
encodes	O
the	O
gene	O
product	O
responsible	O
for	O
the	O
most	O
widely	O
studied	O
endogenous	O
PLD	O
activity	O
.	O

Electrophysiological	O
studies	O
reveal	O
that	O
Pi	S-Chemical_Compound
transport	O
by	O
Na	O
/	O
Pi	O
cotransporters	O
is	O
electrogenic	O
.	O

Cloning	O
and	O
expression	O
of	O
the	O
adenosine	O
kinase	O
gene	O
from	O
rat	O
and	O
human	O
tissues	O
.	O

We	O
have	O
expressed	O
both	O
forms	O
in	O
E	O
.	O
coli	O
and	O
produced	O
soluble	O
active	O
enzyme	O
which	O
catalyzes	O
the	O
phosphorylation	O
of	O
adenosine	S-Chemical_Compound
with	O
high	O
specific	O
activity	O
in	O
vitro	O
and	O
is	O
susceptible	O
to	O
known	O
adenosine	O
kinase	O
inhibitors	O
.	O

However	O
,	O
when	O
lipids	S-Chemical_Compound
were	O
presented	O
together	O
with	O
phosphatidylserine	S-Chemical_Compound
acting	O
as	O
a	O
carrier	O
,	O
phosphorylation	O
of	O
PtdIns	B-Chemical_Compound
(	I-Chemical_Compound
4	I-Chemical_Compound
,	I-Chemical_Compound
5	I-Chemical_Compound
)	I-Chemical_Compound
P2	E-Chemical_Compound
was	O
also	O
observed	O
.	O

This	O
region	O
,	O
along	O
with	O
an	O
adjoining	O
strip	O
of	O
basic	O
residues	O
,	O
appear	O
to	O
constitute	O
the	O
membrane	O
binding	O
motif	O
.	O

Trx	O
associated	O
with	O
the	O
N	O
-	O
terminal	O
portion	O
of	O
ASK1	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

The	O
interaction	O
between	O
Trx	O
and	O
ASK1	O
was	O
found	O
to	O
be	O
highly	O
dependent	O
on	O
the	O
redox	O
status	O
of	O
Trx	O
.	O

Activation	O
of	O
the	O
ATM	O
kinase	O
by	O
ionizing	O
radiation	O
and	O
phosphorylation	O
of	O
p53	O
.	O

To	O
determine	O
the	O
potential	O
in	O
vivo	O
targets	O
of	O
the	O
p19	O
(	O
SKP1	O
)	O
/	O
p45	O
(	O
SKP2	O
)	O
/	O
CUL	O
-	O
1	O
complex	O
,	O
we	O
have	O
used	O
the	O
specific	O
antisense	O
oligodeoxynucleotides	O
against	O
either	O
SKP1	O
,	O
SKP2	O
,	O
or	O
CUL	O
-	O
1	O
RNA	O
to	O
inhibit	O
their	O
expression	O
.	O

Nuclear	O
export	O
of	O
the	O
stress	O
-	O
activated	O
protein	O
kinase	O
p38	O
mediated	O
by	O
its	O
substrate	O
MAPKAP	O
kinase	O
-	O
2	O
.	O

glc7	O
-	O
10	O
mutant	O
cells	O
exhibit	O
low	O
kinetochore	O
-	O
microtubule	O
binding	O
activity	O
in	O
vitro	O
and	O
a	O
high	O
frequency	O
of	O
chromosome	O
loss	O
in	O
vivo	O
.	O

Furthermore	O
,	O
addition	O
of	O
recombinant	O
Ndc10p	O
reconstitutes	O
the	O
microtubule	O
-	O
binding	O
activity	O
of	O
a	O
glc7	O
-	O
10	O
extract	O
to	O
wild	O
-	O
type	O
levels	O
.	O

We	O
also	O
report	O
here	O
on	O
the	O
structural	O
organization	O
and	O
chromosomal	O
localization	O
of	O
the	O
human	O
SMVT	O
gene	O
.	O

Aldose	O
reductase	O
,	O
a	O
key	O
enzyme	O
in	O
the	O
oxidative	O
deamination	O
of	O
norepinephrine	S-Chemical_Compound
in	O
rats	O
.	O

The	O
present	O
study	O
confirmed	O
that	O
aldose	O
reductase	O
generates	O
DHPG	S-Chemical_Compound
from	O
NE	S-Chemical_Compound
in	O
the	O
presence	O
of	O
MAO	O
.	O

Phosphorylation	O
of	O
deoxycytidine	S-Chemical_Compound
analogs	O
by	O
cellular	O
enzymes	O
is	O
a	O
prerequisite	O
for	O
the	O
activity	O
of	O
these	O
compounds	O
.	O

Thus	O
,	O
Hsl1	O
and	O
Hsl7	O
promote	O
proper	O
timing	O
of	O
cell	O
cycle	O
progression	O
by	O
coupling	O
septin	O
ring	O
assembly	O
to	O
alleviation	O
of	O
Swe1	O
-	O
dependent	O
inhibition	O
of	O
Cdc28	O
.	O

TLR2	O
-	O
deficient	O
macrophages	O
were	O
hyporesponsive	O
to	O
several	O
Gram	O
-	O
positive	O
bacterial	O
cell	O
walls	O
as	O
well	O
as	O
Staphylococcus	O
aureus	O
peptidoglycan	S-Chemical_Compound
.	O

Phosphorylation	O
studies	O
suggested	O
that	O
the	O
stimulatory	O
effect	O
of	O
both	O
GTPase	O
and	O
sphingosine	S-Chemical_Compound
results	O
in	O
exposure	O
of	O
the	O
activation	O
loop	O
,	O
making	O
it	O
accessible	O
for	O
intermolecular	O
phosphorylation	O
.	O

Whereas	O
the	O
transcription	O
of	O
an	O
active	O
allele	O
was	O
markedly	O
induced	O
by	O
serum	O
starvation	O
or	O
clump	O
formation	O
of	O
the	O
cells	O
,	O
treatment	O
with	O
5	B-Chemical_Compound
-	I-Chemical_Compound
aza	I-Chemical_Compound
-	I-Chemical_Compound
2	I-Chemical_Compound
'	I-Chemical_Compound
deoxycytidine	E-Chemical_Compound
activated	O
a	O
silent	O
allele	O
with	O
a	O
subsequent	O
up	O
-	O
regulation	O
of	O
an	O
active	O
allele	O
,	O
supporting	O
the	O
genomic	O
imprinting	O
and	O
autoregulation	O
of	O
the	O
gene	O
.	O

This	O
phenomenon	O
was	O
also	O
seen	O
with	O
high	O
concentrations	O
of	O
some	O
preparations	O
of	O
LPS	S-Chemical_Compound
.	O

Since	O
the	O
natural	O
site	O
of	O
herpesvirus	O
latency	O
is	O
in	O
neurons	O
,	O
we	O
investigated	O
the	O
status	O
of	O
ND10	O
and	O
centromeres	O
in	O
uninfected	O
and	O
infected	O
human	O
cells	O
with	O
neuronal	O
characteristics	O
.	O

Furthermore	O
,	O
the	O
ability	O
of	O
ICP0	O
to	O
activate	O
gene	O
expression	O
in	O
transfection	O
assays	O
in	O
NT2	O
cells	O
was	O
poor	O
compared	O
to	O
Vero	O
cells	O
.	O

We	O
report	O
here	O
for	O
the	O
first	O
time	O
,	O
that	O
the	O
SV40	O
small	O
t	O
-	O
antigen	O
inhibits	O
mammary	O
gland	O
differentiation	O
during	O
mid	O
-	O
pregnancy	O
and	O
that	O
about	O
10	O
%	O
of	O
multiparous	O
WAP	O
-	O
SVt	O
transgenic	O
animals	O
develop	O
breast	O
tumors	O
with	O
latencies	O
ranging	O
from	O
10	O
-	O
17	O
months	O
.	O

TRAF6	O
is	O
a	O
signal	O
transducer	O
that	O
activates	O
IkappaB	O
kinase	O
(	O
IKK	O
)	O
and	O
Jun	O
amino	O
-	O
terminal	O
kinase	O
(	O
JNK	O
)	O
in	O
response	O
to	O
pro	O
-	O
inflammatory	O
mediators	O
such	O
as	O
interleukin	O
-	O
1	O
(	O
IL	O
-	O
1	O
)	O
and	O
lipopolysaccharides	S-Chemical_Compound
(	O
LPS	S-Chemical_Compound
)	O
.	O

This	O
Ubc	O
complex	O
,	O
together	O
with	O
TRAF6	O
,	O
catalyses	O
the	O
formation	O
of	O
a	O
Lys	B-Chemical_Compound
63	E-Chemical_Compound
(	O
K63	S-Chemical_Compound
)	O
-	O
linked	O
polyubiquitin	O
chain	O
that	O
mediates	O
IKK	O
activation	O
through	O
a	O
unique	O
proteasome	O
-	O
independent	O
mechanism	O
.	O

We	O
find	O
that	O
the	O
TAK1	O
kinase	O
complex	O
phosphorylates	O
and	O
activates	O
IKK	O
in	O
a	O
manner	O
that	O
depends	O
on	O
TRAF6	O
and	O
Ubc13	O
-	O
Uev1A	O
.	O

Moreover	O
,	O
the	O
activity	O
of	O
TAK1	O
to	O
phosphorylate	O
MKK6	O
,	O
which	O
activates	O
the	O
JNK	O
-	O
p38	O
kinase	O
pathway	O
,	O
is	O
directly	O
regulated	O
by	O
K63	S-Chemical_Compound
-	O
linked	O
polyubiquitination	O
.	O

Lysine	B-Chemical_Compound
9	E-Chemical_Compound
of	O
histone	O
H3	O
is	O
methylated	O
by	O
SUV39H1	O
(	O
ref	O
.	O
2	O
)	O
,	O
creating	O
a	O
binding	O
site	O
for	O
the	O
chromo	O
domain	O
of	O
HP1	O
(	O
refs	O
3	O
,	O
4	O
)	O
.	O

Cytokines	O
often	O
deliver	O
simultaneous	O
,	O
yet	O
distinct	O
,	O
cell	O
growth	O
and	O
cell	O
survival	O
signals	O
.	O

Thus	O
,	O
p70S6K	O
is	O
itself	O
a	O
dual	O
pathway	O
kinase	O
,	O
signaling	O
cell	O
survival	O
as	O
well	O
as	O
growth	O
through	O
differential	O
substrates	O
which	O
include	O
mitochondrial	O
BAD	O
and	O
the	O
ribosomal	O
subunit	O
S6	O
,	O
respectively	O
.	O

The	O
NF	O
-	O
kappa	O
B	O
transcription	O
factor	O
regulates	O
genes	O
involved	O
in	O
apoptotic	O
,	O
immune	O
,	O
and	O
inflammatory	O
responses	O
.	O

In	O
contrast	O
,	O
DFMO	S-Chemical_Compound
had	O
no	O
effect	O
on	O
a	O
gene	O
reporter	O
construct	O
dependent	O
on	O
the	O
kappa	O
B	O
site	O
present	O
in	O
the	O
interleukin	O
-	O
8	O
gene	O
.	O

Moreover	O
,	O
an	O
additional	O
functional	O
NLS	O
was	O
mapped	O
within	O
the	O
unique	O
Loop	O
region	O
of	O
p130	O
.	O

At	O
the	O
rDNA	O
repeats	O
,	O
we	O
show	O
that	O
histone	O
H3	O
and	O
H4	O
tails	O
are	O
required	O
for	O
silencing	O
and	O
rDNA	O
-	O
associated	O
H4	O
is	O
hypoacetylated	O
in	O
a	O
Sir2	O
-	O
dependent	O
manner	O
.	O

LiCl	S-Chemical_Compound
,	O
an	O
established	O
inhibitor	O
of	O
GSK	O
-	O
3	O
,	O
sensitized	O
primary	O
rat	O
hepatocytes	O
toward	O
TNF	O
-	O
alpha	O
-	O
mediated	O
apoptosis	O
resulting	O
in	O
90	O
%	O
cell	O
death	O
after	O
24	O
h	O
.	O

An	O
E2F	O
-	O
binding	O
site	O
mediates	O
the	O
activation	O
of	O
the	O
proliferative	O
isoform	O
of	O
6	O
-	O
phosphofructo	O
-	O
2	O
-	O
kinase	O
/	O
fructose	O
-	O
2	O
,	O
6	O
-	O
bisphosphatase	O
by	O
phosphatidylinositol	O
3	O
-	O
kinase	O
.	O

We	O
found	O
that	O
the	O
predominant	O
E2F	O
complex	O
bound	O
to	O
the	O
F	O
-	O
type	O
promoter	O
in	O
unstimulated	O
/	O
quiescent	O
cells	O
contains	O
E2F4	O
,	O
DP1	O
and	O
p130	O
proteins	O
.	O

Using	O
the	O
Rat	O
-	O
1	O
ER	O
-	O
E2F1	O
cell	O
line	O
where	O
E2F1	O
activity	O
can	O
be	O
conditionally	O
induced	O
,	O
we	O
demonstrated	O
that	O
E2F	O
activity	O
is	O
involved	O
in	O
the	O
in	O
vivo	O
transcriptional	O
regulation	O
of	O
the	O
F	O
-	O
type	O
6PF2K	O
/	O
Fru	O
-	O
2	O
,	O
6	O
-	O
BPase	O
gene	O
.	O

Two	O
TOR	O
complexes	O
,	O
only	O
one	O
of	O
which	O
is	O
rapamycin	S-Chemical_Compound
sensitive	O
,	O
have	O
distinct	O
roles	O
in	O
cell	O
growth	O
control	O
.	O

TORC1	O
and	O
possibly	O
TORC2	O
are	O
conserved	O
from	O
yeast	O
to	O
man	O
.	O

Subtle	O
differences	O
in	O
TLR	O
signaling	O
pathways	O
are	O
now	O
becoming	O
apparent	O
,	O
which	O
reveal	O
how	O
the	O
innate	O
immune	O
system	O
decides	O
at	O
a	O
very	O
early	O
stage	O
the	O
direction	O
in	O
which	O
the	O
adaptive	O
immune	O
response	O
will	O
develop	O
.	O

Patients	O
with	O
NAGS	O
deficiency	O
develop	O
hyperammonemia	O
because	O
CPSI	O
is	O
inactive	O
without	O
NAG	S-Chemical_Compound
.	O

Given	O
that	O
both	O
the	O
ATR	O
and	O
Rad9	O
-	O
Rad1	O
-	O
Hus1	O
complexes	O
are	O
involved	O
in	O
Chk1	O
activation	O
,	O
it	O
is	O
possible	O
that	O
Claspin	O
works	O
as	O
an	O
adaptor	O
molecule	O
bringing	O
these	O
molecules	O
together	O
.	O

Here	O
we	O
provide	O
evidence	O
that	O
in	O
B	O
cells	O
Cbl	O
-	O
b	O
functions	O
as	O
a	O
negative	O
regulator	O
of	O
B	O
cell	O
antigen	O
receptor	O
(	O
BCR	O
)	O
signaling	O
during	O
the	O
normal	O
course	O
of	O
a	O
response	O
.	O

The	O
complex	O
promotes	O
activation	O
of	O
downstream	O
caspase	O
cascade	O
and	O
induces	O
degradation	O
of	O
IkappaBalpha	O
.	O

To	O
date	O
,	O
more	O
than	O
70	O
proteins	O
have	O
been	O
identified	O
to	O
be	O
substrates	O
of	O
caspases	O
in	O
mammalian	O
cells	O
.	O

Activation	O
of	O
the	O
Wnt	O
pathway	O
results	O
in	O
stabilization	O
of	O
the	O
transcriptional	O
coactivator	O
beta	O
-	O
catenin	O
.	O

A	O
single	O
dose	O
of	O
DEN	S-Chemical_Compound
induced	O
a	O
centrilobular	O
p53	O
response	O
that	O
peaked	O
at	O
24	O
h	O
.	O

The	O
data	O
support	O
the	O
hypothesis	O
that	O
EAF	O
hepatocytes	O
are	O
initiated	O
via	O
epigenetic	O
mechanisms	O
.	O

Consistent	O
with	O
a	O
role	O
of	O
this	O
phosphatase	O
on	O
cell	O
wall	O
physiology	O
,	O
cells	O
lacking	O
Msg5	O
displayed	O
an	O
increased	O
sensitivity	O
to	O
the	O
cell	O
wall	O
-	O
interfering	O
compound	O
Congo	B-Chemical_Compound
Red	E-Chemical_Compound
.	O

Under	O
activating	O
conditions	O
,	O
a	O
decrease	O
in	O
the	O
affinity	O
between	O
Msg5	O
and	O
Slt2	O
was	O
observed	O
,	O
leading	O
us	O
to	O
suggest	O
that	O
the	O
mechanism	O
by	O
which	O
Slt2	O
controls	O
the	O
action	O
of	O
Msg5	O
was	O
via	O
the	O
modulation	O
of	O
protein	O
-	O
protein	O
interactions	O
.	O

Histones	O
H3	O
and	O
H4	O
simultaneously	O
become	O
hyperacetylated	O
,	O
but	O
it	O
remains	O
unclear	O
whether	O
this	O
is	O
a	O
prerequisite	O
or	O
a	O
consequence	O
of	O
E2F	O
binding	O
.	O

In	O
our	O
hands	O
,	O
ectopically	O
expressed	O
E2F1	O
also	O
bound	O
the	O
unrelated	O
HAT	O
Tip60	O
and	O
induced	O
recruitment	O
of	O
five	O
subunits	O
of	O
the	O
Tip60	O
complex	O
(	O
Tip60	O
,	O
TRRAP	O
,	O
p400	O
,	O
Tip48	O
,	O
and	O
Tip49	O
)	O
to	O
target	O
promoters	O
in	O
vivo	O
.	O

Delayed	O
gammaH2AX	O
phosphorylation	O
and	O
absence	O
of	O
ATM	O
autophosphorylation	O
at	O
Ser1981	S-Chemical_Compound
suggest	O
that	O
E2F1	O
stimulates	O
ATM	O
through	O
a	O
unique	O
mechanism	O
that	O
is	O
distinct	O
from	O
agents	O
that	O
cause	O
DNA	O
double	O
-	O
strand	O
breaks	O
.	O

In	O
this	O
study	O
,	O
we	O
showed	O
that	O
the	O
transcription	O
of	O
human	O
MCM10	O
and	O
TopBP1	O
is	O
activated	O
by	O
transcription	O
factors	O
E2F1	O
-	O
3	O
,	O
but	O
not	O
by	O
factors	O
E2F4	O
-	O
7	O
.	O

Fibroblast	O
growth	O
factor	O
receptor	O
1	O
(	O
FGFR1	O
)	O
gene	O
expression	O
is	O
positively	O
and	O
negatively	O
regulated	O
during	O
muscle	O
differentiation	O
.	O

We	O
recently	O
reported	O
that	O
FGFR1	O
gene	O
expression	O
was	O
up	O
-	O
regulated	O
by	O
Sp	O
transcription	O
factors	O
in	O
proliferating	O
myoblasts	O
.	O

The	O
physiological	O
and	O
pathological	O
roles	O
of	O
RIP2	O
are	O
mediated	O
through	O
its	O
involvement	O
in	O
multiple	O
NF	O
-	O
kappaB	O
activation	O
pathways	O
,	O
including	O
those	O
triggered	O
by	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)	O
,	O
interleukin	O
1	O
(	O
IL	O
-	O
1	O
)	O
,	O
Toll	O
-	O
like	O
receptor	O
2	O
(	O
TLR2	O
)	O
,	O
TLR3	O
,	O
TLR4	O
and	O
Nod1	O
.	O

Although	O
there	O
is	O
ample	O
evidence	O
that	O
p21	O
induction	O
by	O
p53	O
leads	O
to	O
Cdk2	O
inhibition	O
,	O
it	O
is	O
unclear	O
whether	O
this	O
checkpoint	O
event	O
also	O
leads	O
to	O
Cdk4	O
inhibition	O
.	O

The	O
induced	O
p21	O
binds	O
to	O
both	O
the	O
Cdk4	O
/	O
cyclin	O
D	O
and	O
Cdk2	O
/	O
cyclin	O
E	O
complexes	O
and	O
inhibits	O
both	O
of	O
their	O
kinase	O
activities	O
.	O

Together	O
,	O
these	O
findings	O
establish	O
that	O
activation	O
of	O
the	O
p53	O
-	O
p21	O
pathway	O
is	O
responsible	O
for	O
the	O
DAP	S-Chemical_Compound
-	O
induced	O
G	O
(	O
1	O
)	O
-	O
phase	O
checkpoint	O
response	O
and	O
provide	O
the	O
first	O
solid	O
evidence	O
that	O
p21	O
induction	O
by	O
p53	O
during	O
a	O
DNA	O
damage	O
-	O
induced	O
G	O
(	O
1	O
)	O
-	O
phase	O
checkpoint	O
response	O
inhibits	O
both	O
Cdk4	O
and	O
Cdk2	O
activities	O
.	O

E2F	O
transcription	O
factors	O
play	O
a	O
pivotal	O
role	O
in	O
the	O
regulation	O
of	O
cellular	O
proliferation	O
and	O
can	O
be	O
subdivided	O
into	O
activating	O
and	O
repressing	O
family	O
members	O
[	O
1	O
]	O
.	O

Initiation	O
of	O
DNA	O
damage	O
signals	O
causes	O
the	O
release	O
of	O
Crt1	O
and	O
Ssn6	O
-	O
Tup1	O
from	O
the	O
promoter	O
,	O
coactivator	O
recruitment	O
,	O
and	O
derepression	O
of	O
transcription	O
,	O
indicating	O
that	O
Crt1	O
plays	O
a	O
crucial	O
role	O
in	O
the	O
switch	O
between	O
gene	O
repression	O
and	O
activation	O
.	O

In	O
addition	O
,	O
we	O
identified	O
a	O
C	O
-	O
terminal	O
repression	O
domain	O
,	O
which	O
is	O
independent	O
of	O
Ssn6	O
-	O
Tup1	O
and	O
HDACs	O
and	O
functions	O
at	O
native	O
genes	O
in	O
vivo	O
.	O

Dietary	O
heme	S-Chemical_Compound
iron	S-Chemical_Compound
is	O
an	O
important	O
nutritional	O
source	O
of	O
iron	S-Chemical_Compound
in	O
carnivores	O
and	O
omnivores	O
that	O
is	O
more	O
readily	O
absorbed	O
than	O
non	O
-	O
heme	S-Chemical_Compound
iron	S-Chemical_Compound
derived	O
from	O
vegetables	O
and	O
grain	O
.	O

We	O
show	O
that	O
GSK3beta	O
/	O
Axin	O
complexes	O
are	O
rapidly	O
(	O
t1	O
/	O
2	O
<	O
3	O
min	O
)	O
disrupted	O
upon	O
Wnt	O
stimulation	O
and	O
that	O
changes	O
in	O
GSK3beta	O
/	O
Axin	O
association	O
substantially	O
precede	O
both	O
beta	O
-	O
catenin	O
stabilization	O
and	O
Axin	O
degradation	O
.	O

Kinetic	O
analysis	O
demonstrated	O
that	O
autophosphorylation	O
results	O
in	O
a	O
more	O
than	O
9	O
-	O
fold	O
increase	O
in	O
protein	O
kinase	O
activity	O
.	O

Autophosphorylation	O
was	O
Rad53	O
concentration	O
-	O
dependent	O
,	O
indicating	O
that	O
the	O
reaction	O
follows	O
an	O
intermolecular	O
mechanism	O
.	O

In	O
contrast	O
to	O
previous	O
studies	O
in	O
which	O
components	O
of	O
the	O
growth	O
factor	O
signalling	O
pathways	O
were	O
overexpressed	O
,	O
hdm2	O
mRNA	O
expression	O
is	O
not	O
induced	O
with	O
immediate	O
-	O
early	O
kinetics	O
in	O
these	O
cells	O
.	O

Phosphorylation	O
of	O
the	O
chromosomal	O
passenger	O
protein	O
Bir1	O
is	O
required	O
for	O
localization	O
of	O
Ndc10	O
to	O
the	O
spindle	O
during	O
anaphase	O
and	O
full	O
spindle	O
elongation	O
.	O

Here	O
we	O
report	O
that	O
,	O
in	O
contrast	O
to	O
uninfected	O
cells	O
,	O
mdm2	O
was	O
undetectable	O
upon	O
treatment	O
of	O
infected	O
fibroblasts	O
with	O
the	O
proteasome	O
inhibitor	O
MG132	S-Chemical_Compound
.	O

Short	O
interfering	O
RNA	O
-	O
mediated	O
depletion	O
of	O
IE2	O
-	O
86	O
restored	O
the	O
ability	O
of	O
HCMV	O
-	O
infected	O
cells	O
to	O
accumulate	O
mdm2	O
in	O
response	O
to	O
proteasome	O
inhibition	O
.	O

Loss	O
of	O
tuberin	O
,	O
the	O
product	O
of	O
TSC2	O
gene	O
,	O
increases	O
mammalian	O
target	O
of	O
rapamycin	O
(	O
mTOR	O
)	O
signaling	O
,	O
promoting	O
cell	O
growth	O
and	O
tumor	O
development	O
.	O

Thus	O
,	O
tuberin	O
bound	O
by	O
14	O
-	O
3	O
-	O
3	O
in	O
response	O
to	O
AKT	O
phosphorylation	O
is	O
sequestered	O
away	O
from	O
its	O
membrane	O
-	O
bound	O
activation	O
partner	O
(	O
hamartin	O
)	O
and	O
its	O
target	O
GTPase	O
(	O
Rheb	O
)	O
to	O
relieve	O
the	O
growth	O
inhibitory	O
effects	O
of	O
this	O
tumor	O
suppressor	O
.	O

p21	O
induction	O
leads	O
to	O
increased	O
p21	O
complex	O
formation	O
with	O
cyclin	O
E	O
/	O
CDK2	O
,	O
which	O
occurs	O
when	O
cyclin	O
E	O
and	O
CDK2	O
levels	O
remain	O
constant	O
.	O

Cdk	O
-	O
inhibitory	O
activity	O
and	O
stability	O
of	O
p27Kip1	O
are	O
directly	O
regulated	O
by	O
oncogenic	O
tyrosine	S-Chemical_Compound
kinases	O
.	O

Experimental	O
analysis	O
revealed	O
that	O
the	O
membrane	O
-	O
bound	O
osmosensor	O
Sho1	O
is	O
phosphorylated	O
by	O
Hog1	O
and	O
that	O
phosphorylation	O
occurs	O
on	O
Ser	B-Chemical_Compound
-	I-Chemical_Compound
166	E-Chemical_Compound
.	O

Moreover	O
,	O
Sho1	O
exists	O
in	O
a	O
homo	O
-	O
oligomeric	O
complex	O
,	O
and	O
phosphorylation	O
by	O
Hog1	O
promotes	O
a	O
transition	O
from	O
the	O
oligomeric	O
to	O
monomeric	O
state	O
.	O

PRAS40	O
binding	O
to	O
raptor	O
was	O
severely	O
inhibited	O
by	O
mutation	O
of	O
PRAS40	O
(	O
Phe	B-Chemical_Compound
(	I-Chemical_Compound
129	I-Chemical_Compound
)	E-Chemical_Compound
to	O
Ala	S-Chemical_Compound
)	O
.	O

Immediately	O
carboxyl	O
-	O
terminal	O
to	O
Phe	B-Chemical_Compound
(	I-Chemical_Compound
129	I-Chemical_Compound
)	E-Chemical_Compound
are	O
two	O
small	O
hydrophobic	O
amino	O
acid	O
followed	O
by	O
two	O
acidic	O
residues	O
.	O

The	O
deacetylated	O
p53	O
binds	O
poorly	O
to	O
the	O
target	O
promoter	O
(	O
p21	O
)	O
,	O
which	O
results	O
in	O
switching	O
off	O
the	O
p53	O
response	O
,	O
essential	O
for	O
re	O
-	O
entry	O
into	O
the	O
cell	O
cycle	O
.	O

Overall	O
,	O
our	O
results	O
indicate	O
that	O
nimbolide	S-Chemical_Compound
can	O
sensitize	O
tumor	O
cells	O
to	O
chemotherapeutic	O
agents	O
through	O
interaction	O
with	O
IKK	O
,	O
leading	O
to	O
inhibition	O
of	O
NF	O
-	O
kappaB	O
-	O
regulated	O
proteins	O
.	O

The	O
requirement	O
for	O
p50	O
NF	O
-	O
kappaB	O
in	O
TNF	O
-	O
induced	O
VCAM	O
-	O
1	O
expression	O
may	O
be	O
associated	O
with	O
its	O
interaction	O
with	O
and	O
phosphorylation	O
by	O
DNA	O
-	O
PK	O
,	O
which	O
appears	O
to	O
be	O
dominant	O
over	O
the	O
requirement	O
for	O
p65	O
NF	O
-	O
kappaB	O
activation	O
.	O

Re	O
-	O
establishing	O
wild	O
-	O
type	O
p50	O
NF	O
-	O
kappaB	O
,	O
but	O
not	O
its	O
serine	B-Chemical_Compound
20	E-Chemical_Compound
/	O
alanine	S-Chemical_Compound
mutant	O
,	O
in	O
p50	O
NF	O
-	O
kappaB	O
(	O
-	O
/	O
-	O
)	O
fibroblasts	O
reversed	O
VCAM	O
-	O
1	O
expression	O
after	O
TNF	O
treatment	O
,	O
demonstrating	O
the	O
importance	O
of	O
the	O
serine	B-Chemical_Compound
20	E-Chemical_Compound
phosphorylation	O
site	O
in	O
the	O
induction	O
of	O
VCAM	O
-	O
1	O
expression	O
.	O

Together	O
,	O
these	O
results	O
elucidate	O
a	O
novel	O
mechanism	O
for	O
the	O
involvement	O
of	O
DNA	O
-	O
PK	O
in	O
the	O
positive	O
regulation	O
of	O
p50	O
NF	O
-	O
kappaB	O
to	O
drive	O
VCAM	O
-	O
1	O
expression	O
.	O

Consistently	O
,	O
Zac1	O
overexpression	O
suppressed	O
cellular	O
NF	O
-	O
kappaB	O
activity	O
.	O

In	O
U87MG	O
and	O
U251	O
cells	O
,	O
DLL4	O
-	O
induced	O
cellular	O
migration	O
and	O
invasion	O
could	O
be	O
inhibited	O
by	O
either	O
beta	O
-	O
catenin	O
or	O
a	O
p50	O
inhibitor	O
.	O

In	O
addition	O
,	O
in	O
THP	O
-	O
1	O
cells	O
,	O
oroxylin	B-Chemical_Compound
A	E-Chemical_Compound
significantly	O
suppressed	O
lipopolysaccharide	S-Chemical_Compound
(	O
LPS	S-Chemical_Compound
)	O
-	O
induced	O
secretion	O
of	O
prototypical	O
proinflammatory	O
cytokine	O
IL	O
-	O
6	O
but	O
not	O
IL	O
-	O
1beta	O
,	O
and	O
it	O
was	O
confirmed	O
at	O
the	O
transcription	O
level	O
.	O

In	O
summary	O
,	O
oroxylin	B-Chemical_Compound
A	E-Chemical_Compound
modulated	O
NF	O
-	O
kappaB	O
signaling	O
pathway	O
involved	O
in	O
inflammation	O
-	O
induced	O
cancer	O
initiation	O
and	O
progression	O
and	O
therefore	O
could	O
be	O
a	O
potential	O
cancer	O
chemoprevention	O
agent	O
for	O
inflammation	O
-	O
related	O
cancer	O
.	O

The	O
alternate	O
substrate	O
alpha	B-Chemical_Compound
-	I-Chemical_Compound
methylisocitrate	E-Chemical_Compound
is	O
derived	O
from	O
alpha	B-Chemical_Compound
-	I-Chemical_Compound
methyl	I-Chemical_Compound
-	I-Chemical_Compound
cis	I-Chemical_Compound
-	I-Chemical_Compound
aconitate	E-Chemical_Compound
during	O
crystallization	O
and	O
is	O
observed	O
to	O
bind	O
in	O
the	O
active	O
site	O
in	O
a	O
manner	O
very	O
similar	O
to	O
that	O
observed	O
for	O
isocitrate	S-Chemical_Compound
.	O

These	O
results	O
demonstrate	O
that	O
Rho	O
physically	O
interacts	O
with	O
a	O
68	O
-	O
kDa	O
PIP5K	O
,	O
although	O
whether	O
the	O
association	O
is	O
direct	O
or	O
indirect	O
is	O
unknown	O
.	O

The	O
shorter	O
of	O
the	O
two	O
cDNAs	O
(	O
3	O
kilobases	O
(	O
kb	O
)	O
)	O
was	O
found	O
to	O
encode	O
an	O
open	O
reading	O
frame	O
of	O
2964	O
base	O
pairs	O
and	O
,	O
when	O
expressed	O
in	O
Pichia	O
pastoris	O
,	O
was	O
found	O
to	O
encode	O
an	O
enzyme	O
that	O
could	O
cleave	O
high	O
mannose	S-Chemical_Compound
oligosaccharides	S-Chemical_Compound
,	O
oligosaccharides	S-Chemical_Compound
isolated	O
from	O
alpha	O
-	O
mannosidosis	O
fibroblasts	O
,	O
and	O
p	B-Chemical_Compound
-	I-Chemical_Compound
nitrophenyl	I-Chemical_Compound
-	I-Chemical_Compound
alpha	I-Chemical_Compound
-	I-Chemical_Compound
D	I-Chemical_Compound
-	I-Chemical_Compound
mannopyranoside	E-Chemical_Compound
substrates	O
.	O

Phosphatidylinositol	O
-	O
4	O
-	O
phosphate	O
5	O
-	O
kinases	O
(	O
PIP5Ks	O
)	O
utilize	O
phosphatidylinositols	S-Chemical_Compound
containing	O
D	O
-	O
3	O
-	O
position	O
phosphates	S-Chemical_Compound
as	O
substrates	O
to	O
form	O
phosphatidylinositol	B-Chemical_Compound
3	I-Chemical_Compound
,	I-Chemical_Compound
4	I-Chemical_Compound
-	I-Chemical_Compound
bisphosphate	E-Chemical_Compound
.	O

These	O
unexpected	O
activities	O
position	O
the	O
PIP5Ks	O
as	O
potential	O
participants	O
in	O
the	O
generation	O
of	O
all	O
polyphosphoinositide	S-Chemical_Compound
signaling	O
molecules	O
.	O

Noninduced	O
and	O
induced	O
cells	O
were	O
alkalinized	O
to	O
an	O
equivalent	O
pHi	O
(	O
approximately	O
7	O
.	O
7	O
)	O
by	O
transient	O
exposure	O
to	O
a	O
50	O
mM	O
HCO3	B-Chemical_Compound
-	E-Chemical_Compound
,	O
Cl	B-Chemical_Compound
-	E-Chemical_Compound
-	O
free	O
solution	O
.	O

In	O
the	O
absence	O
of	O
extracellular	O
Cl	B-Chemical_Compound
-	E-Chemical_Compound
and	O
taurocholate	S-Chemical_Compound
,	O
isohydric	O
reduction	O
of	O
superfusate	O
HCO3	B-Chemical_Compound
-	E-Chemical_Compound
concentration	O
from	O
50	O
to	O
25	O
mM	O
resulted	O
in	O
an	O
insignificant	O
change	O
in	O
pHi	O
over	O
time	O
(	O
dpHi	O
/	O
dt	O
)	O
in	O
both	O
groups	O
.	O

These	O
data	O
indicate	O
that	O
oatp	O
-	O
mediated	O
taurocholate	S-Chemical_Compound
transport	O
is	O
Na	B-Chemical_Compound
+	E-Chemical_Compound
-	O
independent	O
,	O
saturable	O
,	O
and	O
accompanied	O
by	O
HCO3	B-Chemical_Compound
-	E-Chemical_Compound
exchange	O
.	O

Skp1	O
binds	O
a	O
motif	O
called	O
the	O
F	O
-	O
box	O
and	O
in	O
turn	O
F	O
-	O
box	O
proteins	O
appear	O
to	O
recruit	O
specific	O
substrates	O
for	O
ubiquitination	O
.	O

We	O
found	O
that	O
the	O
endogenous	O
CCT	O
complex	O
in	O
yeast	O
was	O
essential	O
for	O
the	O
maturation	O
of	O
cyclin	O
E	O
in	O
vivo	O
.	O

Functional	O
interactions	O
of	O
transforming	O
growth	O
factor	O
beta	O
-	O
activated	O
kinase	O
1	O
with	O
IkappaB	O
kinases	O
to	O
stimulate	O
NF	O
-	O
kappaB	O
activation	O
.	O

Dvl	O
-	O
1	O
,	O
which	O
was	O
genetically	O
shown	O
to	O
function	O
upstream	O
of	O
GSK	O
-	O
3beta	O
,	O
inhibited	O
the	O
phosphorylation	O
of	O
Axin	O
by	O
GSK	O
-	O
3beta	O
in	O
vitro	O
.	O

A	O
brief	O
,	O
3	O
min	O
period	O
of	O
global	O
forebrain	O
ischemia	O
in	O
the	O
rat	O
,	O
induced	O
by	O
bilateral	O
common	O
carotid	O
occlusion	O
combined	O
with	O
hypotension	O
,	O
confers	O
resistance	O
to	O
hippocampal	O
pyramidal	O
neurons	O
against	O
a	O
subsequent	O
10	O
min	O
ischemia	O
,	O
which	O
is	O
normally	O
lethal	O
to	O
these	O
cells	O
.	O

Upon	O
binding	O
of	O
a	O
Wnt	O
to	O
its	O
receptor	O
,	O
GSK3beta	O
is	O
inhibited	O
through	O
an	O
unknown	O
mechanism	O
involving	O
Dishevelled	O
(	O
Dsh	O
)	O
,	O
resulting	O
in	O
the	O
dephosphorylation	O
and	O
stabilization	O
of	O
beta	O
-	O
catenin	O
,	O
which	O
translocates	O
to	O
the	O
nucleus	O
and	O
interacts	O
with	O
Lef	O
/	O
Tcf	O
transcription	O
factors	O
to	O
activate	O
target	O
gene	O
expression	O
.	O

In	O
the	O
absence	O
of	O
IKK	O
gamma	O
,	O
which	O
normally	O
connects	O
IKK	O
to	O
upstream	O
activators	O
,	O
no	O
IKK	O
or	O
NF	O
-	O
kappa	O
B	O
activation	O
can	O
occur	O
.	O

Surprisingly	O
,	O
however	O
,	O
of	O
the	O
two	O
catalytic	O
subunits	O
,	O
only	O
IKK	O
beta	O
is	O
essential	O
for	O
NF	O
-	O
kappa	O
B	O
activation	O
in	O
response	O
to	O
proinflammatory	O
stimuli	O
.	O

Analysis	O
of	O
promoter	O
binding	O
by	O
the	O
E2F	O
and	O
pRB	O
families	O
in	O
vivo	O
:	O
distinct	O
E2F	O
proteins	O
mediate	O
activation	O
and	O
repression	O
.	O

The	O
E2F	O
transcription	O
factor	O
plays	O
a	O
pivotal	O
role	O
in	O
the	O
timely	O
activation	O
of	O
gene	O
expression	O
during	O
mammalian	O
cell	O
cycle	O
progression	O
,	O
whereas	O
pRB	O
and	O
related	O
proteins	O
control	O
cell	O
growth	O
in	O
part	O
through	O
the	O
ability	O
to	O
block	O
the	O
action	O
of	O
E2F	O
.	O

To	O
identify	O
physiologically	O
important	O
E2F	O
-	O
responsive	O
promoters	O
and	O
to	O
study	O
their	O
occupancy	O
and	O
histone	O
acetylation	O
state	O
in	O
vivo	O
,	O
we	O
have	O
taken	O
advantage	O
of	O
a	O
cross	O
-	O
linking	O
approach	O
in	O
synchronized	O
,	O
living	O
cells	O
.	O

These	O
findings	O
suggest	O
that	O
repression	O
and	O
activation	O
of	O
E2F	O
-	O
responsive	O
genes	O
may	O
occur	O
through	O
distinct	O
E2F	O
heterodimers	O
that	O
direct	O
the	O
sequential	O
recruitment	O
of	O
enzymes	O
able	O
to	O
deacetylate	O
and	O
then	O
acetylate	O
core	O
histones	O
.	O

Loss	O
of	O
heterozygosity	O
at	O
this	O
locus	O
was	O
observed	O
in	O
50	O
%	O
of	O
invasive	O
tumors	O
but	O
in	O
none	O
of	O
the	O
borderline	O
tumors	O
.	O

Genetic	O
evidence	O
suggests	O
that	O
the	O
p21	O
-	O
activated	O
protein	O
kinase	O
(	O
PAK	O
)	O
Ste20p	O
functions	O
upstream	O
of	O
Ste11p	O
,	O
and	O
Ste20p	O
has	O
been	O
shown	O
to	O
phosphorylate	O
Ste11p	O
in	O
vitro	O
.	O

RESULTS	O
:	O
Ste20p	O
phosphorylated	O
Ste11p	O
on	O
Ser302	S-Chemical_Compound
and	O
/	O
or	O
Ser306	S-Chemical_Compound
and	O
Thr307	S-Chemical_Compound
in	O
yeast	O
,	O
residues	O
that	O
are	O
conserved	O
in	O
MEKKs	O
of	O
other	O
organisms	O
.	O

CDC28	O
immunoprecipitate	O
derived	O
from	O
the	O
YPH499	O
strain	O
grown	O
under	O
low	O
phosphate	S-Chemical_Compound
conditions	O
phosphorylated	O
GST	O
-	O
PHO2	O
in	O
vitro	O
.	O

Glycogen	O
synthase	O
kinase	O
-	O
3	O
(	O
GSK	O
-	O
3	O
)	O
-	O
alpha	O
and	O
-	O
beta	O
are	O
closely	O
related	O
protein	O
-	O
serine	S-Chemical_Compound
kinases	O
,	O
which	O
act	O
as	O
inhibitory	O
components	O
of	O
Wnt	O
signalling	O
during	O
embryonic	O
development	O
and	O
cell	O
proliferation	O
in	O
adult	O
tissues	O
.	O

Here	O
we	O
show	O
that	O
disruption	O
of	O
the	O
murine	O
GSK	O
-	O
3beta	O
gene	O
results	O
in	O
embryonic	O
lethality	O
caused	O
by	O
severe	O
liver	O
degeneration	O
during	O
mid	O
-	O
gestation	O
,	O
a	O
phenotype	O
consistent	O
with	O
excessive	O
tumour	O
necrosis	O
factor	O
(	O
TNF	O
)	O
toxicity	O
,	O
as	O
observed	O
in	O
mice	O
lacking	O
genes	O
involved	O
in	O
the	O
activation	O
of	O
the	O
transcription	O
factor	O
activation	O
NF	O
-	O
kappaB	O
.	O

Fibroblasts	O
from	O
GSK	O
-	O
3beta	O
-	O
deficient	O
embryos	O
were	O
hypersensitive	O
to	O
TNF	O
-	O
alpha	O
and	O
showed	O
reduced	O
NF	O
-	O
kappaB	O
function	O
.	O

We	O
examined	O
the	O
pattern	O
of	O
activation	O
and	O
deactivation	O
of	O
the	O
stress	O
-	O
activated	O
protein	O
kinase	O
signalling	O
molecules	O
c	O
-	O
Jun	O
NH2	O
-	O
terminal	O
kinase	O
(	O
JNK	O
)	O
and	O
p38	O
kinase	O
in	O
skeletal	O
muscle	O
in	O
response	O
to	O
prolonged	O
strenuous	O
running	O
exercise	O
in	O
human	O
subjects	O
.	O

The	O
phosphorylation	O
state	O
of	O
p38	O
(	O
alpha	O
and	O
gamma	O
)	O
and	O
the	O
upstream	O
regulators	O
of	O
JNK	O
and	O
p38	O
,	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
kinase	O
4	O
(	O
MKK4	O
)	O
and	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
kinase	O
6	O
(	O
MKK6	O
)	O
,	O
were	O
assessed	O
using	O
phosphospecific	O
antibodies	O
.	O

GTPase	O
binding	O
will	O
refold	O
part	O
of	O
the	O
IS	O
domain	O
and	O
unfold	O
the	O
rest	O
.	O

Cloning	O
,	O
Golgi	O
localization	O
,	O
and	O
enzyme	O
activity	O
of	O
the	O
full	O
-	O
length	O
heparin	S-Chemical_Compound
/	O
heparan	B-Chemical_Compound
sulfate	E-Chemical_Compound
-	O
glucuronic	B-Chemical_Compound
acid	E-Chemical_Compound
C5	O
-	O
epimerase	O
.	O

An	O
assay	O
with	O
increased	O
sensitivity	O
was	O
devised	O
that	O
detects	O
enzyme	O
activity	O
in	O
extracts	O
prepared	O
from	O
cultured	O
cells	O
and	O
in	O
recombinant	O
proteins	O
.	O

Finally	O
,	O
Tat	O
inhibition	O
of	O
microglial	O
adenylyl	O
cyclase	O
was	O
not	O
due	O
to	O
non	O
-	O
specific	O
cytotoxicity	O
.	O

We	O
describe	O
the	O
analysis	O
of	O
12	O
novel	O
targets	O
,	O
some	O
regulated	O
by	O
Ace2p	O
or	O
Swi5p	O
alone	O
and	O
some	O
by	O
both	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
found	O
that	O
Syk	O
played	O
a	O
different	O
role	O
in	O
IL	O
-	O
1	O
-	O
and	O
TNF	O
-	O
alpha	O
-	O
induced	O
chemokine	O
production	O
through	O
a	O
signaling	O
complex	O
involving	O
Syk	O
and	O
TRAF6	O
.	O

Two	O
different	O
transcripts	O
encoding	O
a	O
full	O
-	O
length	O
and	O
truncated	O
sAC	O
were	O
identified	O
by	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
and	O
RNase	O
protection	O
analysis	O
.	O

The	O
truncated	O
sAC	O
transcript	O
lacks	O
exon	O
11	O
with	O
a	O
premature	O
termination	O
of	O
the	O
open	O
reading	O
frame	O
after	O
the	O
catalytic	O
domain	O
.	O

However	O
,	O
cells	O
cease	O
to	O
be	O
viable	O
if	O
the	O
interaction	O
between	O
NTF2	O
and	O
nucleoporins	O
is	O
abolished	O
completely	O
,	O
indicating	O
that	O
this	O
interaction	O
is	O
essential	O
for	O
the	O
function	O
of	O
NTF2	O
in	O
vivo	O
.	O

In	O
addition	O
,	O
we	O
have	O
isolated	O
a	O
dominant	O
negative	O
mutant	O
of	O
NTF2	O
,	O
N77Y	O
,	O
which	O
has	O
increased	O
affinity	O
for	O
nucleoporins	O
.	O

The	O
enzyme	O
was	O
inhibited	O
by	O
1	O
mM	O
propionate	S-Chemical_Compound
,	O
but	O
not	O
by	O
10	O
mM	O
beta	B-Chemical_Compound
-	I-Chemical_Compound
alanine	E-Chemical_Compound
.	O

These	O
properties	O
of	O
human	O
BUP	O
,	O
except	O
the	O
inhibition	O
by	O
beta	B-Chemical_Compound
-	I-Chemical_Compound
alanine	E-Chemical_Compound
,	O
were	O
similar	O
to	O
the	O
rat	O
liver	O
purified	O
enzyme	O
.	O

Some	O
of	O
the	O
Swi4	O
-	O
and	O
Slt2	O
-	O
dependent	O
genes	O
do	O
not	O
require	O
Swi6	O
for	O
either	O
their	O
expression	O
or	O
for	O
Swi4	O
localization	O
to	O
their	O
promoters	O
.	O

In	O
contrast	O
,	O
hCdc14a	O
does	O
not	O
affect	O
the	O
activity	O
of	O
APC	O
(	O
Cdc20	O
)	O
.	O

hCdc14a	O
is	O
a	O
major	O
phosphatase	O
for	O
hCdh1	O
and	O
localizes	O
to	O
centrosomes	O
in	O
HeLa	O
cells	O
.	O

While	O
the	O
role	O
of	O
Hex	O
A	O
and	O
B	O
for	O
the	O
degradation	O
of	O
several	O
anionic	O
and	O
neutral	O
glycoconjugates	O
has	O
been	O
well	O
established	O
,	O
the	O
physiological	O
significance	O
of	O
labile	O
Hex	O
S	O
has	O
remained	O
unclear	O
.	O

Hydrolysis	O
of	O
membrane	O
-	O
bound	O
SM2	S-Chemical_Compound
by	O
the	O
recombinant	O
Hex	O
S	O
was	O
synergistically	O
stimulated	O
by	O
the	O
GM2	O
activator	O
protein	O
and	O
the	O
lysosomal	O
anionic	B-Chemical_Compound
phospholipid	E-Chemical_Compound
bis	B-Chemical_Compound
(	I-Chemical_Compound
monoacylglycero	I-Chemical_Compound
)	I-Chemical_Compound
phosphate	E-Chemical_Compound
.	O

TIP41	O
interacts	O
with	O
TAP42	O
and	O
negatively	O
regulates	O
the	O
TOR	O
signaling	O
pathway	O
.	O

Here	O
,	O
we	O
describe	O
TIP41	O
,	O
a	O
conserved	O
TAP42	O
-	O
interacting	O
protein	O
involved	O
in	O
the	O
regulation	O
of	O
SIT4	O
.	O

This	O
protein	O
occupies	O
E3RS	O
in	O
a	O
specific	O
and	O
stoichiometric	O
manner	O
,	O
stabilizes	O
the	O
E3	O
component	O
,	O
and	O
is	O
likely	O
responsible	O
for	O
its	O
nuclear	O
localization	O
.	O

Here	O
we	O
show	O
that	O
effective	O
activation	O
of	O
RF	O
+	O
B	O
cells	O
is	O
mediated	O
by	O
IgG2a	O
-	O
chromatin	O
immune	O
complexes	O
and	O
requires	O
the	O
synergistic	O
engagement	O
of	O
the	O
antigen	O
receptor	O
and	O
a	O
member	O
of	O
the	O
MyD88	O
-	O
dependent	O
Toll	O
-	O
like	O
receptor	O
(	O
TLR	O
)	O
family	O
.	O

After	O
the	O
appearance	O
of	O
the	O
cortical	O
plate	O
,	O
further	O
p73	O
/	O
Reln	O
-	O
IR	O
cells	O
originate	O
in	O
the	O
medial	O
periolfactory	O
forebrain	O
.	O

E2F	O
-	O
1	O
is	O
capable	O
of	O
promoting	O
both	O
cell	O
cycle	O
progression	O
and	O
apoptosis	O
.	O

The	O
ubiquitin	O
system	O
has	O
been	O
recently	O
implicated	O
in	O
various	O
aspects	O
of	O
transcriptional	O
regulation	O
,	O
including	O
proteasome	O
-	O
dependent	O
degradation	O
of	O
transcriptional	O
activators	O
.	O

The	O
murine	O
and	O
porcine	O
L	O
-	O
threonine	O
dehydrogenase	O
genes	O
(	O
TDH	O
)	O
have	O
been	O
identified	O
previously	O
,	O
but	O
the	O
human	O
gene	O
has	O
not	O
been	O
identified	O
.	O

Despite	O
their	O
interaction	O
with	O
IKK	O
gamma	O
,	O
PP2A	O
-	O
interaction	O
-	O
defective	O
Tax	O
mutants	O
failed	O
to	O
activate	O
NF	O
-	O
kappa	O
B	O
.	O

E2F	O
mediates	O
sustained	O
G2	O
arrest	O
and	O
down	O
-	O
regulation	O
of	O
Stathmin	O
and	O
AIM	O
-	O
1	O
expression	O
in	O
response	O
to	O
genotoxic	O
stress	O
.	O

Here	O
,	O
we	O
show	O
that	O
a	O
BRCA	O
carboxyl	S-Chemical_Compound
terminus	O
(	O
BRCT	O
)	O
domain	O
-	O
containing	O
region	O
of	O
NBS1	O
interacts	O
with	O
a	O
nuclear	O
dots	O
-	O
associated	O
protein	O
,	O
SP100	O
.	O

These	O
results	O
indicate	O
that	O
NBS1	O
is	O
recruited	O
into	O
PODs	O
via	O
interaction	O
with	O
SP100	O
protein	O
.	O

Serine	B-Chemical_Compound
927	E-Chemical_Compound
resides	O
in	O
a	O
conserved	O
motif	O
(	O
Asp	S-Chemical_Compound
-	O
Ser	B-Chemical_Compound
(	I-Chemical_Compound
927	I-Chemical_Compound
)	E-Chemical_Compound
-	O
Gly	S-Chemical_Compound
-	O
Val	S-Chemical_Compound
-	O
Glu	S-Chemical_Compound
-	O
Thr	S-Chemical_Compound
-	O
Ser	B-Chemical_Compound
(	I-Chemical_Compound
932	I-Chemical_Compound
)	E-Chemical_Compound
)	O
homologous	O
to	O
the	O
IKK	O
target	O
sequence	O
in	O
IkappaBalpha	O
.	O

Furthermore	O
,	O
purified	O
IKK1	O
and	O
IKK2	O
can	O
each	O
phosphorylate	O
a	O
glutathione	O
S	O
-	O
transferase	O
-	O
p105	O
(	O
758	O
-	O
967	O
)	O
fusion	O
protein	O
on	O
both	O
regulatory	O
serines	O
in	O
vitro	O
.	O

Thus	O
,	O
it	O
appears	O
that	O
reduced	O
p105	O
recruitment	O
of	O
betaTrCP	O
and	O
subsequent	O
ubiquitination	O
may	O
contribute	O
to	O
delayed	O
p105	O
proteolysis	O
after	O
TNF	O
-	O
alpha	O
stimulation	O
relative	O
to	O
that	O
for	O
IkappaBalpha	O
.	O

Regulation	O
of	O
lymphoid	O
enhancer	O
factor	O
1	O
/	O
T	O
-	O
cell	O
factor	O
by	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
-	O
related	O
Nemo	O
-	O
like	O
kinase	O
-	O
dependent	O
phosphorylation	O
in	O
Wnt	O
/	O
beta	O
-	O
catenin	O
signaling	O
.	O

NLK	O
phosphorylates	O
LEF	O
-	O
1	O
/	O
TCF	O
on	O
two	O
serine	S-Chemical_Compound
/	O
threonine	S-Chemical_Compound
residues	O
located	O
in	O
its	O
central	O
region	O
.	O

This	O
is	O
followed	O
by	O
dimerization	O
of	O
the	O
dimers	O
with	O
their	O
N	O
-	O
terminal	O
sequences	O
.	O

Biotin	S-Chemical_Compound
uptake	O
by	O
human	O
intestinal	O
and	O
liver	O
epithelial	O
cells	O
:	O
role	O
of	O
the	O
SMVT	O
system	O
.	O

Hence	O
,	O
we	O
employed	O
a	O
physiological	O
approach	O
of	O
characterizing	O
biotin	S-Chemical_Compound
uptake	O
by	O
human	O
-	O
derived	O
intestinal	O
Caco	O
-	O
2	O
and	O
HepG2	O
cells	O
at	O
the	O
nanomolar	O
concentration	O
range	O
.	O

We	O
show	O
here	O
that	O
BRCA1	O
is	O
required	O
for	O
ATM	O
-	O
and	O
ATR	O
-	O
dependent	O
phosphorylation	O
of	O
p53	O
,	O
c	O
-	O
Jun	O
,	O
Nbs1	O
and	O
Chk2	O
following	O
exposure	O
to	O
ionizing	O
or	O
ultraviolet	O
radiation	O
,	O
respectively	O
,	O
and	O
is	O
also	O
required	O
for	O
ATM	O
phosphorylation	O
of	O
CtIP	O
.	O

E2F6	O
has	O
been	O
postulated	O
to	O
mediate	O
transcriptional	O
repression	O
by	O
recruiting	O
a	O
histone	O
H3	O
methyltransferase	O
to	O
the	O
DNA	O
.	O

Our	O
findings	O
suggest	O
that	O
the	O
functional	O
impairment	O
of	O
p73	O
could	O
be	O
involved	O
in	O
the	O
development	O
of	O
thyroid	O
malignancies	O
,	O
defining	O
p73	O
as	O
a	O
potential	O
therapeutic	O
target	O
for	O
thyroid	O
cancer	O
.	O

Both	O
Cln3	O
and	O
Cdc28	O
are	O
mainly	O
cytoplasmic	O
during	O
early	O
G1	O
,	O
and	O
become	O
nuclear	O
in	O
late	O
G1	O
.	O

However	O
,	O
the	O
mechanism	O
by	O
which	O
nuclear	O
NF	O
-	O
kappaB	O
is	O
subsequently	O
regulated	O
is	O
not	O
clear	O
.	O

Here	O
we	O
demonstrate	O
that	O
NF	O
-	O
kappaB	O
function	O
is	O
regulated	O
by	O
Pin1	O
-	O
mediated	O
prolyl	S-Chemical_Compound
isomerization	O
and	O
ubiquitin	O
-	O
mediated	O
proteolysis	O
of	O
its	O
p65	O
/	O
RelA	O
subunit	O
.	O

Loss	O
of	O
the	O
tumor	O
suppressor	O
PML	O
in	O
human	O
cancers	O
of	O
multiple	O
histologic	O
origins	O
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
mammalian	O
target	O
of	O
rapamycin	O
(	O
mTOR	O
)	O
regulates	O
Pol	O
I	O
transcription	O
by	O
modulating	O
the	O
activity	O
of	O
TIF	O
-	O
IA	O
,	O
a	O
regulatory	O
factor	O
that	O
senses	O
nutrient	O
and	O
growth	O
-	O
factor	O
availability	O
.	O

Inhibition	O
of	O
mTOR	O
signaling	O
by	O
rapamycin	S-Chemical_Compound
inactivates	O
TIF	O
-	O
IA	O
and	O
impairs	O
transcription	O
-	O
initiation	O
complex	O
formation	O
.	O

The	O
results	O
identify	O
a	O
new	O
target	O
formTOR	O
-	O
signaling	O
pathways	O
and	O
elucidate	O
the	O
molecular	O
mechanism	O
underlying	O
mTOR	O
-	O
dependent	O
regulation	O
of	O
RNA	O
synthesis	O
.	O

These	O
recent	O
findings	O
point	O
to	O
a	O
direct	O
role	O
for	O
Btk	O
in	O
LPS	S-Chemical_Compound
signal	O
transduction	O
and	O
raise	O
interesting	O
questions	O
regarding	O
the	O
mode	O
of	O
activation	O
of	O
Btk	O
following	O
LPS	S-Chemical_Compound
stimulation	O
and	O
the	O
precise	O
nature	O
of	O
the	O
pathways	O
activated	O
downstream	O
of	O
Btk	O
.	O

A	O
better	O
understanding	O
of	O
how	O
Btk	O
functions	O
in	O
LPS	S-Chemical_Compound
signalling	O
will	O
have	O
important	O
implications	O
for	O
inflammatory	O
and	O
autoimmune	O
disorders	O
and	O
therapies	O
thereof	O
.	O

Hierarchical	O
requirement	O
of	O
SWI	O
/	O
SNF	O
in	O
retinoblastoma	O
tumor	O
suppressor	O
-	O
mediated	O
repression	O
of	O
Plk1	O
.	O

The	O
importance	O
of	O
SWI	O
/	O
SNF	O
-	O
dependent	O
histone	O
deacetylation	O
of	O
the	O
Plk1	O
promoter	O
was	O
evident	O
,	O
because	O
blockade	O
of	O
this	O
event	O
restored	O
Plk1	O
expression	O
in	O
the	O
presence	O
of	O
active	O
RB	O
.	O

We	O
have	O
recently	O
cloned	O
the	O
cDNA	O
coding	O
for	O
a	O
highly	O
specific	O
mammalian	O
25	O
kDa	O
thiamine	O
triphosphatase	O
(	O
ThTPase	O
;	O
EC	O
3	O
.	O
6	O
.	O
1	O
.	O
28	O
)	O
.	O

Mg2	B-Chemical_Compound
+	E-Chemical_Compound
ions	O
were	O
required	O
for	O
activity	O
and	O
Ca2	B-Chemical_Compound
+	E-Chemical_Compound
inhibited	O
the	O
enzyme	O
by	O
competition	O
with	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
.	O

With	O
ATP	S-Chemical_Compound
as	O
substrate	O
,	O
the	O
catalytic	O
efficiency	O
was	O
10	O
(	O
-	O
4	O
)	O
-	O
fold	O
lower	O
than	O
with	O
ThTP	S-Chemical_Compound
,	O
confirming	O
the	O
nearly	O
absolute	O
specificity	O
of	O
the	O
25	O
kDa	O
ThTPase	O
for	O
ThTP	S-Chemical_Compound
.	O

Mangiferin	S-Chemical_Compound
enhances	O
glutathione	S-Chemical_Compound
level	O
by	O
almost	O
2	O
-	O
fold	O
more	O
than	O
other	O
anti	O
-	O
oxidants	O
,	O
and	O
at	O
the	O
same	O
time	O
it	O
decreases	O
the	O
levels	O
of	O
GSSG	S-Chemical_Compound
and	O
increases	O
the	O
activity	O
of	O
catalase	O
.	O

Whether	O
other	O
reported	O
putative	O
endogenous	O
ligands	O
of	O
TLR2	O
and	O
TLR4	O
are	O
a	O
result	O
of	O
contamination	O
of	O
pathogen	O
-	O
associated	O
molecular	O
patterns	O
is	O
not	O
clear	O
.	O

It	O
is	O
essential	O
that	O
efforts	O
should	O
be	O
directed	O
to	O
conclusively	O
determine	O
whether	O
the	O
reported	O
putative	O
endogenous	O
ligands	O
of	O
TLRs	O
are	O
a	O
result	O
of	O
the	O
endogenous	O
molecules	O
or	O
of	O
contaminant	O
(	O
s	O
)	O
,	O
before	O
exploring	O
further	O
the	O
implication	O
and	O
therapeutic	O
potential	O
of	O
these	O
putative	O
TLR	O
ligands	O
.	O

Genotoxic	O
stress	O
induces	O
expression	O
of	O
E2F4	O
,	O
leading	O
to	O
its	O
association	O
with	O
p130	O
in	O
prostate	O
carcinoma	O
cells	O
.	O

It	O
has	O
been	O
reported	O
that	O
the	O
Ser	S-Chemical_Compound
/	O
Thr	S-Chemical_Compound
kinase	O
TBK	O
-	O
1	O
is	O
essential	O
for	O
TLR3	O
-	O
mediated	O
activation	O
and	O
phosphorylation	O
of	O
IRF	O
-	O
3	O
.	O

One	O
involves	O
activation	O
of	O
TBK	O
-	O
1	O
and	O
the	O
other	O
recruits	O
and	O
activates	O
PI3	O
kinase	O
and	O
the	O
downstream	O
kinase	O
,	O
Akt	O
,	O
leading	O
to	O
full	O
phosphorylation	O
and	O
activation	O
of	O
IRF	O
-	O
3	O
.	O

The	O
pRb	O
/	O
E2F	O
and	O
Wnt	O
/	O
beta	O
-	O
catenin	O
pathways	O
are	O
two	O
of	O
the	O
most	O
frequently	O
deregulated	O
pathways	O
in	O
human	O
cancers	O
.	O

Thus	O
,	O
neuron	O
survival	O
and	O
death	O
are	O
dependent	O
on	O
the	O
integrity	O
of	O
E2F4	O
-	O
p130	O
-	O
HDAC	O
/	O
Suv39H1	O
complexes	O
.	O

Here	O
,	O
we	O
show	O
that	O
LPS	S-Chemical_Compound
stimulation	O
of	O
monocytes	O
results	O
in	O
MMP	O
-	O
9	O
production	O
through	O
a	O
phosphatidylinositol	O
-	O
3	O
kinase	O
(	O
PI	O
-	O
3K	O
)	O
/	O
Akt	O
/	O
inhibitor	O
of	O
kappaB	O
(	O
IkappaB	O
)	O
kinase	O
-	O
alpha	O
(	O
IKKalpha	O
)	O
/	O
nuclear	O
factor	O
(	O
NF	O
)	O
-	O
kappaB	O
pathway	O
.	O

Importantly	O
,	O
expression	O
of	O
an	O
Erk	O
nonphosphorylatable	O
TSC2	O
mutant	O
in	O
TSC2	O
+	O
/	O
-	O
tumor	O
cells	O
where	O
Erk	O
is	O
constitutively	O
activated	O
blocks	O
tumorigenecity	O
in	O
vivo	O
,	O
while	O
wild	O
-	O
type	O
TSC2	O
is	O
ineffective	O
.	O

Furthermore	O
,	O
we	O
found	O
that	O
the	O
endogenous	O
Mip1	O
-	O
MEKK2	O
complex	O
was	O
dissociated	O
transiently	O
following	O
epidermal	O
growth	O
factor	O
stimulation	O
.	O

The	O
expression	O
of	O
PTEN	O
in	O
PTEN	O
-	O
deficient	O
cells	O
represses	O
RNA	O
Pol	O
I	O
transcription	O
,	O
while	O
decreasing	O
PTEN	O
expression	O
enhances	O
transcription	O
.	O

Proteinase	O
K	O
treatment	O
abrogated	O
IL	O
-	O
8	O
production	O
elicited	O
in	O
these	O
cells	O
by	O
GST	O
-	O
CsgA	O
,	O
but	O
not	O
by	O
synthetic	O
lipoprotein	O
.	O

Work	O
in	O
Xenopus	O
meiotic	O
cell	O
cycles	O
has	O
suggested	O
that	O
Polo	O
kinase	O
functions	O
in	O
a	O
pathway	O
that	O
helps	O
trigger	O
activation	O
of	O
Cdk1	O
.	O

Analysis	O
of	O
Cdc5	O
phosphorylation	O
by	O
mass	O
spectrometry	O
indicates	O
that	O
threonine	B-Chemical_Compound
242	E-Chemical_Compound
is	O
phosphorylated	O
in	O
vivo	O
.	O

Moreover	O
,	O
overexpression	O
and	O
RNA	O
interference	O
experiments	O
support	O
the	O
requirement	O
of	O
endogenous	O
E2F	O
/	O
DP	O
(	O
E2F	O
dimerization	O
partner	O
)	O
activity	O
for	O
ASK	O
-	O
1	O
expression	O
.	O

Our	O
results	O
indicate	O
that	O
E2Fs	O
modulate	O
the	O
expression	O
of	O
ASK	O
-	O
1	O
and	O
suggest	O
that	O
some	O
of	O
the	O
cellular	O
functions	O
of	O
ASK	O
-	O
1	O
may	O
be	O
under	O
the	O
control	O
of	O
E2F	O
transcription	O
factors	O
.	O

In	O
addition	O
,	O
the	O
overexpression	O
of	O
Gip3	O
and	O
Gip4	O
from	O
the	O
galactose	S-Chemical_Compound
promoter	O
restored	O
Dam1	O
phosphorylation	O
in	O
ipl1	O
-	O
321	O
mutant	O
cells	O
and	O
caused	O
wild	O
-	O
type	O
cells	O
to	O
arrest	O
in	O
metaphase	O
with	O
unsegregated	O
chromosomes	O
,	O
suggesting	O
that	O
Gip3	O
and	O
Gip4	O
overexpression	O
impairs	O
Glc7	O
'	O
s	O
mitotic	O
functions	O
.	O

Ribosomal	O
S6	O
kinases	O
(	O
S6Ks	O
)	O
are	O
principal	O
players	O
in	O
the	O
regulation	O
of	O
cell	O
growth	O
and	O
energy	O
metabolism	O
.	O

Last	O
,	O
pulse	O
-	O
chase	O
experiments	O
demonstrate	O
that	O
Hsp70	O
preferentially	O
binds	O
the	O
species	O
of	O
mature	O
PKC	O
that	O
has	O
become	O
dephosphorylated	O
compared	O
with	O
the	O
newly	O
synthesized	O
protein	O
that	O
has	O
yet	O
to	O
be	O
phosphorylated	O
.	O

Association	O
of	O
Cdh1	O
with	O
Bmh1	O
and	O
Bmh2	O
requires	O
Acm1	O
,	O
and	O
the	O
Acm1	O
protein	O
is	O
cell	O
cycle	O
regulated	O
,	O
appearing	O
late	O
in	O
G1	O
and	O
disappearing	O
in	O
late	O
M	O
.	O

Identification	O
of	O
novel	O
phosphorylation	O
sites	O
in	O
MSK1	O
by	O
precursor	O
ion	O
scanning	O
MS	O
.	O

MSK1	O
activity	O
is	O
tightly	O
regulated	O
in	O
cells	O
,	O
and	O
activation	O
requires	O
the	O
phosphorylation	O
of	O
MSK1	O
by	O
either	O
ERK1	O
/	O
2	O
or	O
p38a	O
.	O

Surprisingly	O
,	O
however	O
,	O
mutation	O
of	O
Thr700	S-Chemical_Compound
resulted	O
in	O
a	O
dramatic	O
loss	O
of	O
Thr581	S-Chemical_Compound
phosphorylation	O
,	O
a	O
site	O
essential	O
for	O
activity	O
.	O

The	O
Rtt109	O
-	O
Vps75	O
histone	O
acetyltransferase	O
complex	O
acetylates	O
non	O
-	O
nucleosomal	O
histone	O
H3	O
.	O

The	O
Aurora	O
kinase	O
Ipl1	O
maintains	O
the	O
centromeric	O
localization	O
of	O
PP2A	O
to	O
protect	O
cohesin	O
during	O
meiosis	O
.	O

We	O
suggest	O
that	O
centromeric	O
Ipl1	O
ensures	O
the	O
continued	O
centromeric	O
presence	O
of	O
active	O
Rts1	O
/	O
PP2A	O
,	O
which	O
in	O
turn	O
locally	O
protects	O
cohesin	O
and	O
cohesion	O
.	O

The	O
heterotrimeric	O
mTORC1	O
protein	O
kinase	O
nucleates	O
a	O
signaling	O
network	O
that	O
promotes	O
cell	O
growth	O
in	O
response	O
to	O
insulin	O
and	O
becomes	O
constitutively	O
active	O
in	O
cells	O
missing	O
the	O
TSC1	O
or	O
TSC2	O
tumor	O
suppressors	O
.	O

In	O
addition	O
,	O
we	O
found	O
that	O
beta	O
-	O
arrestin	O
can	O
bind	O
axin	O
and	O
forms	O
a	O
trimeric	O
complex	O
with	O
axin	O
and	O
Dvl	O
.	O

Human	O
DET1	O
has	O
recently	O
been	O
isolated	O
as	O
one	O
of	O
the	O
DDB1	O
-	O
and	O
Cul4A	O
-	O
associated	O
factors	O
,	O
along	O
with	O
an	O
array	O
of	O
WD40	O
-	O
containing	O
substrate	O
receptors	O
of	O
the	O
Cul4A	O
-	O
DDB1	O
ubiquitin	O
ligase	O
.	O

While	O
free	O
UBE2E	O
-	O
3	O
is	O
active	O
and	O
able	O
to	O
enhance	O
UbcH5	O
/	O
Cul4A	O
activity	O
,	O
the	O
DDD	O
core	O
specifically	O
inhibits	O
Cul4A	O
-	O
dependent	O
polyubiquitin	O
chain	O
assembly	O
in	O
vitro	O
.	O

To	O
evaluate	O
the	O
in	O
vivo	O
consequences	O
of	O
altered	O
Cdc34	O
activity	O
,	O
wild	O
-	O
type	O
yCdc34	O
and	O
the	O
phosphosite	O
mutants	O
were	O
introduced	O
into	O
an	O
S	O
.	O
cerevisiae	O
cdc34	O
deletion	O
strain	O
and	O
,	O
following	O
synchronization	O
in	O
G1	O
-	O
phase	O
,	O
progression	O
through	O
the	O
cell	O
cycle	O
was	O
monitored	O
.	O

Immunoprecipitation	O
of	O
p65	O
and	O
IkappaBalpha	O
revealed	O
that	O
acute	O
alcohol	S-Chemical_Compound
exposure	O
for	O
1	O
h	O
decreased	O
NF	O
-	O
kappaB	O
-	O
IkappaBalpha	O
complexes	O
in	O
the	O
cytoplasm	O
.	O

This	O
is	O
particularly	O
surprising	O
because	O
yeasts	O
,	O
unlike	O
vertebrates	O
,	O
employ	O
a	O
single	O
family	O
of	O
cyclins	O
(	O
B	O
type	O
)	O
and	O
the	O
same	O
CDK	O
to	O
promote	O
both	O
S	O
phase	O
and	O
mitosis	O
.	O

We	O
investigated	O
the	O
signaling	O
pathway	O
involved	O
in	O
IL	O
-	O
6	O
production	O
caused	O
by	O
adiponectin	O
in	O
both	O
rheumatoid	O
arthritis	O
synovial	O
fibroblasts	O
and	O
osteoarthritis	O
synovial	O
fibroblasts	O
.	O

Our	O
results	O
suggest	O
that	O
adiponectin	O
increased	O
IL	O
-	O
6	O
production	O
in	O
synovial	O
fibroblasts	O
via	O
the	O
AdipoR1	O
receptor	O
/	O
AMPK	O
/	O
p38	O
/	O
IKKalphabeta	O
and	O
NF	O
-	O
kappaB	O
signaling	O
pathway	O
.	O

PRAS40	O
and	O
PRR5	O
-	O
like	O
protein	O
are	O
new	O
mTOR	O
interactors	O
that	O
regulate	O
apoptosis	O
.	O

PRAS40	O
inhibits	O
mTORC1	O
autophosphorylation	O
and	O
mTORC1	O
kinase	O
activity	O
toward	O
eIF	O
-	O
4E	O
binding	O
protein	O
(	O
4E	O
-	O
BP	O
)	O
and	O
PRAS40	O
itself	O
.	O

HeLa	O
cells	O
in	O
which	O
PRAS40	O
was	O
knocked	O
down	O
were	O
protected	O
against	O
induction	O
of	O
apoptosis	O
by	O
TNFalpha	O
and	O
cycloheximide	S-Chemical_Compound
.	O

Thus	O
,	O
PRAS40	O
and	O
PRR5L	O
are	O
novel	O
mTOR	O
-	O
associated	O
proteins	O
that	O
control	O
the	O
balance	O
between	O
cell	O
growth	O
and	O
cell	O
death	O
.	O

Here	O
we	O
make	O
a	O
detailed	O
analysis	O
of	O
budding	O
yeast	O
cells	O
lacking	O
the	O
kinase	O
domain	O
(	O
bub1DeltaK	O
)	O
.	O

During	O
meiosis	O
this	O
protein	O
regulates	O
the	O
removal	O
of	O
cohesins	O
,	O
the	O
proteins	O
that	O
hold	O
sister	O
chromatids	O
together	O
,	O
from	O
chromosomes	O
.	O

Microglia	O
are	O
innate	O
immune	O
cells	O
in	O
the	O
central	O
nervous	O
system	O
.	O

Our	O
studies	O
showed	O
that	O
fisetin	S-Chemical_Compound
markedly	O
suppressed	O
the	O
production	O
of	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)	O
-	O
alpha	O
,	O
NO	S-Chemical_Compound
,	O
and	O
prostaglandin	B-Chemical_Compound
(	I-Chemical_Compound
PG	I-Chemical_Compound
)	I-Chemical_Compound
E2	E-Chemical_Compound
in	O
lipopolysaccharide	S-Chemical_Compound
(	O
LPS	S-Chemical_Compound
)	O
-	O
stimulated	O
BV	O
-	O
2	O
microglia	O
cells	O
or	O
primary	O
microglia	O
cultures	O
.	O

These	O
results	O
indicate	O
that	O
fisetin	S-Chemical_Compound
has	O
a	O
strong	O
anti	O
-	O
inflammatory	O
activity	O
in	O
brain	O
microglia	O
,	O
and	O
could	O
be	O
a	O
potential	O
therapeutic	O
agent	O
for	O
the	O
treatment	O
of	O
neuroinflammatory	O
diseases	O
.	O

Two	O
carry	O
G1	O
cyclin	O
genes	O
,	O
CLN1	O
and	O
CLN2	O
;	O
another	O
carries	O
HCS26	O
,	O
coding	O
for	O
a	O
putative	O
cyclin	O
,	O
a	O
/	O
alpha	O
swi4	O
-	O
mutants	O
exhibit	O
3	O
-	O
to	O
20	O
-	O
fold	O
reductions	O
in	O
the	O
levels	O
of	O
CLN1	O
,	O
CLN2	O
,	O
and	O
HCS26	O
transcripts	O
.	O

Regulation	O
of	O
proline	O
-	O
rich	O
Akt	O
substrate	O
of	O
40	O
kDa	O
(	O
PRAS40	O
)	O
function	O
by	O
mammalian	O
target	O
of	O
rapamycin	O
complex	O
1	O
(	O
mTORC1	O
)	O
-	O
mediated	O
phosphorylation	O
.	O

Phosphorylation	O
of	O
Ser	B-Chemical_Compound
-	I-Chemical_Compound
221	E-Chemical_Compound
and	O
Ser	B-Chemical_Compound
-	I-Chemical_Compound
183	E-Chemical_Compound
but	O
not	O
Ser	B-Chemical_Compound
-	I-Chemical_Compound
212	E-Chemical_Compound
is	O
sensitive	O
to	O
rapamycin	S-Chemical_Compound
treatment	O
.	O

WD40	O
protein	O
FBW5	O
promotes	O
ubiquitination	O
of	O
tumor	O
suppressor	O
TSC2	O
by	O
DDB1	O
-	O
CUL4	O
-	O
ROC1	O
ligase	O
.	O

Overexpression	O
of	O
FBW5	O
or	O
CUL4A	O
promotes	O
TSC2	O
protein	O
degradation	O
,	O
and	O
this	O
is	O
abrogated	O
by	O
the	O
coexpression	O
of	O
TSC1	O
.	O

Ddb1	O
or	O
Cul4	O
mutations	O
in	O
Drosophila	O
result	O
in	O
Gigas	O
/	O
TSC2	O
protein	O
accumulation	O
and	O
cause	O
growth	O
defects	O
that	O
can	O
be	O
partially	O
rescued	O
by	O
Gigas	O
/	O
Tsc2	O
reduction	O
.	O

METHODS	O
:	O
Rat	O
models	O
of	O
AC	O
(	O
biliary	O
tract	O
obstruction	O
+	O
E	O
.	O
coli	O
injection	O
,	O
n	O
=	O
36	O
)	O
and	O
control	O
models	O
(	O
biliary	O
tract	O
obstruction	O
+	O
saline	O
,	O
n	O
=	O
18	O
)	O
were	O
made	O
.	O

RESULTS	O
:	O
Severe	O
liver	O
tissue	O
injury	O
in	O
rats	O
with	O
AC	O
was	O
evident	O
as	O
shown	O
by	O
pathological	O
examination	O
.	O

These	O
results	O
suggest	O
that	O
epigenetic	O
cancer	O
therapy	O
is	O
possible	O
for	O
some	O
cancers	O
in	O
combination	O
with	O
forced	O
p53	O
activation	O
.	O

Fracture	O
repair	O
is	O
a	O
complex	O
regenerative	O
process	O
initiated	O
in	O
response	O
to	O
injury	O
,	O
resulting	O
in	O
optimal	O
restoration	O
of	O
skeletal	O
function	O
.	O

Biomechanical	O
thresholds	O
regulate	O
inflammation	O
through	O
the	O
NF	O
-	O
kappaB	O
pathway	O
:	O
experiments	O
and	O
modeling	O
.	O

Here	O
,	O
we	O
show	O
that	O
induction	O
of	O
EBV	O
lytic	O
program	O
leads	O
to	O
degradation	O
of	O
p53	O
via	O
an	O
ubiquitin	O
-	O
proteasome	O
pathway	O
independent	O
of	O
MDM2	O
.	O

The	O
BZLF1	O
protein	O
directly	O
functions	O
as	O
an	O
adaptor	O
component	O
of	O
the	O
ECS	O
(	O
Elongin	O
B	O
/	O
C	O
-	O
Cul2	O
/	O
5	O
-	O
SOCS	O
-	O
box	O
protein	O
)	O
ubiquitin	O
ligase	O
complex	O
targeting	O
p53	O
for	O
degradation	O
.	O

These	O
effects	O
were	O
not	O
observed	O
following	O
coculture	O
with	O
nonendothelial	O
cell	O
lines	O
.	O

OBJECTIVE	O
:	O
Cyclosporine	B-Chemical_Compound
A	E-Chemical_Compound
(	O
CsA	S-Chemical_Compound
)	O
,	O
known	O
as	O
an	O
effective	O
immunosuppressive	O
agent	O
,	O
is	O
widely	O
used	O
in	O
clinical	O
fields	O
.	O

Inflammation	O
may	O
influence	O
the	O
stem	O
cell	O
niche	O
and	O
tissue	O
regeneration	O
by	O
influencing	O
cellular	O
responses	O
to	O
hypoxia	O
.	O

NFkappaB	O
and	O
ZAS3	O
are	O
transcription	O
factors	O
that	O
control	O
important	O
cellular	O
processes	O
including	O
immunity	O
,	O
cell	O
survival	O
and	O
apoptosis	O
.	O

In	O
this	O
study	O
,	O
using	O
a	O
yeast	O
two	O
-	O
hybrid	O
system	O
and	O
glutathione	O
-	O
S	O
:	O
-	O
transferase	O
pull	O
-	O
down	O
assays	O
,	O
we	O
determined	O
that	O
RanBPM	O
binds	O
to	O
the	O
TRAF6	O
C	O
-	O
terminus	O
through	O
its	O
SPRY	O
motif	O
.	O

In	O
this	O
communication	O
we	O
report	O
that	O
p53	O
-	O
mediated	O
NF	O
-	O
kappaB2	O
up	O
-	O
regulation	O
significantly	O
contributes	O
to	O
the	O
aggressive	O
oncogenic	O
behavior	O
of	O
cancer	O
cells	O
.	O

Lowering	O
the	O
level	O
of	O
mutant	O
p53	O
in	O
a	O
number	O
of	O
cancer	O
cell	O
lines	O
resulted	O
in	O
a	O
loss	O
of	O
GOF	O
phenotypes	O
directly	O
implicating	O
p53	O
mutants	O
in	O
the	O
process	O
.	O

Rp	B-Chemical_Compound
-	I-Chemical_Compound
cAMPS	E-Chemical_Compound
,	O
a	O
cAMP	S-Chemical_Compound
competitor	O
,	O
significantly	O
corrected	O
Nrf2	O
activity	O
in	O
CF	O
cells	O
,	O
predominantly	O
by	O
increasing	O
the	O
nuclear	O
accumulation	O
of	O
the	O
transcription	O
factor	O
.	O

Here	O
we	O
demonstrate	O
that	O
Tax	O
-	O
IRS	O
is	O
driven	O
by	O
the	O
transcriptional	O
activity	O
of	O
NF	O
-	O
kappaB	O
.	O

Propylene	B-Chemical_Compound
glycol	E-Chemical_Compound
(	O
1	B-Chemical_Compound
,	I-Chemical_Compound
2	I-Chemical_Compound
-	I-Chemical_Compound
propanediol	E-Chemical_Compound
)	O
is	O
a	O
solvent	O
in	O
numerous	O
pharmaceuticals	O
and	O
a	O
major	O
preservative	O
and	O
source	O
of	O
carbohydrates	S-Chemical_Compound
in	O
processed	O
foods	O
.	O

(	O
c	O
)	O
2012	O
Wiley	O
Periodicals	O
,	O
Inc	O
.	O

Kinetic	O
analysis	O
showed	O
that	O
both	O
phosphorylated	O
and	O
unmodified	O
factor	O
was	O
able	O
to	O
hydrolyse	O
GTP	S-Chemical_Compound
with	O
approximately	O
the	O
same	O
maximum	O
rate	O
,	O
indicating	O
that	O
the	O
rate	O
of	O
nucleotide	O
exchange	O
was	O
not	O
impaired	O
by	O
the	O
modification	O
.	O

The	O
N	O
-	O
terminal	O
tetrapeptide	O
is	O
essential	O
for	O
lipid	S-Chemical_Compound
binding	O
and	O
lipase	O
activity	O
.	O

The	O
initial	O
step	O
in	O
the	O
degradation	O
pathways	O
of	O
proline	S-Chemical_Compound
and	O
hydroxyproline	S-Chemical_Compound
is	O
catalyzed	O
by	O
proline	O
oxidase	O
and	O
hydroxyproline	O
oxidase	O
,	O
yielding	O
delta	B-Chemical_Compound
1	I-Chemical_Compound
-	I-Chemical_Compound
pyrroline	I-Chemical_Compound
-	I-Chemical_Compound
5	I-Chemical_Compound
-	I-Chemical_Compound
carboxylate	E-Chemical_Compound
and	O
delta	B-Chemical_Compound
1	I-Chemical_Compound
-	I-Chemical_Compound
pyrroline	I-Chemical_Compound
-	I-Chemical_Compound
3	I-Chemical_Compound
-	I-Chemical_Compound
hydroxy	I-Chemical_Compound
-	I-Chemical_Compound
5	I-Chemical_Compound
-	I-Chemical_Compound
carboxylate	E-Chemical_Compound
,	O
respectively	O
.	O

To	O
determine	O
if	O
this	O
second	O
step	O
in	O
the	O
degradation	O
of	O
proline	S-Chemical_Compound
and	O
hydroxyproline	S-Chemical_Compound
is	O
catalyzed	O
by	O
a	O
common	O
or	O
by	O
separate	O
enzyme	O
(	O
s	O
)	O
,	O
we	O
developed	O
a	O
radioisotopic	O
assay	O
for	O
delta	O
1	O
-	O
pyrroline	O
-	O
3	O
-	O
hydroxy	O
-	O
5	O
-	O
carboxylate	O
dehydrogenase	O
activity	O
.	O

We	O
then	O
compared	O
delta1	O
-	O
pyrroline	O
-	O
3	O
-	O
hydroxy	O
-	O
5	O
-	O
carboxylate	O
dehydrogenase	O
activity	O
with	O
that	O
of	O
delta	O
1	O
-	O
pyrroline	O
-	O
5	O
-	O
carboxylate	O
dehydrogenase	O
in	O
fibroblasts	O
and	O
leukocytes	O
from	O
type	O
II	O
hyperprolinemia	O
patients	O
,	O
heterozygotes	O
,	O
and	O
controls	O
.	O

Inositol	O
polyphosphate	O
4	O
-	O
phosphatase	O
,	O
an	O
enzyme	O
of	O
the	O
inositol	B-Chemical_Compound
phosphate	E-Chemical_Compound
signaling	O
pathway	O
,	O
catalyzes	O
the	O
hydrolysis	O
of	O
the	O
4	O
-	O
position	O
phosphate	S-Chemical_Compound
of	O
inositol	B-Chemical_Compound
3	I-Chemical_Compound
,	I-Chemical_Compound
4	I-Chemical_Compound
-	I-Chemical_Compound
bisphosphate	E-Chemical_Compound
,	O
inositol	B-Chemical_Compound
1	I-Chemical_Compound
,	I-Chemical_Compound
3	I-Chemical_Compound
,	I-Chemical_Compound
4	I-Chemical_Compound
-	I-Chemical_Compound
trisphosphate	E-Chemical_Compound
,	O
and	O
phosphatidylinositol	B-Chemical_Compound
3	I-Chemical_Compound
,	I-Chemical_Compound
4	I-Chemical_Compound
-	I-Chemical_Compound
bisphosphate	E-Chemical_Compound
.	O

Polyclonal	O
antiserum	O
directed	O
against	O
the	O
carboxyl	O
terminus	O
of	O
the	O
4	O
-	O
phosphatase	O
immunoprecipitated	O
>	O
95	O
%	O
of	O
the	O
4	O
-	O
phosphatase	O
activity	O
in	O
crude	O
homogenates	O
of	O
rat	O
brain	O
,	O
heart	O
,	O
skeletal	O
muscle	O
,	O
and	O
spleen	O
,	O
suggesting	O
that	O
this	O
enzyme	O
accounts	O
for	O
the	O
4	B-Chemical_Compound
-	I-Chemical_Compound
phosphate	E-Chemical_Compound
activity	O
present	O
in	O
rat	O
tissues	O
.	O

Expression	O
of	O
this	O
cDNA	O
in	O
Escherichia	O
coli	O
produced	O
an	O
active	O
PIP5K	O
.	O

Distinct	O
from	O
the	O
p21	O
/	O
p27	O
family	O
of	O
CDK	O
inhibitors	O
that	O
form	O
ternary	O
complexes	O
with	O
cyclin	O
-	O
CDKs	O
,	O
only	O
binary	O
complexes	O
of	O
p14	O
,	O
p16	O
,	O
and	O
p18	O
were	O
found	O
in	O
association	O
with	O
CDK4	O
and	O
/	O
or	O
CDK6	O
.	O

All	O
these	O
results	O
support	O
the	O
notion	O
that	O
zeta	O
PKC	O
plays	O
a	O
decisive	O
role	O
in	O
NF	O
-	O
kappa	O
B	O
regulation	O
in	O
mammalian	O
cells	O
.	O

These	O
and	O
other	O
results	O
strongly	O
support	O
the	O
idea	O
that	O
Cln	O
proteins	O
function	O
to	O
activate	O
Cdc28	O
at	O
START	O
.	O

Associations	O
of	O
Rho	O
family	O
GTP	S-Chemical_Compound
-	O
binding	O
proteins	O
with	O
enzymes	O
involved	O
in	O
lipid	S-Chemical_Compound
metabolism	O
have	O
been	O
described	O
.	O

Endogenous	O
PC	S-Chemical_Compound
in	O
the	O
insect	O
cells	O
fulfills	O
the	O
lipid	S-Chemical_Compound
requirement	O
for	O
the	O
expressed	O
BDH	O
since	O
enzymatic	O
activity	O
is	O
lost	O
upon	O
digestion	O
with	O
phospholipase	O
A2	O
and	O
restored	O
selectively	O
by	O
reconstitution	O
with	O
PC	S-Chemical_Compound
vesicles	O
.	O

E2F	O
is	O
a	O
family	O
of	O
transcription	O
factors	O
implicated	O
in	O
the	O
regulation	O
of	O
genes	O
required	O
for	O
progression	O
through	O
G1	O
and	O
entry	O
into	O
the	O
S	O
phase	O
.	O

Domain	O
mapping	O
experiments	O
showed	O
that	O
regions	O
of	O
E2F	O
-	O
1	O
and	O
DP	O
-	O
1	O
that	O
are	O
required	O
for	O
stable	O
association	O
of	O
the	O
two	O
proteins	O
were	O
also	O
required	O
for	O
nuclear	O
localization	O
of	O
DP	O
-	O
1	O
.	O

Furthermore	O
,	O
MAPKKK5	O
that	O
was	O
immunoprecipitated	O
from	O
transfected	O
293	O
cells	O
was	O
able	O
to	O
phosphorylate	O
and	O
activate	O
MKK4	O
in	O
vitro	O
,	O
suggesting	O
that	O
MAPKKK5	O
may	O
be	O
an	O
upstream	O
activator	O
of	O
MKK4	O
in	O
the	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
pathway	O
.	O

2	O
.	O

3	O
.	O

The	O
transport	O
of	O
butyrate	S-Chemical_Compound
into	O
the	O
luminal	O
membrane	O
vesicles	O
was	O
enhanced	O
5	O
-	O
fold	O
at	O
pH	O
5	O
.	O
5	O
compared	O
with	O
pH	O
8	O
.	O
0	O
.	O

The	O
Michaelis	O
-	O
Menten	O
constant	O
(	O
Kt	O
)	O
for	O
the	O
transport	O
of	O
pantothenate	S-Chemical_Compound
and	O
biotin	S-Chemical_Compound
in	O
cDNA	O
-	O
transfected	O
cells	O
is	O
4	O
.	O
9	O
+	O
/	O
-	O
1	O
.	O
1	O
and	O
15	O
.	O
1	O
+	O
/	O
-	O
1	O
.	O
2	O
microM	O
,	O
respectively	O
.	O

p53	O
-	O
dependent	O
and	O
-	O
independent	O
regulation	O
of	O
the	O
death	O
receptor	O
KILLER	O
/	O
DR5	O
gene	O
expression	O
in	O
response	O
to	O
genotoxic	O
stress	O
and	O
tumor	O
necrosis	O
factor	O
alpha	O
.	O

TRID	O
(	O
also	O
known	O
as	O
TRAIL	O
-	O
R3	O
)	O
is	O
an	O
antiapoptotic	O
decoy	O
receptor	O
that	O
lacks	O
the	O
cytoplasmic	O
death	O
domain	O
and	O
competes	O
with	O
KILLER	O
/	O
DR5	O
and	O
DR4	O
for	O
binding	O
to	O
TRAIL	O
.	O

Thus	O
,	O
KILLER	O
/	O
DR5	O
appears	O
a	O
bona	O
fide	O
downstream	O
target	O
of	O
p53	O
that	O
is	O
also	O
regulated	O
in	O
a	O
cell	O
type	O
-	O
specific	O
,	O
trigger	O
-	O
dependent	O
,	O
and	O
p53	O
-	O
independent	O
manner	O
.	O

Cyclin	O
B1	O
localization	O
changes	O
dramatically	O
during	O
the	O
cell	O
cycle	O
,	O
precipitously	O
transiting	O
from	O
the	O
cytoplasm	O
to	O
the	O
nucleus	O
at	O
the	O
beginning	O
of	O
mitosis	O
.	O

In	O
support	O
of	O
this	O
hypothesis	O
,	O
we	O
found	O
that	O
treatment	O
of	O
cells	O
with	O
leptomycin	B-Chemical_Compound
B	E-Chemical_Compound
,	O
which	O
disrupted	O
Cyclin	O
B1	O
-	O
CRM1	O
interactions	O
,	O
led	O
to	O
a	O
marked	O
nuclear	O
accumulation	O
of	O
Cyclin	O
B1	O
.	O

In	O
mitosis	O
,	O
Cyclin	O
B1	O
undergoes	O
phosphorylation	O
at	O
several	O
sites	O
,	O
a	O
subset	O
of	O
which	O
have	O
been	O
proposed	O
to	O
play	O
a	O
role	O
in	O
Cyclin	O
B1	O
accumulation	O
in	O
the	O
nucleus	O
.	O

Progression	O
through	O
and	O
completion	O
of	O
mitosis	O
require	O
the	O
actions	O
of	O
the	O
evolutionarily	O
conserved	O
Polo	O
kinase	O
.	O

Linkage	O
of	O
ATM	O
to	O
cell	O
cycle	O
regulation	O
by	O
the	O
Chk2	O
protein	O
kinase	O
.	O

IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
stimulation	O
of	O
epithelial	O
cells	O
did	O
not	O
generate	O
any	O
ROIs	O
and	O
NF	O
-	O
kappaB	O
induction	O
was	O
not	O
influenced	O
by	O
5	B-Biological_Molecule
-	I-Biological_Molecule
LOX	E-Biological_Molecule
inhibitors	O
.	O

However	O
,	O
reintroduction	O
of	O
a	O
functional	O
5	B-Biological_Molecule
-	I-Biological_Molecule
LOX	E-Biological_Molecule
system	O
in	O
these	O
cells	O
allowed	O
ROI	O
production	O
and	O
5	B-Biological_Molecule
-	I-Biological_Molecule
LOX	E-Biological_Molecule
-	O
dependent	O
NF	O
-	O
kappaB	O
activation	O
.	O

The	O
functional	O
contribution	O
of	O
the	O
kappaB	O
-	O
Sp1	S-Biological_Molecule
composite	O
site	O
in	O
P	O
/	O
I	O
-	O
inducible	O
fas	S-Biological_Molecule
promoter	O
activation	O
was	O
verified	O
by	O
using	O
kappaB	O
-	O
Sp1	S-Biological_Molecule
concatamers	O
(	O
-	O
295	O
to	O
-	O
286	O
)	O
in	O
a	O
thymidine	O
kinase	O
promoter	O
-	O
driven	O
reporter	O
construct	O
and	O
native	O
promoter	O
constructs	O
in	O
Jurkat	O
cells	O
overexpressing	O
IkappaB	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
.	O

Transcriptional	O
regulation	O
of	O
the	O
alpha2	B-Biological_Molecule
integrin	E-Biological_Molecule
gene	O
in	O
cells	O
undergoing	O
megakaryocytic	O
differentiation	O
requires	O
a	O
core	O
promoter	O
between	O
bp	O
-	O
30	O
and	O
-	O
92	O
,	O
a	O
silencer	O
between	O
bp	O
-	O
92	O
and	O
-	O
351	O
,	O
and	O
megakaryocytic	O
enhancers	O
in	O
the	O
distal	O
5	O
'	O
flank	O
.	O

We	O
provide	O
a	O
model	O
of	O
megakaryocytic	O
differentiation	O
in	O
which	O
expression	O
of	O
the	O
alpha2	B-Biological_Molecule
integrin	E-Biological_Molecule
gene	O
requires	O
signaling	O
via	O
the	O
MAP	O
kinase	O
pathway	O
to	O
activate	O
two	O
tandem	O
AP1	O
binding	O
sites	O
in	O
the	O
alpha2	B-Biological_Molecule
integrin	E-Biological_Molecule
enhancer	O
.	O

CTCF	S-Biological_Molecule
is	O
a	O
transcriptional	O
repressor	O
of	O
the	O
c	B-Biological_Molecule
-	I-Biological_Molecule
myc	E-Biological_Molecule
gene	O
.	O

We	O
found	O
that	O
:	O
(	O
i	O
)	O
both	O
CTCF	S-Biological_Molecule
mRNA	O
and	O
protein	O
are	O
down	O
-	O
regulated	O
during	O
terminal	O
differentiation	O
in	O
most	O
cell	O
lines	O
tested	O
;	O
(	O
ii	O
)	O
CTCF	S-Biological_Molecule
down	O
-	O
regulation	O
is	O
retarded	O
and	O
less	O
pronounced	O
than	O
that	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
myc	E-Biological_Molecule
;	O
(	O
iii	O
)	O
CTCF	S-Biological_Molecule
protein	O
is	O
differentially	O
phosphorylated	O
and	O
the	O
phosphorylation	O
profiles	O
depend	O
on	O
the	O
differentiation	O
pathway	O
.	O

The	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
transcription	O
factor	O
is	O
required	O
for	O
development	O
of	O
the	O
T	O
-	O
cell	O
lineage	O
and	O
Th2	O
cytokine	O
gene	O
expression	O
in	O
CD4	S-Biological_Molecule
T	O
-	O
cells	O
.	O

To	O
determine	O
whether	O
oxidative	O
stress	O
dependent	O
NF	O
-	O
kappaB	O
activation	O
is	O
evident	O
in	O
patients	O
with	O
diabetic	O
nephropathy	O
we	O
used	O
an	O
Electrophoretic	O
Mobility	O
Shift	O
Assay	O
based	O
semiquantitative	O
detection	O
system	O
which	O
enabled	O
us	O
to	O
determine	O
NF	O
-	O
kappaB	O
activation	O
in	O
ex	O
vivo	O
isolated	O
peripheral	O
blood	O
mononuclear	O
cells	O
.	O

NF	O
-	O
kappaB	O
activation	O
is	O
at	O
least	O
in	O
part	O
dependent	O
on	O
oxidative	O
stress	O
since	O
thioctic	O
acid	O
(	O
alpha	O
-	O
lipoic	O
acid	O
)	O
reduced	O
NF	O
-	O
kappaB	O
binding	O
activity	O
.	O

IFN	O
-	O
alpha	O
enhanced	O
tyrosine	O
phosphorylation	O
of	O
STAT1	S-Biological_Molecule
,	O
STAT3	S-Biological_Molecule
,	O
STAT4	S-Biological_Molecule
,	O
STAT5a	S-Biological_Molecule
,	O
and	O
STAT5b	S-Biological_Molecule
.	O

We	O
previously	O
reported	O
that	O
gold	O
compounds	O
,	O
especially	O
aurothioglucose	O
(	O
AuTG	O
)	O
containing	O
monovalent	O
gold	O
ion	O
,	O
inhibited	O
the	O
DNA	O
-	O
binding	O
of	O
NF	O
-	O
kappaB	O
in	O
vitro	O
.	O

Allergen	O
-	O
specific	O
T	O
cells	O
in	O
atopic	O
patients	O
are	O
polarized	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
-	O
producing	O
Th2	O
cells	O
,	O
promoting	O
IgE	S-Biological_Molecule
synthesis	O
by	O
B	O
cells	O
.	O

In	O
a	O
series	O
of	O
electrophoretic	O
mobility	O
shift	O
assays	O
with	O
protein	O
extracts	O
of	O
highly	O
polarized	O
Th2	O
clones	O
from	O
atopics	O
and	O
Th1	O
clones	O
from	O
controls	O
we	O
compared	O
DNA	O
-	O
binding	O
activities	O
at	O
the	O
two	O
NFAT	O
-	O
binding	O
elements	O
P0	O
and	O
P1	O
of	O
the	O
crucial	O
proximal	O
human	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
promoter	O
.	O

The	O
activation	O
of	O
this	O
nuclear	O
factor	O
is	O
qualitatively	O
different	O
in	O
rheumatoid	O
synovial	O
T	O
cells	O
to	O
that	O
in	O
other	O
forms	O
of	O
non	O
-	O
rheumatoid	O
arthritis	O
(	O
for	O
example	O
,	O
osteoarthritis	O
,	O
spondyloarthropathies	O
)	O
.	O

NAC	O
also	O
inhibited	O
DC	O
responses	O
induced	O
by	O
CD40	S-Biological_Molecule
engagement	O
.	O

LPS	O
-	O
induced	O
NF	O
-	O
kappaB	O
activation	O
was	O
not	O
inhibited	O
by	O
a	O
dominant	O
negative	O
mutant	O
of	O
TRAF2	S-Biological_Molecule
that	O
is	O
involved	O
in	O
TNF	O
signaling	O
.	O

The	O
ability	O
of	O
type	O
I	O
and	O
type	O
II	O
IFNs	O
to	O
inhibit	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
/	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
13	E-Biological_Molecule
-	O
induced	O
STAT6	S-Biological_Molecule
activity	O
is	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
,	O
and	O
is	O
not	O
unique	O
to	O
monocytes	O
because	O
IFNs	O
induce	O
the	O
same	O
effects	O
in	O
fibroblasts	O
.	O

This	O
study	O
demonstrates	O
that	O
changes	O
in	O
endothelial	O
cell	O
GSSG	O
/	O
GSH	O
cause	O
transcription	O
-	O
independent	O
and	O
transcription	O
-	O
dependent	O
surface	O
expression	O
of	O
different	O
endothelial	O
cell	O
adhesion	O
molecules	O
,	O
which	O
leads	O
to	O
a	O
2	O
-	O
phase	O
neutrophil	O
-	O
endothelial	O
adhesion	O
response	O
.	O

Decreased	O
proteasome	O
-	O
mediated	O
degradation	O
in	O
T	O
cells	O
from	O
the	O
elderly	O
:	O
A	O
role	O
in	O
immune	O
senescence	O
.	O

Thus	O
,	O
decreased	O
proteasome	O
-	O
mediated	O
degradation	O
may	O
be	O
central	O
to	O
immune	O
dysfunction	O
that	O
accompanies	O
aging	O
.	O

Copyright	O
1999	O
Academic	O
Press	O
.	O

In	O
CAT	S-Biological_Molecule
reporter	O
constructions	O
no	O
appreciable	O
level	O
of	O
CAT	S-Biological_Molecule
activity	O
was	O
supported	O
by	O
the	O
beta	B-Biological_Molecule
globin	E-Biological_Molecule
promoter	O
,	O
and	O
only	O
low	O
level	O
activity	O
by	O
the	O
delta	S-Biological_Molecule
promoter	O
.	O

Site	O
-	O
directed	O
mutagenesis	O
of	O
binding	O
sites	O
for	O
the	O
repressor	O
proteins	O
BP1	S-Biological_Molecule
and	O
BP2	S-Biological_Molecule
in	O
the	O
upstream	O
portion	O
of	O
the	O
beta	B-Biological_Molecule
globin	E-Biological_Molecule
gene	O
flanking	O
region	O
led	O
to	O
a	O
4	O
-	O
6	O
fold	O
increase	O
in	O
promoter	O
activity	O
.	O

Evidence	O
is	O
presented	O
showing	O
that	O
DFX	O
treatment	O
reduces	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
bioavailability	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
by	O
inhibiting	O
its	O
steady	O
state	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
by	O
enhancing	O
its	O
inactivation	O
through	O
binding	O
to	O
soluble	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	I-Biological_Molecule
receptor	I-Biological_Molecule
type	I-Biological_Molecule
II	E-Biological_Molecule
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

To	O
test	O
this	O
apparent	O
discrepancy	O
,	O
we	O
realized	O
that	O
HTB	O
and	O
triflusal	O
(	O
but	O
neither	O
aspirin	O
nor	O
salicylate	O
)	O
produced	O
a	O
concentration	O
-	O
dependent	O
inhibition	O
of	O
COX	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
protein	O
expression	O
in	O
peripheral	O
human	O
mononuclear	O
cells	O
.	O

The	O
action	O
of	O
glucocorticosteroids	O
is	O
mediated	O
through	O
glucocorticoid	O
receptors	O
present	O
in	O
the	O
cellular	O
cytoplasm	O
.	O

Through	O
these	O
actions	O
glucocorticosteroids	O
are	O
susceptible	O
to	O
modify	O
functions	O
of	O
cells	O
involved	O
in	O
the	O
allergic	O
inflammatory	O
response	O
.	O

Expression	O
of	O
the	O
alpha	O
-	O
chain	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2Ralpha	E-Biological_Molecule
on	O
peripheral	O
blood	O
monocytes	O
(	O
PBM	O
)	O
was	O
induced	O
by	O
M	O
.	O
tuberculosis	O
by	O
flow	O
cytometry	O
evaluation	O
.	O

The	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2Ralpha	E-Biological_Molecule
promoter	O
containing	O
the	O
nuclear	O
factor	O
kappa	O
B	O
(	O
NF	O
-	O
kappaB	O
)	O
site	O
was	O
transcriptionally	O
induced	O
by	O
M	O
.	O
tuberculosis	O
and	O
this	O
NF	O
-	O
kappaB	O
site	O
could	O
confer	O
inducibility	O
to	O
a	O
heterologous	O
herpes	O
thymidine	O
kinase	O
(	O
TK	O
)	O
promoter	O
by	O
M	O
.	O
tuberculosis	O
.	O

Using	O
antibodies	O
against	O
the	O
p50	S-Biological_Molecule
and	O
p65	S-Biological_Molecule
subunits	O
of	O
NF	O
-	O
kappaB	O
in	O
EMSAs	O
,	O
the	O
involvement	O
of	O
both	O
p50	S-Biological_Molecule
and	O
p65	S-Biological_Molecule
proteins	O
was	O
further	O
demonstrated	O
.	O

Treatment	O
of	O
T	O
cells	O
with	O
a	O
variety	O
of	O
stimuli	O
,	O
including	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
,	O
leads	O
to	O
the	O
translocation	O
of	O
the	O
active	O
p65	O
-	O
50	O
heterodimer	O
to	O
the	O
nucleus	O
,	O
albeit	O
at	O
a	O
lower	O
level	O
in	O
T	O
cells	O
from	O
the	O
elderly	O
.	O

Next	O
,	O
we	O
demonstrated	O
that	O
these	O
viral	O
ligands	O
directly	O
up	O
-	O
regulated	O
monocyte	O
gene	O
expression	O
upon	O
their	O
binding	O
to	O
their	O
appropriate	O
cellular	O
receptors	O
.	O

Because	O
these	O
induced	O
gene	O
products	O
have	O
NF	O
-	O
kappaB	O
sites	O
in	O
their	O
promoter	O
regions	O
,	O
we	O
next	O
examined	O
whether	O
there	O
was	O
an	O
up	O
-	O
regulation	O
of	O
nuclear	O
NF	O
-	O
kappaB	O
levels	O
.	O

Lastly	O
,	O
we	O
demonstrated	O
that	O
p38	O
kinase	O
activity	O
played	O
a	O
central	O
role	O
in	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
production	O
and	O
that	O
it	O
was	O
rapidly	O
up	O
-	O
regulated	O
following	O
infection	O
.	O

We	O
conclude	O
that	O
okadaic	O
acid	O
-	O
induced	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
gene	O
expression	O
is	O
at	O
least	O
partly	O
mediated	O
through	O
the	O
ERK1	O
/	O
2	O
and	O
JNK	O
pathway	O
-	O
dependent	O
activation	O
of	O
NF	O
-	O
kappa	O
B	O
transcriptional	O
capacity	O
.	O

Although	O
it	O
can	O
be	O
incorporated	O
into	O
the	O
DNA	O
of	O
dividing	O
cells	O
,	O
fludarabine	O
is	O
also	O
a	O
potent	O
inhibitor	O
of	O
cells	O
with	O
a	O
low	O
growth	O
fraction	O
,	O
thus	O
it	O
must	O
have	O
other	O
mechanisms	O
of	O
action	O
.	O

This	O
loss	O
of	O
STAT1	S-Biological_Molecule
was	O
also	O
seen	O
in	O
cells	O
from	O
patients	O
treated	O
with	O
fludarabine	O
in	O
vivo	O
.	O

These	O
conflicting	O
observations	O
may	O
be	O
due	O
to	O
different	O
effects	O
of	O
anti	O
-	O
inflammatory	O
agents	O
on	O
adhesion	O
molecule	O
and	O
Hsp	O
expression	O
in	O
EC	O
,	O
respectively	O
.	O

In	O
this	O
study	O
we	O
show	O
that	O
a	O
novel	O
elastase	O
inhibitor	O
,	O
guamerin	O
-	O
derived	O
synthetic	O
peptide	O
(	O
GDSP	O
)	O
,	O
improves	O
the	O
parameters	O
of	O
cerulein	O
-	O
induced	O
acute	O
pancreatitis	O
in	O
the	O
rat	O
.	O

GDSP	O
also	O
completely	O
inhibited	O
superoxide	O
formation	O
in	O
the	O
human	O
neutrophils	O
stimulated	O
by	O
N	O
-	O
formyl	O
-	O
methionine	O
-	O
leucine	O
-	O
phenyl	O
-	O
alanine	O
(	O
fMLP	O
)	O
or	O
12	O
-	O
O	O
-	O
tetradecanoylphorbol	O
-	O
13	O
-	O
acetate	O
(	O
TPA	O
)	O
.	O

A	O
common	O
feature	O
of	O
all	O
stages	O
of	O
atherosclerosis	O
is	O
inflammation	O
of	O
the	O
vessel	O
wall	O
.	O

Moreover	O
,	O
ANG	O
II	O
stimulated	O
NF	O
-	O
kappaB	O
activation	O
in	O
human	O
monocytes	O
,	O
but	O
not	O
in	O
lymphocytes	O
from	O
the	O
same	O
preparation	O
.	O

Propagation	O
of	O
signals	O
from	O
the	O
T	O
cell	O
antigen	O
receptor	O
(	O
TCR	O
)	O
involves	O
a	O
number	O
of	O
adaptor	O
molecules	O
.	O

In	O
contrast	O
,	O
Grb2	S-Biological_Molecule
can	O
be	O
coimmunoprecipitated	O
with	O
Sos1	S-Biological_Molecule
and	O
Sos2	S-Biological_Molecule
but	O
not	O
with	O
SLP	B-Biological_Molecule
-	I-Biological_Molecule
76	E-Biological_Molecule
.	O

Most	O
erythroleukemic	O
cell	O
lines	O
established	O
in	O
vitro	O
coexpress	O
erythrocytic	O
and	O
megakaryocytic	O
markers	O
that	O
often	O
are	O
associated	O
with	O
expression	O
of	O
Spi	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
/	O
or	O
Fli	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
transcription	O
factors	O
known	O
as	O
transactivators	O
of	O
megakaryocyte	O
-	O
specific	O
promoters	O
.	O

Endotoxin	O
(	O
LPS	O
)	O
signal	O
transduction	O
in	O
human	O
monocytes	O
leads	O
to	O
activation	O
of	O
nuclear	O
factor	O
-	O
kappa	O
B	O
(	O
NF	O
-	O
kappaB	O
)	O
and	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
release	O
.	O

Lymphocytes	O
were	O
significantly	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
more	O
sensitive	O
to	O
the	O
direct	O
cytotoxic	O
effects	O
of	O
SMX	O
-	O
NO	O
than	O
neutrophils	O
.	O

6	O
.	O

Beta	B-Biological_Molecule
-	I-Biological_Molecule
catenin	E-Biological_Molecule
is	O
the	O
vertebrate	O
homolog	O
of	O
the	O
Drosophila	O
segment	O
polarity	O
gene	O
Armadillo	O
and	O
plays	O
roles	O
in	O
both	O
cell	O
-	O
cell	O
adhesion	O
and	O
transduction	O
of	O
the	O
Wnt	O
signaling	O
cascade	O
.	O

This	O
enzyme	O
releases	O
arachidonic	O
acid	O
and	O
lyso	O
-	O
phospholipids	O
from	O
membranes	O
which	O
are	O
metabolized	O
to	O
eicosanoids	O
and	O
platelet	O
-	O
activating	O
-	O
factor	O
.	O

Consequently	O
,	O
cytosolic	O
activation	O
,	O
nuclear	O
translocation	O
and	O
DNA	O
-	O
binding	O
of	O
nuclear	O
factor	O
-	O
kappaB	O
were	O
decreased	O
.	O

Molecular	O
regulation	O
of	O
cytokine	O
gene	O
expression	O
during	O
the	O
immune	O
response	O
.	O

Cytokine	O
expression	O
by	O
immune	O
system	O
cells	O
plays	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
the	O
immune	O
response	O
.	O

Targeted	O
mutational	O
analysis	O
demonstrated	O
that	O
a	O
tandem	O
NF	O
-	O
kappa	O
B	O
/	O
Rel	O
binding	O
motif	O
is	O
critical	O
for	O
the	O
gamma	O
3	O
ECS	O
responsiveness	O
to	O
both	O
CD40L	S-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
,	O
while	O
a	O
STAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
-	O
binding	O
site	O
is	O
additionally	O
required	O
for	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
inducibility	O
.	O

We	O
investigated	O
the	O
mechanisms	O
by	O
which	O
proinflammatory	O
mediator	O
,	O
thrombin	S-Biological_Molecule
,	O
released	O
during	O
intravascular	O
coagulation	O
and	O
tissue	O
injury	O
,	O
induces	O
ICAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
(	O
CD54	S-Biological_Molecule
)	O
expression	O
in	O
endothelial	O
cells	O
.	O

Fibroblast	B-Biological_Molecule
growth	I-Biological_Molecule
factor	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
(	O
FGF	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
)	O
enhances	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
production	O
and	O
nuclear	O
translocation	O
of	O
NF	O
-	O
kappaB	O
in	O
FGF	O
receptor	O
-	O
bearing	O
Jurkat	O
T	O
cells	O
.	O

Analogous	O
to	O
costimulation	O
via	O
CD28	S-Biological_Molecule
,	O
this	O
activity	O
is	O
mediated	O
through	O
activation	O
of	O
Rel	O
/	O
kappaB	O
,	O
a	O
family	O
of	O
transcription	O
factors	O
known	O
to	O
regulate	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
and	O
other	O
activation	O
-	O
inducible	O
proteins	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
signaling	O
through	O
the	O
TNF	O
receptor	O
family	O
member	O
,	O
the	O
lymphotoxin	B-Biological_Molecule
-	I-Biological_Molecule
beta	I-Biological_Molecule
(	I-Biological_Molecule
LT	I-Biological_Molecule
-	I-Biological_Molecule
beta	I-Biological_Molecule
)	I-Biological_Molecule
receptor	E-Biological_Molecule
(	O
LT	B-Biological_Molecule
-	I-Biological_Molecule
betaR	E-Biological_Molecule
)	O
,	O
also	O
regulates	O
HIV	O
-	O
1	O
replication	O
.	O

Our	O
data	O
demonstrate	O
that	O
those	O
cell	O
lines	O
lacking	O
capability	O
to	O
form	O
metastatic	O
tumors	O
in	O
vivo	O
are	O
susceptible	O
to	O
TNF	O
induced	O
apoptosis	O
in	O
vitro	O
.	O

C5a	O
,	O
a	O
potent	O
peptide	O
chemoattractant	O
,	O
stimulates	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
(	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
)	O
secretion	O
from	O
peripheral	O
blood	O
mononuclear	O
cells	O
(	O
PBMC	O
)	O
.	O

Packaging	O
of	O
viral	O
particles	O
,	O
integration	O
into	O
the	O
target	O
genome	O
,	O
and	O
stability	O
of	O
the	O
integrated	O
provirus	O
are	O
not	O
affected	O
by	O
the	O
LTR	O
modification	O
.	O

We	O
developed	O
unicellular	O
culture	O
systems	O
for	O
unilineage	O
differentiation	O
of	O
purified	O
hematopoietic	O
progenitor	O
cells	O
followed	O
by	O
daughter	O
cell	O
analysis	O
at	O
cellular	O
and	O
molecular	O
level	O
.	O

By	O
comparing	O
the	O
expression	O
of	O
genes	O
controlling	O
apoptosis	O
,	O
including	O
those	O
encoding	O
several	O
members	O
of	O
the	O
BCL	O
-	O
2	O
family	O
of	O
proteins	O
,	O
the	O
known	O
relative	O
resistance	O
of	O
EBV	O
-	O
immortalized	O
B	O
-	O
cell	O
lines	O
to	O
apoptosis	O
induced	O
by	O
low	O
serum	O
was	O
found	O
to	O
correlate	O
with	O
expression	O
of	O
both	O
BCL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
and	O
A20	S-Biological_Molecule
.	O

Immortalization	O
of	O
CD4	S-Biological_Molecule
(	O
+	O
)	O
and	O
CD8	O
(	O
+	O
)	O
T	O
lymphocytes	O
by	O
human	O
T	O
-	O
cell	O
leukemia	O
virus	O
type	O
1	O
Tax	S-Biological_Molecule
mutants	O
expressed	O
in	O
a	O
functional	O
molecular	O
clone	O
.	O

Furthermore	O
,	O
Id3	S-Biological_Molecule
impedes	O
expression	O
of	O
recombination	O
activating	O
genes	O
and	O
downregulates	O
pre	O
-	O
Talpha	O
mRNA	O
.	O

This	O
correlated	O
with	O
the	O
initiation	O
of	O
signaling	O
downstream	O
of	O
Notch	O
,	O
as	O
evidenced	O
by	O
increased	O
levels	O
of	O
HES	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
transcripts	O
in	O
co	O
-	O
cultivated	O
T	O
cells	O
and	O
of	O
CD23	S-Biological_Molecule
transcripts	O
in	O
co	O
-	O
cultivated	O
B	O
cells	O
.	O

OBJECTIVE	O
:	O
We	O
aimed	O
to	O
find	O
the	O
transcriptional	O
mechanisms	O
that	O
regulate	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
gene	O
to	O
selectively	O
control	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
synthesis	O
.	O

Regulation	O
of	O
low	O
shear	O
flow	O
-	O
induced	O
HAEC	O
VCAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
expression	O
and	O
monocyte	O
adhesion	O
.	O

However	O
,	O
we	O
report	O
in	O
vitro	O
experimental	O
studies	O
in	O
which	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
primed	O
leukocytes	O
and	O
led	O
to	O
an	O
enhanced	O
production	O
of	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	E-Biological_Molecule
(	O
TNF	S-Biological_Molecule
)	O
upon	O
further	O
stimulation	O
by	O
lipopolysaccharide	O
(	O
LPS	O
)	O
.	O

When	O
isolated	O
PBMC	O
were	O
first	O
cultured	O
for	O
20	O
h	O
in	O
the	O
presence	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
on	O
Teflon	O
to	O
prevent	O
adherence	O
,	O
washed	O
to	O
remove	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
and	O
then	O
further	O
cultured	O
in	O
plastic	O
dishes	O
for	O
an	O
additional	O
20	O
h	O
in	O
the	O
presence	O
of	O
LPS	O
or	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
,	O
an	O
enhanced	O
release	O
of	O
TNF	S-Biological_Molecule
was	O
observed	O
.	O

Different	O
sequence	O
requirements	O
for	O
expression	O
in	O
erythroid	O
and	O
megakaryocytic	O
cells	O
within	O
a	O
regulatory	O
element	O
upstream	O
of	O
the	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
gene	O
.	O

Strict	O
dependence	O
of	O
HS	O
I	O
activity	O
on	O
a	O
GATA	O
site	O
implies	O
that	O
assembly	O
of	O
a	O
protein	O
complex	O
containing	O
a	O
GATA	O
-	O
factor	O
,	O
presumably	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
or	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
,	O
is	O
critical	O
to	O
activating	O
or	O
maintaining	O
its	O
function	O
.	O

Adhesion	O
assays	O
under	O
physiological	O
shear	O
flow	O
conditions	O
showed	O
that	O
firm	O
arrest	O
,	O
spreading	O
,	O
and	O
transmigration	O
of	O
monocytes	O
on	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
-	O
activated	O
endothelium	O
was	O
markedly	O
inhibited	O
by	O
IkappaB	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
overexpression	O
.	O

In	O
this	O
report	O
,	O
we	O
show	O
that	O
two	O
tyrosines	O
,	O
Tyr	O
-	O
113	O
and	O
Tyr	O
-	O
128	O
,	O
of	O
SLP	B-Biological_Molecule
-	I-Biological_Molecule
76	E-Biological_Molecule
are	O
required	O
for	O
its	O
binding	O
to	O
Vav	S-Biological_Molecule
,	O
both	O
in	O
vitro	O
and	O
in	O
intact	O
cells	O
.	O

These	O
results	O
point	O
out	O
the	O
involvement	O
of	O
NF	O
-	O
kappa	O
B	O
/	O
Rel	O
family	O
proteins	O
in	O
growth	O
signaling	O
pathways	O
by	O
either	O
regulating	O
proteins	O
involved	O
in	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
signaling	O
or	O
by	O
functionally	O
interfering	O
with	O
the	O
cell	O
cycle	O
progression	O
.	O

LP	O
T	O
cells	O
exhibit	O
enhanced	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
secretion	O
when	O
activated	O
through	O
the	O
CD2	O
pathway	O
.	O

Furthermore	O
,	O
CD28	S-Biological_Molecule
coligation	O
fails	O
to	O
enhance	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
promoter	O
-	O
reporter	O
or	O
RE	O
/	O
AP	O
construct	O
expression	O
in	O
CD2	O
-	O
activated	O
LPMC	O
.	O

Here	O
we	O
show	O
that	O
the	O
lymphoid	O
lineage	O
-	O
determining	O
factors	O
Ikaros	S-Biological_Molecule
and	O
Aiolos	S-Biological_Molecule
can	O
function	O
as	O
strong	O
transcriptional	O
repressors	O
.	O

Therefore	O
,	O
IRF	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
may	O
be	O
an	O
important	O
contributor	O
to	O
IL	O
-	O
12	O
signaling	O
,	O
and	O
we	O
speculate	O
that	O
the	O
defective	O
IL	O
-	O
12	O
responses	O
seen	O
in	O
IRF	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
-	O
/	O
-	O
mice	O
might	O
be	O
attributable	O
,	O
in	O
part	O
,	O
to	O
the	O
absence	O
of	O
this	O
transcription	O
factor	O
.	O

In	O
this	O
review	O
,	O
we	O
summarize	O
our	O
current	O
understanding	O
of	O
the	O
transcriptional	O
regulation	O
of	O
T	O
cell	O
development	O
and	O
function	O
with	O
particular	O
emphasis	O
on	O
the	O
results	O
of	O
recent	O
gene	O
targeting	O
and	O
transgenic	O
experiments	O
.	O

We	O
find	O
that	O
PU	B-Biological_Molecule
.	I-Biological_Molecule
1	E-Biological_Molecule
interacts	O
directly	O
with	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
a	O
zinc	O
finger	O
transcription	O
factor	O
required	O
for	O
erythroid	O
differentiation	O
.	O

We	O
also	O
show	O
that	O
ectopic	O
expression	O
of	O
PU	B-Biological_Molecule
.	I-Biological_Molecule
1	E-Biological_Molecule
in	O
Xenopus	O
embryos	O
is	O
sufficient	O
to	O
block	O
erythropoiesis	O
during	O
normal	O
development	O
.	O

Clinicians	O
are	O
only	O
just	O
beginning	O
to	O
recognize	O
subclinical	O
markers	O
of	O
response	O
,	O
and	O
it	O
may	O
soon	O
be	O
possible	O
to	O
predict	O
response	O
on	O
the	O
basis	O
of	O
genetic	O
composition	O
.	O

Only	O
through	O
considered	O
evaluation	O
of	O
clinical	O
evidence	O
may	O
clinicians	O
determine	O
which	O
therapies	O
should	O
remain	O
novelties	O
and	O
which	O
should	O
become	O
an	O
accepted	O
part	O
of	O
the	O
armamentarium	O
.	O

The	O
intracellular	O
parasite	O
Theileria	O
parva	O
protects	O
infected	O
T	O
cells	O
from	O
apoptosis	O
.	O

A	O
high	O
expression	O
of	O
WT1	S-Biological_Molecule
has	O
been	O
detected	O
in	O
a	O
range	O
of	O
acute	O
leukemias	O
,	O
and	O
WT1	S-Biological_Molecule
is	O
downregulated	O
during	O
induced	O
differentiation	O
of	O
some	O
leukemic	O
cell	O
lines	O
.	O

Overexpression	O
of	O
WT1	S-Biological_Molecule
in	O
some	O
myeloid	O
cell	O
lines	O
confers	O
resistance	O
to	O
differentiation	O
induction	O
.	O

Inhibition	O
of	O
NF	O
-	O
kappaB	O
transcriptional	O
activity	O
and	O
promotion	O
of	O
IkappaBalpha	S-Biological_Molecule
degradation	O
.	O

DZA	O
inhibits	O
the	O
transcriptional	O
activity	O
of	O
NF	O
-	O
kappaB	O
through	O
the	O
hindrance	O
of	O
p65	S-Biological_Molecule
(	O
Rel	B-Biological_Molecule
-	I-Biological_Molecule
A	E-Biological_Molecule
)	O
phosphorylation	O
without	O
reduction	O
of	O
its	O
nuclear	O
translocation	O
and	O
DNA	O
binding	O
activity	O
.	O

The	O
reduction	O
of	O
IkappaBalpha	S-Biological_Molecule
by	O
DZA	O
is	O
neither	O
involved	O
in	O
IkappaB	O
kinase	O
complex	O
activation	O
nor	O
modulated	O
by	O
the	O
addition	O
of	O
homocysteine	O
.	O

STAT1	S-Biological_Molecule
activity	O
was	O
evident	O
on	O
the	O
STAT	O
binding	O
sequences	O
(	O
SBE	O
)	O
present	O
in	O
the	O
promoters	O
of	O
genes	O
which	O
are	O
up	O
-	O
regulated	O
during	O
monocyte	O
to	O
macrophage	O
maturation	O
such	O
as	O
FcgammaRI	S-Biological_Molecule
and	O
ICAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
and	O
in	O
the	O
promoter	O
of	O
the	O
transcription	O
factor	O
IFN	B-Biological_Molecule
regulatory	I-Biological_Molecule
factor	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
.	O

Some	O
pulmonary	O
diseases	O
like	O
bronchitis	O
or	O
asthma	O
bronchiale	O
are	O
mediated	O
by	O
inflammatory	O
mechanisms	O
in	O
bronchial	O
epithelial	O
cells	O
.	O

Protein	O
tyrosine	O
kinase	O
activity	O
,	O
NF	O
-	O
kappaB	O
activity	O
,	O
and	O
the	O
synthesis	O
of	O
cytokine	O
-	O
specific	O
mRNA	O
were	O
inhibited	O
by	O
antioxidants	O
.	O

These	O
data	O
suggest	O
a	O
ROI	O
-	O
dependent	O
NF	O
-	O
kappaB	O
mediated	O
transcription	O
of	O
inflammatory	O
cytokines	O
in	O
bronchial	O
epithelial	O
cells	O
.	O

In	O
addition	O
to	O
Bcl	B-Biological_Molecule
-	I-Biological_Molecule
x	E-Biological_Molecule
,	O
a	O
known	O
CD40	S-Biological_Molecule
-	O
regulated	O
antiapoptotic	O
molecule	O
,	O
we	O
identified	O
a	O
related	O
antiapoptotic	O
molecule	O
,	O
A1	B-Biological_Molecule
/	I-Biological_Molecule
Bfl	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
as	O
a	O
CD40	S-Biological_Molecule
-	O
inducible	O
gene	O
.	O

Clusters	O
of	O
genes	O
expressed	O
by	O
stromal	O
cells	O
and	O
lymphocytes	O
in	O
the	O
breast	O
tumors	O
also	O
were	O
identified	O
in	O
this	O
analysis	O
.	O

We	O
have	O
found	O
that	O
Bcl	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
overexpression	O
leads	O
to	O
the	O
prevention	O
of	O
chemotherapy	O
(	O
paclitaxel	O
)	O
-	O
induced	O
expression	O
of	O
FasL	S-Biological_Molecule
and	O
blocks	O
paclitaxel	O
-	O
induced	O
apoptosis	O
.	O

Thus	O
,	O
it	O
appears	O
that	O
paclitaxel	O
and	O
other	O
drugs	O
that	O
disturb	O
microtubule	O
function	O
kill	O
cells	O
at	O
least	O
in	O
part	O
through	O
the	O
induction	O
of	O
FasL	S-Biological_Molecule
.	O

Oct	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
a	O
POU	O
domain	O
transcription	O
factor	O
,	O
was	O
identified	O
as	O
a	O
repressor	O
of	O
HLA	O
-	O
DRA	O
promoter	O
activity	O
in	O
the	O
Rb	S-Biological_Molecule
-	O
defective	O
cells	O
.	O

These	O
results	O
indicate	O
that	O
within	O
the	O
TCR	O
/	O
CD3	O
signal	O
transduction	O
pathway	O
both	O
PKC	O
and	O
calcineurin	O
are	O
required	O
for	O
the	O
effective	O
activation	O
of	O
the	O
IKK	O
complex	O
and	O
NF	O
-	O
kappaB	O
in	O
T	O
lymphocytes	O
.	O

Eosinophil	B-Biological_Molecule
granule	I-Biological_Molecule
major	I-Biological_Molecule
basic	I-Biological_Molecule
protein	E-Biological_Molecule
(	O
MBP	S-Biological_Molecule
)	O
is	O
expressed	O
exclusively	O
in	O
eosinophils	O
and	O
basophils	O
in	O
hematopoietic	O
cells	O
.	O

In	O
the	O
cell	O
line	O
HT93A	O
,	O
which	O
is	O
capable	O
of	O
differentiating	O
towards	O
both	O
the	O
eosinophil	O
and	O
neutrophil	O
lineages	O
in	O
response	O
to	O
retinoic	O
acid	O
(	O
RA	O
)	O
,	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBPalpha	E-Biological_Molecule
mRNA	O
expression	O
decreased	O
significantly	O
concomitant	O
with	O
eosinophilic	O
and	O
neutrophilic	O
differentiation	O
,	O
whereas	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBPbeta	E-Biological_Molecule
expression	O
was	O
markedly	O
increased	O
.	O

Tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	E-Biological_Molecule
(	O
TNF	S-Biological_Molecule
)	O
and	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
7	E-Biological_Molecule
(	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
7	E-Biological_Molecule
)	O
,	O
secreted	O
during	O
this	O
interaction	O
,	O
are	O
critical	O
cytokines	O
for	O
HIV	O
long	O
terminal	O
repeat	O
transactivation	O
through	O
NF	O
-	O
kappaB	O
-	O
dependent	O
activation	O
.	O

Although	O
the	O
role	O
of	O
CD28	S-Biological_Molecule
in	O
T	O
cell	O
costimulation	O
is	O
firmly	O
established	O
,	O
the	O
mechanisms	O
by	O
which	O
it	O
exerts	O
its	O
costimulatory	O
actions	O
are	O
less	O
clear	O
.	O

NF	O
-	O
kappaB	O
nuclear	O
translocation	O
is	O
secondary	O
to	O
the	O
phosphorylation	O
and	O
subsequent	O
degradation	O
of	O
the	O
NF	O
-	O
kappaB	O
inhibitory	O
molecule	O
IkappaBalpha	S-Biological_Molecule
.	O

IkappaBalpha	S-Biological_Molecule
degradation	O
and	O
NF	O
-	O
kappaB	O
nuclear	O
translocation	O
correlate	O
with	O
transcriptional	O
activation	O
of	O
the	O
inflammatory	O
cytokines	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
.	O

We	O
further	O
explored	O
the	O
effect	O
of	O
dopamine	O
in	O
the	O
presence	O
of	O
phorbol	O
esters	O
or	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
(	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
)	O
known	O
to	O
activate	O
NF	O
-	O
kappaB	O
.	O

The	O
combination	O
of	O
dopamine	O
and	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
led	O
to	O
a	O
stimulation	O
of	O
HIV	O
-	O
1	O
transcription	O
and	O
replication	O
.	O

However	O
,	O
in	O
contrast	O
with	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
,	O
dopamine	O
treatment	O
did	O
not	O
affect	O
NF	O
-	O
kappaB	O
DNA	O
binding	O
activity	O
nor	O
the	O
concentrations	O
of	O
p50	S-Biological_Molecule
,	O
p65	S-Biological_Molecule
and	O
IkappaB	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
proteins	O
,	O
which	O
suggests	O
a	O
distinct	O
NF	O
-	O
kappaB	O
activation	O
mechanism	O
.	O

Because	O
the	O
elevated	O
Myb	O
:	O
Maf	O
status	O
seen	O
in	O
differentiating	O
cells	O
can	O
be	O
recapitulated	O
by	O
overexpression	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Maf	E-Biological_Molecule
in	O
myeloid	O
cell	O
lines	O
,	O
we	O
inducibly	O
expressed	O
the	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Maf	E-Biological_Molecule
cDNA	O
in	O
2	O
bipotent	O
human	O
myeloid	O
progenitor	O
cells	O
.	O

Neutrophil	O
maturation	O
and	O
the	O
role	O
of	O
retinoic	O
acid	O
.	O

Here	O
we	O
present	O
a	O
review	O
of	O
the	O
mechanism	O
of	O
retinoic	O
acid	O
receptor	O
action	O
and	O
the	O
major	O
evidence	O
showing	O
that	O
normal	O
retinoid	O
signaling	O
is	O
required	O
for	O
neutrophil	O
maturation	O
.	O

However	O
,	O
the	O
mechanism	O
by	O
which	O
IFNs	O
mediate	O
this	O
inhibition	O
has	O
not	O
been	O
defined	O
.	O

ROS	O
generation	O
inhibition	O
paralleled	O
NF	O
-	O
kappaB	O
levels	O
in	O
the	O
nucleus	O
.	O

In	O
circulating	O
T	O
cells	O
from	O
a	O
subset	O
of	O
patients	O
with	O
RCCs	O
,	O
the	O
suppression	O
of	O
NFkappaB	O
binding	O
activity	O
is	O
downstream	O
from	O
the	O
stimulus	O
-	O
induced	O
degradation	O
of	O
the	O
cytoplasmic	O
factor	O
IkappaBalpha	S-Biological_Molecule
.	O

The	O
inhibitory	O
agent	O
has	O
several	O
features	O
characteristic	O
of	O
a	O
ganglioside	O
,	O
including	O
sensitivity	O
to	O
neuraminidase	O
but	O
not	O
protease	O
treatment	O
;	O
hydrophobicity	O
;	O
and	O
molecular	O
weight	O
less	O
than	O
3	O
kDa	O
.	O

The	O
flow	O
of	O
information	O
from	O
calcium	O
-	O
mobilizing	O
receptors	O
to	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NFAT	O
)	O
-	O
dependent	O
genes	O
is	O
critically	O
dependent	O
on	O
interaction	O
between	O
the	O
phosphatase	O
calcineurin	O
and	O
the	O
transcription	O
factor	O
NFAT	O
.	O

LTB4	O
increased	O
the	O
expression	O
of	O
the	O
c	B-Biological_Molecule
-	I-Biological_Molecule
fos	E-Biological_Molecule
gene	O
in	O
a	O
time	O
-	O
and	O
concentration	O
-	O
dependent	O
manner	O
.	O

The	O
binding	O
of	O
ISGF3	O
(	O
IFN	O
-	O
stimulated	O
gene	O
factor	O
3	O
)	O
to	O
the	O
conserved	O
IFN	O
-	O
stimulated	O
response	O
element	O
(	O
ISRE	O
)	O
results	O
in	O
transcriptional	O
activation	O
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Moreover	O
,	O
this	O
site	O
is	O
occupied	O
by	O
BSAP	S-Biological_Molecule
in	O
vivo	O
in	O
a	O
CD19	S-Biological_Molecule
-	O
expressing	O
B	O
-	O
cell	O
line	O
but	O
not	O
in	O
plasma	O
or	O
HeLa	O
cells	O
.	O

However	O
,	O
CsA	O
and	O
FK506	O
inhibit	O
the	O
appearance	O
of	O
DNA	O
binding	O
activity	O
of	O
factors	O
that	O
bind	O
to	O
the	O
NF	O
-	O
AT	O
and	O
AP	O
-	O
1	O
sites	O
in	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
enhancer	O
.	O

This	O
phase	O
can	O
occur	O
to	O
some	O
extent	O
outside	O
of	O
the	O
thymus	O
.	O

Second	O
is	O
a	O
controlled	O
phase	O
of	O
TCR	O
gene	O
rearrangement	O
.	O

Negative	O
selection	O
in	O
the	O
cortex	O
appears	O
to	O
be	O
a	O
suicidal	O
inversion	O
of	O
antigen	O
responsiveness	O
:	O
instead	O
of	O
turning	O
on	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
expression	O
,	O
the	O
activated	O
cell	O
destroys	O
its	O
own	O
chromatin	O
.	O

It	O
is	O
interesting	O
that	O
in	O
humans	O
and	O
rats	O
,	O
cortical	O
thymocytes	O
undergoing	O
negative	O
selection	O
can	O
still	O
induce	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2R	I-Biological_Molecule
alpha	E-Biological_Molecule
expression	O
and	O
even	O
be	O
rescued	O
in	O
vitro	O
,	O
if	O
exogenous	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
is	O
provided	O
.	O

Perhaps	O
murine	O
thymocytes	O
are	O
denied	O
this	O
form	O
of	O
rescue	O
because	O
they	O
shut	O
off	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2R	I-Biological_Molecule
beta	I-Biological_Molecule
chain	E-Biological_Molecule
expression	O
at	O
an	O
earlier	O
stage	O
or	O
because	O
they	O
may	O
be	O
uncommonly	O
Bcl	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
deficient	O
(	O
cf	O
.	O
Sentman	O
et	O
al	O
.	O
,	O
1991	O
;	O
Strasser	O
et	O
al	O
.	O
,	O
1991	O
)	O
.	O

The	O
present	O
work	O
has	O
examined	O
the	O
effects	O
of	O
okadaic	O
acid	O
,	O
an	O
inhibitor	O
of	O
type	B-Biological_Molecule
1	E-Biological_Molecule
and	O
2A	B-Biological_Molecule
protein	I-Biological_Molecule
phosphatases	E-Biological_Molecule
,	O
on	O
the	O
regulation	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
jun	E-Biological_Molecule
expression	O
during	O
monocytic	O
differentiation	O
of	O
U	O
-	O
937	O
leukemia	O
cells	O
.	O

c	B-Biological_Molecule
-	I-Biological_Molecule
jun	E-Biological_Molecule
mRNA	O
levels	O
were	O
superinduced	O
in	O
cells	O
treated	O
with	O
both	O
okadaic	O
acid	O
and	O
cycloheximide	O
,	O
whereas	O
inhibition	O
of	O
protein	O
synthesis	O
had	O
little	O
,	O
if	O
any	O
,	O
effect	O
on	O
okadaic	O
acid	O
-	O
induced	O
c	B-Biological_Molecule
-	I-Biological_Molecule
jun	E-Biological_Molecule
transcription	O
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Enhanced	O
NF	O
-	O
kappa	O
B	O
binding	O
activity	O
is	O
followed	O
by	O
functional	O
activation	O
in	O
that	O
inducibility	O
of	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	I-Biological_Molecule
receptor	I-Biological_Molecule
alpha	I-Biological_Molecule
chain	E-Biological_Molecule
is	O
mediated	O
by	O
enhanced	O
NF	O
-	O
kappa	O
B	O
binding	O
and	O
that	O
a	O
heterologous	O
promoter	O
containing	O
the	O
NF	O
-	O
kappa	O
B	O
consensus	O
sequence	O
(	O
-	O
291	O
to	O
-	O
245	O
)	O
of	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	I-Biological_Molecule
receptor	I-Biological_Molecule
alpha	I-Biological_Molecule
chain	E-Biological_Molecule
gene	O
is	O
activated	O
.	O

A	O
modest	O
(	O
20	O
-	O
50	O
%	O
)	O
reduction	O
in	O
TNF	S-Biological_Molecule
promoter	O
activity	O
was	O
observed	O
with	O
the	O
AP	O
-	O
2	O
site	O
mutation	O
.	O

Rather	O
,	O
TNF	O
and	O
PMA	O
can	O
exert	O
their	O
effect	O
only	O
if	O
cells	O
are	O
in	O
an	O
appropriate	O
redox	O
status	O
,	O
because	O
prior	O
modification	O
toward	O
reduction	O
with	O
BHA	O
treatment	O
prevents	O
this	O
activation	O
.	O

Sequence	O
variation	O
in	O
the	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
region	O
of	O
HIV	O
-	O
1	O
was	O
analyzed	O
in	O
viral	O
isolates	O
of	O
17	O
infected	O
individuals	O
.	O

The	O
transcriptional	O
activity	O
of	O
the	O
heterodimer	O
is	O
regulated	O
by	O
signal	O
-	O
dependent	O
phosphorylation	O
and	O
dephosphorylation	O
events	O
.	O

c	B-Biological_Molecule
-	I-Biological_Molecule
Jun	E-Biological_Molecule
protein	O
isolated	O
from	O
phorbol	O
ester	O
-	O
induced	O
cells	O
did	O
not	O
target	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Fos	E-Biological_Molecule
for	O
degradation	O
,	O
which	O
suggests	O
that	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Fos	E-Biological_Molecule
is	O
transiently	O
stabilized	O
after	O
stimulation	O
of	O
cell	O
growth	O
.	O

Incubation	O
of	O
Jurkat	O
T	O
cells	O
(	O
1	O
x	O
10	O
(	O
6	O
)	O
cells	O
/	O
ml	O
)	O
with	O
a	O
natural	O
thiol	O
antioxidant	O
,	O
alpha	O
-	O
lipoic	O
acid	O
,	O
prior	O
to	O
the	O
stimulation	O
of	O
cells	O
was	O
found	O
to	O
inhibit	O
NF	O
-	O
kappa	O
B	O
activation	O
induced	O
by	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
(	O
25	O
ng	O
/	O
ml	O
)	O
or	O
by	O
phorbol	O
12	O
-	O
myristate	O
13	O
-	O
acetate	O
(	O
50	O
ng	O
/	O
ml	O
)	O
.	O

Results	O
from	O
in	O
vivo	O
expression	O
studies	O
performed	O
with	O
these	O
NF	O
-	O
kappa	O
B	O
p65	S-Biological_Molecule
mutants	O
revealed	O
the	O
following	O
:	O
1	O
)	O
I	O
kappa	O
B	O
/	O
MAD	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
completely	O
inhibits	O
NF	O
-	O
kappa	O
B	O
p65	S-Biological_Molecule
-	O
dependent	O
transcriptional	O
activation	O
mediated	O
through	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
kappa	O
B	O
enhancer	O
in	O
human	O
T	O
lymphocytes	O
,	O
2	O
)	O
the	O
binding	O
of	O
I	O
kappa	O
B	O
/	O
MAD	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
to	O
NF	O
-	O
kappa	O
B	O
p65	S-Biological_Molecule
is	O
sufficient	O
to	O
retarget	O
NF	O
-	O
kappa	O
B	O
p65	S-Biological_Molecule
from	O
the	O
nucleus	O
to	O
the	O
cytoplasm	O
,	O
3	O
)	O
selective	O
deletion	O
of	O
the	O
functional	O
nuclear	O
localization	O
signal	O
present	O
in	O
the	O
Rel	O
homology	O
domain	O
of	O
NF	O
-	O
kappa	O
B	O
p65	S-Biological_Molecule
disrupts	O
its	O
ability	O
to	O
engage	O
I	O
kappa	O
B	O
/	O
MAD	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
,	O
and	O
4	O
)	O
the	O
unique	O
C	O
-	O
terminus	O
of	O
NF	O
-	O
kappa	O
B	O
p65	S-Biological_Molecule
attenuates	O
its	O
own	O
nuclear	O
localization	O
and	O
contains	O
sequences	O
that	O
are	O
required	O
for	O
I	O
kappa	O
B	O
-	O
mediated	O
inhibition	O
of	O
NF	O
-	O
kappa	O
B	O
p65	S-Biological_Molecule
DNA	O
binding	O
activity	O
.	O

However	O
,	O
no	O
loss	O
of	O
DNA	O
binding	O
activity	O
is	O
observed	O
,	O
presumably	O
reflecting	O
the	O
unique	O
C	O
-	O
terminal	O
domain	O
that	O
is	O
distinct	O
from	O
that	O
present	O
in	O
NF	O
-	O
kappa	O
B	O
p65	S-Biological_Molecule
.	O

Resolution	O
of	O
whole	O
cell	O
extract	O
through	O
two	O
chromatographic	O
steps	O
yields	O
a	O
single	O
protein	O
fraction	O
requiring	O
only	O
the	O
addition	O
of	O
TFIID	O
for	O
the	O
initiation	O
of	O
transcription	O
at	O
RNA	O
polymerase	O
II	O
promoters	O
.	O

In	O
contrast	O
to	O
the	O
transient	O
NF	O
-	O
kappa	O
B	O
activation	O
induced	O
by	O
phorbol	O
ester	O
,	O
the	O
permanent	O
NF	O
-	O
kappa	O
B	O
translocation	O
induced	O
by	O
HIV	O
infection	O
was	O
not	O
dependent	O
on	O
PKC	B-Biological_Molecule
isoenzymes	I-Biological_Molecule
alpha	E-Biological_Molecule
and	O
beta	S-Biological_Molecule
as	O
shown	O
by	O
the	O
use	O
of	O
a	O
specific	O
inhibitor	O
(	O
GF	O
109203X	O
)	O
.	O

Con	B-Biological_Molecule
A	E-Biological_Molecule
stimulation	O
was	O
found	O
to	O
increase	O
both	O
binding	O
of	O
AP	O
-	O
1	O
to	O
the	O
AP	O
-	O
1	O
consensus	O
sequence	O
,	O
TRE	O
,	O
and	O
AP	O
-	O
1	O
enhancer	O
activity	O
,	O
in	O
Jurkat	O
cells	O
.	O

We	O
conclude	O
that	O
stimulation	O
with	O
mitogenic	O
lectins	O
is	O
sufficient	O
to	O
increase	O
both	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Fos	E-Biological_Molecule
and	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Jun	E-Biological_Molecule
protein	O
levels	O
,	O
AP	O
-	O
1	O
binding	O
and	O
AP	O
-	O
1	O
enhancer	O
activity	O
in	O
Jurkat	O
cells	O
and	O
that	O
they	O
act	O
via	O
mechanisms	O
that	O
could	O
involve	O
the	O
activation	O
of	O
PKC	S-Biological_Molecule
.	O

Treatment	O
with	O
okadaic	O
acid	O
resulted	O
in	O
a	O
striking	O
increase	O
in	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
mRNA	O
transcripts	O
within	O
1	O
h	O
of	O
stimulation	O
and	O
large	O
amounts	O
of	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
were	O
released	O
into	O
the	O
culture	O
media	O
.	O

Human	O
immunodeficiency	O
virus	O
type	O
1	O
Nef	S-Biological_Molecule
protein	O
inhibits	O
NF	O
-	O
kappa	O
B	O
induction	O
in	O
human	O
T	O
cells	O
.	O

This	O
activation	O
is	O
mediated	O
by	O
the	O
host	O
transcription	O
factor	O
NF	O
-	O
kappa	O
B	O
[	O
G	O
.	O
Nabel	O
and	O
D	O
.	O
Baltimore	O
,	O
Nature	O
(	O
London	O
)	O
326	O
:	O
711	O
-	O
717	O
,	O
1987	O
]	O
.	O

We	O
refer	O
to	O
the	O
kappa	O
B	O
-	O
binding	O
,	O
truncated	O
protein	O
as	O
p50B	S-Biological_Molecule
by	O
analogy	O
with	O
p50	S-Biological_Molecule
-	O
NF	O
-	O
kappa	O
B	O
and	O
to	O
the	O
full	O
-	O
length	O
protein	O
as	O
p97	S-Biological_Molecule
.	O

p50B	S-Biological_Molecule
is	O
able	O
to	O
form	O
heteromeric	O
kappa	O
B	O
-	O
binding	O
complexes	O
with	O
RelB	S-Biological_Molecule
,	O
as	O
well	O
as	O
with	O
p65	S-Biological_Molecule
and	O
p50	S-Biological_Molecule
,	O
the	O
two	O
subunits	O
of	O
NF	O
-	O
kappa	O
B	O
.	O

Activation	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
enhancer	O
is	O
not	O
dependent	O
on	O
NFAT	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
.	O

Two	O
binding	O
proteins	O
are	O
detected	O
in	O
K562	O
nuclear	O
extracts	O
,	O
while	O
only	O
one	O
is	O
found	O
in	O
extracts	O
from	O
HeLa	O
cells	O
.	O

A	O
novel	O
T	O
cell	O
-	O
specific	O
negative	O
regulatory	O
element	O
(	O
NRE	O
)	O
composed	O
of	O
two	O
protein	O
-	O
binding	O
sites	O
were	O
mapped	O
in	O
the	O
5	O
'	O
flanking	O
region	O
of	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
gene	O
:	O
-	O
311CTCCCTTCT	O
-	O
303	O
(	O
NRE	O
-	O
I	O
)	O
and	O
-	O
288CTTTTTGCTT	O
-	O
TGC	O
-	O
300	O
(	O
NRE	O
-	O
II	O
)	O
.	O

A	O
T	O
cell	O
-	O
specific	O
protein	O
Neg	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
a	O
ubiquitous	O
protein	O
Neg	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
binding	O
to	O
NRE	O
-	O
I	O
and	O
NRE	O
-	O
II	O
,	O
respectively	O
,	O
were	O
identified	O
.	O

Phorbol	O
esters	O
are	O
required	O
to	O
induce	O
AIM	S-Biological_Molecule
/	O
CD69	S-Biological_Molecule
cell	O
-	O
surface	O
expression	O
as	O
well	O
as	O
for	O
triggering	O
the	O
proliferation	O
of	O
T	O
cells	O
in	O
conjunction	O
with	O
anti	O
-	O
AIM	S-Biological_Molecule
mAb	O
.	O

The	O
B	O
cell	O
-	O
specific	O
nuclear	O
factor	O
OTF	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
positively	O
regulates	O
transcription	O
of	O
the	O
human	O
class	O
II	O
transplantation	O
gene	O
,	O
DRA	S-Biological_Molecule
.	O

Our	O
analyses	O
show	O
that	O
several	O
Oct2	S-Biological_Molecule
isoforms	O
can	O
stimulate	O
from	O
a	O
remote	O
position	O
but	O
that	O
this	O
stimulation	O
is	O
restricted	O
to	O
B	O
cells	O
.	O

Transcription	O
factor	O
AP	O
-	O
2	O
activates	O
gene	O
expression	O
of	O
HTLV	O
-	O
I	O
.	O

Transfection	O
of	O
an	O
AP	O
-	O
2	O
expression	O
construct	O
into	O
T	O
-	O
lymphocytes	O
activated	O
gene	O
expression	O
from	O
the	O
HTLV	O
-	O
I	O
LTR	O
.	O

However	O
,	O
exposure	O
of	O
U	O
-	O
937	O
cells	O
to	O
1	O
,	O
25	O
-	O
(	O
OH	O
)	O
2D3	O
increased	O
by	O
200	O
%	O
the	O
level	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
beta	E-Biological_Molecule
mRNA	O
detected	O
and	O
decreased	O
by	O
three	O
orders	O
of	O
magnitude	O
the	O
concentration	O
of	O
LPS	O
required	O
to	O
achieve	O
steady	O
state	O
mRNA	O
levels	O
equivalent	O
to	O
those	O
observed	O
in	O
U	O
-	O
937	O
cells	O
not	O
preincubated	O
with	O
the	O
hormone	O
.	O
2	O
+	O
o	O

HIV	B-Biological_Molecule
-	I-Biological_Molecule
TF1	E-Biological_Molecule
had	O
a	O
molecular	O
weight	O
of	O
39	O
,	O
000	O
.	O

The	O
latter	O
"	O
nuclear	O
factor	O
for	O
activated	O
T	O
cells	O
"	O
likely	O
contributes	O
to	O
the	O
tissue	O
specificity	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
gene	O
expression	O
.	O

Using	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
we	O
have	O
studied	O
these	O
transcription	O
factors	O
in	O
primary	O
T	O
cells	O
from	O
human	O
blood	O
to	O
verify	O
their	O
presence	O
in	O
a	O
physiologic	O
setting	O
and	O
to	O
identify	O
the	O
signals	O
that	O
stimulate	O
factor	O
activity	O
.	O

Only	O
the	O
activities	O
for	O
NF	O
-	O
AT	O
and	O
AP	O
-	O
1	O
sites	O
require	O
two	O
signals	O
for	O
optimal	O
induction	O
,	O
i	O
.	O
e	O
.	O
,	O
PMA	O
plus	O
either	O
lectin	O
or	O
antibody	O
to	O
the	O
CD3	O
or	O
CD28	S-Biological_Molecule
surface	O
molecules	O
.	O

The	O
transcription	O
factor	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
is	O
expressed	O
in	O
a	O
subset	O
of	O
hemopoietic	O
cells	O
,	O
where	O
it	O
mediates	O
the	O
cell	O
-	O
type	O
specific	O
expression	O
of	O
several	O
genes	O
.	O

The	O
activity	O
of	O
the	O
enhancer	O
is	O
almost	O
completely	O
dependent	O
on	O
the	O
integrity	O
of	O
a	O
dimeric	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
binding	O
site	O
.	O

Primary	O
structure	O
analysis	O
showed	O
that	O
the	O
encoded	O
protein	O
contains	O
three	O
tandem	O
zinc	O
-	O
finger	O
sequences	O
of	O
the	O
type	O
Cys2	O
-	O
Xaa12	O
-	O
His2	O
.	O

Comparing	O
the	O
regulation	O
of	O
these	O
related	O
zinc	O
-	O
finger	O
-	O
encoding	O
genes	O
showed	O
coordinate	O
induction	O
upon	O
mitogenic	O
stimulation	O
of	O
resting	O
T	O
lymphocytes	O
and	O
of	O
resting	O
fibroblasts	O
.	O

Such	O
transcription	O
factors	O
play	O
a	O
key	O
role	O
in	O
the	O
development	O
of	O
the	O
mature	O
T	O
-	O
cell	O
phenotype	O
by	O
functioning	O
as	O
'	O
master	O
regulators	O
of	O
T	O
-	O
cell	O
differentiation	O
'	O
.	O

To	O
examine	O
the	O
role	O
of	O
protein	O
phosphatases	O
in	O
T	O
cell	O
activation	O
,	O
Jurkat	O
cells	O
were	O
treated	O
with	O
okadaic	O
acid	O
,	O
an	O
inhibitor	O
of	O
type	O
1	O
and	O
2A	O
phosphatases	O
,	O
and	O
nuclear	O
extracts	O
were	O
examined	O
for	O
the	O
presence	O
of	O
AP1	O
as	O
a	O
measure	O
of	O
early	O
T	O
cell	O
activation	O
.	O

Surprisingly	O
,	O
while	O
the	O
addition	O
of	O
phytohemagglutinin	S-Biological_Molecule
further	O
enhanced	O
the	O
induction	O
of	O
AP1	O
,	O
the	O
addition	O
of	O
PMA	O
inhibited	O
it	O
.	O

By	O
comparison	O
,	O
PMA	O
is	O
a	O
very	O
inefficient	O
inducer	O
of	O
the	O
jun	O
gene	O
family	O
in	O
Jurkat	O
cells	O
.	O

Transactivation	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
promoter	O
by	O
human	O
herpesvirus	O
6	O
(	O
HHV	O
-	O
6	O
)	O
strains	O
GS	O
and	O
Z	O
-	O
29	O
in	O
primary	O
human	O
T	O
lymphocytes	O
and	O
identification	O
of	O
transactivating	O
HHV	O
-	O
6	O
(	O
GS	O
)	O
gene	O
fragments	O
.	O

This	O
study	O
examines	O
the	O
regions	O
of	O
the	O
HIV	O
promoter	O
required	O
for	O
HHV	O
-	O
6	O
transactivation	O
in	O
a	O
heterogeneous	O
population	O
of	O
primary	O
human	O
T	O
lymphocytes	O
with	O
or	O
without	O
antigenic	O
stimulation	O
.	O

However	O
,	O
this	O
mutated	O
NF	O
kappa	O
B	O
promoter	O
was	O
not	O
transactivated	O
during	O
HHV	O
-	O
6	O
(	O
GS	O
)	O
infection	O
or	O
after	O
cotransfection	O
with	O
pZVB70	O
or	O
pZVB10	O
.	O

We	O
have	O
therefore	O
investigated	O
the	O
changes	O
in	O
protein	O
kinase	O
C	O
(	O
PKC	O
)	O
activity	O
upon	O
exposure	O
of	O
monocytes	O
to	O
M	B-Biological_Molecule
-	I-Biological_Molecule
CSF	E-Biological_Molecule
.	O

Inhibition	O
of	O
PKC	O
by	O
the	O
isoquinoline	O
derivative	O
H7	O
abolishes	O
induction	O
of	O
M	B-Biological_Molecule
-	I-Biological_Molecule
CSF	E-Biological_Molecule
by	O
M	B-Biological_Molecule
-	I-Biological_Molecule
CSF	E-Biological_Molecule
.	O

Expression	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
jun	E-Biological_Molecule
,	O
jun	B-Biological_Molecule
B	E-Biological_Molecule
and	O
jun	B-Biological_Molecule
D	E-Biological_Molecule
proto	O
-	O
oncogenes	O
in	O
human	O
peripheral	O
-	O
blood	O
granulocytes	O
.	O

The	O
other	O
is	O
a	O
region	O
interposed	O
between	O
the	O
21	O
-	O
bp	O
elements	O
.	O

However	O
,	O
the	O
C26	O
element	O
alone	O
,	O
even	O
when	O
repeated	O
,	O
could	O
not	O
be	O
activated	O
by	O
p40tax	S-Biological_Molecule
,	O
unlike	O
other	O
NF	O
-	O
kappa	O
B	O
-	O
binding	O
elements	O
.	O

Our	O
results	O
also	O
demonstrate	O
that	O
TPA	O
-	O
dependent	O
activation	O
of	O
the	O
HTLV	O
-	O
I	O
enhancer	O
may	O
be	O
mediated	O
through	O
the	O
C26	O
element	O
.	O

Inhibition	O
of	O
phorbol	O
ester	O
-	O
induced	O
monocytic	O
differentiation	O
by	O
dexamethasone	O
is	O
associated	O
with	O
down	O
-	O
regulation	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
fos	E-Biological_Molecule
and	O
c	B-Biological_Molecule
-	I-Biological_Molecule
jun	E-Biological_Molecule
(	O
AP	O
-	O
1	O
)	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
treatment	O
of	O
human	O
myeloid	O
leukemia	O
cells	O
with	O
12	O
-	O
O	O
-	O
tetradecanoylphorbol	O
-	O
13	O
-	O
acetate	O
(	O
TPA	O
)	O
is	O
associated	O
with	O
induction	O
of	O
monocytic	O
differentiation	O
and	O
expression	O
of	O
the	O
c	B-Biological_Molecule
-	I-Biological_Molecule
jun	E-Biological_Molecule
and	O
c	B-Biological_Molecule
-	I-Biological_Molecule
fos	E-Biological_Molecule
early	O
response	O
genes	O
.	O

These	O
findings	O
suggest	O
that	O
dexamethasone	O
down	O
-	O
regulates	O
TPA	O
-	O
induced	O
transcription	O
of	O
the	O
c	B-Biological_Molecule
-	I-Biological_Molecule
jun	E-Biological_Molecule
gene	O
during	O
monocytic	O
differentiation	O
by	O
inhibiting	O
activation	O
of	O
the	O
AP	O
-	O
1	O
site	O
.	O

Evaluation	O
of	O
the	O
role	O
of	O
ligand	O
and	O
thermal	O
activation	O
of	O
specific	O
DNA	O
binding	O
by	O
in	O
vitro	O
synthesized	O
human	O
glucocorticoid	O
receptor	O
.	O

We	O
have	O
used	O
a	O
DNA	O
-	O
binding	O
/	O
immunoprecipitation	O
assay	O
to	O
analyze	O
the	O
capacity	O
of	O
human	O
glucocorticoid	O
receptor	O
(	O
hGR	O
)	O
,	O
generated	O
in	O
rabbit	O
reticulocyte	O
lysates	O
,	O
to	O
bind	O
DNA	O
.	O

Negative	O
regulation	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
expression	O
in	O
monocytes	O
:	O
role	O
of	O
the	O
65	B-Biological_Molecule
-	I-Biological_Molecule
kDa	E-Biological_Molecule
plus	O
50	B-Biological_Molecule
-	I-Biological_Molecule
kDa	E-Biological_Molecule
NF	O
-	O
kappa	O
B	O
dimer	O
.	O

Antiserum	O
specific	O
for	O
NF	O
-	O
kappa	O
B	O
binding	O
proteins	O
,	O
but	O
not	O
c	O
-	O
rel	O
-	O
specific	O
antiserum	O
,	O
disrupted	O
heterodimer	O
complex	O
formation	O
.	O

Glucocorticoids	O
are	O
known	O
to	O
downregulate	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
beta	E-Biological_Molecule
production	O
in	O
monocytic	O
cells	O
by	O
two	O
different	O
mechanims	O
:	O
direct	O
inhibition	O
of	O
the	O
gene	O
transcription	O
and	O
destabilization	O
of	O
the	O
preformed	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
beta	E-Biological_Molecule
mRNA	O
.	O

This	O
difference	O
was	O
also	O
seen	O
at	O
the	O
mRNA	O
level	O
.	O

One	O
of	O
the	O
factors	O
bound	O
to	O
a	O
novel	O
dyad	O
symmetrical	O
sequence	O
.	O

Thus	O
,	O
depending	O
on	O
the	O
cellular	O
environment	O
,	O
the	O
short	O
-	O
and	O
long	O
-	O
term	O
effects	O
of	O
Tax	S-Biological_Molecule
expression	O
can	O
be	O
quite	O
different	O
.	O

The	O
human	O
immunodeficiency	O
viruses	O
(	O
HIVs	O
)	O
may	O
include	O
a	O
spectrum	O
of	O
retroviruses	O
with	O
varying	O
potential	O
to	O
infect	O
their	O
host	O
,	O
undergo	O
long	O
periods	O
of	O
latent	O
infection	O
,	O
and	O
induce	O
pathology	O
.	O

This	O
enhancer	O
in	O
HIV	O
-	O
1	O
is	O
the	O
T	O
-	O
cell	O
activation	O
response	O
element	O
;	O
in	O
HIV	O
-	O
2	O
,	O
however	O
,	O
it	O
is	O
the	O
second	O
enhancer	O
that	O
is	O
mainly	O
responsible	O
for	O
activation	O
in	O
response	O
to	O
T	O
-	O
cell	O
activators	O
.	O

These	O
results	O
indicate	O
that	O
in	O
monocytic	O
cell	O
lineage	O
,	O
HIV	O
-	O
1	O
could	O
mimic	O
some	O
differentiation	O
/	O
activation	O
stimuli	O
allowing	O
nuclear	O
NF	O
-	O
KB	O
expression	O
.	O

Gel	O
mobility	O
shift	O
assays	O
using	O
a	O
synthetic	O
E6	O
motif	O
detected	O
a	O
B	O
-	O
cell	O
-	O
specific	O
complex	O
in	O
addition	O
to	O
a	O
ubiquitous	O
band	O
found	O
also	O
in	O
T	O
cells	O
and	O
HeLa	O
cells	O
.	O

In	O
striking	O
contrast	O
to	O
the	O
mouse	O
Ig	O
heavy	O
-	O
chain	O
enhancer	O
,	O
in	O
which	O
the	O
octamer	O
motif	O
acts	O
as	O
a	O
B	O
-	O
cell	O
-	O
specific	O
enhancer	O
element	O
,	O
the	O
human	O
enhancer	O
contains	O
an	O
octamerlike	O
sequence	O
with	O
one	O
base	O
substitution	O
which	O
bound	O
octamer	O
-	O
binding	O
proteins	O
with	O
only	O
very	O
low	O
affinity	O
and	O
showed	O
no	O
enhancer	O
activity	O
of	O
its	O
own	O
.	O

However	O
,	O
in	O
either	O
EL	O
-	O
4	O
(	O
T	O
)	O
cells	O
or	O
S194	O
cells	O
,	O
both	O
lower	O
-	O
affinity	O
sites	O
can	O
be	O
significantly	O
induced	O
by	O
the	O
tax	S-Biological_Molecule
gene	O
product	O
of	O
human	O
T	O
-	O
cell	O
leukemia	O
virus	O
type	O
I	O
,	O
showing	O
that	O
NF	O
-	O
kappa	O
B	O
activity	O
can	O
be	O
modulated	O
even	O
in	O
a	O
B	O
-	O
cell	O
line	O
that	O
constitutively	O
expresses	O
this	O
factor	O
.	O

This	O
probe	O
was	O
used	O
to	O
identify	O
a	O
rel	O
-	O
related	O
complementary	O
DNA	O
that	O
hybridized	O
to	O
a	O
2	O
.	O
6	O
-	O
kilobase	O
messenger	O
RNA	O
present	O
in	O
human	O
T	O
and	O
B	O
lymphocytes	O
.	O

Therefore	O
the	O
rel	O
-	O
related	O
65	O
-	O
kD	O
protein	O
may	O
represent	O
the	O
p65	S-Biological_Molecule
subunit	O
of	O
the	O
active	O
NF	O
-	O
kappa	O
B	O
transcription	O
factor	O
complex	O
.	O

Tissue	O
-	O
specific	O
expression	O
of	O
the	O
platelet	O
GPIIb	S-Biological_Molecule
gene	O
.	O

Recent	O
development	O
of	O
primary	O
cultures	O
of	O
human	O
megakaryocytes	O
and	O
the	O
molecular	O
cloning	O
of	O
genes	O
that	O
are	O
specific	O
to	O
this	O
lineage	O
offer	O
the	O
possibility	O
of	O
getting	O
some	O
insights	O
into	O
the	O
genetic	O
mechanisms	O
that	O
control	O
megakaryocytopoiesis	O
.	O

Two	O
domains	O
centered	O
at	O
positions	O
-	O
345	O
and	O
-	O
540	O
,	O
respectively	O
,	O
bind	O
proteins	O
that	O
are	O
present	O
in	O
megakaryocytic	O
cells	O
and	O
nonrelated	O
cells	O
as	O
well	O
.	O

Finally	O
,	O
two	O
other	O
domains	O
,	O
located	O
at	O
positions	O
-	O
460	O
and	O
-	O
510	O
,	O
interact	O
with	O
proteins	O
that	O
are	O
only	O
present	O
in	O
megakaryocytic	O
cells	O
.	O

Human	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
alpha	E-Biological_Molecule
gene	O
regulation	O
in	O
phorbol	O
ester	O
stimulated	O
T	O
and	O
B	O
cell	O
lines	O
.	O

Hydrogen	O
peroxide	O
and	O
oxygen	O
radicals	O
are	O
agents	O
commonly	O
produced	O
during	O
inflammatory	O
processes	O
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
micromolar	O
concentrations	O
of	O
H2O2	O
can	O
induce	O
the	O
expression	O
and	O
replication	O
of	O
HIV	O
-	O
1	O
in	O
a	O
human	O
T	O
cell	O
line	O
.	O

This	O
suggests	O
that	O
diverse	O
agents	O
thought	O
to	O
activate	O
NF	O
-	O
kappa	O
B	O
by	O
distinct	O
intracellular	O
pathways	O
might	O
all	O
act	O
through	O
a	O
common	O
mechanism	O
involving	O
the	O
synthesis	O
of	O
ROI	O
.	O

Southwestern	O
and	O
gel	O
renaturation	O
experiments	O
with	O
the	O
use	O
of	O
purified	O
protein	O
fractions	O
revealed	O
that	O
TCF	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
alpha	E-Biological_Molecule
activity	O
is	O
derived	O
from	O
a	O
family	O
of	O
57	O
-	O
to	O
53	O
-	O
kD	O
proteins	O
that	O
are	O
abundantly	O
expressed	O
in	O
mature	O
and	O
immature	O
T	O
-	O
cell	O
lines	O
(	O
Jurkat	O
,	O
CCRF	O
-	O
CEM	O
)	O
and	O
not	O
in	O
mature	O
B	O
cells	O
(	O
JY	O
,	O
Namalwa	O
)	O
or	O
nonlymphoid	O
(	O
HeLa	O
)	O
cell	O
lines	O
.	O

A	O
novel	O
T	O
-	O
cell	O
trans	O
-	O
activator	O
that	O
recognizes	O
a	O
phorbol	O
ester	O
-	O
inducible	O
element	O
of	O
the	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
promoter	O
.	O

However	O
,	O
despite	O
its	O
ability	O
to	O
activate	O
transcription	O
of	O
a	O
transfected	O
reporter	O
gene	O
,	O
the	O
factor	O
is	O
apparently	O
unable	O
to	O
bind	O
to	O
the	O
endogenous	O
Ig	O
heavy	O
chain	O
enhancer	O
in	O
non	O
-	O
lymphoid	O
cells	O
:	O
In	O
previous	O
experiments	O
by	O
others	O
,	O
the	O
characteristic	O
in	O
vivo	O
footprint	O
of	O
this	O
factor	O
,	O
designated	O
NF	B-Biological_Molecule
-	I-Biological_Molecule
muE3	E-Biological_Molecule
,	O
was	O
detected	O
in	O
B	O
cells	O
but	O
not	O
in	O
non	O
-	O
B	O
cells	O
.	O

Identification	O
of	O
a	O
novel	O
factor	O
that	O
interacts	O
with	O
an	O
immunoglobulin	O
heavy	O
-	O
chain	O
promoter	O
and	O
stimulates	O
transcription	O
in	O
conjunction	O
with	O
the	O
lymphoid	O
cell	O
-	O
specific	O
factor	O
OTF2	S-Biological_Molecule
.	O

Based	O
on	O
these	O
results	O
,	O
we	O
propose	O
that	O
NTF	O
and	O
OTF2	S-Biological_Molecule
interactions	O
(	O
both	O
with	O
their	O
cognate	O
DNA	O
elements	O
and	O
possibly	O
at	O
the	O
protein	O
-	O
protein	O
level	O
)	O
may	O
be	O
critical	O
to	O
B	O
-	O
cell	O
-	O
specific	O
expression	O
and	O
that	O
these	O
interactions	O
provide	O
additional	O
pathways	O
for	O
regulating	O
gene	O
expression	O
.	O

Secondarily	O
,	O
heat	O
shock	O
of	O
Hyon	O
cells	O
stabilized	O
the	O
c	B-Biological_Molecule
-	I-Biological_Molecule
myc	E-Biological_Molecule
mRNA	O
level	O
by	O
increasing	O
its	O
half	O
-	O
life	O
from	O
24	O
to	O
45	O
min	O
.	O

Tandem	O
AP	O
-	O
1	O
-	O
binding	O
sites	O
within	O
the	O
human	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
globin	E-Biological_Molecule
dominant	O
control	O
region	O
function	O
as	O
an	O
inducible	O
enhancer	O
in	O
erythroid	O
cells	O
.	O

Enhancer	O
activity	O
appears	O
to	O
be	O
mediated	O
by	O
the	O
binding	O
of	O
a	O
complex	O
of	O
proteins	O
from	O
the	O
jun	O
and	O
fos	O
families	O
to	O
tandem	O
AP	O
-	O
1	O
consensus	O
sequences	O
.	O

Further	O
results	O
,	O
in	O
which	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
gal	E-Biological_Molecule
activity	O
is	O
correlated	O
with	O
NF	O
-	O
AT	O
-	O
binding	O
activity	O
,	O
indicate	O
that	O
the	O
concentration	O
of	O
NF	O
-	O
AT	O
must	O
exceed	O
a	O
critical	O
threshold	O
before	O
transcription	O
initiates	O
.	O

Similar	O
constructs	O
controlled	O
by	O
NF	O
-	O
kappa	O
B	O
or	O
the	O
entire	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
enhancer	O
show	O
bimodal	O
expression	O
patterns	O
during	O
induction	O
,	O
suggesting	O
that	O
thresholds	O
set	O
by	O
the	O
concentration	O
of	O
transcription	O
factors	O
may	O
be	O
a	O
common	O
property	O
of	O
inducible	O
genes	O
.	O

At	O
the	O
end	O
of	O
this	O
incubation	O
the	O
resting	O
cells	O
were	O
stimulated	O
with	O
M	B-Biological_Molecule
-	I-Biological_Molecule
CSF	E-Biological_Molecule
,	O
and	O
RNA	O
was	O
isolated	O
for	O
analysis	O
by	O
Northern	O
blotting	O
.	O

We	O
found	O
a	O
dissociation	O
of	O
NF	O
-	O
kappa	O
B	O
translocation	O
from	O
transactivation	O
of	O
either	O
the	O
HIV	O
LTR	O
or	O
the	O
HIV	O
enhancer	O
.	O

Each	O
of	O
these	O
domains	O
possessed	O
strong	O
homology	O
to	O
motifs	O
previously	O
found	O
to	O
bind	O
the	O
cellular	O
factor	O
NF	O
-	O
kappa	O
B	O
.	O

Involvement	O
of	O
cyclic	O
AMP	O
-	O
dependent	O
protein	O
kinases	O
in	O
the	O
signal	O
transduction	O
pathway	O
for	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
.	O

This	O
inhibitor	O
did	O
not	O
affect	O
protein	O
kinase	O
C	O
-	O
mediated	O
gene	O
transcription	O
,	O
suggesting	O
that	O
cyclic	O
AMP	O
-	O
dependent	O
protein	O
kinases	O
are	O
involved	O
in	O
the	O
signal	O
transduction	O
pathway	O
for	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
in	O
a	O
number	O
of	O
responsive	O
cell	O
types	O
.	O

Paramyxovirus	O
infection	O
induced	O
a	O
5	O
-	O
to	O
10	O
-	O
fold	O
increase	O
in	O
the	O
steady	O
-	O
state	O
level	O
of	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
RNA	O
in	O
U9	O
-	O
IIIB	O
cells	O
compared	O
with	O
U937	O
cells	O
,	O
suggesting	O
that	O
HIV	O
-	O
infected	O
monocytic	O
cells	O
produced	O
higher	O
levels	O
of	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
than	O
did	O
normal	O
cells	O
after	O
a	O
secondary	O
virus	O
infection	O
.	O

The	O
relationship	O
of	O
the	O
N	O
-	O
Oct	O
proteins	O
to	O
Oct	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
Oct	B-Biological_Molecule
-	I-Biological_Molecule
2A	E-Biological_Molecule
was	O
analyzed	O
by	O
proteolytic	O
clipping	O
bandshift	O
assays	O
and	O
by	O
their	O
reactivity	O
towards	O
antisera	O
raised	O
against	O
recombinant	O
Oct	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
Oct	B-Biological_Molecule
-	I-Biological_Molecule
2A	E-Biological_Molecule
proteins	O
.	O

In	O
melanoma	O
cells	O
that	O
contain	O
the	O
N	B-Biological_Molecule
-	I-Biological_Molecule
Oct	I-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
factor	O
,	O
a	O
transfected	O
lymphocyte	O
-	O
specific	O
promoter	O
was	O
neither	O
activated	O
nor	O
was	O
it	O
repressed	O
upon	O
contransfection	O
with	O
an	O
Oct	B-Biological_Molecule
-	I-Biological_Molecule
2A	E-Biological_Molecule
expression	O
vector	O
.	O

The	O
amino	O
-	O
terminal	O
domain	O
has	O
regions	O
homologous	O
to	O
the	O
oncogene	O
rel	O
and	O
to	O
the	O
developmentally	O
important	O
gene	O
dorsal	O
of	O
Drosophila	O
.	O

This	O
gene	O
is	O
yet	O
another	O
in	O
a	O
growing	O
list	O
of	O
important	O
regulatory	O
molecules	O
whose	O
expression	O
is	O
transcriptionally	O
induced	O
upon	O
cellular	O
activation	O
.	O

The	O
corresponding	O
region	O
in	O
the	O
second	O
AIDS	O
retrovirus	O
,	O
HIV	O
-	O
2	O
,	O
contains	O
a	O
conserved	O
and	O
a	O
divergent	O
NF	O
kappa	O
B	O
binding	O
site	O
.	O

In	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
NF	O
kappa	O
B	O
binds	O
to	O
both	O
conserved	O
sites	O
in	O
the	O
HIV	O
-	O
1	O
transcriptional	O
enhancer	O
and	O
only	O
to	O
the	O
single	O
conserved	O
site	O
in	O
the	O
HIV	O
-	O
2	O
transcriptional	O
enhancer	O
.	O

We	O
show	O
that	O
ES	O
-	O
derived	O
embryoid	O
bodies	O
express	O
the	O
full	O
complement	O
of	O
mouse	O
embryonic	O
globin	O
genes	O
in	O
the	O
correct	O
temporal	O
order	O
and	O
that	O
on	O
further	O
differentiation	O
,	O
a	O
switch	O
occurs	O
to	O
the	O
fetal	O
/	O
adult	O
genes	O
.	O

The	O
human	O
T	O
-	O
cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV	O
-	O
I	O
)	O
promoter	O
contains	O
three	O
copies	O
of	O
imperfect	O
repeats	O
of	O
a	O
21	O
-	O
base	O
pair	O
sequence	O
designated	O
here	O
as	O
TRE	O
(	O
Tax	O
-	O
response	O
element	O
)	O
that	O
is	O
responsive	O
to	O
the	O
virally	O
encoded	O
transactivator	O
protein	O
Tax	S-Biological_Molecule
.	O

Fourth	O
,	O
extensive	O
purification	O
by	O
several	O
cycles	O
of	O
TRE	O
-	O
DNA	O
affinity	O
chromatography	O
resulted	O
in	O
the	O
32	O
,	O
36	O
to	O
42	O
and	O
110	O
kD	O
proteins	O
and	O
to	O
less	O
extent	O
the	O
50	O
kD	O
factor	O
.	O

Cell	O
type	O
specificity	O
and	O
activation	O
requirements	O
for	O
NFAT	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
(	O
nuclear	O
factor	O
of	O
activated	O
T	O
-	O
cells	O
)	O
transcriptional	O
activity	O
determined	O
by	O
a	O
new	O
method	O
using	O
transgenic	O
mice	O
to	O
assay	O
transcriptional	O
activity	O
of	O
an	O
individual	O
nuclear	O
factor	O
.	O

The	O
Oct	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
protein	O
is	O
present	O
in	O
all	O
cell	O
types	O
analyzed	O
so	O
far	O
,	O
whereas	O
Oct	B-Biological_Molecule
-	I-Biological_Molecule
2A	E-Biological_Molecule
and	O
Oct	B-Biological_Molecule
-	I-Biological_Molecule
2B	E-Biological_Molecule
are	O
found	O
mainly	O
in	O
B	O
lymphocytes	O
.	O

Recently	O
,	O
a	O
number	O
of	O
other	O
octamer	O
factor	O
variants	O
were	O
identified	O
.	O

Thrombin	S-Biological_Molecule
stimulation	O
of	O
the	O
T	O
leukemic	O
cell	O
line	O
Jurkat	O
induced	O
a	O
transient	O
increase	O
in	O
[	O
Ca2	O
+	O
]	O
i	O
.	O

Finally	O
,	O
we	O
demonstrate	O
that	O
thrombin	S-Biological_Molecule
and	O
TRP	O
enhanced	O
CD69	S-Biological_Molecule
expression	O
and	O
interleukin	B-Biological_Molecule
2	E-Biological_Molecule
production	O
induced	O
by	O
T	O
cell	O
receptor	O
cross	O
-	O
linking	O
in	O
both	O
Jurkat	O
T	O
cells	O
and	O
peripheral	O
blood	O
lymphocytes	O
.	O

In	O
nuclear	O
run	O
-	O
on	O
analysis	O
,	O
such	O
tolerant	O
cells	O
show	O
only	O
a	O
low	O
degree	O
of	O
transcription	O
,	O
indicating	O
that	O
tolerance	O
operates	O
at	O
or	O
upstream	O
of	O
the	O
transcription	O
level	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrate	O
that	O
tolerance	O
to	O
LPS	O
is	O
determined	O
by	O
post	O
-	O
receptor	O
mechanisms	O
that	O
involve	O
an	O
altered	O
composition	O
of	O
the	O
NF	O
-	O
kappa	O
B	O
complex	O
.	O

We	O
have	O
examined	O
the	O
effect	O
of	O
alpha	O
-	O
tocopherol	O
(	O
alpha	O
-	O
tcp	O
)	O
on	O
one	O
cellular	O
event	O
in	O
atherosclerotic	O
plaque	O
development	O
,	O
monocyte	O
adhesion	O
to	O
stimulated	O
endothelial	O
cells	O
(	O
ECs	O
)	O
.	O

Our	O
results	O
point	O
to	O
a	O
novel	O
alternative	O
mechanism	O
of	O
action	O
of	O
alpha	O
-	O
tcp	O
.	O

In	O
the	O
second	O
approach	O
,	O
we	O
tested	O
the	O
generality	O
of	O
this	O
phenomenon	O
by	O
transiently	O
expressing	O
LMP1	S-Biological_Molecule
from	O
a	O
strong	O
constitutively	O
active	O
promoter	O
in	O
a	O
range	O
of	O
different	O
cell	O
types	O
.	O

LPS	O
-	O
stimulated	O
translocation	O
of	O
NF	O
-	O
kappa	O
B	O
in	O
CHO	O
/	O
CD14	S-Biological_Molecule
cells	O
resembled	O
the	O
same	O
response	O
in	O
the	O
murine	O
macrophage	O
-	O
like	O
cell	O
line	O
RAW	O
264	O
.	O
7	O
.	O

These	O
results	O
imply	O
that	O
TK	O
activity	O
is	O
not	O
obligatory	O
for	O
CD14	S-Biological_Molecule
-	O
mediated	O
signal	O
transduction	O
to	O
occur	O
in	O
response	O
to	O
LPS	O
.	O

To	O
identify	O
potential	O
cellular	O
homologues	O
of	O
cyclosporin	O
A	O
that	O
might	O
regulate	O
calcium	O
signalling	O
,	O
we	O
have	O
cloned	O
human	O
genes	O
encoding	O
cyclophilin	B-Biological_Molecule
B	E-Biological_Molecule
-	O
binding	O
-	O
proteins	O
using	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
.	O

Since	O
HUVECs	O
released	O
superoxide	O
anions	O
in	O
response	O
to	O
TNF	S-Biological_Molecule
,	O
and	O
H2O2	O
induces	O
VCAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
PDTC	O
may	O
act	O
as	O
a	O
radical	O
scavenger	O
.	O

Little	O
is	O
known	O
about	O
how	O
the	O
very	O
early	O
events	O
induced	O
by	O
CD40	S-Biological_Molecule
cross	O
-	O
linking	O
link	O
to	O
cellular	O
responses	O
.	O

Studies	O
presented	O
here	O
show	O
that	O
overall	O
NF	O
-	O
kappa	O
B	O
signal	O
transduction	O
begins	O
with	O
a	O
parallel	O
series	O
of	O
stimuli	O
-	O
specific	O
pathways	O
through	O
which	O
cytokines	O
(	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
alpha	E-Biological_Molecule
)	O
,	O
oxidants	O
(	O
hydrogen	O
peroxide	O
and	O
mitomycin	O
C	O
)	O
,	O
and	O
phorbol	O
ester	O
(	O
phorbol	O
12	O
-	O
myristate	O
13	O
-	O
acetate	O
)	O
individually	O
initiate	O
signaling	O
.	O

We	O
propose	O
that	O
adherent	O
monocytes	O
regulate	O
nuclear	O
processing	O
(	O
or	O
decay	O
)	O
of	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
alpha	E-Biological_Molecule
/	O
MAD	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
mRNA	O
,	O
thereby	O
increasing	O
mRNA	O
levels	O
without	O
stimulating	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
alpha	E-Biological_Molecule
/	O
MAD	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
gene	O
transcription	O
.	O

3	O
.	O

A	O
possible	O
signaling	O
role	O
for	O
the	O
Syk	S-Biological_Molecule
tyrosine	O
kinase	O
.	O

In	O
addition	O
,	O
integrin	O
ligation	O
leads	O
to	O
nuclear	O
translocation	O
of	O
the	O
p50	S-Biological_Molecule
and	O
p65	S-Biological_Molecule
subunits	O
of	O
the	O
NF	O
-	O
kappa	O
B	O
transcription	O
factor	O
,	O
to	O
activation	O
of	O
a	O
reporter	O
gene	O
driven	O
by	O
a	O
promoter	O
containing	O
NF	O
-	O
kappa	O
B	O
sites	O
,	O
and	O
to	O
increased	O
levels	O
of	O
mRNAs	O
for	O
immediate	O
-	O
early	O
genes	O
,	O
including	O
the	O
cytokine	O
interleukin	B-Biological_Molecule
(	I-Biological_Molecule
IL	I-Biological_Molecule
)	I-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
beta	E-Biological_Molecule
.	O

Whereas	O
different	O
anti	O
-	O
CD4	S-Biological_Molecule
mAb	O
or	O
HIV	O
-	O
1	O
gp120	S-Biological_Molecule
could	O
all	O
trigger	O
activation	O
of	O
the	O
protein	O
tyrosine	O
kinases	O
p56lck	S-Biological_Molecule
and	O
p59fyn	S-Biological_Molecule
and	O
phosphorylation	O
of	O
the	O
Shc	O
adaptor	O
protein	O
,	O
which	O
mediates	O
signals	O
to	O
Ras	O
,	O
they	O
differed	O
significantly	O
in	O
their	O
ability	O
to	O
activate	O
NF	O
-	O
AT	O
.	O

The	O
results	O
identify	O
functionally	O
distinct	O
epitopes	O
on	O
the	O
CD4	S-Biological_Molecule
coreceptor	O
involved	O
in	O
activation	O
of	O
the	O
Ras	O
/	O
protein	O
kinase	O
C	O
and	O
calcium	O
pathways	O
.	O

LFA	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
induced	O
moderate	O
levels	O
of	O
AP	O
-	O
1	O
,	O
but	O
did	O
not	O
influence	O
the	O
levels	O
of	O
NF	O
-	O
kappa	O
B	O
,	O
while	O
B7	S-Biological_Molecule
costimulation	O
strongly	O
induced	O
both	O
AP	O
-	O
1	O
and	O
substantially	O
enhanced	O
NF	O
-	O
kappa	O
B	O
binding	O
proteins	O
.	O

Analysis	O
of	O
the	O
expression	O
of	O
human	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
alpha	E-Biological_Molecule
protein	O
in	O
stable	O
transfectants	O
of	O
mouse	O
70Z	O
/	O
3	O
cells	O
shows	O
that	O
,	O
as	O
for	O
the	O
endogenous	O
murine	O
protein	O
,	O
exogenous	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
alpha	E-Biological_Molecule
is	O
degraded	O
in	O
response	O
to	O
inducers	O
of	O
NF	O
-	O
kappa	O
B	O
activity	O
,	O
such	O
as	O
phorbol	O
myristate	O
acetate	O
or	O
lipopolysaccharide	O
.	O

Order	O
of	O
addition	O
and	O
off	O
-	O
rate	O
experiments	O
indicate	O
that	O
the	O
VDR	S-Biological_Molecule
-	O
retinoid	O
X	O
receptor	O
heterodimer	O
blocks	O
NFATp	S-Biological_Molecule
/	O
AP	O
-	O
1	O
complex	O
formation	O
and	O
then	O
stably	O
associates	O
with	O
the	O
NF	B-Biological_Molecule
-	I-Biological_Molecule
AT	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
element	O
.	O

Glucocorticoids	O
are	O
among	O
the	O
most	O
potent	O
anti	O
-	O
inflammatory	O
and	O
immunosuppressive	O
agents	O
.	O

Priming	O
occurred	O
after	O
several	O
hours	O
of	O
treatment	O
,	O
and	O
the	O
primed	O
state	O
was	O
induced	O
by	O
either	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
or	O
GM	B-Biological_Molecule
-	I-Biological_Molecule
CSF	E-Biological_Molecule
,	O
but	O
not	O
M	B-Biological_Molecule
-	I-Biological_Molecule
CSF	E-Biological_Molecule
.	O

MZF	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
represses	O
CAT	S-Biological_Molecule
reporter	O
gene	O
expression	O
via	O
GAL4	S-Biological_Molecule
binding	O
sites	O
in	O
the	O
nonhematopoietic	O
cell	O
lines	O
NIH	O
3T3	O
and	O
293	O
.	O

By	O
comparison	O
,	O
an	O
isotype	O
-	O
matched	O
antibody	O
had	O
no	O
effect	O
on	O
NF	O
-	O
kappa	O
B	O
activation	O
.	O

NF	O
-	O
kappa	O
B	O
elevation	O
results	O
in	O
these	O
phenotypic	O
abnormalities	O
because	O
mice	O
lacking	O
both	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
alpha	E-Biological_Molecule
and	O
the	O
p50	S-Biological_Molecule
subunit	O
of	O
NF	O
-	O
kappa	O
B	O
show	O
a	O
dramatically	O
delayed	O
onset	O
of	O
abnormalities	O
.	O

Our	O
results	O
indicate	O
that	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
b	I-Biological_Molecule
beta	E-Biological_Molecule
,	O
but	O
not	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
alpha	E-Biological_Molecule
,	O
is	O
required	O
for	O
the	O
signal	O
-	O
dependent	O
activation	O
of	O
NF	O
-	O
kappa	O
B	O
in	O
fibroblasts	O
.	O

The	O
T	O
cell	O
activation	O
is	O
initiated	O
by	O
interaction	O
of	O
specific	O
Ags	S-Biological_Molecule
with	O
TCR	O
,	O
followed	O
by	O
activation	O
of	O
intracellular	O
biochemical	O
events	O
leading	O
to	O
activation	O
of	O
several	O
genes	O
.	O

Translocation	O
of	O
NF	O
-	O
kappa	O
B	O
p50	S-Biological_Molecule
/	O
p65	S-Biological_Molecule
was	O
also	O
observed	O
following	O
stimulation	O
of	O
CR1	S-Biological_Molecule
or	O
CR3	O
of	O
uninfected	O
peripheral	O
blood	O
monocytes	O
from	O
HIV	O
-	O
seronegative	O
donors	O
.	O

rNF	B-Biological_Molecule
-	I-Biological_Molecule
IL6	E-Biological_Molecule
expressed	O
in	O
bacteria	O
was	O
shown	O
to	O
specifically	O
bind	O
to	O
PRE	O
-	O
I	O
.	O

While	O
a	O
nuclear	O
factor	O
(	O
s	O
)	O
from	O
both	O
peripheral	O
blood	O
monocytes	O
and	O
T	O
cells	O
binds	O
the	O
peri	O
-	O
kappa	O
B	O
site	O
,	O
electrophoretic	O
mobility	O
shift	O
assays	O
suggest	O
that	O
either	O
a	O
different	O
protein	O
binds	O
to	O
this	O
site	O
in	O
monocytes	O
versus	O
T	O
cells	O
or	O
that	O
the	O
protein	O
recognizing	O
this	O
enhancer	O
element	O
undergoes	O
differential	O
modification	O
in	O
monocytes	O
and	O
T	O
cells	O
,	O
thus	O
supporting	O
the	O
transfection	O
data	O
.	O

Taken	O
together	O
,	O
our	O
data	O
suggest	O
that	O
p95vav	S-Biological_Molecule
plays	O
an	O
important	O
role	O
at	O
an	O
yet	O
unidentified	O
proximal	O
position	O
in	O
the	O
TCR	O
signaling	O
cascade	O
.	O

Activation	O
of	O
NF	O
-	O
kappa	O
B	O
by	O
phosphatase	O
inhibitors	O
involves	O
the	O
phosphorylation	O
of	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
alpha	E-Biological_Molecule
at	O
phosphatase	O
2A	O
-	O
sensitive	O
sites	O
.	O

The	O
class	O
II	O
major	O
histocompatibility	O
complex	O
gene	O
HLA	O
-	O
DRA	O
is	O
expressed	O
in	O
B	O
cells	O
,	O
activated	O
T	O
lymphocytes	O
,	O
and	O
in	O
antigen	O
-	O
presenting	O
cells	O
.	O

Interleukin	B-Biological_Molecule
4	E-Biological_Molecule
activates	O
a	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
(	O
Stat	O
)	O
protein	O
which	O
interacts	O
with	O
an	O
interferon	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
activation	O
site	O
-	O
like	O
sequence	O
upstream	O
of	O
the	O
I	O
epsilon	O
exon	O
in	O
a	O
human	O
B	O
cell	O
line	O
.	O

Cotransfection	O
of	O
JAK3	S-Biological_Molecule
with	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
Stat	O
into	O
COS	O
-	O
7	O
cells	O
produced	O
an	O
intracellular	O
activity	O
which	O
bound	O
the	O
same	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
activation	O
site	O
-	O
like	O
sequence	O
and	O
comigrated	O
with	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
NAF	O
in	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O

These	O
results	O
show	O
that	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
NAF	O
is	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
Stat	O
,	O
which	O
is	O
activated	O
by	O
JAK3	S-Biological_Molecule
in	O
response	O
to	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
receptor	O
engagement	O
.	O

Lymphocytes	O
are	O
particularly	O
susceptible	O
to	O
DNA	O
damage	O
-	O
induced	O
apoptosis	O
,	O
a	O
response	O
which	O
may	O
serve	O
as	O
a	O
form	O
of	O
'	O
altruistic	O
suicide	O
'	O
to	O
counter	O
their	O
intrinsic	O
high	O
potential	O
for	O
mutation	O
and	O
clonal	O
expansion	O
.	O

Here	O
we	O
show	O
DNA	O
damage	O
-	O
induced	O
apoptosis	O
in	O
these	O
T	O
lymphocytes	O
is	O
dependent	O
on	O
the	O
antioncogenic	O
transcription	O
factor	O
interferon	B-Biological_Molecule
regulatory	I-Biological_Molecule
factor	I-Biological_Molecule
(	I-Biological_Molecule
IRF	I-Biological_Molecule
)	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
.	O

We	O
also	O
show	O
that	O
mitogen	O
induction	O
of	O
the	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
beta	I-Biological_Molecule
converting	I-Biological_Molecule
enzyme	E-Biological_Molecule
(	O
ICE	S-Biological_Molecule
)	O
gene	O
,	O
a	O
mammalian	O
homologue	O
of	O
the	O
Caenorhabditis	O
elegans	O
cell	O
death	O
gene	O
ced	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
,	O
is	O
IRF	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
-	O
dependent	O
.	O

Regulation	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
jun	E-Biological_Molecule
mRNA	O
expression	O
by	O
hydroxyurea	O
in	O
human	O
K562	O
cells	O
during	O
erythroid	O
differentiation	O
[	O
published	O
erratum	O
appears	O
in	O
Biochim	O
Biophys	O
Acta	O
1995	O
Dec	O
27	O
;	O
1264	O
(	O
3	O
)	O
:	O
409	O
]	O

In	O
addition	O
,	O
HU	O
stimulates	O
the	O
synthesis	O
of	O
fetal	O
hemoglobin	O
in	O
sickle	O
cell	O
anemia	O
patients	O
.	O

HU	O
induced	O
a	O
dose	O
-	O
dependent	O
stimulation	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
jun	E-Biological_Molecule
synthesis	O
.	O

In	O
addition	O
,	O
the	O
level	O
of	O
jun	O
protein	O
was	O
elevated	O
by	O
2	O
to	O
5	O
-	O
fold	O
within	O
4	O
h	O
in	O
HU	O
treated	O
cells	O
.	O

Delineation	O
of	O
the	O
CD28	S-Biological_Molecule
signaling	O
cascade	O
was	O
found	O
to	O
involve	O
protein	O
tyrosine	O
kinase	O
activity	O
,	O
followed	O
by	O
the	O
activation	O
of	O
phospholipase	O
A2	O
and	O
5	O
-	O
lipoxygenase	O
.	O

Tat	S-Biological_Molecule
is	O
an	O
essential	O
regulatory	O
protein	O
for	O
the	O
replication	O
of	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
.	O

Stimulation	O
of	O
NK	O
cells	O
with	O
CD16	O
ligands	O
induces	O
NFAT	O
-	O
like	O
DNA	O
binding	O
activity	O
in	O
the	O
nuclear	O
extracts	O
from	O
these	O
cells	O
,	O
as	O
detected	O
in	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O

Constitutive	O
tyrosine	O
phosphorylation	O
of	O
a	O
130	O
-	O
kD	O
protein	O
(	O
s	O
)	O
was	O
observed	O
in	O
the	O
tax	S-Biological_Molecule
transformed	O
fibroblast	O
B	O
line	O
and	O
in	O
HTLV	O
-	O
1	O
transformed	O
human	O
lymphoid	O
lines	O
,	O
but	O
not	O
in	O
thymocytes	O
from	O
Thy	O
-	O
tax	O
transgenic	O
mice	O
.	O

Tyrosine	O
phosphorylation	O
of	O
this	O
protein	O
could	O
also	O
be	O
induced	O
in	O
Balb	O
/	O
c3T3	O
cells	O
using	O
a	O
supernatant	O
from	O
the	O
B	O
line	O
,	O
which	O
was	O
associated	O
with	O
induction	O
of	O
cell	O
proliferation	O
.	O

Erythropoietin	S-Biological_Molecule
(	O
Epo	S-Biological_Molecule
)	O
,	O
the	O
primary	O
regulator	O
of	O
the	O
production	O
of	O
erythroid	O
cells	O
,	O
acts	O
by	O
binding	O
to	O
a	O
cell	O
surface	O
receptor	O
(	O
EpoR	S-Biological_Molecule
)	O
on	O
erythroid	O
progenitors	O
.	O

We	O
used	O
deletion	O
analysis	O
and	O
transfection	O
assays	O
with	O
reporter	O
gene	O
constructs	O
to	O
examine	O
the	O
transcription	O
control	O
elements	O
in	O
the	O
5	O
'	O
flanking	O
region	O
of	O
the	O
human	O
EpoR	S-Biological_Molecule
gene	O
.	O

PU	B-Biological_Molecule
.	I-Biological_Molecule
1	E-Biological_Molecule
seems	O
to	O
be	O
required	O
for	O
early	O
development	O
of	O
multiple	O
hematopoietic	O
lineages	O
,	O
but	O
its	O
expression	O
in	O
mature	O
cells	O
is	O
preferentially	O
observed	O
in	O
cells	O
of	O
the	O
B	O
-	O
cell	O
-	O
and	O
monocyte	O
/	O
macrophage	O
-	O
differentiation	O
lineage	O
.	O

Functional	O
antagonism	O
between	O
vitamin	O
D3	O
and	O
retinoic	O
acid	O
in	O
the	O
regulation	O
of	O
CD14	S-Biological_Molecule
and	O
CD23	S-Biological_Molecule
expression	O
during	O
monocytic	O
differentiation	O
of	O
U	O
-	O
937	O
cells	O
.	O

The	O
results	O
suggest	O
that	O
there	O
exists	O
a	O
functional	O
antagonism	O
between	O
VitD3	O
and	O
RA	O
that	O
may	O
have	O
important	O
implications	O
for	O
the	O
regulation	O
of	O
certain	O
immune	O
and	O
inflammatory	O
responses	O
through	O
their	O
inverse	O
effects	O
on	O
CD14	S-Biological_Molecule
and	O
CD23	S-Biological_Molecule
gene	O
expression	O
.	O

Cytokines	O
,	O
the	O
peptide	O
hormones	O
which	O
control	O
the	O
homeostasis	O
of	O
the	O
immune	O
system	O
and	O
also	O
play	O
a	O
fundamental	O
role	O
in	O
inflammatory	O
and	O
immune	O
mediated	O
reactions	O
,	O
have	O
been	O
involved	O
at	O
multiple	O
levels	O
in	O
the	O
pathogenesis	O
of	O
the	O
acquired	O
immune	O
deficiency	O
syndrome	O
(	O
AIDS	O
)	O
.	O

Activated	O
mononuclear	O
cells	O
,	O
particularly	O
B	O
cells	O
which	O
are	O
in	O
a	O
state	O
of	O
chronic	O
activation	O
in	O
HIV	O
infected	O
individuals	O
,	O
release	O
HIV	O
-	O
inductive	O
cytokines	O
and	O
thus	O
play	O
a	O
potentially	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
HIV	O
infection	O
.	O

HIV	O
-	O
1	O
can	O
also	O
establish	O
a	O
latent	O
or	O
persistent	O
infection	O
in	O
some	O
T	O
cell	O
lines	O
that	O
show	O
minimal	O
constitutive	O
virus	O
expression	O
.	O

Various	O
gene	O
products	O
from	O
other	O
viruses	O
(	O
HTLV	O
-	O
1	O
,	O
HSV	O
,	O
EBV	O
,	O
CMV	O
,	O
HBV	O
,	O
and	O
HHV	O
-	O
6	O
)	O
can	O
also	O
enhance	O
HIV	O
-	O
1	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
-	O
driven	O
reporter	O
gene	O
activity	O
.	O

Furthermore	O
,	O
we	O
demonstrate	O
that	O
p21ras	S-Biological_Molecule
is	O
essential	O
for	O
NO	O
-	O
induced	O
downstream	O
signaling	O
,	O
such	O
as	O
NF	O
-	O
kappa	O
B	O
activation	O
,	O
and	O
that	O
endogenous	O
NO	O
can	O
activate	O
p21ras	S-Biological_Molecule
in	O
the	O
same	O
cell	O
.	O

Monocyte	O
-	O
macrophage	O
differentiation	O
was	O
used	O
as	O
a	O
model	O
system	O
for	O
studying	O
gene	O
regulation	O
of	O
the	O
human	O
vacuolar	O
H	O
(	O
+	O
)	O
-	O
ATPase	O
(	O
V	O
-	O
ATPase	O
)	O
.	O

Conversely	O
,	O
calcium	O
-	O
independent	O
anti	O
-	O
CD28	O
Ab	O
and	O
PMA	O
-	O
induced	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
production	O
was	O
resistant	O
.	O

A	O
human	O
T	O
lymphoid	O
cell	O
line	O
,	O
PEER	O
,	O
dies	O
by	O
apoptosis	O
in	O
the	O
presence	O
of	O
PMA	O
and	O
calcium	O
ionophore	O
.	O

A	O
new	O
gene	O
,	O
TINUR	S-Biological_Molecule
,	O
was	O
cloned	O
from	O
apoptotic	O
PEER	O
cells	O
.	O

Pretreatment	O
of	O
monocytes	O
with	O
pertussis	O
toxin	O
inhibited	O
these	O
functions	O
of	O
PAF	O
,	O
whereas	O
cholera	O
toxin	O
had	O
no	O
inhibitory	O
effect	O
.	O

IL	O
-	O
1	O
receptor	O
and	O
TCR	O
signals	O
synergize	O
to	O
activate	O
NF	O
-	O
kappa	O
B	O
-	O
mediated	O
gene	O
transcription	O
.	O

In	O
this	O
report	O
we	O
describe	O
how	O
signals	O
initiated	O
through	O
the	O
type	B-Biological_Molecule
I	I-Biological_Molecule
IL	I-Biological_Molecule
-	I-Biological_Molecule
1R	E-Biological_Molecule
interact	O
with	O
signals	O
from	O
the	O
antigen	O
receptor	O
to	O
synergistically	O
augment	O
the	O
transactivating	O
properties	O
of	O
NF	O
-	O
kappa	O
B	O
.	O

Antigen	O
receptor	O
signals	O
prolong	O
NF	O
-	O
kappa	O
B	O
-	O
DNA	O
interaction	O
,	O
probably	O
by	O
functionally	O
antagonizing	O
the	O
IL	O
-	O
1	O
-	O
induced	O
synthesis	O
of	O
a	O
protein	O
(	O
s	O
)	O
responsible	O
for	O
the	O
transient	O
NF	O
-	O
kappa	O
B	O
-	O
DNA	O
interaction	O
and	O
consequently	O
synergistically	O
enhance	O
IL	O
-	O
1	O
-	O
induced	O
NF	O
-	O
kappa	O
B	O
-	O
dependent	O
gene	O
transcription	O
.	O

The	O
nuclear	O
activity	O
of	O
NF	O
-	O
kappa	O
B	O
is	O
tightly	O
regulated	O
from	O
the	O
cytoplasmic	O
compartment	O
by	O
an	O
inhibitory	O
subunit	O
called	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
alpha	E-Biological_Molecule
.	O

This	O
cytoplasmic	O
inhibitor	O
is	O
rapidly	O
phosphorylated	O
and	O
degraded	O
in	O
response	O
to	O
a	O
diverse	O
set	O
of	O
NF	O
-	O
kappa	O
B	O
-	O
inducing	O
agents	O
,	O
including	O
T	O
-	O
cell	O
mitogens	O
,	O
proinflammatory	O
cytokines	O
,	O
and	O
viral	O
transactivators	O
such	O
as	O
the	O
Tax	S-Biological_Molecule
protein	O
of	O
human	O
T	O
-	O
cell	O
leukemia	O
virus	O
type	O
1	O
.	O

The	O
human	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
(	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
)	O
gene	O
is	O
expressed	O
almost	O
exclusively	O
in	O
activated	O
T	O
cells	O
.	O

Second	O
,	O
tyrphostin	O
,	O
a	O
tyrosine	O
kinase	O
inhibitor	O
,	O
impaired	O
the	O
expression	O
of	O
the	O
first	O
but	O
not	O
the	O
second	O
junB	S-Biological_Molecule
mRNA	O
peak	O
.	O

Western	O
blot	O
analysis	O
showed	O
that	O
N	O
-	O
acetyl	O
-	O
cysteine	O
reduced	O
the	O
accumulation	O
of	O
the	O
47	O
-	O
kD	O
mature	O
glycoprotein	O
in	O
LPS	O
-	O
treated	O
cells	O
,	O
a	O
finding	O
consistent	O
with	O
the	O
results	O
of	O
the	O
immunofluorescence	O
studies	O
.	O

First	O
,	O
we	O
show	O
that	O
persistent	O
HIV	O
infection	O
results	O
in	O
the	O
activation	O
of	O
NF	O
-	O
kappa	O
B	O
not	O
only	O
in	O
monocytic	O
cells	O
but	O
also	O
in	O
macrophages	O
.	O

Peripheral	O
blood	O
mononuclear	O
cells	O
from	O
seventeen	O
patients	O
with	O
primary	O
myelodysplastic	O
syndromes	O
(	O
MDS	O
)	O
in	O
advanced	O
stage	O
were	O
enriched	O
for	O
blasts	O
and	O
tested	O
for	O
(	O
1	O
)	O
karyotype	O
,	O
(	O
2	O
)	O
genomic	O
configuration	O
and	O
(	O
3	O
)	O
expression	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
,	O
GM	B-Biological_Molecule
-	I-Biological_Molecule
CSF	E-Biological_Molecule
,	O
FMS	S-Biological_Molecule
and	O
EGR	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
genes	O
which	O
are	O
all	O
located	O
on	O
the	O
long	O
arm	O
of	O
chromosome	O
5	O
.	O

Aims	O
of	O
the	O
study	O
were	O
to	O
(	O
1	O
)	O
assess	O
the	O
potential	O
role	O
of	O
the	O
expression	O
of	O
these	O
genes	O
in	O
the	O
maintenance	O
and	O
expansion	O
of	O
the	O
neoplastic	O
clones	O
and	O
(	O
2	O
)	O
search	O
for	O
constitutional	O
losses	O
or	O
rearrangements	O
of	O
one	O
allele	O
followed	O
by	O
a	O
deletion	O
of	O
the	O
second	O
allele	O
of	O
the	O
same	O
genes	O
in	O
the	O
leukemic	O
cells	O
.	O

Thus	O
,	O
deregulation	O
of	O
genes	O
encoding	O
for	O
certain	O
hemopoietic	O
growth	O
factors	O
or	O
receptors	O
does	O
not	O
seem	O
to	O
represent	O
a	O
major	O
mechanism	O
of	O
MDS	O
progression	O
.	O

Thus	O
,	O
Mn	B-Biological_Molecule
-	I-Biological_Molecule
SOD	E-Biological_Molecule
RNA	O
protein	O
levels	O
and	O
activity	O
were	O
markedly	O
reduced	O
in	O
the	O
presence	O
of	O
Tat	S-Biological_Molecule
.	O

A	O
truncated	O
Tat	S-Biological_Molecule
protein	O
(	O
Tat1	O
-	O
72	O
)	O
,	O
known	O
to	O
transactivate	O
the	O
HIV	O
-	O
1	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
,	O
no	O
longer	O
affected	O
Mn	B-Biological_Molecule
-	I-Biological_Molecule
SOD	E-Biological_Molecule
expression	O
,	O
the	O
cellular	O
redox	O
state	O
or	O
TNF	O
-	O
mediated	O
cytotoxicity	O
.	O

Thus	O
,	O
our	O
experiments	O
demonstrate	O
that	O
the	O
C	O
-	O
terminal	O
region	O
of	O
HIV	O
-	O
1	O
Tat	S-Biological_Molecule
is	O
required	O
to	O
suppress	O
Mn	B-Biological_Molecule
-	I-Biological_Molecule
SOD	E-Biological_Molecule
expression	O
and	O
to	O
induce	O
pro	O
-	O
oxidative	O
conditions	O
reflected	O
by	O
a	O
drop	O
in	O
reduced	O
glutathione	O
(	O
GSH	O
)	O
and	O
the	O
GSH	O
:	O
oxidized	O
GSH	O
(	O
GSSG	O
)	O
ratio	O
.	O

The	O
results	O
indicated	O
that	O
both	O
genes	O
are	O
expressed	O
in	O
T	O
cells	O
throughout	O
their	O
development	O
,	O
supporting	O
the	O
notion	O
that	O
PEBP2	O
is	O
a	O
T	O
-	O
cell	O
-	O
specific	O
transcription	O
factor	O
.	O

Regulation	O
of	O
cell	O
-	O
type	O
-	O
specific	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
2	I-Biological_Molecule
receptor	I-Biological_Molecule
alpha	I-Biological_Molecule
-	I-Biological_Molecule
chain	E-Biological_Molecule
gene	O
expression	O
:	O
potential	O
role	O
of	O
physical	O
interactions	O
between	O
Elf	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
HMG	B-Biological_Molecule
-	I-Biological_Molecule
I	I-Biological_Molecule
(	I-Biological_Molecule
Y	I-Biological_Molecule
)	E-Biological_Molecule
,	O
and	O
NF	O
-	O
kappa	O
B	O
family	O
proteins	O
.	O

The	O
interleukin	B-Biological_Molecule
2	I-Biological_Molecule
receptor	I-Biological_Molecule
alpha	I-Biological_Molecule
-	I-Biological_Molecule
chain	E-Biological_Molecule
(	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2R	I-Biological_Molecule
alpha	E-Biological_Molecule
)	O
gene	O
is	O
rapidly	O
and	O
potently	O
induced	O
in	O
T	O
cells	O
in	O
response	O
to	O
mitogenic	O
stimuli	O
.	O

Detailed	O
structural	O
analysis	O
of	O
the	O
first	O
12	O
cDNAs	O
(	O
HZF	B-Biological_Molecule
1	E-Biological_Molecule
-	O
10	S-Biological_Molecule
)	O
and	O
a	O
partial	O
characterization	O
of	O
HZF	B-Biological_Molecule
11	E-Biological_Molecule
-	O
42	S-Biological_Molecule
revealed	O
that	O
a	O
common	O
feature	O
of	O
human	O
Kruppel	O
-	O
related	O
zinc	O
finger	O
proteins	O
is	O
the	O
presence	O
of	O
tandem	O
arrays	O
of	O
zinc	O
fingers	O
ranging	O
in	O
number	O
from	O
3	O
to	O
over	O
20	O
that	O
are	O
preferentially	O
located	O
in	O
the	O
carboxy	O
-	O
terminal	O
regions	O
of	O
the	O
proteins	O
.	O

In	O
addition	O
,	O
several	O
novel	O
KRAB	O
-	O
containing	O
zinc	O
finger	O
genes	O
and	O
a	O
novel	O
conserved	O
sequence	O
element	O
were	O
identified	O
.	O

This	O
liberates	O
NF	O
-	O
kappa	O
B	O
to	O
translocate	O
to	O
the	O
nucleus	O
and	O
initiate	O
transcription	O
of	O
genes	O
important	O
for	O
the	O
defense	O
of	O
the	O
organism	O
.	O

DESIGN	O
AND	O
METHODS	O
:	O
The	O
effect	O
of	O
all	O
-	O
trans	O
and	O
9	O
-	O
cis	O
RA	O
on	O
HIV	O
-	O
1	O
production	O
in	O
T	O
-	O
lymphoid	O
(	O
H9	O
,	O
CEM	O
)	O
and	O
monocytoid	O
(	O
U937	O
,	O
THP	O
-	O
1	O
)	O
cell	O
lines	O
was	O
measured	O
during	O
acute	O
and	O
chronic	O
infection	O
.	O

Several	O
criteria	O
indicated	O
that	O
the	O
defect	O
in	O
this	O
cell	O
line	O
influences	O
the	O
activity	O
of	O
an	O
isotype	O
-	O
specific	O
transcription	O
factor	O
.	O

The	O
DQB	O
X2	O
-	O
box	O
was	O
able	O
to	O
restore	O
expression	O
to	O
the	O
silent	O
DRA	O
reporter	O
construct	O
.	O

Additionally	O
,	O
infected	O
T	O
cells	O
displayed	O
lower	O
levels	O
of	O
CD45	S-Biological_Molecule
on	O
their	O
surfaces	O
.	O

ERP	S-Biological_Molecule
,	O
a	O
new	O
member	O
of	O
the	O
ets	O
transcription	O
factor	O
/	O
oncoprotein	O
family	O
:	O
cloning	O
,	O
characterization	O
,	O
and	O
differential	O
expression	O
during	O
B	O
-	O
lymphocyte	O
development	O
.	O

To	O
identify	O
ets	O
-	O
related	O
transcriptional	O
regulators	O
expressed	O
in	O
pre	O
-	O
B	O
lymphocytes	O
that	O
may	O
interact	O
with	O
either	O
the	O
pi	O
or	O
the	O
microB	O
site	O
,	O
we	O
have	O
used	O
a	O
PCR	O
approach	O
with	O
degenerate	O
oligonucleotides	O
encoding	O
conserved	O
sequences	O
in	O
all	O
members	O
of	O
the	O
ets	O
family	O
.	O

Three	O
additional	O
smaller	O
regions	O
show	O
homology	O
to	O
the	O
ELK	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
SAP	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
genes	O
,	O
a	O
subgroup	O
of	O
the	O
ets	O
gene	O
family	O
that	O
interacts	O
with	O
the	O
serum	B-Biological_Molecule
response	I-Biological_Molecule
factor	E-Biological_Molecule
.	O

The	O
stimulatory	O
effects	O
of	O
gp160	S-Biological_Molecule
are	O
mediated	O
through	O
the	O
CD4	S-Biological_Molecule
molecule	O
,	O
since	O
pretreatment	O
with	O
soluble	O
CD4	S-Biological_Molecule
abrogates	O
its	O
activity	O
.	O

This	O
inhibition	O
was	O
not	O
mediated	O
through	O
Nef	S-Biological_Molecule
phosphorylation	O
on	O
Thr	O
-	O
15	O
or	O
GTP	O
-	O
binding	O
activity	O
because	O
mutations	O
in	O
critical	O
sites	O
did	O
not	O
alter	O
this	O
inhibition	O
.	O

NM23	O
was	O
identified	O
in	O
a	O
system	O
of	O
murine	O
melanoma	O
cell	O
lines	O
,	O
in	O
which	O
an	O
inverse	O
relationship	O
was	O
found	O
between	O
NM23	O
expression	O
and	O
metastatic	O
ability	O
.	O

Therefore	O
we	O
investigated	O
the	O
modifications	O
imposed	O
on	O
NF	O
-	O
kappa	O
B	O
/	O
I	O
kappa	O
B	O
components	O
following	O
stimulation	O
and	O
show	O
that	O
the	O
final	O
step	O
of	O
NF	O
-	O
kappa	O
B	O
induction	O
in	O
vivo	O
involves	O
phosphorylation	O
of	O
several	O
members	O
of	O
the	O
NF	O
-	O
kappa	O
B	O
/	O
I	O
kappa	O
B	O
protein	O
families	O
.	O

Our	O
studies	O
reveal	O
that	O
inactivation	O
of	O
the	O
v	B-Biological_Molecule
-	I-Biological_Molecule
abl	E-Biological_Molecule
protein	O
tyrosine	O
kinase	O
triggers	O
high	O
-	O
frequency	O
rearrangement	O
of	O
kappa	S-Biological_Molecule
and	O
lambda	B-Biological_Molecule
light	I-Biological_Molecule
-	I-Biological_Molecule
chain	E-Biological_Molecule
genes	O
.	O

Together	O
these	O
data	O
demonstrate	O
that	O
the	O
v	B-Biological_Molecule
-	I-Biological_Molecule
abl	E-Biological_Molecule
protein	O
specifically	O
interferes	O
with	O
light	O
-	O
chain	O
gene	O
rearrangement	O
by	O
suppressing	O
at	O
least	O
two	O
pathways	O
essential	O
for	O
this	O
stage	O
of	O
B	O
-	O
cell	O
differentiation	O
and	O
suggest	O
that	O
tyrosine	O
phosphorylation	O
is	O
important	O
in	O
regulating	O
RAG	O
gene	O
expression	O
.	O

[	O
An	O
overexpression	O
of	O
retinoic	B-Biological_Molecule
acid	I-Biological_Molecule
receptor	I-Biological_Molecule
alpha	E-Biological_Molecule
blocks	O
myeloid	O
cell	O
differentiation	O
at	O
the	O
promyelocyte	O
stage	O
]	O

Retinoic	O
acid	O
(	O
RA	O
)	O
,	O
a	O
vitamin	O
A	O
derivative	O
,	O
exerts	O
a	O
wide	O
range	O
of	O
biological	O
effects	O
related	O
to	O
cell	O
proliferation	O
and	O
differentiation	O
.	O

The	O
addition	O
of	O
either	O
TNF	B-Biological_Molecule
alpha	E-Biological_Molecule
or	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
partially	O
recovered	O
cyclosporin	O
A	O
-	O
induced	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2R	I-Biological_Molecule
alpha	E-Biological_Molecule
inhibition	O
,	O
but	O
only	O
TNF	B-Biological_Molecule
alpha	E-Biological_Molecule
completely	O
recovered	O
NF	O
.	O
kappa	O
B	O
activation	O
.	O

Two	O
groups	O
of	O
U937	O
promonocytic	O
cells	O
were	O
obtained	O
by	O
limiting	O
dilution	O
cloning	O
which	O
differed	O
strikingly	O
in	O
their	O
ability	O
to	O
support	O
human	O
immunodeficiency	O
virus	O
1	O
(	O
HIV	O
-	O
1	O
)	O
replication	O
.	O

HS	O
II	O
was	O
weak	O
in	O
hematopoietic	O
cell	O
lines	O
,	O
absent	O
in	O
Hela	O
,	O
and	O
greatly	O
enhanced	O
in	O
Jurkat	O
,	O
suggesting	O
that	O
this	O
region	O
might	O
be	O
implicated	O
in	O
the	O
cis	O
-	O
activation	O
of	O
tal	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
promoter	O
1b	O
in	O
this	O
cell	O
line	O
.	O

EBNA	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
trans	O
-	O
activates	O
cellular	O
and	O
viral	O
genes	O
like	O
CD23	S-Biological_Molecule
,	O
c	B-Biological_Molecule
-	I-Biological_Molecule
fgr	E-Biological_Molecule
,	O
latent	B-Biological_Molecule
membrane	I-Biological_Molecule
protein	I-Biological_Molecule
1	E-Biological_Molecule
(	O
LMP1	S-Biological_Molecule
)	O
and	O
terminal	B-Biological_Molecule
protein	I-Biological_Molecule
1	E-Biological_Molecule
(	O
TP1	S-Biological_Molecule
)	O
.	O

None	O
of	O
the	O
DNA	O
fragments	O
investigated	O
indicated	O
interaction	O
of	O
EBNA	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
with	O
the	O
DNA	O
via	O
protein	O
-	O
protein	O
interactions	O
.	O

Insertion	O
of	O
this	O
chimeric	O
promoter	O
(	O
ISG15	O
LTR	O
)	O
upstream	O
of	O
the	O
human	O
IFNA2	S-Biological_Molecule
gene	O
directed	O
high	O
levels	O
of	O
IFN	O
synthesis	O
in	O
Tat	S-Biological_Molecule
-	O
expressing	O
cells	O
,	O
while	O
this	O
promoter	O
was	O
not	O
responsive	O
to	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
alpha	E-Biological_Molecule
-	O
mediated	O
activation	O
.	O

However	O
,	O
PDTC	O
failed	O
to	O
inhibit	O
the	O
endonuclease	O
activity	O
contained	O
in	O
the	O
whole	O
cell	O
lysates	O
.	O

The	O
T	O
cell	O
surface	O
molecule	O
CD28	S-Biological_Molecule
binds	O
to	O
ligands	O
on	O
accessory	O
cells	O
and	O
APCs	O
,	O
playing	O
an	O
important	O
costimulatory	O
role	O
in	O
the	O
response	O
of	O
T	O
cells	O
to	O
Ags	O
.	O

EL	O
-	O
4	O
cells	O
were	O
transfected	O
with	O
a	O
plasmid	O
containing	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
promoter	O
and	O
enhancer	O
region	O
linked	O
to	O
the	O
chloramphenicol	B-Biological_Molecule
acetyltransferase	E-Biological_Molecule
(	O
CAT	S-Biological_Molecule
)	O
reporter	O
gene	O
.	O

Based	O
on	O
sequence	O
homology	O
we	O
identified	O
two	O
binding	O
motifs	O
for	O
Pit	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
seven	O
half	O
-	O
sites	O
for	O
glucocorticoid	B-Biological_Molecule
receptor	E-Biological_Molecule
/	O
progesterone	B-Biological_Molecule
receptor	E-Biological_Molecule
(	O
PR	S-Biological_Molecule
)	O
binding	O
.	O

We	O
focused	O
our	O
studies	O
on	O
the	O
role	O
of	O
Pit	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
of	O
PR	S-Biological_Molecule
as	O
potential	O
transcriptional	O
regulators	O
,	O
since	O
the	O
POU	O
domain	O
protein	O
Pit	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
is	O
essential	O
in	O
the	O
control	O
of	O
pituitary	O
PRL	S-Biological_Molecule
expression	O
,	O
and	O
progesterone	O
induces	O
decidual	O
transformation	O
of	O
the	O
endometrial	O
stroma	O
,	O
a	O
differentiation	O
process	O
during	O
which	O
the	O
decidual	O
PRL	S-Biological_Molecule
gene	O
is	O
activated	O
.	O

Addition	O
of	O
rIL	O
-	O
2	O
fully	O
restored	O
the	O
proliferative	O
response	O
and	O
partially	O
restored	O
the	O
production	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
,	O
but	O
not	O
that	O
of	O
other	O
cytokines	O
.	O

In	O
this	O
study	O
we	O
investigated	O
the	O
effect	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
on	O
the	O
expression	O
of	O
cytokine	O
genes	O
in	O
monocytes	O
evoked	O
by	O
other	O
T	O
-	O
helper	O
cell	O
cytokines	O
:	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
,	O
and	O
GM	B-Biological_Molecule
-	I-Biological_Molecule
CSF	E-Biological_Molecule
.	O

IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
down	O
-	O
regulated	O
mRNA	O
accumulation	O
of	O
the	O
proinflammatory	O
cytokines	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
beta	E-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
,	O
and	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
in	O
monocytes	O
stimulated	O
with	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
,	O
and	O
GM	B-Biological_Molecule
-	I-Biological_Molecule
CSF	E-Biological_Molecule
.	O

This	O
was	O
supported	O
by	O
the	O
observation	O
that	O
the	O
down	O
-	O
regulatory	O
capacity	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
appeared	O
to	O
be	O
dependent	O
on	O
de	O
novo	O
protein	O
synthesis	O
.	O

Long	O
-	O
term	O
inositol	O
phosphate	O
release	O
,	O
but	O
not	O
tyrosine	O
kinase	O
activity	O
,	O
correlates	O
with	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
secretion	O
and	O
NF	O
-	O
AT	O
induction	O
in	O
anti	O
-	O
CD3	O
-	O
activated	O
peripheral	O
human	O
T	O
lymphocytes	O
.	O

The	O
cascade	O
of	O
events	O
within	O
the	O
first	O
few	O
minutes	O
of	O
T	O
cell	O
stimulation	O
has	O
been	O
well	O
characterized	O
.	O

To	O
model	O
effective	O
versus	O
ineffective	O
CD3	O
-	O
mediated	O
stimulation	O
in	O
peripheral	O
T	O
cells	O
,	O
we	O
used	O
two	O
anti	O
-	O
CD3	O
mAbs	O
that	O
differ	O
in	O
their	O
ability	O
to	O
stimulate	O
purified	O
T	O
cells	O
:	O
OKT3	O
,	O
which	O
causes	O
early	O
second	O
messenger	O
generation	O
but	O
is	O
unable	O
to	O
activate	O
T	O
cells	O
without	O
a	O
second	O
signal	O
,	O
and	O
64	O
.	O
1	O
,	O
which	O
stimulates	O
T	O
cell	O
proliferation	O
on	O
its	O
own	O
.	O

Binding	O
of	O
superantigens	O
to	O
MHC	O
class	O
II	O
molecules	O
results	O
in	O
transduction	O
of	O
biochemical	O
signals	O
leading	O
to	O
cellular	O
activation	O
and	O
gene	O
expression	O
.	O

Here	O
we	O
report	O
that	O
CD28	S-Biological_Molecule
engagement	O
,	O
however	O
,	O
exerts	O
opposite	O
effects	O
on	O
the	O
transcription	O
factor	O
AP	O
-	O
1	O
.	O

Sequence	O
homology	O
,	O
single	O
nucleotide	O
mutations	O
,	O
and	O
anti	O
-	O
CD28	S-Biological_Molecule
Ab	O
stimulation	O
studies	O
established	O
that	O
the	O
NF	O
-	O
kappa	O
B	O
-	O
like	O
sequence	O
in	O
the	O
promoter	O
of	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
gene	O
functioned	O
as	O
a	O
CD28	S-Biological_Molecule
response	O
element	O
.	O

The	O
two	O
tiny	O
ring	O
X	O
chromosomes	O
studied	O
with	O
an	O
antibody	O
specific	O
for	O
the	O
acetylated	O
isoforms	O
of	O
histone	B-Biological_Molecule
H4	E-Biological_Molecule
marking	O
transcribed	O
chromatin	O
domains	O
were	O
labeled	O
at	O
a	O
level	O
consistent	O
with	O
their	O
being	O
active	O
.	O

The	O
P	O
sequence	O
of	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
gene	O
,	O
defined	O
as	O
a	O
responsive	O
element	O
for	O
PMA	O
and	O
calcium	O
ionophore	O
(	O
A23187	O
)	O
,	O
shares	O
sequence	O
similarity	O
with	O
the	O
NF	O
kappa	O
B	O
and	O
the	O
NF	O
-	O
activated	O
T	O
cell	O
binding	O
sites	O
.	O

Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
NF	O
-	O
AT	O
-	O
like	O
factors	O
are	O
involved	O
in	O
the	O
regulation	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
genes	O
.	O

The	O
two	O
human	O
GATA3	S-Biological_Molecule
zinc	O
fingers	O
are	O
encoded	O
by	O
two	O
separate	O
exons	O
highly	O
conserved	O
with	O
those	O
of	O
GATA1	S-Biological_Molecule
,	O
but	O
no	O
other	O
structural	O
homologies	O
between	O
these	O
two	O
genes	O
can	O
be	O
found	O
.	O

The	O
response	O
of	O
mammalian	O
cells	O
to	O
stress	O
is	O
controlled	O
by	O
transcriptional	O
regulatory	O
proteins	O
such	O
as	O
nuclear	O
factor	O
kappa	O
B	O
(	O
NF	O
-	O
kappa	O
B	O
)	O
to	O
induce	O
a	O
wide	O
variety	O
of	O
early	O
response	O
genes	O
.	O

Site	O
B	O
(	O
nt	O
4519	O
to	O
4545	O
)	O
specifically	O
bound	O
four	O
distinct	O
nuclear	O
protein	O
complexes	O
:	O
a	O
ubiquitous	O
factor	O
,	O
a	O
T	O
-	O
cell	O
-	O
specific	O
factor	O
,	O
a	O
B	O
-	O
cell	O
-	O
specific	O
factor	O
,	O
and	O
the	O
monocyte	O
/	O
macrophage	O
-	O
and	O
B	O
-	O
cell	O
-	O
specific	O
transcription	O
factor	O
PU	B-Biological_Molecule
.	I-Biological_Molecule
1	E-Biological_Molecule
/	O
Spi	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
.	O

NF	O
-	O
kappa	O
B	O
is	O
a	O
rapidly	O
inducible	O
transcriptional	O
activator	O
that	O
responds	O
to	O
a	O
variety	O
of	O
signals	O
and	O
influences	O
the	O
expression	O
of	O
many	O
genes	O
involved	O
in	O
the	O
immune	O
response	O
.	O

Very	O
little	O
information	O
exists	O
linking	O
these	O
two	O
important	O
classes	O
of	O
signaling	O
molecules	O
.	O

On	O
the	O
other	O
hand	O
,	O
stimulation	O
of	O
T	O
cells	O
by	O
mitogens	O
or	O
antibodies	O
to	O
the	O
T	O
-	O
cell	O
receptor	O
(	O
TCR	O
)	O
-	O
CD3	O
complex	O
resulted	O
in	O
the	O
down	O
-	O
regulation	O
of	O
transcriptional	O
factors	O
NF	O
-	O
kappa	O
B	O
and	O
AP	O
-	O
1	O
in	O
cells	O
expressing	O
the	O
nef	S-Biological_Molecule
gene	O
compared	O
with	O
cells	O
not	O
expressing	O
the	O
nef	O
gene	O
.	O

We	O
found	O
,	O
moreover	O
,	O
that	O
in	O
SK	O
-	O
N	O
-	O
Be	O
(	O
2	O
)	O
cells	O
protein	O
kinase	O
C	O
(	O
PKC	O
)	O
enzymatic	O
activity	O
was	O
much	O
lower	O
compared	O
with	O
that	O
in	O
a	O
control	O
cell	O
line	O
and	O
that	O
the	O
low	O
PKC	O
enzymatic	O
activity	O
was	O
due	O
to	O
low	O
PKC	O
protein	O
expression	O
.	O

Genes	O
encoding	O
general	O
initiation	O
factors	O
for	O
RNA	O
polymerase	O
II	O
transcription	O
are	O
dispersed	O
in	O
the	O
human	O
genome	O
.	O

General	O
transcription	O
factors	O
are	O
required	O
for	O
accurate	O
initiation	O
of	O
transcription	O
by	O
RNA	O
polymerase	O
II	O
.	O

However	O
,	O
a	O
TH	O
-	O
dependent	O
positive	O
effect	O
is	O
elicited	O
by	O
selective	O
interaction	O
of	O
the	O
THR	O
beta	O
-	O
PPAR	O
but	O
not	O
the	O
THR	O
alpha	O
-	O
PPAR	O
heterodimer	O
with	O
a	O
novel	O
TRE	O
(	O
DR	O
+	O
2	O
)	O
.	O

Incubation	O
of	O
human	O
endothelial	O
cells	O
(	O
ECs	O
)	O
in	O
hypoxia	O
,	O
PO2	O
approximately	O
14	O
-	O
18	O
Torr	O
,	O
led	O
to	O
time	O
-	O
dependent	O
release	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
antigen	O
into	O
the	O
conditioned	O
medium	O
;	O
this	O
was	O
accompanied	O
by	O
increased	O
chemotactic	O
activity	O
for	O
PMNs	O
,	O
blocked	O
by	O
antibody	O
to	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
.	O

Again	O
,	O
in	O
vitro	O
supershift	O
studies	O
indicate	O
that	O
the	O
presence	O
of	O
p50	S-Biological_Molecule
,	O
p52	S-Biological_Molecule
,	O
p65	S-Biological_Molecule
,	O
and	O
cRel	S-Biological_Molecule
correlates	O
with	O
positive	O
function	O
whereas	O
the	O
presence	O
of	O
only	O
p50	S-Biological_Molecule
and	O
p52	S-Biological_Molecule
correlates	O
with	O
negative	O
function	O
.	O

Targeted	O
mutagenesis	O
of	O
the	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
gene	O
in	O
embryonic	O
stem	O
cells	O
has	O
demonstrated	O
its	O
requirement	O
in	O
normal	O
erythroid	O
development	O
.	O

The	O
transcription	O
factor	O
AP	O
-	O
1	O
is	O
an	O
important	O
human	O
mediator	O
of	O
the	O
cellular	O
response	O
to	O
serum	O
,	O
growth	O
factors	O
,	O
and	O
phorbol	O
esters	O
such	O
as	O
12	O
-	O
O	O
-	O
tetradecanoyl	O
-	O
phorbol	O
-	O
13	O
acetate	O
(	O
TPA	O
)	O
.	O

Recent	O
findings	O
suggest	O
an	O
involvement	O
of	O
reactive	O
oxygen	O
species	O
in	O
the	O
pathway	O
of	O
TPA	O
and	O
protein	O
kinase	O
C	O
leading	O
to	O
expression	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
fos	E-Biological_Molecule
and	O
c	B-Biological_Molecule
-	I-Biological_Molecule
jun	E-Biological_Molecule
mRNA	O
.	O

These	O
studies	O
support	O
the	O
idea	O
that	O
superoxide	O
anion	O
radical	O
plays	O
a	O
role	O
in	O
the	O
expression	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
fos	E-Biological_Molecule
mRNA	O
.	O

Recent	O
reports	O
demonstrated	O
that	O
ionizing	O
radiation	O
in	O
the	O
dose	O
range	O
of	O
2	O
-	O
50	O
Gy	O
results	O
in	O
expression	O
of	O
NF	O
-	O
kappa	O
B	O
in	O
human	O
KG	O
-	O
1	O
myeloid	O
leukemia	O
cells	O
and	O
human	O
B	O
-	O
lymphocyte	O
precursor	O
cells	O
;	O
the	O
precise	O
mechanism	O
involved	O
and	O
the	O
significance	O
are	O
not	O
yet	O
known	O
.	O

These	O
results	O
are	O
in	O
a	O
dose	O
range	O
where	O
the	O
viability	O
of	O
the	O
cells	O
remains	O
very	O
high	O
.	O

This	O
arrangement	O
of	O
Ets	O
sites	O
,	O
coupled	O
with	O
the	O
tissue	O
-	O
and	O
developmental	O
-	O
specific	O
expression	O
of	O
Ets	O
members	O
,	O
likely	O
play	O
a	O
key	O
role	O
in	O
defining	O
the	O
pattern	O
of	O
alpha	B-Biological_Molecule
4	I-Biological_Molecule
integrin	E-Biological_Molecule
.	O

Lipopolysaccharide	O
induction	O
of	O
tissue	O
factor	O
gene	O
expression	O
in	O
monocytic	O
cells	O
is	O
mediated	O
by	O
binding	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Rel	E-Biological_Molecule
/	O
p65	S-Biological_Molecule
heterodimers	O
to	O
a	O
kappa	O
B	O
-	O
like	O
site	O
.	O

Here	O
we	O
report	O
the	O
characterization	O
of	O
a	O
nuclear	O
complex	O
from	O
human	O
monocytic	O
cells	O
that	O
bound	O
to	O
a	O
kappa	O
B	O
-	O
like	O
site	O
,	O
5	O
'	O
-	O
CGGAGTTTCC	O
-	O
3	O
'	O
,	O
in	O
the	O
5	O
'	O
-	O
flanking	O
region	O
of	O
the	O
human	O
TF	S-Biological_Molecule
gene	O
.	O

To	O
characterize	O
mechanisms	O
responsible	O
for	O
these	O
LIF	S-Biological_Molecule
effects	O
,	O
levels	O
of	O
HIV	O
mRNA	O
,	O
activation	O
of	O
the	O
DNA	O
binding	O
protein	O
nuclear	O
factor	O
(	O
NF	O
)	O
-	O
kB	O
,	O
signal	O
transduction	O
pathways	O
,	O
and	O
potential	O
interactions	O
with	O
other	O
cytokines	O
were	O
analyzed	O
.	O

The	O
Tat	S-Biological_Molecule
-	O
mediated	O
increase	O
in	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
promoter	O
activity	O
could	O
selectively	O
be	O
blocked	O
by	O
antisense	O
tat	S-Biological_Molecule
or	O
-	O
unlike	O
the	O
analogous	O
effect	O
of	O
human	O
T	O
-	O
cell	O
lymphotropic	O
virus	O
type	O
1	O
Tax	S-Biological_Molecule
-	O
by	O
cyclosporin	O
A	O
.	O

The	O
observed	O
increase	O
in	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
levels	O
might	O
facilitate	O
virus	O
spread	O
from	O
or	O
to	O
T	O
cells	O
.	O

Purified	O
recombinant	O
Jun	O
and	O
Fos	O
proteins	O
failed	O
to	O
bind	O
directly	O
to	O
the	O
NFAT	O
motif	O
.	O

Positive	O
autoregulation	O
of	O
GR	S-Biological_Molecule
expression	O
was	O
also	O
observed	O
in	O
glucocorticoid	O
-	O
resistant	O
CEM	O
-	O
C1	O
cells	O
,	O
which	O
contain	O
functional	O
GR	S-Biological_Molecule
,	O
but	O
whose	O
growth	O
is	O
unaffected	O
by	O
glucocorticoids	O
.	O

The	O
stimulation	O
of	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
alpha	E-Biological_Molecule
production	O
by	O
okadaic	O
acid	O
was	O
more	O
modest	O
than	O
that	O
of	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
beta	E-Biological_Molecule
.	O

The	O
sequence	O
located	O
upstream	O
of	O
the	O
J	O
delta	O
1	O
segment	O
corresponded	O
to	O
the	O
previously	O
reported	O
germ	O
-	O
line	O
sequence	O
.	O

Finally	O
,	O
no	O
transcription	O
of	O
the	O
RAG	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
gene	O
could	O
be	O
detected	O
in	O
all	O
NK	O
cell	O
lines	O
or	O
clones	O
analyzed	O
.	O

However	O
,	O
the	O
tissue	O
specificity	O
of	O
this	O
promoter	O
is	O
only	O
partial	O
because	O
it	O
is	O
active	O
in	O
all	O
of	O
the	O
hematopoietic	O
cells	O
tested	O
here	O
,	O
regardless	O
of	O
whether	O
they	O
constitutively	O
express	O
Fc	B-Biological_Molecule
epsilon	I-Biological_Molecule
RI	I-Biological_Molecule
-	I-Biological_Molecule
gamma	I-Biological_Molecule
chain	E-Biological_Molecule
transcripts	O
.	O

Interleukin	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
(	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
)	O
is	O
exclusively	O
expressed	O
by	O
activated	O
T	O
and	O
natural	O
killer	O
cells	O
,	O
a	O
function	O
that	O
is	O
tightly	O
controlled	O
both	O
in	O
a	O
lineage	O
-	O
specific	O
and	O
in	O
a	O
stimulation	O
-	O
dependent	O
manner	O
.	O

Over	O
its	O
3	O
'	O
end	O
,	O
it	O
binds	O
a	O
factor	O
that	O
is	O
ubiquitously	O
and	O
constitutively	O
expressed	O
.	O

These	O
characteristics	O
make	O
the	O
ACT	O
-	O
1	O
site	O
analogous	O
to	O
the	O
activating	O
ARRE	O
-	O
1	O
site	O
in	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
promoter	O
.	O

A	O
dominant	O
inhibitory	O
ras	O
mutant	O
specifically	O
blocked	O
antigen	O
receptor	O
agonism	O
,	O
indicating	O
that	O
ras	O
activity	O
is	O
required	O
for	O
antigen	O
receptor	O
signaling	O
.	O

We	O
further	O
characterize	O
which	O
AP1	O
family	O
members	O
can	O
assume	O
this	O
role	O
.	O

To	O
further	O
evaluate	O
the	O
role	O
of	O
X	O
box	O
DNA	O
-	O
binding	O
proteins	O
in	O
class	O
II	O
gene	O
expression	O
,	O
the	O
role	O
of	O
the	O
X	O
box	O
region	O
was	O
examined	O
in	O
both	O
class	O
II	O
-	O
positive	O
and	O
-	O
negative	O
lymphoid	O
cells	O
.	O

In	O
contrast	O
to	O
wild	O
-	O
type	O
B	O
cells	O
,	O
neither	O
of	O
the	O
class	O
II	O
mutant	O
cell	O
lines	O
could	O
use	O
the	O
X	O
box	O
region	O
to	O
direct	O
the	O
expression	O
of	O
a	O
transiently	O
transfected	O
reporter	O
gene	O
,	O
indicating	O
that	O
the	O
X	O
box	O
-	O
dependent	O
transcriptional	O
pathway	O
is	O
defective	O
in	O
these	O
cells	O
.	O

One	O
of	O
the	O
essential	O
proteins	O
which	O
bound	O
to	O
the	O
enhancer	O
was	O
similar	O
or	O
identical	O
to	O
members	O
of	O
the	O
C	O
/	O
EBP	O
family	O
of	O
transcription	O
factors	O
required	O
for	O
both	O
IL	O
-	O
1	O
-	O
and	O
LPS	O
-	O
specific	O
induction	O
of	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
gene	O
(	O
i	O
.	O
e	O
.	O
,	O
the	O
NF	B-Biological_Molecule
-	I-Biological_Molecule
IL6	E-Biological_Molecule
proteins	O
)	O
.	O

The	O
divergent	O
effects	O
of	O
hemin	O
and	O
TPA	O
on	O
gene	O
expression	O
in	O
K562	O
cells	O
are	O
mediated	O
,	O
in	O
part	O
,	O
by	O
their	O
contrasting	O
effects	O
on	O
the	O
transcription	O
factor	O
NF	O
-	O
E2	O
.	O

Within	O
this	O
region	O
,	O
we	O
define	O
a	O
minimal	O
promoter	O
(	O
-	O
62	O
to	O
+	O
54	O
)	O
that	O
displays	O
erythroid	O
-	O
specific	O
activity	O
and	O
contains	O
two	O
DNA	O
binding	O
sites	O
.	O

Transcriptional	O
regulation	O
of	O
interleukin	B-Biological_Molecule
3	E-Biological_Molecule
(	O
IL3	S-Biological_Molecule
)	O
in	O
primary	O
human	O
T	O
lymphocytes	O
.	O

We	O
studied	O
the	O
functional	O
interaction	O
between	O
human	O
embryonic	O
zeta	B-Biological_Molecule
2	I-Biological_Molecule
globin	E-Biological_Molecule
promoter	O
and	O
the	O
alpha	B-Biological_Molecule
globin	E-Biological_Molecule
regulatory	O
element	O
(	O
HS	O
-	O
40	O
)	O
located	O
40	O
kb	O
upstream	O
of	O
the	O
zeta	B-Biological_Molecule
2	I-Biological_Molecule
globin	E-Biological_Molecule
gene	O
.	O

Site	O
-	O
directed	O
mutagenesis	O
further	O
demonstrated	O
that	O
the	O
enhancer	O
function	O
of	O
one	O
of	O
the	O
two	O
NF	O
-	O
E2	O
/	O
AP1	O
motifs	O
of	O
HS	O
-	O
40	O
is	O
mediated	O
through	O
its	O
binding	O
to	O
NF	O
-	O
E2	O
but	O
not	O
AP1	O
transcription	O
factor	O
.	O

Costimulation	O
of	O
peripheral	O
blood	O
T	O
cell	O
activation	O
by	O
human	O
endothelial	O
cells	O
.	O

In	O
summary	O
,	O
our	O
data	O
suggest	O
that	O
changes	O
in	O
the	O
composition	O
of	O
transcription	O
factor	O
AP	O
-	O
1	O
is	O
a	O
key	O
molecular	O
mechanism	O
for	O
increasing	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
transcription	O
and	O
may	O
underlie	O
the	O
phenomenon	O
of	O
costimulation	O
by	O
EC	O
.	O

Negative	O
transcriptional	O
regulation	O
of	O
human	O
interleukin	B-Biological_Molecule
2	E-Biological_Molecule
(	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
)	O
gene	O
by	O
glucocorticoids	O
through	O
interference	O
with	O
nuclear	O
transcription	O
factors	O
AP	O
-	O
1	O
and	O
NF	O
-	O
AT	O
.	O

IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
gene	O
transcription	O
is	O
affected	O
by	O
several	O
nuclear	O
proteins	O
.	O

It	O
has	O
previously	O
been	O
shown	O
that	O
transcripts	O
of	O
the	O
E2A	S-Biological_Molecule
gene	O
can	O
be	O
detected	O
in	O
a	O
wide	O
range	O
of	O
cell	O
types	O
.	O

We	O
found	O
that	O
Nef	S-Biological_Molecule
inhibited	O
the	O
recruitment	O
of	O
AP	O
-	O
1	O
DNA	O
-	O
binding	O
activity	O
in	O
mitogen	O
-	O
stimulated	O
human	O
T	O
-	O
cells	O
.	O

Cloning	O
and	O
functional	O
characterization	O
of	O
early	B-Biological_Molecule
B	I-Biological_Molecule
-	I-Biological_Molecule
cell	I-Biological_Molecule
factor	E-Biological_Molecule
,	O
a	O
regulator	O
of	O
lymphocyte	O
-	O
specific	O
gene	O
expression	O
.	O

Elf	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
binds	O
exclusively	O
to	O
the	O
underphosphorylated	O
form	O
of	O
Rb	S-Biological_Molecule
and	O
fails	O
to	O
bind	O
to	O
Rb	S-Biological_Molecule
mutants	O
derived	O
from	O
patients	O
with	O
retinoblastoma	O
.	O

Recent	O
studies	O
have	O
provided	O
new	O
insights	O
into	O
how	O
the	O
individual	O
genes	O
of	O
the	O
cluster	O
are	O
regulated	O
through	O
development	O
.	O

In	O
contrast	O
,	O
the	O
binding	O
of	O
the	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NF	O
-	O
AT	O
)	O
to	O
its	O
response	O
element	O
in	O
the	O
IL2	S-Biological_Molecule
enhancer	O
and	O
to	O
an	O
NF	O
-	O
AT	O
-	O
like	O
response	O
element	O
present	O
in	O
the	O
IL4	S-Biological_Molecule
enhancer	O
was	O
abnormal	O
.	O

To	O
ascertain	O
whether	O
the	O
abnormal	O
NF	O
-	O
AT	O
binding	O
activity	O
was	O
related	O
to	O
an	O
impaired	O
function	O
,	O
we	O
transfected	O
patient	O
and	O
control	O
T	O
lymphocytes	O
with	O
constructs	O
containing	O
the	O
reporter	O
gene	O
encoding	O
chloramphenicol	B-Biological_Molecule
acetyl	I-Biological_Molecule
transferase	E-Biological_Molecule
(	O
CAT	S-Biological_Molecule
)	O
under	O
the	O
control	O
of	O
the	O
entire	O
IL2	S-Biological_Molecule
regulatory	O
region	O
or	O
of	O
multimers	O
of	O
individual	O
enhancer	O
sequences	O
.	O

Treatment	O
of	O
HL	O
-	O
60	O
eosinophilic	O
sublines	O
with	O
either	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
or	O
butyric	O
acid	O
increased	O
the	O
expression	O
of	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
mRNA	O
concomitant	O
with	O
the	O
expression	O
of	O
eosinophil	O
-	O
specific	O
genes	O
,	O
whereas	O
levels	O
of	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
mRNA	O
remained	O
relatively	O
constant	O
.	O

Dependence	O
for	O
the	O
proliferative	O
response	O
to	O
erythropoietin	S-Biological_Molecule
on	O
an	O
established	O
erythroid	O
differentiation	O
program	O
in	O
a	O
human	O
hematopoietic	O
cell	O
line	O
,	O
UT	O
-	O
7	O
.	O

The	O
number	O
of	O
gamma	O
-	O
positive	O
cells	O
and	O
their	O
fluorescence	O
intensity	O
were	O
higher	O
in	O
UT	O
-	O
7	O
Epo	O
than	O
in	O
UT	O
-	O
7	O
cells	O
(	O
0	O
to	O
17	O
%	O
barely	O
positive	O
cells	O
and	O
23	O
to	O
40	O
%	O
clearly	O
positive	O
cells	O
,	O
respectively	O
)	O
,	O
indicating	O
that	O
the	O
increase	O
in	O
globin	O
mRNA	O
observed	O
in	O
UT	O
-	O
7	O
Epo	O
is	O
due	O
to	O
both	O
an	O
increase	O
of	O
gene	O
expression	O
per	O
cell	O
and	O
an	O
increase	O
in	O
numbers	O
of	O
cells	O
containing	O
gamma	O
-	O
globin	O
.	O

PKC	B-Biological_Molecule
-	I-Biological_Molecule
zeta	E-Biological_Molecule
belongs	O
to	O
this	O
family	O
and	O
is	O
known	O
to	O
be	O
an	O
important	O
step	O
in	O
NF	O
-	O
kappa	O
B	O
activation	O
in	O
other	O
cell	O
systems	O
.	O

Lastly	O
,	O
we	O
demonstrate	O
a	O
selective	O
inhibition	O
of	O
p24	O
production	O
by	O
HIV	O
-	O
infected	O
human	O
macrophages	O
when	O
treated	O
with	O
AO	O
to	O
PKC	O
-	O
zeta	O
.	O

A	O
newly	O
identified	O
motif	O
called	O
the	O
B29	S-Biological_Molecule
conserved	O
sequence	O
(	O
BCS	O
)	O
,	O
found	O
upstream	O
of	O
both	O
human	O
and	O
murine	O
B29	S-Biological_Molecule
promoters	O
,	O
appears	O
to	O
stimulate	O
B29	S-Biological_Molecule
transcription	O
through	O
a	O
novel	O
mechanism	O
.	O

Expression	O
of	O
MEK1	S-Biological_Molecule
-	O
interfering	O
mutants	O
inhibited	O
the	O
stimulation	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
promoter	O
-	O
driven	O
transcription	O
and	O
blocked	O
the	O
ability	O
of	O
constitutively	O
active	O
Ras	O
and	O
Raf	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
to	O
costimulate	O
NF	O
-	O
AT	O
activity	O
with	O
a	O
calcium	O
ionophore	O
.	O

Elevation	O
of	O
the	O
levels	O
of	O
circulating	O
immune	O
complexes	O
frequently	O
accompanies	O
HIV	O
-	O
1	O
infection	O
and	O
is	O
a	O
prognostic	O
indicator	O
of	O
clinical	O
progression	O
from	O
asymptomatic	O
infection	O
to	O
AIDS	O
.	O

In	O
THP	O
-	O
1	O
cells	O
,	O
Fc	O
gamma	O
R	O
cross	O
-	O
linking	O
induced	O
NF	O
-	O
kappa	O
B	O
,	O
which	O
is	O
known	O
to	O
bind	O
to	O
the	O
regulatory	O
region	O
of	O
the	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
of	O
HIV	O
-	O
1	O
and	O
to	O
activate	O
HIV	O
-	O
1	O
transcription	O
.	O

Anti	O
-	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
antibody	O
but	O
not	O
anti	O
-	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
beta	E-Biological_Molecule
antibody	O
strongly	O
inhibited	O
both	O
the	O
induction	O
of	O
HIV	O
-	O
1	O
-	O
LTR	O
-	O
driven	O
transcription	O
and	O
the	O
induction	O
of	O
NF	O
-	O
kappa	O
B	O
by	O
Fc	O
gamma	O
R	O
cross	O
-	O
linking	O
.	O

These	O
results	O
indicate	O
that	O
Fc	O
gamma	O
R	O
can	O
mediate	O
a	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
-	O
dependent	O
induction	O
of	O
HIV	O
-	O
1	O
gene	O
transcription	O
and	O
suggest	O
that	O
immune	O
complexes	O
may	O
contribute	O
to	O
the	O
pathophysiology	O
of	O
HIV	O
-	O
1	O
infection	O
by	O
augmenting	O
viral	O
replication	O
in	O
monocytes	O
.	O

We	O
previously	O
demonstrated	O
that	O
both	O
synthetic	O
(	O
Exosurf	O
)	O
and	O
modified	O
natural	O
surfactant	O
(	O
Survanta	O
)	O
downregulated	O
endotoxin	O
-	O
stimulated	O
inflammatory	O
cytokine	O
mRNA	O
levels	O
and	O
protein	O
products	O
(	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
[	O
TNF	S-Biological_Molecule
]	O
,	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
[	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
]	O
,	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
[	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
]	O
)	O
in	O
human	O
alveolar	O
macrophages	O
.	O

We	O
conclude	O
that	O
soluble	O
TNF	O
receptors	O
can	O
inhibit	O
stimuli	O
-	O
induced	O
HIV	O
-	O
1	O
expression	O
and	O
NK	O
-	O
kappa	O
B	O
DNA	O
-	O
binding	O
activity	O
in	O
chronically	O
infected	O
U1	O
cells	O
.	O

This	O
may	O
explain	O
the	O
strong	O
cyto	O
-	O
differentiating	O
potential	O
of	O
AM580	O
in	O
PML	B-Biological_Molecule
-	I-Biological_Molecule
RAR	E-Biological_Molecule
-	O
containing	O
leukemic	O
cells	O
.	O

This	O
pattern	O
of	O
distribution	O
is	O
,	O
thus	O
far	O
,	O
unique	O
to	O
the	O
GATA	O
transcription	O
factors	O
and	O
suggests	O
a	O
protein	O
-	O
protein	O
interaction	O
with	O
other	O
components	O
of	O
the	O
nuclear	O
bodies	O
via	O
the	O
GATA	O
zinc	O
finger	O
domain	O
.	O

This	O
resulted	O
in	O
concomitant	O
decrease	O
in	O
nuclear	O
NF	O
-	O
kappaB	O
DNA	O
-	O
binding	O
activity	O
and	O
endogenous	O
long	O
terminal	O
repeat	O
transcriptional	O
activity	O
.	O

Thus	O
,	O
changes	O
in	O
the	O
Sp1	S-Biological_Molecule
binding	O
sites	O
had	O
the	O
most	O
dramatic	O
effects	O
on	O
SIVmac	O
replication	O
in	O
primary	O
macrophage	O
cultures	O
.	O

Consequently	O
,	O
IkappaBbeta	S-Biological_Molecule
protein	O
expression	O
is	O
chronically	O
downregulated	O
in	O
HTLV	O
-	O
1	O
-	O
infected	O
T	O
lymphocytes	O
.	O

Because	O
the	O
binding	O
site	O
showed	O
some	O
sequence	O
similarity	O
with	O
the	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NFAT	O
)	O
binding	O
site	O
,	O
we	O
compared	O
the	O
kinetics	O
of	O
induction	O
of	O
the	O
two	O
binding	O
complexes	O
and	O
the	O
molecular	O
masses	O
of	O
the	O
two	O
proteins	O
.	O

The	O
CMAT	O
protein	O
appears	O
to	O
be	O
a	O
novel	O
inducible	O
protein	O
involved	O
in	O
the	O
regulation	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
myb	E-Biological_Molecule
expression	O
during	O
T	O
-	O
cell	O
activation	O
.	O

CD36	S-Biological_Molecule
is	O
a	O
cell	O
surface	O
glycoprotein	O
composed	O
of	O
a	O
single	O
polypeptide	O
chain	O
,	O
which	O
interacts	O
with	O
thrombospondin	O
,	O
collagens	O
type	O
I	O
and	O
IV	O
,	O
oxidized	O
low	O
density	O
lipoprotein	O
,	O
fatty	O
acids	O
,	O
anionic	O
phospholipids	O
,	O
and	O
erythrocytes	O
parasitized	O
with	O
Plasmodium	O
falciparum	O
.	O

Within	O
the	O
above	O
region	O
,	O
the	O
fragment	O
spanning	O
nucleotides	O
-	O
158	O
to	O
-	O
90	O
was	O
required	O
for	O
optimal	O
transcription	O
in	O
monocytic	O
cells	O
.	O

Disruption	O
of	O
the	O
PEBP2	O
/	O
CBF	O
site	O
markedly	O
diminished	O
the	O
role	O
of	O
the	O
PEBP2	O
/	O
CBF	O
factors	O
in	O
the	O
constitutive	O
transcription	O
of	O
the	O
CD36	S-Biological_Molecule
gene	O
.	O

The	O
involvement	O
of	O
members	O
of	O
the	O
PEBP2	O
/	O
CBF	O
family	O
in	O
chromosome	O
translocations	O
associated	O
with	O
acute	O
myeloid	O
leukemia	O
,	O
and	O
in	O
the	O
transcriptional	O
regulation	O
of	O
the	O
myeloid	O
-	O
specific	O
genes	O
encoding	O
for	O
myeloperoxidase	S-Biological_Molecule
,	O
elastase	O
,	O
and	O
the	O
colony	O
-	O
stimulating	O
factor	O
receptor	O
,	O
highlights	O
the	O
relevance	O
of	O
the	O
regulation	O
of	O
the	O
CD36	S-Biological_Molecule
gene	O
promoter	O
in	O
monocytic	O
cells	O
by	O
members	O
of	O
the	O
PEBP2	O
/	O
CBF	O
family	O
.	O

S	O
.	O
,	O
Chesney	O
,	O
J	O
.	O
,	O
Sherry	O
,	O
B	O
.	O
,	O
Schmidtmayerova	O
,	O
H	O
.	O
,	O
Zhang	O
,	O
X	O
.	O
,	O
Bukrinsky	O
,	O
M	O
.	O
,	O
Ulrich	O
,	O
P	O
.	O
,	O
Cerami	O
,	O
A	O
.	O
&	O
Tracey	O
,	O
J	O
.	O
(	O
1996	O
)	O
J	O
.	O
Exp	O
.	O
Med	O
.	O
,	O
in	O
press	O
]	O
.	O

A	O
signal	O
transduction	O
pathway	O
activated	O
by	O
many	O
cytokines	O
has	O
recently	O
been	O
elaborated	O
.	O

STAT5	S-Biological_Molecule
-	O
and	O
STAT1	S-Biological_Molecule
-	O
related	O
factors	O
were	O
detected	O
in	O
ALL	O
and	O
STAT1	S-Biological_Molecule
-	O
,	O
STAT3	S-Biological_Molecule
-	O
,	O
and	O
STAT5	S-Biological_Molecule
-	O
related	O
proteins	O
were	O
present	O
in	O
nuclear	O
cell	O
extracts	O
from	O
AML	O
.	O

Since	O
the	O
cells	O
were	O
not	O
treated	O
with	O
cytokines	O
before	O
the	O
nuclear	O
proteins	O
were	O
extracted	O
,	O
we	O
conclude	O
that	O
these	O
factors	O
are	O
constitutively	O
activated	O
in	O
vivo	O
.	O

We	O
have	O
shown	O
that	O
1	O
-	O
(	O
5	O
-	O
chloronaphthalene	O
-	O
1	O
-	O
sulfonyl	O
)	O
-	O
1H	O
-	O
hexahydro	O
-	O
1	O
,	O
4	O
-	O
diazepine	O
hydrochloride	O
(	O
ML	O
-	O
9	O
)	O
,	O
an	O
inhibitor	O
of	O
myosin	O
light	O
chain	O
kinase	O
,	O
induces	O
differentiation	O
of	O
monocytoid	O
leukemia	O
cell	O
lines	O
U937	O
and	O
THP	O
-	O
1	O
but	O
not	O
of	O
myeloblastic	O
leukemic	O
ML	O
-	O
1	O
cell	O
or	O
erythroleukemia	O
K562	O
cells	O
.	O

ML	O
-	O
9	O
induced	O
nitroblue	O
tetrazolium	O
(	O
NBT	O
)	O
-	O
reducing	O
activity	O
of	O
U937	O
cell	O
more	O
rapidly	O
than	O
VD3	O
:	O
This	O
differentiation	O
marker	O
was	O
induced	O
significantly	O
after	O
incubation	O
with	O
ML	O
-	O
9	O
and	O
VD3	O
for	O
4	O
hours	O
and	O
1	O
day	O
,	O
respectively	O
.	O

The	O
effects	O
of	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
on	O
the	O
transcription	O
factors	O
were	O
specific	O
,	O
since	O
no	O
change	O
was	O
observed	O
in	O
the	O
expression	O
of	O
NF	B-Biological_Molecule
-	I-Biological_Molecule
IL	I-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
or	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
alpha	E-Biological_Molecule
,	O
the	O
inhibitor	O
of	O
NF	O
-	O
kappa	O
B	O
.	O

To	O
identify	O
the	O
molecular	O
basis	O
for	O
specificity	O
and	O
inducibility	O
,	O
the	O
chromatin	O
configuration	O
of	O
the	O
human	O
B7	O
.	O
1	O
gene	O
was	O
examined	O
in	O
intact	O
nuclei	O
from	O
various	O
cell	O
types	O
.	O

While	O
p45	S-Biological_Molecule
expression	O
was	O
shown	O
to	O
be	O
restricted	O
to	O
erythroid	O
cells	O
,	O
megakaryocytes	O
and	O
mast	O
cells	O
in	O
hematopoietic	O
lineage	O
,	O
we	O
found	O
in	O
this	O
study	O
that	O
p45	S-Biological_Molecule
mRNA	O
is	O
abundantly	O
transcribed	O
in	O
the	O
granulocyte	O
fraction	O
of	O
human	O
peripheral	O
blood	O
cells	O
.	O

As	O
neutrophils	O
occupy	O
approximately	O
92	O
%	O
of	O
the	O
cells	O
in	O
this	O
fraction	O
,	O
the	O
cells	O
expressing	O
p45	S-Biological_Molecule
is	O
most	O
likely	O
to	O
be	O
neutrophils	O
.	O

Similar	O
downregulation	O
of	O
BCL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
mRNA	O
was	O
seen	O
in	O
human	O
B	O
cells	O
stimulated	O
with	O
Staphylococcus	O
aureus	O
plus	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
or	O
anti	O
-	O
IgM	O
antibodies	O
and	O
in	O
human	O
T	O
lymphocytes	O
stimulated	O
with	O
phytohemagglutinin	S-Biological_Molecule
.	O

We	O
have	O
isolated	O
a	O
novel	O
cDNA	O
clone	O
encoding	O
interferon	B-Biological_Molecule
(	I-Biological_Molecule
IFN	I-Biological_Molecule
)	I-Biological_Molecule
consensus	I-Biological_Molecule
sequence	I-Biological_Molecule
-	I-Biological_Molecule
binding	I-Biological_Molecule
protein	I-Biological_Molecule
in	I-Biological_Molecule
adult	I-Biological_Molecule
T	I-Biological_Molecule
-	I-Biological_Molecule
cell	I-Biological_Molecule
leukemia	I-Biological_Molecule
cell	I-Biological_Molecule
line	I-Biological_Molecule
or	I-Biological_Molecule
activated	I-Biological_Molecule
T	I-Biological_Molecule
cells	E-Biological_Molecule
(	O
ICSAT	S-Biological_Molecule
)	O
;	O
this	O
protein	O
is	O
the	O
human	O
homolog	O
of	O
the	O
recently	O
cloned	O
Pip	S-Biological_Molecule
/	O
LSIRF	S-Biological_Molecule
.	O

Transcription	O
factors	O
of	O
T	O
and	O
B	O
lymphocytes	O
-	O
-	O
basic	O
research	O
and	O
clinical	O
perspectives	O
for	O
gastroenterology	O
.	O

The	O
structural	O
classes	O
of	O
transcription	O
factors	O
are	O
described	O
and	O
basic	O
methods	O
for	O
detection	O
and	O
analysis	O
of	O
transcription	O
factors	O
are	O
detailed	O
.	O

We	O
investigated	O
oligonucleotide	O
-	O
directed	O
triple	O
helix	O
formation	O
across	O
this	O
regulatory	O
sequence	O
as	O
a	O
potential	O
tool	O
to	O
inhibit	O
GM	B-Biological_Molecule
-	I-Biological_Molecule
CSF	E-Biological_Molecule
gene	O
transcription	O
.	O

This	O
is	O
achieved	O
in	O
part	O
through	O
the	O
positive	O
activities	O
of	O
the	O
AP	O
-	O
1	O
and	O
Elf	O
-	O
1	O
sites	O
in	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
promoter	O
.	O

The	O
lymphoid	O
-	O
specific	O
transcription	O
factor	O
Oct	B-Biological_Molecule
-	I-Biological_Molecule
2a	E-Biological_Molecule
is	O
implicated	O
in	O
B	O
cell	O
-	O
specific	O
transcriptional	O
activity	O
via	O
the	O
octamer	O
motif	O
.	O

Other	O
experimental	O
strategies	O
have	O
implicated	O
BSAP	S-Biological_Molecule
in	O
the	O
control	O
of	O
cell	O
proliferation	O
,	O
isotype	O
switching	O
and	O
transcription	O
of	O
the	O
immunoglobulin	O
heavy	O
-	O
chain	O
gene	O
at	O
late	O
stages	O
of	O
B	O
-	O
cell	O
differentiation	O
.	O

The	O
Ets	O
proteins	O
share	O
a	O
conserved	O
Ets	O
domain	O
that	O
mediates	O
specific	O
DNA	O
binding	O
.	O

Spi	B-Biological_Molecule
-	I-Biological_Molecule
B	E-Biological_Molecule
binds	O
DNA	O
sequences	O
containing	O
a	O
core	O
5	O
'	O
-	O
GGAA	O
-	O
3	O
'	O
and	O
activates	O
transcription	O
through	O
this	O
motif	O
.	O

DeltaSpi	B-Biological_Molecule
-	I-Biological_Molecule
B	E-Biological_Molecule
product	O
was	O
not	O
able	O
to	O
bind	O
DNA	O
and	O
was	O
recovered	O
in	O
cytoplasmic	O
cellular	O
extracts	O
.	O

Activation	O
protein	O
1	O
-	O
dependent	O
transcriptional	O
activation	O
of	O
interleukin	B-Biological_Molecule
2	E-Biological_Molecule
gene	O
by	O
Ca2	B-Biological_Molecule
+	I-Biological_Molecule
/	I-Biological_Molecule
calmodulin	I-Biological_Molecule
kinase	I-Biological_Molecule
type	I-Biological_Molecule
IV	I-Biological_Molecule
/	I-Biological_Molecule
Gr	E-Biological_Molecule
.	O

The	O
Ca2	B-Biological_Molecule
+	I-Biological_Molecule
/	I-Biological_Molecule
calmodulin	I-Biological_Molecule
-	I-Biological_Molecule
dependent	I-Biological_Molecule
protein	I-Biological_Molecule
kinase	I-Biological_Molecule
(	I-Biological_Molecule
CaMK	I-Biological_Molecule
)	I-Biological_Molecule
type	I-Biological_Molecule
IV	I-Biological_Molecule
/	I-Biological_Molecule
Gr	E-Biological_Molecule
is	O
selectively	O
expressed	O
in	O
T	O
lymphocytes	O
and	O
is	O
activated	O
after	O
signaling	O
via	O
the	O
T	O
cell	O
antigen	O
receptor	O
(	O
TCR	O
)	O
,	O
indicating	O
that	O
it	O
mediates	O
some	O
of	O
the	O
Ca	O
(	O
2	O
+	O
)	O
-	O
dependent	O
transcriptional	O
events	O
that	O
follow	O
TCR	O
engagement	O
.	O

We	O
have	O
defined	O
the	O
mechanisms	O
of	O
transactivation	O
by	O
NFAT1	S-Biological_Molecule
.	O

Constitutive	O
expression	O
of	O
specific	O
interferon	O
isotypes	O
in	O
peripheral	O
blood	O
leukocytes	O
from	O
normal	O
individuals	O
and	O
in	O
promonocytic	O
U937	O
cells	O
.	O

The	O
cyclosporin	O
A	O
(	O
CsA	O
)	O
/	O
FK506	O
-	O
sensitive	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NFAT	O
)	O
plays	O
a	O
key	O
role	O
in	O
the	O
inducible	O
expression	O
of	O
cytokine	O
genes	O
in	O
T	O
cells	O
.	O

Northern	O
analysis	O
using	O
a	O
probe	O
encompassing	O
a	O
common	O
region	O
of	O
both	O
isoforms	O
showed	O
two	O
mRNA	O
species	O
of	O
2	O
.	O
7	O
and	O
4	O
.	O
5	O
kilobase	O
pairs	O
,	O
while	O
an	O
NFATc	B-Biological_Molecule
.	I-Biological_Molecule
beta	E-Biological_Molecule
-	O
specific	O
probe	O
detected	O
only	O
the	O
4	O
.	O
5	O
-	O
kilobase	O
pair	O
mRNA	O
which	O
was	O
preferentially	O
expressed	O
in	O
the	O
spleen	O
.	O

Cytokine	O
-	O
modulating	O
activity	O
of	O
tepoxalin	O
,	O
a	O
new	O
potential	O
antirheumatic	O
.	O

Tepoxalin	O
is	O
a	O
new	O
dual	O
cyclooxygenase	O
/	O
5	O
-	O
lipoxygenase	O
anti	O
-	O
inflammatory	O
compound	O
currently	O
under	O
clinical	O
investigation	O
.	O

These	O
data	O
suggest	O
that	O
the	O
action	O
of	O
tepoxalin	O
to	O
inhibit	O
proliferation	O
in	O
PBMC	O
may	O
be	O
at	O
least	O
in	O
part	O
due	O
to	O
its	O
ability	O
to	O
reduce	O
the	O
amount	O
of	O
available	O
iron	O
resulting	O
in	O
decreased	O
activation	O
of	O
NF	O
kappa	O
B	O
and	O
subsequent	O
inhibition	O
of	O
cytokine	O
production	O
.	O

Upon	O
infection	O
,	O
Wp	S-Biological_Molecule
is	O
initially	O
active	O
,	O
followed	O
by	O
a	O
switch	O
to	O
Cp	S-Biological_Molecule
for	O
the	O
duration	O
of	O
latency	O
.	O

Site	O
-	O
directed	O
mutagenesis	O
of	O
these	O
cis	O
elements	O
demonstrated	O
that	O
Cp	S-Biological_Molecule
activity	O
is	O
highly	O
dependent	O
on	O
the	O
presence	O
of	O
a	O
properly	O
positioned	O
CCAAT	O
box	O
,	O
with	O
the	O
dependence	O
on	O
the	O
distal	O
CCAAT	O
box	O
apparent	O
only	O
when	O
the	O
proximal	O
CCAAT	O
box	O
was	O
deleted	O
or	O
mutated	O
.	O

Various	O
modes	O
of	O
basic	O
helix	O
-	O
loop	O
-	O
helix	O
protein	O
-	O
mediated	O
regulation	O
of	O
murine	O
leukemia	O
virus	O
transcription	O
in	O
lymphoid	O
cell	O
lines	O
.	O

Chemoattractants	O
stimulate	O
the	O
expression	O
of	O
several	O
inflammatory	O
cytokines	O
and	O
chemokines	O
,	O
which	O
in	O
turn	O
may	O
activate	O
their	O
respective	O
receptors	O
and	O
initiate	O
an	O
autocrine	O
regulatory	O
mechanism	O
for	O
persistent	O
cytokine	O
and	O
chemokine	O
gene	O
expression	O
.	O

The	O
lymphocyte	O
-	O
specific	O
immunoglobulin	O
mu	O
heavy	O
-	O
chain	O
gene	O
intronic	O
enhancer	O
is	O
regulated	O
by	O
multiple	O
nuclear	O
factors	O
.	O

The	O
core	O
GGAAs	O
of	O
the	O
muA	O
and	O
muB	O
sites	O
are	O
separated	O
by	O
30	O
nucleotides	O
,	O
suggesting	O
that	O
ETS	O
proteins	O
bind	O
to	O
these	O
sites	O
from	O
these	O
same	O
side	O
of	O
the	O
DNA	O
helix	O
.	O

U1	O
lines	O
overexpressing	O
C	O
/	O
EBP	O
activator	O
NF	B-Biological_Molecule
-	I-Biological_Molecule
IL	I-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
produced	O
more	O
viral	O
mRNA	O
and	O
virus	O
particles	O
following	O
cellular	O
activation	O
than	O
control	O
lines	O
,	O
demonstrating	O
that	O
C	O
/	O
EBP	O
proteins	O
are	O
limiting	O
for	O
virus	O
transcription	O
.	O

Cell	O
activation	O
resulted	O
in	O
a	O
delayed	O
induction	O
of	O
STAT	O
DNA	O
-	O
binding	O
activity	O
,	O
which	O
was	O
sustained	O
for	O
several	O
days	O
,	O
was	O
composed	O
predominantly	O
of	O
Stat1	S-Biological_Molecule
and	O
Stat3	S-Biological_Molecule
,	O
and	O
was	O
blocked	O
by	O
cycloheximide	O
and	O
actinomycin	O
D	O
.	O

The	O
role	O
of	O
early	B-Biological_Molecule
growth	I-Biological_Molecule
response	I-Biological_Molecule
gene	I-Biological_Molecule
1	E-Biological_Molecule
(	O
egr	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
)	O
in	O
regulation	O
of	O
the	O
immune	O
response	O
.	O

The	O
results	O
suggest	O
a	O
new	O
option	O
for	O
HIV	O
gene	O
therapy	O
;	O
bcl	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
muteins	O
that	O
have	O
noncleavable	O
alterations	O
surrounding	O
the	O
HIV	B-Biological_Molecule
protease	E-Biological_Molecule
cleavage	O
site	O
.	O

Ligand	O
activation	O
of	O
c	O
-	O
ErbB	O
induced	O
the	O
tyrosine	O
phosphorylation	O
,	O
DNA	O
-	O
binding	O
,	O
and	O
reporter	O
gene	O
transcription	O
of	O
Stat	B-Biological_Molecule
5b	E-Biological_Molecule
in	O
erythroblasts	O
.	O

Even	O
though	O
the	O
mechanisms	O
by	O
which	O
Tax	S-Biological_Molecule
induces	O
transformation	O
are	O
still	O
unknown	O
,	O
it	O
seems	O
likely	O
that	O
the	O
ability	O
of	O
Tax	S-Biological_Molecule
to	O
alter	O
the	O
expression	O
of	O
many	O
cellular	O
genes	O
plays	O
an	O
important	O
part	O
in	O
this	O
process	O
.	O

Epstein	O
-	O
Barr	O
virus	O
(	O
EBV	O
)	O
,	O
the	O
causative	O
agent	O
of	O
infectious	O
mononucleosis	O
,	O
is	O
a	O
human	O
herpesvirus	O
associated	O
with	O
epithelial	O
cell	O
malignancies	O
(	O
nasopharyngeal	O
carcinoma	O
)	O
as	O
well	O
as	O
B	O
-	O
cell	O
malignancies	O
.	O

Two	O
interferon	O
-	O
stimulated	O
response	O
elements	O
(	O
ISRE	O
)	O
flank	O
a	O
multiple	O
transcription	O
start	O
site	O
region	O
identifying	O
MNDA	S-Biological_Molecule
as	O
a	O
TATA	O
-	O
less	O
interferon	O
-	O
regulated	O
gene	O
.	O

In	O
addition	O
,	O
DNA	O
methylation	O
was	O
revealed	O
as	O
one	O
of	O
the	O
possible	O
factors	O
in	O
establishing	O
MNDA	S-Biological_Molecule
expression	O
.	O

Finally	O
,	O
it	O
is	O
demonstrated	O
that	O
macrophages	O
in	O
the	O
adrenal	O
gland	O
,	O
the	O
major	O
site	O
of	O
endogenous	O
GC	O
production	O
,	O
express	O
sialoadhesin	S-Biological_Molecule
.	O

Cell	O
-	O
type	O
-	O
specific	O
regulation	O
of	O
the	O
human	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
alpha	E-Biological_Molecule
gene	O
in	O
B	O
cells	O
and	O
T	O
cells	O
by	O
NFATp	S-Biological_Molecule
and	O
ATF	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
/	O
JUN	O
.	O

The	O
downstream	O
regulatory	O
region	O
contains	O
a	O
cyclic	O
AMP	O
-	O
responsive	O
element	O
(	O
CRE	O
)	O
.	O

We	O
show	O
by	O
antibody	O
supershift	O
experiments	O
and	O
UV	O
cross	O
-	O
linking	O
followed	O
by	O
denaturing	O
polyacrylamide	O
gel	O
electrophoresis	O
that	O
both	O
CREB	O
and	O
ATF	O
family	O
members	O
bind	O
to	O
this	O
region	O
in	O
vitro	O
.	O

bcl	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
expression	O
is	O
increased	O
following	O
phorbol	O
ester	O
treatment	O
,	O
and	O
the	O
increased	O
expression	O
is	O
dependent	O
on	O
the	O
CRE	O
site	O
.	O

It	O
is	O
possible	O
that	O
the	O
CRE	O
site	O
is	O
responsible	O
for	O
induction	O
of	O
bcl	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
expression	O
in	O
other	O
cell	O
types	O
,	O
particularly	O
those	O
in	O
which	O
protein	O
kinase	O
C	O
is	O
involved	O
.	O

Activation	O
of	O
NF	O
-	O
kappa	O
B	O
is	O
induced	O
by	O
prooxidants	O
and	O
several	O
stimuli	O
eliciting	O
oxidative	O
stress	O
,	O
such	O
as	O
cytokines	O
,	O
lipopolysaccharide	O
,	O
UV	O
irradiation	O
and	O
other	O
mediators	O
.	O

Transcriptional	O
and	O
posttranscriptional	O
regulation	O
of	O
erythroid	O
gene	O
expression	O
in	O
anthracycline	O
-	O
induced	O
differentiation	O
of	O
human	O
erythroleukemic	O
cells	O
.	O

Because	O
the	O
increase	O
in	O
erythroid	O
mRNA	O
steady	O
-	O
state	O
level	O
in	O
anthracycline	O
-	O
treated	O
cells	O
was	O
inhibited	O
by	O
cycloheximide	O
,	O
this	O
suggests	O
that	O
transcriptional	O
activation	O
in	O
ACLA	O
-	O
treated	O
cells	O
and	O
mRNA	O
stabilization	O
in	O
DOX	O
-	O
treated	O
cells	O
were	O
dependent	O
on	O
de	O
novo	O
protein	O
synthesis	O
.	O

Using	O
selective	O
inhibitors	O
,	O
we	O
investigated	O
the	O
signaling	O
pathways	O
involved	O
in	O
the	O
CD28	S-Biological_Molecule
-	O
mediated	O
induction	O
of	O
AP	O
-	O
1	O
and	O
NF	O
-	O
kappaB	O
.	O

In	O
contrast	O
,	O
AP	O
-	O
1	O
generation	O
was	O
inhibited	O
by	O
wortmannin	O
and	O
was	O
also	O
variably	O
sensitive	O
to	O
chloroquine	O
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
the	O
supernatant	O
from	O
activated	O
T	O
-	O
lymphocytes	O
is	O
able	O
to	O
induce	O
the	O
transcription	O
of	O
a	O
potent	O
cytokine	O
,	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	I-Biological_Molecule
2	E-Biological_Molecule
in	O
glial	O
cells	O
.	O

The	O
activating	O
stimulus	O
invokes	O
signaling	O
mechanisms	O
distinct	O
from	O
known	O
kinase	O
or	O
protease	O
pathways	O
.	O

Activation	O
of	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	I-Biological_Molecule
2	E-Biological_Molecule
transcription	O
correlates	O
with	O
the	O
loss	O
of	O
binding	O
activity	O
for	O
an	O
80	O
kDA	O
glial	O
labile	O
repressor	O
protein	O
,	O
GLRP	S-Biological_Molecule
,	O
to	O
a	O
responsive	O
region	O
within	O
the	O
TFG	B-Biological_Molecule
-	I-Biological_Molecule
beta	I-Biological_Molecule
2	E-Biological_Molecule
promoter	O
.	O

In	O
exerting	O
their	O
antiproliferative	O
effects	O
,	O
GCS	O
diffuse	O
into	O
target	O
cells	O
where	O
they	O
bind	O
their	O
cytoplasmic	O
receptor	O
,	O
which	O
in	O
turn	O
translocates	O
to	O
the	O
nucleus	O
where	O
it	O
inhibits	O
transcription	O
of	O
cytokine	O
genes	O
through	O
direct	O
binding	O
to	O
the	O
glucocorticoid	O
response	O
elements	O
(	O
GRE	O
)	O
,	O
which	O
are	O
located	O
in	O
the	O
promoter	O
region	O
of	O
cytokine	O
genes	O
or	O
,	O
alternatively	O
,	O
through	O
antagonism	O
of	O
the	O
action	O
of	O
transcription	O
factors	O
required	O
for	O
optimal	O
transcriptional	O
activation	O
.	O

TSC2	S-Biological_Molecule
messenger	O
RNA	O
was	O
widely	O
expressed	O
in	O
various	O
cell	O
types	O
throughout	O
the	O
body	O
,	O
including	O
epithelia	O
,	O
lymphocytes	O
,	O
and	O
cells	O
with	O
endocrine	O
functions	O
,	O
e	O
.	O
g	O
.	O
,	O
adrenal	O
cortex	O
and	O
anterior	O
pituitary	O
.	O

In	O
fetal	O
liver	O
of	O
PU	B-Biological_Molecule
.	I-Biological_Molecule
1	E-Biological_Molecule
-	O
/	O
-	O
mice	O
,	O
which	O
lack	O
lymphoid	O
and	O
myeloid	O
cells	O
,	O
expression	O
of	O
Btk	S-Biological_Molecule
was	O
reduced	O
two	O
-	O
to	O
threefold	O
but	O
not	O
abolished	O
.	O

PRRIII	O
contains	O
a	O
Stat	O
protein	O
binding	O
site	O
that	O
overlaps	O
with	O
an	O
EBS	O
motif	O
(	O
GASd	O
/	O
EBSd	O
)	O
.	O

Lymphocytes	O
from	O
CML	O
patients	O
lack	O
a	O
47	O
kDa	O
factor	O
having	O
affinity	O
for	O
a	O
genomic	O
sterol	O
regulatory	O
sequence	O
.	O

Deranged	O
cellular	O
cholesterol	O
homeostasis	O
has	O
been	O
widely	O
recognized	O
in	O
the	O
initiation	O
as	O
well	O
as	O
progression	O
of	O
various	O
types	O
of	O
cancers	O
including	O
chronic	O
myeloid	O
leukaemia	O
(	O
CML	O
)	O
.	O

CIF	O
inhibited	O
induction	O
of	O
either	O
construct	O
as	O
did	O
cyclosporine	O
,	O
which	O
is	O
known	O
to	O
block	O
activation	O
of	O
the	O
NFAT	O
element	O
.	O

CIF	O
failed	O
to	O
inhibit	O
several	O
other	O
enhancer	O
elements	O
.	O

Stably	O
transfected	O
Jurkat	O
cells	O
behaved	O
similarly	O
to	O
the	O
transiently	O
transfected	O
ones	O
with	O
respect	O
to	O
inhibition	O
by	O
CIF	O
and	O
cyclosporine	O
.	O

Our	O
results	O
suggest	O
that	O
the	O
germline	O
promoters	O
and	O
V	O
region	O
promoters	O
differ	O
in	O
their	O
dependence	O
on	O
octamer	O
for	O
activation	O
and	O
respond	O
differently	O
to	O
enhancer	O
activation	O
.	O

The	O
promoter	O
region	O
lacked	O
a	O
TATA	O
box	O
but	O
contained	O
potential	O
binding	O
sites	O
for	O
the	O
transcriptional	O
factors	O
including	O
two	O
Sp1	S-Biological_Molecule
,	O
CRE	O
,	O
Myb	S-Biological_Molecule
and	O
NFkB	O
located	O
at	O
positions	O
-	O
153	O
,	O
-	O
178	O
,	O
-	O
286	O
,	O
-	O
875	O
,	O
and	O
-	O
1011	O
,	O
respectively	O
.	O

IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
13	E-Biological_Molecule
up	O
-	O
regulated	O
the	O
expression	O
of	O
both	O
genomic	O
and	O
spliced	O
HIV	O
mRNA	O
in	O
monocytes	O
cultured	O
on	O
Teflon	O
,	O
as	O
determined	O
by	O
Northern	O
analysis	O
and	O
p24	B-Biological_Molecule
Ag	E-Biological_Molecule
assay	O
.	O

The	O
closest	O
match	O
to	O
the	O
known	O
SP	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
consensus	O
sequence	O
within	O
the	O
respective	O
region	O
is	O
a	O
TCCCCTCCCCT	O
motif	O
.	O

Quantitative	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
showed	O
an	O
increase	O
in	O
steady	O
-	O
state	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
mRNA	O
after	O
3	O
to	O
4	O
hours	O
of	O
cross	O
-	O
linking	O
.	O

However	O
,	O
V3	O
-	O
BH10	O
enhanced	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
-	O
induced	O
mRNA	O
expression	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
fos	E-Biological_Molecule
but	O
not	O
c	B-Biological_Molecule
-	I-Biological_Molecule
myc	E-Biological_Molecule
or	O
junB	S-Biological_Molecule
.	O

Glycation	O
-	O
dependent	O
,	O
reactive	O
oxygen	O
species	O
-	O
mediated	O
suppression	O
of	O
the	O
insulin	S-Biological_Molecule
gene	O
promoter	O
activity	O
in	O
HIT	O
cells	O
.	O

In	O
agreement	O
with	O
this	O
,	O
decrease	O
in	O
the	O
insulin	S-Biological_Molecule
mRNA	O
and	O
insulin	S-Biological_Molecule
content	O
was	O
observed	O
in	O
the	O
glycation	O
-	O
induced	O
cells	O
.	O

Also	O
,	O
gel	O
mobility	O
shift	O
analyses	O
using	O
specific	O
antiserum	O
revealed	O
decrease	O
in	O
the	O
DNA	O
-	O
binding	O
activity	O
of	O
an	O
insulin	B-Biological_Molecule
gene	I-Biological_Molecule
transcription	I-Biological_Molecule
factor	E-Biological_Molecule
,	O
PDX	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
/	O
IPF1	S-Biological_Molecule
/	O
STF	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
.	O

We	O
have	O
previously	O
identified	O
an	O
enhancer	O
element	O
,	O
PRE	O
-	O
I	O
,	O
that	O
is	O
essential	O
for	O
the	O
function	O
of	O
the	O
human	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
promoter	O
.	O

To	O
investigate	O
the	O
mechanisms	O
responsible	O
for	O
tissue	O
-	O
specific	O
expression	O
of	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
gene	O
,	O
we	O
analyzed	O
nuclear	O
factors	O
binding	O
to	O
the	O
PRE	O
-	O
I	O
site	O
and	O
compared	O
the	O
binding	O
activities	O
of	O
these	O
factors	O
to	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
promoter	O
of	O
Th1	O
and	O
Th2	O
cells	O
.	O

In	O
the	O
mouse	O
Th2	O
D10	O
cells	O
and	O
in	O
the	O
human	O
Th2	O
clones	O
,	O
POS	O
-	O
1	O
(	O
designated	O
POS	O
-	O
1b	O
)	O
contains	O
NF	B-Biological_Molecule
-	I-Biological_Molecule
IL6beta	E-Biological_Molecule
,	O
Jun	O
,	O
and	O
NF	O
-	O
ATc	O
/	O
p	O
.	O

Several	O
studies	O
have	O
pointed	O
to	O
a	O
link	O
between	O
immune	O
and	O
endocrine	O
systems	O
,	O
including	O
a	O
regulatory	O
function	O
of	O
GH	O
on	O
monocyte	O
activation	O
.	O

Impaired	O
induction	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
fos	E-Biological_Molecule
/	O
c	B-Biological_Molecule
-	I-Biological_Molecule
jun	E-Biological_Molecule
genes	O
and	O
of	O
transcriptional	O
regulatory	O
proteins	O
binding	O
distinct	O
c	B-Biological_Molecule
-	I-Biological_Molecule
fos	E-Biological_Molecule
/	O
c	B-Biological_Molecule
-	I-Biological_Molecule
jun	E-Biological_Molecule
promoter	O
elements	O
in	O
activated	O
human	O
T	O
cells	O
during	O
aging	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
whether	O
aberrancies	O
in	O
the	O
regulation	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
fos	E-Biological_Molecule
/	O
c	B-Biological_Molecule
-	I-Biological_Molecule
jun	E-Biological_Molecule
at	O
the	O
mRNA	O
or	O
protein	O
level	O
might	O
underlie	O
the	O
age	O
-	O
associated	O
impairments	O
of	O
AP	O
-	O
1	O
in	O
human	O
T	O
cells	O
.	O

These	O
results	O
suggest	O
that	O
underlying	O
aberrancies	O
in	O
the	O
induction	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
fos	E-Biological_Molecule
/	O
c	B-Biological_Molecule
-	I-Biological_Molecule
jun	E-Biological_Molecule
as	O
well	O
as	O
their	O
nuclear	O
regulatory	O
proteins	O
may	O
contribute	O
to	O
the	O
age	O
-	O
related	O
impairments	O
of	O
AP	O
-	O
1	O
activation	O
in	O
human	O
T	O
cells	O
.	O

One	O
of	O
these	O
subregions	O
,	O
NRE	O
gamma	O
,	O
is	O
active	O
in	O
both	O
HeLa	O
cervical	O
carcinoma	O
cells	O
and	O
Huh7	O
hepatoma	O
cells	O
and	O
was	O
found	O
to	O
be	O
bound	O
by	O
a	O
protein	O
factor	O
present	O
in	O
both	O
cell	O
types	O
.	O

Mutations	O
which	O
abrogated	O
the	O
gene	O
-	O
suppressive	O
activity	O
of	O
NRE	O
gamma	O
prevented	O
RFX1	S-Biological_Molecule
from	O
binding	O
to	O
NRE	O
gamma	O
.	O

Characterization	O
of	O
the	O
human	O
platelet	B-Biological_Molecule
/	I-Biological_Molecule
endothelial	I-Biological_Molecule
cell	I-Biological_Molecule
adhesion	I-Biological_Molecule
molecule	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
promoter	O
:	O
identification	O
of	O
a	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
binding	O
element	O
required	O
for	O
optimal	O
transcriptional	O
activity	O
.	O

These	O
blast	O
cells	O
express	O
lineage	O
-	O
specific	O
transcription	O
factors	O
such	O
as	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
common	O
to	O
these	O
lineages	O
and	O
frequently	O
express	O
erythroid	O
-	O
specific	O
mRNAs	O
such	O
as	O
gamma	O
-	O
globin	O
and	O
erythroid	B-Biological_Molecule
delta	I-Biological_Molecule
-	I-Biological_Molecule
aminolevulinate	I-Biological_Molecule
synthase	E-Biological_Molecule
(	O
ALAS	B-Biological_Molecule
-	I-Biological_Molecule
E	E-Biological_Molecule
)	O
,	O
indicating	O
that	O
most	O
of	O
the	O
blasts	O
in	O
M7	O
and	O
TMD	O
cases	O
have	O
erythroid	O
and	O
megakaryocytic	O
phenotypes	O
.	O

In	O
humans	O
,	O
similar	O
effects	O
were	O
observed	O
with	O
homologous	O
members	O
of	O
the	O
CCAAT	O
/	O
enhancer	O
-	O
binding	O
protein	O
(	O
C	O
/	O
EBP	O
)	O
family	O
of	O
transcriptional	O
regulators	O
,	O
especially	O
the	O
human	O
homolog	O
of	O
chicken	O
NF	B-Biological_Molecule
-	I-Biological_Molecule
M	E-Biological_Molecule
,	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBP	I-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
(	O
NF	B-Biological_Molecule
-	I-Biological_Molecule
IL6	E-Biological_Molecule
)	O
.	O

A	O
1	O
.	O
2	O
-	O
kb	O
cDNA	O
encoding	O
full	O
-	O
length	O
human	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBP	I-Biological_Molecule
-	I-Biological_Molecule
epsilon	E-Biological_Molecule
was	O
cloned	O
from	O
a	O
promyelocyte	O
-	O
late	O
myeloblast	O
-	O
derived	O
lambda	O
gt11	O
library	O
.	O

Cotransfection	O
with	O
a	O
transdominant	O
negative	O
mutant	O
of	O
the	O
NF	O
-	O
YA	O
subunit	O
abolishes	O
the	O
transcriptional	O
activation	O
by	O
heme	O
,	O
indicating	O
that	O
NF	O
-	O
Y	O
plays	O
an	O
essential	O
role	O
in	O
this	O
activation	O
.	O

Numerous	O
genes	O
required	O
during	O
the	O
immune	O
or	O
inflammation	O
response	O
as	O
well	O
as	O
the	O
adhesion	O
process	O
are	O
regulated	O
by	O
nuclear	O
factor	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
.	O

A	O
negative	O
regulatory	O
region	O
containing	O
a	O
glucocorticosteroid	O
response	O
element	O
(	O
nGRE	O
)	O
in	O
the	O
human	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
gene	O
.	O

A	O
novel	O
member	O
of	O
the	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)	O
receptor	O
family	O
,	O
designated	O
TRAMP	S-Biological_Molecule
,	O
has	O
been	O
identified	O
.	O

In	O
this	O
manuscript	O
we	O
have	O
investigated	O
the	O
molecular	O
mechanisms	O
by	O
which	O
T	O
cell	O
lines	O
stimulated	O
with	O
phorbol	O
12	O
-	O
myristate	O
13	O
-	O
acetate	O
(	O
PMA	O
)	O
and	O
phytohemagglutin	S-Biological_Molecule
(	O
PHA	S-Biological_Molecule
)	O
display	O
significantly	O
higher	O
levels	O
of	O
NF	B-Biological_Molecule
-	I-Biological_Molecule
kappa	I-Biological_Molecule
B1	E-Biological_Molecule
encoding	O
transcripts	O
than	O
cells	O
stimulated	O
with	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
,	O
despite	O
the	O
fact	O
that	O
both	O
stimuli	O
activate	O
NF	O
-	O
kappa	O
B	O
.	O

By	O
contrast	O
,	O
these	O
effects	O
were	O
not	O
observed	O
upon	O
pulse	O
-	O
treatment	O
with	O
6	O
microM	O
ICRF	O
-	O
193	O
.	O

In	O
the	O
present	O
report	O
,	O
we	O
identified	O
NF	O
-	O
kappa	O
B	O
proteins	O
extracted	O
from	O
human	O
thymocyte	O
nuclei	O
as	O
being	O
p50	S-Biological_Molecule
/	O
p65	S-Biological_Molecule
and	O
p50	S-Biological_Molecule
/	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Rel	E-Biological_Molecule
complexes	O
.	O

Alteration	O
of	O
a	O
single	O
serine	O
in	O
the	O
basic	O
domain	O
of	O
the	O
Epstein	O
-	O
Barr	O
virus	O
ZEBRA	S-Biological_Molecule
protein	O
separates	O
its	O
functions	O
of	O
transcriptional	O
activation	O
and	O
disruption	O
of	O
latency	O
.	O

The	O
ZEBRA	S-Biological_Molecule
protein	O
from	O
Epstein	O
-	O
Barr	O
virus	O
(	O
EBV	O
)	O
activates	O
a	O
switch	O
from	O
the	O
latent	O
to	O
the	O
lytic	O
expression	O
program	O
of	O
the	O
virus	O
.	O

This	O
ROS	O
pathway	O
was	O
also	O
characterized	O
by	O
the	O
use	O
of	O
other	O
inhibitors	O
.	O

This	O
finding	O
indicates	O
that	O
phospholipase	O
A2	O
and	O
5	B-Biological_Molecule
-	I-Biological_Molecule
lipoxygenase	E-Biological_Molecule
are	O
also	O
involved	O
.	O

Generation	O
of	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
,	O
interleukin	B-Biological_Molecule
1	I-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
,	O
granulocyte	B-Biological_Molecule
-	I-Biological_Molecule
macrophage	I-Biological_Molecule
colony	I-Biological_Molecule
-	I-Biological_Molecule
stimulating	I-Biological_Molecule
factor	E-Biological_Molecule
and	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
from	O
10	O
(	O
-	O
5	O
)	O
M	O
Azeptin	O
-	O
treated	O
PBL	O
and	O
human	O
monocytes	O
(	O
HM	O
)	O
was	O
decreased	O
to	O
approximately	O
1	O
/	O
3	O
to	O
2	O
/	O
3	O
of	O
the	O
control	O
levels	O
.	O

Being	O
compatible	O
with	O
those	O
results	O
,	O
Azeptin	O
(	O
10	O
(	O
-	O
5	O
)	O
M	O
)	O
suppressed	O
activation	O
of	O
NF	O
-	O
kappa	O
B	O
in	O
PBL	O
,	O
HM	O
and	O
HF	O
.	O

These	O
results	O
link	O
regulatory	O
factors	O
critical	O
to	O
T	O
cell	O
commitment	O
directly	O
to	O
HIV	O
-	O
1	O
replication	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
role	O
of	O
these	O
transcription	O
factors	O
in	O
uninduced	O
and	O
LPS	O
-	O
induced	O
TF	S-Biological_Molecule
gene	O
expression	O
in	O
human	O
monocytic	O
THP	O
-	O
1	O
cells	O
.	O

Despite	O
these	O
findings	O
,	O
the	O
molecular	O
mechanisms	O
by	O
which	O
Ets	O
and	O
NF	O
-	O
kappaB	O
/	O
NFAT	O
proteins	O
cooperatively	O
regulate	O
inducible	O
T	O
-	O
cell	O
gene	O
expression	O
remained	O
unknown	O
.	O

In	O
addition	O
,	O
the	O
Ets	O
-	O
NF	O
-	O
kappaB	O
/	O
NFAT	O
interaction	O
requires	O
the	O
presence	O
of	O
DNA	O
binding	O
sites	O
for	O
both	O
proteins	O
,	O
as	O
it	O
is	O
abolished	O
by	O
the	O
DNA	O
intercalating	O
agents	O
propidium	O
iodide	O
and	O
ethidium	O
bromide	O
and	O
enhanced	O
by	O
the	O
presence	O
of	O
synthetic	O
oligonucleotides	O
containing	O
binding	O
sites	O
for	O
Ets	O
and	O
NF	O
-	O
kappaB	O
proteins	O
.	O

Chromosomal	O
translocation	O
resulting	O
in	O
abnormal	O
expression	O
of	O
the	O
LAZ3	S-Biological_Molecule
/	O
BCL6	S-Biological_Molecule
gene	O
in	O
B	O
cells	O
has	O
been	O
implicated	O
in	O
the	O
tumorigenesis	O
of	O
non	O
-	O
Hodgkin	O
lymphoma	O
(	O
NHL	O
)	O
.	O

The	O
parallel	O
induction	O
of	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
alpha	E-Biological_Molecule
synthesis	O
may	O
allow	O
for	O
the	O
continuous	O
presence	O
of	O
a	O
cytoplasmic	O
reservoir	O
of	O
p50	S-Biological_Molecule
/	O
RelA	S-Biological_Molecule
(	O
p65	S-Biological_Molecule
)	O
complexes	O
that	O
are	O
readily	O
available	O
for	O
inducer	O
-	O
mediated	O
stimulation	O
.	O

Human	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
promoter	O
/	O
enhancer	O
-	O
luciferase	O
gene	O
construct	O
transfected	O
to	O
T	O
-	O
cell	O
clones	O
was	O
transcribed	O
on	O
either	O
TCR	O
or	O
IL	O
-	O
2R	O
stimulation	O
and	O
was	O
clearly	O
downregulated	O
by	O
dexamethasone	O
,	O
indicating	O
that	O
the	O
approximately	O
500	O
-	O
bp	O
human	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
gene	O
segment	O
located	O
5	O
'	O
upstream	O
of	O
the	O
coding	O
region	O
contains	O
activation	O
-	O
inducible	O
enhancer	O
elements	O
responsible	O
for	O
the	O
regulation	O
by	O
GC	O
.	O

Oncogenic	O
forms	O
of	O
NOTCH1	S-Biological_Molecule
lacking	O
either	O
the	O
primary	O
binding	O
site	O
for	O
RBP	B-Biological_Molecule
-	I-Biological_Molecule
Jkappa	E-Biological_Molecule
or	O
nuclear	O
localization	O
sequences	O
retain	O
the	O
ability	O
to	O
associate	O
with	O
RBP	B-Biological_Molecule
-	I-Biological_Molecule
Jkappa	E-Biological_Molecule
and	O
activate	O
transcription	O
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
the	O
AP	O
-	O
1	O
site	O
and	O
a	O
distal	O
promoter	O
element	O
regulate	O
transcriptional	O
induction	O
of	O
collagenase	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
during	O
monocytic	O
differentiation	O
.	O

CONCLUSIONS	O
:	O
Our	O
results	O
establish	O
that	O
PI	B-Biological_Molecule
3	I-Biological_Molecule
-	I-Biological_Molecule
kinase	E-Biological_Molecule
can	O
both	O
positively	O
and	O
negatively	O
regulate	O
T	O
-	O
cell	O
function	O
,	O
and	O
uncover	O
a	O
previously	O
unrecognized	O
function	O
for	O
PI	B-Biological_Molecule
3	I-Biological_Molecule
-	I-Biological_Molecule
kinase	E-Biological_Molecule
in	O
T	O
cells	O
as	O
a	O
selective	O
negative	O
regulator	O
of	O
TCR	O
-	O
signalling	O
events	O
and	O
therefore	O
as	O
a	O
determinant	O
of	O
T	O
-	O
cell	O
homeostasis	O
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
the	O
T	O
cell	O
tropic	O
strain	O
of	O
HIV	O
,	O
LAI	O
,	O
does	O
not	O
replicate	O
in	O
naive	O
CD4	S-Biological_Molecule
T	O
cells	O
stimulated	O
by	O
cross	O
-	O
linking	O
CD3	O
and	O
CD28	S-Biological_Molecule
.	O

The	O
suppression	O
of	O
productive	O
LAI	O
replication	O
in	O
naive	O
T	O
cells	O
is	O
not	O
due	O
to	O
differential	O
expression	O
of	O
viral	O
coreceptors	O
,	O
nor	O
is	O
it	O
due	O
to	O
inhibition	O
of	O
activation	O
of	O
the	O
important	O
HIV	O
transcription	O
factors	O
,	O
nuclear	O
factor	O
-	O
kappaB	O
and	O
activator	O
protein	O
-	O
1	O
.	O

We	O
also	O
show	O
that	O
calcineurin	O
associated	O
with	O
the	O
N	O
-	O
terminal	O
domain	O
of	O
NFATx1	S-Biological_Molecule
at	O
multiple	O
docking	O
sites	O
and	O
caused	O
a	O
reduction	O
of	O
size	O
,	O
indicative	O
of	O
dephosphorylation	O
,	O
in	O
NFATx1	S-Biological_Molecule
.	O

Pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
)	O
is	O
an	O
inhibitor	O
of	O
NF	O
kappaB	O
in	O
most	O
cells	O
;	O
however	O
,	O
we	O
show	O
that	O
PDTC	O
is	O
also	O
a	O
potent	O
scavenger	O
of	O
NO	O
through	O
formation	O
of	O
mononitrosyl	O
iron	O
complexes	O
with	O
PDTC	O
.	O

In	O
astrocytes	O
PDTC	O
also	O
dramatically	O
induces	O
the	O
NF	O
kappaB	O
-	O
dependent	O
enzyme	O
,	O
iNOS	S-Biological_Molecule
,	O
supporting	O
the	O
physiologic	O
relevance	O
of	O
endogenous	O
NO	O
regulation	O
of	O
NF	O
kappaB	O
.	O

The	O
effects	O
of	O
RA	O
on	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	I-Biological_Molecule
-	I-Biological_Molecule
alpha	I-Biological_Molecule
receptor	E-Biological_Molecule
expression	O
was	O
determined	O
by	O
flow	O
cytometry	O
on	O
T	O
cells	O
.	O

Unexpectedly	O
,	O
the	O
CD8	O
+	O
T	O
-	O
cell	O
subpopulation	O
failed	O
to	O
respond	O
.	O

Epitope	O
enhancement	O
was	O
used	O
to	O
confirm	O
the	O
strict	O
lineage	O
-	O
and	O
stage	O
-	O
specific	O
expression	O
of	O
MNDA	S-Biological_Molecule
in	O
bone	O
marrow	O
as	O
well	O
as	O
in	O
other	O
paraffin	O
-	O
embedded	O
fixed	O
tissues	O
.	O

The	O
results	O
indicate	O
that	O
DNA	O
methylation	O
,	O
chromatin	O
structure	O
,	O
and	O
transactivation	O
at	O
an	O
Sp1	S-Biological_Molecule
site	O
contribute	O
to	O
the	O
highly	O
restricted	O
expression	O
of	O
this	O
myelomonocytic	O
lineage	O
specific	O
gene	O
.	O

The	O
expression	O
of	O
major	O
histocompatibility	O
complex	O
(	O
MHC	O
)	O
class	O
II	O
antigens	O
is	O
constitutive	O
in	O
professional	O
antigen	O
presenting	O
cells	O
(	O
APCs	O
)	O
but	O
can	O
also	O
be	O
induced	O
by	O
interferon	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
(	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
)	O
on	O
the	O
majority	O
of	O
the	O
non	O
professional	O
APCs	O
(	O
e	O
.	O
g	O
.	O
fibroblasts	O
)	O
.	O

To	O
validate	O
the	O
method	O
,	O
we	O
made	O
use	O
of	O
earlier	O
receptor	O
binding	O
studies	O
indicating	O
that	O
normal	O
human	O
monocytes	O
and	O
activated	O
,	O
but	O
not	O
resting	O
,	O
lymphocytes	O
expressed	O
the	O
VDR	S-Biological_Molecule
.	O

Following	O
an	O
initial	O
genotype	O
screening	O
of	O
85	O
normal	O
volunteers	O
by	O
polymerase	O
chain	O
reaction	O
or	O
restriction	O
fragment	O
length	O
polymorphism	O
analysis	O
,	O
14	O
individuals	O
with	O
the	O
Bb	O
genotype	O
,	O
12	O
with	O
the	O
bb	O
genotype	O
,	O
and	O
12	O
with	O
the	O
BB	O
genotype	O
were	O
selected	O
.	O

Recently	O
,	O
CD40	S-Biological_Molecule
also	O
has	O
been	O
shown	O
to	O
be	O
expressed	O
by	O
mesenchymal	O
cells	O
,	O
including	O
human	O
fibroblasts	O
.	O

Little	O
is	O
known	O
about	O
the	O
role	O
of	O
CD40	S-Biological_Molecule
in	O
fibroblasts	O
.	O

Tap	O
:	O
a	O
novel	O
cellular	O
protein	O
that	O
interacts	O
with	O
tip	O
of	O
herpesvirus	O
saimiri	O
and	O
induces	O
lymphocyte	O
aggregation	O
.	O

Thus	O
,	O
Tap	O
is	O
likely	O
to	O
be	O
an	O
important	O
cellular	O
mediator	O
of	O
Tip	O
function	O
in	O
T	O
cell	O
transformation	O
by	O
herpesvirus	O
saimiri	O
.	O

One	O
gene	O
encodes	O
a	O
protein	O
,	O
RFX5	S-Biological_Molecule
,	O
that	O
is	O
a	O
member	O
of	O
the	O
RFX	O
family	O
of	O
DNA	O
binding	O
proteins	O
.	O

Furthermore	O
,	O
these	O
plasmids	O
were	O
not	O
active	O
in	O
RJ2	O
.	O
2	O
.	O
5	O
,	O
an	O
in	O
vitro	O
mutagenized	O
derivative	O
of	O
Raji	O
in	O
which	O
both	O
copies	O
of	O
CIITA	S-Biological_Molecule
are	O
defective	O
.	O

Emphasis	O
is	O
placed	O
on	O
cytokines	O
that	O
have	O
been	O
studied	O
in	O
periodontitis	O
,	O
principally	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
,	O
IL	O
-	O
1	O
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
and	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
interferon	E-Biological_Molecule
.	O

To	O
investigate	O
whether	O
the	O
molar	O
ratio	O
of	O
HSF2	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
and	O
HSF2	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
isoforms	O
is	O
crucial	O
for	O
the	O
activation	O
of	O
HSF2	S-Biological_Molecule
and	O
whether	O
the	O
HSF2	S-Biological_Molecule
isoforms	O
play	O
functionally	O
distinct	O
roles	O
during	O
the	O
hemin	O
-	O
mediated	O
erythroid	O
differentiation	O
,	O
we	O
generated	O
cell	O
clones	O
expressing	O
different	O
levels	O
of	O
HSF2	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
and	O
HSF2	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
.	O

Giant	O
cell	O
arteritis	O
(	O
GCA	O
)	O
is	O
a	O
vasculitic	O
syndrome	O
that	O
preferentially	O
affects	O
medium	O
and	O
large	O
-	O
sized	O
arteries	O
.	O

Dose	O
-	O
dependence	O
studies	O
using	O
histamine	O
and	O
dimaprit	O
showed	O
that	O
the	O
EC50	O
values	O
for	O
cAMP	O
production	O
and	O
c	B-Biological_Molecule
-	I-Biological_Molecule
fos	E-Biological_Molecule
increase	O
were	O
similar	O
,	O
suggesting	O
that	O
cAMP	O
might	O
be	O
involved	O
in	O
c	B-Biological_Molecule
-	I-Biological_Molecule
fos	E-Biological_Molecule
induction	O
via	O
H2	B-Biological_Molecule
receptors	E-Biological_Molecule
.	O

Therefore	O
,	O
inactivation	O
of	O
the	O
IgH	O
3	O
'	O
enhancer	O
is	O
a	O
multifactorial	O
process	O
affecting	O
several	O
transcription	O
factors	O
that	O
control	O
the	O
cell	O
-	O
specific	O
and	O
developmental	O
activity	O
of	O
the	O
enhancer	O
.	O

Cis	O
-	O
acting	O
elements	O
with	O
NFkappaB	O
,	O
AP1	O
and	O
ETS	O
-	O
like	O
binding	O
motifs	O
have	O
been	O
identified	O
in	O
the	O
promoter	O
region	O
of	O
the	O
GM	B-Biological_Molecule
-	I-Biological_Molecule
CSF	E-Biological_Molecule
gene	O
,	O
and	O
are	O
important	O
or	O
essential	O
for	O
transcriptional	O
activity	O
following	O
T	O
cell	O
activation	O
.	O

Our	O
results	O
suggest	O
that	O
constitutive	O
ETS1	S-Biological_Molecule
,	O
and	O
inducible	O
NFkappaB	O
and	O
AP1	O
,	O
cooperate	O
as	O
part	O
of	O
a	O
higher	O
order	O
transcriptional	O
complex	O
in	O
activated	O
T	O
cells	O
.	O

In	O
vivo	O
genomic	O
DMS	O
footprinting	O
revealed	O
upstream	O
of	O
the	O
major	O
transcription	O
initiation	O
sites	O
,	O
the	O
presence	O
of	O
at	O
least	O
three	O
protein	O
binding	O
sites	O
,	O
two	O
of	O
which	O
were	O
constitutively	O
occupied	O
.	O

In	O
fact	O
,	O
mAb	O
L243	O
but	O
not	O
the	O
staphylococcal	O
superantigens	O
,	O
staphylococcal	O
exotoxin	O
toxic	B-Biological_Molecule
shock	I-Biological_Molecule
syndrome	I-Biological_Molecule
toxin	I-Biological_Molecule
-	I-Biological_Molecule
I	E-Biological_Molecule
or	O
staphylococcal	B-Biological_Molecule
enterotoxin	I-Biological_Molecule
B	E-Biological_Molecule
,	O
regulate	O
the	O
NF	O
-	O
kappa	O
B	O
binding	O
activity	O
.	O

We	O
investigated	O
the	O
transactivation	O
potential	O
of	O
Stat6	S-Biological_Molecule
and	O
found	O
that	O
it	O
is	O
not	O
restricted	O
to	O
lymphocytes	O
.	O

Deletion	O
analysis	O
of	O
the	O
carboxyl	O
-	O
terminal	O
region	O
of	O
Stat6	S-Biological_Molecule
and	O
recombination	O
of	O
this	O
region	O
with	O
a	O
heterologous	O
DNA	O
binding	O
domain	O
allowed	O
the	O
delimitation	O
and	O
characterization	O
of	O
the	O
transactivation	O
domain	O
of	O
Stat6	S-Biological_Molecule
.	O

The	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
2	I-Biological_Molecule
IL	I-Biological_Molecule
-	I-Biological_Molecule
2	I-Biological_Molecule
receptor	I-Biological_Molecule
beta	I-Biological_Molecule
-	I-Biological_Molecule
chain	E-Biological_Molecule
(	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2Rbeta	E-Biological_Molecule
)	O
is	O
an	O
essential	O
component	O
of	O
the	O
receptors	O
for	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
15	E-Biological_Molecule
.	O

Anti	O
-	O
Ehrlichia	O
chaffeensis	O
antibody	O
complexed	O
with	O
E	O
.	O
chaffeensis	O
induces	O
potent	O
proinflammatory	O
cytokine	O
mRNA	O
expression	O
in	O
human	O
monocytes	O
through	O
sustained	O
reduction	O
of	O
IkappaB	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
and	O
activation	O
of	O
NF	O
-	O
kappaB	O
.	O

The	O
expression	O
of	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
mRNAs	O
was	O
also	O
induced	O
.	O

SAC	O
consistently	O
exhibited	O
a	O
dose	O
-	O
dependent	O
inhibition	O
of	O
NF	O
-	O
kappa	O
B	O
activation	O
induced	O
by	O
both	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
and	O
H2O2	O
.	O

Our	O
data	O
suggest	O
that	O
SAC	O
may	O
act	O
via	O
antioxidant	O
mechanisms	O
to	O
block	O
NF	O
-	O
kappa	O
B	O
activation	O
in	O
Jurkat	O
cells	O
.	O

Co	O
-	O
stimulation	O
of	O
microglia	O
with	O
suboptimal	O
concentrations	O
of	O
A	O
beta	O
(	O
25	O
-	O
35	O
)	O
and	O
100	O
U	O
/	O
ml	O
IFN	B-Biological_Molecule
gamma	E-Biological_Molecule
resulted	O
in	O
the	O
detection	O
of	O
a	O
specific	O
NF	O
-	O
kappa	O
B	O
DNA	O
-	O
binding	O
activity	O
in	O
nuclear	O
extracts	O
,	O
as	O
determined	O
in	O
gel	O
mobility	O
shift	O
assays	O
.	O

Electrophoretic	O
mobility	O
shift	O
(	O
EMS	O
)	O
analyses	O
utilizing	O
oligonucleotides	O
homologous	O
to	O
each	O
of	O
the	O
21	O
bp	O
repeat	O
elements	O
reacted	O
with	O
nuclear	O
extracts	O
derived	O
from	O
cell	O
lines	O
of	O
lymphocytic	O
,	O
monocytic	O
,	O
neuronal	O
,	O
and	O
glial	O
cell	O
origin	O
have	O
demonstrated	O
differential	O
binding	O
of	O
cellular	O
factors	O
to	O
the	O
three	O
21	O
bp	O
repeats	O
(	O
1	O
-	O
4	O
)	O
.	O

In	O
this	O
report	O
,	O
we	O
describe	O
the	O
cloning	O
of	O
human	B-Biological_Molecule
GATA	I-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
(	O
hGATA	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
)	O
and	O
show	O
that	O
hGATA	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
selectively	O
interacts	O
with	O
the	O
-	O
70	O
GATA	O
site	O
within	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
proximal	O
promoter	O
region	O
.	O

In	O
resting	O
Raji	O
cells	O
,	O
little	O
to	O
no	O
binding	O
to	O
the	O
X2	O
box	O
was	O
observed	O
.	O

It	O
is	O
known	O
that	O
the	O
expression	O
levels	O
of	O
intercellular	B-Biological_Molecule
adhesion	I-Biological_Molecule
molecule	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
(	O
ICAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
)	O
in	O
adult	O
T	O
cell	O
leukemia	O
(	O
ATL	O
)	O
cells	O
are	O
high	O
,	O
whereas	O
those	O
in	O
T	O
-	O
lymphoid	O
cells	O
are	O
not	O
.	O

In	O
contrast	O
,	O
proviruses	O
carrying	O
mutations	O
in	O
the	O
Sp1	S-Biological_Molecule
sites	O
were	O
totally	O
defective	O
in	O
terms	O
of	O
replication	O
.	O

Here	O
we	O
show	O
,	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
that	O
ascorbate	O
increases	O
the	O
binding	O
of	O
NF	O
-	O
kappaB	O
to	O
DNA	O
in	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
-	O
stimulated	O
Jurkat	O
cells	O
.	O

Pancreatic	O
islet	O
expression	O
studies	O
and	O
polymorphic	O
DNA	O
markers	O
in	O
the	O
genes	O
encoding	O
hepatocyte	B-Biological_Molecule
nuclear	I-Biological_Molecule
factor	I-Biological_Molecule
-	I-Biological_Molecule
3alpha	E-Biological_Molecule
,	O
-	B-Biological_Molecule
3beta	E-Biological_Molecule
,	O
-	B-Biological_Molecule
3gamma	E-Biological_Molecule
,	O
-	B-Biological_Molecule
4gamma	E-Biological_Molecule
,	O
and	O
-	B-Biological_Molecule
6	E-Biological_Molecule
.	O

The	O
transcriptional	O
hierarchy	O
of	O
HNFs	O
suggests	O
that	O
other	O
proteins	O
of	O
the	O
regulatory	O
cascade	O
might	O
be	O
responsible	O
for	O
other	O
forms	O
of	O
MODY	O
and	O
/	O
or	O
late	O
-	O
onset	O
type	O
2	O
diabetes	O
.	O

The	O
rapid	O
up	O
-	O
regulation	O
of	O
RP1	S-Biological_Molecule
mRNA	O
in	O
properly	O
activated	O
T	O
cells	O
suggests	O
that	O
this	O
gene	O
might	O
belong	O
to	O
the	O
immediate	O
/	O
early	O
gene	O
family	O
,	O
which	O
controls	O
the	O
signal	O
transduction	O
cascade	O
downstream	O
of	O
the	O
TCR	O
.	O

As	O
the	O
expression	O
level	O
of	O
the	O
RP1	S-Biological_Molecule
gene	O
in	O
activated	O
T	O
cells	O
and	O
a	O
spectrum	O
of	O
tumor	O
-	O
derived	O
cell	O
lines	O
correlates	O
with	O
the	O
proliferative	O
status	O
of	O
the	O
cells	O
,	O
members	O
of	O
the	O
EB1	O
-	O
like	O
gene	O
family	O
may	O
not	O
only	O
be	O
involved	O
in	O
the	O
tumorigenesis	O
of	O
colorectal	O
cancers	O
but	O
may	O
also	O
play	O
a	O
role	O
in	O
the	O
proliferative	O
control	O
of	O
normal	O
cells	O
.	O

Induction	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
expression	O
in	O
monocytic	O
cells	O
by	O
Cryptococcus	O
neoformans	O
and	O
Candida	O
albicans	O
.	O

These	O
EKLF	S-Biological_Molecule
-	O
/	O
-	O
ES	O
cells	O
were	O
capable	O
of	O
undergoing	O
in	O
vitro	O
differentiation	O
to	O
form	O
definitive	O
erythroid	O
colonies	O
that	O
were	O
similar	O
in	O
size	O
and	O
number	O
to	O
those	O
formed	O
by	O
wild	O
-	O
type	O
ES	O
cells	O
.	O

The	O
ratio	O
of	O
adult	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
globin	E-Biological_Molecule
/	O
alpha	B-Biological_Molecule
-	I-Biological_Molecule
globin	E-Biological_Molecule
mRNA	O
in	O
the	O
mutant	O
ES	O
cells	O
was	O
1	O
/	O
15	O
of	O
that	O
in	O
wild	O
-	O
type	O
ES	O
cells	O
.	O

EBF	S-Biological_Molecule
and	O
E47	S-Biological_Molecule
collaborate	O
to	O
induce	O
expression	O
of	O
the	O
endogenous	O
immunoglobulin	O
surrogate	O
light	O
chain	O
genes	O
.	O

The	O
C	O
/	O
EBP	O
motif	O
is	O
bound	O
by	O
Ig	B-Biological_Molecule
/	I-Biological_Molecule
EBP	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
in	O
pre	O
-	O
B	O
cell	O
and	O
T	O
cell	O
extracts	O
,	O
but	O
is	O
replaced	O
by	O
nuclear	B-Biological_Molecule
factor	I-Biological_Molecule
-	I-Biological_Molecule
IL	I-Biological_Molecule
-	I-Biological_Molecule
6beta	E-Biological_Molecule
or	O
a	O
nuclear	B-Biological_Molecule
factor	I-Biological_Molecule
-	I-Biological_Molecule
IL	I-Biological_Molecule
-	I-Biological_Molecule
6beta	E-Biological_Molecule
-	O
Ig	B-Biological_Molecule
/	I-Biological_Molecule
EBP	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
heterodimer	O
in	O
plasmacytoma	O
cell	O
extracts	O
.	O

In	O
this	O
study	O
,	O
a	O
combined	O
pharmacologic	O
and	O
genetic	O
strategy	O
using	O
two	O
PKC	O
(	O
NF	O
-	O
kappa	O
B	O
)	O
inhibitors	O
,	O
pentoxifylline	O
(	O
PTX	O
)	O
and	O
Go	O
-	O
6976	O
,	O
and	O
a	O
stably	O
expressed	O
anti	O
-	O
Tat	S-Biological_Molecule
single	O
-	O
chain	O
intracellular	O
antibody	O
(	O
sFv	O
intrabody	O
)	O
was	O
employed	O
to	O
obtain	O
cooperative	O
inhibition	O
of	O
both	O
HIV	O
-	O
1	O
LTR	O
-	O
driven	O
gene	O
expression	O
and	O
HIV	O
-	O
1	O
replication	O
.	O

Together	O
,	O
these	O
results	O
suggest	O
that	O
in	O
future	O
clinical	O
gene	O
therapy	O
trials	O
,	O
a	O
combined	O
pharmacologic	O
and	O
genetic	O
strategy	O
like	O
the	O
one	O
reported	O
here	O
may	O
improve	O
the	O
survival	O
of	O
transduced	O
cells	O
and	O
prolong	O
clinical	O
benefit	O
.	O

We	O
investigated	O
the	O
trophic	O
effect	O
resulting	O
from	O
activation	O
of	O
such	O
a	O
receptor	O
by	O
using	O
the	O
reporter	O
gene	O
strategy	O
.	O

The	O
involvement	O
of	O
the	O
CCK	B-Biological_Molecule
(	I-Biological_Molecule
B	I-Biological_Molecule
)	I-Biological_Molecule
receptor	E-Biological_Molecule
in	O
such	O
a	O
stimulation	O
was	O
demonstrated	O
by	O
the	O
inhibiting	O
effect	O
of	O
the	O
selective	O
CCK	B-Biological_Molecule
(	I-Biological_Molecule
B	I-Biological_Molecule
)	I-Biological_Molecule
receptor	E-Biological_Molecule
antagonist	O
PD	O
-	O
135	O
,	O
158	O
.	O

To	O
better	O
understand	O
the	O
AP	O
-	O
1	O
-	O
dependent	O
luciferase	S-Biological_Molecule
expression	O
in	O
Jurkat	O
T	O
cells	O
,	O
we	O
tested	O
two	O
specific	O
inhibitors	O
of	O
serine	B-Biological_Molecule
/	I-Biological_Molecule
threonine	I-Biological_Molecule
phosphatases	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
-	B-Biological_Molecule
2A	E-Biological_Molecule
:	O
okadaic	O
acid	O
and	O
calyculin	O
A	O
.	O

Epstein	O
-	O
Barr	O
virus	O
(	O
EBV	O
)	O
,	O
an	O
oncogenic	O
human	O
herpesvirus	O
,	O
binds	O
to	O
and	O
infects	O
normal	O
human	O
B	O
lymphocytes	O
via	O
CD21	S-Biological_Molecule
,	O
the	O
CR2	S-Biological_Molecule
complement	O
receptor	O
.	O

Activation	O
of	O
transcription	O
factor	O
NF	O
-	O
kappa	O
B	O
by	O
phagocytic	O
stimuli	O
in	O
human	O
neutrophils	O
.	O

Cytokine	O
-	O
stimulated	O
cell	O
surface	O
expression	O
of	O
vascular	B-Biological_Molecule
cell	I-Biological_Molecule
adhesion	I-Biological_Molecule
molecule	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
(	O
VCAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
CD106	S-Biological_Molecule
)	O
and	O
E	B-Biological_Molecule
-	I-Biological_Molecule
selectin	E-Biological_Molecule
(	O
ELAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
CD62E	S-Biological_Molecule
)	O
,	O
but	O
not	O
of	O
intercellular	B-Biological_Molecule
adhesion	I-Biological_Molecule
molecule	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
(	O
ICAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
CD54	S-Biological_Molecule
)	O
,	O
was	O
time	O
-	O
and	O
dose	O
-	O
dependently	O
inhibited	O
by	O
TCP	O
succinate	O
but	O
not	O
by	O
TCP	O
or	O
TCP	O
acetate	O
.	O

TCP	O
succinate	O
(	O
20	O
microM	O
,	O
72	O
h	O
)	O
,	O
but	O
not	O
TCP	O
(	O
200	O
microM	O
,	O
72	O
h	O
)	O
,	O
reduced	O
U	O
-	O
937	O
cell	O
adhesion	O
to	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
-	O
stimulated	O
(	O
10	O
U	O
/	O
ml	O
,	O
6	O
h	O
)	O
HUVEC	O
by	O
30	O
%	O
(	O
P	O
<	O
0	O
.	O
025	O
)	O
and	O
to	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
beta	E-Biological_Molecule
-	O
stimulated	O
HUVEC	O
by	O
56	O
%	O
(	O
P	O
<	O
0	O
.	O
010	O
)	O
.	O

Distinct	O
mechanisms	O
for	O
N	O
-	O
acetylcysteine	O
inhibition	O
of	O
cytokine	O
-	O
induced	O
E	B-Biological_Molecule
-	I-Biological_Molecule
selectin	E-Biological_Molecule
and	O
VCAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
expression	O
.	O

We	O
have	O
examined	O
the	O
effects	O
of	O
N	O
-	O
acetyl	O
-	O
L	O
-	O
cysteine	O
(	O
NAC	O
)	O
,	O
a	O
well	O
-	O
characterized	O
,	O
thiol	O
-	O
containing	O
antioxidant	O
,	O
on	O
agonist	O
-	O
induced	O
monocytic	O
cell	O
adhesion	O
to	O
endothelial	O
cells	O
(	O
EC	O
)	O
.	O

Although	O
NAC	O
reduced	O
nuclear	O
factor	O
-	O
kappa	O
B	O
(	O
NF	O
-	O
kappa	O
B	O
)	O
activation	O
in	O
EC	O
as	O
measured	O
by	O
gel	O
-	O
shift	O
assays	O
using	O
an	O
oligonucleotide	O
probe	O
corresponding	O
to	O
the	O
consensus	O
NF	O
-	O
kappa	O
B	O
binding	O
sites	O
of	O
the	O
VCAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
gene	O
(	O
VCAM	O
-	O
NF	O
-	O
kappa	O
B	O
)	O
,	O
the	O
antioxidant	O
had	O
no	O
appreciable	O
effect	O
when	O
an	O
oligomer	O
corresponding	O
to	O
the	O
consensus	O
NF	O
-	O
kappa	O
B	O
binding	O
site	O
of	O
the	O
E	B-Biological_Molecule
-	I-Biological_Molecule
selectin	E-Biological_Molecule
gene	O
(	O
E	B-Biological_Molecule
-	I-Biological_Molecule
selectin	E-Biological_Molecule
-	O
NF	O
-	O
kappa	O
B	O
)	O
was	O
used	O
.	O

In	O
vitro	O
studies	O
demonstrated	O
that	O
whereas	O
the	O
binding	O
affinity	O
of	O
NF	O
-	O
kappa	O
B	O
to	O
the	O
VCAM	O
-	O
NF	O
-	O
kappa	O
B	O
oligomer	O
peaked	O
at	O
a	O
GSH	O
-	O
to	O
-	O
oxidized	O
glutathione	O
(	O
GSSG	O
)	O
ratio	O
of	O
approximately	O
200	O
and	O
decreased	O
at	O
higher	O
ratios	O
,	O
the	O
binding	O
to	O
the	O
E	B-Biological_Molecule
-	I-Biological_Molecule
selectin	E-Biological_Molecule
-	O
NF	O
-	O
kappa	O
B	O
oligomer	O
appeared	O
relatively	O
unaffected	O
even	O
at	O
ratios	O
>	O
400	O
,	O
i	O
.	O
e	O
.	O
,	O
those	O
achieved	O
in	O
EC	O
treated	O
with	O
40	O
mM	O
NAC	O
.	O

In	O
the	O
current	O
studies	O
,	O
we	O
evaluated	O
the	O
combinatorial	O
effects	O
of	O
monocyte	O
adhesion	O
and	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
on	O
intracellular	O
signaling	O
pathways	O
.	O

Few	O
of	O
these	O
factors	O
are	O
expressed	O
exclusively	O
in	O
myeloid	O
cells	O
;	O
instead	O
it	O
appears	O
that	O
they	O
cooperatively	O
regulate	O
transcription	O
of	O
myeloid	O
-	O
specific	O
genes	O
.	O

2	O
.	O

When	O
apoptotic	O
lymphocytes	O
from	O
exposed	O
individuals	O
were	O
compared	O
to	O
apoptotic	O
lymphocytes	O
from	O
the	O
control	O
group	O
,	O
statistically	O
-	O
significant	O
differences	O
between	O
each	O
mean	O
group	O
were	O
detected	O
(	O
26	O
.	O
4	O
+	O
/	O
-	O
1	O
.	O
8	O
and	O
12	O
.	O
1	O
+	O
/	O
-	O
1	O
.	O
3	O
,	O
respectively	O
)	O
,	O
indicating	O
an	O
increased	O
rate	O
of	O
apoptosis	O
in	O
80	O
.	O
5	O
%	O
of	O
exposed	O
individuals	O
(	O
P	O
<	O
0	O
.	O
0001	O
,	O
Mann	O
-	O
Whitney	O
U	O
-	O
Test	O
)	O
.	O

Indeed	O
,	O
addition	O
of	O
inhibitors	O
of	O
NF	O
-	O
kappa	O
B	O
activation	O
pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
)	O
,	O
to	O
the	O
lymphocytes	O
of	O
the	O
chemically	O
-	O
exposed	O
group	O
was	O
capable	O
of	O
inhibiting	O
programmed	O
cell	O
death	O
by	O
40	O
%	O
.	O

However	O
,	O
the	O
intracellular	O
mechanisms	O
for	O
these	O
effects	O
of	O
ethanol	O
are	O
yet	O
to	O
be	O
understood	O
.	O

Thus	O
,	O
such	O
unique	O
activation	O
of	O
the	O
inhibitory	O
p50	S-Biological_Molecule
/	O
p50	S-Biological_Molecule
homodimer	O
by	O
acute	O
ethanol	O
treatment	O
may	O
result	O
in	O
inhibition	O
rather	O
than	O
activation	O
of	O
NF	O
-	O
kappa	O
B	O
-	O
regulated	O
inflammatory	O
cytokine	O
genes	O
.	O

The	O
development	O
of	O
resistance	O
to	O
host	O
defense	O
mechanisms	O
such	O
as	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)	O
-	O
and	O
Fas	S-Biological_Molecule
-	O
mediated	O
apoptosis	O
of	O
transformed	O
or	O
virus	O
-	O
infected	O
cells	O
may	O
be	O
a	O
critical	O
component	O
in	O
the	O
development	O
of	O
disease	O
.	O

NF	O
-	O
AT	O
activation	O
induced	O
by	O
a	O
CAML	S-Biological_Molecule
-	O
interacting	O
member	O
of	O
the	O
tumor	O
necrosis	O
factor	O
receptor	O
superfamily	O
.	O

This	O
study	O
describes	O
the	O
characterization	O
of	O
two	O
additional	O
cis	O
-	O
acting	O
elements	O
that	O
interact	O
with	O
members	O
of	O
the	O
NF	O
kappa	O
B	O
/	O
rel	O
transcription	O
factor	O
family	O
in	O
an	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
-	O
independent	O
fashion	O
.	O

Core	O
-	O
specific	O
mAb	O
inhibited	O
mCD14	S-Biological_Molecule
-	O
mediated	O
uptake	O
of	O
homologous	O
and	O
heterologous	O
LPS	O
,	O
while	O
producing	O
less	O
concurrent	O
enhancement	O
of	O
non	O
-	O
mCD14	S-Biological_Molecule
-	O
mediated	O
LPS	O
uptake	O
.	O

By	O
immunocytochemistry	O
,	O
25	O
+	O
/	O
-	O
7	O
%	O
of	O
the	O
human	O
neutrophils	O
were	O
shown	O
to	O
express	O
immunoreactive	O
GH	S-Biological_Molecule
,	O
whereas	O
eosinophils	O
were	O
negative	O
.	O

Interestingly	O
,	O
co	O
-	O
immunoprecipitation	O
analysis	O
also	O
revealed	O
that	O
Tax	S-Biological_Molecule
mutant	O
IEXC29S	O
is	O
unable	O
to	O
interact	O
with	O
NGFI	B-Biological_Molecule
-	I-Biological_Molecule
A	E-Biological_Molecule
/	O
Egr	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
whereas	O
Tax	S-Biological_Molecule
mutant	O
IEXL320G	O
is	O
able	O
to	O
interact	O
with	O
NGFI	B-Biological_Molecule
-	I-Biological_Molecule
A	E-Biological_Molecule
/	O
Egr	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
.	O

Like	O
ML	O
-	O
1a	O
,	O
human	O
dermal	O
microvessel	O
endothelial	O
cells	O
(	O
MVEC	O
)	O
treated	O
with	O
TNF	O
rapidly	O
activated	O
(	O
within	O
30	O
min	O
)	O
NF	O
-	O
kappa	O
B	O
;	O
this	O
effect	O
was	O
completely	O
abolished	O
by	O
co	O
-	O
treatment	O
with	O
phenylarsine	O
oxide	O
(	O
PAO	O
)	O
,	O
a	O
specific	O
inhibitor	O
of	O
PTPase	O
.	O

The	O
spatial	O
distribution	O
of	O
human	O
immunoglobulin	O
genes	O
within	O
the	O
nucleus	O
:	O
evidence	O
for	O
gene	O
topography	O
independent	O
of	O
cell	O
type	O
and	O
transcriptional	O
activity	O
.	O

Since	O
a	O
common	O
pathological	O
finding	O
in	O
human	O
T	O
-	O
cell	O
leukemia	O
virus	O
type	O
1	O
(	O
HTLV	O
-	O
1	O
)	O
-	O
associated	O
diseases	O
is	O
the	O
infiltration	O
of	O
HTLV	O
-	O
1	O
-	O
infected	O
T	O
lymphocytes	O
into	O
various	O
organs	O
,	O
we	O
have	O
looked	O
for	O
the	O
profile	O
of	O
adhesion	O
molecules	O
expressed	O
by	O
HTLV	O
-	O
1	O
-	O
transformed	O
T	O
cells	O
.	O

Nonadherent	O
neutrophils	O
were	O
removed	O
by	O
sealing	O
and	O
inverting	O
the	O
culture	O
well	O
.	O

Immunocytochemistry	O
60	O
minutes	O
after	O
stimulation	O
revealed	O
that	O
NFkappaB	O
was	O
located	O
in	O
the	O
cytoplasm	O
in	O
unstimulated	O
cells	O
;	O
however	O
,	O
the	O
addition	O
of	O
TNFalpha	S-Biological_Molecule
caused	O
NFkappaB	O
to	O
translocate	O
into	O
the	O
nucleus	O
.	O

The	O
active	O
ingredients	O
mediating	O
the	O
pharmacological	O
effect	O
are	O
mainly	O
sesquiterpene	O
lactones	O
,	O
such	O
as	O
helenalin	O
,	O
11alpha	O
,	O
13	O
-	O
dihydrohelenalin	O
,	O
chamissonolid	O
and	O
their	O
ester	O
derivatives	O
.	O

Combinations	O
of	O
hypoxia	O
and	O
LPS	O
significantly	O
increased	O
lymphocyte	O
binding	O
,	O
and	O
such	O
increases	O
were	O
inhibited	O
by	O
addition	O
of	O
anti	O
-	O
ICAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
antibodies	O
or	O
antisense	O
oligonucleotides	O
.	O

We	O
suspect	O
that	O
the	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBP	I-Biological_Molecule
epsilon	E-Biological_Molecule
promoter	O
/	O
enhancer	O
contains	O
a	O
retinoic	O
acid	O
-	O
response	O
element	O
that	O
is	O
directly	O
stimulated	O
by	O
retinoids	O
.	O

Regulation	O
of	O
nuclear	O
factor	O
-	O
kappa	O
B	O
and	O
its	O
inhibitor	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
/	O
MAD	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
in	O
monocytes	O
by	O
Mycobacterium	O
tuberculosis	O
and	O
during	O
human	O
tuberculosis	O
.	O

We	O
found	O
a	O
constitutive	O
degradation	O
of	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
,	O
the	O
major	O
cytoplasmic	O
inhibitor	O
of	O
nuclear	O
factor	O
kappa	O
B	O
(	O
NF	O
-	O
kappa	O
B	O
)	O
,	O
in	O
freshly	O
isolated	O
PBMC	O
and	O
monocytes	O
from	O
patients	O
with	O
tuberculosis	O
.	O

The	O
expression	O
of	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
gene	O
,	O
which	O
is	O
responsive	O
to	O
activation	O
by	O
NF	O
-	O
kappa	O
B	O
,	O
was	O
up	O
-	O
regulated	O
in	O
PBMC	O
and	O
monocytes	O
from	O
patients	O
,	O
but	O
not	O
in	O
mononuclear	O
cells	O
from	O
healthy	O
subjects	O
or	O
those	O
with	O
nontuberculous	O
lung	O
diseases	O
.	O

Peripheral	O
blood	O
mononuclear	O
cells	O
(	O
pbmc	O
)	O
and	O
bone	O
marrow	O
cells	O
of	O
26	O
patients	O
were	O
examined	O
for	O
c	B-Biological_Molecule
-	I-Biological_Molecule
fos	E-Biological_Molecule
,	O
c	B-Biological_Molecule
-	I-Biological_Molecule
myc	E-Biological_Molecule
,	O
p53	S-Biological_Molecule
and	O
the	O
hybrid	O
bcr	O
/	O
abl	O
mRNA	O
levels	O
.	O

Here	O
we	O
describe	O
cloning	O
and	O
characterization	O
of	O
full	O
-	O
length	O
cDNA	O
encoding	O
murine	B-Biological_Molecule
(	I-Biological_Molecule
m	I-Biological_Molecule
)	I-Biological_Molecule
NFATc	E-Biological_Molecule
which	O
predicts	O
that	O
the	O
protein	O
has	O
all	O
the	O
conserved	O
structural	O
motifs	O
of	O
NFAT	O
family	O
members	O
,	O
including	O
the	O
rel	O
homology	O
domain	O
,	O
the	O
NFAT	O
homology	O
domain	O
and	O
the	O
nuclear	O
translocation	O
signals	O
.	O

Phosphatidylinositol	O
3	O
-	O
kinase	O
couples	O
the	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
receptor	O
to	O
the	O
cell	O
cycle	O
regulator	O
E2F	O
.	O

Protein	B-Biological_Molecule
kinase	I-Biological_Molecule
B	E-Biological_Molecule
(	O
PKB	S-Biological_Molecule
)	O
is	O
activated	O
by	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
via	O
PI3K	O
.	O

Thiol	O
modulation	O
inhibits	O
the	O
interleukin	O
(	O
IL	O
)	O
-	O
1	O
-	O
mediated	O
activation	O
of	O
an	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
receptor	E-Biological_Molecule
-	O
associated	O
protein	O
kinase	O
and	O
NF	O
-	O
kappa	O
B	O
.	O

One	O
ATF	O
/	O
CRE	O
motif	O
is	O
located	O
in	O
the	O
distal	O
promoter	O
at	O
the	O
nuclear	O
matrix	O
-	O
associated	O
Site	O
IV	O
,	O
and	O
the	O
second	O
motif	O
is	O
present	O
in	O
the	O
proximal	O
promoter	O
at	O
Site	O
I	O
.	O
Both	O
ATF	O
/	O
CRE	O
motifs	O
overlap	O
binding	O
sequences	O
for	O
the	O
multifunctional	O
YY1	O
transcription	O
factor	O
,	O
which	O
has	O
previously	O
been	O
shown	O
to	O
be	O
nuclear	O
matrix	O
associated	O
.	O

Moreover	O
,	O
we	O
observed	O
constitutive	O
association	O
of	O
STAT3	O
with	O
each	O
STAT5	O
isomer	O
.	O

These	O
data	O
suggest	O
that	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
7	E-Biological_Molecule
induce	O
assembly	O
of	O
STAT	O
heterodimers	O
in	O
a	O
similar	O
manner	O
and	O
that	O
subsequent	O
cellular	O
responses	O
may	O
be	O
driven	O
by	O
induction	O
of	O
similar	O
sets	O
of	O
genes	O
.	O

As	O
shown	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
and	O
electrophoretic	O
mobility	O
shift	O
assay	O
,	O
respectively	O
,	O
treatment	O
with	O
CsA	O
leads	O
to	O
decreased	O
TF	S-Biological_Molecule
mRNA	O
expression	O
and	O
reduced	O
activation	O
of	O
the	O
NF	O
-	O
kappaB	O
transcription	O
factor	O
,	O
which	O
is	O
known	O
to	O
contribute	O
to	O
the	O
induction	O
of	O
the	O
TF	S-Biological_Molecule
promotor	O
in	O
human	O
monocytes	O
.	O

Agonistic	O
activity	O
of	O
a	O
CD40	S-Biological_Molecule
-	O
specific	O
single	O
-	O
chain	O
Fv	O
constructed	O
from	O
the	O
variable	O
regions	O
of	O
mAb	O
G28	O
-	O
5	O
.	O

A	O
single	O
-	O
chain	O
Fv	O
(	O
sFv	O
)	O
was	O
expressed	O
from	O
the	O
variable	O
regions	O
of	O
the	O
CD40	S-Biological_Molecule
-	O
specific	O
mAb	O
G28	O
-	O
5	O
.	O

Surprisingly	O
,	O
G28	O
-	O
5	O
sFv	O
was	O
a	O
potent	O
CD40	S-Biological_Molecule
agonist	O
that	O
rapidly	O
crosslinked	O
CD40	S-Biological_Molecule
on	O
the	O
cell	O
surface	O
but	O
did	O
not	O
crosslink	O
CD40	S-Biological_Molecule
-	O
Ig	O
in	O
solution	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
ER	B-Biological_Molecule
alpha	E-Biological_Molecule
(	O
referred	O
to	O
throughout	O
as	O
ER	S-Biological_Molecule
)	O
on	O
DNA	O
-	O
binding	O
activities	O
of	O
transcription	O
factors	O
involved	O
in	O
regulating	O
the	O
expression	O
of	O
erythroid	O
-	O
specific	O
genes	O
,	O
and	O
,	O
in	O
particular	O
,	O
the	O
histone	B-Biological_Molecule
H5	E-Biological_Molecule
gene	O
.	O

We	O
hypothesize	O
that	O
interference	O
in	O
DNA	O
-	O
binding	O
activities	O
of	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
CACCC	O
-	O
binding	O
proteins	O
is	O
the	O
mechanism	O
by	O
which	O
the	O
ER	S-Biological_Molecule
inhibits	O
regulation	O
of	O
these	O
genes	O
.	O

The	O
binding	O
site	O
for	O
nuclear	O
factor	O
-	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
is	O
present	O
at	O
the	O
promoter	O
region	O
of	O
the	O
germline	O
Cepsilon	O
gene	O
,	O
but	O
there	O
is	O
little	O
information	O
on	O
whether	O
this	O
factor	O
is	O
involved	O
in	O
regulating	O
IgE	O
synthesis	O
by	O
human	O
B	O
cells	O
.	O

Of	O
note	O
,	O
CD40	S-Biological_Molecule
-	O
mediated	O
enhancement	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
-	O
driven	O
germline	O
Cepsilon	O
transcription	O
was	O
markedly	O
decreased	O
by	O
NAC	O
or	O
by	O
a	O
decoy	O
oligodeoxynucleotide	O
for	O
NF	O
-	O
kappaB	O
.	O

NAC	O
inhibited	O
the	O
generation	O
of	O
Smu	O
/	O
Sepsilon	O
switch	O
fragments	O
in	O
normal	O
human	O
B	O
cells	O
costimulated	O
with	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
and	O
anti	O
-	O
CD40	S-Biological_Molecule
monoclonal	O
antibody	O
.	O

These	O
results	O
suggest	O
that	O
coordination	O
of	O
NF	O
-	O
kappaB	O
and	O
STAT6	S-Biological_Molecule
may	O
be	O
required	O
for	O
induction	O
of	O
germline	O
Cepsilon	O
transcription	O
by	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
,	O
and	O
that	O
CD40	S-Biological_Molecule
-	O
mediated	O
NF	O
-	O
kappaB	O
activation	O
may	O
be	O
important	O
in	O
regulating	O
both	O
enhancement	O
of	O
germline	O
Cepsilon	O
transcription	O
and	O
class	O
switching	O
to	O
IgE	O
.	O

RESULTS	O
:	O
After	O
nonspecific	O
stimulation	O
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
production	O
by	O
CD4	O
+	O
T	O
cells	O
from	O
both	O
atopic	O
and	O
nonatopic	O
subjects	O
with	O
asthma	O
was	O
significantly	O
enhanced	O
compared	O
with	O
that	O
by	O
cells	O
from	O
healthy	O
controls	O
.	O

Regulation	O
of	O
NF	O
-	O
kappa	O
B	O
activity	O
by	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
alpha	E-Biological_Molecule
and	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
beta	E-Biological_Molecule
stability	O
.	O

In	O
addition	O
,	O
both	O
RelA	S-Biological_Molecule
and	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Rel	E-Biological_Molecule
,	O
but	O
not	O
NF	B-Biological_Molecule
-	I-Biological_Molecule
kappa	I-Biological_Molecule
B1	E-Biological_Molecule
,	O
were	O
shown	O
to	O
transactivate	O
an	O
ICAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
kappa	O
B	O
-	O
reporter	O
construct	O
.	O

The	O
second	O
complex	O
contained	O
RelA	S-Biological_Molecule
,	O
and	O
exhibited	O
higher	O
affinity	O
towards	O
the	O
ICAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
kappa	O
B	O
than	O
to	O
the	O
HIV	O
kappa	O
B	O
site	O
.	O

These	O
data	O
show	O
that	O
the	O
detection	O
of	O
upregulated	O
p50	S-Biological_Molecule
homodimers	O
in	O
LPS	O
tolerant	O
cells	O
is	O
dependent	O
on	O
subtle	O
differences	O
in	O
the	O
sequence	O
of	O
the	O
DNA	O
binding	O
motif	O
.	O

These	O
cells	O
,	O
stimulated	O
by	O
an	O
agonistic	O
monoclonal	O
antibody	O
against	O
CD40	S-Biological_Molecule
or	O
by	O
transfection	O
with	O
a	O
CD40L	S-Biological_Molecule
expression	O
vector	O
,	O
secreted	O
p40	S-Biological_Molecule
and	O
showed	O
enhanced	O
p40	S-Biological_Molecule
mRNA	O
expression	O
.	O

These	O
results	O
suggest	O
that	O
the	O
NF	O
-	O
kappaB	O
binding	O
site	O
located	O
around	O
120	O
bp	O
upstream	O
of	O
the	O
transcription	O
initiation	O
site	O
in	O
murine	O
and	O
human	O
p40	S-Biological_Molecule
promoter	O
regions	O
could	O
be	O
important	O
for	O
the	O
p40	S-Biological_Molecule
induction	O
by	O
CD40	S-Biological_Molecule
ligation	O
via	O
activation	O
of	O
NF	O
-	O
kappaB	O
.	O

Oxidants	O
,	O
transcription	O
factors	O
,	O
and	O
intestinal	O
inflammation	O
.	O

In	O
contrast	O
,	O
CD19	S-Biological_Molecule
cross	O
-	O
linking	O
in	O
BLIN	O
-	O
1	O
cells	O
resulted	O
in	O
the	O
induction	O
of	O
NF	O
-	O
kappaB	O
,	O
but	O
had	O
no	O
apparent	O
effect	O
on	O
AP	O
-	O
1	O
-	O
binding	O
activity	O
.	O

Transient	O
expression	O
analyses	O
in	O
cells	O
of	O
neuroglial	O
and	O
lymphocytic	O
origin	O
demonstrated	O
that	O
some	O
of	O
these	O
LTRs	O
had	O
activities	O
which	O
varied	O
significantly	O
from	O
the	O
LAI	O
LTR	O
in	O
U	O
-	O
373	O
MG	O
cells	O
(	O
an	O
astrocytoma	O
cell	O
line	O
)	O
as	O
well	O
as	O
in	O
Jurkat	O
cells	O
(	O
a	O
CD4	S-Biological_Molecule
-	O
positive	O
lymphocyte	O
cell	O
line	O
)	O
.	O

These	O
findings	O
suggest	O
that	O
LTR	O
sequence	O
changes	O
can	O
significantly	O
affect	O
basal	O
LTR	O
function	O
and	O
transcription	O
factor	O
recruitment	O
,	O
which	O
may	O
,	O
in	O
turn	O
,	O
alter	O
the	O
course	O
of	O
viral	O
replication	O
in	O
cells	O
of	O
CNS	O
and	O
immune	O
system	O
origin	O
.	O

Tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
receptor	I-Biological_Molecule
-	I-Biological_Molecule
activated	I-Biological_Molecule
factor	I-Biological_Molecule
6	E-Biological_Molecule
(	O
TRAF6	S-Biological_Molecule
)	O
and	O
the	O
nuclear	B-Biological_Molecule
factor	I-Biological_Molecule
kappaB	I-Biological_Molecule
(	I-Biological_Molecule
NF	I-Biological_Molecule
-	I-Biological_Molecule
kappaB	I-Biological_Molecule
)	I-Biological_Molecule
-	I-Biological_Molecule
inducing	I-Biological_Molecule
kinase	E-Biological_Molecule
(	O
NIK	S-Biological_Molecule
)	O
are	O
both	O
involved	O
in	O
subsequent	O
steps	O
of	O
NF	O
-	O
kappaB	O
activation	O
.	O

Conversely	O
,	O
a	O
dominant	O
negative	O
version	O
of	O
TRAF6	S-Biological_Molecule
failed	O
to	O
block	O
hToll	O
-	O
induced	O
activation	O
of	O
stress	O
-	O
activated	O
protein	O
kinase	O
/	O
c	O
-	O
Jun	O
NH2	O
-	O
terminal	O
kinases	O
,	O
thus	O
suggesting	O
an	O
early	O
divergence	O
of	O
the	O
two	O
pathways	O
.	O

These	O
results	O
lead	O
to	O
a	O
general	O
model	O
for	O
the	O
synergistic	O
function	O
of	O
activation	O
domains	O
in	O
Oct	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
OCA	B-Biological_Molecule
-	I-Biological_Molecule
B	E-Biological_Molecule
(	O
mediated	O
by	O
the	O
combined	O
action	O
of	O
the	O
multiple	O
USA	O
components	O
)	O
and	O
,	O
further	O
,	O
suggest	O
a	O
functional	O
redundancy	O
in	O
general	O
coactivators	O
.	O

Ligand	O
binding	O
to	O
the	O
ligand	O
binding	O
domain	O
of	O
these	O
receptors	O
induces	O
conformational	O
changes	O
that	O
are	O
evidenced	O
by	O
an	O
increased	O
resistance	O
of	O
this	O
domain	O
to	O
proteases	O
.	O

Using	O
the	O
wild	O
-	O
type	O
or	O
mutated	O
human	O
retinoic	B-Biological_Molecule
acid	I-Biological_Molecule
receptor	I-Biological_Molecule
alpha	E-Biological_Molecule
as	O
a	O
model	O
,	O
kDa	O
values	O
determined	O
by	O
classical	O
competition	O
binding	O
assays	O
using	O
tritiated	O
ligands	O
are	O
in	O
agreement	O
with	O
those	O
measured	O
by	O
the	O
proteolytic	O
assay	O
.	O

A	O
small	O
population	O
of	O
UT	O
-	O
7	O
/	O
GM	O
cells	O
positively	O
stained	O
for	O
hemoglobin	O
(	O
Hb	O
)	O
after	O
a	O
7	O
-	O
day	O
exposure	O
to	O
TPO	S-Biological_Molecule
.	O

Redox	O
signals	O
and	O
NF	O
-	O
kappaB	O
activation	O
in	O
T	O
cells	O
.	O

Fibrinogen	O
activates	O
NF	O
-	O
kappa	O
B	O
transcription	O
factors	O
in	O
mononuclear	O
phagocytes	O
.	O

Fibrinogen	O
also	O
caused	O
activation	O
of	O
AP	O
-	O
1	O
,	O
but	O
not	O
SP1	S-Biological_Molecule
or	O
cAMP	O
response	O
element	O
-	O
binding	O
protein	O
(	O
CREB	O
)	O
factors	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrate	O
that	O
MyD88	S-Biological_Molecule
is	O
a	O
critical	O
component	O
in	O
the	O
signaling	O
cascade	O
that	O
is	O
mediated	O
by	O
IL	O
-	O
1	O
receptor	O
as	O
well	O
as	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
18	E-Biological_Molecule
receptor	O
.	O

One	O
site	O
is	O
similar	O
to	O
activated	O
TNFRII	S-Biological_Molecule
in	O
associating	O
with	O
TNFR	O
-	O
associated	O
factors	O
TRAF1	S-Biological_Molecule
and	O
TRAF2	S-Biological_Molecule
,	O
and	O
the	O
second	O
site	O
is	O
similar	O
to	O
TNFRI	S-Biological_Molecule
in	O
associating	O
with	O
the	O
TNFRI	S-Biological_Molecule
death	O
domain	O
interacting	O
protein	O
TRADD	S-Biological_Molecule
.	O

IkappaB	B-Biological_Molecule
alpha	E-Biological_Molecule
phosphorylation	O
on	O
Ser	O
-	O
32	O
and	O
Ser	O
-	O
36	O
is	O
followed	O
by	O
its	O
degradation	O
and	O
NF	O
-	O
kappaB	O
activation	O
.	O

This	O
inhibition	O
is	O
not	O
accompanied	O
by	O
a	O
loss	O
in	O
viability	O
,	O
and	O
DMDTC	O
-	O
treated	O
T	O
cells	O
retain	O
other	O
active	O
signaling	O
pathways	O
throughout	O
the	O
exposure	O
duration	O
.	O

Furthermore	O
,	O
endogenous	O
IKK	O
enzymatic	O
activity	O
was	O
significantly	O
elevated	O
in	O
HTLV	O
-	O
1	O
-	O
infected	O
and	O
Tax	S-Biological_Molecule
-	O
expressing	O
T	O
-	O
cell	O
lines	O
.	O

This	O
pathway	O
resulted	O
in	O
the	O
induction	O
of	O
the	O
transcription	O
factors	O
NF	O
-	O
kappa	O
B	O
,	O
NF	O
-	O
AT	O
,	O
and	O
proteins	O
binding	O
to	O
the	O
CD28	S-Biological_Molecule
response	O
element	O
of	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
promoter	O
.	O

Both	O
iNO	O
production	O
and	O
endothelial	O
VCAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
expression	O
were	O
induced	O
simultaneously	O
with	O
bacterial	O
LPS	O
and	O
murine	O
-	O
specific	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
.	O

Inhibition	O
of	O
iNO	B-Biological_Molecule
synthase	E-Biological_Molecule
(	O
iNOS	S-Biological_Molecule
)	O
activity	O
with	O
N	O
omega	O
-	O
monomethyl	O
-	O
L	O
-	O
arginine	O
in	O
endothelial	O
-	O
RAW264	O
.	O
7	O
cocultures	O
,	O
stimulated	O
with	O
murine	O
-	O
specific	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
and	O
LPS	O
,	O
decreased	O
iNO	O
production	O
by	O
86	O
%	O
,	O
augmented	O
VCAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
iNOS	S-Biological_Molecule
expression	O
in	O
endothelial	O
and	O
RAW264	O
.	O
7	O
cells	O
,	O
respectively	O
,	O
and	O
increased	O
monocyte	O
adhesion	O
to	O
the	O
endothelial	O
cell	O
surface	O
.	O

S9a	O
at	O
10	O
to	O
100	O
nM	O
inhibited	O
HIV	O
production	O
as	O
potently	O
as	O
3	O
'	O
-	O
azido	O
-	O
3	O
'	O
-	O
deoxythymidine	O
(	O
AZT	O
)	O
,	O
an	O
inhibitor	O
of	O
viral	O
reverse	O
transcriptase	O
.	O

Retinoic	O
acid	O
inhibits	O
CD40	S-Biological_Molecule
+	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
-	O
mediated	O
IgE	O
production	O
in	O
vitro	O
.	O

Taken	O
together	O
,	O
this	O
study	O
shows	O
that	O
RA	O
inhibits	O
IgE	O
production	O
of	O
anti	O
-	O
CD40	S-Biological_Molecule
+	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
-	O
stimulated	O
B	O
cells	O
in	O
vitro	O
.	O

An	O
increase	O
in	O
the	O
ratio	O
of	O
memory	O
to	O
naive	O
T	O
cells	O
has	O
been	O
postulated	O
to	O
underlie	O
immune	O
hyporesponsiveness	O
accompanying	O
aging	O
.	O

Although	O
treatment	O
with	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
induced	O
nuclear	O
localization	O
of	O
NFkappaB	O
in	O
both	O
memory	O
and	O
naive	O
T	O
cell	O
subsets	O
,	O
irrespective	O
of	O
the	O
age	O
of	O
the	O
donor	O
,	O
the	O
levels	O
of	O
induced	O
NFkappaB	O
were	O
significantly	O
lower	O
in	O
both	O
subsets	O
of	O
T	O
cells	O
obtained	O
from	O
the	O
elderly	O
,	O
when	O
compared	O
to	O
those	O
in	O
young	O
.	O

In	O
addition	O
,	O
mild	O
detergent	O
treatment	O
of	O
cell	O
extracts	O
indicated	O
that	O
a	O
substantial	O
amount	O
of	O
cytoplasmic	O
NF	O
-	O
kappaB	O
is	O
complexed	O
with	O
IkappaB	B-Biological_Molecule
alpha	E-Biological_Molecule
or	O
some	O
other	O
inhibitory	O
factor	O
.	O

We	O
examined	O
signaling	O
molecules	O
of	O
peripheral	O
blood	O
T	O
lymphocytes	O
obtained	O
from	O
women	O
with	O
breast	O
cancer	O
.	O

Transcription	O
of	O
a	O
minimal	O
promoter	O
from	O
the	O
NF	B-Biological_Molecule
-	I-Biological_Molecule
IL6	E-Biological_Molecule
gene	O
is	O
regulated	O
by	O
CREB	O
/	O
ATF	O
and	O
SP1	S-Biological_Molecule
proteins	O
in	O
U937	O
promonocytic	O
cells	O
.	O

Our	O
data	O
suggest	O
that	O
CD30	S-Biological_Molecule
critically	O
regulates	O
the	O
CD40	S-Biological_Molecule
-	O
mediated	O
differentiation	O
of	O
non	O
-	O
antigen	O
-	O
selected	O
human	O
B	O
cells	O
.	O

BMT	O
inhibited	O
the	O
replication	O
of	O
HIV	O
-	O
1	O
in	O
both	O
laboratory	O
and	O
primary	O
isolates	O
in	O
vitro	O
.	O

After	O
PDBu	O
+	O
iono	O
stimulation	O
,	O
the	O
cells	O
showed	O
similar	O
ROI	O
formation	O
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
secretion	O
.	O

Because	O
point	O
mutagenesis	O
cannot	O
distinguish	O
between	O
family	O
members	O
,	O
it	O
is	O
not	O
known	O
which	O
protein	O
activates	O
5	O
'	O
HS3	O
.	O

In	O
addition	O
,	O
the	O
procedure	O
described	O
herein	O
could	O
prove	O
useful	O
in	O
other	O
cell	O
types	O
that	O
express	O
high	O
levels	O
of	O
endogenous	O
proteases	O
.	O

Transcription	O
factor	O
activation	O
in	O
lymphokine	O
activated	O
killer	O
cells	O
and	O
lymphocytes	O
from	O
patients	O
receiving	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
immunotherapy	O
.	O

Here	O
we	O
report	O
an	O
analysis	O
of	O
the	O
transcription	O
factor	O
families	O
AP	O
-	O
1	O
,	O
Sp1	S-Biological_Molecule
,	O
NF	O
-	O
kappaB	O
,	O
and	O
signal	O
transducers	O
and	O
activators	O
of	O
transcription	O
(	O
STAT	O
)	O
in	O
cancer	O
patients	O
'	O
lymphocytes	O
before	O
and	O
after	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
immunotherapy	O
,	O
as	O
assessed	O
by	O
a	O
gel	O
-	O
shift	O
assay	O
.	O

Its	O
50	O
%	O
effective	O
and	O
cytotoxic	O
concentrations	O
were	O
0	O
.	O
016	O
and	O
2	O
.	O
2	O
microg	O
/	O
ml	O
in	O
PMA	O
-	O
stimulated	O
U1	O
cells	O
,	O
respectively	O
.	O

Cepharanthine	O
was	O
found	O
to	O
suppress	O
HIV	O
-	O
1	O
LTR	O
-	O
driven	O
gene	O
expression	O
through	O
the	O
inhibition	O
of	O
NF	O
-	O
kappaB	O
activation	O
.	O

Replication	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
-	O
1	O
(	O
HIV	O
-	O
1	O
)	O
is	O
highly	O
dependent	O
on	O
the	O
state	O
of	O
activation	O
of	O
the	O
infected	O
cells	O
and	O
is	O
modulated	O
by	O
interactions	O
between	O
viral	O
and	O
host	O
cellular	O
factors	O
.	O

Further	O
studies	O
were	O
carried	O
out	O
using	O
differential	O
RNA	O
display	O
(	O
DD	O
)	O
.	O

Downstream	O
activation	O
of	O
a	O
TATA	O
-	O
less	O
promoter	O
by	O
Oct	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
,	O
Bob1	S-Biological_Molecule
,	O
and	O
NF	O
-	O
kappaB	O
directs	O
expression	O
of	O
the	O
homing	O
receptor	O
BLR1	S-Biological_Molecule
to	O
mature	O
B	O
cells	O
.	O

The	O
oxidant	O
stress	O
-	O
induced	O
signaling	O
resulted	O
in	O
an	O
increased	O
surface	O
expression	O
of	O
a	O
subset	O
of	O
CAMs	O
,	O
ICAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
E	B-Biological_Molecule
-	I-Biological_Molecule
selectin	E-Biological_Molecule
,	O
and	O
VCAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
in	O
HUVEC	O
.	O

TS	O
induces	O
the	O
synthesis	O
of	O
heat	O
shock	O
(	O
HS	O
)	O
/	O
stress	O
proteins	O
(	O
HSP	O
)	O
,	O
and	O
,	O
in	O
particular	O
,	O
of	O
Hsp70	O
.	O

While	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
does	O
not	O
activate	O
STAT5	S-Biological_Molecule
,	O
it	O
induces	O
expression	O
of	O
STAT5	S-Biological_Molecule
-	O
regulated	O
genes	O
in	O
CTLL	O
-	O
2	O
,	O
i	O
.	O
e	O
.	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
casein	E-Biological_Molecule
,	O
a	O
cytokine	B-Biological_Molecule
-	I-Biological_Molecule
inducible	I-Biological_Molecule
SH2	I-Biological_Molecule
-	I-Biological_Molecule
containing	I-Biological_Molecule
protein	E-Biological_Molecule
(	O
CIS	S-Biological_Molecule
)	O
,	O
and	O
oncostatin	B-Biological_Molecule
M	E-Biological_Molecule
(	O
OSM	S-Biological_Molecule
)	O
,	O
suggesting	O
that	O
STAT6	S-Biological_Molecule
activated	O
by	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
substitutes	O
for	O
the	O
function	O
of	O
STAT5	S-Biological_Molecule
in	O
T	O
cells	O
.	O

This	O
observation	O
is	O
likely	O
to	O
relate	O
to	O
the	O
findings	O
that	O
TAL1	S-Biological_Molecule
and	O
LMO	O
are	O
highly	O
synergistic	O
in	O
T	O
-	O
cell	O
tumorigenesis	O
in	O
double	O
-	O
transgenic	O
mice	O
.	O

Promoter	O
analysis	O
revealed	O
that	O
a	O
GATA	O
site	O
in	O
a	O
cryptic	O
promoter	O
in	O
the	O
second	O
intron	O
was	O
essential	O
and	O
sufficient	O
for	O
the	O
TAL1	S-Biological_Molecule
-	O
and	O
LMO	O
-	O
dependent	O
transcriptional	O
activation	O
,	O
and	O
GATA3	S-Biological_Molecule
binds	O
to	O
this	O
site	O
.	O

Because	O
this	O
region	O
of	O
Stat3alpha	S-Biological_Molecule
is	O
involved	O
in	O
transcriptional	O
activation	O
,	O
our	O
findings	O
suggest	O
the	O
possibility	O
that	O
Stat3gamma	S-Biological_Molecule
may	O
be	O
transcriptionally	O
inactive	O
and	O
may	O
compete	O
with	O
Stat3alpha	S-Biological_Molecule
for	O
Stat3	S-Biological_Molecule
binding	O
sites	O
in	O
these	O
terminally	O
differentiated	O
myeloid	O
cells	O
.	O

We	O
performed	O
an	O
analysis	O
of	O
the	O
mechanisms	O
by	O
which	O
two	O
PKC	O
inhibitors	O
,	O
Calphostin	O
C	O
and	O
Staurosporine	O
,	O
prevent	O
the	O
FN	S-Biological_Molecule
-	O
induced	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
response	O
.	O

We	O
have	O
found	O
that	O
these	O
different	O
sets	O
of	O
signals	O
target	O
a	O
common	O
cis	O
-	O
acting	O
element	O
in	O
the	O
promoter	O
of	O
this	O
gene	O
,	O
the	O
IRF	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
gamma	O
-	O
activated	O
site	O
(	O
GAS	O
)	O
.	O

METHODS	O
:	O
E	O
.	O
histolytica	O
infection	O
was	O
established	O
in	O
human	O
intestinal	O
xenografts	O
in	O
severe	O
combined	O
immunodeficient	O
(	O
SCID	O
-	O
HU	O
-	O
INT	O
)	O
mice	O
.	O

Inhibition	O
of	O
the	O
gut	O
inflammatory	O
response	O
by	O
the	O
antisense	O
oligonucleotide	O
or	O
the	O
depletion	O
of	O
neutrophils	O
from	O
SCID	O
-	O
HU	O
-	O
INT	O
mice	O
blocked	O
the	O
increase	O
in	O
intestinal	O
permeability	O
observed	O
with	O
amebic	O
infection	O
.	O

Cellular	O
pathways	O
for	O
induction	O
of	O
programmed	O
cell	O
death	O
(	O
PCD	O
)	O
have	O
been	O
identified	O
,	O
but	O
little	O
is	O
known	O
about	O
specific	O
extracellular	O
matrix	O
processes	O
that	O
may	O
affect	O
apoptosis	O
along	O
those	O
pathways	O
.	O

The	O
p50	S-Biological_Molecule
and	O
p65	S-Biological_Molecule
proteins	O
,	O
constituents	O
of	O
the	O
prototypic	O
nuclear	O
factor	O
kappaB	O
,	O
were	O
identified	O
as	O
components	O
of	O
the	O
DNA	O
-	O
protein	O
complexes	O
by	O
anti	O
-	O
peptide	O
antibodies	O
in	O
gel	O
supershift	O
assays	O
.	O

Neither	O
of	O
the	O
two	O
toxins	O
affected	O
kappaB	O
binding	O
activity	O
induced	O
by	O
TNFalpha	S-Biological_Molecule
in	O
the	O
same	O
cells	O
.	O

These	O
results	O
imply	O
a	O
potential	O
role	O
of	O
the	O
anaphylatoxins	O
C5a	S-Biological_Molecule
and	O
C3a	S-Biological_Molecule
in	O
regulating	O
leukocytes	O
gene	O
expression	O
through	O
G	O
protein	O
-	O
coupled	O
transcription	O
factor	O
activation	O
.	O

Experiments	O
in	O
COS	O
-	O
1	O
and	O
EL	O
-	O
4	O
cells	O
confirmed	O
both	O
hypotheses	O
and	O
revealed	O
that	O
the	O
second	O
factor	O
activated	O
by	O
Tpl	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
is	O
NF	O
-	O
kappaB	O
.	O

Synergistic	O
proinflammatory	O
effects	O
of	O
mechanical	O
stress	O
and	O
molecules	O
such	O
as	O
bacterial	O
endotoxin	O
were	O
observed	O
,	O
suggesting	O
that	O
mechanical	O
ventilation	O
might	O
be	O
particularly	O
deleterious	O
in	O
preinjured	O
or	O
infected	O
lungs	O
.	O

We	O
report	O
here	O
that	O
Stat6	S-Biological_Molecule
interacts	O
with	O
three	O
binding	O
sites	O
in	O
the	O
human	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
promoter	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O

B	O
cells	O
and	O
epithelial	O
cells	O
have	O
a	O
pivotal	O
role	O
in	O
the	O
life	O
cycle	O
of	O
the	O
virus	O
.	O

Molecular	O
cloning	O
of	O
FKHRL1P2	S-Biological_Molecule
,	O
a	O
member	O
of	O
the	O
developmentally	O
regulated	O
fork	O
head	O
domain	O
transcription	O
factor	O
family	O
.	O

Activation	O
of	O
the	O
human	O
delta	B-Biological_Molecule
-	I-Biological_Molecule
globin	E-Biological_Molecule
gene	O
promoter	O
in	O
primary	O
adult	O
erythroid	O
cells	O
.	O

The	O
master	O
switch	O
for	O
the	O
expression	O
of	O
these	O
genes	O
is	O
the	O
class	B-Biological_Molecule
II	I-Biological_Molecule
transactivator	E-Biological_Molecule
(	O
CIITA	S-Biological_Molecule
)	O
.	O

Finally	O
,	O
the	O
inhibition	O
of	O
class	O
II	O
gene	O
expression	O
by	O
the	O
glucocorticoid	O
hormone	O
could	O
be	O
attributed	O
to	O
the	O
squelching	O
of	O
CBP	S-Biological_Molecule
by	O
the	O
glucocorticoid	B-Biological_Molecule
receptor	E-Biological_Molecule
.	O

IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
promoter	O
activation	O
in	O
Jurkat	O
T	O
cells	O
stimulated	O
with	O
superantigen	O
presented	O
by	O
Raji	O
B	O
cells	O
requires	O
CD28	S-Biological_Molecule
activation	O
.	O

These	O
observations	O
can	O
be	O
linked	O
with	O
the	O
inhibition	O
of	O
NF	O
-	O
kappa	O
B	O
activation	O
when	O
uninfected	O
monocytes	O
are	O
induced	O
by	O
either	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
alpha	E-Biological_Molecule
(	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
)	O
phorbol	O
12	O
-	O
myristate	O
13	O
-	O
acetate	O
(	O
PMA	O
)	O
or	O
lipopolysaccharide	O
(	O
LPS	O
)	O
.	O

Interleukin	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
stabilizes	O
inhibitory	B-Biological_Molecule
kappaB	I-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
in	O
human	O
monocytes	O
.	O

The	O
primary	O
reservoir	O
of	O
infection	O
consists	O
of	O
latently	O
infected	O
B	O
lymphocytes	O
and	O
possibly	O
other	O
mononuclear	O
cells	O
.	O

In	O
this	O
study	O
we	O
investigated	O
the	O
effects	O
of	O
C3a	S-Biological_Molecule
and	O
C3a	B-Biological_Molecule
(	I-Biological_Molecule
desArg	I-Biological_Molecule
)	E-Biological_Molecule
on	O
gene	O
expression	O
and	O
protein	O
secretion	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
in	O
human	O
PBMCs	O
,	O
either	O
alone	O
or	O
in	O
combination	O
with	O
LPS	O
or	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
.	O

Furthermore	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
C3a	S-Biological_Molecule
and	O
C3a	B-Biological_Molecule
(	I-Biological_Molecule
desArg	I-Biological_Molecule
)	E-Biological_Molecule
on	O
induction	O
of	O
NF	O
-	O
kappaB	O
and	O
activating	O
protein	O
-	O
1	O
binding	O
.	O

TNF	O
stimulated	O
expression	O
of	O
both	O
intercellular	B-Biological_Molecule
adhesion	I-Biological_Molecule
molecule	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
E	B-Biological_Molecule
-	I-Biological_Molecule
selectin	E-Biological_Molecule
in	O
HUVECs	O
,	O
but	O
in	O
HUAECs	O
,	O
only	O
intercellular	B-Biological_Molecule
adhesion	I-Biological_Molecule
molecule	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
was	O
increased	O
.	O

Interfering	O
with	O
either	O
NF	O
-	O
kappaB	O
activation	O
(	O
proteasome	O
inhibitor	O
)	O
or	O
translocation	O
(	O
double	O
-	O
stranded	O
oligonucleotides	O
containing	O
NF	O
-	O
kappaB	O
binding	O
sequence	O
)	O
prevents	O
the	O
development	O
of	O
A	O
/	O
R	O
tolerance	O
(	O
ie	O
,	O
the	O
increase	O
in	O
A	O
/	O
R	O
-	O
induced	O
PMN	O
adhesion	O
to	O
HUVECs	O
is	O
the	O
same	O
after	O
the	O
first	O
and	O
second	O
A	O
/	O
R	O
challenges	O
)	O
.	O

Extracellular	O
generation	O
of	O
NO	O
(	O
NO	O
donor	O
)	O
did	O
not	O
effect	O
the	O
hyperadhesion	O
response	O
induced	O
by	O
the	O
initial	O
A	O
/	O
R	O
challenge	O
.	O

Inhibition	O
of	O
NOS	S-Biological_Molecule
during	O
the	O
second	O
A	O
/	O
R	O
insult	O
results	O
in	O
the	O
generation	O
of	O
an	O
oxidant	O
stress	O
similar	O
to	O
that	O
observed	O
after	O
the	O
first	O
A	O
/	O
R	O
challenge	O
.	O

The	O
aberrant	O
CD4	S-Biological_Molecule
(	O
-	O
)	O
CD8	O
(	O
-	O
)	O
T	O
cells	O
from	O
lpr	O
/	O
lpr	O
and	O
gld	O
/	O
gld	O
mice	O
,	O
which	O
have	O
mutations	O
in	O
the	O
genes	O
encoding	O
Fas	S-Biological_Molecule
and	O
FasL	S-Biological_Molecule
,	O
respectively	O
,	O
have	O
an	O
activated	O
phenotype	O
and	O
constitutively	O
express	O
high	O
levels	O
of	O
fasL	S-Biological_Molecule
mRNA	O
,	O
prompting	O
us	O
to	O
ask	O
what	O
role	O
if	O
any	O
the	O
FLRE	O
and	O
Egr	O
family	O
proteins	O
have	O
in	O
this	O
aberrant	O
expression	O
of	O
fasL	S-Biological_Molecule
.	O

T	O
cell	O
priming	O
enhances	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
gene	O
expression	O
by	O
increasing	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
.	O

Inhibition	O
of	O
NF	O
-	O
kappa	O
B	O
activation	O
in	O
vitro	O
and	O
in	O
vivo	O
:	O
role	O
of	O
26S	O
proteasome	O
.	O

This	O
induction	O
of	O
apoptosis	O
was	O
abolished	O
by	O
the	O
caspase	O
inhibitor	O
zVAD	O
-	O
fmk	O
,	O
correlated	O
with	O
the	O
inhibition	O
of	O
nuclear	O
factor	O
-	O
kappa	O
B	O
(	O
NF	O
-	O
kappaB	O
)	O
,	O
and	O
was	O
mimicked	O
by	O
a	O
cell	O
permeable	O
inhibitory	O
peptide	O
of	O
NF	O
-	O
kappaB	O
,	O
SN	O
-	O
50	O
;	O
other	O
NF	O
-	O
kappaB	O
inhibitors	O
,	O
curcumin	O
and	O
pyrrolidine	O
dithiocarbamate	O
;	O
and	O
the	O
proteasome	O
inhibitor	O
,	O
MG	O
-	O
132	O
.	O

Gliotoxin	O
also	O
augmented	O
dramatically	O
the	O
early	O
(	O
2	O
-	O
6	O
h	O
)	O
pro	O
-	O
apoptotic	O
effects	O
of	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
(	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
)	O
in	O
neutrophils	O
and	O
unmasked	O
the	O
ability	O
of	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
to	O
induce	O
eosinophil	O
apoptosis	O
.	O

We	O
provide	O
evidence	O
that	O
several	O
NF	O
-	O
kappaB	O
complexes	O
are	O
constitutively	O
found	O
in	O
the	O
nuclei	O
of	O
thymocytes	O
either	O
freshly	O
isolated	O
from	O
the	O
thymus	O
or	O
maintained	O
in	O
coculture	O
with	O
autologous	O
or	O
heterologous	O
TEC	O
.	O

CD44	S-Biological_Molecule
is	O
a	O
ubiquitous	O
molecule	O
also	O
known	O
as	O
hyaluronic	O
acid	O
or	O
homing	O
receptor	O
.	O

At	O
10	O
to	O
100	O
micromol	O
/	O
L	O
for	O
>	O
24	O
hours	O
,	O
oleate	O
inhibited	O
the	O
expression	O
of	O
all	O
adhesion	O
molecules	O
tested	O
.	O

Incubation	O
of	O
endothelial	O
cells	O
with	O
oleate	O
for	O
72	O
hours	O
decreased	O
the	O
relative	O
proportions	O
of	O
saturated	O
(	O
palmitic	O
and	O
stearic	O
)	O
acids	O
in	O
total	O
cell	O
lipids	O
and	O
increased	O
the	O
proportions	O
of	O
oleate	O
in	O
total	O
cell	O
lipids	O
without	O
significantly	O
changing	O
the	O
relative	O
proportions	O
of	O
polyunsaturated	O
fatty	O
acids	O
.	O

Our	O
previous	O
results	O
show	O
that	O
recombinant	O
gp41	S-Biological_Molecule
(	O
aa565	O
-	O
647	O
)	O
,	O
the	O
extracellular	O
domain	O
of	O
HIV	O
-	O
1	O
transmembrane	O
glycoprotein	O
,	O
stimulates	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
(	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
)	O
production	O
in	O
human	O
monocytes	O
.	O

Apoptosis	O
induced	O
through	O
the	O
TCR	O
in	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
is	O
mostly	O
mediated	O
by	O
the	O
inducible	O
expression	O
of	O
Fas	B-Biological_Molecule
ligand	E-Biological_Molecule
(	O
FasL	S-Biological_Molecule
)	O
as	O
a	O
primary	O
event	O
leading	O
to	O
the	O
commitment	O
to	O
death	O
.	O

In	O
addition	O
,	O
blocking	O
TNF	O
,	O
itself	O
a	O
positive	O
regulator	O
of	O
NF	O
-	O
kappaB	O
,	O
with	O
neutralizing	O
antibodies	O
renders	O
the	O
cells	O
more	O
susceptible	O
to	O
anti	O
-	O
Fas	S-Biological_Molecule
-	O
mediated	O
apoptosis	O
.	O

The	O
CD34	S-Biological_Molecule
+	O
myelomonocytic	O
cell	O
line	O
KG1	O
differentiates	O
into	O
dendritic	O
-	O
like	O
cells	O
in	O
response	O
to	O
granulocyte	B-Biological_Molecule
-	I-Biological_Molecule
macrophage	I-Biological_Molecule
CSF	E-Biological_Molecule
plus	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
,	O
or	O
PMA	O
(	O
with	O
or	O
without	O
the	O
calcium	O
ionophore	O
ionomycin	O
,	O
or	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
)	O
,	O
with	O
different	O
stimuli	O
mediating	O
different	O
aspects	O
of	O
the	O
process	O
.	O

IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
-	O
mediated	O
cell	O
cycle	O
progression	O
and	O
inhibition	O
of	O
apoptosis	O
does	O
not	O
require	O
NF	O
-	O
kappa	O
B	O
or	O
activating	O
protein	O
-	O
1	O
activation	O
in	O
primary	O
human	O
T	O
cells	O
.	O

To	O
determine	O
whether	O
either	O
or	O
both	O
of	O
these	O
transcription	O
factors	O
are	O
involved	O
in	O
cell	O
survival	O
or	O
cell	O
cycle	O
progression	O
in	O
response	O
to	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
,	O
primary	O
human	O
T	O
cells	O
responsive	O
to	O
the	O
growth	O
factor	O
were	O
analyzed	O
for	O
NF	O
-	O
kappa	O
B	O
and	O
AP	O
-	O
1	O
activation	O
.	O

Dephosphorylation	O
of	O
4E	B-Biological_Molecule
-	I-Biological_Molecule
BP1	E-Biological_Molecule
was	O
also	O
observed	O
when	O
U	O
-	O
937	O
cells	O
were	O
induced	O
to	O
differentiate	O
into	O
monocytes	O
/	O
macrophages	O
following	O
treatment	O
with	O
retinoic	O
acid	O
or	O
DMSO	O
.	O

Taken	O
together	O
,	O
these	O
data	O
provide	O
evidence	O
for	O
differential	O
regulation	O
of	O
the	O
translational	O
machinery	O
during	O
human	O
myeloid	O
differentiation	O
,	O
specific	O
to	O
the	O
monocytic	O
/	O
macrophage	O
pathway	O
or	O
to	O
the	O
granulocytic	O
pathway	O
.	O

CD40	S-Biological_Molecule
expression	O
could	O
be	O
enhanced	O
in	O
CD40	S-Biological_Molecule
-	O
positive	O
MM	O
by	O
stimulation	O
with	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
and	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
but	O
not	O
by	O
interleukin	B-Biological_Molecule
(	I-Biological_Molecule
IL	I-Biological_Molecule
)	I-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
or	O
CD40	S-Biological_Molecule
triggering	O
.	O

Furthermore	O
,	O
CD40	S-Biological_Molecule
ligation	O
of	O
a	O
HLA	B-Biological_Molecule
-	I-Biological_Molecule
A2	E-Biological_Molecule
+	O
,	O
MelanA	S-Biological_Molecule
/	O
MART1	S-Biological_Molecule
+	O
MM	O
cell	O
line	O
enhanced	O
its	O
susceptibility	O
to	O
specific	O
lysis	O
by	O
a	O
HLA	B-Biological_Molecule
-	I-Biological_Molecule
A2	E-Biological_Molecule
-	O
restricted	O
,	O
MelanA	S-Biological_Molecule
/	O
MART	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
-	O
specific	O
CTL	O
clone	O
.	O

In	O
parallel	O
,	O
upregulation	O
of	O
the	O
lung	O
vascular	O
adhesion	O
molecule	O
,	O
intercellular	B-Biological_Molecule
adhesion	I-Biological_Molecule
molecule	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
was	O
greatly	O
reduced	O
by	O
intrapulmonary	O
instillation	O
of	O
phosphonate	O
-	O
containing	O
liposomes	O
.	O

It	O
is	O
known	O
that	O
sulfated	O
polysaccharides	O
can	O
mimic	O
the	O
action	O
of	O
common	O
T	O
-	O
cell	O
mitogens	O
.	O

DNA	O
fragmentation	O
was	O
efficiently	O
blocked	O
by	O
the	O
caspase	O
inhibitor	O
Z	O
-	O
VAD	O
-	O
fmk	O
and	O
partially	O
blocked	O
by	O
Ac	O
-	O
DEVD	O
-	O
fmk	O
,	O
suggesting	O
that	O
SN50	O
-	O
mediated	O
apoptosis	O
is	O
caspase	O
-	O
dependent	O
.	O

Concomitant	O
with	O
receptor	O
oligomerization	O
,	O
the	O
IL	O
-	O
1R	O
-	O
associated	O
kinase	O
(	O
IRAK	O
)	O
is	O
recruited	O
to	O
the	O
TLR2	S-Biological_Molecule
complex	O
.	O

Moreover	O
,	O
both	O
deletion	O
mutants	O
could	O
still	O
form	O
complexes	O
with	O
wild	O
-	O
type	O
TLR2	S-Biological_Molecule
and	O
act	O
in	O
a	O
dominant	O
-	O
negative	O
(	O
DN	O
)	O
fashion	O
to	O
block	O
TLR2	S-Biological_Molecule
-	O
mediated	O
signal	O
transduction	O
.	O

These	O
results	O
suggest	O
that	O
the	O
activation	O
signals	O
in	O
human	O
B	O
cells	O
and	O
monocytes	O
differ	O
following	O
CD40	S-Biological_Molecule
stimulation	O
.	O

Suppression	O
of	O
NF	O
-	O
kappaB	O
activation	O
in	O
normal	O
T	O
cells	O
by	O
supernatant	O
fluid	O
from	O
human	O
renal	O
cell	O
carcinomas	O
.	O

Activity	O
against	O
macrovascular	O
EC	O
(	O
HUVEC	O
)	O
and	O
microvascular	O
EC	O
(	O
human	O
bone	O
marrow	O
EC	O
immortalized	O
by	O
SV40	O
)	O
antigens	O
was	O
detected	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

The	O
binding	O
of	O
the	O
mAECA	O
to	O
human	O
aortic	O
EC	O
was	O
studied	O
by	O
immunohistochemistry	O
.	O

The	O
secretion	O
levels	O
of	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
(	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
)	O
and	O
von	B-Biological_Molecule
Willebrand	I-Biological_Molecule
factor	E-Biological_Molecule
(	O
vWF	S-Biological_Molecule
)	O
were	O
determined	O
,	O
to	O
serve	O
as	O
markers	O
for	O
EC	O
activation	O
.	O

All	O
mAECA	O
possessed	O
high	O
activity	O
against	O
macrovascular	O
EC	O
,	O
but	O
none	O
had	O
significant	O
antimicrovascular	O
EC	O
activity	O
.	O

LMP1	S-Biological_Molecule
needs	O
only	O
11	O
amino	O
acids	O
to	O
activate	O
NF	O
-	O
kappaB	O
or	O
synergize	O
with	O
TRADD	S-Biological_Molecule
in	O
NF	O
-	O
kappaB	O
activation	O
,	O
while	O
TNFR1	S-Biological_Molecule
requires	O
approximately	O
70	O
residues	O
.	O

A	O
reporter	O
construct	O
containing	O
the	O
5	O
'	O
-	O
flanking	O
region	O
of	O
the	O
mouse	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
gene	O
displayed	O
weak	O
activity	O
when	O
transfected	O
into	O
RAW264	O
.	O
7	O
macrophage	O
-	O
like	O
cells	O
.	O

Mutations	O
of	O
this	O
site	O
that	O
destroyed	O
potential	O
ets	O
transcription	O
factor	O
binding	O
sites	O
had	O
reduced	O
transcriptional	O
activity	O
.	O

Possible	O
differences	O
in	O
the	O
mechanism	O
(	O
s	O
)	O
of	O
action	O
of	O
different	O
glucocorticoid	O
hormone	O
compounds	O
.	O

In	O
this	O
paper	O
we	O
shall	O
advance	O
the	O
hypothesis	O
that	O
:	O
(	O
i	O
)	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
indirectly	O
controls	O
immune	O
surveillance	O
;	O
and	O
(	O
ii	O
)	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
controls	O
DNA	O
repair	O
and	O
tumor	O
suppression	O
through	O
the	O
regulation	O
of	O
wild	O
type	O
p53	S-Biological_Molecule
.	O

Their	O
constitutive	O
expression	O
is	O
limited	O
to	O
B	O
lymphocytes	O
and	O
thymic	O
epithelial	O
cells	O
.	O

Thus	O
,	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Fos	E-Biological_Molecule
/	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Jun	E-Biological_Molecule
heterodimers	O
might	O
contribute	O
to	O
the	O
repression	O
of	O
DRA	S-Biological_Molecule
gene	O
expression	O
.	O

M	O
-	O
CSF	O
treatment	O
was	O
also	O
associated	O
with	O
a	O
rapid	O
induction	O
of	O
the	O
jun	B-Biological_Molecule
-	I-Biological_Molecule
B	E-Biological_Molecule
gene	O
,	O
although	O
expression	O
of	O
this	O
gene	O
was	O
prolonged	O
compared	O
to	O
that	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
jun	E-Biological_Molecule
.	O

Taken	O
together	O
,	O
the	O
results	O
indicate	O
that	O
M	O
-	O
CSF	O
treatment	O
is	O
associated	O
with	O
differential	O
activation	O
of	O
multiple	O
members	O
of	O
the	O
jun	O
/	O
fos	O
family	O
and	O
that	O
expression	O
of	O
these	O
genes	O
could	O
contribute	O
to	O
nuclear	O
signaling	O
mechanisms	O
that	O
regulate	O
a	O
specific	O
program	O
of	O
monocyte	O
differentiation	O
.	O

The	O
effects	O
of	O
human	O
immunodeficiency	O
virus	O
1	O
(	O
HIV	O
-	O
1	O
)	O
infection	O
on	O
cellular	O
differentiation	O
and	O
NF	O
-	O
kappa	O
B	O
DNA	O
binding	O
activity	O
have	O
been	O
investigated	O
in	O
a	O
new	O
model	O
of	O
myeloid	O
differentiation	O
.	O

Stimulation	O
of	O
T	O
cells	O
with	O
antigen	O
results	O
in	O
activation	O
of	O
several	O
kinases	O
,	O
including	O
protein	O
kinase	O
C	O
(	O
PKC	O
)	O
,	O
that	O
may	O
mediate	O
the	O
later	O
induction	O
of	O
activation	O
-	O
related	O
genes	O
.	O

We	O
have	O
previously	O
shown	O
that	O
prolonged	O
treatment	O
of	O
the	O
untransformed	O
T	O
cell	O
clone	O
Ar	O
-	O
5	O
with	O
phorbol	O
esters	O
results	O
in	O
downmodulation	O
of	O
the	O
alpha	O
and	O
beta	O
isozymes	O
of	O
PKC	O
,	O
and	O
abrogates	O
induction	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
mRNA	O
and	O
protein	O
.	O

Dimerization	O
among	O
transcription	O
factors	O
has	O
become	O
a	O
recurrent	O
theme	O
in	O
the	O
regulation	O
of	O
eukaryotic	O
gene	O
expression	O
.	O

The	O
purified	O
homodimer	O
(	O
two	O
p50s	S-Biological_Molecule
)	O
of	O
the	O
DNA	O
-	O
binding	O
subunit	O
of	O
NF	O
-	O
kappa	O
B	O
binds	O
the	O
B2	O
site	O
of	O
proenkephalin	S-Biological_Molecule
relatively	O
better	O
than	O
does	O
the	O
heterotetramer	O
(	O
two	O
p65s	S-Biological_Molecule
plus	O
two	O
p50s	S-Biological_Molecule
)	O
form	O
of	O
the	O
factor	O
.	O

We	O
demonstrate	O
in	O
this	O
report	O
that	O
the	O
5	O
'	O
flanking	O
DNA	O
of	O
the	O
15	B-Biological_Molecule
-	I-Biological_Molecule
lox	E-Biological_Molecule
gene	O
contains	O
sequences	O
which	O
down	O
-	O
regulate	O
its	O
activity	O
in	O
a	O
variety	O
of	O
non	O
-	O
erythroid	O
cell	O
lines	O
but	O
not	O
in	O
two	O
erythroid	O
cell	O
lines	O
.	O

The	O
element	O
has	O
characteristics	O
of	O
a	O
transcriptional	O
'	O
silencer	O
'	O
since	O
it	O
functions	O
in	O
both	O
orientations	O
.	O

This	O
requirement	O
has	O
been	O
attributed	O
to	O
the	O
activation	O
of	O
the	O
transcription	O
factor	O
NF	O
-	O
kappa	O
B	O
,	O
which	O
synergizes	O
with	O
the	O
constitutive	O
transcription	O
factor	O
Sp1	S-Biological_Molecule
to	O
drive	O
the	O
HIV	O
-	O
1	O
promoter	O
.	O

T	O
cells	O
lack	O
active	O
NF	O
-	O
kappa	O
B	O
but	O
express	O
Sp1	S-Biological_Molecule
as	O
expected	O
.	O

Protein	O
phosphorylation	O
has	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
these	O
two	O
factors	O
:	O
(	O
1	O
)	O
it	O
induces	O
the	O
transactivating	O
capacity	O
of	O
the	O
AP	O
-	O
1	O
protein	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Jun	E-Biological_Molecule
;	O
and	O
(	O
2	O
)	O
it	O
is	O
involved	O
in	O
the	O
release	O
of	O
the	O
cytoplasmic	O
inhibitor	O
,	O
I	O
kappa	O
B	O
,	O
from	O
NF	O
-	O
kappa	O
B	O
,	O
allowing	O
translocation	O
of	O
the	O
latter	O
into	O
the	O
nucleus	O
.	O

We	O
have	O
recently	O
shown	O
that	O
both	O
phosphorylation	O
processes	O
require	O
T	O
-	O
cell	O
costimulation	O
.	O

The	O
expression	O
of	O
MHC	O
class	O
II	O
genes	O
in	O
mouse	O
T	O
cells	O
can	O
be	O
reconstituted	O
upon	O
transfection	O
with	O
the	O
human	O
CIITA	S-Biological_Molecule
cDNA	O
.	O

The	O
three	O
regions	O
concerned	O
are	O
:	O
1	O
)	O
a	O
region	O
between	O
-	O
73	O
and	O
-	O
36	O
,	O
which	O
is	O
the	O
minimal	O
element	O
inducible	O
by	O
LPS	O
or	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
;	O
2	O
)	O
an	O
element	O
located	O
between	O
-	O
181	O
and	O
-	O
73	O
,	O
which	O
appeared	O
to	O
regulate	O
the	O
response	O
to	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
and	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
negatively	O
;	O
and	O
3	O
)	O
a	O
distal	O
element	O
upstream	O
of	O
-	O
224	O
,	O
which	O
was	O
inducible	O
by	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
alone	O
.	O

The	O
increase	O
in	O
LT	O
-	O
293	O
CAT	S-Biological_Molecule
activity	O
mirrored	O
the	O
increase	O
in	O
LT	O
biologic	O
activity	O
seen	O
under	O
these	O
conditions	O
.	O

Induction	O
of	O
tyrosine	O
phosphorylation	O
and	O
T	O
-	O
cell	O
activation	O
by	O
vanadate	O
peroxide	O
,	O
an	O
inhibitor	O
of	O
protein	O
tyrosine	O
phosphatases	O
.	O

Our	O
results	O
indicate	O
that	O
not	O
only	O
the	O
reported	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
NF	B-Biological_Molecule
-	I-Biological_Molecule
AT	E-Biological_Molecule
and	O
NFIL	B-Biological_Molecule
-	I-Biological_Molecule
2A	E-Biological_Molecule
sites	O
and	O
Ig	B-Biological_Molecule
kappa	I-Biological_Molecule
B	E-Biological_Molecule
site	O
,	O
but	O
also	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
AP	O
-	O
1	O
and	O
kappa	O
B	O
-	O
like	O
sites	O
are	O
terminals	O
of	O
FK506	O
-	O
sensitive	O
pathway	O
involving	O
Ca2	O
+	O
mobilization	O
.	O

Monocyte	O
tethering	O
by	O
P	B-Biological_Molecule
-	I-Biological_Molecule
selectin	E-Biological_Molecule
regulates	O
monocyte	B-Biological_Molecule
chemotactic	I-Biological_Molecule
protein	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
secretion	O
.	O

Increased	O
cytokine	O
secretion	O
was	O
specifically	O
inhibited	O
by	O
G1	O
,	O
an	O
anti	O
-	O
P	B-Biological_Molecule
-	I-Biological_Molecule
selectin	E-Biological_Molecule
mAb	O
that	O
prevents	O
P	B-Biological_Molecule
-	I-Biological_Molecule
selectin	E-Biological_Molecule
from	O
binding	O
to	O
its	O
ligand	O
(	O
P	B-Biological_Molecule
-	I-Biological_Molecule
selectin	I-Biological_Molecule
glycoprotein	I-Biological_Molecule
ligand	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
)	O
on	O
myeloid	O
cells	O
.	O

Differential	O
induction	O
of	O
the	O
NF	O
-	O
AT	O
complex	O
during	O
restimulation	O
and	O
the	O
induction	O
of	O
T	O
-	O
cell	O
anergy	O
.	O

The	O
pattern	O
of	O
binding	O
activity	O
in	O
restimulated	O
T	O
cells	O
is	O
consistent	O
with	O
the	O
pattern	O
that	O
has	O
previously	O
been	O
shown	O
to	O
regulate	O
T	O
-	O
cell	O
-	O
specific	O
expression	O
of	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
and	O
the	O
beta	O
chain	O
of	O
the	O
TcR	O
genes	O
.	O

Type	O
II	O
major	O
histocompatibility	O
complex	O
combined	O
immune	O
deficiency	O
(	O
type	O
II	O
MHC	O
CID	O
or	O
bare	O
lymphocyte	O
syndrome	O
)	O
is	O
a	O
congenital	O
immunodeficiency	O
disease	O
characterized	O
by	O
absent	O
MHC	O
class	O
II	O
expression	O
.	O

Levels	O
of	O
the	O
octamer	O
,	O
NF	O
-	O
kappa	O
B	O
(	O
p50	S-Biological_Molecule
-	O
p65	S-Biological_Molecule
heterodimer	O
)	O
,	O
and	O
AP	O
-	O
1	O
transcriptional	O
factors	O
are	O
constitutively	O
elevated	O
in	O
freshly	O
isolated	O
Ipr	O
CD4	O
-	O
8	O
-	O
T	O
cells	O
,	O
consistent	O
with	O
the	O
activated	O
phenotype	O
of	O
these	O
cells	O
.	O

MIP1	O
alpha	O
nuclear	O
protein	O
(	O
MNP	O
)	O
,	O
a	O
novel	O
transcription	O
factor	O
expressed	O
in	O
hematopoietic	O
cells	O
that	O
is	O
crucial	O
for	O
transcription	O
of	O
the	O
human	O
MIP	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
alpha	E-Biological_Molecule
gene	O
.	O

It	O
also	O
induces	O
chemotaxis	O
and	O
inflammatory	O
responses	O
in	O
mature	O
cell	O
types	O
.	O

In	O
coimmunoprecipitation	O
experiments	O
using	O
transfected	O
COS	O
cells	O
,	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
ER	S-Biological_Molecule
associate	O
in	O
a	O
ligand	O
-	O
dependent	O
manner	O
.	O

Finally	O
,	O
micromolar	O
amounts	O
of	O
pyrrolidine	O
dithiocarbamate	O
,	O
an	O
oxygen	O
radical	O
scavenger	O
that	O
efficiently	O
blocked	O
the	O
nuclear	O
appearance	O
of	O
NF	O
-	O
kappa	O
B	O
in	O
T	O
-	O
lymphocytes	O
,	O
also	O
inhibited	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
secretion	O
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2R	I-Biological_Molecule
alpha	E-Biological_Molecule
cell	O
surface	O
expression	O
,	O
and	O
T	O
-	O
cell	O
proliferation	O
.	O

Moreover	O
,	O
cyclosporine	O
,	O
at	O
concentrations	O
readily	O
accomplished	O
in	O
clinical	O
practice	O
,	O
was	O
found	O
to	O
inhibit	O
the	O
emergence	O
of	O
these	O
DNA	O
-	O
binding	O
proteins	O
in	O
normal	O
human	O
T	O
cells	O
signaled	O
via	O
cell	O
surface	O
proteins	O
implicated	O
in	O
antigen	O
-	O
dependent	O
T	O
cell	O
activation	O
and	O
in	O
T	O
cells	O
stimulated	O
by	O
mobilization	O
of	O
cellular	O
calcium	O
and	O
activation	O
of	O
protein	O
kinase	O
C	O
.	O

NF	O
-	O
kappa	O
B	O
is	O
a	O
pleiotropic	O
regulator	O
of	O
a	O
variety	O
of	O
genes	O
implicated	O
in	O
the	O
cellular	O
response	O
to	O
injury	O
.	O

Antisense	O
phosphorothioate	O
oligonucleotides	O
to	O
the	O
p50	S-Biological_Molecule
and	O
p65	S-Biological_Molecule
subunits	O
of	O
the	O
NF	O
-	O
kappa	O
B	O
complex	O
were	O
used	O
to	O
define	O
the	O
physiologic	O
role	O
of	O
this	O
transcription	O
factor	O
in	O
resting	O
and	O
stimulated	O
granulocytes	O
.	O

A	O
reduction	O
in	O
the	O
expression	O
of	O
p65	S-Biological_Molecule
was	O
produced	O
by	O
treatment	O
with	O
the	O
phosphorothioate	O
antisense	O
oligodeoxynucleotide	O
.	O

When	O
the	O
promoter	O
region	O
was	O
linked	O
with	O
a	O
heterologous	O
reporter	O
gene	O
,	O
we	O
found	O
that	O
the	O
promoter	O
region	O
is	O
inducible	O
by	O
both	O
interferons	O
(	O
interferon	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
and	O
-	B-Biological_Molecule
gamma	E-Biological_Molecule
)	O
and	O
interferon	B-Biological_Molecule
regulatory	I-Biological_Molecule
factor	I-Biological_Molecule
1	E-Biological_Molecule
.	O

Molecular	O
,	O
biochemical	O
and	O
epidemiological	O
evidence	O
implicate	O
HTLV	O
-	O
I	O
as	O
an	O
etiologic	O
agent	O
of	O
adult	O
T	O
cell	O
leukemia	O
(	O
ATL	O
)	O
.	O

RelA	S-Biological_Molecule
(	O
p65	S-Biological_Molecule
)	O
functions	O
as	O
the	O
critical	O
transactivating	O
component	O
of	O
the	O
heterodimeric	O
p50	S-Biological_Molecule
-	O
p65	S-Biological_Molecule
NF	O
-	O
kappa	O
B	O
complex	O
and	O
contains	O
a	O
high	O
-	O
affinity	O
binding	O
site	O
for	O
its	O
cytoplasmic	O
inhibitor	O
,	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
alpha	E-Biological_Molecule
.	O

Subsequent	O
studies	O
have	O
revealed	O
that	O
(	O
i	O
)	O
cytoplasmic	O
RelA	S-Biological_Molecule
is	O
stably	O
associated	O
not	O
only	O
with	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
alpha	E-Biological_Molecule
but	O
also	O
with	O
other	O
ankyrin	O
motif	O
-	O
rich	O
proteins	O
including	O
the	O
products	O
of	O
the	O
NF	B-Biological_Molecule
-	I-Biological_Molecule
kappa	I-Biological_Molecule
B2	E-Biological_Molecule
(	O
p100	S-Biological_Molecule
)	O
and	O
NF	B-Biological_Molecule
-	I-Biological_Molecule
kappa	I-Biological_Molecule
B1	E-Biological_Molecule
(	O
p105	S-Biological_Molecule
)	O
genes	O
;	O
(	O
ii	O
)	O
in	O
contrast	O
to	O
RelA	S-Biological_Molecule
-	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
alpha	E-Biological_Molecule
,	O
RelA	S-Biological_Molecule
-	O
p100	S-Biological_Molecule
cytoplasmic	O
complexes	O
are	O
not	O
dissociated	O
following	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
alpha	E-Biological_Molecule
activation	O
;	O
(	O
iii	O
)	O
p100	S-Biological_Molecule
functions	O
as	O
a	O
potent	O
inhibitor	O
of	O
RelA	S-Biological_Molecule
-	O
mediated	O
transcription	O
in	O
vivo	O
;	O
(	O
iv	O
)	O
the	O
interaction	O
of	O
RelA	S-Biological_Molecule
and	O
p100	S-Biological_Molecule
involves	O
the	O
conserved	O
Rel	O
homology	O
domain	O
of	O
both	O
proteins	O
but	O
not	O
the	O
nuclear	O
localization	O
signal	O
of	O
RelA	S-Biological_Molecule
,	O
which	O
is	O
required	O
for	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
alpha	E-Biological_Molecule
binding	O
;	O
(	O
v	O
)	O
p100	S-Biological_Molecule
inhibition	O
of	O
RelA	S-Biological_Molecule
function	O
requires	O
the	O
C	O
-	O
terminal	O
ankyrin	O
motif	O
domain	O
,	O
which	O
mediates	O
cytoplasmic	O
retention	O
of	O
RelA	S-Biological_Molecule
;	O
and	O
(	O
vi	O
)	O
as	O
observed	O
with	O
I	B-Biological_Molecule
kappa	I-Biological_Molecule
B	I-Biological_Molecule
alpha	E-Biological_Molecule
,	O
nuclear	O
RelA	S-Biological_Molecule
stimulates	O
p100	S-Biological_Molecule
mRNA	O
and	O
protein	O
expression	O
.	O

Calcineurin	O
,	O
a	O
Ca2	O
+	O
/	O
calmodulin	O
-	O
dependent	O
protein	O
phosphatase	O
,	O
is	O
the	O
FK	O
-	O
506	O
-	O
and	O
CsA	O
-	O
sensitive	O
enzyme	O
required	O
for	O
TcR	O
mediated	O
activation	O
of	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
promoter	O
.	O

Cytokines	O
have	O
been	O
identified	O
by	O
immunohistochemistry	O
in	O
granulomas	O
in	O
animal	O
models	O
of	O
bacillus	O
Calmette	O
-	O
Guerin	O
(	O
BCG	O
)	O
infection	O
and	O
are	O
released	O
by	O
mononuclear	O
phagocytes	O
upon	O
stimulation	O
by	O
mycobacterial	O
proteins	O
.	O

Both	O
LAM	O
-	O
and	O
LPS	O
-	O
inducible	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
promoter	O
activity	O
was	O
localized	O
to	O
a	O
DNA	O
fragment	O
,	O
positions	O
-	O
158	O
to	O
-	O
49	O
,	O
by	O
deletion	O
analysis	O
and	O
chloramphenicol	B-Biological_Molecule
acetyltransferase	E-Biological_Molecule
assay	O
.	O

IBR	S-Biological_Molecule
is	O
a	O
503	O
-	O
amino	O
-	O
acid	O
-	O
long	O
acidic	O
protein	O
which	O
is	O
99	O
.	O
0	O
%	O
identical	O
to	O
the	O
recently	O
reported	O
human	O
NRF	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
/	O
alpha	B-Biological_Molecule
-	I-Biological_Molecule
Pal	I-Biological_Molecule
factor	E-Biological_Molecule
and	O
highly	O
related	O
to	O
the	O
invertebrate	O
transcription	O
factors	O
P3A2	S-Biological_Molecule
and	O
erected	B-Biological_Molecule
wing	I-Biological_Molecule
gene	E-Biological_Molecule
product	O
(	O
EWG	S-Biological_Molecule
)	O
.	O

These	O
data	O
suggest	O
the	O
potential	O
utility	O
of	O
agents	O
that	O
disrupt	O
calcineurin	O
-	O
mediated	O
signal	O
transduction	O
pathways	O
by	O
blocking	O
formation	O
of	O
the	O
catalytically	O
active	O
dimer	O
of	O
calcineurin	B-Biological_Molecule
A	E-Biological_Molecule
and	O
B	B-Biological_Molecule
subunits	E-Biological_Molecule
.	O

The	O
present	O
study	O
examines	O
the	O
mechanisms	O
involved	O
in	O
LPS	O
-	O
mediated	O
induction	O
of	O
HIV	O
expression	O
in	O
U1	O
cells	O
,	O
a	O
promonocytic	O
cell	O
line	O
chronically	O
infected	O
with	O
HIV	O
.	O

In	O
this	O
regard	O
,	O
anti	O
-	O
inflammatory	O
cytokines	O
inhibited	O
LPS	O
plus	O
GM	B-Biological_Molecule
-	I-Biological_Molecule
CSF	E-Biological_Molecule
-	O
stimulated	O
HIV	O
expression	O
,	O
and	O
this	O
effect	O
closely	O
correlated	O
with	O
inhibition	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
beta	E-Biological_Molecule
release	O
and	O
,	O
in	O
particular	O
,	O
with	O
up	O
-	O
regulation	O
of	O
endogenous	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1ra	E-Biological_Molecule
production	O
.	O

Both	O
primary	O
activation	O
,	O
with	O
phytohemagglutinin	S-Biological_Molecule
or	O
antibodies	O
to	O
CD3	O
,	O
and	O
costimulation	O
,	O
provided	O
by	O
pairs	O
of	O
CD2	O
antibodies	O
or	O
B7	O
-	O
positive	O
(	O
B	O
cells	O
)	O
or	O
B7	O
-	O
negative	O
(	O
endothelial	O
)	O
accessory	O
cells	O
,	O
are	O
mediated	O
through	O
the	O
same	O
cis	O
-	O
elements	O
.	O

The	O
regulation	O
of	O
collagenase	O
expression	O
is	O
cell	O
-	O
type	O
specific	O
;	O
bacterial	O
LPS	O
and	O
zymosan	O
,	O
a	O
yeast	O
cell	O
wall	O
derivative	O
,	O
are	O
potent	O
inducers	O
of	O
collagenase	O
expression	O
in	O
macrophages	O
,	O
but	O
do	O
not	O
alter	O
fibroblast	O
collagenase	O
expression	O
.	O

The	O
role	O
of	O
alterations	O
of	O
the	O
MTS1	S-Biological_Molecule
tumor	O
suppressor	O
gene	O
on	O
chromosome	O
9p21	O
,	O
which	O
encodes	O
p16	S-Biological_Molecule
,	O
the	O
inhibitor	O
of	O
cyclin	B-Biological_Molecule
-	I-Biological_Molecule
dependent	I-Biological_Molecule
-	I-Biological_Molecule
kinase	I-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
and	O
6	S-Biological_Molecule
,	O
in	O
tumorigenesis	O
is	O
not	O
yet	O
clear	O
.	O

In	O
Rel	S-Biological_Molecule
-	O
/	O
-	O
splenic	O
T	O
cell	O
cultures	O
stimulated	O
with	O
phorbol	O
12	O
-	O
myristate	O
13	O
-	O
acetate	O
and	O
ionomycin	O
,	O
the	O
levels	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
,	O
granulocyte	B-Biological_Molecule
-	I-Biological_Molecule
macrophage	I-Biological_Molecule
colony	I-Biological_Molecule
-	I-Biological_Molecule
stimulating	I-Biological_Molecule
factor	E-Biological_Molecule
(	O
GM	B-Biological_Molecule
-	I-Biological_Molecule
CSF	E-Biological_Molecule
)	O
,	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
alpha	E-Biological_Molecule
(	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
)	O
,	O
and	O
gamma	B-Biological_Molecule
interferon	E-Biological_Molecule
(	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
)	O
were	O
only	O
2	O
-	O
to	O
3	O
-	O
fold	O
lower	O
compared	O
with	O
normal	O
T	O
cells	O
.	O

Exogenous	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
,	O
which	O
restitutes	O
the	O
proliferative	O
response	O
of	O
the	O
anti	O
-	O
CD3	O
-	O
and	O
anti	O
-	O
CD28	S-Biological_Molecule
-	O
treated	O
Rel	O
-	O
/	O
-	O
T	O
cells	O
,	O
restores	O
production	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
,	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
,	O
and	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
,	O
but	O
not	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
and	O
GM	B-Biological_Molecule
-	I-Biological_Molecule
CSF	E-Biological_Molecule
expression	O
to	O
approximately	O
normal	O
levels	O
.	O

Here	O
we	O
demonstrate	O
that	O
CD28RE	O
binds	O
an	O
inducible	O
protein	O
with	O
a	O
molecular	O
mass	O
of	O
approximately	O
35	O
kDa	O
called	O
nuclear	O
factor	O
of	O
mitogenic	O
-	O
activated	O
T	O
cells	O
(	O
NF	O
-	O
MATp35	O
)	O
that	O
is	O
clearly	O
different	O
from	O
the	O
known	O
NF	O
-	O
kappaB	O
/	O
Rel	O
family	O
members	O
.	O

When	O
unstimulated	O
HeLa	O
cells	O
are	O
ruptured	O
in	O
hypotonic	O
buffer	O
without	O
salt	O
or	O
detergent	O
,	O
immunoadsorption	O
of	O
either	O
STAT1	S-Biological_Molecule
or	O
STAT2	S-Biological_Molecule
from	O
the	O
resulting	O
cytosol	O
yields	O
coimmunoadsorption	O
of	O
the	O
other	O
STAT	O
protein	O
.	O

Globin	O
gene	O
switching	O
.	O

To	O
characterize	O
the	O
protein	O
-	O
DNA	O
interactions	O
important	O
for	O
the	O
developmental	O
control	O
of	O
the	O
human	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
globin	E-Biological_Molecule
locus	O
,	O
we	O
analyzed	O
by	O
in	O
vivo	O
dimethyl	O
sulfate	O
footprinting	O
erythroid	O
cells	O
expressing	O
either	O
the	O
fetal	S-Biological_Molecule
or	O
the	O
adult	B-Biological_Molecule
globin	E-Biological_Molecule
developmental	O
program	O
.	O

In	O
the	O
locus	O
control	O
region	O
(	O
LCR	O
)	O
of	O
the	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
globin	E-Biological_Molecule
locus	O
,	O
in	O
vivo	O
footprints	O
on	O
NF	O
-	O
E2	O
(	O
or	O
AP	O
-	O
1	O
)	O
and	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
motifs	O
remained	O
the	O
same	O
regardless	O
of	O
whether	O
the	O
fetal	S-Biological_Molecule
or	O
the	O
adult	B-Biological_Molecule
globin	I-Biological_Molecule
genes	E-Biological_Molecule
are	O
expressed	O
.	O

As	O
judged	O
by	O
supershifting	O
the	O
DNA	O
-	O
protein	O
complexes	O
with	O
Abs	O
recognizing	O
specific	O
components	O
of	O
the	O
NF	O
-	O
kappa	O
B	O
/	O
Rel	O
protein	O
family	O
,	O
the	O
p50	S-Biological_Molecule
/	O
p65	S-Biological_Molecule
(	O
Rel	B-Biological_Molecule
A	E-Biological_Molecule
)	O
heterodimeric	O
form	O
of	O
NF	O
-	O
kappa	O
B	O
is	O
primarily	O
affected	O
.	O

The	O
process	O
of	O
activation	O
involves	O
calcium	O
mobilization	O
,	O
activation	O
of	O
protein	O
kinase	O
C	O
(	O
PKC	O
)	O
,	O
and	O
phosphorylation	O
of	O
tyrosine	O
kinases	O
.	O

p21	B-Biological_Molecule
(	I-Biological_Molecule
ras	I-Biological_Molecule
)	E-Biological_Molecule
,	O
a	O
guanine	O
nucleotide	O
binding	O
factor	O
,	O
mediates	O
T	O
-	O
cell	O
signal	O
transduction	O
through	O
PKC	O
-	O
dependent	O
and	O
PKC	O
-	O
independent	O
pathways	O
.	O

Restimulation	O
of	O
T	O
cell	O
blasts	O
up	O
-	O
regulates	O
Fas	S-Biological_Molecule
and	O
Fas	B-Biological_Molecule
ligand	E-Biological_Molecule
expression	O
,	O
with	O
subsequent	O
interaction	O
leading	O
to	O
cell	O
death	O
.	O

In	O
this	O
study	O
,	O
we	O
characterize	O
an	O
essential	O
upstream	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
response	O
element	O
that	O
contains	O
both	O
consensus	O
and	O
non	O
-	O
consensus	O
GAS	O
motifs	O
,	O
two	O
putative	O
Ets	O
binding	O
sites	O
(	O
EBS	O
)	O
,	O
one	O
of	O
which	O
overlaps	O
the	O
consensus	O
GAS	O
motif	O
,	O
and	O
a	O
GATA	O
motif	O
,	O
which	O
overlaps	O
the	O
non	O
-	O
consensus	O
GAS	O
motif	O
.	O

Multiple	O
factors	O
including	O
Stat5	S-Biological_Molecule
,	O
Elf	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
HMG	B-Biological_Molecule
-	I-Biological_Molecule
I	I-Biological_Molecule
(	I-Biological_Molecule
Y	I-Biological_Molecule
)	E-Biological_Molecule
and	O
GATA	O
family	O
proteins	O
bind	O
to	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
response	O
element	O
and	O
mutation	O
of	O
any	O
one	O
of	O
these	O
binding	O
sites	O
diminishes	O
the	O
activity	O
of	O
this	O
element	O
.	O

An	O
unidentified	O
Ets	O
family	O
protein	O
binds	O
to	O
the	O
EBS	O
overlapping	O
the	O
consensus	O
GAS	O
motif	O
and	O
appears	O
to	O
negatively	O
regulate	O
the	O
human	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2R	I-Biological_Molecule
alpha	E-Biological_Molecule
promoter	O
.	O

Active	O
suppression	O
of	O
the	O
class	B-Biological_Molecule
II	I-Biological_Molecule
transactivator	E-Biological_Molecule
-	O
encoding	O
AIR	O
-	O
1	O
locus	O
is	O
responsible	O
for	O
the	O
lack	O
of	O
major	O
histocompatibility	O
complex	O
class	O
II	O
gene	O
expression	O
observed	O
during	O
differentiation	O
from	O
B	O
cells	O
to	O
plasma	O
cells	O
.	O

These	O
findings	O
further	O
support	O
our	O
previous	O
observations	O
on	O
the	O
distinct	O
regulation	O
of	O
expression	O
of	O
the	O
human	O
HLA	O
-	O
DQ	O
class	O
II	O
subset	O
,	O
which	O
may	O
be	O
thus	O
controlled	O
at	O
the	O
posttranscriptional	O
level	O
by	O
a	O
CIITA	S-Biological_Molecule
-	O
independent	O
mechanism	O
.	O

Silencing	O
of	O
human	O
fetal	B-Biological_Molecule
globin	E-Biological_Molecule
expression	O
is	O
impaired	O
in	O
the	O
absence	O
of	O
the	O
adult	O
beta	O
-	O
globin	O
gene	O
activator	O
protein	O
EKLF	S-Biological_Molecule
.	O

Nasal	O
NK	O
-	O
and	O
T	O
-	O
cell	O
lymphomas	O
share	O
the	O
same	O
type	O
of	O
Epstein	O
-	O
Barr	O
virus	O
latency	O
as	O
nasopharyngeal	O
carcinoma	O
and	O
Hodgkin	O
'	O
s	O
disease	O
.	O

ISH	O
for	O
EBV	O
-	O
encoded	O
small	O
non	O
-	O
polyadenylated	O
RNAs	O
showed	O
that	O
all	O
cases	O
,	O
whether	O
NK	O
or	O
T	O
,	O
harboured	O
EBV	O
in	O
virtually	O
all	O
tumour	O
cells	O
.	O

RT	O
-	O
PCR	O
demonstrated	O
that	O
NL	O
of	O
both	O
subtypes	O
expressed	O
EBNAI	S-Biological_Molecule
of	O
the	O
QUK	O
splice	O
pattern	O
,	O
the	O
latent	O
membrane	O
proteins	O
,	O
LMP1	S-Biological_Molecule
and	O
2	S-Biological_Molecule
and	O
the	O
BamHI	O
A	O
rightward	O
transcripts	O
in	O
the	O
absence	O
of	O
EBNA2	S-Biological_Molecule
mRNAs	O
,	O
compatible	O
with	O
the	O
latency	O
type	O
II	O
pattern	O
.	O

Down	O
-	O
regulation	O
of	O
immunogenic	O
proteins	O
(	O
EBNA2	S-Biological_Molecule
-	O
EBNA6	S-Biological_Molecule
)	O
in	O
nasal	O
lymphoma	O
may	O
enable	O
tumour	O
cells	O
to	O
evade	O
host	O
cytotoxic	O
T	O
-	O
cell	O
surveillance	O
.	O

High	O
levels	O
of	O
Sp140	S-Biological_Molecule
mRNA	O
were	O
detected	O
in	O
human	O
spleen	O
and	O
peripheral	O
blood	O
leukocytes	O
,	O
but	O
not	O
other	O
human	O
tissues	O
.	O

The	O
level	O
of	O
SP140	S-Biological_Molecule
mRNA	O
in	O
myeloid	O
precursor	O
cell	O
lines	O
HL60	O
and	O
NB4	O
markedly	O
increased	O
in	O
response	O
to	O
chemically	O
induced	O
cellular	O
differentiation	O
.	O

Moreover	O
,	O
ZK161422	O
,	O
but	O
not	O
ZK157202	O
,	O
showed	O
preference	O
for	O
gene	O
activation	O
from	O
a	O
promoter	O
carrying	O
a	O
VD	O
response	O
element	O
with	O
a	O
palindromic	O
arrangement	O
of	O
two	O
hexameric	O
receptor	O
binding	O
sites	O
spaced	O
by	O
9	O
nucleotides	O
(	O
IP9	O
)	O
rather	O
than	O
for	O
activation	O
from	O
a	O
response	O
element	O
formed	O
by	O
a	O
direct	O
repeat	O
spaced	O
by	O
3	O
nucleotides	O
(	O
DR3	O
)	O
.	O

NF	O
-	O
kappaB	O
activation	O
was	O
very	O
effective	O
when	O
cells	O
were	O
subjected	O
to	O
hyperthermia	O
before	O
being	O
treated	O
with	O
HOCl	O
.	O

However	O
,	O
its	O
activity	O
becomes	O
lower	O
in	O
the	O
double	O
-	O
positive	O
and	O
a	O
fraction	O
of	O
the	O
CD4	O
+	O
CD8int	O
/	O
-	O
cell	O
population	O
,	O
indicating	O
that	O
an	O
additional	O
enhancer	O
,	O
located	O
in	O
either	O
the	O
first	O
or	O
the	O
third	O
intron	O
of	O
the	O
CD4	S-Biological_Molecule
gene	O
,	O
is	O
required	O
for	O
CD4	S-Biological_Molecule
gene	O
expression	O
in	O
this	O
population	O
.	O

Homodimerization	O
of	O
the	O
human	O
interleukin	B-Biological_Molecule
4	I-Biological_Molecule
receptor	I-Biological_Molecule
alpha	I-Biological_Molecule
chain	E-Biological_Molecule
induces	O
Cepsilon	O
germline	O
transcripts	O
in	O
B	O
cells	O
in	O
the	O
absence	O
of	O
the	O
interleukin	B-Biological_Molecule
2	I-Biological_Molecule
receptor	I-Biological_Molecule
gamma	I-Biological_Molecule
chain	E-Biological_Molecule
.	O

Alternatively	O
,	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4Ralpha	I-Biological_Molecule
chain	E-Biological_Molecule
may	O
transduce	O
intracellular	O
signals	O
that	O
lead	O
to	O
Cepsilon	O
gene	O
transcription	O
independently	O
of	O
its	O
association	O
with	O
other	O
chains	O
.	O

Tax1	S-Biological_Molecule
,	O
a	O
transcriptional	O
trans	O
-	O
activator	O
of	O
the	O
Human	O
T	O
-	O
cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV	O
-	O
I	O
)	O
,	O
induces	O
the	O
expression	O
of	O
many	O
cellular	O
genes	O
through	O
interaction	O
with	O
at	O
least	O
three	O
distinct	O
cellular	O
transcription	O
factors	O
;	O
CREB	O
/	O
ATF	O
,	O
NF	O
-	O
kappaB	O
,	O
and	O
SRF	S-Biological_Molecule
.	O

To	O
elucidate	O
the	O
role	O
of	O
each	O
Tax1	S-Biological_Molecule
-	O
inducible	O
transcriptional	O
pathway	O
in	O
T	O
-	O
cell	O
transformation	O
,	O
we	O
introduced	O
Tax1	S-Biological_Molecule
mutants	O
with	O
different	O
trans	O
-	O
activating	O
phenotypes	O
into	O
peripheral	O
blood	O
lymphocytes	O
(	O
PBL	O
)	O
by	O
retroviral	O
vectors	O
.	O

We	O
then	O
studied	O
the	O
effect	O
of	O
the	O
antibody	O
on	O
aldosterone	O
and	O
progesterone	O
binding	O
to	O
the	O
hMR	S-Biological_Molecule
.	O

Patients	O
with	O
one	O
type	O
of	O
major	O
histocompatibility	O
complex	O
class	O
II	O
combined	O
immunodeficiency	O
have	O
mutations	O
in	O
a	O
gene	O
termed	O
class	B-Biological_Molecule
II	I-Biological_Molecule
transactivator	E-Biological_Molecule
(	O
CIITA	S-Biological_Molecule
)	O
,	O
which	O
coordinately	O
controls	O
the	O
transcription	O
of	O
the	O
three	O
major	O
human	O
class	O
II	O
genes	O
,	O
HLA	O
-	O
DR	O
,	O
-	O
DQ	O
,	O
and	O
-	O
DP	O
.	O

BACKGROUND	O
:	O
Activated	O
platelets	O
tether	O
and	O
activate	O
myeloid	O
leukocytes	O
.	O

Our	O
findings	O
suggest	O
that	O
leukocyte	O
-	O
platelet	O
adhesion	O
contributes	O
to	O
the	O
regulation	O
of	O
inflammatory	O
responses	O
in	O
AMI	O
.	O

Regulation	O
by	O
Egr	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Jun	E-Biological_Molecule
,	O
and	O
NF	O
-	O
kappaB	O
transcription	O
factors	O
.	O

The	O
CRE	O
and	O
kappaB3	O
sites	O
in	O
region	O
II	O
together	O
conferred	O
strong	O
LPS	O
responsiveness	O
to	O
a	O
heterologous	O
promoter	O
,	O
whereas	O
individually	O
they	O
failed	O
to	O
provide	O
transcriptional	O
activation	O
.	O

These	O
studies	O
indicate	O
that	O
maximal	O
LPS	O
induction	O
of	O
the	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
promoter	O
is	O
mediated	O
by	O
concerted	O
participation	O
of	O
at	O
least	O
two	O
separate	O
cis	O
-	O
acting	O
regulatory	O
elements	O
.	O

Previous	O
reports	O
have	O
suggested	O
the	O
CD28	S-Biological_Molecule
stimulation	O
contributes	O
to	O
the	O
activation	O
of	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
promoter	O
by	O
up	O
-	O
regulating	O
the	O
activity	O
of	O
several	O
transcription	O
factors	O
,	O
including	O
AP	O
-	O
1	O
and	O
nuclear	O
factor	O
-	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
/	O
Rel	O
family	O
members	O
as	O
well	O
as	O
an	O
uncharacterized	O
transcription	O
factor	O
called	O
CD28	S-Biological_Molecule
response	O
complex	O
.	O

Also	O
in	O
the	O
current	O
study	O
,	O
binding	O
activity	O
to	O
the	O
CD28RE	O
/	O
AP	O
-	O
1	O
sequence	O
of	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
promoter	O
is	O
evaluated	O
.	O

These	O
data	O
indicate	O
that	O
functional	O
complexes	O
encompassing	O
both	O
the	O
CD28RE	O
and	O
the	O
AP	O
-	O
1	O
-	O
binding	O
sites	O
influence	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
promoter	O
activity	O
in	O
CD28	S-Biological_Molecule
-	O
costimulated	O
T	O
cells	O
.	O

The	O
Zfh	O
family	O
of	O
zinc	O
finger	O
/	O
homeodomain	O
proteins	O
was	O
first	O
identified	O
in	O
Drosophila	O
where	O
it	O
is	O
required	O
for	O
differentiation	O
of	O
tissues	O
such	O
as	O
the	O
central	O
nervous	O
system	O
and	O
muscle	O
.	O

Such	O
repression	O
imposes	O
a	O
requirement	O
for	O
both	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Myb	E-Biological_Molecule
and	O
Ets	O
for	O
transcriptional	O
activity	O
,	O
providing	O
one	O
explanation	O
for	O
why	O
synergy	O
between	O
these	O
factors	O
is	O
important	O
.	O

In	O
DNA	O
-	O
protein	O
binding	O
studies	O
,	O
we	O
detected	O
the	O
binding	O
of	O
transcription	O
factors	O
GABP	B-Biological_Molecule
alpha	E-Biological_Molecule
and	O
-	B-Biological_Molecule
beta	E-Biological_Molecule
to	O
a	O
dyad	O
symmetry	O
element	O
(	O
DSE	O
)	O
of	O
the	O
distal	O
enhancer	O
,	O
which	O
is	O
formed	O
by	O
palindromic	O
binding	O
sites	O
of	O
Ets	O
-	O
like	O
factors	O
.	O

Depletion	O
of	O
intracellular	O
TRAF2	S-Biological_Molecule
and	O
its	O
coassociated	O
proteins	O
also	O
increased	O
the	O
sensitivity	O
of	O
the	O
cell	O
to	O
undergoing	O
apoptosis	O
during	O
activation	O
of	O
death	O
-	O
inducing	O
receptors	O
such	O
as	O
TNFR1	S-Biological_Molecule
.	O

Recently	O
,	O
we	O
demonstrated	O
that	O
the	O
DSE	O
are	O
also	O
cAMP	O
-	O
responsive	O
elements	O
(	O
CRE	O
)	O
,	O
since	O
they	O
mediated	O
activation	O
signals	O
elicited	O
by	O
cholera	O
toxin	O
(	O
Ctx	O
)	O
,	O
a	O
potent	O
activator	O
of	O
the	O
cAMP	O
-	O
dependent	O
protein	O
kinase	O
A	O
(	O
PKA	O
)	O
signal	O
transduction	O
pathway	O
.	O

Copyright	O
1997	O
Academic	O
Press	O
.	O

The	O
Epstein	O
-	O
Barr	O
virus	O
latent	B-Biological_Molecule
membrane	I-Biological_Molecule
protein	I-Biological_Molecule
1	E-Biological_Molecule
(	O
LMP1	S-Biological_Molecule
)	O
is	O
essential	O
for	O
the	O
transformation	O
of	O
B	O
lymphocytes	O
into	O
lymphoblastoid	O
cell	O
lines	O
.	O

In	O
transfection	O
assays	O
,	O
TRADD	S-Biological_Molecule
and	O
TES2	S-Biological_Molecule
synergistically	O
mediated	O
high	O
-	O
level	O
NF	O
-	O
kappaB	O
activation	O
.	O

The	O
allele	O
-	O
specific	O
expression	O
profiles	O
of	O
other	O
imprinted	O
genes	O
,	O
IGF2	S-Biological_Molecule
and	O
H19	S-Biological_Molecule
,	O
on	O
human	O
chromosome	O
11	O
were	O
constant	O
and	O
consistent	O
with	O
those	O
in	O
other	O
tissues	O
.	O

Extinction	O
of	O
immunoglobulin	O
gene	O
expression	O
in	O
B	O
cells	O
upon	O
fusion	O
with	O
HeLa	O
cells	O
is	O
preceded	O
by	O
rapid	O
nuclear	O
depletion	O
of	O
essential	O
transcription	O
factors	O
and	O
is	O
accompanied	O
by	O
widespread	O
inactivation	O
of	O
genes	O
expressed	O
in	O
a	O
B	O
cell	O
-	O
specific	O
manner	O
.	O

When	O
immunoglobulin	O
(	O
Ig	O
)	O
expressing	O
B	O
cells	O
are	O
fused	O
with	O
non	O
-	O
B	O
cells	O
,	O
Ig	O
expression	O
is	O
rapidly	O
suppressed	O
at	O
the	O
level	O
of	O
transcription	O
,	O
a	O
phenomenon	O
termed	O
extinction	O
.	O

We	O
now	O
show	O
that	O
this	O
differential	O
rescue	O
by	O
specific	O
cytokines	O
in	O
Th	O
cells	O
correlates	O
with	O
the	O
level	O
of	O
IkappaBalpha	S-Biological_Molecule
that	O
is	O
regulated	O
by	O
DEX	O
and	O
cytokines	O
.	O

Adherent	O
cells	O
were	O
counted	O
by	O
digital	O
image	O
analysis	O
.	O

At	O
variance	O
,	O
in	O
PAEC	O
incubated	O
with	O
the	O
homologous	O
serum	O
,	O
NF	O
-	O
kappa	O
B	O
was	O
strictly	O
localized	O
in	O
the	O
cell	O
cytoplasm	O
.	O

Treatment	O
of	O
PAEC	O
exposed	O
to	O
xenogeneic	O
serum	O
with	O
the	O
NF	O
-	O
kappa	O
B	O
inhibitors	O
pyrrolidinedithiocarbamate	O
(	O
PDTC	O
,	O
25	O
microM	O
)	O
and	O
tosyl	O
-	O
phechloromethylketone	O
(	O
TPCK	O
,	O
25	O
microM	O
)	O
significantly	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
reduced	O
leukocyte	O
adhesion	O
in	O
respect	O
to	O
PAEC	O
treated	O
with	O
human	O
serum	O
alone	O
.	O

Electrophoretic	O
mobility	O
-	O
shift	O
assays	O
revealed	O
that	O
recombinant	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
increased	O
NF	O
-	O
kappaB	O
binding	O
activity	O
in	O
nuclear	O
extracts	O
of	O
the	O
leukemia	O
cells	O
,	O
and	O
Northern	O
blot	O
analysis	O
showed	O
that	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
increased	O
the	O
abundance	O
of	O
mRNAs	O
encoding	O
the	O
NF	O
-	O
kappaB	O
components	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Rel	E-Biological_Molecule
and	O
KBF1	S-Biological_Molecule
in	O
these	O
cells	O
.	O

Molecular	O
and	O
cellular	O
analysis	O
of	O
human	O
immunodeficiency	O
virus	O
-	O
induced	O
apoptosis	O
in	O
lymphoblastoid	O
T	O
-	O
cell	O
-	O
line	O
-	O
expressing	O
wild	O
-	O
type	O
and	O
mutated	O
CD4	B-Biological_Molecule
receptors	E-Biological_Molecule
.	O

It	O
was	O
concluded	O
that	O
even	O
when	O
LMP1	S-Biological_Molecule
is	O
unable	O
to	O
activate	O
NF	O
-	O
kappaB	O
,	O
it	O
is	O
still	O
capable	O
of	O
inducing	O
certain	O
characteristics	O
of	O
activated	O
B	O
cells	O
,	O
strongly	O
suggesting	O
that	O
LMP1	S-Biological_Molecule
can	O
also	O
activate	O
cells	O
independently	O
of	O
NF	O
-	O
kappaB	O
.	O

Ligation	O
of	O
CD3	O
also	O
induces	O
the	O
tyrosine	O
phosphorylation	O
of	O
HS1	S-Biological_Molecule
,	O
a	O
75	O
-	O
kDa	O
hematopoietic	O
cell	O
-	O
specific	O
intracellular	O
signaling	O
protein	O
of	O
unknown	O
function	O
.	O

Additionally	O
,	O
no	O
tyrosine	O
phosphorylation	O
of	O
HS1	S-Biological_Molecule
was	O
induced	O
by	O
mitogenic	O
pairs	O
of	O
anti	O
-	O
CD2	S-Biological_Molecule
mAbs	O
capable	O
of	O
activating	O
the	O
transcription	O
factor	O
NFAT	O
(	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
)	O
.	O

IL	B-Biological_Molecule
-	I-Biological_Molecule
7	E-Biological_Molecule
reconstitutes	O
multiple	O
aspects	O
of	O
v	B-Biological_Molecule
-	I-Biological_Molecule
Abl	E-Biological_Molecule
-	O
mediated	O
signaling	O
.	O

Activation	O
of	O
this	O
lipid	O
kinase	O
is	O
able	O
to	O
induce	O
critical	O
Rac	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
signaling	O
pathways	O
and	O
can	O
couple	O
p21ras	S-Biological_Molecule
to	O
cell	O
survival	O
mechanisms	O
via	O
the	O
serine	O
/	O
threonine	O
kinase	O
Akt	S-Biological_Molecule
/	O
PKB	S-Biological_Molecule
.	O

The	O
results	O
show	O
that	O
Ras	O
can	O
initiate	O
a	O
Rac	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
mediated	O
pathway	O
that	O
regulates	O
the	O
transcriptional	O
function	O
of	O
AP	O
-	O
1	O
complexes	O
.	O

Ras	O
can	O
initiate	O
Rac	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
regulated	O
signaling	O
pathways	O
in	O
the	O
context	O
of	O
T	O
cell	O
antigen	O
receptor	O
function	O
independently	O
of	O
PtdIns	O
3	O
-	O
kinase	O
activity	O
.	O

Signal	O
transduction	O
abnormalities	O
in	O
T	O
lymphocytes	O
from	O
patients	O
with	O
advanced	O
renal	O
carcinoma	O
:	O
clinical	O
relevance	O
and	O
effects	O
of	O
cytokine	O
therapy	O
.	O

Studies	O
have	O
demonstrated	O
abnormalities	O
of	O
the	O
CD3	O
/	O
T	O
-	O
cell	O
antigen	O
receptor	O
(	O
TCR	O
)	O
and	O
pathways	O
of	O
signal	O
transduction	O
in	O
T	O
lymphocytes	O
from	O
animals	O
and	O
patients	O
with	O
advanced	O
malignancy	O
.	O

Transcriptional	O
regulation	O
of	O
lysosomal	B-Biological_Molecule
acid	I-Biological_Molecule
lipase	E-Biological_Molecule
in	O
differentiating	O
monocytes	O
is	O
mediated	O
by	O
transcription	O
factors	O
Sp1	S-Biological_Molecule
and	O
AP	O
-	O
2	O
.	O

Co	O
-	O
transfections	O
with	O
expression	O
plasmids	O
for	O
Sp1	S-Biological_Molecule
and	O
AP	O
-	O
2	O
further	O
emphasized	O
the	O
important	O
role	O
of	O
these	O
transcription	O
factors	O
in	O
both	O
basal	O
and	O
PMA	O
-	O
enhanced	O
LAL	S-Biological_Molecule
expression	O
.	O

Progesterone	O
acts	O
distally	O
to	O
the	O
initial	O
steps	O
of	O
T	O
cell	O
receptor	O
(	O
TCR	O
)	O
-	O
mediated	O
signal	O
transduction	O
,	O
since	O
it	O
blocks	O
sustained	O
Ca2	O
+	O
signals	O
after	O
thapsigargin	O
stimulation	O
,	O
as	O
well	O
as	O
oscillatory	O
Ca2	O
+	O
signals	O
,	O
but	O
not	O
the	O
Ca2	O
+	O
transient	O
after	O
TCR	O
stimulation	O
.	O

We	O
propose	O
that	O
direct	O
inhibition	O
of	O
K	O
+	O
channels	O
in	O
T	O
cells	O
by	O
progesterone	O
contributes	O
to	O
progesterone	O
-	O
induced	O
immunosuppression	O
.	O

Overexpression	O
of	O
hIRAK	O
enhanced	O
IL	O
-	O
1	O
-	O
stimulated	O
activation	O
of	O
the	O
transcription	O
factor	O
NFkappaB	O
,	O
whereas	O
a	O
truncated	O
form	O
(	O
N	O
-	O
IRAK	O
)	O
specifically	O
inhibited	O
IL	O
-	O
1	O
-	O
dependent	O
NFkappaB	O
activity	O
.	O

IL	O
-	O
12	O
is	O
a	O
75	O
-	O
kDa	O
heterodimeric	O
cytokine	O
composed	O
of	O
two	O
covalently	O
linked	O
p35	S-Biological_Molecule
and	O
p40	S-Biological_Molecule
chains	O
.	O

NK	O
cell	O
membrane	O
extracts	O
retained	O
the	O
capacity	O
to	O
activate	O
EC	O
and	O
induced	O
nuclear	O
translocation	O
of	O
NF	O
-	O
kappaB	O
(	O
p50	S-Biological_Molecule
and	O
p65	S-Biological_Molecule
)	O
.	O

Site	O
-	O
directed	O
mutagenesis	O
demonstrated	O
that	O
these	O
TRAF	O
binding	O
sites	O
exhibited	O
selective	O
binding	O
for	O
different	O
TRAF	O
proteins	O
.	O

Egr	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
the	O
serum	B-Biological_Molecule
response	I-Biological_Molecule
factor	E-Biological_Molecule
were	O
found	O
to	O
interact	O
specifically	O
with	O
the	O
intronic	O
sequence	O
at	O
+	O
265	O
and	O
+	O
448	O
,	O
respectively	O
.	O

In	O
human	O
peripheral	O
blood	O
NK	O
cells	O
,	O
genistein	O
at	O
<	O
0	O
.	O
5	O
micromol	O
/	O
L	O
and	O
DG	O
and	O
GG	O
at	O
0	O
.	O
1	O
-	O
10	O
micromol	O
/	O
L	O
enhanced	O
NK	O
cell	O
-	O
mediated	O
K562	O
cancer	O
cell	O
killing	O
significantly	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Significantly	O
increased	O
oestrogen	O
receptor	O
expression	O
,	O
bcl	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
expression	O
and	O
numbers	O
of	O
CD8	O
+	O
leukocytes	O
were	O
found	O
in	O
ectopic	O
compared	O
with	O
eutopic	O
endometrium	O
in	O
endometriosis	O
,	O
and	O
CD56	S-Biological_Molecule
+	O
endometrial	O
granulated	O
lymphocytes	O
(	O
eGLs	O
)	O
were	O
significantly	O
reduced	O
in	O
ectopic	O
endometrium	O
.	O

Analysis	O
of	O
X	O
-	O
chromosome	O
inactivation	O
patterns	O
can	O
be	O
used	O
to	O
determine	O
whether	O
proliferative	O
disorders	O
are	O
clonal	O
in	O
origin	O
.	O

After	O
corticosteroid	O
suppression	O
of	O
her	O
blood	O
eosinophilia	O
,	O
a	O
clonal	O
population	O
of	O
eosinophils	O
could	O
no	O
longer	O
be	O
detected	O
in	O
purified	O
eosinophils	O
.	O

The	O
type	O
I	O
human	O
T	O
-	O
cell	O
leukemia	O
virus	O
(	O
HTLV	O
-	O
I	O
)	O
induces	O
abnormal	O
growth	O
and	O
subsequent	O
transformation	O
of	O
T	O
cells	O
,	O
which	O
is	O
associated	O
with	O
the	O
development	O
of	O
an	O
acute	O
T	O
-	O
cell	O
malignancy	O
termed	O
adult	O
T	O
-	O
cell	O
leukemia	O
.	O

Engagement	O
of	O
the	O
T	O
-	O
cell	O
receptor	O
(	O
TCR	O
)	O
-	O
CD3	O
complex	O
induces	O
a	O
rapid	O
increase	O
in	O
the	O
activities	O
of	O
Src	O
-	O
family	O
and	O
Syk	S-Biological_Molecule
/	O
Zap	B-Biological_Molecule
-	I-Biological_Molecule
70	E-Biological_Molecule
-	O
family	O
kinases	O
[	O
1	O
]	O
[	O
2	O
]	O
.	O

Unlike	O
the	O
proposed	O
role	O
of	O
Cbl	O
as	O
a	O
negative	O
regulator	O
,	O
our	O
results	O
suggest	O
that	O
the	O
Cbl	O
homologue	O
Cbl	B-Biological_Molecule
-	I-Biological_Molecule
b	E-Biological_Molecule
has	O
a	O
positive	O
role	O
in	O
T	O
-	O
cell	O
signaling	O
,	O
most	O
likely	O
via	O
a	O
direct	O
interaction	O
with	O
the	O
upstream	O
kinase	O
Zap	B-Biological_Molecule
-	I-Biological_Molecule
70	E-Biological_Molecule
.	O

The	O
effect	O
of	O
Dex	O
was	O
completely	O
reversed	O
by	O
a	O
glucocorticoid	B-Biological_Molecule
receptor	E-Biological_Molecule
antagonist	O
,	O
RU38486	O
.	O

RESULTS	O
:	O
The	O
immunolabeling	O
of	O
the	O
catalytic	O
subunit	O
of	O
cAMP	O
-	O
dependent	O
protein	O
kinase	O
was	O
significantly	O
different	O
among	O
groups	O
(	O
P	O
<	O
.	O
001	O
)	O
,	O
with	O
higher	O
values	O
in	O
untreated	O
depressed	O
and	O
manic	O
patients	O
with	O
bipolar	O
disorder	O
compared	O
with	O
untreated	O
euthymic	O
patients	O
with	O
bipolar	O
disorder	O
and	O
healthy	O
subjects	O
.	O

These	O
results	O
indicate	O
that	O
a	O
single	O
cytokine	O
receptor	O
can	O
activate	O
different	O
STAT	O
family	O
members	O
in	O
a	O
cell	O
-	O
specific	O
manner	O
,	O
which	O
might	O
result	O
in	O
cell	O
-	O
specific	O
gene	O
transcription	O
.	O

AML	O
is	O
characterized	O
by	O
a	O
block	O
in	O
myeloid	O
differentiation	O
.	O

We	O
analyzed	O
the	O
ability	O
of	O
the	O
trans	O
-	O
dimer	O
encoded	O
by	O
HLA	O
-	O
DQA1	O
*	O
0501	O
/	O
DQB1	O
*	O
0302	O
to	O
bind	O
a	O
peptide	O
antigen	O
which	O
interacts	O
with	O
DQ	O
molecules	O
encoded	O
by	O
both	O
parental	O
haplotypes	O
.	O

They	O
are	O
growth	O
-	O
inhibited	O
by	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta1	E-Biological_Molecule
.	O

Data	O
regarding	O
the	O
processes	O
by	O
which	O
these	O
cytokines	O
transduce	O
signals	O
from	O
the	O
cell	O
membrane	O
to	O
the	O
nucleus	O
are	O
becoming	O
increasingly	O
complex	O
.	O

Retinoic	O
acid	O
(	O
RA	O
)	O
resistance	O
is	O
a	O
serious	O
problem	O
for	O
patients	O
with	O
acute	O
promyelocytic	O
leukemia	O
(	O
APL	O
)	O
who	O
are	O
receiving	O
all	O
-	O
trans	O
RA	O
.	O

RXRs	O
heterodimerize	O
with	O
1	B-Biological_Molecule
,	I-Biological_Molecule
25	I-Biological_Molecule
-	I-Biological_Molecule
dihydroxyvitamin	I-Biological_Molecule
D3	I-Biological_Molecule
[	I-Biological_Molecule
1	I-Biological_Molecule
,	I-Biological_Molecule
25	I-Biological_Molecule
(	I-Biological_Molecule
OH	I-Biological_Molecule
)	I-Biological_Molecule
2D3	I-Biological_Molecule
]	I-Biological_Molecule
receptor	E-Biological_Molecule
(	O
VDR	S-Biological_Molecule
)	O
,	O
enabling	O
their	O
efficient	O
transcriptional	O
activation	O
.	O

Human	O
immunodeficiency	O
virus	O
-	O
associated	O
Hodgkin	O
'	O
s	O
disease	O
derives	O
from	O
post	O
-	O
germinal	O
center	O
B	O
cells	O
.	O

Human	O
immunodeficiency	O
virus	O
-	O
associated	O
Hodgkin	O
'	O
s	O
disease	O
(	O
HIV	O
-	O
HD	O
)	O
displays	O
several	O
peculiarities	O
when	O
compared	O
with	O
HD	O
of	O
the	O
general	O
population	O
.	O

These	O
effects	O
were	O
specific	O
in	O
that	O
the	O
potentiated	O
phagocytosis	O
of	O
apoptotic	O
neutrophils	O
was	O
completely	O
blocked	O
by	O
the	O
glucocorticoid	B-Biological_Molecule
receptor	E-Biological_Molecule
antagonist	O
RU38486	O
,	O
and	O
glucocorticoids	O
did	O
not	O
promote	O
5	O
-	O
day	O
M	O
phi	O
ingestion	O
of	O
opsonized	O
erythrocytes	O
.	O

The	O
influence	O
on	O
interleukin	B-Biological_Molecule
(	I-Biological_Molecule
IL	I-Biological_Molecule
)	I-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
and	O
interferon	B-Biological_Molecule
(	I-Biological_Molecule
IFN	I-Biological_Molecule
)	I-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
production	O
;	O
IL	O
-	O
2	O
receptor	O
(	O
IL	O
-	O
2R	O
)	O
alpha	O
-	O
,	O
beta	O
-	O
,	O
and	O
gamma	O
-	O
chain	O
;	O
and	O
the	O
signaling	O
pathway	O
molecules	O
Janus	B-Biological_Molecule
kinase	I-Biological_Molecule
(	I-Biological_Molecule
Jak	I-Biological_Molecule
)	I-Biological_Molecule
1	E-Biological_Molecule
,	O
Jak3	S-Biological_Molecule
,	O
signal	B-Biological_Molecule
transducers	I-Biological_Molecule
and	I-Biological_Molecule
activators	I-Biological_Molecule
of	I-Biological_Molecule
transcription	I-Biological_Molecule
(	I-Biological_Molecule
Stat	I-Biological_Molecule
)	I-Biological_Molecule
1	E-Biological_Molecule
,	O
Stat3	S-Biological_Molecule
,	O
and	O
Stat5	S-Biological_Molecule
should	O
be	O
investigated	O
.	O

Jak1	S-Biological_Molecule
,	O
Jak3	S-Biological_Molecule
,	O
Stat1	S-Biological_Molecule
,	O
Stat3	S-Biological_Molecule
,	O
and	O
Stat5	S-Biological_Molecule
expression	O
is	O
suppressed	O
approximately	O
to	O
,	O
or	O
below	O
the	O
level	O
of	O
unstimulated	O
cells	O
.	O

By	O
Edman	O
sequencing	O
we	O
could	O
identify	O
a	O
caspase	B-Biological_Molecule
3	E-Biological_Molecule
cleavage	O
site	O
after	O
Asp584	O
(	O
D584AQPQAGR	O
)	O
,	O
generating	O
a	O
22	O
-	O
kDa	O
C	O
-	O
terminal	O
SP1	S-Biological_Molecule
protein	O
fragment	O
which	O
still	O
contains	O
the	O
DNA	O
binding	O
site	O
.	O

Furthermore	O
,	O
pre	O
-	O
B	O
cell	O
and	O
plasma	O
cell	O
lines	O
were	O
Spi	B-Biological_Molecule
-	I-Biological_Molecule
C	E-Biological_Molecule
-	O
negative	O
,	O
suggesting	O
that	O
Spi	B-Biological_Molecule
-	I-Biological_Molecule
C	E-Biological_Molecule
might	O
be	O
a	O
regulatory	O
molecule	O
during	O
a	O
specific	O
phase	O
of	O
B	O
lymphoid	O
development	O
.	O

One	O
month	O
later	O
she	O
was	O
admitted	O
with	O
signs	O
of	O
acute	O
adrenal	O
failure	O
,	O
i	O
.	O
e	O
.	O
fatigue	O
,	O
severe	O
nausea	O
,	O
blood	O
pressure	O
of	O
80	O
/	O
60	O
mmHg	O
,	O
extracellular	O
dehydration	O
,	O
hyponatremia	O
(	O
118	O
mmol	O
/	O
l	O
)	O
;	O
hyperkalemia	O
(	O
7	O
.	O
6	O
mmol	O
/	O
l	O
)	O
,	O
increased	O
blood	O
urea	O
nitrogen	O
(	O
BUN	O
)	O
(	O
200	O
mg	O
/	O
dl	O
)	O
and	O
creatininemia	O
(	O
2	O
.	O
5	O
mg	O
/	O
dl	O
)	O
,	O
and	O
decreased	O
plasma	O
bicarbonates	O
level	O
(	O
HCO3	O
-	O
:	O
16	O
mmol	O
/	O
l	O
;	O
N	O
:	O
27	O
-	O
30	O
)	O
.	O

However	O
,	O
we	O
detected	O
a	O
significant	O
reduction	O
of	O
the	O
GR	S-Biological_Molecule
mRNA	O
levels	O
in	O
the	O
endobronchial	O
biopsy	O
specimens	O
after	O
FP	O
treatment	O
(	O
36	O
.	O
6	O
+	O
/	O
-	O
23	O
.	O
1	O
and	O
25	O
.	O
0	O
+	O
/	O
-	O
10	O
.	O
9	O
amol	O
GR	S-Biological_Molecule
mRNA	O
/	O
microg	O
RNA	O
,	O
respectively	O
;	O
P	O
<	O
.	O
01	O
)	O
.	O

T	O
cell	O
proliferation	O
and	O
production	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
,	O
and	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
induced	O
by	O
both	O
CD3	O
and	O
CD3	O
/	O
CD28	S-Biological_Molecule
ligation	O
and	O
the	O
nuclear	O
expression	O
of	O
the	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Jun	E-Biological_Molecule
and	O
ATF	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
proteins	O
are	O
each	O
blocked	O
by	O
the	O
p38	O
MAPK	O
inhibitor	O
SB203580	O
.	O

The	O
pocket	O
protein	O
-	O
E2F	O
complexes	O
are	O
convergence	O
points	O
for	O
cell	O
cycle	O
signaling	O
.	O

Bcl	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
expression	O
in	O
reactive	O
follicular	O
hyperplasia	O
,	O
follicular	O
lymphoma	O
,	O
and	O
angioimmunoblastic	O
T	O
-	O
cell	O
lymphoma	O
with	O
hyperplastic	O
germinal	O
centers	O
:	O
heterogeneity	O
of	O
intrafollicular	O
T	O
-	O
cells	O
and	O
their	O
altered	O
distribution	O
in	O
the	O
pathogenesis	O
of	O
angioimmunoblastic	O
T	O
-	O
cell	O
lymphoma	O
.	O

Intrafollicular	O
CD57	S-Biological_Molecule
+	O
cells	O
did	O
not	O
stain	O
for	O
Bcl	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
,	O
and	O
were	O
also	O
depleted	O
in	O
AITL	O
/	O
GC	O
.	O

(	O
5	O
)	O
Some	O
neoplastic	O
cells	O
in	O
AITL	O
stained	O
for	O
Bcl	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
,	O
suggesting	O
up	O
-	O
regulation	O
of	O
Bcl	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
expression	O
in	O
this	O
tumor	O
.	O

Induction	O
of	O
apoptosis	O
of	O
mononucleated	O
cells	O
is	O
a	O
physiological	O
process	O
for	O
regulating	O
the	O
intensity	O
of	O
the	O
immune	O
response	O
.	O

TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
-	O
mediated	O
induction	O
of	O
apoptosis	O
has	O
been	O
well	O
characterized	O
in	O
myeloid	O
cells	O
.	O

We	O
investigated	O
whether	O
E2	O
and	O
Prog	O
could	O
interfere	O
with	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
-	O
induced	O
apoptosis	O
of	O
the	O
monoblastoid	O
U937	O
cell	O
line	O
.	O

Furthermore	O
,	O
the	O
SH2	O
-	O
deleted	O
Grf40	S-Biological_Molecule
mutant	O
led	O
to	O
a	O
marked	O
inhibition	O
of	O
these	O
regulatory	O
activities	O
,	O
the	O
effect	O
of	O
which	O
is	O
apparently	O
stronger	O
than	O
that	O
of	O
the	O
SH2	O
-	O
deleted	O
Grb2	S-Biological_Molecule
mutant	O
.	O

BACKGROUND	O
:	O
We	O
reported	O
on	O
the	O
constitutive	O
interferon	O
-	O
gamma	O
receptor	O
(	O
IFN	O
-	O
gammaR	O
)	O
expression	O
on	O
eosinophils	O
.	O

The	O
results	O
therefore	O
provide	O
initial	O
evidence	O
linking	O
abnormal	O
behavior	O
of	O
STAT	O
pathways	O
for	O
cytokine	O
signaling	O
to	O
the	O
development	O
of	O
an	O
inflammatory	O
disease	O
.	O

HLA	O
class	O
I	O
-	O
mediated	O
induction	O
of	O
cell	O
proliferation	O
involves	O
cyclin	O
E	O
-	O
mediated	O
inactivation	O
of	O
Rb	S-Biological_Molecule
function	O
and	O
induction	O
of	O
E2F	O
activity	O
.	O

HLA	O
class	O
I	O
-	O
mediated	O
inactivation	O
of	O
Rb	S-Biological_Molecule
can	O
be	O
inhibited	O
specifically	O
by	O
neutralizing	O
Abs	O
to	O
basic	O
fibroblast	O
growth	O
factor	O
(	O
bFGF	O
)	O
,	O
suggesting	O
a	O
role	O
for	O
FGF	O
receptors	O
in	O
the	O
signaling	O
process	O
.	O

The	O
molecular	O
basis	O
of	O
GC	O
insensitivity	O
is	O
unknown	O
.	O

Alternative	O
splicing	O
of	O
the	O
GC	B-Biological_Molecule
receptor	E-Biological_Molecule
(	O
GCR	S-Biological_Molecule
)	O
pre	O
-	O
mRNA	O
generates	O
a	O
second	O
GCR	O
,	O
termed	O
GCRbeta	S-Biological_Molecule
,	O
which	O
does	O
not	O
bind	O
GC	O
but	O
antagonizes	O
the	O
transactivating	O
activity	O
of	O
the	O
classic	O
GCR	S-Biological_Molecule
.	O

We	O
conclude	O
that	O
GC	O
-	O
insensitive	O
asthma	O
is	O
associated	O
with	O
increased	O
expression	O
of	O
GCRbeta	S-Biological_Molecule
in	O
airway	O
T	O
cells	O
.	O

Differences	O
in	O
phosphorylation	O
of	O
the	O
IL	O
-	O
2R	O
associated	O
JAK	O
/	O
STAT	O
proteins	O
between	O
HTLV	O
-	O
I	O
(	O
+	O
)	O
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
-	O
independent	O
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
-	O
dependent	O
cell	O
lines	O
and	O
uncultured	O
leukemic	O
cells	O
from	O
patients	O
with	O
adult	O
T	O
-	O
cell	O
lymphoma	O
/	O
leukemia	O
.	O

The	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Myc	E-Biological_Molecule
oncoprotein	O
is	O
important	O
in	O
control	O
of	O
cellular	O
proliferation	O
and	O
differentiation	O
,	O
while	O
Yin	B-Biological_Molecule
-	I-Biological_Molecule
Yang	I-Biological_Molecule
1	E-Biological_Molecule
(	O
YY1	S-Biological_Molecule
)	O
has	O
been	O
shown	O
to	O
control	O
the	O
expression	O
of	O
a	O
number	O
of	O
cellular	O
and	O
viral	O
genes	O
.	O

Binding	O
of	O
glucocorticoids	O
to	O
hGR	S-Biological_Molecule
down	O
-	O
regulates	O
the	O
transcription	O
of	O
inflammatory	O
genes	O
that	O
can	O
propagate	O
IBD	O
.	O

IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
levels	O
in	O
all	O
IBD	O
groups	O
with	O
and	O
without	O
steroids	O
were	O
significantly	O
different	O
from	O
those	O
in	O
control	O
subjects	O
.	O

Furthermore	O
,	O
NF90	S-Biological_Molecule
was	O
phosphorylated	O
in	O
a	O
double	O
-	O
stranded	O
RNA	O
-	O
dependent	O
manner	O
likely	O
by	O
the	O
interferon	B-Biological_Molecule
-	I-Biological_Molecule
induced	I-Biological_Molecule
,	I-Biological_Molecule
double	I-Biological_Molecule
-	I-Biological_Molecule
stranded	I-Biological_Molecule
RNA	I-Biological_Molecule
-	I-Biological_Molecule
dependent	I-Biological_Molecule
protein	I-Biological_Molecule
kinase	E-Biological_Molecule
,	O
PKR	S-Biological_Molecule
.	O

As2O3	O
-	O
induced	O
apoptosis	O
was	O
preceded	O
by	O
delta	O
psi	O
(	O
m	O
)	O
collapse	O
.	O

As2O3	O
may	O
prove	O
useful	O
in	O
the	O
treatment	O
of	O
malignant	O
lymphoproliferative	O
disorders	O
.	O

We	O
recently	O
developed	O
an	O
assay	O
in	O
which	O
nuclear	O
export	O
of	O
the	O
shuttling	O
transcription	O
factor	O
NFAT	O
(	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
)	O
can	O
be	O
reconstituted	O
in	O
permeabilized	O
cells	O
with	O
the	O
GTPase	O
Ran	S-Biological_Molecule
and	O
the	O
nuclear	O
export	O
receptor	O
CRM1	S-Biological_Molecule
.	O

Expression	O
of	O
Th1	O
and	O
Th2	O
type	O
cytokines	O
responding	O
to	O
HBsAg	S-Biological_Molecule
and	O
HBxAg	S-Biological_Molecule
in	O
chronic	O
hepatitis	O
B	O
patients	O
.	O

We	O
found	O
that	O
erythropoietin	S-Biological_Molecule
(	O
EPO	S-Biological_Molecule
)	O
and	O
stem	B-Biological_Molecule
cell	I-Biological_Molecule
factor	E-Biological_Molecule
(	O
SCF	S-Biological_Molecule
)	O
activated	O
protein	B-Biological_Molecule
kinase	I-Biological_Molecule
B	E-Biological_Molecule
(	O
PKB	S-Biological_Molecule
/	O
Akt	S-Biological_Molecule
)	O
in	O
EPO	S-Biological_Molecule
-	O
dependent	O
HCD57	O
erythroid	O
cells	O
.	O

We	O
investigated	O
the	O
involvement	O
of	O
STATs	O
in	O
the	O
transformation	O
of	O
T	O
-	O
cells	O
by	O
HTLV	O
-	O
1	O
.	O

Modulation	O
of	O
CD28	S-Biological_Molecule
expression	O
:	O
distinct	O
regulatory	O
pathways	O
during	O
activation	O
and	O
replicative	O
senescence	O
.	O

Glucocorticoid	B-Biological_Molecule
receptor	E-Biological_Molecule
characteristics	O
were	O
examined	O
on	O
mononuclear	O
leukocytes	O
by	O
measuring	O
[	O
3H	O
]	O
dexamethasone	O
binding	O
and	O
the	O
effect	O
of	O
dexamethasone	O
on	O
[	O
3H	O
]	O
thymidine	O
incorporation	O
,	O
which	O
represents	O
an	O
index	O
of	O
DNA	O
synthesis	O
.	O

CONCLUSIONS	O
:	O
These	O
data	O
indicate	O
that	O
the	O
lack	O
of	O
cushingoid	O
features	O
in	O
patients	O
with	O
anorexia	O
nervosa	O
is	O
not	O
ascribable	O
to	O
a	O
reduced	O
sensitivity	O
to	O
glucocorticoids	O
but	O
is	O
more	O
likely	O
due	O
to	O
the	O
paucity	O
of	O
metabolic	O
substrates	O
.	O

1	O
,	O
25	O
-	O
Dihydroxyvitamin	O
D3	O
(	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
)	O
plays	O
a	O
major	O
role	O
in	O
the	O
stimulation	O
of	O
bone	O
growth	O
,	O
mineralization	O
,	O
and	O
intestinal	O
calcium	O
and	O
phosphate	O
absorption	O
;	O
it	O
also	O
acts	O
as	O
a	O
general	O
inhibitor	O
of	O
cellular	O
proliferation	O
.	O

These	O
results	O
provide	O
compelling	O
links	O
between	O
the	O
efficiency	O
of	O
the	O
20	O
-	O
epi	O
analogue	O
in	O
inducing	O
VDR	S-Biological_Molecule
/	O
DRIP	O
interactions	O
,	O
transactivation	O
in	O
vitro	O
,	O
and	O
its	O
enhanced	O
ability	O
to	O
induce	O
cellular	O
differentiation	O
.	O

Immune	O
functions	O
,	O
clinical	O
parameters	O
and	O
hormone	O
receptor	O
status	O
in	O
breast	O
cancer	O
patients	O
.	O

Immune	O
parameters	O
,	O
natural	O
killer	O
cell	O
and	O
T	O
lymphocyte	O
functions	O
and	O
the	O
numbers	O
of	O
circulating	O
T	O
lymphocytes	O
were	O
analysed	O
against	O
the	O
clinical	O
parameters	O
comprising	O
the	O
tumour	O
burden	O
,	O
the	O
stage	O
of	O
the	O
disease	O
and	O
the	O
expression	O
of	O
hormone	O
receptors	O
on	O
the	O
tumour	O
.	O

In	O
order	O
to	O
analyse	O
the	O
immune	O
function	O
data	O
effectively	O
,	O
low	O
responders	O
were	O
identified	O
with	O
stringent	O
cut	O
-	O
off	O
values	O
.	O

This	O
shows	O
that	O
the	O
induction	O
of	O
gene	O
expression	O
by	O
FICZ	O
and	O
UV	O
is	O
Ah	B-Biological_Molecule
receptor	E-Biological_Molecule
dependent	O
.	O

Chemokines	O
are	O
a	O
group	O
of	O
chemotactic	O
cytokines	O
involved	O
in	O
the	O
recruitment	O
of	O
inflammatory	O
cells	O
.	O

H2O2	O
-	O
induced	O
nuclear	O
translocation	O
of	O
STAT3	S-Biological_Molecule
to	O
form	O
sequence	O
-	O
specific	O
DNA	O
-	O
bound	O
complexes	O
was	O
evidenced	O
by	O
immunoblotting	O
of	O
nuclear	O
fractions	O
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
and	O
vanadate	O
was	O
found	O
to	O
strongly	O
synergize	O
with	O
H2O2	O
.	O

Evidence	O
is	O
also	O
presented	O
,	O
using	O
Fe2	O
+	O
/	O
Cu2	O
+	O
ions	O
,	O
that	O
.	O
OH	O
generated	O
from	O
H2O2	O
through	O
Fenton	O
reactions	O
could	O
be	O
a	O
candidate	O
oxygen	O
reactive	O
species	O
to	O
directly	O
activate	O
STAT3	S-Biological_Molecule
.	O

CBP	S-Biological_Molecule
/	O
p300	S-Biological_Molecule
integrates	O
Raf	O
/	O
Rac	O
-	O
signaling	O
pathways	O
in	O
the	O
transcriptional	O
induction	O
of	O
NF	B-Biological_Molecule
-	I-Biological_Molecule
ATc	E-Biological_Molecule
during	O
T	O
cell	O
activation	O
.	O

The	O
presence	O
of	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBP	I-Biological_Molecule
beta	E-Biological_Molecule
was	O
confirmed	O
by	O
immunohistochemistry	O
and	O
Western	O
blot	O
analysis	O
with	O
isolated	O
synovial	O
fibroblasts	O
.	O

This	O
immunosuppressive	O
drug	O
is	O
known	O
to	O
prevent	O
T	O
-	O
cell	O
proliferation	O
,	O
but	O
the	O
precise	O
point	O
at	O
which	O
rapamycin	O
regulates	O
T	O
-	O
cell	O
cycle	O
progression	O
has	O
yet	O
to	O
be	O
elucidated	O
.	O

Moreover	O
,	O
the	O
effects	O
of	O
rapamycin	O
on	O
,	O
and	O
the	O
role	O
of	O
p70	B-Biological_Molecule
(	I-Biological_Molecule
s6k	I-Biological_Molecule
)	E-Biological_Molecule
in	O
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
and	O
PI	O
3	O
-	O
kinase	O
activation	O
of	O
E2Fs	O
have	O
not	O
been	O
characterized	O
.	O

To	O
investigate	O
the	O
effect	O
of	O
treatment	O
with	O
a	O
pan	O
anti	O
gamma	O
/	O
delta	O
antibody	O
,	O
lymphocytes	O
were	O
incubated	O
for	O
3	O
hr	O
with	O
the	O
antibody	O
,	O
and	O
then	O
interleukin	B-Biological_Molecule
(	I-Biological_Molecule
IL	I-Biological_Molecule
)	I-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
,	O
IL	O
-	O
12	O
and	O
progesterone	B-Biological_Molecule
-	I-Biological_Molecule
induced	I-Biological_Molecule
blocking	I-Biological_Molecule
factor	E-Biological_Molecule
(	O
PIBF	S-Biological_Molecule
)	O
expression	O
(	O
by	O
immuno	O
-	O
cytochemistry	O
)	O
as	O
well	O
as	O
natural	O
killer	O
(	O
NK	O
)	O
cell	O
activity	O
were	O
determined	O
.	O

Ninety	O
-	O
seven	O
percent	O
of	O
gamma	O
/	O
delta	O
TCR	O
+	O
pregnancy	O
lymphocytes	O
expressed	O
progesterone	B-Biological_Molecule
receptor	E-Biological_Molecule
.	O

Combined	O
treatment	O
of	O
HPCs	O
with	O
alpha	O
-	O
PML	O
and	O
alpha	O
-	O
Rb	O
oligomers	O
inhibited	O
both	O
PML	S-Biological_Molecule
and	O
Rb	S-Biological_Molecule
protein	O
expression	O
and	O
completely	O
blocked	O
erythroid	O
colony	O
development	O
.	O

Furthermore	O
,	O
PML	S-Biological_Molecule
and	O
pRb	B-Biological_Molecule
105	E-Biological_Molecule
were	O
co	O
-	O
immunoprecipitated	O
in	O
cellular	O
lysates	O
derived	O
from	O
erythroid	O
precursors	O
indicating	O
that	O
this	O
functional	O
interaction	O
may	O
have	O
a	O
biochemical	O
basis	O
.	O

Tyrphostin	O
AG	O
-	O
490	O
inhibits	O
cytokine	O
-	O
mediated	O
JAK3	S-Biological_Molecule
/	O
STAT5a	S-Biological_Molecule
/	O
b	S-Biological_Molecule
signal	O
transduction	O
and	O
cellular	O
proliferation	O
of	O
antigen	O
-	O
activated	O
human	O
T	O
cells	O
.	O

Janus	B-Biological_Molecule
kinase	I-Biological_Molecule
3	E-Biological_Molecule
(	O
JAK3	S-Biological_Molecule
)	O
is	O
a	O
cytoplasmic	O
tyrosine	O
kinase	O
required	O
for	O
T	O
cell	O
development	O
and	O
activated	O
by	O
cytokines	O
that	O
utilize	O
the	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
2	I-Biological_Molecule
(	I-Biological_Molecule
IL	I-Biological_Molecule
-	I-Biological_Molecule
2	I-Biological_Molecule
)	I-Biological_Molecule
receptor	I-Biological_Molecule
common	I-Biological_Molecule
gamma	I-Biological_Molecule
chain	E-Biological_Molecule
(	O
gamma	B-Biological_Molecule
(	I-Biological_Molecule
c	I-Biological_Molecule
)	E-Biological_Molecule
)	O
.	O

Genetic	O
inactivation	O
of	O
JAK3	S-Biological_Molecule
is	O
manifested	O
as	O
severe	O
combined	O
immunodeficiency	O
disease	O
(	O
SCID	O
)	O
in	O
humans	O
and	O
mice	O
.	O

Here	O
we	O
provide	O
novel	O
evidence	O
that	O
AG	O
-	O
490	O
potently	O
inhibits	O
the	O
autokinase	O
activity	O
of	O
JAK3	S-Biological_Molecule
and	O
tyrosine	O
phosphorylation	O
and	O
DNA	O
binding	O
of	O
signal	B-Biological_Molecule
transducer	I-Biological_Molecule
and	I-Biological_Molecule
activator	I-Biological_Molecule
of	I-Biological_Molecule
transcription	I-Biological_Molecule
5a	E-Biological_Molecule
and	O
5b	S-Biological_Molecule
(	O
STAT5a	S-Biological_Molecule
/	O
b	S-Biological_Molecule
)	O
.	O

After	O
binding	O
of	O
ligand	O
,	O
the	O
EPOR	S-Biological_Molecule
activates	O
a	O
variety	O
of	O
signaling	O
pathways	O
that	O
ultimately	O
control	O
cellular	O
proliferation	O
,	O
survival	O
,	O
and	O
specific	O
gene	O
expression	O
.	O

Interestingly	O
,	O
when	O
we	O
fused	O
HT	O
-	O
2	O
cells	O
expressing	O
the	O
EPOR	S-Biological_Molecule
with	O
Ba	O
/	O
F3	O
cells	O
in	O
a	O
complementation	O
assay	O
,	O
the	O
resulting	O
hybridomas	O
proliferated	O
and	O
potently	O
activated	O
STAT	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
and	O
MAPK	O
in	O
response	O
to	O
EPO	S-Biological_Molecule
.	O

These	O
findings	O
delineate	O
a	O
novel	O
pathway	O
in	O
the	O
cytokine	O
network	O
in	O
which	O
Th2	O
lymphocytes	O
"	O
control	O
"	O
eosinophils	O
via	O
the	O
release	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
,	O
and	O
activation	O
of	O
NF	O
-	O
AT	O
in	O
eosinophils	O
.	O

To	O
test	O
whether	O
disordered	O
memory	O
T	O
cell	O
differentiation	O
contributes	O
to	O
the	O
typical	O
Th1	O
-	O
dominated	O
chronic	O
inflammation	O
in	O
RA	O
we	O
investigated	O
differentiation	O
of	O
resting	O
CD4	O
+	O
memory	O
T	O
cells	O
in	O
patients	O
with	O
early	O
(	O
6	O
wk	O
to	O
12	O
mo	O
)	O
untreated	O
RA	O
and	O
in	O
age	O
-	O
and	O
sex	O
-	O
matched	O
healthy	O
controls	O
in	O
vitro	O
.	O

Copyright	O
1999	O
Academic	O
Press	O
.	O

Recent	O
studies	O
suggest	O
that	O
one	O
or	O
more	O
cytoplasmic	O
serine	O
kinases	O
also	O
phosphorylate	O
STAT3	S-Biological_Molecule
and	O
are	O
necessary	O
for	O
maximal	O
gene	O
activation	O
.	O

However	O
,	O
disruption	O
of	O
a	O
membrane	O
-	O
proximal	O
proline	O
-	O
rich	O
sequence	O
motif	O
(	O
'	O
box1	O
'	O
)	O
in	O
either	O
subunit	O
of	O
the	O
bipartite	O
IL	O
-	O
4R	O
abolished	O
not	O
only	O
ligand	O
-	O
induced	O
tyrosine	O
phosphorylation	O
of	O
Janus	O
kinases	O
JAK1	S-Biological_Molecule
and	O
JAK3	S-Biological_Molecule
,	O
but	O
also	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
-	O
triggered	O
activation	O
of	O
STAT5	O
and	O
concomitant	O
cell	O
proliferation	O
.	O

However	O
,	O
a	O
minority	O
of	O
genes	O
are	O
semi	O
-	O
dominant	O
,	O
as	O
heterozygous	O
loss	O
-	O
of	O
-	O
function	O
mutation	O
in	O
these	O
genes	O
leads	O
to	O
phenotypic	O
abnormalities	O
.	O

The	O
allele	O
-	O
specific	O
regulation	O
of	O
Pax5	S-Biological_Molecule
raises	O
the	O
intriguing	O
possibility	O
that	O
monoallelic	O
expression	O
may	O
also	O
be	O
the	O
mechanism	O
causing	O
the	O
haploinsufficiency	O
of	O
other	O
Pax	O
genes	O
.	O

It	O
has	O
been	O
demonstrated	O
that	O
interferon	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
(	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
)	O
and	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
(	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
)	O
have	O
various	O
reverse	O
effects	O
on	O
macrophages	O
;	O
however	O
,	O
the	O
molecular	O
mechanism	O
of	O
this	O
difference	O
has	O
not	O
been	O
fully	O
understood	O
.	O

This	O
finding	O
indicates	O
that	O
L	O
.	O
pneumophila	O
RpoS	S-Biological_Molecule
is	O
not	O
required	O
for	O
a	O
stationary	O
-	O
phase	O
-	O
dependent	O
resistance	O
to	O
stress	O
.	O

Although	O
the	O
mutant	O
strain	O
was	O
able	O
to	O
kill	O
HL	O
-	O
60	O
-	O
and	O
THP	O
-	O
1	O
-	O
derived	O
macrophages	O
,	O
it	O
could	O
not	O
replicate	O
within	O
a	O
protozoan	O
host	O
,	O
Acanthamoeba	O
castellanii	O
.	O

Cutting	O
edge	O
:	O
TCR	O
stimulation	O
by	O
antibody	O
and	O
bacterial	O
superantigen	O
induces	O
Stat3	S-Biological_Molecule
activation	O
in	O
human	O
T	O
cells	O
.	O

Said	O
anthropometric	O
,	O
metabolic	O
and	O
hormonal	O
parameters	O
were	O
compared	O
with	O
the	O
index	O
of	O
lymphocytic	O
infiltration	O
of	O
tumor	O
selected	O
as	O
a	O
prognostic	O
factor	O
.	O

TNFalpha	S-Biological_Molecule
decreased	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
,	O
while	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
increased	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
,	O
the	O
concentration	O
of	O
dexamethasone	O
binding	O
sites	O
in	O
these	O
cells	O
,	O
with	O
no	O
discernible	O
effect	O
on	O
their	O
binding	O
affinity	O
.	O

Modulation	O
of	O
normal	O
erythroid	O
differentiation	O
by	O
the	O
endogenous	O
thyroid	O
hormone	O
and	O
retinoic	O
acid	O
receptors	O
:	O
a	O
possible	O
target	O
for	O
v	B-Biological_Molecule
-	I-Biological_Molecule
erbA	E-Biological_Molecule
oncogene	O
action	O
.	O

Retinoic	O
acid	O
(	O
RA	O
)	O
distinctly	O
modulated	O
the	O
erythroid	O
differentiation	O
program	O
of	O
normal	O
erythroid	O
progenitors	O
and	O
erythroblasts	O
reversibly	O
transformed	O
by	O
a	O
conditional	O
tyrosine	O
kinase	O
oncogene	O
.	O

Thyroid	O
hormone	O
(	O
T3	O
)	O
alone	O
caused	O
similar	O
but	O
weaker	O
effects	O
.	O

A	O
major	O
difficulty	O
in	O
determination	O
of	O
glucocorticoid	B-Biological_Molecule
receptor	E-Biological_Molecule
sites	O
is	O
the	O
very	O
complicated	O
assay	O
procedure	O
.	O

The	O
factor	O
responsible	O
for	O
this	O
activity	O
was	O
designated	O
Oct	O
coactivator	O
from	O
B	O
cells	O
(	O
OCA	B-Biological_Molecule
-	I-Biological_Molecule
B	E-Biological_Molecule
)	O
.	O

Taken	O
together	O
,	O
our	O
results	O
suggest	O
that	O
OCA	B-Biological_Molecule
-	I-Biological_Molecule
B	E-Biological_Molecule
is	O
a	O
tissue	O
-	O
,	O
promoter	O
-	O
,	O
and	O
factor	O
-	O
specific	O
coactivator	O
and	O
that	O
OCA	B-Biological_Molecule
-	I-Biological_Molecule
B	E-Biological_Molecule
may	O
be	O
a	O
major	O
determinant	O
for	O
B	O
cell	O
-	O
specific	O
activation	O
of	O
immunoglobulin	O
promoters	O
.	O

Both	O
c	B-Biological_Molecule
-	I-Biological_Molecule
fos	E-Biological_Molecule
and	O
jun	B-Biological_Molecule
B	E-Biological_Molecule
mRNAs	O
decreased	O
to	O
pre	O
-	O
activation	O
levels	O
within	O
6	O
h	O
,	O
while	O
c	B-Biological_Molecule
-	I-Biological_Molecule
jun	E-Biological_Molecule
mRNA	O
remained	O
elevated	O
.	O

SCL	S-Biological_Molecule
is	O
expressed	O
in	O
erythroid	O
,	O
megakaryocyte	O
and	O
mast	O
cell	O
populations	O
(	O
the	O
same	O
cell	O
lineages	O
as	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
a	O
zinc	O
-	O
finger	O
transcription	O
factor	O
)	O
.	O

The	O
DNA	O
-	O
binding	O
protein	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
is	O
required	O
for	O
normal	O
erythroid	O
development	O
and	O
regulates	O
erythroid	O
-	O
expressed	O
genes	O
in	O
maturing	O
erythroblasts	O
.	O

Interaction	O
of	O
fibronectin	S-Biological_Molecule
with	O
VLA	B-Biological_Molecule
-	I-Biological_Molecule
5	I-Biological_Molecule
receptor	E-Biological_Molecule
on	O
CD4	S-Biological_Molecule
cells	O
induces	O
the	O
AP	O
-	O
1	O
transcription	O
factor	O
.	O

Most	O
B	O
lymphocyte	O
lines	O
expressed	O
negligible	O
levels	O
of	O
1	B-Biological_Molecule
,	I-Biological_Molecule
25	I-Biological_Molecule
(	I-Biological_Molecule
OH	I-Biological_Molecule
)	I-Biological_Molecule
2D3	I-Biological_Molecule
receptor	E-Biological_Molecule
RNA	O
and	O
protein	O
;	O
however	O
;	O
analysis	O
of	O
a	O
lymphoid	O
/	O
myeloid	O
somatic	O
hybrid	O
suggested	O
that	O
suppression	O
of	O
expression	O
of	O
1	B-Biological_Molecule
,	I-Biological_Molecule
25	I-Biological_Molecule
(	I-Biological_Molecule
OH	I-Biological_Molecule
)	I-Biological_Molecule
2D3	I-Biological_Molecule
receptor	E-Biological_Molecule
RNA	O
in	O
B	O
lymphocytes	O
may	O
be	O
a	O
dominant	O
characteristic	O
.	O

Here	O
we	O
report	O
the	O
cloning	O
of	O
murine	O
TCF	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
.	O

Murine	O
and	O
human	O
TCF	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
displayed	O
a	O
95	O
.	O
5	O
%	O
overall	O
amino	O
acid	O
homology	O
.	O

With	O
the	O
murine	O
cDNA	O
clones	O
several	O
aspects	O
of	O
TCF	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
were	O
analyzed	O
.	O

The	O
Tax1	S-Biological_Molecule
-	O
inducible	O
transcription	O
factors	O
identified	O
here	O
are	O
encoded	O
by	O
the	O
members	O
of	O
immediate	O
early	O
genes	O
under	O
the	O
control	O
of	O
growth	O
signals	O
.	O

Since	O
the	O
Rhom	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
gene	O
is	O
such	O
a	O
common	O
site	O
of	O
chromosomal	O
damage	O
in	O
T	O
-	O
cell	O
tumors	O
,	O
the	O
consistency	O
of	O
translocations	O
near	O
the	O
rhombotin	S-Biological_Molecule
gene	O
was	O
further	O
examined	O
.	O

We	O
show	O
that	O
both	O
CREB	S-Biological_Molecule
isoforms	O
are	O
expressed	O
in	O
many	O
cell	O
types	O
and	O
mammalian	O
species	O
.	O

Exposure	O
of	O
RWLeu	O
-	O
4	O
cells	O
to	O
VD3	O
also	O
inhibited	O
proliferation	O
and	O
DNA	O
synthesis	O
with	O
a	O
50	O
%	O
effective	O
dose	O
of	O
3	O
.	O
5	O
-	O
10	O
nM	O
within	O
72	O
h	O
;	O
in	O
addition	O
,	O
protein	O
and	O
RNA	O
synthesis	O
were	O
inhibited	O
by	O
VD3	O
treatment	O
.	O

Lt	O
-	O
4	O
reacted	O
with	O
all	O
HTLV	O
-	O
I	O
-	O
bearing	O
cell	O
lines	O
tested	O
and	O
five	O
out	O
of	O
eight	O
simian	O
cell	O
lines	O
bearing	O
STLV	O
-	O
I	O
,	O
but	O
not	O
with	O
an	O
HTLV	O
-	O
II	O
-	O
bearing	O
cell	O
line	O
.	O

Abnormal	O
renal	O
tubular	O
phosphate	O
transport	O
is	O
considered	O
to	O
be	O
the	O
primary	O
defect	O
in	O
X	O
-	O
linked	O
hypophosphatemic	O
rickets	O
(	O
XLH	O
)	O
.	O

In	O
order	O
to	O
investigate	O
this	O
possibility	O
,	O
we	O
measured	O
the	O
concentration	O
of	O
VDR	S-Biological_Molecule
in	O
PHA	O
-	O
activated	O
peripheral	O
mononuclear	O
cells	O
from	O
10	O
XLH	O
patients	O
.	O

In	O
mutant	O
leukemic	O
cells	O
resistant	O
to	O
the	O
lytic	O
effects	O
of	O
dexamethasone	O
,	O
CVZ	O
both	O
lyses	O
the	O
cells	O
and	O
recognizes	O
a	O
single	O
class	O
of	O
sites	O
similar	O
to	O
the	O
high	O
affinity	O
site	O
in	O
CEM	O
C7	O
cells	O
.	O

Lymphocytic	O
levels	O
of	O
glucocorticoid	B-Biological_Molecule
receptors	E-Biological_Molecule
were	O
evaluated	O
in	O
114	O
patients	O
suffering	O
from	O
Icenko	O
-	O
Cushing	O
'	O
s	O
syndrome	O
.	O

The	O
effects	O
of	O
a	O
competitive	O
progesterone	O
antagonist	O
(	O
RU486	O
)	O
and	O
a	O
specific	O
glucocorticoid	B-Biological_Molecule
receptor	E-Biological_Molecule
blocker	O
(	O
RU43044	O
)	O
were	O
tested	O
on	O
the	O
release	O
of	O
a	O
blocking	O
factor	O
by	O
progesterone	O
-	O
treated	O
pregnancy	O
lymphocytes	O
.	O

Truncation	O
of	O
TR	B-Biological_Molecule
alpha	I-Biological_Molecule
1	E-Biological_Molecule
at	O
amino	O
acid	O
210	O
prevented	O
additional	O
complex	O
formation	O
in	O
the	O
presence	O
of	O
NE	O
without	O
affecting	O
DNA	O
binding	O
,	O
suggesting	O
that	O
the	O
carboxyl	O
-	O
terminus	O
of	O
the	O
TRs	O
is	O
essential	O
for	O
interaction	O
with	O
nuclear	O
proteins	O
.	O

It	O
is	O
stated	O
that	O
GCR	S-Biological_Molecule
of	O
healthy	O
controls	O
and	O
GCS	O
-	O
untreated	O
patients	O
outnumbered	O
those	O
of	O
cortisol	O
-	O
dependent	O
BA	O
patients	O
on	O
hormone	O
therapy	O
.	O

Megakaryocytic	O
and	O
erythrocytic	O
lineages	O
share	O
specific	O
transcription	O
factors	O
.	O

Thus	O
,	O
EBNA	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
transactivation	O
of	O
LMP1	S-Biological_Molecule
amplifies	O
the	O
biological	O
impact	O
of	O
EBNA	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
and	O
underscores	O
its	O
central	O
role	O
in	O
EBV	O
-	O
induced	O
growth	O
transformation	O
.	O

Protein	O
kinase	O
inhibitor	O
H	O
-	O
7	O
blocks	O
accumulation	O
of	O
unspliced	O
mRNA	O
of	O
human	O
T	O
-	O
cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV	O
-	O
I	O
)	O
.	O

Rex	S-Biological_Molecule
,	O
the	O
post	O
-	O
transcriptional	O
regulator	O
of	O
human	O
T	O
-	O
cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV	O
-	O
I	O
)	O
,	O
is	O
known	O
to	O
induce	O
accumulation	O
of	O
the	O
unspliced	O
viral	O
gag	S-Biological_Molecule
-	O
pol	S-Biological_Molecule
mRNA	O
.	O

Mononuclear	O
leukocyte	O
glucocorticoid	B-Biological_Molecule
receptor	E-Biological_Molecule
binding	O
characteristics	O
and	O
down	O
-	O
regulation	O
in	O
major	O
depression	O
.	O

By	O
paired	O
t	O
-	O
test	O
,	O
Bmax	O
decreased	O
significantly	O
in	O
the	O
control	O
group	O
but	O
not	O
in	O
the	O
depressed	O
group	O
.	O

When	O
p56	O
is	O
immunoadsorbed	O
from	O
IM	O
-	O
9	O
cell	O
cytosol	O
,	O
both	O
the	O
70	B-Biological_Molecule
-	E-Biological_Molecule
and	O
90	B-Biological_Molecule
-	I-Biological_Molecule
kDa	I-Biological_Molecule
heat	I-Biological_Molecule
shock	I-Biological_Molecule
proteins	E-Biological_Molecule
are	O
coadsorbed	O
in	O
an	O
immune	O
-	O
specific	O
manner	O
.	O

Detection	O
in	O
non	O
-	O
erythroid	O
cells	O
of	O
a	O
factor	O
with	O
the	O
binding	O
characteristics	O
of	O
the	O
erythroid	O
cell	O
transcription	O
factor	O
EF1	S-Biological_Molecule
.	O

These	O
results	O
suggest	O
that	O
BCL6	S-Biological_Molecule
plays	O
a	O
role	O
in	O
activated	O
lymphocytes	O
as	O
an	O
immediate	O
early	O
gene	O
.	O

The	O
survival	O
-	O
promoting	O
activity	O
of	O
the	O
Bcl	O
-	O
2	O
family	O
of	O
proteins	O
appears	O
to	O
be	O
modulated	O
by	O
interactions	O
between	O
various	O
cellular	O
proteins	O
.	O

Kinetic	O
studies	O
using	O
mixed	O
cytosol	O
indicated	O
that	O
B95	O
-	O
8	O
cytosol	O
did	O
not	O
affect	O
the	O
apparent	O
dissociation	O
rate	O
of	O
[	O
3H	O
]	O
dexamethasone	O
.	O

The	O
STAT	O
proteins	O
utilized	O
by	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
7	E-Biological_Molecule
were	O
identical	O
to	O
those	O
induced	O
by	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
and	O
could	O
be	O
identified	O
as	O
various	O
STAT	O
5	O
isoforms	O
.	O

Only	O
SRI	O
responders	O
showed	O
GCII	S-Biological_Molecule
sites	O
/	O
cell	O
upregulated	O
after	O
6	O
weeks	O
of	O
treatment	O
(	O
t	O
=	O
2	O
.	O
1	O
,	O
df	O
=	O
10	O
;	O
p	O
<	O
.	O
05	O
)	O
.	O

Many	O
cytokines	O
activate	O
signal	O
transducer	O
and	O
activation	O
of	O
transcription	O
(	O
STAT	O
)	O
transcription	O
factors	O
,	O
which	O
,	O
in	O
turn	O
,	O
activate	O
transcription	O
of	O
inflammatory	O
effector	O
genes	O
.	O

From	O
these	O
results	O
,	O
we	O
conclude	O
that	O
CD38	S-Biological_Molecule
is	O
ATRA	O
inducible	O
in	O
myeloid	O
leukemia	O
cells	O
and	O
normal	O
CD34	O
+	O
bone	O
marrow	O
cells	O
.	O

This	O
effect	O
is	O
independent	O
of	O
differentiation	O
and	O
is	O
mediated	O
by	O
RAR	B-Biological_Molecule
alpha	E-Biological_Molecule
in	O
HL	O
-	O
60	O
cells	O
,	O
suggesting	O
a	O
similar	O
role	O
for	O
RAR	B-Biological_Molecule
alpha	E-Biological_Molecule
in	O
CD38	S-Biological_Molecule
expression	O
in	O
other	O
hematopoietic	O
cells	O
.	O

Their	O
effects	O
on	O
the	O
src	O
-	O
family	O
tyrosine	O
kinase	O
genes	O
were	O
different	O
:	O
hck	S-Biological_Molecule
expression	O
was	O
similarly	O
induced	O
by	O
these	O
agents	O
but	O
lyn	S-Biological_Molecule
expression	O
was	O
stronger	O
and	O
more	O
rapid	O
after	O
RA	O
treatment	O
.	O

To	O
examine	O
whether	O
the	O
AP	O
-	O
1	O
enhancer	O
activity	O
is	O
involved	O
in	O
RA	O
-	O
induced	O
monocytic	O
differentiation	O
,	O
THP	O
-	O
1	O
cells	O
were	O
transiently	O
transfected	O
with	O
a	O
chloramphenicol	B-Biological_Molecule
acetyl	I-Biological_Molecule
transferase	E-Biological_Molecule
(	O
CAT	S-Biological_Molecule
)	O
-	O
reporter	O
gene	O
containing	O
5	O
copies	O
of	O
the	O
AP	O
-	O
1	O
binding	O
sites	O
.	O

However	O
,	O
all	O
20	O
cases	O
lacked	O
the	O
t	O
(	O
15	O
;	O
17	O
)	O
and	O
17	O
cases	O
tested	O
lacked	O
the	O
promyelocytic	B-Biological_Molecule
/	I-Biological_Molecule
retinoic	I-Biological_Molecule
acid	I-Biological_Molecule
receptor	I-Biological_Molecule
alpha	E-Biological_Molecule
(	O
RAR	B-Biological_Molecule
alpha	E-Biological_Molecule
)	O
fusion	O
transcript	O
in	O
RT	O
-	O
PCR	O
assays	O
;	O
12	O
cases	O
had	O
46	O
,	O
XX	O
or	O
46	O
,	O
XY	O
karyotypes	O
,	O
whereas	O
2	O
cases	O
had	O
abnormalities	O
of	O
chromosome	O
17q	O
:	O
1	O
with	O
del	O
(	O
17	O
)	O
(	O
q25	O
)	O
and	O
the	O
other	O
with	O
t	O
(	O
11	O
;	O
17	O
)	O
(	O
q23	O
;	O
q21	O
)	O
and	O
the	O
promyelocytic	B-Biological_Molecule
leukemia	I-Biological_Molecule
zinc	I-Biological_Molecule
finger	E-Biological_Molecule
/	O
RAR	B-Biological_Molecule
alpha	E-Biological_Molecule
fusion	O
transcript	O
.	O

Our	O
studies	O
suggest	O
that	O
this	O
form	O
of	O
acute	O
leukemia	O
may	O
arise	O
from	O
transformation	O
of	O
a	O
precursor	O
cell	O
common	O
to	O
both	O
the	O
myeloid	O
and	O
NK	O
cell	O
lineages	O
;	O
thus	O
we	O
propose	O
the	O
designation	O
myeloid	O
/	O
NK	O
acute	O
leukemia	O
.	O

Inhibition	O
of	O
the	O
differentiation	O
of	O
human	O
myeloid	O
cell	O
lines	O
by	O
redox	O
changes	O
induced	O
through	O
glutathione	O
depletion	O
.	O

Moreover	O
,	O
DEM	O
abolished	O
phorbol	O
12	O
-	O
myristate	O
13	O
-	O
acetate	O
-	O
induced	O
activation	O
of	O
the	O
transcription	O
factors	O
AP	O
-	O
1	O
and	O
Egr	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
suggesting	O
that	O
inhibition	O
of	O
differentiation	O
may	O
be	O
due	O
,	O
at	O
least	O
in	O
part	O
,	O
to	O
redox	O
modifications	O
of	O
these	O
proteins	O
.	O

This	O
protein	O
had	O
an	O
apparent	O
molecular	O
mass	O
of	O
84	O
kDa	O
and	O
was	O
not	O
recognized	O
by	O
stat3	S-Biological_Molecule
or	O
stat1	O
mAb	O
or	O
antisera	O
.	O

Taken	O
together	O
,	O
we	O
report	O
that	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
induces	O
tyrosine	O
phosphorylation	O
and	O
subsequent	O
nuclear	O
translocation	O
of	O
stat3	S-Biological_Molecule
and	O
an	O
as	O
yet	O
undefined	O
84	O
-	O
kDa	O
protein	O
in	O
antigen	O
-	O
specific	O
human	O
T	O
cell	O
lines	O
.	O

The	O
present	O
study	O
was	O
undertaken	O
to	O
determine	O
the	O
role	O
of	O
HTLV	O
-	O
I	O
TaxI	S-Biological_Molecule
in	O
the	O
up	O
-	O
regulation	O
of	O
ICAM	B-Biological_Molecule
-	I-Biological_Molecule
I	E-Biological_Molecule
and	O
LFA	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
in	O
human	O
T	O
cells	O
transformed	O
with	O
HTLV	O
-	O
I	O
and	O
the	O
mechanism	O
of	O
down	O
-	O
regulation	O
of	O
ICAM	B-Biological_Molecule
-	I-Biological_Molecule
I	E-Biological_Molecule
and	O
LFA	O
-	O
I	O
in	O
ATL	O
-	O
derived	O
cell	O
lines	O
.	O

Collectively	O
,	O
(	O
a	O
)	O
transcriptional	O
factor	O
(	O
s	O
)	O
necessary	O
for	O
expression	O
of	O
ICAM	B-Biological_Molecule
-	I-Biological_Molecule
I	E-Biological_Molecule
gene	O
may	O
be	O
repressed	O
in	O
MT	O
-	O
I	O
through	O
DNA	O
methylation	O
.	O

Three	O
other	O
ATL	O
cell	O
lines	O
(	O
TL	O
-	O
OmI	O
,	O
H582	O
,	O
HuT102	O
)	O
were	O
found	O
to	O
have	O
little	O
mRNA	O
for	O
the	O
LFA	B-Biological_Molecule
-	I-Biological_Molecule
I	I-Biological_Molecule
beta	I-Biological_Molecule
chain	E-Biological_Molecule
(	O
CD18	S-Biological_Molecule
)	O
.	O

Addition	O
of	O
CM	O
caused	O
a	O
greater	O
than	O
70	O
%	O
reduction	O
of	O
cell	O
proliferation	O
by	O
cell	O
counting	O
and	O
cell	O
cycle	O
.	O

The	O
expression	O
of	O
several	O
cytoskeleton	O
and	O
intracellular	O
proteins	O
increased	O
as	O
determined	O
by	O
immunostaining	O
on	O
slides	O
and	O
by	O
ELISA	O
procedures	O
.	O

These	O
included	O
vimentin	S-Biological_Molecule
,	O
correlating	O
to	O
cell	O
shape	O
changes	O
,	O
cytokeratins	O
8	O
and	O
18	O
,	O
associated	O
with	O
differentiated	O
cell	O
types	O
of	O
prostate	O
epithelia	O
,	O
and	O
neuron	B-Biological_Molecule
-	I-Biological_Molecule
specific	I-Biological_Molecule
enolase	E-Biological_Molecule
and	O
serotonin	O
,	O
associated	O
with	O
neuroendocrine	O
cells	O
.	O

IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
treatment	O
of	O
both	O
T	O
cells	O
and	O
monocytes	O
results	O
in	O
the	O
ligand	O
-	O
induced	O
tyrosine	O
phosphorylation	O
of	O
tyk2	S-Biological_Molecule
and	O
Jak1	S-Biological_Molecule
,	O
but	O
not	O
Jak2	S-Biological_Molecule
or	O
Jak3	S-Biological_Molecule
.	O

These	O
findings	O
suggest	O
a	O
mechanism	O
by	O
which	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
binding	O
to	O
its	O
receptor	O
may	O
activate	O
specific	O
genes	O
involved	O
in	O
immune	O
cell	O
function	O
.	O

Treatment	O
of	O
immunoprecipitated	O
NFATp	S-Biological_Molecule
from	O
untreated	O
HT	O
-	O
2	O
cells	O
with	O
calcineurin	O
resulted	O
in	O
the	O
dephosphorylation	O
of	O
NFATp	S-Biological_Molecule
,	O
demonstrating	O
that	O
NFATp	S-Biological_Molecule
is	O
an	O
in	O
vitro	O
substrate	O
for	O
calcineurin	O
.	O

DESIGN	O
:	O
The	O
effects	O
of	O
hypercortisolaemia	O
,	O
hyperthermia	O
and	O
cellular	O
composition	O
on	O
number	O
of	O
glucocorticoid	B-Biological_Molecule
receptors	E-Biological_Molecule
per	O
cell	O
and	O
their	O
affinity	O
were	O
evaluated	O
,	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
in	O
peripheral	O
blood	O
mononuclear	O
leucocytes	O
of	O
control	O
subjects	O
and	O
in	O
patients	O
with	O
sepsis	O
or	O
septic	O
shock	O
.	O

SUBJECTS	O
:	O
Fifteen	O
patients	O
(	O
age	O
25	O
-	O
79	O
)	O
with	O
sepsis	O
or	O
septic	O
shock	O
who	O
were	O
admitted	O
to	O
an	O
intensive	O
care	O
unit	O
were	O
studied	O
.	O

MEASUREMENTS	O
:	O
The	O
binding	O
capacity	O
and	O
affinity	O
of	O
the	O
glucocorticoid	B-Biological_Molecule
receptors	E-Biological_Molecule
were	O
measured	O
and	O
compared	O
to	O
clinical	O
data	O
and	O
the	O
plasma	O
cortisol	O
concentrations	O
.	O

Inasmuch	O
as	O
these	O
features	O
implicate	O
enhanced	O
calcitriol	O
action	O
in	O
gut	O
and	O
bone	O
,	O
we	O
analyzed	O
the	O
vitamin	B-Biological_Molecule
D	I-Biological_Molecule
receptor	E-Biological_Molecule
(	O
VDR	S-Biological_Molecule
)	O
gene	O
to	O
ascertain	O
whether	O
an	O
abnormality	O
of	O
this	O
gene	O
marks	O
patients	O
with	O
intestinal	O
hyperabsorption	O
of	O
calcium	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
the	O
human	O
GM	B-Biological_Molecule
-	I-Biological_Molecule
CSF	I-Biological_Molecule
receptor	I-Biological_Molecule
alpha	E-Biological_Molecule
promoter	O
directs	O
reporter	O
gene	O
activity	O
in	O
a	O
tissue	O
-	O
specific	O
fashion	O
in	O
myelomonocytic	O
cells	O
,	O
which	O
correlates	O
with	O
its	O
expression	O
pattern	O
as	O
analyzed	O
by	O
reverse	O
transcription	O
PCR	O
.	O

Furthermore	O
,	O
we	O
demonstrate	O
that	O
the	O
PU	O
-	O
SF	O
complex	O
binds	O
to	O
PU	B-Biological_Molecule
.	I-Biological_Molecule
1	E-Biological_Molecule
sites	O
found	O
on	O
a	O
number	O
of	O
myeloid	O
promoters	O
,	O
and	O
its	O
formation	O
requires	O
an	O
intact	O
PU	B-Biological_Molecule
.	I-Biological_Molecule
1	E-Biological_Molecule
site	O
adjacent	O
to	O
a	O
single	O
-	O
stranded	O
region	O
.	O

However	O
,	O
the	O
difference	O
of	O
NDP	B-Biological_Molecule
kinase	E-Biological_Molecule
expression	O
between	O
KA	O
and	O
SCC	O
was	O
not	O
statistically	O
significant	O
.	O

Our	O
results	O
contradict	O
the	O
hypothesis	O
concerning	O
the	O
possible	O
role	O
of	O
nm23	S-Biological_Molecule
gene	O
as	O
a	O
metastatic	O
suppressor	O
gene	O
in	O
human	O
skin	O
cancer	O
.	O

As	O
expected	O
,	O
the	O
TCF	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
protein	O
was	O
detectable	O
only	O
in	O
cell	O
lines	O
of	O
T	O
lineage	O
.	O

Its	O
expression	O
was	O
always	O
restricted	O
to	O
the	O
nucleus	O
.	O

Upon	O
cellular	O
activation	O
,	O
expression	O
of	O
the	O
L	B-Biological_Molecule
-	I-Biological_Molecule
selectin	E-Biological_Molecule
gene	O
is	O
downregulated	O
at	O
both	O
the	O
protein	O
and	O
mRNA	O
levels	O
.	O

These	O
results	O
indicated	O
that	O
ATL	O
cells	O
constitutively	O
overexpress	O
the	O
L	B-Biological_Molecule
-	I-Biological_Molecule
selectin	E-Biological_Molecule
gene	O
that	O
can	O
be	O
transactivated	O
by	O
HTLV	O
-	O
1	O
Tax	S-Biological_Molecule
.	O

The	O
DNA	O
and	O
steroid	O
binding	O
domains	O
of	O
the	O
glucocorticoid	B-Biological_Molecule
receptor	E-Biological_Molecule
are	O
not	O
altered	O
in	O
mononuclear	O
cells	O
of	O
treated	O
CLL	O
patients	O
.	O

In	O
one	O
individual	O
who	O
had	O
not	O
been	O
treated	O
before	O
analysis	O
a	O
silent	O
mutation	O
was	O
found	O
in	O
one	O
receptor	O
allele	O
.	O

Attenuation	O
of	O
gamma	B-Biological_Molecule
interferon	E-Biological_Molecule
-	O
induced	O
tyrosine	O
phosphorylation	O
in	O
mononuclear	O
phagocytes	O
infected	O
with	O
Leishmania	O
donovani	O
:	O
selective	O
inhibition	O
of	O
signaling	O
through	O
Janus	O
kinases	O
and	O
Stat1	O
.	O

Tyrosine	O
phosphorylation	O
of	O
Jak1	S-Biological_Molecule
,	O
Jak2	S-Biological_Molecule
,	O
and	O
Stat1	O
increased	O
markedly	O
,	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
,	O
in	O
U	O
-	O
937	O
cells	O
incubated	O
with	O
gamma	B-Biological_Molecule
interferon	E-Biological_Molecule
.	O

The	O
RpoN	O
mutant	O
,	O
lacking	O
pili	O
,	O
flagella	O
,	O
and	O
nonpilus	O
adhesins	O
,	O
bound	O
poorly	O
and	O
was	O
resistant	O
to	O
ingestion	O
by	O
both	O
macrophages	O
and	O
neutrophils	O
.	O

Studies	O
were	O
initiated	O
with	O
a	O
fragment	O
extending	O
2	O
,	O
738	O
nucleotides	O
5	O
'	O
to	O
the	O
transcription	O
start	O
site	O
and	O
lead	O
to	O
the	O
identification	O
of	O
253	O
nucleotides	O
retaining	O
full	O
promoter	O
activity	O
in	O
human	O
erythroleukemia	O
cells	O
.	O

Using	O
varying	O
conditions	O
,	O
three	O
distinct	O
complexes	O
were	O
shown	O
to	O
interact	O
specifically	O
with	O
the	O
NIP	O
region	O
,	O
although	O
only	O
one	O
correlates	O
with	O
repressor	O
activity	O
.	O

Complex	O
2	O
corresponds	O
to	O
binding	O
of	O
transcription	O
factor	O
(	O
upstream	O
stimulatory	O
factor	O
)	O
to	O
an	O
E	O
-	O
box	O
motif	O
in	O
the	O
5	O
'	O
portion	O
of	O
the	O
NIP	O
region	O
.	O

Jak	B-Biological_Molecule
2	E-Biological_Molecule
was	O
tyrosine	O
phosphorylated	O
within	O
1	O
to	O
3	O
min	O
after	O
stimulation	O
of	O
eosinophils	O
with	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
.	O

Our	O
results	O
suggest	O
that	O
a	O
similar	O
phenomenon	O
may	O
occur	O
in	O
BL	O
in	O
vivo	O
and	O
indicate	O
that	O
the	O
operational	O
definition	O
of	O
EBV	O
latencies	O
is	O
not	O
easily	O
applied	O
to	O
human	O
tumors	O
.	O

The	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
/	O
receptor	O
interaction	O
activates	O
Lyn	S-Biological_Molecule
and	O
Jak2	B-Biological_Molecule
tyrosine	I-Biological_Molecule
kinases	E-Biological_Molecule
and	O
propagates	O
signals	O
via	O
the	O
Ras	O
-	O
Raf	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
-	O
MAP	O
kinase	O
and	O
the	O
Jak	O
-	O
STAT	O
pathways	O
in	O
eosinophils	O
.	O

We	O
found	O
that	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
induces	O
two	O
GAS	O
-	O
binding	O
proteins	O
in	O
eosinophils	O
,	O
one	O
of	O
which	O
is	O
STAT1	O
.	O

Taken	O
together	O
,	O
these	O
data	O
point	O
to	O
a	O
potential	O
mechanism	O
underlying	O
EBV	O
-	O
mediated	O
B	O
cell	O
transformation	O
whereby	O
constitutive	O
induction	O
of	O
key	O
cell	O
cycle	O
regulators	O
by	O
LMP	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
can	O
lead	O
to	O
pRb	S-Biological_Molecule
hyperphosphorylation	O
and	O
uncontrolled	O
cell	O
proliferation	O
.	O

We	O
have	O
determined	O
the	O
functional	O
role	O
of	O
C	O
/	O
EBP	O
proteins	O
and	O
C	O
/	O
EBP	O
sites	O
in	O
regulating	O
transcription	O
from	O
the	O
HIV	O
-	O
1	O
LTR	O
in	O
monocytes	O
/	O
macrophages	O
.	O

We	O
have	O
recently	O
demonstrated	O
that	O
stimulation	O
of	O
human	O
T	O
and	O
natural	O
killer	O
cells	O
with	O
IL	O
-	O
12	O
induces	O
tyrosine	O
phosphorylation	O
of	O
the	O
Janus	O
family	O
tyrosine	O
kinase	O
JAK2	S-Biological_Molecule
and	O
Tyk2	S-Biological_Molecule
,	O
implicating	O
these	O
kinases	O
in	O
the	O
immediate	O
biochemical	O
response	O
to	O
IL	O
-	O
12	O
.	O

DR	B-Biological_Molecule
-	I-Biological_Molecule
nm23	E-Biological_Molecule
mRNA	O
is	O
preferentially	O
expressed	O
at	O
early	O
stages	O
of	O
myeloid	O
differentiation	O
of	O
highly	O
purified	O
CD34	S-Biological_Molecule
+	O
cells	O
.	O

We	O
previously	O
have	O
demonstrated	O
a	O
requirement	O
for	O
oxidative	O
events	O
during	O
cell	O
cycle	O
entry	O
in	O
T	O
lymphocytes	O
and	O
have	O
hypothesised	O
that	O
reactive	O
oxygen	O
species	O
may	O
act	O
as	O
intracellular	O
signalling	O
agents	O
during	O
lymphocyte	O
activation	O
.	O

This	O
inhibitory	O
effect	O
was	O
limited	O
to	O
the	O
first	O
2	O
h	O
after	O
mitogenic	O
activation	O
,	O
localizing	O
the	O
time	O
-	O
frame	O
of	O
action	O
of	O
cysteamine	O
to	O
within	O
the	O
commitment	O
period	O
.	O

RESULTS	O
:	O
Flutamide	O
was	O
well	O
tolerated	O
in	O
all	O
women	O
,	O
with	O
the	O
noticeable	O
exception	O
of	O
one	O
patient	O
who	O
presented	O
increased	O
serum	O
transaminase	O
after	O
8	O
months	O
of	O
therapy	O
.	O

Before	O
treatment	O
,	O
the	O
number	O
of	O
androgen	B-Biological_Molecule
receptors	E-Biological_Molecule
was	O
higher	O
in	O
the	O
luteal	O
than	O
in	O
the	O
follicular	O
phase	O
.	O

HIV	O
-	O
1	O
envelope	O
glycoproteins	O
induce	O
activation	O
of	O
activated	O
protein	O
-	O
1	O
in	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
[	O
published	O
erratum	O
appears	O
in	O
J	O
Biol	O
Chem	O
1995	O
Dec	O
1	O
;	O
270	O
(	O
48	O
)	O
:	O
29038	O
]	O

Individually	O
or	O
collectively	O
,	O
none	O
of	O
the	O
three	O
enhancer	O
-	O
binding	O
proteins	O
(	O
LEF	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
Ets	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
and	O
TFE	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
)	O
could	O
activate	O
transcription	O
in	O
the	O
absence	O
of	O
Sp1	S-Biological_Molecule
.	O

Dephosphorylation	O
by	O
in	O
vitro	O
treatment	O
with	O
calcineurin	O
or	O
alkaline	B-Biological_Molecule
phosphatase	E-Biological_Molecule
restores	O
NFATp	S-Biological_Molecule
DNA	O
binding	O
activity	O
and	O
its	O
ability	O
to	O
reconstitute	O
an	O
NFAT	O
complex	O
with	O
Fos	O
and	O
Jun	O
proteins	O
.	O

Egr	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
antisense	O
oligomers	O
in	O
the	O
culture	O
media	O
blocked	O
macrophage	O
differentiation	O
in	O
both	O
myeloid	O
leukemia	O
cell	O
lines	O
and	O
normal	O
myeloblasts	O
.	O

In	O
addition	O
,	O
our	O
results	O
indicate	O
that	O
the	O
tal	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
1A	O
promoter	O
,	O
which	O
contains	O
two	O
consensus	O
GATA	O
-	O
binding	O
sites	O
,	O
is	O
active	O
mainly	O
in	O
these	O
lineages	O
.	O

The	O
BAT	O
box	O
and	O
Oct	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
were	O
also	O
implicated	O
in	O
the	O
induction	O
of	O
CD20	S-Biological_Molecule
in	O
the	O
pre	O
-	O
B	O
cell	O
line	O
,	O
PB	O
-	O
697	O
,	O
via	O
phorbol	O
esters	O
.	O

Total	O
RNA	O
isolated	O
from	O
the	O
index	O
subject	O
'	O
s	O
mononuclear	O
leukocytes	O
was	O
used	O
to	O
produce	O
first	O
strand	O
hGR	S-Biological_Molecule
cDNAs	O
,	O
and	O
the	O
entire	O
hGR	S-Biological_Molecule
cDNA	O
was	O
amplified	O
in	O
segments	O
and	O
sequenced	O
.	O

When	O
the	O
wild	O
-	O
type	O
hGR	S-Biological_Molecule
and	O
hGR	S-Biological_Molecule
-	O
Ile	O
729	O
were	O
expressed	O
in	O
CV	O
-	O
1	O
cells	O
that	O
were	O
cotransfected	O
with	O
the	O
mouse	O
mammary	O
tumor	O
virus	O
long	O
terminal	O
repeat	O
fused	O
to	O
the	O
chloramphenicol	B-Biological_Molecule
acetyl	I-Biological_Molecule
transferase	E-Biological_Molecule
(	O
CAT	S-Biological_Molecule
)	O
gene	O
,	O
the	O
hGR	S-Biological_Molecule
-	O
Ile	O
729	O
conferred	O
a	O
fourfold	O
decrease	O
in	O
apparent	O
potency	O
on	O
dexamethasone	O
stimulation	O
of	O
CAT	S-Biological_Molecule
activity	O
.	O

As	O
described	O
by	O
Jun	O
Liu	O
,	O
these	O
drugs	O
manifest	O
their	O
effects	O
in	O
an	O
unprecedented	O
fashion	O
.	O

MTIIa	S-Biological_Molecule
mRNA	O
levels	O
increased	O
significantly	O
.	O

An	O
exogenously	O
expressed	O
Cbf	B-Biological_Molecule
alpha	I-Biological_Molecule
2	E-Biological_Molecule
-	O
encoded	O
subunit	O
(	O
CBF	B-Biological_Molecule
alpha	E-Biological_Molecule
2	O
-	O
451	O
)	O
stimulated	O
transcription	O
from	O
the	O
SL3	O
enhancer	O
in	O
P19	O
and	O
HeLa	O
cells	O
.	O

They	O
also	O
provided	O
support	O
for	O
the	O
hypothesis	O
that	O
CBF	O
is	O
a	O
factor	O
in	O
T	O
lymphocytes	O
that	O
is	O
responsible	O
for	O
recognition	O
of	O
the	O
SL3	O
cores	O
.	O

We	O
hypothesize	O
that	O
activation	O
of	O
this	O
protein	O
,	O
designated	O
hStat5	S-Biological_Molecule
,	O
helps	O
govern	O
the	O
biological	O
effects	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
during	O
the	O
immune	O
response	O
.	O

IL	B-Biological_Molecule
-	I-Biological_Molecule
13	E-Biological_Molecule
Induced	O
the	O
same	O
complexes	O
as	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
,	O
a	O
finding	O
explained	O
by	O
our	O
studies	O
implicating	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4R	E-Biological_Molecule
as	O
a	O
shared	O
component	O
of	O
the	O
receptors	O
.	O

Previous	O
protein	O
-	O
DNA	O
binding	O
studies	O
have	O
shown	O
that	O
HS	B-Biological_Molecule
-	I-Biological_Molecule
40	E-Biological_Molecule
consists	O
of	O
multiple	O
nuclear	O
factor	O
binding	O
motifs	O
that	O
are	O
occupied	O
in	O
vivo	O
in	O
an	O
erythroid	O
lineage	O
-	O
and	O
developmental	O
stage	O
-	O
specific	O
manner	O
.	O

Erythropoietin	S-Biological_Molecule
stimulates	O
transcription	O
of	O
the	O
TAL1	S-Biological_Molecule
/	O
SCL	S-Biological_Molecule
gene	O
and	O
phosphorylation	O
of	O
its	O
protein	O
products	O
.	O

Since	O
the	O
terminal	O
events	O
of	O
erythropoiesis	O
are	O
controlled	O
by	O
the	O
glycoprotein	O
hormone	O
erythropoietin	S-Biological_Molecule
(	O
Epo	S-Biological_Molecule
)	O
,	O
we	O
investigated	O
whether	O
the	O
expression	O
or	O
activity	O
of	O
the	O
TAL1	S-Biological_Molecule
gene	O
and	O
its	O
protein	O
products	O
were	O
affected	O
by	O
Epo	S-Biological_Molecule
in	O
splenic	O
erythroblasts	O
from	O
mice	O
infected	O
with	O
an	O
anemia	O
-	O
inducing	O
strain	O
of	O
Friend	O
virus	O
(	O
FVA	O
cells	O
)	O
.	O

An	O
antiserum	O
to	O
this	O
enzyme	O
was	O
used	O
to	O
isolate	O
a	O
cDNA	O
clone	O
.	O

Inhibition	O
of	O
membrane	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2R	I-Biological_Molecule
alpha	E-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2R	I-Biological_Molecule
beta	E-Biological_Molecule
expression	O
by	O
10	O
(	O
-	O
6	O
)	O
M	O
DM	O
was	O
partially	O
reversible	O
by	O
recombinant	O
human	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
(	O
rhIL	O
-	O
2	O
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
whether	O
NF	O
-	O
kappa	O
B	O
is	O
related	O
to	O
a	O
particular	O
cell	O
type	O
and	O
/	O
or	O
differentiation	O
step	O
during	O
immunopoiesis	O
.	O

We	O
next	O
studied	O
p65	S-Biological_Molecule
and	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Rel	E-Biological_Molecule
protein	O
expression	O
in	O
FDC	O
clusters	O
.	O

Furthermore	O
,	O
R24	O
treatment	O
resulted	O
in	O
translocation	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
rel	E-Biological_Molecule
,	O
but	O
little	O
or	O
no	O
NF	O
kappa	O
B	O
p50	S-Biological_Molecule
or	O
p65	S-Biological_Molecule
,	O
from	O
the	O
cytoplasm	O
to	O
the	O
nucleus	O
and	O
an	O
increase	O
of	O
NF	O
kappa	O
B	O
binding	O
complexes	O
containing	O
c	B-Biological_Molecule
-	I-Biological_Molecule
rel	E-Biological_Molecule
and	O
p50	S-Biological_Molecule
.	O

R24	O
-	O
stimulated	O
increases	O
in	O
proliferation	O
,	O
cytotoxicity	O
,	O
and	O
cell	O
surface	O
protein	O
expression	O
could	O
be	O
blocked	O
by	O
cyclosporin	O
and	O
staurosporin	O
,	O
indicating	O
that	O
cyclophilin	O
/	O
calcineurin	O
and	O
protein	O
kinase	O
C	O
may	O
be	O
involved	O
in	O
the	O
R24	O
signaling	O
pathway	O
.	O

Additionally	O
,	O
herbimycin	O
A	O
,	O
a	O
tyrosine	O
kinase	O
inhibitor	O
,	O
blocked	O
the	O
R24	O
-	O
stimulated	O
increase	O
in	O
proliferation	O
but	O
not	O
cytotoxicity	O
at	O
concentrations	O
consistent	O
with	O
specificity	O
for	O
tyrosine	O
kinases	O
.	O

When	O
responses	O
to	O
G	O
(	O
Anh	O
)	O
MTetra	O
were	O
compared	O
with	O
those	O
to	O
LPS	O
and	O
muramyldipeptide	O
(	O
MDP	O
)	O
,	O
it	O
was	O
found	O
that	O
the	O
optimal	O
response	O
to	O
G	O
(	O
Anh	O
)	O
MTetra	O
induction	O
was	O
similar	O
to	O
that	O
of	O
LPS	O
but	O
significantly	O
higher	O
than	O
the	O
response	O
to	O
MDP	O
.	O

Transcription	O
factor	O
NF	O
-	O
kappa	O
B	O
(	O
p50	S-Biological_Molecule
/	O
p65	S-Biological_Molecule
)	O
is	O
generally	O
localized	O
to	O
the	O
cytoplasm	O
by	O
its	O
inhibitor	O
I	O
kappa	O
B	O
.	O

Overproduced	O
I	O
kappa	O
B	O
,	O
free	O
from	O
NF	O
-	O
kappa	O
B	O
,	O
is	O
rapidly	O
degraded	O
.	O

This	O
signal	O
transduction	O
is	O
dependent	O
on	O
the	O
cytoplasmic	O
domain	O
,	O
which	O
consists	O
of	O
213	O
amino	O
acids	O
.	O

Our	O
results	O
indicated	O
that	O
the	O
extracellular	O
domain	O
of	O
the	O
type	B-Biological_Molecule
II	I-Biological_Molecule
IL	I-Biological_Molecule
-	I-Biological_Molecule
1R	E-Biological_Molecule
was	O
capable	O
of	O
functionally	O
interacting	O
with	O
interleukin	O
-	O
1	O
and	O
transmitting	O
the	O
resulting	O
signal	O
to	O
a	O
heterologous	O
cytoplasmic	O
domain	O
.	O

Cells	O
from	O
TNFRp55	S-Biological_Molecule
-	O
/	O
-	O
mutant	O
mice	O
lack	O
expression	O
of	O
TNFRp55	S-Biological_Molecule
but	O
display	O
normal	O
numbers	O
of	O
high	O
affinity	O
TNFRp75	S-Biological_Molecule
molecules	O
.	O

Minimally	O
modified	O
low	O
density	O
lipoprotein	O
-	O
induced	O
inflammatory	O
responses	O
in	O
endothelial	O
cells	O
are	O
mediated	O
by	O
cyclic	O
adenosine	O
monophosphate	O
.	O

In	O
the	O
present	O
studies	O
we	O
have	O
examined	O
the	O
signaling	O
pathways	O
by	O
which	O
this	O
monocyte	O
-	O
specific	O
response	O
is	O
induced	O
.	O

Enhanced	O
TR75	S-Biological_Molecule
expression	O
on	O
OM	O
-	O
10	O
.	O
1	O
cells	O
followed	O
the	O
same	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
-	O
dose	O
dependency	O
as	O
that	O
observed	O
for	O
HIV	O
-	O
1	O
production	O
.	O

Antibody	O
cross	O
-	O
linking	O
of	O
TR55	S-Biological_Molecule
,	O
in	O
the	O
absence	O
of	O
exogenous	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
,	O
induced	O
maximal	O
HIV	O
-	O
1	O
expression	O
,	O
an	O
up	O
-	O
modulation	O
of	O
surface	O
TR75	S-Biological_Molecule
,	O
and	O
nuclear	O
NF	O
-	O
kappa	O
B	O
activity	O
in	O
OM	O
-	O
10	O
.	O
1	O
cultures	O
.	O

Ras	O
oncogene	O
transformation	O
of	O
human	O
B	O
lymphoblasts	O
is	O
associated	O
with	O
lymphocyte	O
activation	O
and	O
with	O
a	O
block	O
of	O
differentiation	O
.	O

These	O
inhibitory	O
effects	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Rel	E-Biological_Molecule
correlate	O
with	O
its	O
DNA	O
-	O
binding	O
activity	O
but	O
not	O
with	O
its	O
ability	O
to	O
heterodimerize	O
with	O
p50	S-Biological_Molecule
,	O
suggesting	O
that	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Rel	E-Biological_Molecule
inhibition	O
involves	O
competition	O
with	O
p50	S-Biological_Molecule
/	O
p65	S-Biological_Molecule
for	O
occupancy	O
of	O
the	O
kappa	O
B	O
enhancer	O
element	O
.	O

Functional	O
activation	O
of	O
an	O
HIV	O
reporter	O
plasmid	O
by	O
p49	S-Biological_Molecule
/	O
p65	S-Biological_Molecule
in	O
transiently	O
transfected	O
Jurkat	O
T	O
-	O
leukemia	O
cells	O
was	O
also	O
inhibited	O
by	O
coexpression	O
of	O
MAD	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
.	O

Tax1	S-Biological_Molecule
strongly	O
activates	O
the	O
enhancer	O
activity	O
of	O
this	O
motif	O
,	O
in	O
both	O
epithelial	O
HeLa	O
and	O
lymphoid	O
Jurkat	O
cells	O
.	O

This	O
activation	O
was	O
not	O
observed	O
in	O
undifferentiated	O
embryocarcinoma	O
F9	O
cells	O
.	O

Inhibition	O
by	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
of	O
proinflammatory	O
cytokine	O
release	O
appears	O
to	O
occur	O
at	O
the	O
level	O
of	O
gene	O
transcription	O
for	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
and	O
both	O
transcriptionally	O
and	O
posttranscriptionally	O
for	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
.	O

In	O
studies	O
initiated	O
to	O
evaluate	O
relationships	O
between	O
EBV	O
latent	O
genes	O
and	O
p53	S-Biological_Molecule
,	O
p53	S-Biological_Molecule
levels	O
were	O
found	O
to	O
increase	O
approximately	O
10	O
-	O
fold	O
4	O
to	O
5	O
days	O
after	O
EBV	O
infection	O
of	O
purified	O
resting	O
human	O
B	O
cells	O
;	O
the	O
induced	O
p53	S-Biological_Molecule
was	O
transcriptionally	O
active	O
.	O

This	O
inhibition	O
of	O
transcription	O
is	O
specific	O
for	O
NFkappaB	O
;	O
in	O
the	O
absence	O
of	O
tyrosine	O
kinase	O
activity	O
,	O
AP	O
-	O
1	O
-	O
dependent	O
transcription	O
is	O
enhanced	O
.	O

Induction	O
of	O
NF	O
-	O
kappaB	O
-	O
dependent	O
gene	O
expression	O
in	O
transiently	O
transfected	O
human	O
monocytic	O
THP	O
-	O
1	O
cells	O
and	O
human	O
umbilical	O
vein	O
endothelial	O
cells	O
was	O
inhibited	O
by	O
elevated	O
cAMP	O
and	O
by	O
overexpression	O
of	O
the	O
catalytic	O
subunit	O
of	O
protein	O
kinase	O
A	O
(	O
PKA	O
)	O
.	O

The	O
ATRA	O
-	O
induced	O
expression	O
of	O
IRF	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
an	O
activator	O
of	O
transcription	O
and	O
repressor	O
of	O
transformation	O
,	O
may	O
be	O
one	O
of	O
the	O
molecular	O
mechanisms	O
of	O
ATRA	O
-	O
induced	O
growth	O
inhibition	O
,	O
and	O
the	O
basis	O
for	O
the	O
synergistic	O
actions	O
of	O
ATRA	O
and	O
IFNs	O
in	O
myeloid	O
leukemia	O
cells	O
.	O

The	O
inhibiting	O
effect	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
was	O
slightly	O
more	O
pronounced	O
than	O
that	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
.	O

NF	B-Biological_Molecule
-	I-Biological_Molecule
IL6	E-Biological_Molecule
mRNA	O
levels	O
were	O
not	O
affected	O
by	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
or	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
,	O
suggesting	O
that	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
affects	O
binding	O
activity	O
of	O
preexisting	O
NF	B-Biological_Molecule
-	I-Biological_Molecule
IL6	E-Biological_Molecule
.	O

Furthermore	O
,	O
neither	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
nor	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
showed	O
any	O
effect	O
on	O
I	O
-	O
kappa	O
B	O
mRNA	O
expression	O
as	O
determined	O
by	O
Northern	O
experiments	O
.	O

To	O
examine	O
the	O
molecular	O
basis	O
of	O
constitutive	O
NF	O
-	O
kappaB	O
DNA	O
-	O
binding	O
activity	O
in	O
HIV1	O
-	O
infected	O
cells	O
,	O
we	O
analyzed	O
the	O
phosphorylation	O
and	O
turnover	O
of	O
IkappaBalpha	S-Biological_Molecule
protein	O
,	O
the	O
activity	O
of	O
the	O
double	B-Biological_Molecule
-	I-Biological_Molecule
stranded	I-Biological_Molecule
RNA	I-Biological_Molecule
-	I-Biological_Molecule
dependent	I-Biological_Molecule
protein	I-Biological_Molecule
kinase	E-Biological_Molecule
(	O
PKR	S-Biological_Molecule
)	O
and	O
the	O
intracellular	O
levels	O
of	O
NF	O
-	O
kappaB	O
subunits	O
in	O
the	O
PLB	O
-	O
985	O
and	O
U937	O
myeloid	O
cell	O
models	O
.	O

These	O
results	O
suggest	O
that	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
may	O
inhibit	O
the	O
transcription	O
of	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
gene	O
by	O
affecting	O
NF	O
-	O
kappaB	O
binding	O
activity	O
,	O
while	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
may	O
inhibit	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
mRNA	O
levels	O
post	O
-	O
transcriptionally	O
,	O
without	O
suppressing	O
promoter	O
activity	O
.	O

Therefore	O
,	O
we	O
have	O
studied	O
the	O
transcriptional	O
regulation	O
of	O
intercellular	B-Biological_Molecule
adhesion	I-Biological_Molecule
molecule	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
(	O
ICAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
)	O
as	O
adhesion	O
molecules	O
are	O
likely	O
to	O
play	O
a	O
causal	O
role	O
in	O
inflammation	O
in	O
promoting	O
cell	O
-	O
cell	O
and	O
cell	O
-	O
matrix	O
interactions	O
.	O

Our	O
data	O
support	O
the	O
notion	O
that	O
NF	O
(	O
kappa	O
)	O
B	O
and	O
I	O
(	O
kappa	O
)	O
B	O
proteases	O
play	O
obligate	O
roles	O
in	O
T	O
cell	O
activation	O
and	O
mitogenesis	O
,	O
roles	O
that	O
are	O
enhanced	O
significantly	O
by	O
NAC	O
.	O

Rather	O
,	O
tyrosine	O
phosphorylation	O
was	O
shown	O
to	O
be	O
directly	O
involved	O
in	O
mediating	O
CD40	S-Biological_Molecule
-	O
dependent	O
signals	O
.	O

These	O
observations	O
establish	O
the	O
importance	O
of	O
different	O
signal	O
transducing	O
pathways	O
leading	O
to	O
CD40	S-Biological_Molecule
activation	O
of	O
B	O
lymphocytes	O
.	O

These	O
findings	O
indicate	O
that	O
T	O
cells	O
representing	O
different	O
activation	O
and	O
/	O
or	O
differentiation	O
stages	O
can	O
be	O
differentially	O
responsive	O
to	O
ROI	O
-	O
mediated	O
signals	O
.	O

Differential	O
nuclear	O
localization	O
of	O
p50	S-Biological_Molecule
,	O
p52	S-Biological_Molecule
,	O
and	O
RelB	S-Biological_Molecule
proteins	O
in	O
human	O
accessory	O
cells	O
of	O
the	O
immune	O
response	O
in	O
situ	O
.	O

Recently	O
,	O
it	O
has	O
been	O
shown	O
that	O
RelB	S-Biological_Molecule
knockout	O
mice	O
have	O
no	O
dendritic	O
cells	O
(	O
DC	O
)	O
.	O

A	O
constitutive	O
NF	O
-	O
kappa	O
B	O
activity	O
has	O
been	O
reported	O
in	O
mature	O
macrophages	O
.	O

In	O
this	O
study	O
we	O
analyzed	O
the	O
effect	O
of	O
CD40	S-Biological_Molecule
stimulation	O
on	O
the	O
activity	O
and	O
nuclear	O
appearance	O
of	O
Rel	O
/	O
nuclear	O
factor	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
factors	O
in	O
primary	O
murine	O
B	O
lymphocytes	O
.	O

Since	O
LPS	O
and	O
anti	O
-	O
IgM	S-Biological_Molecule
were	O
unable	O
to	O
activate	O
RelB	S-Biological_Molecule
,	O
CD40	S-Biological_Molecule
appears	O
to	O
trigger	O
a	O
special	O
program	O
of	O
gene	O
expression	O
involved	O
in	O
the	O
proliferation	O
and	O
/	O
or	O
differentiation	O
of	O
B	O
lymphocytes	O
.	O

Activation	O
of	O
nuclear	O
factor	O
-	O
kappaB	O
via	O
T	O
cell	O
receptor	O
requires	O
a	O
Raf	O
kinase	O
and	O
Ca2	O
+	O
influx	O
.	O

Functional	O
synergy	O
between	O
Raf	O
and	O
calcineurin	O
.	O

TCR	O
signaling	O
was	O
triggered	O
by	O
treating	O
Jurkat	O
T	O
cells	O
with	O
PHA	S-Biological_Molecule
or	O
anti	O
-	O
CD3	S-Biological_Molecule
Abs	O
,	O
and	O
NF	O
-	O
kappaB	O
activation	O
was	O
monitored	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
and	O
/	O
or	O
by	O
kappaB	O
-	O
dependent	O
reporter	O
assays	O
.	O

Cytomegalovirus	O
(	O
CMV	O
)	O
infection	O
is	O
nonpermissive	O
or	O
persistent	O
in	O
many	O
lymphoid	O
and	O
myeloid	O
cell	O
types	O
but	O
can	O
be	O
activated	O
in	O
differentiated	O
macrophages	O
.	O

Constitutive	O
nuclear	O
appearance	O
was	O
also	O
observed	O
for	O
NF	O
-	O
kB2	O
/	O
p52	S-Biological_Molecule
.	O

It	O
is	O
remarkable	O
that	O
in	O
B	O
-	O
CLL	O
cells	O
the	O
nuclear	O
appearance	O
and	O
DNA	O
binding	O
of	O
specific	O
transcription	O
factors	O
is	O
dramatically	O
affected	O
whereas	O
other	O
members	O
of	O
the	O
same	O
factor	O
family	O
remained	O
unaltered	O
in	O
these	O
leukemic	O
cells	O
.	O

After	O
a	O
2	O
-	O
day	O
incubation	O
in	O
LDL	O
,	O
the	O
binding	O
of	O
NF	O
-	O
kappa	O
B	O
,	O
which	O
is	O
believed	O
to	O
be	O
a	O
key	O
oxidative	O
-	O
stress	O
sensor	O
for	O
VCAM	O
regulation	O
,	O
remains	O
at	O
basal	O
level	O
.	O

However	O
,	O
the	O
nature	O
of	O
the	O
subunit	O
involved	O
in	O
this	O
mechanism	O
has	O
not	O
been	O
defined	O
.	O

Using	O
semiquantitative	O
RT	O
-	O
PCR	O
,	O
we	O
found	O
a	O
striking	O
increase	O
in	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
mRNA	O
levels	O
only	O
in	O
resuscitated	O
HS	O
,	O
with	O
peak	O
levels	O
observed	O
1	O
h	O
after	O
initiation	O
of	O
resuscitation	O
.	O

In	O
situ	O
DNA	O
binding	O
assay	O
determined	O
Stat3	S-Biological_Molecule
activation	O
predominantly	O
within	O
alveoli	O
.	O

CheY	S-Biological_Molecule
-	O
dependent	O
methylation	O
of	O
the	O
asparagine	O
receptor	O
,	O
McpB	S-Biological_Molecule
,	O
during	O
chemotaxis	O
in	O
Bacillus	O
subtilis	O
.	O

We	O
show	O
that	O
the	O
next	O
step	O
is	O
dissociation	O
of	O
50S	O
subunits	O
from	O
the	O
70S	O
posttermination	O
complex	O
and	O
that	O
it	O
is	O
catalyzed	O
by	O
RRF	S-Biological_Molecule
and	O
EF	B-Biological_Molecule
-	I-Biological_Molecule
G	E-Biological_Molecule
and	O
requires	O
GTP	O
hydrolysis	O
.	O

Yet	O
,	O
endoglycosidase	B-Biological_Molecule
H	E-Biological_Molecule
insensitivity	O
indicates	O
an	O
aberrant	O
oligosaccharide	O
structure	O
.	O

Persuasive	O
data	O
exist	O
as	O
to	O
the	O
importance	O
of	O
environmental	O
factors	O
in	O
the	O
pathogenesis	O
of	O
sporadic	O
colorectal	O
cancer	O
.	O

The	O
pattern	O
of	O
lysyl	O
hydroxylation	O
in	O
the	O
nontriple	O
helical	O
domains	O
of	O
collagen	O
is	O
critical	O
in	O
determining	O
the	O
cross	O
-	O
linking	O
pathways	O
that	O
are	O
tissue	O
specific	O
.	O

However	O
,	O
fully	O
differentiated	O
BMSCs	O
,	O
but	O
not	O
NSFs	O
,	O
exhibited	O
a	O
significantly	O
elevated	O
level	O
(	O
6	O
-	O
fold	O
increase	O
)	O
of	O
PLOD2	S-Biological_Molecule
mRNA	O
.	O

Also	O
based	O
on	O
the	O
structure	O
,	O
Phe300	O
has	O
been	O
reported	O
to	O
be	O
hydroxylated	O
due	O
to	O
a	O
naturally	O
occurring	O
posttranslational	O
modification	O
[	O
Goodwill	O
,	O
K	O
.	O
E	O
.	O
,	O
Sabatier	O
,	O
C	O
.	O
,	O
and	O
Stevens	O
,	O
R	O
.	O
C	O
.	O
(	O
1998	O
)	O
Biochemistry	O
37	O
,	O
13437	O
-	O
13445	O
]	O
.	O

The	O
kinetics	O
of	O
remethylation	O
of	O
the	O
p16	S-Biological_Molecule
exon	O
2	O
,	O
PAX	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
exon	O
5	O
,	O
c	B-Biological_Molecule
-	I-Biological_Molecule
ABL	E-Biological_Molecule
exon	O
11	O
,	O
and	O
MYF	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
exon	O
3	O
loci	O
were	O
examined	O
following	O
5	O
-	O
Aza	O
-	O
CdR	O
treatment	O
because	O
these	O
genes	O
contain	O
exonic	O
CpG	O
islands	O
which	O
are	O
hypermethylated	O
in	O
T24	O
cells	O
.	O

Of	O
the	O
8	O
MSI	O
-	O
H	O
patients	O
,	O
5	O
presented	O
hMLH1	S-Biological_Molecule
methylation	O
,	O
whereas	O
no	O
low	O
-	O
frequency	O
MSI	O
(	O
MSI	O
-	O
L	O
)	O
and	O
microsatellite	O
stable	O
(	O
MSS	O
)	O
cases	O
exhibited	O
hMLH1	S-Biological_Molecule
methylation	O
(	O
5	O
/	O
8	O
vs	O
.	O
0	O
/	O
43	O
,	O
p	O
<	O
0	O
.	O
00001	O
)	O
.	O

Ring	O
-	O
A	O
reduction	O
to	O
5alpha	O
-	O
DH	O
-	O
progesterone	O
,	O
20alpha	O
-	O
DH	O
-	O
5alpha	O
-	O
DH	O
-	O
progesterone	O
,	O
and	O
3beta	O
,	O
5alpha	O
-	O
tetrahydro	O
(	O
TH	O
)	O
-	O
progesterone	O
was	O
also	O
documented	O
.	O

We	O
expressed	O
three	O
different	O
constructs	O
of	O
full	O
-	O
length	O
human	O
TSHR	S-Biological_Molecule
in	O
insect	O
cells	O
:	O
(	O
a	O
)	O
a	O
TSHR	S-Biological_Molecule
cDNA	O
lacking	O
signal	O
sequence	O
(	O
TSHR	S-Biological_Molecule
-	O
ns	O
)	O
,	O
(	O
b	O
)	O
a	O
TSHR	S-Biological_Molecule
cDNA	O
containing	O
human	O
TSHR	S-Biological_Molecule
signal	O
sequence	O
(	O
TSHR	S-Biological_Molecule
-	O
hs	O
)	O
and	O
(	O
c	O
)	O
a	O
TSHR	S-Biological_Molecule
cDNA	O
with	O
baculovirus	O
envelope	O
protein	O
encoded	O
signal	O
sequence	O
gp	O
-	O
67	O
(	O
TSHR	S-Biological_Molecule
-	O
gp	O
)	O
.	O

However	O
,	O
only	O
glycosylated	O
proteins	O
(	O
TSHR	S-Biological_Molecule
-	O
hs	O
and	O
TSHR	S-Biological_Molecule
-	O
gp	O
)	O
neutralized	O
the	O
TBII	O
activity	O
of	O
sera	O
from	O
autoimmune	O
thyroid	O
patients	O
,	O
confirming	O
the	O
importance	O
of	O
glycosylation	O
for	O
patient	O
autoantibody	O
reactivity	O
.	O

BasT	S-Biological_Molecule
,	O
a	O
membrane	O
-	O
bound	O
transducer	O
protein	O
for	O
amino	O
acid	O
detection	O
in	O
Halobacterium	O
salinarum	O
.	O

We	O
show	O
here	O
that	O
BasT	S-Biological_Molecule
is	O
a	O
halobacterial	O
transducer	O
protein	O
(	O
Htp	O
)	O
responsible	O
for	O
chemotaxis	O
towards	O
five	O
attractant	O
amino	O
acids	O
.	O

CG	O
,	O
LH	O
,	O
FSH	O
,	O
and	O
TSH	O
are	O
a	O
family	O
of	O
heterodimeric	O
glycoprotein	O
hormones	O
that	O
contain	O
a	O
common	O
alpha	O
-	O
subunit	O
,	O
but	O
differ	O
in	O
their	O
hormone	O
-	O
specific	O
beta	O
-	O
subunits	O
.	O

The	O
thermal	O
stabilities	O
(	O
T	O
(	O
m	O
)	O
)	O
of	O
the	O
COL1	O
,	O
COL2	O
,	O
and	O
COL3	O
domains	O
were	O
38	O
,	O
49	O
and	O
40	O
degrees	O
C	O
,	O
respectively	O
.	O

An	O
increase	O
in	O
histone	S-Biological_Molecule
acetylation	O
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
antagonizing	O
the	O
immunoinhibitory	O
effect	O
are	O
necessary	O
for	O
augmentation	O
by	O
butyrate	O
of	O
in	O
vitro	O
anti	O
-	O
TNP	O
antibody	O
production	O
.	O

To	O
provide	O
more	O
reliable	O
IFAs	O
,	O
we	O
established	O
recombinant	O
Semliki	O
Forest	O
viruses	O
(	O
rSFVs	O
)	O
expressing	O
the	O
HHV	O
-	O
8	O
-	O
specific	O
proteins	O
ORF73	S-Biological_Molecule
and	O
K8	B-Biological_Molecule
.	I-Biological_Molecule
1	E-Biological_Molecule
and	O
used	O
BHK	O
-	O
21	O
cells	O
infected	O
with	O
these	O
rSFVs	O
for	O
IFA	O
(	O
ORF73	S-Biological_Molecule
-	O
IFA	O
and	O
K8	B-Biological_Molecule
.	I-Biological_Molecule
1	E-Biological_Molecule
-	O
IFA	O
)	O
.	O

Titers	O
measured	O
by	O
rSFV	O
-	O
based	O
IFAs	O
and	O
PEL	O
-	O
based	O
IFAs	O
correlated	O
well	O
(	O
correlation	O
coefficients	O
of	O
>	O
0	O
.	O
9	O
)	O
,	O
and	O
concordances	O
of	O
seroreactivities	O
between	O
rSFV	O
-	O
based	O
and	O
PEL	O
-	O
based	O
IFAs	O
were	O
>	O
97	O
%	O
(	O
kappa	O
>	O
0	O
.	O
93	O
)	O
.	O

HHV	O
-	O
8	O
prevalences	O
determined	O
by	O
K8	B-Biological_Molecule
.	I-Biological_Molecule
1	E-Biological_Molecule
-	O
IFA	O
among	O
the	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
-	O
positive	O
(	O
HIV	O
(	O
+	O
)	O
)	O
Kaposi	O
'	O
s	O
sarcoma	O
(	O
KS	O
)	O
patients	O
,	O
HIV	O
(	O
+	O
)	O
KS	O
(	O
-	O
)	O
patients	O
,	O
and	O
healthy	O
controls	O
were	O
100	O
,	O
65	O
,	O
and	O
6	O
.	O
7	O
%	O
,	O
respectively	O
,	O
which	O
were	O
consistent	O
with	O
prior	O
reports	O
.	O

Hsl7p	S-Biological_Molecule
,	O
the	O
yeast	O
homologue	O
of	O
human	O
JBP1	S-Biological_Molecule
,	O
is	O
a	O
protein	O
methyltransferase	O
.	O

The	O
present	O
experiments	O
demonstrated	O
that	O
MCF	O
-	O
7	O
,	O
MCF	O
-	O
7ras	O
,	O
T47D	O
,	O
MDA	O
-	O
MB	O
-	O
231	O
,	O
and	O
MDA	O
-	O
MB	O
-	O
435	O
cells	O
transiently	O
differentiate	O
before	O
undergoing	O
apoptosis	O
in	O
response	O
to	O
quinidine	O
.	O

Because	O
the	O
base	O
-	O
labile	O
,	O
volatile	O
[	O
methyl	O
-	O
(	O
3	O
)	O
H	O
]	O
radioactivity	O
of	O
eEF1A	S-Biological_Molecule
could	O
be	O
released	O
by	O
trypsin	O
treatment	O
but	O
not	O
by	O
carboxypeptidase	B-Biological_Molecule
Y	E-Biological_Molecule
or	O
chymotrypsin	S-Biological_Molecule
treatment	O
,	O
we	O
suggest	O
that	O
the	O
methyl	O
ester	O
is	O
present	O
on	O
the	O
alpha	O
-	O
carboxyl	O
group	O
of	O
its	O
C	O
-	O
terminal	O
lysine	O
residue	O
.	O

The	O
rapid	O
turnover	O
of	O
the	O
methyl	O
ester	O
suggests	O
that	O
the	O
methylation	O
/	O
demethylation	O
of	O
eEF1A	S-Biological_Molecule
at	O
the	O
C	O
-	O
terminal	O
carboxyl	O
group	O
may	O
represent	O
a	O
novel	O
mode	O
of	O
regulation	O
of	O
the	O
activity	O
of	O
this	O
protein	O
in	O
yeast	O
.	O

Circular	O
dichroism	O
spectroscopy	O
of	O
an	O
N	O
-	O
terminal	O
peptide	O
,	O
PrP	S-Biological_Molecule
(	O
37	O
-	O
53	O
)	O
,	O
showed	O
that	O
the	O
PPII	O
helix	O
is	O
formed	O
in	O
aqueous	O
buffer	O
;	O
as	O
it	O
also	O
contains	O
an	O
Xaa	O
-	O
Pro	O
-	O
Gly	O
consensus	O
sequence	O
,	O
it	O
may	O
act	O
as	O
a	O
substrate	O
for	O
the	O
collagen	O
-	O
modifying	O
enzyme	O
prolyl	O
4	O
-	O
hydroxylase	O
.	O

STUDY	O
METHOD	O
:	O
The	O
participants	O
received	O
placebo	O
(	O
n	O
=	O
6	O
)	O
or	O
3	O
-	O
acetyl	O
-	O
7	O
-	O
oxo	O
-	O
DHEA	O
(	O
n	O
=	O
16	O
)	O
at	O
50	O
mg	O
/	O
d	O
for	O
7	O
days	O
followed	O
by	O
a	O
7	O
-	O
day	O
washout	O
;	O
100	O
mg	O
/	O
d	O
for	O
7	O
days	O
followed	O
by	O
a	O
7	O
-	O
day	O
washout	O
;	O
and	O
200	O
mg	O
/	O
d	O
for	O
28	O
days	O
.	O

DNA	O
sequence	O
analysis	O
revealed	O
that	O
aureusidin	B-Biological_Molecule
synthase	E-Biological_Molecule
belongs	O
to	O
the	O
plant	O
polyphenol	O
oxidase	O
family	O
,	O
providing	O
an	O
unequivocal	O
example	O
of	O
the	O
function	O
of	O
the	O
polyphenol	O
oxidase	O
homolog	O
in	O
plants	O
,	O
i	O
.	O
e	O
.	O
,	O
flower	O
coloration	O
.	O

E	B-Biological_Molecule
-	I-Biological_Molecule
Cadherin	E-Biological_Molecule
is	O
a	O
transmembrane	O
glycoprotein	O
that	O
mediates	O
Ca2	O
+	O
-	O
dependent	O
intercellular	O
adhesion	O
in	O
normal	O
epithelium	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
identified	O
a	O
novel	O
ChM	B-Biological_Molecule
-	I-Biological_Molecule
I	E-Biological_Molecule
like	O
molecule	O
,	O
designated	O
ChM1L	S-Biological_Molecule
.	O

The	O
mutant	O
cDNA	O
was	O
transiently	O
transfected	O
in	O
either	O
HeLa	O
cells	O
,	O
myoblasts	O
of	O
rat	O
skeletal	O
muscle	O
primary	O
cultures	O
,	O
or	O
regenerating	O
soleus	O
muscle	O
fibers	O
of	O
adult	O
rats	O
.	O

Targeting	O
of	O
HIF	O
-	O
alpha	O
to	O
the	O
von	B-Biological_Molecule
Hippel	I-Biological_Molecule
-	I-Biological_Molecule
Lindau	E-Biological_Molecule
ubiquitylation	O
complex	O
by	O
O2	O
-	O
regulated	O
prolyl	O
hydroxylation	O
.	O

HIF	O
(	O
hypoxia	O
-	O
inducible	O
factor	O
)	O
is	O
a	O
transcription	O
factor	O
that	O
plays	O
a	O
pivotal	O
role	O
in	O
cellular	O
adaptation	O
to	O
changes	O
in	O
oxygen	O
availability	O
.	O

In	O
the	O
presence	O
of	O
oxygen	O
,	O
HIF	O
is	O
targeted	O
for	O
destruction	O
by	O
an	O
E3	O
ubiquitin	S-Biological_Molecule
ligase	O
containing	O
the	O
von	B-Biological_Molecule
Hippel	I-Biological_Molecule
-	I-Biological_Molecule
Lindau	I-Biological_Molecule
tumor	I-Biological_Molecule
suppressor	E-Biological_Molecule
protein	O
(	O
pVHL	S-Biological_Molecule
)	O
.	O

One	O
was	O
found	O
to	O
be	O
present	O
in	O
the	O
culture	O
medium	O
and	O
in	O
the	O
periplasm	O
,	O
and	O
the	O
other	O
could	O
only	O
be	O
detected	O
inside	O
the	O
cell	O
.	O

The	O
hypoglycosylated	O
invertase	S-Biological_Molecule
accumulated	O
within	O
the	O
cells	O
of	O
the	O
transformants	O
to	O
an	O
unusual	O
level	O
(	O
up	O
to	O
130	O
units	O
/	O
10	O
(	O
10	O
)	O
cells	O
)	O
.	O

Tat	S-Biological_Molecule
lysines	O
50	O
and	O
51	O
,	O
target	O
of	O
acetylation	O
by	O
p300	S-Biological_Molecule
/	O
CBP	S-Biological_Molecule
,	O
were	O
also	O
found	O
to	O
be	O
acetylated	O
by	O
hGCN5	S-Biological_Molecule
.	O

We	O
have	O
also	O
determined	O
that	O
H4Ac16	S-Biological_Molecule
is	O
absent	O
from	O
a	O
region	O
of	O
the	O
X	O
chromosome	O
that	O
includes	O
a	O
gene	O
known	O
to	O
be	O
dosage	O
-	O
compensated	O
by	O
a	O
MSL	O
-	O
independent	O
mechanism	O
.	O

Chromatin	O
immunoprecipitation	O
of	O
dimethylated	O
lysine	O
9	O
on	O
histone	B-Biological_Molecule
H3	E-Biological_Molecule
across	O
53	O
kilobases	O
of	O
the	O
chicken	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
globin	E-Biological_Molecule
locus	O
during	O
erythropoiesis	O
shows	O
an	O
almost	O
complete	O
anticorrelation	O
between	O
regions	O
of	O
elevated	O
lysine	O
9	O
methylation	O
and	O
acetylation	O
.	O

The	O
soluble	O
ectodomain	O
could	O
be	O
released	O
from	O
the	O
cells	O
by	O
treatment	O
with	O
a	O
glycosylphosphatidylinositol	B-Biological_Molecule
-	I-Biological_Molecule
phospholipase	I-Biological_Molecule
C	E-Biological_Molecule
and	O
purified	O
to	O
apparent	O
homogeneity	O
by	O
cobalt	O
-	O
Sepharose	O
chromatography	O
.	O

Two	O
classes	O
of	O
high	O
-	O
affinity	O
binding	O
sites	O
were	O
identified	O
:	O
site	O
A	O
,	O
K	O
(	O
d	O
)	O
0	O
.	O
014	O
nM	O
;	O
site	O
B	O
,	O
K	O
(	O
d	O
)	O
0	O
.	O
83	O
nM	O
.	O

2B4	S-Biological_Molecule
(	O
CD244	S-Biological_Molecule
)	O
and	O
CS1	S-Biological_Molecule
:	O
novel	O
members	O
of	O
the	O
CD2	S-Biological_Molecule
subset	O
of	O
the	O
immunoglobulin	O
superfamily	O
molecules	O
expressed	O
on	O
natural	O
killer	O
cells	O
and	O
other	O
leukocytes	O
.	O

2B4	S-Biological_Molecule
is	O
a	O
member	O
of	O
the	O
CD2	S-Biological_Molecule
subset	O
of	O
the	O
immunoglobulin	O
superfamily	O
molecules	O
expressed	O
on	O
natural	O
killer	O
(	O
NK	O
)	O
cells	O
and	O
other	O
leukocytes	O
.	O

Engagement	O
of	O
2B4	S-Biological_Molecule
on	O
NK	O
-	O
cell	O
surfaces	O
with	O
specific	O
antibodies	O
or	O
CD48	S-Biological_Molecule
can	O
trigger	O
cell	O
-	O
mediated	O
cytotoxicity	O
,	O
interferon	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
secretion	O
,	O
phosphoinositol	O
turnover	O
and	O
NK	O
-	O
cell	O
invasiveness	O
.	O

The	O
function	O
of	O
2B4	S-Biological_Molecule
in	O
CD8	B-Biological_Molecule
+	E-Biological_Molecule
T	O
cells	O
and	O
myeloid	O
cells	O
remains	O
unknown	O
.	O

Signaling	O
through	O
2B4	S-Biological_Molecule
,	O
CS1	S-Biological_Molecule
and	O
other	O
members	O
of	O
the	O
CD2	S-Biological_Molecule
subset	O
may	O
play	O
a	O
major	O
role	O
in	O
the	O
regulation	O
of	O
NK	O
cells	O
and	O
other	O
leukocyte	O
functions	O
.	O

N	O
-	O
glycosylation	O
of	O
CRF	B-Biological_Molecule
receptor	I-Biological_Molecule
type	I-Biological_Molecule
1	E-Biological_Molecule
is	O
important	O
for	O
its	O
ligand	O
-	O
specific	O
interaction	O
.	O

These	O
data	O
indicate	O
the	O
requirement	O
for	O
three	O
or	O
more	O
polysaccharide	O
chains	O
for	O
normal	O
CRFR1	S-Biological_Molecule
function	O
.	O

We	O
used	O
a	O
novel	O
assay	O
to	O
show	O
that	O
missense	O
mutation	O
rates	O
are	O
also	O
substantially	O
reduced	O
in	O
Dnmt1	S-Biological_Molecule
-	O
deficient	O
cells	O
.	O

Finally	O
,	O
we	O
show	O
that	O
methyl	O
group	O
-	O
deficient	O
growth	O
conditions	O
do	O
not	O
cause	O
an	O
increase	O
in	O
missense	O
mutation	O
rates	O
in	O
Dnmt1	S-Biological_Molecule
-	O
proficient	O
cells	O
,	O
as	O
predicted	O
by	O
methyltransferase	O
-	O
mediated	O
mutagenesis	O
models	O
.	O

Eight	O
plasmids	O
were	O
engineered	O
,	O
encoding	O
E1	S-Biological_Molecule
protein	O
mutants	O
in	O
which	O
the	O
four	O
N	O
-	O
linked	O
glycosylation	O
sites	O
of	O
the	O
protein	O
were	O
mutated	O
separately	O
or	O
in	O
combination	O
.	O

To	O
evaluate	O
the	O
role	O
of	O
BAH	S-Biological_Molecule
in	O
vivo	O
,	O
the	O
catalytic	O
domain	O
of	O
BAH	S-Biological_Molecule
was	O
specifically	O
targeted	O
such	O
that	O
the	O
coding	O
regions	O
of	O
junctin	S-Biological_Molecule
and	O
humbug	S-Biological_Molecule
remained	O
undisturbed	O
.	O

The	O
developmental	O
defects	O
present	O
in	O
BAH	S-Biological_Molecule
null	O
mice	O
are	O
similar	O
to	O
defects	O
observed	O
in	O
knock	O
-	O
outs	O
and	O
hypomorphs	O
of	O
the	O
Notch	O
ligand	O
Serrate	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
.	O

In	O
this	O
work	O
,	O
beta	O
-	O
hydroxylation	O
of	O
Asp	O
residues	O
in	O
EGF	O
domains	O
is	O
demonstrated	O
for	O
a	O
soluble	O
form	O
of	O
a	O
Notch	O
ligand	O
,	O
human	O
Jagged	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
.	O

We	O
isolated	O
a	O
4	O
.	O
6	O
kb	O
full	O
-	O
length	O
mouse	O
cDNA	O
encoding	O
a	O
1307	O
-	O
amino	O
acid	O
protein	O
migrating	O
as	O
a	O
180	O
kD	O
band	O
,	O
which	O
was	O
termed	O
ESET	S-Biological_Molecule
(	O
ERG	B-Biological_Molecule
-	I-Biological_Molecule
associated	I-Biological_Molecule
protein	I-Biological_Molecule
with	I-Biological_Molecule
SET	I-Biological_Molecule
domain	E-Biological_Molecule
)	O
.	O

Promoter	O
methylation	O
status	O
of	O
the	O
DNA	O
repair	O
genes	O
hMLH1	S-Biological_Molecule
and	O
MGMT	S-Biological_Molecule
in	O
gastric	O
carcinoma	O
and	O
metaplastic	O
mucosa	O
.	O

FIH	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
is	O
an	O
asparaginyl	O
hydroxylase	O
enzyme	O
that	O
regulates	O
the	O
transcriptional	O
activity	O
of	O
hypoxia	O
-	O
inducible	O
factor	O
.	O

MATERIALS	O
AND	O
METHODS	O
:	O
Western	O
Blot	O
analysis	O
of	O
ADAM10	S-Biological_Molecule
is	O
performed	O
on	O
platelet	O
homogenates	O
from	O
33	O
sporadic	O
AD	O
patients	O
and	O
on	O
26	O
age	O
-	O
matched	O
control	O
subjects	O
.	O

CONCLUSIONS	O
:	O
ADAM10	S-Biological_Molecule
is	O
expressed	O
in	O
platelets	O
.	O

Peptides	O
that	O
had	O
originated	O
from	O
bone	O
type	O
I	O
collagen	O
and	O
cartilage	O
type	B-Biological_Molecule
II	I-Biological_Molecule
collagen	E-Biological_Molecule
were	O
identified	O
.	O

The	O
equivalent	O
peptide	O
fraction	O
from	O
a	O
normal	O
child	O
'	O
s	O
urine	O
gave	O
a	O
ratio	O
of	O
HP	O
to	O
LP	O
of	O
1	O
.	O
5	O
:	O
1	O
typical	O
for	O
normal	O
bone	O
collagen	O
.	O

A	O
second	O
cross	O
-	O
linked	O
peptide	O
that	O
is	O
derived	O
from	O
the	O
C	O
-	O
telopeptide	O
domain	O
of	O
cartilage	O
type	B-Biological_Molecule
II	I-Biological_Molecule
collagen	E-Biological_Molecule
showed	O
both	O
HP	O
and	O
LP	O
in	O
a	O
2	O
:	O
1	O
ratio	O
,	O
compared	O
with	O
18	O
:	O
1	O
for	O
the	O
equivalent	O
peptide	O
from	O
a	O
normal	O
child	O
'	O
s	O
urine	O
.	O

Since	O
PLOD1	S-Biological_Molecule
is	O
null	O
,	O
other	O
PLOD	O
genes	O
must	O
be	O
responsible	O
for	O
the	O
helical	O
hydroxylation	O
activity	O
that	O
results	O
in	O
HP	O
.	O

Proposed	O
functions	O
range	O
from	O
transcriptional	O
regulation	O
to	O
the	O
higher	O
order	O
packing	O
of	O
chromatin	O
in	O
progress	O
of	O
mitotic	O
condensation	O
.	O

Interestingly	O
,	O
hPAR	B-Biological_Molecule
(	I-Biological_Molecule
2	I-Biological_Molecule
)	E-Biological_Molecule
N222A	O
displayed	O
a	O
loss	O
in	O
sensitivity	O
towards	O
all	O
PAR	B-Biological_Molecule
(	I-Biological_Molecule
2	I-Biological_Molecule
)	E-Biological_Molecule
agonists	O
tested	O
.	O

hPAR	B-Biological_Molecule
(	I-Biological_Molecule
2	I-Biological_Molecule
)	E-Biological_Molecule
N30A	O
,	O
N222Q	O
displayed	O
increased	O
sensitivity	O
towards	O
tryptase	O
,	O
but	O
a	O
loss	O
in	O
sensitivity	O
towards	O
trypsin	O
and	O
the	O
synthetic	O
peptide	O
SLIGRL	O
-	O
NH	O
(	O
2	O
)	O
,	O
although	O
this	O
loss	O
in	O
sensitivity	O
towards	O
trypsin	O
and	O
SLIGRL	O
-	O
NH	O
(	O
2	O
)	O
was	O
secondary	O
to	O
changes	O
in	O
cell	O
-	O
surface	O
expression	O
.	O

Herein	O
,	O
we	O
investigated	O
the	O
relationship	O
between	O
NAT2	S-Biological_Molecule
genotypes	O
and	O
the	O
pharmacokinetics	O
of	O
SP	O
in	O
healthy	O
Japanese	O
subjects	O
,	O
as	O
well	O
as	O
the	O
adverse	O
events	O
of	O
SASP	O
in	O
patients	O
with	O
inflammatory	O
bowel	O
disease	O
(	O
IBD	O
)	O
.	O

In	O
patients	O
with	O
IBD	O
,	O
skin	O
rash	O
was	O
seen	O
in	O
3	O
of	O
6	O
Rapid	O
Types	O
and	O
1	O
of	O
6	O
Intermediate	O
Types	O
,	O
consistent	O
with	O
the	O
concept	O
that	O
hypersensitive	O
reactions	O
are	O
independent	O
of	O
serum	O
SP	O
concentrations	O
.	O

Effect	O
of	O
the	O
alcohol	O
extract	O
of	O
the	O
seeds	O
of	O
Mucuna	O
pruriens	O
on	O
free	O
radicals	O
and	O
oxidative	O
stress	O
in	O
albino	O
rats	O
.	O

Studies	O
on	O
the	O
inhibition	O
of	O
human	O
cytochromes	O
P450	O
by	O
selenocysteine	O
Se	O
-	O
conjugates	O
.	O

For	O
Se	O
-	O
phenyl	O
-	O
L	O
-	O
selenocysteine	O
,	O
however	O
,	O
significant	O
increases	O
in	O
P450	O
inhibition	O
were	O
obtained	O
by	O
beta	O
-	O
lyase	O
pre	O
-	O
incubation	O
.	O

These	O
results	O
led	O
us	O
to	O
consider	O
the	O
development	O
of	O
an	O
effective	O
anti	O
-	O
HCV	O
peptide	O
.	O

Understanding	O
how	O
corticosteroids	O
work	O
in	O
asthma	O
may	O
help	O
in	O
designing	O
novel	O
corticosteroids	O
with	O
fewer	O
systemic	O
effects	O
,	O
as	O
well	O
as	O
novel	O
anti	O
-	O
inflammatory	O
approaches	O
.	O

Two	O
synthetic	O
peptides	O
were	O
studied	O
:	O
a	O
nine	O
-	O
residue	O
MUC1	S-Biological_Molecule
peptide	O
of	O
the	O
sequence	O
,	O
Thr1	O
-	O
Ser2	O
-	O
Ala3	O
-	O
Pro4	O
-	O
Asp5	O
-	O
Thr6	O
-	O
Arg7	O
-	O
Pro8	O
-	O
Ala9	O
,	O
and	O
a	O
Tn	O
-	O
glycosylated	O
version	O
of	O
this	O
peptide	O
,	O
Thr1	O
-	O
Ser2	O
-	O
Ala3	O
-	O
Pro4	O
-	O
Asp5	O
-	O
Thr6	O
(	O
alphaGalNAc	O
)	O
-	O
Arg7	O
-	O
Pro8	O
-	O
Ala9	O
.	O

This	O
positive	O
feedback	O
loop	O
,	O
and	O
the	O
reverse	O
loop	O
in	O
which	O
H3	S-Biological_Molecule
-	O
K79	O
methylation	O
weakens	O
Sir	O
protein	O
association	O
and	O
leads	O
to	O
further	O
methylation	O
,	O
suggests	O
a	O
model	O
for	O
position	O
-	O
effect	O
variegation	O
.	O

The	O
mechanism	O
by	O
which	O
hypoxia	O
induces	O
gene	O
transcription	O
involves	O
the	O
inhibition	O
of	O
hypoxia	B-Biological_Molecule
-	I-Biological_Molecule
inducible	I-Biological_Molecule
factor	I-Biological_Molecule
(	I-Biological_Molecule
HIF	I-Biological_Molecule
)	I-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
prolyl	O
hydroxylase	O
activity	O
,	O
which	O
prevents	O
von	B-Biological_Molecule
Hippel	I-Biological_Molecule
-	I-Biological_Molecule
Lindau	E-Biological_Molecule
(	O
vHL	S-Biological_Molecule
)	O
-	O
dependent	O
targeting	O
of	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
to	O
the	O
ubiquitin	S-Biological_Molecule
-	O
proteasome	O
pathway	O
.	O

CsA	O
stimulated	O
the	O
enzymatic	O
activity	O
in	O
the	O
presence	O
of	O
a	O
peptide	O
that	O
mimicked	O
the	O
557	O
-	O
576	O
sequence	O
of	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
.	O

The	O
enzyme	O
promoted	O
[	O
(	O
35	O
)	O
S	O
]	O
vHL	S-Biological_Molecule
binding	O
to	O
glutathione	O
S	O
-	O
transferase	O
(	O
GST	O
)	O
.	O
ODD	O
fusion	O
protein	O
.	O

We	O
conclude	O
that	O
CsA	O
destabilizes	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
by	O
promoting	O
hydroxylation	O
of	O
Pro	O
-	O
564	O
in	O
the	O
ODD	O
domain	O
.	O

In	O
addition	O
,	O
muscles	O
in	O
DG	S-Biological_Molecule
(	O
S654A	O
)	O
/	O
CT	O
transgenic	O
mice	O
had	O
little	O
or	O
no	O
evidence	O
of	O
muscular	O
dystrophy	O
when	O
compared	O
to	O
DG	S-Biological_Molecule
(	O
S654A	O
)	O
littermates	O
.	O

These	O
findings	O
suggested	O
that	O
a	O
carboxypeptidase	O
-	O
like	O
enzyme	O
may	O
be	O
involved	O
in	O
hmGSH	O
synthesis	O
in	O
vivo	O
.	O

The	O
distinct	O
triple	O
helical	O
recognition	O
motifs	O
for	O
these	O
receptors	O
,	O
GXOGER	O
and	O
(	O
GPO	O
)	O
n	O
,	O
respectively	O
,	O
all	O
contain	O
hydroxyproline	O
.	O

The	O
apolipoprotein	B-Biological_Molecule
E	I-Biological_Molecule
(	I-Biological_Molecule
apoE	I-Biological_Molecule
)	I-Biological_Molecule
receptor	I-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
(	O
apoER2	S-Biological_Molecule
)	O
,	O
another	O
member	O
of	O
the	O
LDL	O
receptor	O
family	O
with	O
functions	O
in	O
cellular	O
signal	O
transmission	O
,	O
also	O
undergoes	O
sequential	O
proteolytic	O
processing	O
,	O
resulting	O
in	O
intracellular	O
domain	O
release	O
into	O
the	O
cytoplasm	O
.	O

The	O
penultimate	O
processing	O
step	O
also	O
involves	O
cleavage	O
of	O
the	O
apoER2	S-Biological_Molecule
extracellular	O
domain	O
.	O

Inactivation	O
of	O
p16	S-Biological_Molecule
gene	O
in	O
leukemia	O
.	O

We	O
suggest	O
that	O
histone	B-Biological_Molecule
H3	E-Biological_Molecule
modification	O
at	O
lysine	O
9	O
directly	O
regulates	O
chromatin	O
condensation	O
by	O
recruiting	O
MENT	S-Biological_Molecule
to	O
chromatin	O
in	O
a	O
fashion	O
that	O
is	O
spatially	O
constrained	O
from	O
active	O
genes	O
by	O
gene	O
boundary	O
elements	O
and	O
histone	S-Biological_Molecule
hyperacetylation	O
.	O

Using	O
conditional	O
alleles	O
of	O
NEO1	S-Biological_Molecule
,	O
we	O
find	O
that	O
loss	O
of	O
Neo1p	S-Biological_Molecule
function	O
causes	O
cargo	O
-	O
specific	O
defects	O
in	O
anterograde	O
protein	O
transport	O
early	O
in	O
the	O
secretory	O
pathway	O
and	O
perturbs	O
glycosylation	O
in	O
the	O
Golgi	O
complex	O
.	O

Fabrication	O
of	O
nickel	O
and	O
chromium	O
nanoparticles	O
using	O
the	O
protein	O
cage	O
of	O
apoferritin	O
.	O

The	O
iron	O
storage	O
protein	O
,	O
apoferritin	O
,	O
has	O
a	O
cavity	O
in	O
which	O
iron	O
is	O
oxidized	O
and	O
stored	O
as	O
a	O
hydrated	O
oxide	O
core	O
.	O

Recombinant	O
L	B-Biological_Molecule
-	I-Biological_Molecule
ferritin	E-Biological_Molecule
showed	O
less	O
precipitation	O
even	O
above	O
a	O
pH	O
of	O
8	O
.	O
65	O
.	O

Herein	O
,	O
we	O
investigated	O
the	O
role	O
of	O
histone	S-Biological_Molecule
deacetylation	O
on	O
the	O
mitotic	O
process	O
by	O
inhibiting	O
histone	S-Biological_Molecule
deacetylases	O
shortly	O
before	O
mitosis	O
in	O
human	O
primary	O
fibroblasts	O
.	O

Inhibition	O
of	O
histone	S-Biological_Molecule
deacetylation	O
before	O
mitosis	O
produced	O
defective	O
chromosome	O
condensation	O
and	O
impaired	O
mitotic	O
progression	O
in	O
living	O
cells	O
,	O
suggesting	O
that	O
improper	O
chromosome	O
condensation	O
may	O
induce	O
mitotic	O
checkpoint	O
activation	O
.	O

Hydroxylated	O
kininogens	S-Biological_Molecule
and	O
kinins	S-Biological_Molecule
.	O

The	O
single	O
glycosylation	O
mutants	O
(	O
G1	O
,	O
G2	O
,	O
and	O
G3	O
)	O
,	O
but	O
not	O
the	O
double	O
mutant	O
(	O
G23	O
)	O
or	O
the	O
triple	O
mutant	O
(	O
G123	O
)	O
,	O
were	O
found	O
to	O
be	O
capable	O
of	O
inducing	O
virus	O
neutralizing	O
antibodies	O
.	O

Digestion	O
by	O
N	O
-	O
glycosidase	O
significantly	O
decreased	O
the	O
capacity	O
of	O
cells	O
to	O
bind	O
IL	O
-	O
1	O
,	O
and	O
reduced	O
by	O
approximately	O
20	O
,	O
000	O
D	O
the	O
M	O
(	O
r	O
)	O
of	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1RtI	E-Biological_Molecule
.	O

CONCLUSION	O
:	O
The	O
Pro582Ser	O
change	O
represents	O
a	O
common	O
polymorphism	O
of	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
that	O
does	O
not	O
impair	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
prolyl	O
hydroxylation	O
.	O

In	O
addition	O
,	O
the	O
level	O
of	O
protein	O
acetylation	O
was	O
markedly	O
lower	O
in	O
PARP	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
-	O
/	O
-	O
cells	O
than	O
control	O
(	O
PARP	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
+	O
/	O
+	O
)	O
cells	O
.	O

Surprisingly	O
,	O
the	O
expression	O
levels	O
of	O
histone	S-Biological_Molecule
acetyltransferases	O
(	O
HATs	O
)	O
,	O
p300	S-Biological_Molecule
,	O
cAMP	B-Biological_Molecule
response	I-Biological_Molecule
element	I-Biological_Molecule
-	I-Biological_Molecule
binding	I-Biological_Molecule
protein	I-Biological_Molecule
-	I-Biological_Molecule
binding	I-Biological_Molecule
protein	E-Biological_Molecule
(	O
CBP	S-Biological_Molecule
)	O
,	O
and	O
p300	B-Biological_Molecule
/	I-Biological_Molecule
CBP	I-Biological_Molecule
-	I-Biological_Molecule
associated	I-Biological_Molecule
factor	E-Biological_Molecule
(	O
PCAF	S-Biological_Molecule
)	O
,	O
were	O
significantly	O
reduced	O
in	O
PARP	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
-	O
/	O
-	O
cells	O
,	O
as	O
compared	O
with	O
PARP	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
+	O
/	O
+	O
cells	O
.	O

These	O
results	O
suggest	O
that	O
PARP	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
is	O
required	O
for	O
the	O
proper	O
expression	O
of	O
particular	O
HATs	O
.	O

Since	O
p300	S-Biological_Molecule
and	O
CBP	S-Biological_Molecule
are	O
coactivators	O
of	O
NF	O
-	O
kappaB	O
,	O
we	O
propose	O
here	O
that	O
PARP	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
participates	O
in	O
NF	O
-	O
kappaB	O
-	O
dependent	O
transcription	O
by	O
means	O
of	O
maintaining	O
the	O
expression	O
of	O
HATs	O
.	O

The	O
recently	O
discovered	O
CLECSF6	S-Biological_Molecule
protein	O
displays	O
the	O
features	O
of	O
a	O
receptor	O
involved	O
in	O
the	O
down	O
-	O
modulation	O
of	O
leukocyte	O
activation	O
.	O

Epigenetic	O
switch	O
from	O
posttranscriptional	O
to	O
transcriptional	O
silencing	O
is	O
correlated	O
with	O
promoter	O
hypermethylation	O
.	O

The	O
results	O
suggest	O
that	O
a	O
switch	O
between	O
posttranscriptional	O
and	O
transcriptional	O
gene	O
silencing	O
could	O
be	O
a	O
mechanism	O
leading	O
to	O
irrevocable	O
shut	O
down	O
of	O
gene	O
expression	O
within	O
a	O
finite	O
number	O
of	O
generations	O
.	O

The	O
frequency	O
and	O
mechanism	O
of	O
p16	B-Biological_Molecule
(	I-Biological_Molecule
INK4A	I-Biological_Molecule
)	E-Biological_Molecule
and	O
p14	B-Biological_Molecule
(	I-Biological_Molecule
ARF	I-Biological_Molecule
)	E-Biological_Molecule
gene	O
alterations	O
were	O
studied	O
in	O
cell	O
samples	O
from	O
30	O
patients	O
with	O
Philadelphia	O
(	O
Ph	O
)	O
chromosome	O
-	O
positive	O
chronic	O
myeloid	O
leukaemia	O
(	O
CML	O
)	O
,	O
both	O
at	O
diagnosis	O
and	O
at	O
the	O
onset	O
of	O
the	O
accelerated	O
phase	O
(	O
AP	O
)	O
of	O
the	O
disease	O
.	O

These	O
observations	O
prompted	O
us	O
to	O
examine	O
the	O
expression	O
profile	O
of	O
the	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Myc	E-Biological_Molecule
target	O
genes	O
,	O
carbamoyl	B-Biological_Molecule
-	I-Biological_Molecule
phosphate	I-Biological_Molecule
synthase	E-Biological_Molecule
-	O
aspartate	B-Biological_Molecule
carbamoyltransferase	E-Biological_Molecule
-	O
dihydroorotase	S-Biological_Molecule
(	O
cad	S-Biological_Molecule
)	O
and	O
nucleolin	S-Biological_Molecule
(	O
nuc	S-Biological_Molecule
)	O
.	O

Likewise	O
,	O
deletion	O
of	O
the	O
K9	O
-	O
MeH3	S-Biological_Molecule
methyltransferase	O
Clr4	S-Biological_Molecule
/	O
Suvar39	S-Biological_Molecule
causes	O
defective	O
chromosome	O
segregation	O
.	O

Here	O
,	O
we	O
create	O
fission	O
yeast	O
strains	O
retaining	O
one	O
histone	B-Biological_Molecule
H3	E-Biological_Molecule
and	O
H4	S-Biological_Molecule
gene	O
;	O
the	O
creation	O
of	O
these	O
strains	O
allows	O
mutation	O
of	O
specific	O
N	O
-	O
terminal	O
tail	O
residues	O
and	O
their	O
role	O
in	O
centromeric	O
silencing	O
and	O
chromosome	O
stability	O
to	O
be	O
investigated	O
.	O

Our	O
data	O
highlight	O
the	O
striking	O
divergence	O
between	O
the	O
histone	S-Biological_Molecule
tail	O
requirements	O
for	O
the	O
fission	O
yeast	O
and	O
budding	O
yeast	O
silencing	O
pathways	O
.	O

Methylation	O
in	O
vivo	O
is	O
a	O
post	O
-	O
translational	O
modification	O
observed	O
in	O
several	O
organisms	O
belonging	O
to	O
eucarya	O
,	O
bacteria	O
,	O
and	O
archaea	O
.	O

Rapid	O
screening	O
for	O
S	O
-	O
adenosylmethionine	O
-	O
dependent	O
methylation	O
products	O
by	O
enzyme	O
-	O
transferred	O
isotope	O
patterns	O
analysis	O
.	O

Based	O
on	O
this	O
unique	O
isotopic	O
pattern	O
,	O
methylation	O
product	O
(	O
s	O
)	O
can	O
be	O
easily	O
detected	O
even	O
from	O
a	O
mixture	O
of	O
cellular	O
components	O
.	O

Subunit	O
-	O
specific	O
sulphation	O
of	O
oligosaccharides	O
relating	O
to	O
charge	O
-	O
heterogeneity	O
in	O
porcine	O
lutrophin	O
isoforms	O
.	O

Oligosaccharides	O
were	O
predominantly	O
sulphated	O
(	O
S	O
-	O
1	O
and	O
S	O
-	O
2	O
)	O
and	O
infrequently	O
sialylated	O
(	O
N	O
-	O
1	O
and	O
S	O
-	O
N	O
)	O
.	O

All	O
were	O
of	O
the	O
biantennary	O
complex	O
type	O
.	O

Among	O
the	O
group	O
of	O
patients	O
transplanted	O
for	O
alcoholic	O
cirrhosis	O
,	O
the	O
frequency	O
of	O
MTHFR	S-Biological_Molecule
variants	O
CC	O
versus	O
CT	O
and	O
TT	O
was	O
significantly	O
higher	O
in	O
patients	O
with	O
HCC	O
than	O
in	O
patients	O
without	O
macroscopic	O
evidence	O
of	O
HCC	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
.	O

Transfection	O
studies	O
demonstrate	O
that	O
the	O
CXXC	O
-	O
3	O
domain	O
indeed	O
targets	O
nonmethylated	O
CpG	O
sites	O
in	O
vivo	O
.	O

AIM	O
:	O
To	O
produce	O
biologically	O
active	O
recombinant	O
human	O
(	O
rh	O
)	O
ZP	O
proteins	O
in	O
a	O
human	O
cell	O
for	O
use	O
in	O
sperm	O
function	O
tests	O
.	O

The	O
effect	O
of	O
the	O
recombinant	O
proteins	O
on	O
the	O
human	O
AR	O
was	O
assessed	O
.	O

Leu	O
-	O
574	O
of	O
human	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
is	O
a	O
molecular	O
determinant	O
of	O
prolyl	O
hydroxylation	O
.	O

The	O
von	B-Biological_Molecule
Hippel	I-Biological_Molecule
-	I-Biological_Molecule
Lindau	E-Biological_Molecule
(	O
VHL	S-Biological_Molecule
)	O
E3	O
ubiquitin	S-Biological_Molecule
ligase	O
binds	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
through	O
specific	O
recognition	O
of	O
hydroxylated	O
Pro	O
-	O
402	O
or	O
Pro	O
-	O
564	O
,	O
both	O
of	O
which	O
are	O
modified	O
by	O
the	O
oxygen	O
-	O
dependent	O
HIF	O
prolyl	O
hydroxylases	O
(	O
PHDs	O
/	O
HPHs	O
)	O
.	O

CONCLUSION	O
:	O
The	O
transferrin	S-Biological_Molecule
microheterogeneity	O
pattern	O
shifted	O
towards	O
reduced	O
glycosylation	O
and	O
sialylation	O
in	O
addition	O
to	O
a	O
decrease	O
in	O
total	O
transferrin	S-Biological_Molecule
concentration	O
in	O
fetal	O
blood	O
compared	O
to	O
that	O
of	O
non	O
-	O
pregnant	O
and	O
pregnant	O
women	O
.	O

Tri	O
-	O
methylated	O
lysine	O
20	O
on	O
histone	B-Biological_Molecule
H4	E-Biological_Molecule
(	O
Me	O
(	O
3	O
)	O
K20H4	S-Biological_Molecule
)	O
is	O
a	O
marker	O
of	O
constitutive	O
heterochromatin	O
in	O
murine	O
interphase	O
and	O
metaphase	O
cells	O
.	O

To	O
determine	O
the	O
implication	O
of	O
aberrant	O
methylation	O
,	O
one	O
of	O
the	O
most	O
frequent	O
mechanisms	O
of	O
silencing	O
the	O
tumor	O
suppressor	O
or	O
cancer	O
-	O
related	O
genes	O
,	O
we	O
examined	O
the	O
methylation	O
status	O
of	O
DLC	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
promoter	O
region	O
in	O
breast	O
cancer	O
cell	O
lines	O
and	O
primary	O
breast	O
tumors	O
.	O

These	O
data	O
suggest	O
that	O
hypermethylation	O
is	O
responsible	O
for	O
silencing	O
of	O
DLC	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
gene	O
in	O
a	O
limited	O
portion	O
of	O
breast	O
cancers	O
.	O

Neutralizing	O
antibody	O
titers	O
have	O
been	O
correlated	O
with	O
protection	O
following	O
vaccination	O
against	O
many	O
viral	O
pathogens	O
.	O

However	O
,	O
the	O
potency	O
and	O
titers	O
of	O
neutralizing	O
antibodies	O
that	O
arise	O
during	O
HIV	O
infection	O
are	O
generally	O
discouragingly	O
low	O
and	O
the	O
antibodies	O
that	O
do	O
arise	O
recognize	O
mainly	O
autologous	O
virus	O
.	O

The	O
MSP	O
assay	O
detected	O
hypermethylation	O
of	O
p16	S-Biological_Molecule
in	O
9	O
patients	O
(	O
22	O
%	O
)	O
,	O
E	B-Biological_Molecule
-	I-Biological_Molecule
cadherin	E-Biological_Molecule
in	O
9	O
patients	O
(	O
22	O
%	O
)	O
,	O
and	O
RARbeta	S-Biological_Molecule
in	O
6	O
patients	O
(	O
15	O
%	O
)	O
.	O

The	O
positive	O
rates	O
were	O
37	O
,	O
50	O
,	O
40	O
,	O
and	O
75	O
%	O
in	O
stages	O
I	O
,	O
II	O
,	O
III	O
,	O
and	O
IV	O
,	O
respectively	O
.	O

Neither	O
the	O
CEA	O
-	O
specific	O
signal	O
nor	O
hypermethylation	O
was	O
detected	O
in	O
serum	O
from	O
control	O
volunteers	O
.	O

H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
formation	O
took	O
place	O
also	O
in	O
the	O
presence	O
of	O
SOD	O
and	O
gave	O
a	O
smaller	O
yet	O
significant	O
interfering	O
signal	O
.	O

Interestingly	O
,	O
we	O
have	O
found	O
a	O
similar	O
stimulatory	O
effect	O
of	O
S	O
-	O
adenosylhomocysteine	O
(	O
SAH	O
)	O
,	O
the	O
methylation	O
product	O
of	O
SAM	O
,	O
on	O
antibiotic	O
production	O
in	O
the	O
four	O
strains	O
.	O

A	O
phosphatidylserine	O
-	O
binding	O
site	O
in	O
the	O
cytosolic	O
fragment	O
of	O
Clostridium	O
sordellii	O
lethal	O
toxin	O
facilitates	O
glucosylation	O
of	O
membrane	O
-	O
bound	O
Rac	O
and	O
is	O
required	O
for	O
cytotoxicity	O
.	O

The	O
binding	O
of	O
LT	B-Biological_Molecule
(	I-Biological_Molecule
cyt	I-Biological_Molecule
)	E-Biological_Molecule
to	O
phosphatidylserine	O
increases	O
by	O
two	O
orders	O
of	O
magnitude	O
the	O
rate	O
of	O
glucosylation	O
of	O
liposome	O
-	O
bound	O
geranyl	O
-	O
geranylated	O
Rac	O
-	O
GDP	O
.	O

The	O
same	O
substitutions	O
are	O
also	O
found	O
to	O
increase	O
heat	O
stability	O
in	O
the	O
absence	O
of	O
any	O
sugar	O
derivatives	O
,	O
where	O
a	O
mechanism	O
based	O
on	O
prevention	O
of	O
glycation	O
can	O
no	O
longer	O
be	O
invoked	O
.	O

The	O
stabilizing	O
effect	O
of	O
Lys	O
-	O
-	O
-	O
-	O
Arg	O
substitutions	O
is	O
rationalized	O
on	O
the	O
basis	O
of	O
a	O
detailed	O
analysis	O
of	O
the	O
crystal	O
structures	O
of	O
wild	O
-	O
type	O
XI	S-Biological_Molecule
and	O
of	O
engineered	O
variants	O
with	O
Lys	O
-	O
-	O
-	O
-	O
Arg	O
substitution	O
at	O
four	O
distinct	O
locations	O
,	O
residues	O
253	O
,	O
309	O
,	O
319	O
,	O
and	O
323	O
.	O

Protein	O
arginine	O
methyltransferases	O
(	O
PRMTs	O
)	O
have	O
been	O
implicated	O
in	O
transcriptional	O
activation	O
and	O
repression	O
,	O
but	O
their	O
role	O
in	O
controlling	O
cell	O
growth	O
and	O
proliferation	O
remains	O
obscure	O
.	O

We	O
also	O
discuss	O
the	O
role	O
of	O
sex	O
hormones	O
,	O
especially	O
estrogen	O
,	O
in	O
the	O
generation	O
of	O
the	O
sex	O
-	O
specific	O
radiation	O
-	O
induced	O
methylation	O
changes	O
.	O

To	O
isolate	O
useful	O
microbial	O
enzymes	O
from	O
uncultured	O
soil	O
microorganisms	O
,	O
a	O
metagenome	O
was	O
isolated	O
from	O
soil	O
samples	O
,	O
and	O
a	O
metagenomic	O
library	O
was	O
constructed	O
by	O
using	O
the	O
pUC19	O
vector	O
.	O

The	O
amylase	O
hydrolyzed	O
soluble	O
starch	O
and	O
cyclodextrins	O
to	O
produce	O
high	O
levels	O
of	O
maltose	O
and	O
hydrolyzed	O
pullulan	O
to	O
panose	O
.	O

4	B-Biological_Molecule
-	I-Biological_Molecule
Hydroxyphenylpyruvate	I-Biological_Molecule
dioxygenase	E-Biological_Molecule
.	O

Naturally	O
occurring	O
multi	O
-	O
ketone	O
molecules	O
act	O
as	O
allelopathic	O
agents	O
by	O
inhibiting	O
HPPD	S-Biological_Molecule
and	O
preventing	O
the	O
production	O
of	O
homogentisate	O
and	O
hence	O
required	O
redox	O
cofactors	O
.	O

Sequence	O
analysis	O
of	O
full	O
length	O
LH2	S-Biological_Molecule
cDNAs	O
and	O
1kb	O
of	O
the	O
promoter	O
region	O
of	O
LH2	S-Biological_Molecule
does	O
not	O
show	O
mutations	O
that	O
could	O
explain	O
the	O
decreased	O
expression	O
of	O
LH2	S-Biological_Molecule
.	O

In	O
this	O
study	O
,	O
cartilage	O
link	O
protein	O
(	O
cLP	O
)	O
and	O
the	O
G1	O
-	O
domains	O
of	O
aggrecan	S-Biological_Molecule
(	O
AG1	O
)	O
and	O
versican	S-Biological_Molecule
(	O
VG1	O
)	O
were	O
expressed	O
in	O
Drosophila	O
S2	O
cells	O
.	O

Rad6	S-Biological_Molecule
-	O
mediated	O
ubiquitylation	O
of	O
histone	B-Biological_Molecule
H2B	E-Biological_Molecule
at	O
lysine	O
123	O
has	O
been	O
linked	O
to	O
transcriptional	O
activation	O
and	O
the	O
regulation	O
of	O
lysine	O
methylation	O
on	O
histone	B-Biological_Molecule
H3	E-Biological_Molecule
.	O

This	O
fact	O
suggests	O
that	O
Rad6	S-Biological_Molecule
is	O
recruited	O
to	O
promoters	O
independently	O
of	O
the	O
Paf1	S-Biological_Molecule
complex	O
but	O
then	O
requires	O
this	O
complex	O
for	O
entrance	O
into	O
the	O
coding	O
region	O
of	O
genes	O
in	O
a	O
Pol	O
II	O
-	O
associated	O
manner	O
.	O

To	O
assess	O
how	O
glycoconjugate	O
glycan	O
moieties	O
participate	O
in	O
the	O
biogenesis	O
of	O
PrP	B-Biological_Molecule
(	I-Biological_Molecule
Sc	I-Biological_Molecule
)	E-Biological_Molecule
,	O
an	O
exhaustive	O
comparative	O
analysis	O
of	O
the	O
expression	O
of	O
about	O
200	O
glycosylation	O
-	O
related	O
genes	O
was	O
performed	O
on	O
prion	S-Biological_Molecule
-	O
infected	O
or	O
not	O
,	O
hypothalamus	O
-	O
derived	O
GT1	O
cells	O
by	O
hybridization	O
of	O
DNA	O
microarrays	O
,	O
semiquantitative	O
RT	O
-	O
PCR	O
,	O
and	O
biochemical	O
assays	O
.	O

beta	O
-	O
Heterochromatin	O
in	O
the	O
chromocenter	O
is	O
depleted	O
in	O
these	O
isoforms	O
,	O
but	O
relatively	O
enriched	O
in	O
H4	S-Biological_Molecule
acetylated	O
at	O
lysine	O
12	O
.	O

The	O
loss	O
of	O
NKX3	B-Biological_Molecule
.	I-Biological_Molecule
1	E-Biological_Molecule
expression	O
in	O
testicular	O
-	O
-	O
and	O
prostate	O
-	O
-	O
cancers	O
is	O
not	O
caused	O
by	O
promoter	O
hypermethylation	O
.	O

Both	O
polypeptides	O
are	O
distinguished	O
by	O
strong	O
anti	O
-	O
angiogenic	O
activity	O
in	O
vivo	O
restricting	O
the	O
growth	O
of	O
solid	O
tumors	O
and	O
metastasis	O
.	O

Comparing	O
gene	O
expression	O
profiles	O
of	O
these	O
two	O
lines	O
after	O
5	O
-	O
AzaC	O
treatment	O
,	O
we	O
identified	O
36	O
genes	O
that	O
had	O
relatively	O
low	O
basal	O
levels	O
in	O
MDAMB468	O
cells	O
compared	O
to	O
the	O
DU99	O
line	O
and	O
were	O
induced	O
in	O
the	O
cancer	O
cell	O
line	O
but	O
not	O
in	O
the	O
normal	O
breast	O
epithelial	O
line	O
.	O

We	O
also	O
report	O
complete	O
osteocalcin	S-Biological_Molecule
sequences	O
for	O
chimpanzee	O
(	O
Pan	O
troglodytes	O
)	O
and	O
gorilla	O
(	O
Gorilla	O
gorilla	O
gorilla	O
)	O
and	O
a	O
partial	O
sequence	O
for	O
orangutan	O
(	O
Pongo	O
pygmaeus	O
)	O
,	O
all	O
of	O
which	O
are	O
previously	O
unreported	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
relationship	O
between	O
H3	S-Biological_Molecule
-	O
K9	O
methylation	O
,	O
transcriptional	O
repression	O
,	O
and	O
HP1	O
recruitment	O
by	O
comparing	O
the	O
effects	O
of	O
tethering	O
two	O
H3	S-Biological_Molecule
-	O
K9	O
-	O
specific	O
histone	O
methyltransferases	O
,	O
SUV39H1	S-Biological_Molecule
and	O
G9a	S-Biological_Molecule
,	O
to	O
chromatin	O
on	O
transcription	O
and	O
HP1	O
recruitment	O
.	O

In	O
vitro	O
differentiation	O
of	O
human	O
umbilical	O
cord	O
blood	O
-	O
derived	O
mesenchymal	O
stem	O
cells	O
into	O
hepatocyte	O
-	O
like	O
cells	O
.	O

Small	O
interfering	O
RNAs	O
that	O
trigger	O
posttranscriptional	O
gene	O
silencing	O
are	O
not	O
required	O
for	O
the	O
histone	B-Biological_Molecule
H3	E-Biological_Molecule
Lys9	O
methylation	O
necessary	O
for	O
transgenic	O
tandem	O
repeat	O
stabilization	O
in	O
Neurospora	O
crassa	O
.	O

In	O
Neurospora	O
crassa	O
,	O
the	O
introduction	O
of	O
a	O
transgene	O
can	O
lead	O
to	O
small	O
interfering	O
RNA	O
(	O
siRNA	O
)	O
-	O
mediated	O
posttranscriptional	O
gene	O
silencing	O
(	O
PTGS	O
)	O
of	O
homologous	O
genes	O
.	O

siRNAs	O
can	O
also	O
guide	O
locus	O
-	O
specific	O
methylation	O
of	O
Lys9	O
of	O
histone	B-Biological_Molecule
H3	E-Biological_Molecule
(	O
Lys9H3	S-Biological_Molecule
)	O
in	O
Schizosaccharomyces	O
pombe	O
.	O

Thus	O
,	O
LARGE	S-Biological_Molecule
is	O
a	O
potential	O
therapeutic	O
target	O
.	O

Still	O
the	O
collagen	O
produced	O
in	O
the	O
presence	O
of	O
minoxidil	O
displays	O
some	O
remarkable	O
features	O
:	O
hydroxylation	O
of	O
triple	O
helical	O
lysine	O
residues	O
is	O
reduced	O
to	O
50	O
%	O
and	O
lysylpyridinoline	O
cross	O
-	O
linking	O
is	O
increased	O
at	O
the	O
expense	O
of	O
hydroxylysylpyridinoline	O
cross	O
-	O
linking	O
.	O

Two	O
C	O
-	O
methyl	O
derivatives	O
of	O
[	O
11C	O
]	O
WAY	O
-	O
100635	O
-	O
-	O
effects	O
of	O
an	O
amido	O
alpha	O
-	O
methyl	O
group	O
on	O
metabolism	O
and	O
brain	O
5	B-Biological_Molecule
-	I-Biological_Molecule
HT1A	E-Biological_Molecule
receptor	O
radioligand	O
behavior	O
in	O
monkey	O
.	O

RESULTS	O
:	O
SWAY	O
and	O
(	O
R	O
,	O
S	O
)	O
-	O
JWAY	O
were	O
found	O
to	O
be	O
high	O
-	O
affinity	O
antagonists	O
at	O
5	B-Biological_Molecule
-	I-Biological_Molecule
HT1A	E-Biological_Molecule
receptors	O
.	O

After	O
injection	O
of	O
[	O
11C	O
]	O
SWAY	O
into	O
monkey	O
,	O
radioactivity	O
uptake	O
in	O
brain	O
reached	O
a	O
maximum	O
of	O
3	O
%	O
at	O
4	O
.	O
5	O
minutes	O
and	O
decreased	O
to	O
0	O
.	O
7	O
%	O
at	O
72	O
minutes	O
.	O

After	O
injection	O
of	O
[	O
11C	O
]	O
(	O
R	O
,	O
S	O
)	O
-	O
JWAY	O
alone	O
,	O
radioactivity	O
uptake	O
in	O
brain	O
reached	O
a	O
maximum	O
of	O
4	O
.	O
8	O
%	O
at	O
2	O
.	O
5	O
minutes	O
and	O
decreased	O
to	O
1	O
.	O
2	O
%	O
at	O
90	O
minutes	O
.	O

So	O
far	O
,	O
because	O
of	O
the	O
impairment	O
of	O
maturation	O
and	O
of	O
the	O
targeting	O
process	O
,	O
transfecting	O
DUOX	O
into	O
nonthyroid	O
cell	O
lines	O
has	O
not	O
led	O
to	O
the	O
expression	O
of	O
a	O
functional	O
H2O2	O
-	O
generating	O
system	O
at	O
the	O
plasma	O
membrane	O
.	O

TPO	S-Biological_Molecule
co	O
-	O
transfection	O
produced	O
a	O
slight	O
increase	O
in	O
the	O
enzymatic	O
activity	O
,	O
whereas	O
p22	B-Biological_Molecule
(	I-Biological_Molecule
phox	I-Biological_Molecule
)	E-Biological_Molecule
,	O
the	O
22	O
-	O
kDa	O
subunit	O
of	O
the	O
leukocyte	O
NADPH	O
oxidase	O
,	O
had	O
no	O
effect	O
.	O

The	O
method	O
was	O
then	O
applied	O
to	O
the	O
analysis	O
of	O
glycan	O
heterogeneities	O
at	O
seven	O
N	O
-	O
glycosylation	O
sites	O
in	O
each	O
of	O
the	O
plasma	O
and	O
cellular	O
fibronectins	S-Biological_Molecule
(	O
FNs	S-Biological_Molecule
)	O
.	O

Chromatin	O
in	O
this	O
promoter	O
also	O
becomes	O
more	O
accessible	O
after	O
UV	O
.	O

The	O
acetylated	O
isoforms	O
of	O
histone	B-Biological_Molecule
H4	E-Biological_Molecule
from	O
mouse	O
lymphosarcoma	O
cells	O
treated	O
with	O
HDAC	O
inhibitors	O
trichostatin	O
A	O
(	O
TSA	O
)	O
and	O
depsipeptide	O
(	O
DDP	O
)	O
were	O
separated	O
by	O
acetic	O
acid	O
urea	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
(	O
AU	O
-	O
PAGE	O
)	O
,	O
in	O
-	O
gel	O
digested	O
,	O
and	O
analyzed	O
by	O
matrix	O
assisted	O
laser	O
desorption	O
/	O
ionization	O
time	O
-	O
of	O
-	O
flight	O
mass	O
spectrometry	O
(	O
MALDI	O
-	O
TOF	O
MS	O
)	O
and	O
liquid	O
chromatography	O
tandem	O
mass	O
spectrometry	O
(	O
LC	O
-	O
MS	O
/	O
MS	O
)	O
.	O

Our	O
studies	O
indicate	O
that	O
altered	O
activity	O
of	O
ceruloplasmin	S-Biological_Molecule
may	O
present	O
a	O
vulnerability	O
factor	O
for	O
iron	O
induced	O
oxidative	O
stress	O
in	O
PD	O
.	O

Oxygen	O
-	O
dependent	O
ubiquitination	O
and	O
degradation	O
of	O
hypoxia	B-Biological_Molecule
-	I-Biological_Molecule
inducible	I-Biological_Molecule
factor	I-Biological_Molecule
1alpha	E-Biological_Molecule
(	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
)	O
plays	O
a	O
central	O
role	O
in	O
regulating	O
transcriptional	O
responses	O
to	O
hypoxia	O
.	O

The	O
developed	O
homogeneous	O
assay	O
would	O
provide	O
a	O
convenient	O
way	O
of	O
probing	O
the	O
biochemical	O
properties	O
of	O
the	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
-	O
VBC	O
interaction	O
and	O
PHDs	O
,	O
and	O
of	O
screening	O
modulators	O
for	O
the	O
interaction	O
as	O
well	O
as	O
the	O
enzyme	O
.	O

We	O
have	O
analysed	O
the	O
promoters	O
of	O
the	O
human	O
CIDE	B-Biological_Molecule
-	E-Biological_Molecule
B	O
gene	O
,	O
particularly	O
the	O
mechanism	O
of	O
cell	O
-	O
specific	O
transcription	O
.	O

The	O
proteasome	O
regulatory	O
particle	O
alters	O
the	O
SAGA	O
coactivator	O
to	O
enhance	O
its	O
interactions	O
with	O
transcriptional	O
activators	O
.	O

RESULTS	O
:	O
The	O
significant	O
enhanced	O
expression	O
of	O
the	O
fibrinogen	B-Biological_Molecule
gamma	I-Biological_Molecule
-	I-Biological_Molecule
chain	E-Biological_Molecule
and	O
reduced	O
expression	O
of	O
haptoglobin	B-Biological_Molecule
beta	I-Biological_Molecule
-	I-Biological_Molecule
chain	E-Biological_Molecule
were	O
demonstrated	O
in	O
the	O
profiles	O
of	O
untreated	O
CH	O
patients	O
using	O
both	O
silver	O
staining	O
and	O
lectin	O
detection	O
methods	O
.	O

CONCLUSIONS	O
:	O
Plasma	O
from	O
untreated	O
CH	O
patients	O
demonstrated	O
different	O
altered	O
expression	O
of	O
fibrinogen	O
and	O
haptoglobin	S-Biological_Molecule
polypeptide	O
chains	O
,	O
which	O
was	O
normalized	O
when	O
patients	O
were	O
treated	O
.	O

Collectively	O
,	O
these	O
data	O
suggest	O
that	O
adiponectin	S-Biological_Molecule
multimer	O
composition	O
is	O
affected	O
by	O
changes	O
in	O
PTM	O
in	O
response	O
to	O
physiological	O
factors	O
.	O

Heterochromatin	O
assembly	O
:	O
a	O
new	O
twist	O
on	O
an	O
old	O
model	O
.	O

This	O
is	O
achieved	O
through	O
its	O
packaging	O
into	O
chromatin	O
.	O

Acetylation	O
genotype	O
and	O
phenotype	O
in	O
patients	O
with	O
systemic	O
lupus	O
erythematosus	O
.	O

Nonadditive	O
regulation	O
of	O
FRI	S-Biological_Molecule
and	O
FLC	O
loci	O
mediates	O
flowering	O
-	O
time	O
variation	O
in	O
Arabidopsis	O
allopolyploids	O
.	O

Two	O
duplicate	O
FLCs	O
(	O
AaFLC1	S-Biological_Molecule
and	O
AaFLC2	S-Biological_Molecule
)	O
originating	O
from	O
A	O
.	O
arenosa	O
are	O
expressed	O
in	O
some	O
allotetraploids	O
but	O
silenced	O
in	O
other	O
lines	O
.	O

The	O
protein	O
was	O
stained	O
with	O
4	O
-	O
chloro	O
-	O
1	O
-	O
naphthol	O
.	O

They	O
further	O
showed	O
that	O
NP	S-Biological_Molecule
is	O
O	O
glycosylated	O
and	O
sialylated	O
and	O
that	O
these	O
modifications	O
are	O
important	O
for	O
interaction	O
between	O
NP	S-Biological_Molecule
and	O
VP35	S-Biological_Molecule
.	O

To	O
increase	O
chances	O
for	O
successful	O
therapy	O
it	O
is	O
important	O
to	O
deliver	O
full	O
-	O
length	O
tumor	O
Ag	O
instead	O
of	O
loading	O
single	O
peptides	O
.	O

This	O
represses	O
HIF	O
-	O
mediated	O
transcription	O
by	O
inhibiting	O
the	O
recruitment	O
of	O
p300	S-Biological_Molecule
/	O
CBP	S-Biological_Molecule
coactivators	O
.	O

HPLC	O
analysis	O
of	O
reaction	O
products	O
revealed	O
three	O
peaks	O
corresponding	O
to	O
isoscopoletin	O
,	O
scopoletin	O
,	O
and	O
scoparone	O
,	O
and	O
their	O
structures	O
were	O
determined	O
using	O
NMR	O
.	O

Methylation	O
of	O
lysine	O
and	O
arginine	O
residues	O
on	O
histone	S-Biological_Molecule
tails	O
affects	O
chromatin	O
structure	O
and	O
gene	O
transcription	O
.	O

In	O
this	O
study	O
we	O
aimed	O
at	O
generating	O
hybrid	O
transgenic	O
silkworms	O
whose	O
PSGs	O
are	O
capable	O
of	O
producing	O
mini	O
-	O
collagens	O
and	O
enough	O
P4H	O
for	O
their	O
prolyl	O
4	O
-	O
hydroxylation	O
.	O

The	O
P4H	O
activity	O
in	O
the	O
transgenic	O
silkworms	O
was	O
130	O
-	O
fold	O
higher	O
than	O
that	O
of	O
wild	O
-	O
type	O
counterparts	O
.	O

A	O
carotenoid	O
synthesis	O
gene	O
cluster	O
containing	O
ten	O
genes	O
was	O
cloned	O
from	O
strain	O
DC263	O
,	O
among	O
which	O
eight	O
genes	O
were	O
involved	O
in	O
carotenoid	O
synthesis	O
.	O

In	O
addition	O
to	O
the	O
crtW	S-Biological_Molecule
gene	O
encoding	O
the	O
4	O
,	O
4	O
'	O
-	O
beta	O
-	O
ionone	O
ring	O
ketolase	O
and	O
the	O
crtZ	S-Biological_Molecule
gene	O
encoding	O
the	O
3	O
,	O
3	O
'	O
-	O
beta	O
-	O
ionone	O
ring	O
hydroxylase	O
that	O
were	O
responsible	O
for	O
astaxanthin	O
synthesis	O
,	O
the	O
cluster	O
also	O
contained	O
a	O
novel	O
gene	O
crtG	S-Biological_Molecule
identified	O
recently	O
encoding	O
the	O
2	O
,	O
2	O
'	O
-	O
beta	O
-	O
ionone	O
ring	O
hydroxylase	O
that	O
further	O
hydroxylate	O
astaxanthin	O
.	O

The	O
genetic	O
organization	O
of	O
the	O
carotenoid	O
synthesis	O
gene	O
clusters	O
in	O
the	O
two	O
Brevundimonas	O
strains	O
was	O
identical	O
.	O

It	O
is	O
likely	O
that	O
the	O
two	O
Brevundimonas	O
strains	O
were	O
evolved	O
from	O
the	O
same	O
ancestor	O
and	O
adapted	O
later	O
to	O
growth	O
in	O
different	O
environments	O
.	O

Probing	O
long	O
-	O
distance	O
regulatory	O
interactions	O
in	O
the	O
Drosophila	O
melanogaster	O
bithorax	O
complex	O
using	O
Dam	O
identification	O
.	O

In	O
this	O
study	O
,	O
LAQ824	O
mediated	O
apoptosis	O
was	O
found	O
to	O
occur	O
mainly	O
via	O
activation	O
of	O
the	O
mitochondrial	O
death	O
pathway	O
by	O
inducing	O
Apaf1	S-Biological_Molecule
and	O
caspase	B-Biological_Molecule
9	E-Biological_Molecule
and	O
promoting	O
mitochondrial	O
release	O
of	O
key	O
proapoptotic	O
factors	O
in	O
lung	O
cancer	O
cells	O
,	O
but	O
not	O
in	O
normal	O
fibroblast	O
cells	O
.	O

In	O
addition	O
,	O
LAQ824	O
was	O
found	O
to	O
induce	O
Bax	S-Biological_Molecule
translocation	O
in	O
lung	O
cancer	O
cell	O
,	O
which	O
may	O
play	O
important	O
role	O
in	O
the	O
induction	O
of	O
the	O
release	O
of	O
mitochondrial	O
proapoptotic	O
factors	O
.	O

Here	O
,	O
we	O
identify	O
the	O
requirements	O
for	O
such	O
selective	O
targeting	O
.	O

Consequently	O
,	O
PHD3	S-Biological_Molecule
is	O
found	O
in	O
high	O
-	O
molecular	O
-	O
mass	O
fractions	O
that	O
were	O
enriched	O
in	O
hypoxia	O
.	O

Interestingly	O
,	O
within	O
the	O
lower	O
-	O
molecular	O
-	O
mass	O
complex	O
,	O
PHD3	S-Biological_Molecule
exhibits	O
higher	O
specific	O
activity	O
towards	O
hydroxylation	O
of	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
and	O
co	O
-	O
localizes	O
with	O
Siah2	S-Biological_Molecule
,	O
suggesting	O
that	O
Siah2	S-Biological_Molecule
limits	O
the	O
availability	O
of	O
the	O
more	O
active	O
form	O
of	O
PHD3	S-Biological_Molecule
.	O

The	O
same	O
cells	O
become	O
permissive	O
for	O
HCMV	O
lytic	O
infection	O
after	O
induction	O
of	O
cell	O
differentiation	O
by	O
treatment	O
with	O
12	O
-	O
O	O
-	O
tetradecanoylphorbol	O
-	O
13	O
-	O
acetate	O
.	O

Studies	O
on	O
hypoxia	O
-	O
sensitive	O
pathways	O
have	O
revealed	O
a	O
series	O
of	O
Fe	O
(	O
II	O
)	O
-	O
dependent	O
dioxygenases	O
that	O
regulate	O
hypoxia	O
-	O
inducible	O
factor	O
(	O
HIF	O
)	O
by	O
prolyl	O
and	O
asparaginyl	O
hydroxylation	O
.	O

Nevertheless	O
,	O
development	O
of	O
pharmaceutical	O
agents	O
to	O
control	O
PRMT	O
functions	O
could	O
lead	O
to	O
significant	O
new	O
targets	O
.	O

The	O
cold	O
and	O
menthol	O
receptor	O
TRPM8	S-Biological_Molecule
contains	O
a	O
functionally	O
important	O
double	O
cysteine	O
motif	O
.	O

To	O
do	O
this	O
,	O
amino	O
-	O
terminal	O
c	B-Biological_Molecule
-	I-Biological_Molecule
myc	E-Biological_Molecule
or	O
hemagglutinin	S-Biological_Molecule
epitope	O
-	O
tagged	O
proteins	O
were	O
incorporated	O
and	O
expressed	O
in	O
Chinese	O
hamster	O
ovary	O
cells	O
.	O

Finally	O
,	O
we	O
showed	O
in	O
Perfluoro	O
-	O
octanoic	O
acid	O
-	O
polyacrylamide	O
gels	O
that	O
TRPM8	S-Biological_Molecule
can	O
form	O
a	O
tetramer	O
(	O
in	O
addition	O
to	O
dimer	O
and	O
trimer	O
forms	O
)	O
,	O
consistent	O
with	O
current	O
thinking	O
that	O
functional	O
TRP	O
ion	O
channels	O
are	O
tetrameric	O
.	O

These	O
data	O
indicate	O
that	O
Foxp3	S-Biological_Molecule
may	O
regulate	O
transcription	O
through	O
direct	O
chromatin	O
remodeling	O
and	O
show	O
that	O
Foxp3	S-Biological_Molecule
function	O
is	O
influenced	O
by	O
signals	O
from	O
the	O
TCR	O
.	O

Recently	O
,	O
an	O
unknown	O
activity	O
has	O
been	O
attributed	O
to	O
some	O
urine	O
samples	O
(	O
denominated	O
'	O
unstable	O
'	O
urine	O
by	O
the	O
World	O
Anti	O
-	O
Doping	O
Agency	O
;	O
WADA	O
)	O
.	O

Consequently	O
,	O
to	O
understand	O
whether	O
spatial	O
relationships	O
that	O
are	O
not	O
coincident	O
are	O
nonrandom	O
and	O
potentially	O
biologically	O
important	O
,	O
it	O
is	O
necessary	O
to	O
develop	O
statistical	O
approaches	O
.	O

Real	O
-	O
time	O
PCR	O
demonstrates	O
that	O
CG	O
-	O
1521	O
induces	O
p21	S-Biological_Molecule
transcription	O
whereas	O
trichostatin	O
A	O
does	O
not	O
alter	O
the	O
steady	O
state	O
level	O
of	O
p21	S-Biological_Molecule
mRNA	O
.	O

In	O
this	O
study	O
,	O
we	O
identify	O
the	O
N	O
-	O
glycosylation	O
sites	O
of	O
carboxylase	O
by	O
mass	O
spectrometric	O
peptide	O
mapping	O
analyses	O
combined	O
with	O
site	O
-	O
directed	O
mutagenesis	O
.	O

Furthermore	O
,	O
the	O
potential	O
glycosylation	O
site	O
at	O
N570	O
is	O
glycosylated	O
only	O
if	O
all	O
five	O
natural	O
glycosylation	O
sites	O
are	O
simultaneously	O
mutated	O
.	O

Our	O
previous	O
studies	O
demonstrated	O
that	O
inhibition	O
of	O
histone	S-Biological_Molecule
deacetylases	O
(	O
HDACs	O
)	O
by	O
trichostatin	O
A	O
reactivates	O
estrogen	B-Biological_Molecule
receptor	I-Biological_Molecule
alpha	E-Biological_Molecule
(	O
ER	S-Biological_Molecule
)	O
gene	O
expression	O
in	O
ER	S-Biological_Molecule
-	O
negative	O
breast	O
cancer	O
cells	O
.	O

The	O
biological	O
activities	O
of	O
the	O
type	O
I	O
and	O
II	O
and	O
type	O
II	O
variants	O
were	O
twofold	O
that	O
of	O
the	O
Third	O
International	O
tPA	S-Biological_Molecule
Standard	O
(	O
98	O
/	O
714	O
)	O
produced	O
in	O
the	O
CHO	O
cell	O
line	O
,	O
and	O
the	O
activity	O
of	O
type	O
II	O
variant	O
was	O
12	O
.	O
6	O
%	O
higher	O
than	O
that	O
of	O
the	O
type	O
I	O
and	O
II	O
variants	O
.	O

These	O
results	O
demonstrate	O
that	O
tPA	S-Biological_Molecule
produced	O
in	O
urea	O
-	O
cycle	O
-	O
enzyme	O
-	O
producing	O
OTC	S-Biological_Molecule
cells	O
have	O
a	O
very	O
high	O
biological	O
activity	O
and	O
the	O
percentage	O
of	O
type	O
II	O
variant	O
which	O
is	O
very	O
valuable	O
for	O
the	O
biopharmaceutical	O
industry	O
is	O
higher	O
than	O
that	O
of	O
any	O
report	O
using	O
CHO	O
cells	O
.	O

An	O
in	O
vivo	O
assay	O
to	O
quantify	O
stable	O
protein	O
phosphatase	O
2A	O
(	O
PP2A	O
)	O
heterotrimeric	O
species	O
.	O

The	O
mechanisms	O
that	O
trigger	O
such	O
posttranslational	O
modifications	O
,	O
as	O
well	O
as	O
their	O
consequences	O
,	O
are	O
still	O
under	O
investigation	O
.	O

These	O
results	O
strongly	O
support	O
an	O
activation	O
role	O
for	O
CYP1A2	S-Biological_Molecule
in	O
PhIP	O
-	O
induced	O
mutagenesis	O
and	O
DNA	O
damage	O
and	O
suggest	O
a	O
modest	O
effect	O
of	O
human	O
NAT2	S-Biological_Molecule
and	O
its	O
genetic	O
polymorphism	O
on	O
PhIP	O
DNA	O
adduct	O
levels	O
.	O

In	O
the	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
,	O
correlation	O
between	O
the	O
methylation	O
profile	O
in	O
tumor	O
and	O
paired	O
saliva	O
is	O
excellent	O
;	O
thus	O
methylation	O
analysis	O
in	O
saliva	O
is	O
a	O
very	O
promising	O
approach	O
for	O
early	O
cancer	O
detection	O
in	O
high	O
risk	O
patients	O
or	O
for	O
the	O
post	O
treatment	O
follow	O
up	O
and	O
rapid	O
diagnosis	O
of	O
relapse	O
.	O

After	O
optimized	O
for	O
effectively	O
capturing	O
p300	S-Biological_Molecule
/	O
CBP	S-Biological_Molecule
,	O
the	O
assay	O
was	O
utilized	O
for	O
evaluating	O
direct	O
effects	O
of	O
posttranslational	O
modifications	O
of	O
the	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
C	O
-	O
TAD	O
on	O
p300	S-Biological_Molecule
binding	O
.	O

CCR4	S-Biological_Molecule
/	O
NOT	O
complex	O
associates	O
with	O
the	O
proteasome	O
and	O
regulates	O
histone	S-Biological_Molecule
methylation	O
.	O

Consistent	O
with	O
the	O
genetic	O
and	O
biochemical	O
interactions	O
linking	O
CCR4	S-Biological_Molecule
/	O
NOT	O
with	O
proteasome	O
and	O
Set1	S-Biological_Molecule
-	O
mediated	O
methylation	O
,	O
we	O
find	O
that	O
loss	O
of	O
Not4	S-Biological_Molecule
decreases	O
global	O
and	O
gene	O
-	O
specific	O
H3K4	S-Biological_Molecule
trimethylation	O
(	O
H3K4me3	S-Biological_Molecule
)	O
and	O
decreases	O
19S	O
proteasome	O
recruitment	O
to	O
the	O
PMA1	S-Biological_Molecule
gene	O
.	O

In	O
addition	O
,	O
local	O
skin	O
inflammation	O
in	O
rats	O
caused	O
by	O
an	O
anti	O
-	O
Crry	S-Biological_Molecule
monoclonal	O
antibody	O
was	O
suppressed	O
when	O
AcPepA	O
and	O
the	O
antibody	O
were	O
injected	O
together	O
,	O
while	O
PepA	O
had	O
little	O
inhibitory	O
capacity	O
.	O

The	O
first	O
phase	O
precedes	O
transcription	O
initiation	O
and	O
is	O
characterized	O
exclusively	O
by	O
a	O
rapid	O
increase	O
in	O
histone	B-Biological_Molecule
H4	E-Biological_Molecule
acetylation	O
over	O
a	O
large	O
upstream	O
domain	O
.	O

Here	O
we	O
show	O
that	O
continuous	O
inhibition	O
of	O
proteasomal	O
chymotrypsin	O
-	O
like	O
peptidase	O
activity	O
by	O
the	O
proteasome	O
inhibitor	O
bortezomib	O
induces	O
in	O
human	O
Namalwa	O
Burkitt	O
lymphoma	O
cells	O
increased	O
de	O
novo	O
biogenesis	O
of	O
proteasomes	O
accompanied	O
by	O
increased	O
expression	O
of	O
the	O
proteasome	O
maturation	O
protein	O
POMP	S-Biological_Molecule
,	O
increased	O
expression	O
of	O
19S	O
-	O
20S	O
-	O
19S	O
proteasomes	O
,	O
and	O
abrogation	O
of	O
expression	O
of	O
beta	O
1i	O
,	O
beta	O
2i	O
and	O
beta	O
5i	O
immunosubunits	O
and	O
PA28	S-Biological_Molecule
in	O
favor	O
of	O
increased	O
expression	O
of	O
constitutive	O
proteolytic	O
beta1	O
,	O
beta2	O
and	O
beta	O
5	O
subunits	O
and	O
19S	O
regulatory	O
complexes	O
.	O

Cells	O
harboring	O
these	O
proteasomal	O
alterations	O
display	O
rapid	O
proliferation	O
and	O
cell	O
cycle	O
progression	O
,	O
and	O
acquire	O
resistance	O
to	O
apoptosis	O
induced	O
by	O
proteasome	O
inhibitors	O
,	O
gamma	O
-	O
irradiation	O
and	O
staurosporine	O
.	O

Disruption	O
of	O
the	O
actin	O
cytoskeleton	O
with	O
cytochalasin	O
D	O
phenocopied	O
the	O
lrECM	O
-	O
induced	O
cell	O
rounding	O
and	O
histone	S-Biological_Molecule
deacetylation	O
.	O

EZH2	S-Biological_Molecule
mRNA	O
expression	O
was	O
measured	O
by	O
real	O
-	O
time	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
,	O
and	O
the	O
methylation	O
analysis	O
was	O
performed	O
using	O
methylation	O
-	O
specific	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
.	O

In	O
patients	O
with	O
recurrent	O
TCC	O
,	O
APAF	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
IGFBP	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
methylation	O
levels	O
were	O
significantly	O
higher	O
(	O
p	O
=	O
0	O
.	O
03	O
and	O
p	O
=	O
0	O
.	O
01	O
,	O
respectively	O
)	O
,	O
which	O
was	O
not	O
observed	O
when	O
EZH2	S-Biological_Molecule
mRNA	O
expression	O
or	O
DAPK	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
methylation	O
levels	O
were	O
related	O
to	O
the	O
clinical	O
outcome	O
.	O

Here	O
,	O
using	O
conventional	O
biochemical	O
approaches	O
,	O
we	O
purified	O
a	O
plant	O
histone	S-Biological_Molecule
Arg	O
methyltransferase	O
from	O
cauliflower	O
(	O
Brassica	O
oleracea	O
)	O
that	O
was	O
nearly	O
identical	O
to	O
AtPRMT5	S-Biological_Molecule
,	O
an	O
Arabidopsis	O
(	O
Arabidopsis	O
thaliana	O
)	O
homolog	O
of	O
human	O
PRMT5	S-Biological_Molecule
.	O

Treatment	O
of	O
the	O
chronic	O
hepatitis	O
C	O
virus	O
(	O
HCV	O
)	O
infection	O
is	O
an	O
unmet	O
medical	O
need	O
,	O
and	O
the	O
HCV	O
NS3	S-Biological_Molecule
serine	O
protease	O
(	O
NS3	S-Biological_Molecule
-	O
SP	O
)	O
has	O
been	O
used	O
as	O
an	O
attractive	O
target	O
of	O
antiviral	O
screening	O
against	O
HCV	O
.	O

Due	O
to	O
lack	O
of	O
an	O
appropriate	O
methodology	O
,	O
different	O
IGF	B-Biological_Molecule
-	I-Biological_Molecule
II	E-Biological_Molecule
isoforms	O
have	O
not	O
been	O
demonstrated	O
and	O
characterized	O
in	O
the	O
rat	O
circulation	O
,	O
thus	O
preventing	O
a	O
better	O
understanding	O
of	O
the	O
physiological	O
and	O
pathological	O
roles	O
of	O
IGF	B-Biological_Molecule
-	I-Biological_Molecule
II	E-Biological_Molecule
.	O

Overexpression	O
of	O
various	O
candidates	O
led	O
to	O
the	O
identification	O
of	O
a	O
single	O
gene	O
(	O
named	O
GALACTOSYLTRANSFERASE1	S-Biological_Molecule
[	O
GALT1	S-Biological_Molecule
]	O
)	O
that	O
increased	O
the	O
originally	O
very	O
low	O
Lewis	O
a	O
epitope	O
levels	O
in	O
planta	O
.	O

Recombinant	O
GALT1	S-Biological_Molecule
protein	O
produced	O
in	O
insect	O
cells	O
was	O
capable	O
of	O
transferring	O
beta1	O
,	O
3	O
-	O
linked	O
galactose	O
residues	O
to	O
various	O
N	O
-	O
glycan	O
acceptor	O
substrates	O
,	O
and	O
subsequent	O
treatment	O
of	O
the	O
reaction	O
products	O
with	O
alpha1	B-Biological_Molecule
,	I-Biological_Molecule
4	I-Biological_Molecule
-	I-Biological_Molecule
fucosyltransferase	E-Biological_Molecule
resulted	O
in	O
the	O
generation	O
of	O
Lewis	O
a	O
structures	O
.	O

Moreover	O
,	O
cell	O
biological	O
characterization	O
of	O
a	O
transiently	O
expressed	O
GALT1	S-Biological_Molecule
-	O
fluorescent	O
protein	O
fusion	O
using	O
confocal	O
laser	O
scanning	O
microscopy	O
revealed	O
the	O
exclusive	O
location	O
of	O
GALT1	S-Biological_Molecule
within	O
the	O
Golgi	O
apparatus	O
,	O
which	O
is	O
in	O
good	O
agreement	O
with	O
the	O
proposed	O
physiological	O
action	O
of	O
the	O
enzyme	O
.	O

For	O
all	O
core	O
histones	S-Biological_Molecule
,	O
the	O
modifications	O
in	O
the	O
G1	O
and	O
S	O
phases	O
were	O
largely	O
identical	O
but	O
drastically	O
different	O
during	O
mitosis	O
.	O

Modification	O
changes	O
between	O
S	O
and	O
G2	O
/	O
M	O
phases	O
were	O
quantified	O
using	O
the	O
SILAC	O
(	O
stable	O
isotope	O
labeling	O
by	O
amino	O
acids	O
in	O
cell	O
culture	O
)	O
approach	O
.	O

Their	O
overall	O
structure	O
and	O
the	O
multiprotein	O
complexes	O
in	O
which	O
they	O
are	O
carrying	O
out	O
their	O
activities	O
are	O
discussed	O
.	O

Glycosylation	O
of	O
alpha	O
1	O
-	O
acid	O
glycoprotein	O
in	O
relation	O
to	O
duration	O
of	O
disease	O
in	O
acute	O
and	O
chronic	O
infection	O
and	O
inflammation	O
.	O

The	O
scaffold	O
proteins	O
that	O
assemble	O
these	O
kinase	O
complexes	O
are	O
poorly	O
characterized	O
.	O

To	O
further	O
investigate	O
the	O
mechanism	O
of	O
proteasome	O
dysfunction	O
,	O
ATP	O
levels	O
and	O
subunit	O
protein	O
levels	O
of	O
19S	O
ATPase	O
Rpt6	S-Biological_Molecule
and	O
20S	B-Biological_Molecule
beta5	E-Biological_Molecule
were	O
measured	O
and	O
noted	O
to	O
be	O
decreased	O
in	O
the	O
ventral	O
midbrain	O
,	O
but	O
not	O
in	O
the	O
striatum	O
.	O

Our	O
results	O
demonstrate	O
that	O
the	O
N	O
-	O
terminal	O
and	O
trefoil	O
domains	O
of	O
bovine	O
rZP4	S-Biological_Molecule
are	O
dispensable	O
for	O
formation	O
of	O
the	O
sperm	O
-	O
binding	O
active	O
bovine	O
rZP3	S-Biological_Molecule
/	O
rZP4	S-Biological_Molecule
complex	O
and	O
,	O
furthermore	O
,	O
that	O
the	O
molecular	O
interactions	O
between	O
rZP3	S-Biological_Molecule
and	O
rZP4	S-Biological_Molecule
are	O
conserved	O
in	O
the	O
bovine	O
and	O
porcine	O
systems	O
.	O

Receptor	B-Biological_Molecule
for	I-Biological_Molecule
activated	I-Biological_Molecule
C	I-Biological_Molecule
kinase	I-Biological_Molecule
1	E-Biological_Molecule
(	O
RACK1	S-Biological_Molecule
)	O
competes	O
with	O
heat	B-Biological_Molecule
shock	I-Biological_Molecule
protein	I-Biological_Molecule
90	E-Biological_Molecule
(	O
HSP90	S-Biological_Molecule
)	O
for	O
binding	O
to	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
and	O
mediates	O
O2	O
-	O
independent	O
ubiquitination	O
and	O
proteasomal	O
degradation	O
.	O

The	O
interaction	O
of	O
the	O
SRA	O
domain	O
of	O
ICBP90	S-Biological_Molecule
with	O
a	O
novel	O
domain	O
of	O
DNMT1	S-Biological_Molecule
is	O
involved	O
in	O
the	O
regulation	O
of	O
VEGF	S-Biological_Molecule
gene	O
expression	O
.	O

In	O
search	O
for	O
proteins	O
that	O
interact	O
with	O
the	O
set	O
and	O
ring	O
-	O
associated	O
(	O
SRA	O
)	O
domain	O
of	O
ICBP90	S-Biological_Molecule
,	O
we	O
used	O
the	O
two	O
-	O
hybrid	O
system	O
and	O
screened	O
a	O
placental	O
cDNA	O
library	O
.	O

Several	O
clones	O
coding	O
for	O
a	O
new	O
domain	O
of	O
DNMT1	S-Biological_Molecule
were	O
found	O
.	O

Methylation	O
of	O
lysine	O
residues	O
on	O
histones	S-Biological_Molecule
participates	O
in	O
transcriptional	O
gene	O
regulation	O
.	O

G9a	S-Biological_Molecule
methyltransferase	O
is	O
a	O
euchromatic	O
histone	B-Biological_Molecule
H3	E-Biological_Molecule
lysine	O
9	O
methyltransferase	O
.	O

Automethylation	O
of	O
G9a	S-Biological_Molecule
did	O
not	O
impair	O
or	O
activate	O
the	O
enzymatic	O
activity	O
in	O
vitro	O
.	O

Moreover	O
,	O
delays	O
in	O
PR	B-Biological_Molecule
-	I-Biological_Molecule
Set7	E-Biological_Molecule
synthesis	O
and	O
K20	O
methylation	O
which	O
accompany	O
altered	O
cell	O
cycle	O
progression	O
during	O
sodium	O
butyrate	O
treatment	O
appear	O
to	O
be	O
secondary	O
to	O
histone	S-Biological_Molecule
hyperacetylation	O
or	O
other	O
effects	O
of	O
butyrate	O
since	O
depletion	O
of	O
PR	B-Biological_Molecule
-	I-Biological_Molecule
Set7	E-Biological_Molecule
did	O
not	O
affect	O
cell	O
cycle	O
progression	O
.	O

We	O
next	O
determined	O
N	O
-	O
glycosylation	O
sites	O
of	O
human	O
NAAA	S-Biological_Molecule
by	O
site	O
-	O
directed	O
mutagenesis	O
addressed	O
to	O
asparagine	O
residues	O
in	O
six	O
potential	O
N	O
-	O
glycosylation	O
sites	O
.	O

Although	O
ubiquitin	S-Biological_Molecule
-	O
enriched	O
protein	O
inclusions	O
represent	O
an	O
almost	O
invariant	O
feature	O
of	O
neurodegenerative	O
diseases	O
,	O
the	O
mechanism	O
underlying	O
their	O
biogenesis	O
remains	O
unclear	O
.	O

In	O
particular	O
,	O
whether	O
the	O
topology	O
of	O
ubiquitin	S-Biological_Molecule
linkages	O
influences	O
the	O
dynamics	O
of	O
inclusions	O
is	O
not	O
well	O
explored	O
.	O

The	O
authors	O
describe	O
the	O
development	O
,	O
validation	O
,	O
and	O
execution	O
of	O
a	O
high	O
-	O
throughput	O
screening	O
measuring	O
the	O
ubiquitination	O
of	O
p53	S-Biological_Molecule
by	O
mdm2	S-Biological_Molecule
,	O
with	O
p53	S-Biological_Molecule
labeled	O
with	O
europium	O
and	O
the	O
other	O
substrate	O
(	O
Ub	O
-	O
UbcH5b	S-Biological_Molecule
)	O
labeled	O
with	O
a	O
Cy5	O
on	O
the	O
ubiquitin	S-Biological_Molecule
.	O

Here	O
we	O
characterize	O
a	O
hereditary	O
complex	O
of	O
non	O
-	O
CpG	O
methylation	O
,	O
with	O
the	O
transgenerational	O
maintenance	O
of	O
three	O
distinct	O
profiles	O
in	O
a	O
constant	O
ratio	O
,	O
associated	O
with	O
extensive	O
CpG	O
methylation	O
.	O

As	O
predicted	O
,	O
non	O
-	O
CpG	O
DNA	O
methylation	O
profiles	O
were	O
abrogated	O
in	O
a	O
mutant	O
lacking	O
Dnmt1	S-Biological_Molecule
,	O
the	O
enzymes	O
responsible	O
for	O
CpG	O
methylation	O
,	O
but	O
not	O
in	O
mutants	O
defective	O
for	O
either	O
Dnmt3a	S-Biological_Molecule
or	O
Dnmt2	S-Biological_Molecule
.	O

Neither	O
CGI	O
hypermethylation	O
at	O
a	O
single	O
gene	O
loci	O
nor	O
the	O
combination	O
of	O
multiple	O
gene	O
sites	O
was	O
correlated	O
to	O
the	O
pathological	O
stage	O
,	O
grade	O
or	O
biochemical	O
recurrence	O
following	O
radical	O
prostatectomy	O
.	O

Tu	O
-	O
IFN	O
was	O
compared	O
to	O
a	O
standard	O
acid	O
-	O
labile	O
IFN	O
by	O
affinity	O
chromatography	O
on	O
Con	B-Biological_Molecule
A	E-Biological_Molecule
-	O
sepharose	O
.	O

Post	O
-	O
translational	O
modification	O
plays	O
crucial	O
roles	O
in	O
signal	O
transduction	O
in	O
eukaryotic	O
cells	O
.	O

Site	O
-	O
specific	O
phosphorylation	O
of	O
CREB	O
and	O
hydroxylation	O
of	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
were	O
confirmed	O
by	O
matrix	O
-	O
assisted	O
laser	O
desorption	O
/	O
ionization	O
time	O
-	O
of	O
-	O
flight	O
(	O
MALDI	O
-	O
TOF	O
)	O
and	O
NMR	O
.	O

Furthermore	O
,	O
ubiquitination	O
of	O
IFNAR1	S-Biological_Molecule
promotes	O
its	O
interaction	O
with	O
the	O
AP2	O
adaptin	O
complex	O
that	O
is	O
required	O
for	O
the	O
robust	O
internalization	O
of	O
IFNAR1	S-Biological_Molecule
,	O
implicating	O
cooperation	O
between	O
site	O
-	O
specific	O
ubiquitination	O
and	O
the	O
linear	O
endocytic	O
motif	O
in	O
regulating	O
this	O
process	O
.	O

YC	O
-	O
1	O
was	O
administered	O
with	O
chemo	O
-	O
cytotoxic	O
drug	O
,	O
cisplatin	O
,	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

When	O
combined	O
with	O
cisplatin	O
,	O
YC	O
-	O
1	O
further	O
promoted	O
tumor	O
cell	O
apoptosis	O
,	O
decreased	O
the	O
expression	O
of	O
P	O
-	O
Stat3	S-Biological_Molecule
(	O
705	O
)	O
,	O
Bcl	B-Biological_Molecule
-	I-Biological_Molecule
xL	E-Biological_Molecule
,	O
CyclinD1	S-Biological_Molecule
and	O
survivin	S-Biological_Molecule
,	O
and	O
induced	O
the	O
cleavage	O
of	O
caspase	B-Biological_Molecule
9	E-Biological_Molecule
and	O
PARP	O
.	O

Sequence	O
analysis	O
of	O
the	O
catalytic	O
domains	O
of	O
the	O
PHDs	O
in	O
the	O
light	O
of	O
crystal	O
structures	O
for	O
PHD2	S-Biological_Molecule
,	O
and	O
results	O
for	O
other	O
2OG	O
oxygenases	O
,	O
suggested	O
that	O
either	O
the	O
C	O
-	O
terminal	O
region	O
or	O
a	O
loop	O
linking	O
two	O
beta	O
-	O
strands	O
(	O
beta2	O
and	O
beta3	O
in	O
human	O
PHD2	S-Biological_Molecule
)	O
are	O
important	O
in	O
determining	O
substrate	O
selectivity	O
.	O

In	O
this	O
study	O
,	O
we	O
present	O
a	O
combined	O
proteomics	O
and	O
genomics	O
study	O
of	O
SMYD2	S-Biological_Molecule
designed	O
to	O
elucidate	O
its	O
molecular	O
roles	O
.	O

In	O
particular	O
,	O
we	O
report	O
that	O
SMYD2	S-Biological_Molecule
interacted	O
with	O
HSP90alpha	S-Biological_Molecule
independently	O
of	O
the	O
SET	O
and	O
MYND	O
domains	O
,	O
with	O
EBP41L3	S-Biological_Molecule
through	O
the	O
MYND	O
domain	O
,	O
and	O
with	O
p53	S-Biological_Molecule
through	O
the	O
SET	O
domain	O
.	O

TACC2	S-Biological_Molecule
is	O
one	O
of	O
the	O
genes	O
up	O
-	O
regulated	O
as	O
a	O
result	O
of	O
SMYD2	S-Biological_Molecule
gain	O
of	O
function	O
.	O

This	O
superfamily	O
is	O
formed	O
by	O
more	O
than	O
30	O
structurally	O
related	O
secreted	O
proteins	O
.	O

Indeed	O
,	O
the	O
conformation	O
of	O
several	O
loops	O
differs	O
between	O
both	O
monomers	O
.	O

In	O
particular	O
,	O
the	O
prehelix	O
loop	O
,	O
which	O
plays	O
a	O
crucial	O
role	O
in	O
the	O
type	O
I	O
receptor	O
interactions	O
of	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
,	O
adopts	O
two	O
rather	O
different	O
conformations	O
in	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
,	O
indicating	O
possible	O
dynamic	O
flexibility	O
of	O
the	O
prehelix	O
loop	O
in	O
its	O
unbound	O
conformation	O
.	O

Effect	O
of	O
glucagon	S-Biological_Molecule
and	O
phorbol	O
myristate	O
acetate	O
on	O
oxidative	O
demethylation	O
and	O
lipid	O
peroxidation	O
in	O
isolated	O
hepatocytes	O
.	O

The	O
accumulation	O
of	O
Dopa	O
,	O
as	O
induced	O
by	O
the	O
inhibitor	O
of	O
aromatic	B-Biological_Molecule
amino	I-Biological_Molecule
acid	I-Biological_Molecule
decarboxylase	E-Biological_Molecule
,	O
NSD	O
1015	O
,	O
was	O
measured	O
in	O
parallel	O
in	O
two	O
dopamine	O
-	O
rich	O
regions	O
,	O
i	O
.	O
e	O
.	O
the	O
limbic	O
system	O
and	O
the	O
corpus	O
striatum	O
,	O
and	O
in	O
two	O
noradrenaline	O
-	O
rich	O
regions	O
,	O
i	O
.	O
e	O
.	O
the	O
neocortex	O
and	O
the	O
lower	O
brain	O
stem	O
.	O

Clonidine	O
caused	O
a	O
dose	O
-	O
dependent	O
locomotor	O
depression	O
.	O

The	O
relationship	O
between	O
the	O
dose	O
of	O
apomorphine	O
and	O
Dopa	O
formation	O
in	O
the	O
neocortex	O
appeared	O
biphasic	O
,	O
the	O
highest	O
dose	O
(	O
3	O
.	O
2	O
mg	O
/	O
kg	O
)	O
having	O
no	O
significant	O
effect	O
.	O

A	O
similar	O
trend	O
was	O
observed	O
for	O
clonidine	O
.	O

The	O
basal	O
importance	O
of	O
dopamine	O
neurones	O
for	O
the	O
locomotor	O
function	O
studied	O
in	O
the	O
present	O
paper	O
is	O
illustrated	O
by	O
the	O
marked	O
inhibition	O
by	O
low	O
doses	O
of	O
apomorphine	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
observations	O
with	O
clonidine	O
suggest	O
a	O
somewhat	O
less	O
striking	O
and	O
perhaps	O
less	O
direct	O
influence	O
of	O
noradrenaline	O
neurones	O
on	O
motor	O
activity	O
.	O

PURPOSE	O
:	O
Our	O
preclinical	O
experiments	O
indicated	O
that	O
Romidepsin	O
(	O
Depsipeptide	O
FK228	O
;	O
DP	O
)	O
mediates	O
growth	O
arrest	O
and	O
apoptosis	O
in	O
cultured	O
lung	O
cancer	O
cells	O
.	O

A	O
variety	O
of	O
molecular	O
end	O
points	O
were	O
assessed	O
in	O
tumor	O
biopsies	O
via	O
immunohistochemistry	O
techniques	O
.	O

RESULTS	O
:	O
Nineteen	O
patients	O
were	O
evaluable	O
for	O
toxicity	O
assessment	O
;	O
18	O
were	O
evaluable	O
for	O
treatment	O
response	O
.	O

Transient	O
stabilization	O
of	O
disease	O
was	O
noted	O
in	O
nine	O
patients	O
.	O

Interleukin	O
1	O
(	O
IL	O
-	O
1	O
)	O
has	O
been	O
reported	O
to	O
stimulate	O
the	O
polyubiquitination	O
and	O
disappearance	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
receptor	I-Biological_Molecule
-	I-Biological_Molecule
associated	I-Biological_Molecule
kinase	I-Biological_Molecule
1	E-Biological_Molecule
(	O
IRAK1	S-Biological_Molecule
)	O
within	O
minutes	O
.	O

It	O
has	O
been	O
thought	O
that	O
the	O
polyubiquitin	S-Biological_Molecule
chains	O
attached	O
to	O
IRAK1	S-Biological_Molecule
are	O
linked	O
via	O
Lys48	O
of	O
ubiquitin	S-Biological_Molecule
,	O
leading	O
to	O
its	O
destruction	O
by	O
the	O
proteasome	O
and	O
explaining	O
the	O
rapid	O
IL	O
-	O
1	O
-	O
induced	O
disappearance	O
of	O
IRAK1	S-Biological_Molecule
.	O

In	O
mammalian	O
cells	O
,	O
ERAD	O
can	O
be	O
blocked	O
by	O
a	O
chemical	O
inhibitor	O
termed	O
Eeyarestatin	O
I	O
,	O
but	O
the	O
mechanism	O
of	O
EerI	O
action	O
is	O
unclear	O
.	O

A	O
pathological	O
hallmark	O
of	O
these	O
childhood	O
neurodegenerative	O
diseases	O
is	O
the	O
presence	O
of	O
distinctive	O
spheroids	O
in	O
distal	O
axons	O
that	O
contain	O
accumulated	O
membranes	O
.	O

In	O
contrast	O
to	O
Nrf2	S-Biological_Molecule
ProTalpha	S-Biological_Molecule
was	O
not	O
subjected	O
to	O
Keap	O
-	O
dependent	O
ubiquitination	O
,	O
degradation	O
and	O
export	O
from	O
the	O
nucleus	O
.	O

We	O
found	O
that	O
a	O
large	O
number	O
of	O
peptides	O
can	O
be	O
modified	O
on	O
the	O
lysine	O
,	O
arginine	O
,	O
histidine	O
,	O
and	O
glutamic	O
acid	O
residues	O
with	O
a	O
mass	O
increase	O
of	O
14	O
or	O
28	O
Da	O
,	O
consistent	O
with	O
methylation	O
.	O

These	O
results	O
suggest	O
the	O
possibility	O
of	O
either	O
exogenous	O
protein	O
methylation	O
during	O
sample	O
handling	O
and	O
processing	O
for	O
mass	O
spectrometry	O
or	O
the	O
existence	O
of	O
SAM	O
-	O
independent	O
pathways	O
for	O
protein	O
methylation	O
.	O

Exposure	O
to	O
the	O
prolonged	O
cold	O
of	O
winter	O
is	O
required	O
to	O
permit	O
awakening	O
from	O
diapause	O
in	O
the	O
spring	O
.	O

There	O
is	O
an	O
additional	O
short	O
N	O
-	O
terminal	O
region	O
that	O
is	O
capable	O
of	O
binding	O
one	O
more	O
copper	O
ion	O
,	O
suggesting	O
a	O
timer	O
mechanism	O
in	O
which	O
this	O
ion	O
is	O
involved	O
.	O

Previous	O
work	O
from	O
our	O
laboratory	O
has	O
established	O
the	O
role	O
of	O
Grb10	S-Biological_Molecule
as	O
a	O
negative	O
regulator	O
of	O
IGF	B-Biological_Molecule
-	I-Biological_Molecule
IR	E-Biological_Molecule
-	O
dependent	O
cell	O
proliferation	O
.	O

We	O
have	O
shown	O
that	O
Grb10	S-Biological_Molecule
binds	O
the	O
E3	O
ubiquitin	S-Biological_Molecule
ligase	O
Nedd4	S-Biological_Molecule
and	O
promotes	O
IGF	B-Biological_Molecule
-	I-Biological_Molecule
I	E-Biological_Molecule
-	O
stimulated	O
ubiquitination	O
,	O
internalization	O
,	O
and	O
degradation	O
of	O
the	O
IGF	B-Biological_Molecule
-	I-Biological_Molecule
IR	E-Biological_Molecule
,	O
thereby	O
giving	O
rise	O
to	O
long	O
-	O
term	O
attenuation	O
of	O
signaling	O
.	O

These	O
results	O
indicate	O
that	O
Grb10	S-Biological_Molecule
and	O
Nedd4	S-Biological_Molecule
play	O
a	O
critical	O
role	O
in	O
mediating	O
IGF	B-Biological_Molecule
-	I-Biological_Molecule
IR	E-Biological_Molecule
down	O
-	O
regulation	O
by	O
promoting	O
ligand	O
-	O
dependent	O
multiubiquitination	O
of	O
the	O
IGF	B-Biological_Molecule
-	I-Biological_Molecule
IR	E-Biological_Molecule
,	O
which	O
is	O
required	O
for	O
receptor	O
internalization	O
and	O
regulates	O
mitogenesis	O
.	O

Many	O
viruses	O
modulate	O
the	O
ubiquitin	S-Biological_Molecule
(	O
Ub	S-Biological_Molecule
)	O
pathway	O
to	O
alter	O
cellular	O
signaling	O
and	O
the	O
antiviral	O
response	O
.	O

Furthermore	O
,	O
overexpression	O
of	O
ISG15	S-Biological_Molecule
diminished	O
the	O
ability	O
of	O
Nedd4	S-Biological_Molecule
to	O
ubiquitinate	O
viral	O
matrix	O
proteins	O
and	O
led	O
to	O
a	O
decrease	O
in	O
the	O
release	O
of	O
Ebola	O
VP40	O
virus	O
-	O
like	O
particles	O
from	O
the	O
cells	O
.	O

We	O
previously	O
proposed	O
that	O
one	O
of	O
the	O
mechanisms	O
by	O
which	O
CRY	O
regulates	O
light	O
responses	O
is	O
via	O
its	O
physical	O
interaction	O
with	O
COP1	S-Biological_Molecule
,	O
a	O
RING	O
motif	O
-	O
containing	O
E3	O
ligase	O
.	O

TDP	B-Biological_Molecule
-	I-Biological_Molecule
43	E-Biological_Molecule
-	O
DeltaNLS	O
accumulates	O
as	O
insoluble	O
cytoplasmic	O
aggregates	O
and	O
sequesters	O
endogenous	O
TDP	B-Biological_Molecule
-	I-Biological_Molecule
43	E-Biological_Molecule
,	O
thereby	O
depleting	O
normal	O
nuclear	O
TDP	B-Biological_Molecule
-	I-Biological_Molecule
43	E-Biological_Molecule
,	O
whereas	O
TDP	B-Biological_Molecule
-	I-Biological_Molecule
43	E-Biological_Molecule
-	O
DeltaNES	O
forms	O
insoluble	O
nuclear	O
aggregates	O
with	O
endogenous	O
TDP	B-Biological_Molecule
-	I-Biological_Molecule
43	E-Biological_Molecule
.	O

Mutant	O
forms	O
of	O
TDP	B-Biological_Molecule
-	I-Biological_Molecule
43	E-Biological_Molecule
also	O
replicate	O
the	O
biochemical	O
profile	O
of	O
pathological	O
TDP	B-Biological_Molecule
-	I-Biological_Molecule
43	E-Biological_Molecule
in	O
FTLD	O
-	O
U	O
/	O
ALS	O
.	O

We	O
have	O
tested	O
this	O
idea	O
and	O
found	O
it	O
to	O
be	O
true	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Here	O
we	O
show	O
that	O
S	O
.	O
pneumoniae	O
activates	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NFAT	O
)	O
signaling	O
pathway	O
and	O
the	O
subsequent	O
up	O
-	O
regulation	O
of	O
inflammatory	O
mediators	O
via	O
a	O
key	O
pneumococcal	O
virulence	O
factor	O
,	O
pneumolysin	S-Biological_Molecule
.	O

Our	O
studies	O
thus	O
bring	O
new	O
insights	O
into	O
the	O
molecular	O
pathogenesis	O
of	O
S	O
.	O
pneumoniae	O
infections	O
through	O
the	O
NFAT	O
-	O
dependent	O
mechanism	O
and	O
further	O
identify	O
CYLD	S-Biological_Molecule
as	O
a	O
negative	O
regulator	O
for	O
NFAT	O
signaling	O
,	O
thereby	O
opening	O
up	O
new	O
therapeutic	O
targets	O
for	O
these	O
diseases	O
.	O

RESULTS	O
:	O
Herein	O
we	O
describe	O
a	O
yeast	O
three	O
-	O
hybrid	O
system	O
that	O
reconstitutes	O
mammalian	O
HIF	O
regulation	O
by	O
the	O
EGLNs	O
and	O
VHL	S-Biological_Molecule
.	O

This	O
is	O
the	O
first	O
report	O
of	O
the	O
essential	O
role	O
of	O
SPOP	S-Biological_Molecule
in	O
ERalpha	S-Biological_Molecule
ubiquitination	O
by	O
the	O
Cullin3	S-Biological_Molecule
-	O
based	O
E3	O
ubiquitin	S-Biological_Molecule
ligase	O
complex	O
.	O

We	O
also	O
demonstrated	O
repression	O
of	O
the	O
transactivation	O
capability	O
of	O
ER	B-Biological_Molecule
alpha	E-Biological_Molecule
;	O
in	O
cultured	O
mammalian	O
cells	O
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
UBA	O
domains	O
are	O
involved	O
in	O
binding	O
two	O
different	O
polyubiquitin	S-Biological_Molecule
isoforms	O
,	O
linear	O
and	O
K48	O
-	O
linked	O
.	O

These	O
data	O
establish	O
EZH2	S-Biological_Molecule
-	O
mediated	O
H3K27triM	S-Biological_Molecule
as	O
a	O
mechanism	O
of	O
tumor	O
-	O
suppressor	O
gene	O
silencing	O
in	O
cancer	O
that	O
is	O
potentially	O
independent	O
of	O
promoter	O
DNA	O
methylation	O
.	O

We	O
conclude	O
that	O
many	O
mitotic	O
divisions	O
are	O
unequal	O
,	O
unlike	O
what	O
was	O
previously	O
thought	O
.	O

Here	O
we	O
show	O
that	O
small	O
HERC	O
proteins	O
interact	O
with	O
each	O
other	O
and	O
localize	O
to	O
the	O
same	O
cellular	O
structures	O
,	O
which	O
we	O
identify	O
as	O
late	O
endosomes	O
and	O
lysosomes	O
.	O

They	O
play	O
important	O
roles	O
in	O
maintaining	O
stem	O
cell	O
pluripotency	O
and	O
in	O
cancer	O
pathogenesis	O
.	O

Carbohydrate	O
heterogeneity	O
is	O
known	O
to	O
modulate	O
the	O
activity	O
of	O
effector	O
cells	O
in	O
the	O
blood	O
,	O
in	O
which	O
fucosylation	O
particularly	O
affects	O
NK	O
cell	O
-	O
mediated	O
killing	O
.	O

Whole	O
blood	O
ADCC	O
assays	O
,	O
containing	O
both	O
types	O
of	O
effector	O
cells	O
,	O
revealed	O
little	O
differences	O
in	O
tumor	O
cell	O
killing	O
between	O
both	O
batches	O
.	O

Monoclonal	O
antibody	O
-	O
based	O
screening	O
assay	O
for	O
factor	B-Biological_Molecule
inhibiting	I-Biological_Molecule
hypoxia	I-Biological_Molecule
-	I-Biological_Molecule
inducible	I-Biological_Molecule
factor	E-Biological_Molecule
inhibitors	O
.	O

SHN	O
-	O
HIF1alpha	S-Biological_Molecule
also	O
showed	O
an	O
Asn803	O
hydroxylation	O
-	O
dependent	O
specificity	O
to	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
in	O
cells	O
.	O

The	O
rpS2	S-Biological_Molecule
(	O
100	O
-	O
293	O
amino	O
acids	O
)	O
domain	O
,	O
but	O
not	O
the	O
amino	O
-	O
terminus	O
of	O
rpS2	S-Biological_Molecule
that	O
includes	O
the	O
RG	O
repeat	O
region	O
was	O
essential	O
for	O
binding	O
to	O
PRMT3	S-Biological_Molecule
and	O
was	O
susceptible	O
to	O
degradation	O
.	O

The	O
ubiquitin	S-Biological_Molecule
-	O
protein	O
ligase	O
Nedd4	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
differentially	O
interacts	O
with	O
and	O
regulates	O
members	O
of	O
the	O
Tweety	O
family	O
of	O
chloride	O
ion	O
channels	O
.	O

Structurally	O
,	O
Tweety	S-Biological_Molecule
proteins	O
are	O
characterized	O
by	O
five	O
membrane	O
-	O
spanning	O
domains	O
and	O
N	O
-	O
glycan	O
modifications	O
important	O
for	O
trafficking	O
to	O
the	O
plasma	O
membrane	O
,	O
where	O
these	O
proteins	O
are	O
oriented	O
with	O
the	O
amino	O
terminus	O
located	O
extracellularly	O
and	O
the	O
carboxyl	O
terminus	O
cytoplasmically	O
.	O

These	O
related	O
proteins	O
can	O
suppress	O
silencing	O
by	O
multiple	O
mechanisms	O
,	O
one	O
of	O
which	O
involves	O
interacting	O
with	O
and	O
inhibiting	O
adenosine	B-Biological_Molecule
kinase	E-Biological_Molecule
(	O
ADK	S-Biological_Molecule
)	O
,	O
a	O
cellular	O
enzyme	O
associated	O
with	O
the	O
methyl	O
cycle	O
that	O
generates	O
S	O
-	O
adenosyl	O
-	O
methionine	O
,	O
an	O
essential	O
methyltransferase	O
cofactor	O
.	O

Finally	O
,	O
we	O
demonstrate	O
that	O
Beet	O
curly	O
top	O
virus	O
L2	S-Biological_Molecule
-	O
mutant	O
DNA	O
present	O
in	O
tissues	O
that	O
have	O
recovered	O
from	O
infection	O
is	O
hypermethylated	O
and	O
that	O
host	O
recovery	O
requires	O
AGO4	S-Biological_Molecule
,	O
a	O
component	O
of	O
the	O
RNA	O
-	O
directed	O
methylation	O
pathway	O
.	O

To	O
assess	O
the	O
medulloblastoma	O
epigenome	O
more	O
comprehensively	O
,	O
we	O
undertook	O
a	O
genomewide	O
investigation	O
to	O
identify	O
genes	O
that	O
display	O
evidence	O
of	O
methylation	O
-	O
dependent	O
regulation	O
.	O

These	O
data	O
reveal	O
a	O
more	O
diverse	O
and	O
expansive	O
medulloblastoma	O
epi	O
genome	O
than	O
previously	O
understood	O
and	O
provide	O
strong	O
evidence	O
that	O
the	O
methylation	O
status	O
of	O
specific	O
genes	O
may	O
contribute	O
to	O
the	O
biological	O
subclassification	O
of	O
medulloblastoma	O
.	O

Moreover	O
,	O
Hltf	S-Biological_Molecule
-	O
deficient	O
mouse	O
embryonic	O
fibroblasts	O
show	O
elevated	O
chromosome	O
breaks	O
and	O
fusions	O
after	O
methyl	O
methane	O
sulfonate	O
treatment	O
.	O

Mutating	O
the	O
highly	O
conserved	O
N	O
terminus	O
increases	O
substrate	O
ubiquitination	O
and	O
the	O
number	O
of	O
substrate	O
lysines	O
targeted	O
,	O
allows	O
ubiquitination	O
of	O
APC	O
substrates	O
lacking	O
their	O
destruction	O
boxes	O
,	O
increases	O
resistance	O
to	O
the	O
APC	O
inhibitors	O
Emi1	S-Biological_Molecule
and	O
BubR1	S-Biological_Molecule
in	O
vitro	O
,	O
and	O
bypasses	O
the	O
spindle	O
checkpoint	O
in	O
vivo	O
.	O

Amplification	O
of	O
Nat1	S-Biological_Molecule
and	O
Nat2	S-Biological_Molecule
from	O
A	O
/	O
J	O
(	O
A	O
)	O
mouse	O
(	O
slow	O
acetylator	O
)	O
genomic	O
DNA	O
by	O
the	O
polymerase	O
chain	O
reaction	O
and	O
subsequent	O
sequencing	O
revealed	O
that	O
Nat1	S-Biological_Molecule
was	O
identical	O
in	O
B6	O
and	O
A	O
mice	O
,	O
whereas	O
Nat2	S-Biological_Molecule
contained	O
a	O
single	O
nucleotide	O
change	O
from	O
adenine	O
in	O
B6	O
to	O
thymine	O
in	O
A	O
mice	O
.	O

Here	O
,	O
we	O
report	O
that	O
UT	B-Biological_Molecule
-	I-Biological_Molecule
A1	E-Biological_Molecule
is	O
ubiquitinated	O
and	O
degraded	O
by	O
the	O
proteasome	O
but	O
not	O
the	O
lysosome	O
proteolytic	O
pathway	O
.	O

MDM2	S-Biological_Molecule
mediates	O
UT	B-Biological_Molecule
-	I-Biological_Molecule
A1	E-Biological_Molecule
ubiquitination	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O

The	O
mechanism	O
is	O
likely	O
to	O
be	O
physiologically	O
important	O
as	O
UT	B-Biological_Molecule
-	I-Biological_Molecule
A1	E-Biological_Molecule
ubiquitination	O
was	O
identified	O
in	O
kidney	O
inner	O
medullary	O
tissue	O
.	O

Although	O
ubiquitination	O
of	O
proliferating	B-Biological_Molecule
cell	I-Biological_Molecule
nuclear	I-Biological_Molecule
antigen	E-Biological_Molecule
(	O
PCNA	S-Biological_Molecule
)	O
is	O
not	O
required	O
for	O
the	O
localization	O
of	O
poleta	S-Biological_Molecule
in	O
foci	O
,	O
it	O
results	O
in	O
an	O
increased	O
residence	O
time	O
in	O
foci	O
.	O
poliota	S-Biological_Molecule
is	O
even	O
more	O
mobile	O
than	O
poleta	S-Biological_Molecule
,	O
both	O
when	O
uniformly	O
distributed	O
and	O
when	O
localized	O
in	O
foci	O
.	O

We	O
and	O
others	O
have	O
shown	O
that	O
this	O
transporter	O
undergoes	O
endocytosis	O
and	O
degradation	O
in	O
response	O
to	O
activation	O
of	O
protein	O
kinase	O
C	O
(	O
PKC	O
)	O
,	O
however	O
,	O
the	O
mechanisms	O
involved	O
remain	O
unclear	O
.	O

Mutation	O
of	O
all	O
11	O
lysine	O
residues	O
in	O
the	O
amino	O
and	O
carboxyl	O
-	O
terminal	O
domains	O
to	O
arginine	O
(	O
11R	O
)	O
abolished	O
this	O
signal	O
.	O

Together	O
these	O
data	O
define	O
a	O
novel	O
mechanism	O
by	O
which	O
the	O
predominant	O
forebrain	O
glutamate	O
transporter	O
can	O
be	O
rapidly	O
targeted	O
for	O
degradation	O
.	O

Both	O
purple	O
and	O
yellow	O
FIH	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
contained	O
high	O
-	O
spin	O
,	O
rhombic	O
Fe	O
(	O
III	O
)	O
centers	O
,	O
as	O
shown	O
by	O
low	O
temperature	O
EPR	O
.	O

Linkage	O
analysis	O
revealed	O
that	O
the	O
galactosyl	O
component	O
was	O
in	O
the	O
furanoic	O
conformation	O
,	O
which	O
was	O
attaching	O
in	O
a	O
terminal	O
non	O
-	O
reducing	O
position	O
.	O

Prolyl	O
hydroxylase	O
domain	O
proteins	O
(	O
PHD	B-Biological_Molecule
isozymes	I-Biological_Molecule
1	E-Biological_Molecule
-	O
3	S-Biological_Molecule
)	O
regulate	O
levels	O
of	O
the	O
alpha	O
-	O
subunit	O
of	O
the	O
hypoxia	O
inducible	O
factor	O
(	O
HIF	O
)	O
through	O
proline	O
hydroxylation	O
,	O
earmarking	O
HIFalpha	O
for	O
proteosome	O
-	O
mediated	O
degradation	O
.	O

Under	O
hypoxic	O
conditions	O
,	O
HIF	O
stabilization	O
leads	O
to	O
enhanced	O
transcription	O
and	O
regulation	O
of	O
a	O
multitude	O
of	O
processes	O
,	O
including	O
erythropoiesis	O
.	O

Arabidopsis	O
has	O
two	O
E3	O
homologs	O
(	O
HISTONE	B-Biological_Molecule
MONOUBIQUITINATION1	E-Biological_Molecule
[	O
HUB1	S-Biological_Molecule
]	O
and	O
HUB2	S-Biological_Molecule
)	O
and	O
three	O
E2	O
homologs	O
(	O
UBIQUITIN	O
CARRIER	O
PROTEIN	O
[	O
UBC1	S-Biological_Molecule
]	O
to	O
UBC3	S-Biological_Molecule
)	O
.	O

By	O
contrast	O
,	O
single	O
ubc1	S-Biological_Molecule
,	O
ubc2	S-Biological_Molecule
,	O
or	O
ubc3	S-Biological_Molecule
mutants	O
show	O
no	O
flowering	O
defect	O
;	O
only	O
ubc1	S-Biological_Molecule
ubc2	S-Biological_Molecule
double	O
mutants	O
,	O
and	O
not	O
double	O
mutants	O
with	O
ubc3	S-Biological_Molecule
,	O
show	O
early	O
flowering	O
and	O
H2Bub1	S-Biological_Molecule
defects	O
.	O

In	O
the	O
light	O
of	O
the	O
important	O
role	O
that	O
YB	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
appears	O
to	O
play	O
in	O
tumourigenesis	O
,	O
our	O
results	O
suggest	O
that	O
RBBP6	S-Biological_Molecule
may	O
be	O
a	O
relevant	O
target	O
for	O
therapeutic	O
drugs	O
aimed	O
at	O
modifying	O
the	O
activity	O
of	O
YB	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
.	O

This	O
contention	O
was	O
corroborated	O
by	O
synthesizing	O
a	O
tridecapeptide	O
corresponding	O
to	O
residues	O
26	O
-	O
38	O
of	O
avidin	S-Biological_Molecule
;	O
this	O
peptide	O
was	O
shown	O
to	O
recognize	O
biotin	O
.	O

The	O
approach	O
taken	O
in	O
this	O
study	O
enabled	O
the	O
experimental	O
distinction	O
between	O
the	O
chemical	O
and	O
structural	O
elements	O
of	O
the	O
binding	O
site	O
.	O

Complex	O
patterns	O
of	O
histidine	O
,	O
hydroxylated	O
amino	O
acids	O
and	O
the	O
GxxxG	O
motif	O
mediate	O
high	O
-	O
affinity	O
transmembrane	O
domain	O
interactions	O
.	O

In	O
this	O
study	O
,	O
a	O
heptad	O
repeat	O
pattern	O
was	O
randomized	O
with	O
all	O
naturally	O
occurring	O
amino	O
acids	O
to	O
uncover	O
novel	O
sequence	O
motifs	O
promoting	O
transmembrane	O
domain	O
interactions	O
.	O

Reconstruction	O
of	O
minimal	O
interaction	O
motifs	O
within	O
the	O
context	O
of	O
an	O
oligo	O
-	O
Leu	O
sequence	O
confirmed	O
that	O
His	O
is	O
part	O
of	O
a	O
hydrogen	O
bonded	O
cluster	O
that	O
is	O
brought	O
into	O
register	O
by	O
the	O
GxxxG	O
motif	O
.	O

Oncogene	O
addiction	O
due	O
to	O
Myc	S-Biological_Molecule
deregulation	O
has	O
been	O
identified	O
in	O
a	O
variety	O
of	O
tumor	O
types	O
.	O

By	O
enlarging	O
the	O
active	O
site	O
crossover	O
loop	O
,	O
we	O
have	O
constructed	O
gain	O
-	O
of	O
-	O
function	O
mutants	O
that	O
can	O
accept	O
substrates	O
that	O
the	O
parent	O
enzyme	O
cannot	O
,	O
including	O
ubiquitin	S-Biological_Molecule
chains	O
of	O
various	O
linkages	O
.	O

A	O
phosphorylation	O
cascade	O
controls	O
the	O
degradation	O
of	O
active	O
SREBP1	S-Biological_Molecule
.	O

Importantly	O
,	O
we	O
demonstrate	O
that	O
the	O
mature	O
form	O
of	O
endogenous	O
SREBP1	S-Biological_Molecule
is	O
phosphorylated	O
on	O
Ser	O
-	O
434	O
.	O

The	O
interaction	O
of	O
papillomavirus	O
E2	S-Biological_Molecule
proteins	O
with	O
cellular	O
Brd4	S-Biological_Molecule
protein	O
is	O
important	O
for	O
transcriptional	O
regulation	O
of	O
viral	O
genes	O
and	O
partitioning	O
of	O
viral	O
genomes	O
.	O

The	O
transgenic	O
flies	O
display	O
ocular	O
fluid	O
discharge	O
,	O
reflecting	O
ocular	O
hypertension	O
,	O
and	O
a	O
progressive	O
decline	O
in	O
their	O
behavioral	O
responses	O
to	O
light	O
.	O

CONCLUSIONS	O
/	O
SIGNIFICANCE	O
:	O
Our	O
results	O
show	O
that	O
aggregation	O
of	O
MYOC	S-Biological_Molecule
in	O
the	O
endoplasmic	O
reticulum	O
activates	O
the	O
UPR	O
,	O
an	O
evolutionarily	O
conserved	O
stress	O
pathway	O
that	O
culminates	O
in	O
apoptosis	O
.	O

BACKGROUND	O
&	O
AIMS	O
:	O
Congenital	O
lactase	O
deficiency	O
(	O
CLD	O
)	O
is	O
a	O
cause	O
of	O
disaccharide	O
intolerance	O
and	O
malabsorption	O
characterized	O
by	O
watery	O
diarrhea	O
in	O
infants	O
fed	O
breast	O
milk	O
or	O
lactose	O
-	O
containing	O
formulas	O
.	O

METHODS	O
:	O
We	O
introduced	O
a	O
mutation	O
into	O
the	O
LPH	S-Biological_Molecule
complementary	O
DNA	O
that	O
resulted	O
in	O
the	O
amino	O
acid	O
substitution	O
G1363S	O
.	O

RESULTS	O
:	O
The	O
mutant	O
protein	O
LPH	S-Biological_Molecule
-	O
G1363S	O
was	O
misfolded	O
and	O
could	O
not	O
exit	O
the	O
endoplasmic	O
reticulum	O
.	O

The	O
intracellular	O
transport	O
and	O
enzymatic	O
activity	O
,	O
but	O
not	O
correct	O
folding	O
,	O
of	O
LPH	S-Biological_Molecule
-	O
G1363S	O
were	O
partially	O
restored	O
by	O
expression	O
at	O
20	O
degrees	O
C	O
.	O

Thus	O
,	O
we	O
propose	O
that	O
ubiquitinated	O
Tau	S-Biological_Molecule
inclusions	O
arise	O
due	O
to	O
shunting	O
of	O
Tau	S-Biological_Molecule
degradation	O
toward	O
a	O
less	O
efficient	O
ubiquitin	S-Biological_Molecule
-	O
dependent	O
pathway	O
.	O

Thus	O
,	O
RAD6	S-Biological_Molecule
clearly	O
plays	O
a	O
role	O
in	O
HRR	O
in	O
addition	O
to	O
its	O
central	O
role	O
in	O
PRR	O
.	O

Our	O
present	O
results	O
suggest	O
that	O
the	O
aberrant	O
accumulation	O
of	O
STAT1	S-Biological_Molecule
protein	O
induced	O
by	O
loss	O
of	O
PKR	S-Biological_Molecule
regulate	O
osteoblast	O
differentiation	O
through	O
both	O
SLIM	S-Biological_Molecule
/	O
STAT1	S-Biological_Molecule
-	O
dependent	O
and	O
-	O
independent	O
pathways	O
.	O

The	O
expression	O
of	O
E6	B-Biological_Molecule
-	I-Biological_Molecule
AP	E-Biological_Molecule
was	O
dramatically	O
induced	O
under	O
a	O
variety	O
of	O
stresses	O
,	O
and	O
overexpression	O
of	O
E6	B-Biological_Molecule
-	I-Biological_Molecule
AP	E-Biological_Molecule
was	O
found	O
to	O
protect	O
against	O
endoplasmic	O
reticulum	O
stress	O
-	O
induced	O
cell	O
death	O
.	O

An	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
membrane	O
complex	O
composed	O
of	O
SPFH1	S-Biological_Molecule
and	O
SPFH2	S-Biological_Molecule
mediates	O
the	O
ER	O
-	O
associated	O
degradation	O
of	O
inositol	O
1	O
,	O
4	O
,	O
5	O
-	O
trisphosphate	O
receptors	O
.	O

We	O
also	O
show	O
that	O
expression	O
of	O
MYPT1	S-Biological_Molecule
enhances	O
HIF	O
-	O
CAD	O
activity	O
in	O
a	O
manner	O
consistent	O
with	O
competition	O
for	O
FIH	S-Biological_Molecule
and	O
that	O
this	O
property	O
extends	O
to	O
other	O
ARD	O
proteins	O
.	O

In	O
vitro	O
,	O
ubiquitin	S-Biological_Molecule
species	O
that	O
cannot	O
polymerize	O
mediate	O
processing	O
.	O

The	O
cholinesterase	O
-	O
like	O
domain	O
,	O
essential	O
in	O
thyroglobulin	S-Biological_Molecule
trafficking	O
for	O
thyroid	O
hormone	O
synthesis	O
,	O
is	O
required	O
for	O
protein	O
dimerization	O
.	O

Electron	O
microscopic	O
observation	O
showed	O
the	O
accumulation	O
of	O
a	O
single	O
-	O
stranded	O
region	O
at	O
the	O
DNA	O
replication	O
fork	O
in	O
yeast	O
cells	O
.	O

AIMS	O
:	O
We	O
previously	O
demonstrated	O
that	O
monohydroxylated	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
OHPAHs	O
)	O
bound	O
to	O
a	O
human	O
estrogen	B-Biological_Molecule
receptor	E-Biological_Molecule
(	O
ER	S-Biological_Molecule
)	O
by	O
a	O
yeast	O
two	O
-	O
hybrid	O
assay	O
,	O
but	O
polycyclic	O
aromatic	O
hydrocarbons	O
did	O
not	O
have	O
a	O
binding	O
activity	O
.	O

In	O
this	O
report	O
,	O
we	O
show	O
that	O
MAML1	S-Biological_Molecule
potentiates	O
p300	S-Biological_Molecule
autoacetylation	O
and	O
p300	S-Biological_Molecule
transcriptional	O
activation	O
.	O

Here	O
the	O
current	O
state	O
of	O
knowledge	O
is	O
reviewed	O
regarding	O
the	O
non	O
-	O
core	O
regions	O
of	O
RAG1	S-Biological_Molecule
and	O
RAG2	S-Biological_Molecule
and	O
how	O
these	O
findings	O
contribute	O
to	O
our	O
broader	O
understanding	O
of	O
recombination	O
.	O

This	O
is	O
initial	O
evidence	O
that	O
pVHL	S-Biological_Molecule
,	O
without	O
any	O
genetic	O
alteration	O
,	O
can	O
be	O
regulated	O
by	O
microRNA	O
and	O
explains	O
the	O
aberrant	O
autocrine	O
VEGF	S-Biological_Molecule
secretion	O
in	O
CLL	O
.	O

Inefficient	O
quality	O
control	O
of	O
thermosensitive	O
proteins	O
on	O
the	O
plasma	O
membrane	O
.	O

When	O
tethered	O
to	O
the	O
ER	O
protein	O
Use1	S-Biological_Molecule
,	O
they	O
are	O
also	O
degraded	O
.	O

For	O
this	O
study	O
,	O
we	O
have	O
generated	O
a	O
series	O
of	O
RMT3	S-Biological_Molecule
alleles	O
that	O
express	O
various	O
amino	O
acid	O
substitutions	O
to	O
characterize	O
the	O
functional	O
domains	O
of	O
Rmt3	S-Biological_Molecule
in	O
Rps2	S-Biological_Molecule
binding	O
,	O
Rps2	S-Biological_Molecule
arginine	O
methylation	O
,	O
and	O
small	O
ribosomal	O
subunit	O
production	O
.	O

CHIP	S-Biological_Molecule
facilitates	O
ubiquitination	O
of	O
inducible	B-Biological_Molecule
nitric	I-Biological_Molecule
oxide	I-Biological_Molecule
synthase	E-Biological_Molecule
and	O
promotes	O
its	O
proteasomal	O
degradation	O
.	O

In	O
addition	O
,	O
our	O
results	O
support	O
a	O
model	O
for	O
how	O
the	O
H3K27me3	S-Biological_Molecule
mark	O
could	O
be	O
preserved	O
in	O
the	O
interphase	O
of	O
the	O
cell	O
cycle	O
,	O
where	O
other	O
events	O
such	O
as	O
histone	S-Biological_Molecule
exchange	O
and	O
demethylation	O
could	O
counteract	O
PRC2	O
function	O
.	O

This	O
chapter	O
describes	O
different	O
assay	O
conditions	O
and	O
detection	O
methods	O
for	O
different	O
family	O
of	O
histone	S-Biological_Molecule
demethylases	O
.	O

The	O
best	O
aptamer	O
identified	O
in	O
this	O
selection	O
binds	O
to	O
the	O
target	O
protein	O
with	O
a	O
K	O
(	O
d	O
)	O
of	O
21	O
nM	O
and	O
discriminates	O
against	O
both	O
the	O
nonacetylated	O
protein	O
and	O
histone	B-Biological_Molecule
H4	E-Biological_Molecule
proteins	O
acetylated	O
at	O
lysine	O
8	O
.	O

Peroxisome	B-Biological_Molecule
proliferator	I-Biological_Molecule
-	I-Biological_Molecule
activated	I-Biological_Molecule
receptor	I-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
abrogates	O
Smad	O
-	O
dependent	O
collagen	O
stimulation	O
by	O
targeting	O
the	O
p300	S-Biological_Molecule
transcriptional	O
coactivator	O
.	O

Wild	O
-	O
type	O
p300	S-Biological_Molecule
,	O
but	O
not	O
a	O
mutant	O
form	O
of	O
p300	S-Biological_Molecule
lacking	O
functional	O
histone	S-Biological_Molecule
acetyltransferase	O
,	O
was	O
able	O
to	O
restore	O
TGF	O
-	O
beta	O
-	O
induced	O
stimulation	O
of	O
COL1A2	S-Biological_Molecule
in	O
the	O
presence	O
of	O
PPAR	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
ligands	O
.	O

p62	S-Biological_Molecule
/	O
SQSTM1	S-Biological_Molecule
was	O
the	O
first	O
protein	O
shown	O
to	O
bind	O
both	O
target	O
-	O
associated	O
ubiquitin	S-Biological_Molecule
(	O
Ub	S-Biological_Molecule
)	O
and	O
LC3	O
conjugated	O
to	O
the	O
phagophore	O
membrane	O
,	O
thereby	O
effectively	O
acting	O
as	O
an	O
autophagic	O
receptor	O
for	O
ubiquitinated	O
targets	O
.	O

NBR1	S-Biological_Molecule
is	O
degraded	O
by	O
autophagy	O
depending	O
on	O
its	O
LC3	O
-	O
interacting	O
region	O
(	O
LIR	O
)	O
but	O
does	O
not	O
strictly	O
require	O
p62	S-Biological_Molecule
for	O
this	O
process	O
.	O

BubR1	S-Biological_Molecule
degradation	O
began	O
before	O
the	O
onset	O
of	O
anaphase	O
.	O

It	O
was	O
noted	O
that	O
the	O
pre	O
-	O
anaphase	O
degradation	O
was	O
regulated	O
by	O
BubR1	S-Biological_Molecule
acetylation	O
.	O

Here	O
we	O
present	O
evidence	O
that	O
GCM1	S-Biological_Molecule
is	O
a	O
major	O
target	O
of	O
hypoxia	O
associated	O
with	O
preeclampsia	O
.	O

Mutation	O
of	O
K6	O
also	O
inhibited	O
processing	O
of	O
SP	B-Biological_Molecule
-	I-Biological_Molecule
C	E-Biological_Molecule
proprotein	O
to	O
the	O
mature	O
peptide	O
in	O
human	O
embryonic	O
kidney	O
293	O
cells	O
.	O

RESULTS	O
:	O
Twelve	O
HIV	O
-	O
1	O
CRF07	O
_	O
BC	O
variants	O
were	O
isolated	O
from	O
the	O
blood	O
of	O
the	O
HIV	O
-	O
1	O
-	O
infected	O
IDUs	O
in	O
Xinjiang	O
province	O
,	O
and	O
20	O
subtype	O
B	O
'	O
isolates	O
were	O
obtained	O
from	O
the	O
FPDs	O
in	O
Anhui	O
and	O
Shanxi	O
provinces	O
of	O
China	O
.	O

The	O
number	O
and	O
location	O
of	O
the	O
potential	O
N	O
-	O
linked	O
glycosylation	O
sites	O
in	O
V1	O
/	O
V2	O
and	O
the	O
C2	O
region	O
of	O
the	O
CRF07	O
_	O
BC	O
viruses	O
were	O
significantly	O
different	O
from	O
those	O
of	O
the	O
subtype	O
B	O
'	O
viruses	O
.	O

It	O
is	O
prudent	O
to	O
screen	O
stabilizers	O
by	O
using	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
,	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
+	O
Fe	O
(	O
II	O
)	O
,	O
and	O
AAPH	O
because	O
these	O
agents	O
represent	O
potential	O
assaults	O
from	O
the	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
commonly	O
present	O
in	O
degraded	O
polysorbate	O
,	O
the	O
residue	O
of	O
aseptic	O
agents	O
and	O
the	O
metal	O
from	O
stainless	O
steel	O
surfaces	O
,	O
and	O
alkylperoxides	O
from	O
degraded	O
polysorbate	O
,	O
respectively	O
.	O

Free	O
Trp	O
protected	O
only	O
the	O
Trp	O
residue	O
in	O
PTH	S-Biological_Molecule
from	O
oxidation	O
by	O
AAPH	O
,	O
the	O
combination	O
of	O
Trp	O
and	O
Met	O
was	O
effective	O
against	O
all	O
three	O
oxidant	O
conditions	O
.	O

This	O
represents	O
a	O
"	O
primitive	O
"	O
model	O
for	O
chromatin	O
regulation	O
analogous	O
to	O
histone	S-Biological_Molecule
modification	O
in	O
eukaryotes	O
.	O

We	O
report	O
the	O
1	O
.	O
84	O
-	O
A	O
crystal	O
structure	O
of	O
PAT	S-Biological_Molecule
in	O
complex	O
with	O
coenzyme	O
A	O
.	O

Cell	O
cycle	O
transitions	O
are	O
controlled	O
,	O
in	O
part	O
,	O
by	O
ubiquitin	S-Biological_Molecule
-	O
dependent	O
proteolysis	O
.	O

The	O
human	O
genome	O
encodes	O
nearly	O
100	O
DUBs	O
with	O
specificity	O
for	O
ubiquitin	S-Biological_Molecule
in	O
five	O
gene	O
families	O
.	O

Paraptosis	O
involves	O
extensive	O
endoplasmic	O
reticulum	O
vacuolization	O
in	O
the	O
absence	O
of	O
caspase	O
activation	O
.	O

Furthermore	O
,	O
the	O
activity	O
of	O
the	O
non	O
-	O
glycosylated	O
enzyme	O
was	O
affected	O
by	O
Hg	O
(	O
2	O
+	O
)	O
and	O
Cu	O
(	O
2	O
+	O
)	O
suggesting	O
that	O
N	O
-	O
glycosylation	O
is	O
involved	O
in	O
the	O
folding	O
of	O
Amy1	S-Biological_Molecule
.	O

We	O
show	O
that	O
the	O
von	B-Biological_Molecule
Hippel	I-Biological_Molecule
-	I-Biological_Molecule
Lindau	I-Biological_Molecule
tumor	I-Biological_Molecule
suppressor	E-Biological_Molecule
protein	O
(	O
pVHL	S-Biological_Molecule
)	O
-	O
E3	O
ligase	O
complex	O
,	O
known	O
for	O
its	O
regulation	O
of	O
hypoxia	O
-	O
inducible	O
factor	O
(	O
HIF	O
)	O
proteins	O
,	O
interacts	O
with	O
and	O
ubiquitylates	O
the	O
beta	B-Biological_Molecule
(	I-Biological_Molecule
2	I-Biological_Molecule
)	I-Biological_Molecule
AR	E-Biological_Molecule
,	O
thereby	O
decreasing	O
receptor	O
abundance	O
.	O

Here	O
we	O
show	O
that	O
DAPK2	S-Biological_Molecule
is	O
down	O
-	O
regulated	O
in	O
Hodgkin	O
lymphoma	O
-	O
derived	O
tumor	O
cell	O
lines	O
and	O
that	O
promoter	O
-	O
region	O
hypermethylation	O
is	O
one	O
mechanism	O
for	O
DAPK2	S-Biological_Molecule
inactivation	O
.	O

Thus	O
,	O
Parkin	S-Biological_Molecule
is	O
cytoprotective	O
,	O
partially	O
by	O
increasing	O
the	O
removal	O
of	O
cellular	O
Abeta	S-Biological_Molecule
through	O
a	O
proteasome	O
-	O
dependent	O
pathway	O
.	O

AdOx	O
inhibits	O
all	O
methylation	O
events	O
within	O
the	O
cell	O
but	O
,	O
by	O
shortening	O
the	O
treatment	O
length	O
to	O
2	O
hours	O
and	O
studying	O
mitotic	O
cells	O
,	O
the	O
only	O
methylation	O
events	O
that	O
are	O
affected	O
are	O
those	O
that	O
occur	O
in	O
late	O
G2	O
.	O

In	O
this	O
study	O
,	O
we	O
characterized	O
how	O
the	O
endocytosis	O
,	O
recycling	O
and	O
degradation	O
of	O
TfR2	S-Biological_Molecule
relates	O
to	O
its	O
function	O
and	O
differs	O
from	O
TfR1	S-Biological_Molecule
.	O

No	O
ubiquitination	O
of	O
TfR2	S-Biological_Molecule
by	O
HA	O
-	O
ubiquitin	S-Biological_Molecule
was	O
detected	O
,	O
indicating	O
a	O
lack	O
of	O
direct	O
TfR2	S-Biological_Molecule
ubiquitination	O
involvement	O
in	O
its	O
degradation	O
.	O

The	O
Sts	O
proteins	O
target	O
tyrosine	O
phosphorylated	O
,	O
ubiquitinated	O
proteins	O
within	O
TCR	O
signaling	O
pathways	O
.	O

Role	O
of	O
DNA	O
methylation	O
and	O
methyl	O
-	O
DNA	O
binding	O
proteins	O
in	O
the	O
repression	O
of	O
5	B-Biological_Molecule
-	I-Biological_Molecule
lipoxygenase	E-Biological_Molecule
promoter	O
activity	O
.	O

5	B-Biological_Molecule
-	I-Biological_Molecule
LO	E-Biological_Molecule
gene	O
expression	O
is	O
mainly	O
restricted	O
to	O
B	O
cells	O
and	O
cells	O
of	O
myeloid	O
origin	O
.	O

In	O
reporter	O
gene	O
assays	O
with	O
in	O
vitro	O
methylated	O
5	B-Biological_Molecule
-	I-Biological_Molecule
LO	E-Biological_Molecule
promoter	O
constructs	O
,	O
the	O
extent	O
of	O
5	B-Biological_Molecule
-	I-Biological_Molecule
LO	E-Biological_Molecule
promoter	O
methylation	O
inversely	O
correlated	O
with	O
its	O
activity	O
.	O

Host	O
cells	O
sense	O
double	O
-	O
stranded	O
RNA	O
(	O
dsRNA	O
)	O
produced	O
during	O
viral	O
replication	O
and	O
initiate	O
type	O
I	O
interferon	O
(	O
IFN	O
-	O
alpha	O
/	O
beta	S-Biological_Molecule
)	O
production	O
,	O
leading	O
to	O
subsequent	O
antiviral	O
responses	O
.	O

In	O
this	O
study	O
,	O
we	O
explored	O
the	O
role	O
of	O
the	O
CSFV	O
E	B-Biological_Molecule
(	I-Biological_Molecule
rns	I-Biological_Molecule
)	E-Biological_Molecule
glycoprotein	O
in	O
the	O
inhibition	O
of	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
production	O
induced	O
by	O
dsRNA	O
[	O
poly	O
(	O
IC	O
)	O
]	O
.	O

The	O
observation	O
that	O
MyD88	S-Biological_Molecule
activated	O
IRF	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
induces	O
expression	O
of	O
alkaline	O
phosphatase	O
suggests	O
that	O
IRF	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
is	O
under	O
autoregulating	O
loop	O
.	O

Using	O
this	O
acetylation	O
indicator	O
,	O
we	O
were	O
able	O
to	O
monitor	O
the	O
dynamic	O
fluctuation	O
of	O
histone	B-Biological_Molecule
H4	E-Biological_Molecule
acetylation	O
levels	O
during	O
mitosis	O
,	O
as	O
well	O
as	O
acetylation	O
changes	O
in	O
response	O
to	O
structurally	O
distinct	O
histone	S-Biological_Molecule
deacetylase	O
inhibitors	O
.	O

Ubiquitylation	O
of	O
the	O
gap	O
junction	O
protein	O
connexin	B-Biological_Molecule
-	I-Biological_Molecule
43	E-Biological_Molecule
signals	O
its	O
trafficking	O
from	O
early	O
endosomes	O
to	O
lysosomes	O
in	O
a	O
process	O
mediated	O
by	O
Hrs	S-Biological_Molecule
and	O
Tsg101	S-Biological_Molecule
.	O

Following	O
internalization	O
,	O
Cx43	S-Biological_Molecule
partly	O
colocalized	O
with	O
the	O
ubiquitin	S-Biological_Molecule
-	O
binding	O
proteins	O
Hrs	S-Biological_Molecule
(	O
hepatocyte	B-Biological_Molecule
growth	I-Biological_Molecule
factor	I-Biological_Molecule
-	I-Biological_Molecule
regulated	I-Biological_Molecule
tyrosine	I-Biological_Molecule
kinase	I-Biological_Molecule
substrate	E-Biological_Molecule
;	O
also	O
known	O
as	O
Hgs	S-Biological_Molecule
)	O
and	O
Tsg101	S-Biological_Molecule
(	O
tumor	B-Biological_Molecule
susceptibility	I-Biological_Molecule
gene	I-Biological_Molecule
101	E-Biological_Molecule
)	O
.	O

Alpha4	S-Biological_Molecule
is	O
an	O
essential	O
regulator	O
of	O
PP2A	O
phosphatase	O
activity	O
.	O

The	O
activity	O
and	O
specificity	O
of	O
serine	O
/	O
threonine	O
phosphatases	O
are	O
governed	O
largely	O
by	O
their	O
associated	O
proteins	O
.	O

During	O
cellular	O
stress	O
,	O
existing	O
PP2A	O
complexes	O
can	O
become	O
unstable	O
.	O

These	O
finding	O
demonstrate	O
a	O
previously	O
unappreciated	O
level	O
of	O
complexity	O
of	O
the	O
ubiquitin	S-Biological_Molecule
system	O
in	O
ERAD	O
and	O
have	O
potentially	O
important	O
ramifications	O
for	O
processes	O
where	O
gp78	S-Biological_Molecule
is	O
implicated	O
including	O
regulation	O
of	O
lipid	O
metabolism	O
,	O
metastasis	O
,	O
cystic	O
fibrosis	O
and	O
neurodegenerative	O
disorders	O
.	O

Studies	O
on	O
hypoxia	O
-	O
sensitive	O
pathways	O
have	O
identified	O
a	O
series	O
of	O
Fe	O
(	O
II	O
)	O
-	O
dependent	O
dioxygenases	O
that	O
regulate	O
hypoxia	O
-	O
inducible	O
factor	O
(	O
HIF	O
)	O
by	O
prolyl	O
and	O
asparaginyl	O
hydroxylation	O
.	O

We	O
exploited	O
stable	O
isotope	O
labeling	O
and	O
MS	O
for	O
relative	O
quantification	O
of	O
F	O
-	O
box	O
proteins	O
in	O
the	O
SCF	O
complexes	O
affinity	O
-	O
purified	O
en	O
masse	O
from	O
budding	O
yeast	O
cells	O
at	O
log	O
and	O
post	O
-	O
diauxic	O
phases	O
,	O
and	O
revealed	O
an	O
increment	O
of	O
Saf1	S-Biological_Molecule
,	O
an	O
F	O
-	O
box	O
protein	O
involved	O
in	O
entry	O
into	O
quiescence	O
,	O
during	O
the	O
diauxic	O
shift	O
.	O

These	O
results	O
illustrate	O
a	O
cellular	O
response	O
to	O
environmental	O
and	O
genetic	O
perturbations	O
through	O
remodeling	O
of	O
the	O
SCF	O
complex	O
-	O
mediated	O
ubiquitination	O
system	O
.	O

Alpha	O
-	O
mannosidosis	O
is	O
caused	O
by	O
the	O
genetic	O
defect	O
of	O
the	O
lysosomal	B-Biological_Molecule
alpha	I-Biological_Molecule
-	I-Biological_Molecule
d	I-Biological_Molecule
-	I-Biological_Molecule
mannosidase	E-Biological_Molecule
(	O
LAMAN	S-Biological_Molecule
)	O
,	O
which	O
is	O
involved	O
in	O
the	O
breakdown	O
of	O
free	O
alpha	O
-	O
linked	O
mannose	O
-	O
containing	O
oligosaccharides	O
originating	O
from	O
glycoproteins	O
with	O
N	O
-	O
linked	O
glycans	O
,	O
and	O
thus	O
manifests	O
itself	O
in	O
an	O
extensive	O
storage	O
of	O
mannose	O
-	O
containing	O
oligosaccharides	O
.	O

The	O
analysis	O
of	O
cathepsin	B-Biological_Molecule
B	E-Biological_Molecule
-	O
derived	O
oligosaccharides	O
revealed	O
a	O
hypermannosylation	O
of	O
glycoproteins	O
in	O
mice	O
with	O
alpha	O
-	O
mannosidosis	O
as	O
indicated	O
by	O
the	O
predominance	O
of	O
extended	O
Man3GlcNAc2	O
oligosaccharides	O
.	O

Treatment	O
with	O
recombinant	O
human	O
alpha	B-Biological_Molecule
-	I-Biological_Molecule
mannosidase	E-Biological_Molecule
partially	O
corrected	O
the	O
hyperglycosylation	O
of	O
lysosomal	O
proteins	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O

Despite	O
essential	O
roles	O
in	O
development	O
and	O
metabolism	O
,	O
regulation	O
of	O
FoxA	O
factors	O
is	O
not	O
well	O
understood	O
.	O

Here	O
,	O
we	O
study	O
one	O
facet	O
of	O
this	O
CHIP	S-Biological_Molecule
-	O
mediated	O
turnover	O
by	O
determining	O
the	O
lysine	O
residues	O
on	O
human	O
Hsp70	S-Biological_Molecule
and	O
Hsp90	S-Biological_Molecule
ubiquitinated	O
by	O
CHIP	S-Biological_Molecule
.	O

Inherent	O
Zn	O
(	O
2	O
+	O
)	O
at	O
the	O
zinc	O
-	O
finger	O
motif	O
is	O
structurally	O
related	O
and	O
essential	O
for	O
SIRT1	S-Biological_Molecule
activity	O
.	O

Usa1p	S-Biological_Molecule
is	O
a	O
recently	O
discovered	O
member	O
of	O
the	O
HRD	O
ubiquitin	S-Biological_Molecule
ligase	O
complex	O
.	O

First	O
,	O
Hrd1p	S-Biological_Molecule
self	O
-	O
degradation	O
,	O
which	O
serves	O
to	O
limit	O
the	O
levels	O
of	O
uncomplexed	O
E3	O
,	O
is	O
absolutely	O
dependent	O
on	O
Usa1p	S-Biological_Molecule
and	O
the	O
ubiquitin	S-Biological_Molecule
-	O
like	O
(	O
Ubl	O
)	O
domain	O
of	O
Usa1p	S-Biological_Molecule
.	O

The	O
Ubl	O
domain	O
of	O
Usa1p	S-Biological_Molecule
was	O
required	O
specifically	O
for	O
Hrd1p	S-Biological_Molecule
self	O
-	O
ubiquitination	O
but	O
not	O
for	O
degradation	O
of	O
either	O
ERAD	O
-	O
L	O
or	O
ERAD	O
-	O
M	O
substrates	O
.	O

Thus	O
,	O
this	O
novel	O
,	O
conserved	O
factor	O
is	O
broadly	O
involved	O
in	O
the	O
function	O
and	O
regulation	O
of	O
the	O
HRD	O
pathway	O
of	O
ERAD	O
.	O

Remarkably	O
,	O
acetylation	O
of	O
the	O
amino	O
-	O
terminal	O
region	O
abrogates	O
high	O
-	O
affinity	O
DNA	O
binding	O
and	O
selectively	O
prevents	O
processing	O
of	O
G	O
:	O
T	O
mispairs	O
.	O

In	O
contrast	O
,	O
phosphorylation	O
does	O
not	O
markedly	O
alter	O
DNA	O
interactions	O
,	O
but	O
may	O
preserve	O
G	O
:	O
T	O
processing	O
in	O
vivo	O
by	O
preventing	O
CBP	S-Biological_Molecule
-	O
mediated	O
acetylation	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
transcriptionally	O
active	O
/	O
competent	O
gene	O
-	O
enriched	O
chromatin	O
fragments	O
are	O
enriched	O
in	O
newly	O
methylated	O
histones	B-Biological_Molecule
H3	E-Biological_Molecule
and	O
H4	S-Biological_Molecule
.	O

Aggregation	O
and	O
glycation	O
processes	O
in	O
proteins	O
have	O
a	O
particular	O
interest	O
in	O
medicine	O
fields	O
and	O
in	O
food	O
technology	O
.	O

DNA	O
double	O
-	O
strand	O
breaks	O
(	O
DSBs	O
)	O
are	O
highly	O
cytotoxic	O
lesions	O
that	O
are	O
generated	O
by	O
ionizing	O
radiation	O
and	O
various	O
DNA	O
-	O
damaging	O
chemicals	O
.	O

Acetylated	O
H3	S-Biological_Molecule
and	O
phosphorylated	O
H3	S-Biological_Molecule
are	O
enriched	O
at	O
the	O
promoter	O
of	O
EGR	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
;	O
and	O
EGR	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
is	O
enriched	O
at	O
the	O
promoters	O
of	O
tissue	B-Biological_Molecule
factor	E-Biological_Molecule
and	O
plasminogen	B-Biological_Molecule
activator	I-Biological_Molecule
inhibitor	I-Biological_Molecule
1	E-Biological_Molecule
in	O
response	O
to	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
,	O
and	O
attenuated	O
by	O
PD98059	O
,	O
Garcinol	O
,	O
and	O
mitogen	B-Biological_Molecule
and	I-Biological_Molecule
stress	I-Biological_Molecule
-	I-Biological_Molecule
activated	I-Biological_Molecule
protein	I-Biological_Molecule
kinase	I-Biological_Molecule
1	E-Biological_Molecule
/	O
2	S-Biological_Molecule
short	O
interfering	O
RNA	O
.	O

Moreover	O
,	O
patients	O
with	O
multiple	O
myeloma	O
overexpressing	O
USP9X	S-Biological_Molecule
have	O
a	O
poor	O
prognosis	O
.	O

Oxidative	O
stress	O
-	O
specific	O
interaction	O
between	O
FANCD2	S-Biological_Molecule
and	O
FOXO3a	S-Biological_Molecule
.	O

SH3	O
domains	O
from	O
a	O
subset	O
of	O
BAR	O
proteins	O
define	O
a	O
Ubl	O
-	O
binding	O
domain	O
and	O
implicate	O
parkin	S-Biological_Molecule
in	O
synaptic	O
ubiquitination	O
.	O

High	O
molecular	O
weight	O
glycosylated	O
protease	O
in	O
calf	O
brain	O
.	O

The	O
purification	O
procedure	O
involves	O
ammonium	O
sulfate	O
fractionation	O
of	O
the	O
cytosol	O
followed	O
by	O
chromatography	O
on	O
DEAE	O
-	O
Sephacel	O
,	O
hydroxylapatite	O
,	O
concanavalin	B-Biological_Molecule
A	E-Biological_Molecule
-	O
Sepharose	O
4B	O
and	O
Sephacryl	O
S	O
-	O
300	O
.	O

Aggregation	O
may	O
be	O
reversed	O
by	O
treating	O
the	O
protease	O
with	O
certain	O
organic	O
solvents	O
.	O

The	O
predicted	O
O	B-Biological_Molecule
-	I-Biological_Molecule
acetyl	I-Biological_Molecule
transferase	E-Biological_Molecule
protein	O
encoded	O
by	O
this	O
gene	O
was	O
found	O
to	O
consist	O
of	O
333	O
amino	O
acids	O
,	O
(	O
37	O
,	O
185	O
daltons	O
)	O
and	O
to	O
have	O
some	O
similarity	O
with	O
the	O
galactose	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
-	I-Biological_Molecule
phosphate	I-Biological_Molecule
uridylyltransferase	E-Biological_Molecule
protein	O
of	O
Escherichia	O
coli	O
.	O

Our	O
results	O
reveal	O
a	O
molecular	O
linkage	O
between	O
p21	S-Biological_Molecule
abundance	O
and	O
radiation	O
-	O
induced	O
carcinogenesis	O
.	O

The	O
coordinated	O
induction	O
of	O
both	O
IGF	B-Biological_Molecule
-	I-Biological_Molecule
I	E-Biological_Molecule
promoters	O
by	O
GH	S-Biological_Molecule
is	O
accompanied	O
by	O
hyperacetylation	O
of	O
histones	B-Biological_Molecule
H3	E-Biological_Molecule
and	O
H4	S-Biological_Molecule
in	O
promoter	O
-	O
associated	O
chromatin	O
,	O
a	O
decline	O
in	O
monomethylation	O
at	O
lysine	O
4	O
of	O
histone	B-Biological_Molecule
H3	E-Biological_Molecule
,	O
and	O
recruitment	O
of	O
RNA	O
Pol	O
II	O
to	O
IGF	B-Biological_Molecule
-	I-Biological_Molecule
I	E-Biological_Molecule
promoter	O
2	O
.	O

However	O
,	O
the	O
role	O
that	O
dysregulation	O
of	O
Bfl	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
turnover	O
plays	O
in	O
cancer	O
is	O
not	O
known	O
.	O

Coexpression	O
of	O
Bfl	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
constitutively	O
active	O
Lck	S-Biological_Molecule
promoted	O
tumor	O
formation	O
,	O
whereas	O
Lck	S-Biological_Molecule
knockdown	O
in	O
tumor	O
-	O
derived	O
cells	O
suppressed	O
leukemia	O
/	O
lymphomagenesis	O
.	O

Knockdown	O
of	O
SENP2	S-Biological_Molecule
also	O
caused	O
a	O
marked	O
reduction	O
in	O
the	O
level	O
of	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBPbeta	E-Biological_Molecule
protein	O
but	O
not	O
in	O
that	O
of	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBPbeta	E-Biological_Molecule
mRNA	O
.	O

SIRT1	S-Biological_Molecule
promotes	O
proliferation	O
and	O
prevents	O
senescence	O
through	O
targeting	O
LKB1	S-Biological_Molecule
in	O
primary	O
porcine	O
aortic	O
endothelial	O
cells	O
.	O

METHODS	O
AND	O
RESULTS	O
:	O
An	O
in	O
vitro	O
senescence	O
model	O
was	O
established	O
by	O
prolonged	O
culture	O
of	O
primary	O
endothelial	O
cells	O
isolated	O
from	O
porcine	O
aorta	O
.	O

These	O
results	O
suggest	O
that	O
NRG1	S-Biological_Molecule
type	O
IV	O
expression	O
levels	O
associated	O
with	O
SNP8NRG243177	O
[	O
T	O
/	O
T	O
]	O
can	O
selectively	O
modify	O
signaling	O
of	O
NRG1	S-Biological_Molecule
released	O
from	O
somato	O
-	O
dendritic	O
compartments	O
,	O
in	O
contrast	O
to	O
the	O
type	O
III	O
NRG1	S-Biological_Molecule
that	O
is	O
also	O
associated	O
with	O
axons	O
.	O

A	O
live	O
attenuated	O
influenza	O
A	O
/	O
Vietnam	O
/	O
1203	O
/	O
2004	O
(	O
H5N1	O
)	O
vaccine	O
virus	O
(	O
VN04	O
ca	O
)	O
has	O
receptor	O
binding	O
specificity	O
to	O
alpha2	O
,	O
3	O
-	O
linked	O
sialosides	O
(	O
alpha2	O
,	O
3SAL	O
)	O
,	O
and	O
a	O
single	O
dose	O
induces	O
a	O
minimal	O
serum	O
antibody	O
response	O
in	O
mice	O
and	O
ferrets	O
.	O

Although	O
a	O
number	O
of	O
large	O
-	O
plaque	O
-	O
size	O
HA	S-Biological_Molecule
variants	O
with	O
amino	O
acid	O
changes	O
in	O
the	O
HA	S-Biological_Molecule
receptor	O
binding	O
region	O
were	O
identified	O
,	O
none	O
of	O
these	O
mutations	O
affected	O
virus	O
receptor	O
binding	O
preference	O
and	O
immunogenicity	O
.	O

Besides	O
the	O
ubiquitously	O
expressed	O
Gsalpha	S-Biological_Molecule
,	O
which	O
is	O
of	O
broad	O
biological	O
importance	O
,	O
GNAS	S-Biological_Molecule
gives	O
rise	O
to	O
an	O
antisense	O
transcript	O
and	O
to	O
several	O
Gsalpha	S-Biological_Molecule
variants	O
that	O
are	O
transcribed	O
from	O
the	O
nonmethylated	O
parental	O
allele	O
.	O

We	O
now	O
showed	O
in	O
mice	O
that	O
deletion	O
of	O
the	O
region	O
equivalent	O
to	O
delNESP55	O
/	O
delAS3	O
-	O
4	O
on	O
the	O
paternal	O
allele	O
(	O
DeltaNesp55	O
(	O
p	O
)	O
)	O
leads	O
to	O
healthy	O
animals	O
without	O
Gnas	S-Biological_Molecule
methylation	O
changes	O
.	O

Vascular	O
endothelial	O
cells	O
display	O
a	O
wide	O
panel	O
of	O
responses	O
to	O
changes	O
in	O
the	O
shear	O
stress	O
that	O
is	O
exerted	O
on	O
them	O
by	O
blood	O
flow	O
.	O

Here	O
,	O
we	O
focused	O
on	O
the	O
functions	O
of	O
DNA	B-Biological_Molecule
methyltransferase	I-Biological_Molecule
-	I-Biological_Molecule
3b	E-Biological_Molecule
(	O
Dnmt3b	S-Biological_Molecule
)	O
,	O
of	O
which	O
deregulated	O
activity	O
is	O
linked	O
to	O
several	O
human	O
pathologies	O
.	O

In	O
addition	O
,	O
analysis	O
of	O
deregulated	O
expression	O
programs	O
in	O
Dnmt3b	S-Biological_Molecule
mutant	O
embryos	O
,	O
using	O
DNA	O
microarrays	O
,	O
highlighted	O
illegitimate	O
activation	O
of	O
several	O
germ	O
-	O
line	O
genes	O
in	O
somatic	O
tissues	O
that	O
appeared	O
to	O
be	O
linked	O
directly	O
to	O
their	O
hypomethylation	O
in	O
mutant	O
embryos	O
.	O

On	O
a	O
cellular	O
level	O
,	O
loss	O
of	O
CRTAP	S-Biological_Molecule
in	O
human	O
OI	O
fibroblasts	O
led	O
to	O
a	O
secondary	O
loss	O
of	O
P3H1	S-Biological_Molecule
,	O
and	O
vice	O
versa	O
.	O

Oestradiol	O
potentiates	O
the	O
glycosylation	O
induced	O
by	O
GnRH	S-Biological_Molecule
and	O
reduces	O
sialylation	O
,	O
while	O
testosterone	O
increases	O
sialylation	O
.	O

In	O
vitro	O
hydroxylation	O
of	O
aspartic	O
acid	O
has	O
recently	O
been	O
demonstrated	O
in	O
a	O
synthetic	O
peptide	O
based	O
on	O
the	O
structure	O
of	O
the	O
first	O
epidermal	O
growth	O
factor	O
domain	O
in	O
human	O
factor	B-Biological_Molecule
IX	E-Biological_Molecule
(	O
Gronke	O
,	O
R	O
.	O
S	O
.	O
,	O
VanDusen	O
,	O
W	O
.	O
J	O
.	O
,	O
Garsky	O
,	O
V	O
.	O
M	O
.	O
,	O
Jacobs	O
,	O
J	O
.	O
W	O
.	O
,	O
Sardana	O
,	O
M	O
.	O
K	O
.	O
,	O
Stern	O
,	O
A	O
.	O
M	O
.	O
,	O
and	O
Friedman	O
,	O
P	O
.	O
A	O
.	O
(	O
1989	O
)	O
Proc	O
.	O
Natl	O
.	O
Acad	O
.	O
Sci	O
.	O
U	O
.	O
S	O
.	O
A	O
.	O
86	O
,	O
3609	O
-	O
3613	O
)	O
.	O

The	O
objective	O
of	O
these	O
experiments	O
was	O
to	O
ascertain	O
whether	O
the	O
kinetic	O
behavior	O
of	O
the	O
MBP	S-Biological_Molecule
isoforms	O
reflected	O
differences	O
in	O
the	O
structures	O
of	O
this	O
molecular	O
family	O
.	O

A	O
model	O
system	O
for	O
studies	O
of	O
mechanisms	O
governing	O
the	O
alterations	O
of	O
glycosylation	O
of	O
plasma	O
glycoproteins	O
was	O
developed	O
.	O

Maximal	O
activity	O
for	O
the	O
enzyme	O
,	O
at	O
all	O
purification	O
levels	O
,	O
occurs	O
at	O
about	O
pH	O
8	O
for	O
all	O
substrate	O
histones	S-Biological_Molecule
.	O

We	O
have	O
taken	O
advantage	O
of	O
this	O
interaction	O
to	O
devise	O
a	O
purification	O
procedure	O
for	O
the	O
"	O
GC	O
-	O
box	O
"	O
binding	O
transcription	O
factor	O
Sp1	S-Biological_Molecule
.	O

To	O
test	O
for	O
continued	O
H4	S-Biological_Molecule
acetylation	O
in	O
metaphase	O
chromosomes	O
.	O

The	O
results	O
demonstrate	O
that	O
a	O
cycle	O
of	O
H4	S-Biological_Molecule
acetylation	O
and	O
deacetylation	O
continues	O
within	O
metaphase	O
chromosomes	O
.	O

Western	O
blotting	O
and	O
immunostaining	O
with	O
R5	O
and	O
R6	O
showed	O
a	O
net	O
reduction	O
in	O
labeling	O
of	O
H4	S-Biological_Molecule
from	O
metaphase	O
cells	O
,	O
with	O
major	O
reductions	O
in	O
the	O
more	O
-	O
acetylated	O
isoforms	O
H4Ac3	S-Biological_Molecule
-	O
4	O
.	O

With	O
the	O
exception	O
of	O
[	O
Sar1	O
,	O
Thr	O
(	O
ObetaMe	O
)	O
8	O
]	O
angiotensin	B-Biological_Molecule
II	E-Biological_Molecule
,	O
which	O
gave	O
lower	O
antagonistic	O
properties	O
,	O
all	O
other	O
analogs	O
had	O
either	O
similar	O
antagonistic	O
properties	O
or	O
were	O
better	O
antagonists	O
in	O
adrenal	O
medulla	O
than	O
in	O
smooth	O
muscle	O
.	O

An	O
enzymatic	O
activity	O
responsible	O
for	O
the	O
hydroxylation	O
of	O
CMP	O
-	O
NeuAc	O
into	O
CMP	O
-	O
N	O
-	O
glycolylneuraminic	O
acid	O
(	O
CMP	O
-	O
NeuGc	O
)	O
was	O
found	O
in	O
the	O
cytosolic	O
fraction	O
after	O
cellular	O
fractionation	O
of	O
the	O
mucosa	O
of	O
rat	O
small	O
intestine	O
.	O

Radiomethyl	O
incorporation	O
in	O
vitro	O
into	O
Nepsilon	O
-	O
methyllysine	O
of	O
histones	S-Biological_Molecule
from	O
rat	O
liver	O
nuclei	O
incubated	O
in	O
the	O
presence	O
of	O
S	O
-	O
adenosyl	O
[	O
methyl	O
-	O
3H	O
]	O
methionine	O
is	O
stimulated	O
if	O
the	O
polycations	O
polylysines	O
,	O
protamines	O
,	O
or	O
histones	O
are	O
added	O
to	O
the	O
incubation	O
mixture	O
.	O

Deamidation	O
of	O
calmodulin	S-Biological_Molecule
at	O
pH	O
7	O
.	O
4	O
is	O
unaffected	O
by	O
the	O
addition	O
of	O
10	O
(	O
-	O
7	O
)	O
M	O
Ca2	O
+	O
;	O
however	O
,	O
at	O
4	O
X	O
10	O
(	O
-	O
6	O
)	O
M	O
Ca2	O
+	O
,	O
the	O
rate	O
of	O
deamidation	O
is	O
inhibited	O
by	O
approximately	O
70	O
%	O
.	O

All	O
three	O
assays	O
can	O
be	O
carried	O
out	O
at	O
collagen	O
concentrations	O
.	O
that	O
range	O
from	O
0	O
.	O
06	O
to	O
2	O
mg	O
/	O
ml	O
and	O
give	O
linear	O
double	O
reciprocal	O
plots	O
for	O
both	O
tissue	O
and	O
bacterial	O
collagenases	O
that	O
can	O
be	O
used	O
to	O
evaluate	O
the	O
kinetic	O
parameters	O
Km	O
and	O
kcat	O
or	O
Vmax	O
.	O

This	O
difference	O
was	O
seen	O
on	O
antigens	O
isolated	O
from	O
cells	O
of	O
the	O
parental	O
strains	O
as	O
well	O
as	O
from	O
the	O
F1	O
cross	O
.	O

These	O
results	O
suggest	O
that	O
the	O
dominant	O
nature	O
of	O
the	O
cheD	S-Biological_Molecule
mutations	O
is	O
manifested	O
as	O
a	O
general	O
defect	O
in	O
the	O
regulation	O
of	O
demethylation	O
.	O

In	O
addition	O
,	O
strains	O
with	O
this	O
mutation	O
accumulate	O
abnormal	O
and	O
unstable	O
ribosomal	O
particles	O
;	O
50	O
-	O
S	O
and	O
30	O
-	O
S	O
subunits	O
are	O
formed	O
,	O
but	O
at	O
a	O
lower	O
rate	O
.	O

(	O
b	O
)	O
The	O
induction	O
of	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
galactosidase	E-Biological_Molecule
in	O
vivo	O
exhibits	O
normal	O
kinetics	O
and	O
the	O
enzyme	O
has	O
a	O
normal	O
rate	O
of	O
thermal	O
denaturation	O
.	O

It	O
was	O
established	O
that	O
only	O
the	O
A	O
closest	O
to	O
the	O
5	O
'	O
end	O
is	O
dimethylated	O
,	O
the	O
other	O
one	O
being	O
unmodified	O
.	O

This	O
suggests	O
that	O
dimethylation	O
takes	O
place	O
in	O
two	O
successive	O
stages	O
.	O

Types	O
I	O
,	O
II	S-Biological_Molecule
and	O
III	B-Biological_Molecule
collagen	E-Biological_Molecule
were	O
isolated	O
from	O
calvarium	O
,	O
skin	O
and	O
cartilage	O
from	O
a	O
patient	O
with	O
recessive	O
lethal	O
osteogenesis	O
imperfecta	O
.	O
the	O
distribution	O
of	O
the	O
various	O
collagen	O
types	O
was	O
normal	O
in	O
all	O
three	O
tissues	O
.	O

Similar	O
observations	O
were	O
made	O
with	O
collagen	O
from	O
fetuses	O
at	O
various	O
stages	O
of	O
development	O
.	O

Chicken	O
bone	O
marrow	O
cells	O
infected	O
in	O
vitro	O
with	O
a	O
temperature	O
-	O
sensitive	O
avian	O
erythroblastosis	O
virus	O
fall	O
to	O
produce	O
hemoglobin	O
at	O
36	O
degrees	O
C	O
.	O

Several	O
(	O
but	O
not	O
all	O
)	O
specific	O
restriction	O
sites	O
associated	O
with	O
both	O
the	O
alpha	O
and	O
beta	O
domains	O
become	O
unmethylated	O
after	O
the	O
switch	O
from	O
36	O
degrees	O
C	O
to	O
42	O
degrees	O
C	O
.	O

The	O
magnitude	O
of	O
these	O
methylation	O
switches	O
is	O
small	O
compared	O
with	O
changes	O
that	O
occur	O
in	O
these	O
genes	O
during	O
normal	O
avian	O
erythropoiesis	O
.	O

Finally	O
,	O
we	O
show	O
that	O
deglycosylation	O
of	O
the	O
SIV	O
envelope	O
results	O
in	O
a	O
molecule	O
which	O
binds	O
neither	O
soluble	O
CD4	S-Biological_Molecule
nor	O
the	O
neutralizing	O
monoclonal	O
antibodies	O
being	O
investigated	O
here	O
and	O
does	O
not	O
elicit	O
sera	O
with	O
a	O
significant	O
neutralizing	O
titer	O
.	O

Abnormal	O
glycosylation	O
of	O
alpha	B-Biological_Molecule
2	I-Biological_Molecule
-	I-Biological_Molecule
macroglobulin	E-Biological_Molecule
,	O
a	O
non	O
-	O
acute	O
-	O
phase	O
protein	O
in	O
patients	O
with	O
autoimmune	O
diseases	O
.	O

We	O
used	O
the	O
concanavalin	B-Biological_Molecule
A	E-Biological_Molecule
(	O
Con	B-Biological_Molecule
A	E-Biological_Molecule
)	O
blots	O
in	O
conjunction	O
with	O
the	O
peptide	O
mapping	O
techniques	O
to	O
analyze	O
serum	O
samples	O
and	O
cerebrospinal	O
fluids	O
(	O
CSF	O
)	O
obtained	O
from	O
patients	O
with	O
autoimmune	O
diseases	O
:	O
systemic	O
lupus	O
erythematosus	O
(	O
SLE	O
)	O
,	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
,	O
mixed	O
connective	O
tissue	O
disease	O
(	O
MCTD	O
)	O
,	O
scleroderma	O
(	O
SCL	O
)	O
,	O
Sjogren	O
'	O
s	O
syndrome	O
(	O
SS	O
)	O
,	O
and	O
polymyositis	O
(	O
PM	O
)	O
;	O
diseases	O
of	O
probable	O
autoimmune	O
origin	O
:	O
hepatopathies	O
(	O
HP	O
)	O
;	O
diseases	O
of	O
suspected	O
autoimmune	O
origin	O
:	O
schizophrenia	O
and	O
Alzheimer	O
'	O
s	O
disease	O
(	O
AZ	O
)	O
;	O
and	O
conditions	O
not	O
related	O
to	O
autoimmunity	O
:	O
pregnancy	O
(	O
PG	O
)	O
and	O
elevation	O
of	O
the	O
carcinoembryonic	B-Biological_Molecule
antigen	E-Biological_Molecule
(	O
CEA	S-Biological_Molecule
)	O
,	O
in	O
comparison	O
to	O
normal	O
donors	O
(	O
NHS	O
)	O
.	O

However	O
,	O
when	O
they	O
were	O
examined	O
by	O
lectin	O
blots	O
using	O
Con	B-Biological_Molecule
A	E-Biological_Molecule
,	O
the	O
Con	B-Biological_Molecule
A	E-Biological_Molecule
-	O
reactive	O
fragments	O
increased	O
specifically	O
and	O
significantly	O
in	O
samples	O
derived	O
from	O
patients	O
of	O
SLE	O
,	O
SCL	O
,	O
MCTD	O
,	O
and	O
RA	O
.	O

Immunoblotting	O
with	O
antiserum	O
sc	O
-	O
65	O
raised	O
against	O
Rap1	O
identified	O
the	O
carboxyl	O
-	O
methylated	O
23	O
-	O
kDa	O
protein	O
as	O
Rap1	O
.	O

Altered	O
glycosylation	O
and	O
selected	O
mutation	O
in	O
recombinant	O
human	O
complement	B-Biological_Molecule
component	I-Biological_Molecule
C9	E-Biological_Molecule
:	O
effects	O
on	O
haemolytic	O
activity	O
.	O

Another	O
mutant	O
,	O
lacking	O
23	O
N	O
-	O
terminal	O
amino	O
acids	O
,	O
previously	O
showing	O
increased	O
polymerization	O
when	O
produced	O
in	O
vitro	O
,	O
polymerized	O
on	O
secretion	O
,	O
rendering	O
it	O
inactive	O
.	O

To	O
assess	O
whether	O
glycosylation	O
might	O
be	O
responsible	O
for	O
the	O
variation	O
in	O
hormone	O
action	O
,	O
both	O
alkaline	O
and	O
neutral	O
TSH	O
isoforms	O
were	O
tested	O
for	O
recognition	O
of	O
their	O
carbohydrate	O
chains	O
by	O
concanavalin	B-Biological_Molecule
A	E-Biological_Molecule
(	O
Con	B-Biological_Molecule
A	E-Biological_Molecule
)	O
and	O
ricin	O
.	O

Studies	O
on	O
the	O
structure	O
and	O
function	O
of	O
glycosylated	O
and	O
nonglycosylated	O
neu	B-Biological_Molecule
differentiation	I-Biological_Molecule
factors	E-Biological_Molecule
.	O

Similarities	O
and	O
differences	O
of	O
the	O
alpha	O
and	O
beta	O
isoforms	O
.	O

Neutrophil	O
G	B-Biological_Molecule
gamma	I-Biological_Molecule
2	E-Biological_Molecule
methylation	O
was	O
stimulated	O
by	O
activation	O
of	O
G	O
protein	O
with	O
guanosine	O
5	O
'	O
-	O
[	O
beta	O
,	O
gamma	O
-	O
thio	O
]	O
triphosphate	O
.	O

These	O
data	O
raise	O
the	O
possibility	O
that	O
the	O
Sky	S-Biological_Molecule
tyrosine	O
kinase	O
is	O
involved	O
in	O
the	O
development	O
and	O
/	O
or	O
progression	O
of	O
mammary	O
tumors	O
.	O

The	O
W187N	O
mutant	O
and	O
the	O
double	O
mutant	O
F189N	O
/	O
S191A	O
lacking	O
the	O
requisite	O
glycosylation	O
signals	O
exhibited	O
little	O
alteration	O
in	O
affinity	O
,	O
as	O
did	O
the	O
P194L	O
and	O
P197H	O
mutations	O
.	O

However	O
,	O
this	O
truncated	O
protein	O
was	O
not	O
able	O
to	O
complement	O
E	O
.	O
coli	O
cysG	S-Biological_Molecule
cells	O
,	O
thereby	O
suggesting	O
that	O
the	O
first	O
201	O
amino	O
acids	O
of	O
the	O
CysG	S-Biological_Molecule
protein	O
had	O
an	O
enzymic	O
activity	O
associated	O
with	O
the	O
conversion	O
of	O
dihydrosirohydrochlorin	O
into	O
sirohaem	O
.	O

It	O
is	O
neither	O
understood	O
how	O
hCG	O
synthesis	O
is	O
initiated	O
and	O
maintained	O
at	O
the	O
beginning	O
of	O
gestation	O
nor	O
what	O
control	O
mechanisms	O
are	O
responsible	O
for	O
the	O
down	O
-	O
regulation	O
of	O
the	O
synthesis	O
at	O
the	O
end	O
of	O
the	O
first	O
trimester	O
.	O

Experimental	O
deglycosylation	O
induces	O
a	O
different	O
conformation	O
of	O
hCG	O
,	O
which	O
partly	O
acquires	O
antagonistic	O
properties	O
.	O

Methylation	O
of	O
these	O
proteins	O
in	O
vitro	O
is	O
blocked	O
by	O
farnesylthioacetic	O
acid	O
.	O

METHOD	O
:	O
Thirty	O
-	O
one	O
sera	O
were	O
investigated	O
from	O
11	O
men	O
and	O
9	O
women	O
with	O
ASD	O
and	O
compared	O
with	O
27	O
sera	O
from	O
27	O
patients	O
with	O
systemic	O
diseases	O
.	O

We	O
studied	O
the	O
course	O
of	O
one	O
case	O
of	O
ASD	O
for	O
15	O
months	O
.	O

CONCLUSIONS	O
:	O
Serum	O
ferritin	O
levels	O
have	O
a	O
diagnostic	O
value	O
for	O
acute	O
ASD	O
.	O

Subcellular	O
localization	O
of	O
the	O
UDP	B-Biological_Molecule
-	I-Biological_Molecule
N	I-Biological_Molecule
-	I-Biological_Molecule
acetyl	I-Biological_Molecule
-	I-Biological_Molecule
D	I-Biological_Molecule
-	I-Biological_Molecule
galactosamine	I-Biological_Molecule
:	I-Biological_Molecule
polypeptide	I-Biological_Molecule
N	I-Biological_Molecule
-	I-Biological_Molecule
acetylgalactosaminyltransferase	E-Biological_Molecule
-	O
mediated	O
O	O
-	O
glycosylation	O
reaction	O
in	O
the	O
submaxillary	O
gland	O
.	O

Labeling	O
was	O
undetectable	O
in	O
the	O
rough	O
endoplasmic	O
reticulum	O
,	O
its	O
transitional	O
elements	O
,	O
and	O
smooth	O
-	O
membraned	O
structures	O
close	O
to	O
them	O
,	O
the	O
trans	O
Golgi	O
apparatus	O
,	O
mucin	O
droplets	O
,	O
and	O
the	O
plasma	O
membrane	O
.	O

Thus	O
,	O
the	O
initial	O
step	O
of	O
UDP	B-Biological_Molecule
-	I-Biological_Molecule
GalNAc	I-Biological_Molecule
:	I-Biological_Molecule
polypeptide	I-Biological_Molecule
N	I-Biological_Molecule
-	I-Biological_Molecule
acetylgalactosaminyltransferase	E-Biological_Molecule
-	O
mediated	O
O	O
-	O
glycosylation	O
in	O
porcine	O
and	O
bovine	O
submaxillary	O
gland	O
cells	O
occurs	O
in	O
the	O
cis	O
Golgi	O
apparatus	O
.	O

Methylation	O
of	O
5	O
-	O
CCGG	O
-	O
3	O
'	O
sequences	O
by	O
Hpall	B-Biological_Molecule
methyltransferase	E-Biological_Molecule
gave	O
similar	O
results	O
.	O

Cotranscription	O
of	O
two	O
genes	O
necessary	O
for	O
ribosomal	B-Biological_Molecule
protein	I-Biological_Molecule
L11	E-Biological_Molecule
methylation	O
(	O
prmA	S-Biological_Molecule
)	O
and	O
pantothenate	O
transport	O
(	O
panF	S-Biological_Molecule
)	O
in	O
Escherichia	O
coli	O
K	O
-	O
12	O
.	O

Somatic	O
B	O
-	O
type	O
lamins	O
,	O
in	O
contrast	O
,	O
are	O
permanently	O
isoprenylated	O
and	O
,	O
although	O
depolymerized	O
during	O
mitosis	O
,	O
remain	O
associated	O
with	O
remnants	O
of	O
nuclear	O
envelope	O
membranes	O
.	O

Three	O
forms	O
of	O
alpha	B-Biological_Molecule
-	I-Biological_Molecule
MSH	E-Biological_Molecule
were	O
detected	O
,	O
and	O
the	O
major	O
form	O
had	O
the	O
same	O
HPLC	O
chromatographic	O
properties	O
as	O
synthetic	O
monoacetylated	O
alpha	B-Biological_Molecule
-	I-Biological_Molecule
MSH	E-Biological_Molecule
.	O

Given	O
the	O
position	O
of	O
Order	O
Cladistia	O
in	O
the	O
phylogeny	O
of	O
actinopterygian	O
fish	O
,	O
it	O
appears	O
that	O
N	O
-	O
acetylation	O
of	O
POMC	S-Biological_Molecule
-	O
related	O
products	O
is	O
an	O
ancestral	O
trait	O
of	O
osteichthyean	O
fish	O
.	O

Evidence	O
for	O
receptor	O
phosphorylation	O
is	O
lacking	O
,	O
however	O
,	O
for	O
G	O
-	O
protein	O
-	O
coupled	O
receptors	O
that	O
bind	O
larger	O
ligands	O
,	O
such	O
as	O
LH	O
/	O
CG	O
.	O

The	O
cDNA	O
of	O
a	O
novel	O
matrix	O
metalloproteinase	O
,	O
collagenase	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
(	O
MMP	B-Biological_Molecule
-	I-Biological_Molecule
13	E-Biological_Molecule
)	O
has	O
been	O
isolated	O
from	O
a	O
breast	O
tumor	O
library	O
(	O
Freije	O
,	O
J	O
.	O
M	O
.	O
P	O
.	O
,	O
Dicz	O
-	O
Itza	O
,	O
I	O
.	O
,	O
Balbin	O
,	O
M	O
.	O
,	O
Sanchez	O
,	O
L	O
.	O
M	O
.	O
,	O
Blasco	O
,	O
R	O
.	O
,	O
Tolivia	O
,	O
J	O
.	O
,	O
and	O
Lopez	O
-	O
Otin	O
,	O
C	O
.	O
(	O
1994	O
)	O
J	O
.	O
Biol	O
.	O
Chem	O
.	O
269	O
,	O
16766	O
-	O
16773	O
)	O
,	O
and	O
a	O
potential	O
role	O
in	O
tumor	O
progression	O
has	O
been	O
proposed	O
for	O
this	O
enzyme	O
.	O

Further	O
processing	O
resulted	O
in	O
cleavage	O
of	O
the	O
Glu84	O
-	O
Tyr85	O
peptide	O
bond	O
to	O
the	O
final	O
active	O
enzyme	O
(	O
M	O
(	O
r	O
)	O
48	O
,	O
000	O
)	O
.	O

About	O
50	O
%	O
of	O
the	O
transferred	O
oligosaccharides	O
were	O
endo	O
H	O
sensitive	O
,	O
indicating	O
that	O
the	O
lipid	O
-	O
linked	O
precursor	O
had	O
completed	O
its	O
synthesis	O
to	O
Glc3	O
-	O
Man9	O
-	O
GlcNAc2	O
.	O

This	O
percentage	O
dropped	O
to	O
20	O
%	O
for	O
glycoforms	O
carrying	O
the	O
oligosaccharide	O
in	O
the	O
first	O
sequon	O
.	O

Role	O
of	O
glucosamine	O
synthesis	O
in	O
the	O
stimulation	O
of	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
gene	O
transcription	O
by	O
glucose	O
and	O
EGF	S-Biological_Molecule
.	O

Transforming	B-Biological_Molecule
growth	I-Biological_Molecule
factor	I-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
(	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
)	O
gene	O
transcription	O
is	O
regulated	O
by	O
both	O
epidermal	B-Biological_Molecule
growth	I-Biological_Molecule
factor	E-Biological_Molecule
(	O
EGF	S-Biological_Molecule
)	O
and	O
glucose	O
.	O

Previous	O
studies	O
have	O
suggested	O
that	O
the	O
metabolism	O
of	O
glucose	O
to	O
glucosamine	O
through	O
the	O
enzyme	O
L	B-Biological_Molecule
-	I-Biological_Molecule
glutamine	I-Biological_Molecule
:	I-Biological_Molecule
D	I-Biological_Molecule
-	I-Biological_Molecule
fructose	I-Biological_Molecule
-	I-Biological_Molecule
6	I-Biological_Molecule
-	I-Biological_Molecule
phosphate	I-Biological_Molecule
amidotransferase	E-Biological_Molecule
(	O
GFAT	S-Biological_Molecule
)	O
plays	O
a	O
critical	O
role	O
in	O
the	O
glucose	O
signaling	O
.	O

MDA	O
-	O
MB	O
-	O
468	O
cells	O
also	O
exhibited	O
a	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
transcriptional	O
response	O
to	O
low	O
concentrations	O
of	O
glucose	O
.	O

The	O
mRNA	O
for	O
lysyl	O
hydroxylase	O
was	O
reduced	O
by	O
one	O
-	O
third	O
under	O
the	O
influence	O
of	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	I-Biological_Molecule
1	E-Biological_Molecule
.	O

Treatment	O
of	O
Gc	S-Biological_Molecule
protein	O
with	O
immobilized	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
galactosidase	E-Biological_Molecule
and	O
sialidase	O
generates	O
a	O
remarkably	O
high	O
titered	O
macrophage	O
-	O
activating	O
factor	O
(	O
GcMAF	S-Biological_Molecule
)	O
.	O

Loss	O
of	O
the	O
precursor	O
activity	O
was	O
the	O
result	O
of	O
deglycosylation	O
of	O
plasma	O
Gc	S-Biological_Molecule
protein	O
by	O
alpha	B-Biological_Molecule
-	I-Biological_Molecule
N	I-Biological_Molecule
-	I-Biological_Molecule
acetylgalactosaminidase	E-Biological_Molecule
activity	O
found	O
in	O
the	O
patient	O
plasma	O
.	O

Regulatory	O
adaptation	O
of	O
isoprenoid	O
biosynthesis	O
and	O
the	O
LDL	B-Biological_Molecule
receptor	E-Biological_Molecule
pathway	O
in	O
fibroblasts	O
from	O
patients	O
with	O
mevalonate	B-Biological_Molecule
kinase	E-Biological_Molecule
deficiency	O
.	O

The	O
higher	O
level	O
of	O
protein	O
glycosylation	O
in	O
M21	O
cells	O
correlated	O
well	O
with	O
increased	O
D	O
-	O
[	O
2	O
-	O
3H	O
]	O
mannose	O
incorporation	O
into	O
precursor	O
pools	O
of	O
dolichyl	O
phosphomannose	O
and	O
dolichyl	O
pyrophosphoryl	O
oligosaccharides	O
and	O
into	O
glycoproteins	O
.	O

CpG	O
methylation	O
around	O
the	O
promoter	O
region	O
of	O
the	O
E	B-Biological_Molecule
-	I-Biological_Molecule
cadherin	E-Biological_Molecule
gene	O
was	O
detected	O
in	O
46	O
%	O
of	O
liver	O
tissues	O
showing	O
chronic	O
hepatitis	O
or	O
cirrhosis	O
and	O
67	O
%	O
of	O
HCCs	O
examined	O
.	O

Characterization	O
of	O
the	O
ETSA	O
-	O
21	O
antigen	O
,	O
a	O
glycosylphosphatidyl	O
-	O
inositol	O
anchor	O
glycoprotein	O
identified	O
in	O
breast	O
cancer	O
cells	O
using	O
monoclonal	O
antibody	O
B21	O
.	O

The	O
secreted	O
procollagen	O
molecules	O
had	O
a	O
2	O
:	O
1	O
pro	O
alpha	B-Biological_Molecule
1	I-Biological_Molecule
(	I-Biological_Molecule
1	I-Biological_Molecule
)	E-Biological_Molecule
:	O
pro	O
alpha	B-Biological_Molecule
2	I-Biological_Molecule
(	I-Biological_Molecule
I	I-Biological_Molecule
)	E-Biological_Molecule
chain	O
ratio	O
but	O
the	O
polysome	O
-	O
bound	O
peptides	O
did	O
not	O
.	O

Interactions	O
leading	O
to	O
heterotrimer	O
formation	O
are	O
a	O
late	O
event	O
which	O
may	O
affect	O
the	O
rate	O
of	O
release	O
of	O
the	O
completed	O
pro	O
alpha	B-Biological_Molecule
1	I-Biological_Molecule
(	I-Biological_Molecule
I	I-Biological_Molecule
)	E-Biological_Molecule
chain	O
from	O
the	O
polysome	O
.	O

Cytotoxic	O
T	O
lymphocytes	O
derived	O
from	O
bone	O
marrow	O
mononuclear	O
cells	O
of	O
multiple	O
myeloma	O
patients	O
recognize	O
an	O
underglycosylated	O
form	O
of	O
MUC1	S-Biological_Molecule
mucin	O
.	O

In	O
this	O
study	O
,	O
we	O
attempted	O
to	O
induce	O
such	O
CTL	O
from	O
six	O
other	O
multiple	O
myeloma	O
patients	O
consecutively	O
in	O
order	O
to	O
show	O
that	O
the	O
induction	O
of	O
the	O
CTL	O
line	O
TN	O
had	O
not	O
resulted	O
from	O
some	O
idiosyncrasy	O
of	O
the	O
first	O
patient	O
.	O

Bone	O
marrow	O
mononuclear	O
cells	O
were	O
used	O
to	O
induce	O
CTL	O
,	O
because	O
they	O
contain	O
myeloma	O
cells	O
that	O
might	O
stimulate	O
the	O
autologous	O
lymphocytes	O
.	O

Both	O
CTL	O
lines	O
lysed	O
MUC1	S-Biological_Molecule
+	O
myeloma	O
and	O
breast	O
carcinoma	O
cell	O
lines	O
.	O

MUC1	S-Biological_Molecule
was	O
transfected	O
into	O
a	O
human	O
colonic	O
carcinoma	O
cell	O
line	O
.	O

These	O
six	O
cases	O
were	O
also	O
investigated	O
by	O
Southern	O
blot	O
analysis	O
with	O
methylcytosine	O
-	O
sensitive	O
restriction	O
enzymes	O
and	O
this	O
method	O
showed	O
an	O
increase	O
in	O
DNA	O
methylation	O
in	O
only	O
four	O
of	O
the	O
six	O
cases	O
.	O

A	O
strategy	O
of	O
tRNA	O
recognition	O
that	O
includes	O
determinants	O
of	O
RNA	O
structure	O
.	O

The	O
initiating	O
reaction	O
is	O
the	O
nonenzymatic	O
addition	O
of	O
sugars	O
such	O
as	O
glucose	O
to	O
the	O
primary	O
amino	O
groups	O
of	O
proteins	O
,	O
i	O
.	O
e	O
.	O
,	O
mainly	O
to	O
lysine	O
residues	O
.	O

In	O
addition	O
,	O
we	O
tried	O
to	O
generate	O
AGE	O
-	O
LDL	O
by	O
reaction	O
with	O
AGE	O
-	O
peptides	O
(	O
<	O
10	O
kD	O
)	O
obtained	O
by	O
enzymatic	O
digestion	O
of	O
long	O
-	O
term	O
glycated	O
fibronectin	S-Biological_Molecule
as	O
a	O
model	O
for	O
connective	O
tissue	O
AGE	O
-	O
peptides	O
.	O

AGE	O
-	O
formation	O
can	O
be	O
assessed	O
by	O
monitoring	O
of	O
fluorescence	O
(	O
370	O
/	O
440	O
nm	O
)	O
which	O
is	O
easily	O
differentiated	O
from	O
the	O
much	O
lower	O
autofluorescence	O
of	O
oxidized	O
low	O
density	O
lipoproteins	O
(	O
oxLDL	O
)	O
.	O

We	O
observed	O
(	O
a	O
)	O
that	O
the	O
rate	O
of	O
AGE	O
formation	O
is	O
reduced	O
by	O
BHT	O
/	O
EDTA	O
both	O
on	O
LDL	O
and	O
serum	B-Biological_Molecule
albumin	E-Biological_Molecule
(	O
glycation	O
vs	O
.	O
glycoxidation	O
)	O
,	O
(	O
b	O
)	O
long	O
-	O
term	O
glycated	O
LDL	O
is	O
more	O
readily	O
oxidized	O
than	O
unglycated	O
LDL	O
,	O
(	O
c	O
)	O
oxLDL	O
is	O
more	O
prone	O
to	O
AGE	O
-	O
modification	O
,	O
(	O
d	O
)	O
AGE	O
-	O
modification	O
of	O
LDL	O
strongly	O
alters	O
its	O
epitope	O
spectrum	O
and	O
(	O
e	O
)	O
that	O
aminoguanidine	O
at	O
higher	O
concentrations	O
(	O
1	O
-	O
10	O
mM	O
)	O
inhibits	O
copper	O
-	O
catalyzed	O
LDL	O
oxidation	O
in	O
the	O
way	O
of	O
a	O
classical	O
antioxidant	O
.	O

Jacalin	O
interaction	O
with	O
this	O
oligosaccharide	O
is	O
not	O
influenced	O
by	O
the	O
presence	O
of	O
sialic	O
acid	O
on	O
the	O
galactose	O
moiety	O
.	O

RESULTS	O
:	O
There	O
was	O
no	O
difference	O
in	O
the	O
binding	O
of	O
jacalin	O
to	O
IgA1	O
from	O
patients	O
with	O
HSP	O
compared	O
to	O
controls	O
(	O
p	O
=	O
0	O
.	O
5	O
)	O
.	O

CONCLUSION	O
:	O
The	O
O	O
-	O
linked	O
oligosaccharides	O
of	O
serum	O
IgA1	O
from	O
children	O
with	O
acute	O
HSP	O
are	O
deficient	O
in	O
salic	O
acid	O
compared	O
to	O
serum	O
IgA1	O
from	O
control	O
children	O
.	O

Alteration	O
of	O
glycosylation	O
renders	O
HIV	O
sensitive	O
to	O
inactivation	O
by	O
normal	O
human	O
serum	O
.	O

In	O
this	O
study	O
,	O
NHS	O
sensitivity	O
of	O
HIV	O
was	O
assessed	O
following	O
viral	O
propagation	O
in	O
human	O
cells	O
that	O
were	O
manipulated	O
to	O
express	O
the	O
alpha	O
-	O
galactosyl	O
epitope	O
.	O

Viral	O
inactivation	O
was	O
abolished	O
by	O
the	O
addition	O
of	O
a	O
synthetic	O
disaccharide	O
that	O
contains	O
the	O
alpha	O
-	O
galactosyl	O
epitope	O
,	O
indicating	O
that	O
virolysis	O
is	O
mediated	O
by	O
anti	O
-	O
alpha	O
-	O
galactosyl	O
natural	O
Ab	O
.	O

These	O
results	O
demonstrate	O
that	O
,	O
like	O
other	O
retroviruses	O
bearing	O
the	O
alpha	O
-	O
galactosyl	O
epitope	O
,	O
HIV	O
modified	O
to	O
express	O
this	O
epitope	O
is	O
inactivated	O
in	O
NHS	O
.	O

In	O
man	O
two	O
genetically	O
distinct	O
storage	O
disorders	O
are	O
associated	O
with	O
either	O
a	O
primary	O
or	O
a	O
secondary	O
deficiency	O
of	O
lysosomal	B-Biological_Molecule
neuraminidase	E-Biological_Molecule
:	O
sialidosis	O
and	O
galactosialidosis	O
.	O

In	O
addition	O
,	O
these	O
mice	O
have	O
an	O
altered	O
immune	O
response	O
that	O
has	O
also	O
been	O
coupled	O
to	O
a	O
deficiency	O
of	O
the	O
Neu	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
neuraminidase	O
.	O

It	O
was	O
synthesized	O
by	O
a	O
baculovirus	O
vector	O
-	O
insect	O
cell	O
system	O
using	O
two	O
cDNAs	O
encoding	O
the	O
glycoprotein	O
alpha	O
and	O
FSH	B-Biological_Molecule
beta	E-Biological_Molecule
subunits	O
.	O

Rec	O
-	O
pFSH	O
was	O
secreted	O
into	O
the	O
culture	O
medium	O
at	O
about	O
1	O
mg	O
/	O
l	O
and	O
purified	O
in	O
six	O
fractions	O
,	O
because	O
of	O
the	O
heterogeneity	O
of	O
the	O
sugar	O
group	O
,	O
by	O
S	O
-	O
Sepharose	O
and	O
concanavalin	O
A	O
-	O
Sepharose	O
column	O
chromatography	O
.	O

Protein	B-Biological_Molecule
-	I-Biological_Molecule
disulfide	I-Biological_Molecule
isomerase	E-Biological_Molecule
(	O
PDI	S-Biological_Molecule
)	O
has	O
been	O
shown	O
to	O
be	O
a	O
multifunctional	O
enzyme	O
catalyzing	O
the	O
formation	O
of	O
disulfide	O
bonds	O
,	O
as	O
well	O
as	O
being	O
a	O
component	O
of	O
the	O
enzymes	O
prolyl	O
4	O
-	O
hydroxylase	O
(	O
P4	O
-	O
H	O
)	O
and	O
microsomal	O
triglyceride	O
transfer	O
protein	O
.	O

To	O
investigate	O
the	O
role	O
of	O
this	O
multifunctional	O
protein	O
within	O
a	O
cellular	O
context	O
,	O
we	O
have	O
established	O
a	O
semi	O
-	O
permeabilized	O
cell	O
system	O
that	O
reconstitutes	O
the	O
synthesis	O
,	O
folding	O
,	O
modification	O
,	O
and	O
assembly	O
of	O
procollagen	O
as	O
they	O
would	O
occur	O
in	O
the	O
cell	O
.	O

We	O
demonstrate	O
here	O
that	O
P4	O
-	O
H	O
associates	O
transiently	O
with	O
the	O
triple	O
helical	O
domain	O
during	O
the	O
assembly	O
of	O
procollagen	O
.	O

The	O
gp120	S-Biological_Molecule
glycoprotein	O
,	O
which	O
can	O
be	O
shed	O
from	O
the	O
envelope	O
complex	O
,	O
elicits	O
both	O
virus	O
-	O
neutralizing	O
and	O
non	O
-	O
neutralizing	O
antibodies	O
during	O
natural	O
infection	O
.	O

The	O
prolyihydroxylase	O
subunit	O
genes	O
were	O
cloned	O
on	O
either	O
side	O
of	O
a	O
bidirectional	O
galactose	O
-	O
inducible	O
promoter	O
in	O
a	O
low	O
-	O
copy	O
minichromosome	O
yeast	O
expression	O
vector	O
,	O
pYEUra3	O
,	O
which	O
is	O
URA3	S-Biological_Molecule
selectable	O
.	O

The	O
biological	O
significance	O
of	O
this	O
observation	O
is	O
discussed	O
as	O
well	O
as	O
the	O
need	O
to	O
carefully	O
select	O
CD34	S-Biological_Molecule
-	O
specific	O
monoclonal	O
antibodies	O
for	O
research	O
and	O
clinical	O
purposes	O
.	O

Crystal	O
structures	O
of	O
two	O
self	O
-	O
hydroxylating	O
ribonucleotide	O
reductase	O
protein	O
R2	S-Biological_Molecule
mutants	O
:	O
structural	O
basis	O
for	O
the	O
oxygen	O
-	O
insertion	O
step	O
of	O
hydroxylation	O
reactions	O
catalyzed	O
by	O
diiron	O
proteins	O
.	O

In	O
protein	O
R2	S-Biological_Molecule
,	O
the	O
likely	O
reaction	O
site	O
for	O
dioxygen	O
is	O
close	O
to	O
Phe208	O
.	O

In	O
another	O
mutant	O
,	O
F208Y	O
,	O
the	O
"	O
foreign	O
"	O
residue	O
Tyr208	O
is	O
hydroxylated	O
to	O
Dopa	O
.	O

Variations	O
in	O
N	O
-	O
glycosylation	O
and	O
proteolytic	O
maturation	O
account	O
for	O
the	O
difference	O
in	O
molecular	O
mass	O
between	O
mature	O
recombinant	O
(	O
72	O
kDa	O
)	O
and	O
human	O
placental	O
haSMase	S-Biological_Molecule
(	O
75	O
kDa	O
)	O
.	O

To	O
do	O
this	O
,	O
we	O
used	O
a	O
novel	O
UV	O
laser	O
-	O
induced	O
protein	O
-	O
DNA	O
cross	O
-	O
linking	O
technique	O
,	O
combined	O
with	O
immunochemical	O
and	O
molecular	O
biology	O
approaches	O
.	O

Moreover	O
,	O
stress	O
kinase	O
activation	O
is	O
essential	O
for	O
CpG	O
-	O
DNA	O
-	O
induced	O
cytokine	O
release	O
of	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
alpha	E-Biological_Molecule
(	O
TNFalpha	S-Biological_Molecule
)	O
and	O
interleukin	O
-	O
12	O
(	O
IL	O
-	O
12	O
)	O
,	O
as	O
inhibition	O
of	O
p38	O
results	O
in	O
severe	O
impairment	O
of	O
this	O
biological	O
response	O
.	O

We	O
further	O
demonstrate	O
that	O
cellular	O
uptake	O
via	O
endocytosis	O
and	O
subsequent	O
endosomal	O
maturation	O
is	O
essential	O
for	O
signalling	O
,	O
since	O
competition	O
by	O
non	O
-	O
CpG	O
-	O
DNA	O
or	O
compounds	O
blocking	O
endosomal	O
maturation	O
such	O
as	O
chloroquine	O
or	O
bafilomycin	O
A	O
prevent	O
all	O
aspects	O
of	O
cellular	O
activation	O
.	O

Loss	O
of	O
Scj1p	S-Biological_Molecule
induces	O
the	O
unfolded	O
protein	O
response	O
pathway	O
,	O
and	O
results	O
in	O
a	O
cell	O
wall	O
defect	O
when	O
combined	O
with	O
an	O
oligosaccharyltransferase	O
mutation	O
.	O

We	O
propose	O
that	O
the	O
major	O
role	O
for	O
Scj1p	S-Biological_Molecule
is	O
to	O
cooperate	O
with	O
Kar2p	S-Biological_Molecule
to	O
mediate	O
maturation	O
of	O
proteins	O
in	O
the	O
RER	O
lumen	O
.	O

To	O
facilitate	O
detection	O
of	O
expressed	O
HHV	O
-	O
8	O
gB	S-Biological_Molecule
,	O
the	O
cytoplasmic	O
tail	O
of	O
the	O
glycoprotein	O
was	O
tagged	O
with	O
the	O
influenza	O
hemagglutinin	S-Biological_Molecule
(	O
HA	S-Biological_Molecule
)	O
epitope	O
.	O

HHV	O
-	O
8	O
gB	S-Biological_Molecule
-	O
HA	O
was	O
sensitive	O
to	O
endoglycosidase	B-Biological_Molecule
H	E-Biological_Molecule
treatment	O
,	O
and	O
immunofluorescence	O
revealed	O
that	O
HHV	O
-	O
8	O
gB	S-Biological_Molecule
-	O
HA	O
was	O
detectable	O
in	O
the	O
perinuclear	O
region	O
of	O
CHO	O
-	O
K1	O
cells	O
.	O

Because	O
both	O
HHV	O
-	O
8	O
and	O
EBV	O
are	O
gamma	O
-	O
herpesviruses	O
,	O
the	O
ability	O
of	O
HHV	O
-	O
8	O
gB	S-Biological_Molecule
to	O
interact	O
with	O
and	O
functionally	O
complement	O
EBV	O
gp110	S-Biological_Molecule
was	O
examined	O
.	O

Mutations	O
of	O
appropriate	O
residues	O
showed	O
that	O
myristoylation	O
of	O
the	O
protein	O
was	O
not	O
necessary	O
for	O
enzyme	O
activity	O
.	O

The	O
enzyme	O
catalyzed	O
the	O
non	O
-	O
processive	O
synthesis	O
of	O
2	O
'	O
-	O
5	O
'	O
-	O
linked	O
oligoadenylate	O
products	O
containing	O
up	O
to	O
30	O
residues	O
.	O

Avidin	S-Biological_Molecule
and	O
modified	O
avidins	S-Biological_Molecule
were	O
labeled	O
with	O
111In	O
using	O
diethyleneamine	O
pentaacetic	O
acid	O
-	O
biotin	O
and	O
were	O
administered	O
intraperitoneally	O
into	O
the	O
tumor	O
-	O
bearing	O
mice	O
.	O

RESULTS	O
:	O
Deglycosylated	O
avidins	S-Biological_Molecule
revealed	O
a	O
major	O
band	O
of	O
smaller	O
molecules	O
on	O
SDS	O
/	O
PAGE	O
.	O

A	O
novel	O
aromatic	O
-	O
ring	O
-	O
hydroxylating	O
dioxygenase	O
from	O
the	O
diterpenoid	O
-	O
degrading	O
bacterium	O
Pseudomonas	O
abietaniphila	O
BKME	O
-	O
9	O
.	O

Pseudomonas	O
abietaniphila	O
BKME	O
-	O
9	O
is	O
able	O
to	O
degrade	O
dehydroabietic	O
acid	O
(	O
DhA	O
)	O
via	O
ring	O
hydroxylation	O
by	O
a	O
novel	O
dioxygenase	O
.	O

Expression	O
in	O
Escherichia	O
coli	O
of	O
ditA1A2A3	S-Biological_Molecule
,	O
encoding	O
the	O
diterpenoid	O
dioxygenase	O
without	O
its	O
putative	O
reductase	O
component	O
,	O
resulted	O
in	O
a	O
functional	O
enzyme	O
.	O

DNA	O
methylation	O
and	O
chromatin	O
modification	O
.	O

Cr	O
(	O
IV	O
)	O
-	O
induced	O
NF	O
-	O
kappa	O
B	O
activation	O
is	O
dose	O
-	O
dependent	O
.	O

The	O
results	O
show	O
that	O
Cr	O
(	O
IV	O
)	O
can	O
cause	O
NF	O
-	O
kappa	O
B	O
activation	O
,	O
DNA	O
strand	O
breaks	O
and	O
dG	O
hydroxylation	O
through	O
.	O
OH	O
radical	O
-	O
initiated	O
reactions	O
.	O

This	O
reactive	O
chromium	O
intermediate	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
mechanism	O
of	O
Cr	O
(	O
VI	O
)	O
-	O
induced	O
carcinogenesis	O
.	O

We	O
investigated	O
whether	O
the	O
increase	O
in	O
hydroxylysylpyridinoline	O
is	O
due	O
to	O
overhydroxylation	O
of	O
lysyl	O
residues	O
in	O
the	O
collagen	O
molecule	O
,	O
which	O
may	O
also	O
be	O
associated	O
with	O
an	O
increase	O
of	O
glycosylated	O
hydroxylysine	O
residues	O
.	O

Our	O
results	O
showed	O
that	O
the	O
overhydroxylation	O
of	O
lysyl	O
residues	O
,	O
which	O
is	O
required	O
for	O
the	O
generation	O
of	O
hydroxylysylpyridinoline	O
,	O
is	O
not	O
only	O
restricted	O
to	O
the	O
telopeptides	O
but	O
also	O
affects	O
the	O
helical	O
part	O
of	O
the	O
molecule	O
.	O

With	O
confocal	O
microscopy	O
on	O
whole	O
cells	O
,	O
strong	O
immunofluorescence	O
was	O
seen	O
in	O
association	O
with	O
mitotic	O
chromosomes	O
as	O
well	O
as	O
a	O
prominent	O
punctate	O
pattern	O
of	O
labeling	O
throughout	O
the	O
mitotic	O
cell	O
,	O
whereas	O
interphase	O
cells	O
showed	O
very	O
little	O
,	O
if	O
any	O
,	O
specific	O
fluorescence	O
.	O

Analysis	O
of	O
lipid	O
-	O
linked	O
oligosaccharides	O
revealed	O
an	O
accumulation	O
of	O
Man9GlcNAc2	O
intermediates	O
due	O
to	O
dolichol	B-Biological_Molecule
pyrophosphate	I-Biological_Molecule
-	I-Biological_Molecule
Man9GlcNAc2	I-Biological_Molecule
alpha	I-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
,	I-Biological_Molecule
3	I-Biological_Molecule
glucosyltransferase	E-Biological_Molecule
deficiency	O
.	O

Phosphorylation	O
of	O
RTP	S-Biological_Molecule
,	O
an	O
ER	O
stress	O
-	O
responsive	O
cytoplasmic	O
protein	O
.	O

Western	O
blot	O
analysis	O
showed	O
that	O
RTP	S-Biological_Molecule
expression	O
was	O
induced	O
in	O
human	O
umbilical	O
vein	O
endothelial	O
cells	O
under	O
conditions	O
causing	O
endoplasmic	O
reticulum	O
stress	O
.	O

Using	O
radiolabeled	O
internal	O
tracers	O
,	O
we	O
show	O
that	O
recovery	O
of	O
each	O
major	O
class	O
of	O
glycans	O
is	O
as	O
good	O
or	O
better	O
than	O
with	O
conventional	O
approaches	O
for	O
isolating	O
individual	O
classes	O
,	O
and	O
that	O
cross	O
-	O
contamination	O
is	O
minimal	O
.	O

Similar	O
studies	O
indicate	O
that	O
this	O
linkage	O
is	O
very	O
rare	O
in	O
ganglioside	O
glycans	O
,	O
even	O
in	O
wild	O
-	O
type	O
tissues	O
.	O

In	O
this	O
study	O
we	O
fractionated	O
the	O
lymphoblastoid	O
cells	O
to	O
locate	O
the	O
methyltransferases	O
and	O
the	O
substrates	O
in	O
cells	O
.	O

In	O
the	O
cell	O
lines	O
and	O
xenografts	O
with	O
extensive	O
methylation	O
,	O
no	O
RASSF1A	S-Biological_Molecule
gene	O
expression	O
was	O
found	O
.	O

These	O
findings	O
suggest	O
that	O
promoter	O
hypermethylation	O
may	O
participate	O
in	O
the	O
transcriptional	O
inactivation	O
of	O
the	O
RASSF1A	S-Biological_Molecule
gene	O
in	O
NPC	O
.	O

However	O
,	O
at	O
present	O
,	O
it	O
is	O
not	O
known	O
whether	O
methylation	O
represses	O
GSTP1	S-Biological_Molecule
gene	O
expression	O
in	O
human	O
prostate	O
cancer	O
.	O

Embryos	O
injected	O
with	O
either	O
one	O
of	O
these	O
analogs	O
cleaved	O
normally	O
until	O
the	O
mid	O
-	O
blastula	O
stage	O
,	O
but	O
underwent	O
massive	O
cell	O
dissociation	O
and	O
stopped	O
development	O
at	O
the	O
early	O
gastrula	O
stage	O
.	O

The	O
filtration	O
measurements	O
were	O
made	O
with	O
a	O
Hemorheometer	O
,	O
which	O
uses	O
the	O
"	O
initial	O
flow	O
rate	O
"	O
principle	O
.	O

Patients	O
with	O
severe	O
retinopathy	O
also	O
had	O
significantly	O
increased	O
IR	O
,	O
in	O
comparison	O
to	O
those	O
with	O
or	O
without	O
mild	O
retinopathy	O
.	O

C	O
.	O
elegans	O
EGL	B-Biological_Molecule
-	I-Biological_Molecule
9	E-Biological_Molecule
and	O
mammalian	O
homologs	O
define	O
a	O
family	O
of	O
dioxygenases	O
that	O
regulate	O
HIF	O
by	O
prolyl	O
hydroxylation	O
.	O

This	O
mutated	O
VR1	S-Biological_Molecule
was	O
not	O
glycosylated	O
,	O
confirming	O
the	O
extracellular	O
location	O
of	O
N604	O
and	O
its	O
role	O
as	O
the	O
exclusive	O
site	O
of	O
glycosylation	O
of	O
the	O
VR1	S-Biological_Molecule
protein	O
.	O

In	O
the	O
light	O
of	O
conflicting	O
literature	O
data	O
on	O
biochemical	O
characteristics	O
of	O
VR1	S-Biological_Molecule
,	O
our	O
data	O
suggest	O
that	O
dorsal	O
root	O
ganglion	O
-	O
derived	O
F	O
-	O
11	O
cells	O
provide	O
a	O
powerful	O
experimental	O
system	O
for	O
the	O
study	O
of	O
VR1	S-Biological_Molecule
biochemistry	O
.	O

Since	O
its	O
discovery	O
,	O
methylation	O
of	O
DNA	O
in	O
mammalian	O
cells	O
has	O
been	O
correlated	O
with	O
transcriptional	O
repression	O
and	O
with	O
specialized	O
chromatin	O
structures	O
.	O

Null	O
mutations	O
have	O
been	O
generated	O
in	O
mice	O
for	O
several	O
MBD	O
family	O
members	O
,	O
the	O
phenotypes	O
of	O
the	O
mutant	O
animals	O
raise	O
important	O
questions	O
regarding	O
the	O
functions	O
of	O
the	O
MBD	O
family	O
.	O

Molecular	O
and	O
immunohistochemical	O
study	O
of	O
the	O
inactivation	O
of	O
the	O
p16	S-Biological_Molecule
gene	O
in	O
primary	O
hepatocellular	O
carcinoma	O
.	O

Previous	O
patho	O
-	O
epidemiological	O
studies	O
indicated	O
that	O
thyroid	O
lymphoma	O
(	O
TL	O
)	O
evolves	O
among	O
active	O
lymphoid	O
cells	O
in	O
chronic	O
lymphocytic	O
thyroiditis	O
(	O
CLTH	O
)	O
.	O

Frequency	O
of	O
methylation	O
was	O
higher	O
in	O
B	O
-	O
cell	O
(	O
27	O
of	O
34	O
,	O
79	O
.	O
4	O
%	O
)	O
than	O
in	O
T	O
-	O
cell	O
malignancies	O
(	O
eight	O
of	O
16	O
,	O
50	O
%	O
)	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Isoniazid	O
is	O
the	O
major	O
drug	O
incriminated	O
in	O
this	O
hepatotoxicity	O
.	O

Univariate	O
analysis	O
and	O
logistic	O
regression	O
analysis	O
were	O
used	O
to	O
evaluate	O
the	O
risk	O
factors	O
of	O
isoniazid	O
-	O
induced	O
hepatitis	O
.	O

The	O
current	O
study	O
was	O
designed	O
to	O
shed	O
light	O
on	O
the	O
question	O
whether	O
the	O
multiple	O
X	O
chromosomes	O
in	O
testicular	O
germ	O
cell	O
tumor	O
are	O
active	O
or	O
inactive	O
through	O
a	O
complex	O
mechanism	O
of	O
X	O
chromosomal	O
gain	O
and	O
XIST	S-Biological_Molecule
expression	O
.	O

Bisulfite	O
genomic	O
sequencing	O
was	O
used	O
to	O
analyze	O
the	O
methylation	O
patterns	O
of	O
the	O
AR	S-Biological_Molecule
,	O
FMR1	S-Biological_Molecule
and	O
GPC3	S-Biological_Molecule
genes	O
.	O

CONCLUSIONS	O
:	O
The	O
current	O
data	O
may	O
suggest	O
the	O
potential	O
oncogenic	O
implications	O
of	O
X	O
chromosomal	O
gain	O
in	O
testicular	O
germ	O
cell	O
tumors	O
.	O

They	O
displayed	O
a	O
reasonably	O
high	O
degree	O
(	O
74	O
-	O
94	O
,	O
85	O
-	O
93	O
,	O
75	O
-	O
91	O
%	O
,	O
for	O
alpha	O
,	O
FSH	B-Biological_Molecule
beta	E-Biological_Molecule
and	O
LH	B-Biological_Molecule
beta	E-Biological_Molecule
subunits	O
,	O
respectively	O
)	O
of	O
identity	O
when	O
deduced	O
amino	O
acids	O
were	O
compared	O
with	O
homologous	O
sequences	O
from	O
partial	O
available	O
mammals	O
including	O
human	O
,	O
cattle	O
,	O
sheep	O
,	O
pig	O
,	O
rat	O
,	O
mouse	O
.	O

These	O
culture	O
experiments	O
support	O
the	O
idea	O
that	O
a	O
gonadal	O
environment	O
is	O
not	O
required	O
for	O
demethylation	O
of	O
the	O
region	O
in	O
at	O
least	O
a	O
fraction	O
of	O
PGCs	O
.	O

Inhibition	O
of	O
complex	O
glycosylation	O
increases	O
the	O
formation	O
of	O
PrPsc	S-Biological_Molecule
.	O

The	O
Xenopus	O
laevis	O
egg	O
vitelline	O
envelope	O
is	O
composed	O
of	O
five	O
glycoproteins	O
(	O
ZPA	S-Biological_Molecule
,	O
ZPB	S-Biological_Molecule
,	O
ZPC	S-Biological_Molecule
,	O
ZPD	S-Biological_Molecule
,	O
and	O
ZPX	S-Biological_Molecule
)	O
.	O

The	O
N	O
-	O
linked	O
glycans	O
of	O
the	O
VE	O
were	O
composed	O
predominantly	O
of	O
a	O
heterogeneous	O
mixture	O
of	O
high	O
-	O
mannose	O
(	O
5	O
-	O
9	O
)	O
and	O
neutral	O
,	O
complex	O
oligosaccharides	O
primarily	O
derived	O
from	O
ZPC	S-Biological_Molecule
(	O
the	O
dominant	O
glycoprotein	O
)	O
.	O

The	O
consensus	O
sequence	O
for	O
N	O
-	O
linked	O
glycosylation	O
at	O
the	O
evolutionarily	O
conserved	O
residue	O
N113	O
of	O
the	O
ZPC	S-Biological_Molecule
protein	O
sequence	O
was	O
glycosylated	O
solely	O
with	O
high	O
-	O
mannose	O
oligosaccharides	O
.	O

Further	O
,	O
peptide	O
N	O
-	O
glycohydrolase	O
F	O
and	O
endo	B-Biological_Molecule
-	I-Biological_Molecule
alpha	I-Biological_Molecule
-	I-Biological_Molecule
N	I-Biological_Molecule
-	I-Biological_Molecule
acetylgalactosaminidase	E-Biological_Molecule
,	O
which	O
are	O
specific	O
for	O
the	O
cleavage	O
of	O
N	O
-	O
glycan	O
and	O
O	O
-	O
glycan	O
linkages	O
,	O
respectively	O
,	O
in	O
glycoproteins	O
were	O
used	O
.	O

Pretreatment	O
with	O
either	O
of	O
them	O
also	O
reduced	O
both	O
PGD2	O
and	O
PGE2	O
binding	O
activities	O
.	O

The	O
reduction	O
was	O
dependent	O
on	O
the	O
pretreatment	O
time	O
and	O
enzyme	O
concentration	O
.	O

Moreover	O
,	O
pretreatment	O
with	O
TSA	O
also	O
increased	O
VP	O
-	O
16	O
-	O
induced	O
apoptosis	O
in	O
a	O
p53	S-Biological_Molecule
-	O
dependent	O
and	O
-	O
independent	O
manner	O
.	O

Suv39h1	S-Biological_Molecule
and	O
Suv39h2	S-Biological_Molecule
govern	O
methylation	O
of	O
histone	B-Biological_Molecule
H3	E-Biological_Molecule
Lys9	O
(	O
H3	S-Biological_Molecule
-	O
Lys9	O
)	O
in	O
heterochromatic	O
regions	O
.	O

Using	O
chromatin	O
immunoprecipitation	O
(	O
ChIP	O
)	O
analysis	O
,	O
we	O
found	O
that	O
telomeres	O
were	O
enriched	O
in	O
di	O
-	O
and	O
trimethylated	O
H3	S-Biological_Molecule
-	O
Lys9	O
but	O
that	O
telomeres	O
of	O
SUV39DN	O
cells	O
had	O
less	O
dimethylated	O
and	O
trimethylated	O
H3	S-Biological_Molecule
-	O
Lys9	O
but	O
more	O
monomethylated	O
H3	S-Biological_Molecule
-	O
Lys9	O
.	O

The	O
structure	O
of	O
Tokyo	O
V	O
fibrin	O
appeared	O
severely	O
perturbed	O
,	O
since	O
there	O
are	O
large	O
pores	O
inside	O
the	O
tangled	O
fibrin	O
networks	O
and	O
fiber	O
ends	O
at	O
the	O
boundaries	O
.	O

This	O
tool	O
allowed	O
rapid	O
visualization	O
of	O
the	O
two	O
distinctive	O
patterns	O
of	O
sequon	O
variation	O
found	O
in	O
HIV	O
-	O
1	O
,	O
HIV	O
-	O
2	O
,	O
and	O
SIV	O
CPZ	O
.	O

The	O
second	O
pattern	O
(	O
shifting	O
)	O
refers	O
to	O
sites	O
embedded	O
in	O
regions	O
of	O
extreme	O
local	O
length	O
variation	O
and	O
is	O
characterized	O
by	O
shifts	O
in	O
terms	O
of	O
the	O
relative	O
position	O
and	O
local	O
density	O
of	O
sequons	O
;	O
these	O
sites	O
tend	O
to	O
be	O
populated	O
by	O
complex	O
carbohydrates	O
.	O

The	O
results	O
indicate	O
that	O
reducing	O
conditions	O
,	O
achieved	O
using	O
N	O
-	O
propylgallate	O
(	O
nPG	O
)	O
or	O
N	O
-	O
acetylcysteine	O
(	O
NAC	O
)	O
,	O
stabilize	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
,	O
facilitate	O
its	O
DNA	O
binding	O
,	O
and	O
increase	O
its	O
phosphorylation	O
even	O
under	O
normal	O
oxygen	O
conditions	O
.	O

Hypoxia	O
-	O
inducible	O
factor	O
-	O
1	O
(	O
HIF	O
-	O
1	O
)	O
is	O
a	O
master	O
regulator	O
of	O
cellular	O
adaptive	O
responses	O
to	O
hypoxia	O
.	O

We	O
demonstrate	O
that	O
muscarinic	O
acetylcholine	O
signals	O
induce	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
expression	O
and	O
transcriptional	O
activity	O
in	O
a	O
receptor	O
subtype	O
-	O
specific	O
manner	O
using	O
HEK293	O
cells	O
transiently	O
overexpressing	O
each	O
of	O
M1	S-Biological_Molecule
-	O
M4	B-Biological_Molecule
muscarinic	I-Biological_Molecule
acetylcholine	I-Biological_Molecule
receptors	E-Biological_Molecule
.	O

The	O
object	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
effect	O
of	O
elevated	O
in	O
vitro	O
glucose	O
concentrations	O
on	O
protein	O
modification	O
and	O
functional	O
changes	O
in	O
human	O
erythrocytes	O
.	O

At	O
24	O
h	O
,	O
a	O
significant	O
protein	O
oxidation	O
(	O
at	O
25	O
and	O
45	O
mM	O
glucose	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
and	O
G	O
-	O
actin	O
increase	O
was	O
observed	O
for	O
all	O
concentrations	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Accumulating	O
evidence	O
indicates	O
that	O
aberrant	O
activation	O
of	O
androgen	B-Biological_Molecule
receptor	E-Biological_Molecule
(	O
AR	S-Biological_Molecule
)	O
via	O
signal	O
transduction	O
pathways	O
,	O
AR	S-Biological_Molecule
gene	O
mutation	O
and	O
/	O
or	O
amplification	O
,	O
and	O
/	O
or	O
coregulator	O
alterations	O
may	O
contribute	O
to	O
the	O
progression	O
of	O
prostate	O
cancer	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
effects	O
of	O
protein	O
kinase	O
A	O
(	O
PKA	O
)	O
signaling	O
and	O
its	O
downstream	O
factors	O
on	O
AR	S-Biological_Molecule
activity	O
at	O
the	O
prostate	B-Biological_Molecule
-	I-Biological_Molecule
specific	I-Biological_Molecule
antigen	E-Biological_Molecule
(	O
PSA	S-Biological_Molecule
)	O
gene	O
were	O
tested	O
.	O

Remarkably	O
,	O
mammalian	O
two	O
-	O
hybrid	O
assay	O
indicated	O
that	O
p300	S-Biological_Molecule
/	O
CBP	S-Biological_Molecule
may	O
bridge	O
the	O
interaction	O
between	O
AR	S-Biological_Molecule
and	O
CREB	O
,	O
suggesting	O
a	O
novel	O
enhanceosomal	O
cooperation	O
.	O

In	O
this	O
work	O
,	O
basidiomycetous	O
yeasts	O
belonging	O
to	O
Pseudozyma	O
spp	O
.	O
were	O
studied	O
with	O
respect	O
to	O
their	O
amenability	O
to	O
heterologous	O
protein	O
production	O
.	O

Single	O
plasmid	O
or	O
cotransformation	O
experiments	O
routinely	O
afforded	O
100	O
to	O
200	O
independent	O
transformants	O
for	O
the	O
two	O
tested	O
species	O
of	O
Pseudozyma	O
.	O

N	O
-	O
glycosylation	O
patterns	O
of	O
native	O
Pseudozyma	O
flocculosa	O
secreted	O
proteins	O
were	O
comprised	O
of	O
one	O
or	O
a	O
few	O
short	O
glycan	O
chains	O
that	O
possess	O
a	O
classic	O
eukaryotic	O
structure	O
typical	O
of	O
higher	O
fungi	O
and	O
animal	O
cells	O
.	O

These	O
results	O
suggest	O
that	O
the	O
binding	O
of	O
hydroxylated	O
lecithin	O
to	O
unfolded	O
monomers	O
or	O
intermediate	O
products	O
of	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
lg	E-Biological_Molecule
reduces	O
the	O
extent	O
of	O
heat	O
-	O
induced	O
aggregation	O
of	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
lg	E-Biological_Molecule
and	O
consequently	O
decreases	O
the	O
interactions	O
between	O
unadsorbed	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
lg	E-Biological_Molecule
and	O
adsorbed	O
protein	O
.	O

In	O
the	O
presence	O
of	O
oxygen	O
,	O
HIFalpha	O
family	O
members	O
are	O
hydroxylated	O
on	O
one	O
of	O
two	O
conserved	O
prolyl	O
residues	O
by	O
members	O
of	O
the	O
egg	O
-	O
laying	O
-	O
defective	O
nine	O
(	O
EGLN	O
)	O
family	O
.	O

Together	O
,	O
these	O
findings	O
demonstrate	O
that	O
each	O
hydroxylated	O
proline	O
of	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
has	O
a	O
distinct	O
activity	O
in	O
controlling	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
stability	O
in	O
response	O
to	O
different	O
levels	O
of	O
oxygenation	O
.	O

Is	O
this	O
position	O
equally	O
important	O
for	O
enhancement	O
of	O
both	O
enzyme	O
activities	O
?	O

This	O
provides	O
evidence	O
that	O
H3K36me2	S-Biological_Molecule
is	O
established	O
during	O
the	O
initial	O
instances	O
of	O
gene	O
transcription	O
,	O
with	O
subsequent	O
transcription	O
having	O
at	O
most	O
a	O
maintenance	O
role	O
.	O

However	O
,	O
two	O
centres	O
inappropriately	O
excluded	O
macroprolactinaemia	O
as	O
the	O
cause	O
of	O
the	O
elevated	O
prolactin	S-Biological_Molecule
,	O
and	O
a	O
further	O
two	O
did	O
not	O
consider	O
it	O
at	O
all	O
.	O

A	O
65	O
-	O
kd	O
band	O
,	O
attributed	O
in	O
part	O
to	O
inactive	O
AChE	S-Biological_Molecule
,	O
was	O
increased	O
as	O
became	O
the	O
most	O
abundant	O
AChE	S-Biological_Molecule
subunit	O
in	O
BDL	O
liver	O
.	O

Epigenetic	O
modifications	O
such	O
as	O
DNA	O
methylation	O
and	O
changes	O
in	O
chromatin	O
structure	O
are	O
changes	O
in	O
the	O
chemical	O
composition	O
or	O
structure	O
of	O
DNA	O
that	O
work	O
by	O
regulating	O
gene	O
expression	O
.	O

Additionally	O
,	O
we	O
mapped	O
the	O
region	O
of	O
Yng1p	S-Biological_Molecule
required	O
for	O
overexpression	O
of	O
toxicity	O
to	O
the	O
PHD	O
finger	O
,	O
showed	O
that	O
this	O
region	O
capable	O
of	O
binding	O
lysine	O
4	O
-	O
methylated	O
histone	B-Biological_Molecule
H3	E-Biological_Molecule
in	O
vitro	O
,	O
and	O
demonstrated	O
that	O
mutations	O
of	O
the	O
PHD	O
finger	O
that	O
abolish	O
binding	O
in	O
vitro	O
are	O
no	O
longer	O
toxic	O
in	O
vivo	O
.	O

Interaction	O
of	O
HIV	O
-	O
1	O
with	O
dendritic	B-Biological_Molecule
cell	I-Biological_Molecule
-	I-Biological_Molecule
specific	I-Biological_Molecule
intercellular	I-Biological_Molecule
adhesion	I-Biological_Molecule
molecule	I-Biological_Molecule
-	I-Biological_Molecule
3	I-Biological_Molecule
-	I-Biological_Molecule
grabbing	I-Biological_Molecule
nonintegrin	E-Biological_Molecule
-	O
expressing	O
cells	O
is	O
influenced	O
by	O
gp120	S-Biological_Molecule
envelope	O
modifications	O
associated	O
with	O
disease	O
progression	O
.	O

These	O
results	O
indicate	O
that	O
the	O
interaction	O
between	O
HIV	O
-	O
1	O
and	O
immature	O
dendritic	O
cells	O
via	O
such	O
molecules	O
as	O
dendritic	B-Biological_Molecule
cell	I-Biological_Molecule
-	I-Biological_Molecule
specific	I-Biological_Molecule
intercellular	I-Biological_Molecule
adhesion	I-Biological_Molecule
molecule	I-Biological_Molecule
-	I-Biological_Molecule
3	I-Biological_Molecule
-	I-Biological_Molecule
grabbing	I-Biological_Molecule
nonintegrin	E-Biological_Molecule
may	O
have	O
a	O
role	O
in	O
selecting	O
viruses	O
undergoing	O
transmission	O
and	O
evolution	O
during	O
disease	O
progression	O
.	O

Hypoxia	B-Biological_Molecule
-	I-Biological_Molecule
inducible	I-Biological_Molecule
transcription	I-Biological_Molecule
factor	I-Biological_Molecule
1alpha	E-Biological_Molecule
(	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
)	O
is	O
a	O
key	O
player	O
in	O
the	O
response	O
to	O
hypoxia	O
.	O

Aberrant	O
hypermethylation	O
of	O
p14ARF	S-Biological_Molecule
and	O
O6	B-Biological_Molecule
-	I-Biological_Molecule
methylguanine	I-Biological_Molecule
-	I-Biological_Molecule
DNA	I-Biological_Molecule
methyltransferase	E-Biological_Molecule
genes	O
in	O
astrocytoma	O
progression	O
.	O

Mechanisms	O
of	O
ceramide	O
-	O
mediated	O
repression	O
of	O
the	O
human	O
telomerase	B-Biological_Molecule
reverse	I-Biological_Molecule
transcriptase	E-Biological_Molecule
promoter	O
via	O
deacetylation	O
of	O
Sp3	S-Biological_Molecule
by	O
histone	B-Biological_Molecule
deacetylase	I-Biological_Molecule
1	E-Biological_Molecule
.	O

Adenoma	O
and	O
early	O
tumor	O
Stage	O
I	O
(	O
International	O
Union	O
Against	O
Cancer	O
)	O
displayed	O
both	O
unmethylated	O
and	O
methylated	O
secreted	B-Biological_Molecule
frizzled	I-Biological_Molecule
-	I-Biological_Molecule
related	I-Biological_Molecule
protein	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
promoter	O
sequences	O
,	O
whereas	O
advanced	O
tumor	O
stages	O
showed	O
only	O
methylated	O
secreted	B-Biological_Molecule
frizzled	I-Biological_Molecule
-	I-Biological_Molecule
related	I-Biological_Molecule
protein	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
(	O
P	O
=	O
0	O
.	O
05	O
)	O
.	O

In	O
developing	O
porcine	O
enamel	O
,	O
the	O
space	O
between	O
enamel	O
rods	O
selectively	O
binds	O
lectins	O
and	O
ameloblastin	S-Biological_Molecule
(	O
Ambn	S-Biological_Molecule
)	O
N	O
-	O
terminal	O
antibodies	O
.	O

As	O
a	O
model	O
for	O
understanding	O
this	O
variation	O
,	O
we	O
characterized	O
natural	O
resistance	O
to	O
hypostatin	O
,	O
a	O
new	O
inhibitor	O
of	O
cell	O
expansion	O
.	O

This	O
in	O
turn	O
up	O
-	O
regulates	O
epidermal	B-Biological_Molecule
growth	I-Biological_Molecule
factor	I-Biological_Molecule
receptor	E-Biological_Molecule
(	O
EGFR	S-Biological_Molecule
)	O
signaling	O
to	O
mediate	O
Src	S-Biological_Molecule
activation	O
,	O
leading	O
to	O
E	B-Biological_Molecule
-	I-Biological_Molecule
cadherin	E-Biological_Molecule
ubiquitination	O
and	O
lysosomal	O
degradation	O
.	O

The	O
histone	S-Biological_Molecule
-	O
like	O
NF	O
-	O
Y	O
is	O
a	O
bifunctional	O
transcription	O
factor	O
.	O

Unbiased	O
identification	O
of	O
binding	O
sites	O
shows	O
that	O
the	O
majority	O
of	O
genes	O
are	O
bound	O
by	O
NF	O
-	O
Y	O
in	O
the	O
promoter	O
and	O
/	O
or	O
within	O
the	O
coding	O
region	O
.	O

Our	O
results	O
suggest	O
that	O
S3	O
and	O
S4	O
charged	O
amino	O
acids	O
play	O
an	O
evolutionarily	O
conserved	O
role	O
in	O
the	O
biogenesis	O
and	O
gating	O
of	O
KCa	O
channels	O
.	O

Characterization	O
of	O
the	O
molecular	O
interaction	O
between	O
tropoelastin	S-Biological_Molecule
and	O
DANCE	S-Biological_Molecule
/	O
fibulin	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
.	O

Fibulin	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
is	O
believed	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
elastic	O
fiber	O
formation	O
.	O

These	O
results	O
suggested	O
that	O
the	O
whole	O
molecule	O
of	O
tropoelastin	S-Biological_Molecule
was	O
required	O
for	O
the	O
interaction	O
with	O
fibulin	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
.	O

To	O
further	O
understand	O
cellular	O
mechanisms	O
of	O
TRB3	S-Biological_Molecule
regulation	O
,	O
we	O
performed	O
a	O
yeast	O
two	O
-	O
hybrid	O
screen	O
to	O
identify	O
novel	O
TRB3	O
interacting	O
proteins	O
and	O
totally	O
obtained	O
ten	O
in	O
-	O
frame	O
fused	O
preys	O
.	O

SIAH1	S-Biological_Molecule
could	O
interact	O
with	O
TRB3	S-Biological_Molecule
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Histone	B-Biological_Molecule
deacetylase	I-Biological_Molecule
3	E-Biological_Molecule
(	O
HDAC3	S-Biological_Molecule
)	O
is	O
a	O
highly	O
conserved	O
,	O
ubiquitously	O
expressed	O
protein	O
that	O
forms	O
multiprotein	O
corepressor	O
complexes	O
to	O
repress	O
gene	O
transcription	O
.	O

Treatment	O
of	O
mitotic	O
cells	O
with	O
Trichostatin	O
A	O
,	O
an	O
HDAC	O
inhibitor	O
,	O
resulted	O
in	O
similar	O
spindle	O
defects	O
independent	O
of	O
transcriptional	O
regulation	O
.	O

Together	O
,	O
our	O
data	O
revealed	O
a	O
novel	O
regulatory	O
mechanism	O
for	O
the	O
tumor	O
suppressor	O
function	O
of	O
Merlin	S-Biological_Molecule
.	O

Enzymatic	O
mechanism	O
and	O
product	O
specificity	O
of	O
SET	O
-	O
domain	O
protein	O
lysine	O
methyltransferases	O
.	O

Overexpression	O
of	O
wild	O
-	O
type	O
Cdc34p	S-Biological_Molecule
,	O
but	O
not	O
that	O
of	O
an	O
E2	O
-	O
defective	O
mutant	O
of	O
Cdc34p	S-Biological_Molecule
,	O
increased	O
repRNA	O
accumulation	O
,	O
suggesting	O
a	O
significant	O
role	O
for	O
the	O
ubiquitin	S-Biological_Molecule
-	O
conjugating	O
enzyme	O
function	O
of	O
Cdc34p	S-Biological_Molecule
in	O
TBSV	O
replication	O
.	O

Also	O
,	O
Cdc34p	S-Biological_Molecule
was	O
able	O
to	O
ubiquitinate	O
p33	S-Biological_Molecule
in	O
vitro	O
.	O

Ependymomas	O
are	O
the	O
third	O
most	O
common	O
brain	O
tumor	O
in	O
children	O
.	O

We	O
evaluated	O
the	O
MGMT	S-Biological_Molecule
gene	O
promoter	O
methylation	O
and	O
the	O
immunohistochemical	O
MGMT	S-Biological_Molecule
protein	O
expression	O
in	O
12	O
recurrent	O
anaplastic	O
ependymomas	O
affecting	O
children	O
.	O

In	O
this	O
review	O
,	O
we	O
summarize	O
recent	O
reports	O
on	O
targeting	O
the	O
aggresome	O
pathway	O
and	O
HDAC6	S-Biological_Molecule
in	O
hematologic	O
malignancies	O
.	O

The	O
S	O
-	O
P	O
-	O
A	O
motif	O
and	O
other	O
specificity	O
determinants	O
define	O
the	O
set	O
of	O
cognate	O
E2	O
enzymes	O
for	O
CHIP	S-Biological_Molecule
,	O
which	O
likely	O
includes	O
several	O
Class	O
III	O
E2	O
enzymes	O
.	O

Regulation	O
of	O
Nedd4	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
self	O
-	O
ubiquitination	O
and	O
stability	O
by	O
a	O
PY	O
motif	O
located	O
within	O
its	O
HECT	O
-	O
domain	O
.	O

On	O
the	O
other	O
hand	O
,	O
while	O
reaction	O
with	O
peanut	O
agglutinin	S-Biological_Molecule
(	O
PNA	S-Biological_Molecule
)	O
,	O
which	O
specific	O
for	O
core	O
disaccharide	O
galactose	O
beta	O
(	O
1	O
-	O
-	O
>	O
3	O
)	O
N	O
-	O
acetylgalactosamine	O
,	O
was	O
only	O
seen	O
in	O
cortical	O
thymocytes	O
,	O
reaction	O
with	O
Galanthus	O
nivalis	O
agglutinin	S-Biological_Molecule
(	O
GNA	S-Biological_Molecule
)	O
,	O
which	O
specific	O
for	O
terminal	O
mannose	O
residues	O
,	O
was	O
seen	O
in	O
both	O
cortex	O
and	O
medulla	O
.	O

Residues	O
encoded	O
by	O
the	O
3	O
'	O
end	O
of	O
the	O
exon	O
specify	O
FMRP	O
'	O
s	O
RGG	O
box	O
,	O
an	O
RNA	O
binding	O
domain	O
that	O
interacts	O
with	O
G	O
-	O
quartet	O
motifs	O
.	O

In	O
the	O
Ex15c	O
variant	O
the	O
first	O
strand	O
of	O
this	O
sheet	O
is	O
truncated	O
,	O
and	O
this	O
significantly	O
perturbs	O
the	O
side	O
-	O
chain	O
conformations	O
of	O
the	O
arginine	O
residues	O
in	O
the	O
RG	O
-	O
rich	O
region	O
.	O

These	O
effects	O
are	O
not	O
due	O
to	O
the	O
loss	O
of	O
R	O
507	O
methylation	O
as	O
a	O
conformational	O
switch	O
-	O
containing	O
peptide	O
reacted	O
under	O
substrate	O
excess	O
and	O
in	O
methyl	O
donor	O
excess	O
was	O
not	O
significantly	O
methylated	O
.	O

OBJECTIVES	O
:	O
The	O
goal	O
of	O
the	O
present	O
work	O
was	O
to	O
identify	O
a	O
potent	O
Nrf2	S-Biological_Molecule
activator	O
from	O
plants	O
as	O
a	O
chemopreventive	O
compound	O
and	O
to	O
demonstrate	O
the	O
efficacy	O
of	O
the	O
compound	O
in	O
battling	O
arsenic	O
-	O
induced	O
toxicity	O
.	O

Informatic	O
analysis	O
of	O
the	O
P	O
.	O
syringae	O
genome	O
suggests	O
only	O
one	O
putative	O
non	O
-	O
heme	O
iron	O
hydroxylase	O
,	O
AspH	S-Biological_Molecule
.	O

CHIP	S-Biological_Molecule
interacts	O
with	O
iNOS	S-Biological_Molecule
and	O
promotes	O
its	O
ubiquitination	O
and	O
degradation	O
by	O
the	O
proteasome	O
as	O
well	O
as	O
its	O
sequestration	O
to	O
the	O
aggresome	O
.	O

STAT1	S-Biological_Molecule
acetylation	O
induces	O
binding	O
of	O
TCP45	S-Biological_Molecule
,	O
which	O
catalyzes	O
dephosphorylation	O
and	O
latency	O
of	O
STAT1	S-Biological_Molecule
.	O

We	O
also	O
highlight	O
unresolved	O
problems	O
in	O
this	O
area	O
,	O
including	O
the	O
question	O
of	O
how	O
a	O
particular	O
steady	O
-	O
state	O
level	O
of	O
untargeted	O
acetylation	O
is	O
set	O
in	O
the	O
absence	O
of	O
cis	O
-	O
dependent	O
mechanisms	O
that	O
instruct	O
the	O
activity	O
of	O
KATs	O
and	O
HDACs	O
.	O

Taken	O
together	O
,	O
we	O
propose	O
that	O
Hdm2	S-Biological_Molecule
is	O
a	O
Ku70	S-Biological_Molecule
Ub	S-Biological_Molecule
ligase	O
and	O
that	O
Akt	O
inhibits	O
Bax	S-Biological_Molecule
-	O
mediated	O
apoptosis	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
maintaining	O
Ku70	S-Biological_Molecule
levels	O
through	O
the	O
promotion	O
of	O
Hdm2	S-Biological_Molecule
nuclear	O
translocation	O
.	O

Virus	O
infection	O
induces	O
host	O
antiviral	O
responses	O
including	O
induction	O
of	O
type	O
I	O
IFNs	O
.	O

Mutation	O
of	O
p65	S-Biological_Molecule
at	O
Ser468	O
largely	O
prevents	O
p65	S-Biological_Molecule
ubiquitination	O
and	O
proteasomal	O
degradation	O
.	O

These	O
data	O
suggest	O
that	O
MDM2	S-Biological_Molecule
acts	O
as	O
an	O
ubiquitin	S-Biological_Molecule
E3	O
ligase	O
,	O
downstream	O
of	O
p53	S-Biological_Molecule
,	O
to	O
regulate	O
the	O
degradation	O
of	O
mammalian	O
FOXO	O
factors	O
.	O

The	O
analysis	O
of	O
chimeric	O
proteins	O
with	O
various	O
N	O
-	O
terminal	O
segments	O
of	O
histone	B-Biological_Molecule
H4	E-Biological_Molecule
fused	O
to	O
iso	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
-	I-Biological_Molecule
cytochrome	I-Biological_Molecule
c	E-Biological_Molecule
revealed	O
that	O
efficient	O
acetylation	O
by	O
NatD	S-Biological_Molecule
required	O
at	O
least	O
30	O
to	O
50	O
amino	O
acid	O
residues	O
of	O
the	O
N	O
terminus	O
of	O
histone	B-Biological_Molecule
H4	E-Biological_Molecule
.	O

A	O
battery	O
of	O
acute	O
-	O
phase	O
genes	O
(	O
eg	O
C	B-Biological_Molecule
-	I-Biological_Molecule
reactive	I-Biological_Molecule
protein	E-Biological_Molecule
and	O
haptoglobin	S-Biological_Molecule
)	O
induced	O
by	O
cytokine	O
exposure	O
was	O
repressed	O
by	O
AHR	S-Biological_Molecule
activation	O
in	O
mouse	O
hepatocytes	O
.	O

This	O
process	O
is	O
initiated	O
by	O
a	O
family	O
of	O
mechanistically	O
and	O
structurally	O
related	O
E1	O
(	O
or	O
activating	O
)	O
enzymes	O
.	O

A	O
broad	O
understanding	O
of	O
how	O
E1	O
enzymes	O
activate	O
UBLs	O
and	O
how	O
they	O
selectively	O
coordinate	O
UBLs	O
with	O
downstream	O
function	O
has	O
come	O
from	O
enzymatic	O
,	O
structural	O
and	O
genetic	O
studies	O
.	O

We	O
found	O
that	O
AA	O
exposure	O
results	O
in	O
a	O
concentration	O
-	O
dependent	O
increase	O
in	O
FANCD2	S-Biological_Molecule
monoubiquitination	O
,	O
which	O
is	O
dependent	O
upon	O
the	O
FANC	O
core	O
complex	O
.	O

Like	O
several	O
other	O
intracellular	O
pathogens	O
,	O
Mycobacterium	O
marinum	O
(	O
Mm	O
)	O
escapes	O
from	O
phagosomes	O
into	O
the	O
host	O
cytosol	O
where	O
it	O
can	O
polymerize	O
actin	O
,	O
leading	O
to	O
motility	O
that	O
promotes	O
spread	O
to	O
neighboring	O
cells	O
.	O

Hypothalamic	O
sections	O
of	O
4	O
subjects	O
with	O
narcolepsy	O
and	O
5	O
nonneurologic	O
controls	O
were	O
examined	O
immunohistochemically	O
with	O
antibodies	O
against	O
ubiquitin	S-Biological_Molecule
(	O
a	O
marker	O
of	O
aggregated	O
protein	O
)	O
,	O
allograft	B-Biological_Molecule
inflammatory	I-Biological_Molecule
factor	I-Biological_Molecule
1	E-Biological_Molecule
(	O
AIF1	S-Biological_Molecule
,	O
a	O
microglial	O
activation	O
marker	O
)	O
,	O
glial	B-Biological_Molecule
fibrillary	I-Biological_Molecule
acidic	I-Biological_Molecule
protein	E-Biological_Molecule
(	O
GFAP	S-Biological_Molecule
,	O
a	O
reactive	O
astrocytic	O
marker	O
)	O
,	O
and	O
hypocretin	S-Biological_Molecule
.	O

Further	O
,	O
we	O
noted	O
that	O
even	O
in	O
patients	O
with	O
dementia	O
neuropathology	O
,	O
the	O
lateral	O
hypothalamic	O
hypocretin	S-Biological_Molecule
area	O
was	O
spared	O
from	O
ubiquitinated	O
inclusions	O
.	O

USP2a	S-Biological_Molecule
mRNA	O
and	O
protein	O
levels	O
were	O
also	O
reduced	O
after	O
cisplatin	O
exposure	O
.	O

Prolyl	B-Biological_Molecule
3	I-Biological_Molecule
-	I-Biological_Molecule
hydroxylase	I-Biological_Molecule
1	E-Biological_Molecule
and	O
CRTAP	S-Biological_Molecule
are	O
mutually	O
stabilizing	O
in	O
the	O
endoplasmic	O
reticulum	O
collagen	O
prolyl	O
3	O
-	O
hydroxylation	O
complex	O
.	O

Neurons	O
communicate	O
with	O
each	O
other	O
through	O
synapses	O
.	O

The	O
ubiquitin	S-Biological_Molecule
-	O
proteasome	O
system	O
of	O
protein	O
degradation	O
is	O
one	O
of	O
the	O
critical	O
mechanisms	O
that	O
underlie	O
this	O
process	O
,	O
playing	O
crucial	O
roles	O
in	O
the	O
regulation	O
of	O
synaptic	O
structure	O
and	O
function	O
.	O

CUL4A	S-Biological_Molecule
and	O
B	S-Biological_Molecule
encode	O
subunits	O
of	O
E3	O
-	O
ubiquitin	S-Biological_Molecule
ligases	O
implicated	O
in	O
diverse	O
processes	O
including	O
nucleotide	O
excision	O
repair	O
,	O
regulating	O
gene	O
expression	O
and	O
controlling	O
DNA	O
replication	O
fork	O
licensing	O
.	O

The	O
migration	O
level	O
of	O
ECs	O
co	O
-	O
cultured	O
with	O
VSMCs	O
under	O
NSS	O
was	O
not	O
higher	O
than	O
that	O
under	O
the	O
static	O
condition	O
.	O

It	O
was	O
observed	O
by	O
immunofluorescence	O
staining	O
that	O
the	O
acetylated	O
tubulin	O
was	O
distributed	O
mostly	O
around	O
the	O
cell	O
nucleus	O
in	O
ECs	O
co	O
-	O
cultured	O
with	O
VSMCs	O
.	O

Expression	O
of	O
the	O
T	O
-	O
cell	O
receptor	O
(	O
TCR	O
)	O
:	O
CD3	O
complex	O
is	O
tightly	O
regulated	O
during	O
T	O
-	O
cell	O
development	O
.	O

Specifically	O
data	O
from	O
a	O
number	O
of	O
systems	O
suggests	O
that	O
sequences	O
within	O
the	O
C	O
-	O
terminal	O
CAP	O
domain	O
of	O
CAP	O
proteins	O
have	O
the	O
ability	O
to	O
promote	O
cell	O
-	O
cell	O
adhesion	O
.	O

For	O
expression	O
,	O
H3K27me3	S-Biological_Molecule
marks	O
are	O
removed	O
and	O
replaced	O
by	O
TrxG	O
protein	O
catalysed	O
histone	O
H3	S-Biological_Molecule
-	O
Lys4	O
trimethylation	O
(	O
H3K4me3	S-Biological_Molecule
)	O
.	O

Brain	O
ischemia	O
limits	O
the	O
availability	O
not	O
only	O
of	O
oxygen	O
but	O
also	O
of	O
glucose	O
.	O

We	O
assessed	O
the	O
separate	O
involvement	O
of	O
oxygen	O
and	O
glucose	O
in	O
HIF1alpha	S-Biological_Molecule
regulation	O
in	O
differentiated	O
neuroblastoma	O
cells	O
subjected	O
to	O
ischemia	O
.	O

Regulated	O
degradation	O
of	O
spindle	O
assembly	O
factors	O
by	O
the	O
anaphase	O
-	O
promoting	O
complex	O
.	O

In	O
contrast	O
,	O
rat	O
urinary	O
kallikrein	O
released	O
77	O
%	O
as	O
bradykinin	S-Biological_Molecule
,	O
22	O
%	O
as	O
[	O
Hyp3	O
]	O
-	O
bradykinin	S-Biological_Molecule
and	O
negligible	O
amounts	O
of	O
[	O
Hyp3	O
]	O
-	O
Lys	O
-	O
bradykinin	S-Biological_Molecule
from	O
the	O
identical	O
substrate	O
source	O
indicating	O
that	O
rat	O
tissue	O
kallikreins	O
prefer	O
the	O
Lys	O
-	O
Arg	O
-	O
bond	O
within	O
both	O
unhydroxylated	O
and	O
hydroxylated	O
kininogens	S-Biological_Molecule
.	O

A	O
generational	O
variability	O
is	O
apparent	O
upon	O
continuous	O
culturing	O
of	O
the	O
same	O
hybridoma	O
.	O

Strikingly	O
,	O
examination	O
of	O
class	O
I	O
and	O
class	O
II	O
molecules	O
by	O
isoelectric	O
focusing	O
revealed	O
qualitative	O
differences	O
as	O
well	O
.	O

These	O
data	O
provide	O
the	O
first	O
direct	O
evidence	O
that	O
hydroxylation	O
of	O
procollagen	O
proline	O
residues	O
does	O
occur	O
on	O
nascent	O
chains	O
.	O

Approximately	O
25	O
%	O
of	O
the	O
radioactivity	O
associated	O
with	O
[	O
3H	O
]	O
proline	O
-	O
labeled	O
polysomes	O
was	O
in	O
fully	O
elongated	O
but	O
underhydroxylated	O
(	O
relative	O
to	O
secreted	O
procollagen	O
)	O
pro	O
-	O
alpha	O
-	O
chains	O
.	O

A	O
comparison	O
of	O
accessibility	O
of	O
ribosomal	O
proteins	O
on	O
free	O
and	O
membrane	O
-	O
bound	O
ribosomes	O
:	O
the	O
ribosomal	O
proteins	O
potentially	O
involved	O
in	O
ribosome	O
-	O
membrane	O
binding	O
.	O

The	O
mechanism	O
of	O
the	O
prolonged	O
stimulatory	O
influence	O
of	O
corticotropin	S-Biological_Molecule
(	O
ACTH	S-Biological_Molecule
)	O
on	O
the	O
capacity	O
of	O
adrenocortical	O
cells	O
to	O
produce	O
cortisol	O
in	O
response	O
to	O
ACTH	S-Biological_Molecule
and	O
more	O
specifically	O
the	O
role	O
of	O
11	O
beta	O
-	O
hydroxylation	O
,	O
was	O
studied	O
on	O
guinea	O
-	O
pig	O
adrenocortical	O
cells	O
dispersed	O
from	O
control	O
and	O
ACTH	S-Biological_Molecule
-	O
treated	O
animals	O
.	O

The	O
maximal	O
capacity	O
of	O
11	O
-	O
deoxycortisol	O
conversion	O
into	O
cortisol	O
was	O
increased	O
as	O
a	O
result	O
of	O
the	O
in	O
vivo	O
exposure	O
to	O
ACTH	S-Biological_Molecule
,	O
averaging	O
3423	O
+	O
/	O
-	O
211	O
ng	O
cortisol	O
formed	O
from	O
5	O
micrograms	O
11	O
-	O
deoxycortisol	O
by	O
10	O
(	O
5	O
)	O
cells	O
from	O
ACTH	S-Biological_Molecule
-	O
treated	O
animals	O
vs	O
2074	O
+	O
/	O
-	O
185	O
ng	O
for	O
cells	O
from	O
control	O
guinea	O
-	O
pigs	O
(	O
P	O
less	O
than	O
0	O
.	O
001	O
)	O
.	O

Pyridine	O
borane	O
has	O
been	O
reported	O
as	O
a	O
superior	O
reagent	O
over	O
a	O
wide	O
pH	O
range	O
,	O
5	O
-	O
9	O
,	O
for	O
the	O
reductive	O
methylation	O
of	O
amino	O
groups	O
of	O
proteins	O
with	O
formaldehyde	O
[	O
J	O
.	O
C	O
.	O
Cabacungan	O
,	O
A	O
.	O
I	O
.	O
Ahmed	O
,	O
and	O
R	O
.	O
E	O
.	O
Feeney	O
(	O
1982	O
)	O
Anal	O
.	O
Biochem	O
.	O
124	O
,	O
272	O
-	O
278	O
]	O
.	O

Second	O
,	O
cycloheximide	O
treatment	O
in	O
sheep	O
reduced	O
arylalkylamine	O
N	O
-	O
acetylation	O
at	O
night	O
to	O
one	O
-	O
tenth	O
control	O
values	O
,	O
without	O
altering	O
arylamine	O
N	O
-	O
acetylation	O
.	O

Each	O
repeat	O
contains	O
five	O
potential	O
sites	O
for	O
O	O
-	O
glycosylation	O
,	O
suggesting	O
that	O
this	O
region	O
forms	O
a	O
scaffold	O
for	O
the	O
attachment	O
of	O
the	O
O	O
-	O
linked	O
carbohydrate	O
which	O
makes	O
up	O
more	O
than	O
50	O
%	O
of	O
the	O
molecule	O
.	O

Moreover	O
,	O
regardless	O
of	O
the	O
two	O
insertion	O
points	O
in	O
the	O
alpha	O
-	O
subunit	O
,	O
the	O
CTP	O
sequence	O
was	O
O	O
-	O
glycosylated	O
.	O

Each	O
of	O
these	O
proteins	O
occurs	O
naturally	O
as	O
two	O
populations	O
of	O
molecules	O
,	O
distinguished	O
from	O
each	O
other	O
only	O
by	O
the	O
presence	O
or	O
absence	O
of	O
an	O
oligosaccharide	O
at	O
one	O
glycosylation	O
site	O
.	O

Production	O
of	O
vampire	O
bat	O
plasminogen	S-Biological_Molecule
activator	O
DSPA	B-Biological_Molecule
alpha	I-Biological_Molecule
1	E-Biological_Molecule
in	O
CHO	O
and	O
insect	O
cells	O
.	O

Comparisons	O
of	O
rat	O
sCD4	S-Biological_Molecule
glycopeptides	O
with	O
mutant	O
molecules	O
with	O
only	O
single	O
glycosylation	O
sites	O
and	O
with	O
a	O
truncated	O
form	O
containing	O
only	O
the	O
two	O
NH2	O
-	O
terminal	O
domains	O
,	O
indicate	O
that	O
independent	O
processing	O
occurs	O
at	O
each	O
glycosylation	O
site	O
and	O
that	O
domain	O
interactions	O
can	O
also	O
affect	O
oligosaccharide	O
processing	O
.	O

(	O
C	O
)	O
The	O
extent	O
of	O
galactosylation	O
appears	O
to	O
be	O
influenced	O
by	O
the	O
growth	O
conditions	O
,	O
with	O
the	O
highest	O
levels	O
of	O
galactosylation	O
being	O
found	O
for	O
IgG	O
produced	O
by	O
cells	O
grown	O
in	O
still	O
cultures	O
,	O
rather	O
than	O
cells	O
grown	O
as	O
ascites	O
or	O
in	O
hollow	O
fibre	O
bioreactors	O
.	O

It	O
supported	O
the	O
survival	O
of	O
embryonic	O
chick	O
sensory	O
neurons	O
;	O
half	O
-	O
maximal	O
survival	O
was	O
observed	O
at	O
100	O
ng	O
/	O
ml	O
.	O

Addition	O
of	O
heparin	O
into	O
the	O
medium	O
did	O
not	O
potentiate	O
the	O
activity	O
of	O
NT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
in	O
survival	O
assays	O
.	O

FT	O
samples	O
were	O
obtained	O
from	O
36	O
patients	O
presenting	O
inguinal	O
hernia	O
(	O
23	O
indirect	O
hernia	O
and	O
13	O
direct	O
hernia	O
)	O
who	O
underwent	O
surgery	O
.	O

However	O
,	O
the	O
interfibrillar	O
matrix	O
was	O
more	O
abundant	O
in	O
direct	O
hernias	O
,	O
showing	O
abundant	O
electron	O
-	O
dense	O
particles	O
.	O

Enzyme	O
-	O
linked	O
immunosorbent	O
assays	O
(	O
ELISAs	O
)	O
showed	O
no	O
statistically	O
significant	O
differences	O
in	O
the	O
type	O
I	O
-	O
type	B-Biological_Molecule
III	I-Biological_Molecule
collagen	E-Biological_Molecule
absorbance	O
ratios	O
.	O

Immunohistochemistry	O
revealed	O
no	O
differences	O
in	O
the	O
expression	O
of	O
matrix	B-Biological_Molecule
metalloproteinase	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
.	O

COS	O
-	O
7	O
cells	O
expressing	O
1	O
,	O
360	O
residues	O
from	O
the	O
amino	O
terminus	O
of	O
porcine	O
submaxillary	B-Biological_Molecule
mucin	E-Biological_Molecule
were	O
used	O
to	O
determine	O
whether	O
this	O
region	O
,	O
containing	O
the	O
D1	O
,	O
D2	O
,	O
and	O
D3	O
domains	O
,	O
is	O
involved	O
in	O
forming	O
mucin	O
multimers	O
.	O

Analysis	O
of	O
the	O
proteins	O
immunoprecipitated	O
from	O
the	O
medium	O
of	O
transfected	O
cells	O
by	O
reducing	O
SDS	O
-	O
gel	O
electrophoresis	O
showed	O
a	O
single	O
N	O
-	O
glycosylated	O
protein	O
with	O
no	O
indication	O
of	O
proteolytically	O
processed	O
forms	O
.	O

The	O
expressed	O
protein	O
devoid	O
of	O
N	O
-	O
linked	O
oligosaccharides	O
also	O
formed	O
trimers	O
,	O
but	O
was	O
secreted	O
from	O
cells	O
in	O
significantly	O
less	O
amounts	O
than	O
glycosylated	O
trimers	O
.	O

Coexpression	O
in	O
the	O
same	O
cells	O
of	O
the	O
amino	O
-	O
terminal	O
region	O
and	O
the	O
disulfide	O
-	O
rich	O
carboxyl	O
-	O
terminal	O
domain	O
of	O
the	O
mucin	O
showed	O
that	O
these	O
structures	O
were	O
not	O
disulfide	O
-	O
linked	O
with	O
one	O
another	O
.	O

Both	O
prp2	S-Biological_Molecule
-	O
13	O
and	O
rse1	S-Biological_Molecule
-	O
1	O
mutants	O
accumulate	O
the	O
ER	O
forms	O
of	O
invertase	O
and	O
the	O
vacuolar	O
protease	O
CPY	S-Biological_Molecule
at	O
restrictive	O
temperature	O
.	O

The	O
MTVP	S-Biological_Molecule
transgene	O
promoter	O
region	O
is	O
unmethylated	O
when	O
the	O
transgene	O
is	O
on	O
the	O
active	O
X	O
chromosome	O
and	O
methylated	O
when	O
on	O
the	O
inactive	O
X	O
chromosome	O
.	O

The	O
epidermal	B-Biological_Molecule
growth	I-Biological_Molecule
factor	E-Biological_Molecule
precursor	O
.	O

The	O
protein	O
was	O
shown	O
to	O
have	O
a	O
molecular	O
mass	O
of	O
about	O
160	O
kDa	O
and	O
the	O
N	O
-	O
terminal	O
sequence	O
SAPNHWSXPE	O
.	O

The	O
expressed	O
phytase	S-Biological_Molecule
had	O
two	O
pH	O
optima	O
(	O
2	O
to	O
2	O
.	O
5	O
and	O
5	O
to	O
5	O
.	O
5	O
)	O
and	O
a	O
temperature	O
optimum	O
between	O
55	O
and	O
60	O
degrees	O
C	O
,	O
and	O
it	O
cross	O
-	O
reacted	O
with	O
a	O
rabbit	O
polyclonal	O
antibody	O
against	O
the	O
wild	O
-	O
type	O
enzyme	O
.	O

Increased	O
collagen	O
type	O
IV	O
production	O
evoked	O
by	O
GA	O
in	O
5	O
.	O
5	O
and	O
25	O
mM	O
glucose	O
in	O
mouse	O
mesangial	O
cells	O
was	O
prevented	O
by	O
both	O
general	O
(	O
GF	O
-	O
109203X	O
)	O
and	O
beta	O
-	O
specific	O
(	O
LY	O
-	O
379196	O
)	O
PKC	O
inhibitors	O
.	O

The	O
findings	O
indicate	O
that	O
Amadori	O
-	O
modified	O
albumin	S-Biological_Molecule
stimulates	O
mesangial	O
cell	O
PKC	O
activity	O
,	O
and	O
that	O
activation	O
of	O
the	O
PKC	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
isoform	O
is	O
linked	O
to	O
the	O
stimulation	O
of	O
collagen	O
type	O
IV	O
production	O
.	O

In	O
developing	O
egg	O
chambers	O
,	O
YA	S-Biological_Molecule
protein	O
is	O
made	O
but	O
excluded	O
from	O
nuclei	O
of	O
nurse	O
cells	O
and	O
oocytes	O
;	O
upon	O
egg	O
activation	O
,	O
YA	S-Biological_Molecule
acquires	O
the	O
ability	O
to	O
enter	O
nuclei	O
and	O
becomes	O
incorporated	O
into	O
the	O
nuclear	O
lamina	O
in	O
unfertilized	O
eggs	O
and	O
embryos	O
.	O

The	O
three	O
most	O
extensively	O
characterized	O
mechanisms	O
for	O
epigenetic	O
gene	O
-	O
regulation	O
are	O
(	O
i	O
)	O
changing	O
patterns	O
of	O
DNA	O
methylation	O
,	O
(	O
ii	O
)	O
histone	S-Biological_Molecule
acetylations	O
/	O
deacetylations	O
,	O
and	O
(	O
iii	O
)	O
alterations	O
in	O
regulatory	O
feedback	O
loops	O
for	O
growth	O
factors	O
.	O

RESULTS	O
:	O
In	O
patients	O
with	O
alcoholism	O
,	O
the	O
abnormal	O
transferrin	S-Biological_Molecule
and	O
alpha	B-Biological_Molecule
(	I-Biological_Molecule
1	I-Biological_Molecule
)	I-Biological_Molecule
-	I-Biological_Molecule
antitrypsin	E-Biological_Molecule
isoforms	O
were	O
devoid	O
of	O
a	O
variable	O
number	O
of	O
entire	O
N	O
-	O
glycan	O
moieties	O
and	O
were	O
identical	O
with	O
those	O
present	O
in	O
CDG1	O
.	O

Acetylation	O
imparts	O
a	O
significant	O
enhancement	O
in	O
the	O
proteolytic	O
stability	O
of	O
these	O
two	O
peptides	O
.	O

METHODS	O
:	O
The	O
kinetics	O
of	O
the	O
formation	O
of	O
N	O
-	O
demethylsertraline	O
were	O
determined	O
in	O
human	O
liver	O
microsomes	O
from	O
six	O
genotyped	O
CYP2C19	S-Biological_Molecule
extensive	O
(	O
EM	O
)	O
and	O
three	O
poor	O
metabolisers	O
(	O
PM	O
)	O
.	O

Selective	O
inhibitors	O
of	O
and	O
specific	O
monoclonal	O
antibodies	O
to	O
various	O
cytochrome	O
P450	O
isoforms	O
were	O
also	O
employed	O
.	O

These	O
results	O
demonstrated	O
that	O
:	O
(	O
1	O
)	O
dephosphorylation	O
at	O
Ser20	O
is	O
co	O
-	O
ordinated	O
with	O
an	O
increased	O
steady	O
-	O
state	O
phosphorylation	O
at	O
Ser392	O
after	O
irradiation	O
,	O
without	O
p53	S-Biological_Molecule
protein	O
stabilization	O
,	O
and	O
(	O
2	O
)	O
stabilization	O
of	O
p53	S-Biological_Molecule
protein	O
can	O
occur	O
without	O
Ser15	O
phosphorylation	O
at	O
higher	O
doses	O
of	O
radiation	O
.	O

Moreover	O
,	O
a	O
proportion	O
of	O
kinin	O
peptides	O
is	O
hydroxylated	O
on	O
proline	O
(	O
3	O
)	O
of	O
the	O
bradykinin	S-Biological_Molecule
sequence	O
.	O

Basolateral	O
secretion	O
of	O
SEAP	O
was	O
inhibited	O
40	O
%	O
by	O
ammonium	O
chloride	O
.	O

Luciferase	S-Biological_Molecule
reporter	O
assay	O
and	O
mutational	O
analysis	O
showed	O
that	O
a	O
site	O
similar	O
to	O
the	O
HRE	O
in	O
this	O
motif	O
is	O
functionally	O
essential	O
to	O
hypoxic	O
response	O
.	O

We	O
have	O
animal	O
and	O
human	O
data	O
suggesting	O
that	O
hyperleptinemia	O
rather	O
than	O
,	O
or	O
synergistically	O
with	O
,	O
hyperinsulinemia	O
may	O
play	O
a	O
central	O
role	O
in	O
the	O
genesis	O
of	O
the	O
CVD	O
risk	O
factor	O
cluster	O
that	O
constitutes	O
the	O
syndrome	O
.	O

It	O
also	O
develops	O
hyperleptinemia	O
and	O
leptin	S-Biological_Molecule
insensitivity	O
,	O
and	O
hyperleptinemia	O
is	O
correlated	O
with	O
insulin	S-Biological_Molecule
resistance	O
independent	O
of	O
changes	O
in	O
body	O
weight	O
.	O

Differences	O
in	O
the	O
ligand	O
specificity	O
between	O
CD1d	S-Biological_Molecule
-	O
restricted	O
T	O
cells	O
with	O
limited	O
and	O
diverse	O
T	O
-	O
cell	O
receptor	O
repertoire	O
.	O

The	O
natural	O
killer	O
(	O
NK	O
)	O
T	O
-	O
lymphocyte	O
population	O
consists	O
of	O
two	O
subsets	O
utilizing	O
a	O
diverse	O
and	O
restricted	O
T	O
-	O
cell	O
receptor	O
(	O
TCR	O
)	O
repertoire	O
,	O
respectively	O
.	O

N	O
-	O
glycosylation	O
site	O
occupancy	O
of	O
rat	O
alpha	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
,	I-Biological_Molecule
3	I-Biological_Molecule
-	I-Biological_Molecule
fucosyltransferase	I-Biological_Molecule
IV	E-Biological_Molecule
and	O
the	O
effect	O
of	O
glycosylation	O
on	O
enzymatic	O
activity	O
.	O

However	O
,	O
for	O
predicting	O
low	O
fertilization	O
capacity	O
of	O
sperm	O
,	O
combining	O
the	O
glycodelin	S-Biological_Molecule
and	O
sperm	O
concentrations	O
by	O
logistic	O
regression	O
analysis	O
did	O
not	O
significantly	O
increase	O
the	O
information	O
obtained	O
from	O
sperm	O
concentration	O
alone	O
.	O

We	O
have	O
reported	O
previously	O
on	O
the	O
expression	O
of	O
recombinant	O
human	O
type	B-Biological_Molecule
X	I-Biological_Molecule
collagen	E-Biological_Molecule
(	O
hrColX	S-Biological_Molecule
)	O
in	O
HEK	O
293	O
and	O
HT	O
1080	O
cells	O
by	O
using	O
the	O
eukaryotic	O
expression	O
vector	O
pCMVsis	O
(	O
in	O
which	O
CMV	O
stands	O
for	O
cytomegalovirus	O
)	O
.	O

To	O
stabilize	O
the	O
triple	O
helix	O
of	O
hrColX	S-Biological_Molecule
,	O
an	O
hrColX	S-Biological_Molecule
-	O
expressing	O
clone	O
(	O
A6	O
/	O
16	O
)	O
was	O
co	O
-	O
transfected	O
with	O
both	O
alpha	O
and	O
beta	O
subunits	O
of	O
human	O
prolyl	O
4	O
-	O
hydroxylase	O
.	O

Negative	O
regulation	O
of	O
T	O
-	O
cell	O
activation	O
and	O
autoimmunity	O
by	O
Mgat5	S-Biological_Molecule
N	O
-	O
glycosylation	O
.	O

Acetylation	O
of	O
TAF	B-Biological_Molecule
(	I-Biological_Molecule
I	I-Biological_Molecule
)	I-Biological_Molecule
68	E-Biological_Molecule
,	O
a	O
subunit	O
of	O
TIF	O
-	O
IB	O
/	O
SL1	O
,	O
activates	O
RNA	O
polymerase	O
I	O
transcription	O
.	O

The	O
structure	O
of	O
the	O
fungal	O
family	O
12	O
enzyme	O
presented	O
here	O
allows	O
a	O
complete	O
structural	O
characterization	O
of	O
the	O
glycoside	O
hydrolase	O
-	O
C	O
clan	O
.	O

The	O
identification	O
of	O
mutations	O
in	O
MeCP2	S-Biological_Molecule
,	O
the	O
founding	O
member	O
of	O
this	O
family	O
,	O
as	O
causal	O
for	O
the	O
neurological	O
developmental	O
disorder	O
Rett	O
Syndrome	O
provides	O
additional	O
information	O
regarding	O
amino	O
acid	O
residues	O
crucial	O
to	O
the	O
functions	O
of	O
this	O
interesting	O
protein	O
family	O
.	O

Recent	O
studies	O
have	O
defined	O
a	O
key	O
function	O
for	O
the	O
von	B-Biological_Molecule
Hippel	I-Biological_Molecule
-	I-Biological_Molecule
Lindau	I-Biological_Molecule
tumour	I-Biological_Molecule
suppressor	E-Biological_Molecule
E3	O
ubiquitin	S-Biological_Molecule
ligase	O
(	O
VHLE3	S-Biological_Molecule
)	O
in	O
this	O
process	O
,	O
and	O
have	O
defined	O
an	O
interaction	O
with	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
alpha	E-Biological_Molecule
that	O
is	O
regulated	O
by	O
prolyl	O
hydroxylation	O
.	O

A	O
conserved	O
family	O
of	O
prolyl	O
-	O
4	O
-	O
hydroxylases	O
that	O
modify	O
HIF	O
.	O

Whereas	O
H3	S-Biological_Molecule
-	O
Lys4	O
methylation	O
has	O
been	O
correlated	O
with	O
active	O
gene	O
expression	O
,	O
H3	S-Biological_Molecule
-	O
Lys9	O
methylation	O
has	O
been	O
linked	O
to	O
gene	O
silencing	O
and	O
assembly	O
of	O
heterochromatin	O
in	O
mouse	O
and	O
Schizosaccharomyces	O
pombe	O
.	O

In	O
contrast	O
,	O
H3	S-Biological_Molecule
methylated	O
at	O
Lys4	O
is	O
depleted	O
in	O
the	O
inactive	O
X	O
chromosome	O
,	O
except	O
in	O
three	O
'	O
hot	O
spots	O
'	O
of	O
enrichment	O
along	O
its	O
length	O
.	O

Chromosomal	O
integration	O
of	O
retinoic	O
acid	O
response	O
elements	O
prevents	O
cooperative	O
transcriptional	O
activation	O
by	O
retinoic	O
acid	O
receptor	O
and	O
retinoid	O
X	O
receptor	O
.	O

As	O
widely	O
believed	O
treating	O
cells	O
with	O
trichostatin	O
A	O
(	O
TSA	O
)	O
,	O
an	O
inhibitor	O
of	O
histone	S-Biological_Molecule
deacetylase	O
,	O
results	O
in	O
histone	B-Biological_Molecule
H4	E-Biological_Molecule
hyperacetylation	O
and	O
cell	O
cycle	O
arrest	O
.	O

However	O
,	O
the	O
accumulated	O
70	O
-	O
kDa	O
heat	O
shock	O
protein	O
(	O
HSP70	O
)	O
markedly	O
increased	O
up	O
to	O
2	O
to	O
3	O
folds	O
at	O
8	O
h	O
in	O
GA	O
-	O
and	O
GA	O
+	O
TSA	O
-	O
treated	O
cells	O
,	O
and	O
the	O
maximum	O
amount	O
up	O
to	O
5	O
to	O
7	O
folds	O
at	O
20	O
h	O
.	O

The	O
use	O
of	O
dioxygen	O
by	O
HIF	O
prolyl	O
hydroxylase	O
(	O
PHD1	S-Biological_Molecule
)	O
.	O

We	O
conclude	O
that	O
histone	S-Biological_Molecule
deacetylation	O
contributes	O
to	O
the	O
repression	O
of	O
cyclin	B-Biological_Molecule
B1	E-Biological_Molecule
expression	O
in	O
G	O
(	O
0	O
)	O
and	O
G	O
(	O
1	O
)	O
,	O
and	O
that	O
this	O
mechanism	O
requires	O
,	O
in	O
part	O
,	O
the	O
E	O
-	O
box	O
.	O

Topa	O
was	O
identified	O
as	O
3	O
,	O
4	O
,	O
5	O
-	O
trihydroxyphenylalanine	O
(	O
3	O
,	O
4	O
,	O
5	O
-	O
Topa	O
)	O
by	O
comparison	O
to	O
known	O
standards	O
using	O
amino	O
acid	O
analysis	O
,	O
derivatization	O
with	O
phenylisothiocyanate	O
in	O
combination	O
with	O
Edman	O
sequencing	O
,	O
and	O
matrix	O
-	O
assisted	O
laser	O
desorption	O
mass	O
spectrometry	O
with	O
time	O
-	O
of	O
-	O
flight	O
.	O

Stabilization	O
of	O
the	O
hypoxia	O
-	O
inducible	O
factor	O
-	O
1	O
(	O
HIF	O
-	O
1	O
)	O
protein	O
is	O
essential	O
for	O
its	O
role	O
as	O
a	O
regulator	O
of	O
gene	O
expression	O
under	O
low	O
oxygen	O
conditions	O
.	O

Peripherin	S-Biological_Molecule
/	O
rds	S-Biological_Molecule
is	O
an	O
integral	O
membrane	O
glycoprotein	O
found	O
in	O
the	O
rim	O
regions	O
of	O
vertebrate	O
photoreceptor	O
cell	O
discs	O
.	O

Class	O
II	O
histone	B-Biological_Molecule
deacetylases	I-Biological_Molecule
(	I-Biological_Molecule
HDACs	I-Biological_Molecule
)	I-Biological_Molecule
4	E-Biological_Molecule
,	O
5	S-Biological_Molecule
,	O
7	S-Biological_Molecule
,	O
and	O
9	S-Biological_Molecule
repress	O
muscle	O
differentiation	O
through	O
associations	O
with	O
the	O
myocyte	O
enhancer	O
factor	O
2	O
(	O
MEF2	O
)	O
transcription	O
factor	O
.	O

We	O
therefore	O
determined	O
the	O
complete	O
amino	O
acid	O
sequence	O
of	O
hopsarin	B-Biological_Molecule
D	E-Biological_Molecule
.	O

Hopsarin	B-Biological_Molecule
D	E-Biological_Molecule
shows	O
approximately	O
70	O
%	O
similarity	O
with	O
FXa	S-Biological_Molecule
and	O
approximately	O
98	O
%	O
similarity	O
with	O
trocarin	B-Biological_Molecule
D	E-Biological_Molecule
,	O
a	O
Group	O
D	O
prothrombin	S-Biological_Molecule
activator	O
from	O
Tropidechis	O
carinatus	O
.	O

The	O
macrolide	O
antibiotic	O
tylosin	O
has	O
been	O
used	O
extensively	O
in	O
veterinary	O
medicine	O
and	O
exerts	O
potent	O
antimicrobial	O
activity	O
against	O
Gram	O
-	O
positive	O
bacteria	O
.	O

GDP	O
is	O
hydrolyzed	O
by	O
a	O
GDPase	S-Biological_Molecule
,	O
encoded	O
by	O
GDA1	S-Biological_Molecule
,	O
to	O
GMP	O
,	O
which	O
then	O
exits	O
the	O
Golgi	O
lumen	O
in	O
a	O
coupled	O
,	O
equimolar	O
exchange	O
with	O
cytosolic	O
GDP	O
-	O
mannose	O
.	O

Gda1	S-Biological_Molecule
/	O
gda1	S-Biological_Molecule
cells	O
offer	O
a	O
model	O
for	O
discriminating	O
among	O
them	O
.	O

In	O
comparison	O
with	O
the	O
concentrative	O
nucleoside	O
transporter	O
,	O
CNTI	S-Biological_Molecule
,	O
which	O
is	O
confined	O
to	O
the	O
apical	O
membrane	O
,	O
SPNT	S-Biological_Molecule
is	O
expressed	O
predominantly	O
on	O
the	O
apical	O
membrane	O
but	O
with	O
significant	O
expression	O
on	O
the	O
basolateral	O
membrane	O
as	O
well	O
.	O

In	O
transgenic	O
tobacco	O
plants	O
containing	O
the	O
pea	O
PetE	S-Biological_Molecule
promoter	O
fused	O
to	O
uidA	S-Biological_Molecule
,	O
both	O
acetylated	O
and	O
nonacetylated	O
histones	B-Biological_Molecule
H3	E-Biological_Molecule
and	O
H4	S-Biological_Molecule
were	O
present	O
on	O
the	O
integrated	O
transgene	O
.	O

In	O
the	O
current	O
study	O
,	O
the	O
protein	O
expression	O
and	O
subcellular	O
distribution	O
profile	O
of	O
PKC	B-Biological_Molecule
-	I-Biological_Molecule
delta	E-Biological_Molecule
(	O
PKC	B-Biological_Molecule
-	I-Biological_Molecule
delta	E-Biological_Molecule
)	O
,	O
a	O
novel	O
isoform	O
of	O
the	O
PKC	O
family	O
,	O
was	O
determined	O
in	O
mouse	O
oocytes	O
undergoing	O
meiotic	O
maturation	O
and	O
following	O
egg	O
activation	O
.	O

A	O
smaller	O
(	O
47	O
kDa	O
)	O
carboxyl	O
-	O
terminal	O
fragment	O
,	O
presumably	O
the	O
truncated	O
catalytic	O
domain	O
of	O
PKC	B-Biological_Molecule
-	I-Biological_Molecule
delta	E-Biological_Molecule
,	O
was	O
also	O
strongly	O
expressed	O
.	O

By	O
the	O
two	O
-	O
cell	O
stage	O
,	O
expression	O
of	O
the	O
truncated	O
catalytic	O
fragment	O
was	O
minimal	O
.	O

These	O
data	O
demonstrate	O
that	O
the	O
subcellular	O
distribution	O
and	O
posttranslational	O
modification	O
of	O
PKC	B-Biological_Molecule
-	I-Biological_Molecule
delta	E-Biological_Molecule
is	O
cell	O
cycle	O
dependent	O
,	O
suggesting	O
that	O
its	O
activity	O
and	O
/	O
or	O
function	O
likely	O
vary	O
with	O
the	O
progression	O
of	O
meiosis	O
and	O
egg	O
activation	O
.	O

DNA	O
methylation	O
is	O
a	O
mechanism	O
for	O
regulation	O
of	O
gene	O
expression	O
in	O
animals	O
(	O
1	O
-	O
3	O
)	O
.	O

The	O
addition	O
of	O
a	O
methyl	O
group	O
at	O
the	O
5	O
-	O
position	O
of	O
cytosine	O
bases	O
occurs	O
exclusively	O
at	O
CpG	O
dinucleotides	O
.	O

These	O
alterations	O
in	O
the	O
methylation	O
profile	O
are	O
correlated	O
with	O
silencing	O
of	O
tumor	O
suppressor	O
genes	O
such	O
as	O
p15	S-Biological_Molecule
,	O
p16	S-Biological_Molecule
,	O
Rb	S-Biological_Molecule
,	O
VHL	S-Biological_Molecule
,	O
e	B-Biological_Molecule
-	I-Biological_Molecule
cadherin	E-Biological_Molecule
,	O
ER	S-Biological_Molecule
,	O
and	O
HIC1	S-Biological_Molecule
(	O
8	O
)	O
.	O

Using	O
pulse	O
-	O
chase	O
studies	O
,	O
we	O
show	O
that	O
lgl1	S-Biological_Molecule
is	O
a	O
stable	O
protein	O
with	O
a	O
half	O
-	O
life	O
of	O
11	O
.	O
5	O
h	O
.	O

Furthermore	O
,	O
at	O
gestational	O
days	O
20	O
and	O
21	O
(	O
term	O
=	O
22	O
)	O
,	O
foetal	O
distal	O
lung	O
epithelial	O
cells	O
import	O
lgl1	S-Biological_Molecule
protein	O
.	O

Adhesion	O
between	O
the	O
CD44s	S-Biological_Molecule
receptor	O
and	O
hyaluronic	O
acid	O
plays	O
an	O
important	O
role	O
in	O
cell	O
migration	O
,	O
tumour	O
growth	O
and	O
progression	O
.	O

Mutation	O
of	O
these	O
serine	O
residues	O
,	O
as	O
well	O
as	O
an	O
extensive	O
metabolic	O
O	O
-	O
deglycosylation	O
,	O
strongly	O
impaired	O
spontaneous	O
CD44	S-Biological_Molecule
shedding	O
.	O

Furthermore	O
,	O
an	O
O	O
-	O
glycosylation	O
-	O
independent	O
mechanism	O
of	O
CD44	S-Biological_Molecule
cleavage	O
has	O
been	O
identified	O
.	O

Deregulated	O
expression	O
of	O
SPARC	S-Biological_Molecule
/	O
osteonectin	S-Biological_Molecule
,	O
a	O
secreted	O
glycoprotein	O
with	O
multiple	O
biological	O
functions	O
,	O
has	O
been	O
associated	O
with	O
the	O
progression	O
of	O
various	O
cancers	O
.	O

We	O
therefore	O
analysed	O
the	O
expression	O
pattern	O
and	O
methylation	O
status	O
of	O
the	O
SPARC	S-Biological_Molecule
gene	O
in	O
pancreatic	O
cancer	O
.	O

These	O
findings	O
suggest	O
that	O
SPARC	S-Biological_Molecule
is	O
a	O
frequent	O
target	O
for	O
aberrant	O
methylation	O
in	O
pancreatic	O
cancer	O
and	O
that	O
SPARC	S-Biological_Molecule
expression	O
in	O
fibroblasts	O
adjacent	O
to	O
pancreatic	O
cancer	O
cells	O
is	O
regulated	O
through	O
tumor	O
-	O
stromal	O
interactions	O
.	O

In	O
this	O
study	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
1	O
(	O
HIV	O
-	O
1	O
)	O
Tat	S-Biological_Molecule
protein	O
,	O
we	O
demonstrate	O
the	O
benefits	O
of	O
matrix	O
-	O
assisted	O
laser	O
desorption	O
/	O
ionisation	O
mass	O
spectrometry	O
,	O
proteolytic	O
digestion	O
and	O
Edman	O
sequencing	O
for	O
the	O
mapping	O
of	O
acetylation	O
sites	O
.	O

On	O
the	O
other	O
hand	O
,	O
treatment	O
of	O
rostrally	O
derived	O
lines	O
with	O
the	O
demethylating	O
agent	O
,	O
5	O
-	O
azacytidine	O
,	O
decreases	O
methylation	O
and	O
increases	O
expression	O
of	O
the	O
transgene	O
.	O

Peptides	O
generated	O
by	O
enzymatic	O
cleavage	O
showed	O
similarity	O
to	O
the	O
AxCAM	O
F11	S-Biological_Molecule
.	O

We	O
have	O
established	O
a	O
stable	O
,	O
continuous	O
culture	O
Drosophila	O
Schneider	O
2	O
cell	O
line	O
that	O
efficiently	O
expresses	O
a	O
secreted	O
,	O
truncated	O
form	O
of	O
the	O
HIV	O
envelope	O
gp120	S-Biological_Molecule
protein	O
in	O
a	O
regulated	O
manner	O
.	O

An	O
internal	O
fragment	O
of	O
the	O
enzyme	O
,	O
released	O
by	O
endoproteinase	O
Lys	B-Biological_Molecule
-	I-Biological_Molecule
C	E-Biological_Molecule
digestion	O
,	O
was	O
sequenced	O
and	O
used	O
to	O
design	O
a	O
degenerate	O
oligonucleotide	O
primer	O
.	O

However	O
,	O
the	O
effect	O
of	O
2	O
-	O
DG	O
on	O
protein	O
glycosylation	O
and	O
related	O
signal	O
pathways	O
has	O
not	O
been	O
investigated	O
in	O
depth	O
.	O

Methylene	B-Biological_Molecule
-	I-Biological_Molecule
tetrahydrofolate	I-Biological_Molecule
reductase	E-Biological_Molecule
(	O
MTHFR	S-Biological_Molecule
)	O
and	O
methionine	B-Biological_Molecule
synthase	E-Biological_Molecule
(	O
MS	S-Biological_Molecule
)	O
are	O
the	O
enzymes	O
involved	O
in	O
folate	O
metabolism	O
and	O
are	O
thought	O
to	O
influence	O
DNA	O
methylation	O
.	O

Most	O
studies	O
support	O
an	O
inverse	O
association	O
between	O
folate	O
status	O
and	O
the	O
rate	O
of	O
colorectal	O
adenomas	O
and	O
carcinomas	O
.	O

Direct	O
AR	S-Biological_Molecule
acetylation	O
augmented	O
p300	S-Biological_Molecule
binding	O
in	O
vitro	O
.	O

A	O
down	O
-	O
regulation	O
of	O
reelin	S-Biological_Molecule
and	O
glutamic	B-Biological_Molecule
acid	I-Biological_Molecule
decarboxylase	I-Biological_Molecule
(	I-Biological_Molecule
GAD	I-Biological_Molecule
)	I-Biological_Molecule
67	E-Biological_Molecule
mRNAs	O
was	O
detected	O
in	O
gamma	O
-	O
aminobutyric	O
acid	O
(	O
GABA	O
)	O
ergic	O
cortical	O
interneurons	O
of	O
schizophrenia	O
(	O
SZ	O
)	O
postmortem	O
brains	O
(	O
10	O
)	O
,	O
suggesting	O
that	O
the	O
availability	O
of	O
GABA	O
and	O
reelin	S-Biological_Molecule
may	O
be	O
decreased	O
in	O
SZ	O
cortex	O
.	O

Substrate	O
requirements	O
of	O
the	O
oxygen	O
-	O
sensing	O
asparaginyl	O
hydroxylase	O
factor	B-Biological_Molecule
-	I-Biological_Molecule
inhibiting	I-Biological_Molecule
hypoxia	I-Biological_Molecule
-	I-Biological_Molecule
inducible	I-Biological_Molecule
factor	E-Biological_Molecule
.	O

DNMT3b2	S-Biological_Molecule
and	O
3b3	S-Biological_Molecule
were	O
the	O
major	O
isoforms	O
expressed	O
in	O
human	O
cell	O
lines	O
and	O
the	O
mRNA	O
levels	O
of	O
these	O
isoforms	O
closely	O
correlated	O
with	O
their	O
protein	O
levels	O
.	O

Although	O
DNMT3b3	S-Biological_Molecule
may	O
be	O
catalytically	O
inactive	O
,	O
it	O
still	O
may	O
be	O
biologically	O
important	O
because	O
D4Z4	O
and	O
satellites	O
2	O
and	O
3	O
repeat	O
sequences	O
,	O
all	O
known	O
DNMT3b	S-Biological_Molecule
target	O
sequences	O
,	O
were	O
methylated	O
in	O
cells	O
that	O
predominantly	O
expressed	O
DNMT3b3	S-Biological_Molecule
.	O

The	O
main	O
Caenorhabditis	O
elegans	O
collagen	O
P4H	O
form	O
is	O
an	O
unusual	O
PHY	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
/	O
PHY	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
/	O
(	O
PDI	S-Biological_Molecule
)	O
(	O
2	O
)	O
mixed	O
tetramer	O
consisting	O
of	O
two	O
types	O
of	O
catalytic	O
alpha	O
subunit	O
,	O
but	O
the	O
PHY	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
PHY	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
polypeptides	O
also	O
form	O
active	O
PHY	O
/	O
PDI	S-Biological_Molecule
dimers	O
.	O

This	O
phenomenon	O
has	O
been	O
explained	O
in	O
terms	O
of	O
processive	O
binding	O
of	O
the	O
two	O
catalytic	O
subunits	O
to	O
long	O
peptides	O
.	O

All	O
the	O
K	O
(	O
m	O
)	O
values	O
of	O
the	O
PHY	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
/	O
PDI	S-Biological_Molecule
dimer	O
were	O
found	O
to	O
be	O
about	O
1	O
.	O
5	O
-	O
2	O
.	O
5	O
times	O
those	O
of	O
the	O
tetramer	O
,	O
but	O
increasing	O
peptide	O
length	O
led	O
to	O
identical	O
decreases	O
in	O
the	O
values	O
of	O
both	O
enzyme	O
forms	O
.	O

Induction	O
of	O
PHD2	S-Biological_Molecule
by	O
hypoxia	O
was	O
lost	O
in	O
pVHL	S-Biological_Molecule
-	O
deficient	O
RCC4	O
cells	O
.	O

Additionally	O
,	O
compared	O
to	O
the	O
wild	O
-	O
type	O
pseudovirus	O
,	O
two	O
of	O
these	O
mutants	O
were	O
neutralized	O
at	O
higher	O
sera	O
dilutions	O
strengthening	O
the	O
importance	O
of	O
the	O
location	O
of	O
specific	O
N	O
-	O
glycans	O
in	O
limiting	O
the	O
neutralizing	O
response	O
.	O

Hypermethylation	O
of	O
Syk	S-Biological_Molecule
gene	O
in	O
promoter	O
region	O
associated	O
with	O
oncogenesis	O
and	O
metastasis	O
of	O
gastric	O
carcinoma	O
.	O

The	O
relation	O
between	O
silencing	O
of	O
the	O
Syk	S-Biological_Molecule
gene	O
and	O
methylation	O
of	O
Syk	S-Biological_Molecule
promoter	O
region	O
was	O
also	O
studied	O
.	O

CONCLUSION	O
:	O
Hypermethylation	O
leads	O
to	O
silencing	O
of	O
the	O
Syk	S-Biological_Molecule
gene	O
in	O
human	O
gastric	O
carcinoma	O
.	O

Besides	O
the	O
hormonal	O
pathway	O
involved	O
in	O
the	O
progression	O
of	O
preneoplastic	O
and	O
neoplastic	O
lesions	O
,	O
alterations	O
of	O
the	O
DNA	O
methylation	O
status	O
have	O
been	O
shown	O
to	O
be	O
an	O
early	O
signal	O
of	O
tumorigenesis	O
.	O

Human	O
PAD4	S-Biological_Molecule
regulates	O
histone	S-Biological_Molecule
arginine	O
methylation	O
levels	O
via	O
demethylimination	O
.	O

Methylation	O
of	O
arginine	O
(	O
Arg	O
)	O
and	O
lysine	O
residues	O
in	O
histones	S-Biological_Molecule
has	O
been	O
correlated	O
with	O
epigenetic	O
forms	O
of	O
gene	O
regulation	O
.	O

Increased	O
methylation	O
of	O
p16	S-Biological_Molecule
or	O
O6	B-Biological_Molecule
methylguanine	I-Biological_Molecule
methyltranferase	E-Biological_Molecule
(	O
MGMT	S-Biological_Molecule
)	O
was	O
detected	O
in	O
4	O
/	O
8	O
(	O
50	O
%	O
)	O
of	O
the	O
tumor	O
samples	O
from	O
mice	O
promoted	O
with	O
27	O
mg	O
CSC	O
.	O

We	O
also	O
analyzed	O
histone	S-Biological_Molecule
acetylation	O
and	O
methylation	O
by	O
immunocytochemistry	O
with	O
antibodies	O
to	O
H4	S-Biological_Molecule
acetylated	O
at	O
lysine	O
8	O
,	O
H3	S-Biological_Molecule
trimethylated	O
at	O
lysine	O
9	O
,	O
and	O
H3	S-Biological_Molecule
methylated	O
at	O
lysine	O
4	O
.	O

To	O
explore	O
the	O
origins	O
of	O
other	O
acetylated	O
taxoids	O
,	O
the	O
group	O
of	O
recombinant	O
Taxus	O
acyltransferases	O
was	O
investigated	O
with	O
a	O
range	O
of	O
polyhydroxylated	O
taxoids	O
as	O
substrates	O
.	O

These	O
results	O
suggest	O
that	O
both	O
TAX1	S-Biological_Molecule
and	O
TAX19	S-Biological_Molecule
acyltransferases	O
may	O
function	O
at	O
the	O
early	O
C5	O
acetylation	O
step	O
of	O
taxoid	O
metabolism	O
,	O
and	O
that	O
the	O
TAX19	S-Biological_Molecule
acyltransferase	O
,	O
because	O
of	O
its	O
broader	O
specificity	O
for	O
polyhydroxylated	O
taxoids	O
,	O
may	O
also	O
function	O
later	O
in	O
metabolism	O
and	O
be	O
responsible	O
for	O
the	O
production	O
of	O
many	O
other	O
acetylated	O
taxoids	O
.	O

During	O
embryogenesis	O
,	O
the	O
murine	O
Pomt1	S-Biological_Molecule
gene	O
is	O
prominently	O
expressed	O
in	O
the	O
neural	O
tube	O
,	O
the	O
developing	O
eye	O
,	O
and	O
the	O
mesenchyme	O
.	O

The	O
product	O
of	O
the	O
YDR140w	S-Biological_Molecule
gene	O
is	O
required	O
for	O
the	O
methylation	O
of	O
eRF1	S-Biological_Molecule
in	O
vivo	O
and	O
for	O
optimal	O
yeast	O
cell	O
growth	O
.	O

Hepatitis	O
delta	O
virus	O
(	O
HDV	O
)	O
contains	O
a	O
circular	O
RNA	O
which	O
encodes	O
a	O
single	O
protein	O
,	O
hepatitis	B-Biological_Molecule
delta	I-Biological_Molecule
antigen	E-Biological_Molecule
(	O
HDAg	S-Biological_Molecule
)	O
.	O

NS1	S-Biological_Molecule
produced	O
in	O
infected	O
cells	O
is	O
glycosylated	O
at	O
both	O
of	O
these	O
sites	O
.	O

Temperature	O
sensitivity	O
studies	O
comparing	O
the	O
growth	O
of	O
the	O
viruses	O
at	O
37	O
degrees	O
C	O
and	O
39	O
degrees	O
C	O
showed	O
no	O
significant	O
differences	O
compared	O
to	O
the	O
WT	O
virus	O
.	O

Surprisingly	O
,	O
all	O
of	O
these	O
changes	O
are	O
well	O
accommodated	O
within	O
an	O
insulin	S-Biological_Molecule
R6	O
hexamer	O
.	O

Ovarian	O
follicles	O
undergoing	O
OM	O
were	O
incubated	O
in	O
vitro	O
with	O
tritiated	O
[	O
3H	O
]	O
pregnenolone	O
precursor	O
and	O
the	O
tritiated	O
products	O
were	O
extracted	O
,	O
purified	O
,	O
and	O
identified	O
by	O
HPLC	O
,	O
TLC	O
,	O
acetylation	O
,	O
and	O
recrystallization	O
.	O

Plasma	O
20beta	O
-	O
S	O
concentrations	O
increased	O
significantly	O
during	O
the	O
oocyte	O
maturation	O
after	O
injection	O
with	O
a	O
LHRH	S-Biological_Molecule
analog	O
.	O

These	O
results	O
contribute	O
to	O
the	O
knowledge	O
of	O
DHEA	O
,	O
7alpha	O
-	O
hydroxy	O
-	O
DHEA	O
and	O
7beta	O
-	O
hydroxy	O
-	O
DHEA	O
,	O
in	O
relation	O
to	O
antiglucocorticoid	O
activity	O
.	O

Myeloid	O
antigens	O
in	O
childhood	O
lymphoblastic	O
leukemia	O
:	O
clinical	O
data	O
point	O
to	O
regulation	O
of	O
CD66c	S-Biological_Molecule
distinct	O
from	O
other	O
myeloid	O
antigens	O
.	O

The	O
most	O
frequent	O
MyAg	O
(	O
CD66c	S-Biological_Molecule
)	O
is	O
studied	O
further	O
regarding	O
its	O
stability	O
from	O
diagnosis	O
to	O
relapse	O
,	O
prognostic	O
significance	O
and	O
regulation	O
of	O
surface	O
expression	O
.	O

Our	O
results	O
indicate	O
that	O
methylation	O
of	O
NR2B	S-Biological_Molecule
gene	O
in	O
the	O
mouse	O
brain	O
is	O
age	O
-	O
dependent	O
phenomenon	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
the	O
molecular	O
forms	O
and	O
microheterogeneity	O
of	O
oligosaccharide	O
chains	O
of	O
pregnancy	O
-	O
associated	O
CA125	S-Biological_Molecule
,	O
as	O
a	O
first	O
step	O
towards	O
gaining	O
an	O
insight	O
into	O
its	O
possible	O
involvement	O
as	O
a	O
ligand	O
in	O
carbohydrate	O
-	O
dependent	O
interactions	O
.	O

METHODS	O
:	O
Pregnancy	O
-	O
associated	O
CA125	S-Biological_Molecule
was	O
characterized	O
by	O
gel	O
filtration	O
and	O
ion	O
-	O
exchange	O
chromatography	O
,	O
followed	O
by	O
lectin	O
-	O
affinity	O
chromatography	O
with	O
a	O
panel	O
of	O
plant	O
lectins	O
as	O
ligands	O
.	O

COOH	O
-	O
terminal	O
methylation	O
of	O
lamin	B-Biological_Molecule
B	E-Biological_Molecule
and	O
inhibition	O
of	O
methylation	O
by	O
farnesylated	O
peptides	O
corresponding	O
to	O
lamin	B-Biological_Molecule
B	E-Biological_Molecule
and	O
other	O
CAAX	O
motif	O
proteins	O
.	O

Nonfarnesylated	O
peptides	O
were	O
not	O
substrates	O
for	O
the	O
enzyme	O
.	O

We	O
provide	O
quick	O
protocols	O
for	O
the	O
isolation	O
of	O
nuclei	O
from	O
yeast	O
and	O
mammalian	O
cells	O
and	O
give	O
basic	O
procedures	O
for	O
the	O
phosphorylation	O
,	O
acetylation	O
,	O
and	O
methylation	O
of	O
histones	S-Biological_Molecule
(	O
and	O
other	O
proteins	O
)	O
using	O
these	O
subcellular	O
sources	O
that	O
can	O
be	O
carried	O
out	O
in	O
any	O
laboratory	O
.	O

Treatment	O
with	O
2L	O
-	O
Rap	S-Biological_Molecule
-	O
hLL1	O
-	O
gamma4P	O
was	O
significantly	O
better	O
than	O
all	O
controls	O
,	O
including	O
saline	O
,	O
naked	O
hLL1	O
,	O
and	O
nonspecific	O
immunotoxin	O
.	O

This	O
binding	O
was	O
reduced	O
when	O
the	O
cells	O
were	O
treated	O
with	O
the	O
histone	S-Biological_Molecule
deacetylase	O
(	O
HDAC	O
)	O
inhibitor	O
-	O
-	O
trichostatin	O
A	O
(	O
TSA	O
)	O
.	O

We	O
have	O
constructed	O
a	O
mutant	O
form	O
of	O
the	O
beta	O
-	O
1	O
,	O
3	O
-	O
glucanosyltransferase	O
Gas1p	S-Biological_Molecule
(	O
Gas1	S-Biological_Molecule
*	O
p	O
)	O
as	O
a	O
model	O
misfolded	O
GPI	O
-	O
anchored	O
protein	O
.	O

Our	O
data	O
suggest	O
that	O
GPI	O
inositol	O
deacylation	O
plays	O
important	O
roles	O
in	O
the	O
quality	O
control	O
and	O
ER	O
-	O
associated	O
degradation	O
of	O
GPI	O
-	O
anchored	O
proteins	O
.	O

CpG	O
methylation	O
adjacent	O
to	O
the	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBPdelta	E-Biological_Molecule
proximal	O
promoter	O
Sp1	S-Biological_Molecule
site	O
was	O
associated	O
with	O
reduced	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBPdelta	E-Biological_Molecule
expression	O
in	O
a	O
primary	O
breast	O
cancer	O
sample	O
.	O

I	O
.	O

Prion	S-Biological_Molecule
protein	O
-	O
related	O
proteins	O
from	O
zebrafish	O
are	O
complex	O
glycosylated	O
and	O
contain	O
a	O
glycosylphosphatidylinositol	O
anchor	O
.	O

While	O
there	O
is	O
only	O
little	O
sequence	O
homology	O
to	O
mammalian	O
PrP	S-Biological_Molecule
,	O
PrP	S-Biological_Molecule
-	O
related	O
fish	O
proteins	O
were	O
predicted	O
to	O
be	O
modified	O
with	O
N	O
-	O
linked	O
glycans	O
and	O
a	O
C	O
-	O
terminal	O
glycosylphosphatidylinositol	O
(	O
GPI	O
)	O
anchor	O
.	O

Nur77	S-Biological_Molecule
is	O
posttranslationally	O
modified	O
,	O
primarily	O
by	O
phosphorylation	O
on	O
serine	O
residues	O
.	O

One	O
germinal	O
excision	O
event	O
was	O
found	O
that	O
contained	O
an	O
8	O
bp	O
deletion	O
,	O
frameshift	O
mutation	O
in	O
Bronze	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
.	O

Also	O
defective	O
in	O
the	O
noninsulin	S-Biological_Molecule
-	O
dependent	O
diabetic	O
heart	O
is	O
regulation	O
of	O
calcium	O
homeostasis	O
.	O

Although	O
the	O
molecular	O
mechanisms	O
underlying	O
these	O
defects	O
are	O
presently	O
unknown	O
,	O
the	O
possibility	O
that	O
they	O
may	O
be	O
related	O
to	O
aberrations	O
in	O
glucose	O
or	O
lipid	O
metabolism	O
are	O
considered	O
.	O

Also	O
insignificant	O
are	O
defects	O
in	O
lipid	O
metabolism	O
leading	O
to	O
accumulation	O
of	O
toxic	O
lipid	O
amphiphiles	O
or	O
triacylglycerol	O
.	O

Several	O
properties	O
of	O
fibrillar	O
collagens	O
depend	O
on	O
abundance	O
and	O
position	O
of	O
ionic	O
amino	O
acids	O
.	O

We	O
report	O
here	O
the	O
new	O
aspect	O
of	O
the	O
influence	O
of	O
the	O
same	O
modifications	O
on	O
collagen	O
self	O
-	O
aggregation	O
in	O
neutral	O
conditions	O
.	O

Kinetic	O
measurements	O
by	O
turbidimetry	O
showed	O
a	O
sizeable	O
increase	O
of	O
absorbance	O
only	O
for	O
the	O
two	O
N	O
-	O
methylated	O
samples	O
forming	O
specific	O
supramolecular	O
aggregates	O
;	O
however	O
,	O
the	O
derivatization	O
affects	O
aggregation	O
kinetics	O
by	O
increasing	O
lag	O
time	O
and	O
decreasing	O
maximum	O
slope	O
of	O
absorbance	O
variation	O
,	O
and	O
lowers	O
aggregation	O
competency	O
.	O

The	O
colR4	O
and	O
colR15	O
beta	O
-	O
tubulin	O
mutations	O
in	O
Chlamydomonas	O
reinhardtii	O
confer	O
altered	O
sensitivities	O
to	O
microtubule	O
inhibitors	O
and	O
herbicides	O
by	O
enhancing	O
microtubule	O
stability	O
.	O

This	O
pattern	O
of	O
altered	O
sensitivity	O
to	O
different	O
microtubule	O
inhibitors	O
was	O
found	O
to	O
cosegregate	O
and	O
corevert	O
with	O
the	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
tubulin	E-Biological_Molecule
mutations	O
providing	O
the	O
first	O
genetic	O
evidence	O
that	O
the	O
in	O
vivo	O
herbicidal	O
effects	O
of	O
the	O
dinitroanilines	O
,	O
amiprophos	O
methyl	O
,	O
and	O
pronamide	O
are	O
related	O
to	O
microtubule	O
function	O
.	O

Recently	O
,	O
NO	O
was	O
found	O
to	O
attenuate	O
accumulation	O
of	O
hypoxia	B-Biological_Molecule
inducible	I-Biological_Molecule
factor	I-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
(	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
)	O
under	O
hypoxic	O
conditions	O
because	O
of	O
several	O
mechanisms	O
:	O
redistribution	O
of	O
oxygen	O
toward	O
non	O
-	O
respiratory	O
oxygen	O
-	O
dependent	O
targets	O
(	O
like	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
proline	O
hydroxylases	O
-	O
-	O
PHDs	O
,	O
which	O
perform	O
hydroxylation	O
of	O
Pro402	O
/	O
564	O
of	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
leading	O
to	O
its	O
proteasomal	O
degradation	O
)	O
;	O
in	O
addition	O
,	O
peroxynitrite	O
formed	O
during	O
interactions	O
between	O
NO	O
and	O
mitochondria	O
derived	O
superoxide	O
leads	O
to	O
an	O
increase	O
in	O
cytosolic	O
iron	O
/	O
2	O
-	O
oxoglutarate	O
(	O
2	O
-	O
OG	O
)	O
,	O
which	O
required	O
for	O
PHD	O
activation	O
.	O

This	O
interaction	O
is	O
crucial	O
for	O
several	O
aspects	O
of	O
LPL	S-Biological_Molecule
function	O
,	O
such	O
as	O
intracellular	O
/	O
extracellular	O
transport	O
and	O
high	O
capacity	O
attachment	O
to	O
cell	O
surfaces	O
.	O

Since	O
such	O
structures	O
are	O
relatively	O
rare	O
in	O
endothelial	O
HS	O
,	O
we	O
have	O
re	O
-	O
addressed	O
the	O
question	O
of	O
physiological	O
ligand	O
structures	O
for	O
LPL	S-Biological_Molecule
by	O
affinity	O
purification	O
of	O
end	O
-	O
labeled	O
oligosaccharides	O
originating	O
from	O
heparin	O
and	O
HS	O
on	O
immobilized	O
LPL	S-Biological_Molecule
.	O

Structural	O
characterization	O
of	O
Set1	S-Biological_Molecule
RNA	O
recognition	O
motifs	O
and	O
their	O
role	O
in	O
histone	B-Biological_Molecule
H3	E-Biological_Molecule
lysine	O
4	O
methylation	O
.	O

Enhancement	O
of	O
CD8	O
T	O
-	O
cell	O
function	O
through	O
modifying	O
surface	O
glycoproteins	O
in	O
young	O
and	O
old	O
mice	O
.	O

These	O
data	O
support	O
the	O
notion	O
that	O
glycosylated	O
surface	O
proteins	O
hinder	O
CD8	O
T	O
-	O
cell	O
activation	O
and	O
function	O
in	O
both	O
young	O
and	O
old	O
mice	O
,	O
and	O
raise	O
the	O
possibility	O
of	O
significantly	O
improving	O
CD8	O
T	O
cell	O
function	O
in	O
older	O
individuals	O
through	O
enzymatic	O
alteration	O
of	O
surface	O
glycoproteins	O
.	O

In	O
this	O
paper	O
,	O
we	O
demonstrate	O
that	O
pre	O
-	O
treatment	O
with	O
the	O
histone	S-Biological_Molecule
deacetylation	O
inhibitor	O
trichostatin	O
A	O
(	O
TSA	O
)	O
enhances	O
histone	S-Biological_Molecule
acetylation	O
in	O
primary	O
cortical	O
neurons	O
and	O
protects	O
against	O
oxygen	O
/	O
glucose	O
deprivation	O
,	O
a	O
model	O
for	O
ischaemic	O
cell	O
death	O
in	O
vitro	O
.	O

In	O
conclusion	O
,	O
we	O
demonstrate	O
that	O
the	O
enhancement	O
of	O
gelsolin	S-Biological_Molecule
gene	O
expression	O
correlates	O
with	O
neuroprotection	O
induced	O
by	O
the	O
inhibition	O
of	O
histone	S-Biological_Molecule
deacetylation	O
.	O

Genetic	O
or	O
epigenetic	O
silencing	O
of	O
low	B-Biological_Molecule
density	I-Biological_Molecule
lipoprotein	I-Biological_Molecule
receptor	I-Biological_Molecule
-	I-Biological_Molecule
related	I-Biological_Molecule
protein	I-Biological_Molecule
1B	E-Biological_Molecule
expression	O
in	O
oral	O
squamous	O
cell	O
carcinoma	O
.	O

Pronuclear	O
stage	O
porcine	O
embryos	O
do	O
not	O
possess	O
a	O
strict	O
asymmetric	O
distribution	O
of	O
lysine	O
9	O
dimethylation	O
of	O
histone	B-Biological_Molecule
H3	E-Biological_Molecule
based	O
solely	O
on	O
parental	O
origin	O
.	O

However	O
,	O
at	O
the	O
pronuclear	O
stage	O
the	O
pronuclei	O
within	O
in	O
vitro	O
-	O
fertilized	O
porcine	O
embryos	O
possessed	O
an	O
asymmetric	O
distribution	O
of	O
the	O
dimethylated	O
form	O
of	O
H3K9	S-Biological_Molecule
;	O
this	O
distribution	O
was	O
not	O
based	O
solely	O
on	O
the	O
parent	O
-	O
of	O
-	O
origin	O
.	O

Forced	O
RIZ1	S-Biological_Molecule
expression	O
in	O
model	O
CML	O
blast	O
crisis	O
(	O
BC	O
)	O
cell	O
lines	O
decreases	O
proliferation	O
,	O
increases	O
apoptosis	O
and	O
enhances	O
differentiation	O
.	O

METHODS	O
:	O
The	O
protein	O
expression	O
of	O
DNMT1	S-Biological_Molecule
and	O
DNMT3b	S-Biological_Molecule
were	O
examined	O
by	O
immunohistochemistry	O
in	O
paraffin	O
-	O
embedded	O
tissues	O
of	O
ACC	O
from	O
60	O
patients	O
.	O

It	O
was	O
much	O
more	O
expressed	O
in	O
the	O
lower	O
grade	O
or	O
more	O
advanced	O
stage	O
cases	O
.	O

Using	O
in	O
vitro	O
assays	O
,	O
we	O
demonstrated	O
that	O
the	O
levels	O
of	O
iron	O
(	O
Fe	O
)	O
,	O
ascorbate	O
,	O
and	O
various	O
tricarboxylic	O
acid	O
(	O
TCA	O
)	O
cycle	O
intermediates	O
affect	O
PHD	O
activity	O
.	O

During	O
malignant	O
transformation	O
,	O
certain	O
glyco	O
-	O
epitopes	O
of	O
MUC1	S-Biological_Molecule
,	O
such	O
as	O
Tn	O
-	O
antigen	O
,	O
TF	O
-	O
antigen	O
and	O
their	O
sialylated	O
forms	O
become	O
exposed	O
.	O

We	O
also	O
discuss	O
how	O
gene	O
transcription	O
memory	O
may	O
affect	O
the	O
mechanism	O
of	O
pathogenesis	O
and	O
immune	O
evasion	O
.	O

This	O
methodology	O
is	O
applicable	O
to	O
other	O
histones	S-Biological_Molecule
and	O
larger	O
polypeptides	O
and	O
will	O
likely	O
be	O
a	O
valuable	O
tool	O
in	O
understanding	O
the	O
roles	O
of	O
combinatorial	O
patterns	O
of	O
PTMs	O
.	O

The	O
recently	O
identified	O
histone	S-Biological_Molecule
demethylase	O
lysine	B-Biological_Molecule
-	I-Biological_Molecule
specific	I-Biological_Molecule
demethylase	I-Biological_Molecule
1	E-Biological_Molecule
(	O
LSD1	S-Biological_Molecule
)	O
is	O
chemically	O
restricted	O
to	O
demethylation	O
of	O
only	O
mono	O
-	O
and	O
di	O
-	O
but	O
not	O
trimethylated	O
histone	B-Biological_Molecule
H3	E-Biological_Molecule
lysine	O
4	O
(	O
H3K4me3	S-Biological_Molecule
)	O
.	O

As	O
angiogenesis	O
is	O
fundamental	O
to	O
proper	O
wound	O
healing	O
,	O
we	O
examined	O
the	O
effect	O
of	O
TAPS	O
on	O
angiogenesis	O
using	O
human	O
umbilical	O
vein	O
endothelial	O
cells	O
cultured	O
in	O
vitro	O
.	O

Recognizing	O
its	O
inhibitory	O
potential	O
on	O
angiogenesis	O
,	O
we	O
further	O
investigated	O
the	O
action	O
mechanism	O
of	O
TAPS	O
.	O

NC	S-Biological_Molecule
possesses	O
arginine	O
dimethylation	O
sites	O
in	O
each	O
of	O
its	O
two	O
basic	O
regions	O
at	O
positions	O
R10	O
and	O
R32	O
,	O
and	O
methylated	O
NC	S-Biological_Molecule
was	O
less	O
able	O
than	O
wild	O
-	O
type	O
to	O
promote	O
RNA	O
annealing	O
and	O
participate	O
in	O
the	O
initiation	O
of	O
reverse	O
transcription	O
.	O

CONCLUSION	O
:	O
NC	S-Biological_Molecule
is	O
an	O
in	O
-	O
vivo	O
target	O
of	O
PRMT6	S-Biological_Molecule
,	O
and	O
arginine	O
methylation	O
of	O
NC	S-Biological_Molecule
reduces	O
RNA	O
annealing	O
and	O
the	O
initiation	O
of	O
reverse	O
transcription	O
.	O

These	O
findings	O
may	O
lead	O
to	O
ways	O
of	O
driving	O
HIV	O
-	O
infected	O
cells	O
out	O
of	O
latency	O
with	O
drugs	O
that	O
inhibit	O
PRMT6	S-Biological_Molecule
.	O

These	O
data	O
suggested	O
that	O
EGFR	S-Biological_Molecule
-	O
PTK	O
signaling	O
also	O
affects	O
aspects	O
of	O
AAV	O
transduction	O
other	O
than	O
viral	O
second	O
-	O
strand	O
DNA	O
synthesis	O
.	O

Thus	O
,	O
EGFR	S-Biological_Molecule
-	O
PTK	O
signaling	O
modulates	O
ubiquitin	S-Biological_Molecule
(	O
Ub	S-Biological_Molecule
)	O
/	O
proteasome	O
pathway	O
-	O
mediated	O
intracellular	O
trafficking	O
as	O
well	O
as	O
FKBP52	S-Biological_Molecule
-	O
mediated	O
second	O
-	O
strand	O
DNA	O
synthesis	O
of	O
AAV2	O
vectors	O
.	O

The	O
possibility	O
of	O
a	O
unique	O
interdomain	O
disulphide	O
bridge	O
was	O
predicted	O
for	O
LtrF	S-Biological_Molecule
.	O

In	O
snakes	O
,	O
the	O
transferrin	S-Biological_Molecule
(	O
PtrF	S-Biological_Molecule
,	O
HtrF	S-Biological_Molecule
and	O
GtrF	S-Biological_Molecule
)	O
N	O
-	O
lobe	O
"	O
dilysine	O
trigger	O
"	O
occurring	O
in	O
all	O
other	O
known	O
transferrins	S-Biological_Molecule
was	O
not	O
found	O
,	O
which	O
indicates	O
a	O
different	O
mechanism	O
of	O
iron	O
release	O
.	O

While	O
we	O
did	O
not	O
find	O
any	O
evidence	O
that	O
N	O
-	O
linked	O
glycans	O
of	O
E1	S-Biological_Molecule
contribute	O
to	O
the	O
masking	O
of	O
neutralizing	O
epitopes	O
,	O
our	O
data	O
demonstrate	O
that	O
at	O
least	O
three	O
glycans	O
on	O
E2	S-Biological_Molecule
(	O
denoted	O
E2N1	S-Biological_Molecule
,	O
E2N6	S-Biological_Molecule
,	O
and	O
E2N11	S-Biological_Molecule
)	O
reduce	O
the	O
sensitivity	O
of	O
HCVpp	O
to	O
antibody	O
neutralization	O
.	O

Importantly	O
,	O
these	O
three	O
glycans	O
also	O
reduced	O
the	O
access	O
of	O
CD81	S-Biological_Molecule
to	O
its	O
E2	S-Biological_Molecule
binding	O
site	O
,	O
as	O
shown	O
by	O
using	O
a	O
soluble	O
form	O
of	O
the	O
extracellular	O
loop	O
of	O
CD81	S-Biological_Molecule
in	O
inhibition	O
of	O
entry	O
.	O

HTLV	O
-	O
1	O
Tax	S-Biological_Molecule
profoundly	O
represses	O
P2	O
promoter	O
activity	O
and	O
histone	B-Biological_Molecule
deacetylase	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
(	O
HDAC1	S-Biological_Molecule
)	O
potentiates	O
such	O
inhibition	O
.	O

To	O
investigate	O
the	O
clinical	O
significance	O
of	O
epigenetic	O
changes	O
in	O
neuroblastoma	O
,	O
we	O
evaluated	O
the	O
relationship	O
between	O
clinicopathologic	O
variables	O
and	O
the	O
pattern	O
of	O
gene	O
methylation	O
in	O
neuroblastoma	O
cell	O
lines	O
and	O
tumors	O
.	O

AR	O
hydroxylation	O
decreases	O
the	O
extent	O
of	O
ARD	O
binding	O
to	O
FIH	S-Biological_Molecule
while	O
not	O
affecting	O
signaling	O
through	O
the	O
canonical	O
Notch	O
pathway	O
.	O

Crystallographic	O
analyses	O
of	O
the	O
hydroxylated	O
Notch	O
ARD	O
(	O
2	O
.	O
35A	O
)	O
and	O
of	O
Notch	O
peptides	O
bound	O
to	O
FIH	O
(	O
2	O
.	O
4	O
-	O
2	O
.	O
6A	O
)	O
reveal	O
the	O
stereochemistry	O
of	O
hydroxylation	O
on	O
the	O
AR	O
and	O
imply	O
that	O
significant	O
conformational	O
changes	O
are	O
required	O
in	O
the	O
ARD	O
fold	O
in	O
order	O
to	O
enable	O
hydroxylation	O
at	O
the	O
FIH	S-Biological_Molecule
active	O
site	O
.	O

We	O
presently	O
investigated	O
whether	O
sensitivity	O
could	O
be	O
increased	O
by	O
consideration	O
of	O
a	O
third	O
gene	O
,	O
which	O
encodes	O
retinoic	B-Biological_Molecule
acid	I-Biological_Molecule
receptor	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
(	O
RARbeta	S-Biological_Molecule
)	O
.	O

No	O
aberrant	O
methylation	O
was	O
detected	O
in	O
control	O
sera	O
.	O

In	O
the	O
follow	O
-	O
up	O
group	O
,	O
aberrant	O
methylation	O
was	O
demonstrated	O
in	O
2	O
of	O
the	O
3	O
patients	O
who	O
had	O
definite	O
radiologic	O
evidence	O
of	O
recurrences	O
.	O

CONCLUSIONS	O
:	O
Including	O
the	O
MSP	O
assay	O
in	O
conventional	O
follow	O
-	O
up	O
could	O
facilitate	O
early	O
detection	O
of	O
recurrent	O
disease	O
in	O
gastric	O
cancer	O
patients	O
.	O

Site	O
-	O
specific	O
N	O
-	O
glycan	O
characterization	O
of	O
human	O
complement	B-Biological_Molecule
factor	I-Biological_Molecule
H	E-Biological_Molecule
.	O

A	O
17	O
.	O
9	O
-	O
kDa	O
mass	O
decrease	O
,	O
observed	O
after	O
glycosidase	O
treatment	O
,	O
indicated	O
that	O
N	O
-	O
glycosylation	O
is	O
the	O
major	O
post	O
-	O
translational	O
modification	O
of	O
CFH	S-Biological_Molecule
.	O

CFH	S-Biological_Molecule
was	O
not	O
sensitive	O
to	O
endoglycosidase	B-Biological_Molecule
H	E-Biological_Molecule
(	O
Endo	B-Biological_Molecule
H	E-Biological_Molecule
)	O
deglycosylation	O
,	O
indicating	O
the	O
absence	O
of	O
hybrid	O
and	O
oligomannose	O
structures	O
.	O

Thus	O
,	O
we	O
assessed	O
the	O
methylation	O
-	O
dependent	O
regulation	O
of	O
miRNA	O
expression	O
in	O
human	O
malignant	O
cholangiocytes	O
stably	O
transfected	O
to	O
overexpress	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
.	O

Biochemical	O
analysis	O
of	O
the	O
Rpn10DeltaUIM	S-Biological_Molecule
liver	O
showed	O
specific	O
impairment	O
of	O
degradation	O
of	O
ubiquitinated	O
proteins	O
.	O

The	O
binding	O
of	O
CBP	S-Biological_Molecule
and	O
p300	S-Biological_Molecule
,	O
which	O
have	O
histone	S-Biological_Molecule
acetyltransferase	O
activity	O
,	O
as	O
well	O
as	O
binding	O
of	O
retinoid	B-Biological_Molecule
X	I-Biological_Molecule
receptor	I-Biological_Molecule
alpha	E-Biological_Molecule
(	O
RXRalpha	S-Biological_Molecule
)	O
increased	O
on	O
the	O
CRBPII	S-Biological_Molecule
promoter	O
/	O
enhancer	O
region	O
during	O
the	O
perinatal	O
period	O
.	O

We	O
report	O
data	O
on	O
a	O
human	O
P4H	O
possessing	O
a	O
transmembrane	O
domain	O
(	O
P4H	O
-	O
TM	O
)	O
.	O

Its	O
gene	O
is	O
also	O
found	O
in	O
zebrafish	O
but	O
not	O
in	O
flies	O
and	O
nematodes	O
.	O

Promoter	O
methylation	O
status	O
of	O
multiple	O
genes	O
in	O
uveal	O
melanoma	O
.	O

Given	O
that	O
mutations	O
in	O
genes	O
of	O
the	O
RAS	O
pathway	O
are	O
rarely	O
observed	O
in	O
uveal	O
melanoma	O
,	O
epigenetic	O
inactivation	O
of	O
RASSF1A	S-Biological_Molecule
may	O
be	O
an	O
alternative	O
mechanism	O
of	O
tumorigenesis	O
.	O

We	O
analyze	O
the	O
protein	O
arginine	O
methyltransferases	O
(	O
PRMTs	O
)	O
that	O
catalyze	O
the	O
formation	O
of	O
methylarginines	O
in	O
porcine	O
brain	O
.	O

The	O
human	O
U6	O
small	O
nuclear	O
RNA	O
promoter	O
,	O
located	O
5	O
'	O
of	O
the	O
transcription	O
start	O
site	O
,	O
consists	O
of	O
a	O
core	O
region	O
directing	O
basal	O
transcription	O
and	O
an	O
activating	O
region	O
that	O
recruits	O
the	O
transcription	O
factors	O
Oct	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
Staf	S-Biological_Molecule
(	O
ZNF143	S-Biological_Molecule
)	O
.	O

We	O
show	O
that	O
Staf	S-Biological_Molecule
activates	O
U6	O
transcription	O
from	O
a	O
preassembled	O
chromatin	O
template	O
in	O
vitro	O
and	O
associates	O
with	O
several	O
proteins	O
linked	O
to	O
chromatin	O
modification	O
,	O
among	O
them	O
chromodomain	B-Biological_Molecule
-	I-Biological_Molecule
helicase	I-Biological_Molecule
-	I-Biological_Molecule
DNA	I-Biological_Molecule
binding	I-Biological_Molecule
protein	I-Biological_Molecule
8	E-Biological_Molecule
(	O
CHD8	S-Biological_Molecule
)	O
.	O

The	O
importance	O
of	O
these	O
long	O
-	O
range	O
interactions	O
to	O
substrate	O
capture	O
were	O
confirmed	O
by	O
"	O
mutagenesis	O
"	O
experiments	O
on	O
a	O
minimal	O
peptide	O
substrate	O
.	O

HIF	O
-	O
1	O
is	O
a	O
heterodimer	O
of	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
and	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
subunits	O
.	O

Quercetin	O
,	O
a	O
flavonoid	O
with	O
anti	O
-	O
oxidant	O
,	O
anti	O
-	O
inflammatory	O
,	O
and	O
kinase	O
modulating	O
properties	O
,	O
has	O
been	O
found	O
to	O
induce	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
accumulation	O
and	O
VEGF	S-Biological_Molecule
secretion	O
in	O
normoxia	O
.	O

Disruption	O
of	O
the	O
UBP3	S-Biological_Molecule
gene	O
leads	O
to	O
an	O
enhanced	O
activation	O
of	O
the	O
cell	O
wall	O
integrity	O
pathway	O
MAPK	O
Slt2	S-Biological_Molecule
when	O
cells	O
are	O
challenged	O
with	O
a	O
variety	O
of	O
pathway	O
activation	O
agents	O
such	O
as	O
pheromone	O
and	O
Congo	O
red	O
.	O

The	O
in	O
vitro	O
conjugation	O
systems	O
reported	O
here	O
will	O
afford	O
a	O
tool	O
with	O
which	O
to	O
investigate	O
the	O
cross	O
-	O
talk	O
mechanism	O
between	O
two	O
conjugation	O
systems	O
.	O

Cps35	S-Biological_Molecule
is	O
also	O
required	O
for	O
proper	O
H3K79	S-Biological_Molecule
trimethylation	O
.	O

Deubiquitylation	O
of	O
histone	B-Biological_Molecule
H2A	E-Biological_Molecule
activates	O
transcriptional	O
initiation	O
via	O
trans	O
-	O
histone	O
cross	O
-	O
talk	O
with	O
H3K4	S-Biological_Molecule
di	O
-	O
and	O
trimethylation	O
.	O

The	O
levels	O
of	O
ubH2A	S-Biological_Molecule
vary	O
during	O
hepatocyte	O
regeneration	O
,	O
and	O
based	O
on	O
microarray	O
expression	O
data	O
from	O
regenerating	O
liver	O
,	O
we	O
identified	O
USP21	S-Biological_Molecule
,	O
a	O
ubiquitin	S-Biological_Molecule
-	O
specific	O
protease	O
that	O
catalyzes	O
the	O
hydrolysis	O
of	O
ubH2A	S-Biological_Molecule
.	O

All	O
four	O
Uev1	O
proteins	O
can	O
form	O
a	O
stable	O
complex	O
with	O
At	O
Ubc13	S-Biological_Molecule
or	O
with	O
Ubc13	S-Biological_Molecule
from	O
yeast	O
or	O
human	O
and	O
can	O
promote	O
Ubc13	S-Biological_Molecule
-	O
mediated	O
Lys	O
-	O
63	O
polyubiquitination	O
.	O

PIPKIIbeta	S-Biological_Molecule
and	O
SPOP	S-Biological_Molecule
interact	O
and	O
co	O
-	O
localize	O
at	O
nuclear	O
speckles	O
in	O
mammalian	O
cells	O
,	O
and	O
SPOP	S-Biological_Molecule
mediates	O
the	O
ubiquitylation	O
of	O
PIPKIIbeta	S-Biological_Molecule
by	O
Cul3	S-Biological_Molecule
-	O
based	O
ubiquitin	S-Biological_Molecule
ligases	O
.	O

The	O
kinase	O
-	O
dead	O
PIPKIIbeta	S-Biological_Molecule
mutant	O
increases	O
the	O
cellular	O
content	O
of	O
its	O
substrate	O
lipid	O
phosphatidylinositol	O
5	O
-	O
phosphate	O
(	O
PI5P	O
)	O
,	O
suggesting	O
that	O
PI5P	O
may	O
stimulate	O
Cul3	S-Biological_Molecule
-	O
SPOP	S-Biological_Molecule
activity	O
through	O
a	O
p38	O
-	O
dependent	O
signaling	O
pathway	O
.	O

Taken	O
together	O
,	O
these	O
data	O
define	O
a	O
novel	O
mechanism	O
whereby	O
the	O
phosphoinositide	O
PI5P	O
leads	O
to	O
stimulation	O
of	O
Cul3	S-Biological_Molecule
-	O
SPOP	S-Biological_Molecule
ubiquitin	S-Biological_Molecule
ligase	O
activity	O
and	O
also	O
implicate	O
PIPKIIbeta	S-Biological_Molecule
as	O
a	O
key	O
regulator	O
of	O
this	O
signaling	O
pathway	O
through	O
its	O
association	O
with	O
the	O
Cul3	S-Biological_Molecule
-	O
SPOP	S-Biological_Molecule
complex	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
role	O
of	O
E6	S-Biological_Molecule
-	O
associated	O
protein	O
(	O
E6AP	S-Biological_Molecule
)	O
in	O
HPV16	O
E6	S-Biological_Molecule
-	O
induced	O
TSC2	S-Biological_Molecule
degradation	O
.	O

We	O
further	O
found	O
that	O
TSC2	S-Biological_Molecule
bound	O
E6AP	S-Biological_Molecule
in	O
the	O
presence	O
as	O
well	O
as	O
in	O
the	O
absence	O
of	O
HPV16	O
E6	S-Biological_Molecule
.	O

We	O
demonstrate	O
a	O
novel	O
mechanism	O
of	O
tuberin	S-Biological_Molecule
inactivation	O
through	O
ubiquitination	O
by	O
Pam	S-Biological_Molecule
,	O
a	O
putative	O
RING	O
finger	O
-	O
containing	O
E3	O
ubiquitin	S-Biological_Molecule
(	O
Ub	S-Biological_Molecule
)	O
ligase	O
in	O
mammalian	O
cells	O
.	O

T3	O
induces	O
complex	O
gene	O
expression	O
patterns	O
raises	O
the	O
question	O
of	O
how	O
these	O
expression	O
patterns	O
might	O
be	O
regulated	O
.	O

Dependence	O
of	O
reactive	O
oxygen	O
species	O
and	O
FLICE	B-Biological_Molecule
inhibitory	I-Biological_Molecule
protein	E-Biological_Molecule
on	O
lipofectamine	O
-	O
induced	O
apoptosis	O
in	O
human	O
lung	O
epithelial	O
cells	O
.	O

Inhibition	O
of	O
caspase	O
activity	O
by	O
pan	O
-	O
caspase	O
inhibitor	O
(	O
z	O
-	O
VAD	O
-	O
fmk	O
)	O
or	O
by	O
specific	O
caspase	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
inhibitor	O
(	O
z	O
-	O
IETD	O
-	O
fmk	O
)	O
or	O
caspase	B-Biological_Molecule
-	I-Biological_Molecule
9	E-Biological_Molecule
inhibitor	O
(	O
z	O
-	O
LEHD	O
-	O
fmk	O
)	O
inhibited	O
the	O
apoptotic	O
effect	O
of	O
LF	O
.	O

Mice	O
infected	O
with	O
SseL	S-Biological_Molecule
-	O
deficient	O
bacteria	O
mount	O
stronger	O
inflammatory	O
responses	O
,	O
associated	O
with	O
increased	O
production	O
of	O
NF	O
-	O
kappaB	O
-	O
dependent	O
cytokines	O
.	O

Here	O
,	O
we	O
provide	O
evidence	O
that	O
in	O
the	O
differentiation	O
of	O
PC12	O
cells	O
induced	O
by	O
nerve	O
growth	O
factor	O
(	O
NGF	O
)	O
,	O
GSK3beta	S-Biological_Molecule
was	O
increased	O
at	O
both	O
the	O
mRNA	O
and	O
protein	O
levels	O
,	O
whereas	O
E2F1	S-Biological_Molecule
at	O
these	O
two	O
levels	O
was	O
decreased	O
.	O

Synthetic	O
lethal	O
screens	O
identify	O
gene	O
silencing	O
processes	O
in	O
yeast	O
and	O
implicate	O
the	O
acetylated	O
amino	O
terminus	O
of	O
Sir3	S-Biological_Molecule
in	O
recognition	O
of	O
the	O
nucleosome	O
core	O
.	O

Previous	O
studies	O
suggested	O
that	O
H3K79	S-Biological_Molecule
methylation	O
within	O
euchromatin	O
prevents	O
nonspecific	O
binding	O
of	O
the	O
Sir	O
proteins	O
,	O
which	O
in	O
turn	O
facilitates	O
binding	O
of	O
the	O
Sir	O
proteins	O
in	O
unmethylated	O
silent	O
chromatin	O
.	O

Our	O
results	O
suggest	O
that	O
the	O
BAH	O
domain	O
of	O
Sir3	S-Biological_Molecule
binds	O
to	O
histone	B-Biological_Molecule
H3K79	E-Biological_Molecule
and	O
that	O
acetylation	O
of	O
the	O
BAH	O
domain	O
is	O
required	O
for	O
the	O
binding	O
specificity	O
of	O
Sir3	S-Biological_Molecule
for	O
nucleosomes	O
unmethylated	O
at	O
H3K79	S-Biological_Molecule
.	O

Isoniazid	O
acetylating	O
phenotype	O
in	O
patients	O
with	O
paracoccidioidomycosis	O
and	O
its	O
relationship	O
with	O
serum	O
sulfadoxin	O
levels	O
,	O
glucose	B-Biological_Molecule
-	I-Biological_Molecule
6	I-Biological_Molecule
-	I-Biological_Molecule
phosphate	I-Biological_Molecule
dehydrogenase	E-Biological_Molecule
and	O
glutathione	B-Biological_Molecule
reductase	E-Biological_Molecule
activities	O
.	O

Furthermore	O
,	O
sulfadoxin	O
levels	O
were	O
always	O
above	O
50	O
micrograms	O
/	O
ml	O
,	O
a	O
value	O
considered	O
therapeutic	O
.	O

Glycation	O
does	O
not	O
modify	O
bovine	O
serum	B-Biological_Molecule
albumin	E-Biological_Molecule
(	O
BSA	S-Biological_Molecule
)	O
-	O
induced	O
reduction	O
of	O
rat	O
aortic	O
relaxation	O
:	O
the	O
response	O
to	O
glycated	O
and	O
nonglycated	O
BSA	S-Biological_Molecule
is	O
lost	O
in	O
metabolic	O
syndrome	O
.	O

Nonglycated	O
BSA	S-Biological_Molecule
and	O
AGE	O
-	O
BSA	S-Biological_Molecule
significantly	O
diminished	O
relaxation	O
in	O
a	O
35	O
%	O
in	O
the	O
control	O
group	O
but	O
the	O
decrease	O
was	O
similar	O
when	O
using	O
nonglycated	O
BSA	S-Biological_Molecule
and	O
AGE	O
-	O
BSA	S-Biological_Molecule
.	O

This	O
finding	O
supports	O
a	O
model	O
in	O
which	O
the	O
H2A	S-Biological_Molecule
ubiquitin	S-Biological_Molecule
hydrolase	O
USP22	S-Biological_Molecule
is	O
coordinately	O
expressed	O
with	O
Polycomb	O
H2A	S-Biological_Molecule
ubiquitin	S-Biological_Molecule
ligases	O
in	O
order	O
that	O
the	O
transcription	O
of	O
certain	O
critical	O
transforming	O
genes	O
be	O
maintained	O
in	O
the	O
face	O
of	O
the	O
global	O
repression	O
mediated	O
by	O
Polycomb	O
.	O

Pro	O
-	O
inflammatory	O
signaling	O
triggers	O
polyubiquitination	O
of	O
intermediaries	O
(	O
e	O
.	O
g	O
.	O
RIP1	S-Biological_Molecule
)	O
,	O
which	O
activate	O
IkappaB	O
kinases	O
that	O
trigger	O
Ser	O
phosphorylation	O
and	O
degradation	O
of	O
IkappaBalpha	S-Biological_Molecule
,	O
thereby	O
promoting	O
nuclear	O
translocation	O
of	O
NF	O
-	O
kappaB	O
.	O

Abrupt	O
inhibition	O
of	O
the	O
EGFR	S-Biological_Molecule
kinase	O
activity	O
resulted	O
in	O
dissociation	O
of	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Cbl	E-Biological_Molecule
from	O
EGFR	S-Biological_Molecule
.	O

Methylated	O
NEUROD1	S-Biological_Molecule
promoter	O
is	O
a	O
marker	O
for	O
chemosensitivity	O
in	O
breast	O
cancer	O
.	O

CONCLUSIONS	O
:	O
These	O
data	O
support	O
the	O
view	O
that	O
NEUROD1	S-Biological_Molecule
methylation	O
is	O
a	O
chemosensitivity	O
marker	O
in	O
estrogen	B-Biological_Molecule
receptor	E-Biological_Molecule
-	O
negative	O
breast	O
cancer	O
.	O

Since	O
protein	O
ubiquitination	O
is	O
the	O
predominant	O
sorting	O
signal	O
in	O
receptor	O
endocytosis	O
,	O
we	O
investigated	O
whether	O
Nef	S-Biological_Molecule
is	O
ubiquitinated	O
.	O

Lysine	O
-	O
free	O
Nef	S-Biological_Molecule
mutant	O
reintroduced	O
with	O
lysine	O
144	O
(	O
DeltaK10	O
+	O
K144	O
)	O
was	O
shown	O
active	O
in	O
CD4	S-Biological_Molecule
down	O
-	O
regulation	O
.	O

Structural	O
similarities	O
and	O
frequent	O
co	O
-	O
occurrence	O
suggest	O
that	O
the	O
biosynthetic	O
pathways	O
for	O
these	O
compounds	O
share	O
common	O
features	O
.	O

Based	O
on	O
available	O
literature	O
data	O
we	O
propose	O
that	O
oximes	O
produced	O
by	O
CYP79	S-Biological_Molecule
orthologs	O
are	O
common	O
intermediates	O
and	O
that	O
their	O
conversion	O
into	O
beta	O
-	O
and	O
gamma	O
-	O
hydroxynitrile	O
glucosides	O
is	O
mediated	O
by	O
evolutionary	O
diversified	O
multifunctional	O
orthologs	O
to	O
CYP71E1	S-Biological_Molecule
.	O

We	O
designate	O
these	O
as	O
CYP71	O
(	O
betagamma	O
)	O
and	O
CYP71	O
(	O
alphabetagamma	O
)	O
;	O
in	O
combination	O
with	O
the	O
classical	O
CYP71	O
(	O
alpha	O
)	O
(	O
CYP71E1	S-Biological_Molecule
and	O
orthologs	O
)	O
these	O
are	O
able	O
to	O
hydroxylate	O
any	O
of	O
the	O
carbon	O
atoms	O
present	O
in	O
the	O
amino	O
acid	O
and	O
oxime	O
derived	O
nitriles	O
.	O

Comparison	O
of	O
genomic	O
datasets	O
revealed	O
that	O
PKL	S-Biological_Molecule
-	O
dependent	O
genes	O
are	O
enriched	O
for	O
trimethylation	O
of	O
histone	B-Biological_Molecule
H3	E-Biological_Molecule
lysine	O
27	O
(	O
H3K27me3	S-Biological_Molecule
)	O
,	O
a	O
repressive	O
epigenetic	O
mark	O
.	O

HES1	S-Biological_Molecule
interaction	O
with	O
FA	O
core	O
complex	O
members	O
is	O
dependent	O
on	O
a	O
functional	O
FA	O
pathway	O
.	O

Coincidentally	O
,	O
the	O
acetylated	O
histone	B-Biological_Molecule
H3	E-Biological_Molecule
(	O
AcH3	S-Biological_Molecule
)	O
level	O
at	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
promoter	O
region	O
was	O
first	O
enhanced	O
,	O
and	O
then	O
decreased	O
,	O
in	O
TSST	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
-	O
stimulated	O
T	O
cells	O
.	O

Smad	B-Biological_Molecule
ubiquitylation	I-Biological_Molecule
regulatory	I-Biological_Molecule
factor	I-Biological_Molecule
1	E-Biological_Molecule
(	O
Smurf1	S-Biological_Molecule
)	O
,	O
a	O
C2	O
-	O
WW	O
-	O
HECT	O
-	O
domain	O
E3	O
,	O
is	O
crucial	O
for	O
bone	O
homeostasis	O
,	O
in	O
which	O
it	O
suppresses	O
osteoblast	O
activity	O
.	O

Here	O
,	O
we	O
have	O
investigated	O
how	O
the	O
post	O
-	O
synthetic	O
acetylation	O
of	O
HMGB1	S-Biological_Molecule
affects	O
its	O
interaction	O
with	O
negatively	O
supercoiled	O
DNA	O
by	O
employing	O
monoacetylated	O
at	O
Lys2	O
protein	O
,	O
isolated	O
from	O
butyrate	O
-	O
treated	O
cells	O
.	O

Jun	B-Biological_Molecule
-	I-Biological_Molecule
dimerization	I-Biological_Molecule
protein	I-Biological_Molecule
2	E-Biological_Molecule
(	O
JDP2	S-Biological_Molecule
)	O
is	O
a	O
member	O
of	O
the	O
activating	O
protein	O
-	O
1	O
(	O
AP	O
-	O
1	O
)	O
family	O
of	O
transcription	O
factors	O
.	O

As	O
anticipated	O
from	O
the	O
presence	O
of	O
a	O
RING	O
-	O
finger	O
domain	O
,	O
IRF2	B-Biological_Molecule
-	I-Biological_Molecule
BP1	E-Biological_Molecule
enhanced	O
the	O
polyubiquitination	O
of	O
JDP2	S-Biological_Molecule
.	O

Here	O
we	O
report	O
physical	O
interactions	O
between	O
Ago2	S-Biological_Molecule
and	O
the	O
alpha	O
-	O
(	O
P4H	B-Biological_Molecule
-	I-Biological_Molecule
alpha	I-Biological_Molecule
(	I-Biological_Molecule
I	I-Biological_Molecule
)	E-Biological_Molecule
)	O
and	O
beta	O
-	O
(	O
P4H	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
)	O
subunits	O
of	O
the	O
type	O
I	O
collagen	O
prolyl	O
-	O
4	O
-	O
hydroxylase	O
(	O
C	O
-	O
P4H	O
(	O
I	O
)	O
)	O
.	O

In	O
vitro	O
,	O
both	O
Ago2	S-Biological_Molecule
and	O
Ago4	S-Biological_Molecule
seem	O
to	O
be	O
more	O
efficiently	O
hydroxylated	O
than	O
Ago1	S-Biological_Molecule
and	O
Ago3	S-Biological_Molecule
by	O
recombinant	O
human	O
C	O
-	O
P4H	O
(	O
I	O
)	O
.	O

Whether	O
these	O
two	O
regulatory	O
processes	O
interact	O
,	O
however	O
,	O
is	O
unknown	O
.	O

A	O
C	O
-	O
terminal	O
fragment	O
of	O
Cyclin	B-Biological_Molecule
E	E-Biological_Molecule
,	O
generated	O
by	O
caspase	O
-	O
mediated	O
cleavage	O
,	O
is	O
degraded	O
in	O
the	O
absence	O
of	O
a	O
recognizable	O
phosphodegron	O
.	O

Histone	B-Biological_Molecule
H2A	E-Biological_Molecule
ubiquitination	O
in	O
transcriptional	O
regulation	O
and	O
DNA	O
damage	O
repair	O
.	O

These	O
results	O
indicate	O
that	O
the	O
ubiquitin	S-Biological_Molecule
-	O
proteasome	O
system	O
regulates	O
neurite	O
formation	O
through	O
posttranslational	O
modification	O
of	O
TrkA	S-Biological_Molecule
receptors	O
.	O

The	O
genomic	O
landscapes	O
of	O
histone	B-Biological_Molecule
H3	E-Biological_Molecule
-	O
Lys9	O
modifications	O
of	O
gene	O
promoter	O
regions	O
and	O
expression	O
profiles	O
in	O
human	O
bone	O
marrow	O
mesenchymal	O
stem	O
cells	O
.	O

Functional	O
analysis	O
revealed	O
that	O
many	O
key	O
cellular	O
pathways	O
in	O
human	O
bone	O
marrow	O
MSC	O
self	O
-	O
renewal	O
,	O
such	O
as	O
the	O
canonical	O
signaling	O
pathways	O
,	O
cell	O
cycle	O
pathways	O
and	O
cytokine	O
related	O
pathways	O
may	O
be	O
regulated	O
by	O
H3	S-Biological_Molecule
-	O
Lys9	O
modifications	O
.	O

Forkhead	O
box	O
O	O
(	O
FOXO	O
)	O
transcription	O
factors	O
,	O
the	O
key	O
regulators	O
of	O
cell	O
survival	O
,	O
are	O
negatively	O
controlled	O
through	O
the	O
PI3K	O
-	O
Akt	O
signaling	O
pathway	O
.	O

A	O
critical	O
property	O
of	O
microtubules	O
is	O
their	O
rapid	O
and	O
time	O
-	O
sensitive	O
growth	O
and	O
shortening	O
dynamics	O
(	O
dynamic	O
instability	O
)	O
,	O
and	O
suppression	O
of	O
dynamics	O
by	O
antimitotic	O
anticancer	O
drugs	O
(	O
e	O
.	O
g	O
.	O
taxanes	O
and	O
the	O
vinca	O
alkaloids	O
)	O
is	O
central	O
to	O
the	O
anticancer	O
mechanisms	O
of	O
such	O
drugs	O
.	O

Air	S-Biological_Molecule
accumulates	O
at	O
the	O
Slc22a3	S-Biological_Molecule
promoter	O
in	O
correlation	O
with	O
localized	O
H3K9	S-Biological_Molecule
methylation	O
and	O
transcriptional	O
repression	O
.	O

Membrane	O
-	O
anchored	O
HJV	S-Biological_Molecule
acts	O
as	O
a	O
coreceptor	O
for	O
bone	O
morphogenetic	O
proteins	O
and	O
activates	O
the	O
transcription	O
of	O
hepcidin	S-Biological_Molecule
,	O
a	O
hormone	O
that	O
regulates	O
iron	O
efflux	O
from	O
cells	O
.	O

Moreover	O
,	O
nuclear	O
functions	O
of	O
Rsp5	S-Biological_Molecule
in	O
response	O
to	O
various	O
stresses	O
have	O
been	O
discovered	O
.	O

von	B-Biological_Molecule
Willebrand	I-Biological_Molecule
factor	E-Biological_Molecule
(	O
vWF	S-Biological_Molecule
)	O
is	O
a	O
multimeric	O
glycoprotein	O
that	O
supports	O
platelet	O
adhesion	O
on	O
thrombogenic	O
surfaces	O
as	O
part	O
of	O
the	O
normal	O
hemostatic	O
response	O
to	O
vascular	O
injury	O
.	O

A	O
chimeric	O
cDNA	O
that	O
codes	O
for	O
the	O
vWF	S-Biological_Molecule
signal	O
peptide	O
and	O
a	O
segment	O
of	O
vWF	S-Biological_Molecule
internal	O
primary	O
sequence	O
,	O
residues	O
441	O
-	O
730	O
,	O
directs	O
the	O
secretion	O
of	O
a	O
functional	O
vWF	S-Biological_Molecule
fragment	O
from	O
mammalian	O
cells	O
.	O

Genome	O
-	O
wide	O
histone	S-Biological_Molecule
methylation	O
profile	O
for	O
heart	O
failure	O
.	O

X	O
-	O
ray	O
diffraction	O
analyses	O
revealed	O
that	O
hydroxylation	O
does	O
not	O
alter	O
the	O
archetypical	O
ARD	O
conformation	O
in	O
the	O
crystalline	O
state	O
.	O

We	O
propose	O
that	O
intracellular	O
protein	O
hydroxylation	O
is	O
much	O
more	O
common	O
than	O
previously	O
thought	O
and	O
that	O
one	O
of	O
its	O
roles	O
is	O
stabilization	O
of	O
localized	O
regions	O
of	O
ARD	O
folds	O
.	O

BACKGROUND	O
:	O
Recessive	O
forms	O
of	O
osteogenesis	O
imperfecta	O
(	O
OI	O
)	O
may	O
be	O
caused	O
by	O
mutations	O
in	O
LEPRE1	S-Biological_Molecule
,	O
encoding	O
prolyl	B-Biological_Molecule
3	I-Biological_Molecule
-	I-Biological_Molecule
hydroxylase	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
(	O
P3H1	S-Biological_Molecule
)	O
or	O
in	O
CRTAP	S-Biological_Molecule
,	O
encoding	O
cartilage	O
associated	O
protein	O
.	O

RESULTS	O
:	O
Four	O
novel	O
homozygous	O
and	O
compound	O
heterozygous	O
mutations	O
were	O
identified	O
in	O
LEPRE1	S-Biological_Molecule
in	O
four	O
probands	O
.	O

Our	O
observation	O
that	O
a	O
mutant	O
of	O
CXCR4	S-Biological_Molecule
,	O
HA	O
-	O
3K	O
/	O
R	O
CXCR4	S-Biological_Molecule
,	O
which	O
cannot	O
be	O
ubiquitinated	O
and	O
does	O
not	O
mediate	O
a	O
chemotactic	O
response	O
to	O
CXCL12	S-Biological_Molecule
,	O
indicates	O
the	O
importance	O
of	O
this	O
covalent	O
modification	O
not	O
only	O
in	O
marking	O
receptors	O
for	O
degradation	O
but	O
also	O
for	O
permitting	O
CXCR4	S-Biological_Molecule
-	O
mediated	O
signaling	O
.	O

In	O
serum	O
-	O
shock	O
-	O
synchronized	O
cells	O
,	O
transactivational	O
activity	O
of	O
GR	S-Biological_Molecule
,	O
accessed	O
by	O
mRNA	O
expression	O
of	O
an	O
endogenous	O
-	O
responsive	O
gene	O
,	O
fluctuated	O
spontaneously	O
in	O
a	O
circadian	O
fashion	O
in	O
reverse	O
phase	O
with	O
CLOCK	S-Biological_Molecule
/	O
BMAL1	S-Biological_Molecule
mRNA	O
expression	O
.	O

Further	O
,	O
these	O
results	O
suggest	O
that	O
a	O
peripheral	O
target	O
tissue	O
circadian	O
rhythm	O
indirectly	O
influences	O
the	O
functions	O
of	O
every	O
organ	O
and	O
tissue	O
inside	O
the	O
body	O
through	O
modulation	O
of	O
the	O
ubiquitous	O
and	O
diverse	O
actions	O
of	O
glucocorticoids	O
.	O

Transduction	O
of	O
cloned	O
cells	O
and	O
primary	O
antigen	O
-	O
presenting	O
cells	O
(	O
APCs	O
)	O
in	O
vitro	O
demonstrated	O
successful	O
presentation	O
of	O
the	O
peptide	O
on	O
MHC	O
II	O
,	O
and	O
a	O
physiological	O
glycosylation	O
pattern	O
.	O

O	O
-	O
linked	O
N	O
-	O
acetylglucosaminylation	O
of	O
Sp1	S-Biological_Molecule
inhibits	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
promoter	O
.	O

O	O
-	O
GlcNAcylation	O
of	O
the	O
transcription	O
factor	O
Sp1	S-Biological_Molecule
and	O
the	O
presence	O
of	O
Sp1	S-Biological_Molecule
-	O
binding	O
sites	O
in	O
the	O
LTR	O
were	O
found	O
to	O
be	O
crucial	O
for	O
this	O
inhibitory	O
effect	O
.	O

Pulse	O
-	O
chase	O
experiments	O
reveal	O
a	O
44	O
-	O
kD	O
core	O
peptide	O
that	O
initially	O
bears	O
high	O
-	O
mannose	O
chains	O
(	O
giving	O
Mr	O
66	O
kD	O
)	O
and	O
is	O
subsequently	O
processed	O
to	O
a	O
mature	O
protein	O
of	O
Mr	O
87	O
-	O
104	O
kD	O
.	O

This	O
new	O
marker	O
for	O
mononuclear	O
phagocytes	O
illustrates	O
two	O
strategies	O
by	O
which	O
macrophages	O
remodel	O
their	O
membranes	O
in	O
response	O
to	O
inflammatory	O
stimuli	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
whether	O
modulation	O
of	O
PP2A	O
and	O
thus	O
cTnI	S-Biological_Molecule
phosphorylation	O
could	O
improve	O
sepsis	O
-	O
induced	O
contractile	O
dysfunction	O
.	O

Here	O
,	O
we	O
describe	O
the	O
functional	O
characterization	O
of	O
these	O
two	O
mutants	O
as	O
well	O
as	O
a	O
third	O
novel	O
erythrocytosis	O
-	O
associated	O
mutation	O
,	O
P534L	O
.	O

These	O
findings	O
reinforce	O
the	O
importance	O
of	O
HIF	B-Biological_Molecule
-	I-Biological_Molecule
2alpha	E-Biological_Molecule
in	O
human	O
EPO	S-Biological_Molecule
regulation	O
,	O
demonstrate	O
heterogeneity	O
of	O
functional	O
defects	O
arising	O
from	O
these	O
mutations	O
,	O
and	O
point	O
to	O
a	O
critical	O
role	O
for	O
residues	O
C	O
-	O
terminal	O
to	O
the	O
LXXLAP	O
motif	O
in	O
HIF	O
-	O
alpha	O
.	O

Disease	O
-	O
associated	O
mutant	O
ubiquitin	S-Biological_Molecule
causes	O
proteasomal	O
impairment	O
and	O
enhances	O
the	O
toxicity	O
of	O
protein	O
aggregates	O
.	O

Accumulation	O
of	O
UBB	S-Biological_Molecule
+	O
1	O
impairs	O
the	O
proteasome	O
system	O
and	O
enhances	O
toxic	O
protein	O
aggregation	O
,	O
ultimately	O
resulting	O
in	O
cell	O
death	O
.	O

The	O
expression	O
of	O
Ub	S-Biological_Molecule
(	O
ext	O
)	O
markedly	O
enhanced	O
cellular	O
susceptibility	O
to	O
toxic	O
protein	O
aggregates	O
but	O
,	O
surprisingly	O
,	O
did	O
not	O
induce	O
or	O
alter	O
nontoxic	O
protein	O
aggregates	O
in	O
yeast	O
.	O

In	O
this	O
review	O
,	O
we	O
will	O
discuss	O
recent	O
progress	O
in	O
delineating	O
the	O
roles	O
of	O
cullin	O
-	O
RING	O
E3	O
ubiquitin	S-Biological_Molecule
ligases	O
in	O
orchestrating	O
the	O
cellular	O
DNA	O
damage	O
response	O
through	O
ubiquitination	O
of	O
NER	O
factors	O
,	O
histones	S-Biological_Molecule
,	O
and	O
checkpoint	O
effectors	O
.	O

Errors	O
in	O
this	O
histone	S-Biological_Molecule
code	O
may	O
be	O
involved	O
in	O
many	O
human	O
diseases	O
especially	O
cancer	O
,	O
the	O
nature	O
of	O
which	O
could	O
be	O
therapeutically	O
exploited	O
.	O

METHODOLOGY	O
/	O
PRINCIPAL	O
FINDINGS	O
:	O
Genome	O
-	O
wide	O
profiling	O
of	O
the	O
trimethylation	O
of	O
histone	B-Biological_Molecule
H3	E-Biological_Molecule
lysine	O
4	O
(	O
H3K4me3	S-Biological_Molecule
)	O
and	O
lysine	O
27	O
(	O
H3K27me3	S-Biological_Molecule
)	O
was	O
performed	O
using	O
chromatin	O
immunoprecipitation	O
coupled	O
with	O
whole	O
genome	O
promoter	O
microarray	O
(	O
ChIP	O
-	O
chip	O
)	O
techniques	O
.	O

2	O
(	O
2001	O
)	O
446	O
-	O
457	O
;	O
W	O
.	O

Genet	O
.	O

Conversely	O
,	O
the	O
binding	O
to	O
both	O
TREX	O
-	O
2	O
and	O
SAGA	O
was	O
impaired	O
in	O
the	O
sus1	S-Biological_Molecule
-	O
11	O
allele	O
(	O
G37A	O
and	O
W38A	O
)	O
,	O
in	O
which	O
two	O
highly	O
conserved	O
residues	O
were	O
mutated	O
.	O

In	O
vitro	O
experiments	O
demonstrated	O
that	O
dissociation	O
of	O
mutant	O
Sus1	S-Biological_Molecule
from	O
its	O
partners	O
is	O
caused	O
by	O
a	O
reduced	O
affinity	O
toward	O
the	O
TREX	O
-	O
2	O
subunit	O
,	O
Sac3	S-Biological_Molecule
,	O
and	O
the	O
SAGA	O
factor	O
,	O
Sgf11	S-Biological_Molecule
,	O
respectively	O
.	O

Ischemia	B-Biological_Molecule
-	I-Biological_Molecule
reperfusion	I-Biological_Molecule
-	I-Biological_Molecule
inducible	I-Biological_Molecule
protein	E-Biological_Molecule
modulates	O
cell	O
sensitivity	O
to	O
anticancer	O
drugs	O
by	O
regulating	O
activity	O
of	O
efflux	O
transporter	O
.	O

We	O
also	O
show	O
that	O
P	O
-	O
glycoprotein	O
is	O
associated	O
with	O
COP	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
,	O
one	O
of	O
the	O
proteins	O
of	O
the	O
COPI	O
complex	O
.	O

Protein	O
kinase	O
DYRK2	S-Biological_Molecule
is	O
a	O
scaffold	O
that	O
facilitates	O
assembly	O
of	O
an	O
E3	O
ligase	O
.	O

It	O
challenges	O
the	O
notion	O
that	O
cancer	O
is	O
solely	O
associated	O
with	O
an	O
increase	O
in	O
polycomb	O
function	O
and	O
suggests	O
that	O
any	O
imbalance	O
in	O
polycomb	O
activity	O
could	O
drive	O
the	O
cell	O
toward	O
oncogenesis	O
.	O

Collectively	O
,	O
these	O
data	O
provide	O
evidence	O
that	O
cigarette	O
smoke	O
directly	O
engages	O
polycomb	O
machinery	O
to	O
activate	O
a	O
signaling	O
network	O
implicated	O
in	O
maintenance	O
of	O
cancer	O
stem	O
cells	O
.	O

Age	O
-	O
dependent	O
variations	O
of	O
the	O
biosyntheses	O
of	O
fibronectin	S-Biological_Molecule
and	O
fibrous	O
collagens	O
in	O
mouse	O
skin	O
.	O

USP33	S-Biological_Molecule
and	O
Mdm2	S-Biological_Molecule
function	O
reciprocally	O
and	O
favor	O
respectively	O
the	O
stability	O
or	O
lability	O
of	O
the	O
receptor	O
beta	O
-	O
arrestin	O
complex	O
,	O
thus	O
regulating	O
the	O
longevity	O
and	O
subcellular	O
localization	O
of	O
receptor	O
signalosomes	O
.	O

Thus	O
,	O
decreased	O
ubiquitylation	O
may	O
lead	O
to	O
growth	O
-	O
relevant	O
Ras	O
-	O
ERK	O
activation	O
by	O
failing	O
to	O
regulate	O
a	O
step	O
downstream	O
of	O
RTK	O
endocytosis	O
.	O

We	O
further	O
demonstrate	O
that	O
Drosophila	O
Ras	O
is	O
ubiquitylated	O
.	O

Additionally	O
,	O
the	O
co	O
-	O
localization	O
of	O
Fe65	S-Biological_Molecule
and	O
Nedd4	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
were	O
observed	O
via	O
confocal	O
microscopy	O
.	O

Protein	O
arginine	O
N	O
-	O
methyltransferases	O
(	O
PRMTs	O
)	O
methylate	O
arginine	O
residues	O
within	O
proteins	O
using	O
S	O
-	O
adenosyl	O
-	O
L	O
-	O
methionine	O
(	O
AdoMet	O
)	O
to	O
form	O
S	O
-	O
adenosyl	O
-	O
L	O
-	O
homocysteine	O
and	O
methylarginine	O
residues	O
.	O

The	O
peptidyl	O
-	O
prolyl	O
cis	O
-	O
trans	O
isomerase	O
activity	O
of	O
cyclophilin	B-Biological_Molecule
B	E-Biological_Molecule
was	O
shown	O
previously	O
to	O
catalyze	O
the	O
rate	O
of	O
triple	O
helix	O
formation	O
.	O

We	O
show	O
that	O
loss	O
of	O
the	O
Wnt	O
signaling	O
component	O
GSK3	B-Biological_Molecule
beta	E-Biological_Molecule
results	O
in	O
increased	O
levels	O
of	O
aPKC	S-Biological_Molecule
and	O
leads	O
to	O
defects	O
in	O
apical	O
-	O
basal	O
polarity	O
.	O

We	O
further	O
demonstrate	O
that	O
,	O
despite	O
its	O
somewhat	O
relaxed	O
substrate	O
specificity	O
for	O
N	O
-	O
acetylation	O
,	O
Cj1123c	S-Biological_Molecule
cannot	O
acetylate	O
aminoglycosides	O
,	O
indicating	O
a	O
preference	O
for	O
sugar	O
-	O
nucleotide	O
substrates	O
.	O

Removal	O
of	O
harmful	O
protein	O
aggregates	O
is	O
mediated	O
by	O
autophagy	O
,	O
a	O
mechanism	O
by	O
which	O
the	O
cell	O
sequesters	O
cytosolic	O
cargo	O
and	O
delivers	O
it	O
for	O
degradation	O
by	O
the	O
lysosome	O
.	O

It	O
is	O
concluded	O
that	O
the	O
lowering	O
of	O
the	O
binding	O
activity	O
of	O
MDBP	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
may	O
have	O
a	O
stronger	O
effect	O
on	O
the	O
derepression	O
of	O
the	O
gene	O
than	O
the	O
slow	O
demethylation	O
of	O
MDBP	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
DNA	O
binding	O
site	O
.	O

To	O
address	O
the	O
mechanism	O
underlying	O
this	O
phenomenon	O
,	O
we	O
characterized	O
the	O
MoAbs	O
,	O
and	O
found	O
that	O
one	O
of	O
the	O
clones	O
recognized	O
a	O
molecule	O
that	O
was	O
down	O
-	O
regulated	O
in	O
the	O
RzM6	O
-	O
44d	O
cells	O
.	O

This	O
molecule	O
was	O
purified	O
and	O
identified	O
as	O
the	O
70	O
-	O
kDa	O
thyroid	O
autoantigen	O
Ku70	S-Biological_Molecule
.	O

Alzheimer	O
'	O
s	O
disease	O
and	O
Parkinson	O
'	O
s	O
disease	O
are	O
common	O
neurodegenerative	O
diseases	O
that	O
may	O
share	O
some	O
underlying	O
mechanisms	O
of	O
pathogenesis	O
.	O

The	O
differences	O
in	O
charge	O
were	O
mainly	O
due	O
to	O
differences	O
in	O
sialylation	O
of	O
the	O
molecules	O
.	O

NBR1	S-Biological_Molecule
and	O
p62	S-Biological_Molecule
as	O
cargo	O
receptors	O
for	O
selective	O
autophagy	O
of	O
ubiquitinated	O
targets	O
.	O

L	O
-	O
DOPA	O
treatment	O
caused	O
hypersensitive	O
locomotor	O
activity	O
that	O
indicates	O
a	O
dopamine	O
-	O
depleted	O
state	O
.	O

To	O
gain	O
insight	O
into	O
the	O
differential	O
mechanism	O
of	O
gene	O
promoter	O
hypermethylation	O
in	O
acute	O
and	O
chronic	O
leukemia	O
,	O
we	O
identified	O
the	O
methylation	O
status	O
on	O
one	O
part	O
of	O
5	O
'	O
CpG	O
rich	O
region	O
of	O
8	O
genes	O
,	O
DAB2IP	S-Biological_Molecule
,	O
DLC	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
H	B-Biological_Molecule
-	I-Biological_Molecule
cadherin	E-Biological_Molecule
,	O
ID4	S-Biological_Molecule
,	O
Integrin	B-Biological_Molecule
alpha4	E-Biological_Molecule
,	O
RUNX3	S-Biological_Molecule
,	O
SFRP1	S-Biological_Molecule
,	O
and	O
SHP1	S-Biological_Molecule
in	O
bone	O
marrows	O
from	O
acute	O
myeloid	O
leukemia	O
(	O
AML	O
)	O
and	O
chronic	O
myeloid	O
leukemia	O
(	O
CML	O
)	O
patients	O
.	O

Furthermore	O
,	O
we	O
demonstrate	O
that	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
-	O
dependent	O
Jmjd3	S-Biological_Molecule
expression	O
is	O
mediated	O
by	O
STAT6	S-Biological_Molecule
,	O
a	O
major	O
transcription	O
factor	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
-	O
mediated	O
signaling	O
.	O

In	O
C	O
.	O
elegans	O
,	O
the	O
F	O
-	O
box	O
protein	O
FSN	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
controls	O
germline	O
apoptosis	O
by	O
regulating	O
CEP	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
the	O
single	O
ancestral	O
p53	S-Biological_Molecule
family	O
member	O
.	O

The	O
starting	O
material	O
was	O
grain	O
where	O
the	O
expression	O
of	O
rCI	B-Biological_Molecule
alpha	I-Biological_Molecule
1	E-Biological_Molecule
had	O
been	O
directed	O
by	O
an	O
embryo	O
-	O
specific	O
promoter	O
.	O

The	O
amino	O
acid	O
composition	O
and	O
immunoreactivity	O
of	O
CI	B-Biological_Molecule
alpha	I-Biological_Molecule
1	E-Biological_Molecule
was	O
similar	O
to	O
that	O
of	O
an	O
analogous	O
native	O
human	O
CI	B-Biological_Molecule
alpha	I-Biological_Molecule
1	E-Biological_Molecule
and	O
to	O
rCI	B-Biological_Molecule
alpha	I-Biological_Molecule
1	E-Biological_Molecule
produced	O
by	O
the	O
yeast	O
Pichia	O
pastoris	O
.	O

METHODS	O
:	O
Forty	O
-	O
four	O
patients	O
with	O
WG	O
(	O
459	O
serum	O
samples	O
)	O
who	O
participated	O
in	O
a	O
multicenter	O
randomized	O
trial	O
,	O
were	O
tested	O
by	O
capture	O
ELISA	O
for	O
ANCA	O
against	O
PR3	S-Biological_Molecule
and	O
deglycosylated	O
recombinant	O
variants	O
of	O
PR3	S-Biological_Molecule
.	O

Research	O
in	O
yeast	O
further	O
indicates	O
that	O
the	O
ortholog	O
of	O
Sug1	S-Biological_Molecule
,	O
Rpt6	S-Biological_Molecule
,	O
is	O
a	O
link	O
between	O
ubiquitination	O
of	O
histone	B-Biological_Molecule
H2B	E-Biological_Molecule
and	O
H3	S-Biological_Molecule
lysine	O
4	O
trimethylation	O
(	O
H3K4me3	S-Biological_Molecule
)	O
.	O

SKP2	S-Biological_Molecule
and	O
CKS1	S-Biological_Molecule
promote	O
degradation	O
of	O
cell	O
cycle	O
regulators	O
and	O
are	O
associated	O
with	O
hepatocellular	O
carcinoma	O
prognosis	O
.	O

BACKGROUND	O
&	O
AIMS	O
:	O
The	O
cell	O
cycle	O
regulators	O
P21	S-Biological_Molecule
(	O
WAF1	S-Biological_Molecule
)	O
,	O
P27	S-Biological_Molecule
(	O
KIP1	S-Biological_Molecule
)	O
,	O
P57	S-Biological_Molecule
(	O
KIP2	S-Biological_Molecule
)	O
,	O
P130	S-Biological_Molecule
,	O
RASSF1A	S-Biological_Molecule
,	O
and	O
FOXO1	S-Biological_Molecule
are	O
down	O
-	O
regulated	O
during	O
hepatocellular	O
carcinoma	O
(	O
HCC	O
)	O
pathogenesis	O
.	O

Messenger	O
RNA	O
levels	O
of	O
these	O
genes	O
were	O
up	O
-	O
regulated	O
in	O
samples	O
in	O
which	O
these	O
genes	O
were	O
not	O
methylated	O
;	O
protein	O
levels	O
increased	O
only	O
in	O
HCCB	O
because	O
of	O
CKS1	S-Biological_Molecule
-	O
and	O
SKP2	S-Biological_Molecule
-	O
dependent	O
ubiquitination	O
of	O
these	O
proteins	O
in	O
HCCP	O
.	O

In	O
HCC	O
cells	O
,	O
small	O
interfering	O
RNA	O
knockdown	O
of	O
SKP2	S-Biological_Molecule
reduced	O
proliferation	O
and	O
ubiquitination	O
of	O
the	O
cell	O
cycle	O
regulators	O
,	O
whereas	O
SKP2	S-Biological_Molecule
increased	O
proliferation	O
and	O
reduced	O
expression	O
of	O
cell	O
cycle	O
regulators	O
.	O

CONCLUSIONS	O
:	O
Ubiquitination	O
and	O
proteasome	O
degradation	O
of	O
P21WAF1	S-Biological_Molecule
,	O
P27KIP1	S-Biological_Molecule
,	O
P57KIP2	S-Biological_Molecule
,	O
P130	S-Biological_Molecule
,	O
RASSF1A	S-Biological_Molecule
,	O
and	O
FOXO1	S-Biological_Molecule
and	O
mechanisms	O
that	O
prevent	O
degradation	O
of	O
SKP2	S-Biological_Molecule
by	O
APC	O
/	O
C	O
-	O
CDH1	S-Biological_Molecule
contribute	O
to	O
HCC	O
progression	O
.	O

A	O
stronger	O
expression	O
was	O
present	O
in	O
nerve	O
fibers	O
,	O
particularly	O
in	O
PCa	O
,	O
in	O
immune	O
cells	O
and	O
in	O
smooth	O
muscle	O
and	O
endothelial	O
cells	O
of	O
vessels	O
of	O
BPH	O
and	O
PCa	O
.	O

There	O
are	O
approximately	O
79	O
active	O
deubiquitinating	O
enzymes	O
(	O
DUBs	O
)	O
predicted	O
in	O
the	O
human	O
genome	O
.	O

Whereas	O
many	O
cytosolic	O
and	O
membrane	O
components	O
of	O
this	O
system	O
are	O
known	O
,	O
only	O
few	O
luminal	O
players	O
have	O
been	O
identified	O
.	O

Matriptase	S-Biological_Molecule
is	O
a	O
type	O
II	O
transmembrane	O
serine	O
protease	O
containing	O
one	O
potential	O
site	O
for	O
asparagine	O
-	O
linked	O
glycosylation	O
(	O
N	O
-	O
glycosylation	O
)	O
on	O
the	O
catalytic	O
domain	O
(	O
Asn772	O
)	O
.	O

Excess	O
unlabeled	O
LPL	S-Biological_Molecule
prevented	O
the	O
immunoadsorption	O
of	O
this	O
labeled	O
species	O
,	O
hence	O
the	O
labeled	O
species	O
was	O
determined	O
to	O
be	O
LPL	S-Biological_Molecule
.	O

A	O
single	O
35SO4	O
-	O
labeled	O
tryptic	O
peptide	O
was	O
isolated	O
by	O
reverse	O
phase	O
chromatography	O
.	O

The	O
amino	O
acid	O
sequence	O
of	O
the	O
peptide	O
established	O
that	O
the	O
35SO4	O
oligosaccharide	O
is	O
conjugated	O
at	O
Asn	O
-	O
45	O
.	O

Sequential	O
exoglycosidase	O
digestion	O
,	O
thin	O
layer	O
chromatography	O
of	O
the	O
released	O
monosaccharides	O
,	O
and	O
the	O
use	O
of	O
glycosylation	O
inhibitors	O
established	O
that	O
the	O
sulfated	O
sugar	O
is	O
a	O
core	O
N	O
-	O
acetylglucosamine	O
(	O
GlcNAc	O
)	O
.	O

However	O
the	O
7	O
-	O
and	O
6	O
-	O
hydroxy	O
substitution	O
were	O
observed	O
to	O
be	O
more	O
favourable	O
for	O
SOR	O
scavenging	O
activities	O
as	O
compared	O
to	O
other	O
hydroxyl	O
substitutions	O
.	O

In	O
primary	O
dendritic	O
cell	O
and	O
APC	O
cell	O
lines	O
of	O
murine	O
origin	O
,	O
MARCH1	S-Biological_Molecule
had	O
a	O
half	O
-	O
life	O
of	O
<	O
30	O
min	O
.	O

Thrombopoietin	S-Biological_Molecule
(	O
Tpo	S-Biological_Molecule
)	O
,	O
acting	O
through	O
its	O
receptor	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Mpl	E-Biological_Molecule
,	O
is	O
required	O
for	O
hematopoietic	O
stem	O
cell	O
maintenance	O
and	O
megakaryopoiesis	O
.	O

Jmjd1a	S-Biological_Molecule
is	O
a	O
key	O
epigenetic	O
regulator	O
expressed	O
in	O
the	O
testis	O
.	O

Interestingly	O
,	O
the	O
altered	O
histone	S-Biological_Molecule
modifications	O
in	O
Jmjd1a	S-Biological_Molecule
-	O
deficient	O
germ	O
cells	O
caused	O
diminished	O
cAMP	B-Biological_Molecule
-	I-Biological_Molecule
response	I-Biological_Molecule
element	I-Biological_Molecule
modulator	E-Biological_Molecule
(	O
Crem	S-Biological_Molecule
)	O
recruitment	O
to	O
chromatin	O
and	O
decreased	O
expression	O
of	O
the	O
Crem	S-Biological_Molecule
coactivator	O
Act	S-Biological_Molecule
and	O
their	O
target	O
genes	O
Tnp1	S-Biological_Molecule
(	O
transition	B-Biological_Molecule
protein	I-Biological_Molecule
1	E-Biological_Molecule
)	O
,	O
Tnp2	S-Biological_Molecule
,	O
Prm1	S-Biological_Molecule
(	O
protamine	B-Biological_Molecule
1	E-Biological_Molecule
)	O
,	O
and	O
Prm2	S-Biological_Molecule
,	O
all	O
of	O
which	O
are	O
essential	O
for	O
chromatin	O
condensation	O
in	O
spermatids	O
.	O

In	O
agreement	O
with	O
these	O
findings	O
,	O
Jmjd1a	S-Biological_Molecule
deficiency	O
caused	O
extensive	O
germ	O
cell	O
apoptosis	O
and	O
blocked	O
spermatid	O
elongation	O
,	O
resulting	O
in	O
severe	O
oligozoospermia	O
,	O
small	O
testes	O
,	O
and	O
infertility	O
in	O
male	O
mice	O
.	O

Further	O
studies	O
revealed	O
two	O
potential	O
pathways	O
mediated	O
nickel	O
and	O
hypoxia	O
induced	O
c	B-Biological_Molecule
-	I-Biological_Molecule
myc	E-Biological_Molecule
degradation	O
.	O

Among	O
the	O
targets	O
we	O
screened	O
,	O
we	O
identified	O
Fgfr3	S-Biological_Molecule
as	O
a	O
direct	O
transcriptional	O
target	O
of	O
the	O
Ap2delta	S-Biological_Molecule
-	O
Ash2l	S-Biological_Molecule
complex	O
.	O

Thus	O
,	O
we	O
have	O
identified	O
several	O
candidate	O
targets	O
of	O
complexes	O
containing	O
Ap2delta	S-Biological_Molecule
and	O
Ash2l	S-Biological_Molecule
that	O
can	O
be	O
used	O
to	O
further	O
elucidate	O
their	O
roles	O
during	O
development	O
and	O
showed	O
that	O
Fgfr3	S-Biological_Molecule
is	O
a	O
novel	O
direct	O
target	O
of	O
these	O
complexes	O
.	O

Here	O
we	O
report	O
on	O
the	O
characterization	O
of	O
TGIF	S-Biological_Molecule
as	O
an	O
essential	O
component	O
of	O
the	O
tumor	B-Biological_Molecule
necrosis	I-Biological_Molecule
factor	I-Biological_Molecule
alpha	E-Biological_Molecule
(	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
)	O
cytotoxic	O
program	O
.	O

Notably	O
,	O
we	O
found	O
that	O
activation	O
of	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
signaling	O
induced	O
the	O
association	O
of	O
TGIF	S-Biological_Molecule
with	O
Itch	S-Biological_Molecule
/	O
AIP4	S-Biological_Molecule
,	O
resulting	O
in	O
increased	O
accessibility	O
of	O
cFlip	S-Biological_Molecule
(	O
L	O
)	O
for	O
association	O
and	O
ubiquitination	O
by	O
Itch	S-Biological_Molecule
/	O
AIP4	S-Biological_Molecule
.	O

TRC8	S-Biological_Molecule
knockdown	O
had	O
opposite	O
effects	O
in	O
sterol	O
-	O
deprived	O
cells	O
.	O

In	O
Drosophila	O
,	O
growth	O
inhibition	O
by	O
DTrc8	S-Biological_Molecule
was	O
genetically	O
suppressed	O
by	O
loss	O
of	O
specific	O
Mprlp	O
,	O
Padlp	O
N	O
-	O
terminal	O
domain	O
-	O
containing	O
proteins	O
found	O
in	O
the	O
COP9	O
signalosome	O
and	O
eIF3	O
.	O

Furthermore	O
,	O
loss	O
of	O
phosphorylated	O
H3	S-Biological_Molecule
-	O
T45	O
causes	O
phenotypes	O
consistent	O
with	O
replicative	O
defects	O
,	O
and	O
prolonged	O
replication	O
stress	O
results	O
in	O
H3	S-Biological_Molecule
-	O
T45	O
phosphorylation	O
accumulation	O
over	O
time	O
.	O

Set7	B-Biological_Molecule
/	I-Biological_Molecule
9	E-Biological_Molecule
-	O
KMT7	S-Biological_Molecule
binds	O
TAR	S-Biological_Molecule
RNA	O
by	O
itself	O
and	O
in	O
complex	O
with	O
Tat	S-Biological_Molecule
and	O
the	O
positive	O
transcription	O
elongation	O
factor	O
P	O
-	O
TEFb	O
.	O

N4BP1	S-Biological_Molecule
is	O
a	O
newly	O
identified	O
nucleolar	O
protein	O
that	O
undergoes	O
SUMO	O
-	O
regulated	O
polyubiquitylation	O
and	O
proteasomal	O
turnover	O
at	O
promyelocytic	O
leukemia	O
nuclear	O
bodies	O
.	O

However	O
,	O
a	O
small	O
fraction	O
is	O
found	O
at	O
promyelocytic	O
leukemia	O
(	O
PML	O
)	O
nuclear	O
bodies	O
(	O
NBs	O
)	O
.	O

An	O
intronic	O
expansion	O
of	O
GAA	O
triplets	O
in	O
the	O
FXN	S-Biological_Molecule
-	O
encoding	O
gene	O
,	O
FXN	S-Biological_Molecule
,	O
causes	O
gene	O
silencing	O
and	O
thus	O
reduced	O
FXN	S-Biological_Molecule
protein	O
levels	O
.	O

Our	O
data	O
demonstrate	O
that	O
finding	O
novel	O
strategies	O
to	O
overcome	O
the	O
transcription	O
elongation	O
problem	O
may	O
develop	O
into	O
promising	O
new	O
treatments	O
for	O
FRDA	O
.	O

SAGA	O
is	O
a	O
transcriptional	O
coactivator	O
complex	O
that	O
is	O
conserved	O
across	O
eukaryotes	O
and	O
performs	O
multiple	O
functions	O
during	O
transcriptional	O
activation	O
and	O
elongation	O
.	O

The	O
deubiquitinating	O
activity	O
depends	O
on	O
the	O
presence	O
of	O
all	O
four	O
DUBm	O
proteins	O
.	O

In	O
the	O
presence	O
of	O
endotoxin	O
,	O
an	O
increase	O
in	O
caveolin	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
(	O
Cav	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
)	O
expression	O
impairs	O
ET	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
/	O
eNOS	S-Biological_Molecule
signaling	O
;	O
however	O
,	O
the	O
molecular	O
mechanism	O
is	O
unknown	O
.	O

Following	O
LPS	O
pretreatment	O
,	O
CD	O
+	O
ET	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
failed	O
to	O
stimulate	O
eNOS	S-Biological_Molecule
activity	O
(	O
+	O
51	O
%	O
,	O
P	O
>	O
0	O
.	O
05	O
)	O
,	O
which	O
contributed	O
to	O
the	O
reduced	O
levels	O
of	O
eNOS	S-Biological_Molecule
-	O
Ser1177	O
phosphorylation	O
and	O
eNOS	S-Biological_Molecule
-	O
Thr495	O
dephosphorylation	O
,	O
the	O
LPS	O
/	O
CD	O
-	O
induced	O
overexpression	O
and	O
translocation	O
of	O
Cav	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
in	O
the	O
perinuclear	O
region	O
,	O
and	O
the	O
increased	O
perinuclear	O
colocalization	O
of	O
eNOS	S-Biological_Molecule
with	O
Cav	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
.	O

Furthermore	O
,	O
we	O
present	O
that	O
EL4	O
treated	O
with	O
Dox	O
-	O
HPMA	O
(	O
AM	O
)	O
possesses	O
increased	O
sensitivity	O
to	O
galectin	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
-	O
induced	O
apoptosis	O
.	O

We	O
conclude	O
that	O
SIRT1	S-Biological_Molecule
orthologs	O
play	O
a	O
critical	O
role	O
in	O
controlling	O
SREBP	O
-	O
dependent	O
gene	O
regulation	O
governing	O
lipid	O
/	O
cholesterol	O
homeostasis	O
in	O
metazoans	O
in	O
response	O
to	O
fasting	O
cues	O
.	O

Control	O
experiments	O
indicated	O
that	O
the	O
oocyte	O
protein	O
carboxyl	O
methyltransferase	O
was	O
not	O
saturated	O
with	O
endogenous	O
substrates	O
,	O
since	O
protein	O
carboxyl	O
methylation	O
rates	O
could	O
be	O
stimulated	O
up	O
to	O
8	O
-	O
fold	O
by	O
increasing	O
concentrations	O
of	O
injected	O
calmodulin	S-Biological_Molecule
.	O

At	O
steady	O
state	O
,	O
oocyte	O
calmodulin	S-Biological_Molecule
contains	O
approximately	O
0	O
.	O
0002	O
esters	O
/	O
mol	O
of	O
protein	O
,	O
which	O
turn	O
over	O
rapidly	O
.	O

The	O
recently	O
isolated	O
,	O
naturally	O
occurring	O
peptide	O
hormones	O
[	O
Hyp3	O
]	O
-	O
bradykinin	S-Biological_Molecule
and	O
[	O
Hyp3	O
]	O
-	O
Lys	O
-	O
bradykinin	S-Biological_Molecule
were	O
investigated	O
for	O
their	O
agonist	O
activity	O
on	O
solubilized	O
binding	O
sites	O
from	O
human	O
fibroblasts	O
.	O

In	O
contrast	O
,	O
no	O
LAMP	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
could	O
be	O
detected	O
on	O
the	O
cell	O
surface	O
either	O
before	O
or	O
after	O
differentiation	O
of	O
F	O
-	O
9	O
cells	O
.	O

These	O
results	O
demonstrate	O
that	O
differentiation	O
of	O
EC	O
cells	O
is	O
accompanied	O
by	O
changes	O
in	O
the	O
synthesis	O
and	O
glycosylation	O
of	O
LAMP	O
glycoproteins	O
and	O
that	O
these	O
changes	O
are	O
specific	O
for	O
the	O
cell	O
type	O
that	O
results	O
after	O
differentiation	O
.	O

A	O
32	O
,	O
000	O
-	O
Mr	O
fragment	O
was	O
produced	O
by	O
trypsin	O
treatment	O
of	O
the	O
36	O
,	O
000	O
-	O
Mr	O
form	O
of	O
oncostatin	B-Biological_Molecule
M	E-Biological_Molecule
.	O

In	O
order	O
to	O
investigate	O
the	O
possible	O
role	O
of	O
the	O
Trp	O
residue	O
in	O
ACTH	S-Biological_Molecule
as	O
a	O
change	O
-	O
transfer	O
donor	O
in	O
the	O
activation	O
of	O
ACTH	S-Biological_Molecule
receptors	O
,	O
two	O
ACTH	S-Biological_Molecule
analogues	O
(	O
beta	O
-	O
corticotrophins	O
(	O
I	O
-	O
24	O
)	O
with	O
L	O
-	O
Ser1	O
and	O
D	O
-	O
Ser1	O
,	O
respectively	O
)	O
containing	O
pentamethylphenylalanine	O
instead	O
of	O
Trp	O
have	O
been	O
synthesized	O
.	O

The	O
association	O
constants	O
of	O
ACTH	S-Biological_Molecule
(	O
I	O
-	O
24	O
)	O
and	O
(	O
Pmp9	O
)	O
-	O
ACTH	S-Biological_Molecule
(	O
I	O
-	O
24	O
)	O
with	O
the	O
water	O
-	O
soluble	O
acceptor	O
paraquat	O
,	O
were	O
nearly	O
equal	O
.	O

An	O
extensive	O
immunohistochemical	O
study	O
of	O
other	O
normal	O
tissues	O
reveals	O
that	O
the	O
majority	O
show	O
only	O
weak	O
focal	O
staining	O
with	O
SM	O
-	O
3	O
or	O
none	O
at	O
all	O
,	O
the	O
distal	O
tubules	O
and	O
collecting	O
ducts	O
of	O
the	O
kidney	O
,	O
and	O
sebaceous	O
glands	O
being	O
the	O
only	O
normal	O
tissues	O
studied	O
to	O
show	O
homogeneously	O
positive	O
staining	O
.	O

Because	O
cytosine	O
phosphoguanine	O
(	O
CpG	O
)	O
methylation	O
has	O
been	O
reported	O
to	O
correlate	O
inversely	O
with	O
gene	O
activity	O
,	O
the	O
demethylation	O
of	O
cytosine	O
residues	O
in	O
the	O
quail	O
vitellogenin	B-Biological_Molecule
2	E-Biological_Molecule
(	O
Vg2	S-Biological_Molecule
)	O
gene	O
was	O
assessed	O
as	O
a	O
possible	O
contributing	O
factor	O
.	O

Changes	O
in	O
the	O
methylation	O
pattern	O
of	O
CCGG	O
sites	O
of	O
the	O
quail	O
Vg2	S-Biological_Molecule
gene	O
were	O
studied	O
using	O
the	O
methyl	O
-	O
sensitive	O
restriction	O
endonucleases	O
Msp	B-Biological_Molecule
I	E-Biological_Molecule
and	O
Hpa	B-Biological_Molecule
II	E-Biological_Molecule
.	O

Another	O
site	O
,	O
within	O
the	O
3	O
'	O
flanking	O
sequences	O
or	O
the	O
3	O
'	O
structural	O
gene	O
region	O
,	O
underwent	O
estradiol	O
-	O
dependent	O
demethylation	O
in	O
the	O
liver	O
and	O
the	O
oviduct	O
.	O

The	O
expression	O
-	O
linked	O
demethylation	O
of	O
the	O
CCGG	O
sites	O
in	O
the	O
Vg2	S-Biological_Molecule
gene	O
of	O
quail	O
appears	O
to	O
be	O
similar	O
to	O
that	O
reported	O
for	O
the	O
chicken	O
VTGII	S-Biological_Molecule
gene	O
.	O

The	O
native	O
Ag	B-Biological_Molecule
-	I-Biological_Molecule
54	E-Biological_Molecule
,	O
the	O
deglycosylated	O
protein	O
and	O
the	O
protein	O
-	O
free	O
carbohydrate	O
moieties	O
were	O
tested	O
for	O
IgE	O
-	O
binding	O
activity	O
by	O
radioallergosorbent	O
test	O
inhibition	O
using	O
selected	O
sera	O
from	O
individuals	O
with	O
C	O
.	O
herbarum	O
allergy	O
.	O

Inhibitors	O
of	O
2	O
-	O
ketoglutarate	O
-	O
dependent	O
dioxygenases	O
block	O
aspartyl	O
beta	O
-	O
hydroxylation	O
of	O
recombinant	O
human	O
factor	B-Biological_Molecule
IX	E-Biological_Molecule
in	O
several	O
mammalian	O
expression	O
systems	O
.	O

The	O
hydroxylation	O
reaction	O
proceeds	O
with	O
the	O
same	O
stereospecificity	O
and	O
occurs	O
only	O
at	O
the	O
aspartate	O
corresponding	O
to	O
the	O
position	O
seen	O
in	O
vivo	O
.	O

However	O
,	O
neither	O
the	O
variation	O
in	O
amino	O
acid	O
sequence	O
nor	O
the	O
variation	O
in	O
degree	O
or	O
site	O
of	O
glycosylation	O
measurably	O
affected	O
the	O
non	O
-	O
covalent	O
binding	O
of	O
domain	O
1	O
to	O
dimeric	O
IgA	O
.	O

Histamine	B-Biological_Molecule
N	I-Biological_Molecule
-	I-Biological_Molecule
methyltransferase	E-Biological_Molecule
(	O
HNMT	S-Biological_Molecule
)	O
catalyzes	O
the	O
N	O
tau	O
-	O
methylation	O
of	O
histamine	O
.	O

The	O
majority	O
of	O
the	O
correlations	O
did	O
not	O
differ	O
significantly	O
from	O
those	O
predicted	O
for	O
a	O
trait	O
with	O
a	O
heritability	O
of	O
1	O
.	O
0	O
(	O
100	O
%	O
)	O
.	O

With	O
quinonoid	O
-	O
dihydro	O
-	O
6	O
-	O
methylpterin	O
,	O
approximate	O
Km	O
values	O
of	O
NADPH	B-Biological_Molecule
-	I-Biological_Molecule
specific	I-Biological_Molecule
dihydropteridine	I-Biological_Molecule
reductase	E-Biological_Molecule
for	O
NADPH	O
and	O
NADH	O
were	O
estimated	O
to	O
be	O
1	O
.	O
4	O
micron	O
and	O
2	O
,	O
900	O
microns	O
,	O
respectively	O
.	O

However	O
,	O
it	O
was	O
evident	O
that	O
this	O
collagen	O
was	O
considerably	O
underhydroxylated	O
.	O

At	O
high	O
pO	O
(	O
2	O
)	O
[	O
56	O
.	O
0kPa	O
(	O
approx	O
.	O
420mmHg	O
)	O
]	O
,	O
both	O
the	O
amount	O
of	O
collagen	O
deposited	O
in	O
the	O
tissues	O
and	O
the	O
degree	O
of	O
hydroxylation	O
were	O
increased	O
considerably	O
.	O

In	O
mutant	O
cells	O
the	O
rate	O
of	O
prolyl	O
hydroxylation	O
measured	O
after	O
release	O
of	O
inhibition	O
by	O
alpha	O
,	O
alpha	O
'	O
-	O
dipyridyl	O
is	O
the	O
same	O
as	O
in	O
control	O
cells	O
.	O

Extensive	O
enzymatic	O
degradation	O
of	O
the	O
proteins	O
followed	O
by	O
amino	O
acid	O
analysis	O
of	O
the	O
digests	O
yielded	O
a	O
significant	O
amount	O
of	O
material	O
eluting	O
in	O
the	O
position	O
of	O
epsilon	O
-	O
N	O
-	O
acetyllysine	O
.	O

Guide	O
-	O
lines	O
in	O
the	O
design	O
of	O
new	O
antiestrogens	O
and	O
cytotoxic	O
-	O
linked	O
estrogens	O
for	O
the	O
treatment	O
of	O
breast	O
cancer	O
.	O

The	O
grafting	O
of	O
side	O
chains	O
on	O
a	O
weak	O
estrogen	O
of	O
the	O
gem	O
-	O
diphenylethylene	O
category	O
produces	O
"	O
symmetrical	O
"	O
antiestrogens	O
devoid	O
of	O
estrogenic	O
activity	O
.	O

Such	O
activity	O
may	O
be	O
more	O
easily	O
obtained	O
with	O
estrogens	O
bearing	O
reagents	O
for	O
proteins	O
rather	O
than	O
DNA	O
.	O

SDS	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
analyses	O
indicate	O
that	O
Fc	O
epsilon	O
(	O
315	O
-	O
547	O
)	O
is	O
an	O
S	O
-	O
S	O
-	O
linked	O
dimer	O
of	O
apparent	O
molecular	O
mass	O
of	O
68	O
kDa	O
.	O

These	O
results	O
suggest	O
that	O
the	O
presence	O
of	O
N	O
-	O
linked	O
sugars	O
is	O
not	O
necessary	O
for	O
Fc	B-Biological_Molecule
epsilon	I-Biological_Molecule
RI	I-Biological_Molecule
alpha	E-Biological_Molecule
binding	O
.	O

The	O
availability	O
of	O
these	O
recombinant	O
IgE	O
-	O
Fc	O
proteins	O
will	O
be	O
helpful	O
in	O
elucidating	O
the	O
key	O
epitopes	O
essential	O
for	O
the	O
binding	O
of	O
IgE	O
to	O
its	O
high	O
affinity	O
receptor	O
.	O

The	O
precursor	O
of	O
the	O
acid	O
-	O
stimulating	O
hormone	O
gastrin	S-Biological_Molecule
gives	O
rise	O
to	O
multiple	O
peptides	O
differing	O
markedly	O
in	O
biological	O
activity	O
,	O
but	O
the	O
relevant	O
biosynthetic	O
pathways	O
are	O
poorly	O
understood	O
.	O

The	O
translational	O
activity	O
and	O
level	O
of	O
elastin	S-Biological_Molecule
mRNA	O
were	O
essentially	O
unchanged	O
throughout	O
the	O
cell	O
passages	O
.	O

The	O
molecular	O
properties	O
of	O
retinal	B-Biological_Molecule
rod	I-Biological_Molecule
guanyl	I-Biological_Molecule
cyclase	E-Biological_Molecule
were	O
investigated	O
.	O

Extensive	O
mutagenesis	O
studies	O
of	O
the	O
long	O
extracellular	O
domain	O
of	O
the	O
TSH	B-Biological_Molecule
receptor	E-Biological_Molecule
(	O
TSHR	S-Biological_Molecule
)	O
revealed	O
important	O
residues	O
(	O
Cys	O
-	O
301	O
,	O
Tyr	O
-	O
385	O
and	O
Cys	O
-	O
390	O
)	O
for	O
binding	O
of	O
TSH	O
in	O
its	O
C	O
-	O
terminal	O
region	O
.	O

The	O
long	O
extracellular	O
domain	O
of	O
the	O
TSHR	S-Biological_Molecule
has	O
5	O
or	O
6	O
possible	O
asparagine	O
-	O
linked	O
glycosylation	O
sites	O
.	O

In	O
all	O
systems	O
cytochrome	B-Biological_Molecule
b5	E-Biological_Molecule
stimulated	O
benzphetamine	O
N	O
-	O
demethylase	O
activity	O
especially	O
when	O
cytochrome	B-Biological_Molecule
b5	E-Biological_Molecule
was	O
present	O
at	O
0	O
.	O
5	O
:	O
1	O
molar	O
ratio	O
with	O
respect	O
to	O
cytochrome	O
P450LgM2	O
.	O

We	O
have	O
isolated	O
full	O
-	O
length	O
cDNAs	O
encoding	O
two	O
distinct	O
types	O
of	O
CuZn	O
superoxide	O
dismutases	O
(	O
SODs	O
)	O
from	O
the	O
filarial	O
nematode	O
parasite	O
Brugia	O
pahangi	O
.	O

Digestion	O
with	O
N	B-Biological_Molecule
-	I-Biological_Molecule
glycanase	E-Biological_Molecule
indicated	O
that	O
the	O
latter	O
protein	O
corresponded	O
to	O
the	O
EC	O
form	O
,	O
as	O
it	O
possessed	O
N	O
-	O
linked	O
oligosaccharide	O
chains	O
at	O
three	O
sites	O
,	O
leaving	O
a	O
peptide	O
backbone	O
with	O
an	O
estimated	O
molecular	O
mass	O
of	O
22	O
kDa	O
,	O
which	O
was	O
consistent	O
with	O
the	O
additional	O
27	O
amino	O
acids	O
predicted	O
from	O
the	O
cDNA	O
sequence	O
.	O

When	O
this	O
enhancer	O
is	O
placed	O
in	O
an	O
upstream	O
position	O
,	O
however	O
,	O
the	O
kappa	S-Biological_Molecule
gene	O
remains	O
modified	O
and	O
transcriptionally	O
inactive	O
,	O
demonstrating	O
that	O
demethylation	O
is	O
required	O
for	O
kappa	B-Biological_Molecule
chain	E-Biological_Molecule
activation	O
.	O

Deletions	O
of	O
5	O
to	O
8	O
residues	O
within	O
predicted	O
alpha	O
-	O
helices	O
resulted	O
in	O
the	O
failure	O
of	O
export	O
of	O
the	O
mutant	O
protein	O
from	O
the	O
cell	O
.	O

Replacement	O
of	O
Cys29	O
and	O
Cys33	O
by	O
tyrosine	O
residues	O
also	O
resulted	O
in	O
the	O
export	O
of	O
fully	O
active	O
Epo	S-Biological_Molecule
.	O

Therefore	O
,	O
this	O
small	O
disulfide	O
loop	O
is	O
not	O
critical	O
to	O
Epo	S-Biological_Molecule
'	O
s	O
stability	O
or	O
function	O
.	O

Production	O
of	O
the	O
recombinant	O
molecule	O
has	O
largely	O
been	O
confined	O
to	O
mammalian	O
cell	O
systems	O
which	O
have	O
,	O
in	O
general	O
,	O
proven	O
to	O
be	O
inefficient	O
producers	O
of	O
factor	B-Biological_Molecule
VIII	E-Biological_Molecule
.	O

An	O
alcoholic	O
population	O
that	O
we	O
have	O
analyzed	O
is	O
enriched	O
in	O
variant	O
type	O
IIIa	O
compared	O
with	O
nonalcoholic	O
psychiatric	O
and	O
normal	O
controls	O
.	O

The	O
electrophoretic	O
patterns	O
of	O
fibroblast	O
ASA	S-Biological_Molecule
from	O
the	O
IIIa	O
and	O
IV	O
(	O
a	O
)	O
individuals	O
differ	O
in	O
degree	O
of	O
phosphorylation	O
.	O

Purification	O
and	O
characterization	O
of	O
Kurloff	O
cell	O
sialoglycoproteins	O
with	O
acid	O
phosphatase	O
activity	O
.	O

It	O
was	O
therefore	O
designated	O
GP2	S-Biological_Molecule
.	O

Comparison	O
of	O
O	O
-	O
linked	O
carbohydrate	O
chains	O
in	O
MUC	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
mucin	O
from	O
normal	O
breast	O
epithelial	O
cell	O
lines	O
and	O
breast	O
carcinoma	O
cell	O
lines	O
.	O

Identification	O
of	O
N	O
(	O
G	O
)	O
-	O
methylarginine	O
residues	O
in	O
human	O
heterogeneous	O
RNP	O
protein	O
A1	S-Biological_Molecule
:	O
Phe	O
/	O
Gly	O
-	O
Gly	O
-	O
Gly	O
-	O
Arg	O
-	O
Gly	O
-	O
Gly	O
-	O
Gly	O
/	O
Phe	O
is	O
a	O
preferred	O
recognition	O
motif	O
.	O

The	O
expressed	O
protein	O
was	O
targeted	O
to	O
the	O
Sf	O
-	O
9	O
plasma	O
membrane	O
at	O
an	O
apparent	O
density	O
of	O
approximately	O
0	O
.	O
5	O
x	O
10	O
(	O
6	O
)	O
copies	O
/	O
cell	O
as	O
determined	O
by	O
quantitative	O
autoradiography	O
using	O
an	O
HAE1	S-Biological_Molecule
-	O
specific	O
monoclonal	O
antibody	O
.	O

Transport	O
studies	O
with	O
HAE1	S-Biological_Molecule
-	O
recombinant	O
-	O
infected	O
Sf	O
-	O
9	O
cells	O
showed	O
saturable	O
[	O
Km	O
(	O
Cl	O
-	O
)	O
=	O
44	O
mM	O
;	O
Vmax	O
(	O
Cl	O
-	O
)	O
=	O
48	O
mEq	O
/	O
liter	O
of	O
cell	O
waters	O
min	O
]	O
and	O
H2DIDS	O
-	O
inhibitable	O
(	O
K	O
(	O
O	O
.	O
5	O
)	O
=	O
34	O
microM	O
)	O
36Cl	O
-	O
uptake	O
that	O
was	O
not	O
present	O
in	O
uninfected	O
cells	O
.	O

There	O
was	O
a	O
close	O
relationship	O
between	O
mononuclear	O
cell	O
L	B-Biological_Molecule
-	I-Biological_Molecule
type	I-Biological_Molecule
ferritin	E-Biological_Molecule
content	O
and	O
serum	O
ferritin	O
concentration	O
(	O
r	O
=	O
0	O
.	O
95	O
,	O
P	O
<	O
.	O
00001	O
)	O
,	O
suggesting	O
that	O
the	O
excess	O
production	O
of	O
ferritin	O
in	O
cells	O
was	O
directly	O
responsible	O
for	O
the	O
hyperferritinemia	O
.	O

However	O
the	O
FN	S-Biological_Molecule
of	O
fibroblasts	O
from	O
TS	O
-	O
skin	O
lesions	O
was	O
shown	O
by	O
HPAEC	O
to	O
contain	O
a	O
two	O
-	O
to	O
three	O
-	O
fold	O
increased	O
content	O
of	O
carbohydrate	O
.	O

Evidence	O
is	O
presented	O
to	O
demonstrate	O
an	O
involvement	O
of	O
this	O
biological	O
methylation	O
in	O
the	O
integrity	O
and	O
maintenance	O
of	O
myelin	O
.	O

The	O
order	O
and	O
magnitude	O
of	O
the	O
decreased	O
IGF	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
receptor	E-Biological_Molecule
glycosylation	O
,	O
which	O
was	O
followed	O
by	O
a	O
decreased	O
expression	O
of	O
IGF	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
receptors	E-Biological_Molecule
at	O
the	O
cell	O
membrane	O
,	O
correlated	O
well	O
with	O
the	O
inhibition	O
of	O
DNA	O
synthesis	O
.	O

The	O
process	O
of	O
procollagen	S-Biological_Molecule
secretion	O
,	O
therefore	O
,	O
meets	O
the	O
minimal	O
requirements	O
for	O
the	O
rate	O
-	O
limiting	O
step	O
.	O

We	O
now	O
report	O
that	O
another	O
disaccharide	O
,	O
acetylated	O
GlcNAcbeta1	O
-	O
3Gal	O
-	O
naphthalenemethanol	O
(	O
GlcNAcbeta1	O
-	O
3Gal	O
-	O
NM	O
)	O
,	O
has	O
even	O
greater	O
potency	O
and	O
that	O
both	O
compounds	O
will	O
inhibit	O
sialyl	O
LewisX	O
(	O
sLex	O
)	O
-	O
dependent	O
cell	O
adhesion	O
.	O

GlcNAcbeta1	O
-	O
3Gal	O
-	O
NM	O
and	O
Galbeta1	O
-	O
4GlcNAc	O
-	O
NM	O
represent	O
starting	O
points	O
for	O
making	O
enzyme	O
-	O
specific	O
,	O
site	O
-	O
directed	O
inhibitors	O
of	O
glycosyltransferases	O
that	O
could	O
act	O
in	O
living	O
cells	O
.	O

Truncation	O
of	O
the	O
receptor	O
was	O
then	O
confirmed	O
by	O
deglycosylation	O
with	O
N	B-Biological_Molecule
-	I-Biological_Molecule
glycosidase	I-Biological_Molecule
F	E-Biological_Molecule
.	O

Using	O
a	O
HpaII	S-Biological_Molecule
/	O
MspI	S-Biological_Molecule
digestion	O
-	O
polymerase	O
chain	O
reaction	O
based	O
assay	O
,	O
the	O
presence	O
of	O
5	O
-	O
methylcytosine	O
in	O
three	O
CpG	O
dinucleotides	O
within	O
the	O
BRCA2	S-Biological_Molecule
promoter	O
was	O
assessed	O
in	O
18	O
breast	O
or	O
ovarian	O
cancer	O
cell	O
lines	O
,	O
in	O
an	O
SV40	O
large	B-Biological_Molecule
T	I-Biological_Molecule
antigen	E-Biological_Molecule
immortalized	O
cell	O
line	O
derived	O
from	O
normal	O
breast	O
epithelial	O
cells	O
,	O
in	O
64	O
primary	O
sporadic	O
breast	O
cancers	O
and	O
peripheral	O
blood	O
leucocytes	O
from	O
these	O
cases	O
and	O
in	O
a	O
number	O
of	O
other	O
normal	O
human	O
tissues	O
.	O

Four	O
related	O
cysteine	O
-	O
rich	O
polydnavirus	O
gene	O
have	O
been	O
identified	O
in	O
parasitized	O
H	O
.	O
virescens	O
larvae	O
and	O
grouped	O
into	O
a	O
family	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
expression	O
and	O
hemocyte	O
targeting	O
of	O
the	O
cysteine	O
-	O
rich	O
VHv1	B-Biological_Molecule
.	I-Biological_Molecule
4	E-Biological_Molecule
protein	O
.	O

Immunofluorescence	O
assays	O
showed	O
that	O
the	O
VHv1	B-Biological_Molecule
.	I-Biological_Molecule
4	E-Biological_Molecule
protein	O
binds	O
to	O
the	O
hemocytes	O
,	O
most	O
notably	O
the	O
granulocytes	O
,	O
in	O
H	O
.	O
virescens	O
larvae	O
.	O

UDP	B-Biological_Molecule
-	I-Biological_Molecule
N	I-Biological_Molecule
-	I-Biological_Molecule
acetylglucosamine	I-Biological_Molecule
:	I-Biological_Molecule
beta	I-Biological_Molecule
-	I-Biological_Molecule
D	I-Biological_Molecule
-	I-Biological_Molecule
mannoside	I-Biological_Molecule
beta	I-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
,	I-Biological_Molecule
4N	I-Biological_Molecule
-	I-Biological_Molecule
acetylglucosaminyltransferase	I-Biological_Molecule
III	E-Biological_Molecule
(	O
GnT	B-Biological_Molecule
-	I-Biological_Molecule
III	E-Biological_Molecule
,	O
EC	O
2	O
.	O
4	O
.	O
1	O
.	O
144	O
)	O
is	O
a	O
glycoprotein	O
involved	O
in	O
the	O
biosynthesis	O
of	O
N	O
-	O
linked	O
oligosaccharides	O
.	O

To	O
study	O
the	O
roles	O
of	O
N	O
-	O
glycosylation	O
in	O
the	O
GnT	B-Biological_Molecule
-	I-Biological_Molecule
III	E-Biological_Molecule
function	O
,	O
rat	O
GnT	B-Biological_Molecule
-	I-Biological_Molecule
III	E-Biological_Molecule
was	O
expressed	O
in	O
COS	O
-	O
1	O
cells	O
under	O
tunicamycin	O
or	O
castanospermine	O
treatment	O
.	O

The	O
castanospermine	O
-	O
treated	O
GnT	B-Biological_Molecule
-	I-Biological_Molecule
III	E-Biological_Molecule
was	O
not	O
localized	O
in	O
the	O
Golgi	O
,	O
but	O
glucosylation	O
did	O
not	O
affect	O
its	O
activity	O
.	O

All	O
the	O
mutants	O
exhibited	O
lower	O
enzyme	O
activity	O
than	O
the	O
wild	O
-	O
type	O
,	O
but	O
deglycosylation	O
at	O
individual	O
sites	O
had	O
different	O
effects	O
on	O
the	O
enzyme	O
activity	O
.	O

Kinetic	O
analysis	O
revealed	O
that	O
the	O
deglycosylation	O
at	O
Asn243	O
or	O
Asn261	O
resulted	O
in	O
slightly	O
lower	O
affinity	O
for	O
the	O
donor	O
substrate	O
,	O
but	O
the	O
other	O
mutation	O
did	O
not	O
significantly	O
change	O
the	O
K	O
(	O
m	O
)	O
value	O
for	O
either	O
the	O
donor	O
or	O
acceptor	O
.	O

This	O
is	O
the	O
first	O
demonstration	O
that	O
the	O
glycosyltransferase	O
localized	O
in	O
the	O
Golgi	O
apparatus	O
requires	O
N	O
-	O
glycosylation	O
for	O
its	O
activity	O
and	O
retention	O
.	O

Recent	O
studies	O
of	O
osteoporotic	O
bone	O
,	O
for	O
example	O
,	O
have	O
demonstrated	O
that	O
subtle	O
perturbations	O
in	O
the	O
pattern	O
of	O
lysine	O
hydroxylation	O
result	O
in	O
changes	O
in	O
the	O
cross	O
-	O
link	O
profile	O
.	O

In	O
Xenopus	O
BMP4	S-Biological_Molecule
appears	O
to	O
play	O
an	O
essential	O
role	O
in	O
dorsoventral	O
patterning	O
,	O
promoting	O
the	O
development	O
of	O
ventral	O
fates	O
during	O
gastrula	O
stages	O
.	O

Overexpression	O
of	O
either	O
gene	O
inhibits	O
the	O
development	O
of	O
dorsoanterior	O
structures	O
in	O
whole	O
embryos	O
and	O
ventralizes	O
activin	O
-	O
induced	O
dorsal	O
mesoderm	O
in	O
animal	O
caps	O
.	O

Maturation	O
of	O
clusterin	S-Biological_Molecule
is	O
governed	O
by	O
the	O
relative	O
actions	O
of	O
sialyltransferases	O
and	O
sialidases	O
that	O
are	O
present	O
in	O
brain	O
microsomes	O
,	O
golgi	O
bodies	O
,	O
cytosol	O
and	O
plasma	O
membranes	O
.	O

Therefore	O
,	O
in	O
this	O
investigation	O
,	O
we	O
have	O
studied	O
the	O
specific	O
effects	O
of	O
chronic	O
ethanol	O
treatment	O
on	O
the	O
glycosylation	O
of	O
rat	O
brain	O
clusterin	S-Biological_Molecule
and	O
the	O
causes	O
that	O
may	O
lead	O
to	O
any	O
possible	O
defects	O
in	O
the	O
glycosylation	O
process	O
.	O

Secondary	O
structure	O
of	O
P	O
-	O
glycoprotein	O
investigated	O
by	O
circular	O
dichroism	O
and	O
amino	O
acid	O
sequence	O
analysis	O
.	O

The	O
p16INK4A	S-Biological_Molecule
(	O
p16	S-Biological_Molecule
)	O
binds	O
to	O
both	O
cyclin	O
D	O
-	O
CDK4	S-Biological_Molecule
and	O
cyclin	O
D	O
-	O
CDK6	S-Biological_Molecule
and	O
inhibits	O
the	O
progression	O
of	O
the	O
cell	O
cycle	O
from	O
G1	O
to	O
S	O
phase	O
.	O

Unspliced	O
mRNA	O
from	O
RNA	O
segment	O
6	O
of	O
influenza	O
C	O
virus	O
contains	O
a	O
single	O
open	O
reading	O
frame	O
that	O
potentially	O
encodes	O
a	O
polypeptide	O
of	O
374	O
amino	O
acids	O
.	O

Treatment	O
of	O
infected	O
cells	O
with	O
tunicamycin	O
and	O
digestion	O
of	O
immunoprecipitated	O
proteins	O
with	O
various	O
endoglycosidases	O
revealed	O
that	O
P42	S-Biological_Molecule
is	O
modified	O
by	O
the	O
addition	O
of	O
a	O
high	O
-	O
mannose	O
oligosaccharide	O
chain	O
to	O
generate	O
P44	S-Biological_Molecule
.	O

A	O
monoclonal	O
antibody	O
against	O
M1	S-Biological_Molecule
,	O
like	O
anti	O
-	O
CM2	S-Biological_Molecule
serum	O
,	O
was	O
able	O
to	O
immunoprecipitate	O
both	O
the	O
P42	S-Biological_Molecule
and	O
P44	S-Biological_Molecule
proteins	O
.	O

CPD	B-Biological_Molecule
-	I-Biological_Molecule
I	E-Biological_Molecule
consists	O
of	O
a	O
single	O
peptide	O
chain	O
of	O
471	O
amino	O
acid	O
residues	O
,	O
three	O
disulfide	O
bridges	O
and	O
nine	O
N	O
-	O
glycosylated	O
asparaginyl	O
residues	O
,	O
while	O
CPD	B-Biological_Molecule
-	I-Biological_Molecule
II	E-Biological_Molecule
consists	O
of	O
a	O
single	O
peptide	O
chain	O
of	O
481	O
amino	O
acid	O
residues	O
,	O
has	O
three	O
disulfide	O
bridges	O
,	O
one	O
free	O
cysteinyl	O
residue	O
and	O
nine	O
glycosylated	O
asparaginyl	O
residues	O
.	O

No	O
change	O
was	O
seen	O
for	O
position	O
1	O
.	O

As	O
opposed	O
to	O
normal	O
cells	O
,	O
hypermethylation	O
of	O
CpG	O
islands	O
is	O
a	O
frequently	O
observed	O
phenomenon	O
in	O
every	O
cancer	O
type	O
.	O

When	O
indicated	O
,	O
cells	O
were	O
treated	O
with	O
5	O
-	O
aza	O
-	O
2	O
-	O
deoxycytidine	O
(	O
AzadC	O
)	O
or	O
5	O
-	O
azacytidine	O
(	O
AzaC	O
)	O
(	O
Sigma	O
,	O
Taufkirchen	O
,	O
Germany	O
)	O
for	O
different	O
time	O
periods	O
.	O

After	O
centrifugation	O
,	O
protein	O
concentration	O
of	O
the	O
supernatant	O
was	O
determined	O
by	O
BCA	O
-	O
method	O
(	O
Pierce	O
,	O
Rockford	O
,	O
IL	O
)	O
as	O
recommended	O
.	O

As	O
control	O
the	O
methylation	O
-	O
resistant	O
enzyme	O
MspI	O
and	O
an	O
enzyme	O
with	O
no	O
recognition	O
site	O
in	O
the	O
target	O
promoter	O
,	O
EcoRI	O
,	O
were	O
used	O
.	O

DNA	O
was	O
extracted	O
as	O
described	O
above	O
.	O

Absence	O
of	O
IRF	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
expression	O
in	O
leukemia	O
cells	O
is	O
not	O
due	O
to	O
promoter	O
alterations	O

At	O
position	O
-	O
116	O
an	O
A	O
to	O
C	O
substitution	O
was	O
found	O
in	O
EM	O
-	O
2	O
,	O
K	O
-	O
562	O
and	O
CML	O
-	O
T1	O
,	O
whereas	O
Jurkat	O
,	O
BV	O
-	O
173	O
and	O
SD	O
-	O
1	O
exhibited	O
a	O
mixed	O
A	O
/	O
C	O
sequence	O
and	O
U	O
-	O
937	O
,	O
LAMA	O
-	O
84	O
and	O
RPMI	O
-	O
8226	O
no	O
substitution	O
at	O
all	O
(	O
Figure	O
1B	O
)	O
.	O

We	O
used	O
AzadC	O
to	O
generate	O
unmethylated	O
DNA	O
.	O

Accordingly	O
,	O
treatment	O
of	O
the	O
IRF	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
-	O
positive	O
cell	O
line	O
BV	O
-	O
173	O
,	O
SD	O
-	O
1	O
and	O
RPMI	O
-	O
8226	O
with	O
AzadC	O
had	O
no	O
effect	O
on	O
IRF	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
expression	O
(	O
Figure	O
2D	O
)	O
.	O

Genomic	O
DNA	O
from	O
leukemic	O
cells	O
Jurkat	O
,	O
CML	O
-	O
T1	O
,	O
U	O
-	O
937	O
,	O
K	O
-	O
562	O
,	O
EM	O
-	O
2	O
and	O
BV	O
-	O
173	O
was	O
digested	O
with	O
the	O
methylation	O
-	O
sensitive	O
enzymes	O
HpaII	O
,	O
Bsh1236I	O
and	O
HaeII	O
-	O
isochizomer	O
Bsp143II	O
.	O

We	O
then	O
investigated	O
whether	O
the	O
previously	O
described	O
down	O
-	O
regulation	O
of	O
IRF	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
expression	O
in	O
human	O
myeloid	O
leukemias	O
was	O
due	O
to	O
a	O
differential	O
hypermethylation	O
of	O
the	O
promoter	O
,	O
since	O
the	O
presented	O
re	O
-	O
expression	O
due	O
to	O
AzadC	O
-	O
treatment	O
might	O
also	O
be	O
a	O
result	O
of	O
activation	O
of	O
positive	O
transcriptional	O
regulators	O
of	O
IRF	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
.	O

In	O
colon	O
,	O
lung	O
and	O
hematologic	O
malignancies	O
,	O
overexpression	O
of	O
DNMT1	S-Biological_Molecule
,	O
a	O
maintenance	O
DNMT	O
,	O
has	O
been	O
detected	O
(	O
39	O
-	O
41	O
)	O
.	O

In	O
this	O
work	O
,	O
we	O
did	O
not	O
detect	O
significant	O
mRNA	O
expression	O
differences	O
of	O
selected	O
DNMT	O
or	O
MBP	O
,	O
making	O
it	O
an	O
unlikely	O
cause	O
for	O
the	O
observed	O
methylation	O
and	O
thus	O
IRF	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
expression	O
differences	O
in	O
leukemia	O
cells	O
.	O

Indeed	O
,	O
several	O
clinical	O
trials	O
with	O
leukemia	O
patients	O
and	O
patients	O
with	O
myelodysplastic	O
syndromes	O
demonstrated	O
the	O
potential	O
clinical	O
benefit	O
of	O
a	O
treatment	O
with	O
demethylating	O
agents	O
(	O
42	O
-	O
45	O
)	O
.	O

In	O
addition	O
,	O
recent	O
studies	O
have	O
provided	O
strong	O
evidence	O
that	O
dysregulation	O
of	O
Treg	O
development	O
and	O
/	O
or	O
function	O
may	O
be	O
a	O
significant	O
factor	O
in	O
the	O
pathogenesis	O
of	O
several	O
autoimmune	O
disorders	O
(	O
e	O
.	O
g	O
.	O
,	O
multiple	O
sclerosis	O
[	O
5	O
]	O
,	O
myasthenia	O
gravis	O
[	O
6	O
]	O
,	O
and	O
type	O
1	O
diabetes	O
[	O
7	O
]	O
)	O
and	O
virus	O
-	O
induced	O
immunologic	O
disorders	O
(	O
e	O
.	O
g	O
.	O
,	O
human	O
T	O
lymphotropic	O
virus	O
type	O
I	O
[	O
HTLV	O
-	O
I	O
]	O
-	O
associated	O
myelopathy	O
/	O
tropical	O
spastic	O
paraparesis	O
[	O
HAM	O
/	O
TSP	O
]	O
,	O
and	O
HIV	O
-	O
induced	O
AIDS	O
[	O
8	O
-	O
10	O
]	O
)	O
.	O

Unlike	O
full	O
-	O
length	O
Foxp3	S-Biological_Molecule
,	O
which	O
localizes	O
almost	O
exclusively	O
to	O
the	O
nucleus	O
and	O
can	O
bind	O
in	O
a	O
sequence	O
-	O
specific	O
manner	O
to	O
forkhead	O
binding	O
sites	O
,	O
the	O
deltaFKH	B-Biological_Molecule
mutant	E-Biological_Molecule
fails	O
to	O
localize	O
to	O
the	O
nucleus	O
and	O
thus	O
cannot	O
interact	O
with	O
promoter	O
elements	O
or	O
nuclear	O
proteins	O
[	O
16	O
]	O
.	O

Overexpression	O
of	O
full	O
-	O
length	O
Foxp3	S-Biological_Molecule
,	O
but	O
not	O
of	O
deltaFKH	S-Biological_Molecule
,	O
was	O
able	O
to	O
suppress	O
activation	O
of	O
a	O
cotransfected	O
NF	O
-	O
kappaB	O
reporter	O
vector	O
in	O
HEK	O
293T	O
cells	O
(	O
Figure	O
2B	O
)	O
.	O

However	O
,	O
directly	O
comparing	O
the	O
effect	O
of	O
Foxp3	S-Biological_Molecule
overexpression	O
on	O
the	O
activation	O
of	O
these	O
two	O
viral	O
promoters	O
demonstrated	O
that	O
Foxp3	S-Biological_Molecule
was	O
more	O
capable	O
of	O
suppressing	O
transcriptional	O
activation	O
of	O
the	O
HIV	O
-	O
1	O
LTR	O
(	O
Figure	O
3D	O
)	O
compared	O
to	O
the	O
mutated	O
HIV	O
-	O
1	O
LTR	O
(	O
Figure	O
3E	O
)	O
.	O

These	O
results	O
suggest	O
that	O
Foxp3	S-Biological_Molecule
down	O
-	O
regulation	O
of	O
HIV	O
-	O
1	O
LTR	O
activation	O
was	O
mediated	O
at	O
least	O
in	O
part	O
by	O
cis	O
-	O
acting	O
NF	O
-	O
kappaB	O
binding	O
sites	O
.	O

HTLV	O
-	O
I	O
encodes	O
a	O
multifunctional	O
transactivator	O
protein	O
,	O
Tax	S-Biological_Molecule
,	O
capable	O
of	O
activating	O
both	O
the	O
NF	O
-	O
kappaB	O
and	O
CREB	O
pathways	O
[	O
24	O
-	O
29	O
]	O
.	O

To	O
test	O
these	O
hypotheses	O
,	O
we	O
overexpressed	O
HTLV	O
-	O
I	O
Tax	S-Biological_Molecule
,	O
full	O
-	O
length	O
Foxp3	S-Biological_Molecule
,	O
and	O
/	O
or	O
deltaFKH	S-Biological_Molecule
in	O
HEK	O
293T	O
cells	O
cotransfected	O
with	O
an	O
HTLV	O
-	O
I	O
LTR	O
or	O
NF	O
-	O
kappaB	O
reporter	O
vector	O
.	O

We	O
therefore	O
quantitated	O
the	O
Foxp3	S-Biological_Molecule
protein	O
expression	O
in	O
CD4	S-Biological_Molecule
+	O
CD25	S-Biological_Molecule
+	O
T	O
cells	O
by	O
flow	O
cytometry	O
and	O
the	O
HTLV	O
-	O
I	O
proviral	O
load	O
(	O
a	O
surrogate	O
marker	O
of	O
viral	O
replication	O
)	O
by	O
real	O
-	O
time	O
PCR	O
from	O
eight	O
patients	O
with	O
HAM	O
/	O
TSP	O
and	O
eight	O
asymptomatic	O
carriers	O
(	O
ACs	O
)	O
.	O

As	O
expected	O
,	O
patients	O
with	O
HAM	O
/	O
TSP	O
exhibited	O
significantly	O
higher	O
proviral	O
loads	O
(	O
indicated	O
as	O
HTLV	O
-	O
I	O
proviral	O
DNA	O
copies	O
/	O
100	O
cells	O
)	O
(	O
34	O
.	O
68	O
+	O
/	O
-	O
23	O
.	O
19	O
)	O
compared	O
to	O
ACs	O
(	O
4	O
.	O
75	O
+	O
/	O
-	O
5	O
.	O
47	O
)	O
(	O
p	O
=	O
0	O
.	O
0008	O
)	O
.	O

Deletion	O
of	O
the	O
FKH	O
domain	O
of	O
Foxp3	S-Biological_Molecule
dampened	O
the	O
suppressive	O
effect	O
of	O
Foxp3	S-Biological_Molecule
,	O
but	O
did	O
not	O
completely	O
abrogate	O
suppression	O
,	O
as	O
is	O
seen	O
with	O
NF	O
-	O
kappaB	O
-	O
responsive	O
promoters	O
in	O
HEK	O
293T	O
cells	O
.	O

Overexpression	O
of	O
Foxp3	S-Biological_Molecule
was	O
capable	O
of	O
down	O
-	O
regulating	O
forskolin	O
-	O
induced	O
CREB	O
transcriptional	O
activation	O
.	O

However	O
,	O
when	O
we	O
attempted	O
to	O
determine	O
whether	O
Foxp3	S-Biological_Molecule
could	O
physically	O
interact	O
with	O
the	O
coactivator	O
protein	O
p300	S-Biological_Molecule
,	O
we	O
found	O
that	O
p300	S-Biological_Molecule
immunoprecipitated	O
Foxp3	S-Biological_Molecule
when	O
both	O
proteins	O
were	O
overexpressed	O
in	O
HEK	O
293T	O
cells	O
(	O
Figure	O
7D	O
)	O
.	O

It	O
is	O
possible	O
that	O
the	O
FKH	O
domain	O
has	O
a	O
complex	O
tertiary	O
structure	O
that	O
is	O
particularly	O
sensitive	O
to	O
misfolding	O
caused	O
by	O
genetic	O
mutations	O
and	O
that	O
an	O
intact	O
FKH	O
domain	O
is	O
absolutely	O
critical	O
for	O
promoting	O
Foxp3	S-Biological_Molecule
function	O
in	O
the	O
nucleus	O
,	O
whereas	O
the	O
structure	O
of	O
the	O
amino	O
-	O
terminal	O
proline	O
-	O
rich	O
region	O
may	O
tolerate	O
certain	O
mutations	O
as	O
long	O
as	O
the	O
NF	O
-	O
kappaB	O
/	O
NF	O
-	O
AT	O
binding	O
motif	O
remains	O
unaltered	O
.	O

This	O
series	O
of	O
steps	O
allows	O
Tax	S-Biological_Molecule
to	O
recruit	O
coactivator	O
proteins	O
CBP	S-Biological_Molecule
/	O
p300	S-Biological_Molecule
to	O
the	O
viral	O
promoter	O
and	O
facilitate	O
a	O
high	O
level	O
of	O
viral	O
gene	O
expression	O
[	O
24	O
-	O
26	O
]	O
.	O

However	O
,	O
Tax	S-Biological_Molecule
-	O
mediated	O
transactivation	O
of	O
the	O
HTLV	O
-	O
I	O
LTR	O
was	O
inhibited	O
by	O
overexpression	O
of	O
both	O
full	O
-	O
length	O
Foxp3	S-Biological_Molecule
as	O
well	O
as	O
deltaFKH	S-Biological_Molecule
in	O
both	O
HEK	O
293T	O
cells	O
and	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
.	O

Blood	O
samples	O
were	O
obtained	O
after	O
informed	O
consent	O
as	O
part	O
of	O
a	O
clinical	O
protocol	O
reviewed	O
and	O
approved	O
by	O
the	O
NIH	O
institutional	O
review	O
panel	O
.	O

pUC18	O
was	O
purchased	O
from	O
Stratagene	O
(	O
La	O
Jolla	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Wigdahl	O
(	O
Drexel	O
University	O
College	O
of	O
Medicine	O
)	O
.	O

HTLV	O
-	O
I	O
pACH	O
infectious	O
molecular	O
clone	O
has	O
been	O
described	O
previously	O
[	O
30	O
]	O
.	O

pFR	O
-	O
luc	O
,	O
pFA	O
-	O
CMV	O
,	O
pFA2	O
-	O
CREB	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
and	O
pFA2	O
-	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Jun	E-Biological_Molecule
were	O
purchased	O
from	O
Stratagene	O
.	O

Purity	O
of	O
negatively	O
selected	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
was	O
consistently	O
higher	O
than	O
96	O
%	O
as	O
determined	O
by	O
flow	O
cytometry	O
.	O

Nucleofected	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
were	O
also	O
monitored	O
for	O
transfection	O
efficiency	O
and	O
cell	O
viability	O
24	O
h	O
posttransfection	O
as	O
follows	O
.	O

Cell	O
viability	O
,	O
determined	O
by	O
staining	O
with	O
7	O
-	O
amino	O
-	O
actinomycin	O
D	O
(	O
7	O
-	O
AAD	O
;	O
BD	O
Biosciences	O
)	O
,	O
was	O
routinely	O
~	O
70	O
%	O
.	O

Western	O
blot	O
analysis	O
.	O

Cells	O
were	O
washed	O
twice	O
and	O
stained	O
for	O
surface	O
CD4	S-Biological_Molecule
expression	O
with	O
PE	O
-	O
labeled	O
anti	O
-	O
CD4	S-Biological_Molecule
(	O
BD	O
)	O
and	O
CD25	S-Biological_Molecule
expression	O
with	O
FITC	O
-	O
labeled	O
anti	O
-	O
CD25	S-Biological_Molecule
(	O
BD	O
)	O
.	O

Latent	B-Biological_Molecule
membrane	I-Biological_Molecule
protein	I-Biological_Molecule
1	E-Biological_Molecule
(	O
LMP1	S-Biological_Molecule
)	O
is	O
considered	O
the	O
major	O
oncoprotein	O
of	O
EBV	O
,	O
as	O
it	O
transforms	O
rodent	O
fibroblasts	O
to	O
tumorigenicity	O
in	O
nude	O
mice	O
and	O
is	O
expressed	O
in	O
HD	O
,	O
NPC	O
,	O
and	O
immunosuppression	O
-	O
associated	O
tumors	O
[	O
4	O
-	O
8	O
]	O
.	O

Activation	O
of	O
NFkappaB	O
is	O
required	O
for	O
EBV	O
-	O
induced	O
B	O
cell	O
transformation	O
and	O
its	O
inhibition	O
rapidly	O
results	O
in	O
cell	O
death	O
[	O
17	O
,	O
18	O
]	O
.	O

Both	O
the	O
membrane	O
proximal	O
and	O
distal	O
cytoplasmic	O
regions	O
of	O
CD40	S-Biological_Molecule
that	O
bind	O
TRAF6	S-Biological_Molecule
and	O
TRAFs2	S-Biological_Molecule
/	O
3	S-Biological_Molecule
/	O
5	S-Biological_Molecule
,	O
respectively	O
,	O
are	O
necessary	O
for	O
GC	O
formation	O
,	O
but	O
either	O
region	O
is	O
sufficient	O
to	O
induce	O
extrafollicular	O
B	O
cell	O
differentiation	O
and	O
restore	O
low	O
affinity	O
antibody	O
production	O
[	O
22	O
]	O
.	O

LMP1	S-Biological_Molecule
expression	O
was	O
heterogeneous	O
with	O
strong	O
LMP1	S-Biological_Molecule
staining	O
interspersed	O
amongst	O
a	O
background	O
of	O
cells	O
staining	O
weakly	O
for	O
LMP1	S-Biological_Molecule
.	O

Interestingly	O
,	O
a	O
spontaneous	O
wild	O
-	O
type	O
lymphoma	O
also	O
developed	O
in	O
B	O
-	O
1a	O
cells	O
(	O
Figure	O
2A	O
)	O
.	O

Interestingly	O
,	O
very	O
low	O
levels	O
of	O
expression	O
of	O
both	O
light	O
chains	O
were	O
detected	O
by	O
flow	O
cytometry	O
.	O

These	O
findings	O
indicate	O
that	O
expression	O
of	O
LMP1	S-Biological_Molecule
in	O
B	O
-	O
1a	O
cells	O
promotes	O
the	O
development	O
of	O
malignancy	O
and	O
can	O
result	O
in	O
the	O
aberrant	O
escape	O
from	O
allelic	O
exclusion	O
.	O

EMA	O
exclusion	O
of	O
CD19	S-Biological_Molecule
+	O
gated	O
B	O
cells	O
prepared	O
from	O
two	O
wild	O
-	O
type	O
and	O
two	O
LMP1	S-Biological_Molecule
transgenic	O
mice	O
indicated	O
a	O
2	O
-	O
fold	O
increase	O
in	O
viability	O
in	O
the	O
LMP1	S-Biological_Molecule
transgenic	O
lymphocytes	O
compared	O
to	O
wild	O
-	O
type	O
lymphocytes	O
.	O

The	O
level	O
of	O
proliferation	O
was	O
not	O
enhanced	O
upon	O
IL4	S-Biological_Molecule
addition	O
,	O
confirming	O
the	O
IL4	S-Biological_Molecule
independence	O
observed	O
in	O
the	O
viability	O
studies	O
(	O
Figure	O
3C	O
;	O
Table1	O
)	O
.	O

Wild	O
-	O
Type	O
and	O
LMP1	S-Biological_Molecule
Transgenic	O
Lymphoma	O
Cells	O
Do	O
Not	O
Require	O
IL4	S-Biological_Molecule
and	O
Stat6	S-Biological_Molecule
Signaling	O

Activated	O
Stat6	S-Biological_Molecule
(	O
pStat6	S-Biological_Molecule
)	O
,	O
a	O
target	O
of	O
the	O
IL4	B-Biological_Molecule
receptor	E-Biological_Molecule
pathway	O
,	O
was	O
detected	O
in	O
the	O
wild	O
-	O
type	O
and	O
LMP1	S-Biological_Molecule
transgenic	O
lymphocytes	O
(	O
Figure	O
4B	O
)	O
.	O

Progression	O
to	O
lymphoma	O
in	O
both	O
wild	O
-	O
type	O
and	O
LMP1	S-Biological_Molecule
transgenic	O
lymphoma	O
cells	O
led	O
to	O
increased	O
levels	O
of	O
Rb	S-Biological_Molecule
,	O
correspondingly	O
high	O
levels	O
of	O
Cdk2	S-Biological_Molecule
,	O
and	O
decreased	O
levels	O
of	O
p27	S-Biological_Molecule
(	O
Figure	O
6C	O
)	O
.	O

Cucurbitacin	O
I	O
inhibits	O
activation	O
of	O
Stat3	S-Biological_Molecule
by	O
suppressing	O
the	O
activation	O
of	O
its	O
kinase	O
JAK2	S-Biological_Molecule
.	O

Table	O
1	O
summarizes	O
the	O
biological	O
and	O
molecular	O
properties	O
that	O
were	O
identified	O
in	O
wild	O
-	O
type	O
and	O
LMP1	S-Biological_Molecule
transgenic	O
lymphomas	O
.	O

Although	O
LMP1	S-Biological_Molecule
has	O
been	O
shown	O
to	O
deregulate	O
the	O
Rb	S-Biological_Molecule
pathway	O
in	O
epithelial	O
cells	O
[	O
69	O
]	O
,	O
to	O
our	O
knowledge	O
this	O
is	O
the	O
first	O
demonstration	O
of	O
this	O
property	O
in	O
B	O
lymphocytes	O
.	O

The	O
requirement	O
for	O
Akt	S-Biological_Molecule
activation	O
was	O
confirmed	O
by	O
the	O
striking	O
inhibition	O
of	O
lymphoma	O
viability	O
by	O
triciribine	O
,	O
an	O
Akt	S-Biological_Molecule
inhibitor	O
.	O

This	O
effect	O
has	O
also	O
been	O
described	O
in	O
EBV	O
-	O
positive	O
HD	O
biopsies	O
[	O
40	O
]	O
.	O

It	O
has	O
been	O
shown	O
that	O
overstimulation	O
of	O
CD40	S-Biological_Molecule
signaling	O
with	O
agonistic	O
antibodies	O
inhibits	O
GC	O
formation	O
[	O
71	O
]	O
.	O

The	O
transgenic	O
lymphomas	O
mirror	O
multiple	O
aspects	O
of	O
EBV	O
-	O
induced	O
tumors	O
and	O
suggest	O
that	O
in	O
vivo	O
these	O
properties	O
of	O
LMP1	S-Biological_Molecule
are	O
major	O
factors	O
in	O
the	O
development	O
of	O
cancer	O
.	O

Erythrocytes	O
were	O
lysed	O
using	O
0	O
.	O
8	O
%	O
ammonium	O
chloride	O
solution	O
(	O
StemCell	O
Technologies	O
)	O
for	O
10	O
min	O
on	O
ice	O
and	O
washed	O
twice	O
with	O
PBS	O
.	O

Cultures	O
were	O
pulsed	O
for	O
4	O
h	O
with	O
MTS	O
reagent	O
1	O
d	O
post	O
-	O
seeding	O
.	O

Immunohistochemistry	O
.	O

Paraffin	O
-	O
embedded	O
spleen	O
sections	O
were	O
deparaffinized	O
in	O
Histoclear	O
(	O
National	O
Diagnostics	O
)	O
and	O
rehydrated	O
in	O
graded	O
ethanol	O
.	O

Protected	O
probes	O
were	O
resolved	O
on	O
a	O
denaturing	O
4	O
.	O
75	O
%	O
acrylamide	O
gel	O
,	O
dried	O
,	O
and	O
imaged	O
using	O
a	O
phosphorImager	O
(	O
Molecular	O
Dynamics	O
)	O
.	O

Crude	O
lysates	O
were	O
centrifuged	O
at	O
13	O
,	O
000	O
rpm	O
for	O
10	O
min	O
at	O
4	O
degreesC	O
and	O
the	O
supernatants	O
were	O
collected	O
for	O
further	O
analysis	O
.	O

Lysates	O
were	O
boiled	O
in	O
the	O
presence	O
of	O
2	O
.	O
5	O
%	O
beta	O
-	O
mecaptoethanol	O
,	O
separated	O
by	O
denaturing	O
SDS	O
-	O
PAGE	O
,	O
and	O
transferred	O
to	O
0	O
.	O
45	O
-	O
mum	O
Optitran	O
membranes	O
(	O
Schleicher	O
&	O
Schuell	O
)	O
in	O
a	O
Bio	O
-	O
Rad	O
transfer	O
unit	O
.	O

Membranes	O
were	O
immunoblotted	O
with	O
the	O
appropriate	O
primary	O
antibody	O
followed	O
by	O
horseradish	O
peroxidase	S-Biological_Molecule
-	O
tagged	O
secondary	O
antibodies	O
(	O
Amersham	O
Biosciences	O
and	O
Dako	O
)	O
and	O
detected	O
with	O
the	O
SuperSignal	O
West	O
Pico	O
System	O
(	O
Pierce	O
)	O
.	O

(	O
B	O
)	O
EMA	O
exclusion	O
of	O
CD19	S-Biological_Molecule
+	O
gated	O
splenocytes	O
from	O
WT	O
and	O
LMP1	S-Biological_Molecule
transgenic	O
mice	O
showing	O
percentage	O
of	O
viable	O
B	O
cells	O
cultured	O
with	O
(	O
white	O
bars	O
)	O
or	O
without	O
(	O
black	O
bars	O
)	O
IL4	S-Biological_Molecule
for	O
2	O
d	O
.	O

The	O
L32	S-Biological_Molecule
and	O
GAPDH	S-Biological_Molecule
housekeeping	O
genes	O
were	O
used	O
as	O
a	O
loading	O
control	O
.	O

(	O
D	O
and	O
E	O
)	O
MTS	O
assay	O
of	O
(	O
D	O
)	O
WT	O
lymphocytes	O
and	O
(	O
E	O
)	O
LMP1	S-Biological_Molecule
transgenic	O
lymphoma	O
cells	O
cultured	O
with	O
IL4	S-Biological_Molecule
,	O
a	O
neutralizing	O
antibody	O
to	O
IL4	S-Biological_Molecule
,	O
or	O
a	O
rat	O
IgG	O
isotype	O
control	O
at	O
the	O
indicated	O
concentrations	O
.	O

The	O
results	O
are	O
the	O
mean	O
+	O
/	O
-	O
SEM	O
of	O
triplicate	O
samples	O
from	O
a	O
single	O
representative	O
experiment	O
that	O
was	O
repeated	O
twice	O
with	O
similar	O
results	O
.	O

(	O
A	O
)	O
Relative	O
expression	O
of	O
IL10	S-Biological_Molecule
,	O
IL15	S-Biological_Molecule
,	O
and	O
IFNgamma	S-Biological_Molecule
mRNA	O
in	O
WT	O
and	O
LMP1	S-Biological_Molecule
transgenic	O
B	O
cells	O
(	O
CD19	S-Biological_Molecule
+	O
)	O
,	O
as	O
detected	O
with	O
an	O
Rnase	O
protection	O
assay	O
.	O

Mouse	O
lymphoma	O
cell	O
lines	O
967	O
and	O
K46mu	O
were	O
used	O
as	O
controls	O
.	O

Actin	O
was	O
used	O
as	O
a	O
loading	O
control	O
.	O

Scale	O
bar	O
,	O
20	O
mum	O
.	O

We	O
show	O
that	O
effector	O
CTL	O
differentiation	O
occurs	O
in	O
two	O
sequential	O
phases	O
in	O
vitro	O
,	O
characterized	O
by	O
early	O
induction	O
of	O
T	B-Biological_Molecule
-	I-Biological_Molecule
bet	E-Biological_Molecule
and	O
late	O
induction	O
of	O
Eomesodermin	S-Biological_Molecule
(	O
Eomes	S-Biological_Molecule
)	O
,	O
T	O
-	O
box	O
transcription	O
factors	O
that	O
regulate	O
the	O
early	O
and	O
late	O
phases	O
of	O
interferon	B-Biological_Molecule
(	I-Biological_Molecule
IFN	I-Biological_Molecule
)	I-Biological_Molecule
gamma	E-Biological_Molecule
expression	O
,	O
respectively	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
used	O
in	O
vitro	O
systems	O
such	O
as	O
those	O
developed	O
to	O
study	O
CD4	S-Biological_Molecule
+	O
T	O
cell	O
differentiation	O
to	O
define	O
the	O
molecular	O
basis	O
of	O
effector	O
CTL	O
differentiation	O
(	O
5	O
,	O
6	O
)	O
.	O
The	O
T	O
-	O
box	O
transcription	O
factors	O
Eomesodermin	S-Biological_Molecule
(	O
Eomes	S-Biological_Molecule
)	O
and	O
T	B-Biological_Molecule
-	I-Biological_Molecule
bet	E-Biological_Molecule
are	O
needed	O
for	O
important	O
aspects	O
of	O
effector	O
and	O
memory	O
CTL	O
differentiation	O
(	O
7	O
)	O
.	O

Although	O
Runx3	S-Biological_Molecule
is	O
not	O
expressed	O
in	O
naive	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
,	O
its	O
expression	O
is	O
up	O
-	O
regulated	O
during	O
Th1	O
cell	O
differentiation	O
,	O
and	O
Runx3	S-Biological_Molecule
influences	O
Th1	O
cell	O
differentiation	O
and	O
function	O
through	O
direct	O
regulation	O
of	O
theIl4andIfngcytokine	S-Biological_Molecule
genes	O
(	O
15	O
,	O
16	O
)	O
.	O

Distinct	O
expression	O
kinetics	O
of	O
perforin	S-Biological_Molecule
and	O
granzyme	B-Biological_Molecule
B	E-Biological_Molecule
during	O
CTL	O
development	O
in	O
culture	O

Perforin	S-Biological_Molecule
and	O
granzyme	B-Biological_Molecule
B	E-Biological_Molecule
expression	O
are	O
not	O
appreciably	O
regulated	O
by	O
T	B-Biological_Molecule
-	I-Biological_Molecule
bet	E-Biological_Molecule

To	O
test	O
the	O
model	O
outlined	O
in	O
the	O
previous	O
paragraph	O
directly	O
,	O
we	O
compared	O
the	O
expression	O
of	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
,	O
perforin	S-Biological_Molecule
,	O
and	O
granzyme	B-Biological_Molecule
B	E-Biological_Molecule
in	O
CD8	S-Biological_Molecule
+	O
T	O
cells	O
from	O
WT	O
and	O
Tbx21	S-Biological_Molecule
(	O
T	B-Biological_Molecule
-	I-Biological_Molecule
bet	E-Biological_Molecule
)	O
-	O
deficient	O
mice	O
.	O

Notably	O
,	O
this	O
deleterious	O
effect	O
of	O
T	B-Biological_Molecule
-	I-Biological_Molecule
bet	E-Biological_Molecule
deficiency	O
was	O
only	O
observed	O
in	O
differentiating	O
CD8	S-Biological_Molecule
+	O
T	O
cells	O
until	O
day	O
4	O
of	O
culture	O
but	O
was	O
almost	O
completely	O
mitigated	O
by	O
day	O
6	O
(	O
Fig	O
.	O
2	O
A	O
)	O
.	O

We	O
consistently	O
observed	O
a	O
modest	O
reduction	O
in	O
GzmB	S-Biological_Molecule
mRNA	O
in	O
T	B-Biological_Molecule
-	I-Biological_Molecule
bet	E-Biological_Molecule
-	O
deficient	O
T	O
cells	O
(	O
Fig	O
.	O
2	O
B	O
,	O
compare	O
lanes	O
1	O
and	O
4	O
)	O
,	O
which	O
did	O
not	O
translate	O
into	O
a	O
decrease	O
in	O
expression	O
of	O
granzyme	B-Biological_Molecule
B	E-Biological_Molecule
protein	O
(	O
Fig	O
.	O
2	O
C	O
)	O
.	O

We	O
previously	O
reported	O
that	O
Th1	O
cell	O
differentiation	O
was	O
regulated	O
through	O
a	O
feed	O
-	O
forward	O
loop	O
in	O
which	O
T	B-Biological_Molecule
-	I-Biological_Molecule
bet	E-Biological_Molecule
is	O
up	O
-	O
regulated	O
early	O
and	O
induces	O
Runx3	S-Biological_Molecule
,	O
after	O
which	O
T	B-Biological_Molecule
-	I-Biological_Molecule
bet	E-Biological_Molecule
and	O
Runx3	S-Biological_Molecule
cooperate	O
to	O
induce	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
and	O
silence	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
,	O
thus	O
promoting	O
stable	O
differentiation	O
toward	O
the	O
Th1	O
lineage	O
(	O
15	O
,	O
22	O
)	O
.	O

Because	O
of	O
the	O
limited	O
number	O
of	O
CD8	S-Biological_Molecule
+	O
T	O
cells	O
in	O
these	O
mice	O
,	O
and	O
because	O
we	O
saw	O
no	O
difference	O
between	O
Runx3	S-Biological_Molecule
-	O
/	O
-	O
CD8	S-Biological_Molecule
+	O
CD4	S-Biological_Molecule
-	O
SP	O
and	O
CD8	S-Biological_Molecule
+	O
CD4	S-Biological_Molecule
+	O
DP	O
cells	O
in	O
our	O
previous	O
experiments	O
,	O
we	O
used	O
total	O
Runx3	S-Biological_Molecule
-	O
/	O
-	O
CD8	S-Biological_Molecule
+	O
T	O
cells	O
without	O
further	O
fractionation	O
as	O
recipients	O
for	O
retroviral	O
transduction	O
.	O

Indeed	O
,	O
T	B-Biological_Molecule
-	I-Biological_Molecule
bet	E-Biological_Molecule
and	O
Eomes	S-Biological_Molecule
both	O
contribute	O
to	O
perforin	S-Biological_Molecule
expression	O
in	O
NK	O
cells	O
(	O
8	O
,	O
26	O
)	O
,	O
and	O
Eomes	S-Biological_Molecule
induces	O
granzyme	B-Biological_Molecule
B	E-Biological_Molecule
as	O
effectively	O
as	O
T	B-Biological_Molecule
-	I-Biological_Molecule
bet	E-Biological_Molecule
in	O
developing	O
Th2	O
cells	O
(	O
7	O
)	O
;	O
thus	O
,	O
the	O
relative	O
roles	O
of	O
these	O
T	O
-	O
box	O
transcription	O
factors	O
vary	O
depending	O
on	O
cell	O
type	O
.	O

Surprisingly	O
,	O
however	O
,	O
Eomes	S-Biological_Molecule
and	O
T	B-Biological_Molecule
-	I-Biological_Molecule
bet	E-Biological_Molecule
appeared	O
nonredundant	O
in	O
their	O
ability	O
to	O
induce	O
two	O
other	O
markers	O
of	O
CTL	O
function	O
,	O
Prf1	S-Biological_Molecule
and	O
Gzmb	S-Biological_Molecule
(	O
Fig	O
.	O
4	O
C	O
)	O
.	O

Because	O
conventional	O
Eomes	S-Biological_Molecule
-	O
deficient	O
mice	O
die	O
before	O
precursor	O
cells	O
can	O
be	O
isolated	O
for	O
bone	O
marrow	O
transfers	O
(	O
27	O
)	O
and	O
because	O
T	O
cells	O
conditionally	O
deficient	O
in	O
Eomes	S-Biological_Molecule
have	O
only	O
recently	O
been	O
described	O
(	O
9	O
)	O
,	O
we	O
were	O
unable	O
to	O
introduce	O
Runx3	S-Biological_Molecule
into	O
Eomes	S-Biological_Molecule
-	O
deficient	O
CD8	S-Biological_Molecule
+	O
T	O
cells	O
to	O
test	O
formally	O
whether	O
Eomes	S-Biological_Molecule
cooperated	O
with	O
Runx3	S-Biological_Molecule
to	O
induce	O
perforin	S-Biological_Molecule
expression	O
.	O

Glimcher	O
(	O
Harvard	O
School	O
of	O
Public	O
Health	O
,	O
Boston	O
,	O
MA	O
)	O
.	O

CD8	S-Biological_Molecule
+	O
T	O
cells	O
from	O
4	O
-	O
8	O
-	O
wk	O
-	O
old	O
Tcra	S-Biological_Molecule
-	O
/	O
-	O
x	O
P14	O
TCR	O
transgenic	O
(	O
Taconic	O
)	O
,	O
C57BL	O
/	O
6J	O
WT	O
,	O
or	O
Tbx21	S-Biological_Molecule
-	O
/	O
-	O
(	O
The	O
Jackson	O
Laboratory	O
)	O
mice	O
were	O
purified	O
(	O
>	O
95	O
%	O
purity	O
)	O
by	O
negative	O
selection	O
(	O
Invitrogen	O
)	O
from	O
pooled	O
spleen	O
and	O
lymph	O
node	O
cells	O
.	O

Reiner	O
(	O
University	O
of	O
Pennsylvania	O
,	O
Philadelphia	O
,	O
PA	O
)	O
(	O
8	O
)	O
.	O

For	O
real	O
-	O
time	O
PCR	O
detection	O
of	O
immunoprecipitated	O
targets	O
using	O
the	O
SYBR	O
Green	O
PCR	O
Kit	O
,	O
a	O
standard	O
curve	O
was	O
obtained	O
with	O
serial	O
dilutions	O
of	O
input	O
DNA	O
for	O
each	O
sample	O
,	O
and	O
1	O
mul	O
ChIP	O
DNA	O
was	O
used	O
per	O
PCR	O
reaction	O
(	O
performed	O
in	O
duplicates	O
)	O
.	O

In	O
brief	O
,	O
10	O
mug	O
of	O
total	O
RNA	O
was	O
loaded	O
per	O
lane	O
and	O
transferred	O
to	O
positively	O
charged	O
nylon	O
membranes	O
(	O
Hybond	O
-	O
N	O
+	O
;	O
GE	O
Healthcare	O
)	O
,	O
which	O
was	O
confirmed	O
by	O
ethidium	O
bromide	O
staining	O
of	O
ribosomal	O
RNA	O
species	O
on	O
the	O
membrane	O
.	O

Band	O
intensities	O
were	O
acquired	O
by	O
phosphorimaging	O
analysis	O
.	O

Kinetics	O
of	O
gene	O
expression	O
during	O
CD8	S-Biological_Molecule
+	O
T	O
cell	O
differentiation	O
.	O

(	O
A	O
)	O
Kinetics	O
of	O
Prf1	S-Biological_Molecule
,	O
Gzmb	S-Biological_Molecule
,	O
Tbx21	S-Biological_Molecule
(	O
T	B-Biological_Molecule
-	I-Biological_Molecule
bet	E-Biological_Molecule
)	O
,	O
and	O
Eomes	S-Biological_Molecule
mRNA	O
expression	O
in	O
differentiating	O
P14	O
CD8	S-Biological_Molecule
+	O
T	O
cells	O
analyzed	O
by	O
Northern	O
blotting	O
.	O

RNA	O
from	O
day	O
7	O
Th1	O
cells	O
was	O
used	O
as	O
a	O
control	O
.	O

Percentage	O
of	O
Annexin	B-Biological_Molecule
V	E-Biological_Molecule
+	O
(	O
apoptotic	O
)	O
target	O
cells	O
in	O
the	O
CD8	S-Biological_Molecule
-	O
negative	O
EL4	O
target	O
population	O
(	O
dot	O
plots	O
)	O
was	O
determined	O
(	O
histograms	O
)	O
.	O

Results	O
are	O
representative	O
of	O
at	O
least	O
two	O
independent	O
experiments	O
.	O

Runx3	S-Biological_Molecule
is	O
present	O
in	O
naive	O
CD8	S-Biological_Molecule
+	O
T	O
cells	O
and	O
represses	O
Runx1	S-Biological_Molecule
and	O
induces	O
Eomes	S-Biological_Molecule
,	O
perforin	S-Biological_Molecule
,	O
granzyme	B-Biological_Molecule
B	E-Biological_Molecule
,	O
and	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
expression	O
.	O

The	O
increased	O
level	O
of	O
cAMP	O
that	O
results	O
from	O
phosphodiesterase	O
inhibition	O
affects	O
cytoplasmic	O
and	O
nuclear	O
events	O
,	O
resulting	O
in	O
the	O
attenuation	O
of	O
NF	O
-	O
kappaB	O
and	O
the	O
activation	O
of	O
CREB	O
transcriptional	O
DNA	O
binding	O
through	O
pathways	O
that	O
are	O
partially	O
Protein	O
kinase	O
A	O
-	O
independent	O
.	O

With	O
the	O
use	O
of	O
specific	O
inhibitors	O
,	O
we	O
also	O
investigated	O
the	O
role	O
of	O
PKA	O
in	O
LPS	O
-	O
induced	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
production	O
.	O

This	O
study	O
was	O
approved	O
by	O
the	O
Human	O
Research	O
Protections	O
Program	O
and	O
the	O
Institutional	O
Review	O
Board	O
.	O

Hank	O
'	O
s	O
balanced	O
salt	O
solution	O
(	O
HBSS	O
)	O
and	O
RPMI	O
1640	O
were	O
obtained	O
from	O
Irvine	O
Scientific	O
(	O
Santa	O
Ana	O
,	O
CA	O
)	O
.	O

Human	O
Peripheral	O
Blood	O
Mononuclear	O
Cell	O
Isolation	O
and	O
Stimulation	O

The	O
pellet	O
was	O
resuspended	O
in	O
ice	O
-	O
cold	O
SDS	O
sample	O
buffer	O
supplemented	O
with	O
100	O
mM	O
dithiothreitol	O
.	O

The	O
membranes	O
were	O
washed	O
with	O
Tris	O
-	O
buffered	O
saline	O
/	O
Tween	O
20	O
and	O
incubated	O
for	O
1	O
hour	O
at	O
room	O
temperature	O
with	O
the	O
secondary	O
antibody	O
,	O
horseradish	O
peroxidase	O
-	O
linked	O
anti	O
-	O
rabbit	O
IgG	O
diluted	O
1	O
:	O
2000	O
in	O
blocking	O
solution	O
.	O

Western	O
blot	O
data	O
is	O
presented	O
as	O
a	O
percentage	O
of	O
LPS	O
stimulation	O
.	O

The	O
percentage	O
of	O
LPS	O
stimulation	O
was	O
calculated	O
by	O
dividing	O
the	O
mean	O
band	O
pixel	O
total	O
for	O
each	O
treatment	O
arm	O
divided	O
by	O
the	O
mean	O
pixel	O
total	O
of	O
samples	O
stimulated	O
with	O
LPS	O
and	O
multiplying	O
by	O
100	O
.	O

Specificity	O
was	O
determined	O
by	O
a	O
competition	O
assay	O
with	O
the	O
addition	O
of	O
200	O
molar	O
excess	O
of	O
unlabeled	O
double	O
stranded	O
CREB	O
oligonucleotide	O
.	O

Nuclear	O
extracts	O
(	O
10	O
mug	O
)	O
were	O
incubated	O
with	O
5	O
nM	O
NF	O
-	O
kappaB	O
or	O
CREB	O
probe	O
(	O
NF	O
-	O
kB	O
:	O
1x	O
binding	O
buffer	O
,	O
50	O
mM	O
KCl	O
,	O
1	O
mM	O
EDTA	O
,	O
1	O
mM	O
DTT	O
,	O
0	O
.	O
1	O
%	O
NP40	O
,	O
10	O
%	O
glycerol	O
,	O
and	O
50	O
ng	O
/	O
mul	O
poly	O
dI	O
-	O
dC	O
,	O
CREB	O
:	O
1x	O
binding	O
buffer	O
,	O
20	O
mM	O
Tris	O
,	O
pH	O
7	O
.	O
5	O
,	O
50	O
mM	O
KCl	O
,	O
1	O
mM	O
EDTA	O
,	O
1	O
mM	O
DTT	O
,	O
0	O
.	O
10	O
%	O
NP40	O
,	O
6	O
%	O
glycerol	O
,	O
0	O
.	O
1	O
mg	O
/	O
mL	O
BSA	O
and	O
50	O
ng	O
/	O
mul	O
poly	O
dI	O
-	O
dC	O
)	O
and	O
were	O
then	O
electrophoresed	O
through	O
a	O
6	O
%	O
DNA	O
retardation	O
gel	O
at	O
100V	O
for	O
90	O
minutes	O
.	O

The	O
experimental	O
results	O
obtained	O
in	O
this	O
study	O
were	O
derived	O
from	O
four	O
separate	O
experiments	O
with	O
healthy	O
volunteer	O
donors	O
.	O

This	O
classic	O
pathway	O
has	O
been	O
challenged	O
as	O
the	O
sole	O
mechanism	O
involved	O
in	O
the	O
modulation	O
of	O
inflammation	O
by	O
cAMP	O
-	O
enhancing	O
drugs	O
,	O
and	O
alternative	O
mechanisms	O
involving	O
PKA	O
-	O
independent	O
pathways	O
have	O
been	O
proposed	O
.	O
6	O
-	O
8	O
In	O
this	O
series	O
of	O
experiments	O
,	O
we	O
observed	O
a	O
significant	O
attenuation	O
of	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
production	O
in	O
LPS	O
-	O
stimulated	O
human	O
mononuclear	O
cells	O
following	O
PTX	O
administration	O
,	O
independent	O
of	O
PKA	O
activation	O
.	O

However	O
,	O
the	O
reported	O
beneficial	O
effects	O
of	O
PTX	O
are	O
not	O
only	O
related	O
to	O
the	O
downregulation	O
of	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alphabut	E-Biological_Molecule
also	O
to	O
PTX	O
'	O
s	O
hemorrheologic	O
properties	O
,	O
its	O
ability	O
to	O
reduce	O
neutrophil	O
activation	O
,	O
and	O
its	O
beneficial	O
effects	O
on	O
microcirculation	O
,	O
cardiac	O
performance	O
,	O
and	O
organ	O
injury	O
.	O
20	O
-	O
25	O
Herein	O
,	O
we	O
demonstrated	O
that	O
the	O
downregulatory	O
effects	O
of	O
PTX	O
in	O
human	O
mononuclear	O
cells	O
involves	O
modulation	O
of	O
pathways	O
that	O
involve	O
NF	O
-	O
kappaB	O
and	O
CREB	O
,	O
two	O
major	O
transcription	O
factors	O
involved	O
in	O
the	O
inflammatory	O
cascade	O
.	O

This	O
allows	O
the	O
transcription	O
factor	O
to	O
bind	O
to	O
promoter	O
regions	O
of	O
specific	O
pro	O
-	O
inflammatory	O
genes	O
and	O
influence	O
transcription	O
.	O
27	O
,	O
28	O
Because	O
a	O
number	O
of	O
potential	O
kappaB	O
sites	O
are	O
present	O
in	O
the	O
nucleotide	O
sequences	O
of	O
the	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
gene	O
,	O
NF	O
-	O
kappaB	O
is	O
considered	O
to	O
be	O
a	O
critical	O
transcriptional	O
factor	O
involved	O
in	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
gene	O
expression	O
and	O
protein	O
synthesis	O
.	O
29	O
,	O
30	O

This	O
hypothesis	O
is	O
currently	O
under	O
investigation	O
in	O
our	O
laboratory	O
.	O

Furthermore	O
,	O
we	O
utilized	O
a	O
broad	O
PKA	O
inhibitor	O
in	O
this	O
study	O
in	O
addition	O
to	O
H89	O
,	O
but	O
did	O
not	O
examine	O
the	O
effect	O
of	O
specific	O
inhibition	O
of	O
various	O
PKA	O
isoforms	O
.	O

Therefore	O
,	O
PTX	O
may	O
serve	O
as	O
a	O
potential	O
adjunct	O
therapeutic	O
for	O
the	O
treatment	O
of	O
conditions	O
in	O
which	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
production	O
plays	O
a	O
significant	O
role	O
.	O

The	O
relative	O
amounts	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
and	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
produced	O
by	O
Th1	O
cells	O
may	O
influence	O
the	O
balance	O
between	O
clearance	O
and	O
persistent	O
infection	O
with	O
certain	O
pathogens	O
(	O
Moore	O
et	O
al	O
.	O
,	O
2001	O
;	O
Trinchieri	O
,	O
2007	O
)	O
,	O
thus	O
determining	O
whether	O
chronic	O
infection	O
or	O
immunopathology	O
ensues	O
.	O

Again	O
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
-	O
producing	O
Th1	O
cells	O
were	O
differentiated	O
at	O
the	O
high	O
antigen	O
dose	O
in	O
the	O
presence	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
12	E-Biological_Molecule
in	O
DO11	O
.	O
10	O
T	O
cells	O
(	O
Figure	O
2A	O
)	O
.	O

High	O
antigen	O
dose	O
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
12	E-Biological_Molecule
cooperated	O
to	O
induce	O
maximal	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
production	O
(	O
Figures	O
4A	O
and	O
4B	O
)	O
,	O
given	O
that	O
this	O
combination	O
resulted	O
in	O
the	O
highest	O
numbers	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
-	O
producing	O
Th1	O
cells	O
.	O

As	O
in	O
the	O
APC	O
-	O
driven	O
cultures	O
,	O
stronger	O
TCR	O
stimulation	O
together	O
with	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
12	E-Biological_Molecule
led	O
to	O
higher	O
percentages	O
of	O
cells	O
producing	O
both	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
and	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
after	O
1	O
week	O
of	O
culture	O
(	O
Figure	O
5C	O
)	O
.	O

Our	O
demonstration	O
that	O
loss	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
is	O
accompanied	O
by	O
production	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
offers	O
potential	O
additional	O
mechanisms	O
whereby	O
effector	O
T	O
cell	O
responses	O
may	O
be	O
dampened	O
during	O
chronic	O
disease	O
.	O

Although	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
may	O
be	O
differentially	O
regulated	O
in	O
Th1	O
and	O
Th2	O
cells	O
as	O
has	O
been	O
reported	O
(	O
Chang	O
et	O
al	O
.	O
,	O
2007	O
;	O
Wang	O
et	O
al	O
.	O
,	O
2005	O
)	O
,	O
some	O
studies	O
suggest	O
the	O
existence	O
of	O
common	O
pathways	O
,	O
but	O
the	O
molecular	O
basis	O
for	O
these	O
is	O
as	O
yet	O
unclear	O
.	O

That	O
c	B-Biological_Molecule
-	I-Biological_Molecule
maf	E-Biological_Molecule
expression	O
is	O
common	O
to	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
-	O
producing	O
Th1	O
,	O
Th2	O
,	O
and	O
Th17	O
cells	O
and	O
,	O
like	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
,	O
is	O
dependent	O
on	O
ERK	S-Biological_Molecule
activation	O
in	O
Th1	O
and	O
Th17	O
cells	O
for	O
its	O
expression	O
is	O
of	O
interest	O
because	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Maf	E-Biological_Molecule
has	O
been	O
shown	O
to	O
be	O
an	O
essential	O
transcription	O
factor	O
for	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
expression	O
in	O
macrophages	O
(	O
Cao	O
et	O
al	O
.	O
,	O
2005	O
)	O
.	O

With	O
regard	O
to	O
the	O
expression	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
by	O
Th1	O
cells	O
,	O
our	O
data	O
provide	O
a	O
mechanism	O
for	O
how	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
expression	O
is	O
induced	O
and	O
then	O
amplified	O
and	O
regulated	O
by	O
the	O
levels	O
of	O
antigen	O
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
12	E-Biological_Molecule
encountered	O
in	O
the	O
environment	O
.	O

At	O
day	O
5	O
or	O
7	O
,	O
cells	O
were	O
restimulated	O
with	O
immobilized	O
anti	O
-	O
CD3	S-Biological_Molecule
(	O
2	O
mug	O
/	O
ml	O
)	O
and	O
anti	O
-	O
CD28	S-Biological_Molecule
(	O
2	O
mug	O
/	O
ml	O
)	O
(	O
4	O
hr	O
with	O
BrefeldinA	O
[	O
10	O
mug	O
/	O
ml	O
]	O
in	O
the	O
last	O
2	O
hr	O
)	O
or	O
with	O
PdBU	O
and	O
Ionomycin	O
(	O
5	O
hr	O
with	O
BrefeldinA	O
[	O
1	O
mug	O
/	O
ml	O
]	O
)	O
.	O

After	O
ICS	O
FACS	O
,	O
data	O
were	O
collected	O
on	O
a	O
FACSCalibur	O
(	O
Becton	O
Dickinson	O
)	O
and	O
analyzed	O
with	O
FlowJo	O
(	O
Tree	O
Star	O
)	O
.	O

In	O
Vivo	O
Studies	O

Real	O
-	O
Time	O
Quantitative	O
RT	O
-	O
PCR	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
role	O
of	O
the	O
transcription	O
factors	O
,	O
AP	O
-	O
1	O
and	O
NF	O
-	O
kappaB	O
,	O
in	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
and	O
CXCL8	S-Biological_Molecule
regulation	O
in	O
Jurkat	O
T	O
-	O
cells	O
.	O

Phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
exposure	O
resulted	O
in	O
an	O
up	O
-	O
regulation	O
of	O
AP	O
-	O
1	O
and	O
down	O
-	O
regulation	O
of	O
NF	O
-	O
kappaB	O
activity	O
,	O
however	O
,	O
exposure	O
to	O
heat	O
killed	O
(	O
HK	O
)	O
Escherichia	O
.	O
coli	O
MG1655	O
resulted	O
in	O
a	O
dose	O
-	O
dependent	O
increase	O
in	O
NF	O
-	O
kappaB	O
activity	O
without	O
affecting	O
AP	O
-	O
1	O
.	O

Using	O
an	O
NF	O
-	O
kappaB	O
activation	O
inhibitor	O
,	O
we	O
observed	O
complete	O
inhibition	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
expression	O
while	O
CXCL8	S-Biological_Molecule
levels	O
only	O
decreased	O
by	O
40	O
%	O
at	O
the	O
highest	O
concentration	O
.	O

Treatment	O
of	O
Jurkat	O
T	O
-	O
cells	O
with	O
PMA	O
in	O
the	O
presence	O
of	O
JNK	O
-	O
inhibitor	O
suppressed	O
both	O
CXCL8	S-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
while	O
PKC	O
-	O
inhibitor	O
primarily	O
decreased	O
CXCL8	S-Biological_Molecule
expression	O
.	O

Cytokines	O
and	O
chemokines	O
are	O
important	O
in	O
immune	O
cell	O
recruitment	O
and	O
in	O
regulation	O
of	O
inflammatory	O
responses	O
[	O
1	O
]	O
.	O

The	O
time	O
-	O
dependent	O
activation	O
of	O
NF	O
-	O
kappaB	O
by	O
HK	O
E	O
.	O
coli	O
was	O
assessed	O
further	O
using	O
the	O
optimal	O
concentration	O
obtained	O
from	O
figure	O
2b	O
and	O
showed	O
that	O
the	O
NF	O
-	O
kappaB	O
activity	O
increased	O
after	O
3	O
h	O
of	O
exposure	O
(	O
figure	O
2c	O
)	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
PMA	O
was	O
120	O
-	O
fold	O
more	O
effective	O
at	O
inducing	O
CXCL8	S-Biological_Molecule
than	O
HK	O
E	O
.	O
coli	O
.	O

PMA	O
-	O
dependent	O
induction	O
of	O
AP	O
-	O
1	O
and	O
down	O
-	O
regulation	O
of	O
NF	O
-	O
kappaB	O
suggests	O
an	O
involvement	O
of	O
AP	O
-	O
1	O
in	O
CXCL8	S-Biological_Molecule
regulation	O
.	O

Wang	O
and	O
colleagues	O
[	O
37	O
]	O
reported	O
an	O
elevated	O
inflammatory	O
response	O
by	O
obtaining	O
expression	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
following	O
the	O
exposure	O
of	O
T	O
-	O
cells	O
to	O
peptidoglycan	O
.	O

The	O
assessment	O
of	O
Jurkat	O
T	O
-	O
cell	O
inflammatory	O
responses	O
(	O
Table	O
1	O
)	O
revealed	O
an	O
enhanced	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
expression	O
upon	O
exposure	O
to	O
PMA	O
or	O
HK	O
E	O
.	O
coli	O
due	O
to	O
PKC	O
activation	O
[	O
40	O
]	O
.	O

HK	O
E	O
.	O
coli	O
treatment	O
resulted	O
in	O
a	O
significant	O
reduction	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
expression	O
.	O

The	O
time	O
course	O
analysis	O
of	O
cytokine	O
expression	O
showed	O
a	O
correlation	O
between	O
AP	O
-	O
1	O
and	O
the	O
chemokine	O
CXCL8	S-Biological_Molecule
where	O
CXCL8	O
expression	O
was	O
significantly	O
elevated	O
already	O
at	O
2	O
-	O
6	O
h	O
after	O
PMA	O
exposure	O
.	O

These	O
observations	O
indicate	O
that	O
the	O
MAPK	O
pathway	O
and	O
the	O
transcription	O
factor	O
AP	O
-	O
1	O
play	O
an	O
important	O
role	O
in	O
the	O
induction	O
of	O
inflammatory	O
responses	O
in	O
Jurkat	O
T	O
-	O
cells	O
[	O
12	O
,	O
20	O
,	O
22	O
]	O
.	O

Expression	O
of	O
il	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
dropped	O
below	O
basal	O
levels	O
following	O
inhibition	O
of	O
NF	O
-	O
kappaB	O
and	O
JNK	O
whereas	O
cxcl8	S-Biological_Molecule
remained	O
elevated	O
above	O
basal	O
levels	O
(	O
16	O
.	O
5	O
-	O
fold	O
and	O
7	O
.	O
1	O
-	O
fold	O
respectively	O
)	O
following	O
the	O
same	O
treatment	O
.	O

Furthermore	O
,	O
inhibition	O
of	O
PKC	O
did	O
not	O
result	O
in	O
a	O
significant	O
decrease	O
of	O
il	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
or	O
cxcl8	S-Biological_Molecule
,	O
which	O
is	O
in	O
accordance	O
with	O
protein	O
data	O
(	O
figure	O
6	O
)	O
.	O

Activation	O
of	O
NF	O
-	O
kappaB	O
in	O
Jurkat	O
T	O
-	O
cells	O
is	O
dependent	O
on	O
Bcl10	S-Biological_Molecule
activation	O
,	O
which	O
in	O
turn	O
is	O
regulated	O
by	O
PKC	O
.	O

Down	O
-	O
regulation	O
of	O
Bcl10	S-Biological_Molecule
from	O
signals	O
transduced	O
via	O
the	O
TCR	O
/	O
CD28	S-Biological_Molecule
and	O
PKC	O
resulted	O
in	O
a	O
concomitant	O
down	O
-	O
regulation	O
of	O
NF	O
-	O
kappaB	O
.	O

In	O
HIV	O
infected	O
persons	O
,	O
serum	O
CXCL8	S-Biological_Molecule
levels	O
are	O
elevated	O
and	O
this	O
could	O
recruit	O
more	O
T	O
-	O
cells	O
potentially	O
leading	O
to	O
a	O
more	O
rapid	O
progression	O
of	O
the	O
disease	O
since	O
there	O
will	O
be	O
more	O
T	O
-	O
cells	O
available	O
to	O
infect	O
.	O

Furthermore	O
,	O
the	O
CXCL8	S-Biological_Molecule
release	O
was	O
down	O
-	O
regulated	O
by	O
inhibition	O
of	O
JNK	O
activity	O
.	O

Jurkat	O
T	O
-	O
cells	O
(	O
wild	O
type	O
and	O
TCR	O
deficient	O
-	O
TCR	O
-	O
/	O
-	O
)	O
were	O
maintained	O
in	O
90	O
%	O
RPMI	O
1640	O
medium	O
(	O
PAA	O
laboratories	O
,	O
Austria	O
)	O
with	O
1	O
.	O
5	O
mM	O
L	O
-	O
glutamine	O
(	O
Invitrogen	O
,	O
USA	O
)	O
,	O
10	O
%	O
foetal	O
bovine	O
serum	O
(	O
Invitrogen	O
,	O
USA	O
)	O
and	O
1	O
%	O
antibiotic	O
-	O
antimycotic	O
(	O
Invitrogen	O
,	O
USA	O
)	O
and	O
incubated	O
in	O
a	O
stable	O
environment	O
of	O
5	O
%	O
CO2	O
at	O
37degreesC	O
.	O

The	O
cells	O
were	O
pre	O
-	O
incubated	O
with	O
NF	O
-	O
kappaB	O
,	O
JNK	O
and	O
PKC	O
inhibitors	O
and	O
stimulated	O
in	O
24	O
-	O
well	O
plates	O
with	O
different	O
concentrations	O
of	O
PMA	O
,	O
HK	O
E	O
.	O
coli	O
MG1655	O
and	O
Calcium	O
Ionophore	O
A23187	O
.	O

The	O
cells	O
were	O
further	O
centrifuged	O
at	O
8000	O
x	O
g	O
,	O
4degreesC	O
for	O
10	O
min	O
and	O
the	O
supernatants	O
were	O
transferred	O
to	O
new	O
tubes	O
.	O

Transfection	O
of	O
Jurkat	O
T	O
-	O
cells	O
was	O
performed	O
using	O
luciferase	S-Biological_Molecule
reporter	O
plasmids	O
containing	O
NF	O
-	O
kappaB	O
cis	O
-	O
elements	O
.	O

(	O
n	O
=	O
4	O
)	O
.	O

(	O
A	O
)	O
CXCL8	S-Biological_Molecule
expression	O
was	O
partially	O
inhibited	O
following	O
PMA	O
stimulation	O
(	O
grey	O
bars	O
)	O
,	O
whereas	O
the	O
levels	O
were	O
not	O
altered	O
following	O
stimulation	O
with	O
HK	O
E	O
.	O
coli	O
(	O
black	O
bars	O
)	O
,	O
this	O
indicates	O
an	O
induction	O
mainly	O
regulated	O
by	O
AP	O
-	O
1	O
.	O

Statistical	O
significance	O
from	O
the	O
positive	O
control	O
(	O
PMA	O
)	O
was	O
determined	O
using	O
Student	O
'	O
s	O
t	O
-	O
test	O
.	O

CD40	S-Biological_Molecule
engagement	O
results	O
in	O
the	O
formation	O
of	O
a	O
receptor	O
-	O
associated	O
complex	O
that	O
mediates	O
activation	O
of	O
NF	O
-	O
kappaB	O
,	O
stress	O
-	O
activated	O
protein	O
kinases	O
,	O
and	O
other	O
signaling	O
molecules	O
.	O

Known	O
components	O
of	O
the	O
CD40	O
signaling	O
complex	O
include	O
members	O
of	O
the	O
TNF	O
receptor	O
-	O
associated	O
factor	O
(	O
TRAF	O
)	O
family	O
of	O
proteins	O
.	O

To	O
determine	O
the	O
role	O
of	O
HOIP	S-Biological_Molecule
in	O
CD40	S-Biological_Molecule
signaling	O
,	O
we	O
used	O
somatic	O
cell	O
gene	O
targeting	O
to	O
generate	O
mouse	O
B	O
cell	O
lines	O
deficient	O
in	O
HOIP	S-Biological_Molecule
.	O

We	O
found	O
that	O
the	O
CD40	S-Biological_Molecule
-	O
induced	O
upregulation	O
of	O
CD80	S-Biological_Molecule
and	O
activation	O
of	O
germline	O
immunoglobulin	O
epsilon	O
transcription	O
were	O
defective	O
in	O
HOIP	S-Biological_Molecule
-	O
deficient	O
cells	O
.	O

CD40	S-Biological_Molecule
signaling	O
is	O
activated	O
in	O
a	O
T	O
cell	O
-	O
dependent	O
manner	O
,	O
as	O
the	O
ligand	O
for	O
CD40	S-Biological_Molecule
,	O
CD154	S-Biological_Molecule
,	O
is	O
expressed	O
primarily	O
by	O
activated	O
T	O
cells	O
.	O

Similarly	O
,	O
the	O
CD40	S-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
driven	O
production	O
of	O
germline	O
transcripts	O
from	O
the	O
immunoglobulin	O
epsilon	O
heavy	O
chain	O
locus	O
,	O
an	O
event	O
that	O
precedes	O
immunoglobulin	O
gene	O
rearrangement	O
and	O
isotype	O
switching	O
,	O
was	O
defective	O
in	O
the	O
absence	O
of	O
HOIP	S-Biological_Molecule
.	O

Together	O
,	O
our	O
results	O
indicate	O
that	O
HOIP	S-Biological_Molecule
plays	O
a	O
critical	O
role	O
in	O
the	O
activation	O
of	O
signaling	O
pathways	O
that	O
regulate	O
cellular	O
responses	O
to	O
CD40	S-Biological_Molecule
engagement	O
.	O

This	O
cell	O
line	O
has	O
been	O
particularly	O
useful	O
in	O
the	O
characterization	O
of	O
CD40	S-Biological_Molecule
signaling	O
mechanisms	O
due	O
to	O
the	O
relative	O
ease	O
with	O
which	O
its	O
genome	O
can	O
be	O
modified	O
by	O
homologous	O
recombination	O
[	O
7	O
]	O
,	O
[	O
8	O
]	O
,	O
[	O
9	O
]	O
.	O

To	O
enable	O
us	O
to	O
confirm	O
that	O
any	O
signaling	O
or	O
functional	O
defects	O
observed	O
in	O
HOIP	S-Biological_Molecule
-	O
deficient	O
cells	O
were	O
due	O
to	O
disruption	O
of	O
the	O
Rnf31	S-Biological_Molecule
gene	O
,	O
both	O
HOIP	S-Biological_Molecule
-	O
deficient	O
cell	O
lines	O
were	O
transduced	O
with	O
a	O
retrovirus	O
encoding	O
FLAG	O
-	O
tagged	O
wild	O
-	O
type	O
HOIP	S-Biological_Molecule
,	O
thus	O
restoring	O
HOIP	S-Biological_Molecule
protein	O
expression	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

To	O
begin	O
evaluating	O
potential	O
contributions	O
of	O
HOIP	S-Biological_Molecule
to	O
CD40	S-Biological_Molecule
signaling	O
,	O
we	O
assayed	O
the	O
upregulation	O
of	O
CD80	S-Biological_Molecule
induced	O
by	O
engagement	O
of	O
CD40	S-Biological_Molecule
on	O
parental	O
A20	O
.	O
2J	O
,	O
HOIP	S-Biological_Molecule
-	O
deficient	O
,	O
and	O
HOIP	S-Biological_Molecule
-	O
reconstituted	O
cells	O
(	O
Fig	O
.	O
2	O
)	O
.	O

In	O
contrast	O
,	O
upregulation	O
of	O
CD80	S-Biological_Molecule
was	O
restored	O
in	O
HOIP	S-Biological_Molecule
-	O
reconstituted	O
cells	O
,	O
confirming	O
that	O
the	O
defect	O
in	O
CD80	S-Biological_Molecule
upregulation	O
in	O
the	O
HOIP	S-Biological_Molecule
-	O
deficient	O
cells	O
was	O
due	O
to	O
the	O
disruption	O
of	O
Rnf31	S-Biological_Molecule
.	O

This	O
process	O
,	O
known	O
as	O
immunoglobulin	O
class	O
switching	O
(	O
or	O
isotype	O
switching	O
)	O
,	O
allows	O
B	O
cells	O
,	O
initially	O
expressing	O
IgM	O
,	O
to	O
switch	O
to	O
IgA	O
,	O
IgG	O
,	O
or	O
IgE	O
depending	O
on	O
the	O
class	O
of	O
antibody	O
most	O
appropriate	O
for	O
a	O
particular	O
immune	O
response	O
.	O

It	O
follows	O
that	O
HOIP	S-Biological_Molecule
is	O
likely	O
a	O
key	O
mediator	O
of	O
CD40	S-Biological_Molecule
signaling	O
.	O

Therefore	O
,	O
we	O
determined	O
whether	O
the	O
association	O
of	O
HOIP	S-Biological_Molecule
with	O
CD40	S-Biological_Molecule
in	O
A20	O
.	O
2J	O
cells	O
was	O
altered	O
by	O
treatment	O
of	O
cells	O
with	O
an	O
inhibitor	O
of	O
cIAP	O
activity	O
,	O
a	O
membrane	O
-	O
permeable	O
peptide	O
derived	O
from	O
the	O
apoptosis	O
regulator	O
SMAC	O
[	O
15	O
]	O
.	O

However	O
,	O
at	O
least	O
one	O
band	O
of	O
significantly	O
higher	O
molecular	O
weight	O
remained	O
after	O
phosphatase	O
treatment	O
,	O
suggesting	O
that	O
CD40	S-Biological_Molecule
-	O
associated	O
IKKgamma	S-Biological_Molecule
is	O
subject	O
to	O
at	O
least	O
one	O
other	O
modification	O
in	O
addition	O
to	O
phosphorylation	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
protein	O
HOIP	S-Biological_Molecule
is	O
critical	O
for	O
CD40	S-Biological_Molecule
-	O
induced	O
signals	O
that	O
regulate	O
B	O
cell	O
function	O
.	O

Expression	O
of	O
GLepsilon	S-Biological_Molecule
in	O
each	O
sample	O
was	O
normalized	O
to	O
the	O
expression	O
of	O
Hprt1	S-Biological_Molecule
.	O

Images	O
of	O
blots	O
were	O
recorded	O
with	O
a	O
low	O
-	O
light	O
imaging	O
system	O
(	O
LAS4000	O
,	O
Fuji	O
Medical	O
Systems	O
)	O
and	O
on	O
X	O
-	O
ray	O
film	O
.	O

Beads	O
were	O
washed	O
with	O
lysis	O
buffer	O
to	O
remove	O
unbound	O
material	O
.	O

Material	O
eluted	O
from	O
the	O
beads	O
was	O
fractionated	O
by	O
SDS	O
-	O
PAGE	O
and	O
transferred	O
to	O
PVDF	O
membranes	O
for	O
Western	O
blotting	O
.	O

Homologous	O
recombination	O
of	O
the	O
vector	O
with	O
Rnf31	S-Biological_Molecule
resulted	O
in	O
a	O
small	O
chromosomal	O
deletion	O
and	O
the	O
in	O
-	O
frame	O
insertion	O
of	O
neomycin	O
phosphotransferase	O
(	O
NeoR	O
)	O
into	O
the	O
amino	O
-	O
terminal	O
HOIP	S-Biological_Molecule
coding	O
sequence	O
.	O

Transduction	O
of	O
both	O
HOIP	S-Biological_Molecule
-	O
deficient	O
(	O
HOIP	S-Biological_Molecule
-	O
/	O
-	O
)	O
clones	O
with	O
a	O
retrovirus	O
encoding	O
FLAG	O
-	O
HOIP	S-Biological_Molecule
reversed	O
defective	O
CD80	S-Biological_Molecule
upregulation	O
,	O
while	O
transduction	O
with	O
an	O
empty	O
vector	O
(	O
pMIP	O
)	O
did	O
not	O
.	O

Similar	O
results	O
were	O
obtained	O
in	O
a	O
second	O
experiment	O
.	O

A20	O
.	O
2J	O
and	O
HOIP	S-Biological_Molecule
-	O
deficient	O
cells	O
transduced	O
with	O
an	O
empty	O
retroviral	O
vector	O
(	O
A20	O
.	O
2J	O
+	O
pMIP	O
and	O
HOIP	S-Biological_Molecule
-	O
/	O
-	O
+	O
pMIP	O
,	O
respectively	O
)	O
,	O
or	O
HOIP	S-Biological_Molecule
-	O
deficient	O
cells	O
transduced	O
with	O
a	O
HOIP	S-Biological_Molecule
-	O
encoding	O
retrovirus	O
(	O
HOIP	S-Biological_Molecule
-	O
/	O
-	O
+	O
HOIP	S-Biological_Molecule
)	O
were	O
cultured	O
overnight	O
with	O
agonistic	O
anti	O
-	O
CD40	O
or	O
an	O
isotype	O
control	O
antibody	O
(	O
iso	O
)	O
,	O
with	O
or	O
without	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
.	O

Similar	O
results	O
were	O
obtained	O
in	O
a	O
second	O
experiment	O
and	O
in	O
an	O
additional	O
experiment	O
with	O
a	O
second	O
HOIP	S-Biological_Molecule
-	O
deficient	O
clone	O
.	O

Samples	O
of	O
the	O
cell	O
lysates	O
after	O
immunoprecipitation	O
appear	O
in	O
lanes	O
6	O
-	O
8	O
.	O

Similar	O
results	O
were	O
obtained	O
in	O
two	O
additional	O
experiments	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
M	O
-	O
CSF	O
stimulated	O
NF	O
-	O
kappaB	O
transcriptional	O
activity	O
in	O
human	O
monocyte	O
-	O
derived	O
macrophages	O
(	O
MDMs	O
)	O
and	O
the	O
murine	O
macrophage	O
cell	O
line	O
RAW	O
264	O
.	O
7	O
.	O

Macrophage	O
colony	O
-	O
stimulating	O
factor	O
(	O
M	O
-	O
CSF	O
)	O
stimulates	O
mononuclear	O
phagocyte	O
survival	O
and	O
differentiation	O
[	O
3	O
]	O
.	O

There	O
are	O
five	O
members	O
in	O
the	O
NF	O
-	O
kappaB	O
family	O
:	O
RelA	S-Biological_Molecule
/	O
p65	S-Biological_Molecule
,	O
p50	S-Biological_Molecule
,	O
p52	S-Biological_Molecule
,	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Rel	E-Biological_Molecule
and	O
RelB	S-Biological_Molecule
.	O

NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
regulates	O
important	O
developmental	O
processes	O
[	O
9	O
]	O
,	O
[	O
10	O
]	O
.	O

Similarly	O
,	O
constitutively	O
active	O
NF	O
-	O
kappaB	O
was	O
observed	O
in	O
human	O
alveolar	O
macrophages	O
[	O
14	O
]	O
.	O

M	O
-	O
CSF	O
Induces	O
NF	O
-	O
kappaB	O
Transcriptional	O
Activity	O
in	O
Human	O
Monocyte	O
-	O
Derived	O
Macrophages	O
(	O
MDMs	O
)	O
and	O
Mouse	O
Macrophage	O
Cell	O
Line	O
,	O
RAW	O
264	O
.	O
7	O

To	O
determine	O
if	O
M	O
-	O
CSF	O
induced	O
NF	O
-	O
kappaB	O
DNA	O
binding	O
in	O
human	O
macrophages	O
,	O
we	O
performed	O
EMSA	O
analysis	O
on	O
nuclear	O
lysates	O
from	O
M	O
-	O
CSF	O
-	O
treated	O
MDMs	O
.	O

Since	O
M	O
-	O
CSF	O
did	O
not	O
regulate	O
NF	O
-	O
kappaB	O
activation	O
by	O
influencing	O
IkappaBalpha	S-Biological_Molecule
,	O
we	O
next	O
sought	O
to	O
determine	O
if	O
M	O
-	O
CSF	O
affected	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
by	O
post	O
-	O
translational	O
mechanisms	O
.	O

Even	O
though	O
the	O
PKC	O
family	O
consists	O
of	O
10	O
members	O
,	O
finding	O
that	O
PKCalpha	S-Biological_Molecule
/	O
beta	S-Biological_Molecule
inhibitors	O
and	O
intracellular	O
calcium	O
inhibitors	O
reduced	O
M	O
-	O
CSF	O
-	O
induced	O
NF	O
-	O
kappaB	O
activity	O
,	O
suggested	O
PKCalpha	S-Biological_Molecule
was	O
involved	O
in	O
NF	O
-	O
kappaB	O
activation	O
after	O
M	O
-	O
CSF	O
treatment	O
.	O

Expression	O
of	O
WT	O
-	O
PKCalpha	S-Biological_Molecule
did	O
not	O
effect	O
the	O
phosphorylation	O
of	O
either	O
residue	O
with	O
or	O
without	O
M	O
-	O
CSF	O
stimulation	O
.	O

PKC	O
is	O
Essential	O
in	O
Regulating	O
NF	O
-	O
kappaB	O
Activity	O

M	O
-	O
CSF	O
-	O
dependent	O
PKC	O
activity	O
facilitated	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
phosphorylation	O
at	O
Ser276	O
but	O
not	O
Ser536	O
.	O

As	O
predicted	O
,	O
expression	O
of	O
WT	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
(	O
p65	S-Biological_Molecule
WT	O
)	O
in	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
-	O
/	O
-	O
cell	O
line	O
constitutively	O
activated	O
NF	O
-	O
kappaB	O
compared	O
to	O
cells	O
transfected	O
with	O
vector	O
control	O
without	O
any	O
stimulation	O
(	O
Figure	O
8B	O
)	O
.	O

In	O
comparison	O
,	O
transfecting	O
the	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
276S	O
/	O
A	O
construct	O
reduced	O
NF	O
-	O
kappaB	O
activity	O
by	O
5	O
-	O
fold	O
(	O
p	O
=	O
0	O
.	O
006	O
,	O
WT	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
vs	O
.	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
276S	O
/	O
A	O
)	O
,	O
while	O
expressing	O
the	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
536S	O
/	O
A	O
construct	O
increased	O
NF	O
-	O
kappaB	O
activity	O
in	O
the	O
p65	S-Biological_Molecule
-	O
/	O
-	O
cells	O
to	O
levels	O
similar	O
to	O
WT	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
transfected	O
cells	O
.	O

Our	O
data	O
demonstrate	O
that	O
Ser276	O
of	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
is	O
essential	O
in	O
regulating	O
NF	O
-	O
kappaB	O
activity	O
and	O
suggests	O
that	O
PKC	O
regulates	O
NF	O
-	O
kappaB	O
activity	O
by	O
modulating	O
the	O
phosphorylation	O
of	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
at	O
Ser276	O
residue	O
.	O

Post	O
-	O
translational	O
modification	O
of	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
regulates	O
its	O
activating	O
or	O
repressing	O
effects	O
on	O
gene	O
expression	O
.	O

Moreover	O
,	O
mutant	O
constructs	O
containing	O
a	O
point	O
mutation	O
at	O
Ser536	O
of	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
did	O
not	O
reduce	O
NF	O
-	O
kappaB	O
activity	O
in	O
cells	O
lacking	O
endogenous	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
,	O
while	O
the	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
276S	O
/	O
A	O
construct	O
did	O
reduce	O
NF	O
-	O
kappaB	O
activity	O
in	O
these	O
cells	O
.	O

Expression	O
of	O
PKCalpha	S-Biological_Molecule
attenuates	O
apoptosis	O
in	O
many	O
different	O
cell	O
types	O
,	O
while	O
PKCalpha	S-Biological_Molecule
inhibition	O
generally	O
potentiates	O
apoptosis	O
[	O
42	O
]	O
.	O

In	O
contrast	O
to	O
the	O
actions	O
of	O
PKCalpha	S-Biological_Molecule
activation	O
of	O
other	O
conventional	O
PKC	O
isoforms	O
,	O
like	O
PKCbetaI	S-Biological_Molecule
/	O
betaII	S-Biological_Molecule
,	O
appear	O
necessary	O
for	O
macrophage	O
apoptosis	O
.	O

PKCalpha	O
NF	O
-	O
kappaB	O
p65	O
,	O
Lamin	O
B	O
,	O
beta	O
-	O
actin	O
,	O
and	O
GAPDH	O
antibodies	O
,	O
anti	O
-	O
mouse	O
and	O
rabbit	O
IgG	O
-	O
HRP	O
conjugated	O
antibodies	O
,	O
and	O
PKCalpha	B-Biological_Molecule
siRNA	E-Biological_Molecule
were	O
obtained	O
from	O
Santa	O
Cruz	O
Biotechnology	O
(	O
Santa	O
Cruz	O
,	O
CA	O
)	O
.	O

Kinase	O
deficient	O
CMV	O
-	O
PKCalpha	S-Biological_Molecule
(	O
KD	O
-	O
PKCalpha	S-Biological_Molecule
)	O
or	O
wild	O
type	O
pCMV	O
-	O
PKCalpha	S-Biological_Molecule
(	O
WT	O
-	O
PKCalpha	S-Biological_Molecule
)	O
were	O
generous	O
gifts	O
from	O
Alexandra	O
C	O
.	O
Newton	O
(	O
University	O
of	O
California	O
,	O
San	O
Diego	O
,	O
CA	O
)	O
.	O

Cell	O
Culture	O

RAW	O
264	O
.	O
7	O
cells	O
were	O
maintained	O
in	O
RPMI	O
supplemented	O
with	O
5	O
%	O
FBS	O
and	O
antibiotic	O
-	O
antimycotic	O
(	O
1000	O
U	O
/	O
ml	O
penicillin	O
,	O
1000	O
microg	O
/	O
ml	O
streptomycin	O
sulfate	O
,	O
and	O
250	O
ng	O
/	O
ml	O
amphotericin	O
B	O
)	O
at	O
37degreesC	O
.	O

Mouse	O
embryonic	O
fibroblasts	O
(	O
MEFs	O
)	O
cell	O
line	O
lacking	O
specific	O
NFkappaB	O
signaling	O
subunits	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
(	O
p65	S-Biological_Molecule
-	O
/	O
-	O
cell	O
line	O
)	O
[	O
50	O
]	O
were	O
cultured	O
in	O
DMEM	O
medium	O
supplemented	O
with	O
10	O
%	O
FBS	O
and	O
antibiotic	O
-	O
antimycotic	O
solution	O
.	O

Briefly	O
,	O
MDMs	O
were	O
lysed	O
in	O
hypotonic	O
lysis	O
buffer	O
(	O
20	O
mM	O
Hepes	O
,	O
pH	O
7	O
.	O
5	O
;	O
5	O
mM	O
NaF	O
,	O
10	O
microM	O
Na2MoO4	O
0	O
.	O
5	O
%	O
NP	O
-	O
40	O
and	O
0	O
.	O
1	O
mM	O
EDTA	O
)	O
,	O
and	O
then	O
nuclei	O
were	O
resuspended	O
in	O
lysis	O
buffer	O
supplemented	O
with	O
0	O
.	O
5	O
mM	O
DTT	O
and	O
0	O
.	O
2	O
mM	O
PMSF	O
.	O

Briefly	O
,	O
monocytes	O
were	O
resuspended	O
in	O
Amaxa	O
Nucleofactor	O
solution	O
at	O
a	O
density	O
of	O
20x106	O
cells	O
/	O
ml	O
,	O
and	O
2	O
microg	O
of	O
total	O
plasmid	O
DNA	O
100	O
nM	O
of	O
PKCalpha	B-Biological_Molecule
siRNA	E-Biological_Molecule
or	O
control	O
siRNA	O
was	O
added	O
and	O
transfected	O
using	O
program	O
Amaxa	O
Y	O
-	O
01	O
.	O

The	O
next	O
day	O
,	O
cell	O
-	O
free	O
supernatants	O
were	O
collected	O
for	O
the	O
SEAP	O
analysis	O
.	O

Secreted	O
alkaline	O
phosphatase	O
activity	O
was	O
analyzed	O
by	O
GreatEscape	O
SEAP	O
kit	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instruction	O
.	O

Cell	O
apoptosis	O
assay	O
was	O
performed	O
as	O
described	O
previously	O
[	O
51	O
]	O
using	O
the	O
Annexin	B-Biological_Molecule
V	E-Biological_Molecule
-	O
FITC	O
apoptosis	O
detection	O
kit	O
(	O
BD	O
PharMingen	O
,	O
San	O
Diego	O
,	O
CA	O
)	O
.	O

The	O
cells	O
were	O
removed	O
from	O
the	O
culture	O
dish	O
using	O
Accutase	O
(	O
eBioscience	O
,	O
San	O
Diego	O
,	O
CA	O
)	O
and	O
stained	O
with	O
Annexin	B-Biological_Molecule
V	E-Biological_Molecule
-	O
FITC	O
and	O
PI	O
and	O
analyzed	O
by	O
flow	O
cytometry	O
(	O
FACSCalibur	O
;	O
BD	O
PharMingen	O
)	O
.	O

The	O
cells	O
were	O
resuspended	O
in	O
lysis	O
buffer	O
(	O
20	O
mM	O
Tris	O
,	O
5	O
mM	O
MgCl2	O
,	O
1	O
mM	O
EGTA	O
,	O
20	O
mM	O
beta	O
-	O
glycerol	O
phosphate	O
,	O
1	O
mM	O
PMSF	O
2	O
microg	O
/	O
ml	O
aprotinin	O
and	O
2	O
microg	O
/	O
ml	O
leupeptin	O
,	O
pH	O
7	O
.	O
5	O
)	O
,	O
sonicated	O
and	O
centrifuged	O
to	O
obtain	O
whole	O
cell	O
lysates	O
,	O
which	O
were	O
then	O
immunoprecipitated	O
with	O
anti	O
-	O
PKCalpha	O
antibody	O
and	O
protein	O
G	O
-	O
agarose	O
(	O
Invitrogen	O
)	O
.	O

Statistical	O
significance	O
was	O
defined	O
as	O
p	O
<	O
=	O
0	O
.	O
05	O
.	O

Ethics	O
Statement	O

The	O
kinase	O
assay	O
was	O
quantitated	O
using	O
Quantity	O
One	O
software	O
(	O
Bio	O
-	O
Rad	O
)	O
(	O
bottom	O
panel	O
)	O
.	O

The	O
purity	O
of	O
the	O
cytosolic	O
and	O
nuclear	O
fractions	O
was	O
confirmed	O
by	O
immunoblotting	O
with	O
GAPDH	O
and	O
Lamin	O
B	O
,	O
respectively	O
.	O

Data	O
are	O
expressed	O
as	O
relative	O
fold	O
increase	O
of	O
IkappaBalpha	S-Biological_Molecule
or	O
BCL	B-Biological_Molecule
-	I-Biological_Molecule
xl	E-Biological_Molecule
gene	O
expression	O
upon	O
treatment	O
over	O
non	O
-	O
stimulated	O
cells	O
.	O

PKCalpha	S-Biological_Molecule
regulates	O
phosphorylation	O
of	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
at	O
Ser276	O
.	O

(	O
A	O
)	O
MDM	O
or	O
(	O
B	O
)	O
RAW	O
264	O
.	O
7	O
cells	O
were	O
transiently	O
transfected	O
with	O
pNF	O
-	O
kappaB	O
-	O
SEAP	O
along	O
with	O
either	O
WT	O
-	O
PKCalpha	S-Biological_Molecule
or	O
the	O
kinase	O
-	O
deficient	O
(	O
KD	O
)	O
-	O
PKCalpha	S-Biological_Molecule
construct	O
at	O
a	O
1	O
:	O
5	O
ratio	O
.	O

(	O
C	O
)	O
MDMs	O
were	O
removed	O
from	O
the	O
plate	O
using	O
accutase	O
and	O
apoptosis	O
of	O
MDMs	O
was	O
measured	O
by	O
flow	O
cytometry	O
using	O
Annexin	B-Biological_Molecule
V	E-Biological_Molecule
-	O
FITC	O
and	O
propidium	O
iodine	O
(	O
PI	O
)	O
.	O

Shown	O
is	O
data	O
of	O
three	O
independent	O
experiments	O
.	O

The	O
cells	O
were	O
transfected	O
for	O
24	O
hours	O
and	O
serum	O
starved	O
for	O
4	O
hours	O
,	O
and	O
then	O
incubated	O
with	O
10	O
microM	O
of	O
Ro	O
-	O
31	O
-	O
8220	O
for	O
30	O
minutes	O
prior	O
to	O
treatment	O
with	O
10	O
ng	O
/	O
ml	O
of	O
TNFalpha	S-Biological_Molecule
.	O

SHARPIN	S-Biological_Molecule
Is	O
Essential	O
for	O
Cytokine	O
Production	O
,	O
NF	O
-	O
kappaB	O
Signaling	O
,	O
and	O
Induction	O
of	O
Th1	O
Differentiation	O
by	O
Dendritic	O
Cells	O

The	O
endogenous	O
expression	O
of	O
Sharpin	S-Biological_Molecule
mRNA	O
in	O
BMDC	O
was	O
determined	O
by	O
quantitative	O
real	O
time	O
-	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
following	O
culture	O
in	O
medium	O
only	O
or	O
after	O
stimulation	O
with	O
LPS	O
.	O

BMDC	O
were	O
CD11c	S-Biological_Molecule
+	O
and	O
MHC	O
II	O
+	O
with	O
low	O
expression	O
of	O
co	O
-	O
stimulatory	O
molecules	O
CD40	S-Biological_Molecule
,	O
CD80	S-Biological_Molecule
,	O
and	O
CD86	S-Biological_Molecule
.	O

Incubation	O
with	O
the	O
TLR	O
agonists	O
for	O
24	O
hours	O
resulted	O
in	O
increased	O
expression	O
of	O
CD40	S-Biological_Molecule
,	O
CD80	S-Biological_Molecule
,	O
and	O
CD86	S-Biological_Molecule
on	O
BMDC	O
;	O
however	O
,	O
there	O
was	O
no	O
difference	O
in	O
the	O
expression	O
levels	O
of	O
these	O
markers	O
between	O
WT	O
and	O
cpdm	O
BMDC	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

The	O
present	O
report	O
showed	O
that	O
null	O
mutations	O
of	O
the	O
mouse	O
Sharpin	S-Biological_Molecule
gene	O
did	O
not	O
affect	O
the	O
steady	O
-	O
state	O
distribution	O
of	O
splenic	O
DC	O
subsets	O
nor	O
the	O
development	O
and	O
phenotype	O
of	O
BMDC	O
.	O

Such	O
'	O
sterile	O
'	O
inflammation	O
could	O
be	O
initiated	O
and	O
take	O
place	O
in	O
all	O
organs	O
and	O
tissues	O
affected	O
in	O
cpdm	O
mice	O
,	O
thus	O
causing	O
multi	O
-	O
organ	O
inflammatory	O
disorders	O
.	O

This	O
hypothesis	O
is	O
supported	O
by	O
several	O
recent	O
studies	O
.	O

Combined	O
with	O
the	O
dramatic	O
effect	O
of	O
IL12	O
treatment	O
on	O
the	O
phenotype	O
of	O
these	O
mice	O
[	O
5	O
]	O
,	O
this	O
suggests	O
that	O
the	O
Th2	O
-	O
biased	O
systemic	O
inflammation	O
in	O
cpdm	O
mice	O
is	O
caused	O
by	O
reduced	O
IL12P70	O
production	O
from	O
DC	O
.	O

The	O
importance	O
of	O
IL12P70	O
in	O
regulating	O
Th1	O
and	O
Th2	O
immune	O
responses	O
in	O
mice	O
was	O
clearly	O
demonstrated	O
in	O
IL12P35	S-Biological_Molecule
-	O
and	O
IL12P40	S-Biological_Molecule
-	O
deficient	O
mice	O
[	O
38	O
]	O
,	O
[	O
39	O
]	O
and	O
through	O
clinical	O
studies	O
in	O
human	O
patients	O
[	O
40	O
]	O
-	O
[	O
42	O
]	O
.	O

However	O
,	O
selective	O
inhibition	O
of	O
NF	O
-	O
kappaB	O
activation	O
in	O
parenchymal	O
cells	O
of	O
the	O
skin	O
,	O
liver	O
,	O
and	O
intestine	O
results	O
in	O
chronic	O
inflammation	O
driven	O
by	O
NF	O
-	O
kappaB	O
competent	O
leukocytes	O
[	O
47	O
]	O
-	O
[	O
50	O
]	O
.	O

24	O
hours	O
later	O
,	O
cells	O
were	O
incubated	O
with	O
fresh	O
culture	O
medium	O
.	O

The	O
cells	O
were	O
incubated	O
in	O
PBS	O
with	O
0	O
.	O
1	O
%	O
NaN3	O
,	O
1	O
%	O
BSA	O
and	O
10	O
%	O
normal	O
rabbit	O
serum	O
for	O
20	O
minutes	O
on	O
ice	O
,	O
washed	O
and	O
incubated	O
for	O
30	O
minutes	O
on	O
ice	O
with	O
Alex	O
Fluor	O
-	O
labeled	O
anti	O
-	O
CD11c	O
(	O
MCD11C20	O
,	O
CALTAG	O
)	O
in	O
combination	O
with	O
PE	O
-	O
anti	O
-	O
CD40	O
(	O
3	O
/	O
23	O
,	O
BD	O
Biosciences	O
)	O
,	O
PE	O
-	O
anti	O
-	O
CD80	O
(	O
16	O
-	O
10A1	O
,	O
eBioscience	O
)	O
,	O
PE	O
-	O
anti	O
-	O
CD86	O
(	O
P03	O
.	O
1	O
,	O
eBioscience	O
)	O
,	O
PE	O
-	O
anti	O
-	O
CD14	O
(	O
Sa2	O
.	O
8	O
,	O
eBioscience	O
)	O
and	O
biotinylated	O
anti	O
-	O
TLR4	O
(	O
BioLegend	O
)	O
.	O

BMDC	O
were	O
cultured	O
at	O
106	O
cells	O
/	O
mL	O
in	O
10	O
mL	O
of	O
RPMI	O
-	O
1640	O
complete	O
medium	O
in	O
the	O
presence	O
or	O
absence	O
of	O
100	O
ng	O
/	O
mL	O
LPS	O
or	O
25	O
microg	O
/	O
mL	O
poly	O
I	O
:	O
C	O
.	O

Primers	O
and	O
probes	O
were	O
purchased	O
from	O
Applied	O
Biosystems	O
.	O

dNTPs	O
,	O
oligo	O
(	O
dT	O
)	O
15	O
primer	O
,	O
recombinant	O
RNasin	O
Ribonuclease	O
Inhibitor	O
,	O
and	O
M	B-Biological_Molecule
-	I-Biological_Molecule
MLV	I-Biological_Molecule
Reverse	I-Biological_Molecule
Transcriptase	E-Biological_Molecule
(	O
all	O
from	O
Promega	O
,	O
Madison	O
,	O
WI	O
)	O
were	O
used	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instruction	O
.	O

Immunoblots	O
were	O
performed	O
with	O
antibodies	O
(	O
Cell	O
Signaling	O
Technology	O
)	O
against	O
p	O
-	O
IKK1	S-Biological_Molecule
/	O
2	S-Biological_Molecule
(	O
#	O
2697	O
)	O
,	O
p	O
-	O
IkappaBalpha	S-Biological_Molecule
(	O
#	O
9246	O
)	O
,	O
IkappaBalpha	S-Biological_Molecule
(	O
#	O
4814	O
)	O
,	O
p	O
-	O
TBK1	S-Biological_Molecule
(	O
#	O
5483	O
)	O
,	O
p	O
-	O
p38	O
(	O
#	O
9216	O
)	O
,	O
p38	O
(	O
#	O
9212	O
)	O
,	O
p	O
-	O
ERK1	S-Biological_Molecule
/	O
2	S-Biological_Molecule
(	O
#	O
4376	O
)	O
,	O
and	O
ERK1	S-Biological_Molecule
/	O
2	S-Biological_Molecule
(	O
#	O
4695	O
)	O
.	O

In	O
vivo	O
and	O
in	O
vitro	O
features	O
of	O
SHARPIN	S-Biological_Molecule
.	O

(	O
E	O
)	O
Fibroblast	O
(	O
NIH3T3	O
)	O
and	O
macrophages	O
(	O
RAW264	O
.	O
7	O
)	O
cells	O
were	O
transfected	O
with	O
the	O
expression	O
plasmid	O
pFLAG	O
-	O
SHARPIN	S-Biological_Molecule
.	O

Percentages	O
were	O
calculated	O
based	O
on	O
the	O
parental	O
population	O
and	O
were	O
additionally	O
shown	O
as	O
bar	O
graphs	O
(	O
n	O
=	O
2	O
)	O
(	O
B	O
)	O
.	O

Unstained	O
cells	O
served	O
as	O
negative	O
controls	O
.	O

At	O
0	O
,	O
1	O
and	O
2	O
hours	O
,	O
total	O
RNA	O
was	O
extracted	O
and	O
subject	O
to	O
qRT	O
-	O
PCR	O
to	O
measure	O
the	O
expression	O
of	O
Il12p40	S-Biological_Molecule
(	O
A	O
,	O
B	O
)	O
,	O
Il6	S-Biological_Molecule
(	O
C	O
,	O
D	O
)	O
,	O
Gmcsf	S-Biological_Molecule
(	O
E	O
,	O
F	O
)	O
,	O
and	O
Ifnb	S-Biological_Molecule
(	O
G	O
,	O
H	O
)	O
mRNA	O
.	O

(	O
A	O
)	O
Unstimulated	O
WT	O
and	O
cpdm	O
BMDC	O
(	O
5x105	O
)	O
were	O
labeled	O
with	O
PE	O
-	O
labeled	O
anti	O
-	O
TLR4	O
/	O
MD2	O
or	O
anti	O
-	O
CD14	O
and	O
then	O
subject	O
to	O
flow	O
cytometry	O
analysis	O
.	O

(	O
C	O
)	O
Cultured	O
WT	O
and	O
cpdm	O
BMDC	O
(	O
5x105	O
cells	O
in	O
0	O
.	O
2	O
ml	O
complete	O
medium	O
)	O
were	O
washed	O
and	O
stimulated	O
with	O
100	O
ng	O
/	O
ml	O
LPS	O
or	O
25	O
microg	O
/	O
ml	O
poly	O
I	O
:	O
C	O
.	O

Importantly	O
,	O
the	O
antiproliferative	O
effect	O
of	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
in	O
B	O
-	O
cells	O
was	O
completely	O
neutralized	O
by	O
the	O
natural	O
antagonist	O
,	O
noggin	S-Biological_Molecule
.	O

Members	O
of	O
the	O
transforming	B-Biological_Molecule
growth	I-Biological_Molecule
factor	I-Biological_Molecule
beta	E-Biological_Molecule
(	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
)	O
superfamily	O
play	O
central	O
roles	O
in	O
controlling	O
cellular	O
proliferation	O
,	O
differentiation	O
,	O
migration	O
and	O
apoptosis	O
[	O
1	O
]	O
.	O

All	O
experiments	O
in	O
this	O
study	O
were	O
performed	O
under	O
serum	O
-	O
free	O
conditions	O
as	O
FCS	O
has	O
been	O
shown	O
to	O
interfere	O
with	O
BMP	O
-	O
signalling	O
[	O
14	O
]	O
(	O
own	O
observations	O
)	O
.	O

Human	O
B	O
cells	O
express	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
receptors	O

Ramos	O
cells	O
expressed	O
the	O
type	O
I	O
receptors	O
Act	B-Biological_Molecule
-	I-Biological_Molecule
RIA	E-Biological_Molecule
,	O
weakly	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
RIB	E-Biological_Molecule
and	O
the	O
type	O
II	O
receptor	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
RII	E-Biological_Molecule
,	O
but	O
more	O
weakly	O
than	O
normal	O
B	O
cells	O
(	O
Figure	O
4	O
)	O
.	O

HL60	O
cells	O
were	O
used	O
for	O
comparison	O
and	O
weakly	O
expressed	O
Act	B-Biological_Molecule
-	I-Biological_Molecule
RIA	E-Biological_Molecule
and	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
RII	E-Biological_Molecule
.	O

Upon	O
ligand	O
binding	O
,	O
the	O
type	O
II	O
receptor	O
transphosphorylates	O
and	O
activates	O
the	O
type	O
I	O
receptor	O
.	O

Type	O
I	O
receptors	O
can	O
signal	O
via	O
several	O
pathways	O
.	O

The	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
induced	O
phosphorylation	O
was	O
high	O
at	O
the	O
earliest	O
time	O
point	O
tested	O
(	O
15	O
minutes	O
)	O
,	O
and	O
remained	O
high	O
for	O
at	O
least	O
48	O
hours	O
(	O
Figure	O
5	O
)	O
.	O

The	O
amount	O
of	O
Id1	S-Biological_Molecule
-	O
Id4	S-Biological_Molecule
mRNA	O
was	O
quantified	O
by	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
Id1	S-Biological_Molecule
could	O
be	O
a	O
possible	O
target	O
gene	O
for	O
mediating	O
the	O
effects	O
of	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
in	O
human	O
B	O
cells	O
,	O
whereas	O
Id2	S-Biological_Molecule
and	O
Id3	S-Biological_Molecule
not	O
seem	O
to	O
be	O
involved	O
.	O

Additionally	O
,	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
induced	O
cell	O
death	O
in	O
CD27	S-Biological_Molecule
+	O
memory	O
B	O
cells	O
as	O
well	O
as	O
in	O
a	O
Burkitt	O
lymphoma	O
cell	O
line	O
(	O
Ramos	O
)	O
.	O

Importantly	O
,	O
the	O
anti	O
-	O
proliferative	O
effect	O
of	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
could	O
be	O
completely	O
neutralized	O
by	O
the	O
use	O
of	O
a	O
natural	O
inhibitor	O
,	O
Noggin	S-Biological_Molecule
.	O

Other	O
members	O
of	O
the	O
BMP	O
-	O
family	O
have	O
also	O
been	O
reported	O
to	O
induce	O
apoptosis	O
,	O
including	O
in	O
mouse	O
B	O
lineage	O
cells	O
[	O
26	O
]	O
.	O

The	O
antiproliferative	O
and	O
death	O
inducing	O
effect	O
of	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
in	O
B	O
cells	O
with	O
concomitant	O
upregulation	O
of	O
Id1	S-Biological_Molecule
protein	O
is	O
therefore	O
in	O
line	O
with	O
the	O
view	O
that	O
Id	O
proteins	O
are	O
required	O
for	O
the	O
induction	O
of	O
growth	O
arrest	O
and	O
apoptosis	O
in	O
B	O
-	O
lymphocyte	O
progenitors	O
by	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
[	O
40	O
]	O
.	O

Altogether	O
,	O
these	O
results	O
point	O
to	O
an	O
important	O
role	O
for	O
Id	O
proteins	O
in	O
the	O
regulation	O
of	O
normal	O
B	O
cell	O
homeostasis	O
and	O
in	O
diseases	O
,	O
where	O
B	O
cells	O
are	O
involved	O
.	O

We	O
analysed	O
the	O
expression	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
mRNA	O
in	O
peripheral	O
blood	O
B	O
cells	O
by	O
real	O
-	O
time	O
PCR	O
,	O
and	O
report	O
here	O
the	O
upregulation	O
of	O
endogenous	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
transcripts	O
after	O
stimulation	O
with	O
FCS	O
,	O
human	O
AB	O
-	O
serum	O
and	O
,	O
most	O
importantly	O
,	O
anti	O
-	O
IgM	O
.	O

The	O
upregulation	O
of	O
the	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
-	O
transcripts	O
after	O
IgM	O
-	O
crosslinking	O
is	O
of	O
pathophysiologic	O
interest	O
[	O
12	O
]	O
.	O

One	O
well	O
recognized	O
source	O
for	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
production	O
is	O
the	O
human	O
bone	O
and	O
bone	O
marrow	O
stroma	O
[	O
51	O
,	O
8	O
]	O
.	O

BMP	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
mRNA	O
has	O
been	O
demonstrated	O
in	O
murine	O
macrophage	O
cell	O
lines	O
,	O
but	O
not	O
in	O
humans	O
[	O
54	O
]	O
.	O

Taken	O
together	O
,	O
these	O
results	O
provide	O
a	O
rationale	O
to	O
further	O
examine	O
the	O
role	O
of	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
signalling	O
in	O
normal	O
B	O
cell	O
biology	O
as	O
well	O
as	O
in	O
pathologic	O
conditions	O
like	O
B	O
cell	O
malignancies	O
and	O
autoimmune	O
disorders	O
.	O

This	O
procedure	O
yields	O
less	O
than	O
0	O
.	O
5	O
%	O
T	O
cells	O
,	O
0	O
.	O
1	O
%	O
NK	O
cells	O
,	O
and	O
0	O
.	O
5	O
%	O
monocytes	O
as	O
judged	O
by	O
indirect	O
immunofluorescence	O
staining	O
.	O

After	O
washing	O
with	O
TBS	O
/	O
0	O
.	O
1	O
%	O
Tween	O
-	O
20	O
(	O
TBS	O
-	O
T	O
)	O
,	O
the	O
filters	O
were	O
incubated	O
with	O
horseradish	O
peroxidase	O
(	O
HRP	O
)	O
coupled	O
to	O
relevant	O
secondary	O
antibodies	O
(	O
see	O
above	O
)	O
for	O
60	O
minutes	O
at	O
RT	O
.	O

Analysis	O
of	O
BMP	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
messenger	O
RNA	O
(	O
mRNA	O
)	O
expression	O

The	O
expression	O
was	O
then	O
normalized	O
to	O
the	O
expression	O
level	O
of	O
PGK1	S-Biological_Molecule
.	O

Determination	O
of	O
cell	O
death	O

At	O
least	O
1	O
,	O
000	O
cells	O
per	O
sample	O
were	O
run	O
on	O
a	O
BD	O
FACSCalibur	O
flow	O
cytometer	O
.	O

APOBEC3G	S-Biological_Molecule
(	O
A3G	S-Biological_Molecule
)	O
,	O
a	O
member	O
of	O
the	O
recently	O
discovered	O
family	O
of	O
human	O
cytidine	O
deaminases	O
,	O
is	O
expressed	O
in	O
peripheral	O
blood	O
lymphocytes	O
and	O
has	O
been	O
shown	O
to	O
be	O
active	O
against	O
HIV	O
-	O
1	O
and	O
other	O
retroviruses	O
.	O

In	O
primates	O
,	O
the	O
seven	O
paralogs	O
APOBEC3A	S-Biological_Molecule
,	O
B	S-Biological_Molecule
,	O
C	S-Biological_Molecule
,	O
DE	S-Biological_Molecule
,	O
F	S-Biological_Molecule
,	O
G	S-Biological_Molecule
,	O
H	S-Biological_Molecule
(	O
A3A	O
-	O
H	O
)	O
have	O
been	O
described	O
(	O
3	O
)	O
,	O
and	O
they	O
appear	O
to	O
fulfill	O
individual	O
functions	O
.	O

This	O
leads	O
to	O
degradation	O
of	O
the	O
uracile	O
-	O
containing	O
DNA	O
by	O
cellular	O
repair	O
mechanisms	O
or	O
to	O
hypermutation	O
of	O
the	O
viral	O
genome	O
(	O
5	O
,	O
6	O
)	O
.	O

The	O
human	O
hepatic	O
cell	O
lines	O
HepG2	O
and	O
Huh7	O
(	O
kindly	O
provided	O
by	O
Dr	O
Thomas	O
Pietschmann	O
,	O
Department	O
of	O
Molecular	O
Virology	O
,	O
University	O
of	O
Heidelberg	O
)	O
as	O
well	O
as	O
HeLa	O
cells	O
were	O
maintained	O
in	O
Dulbecco	O
'	O
s	O
high	O
glucose	O
modified	O
Eagle	O
'	O
s	O
medium	O
(	O
DMEM	O
)	O
supplemented	O
with	O
10	O
%	O
fetal	O
bovine	O
serum	O
,	O
2	O
mM	O
l	O
-	O
glutamine	O
and	O
100	O
U	O
/	O
ml	O
penicillin	O
-	O
streptomycin	O
.	O

An	O
A	O
-	O
to	O
-	O
C	O
substitution	O
is	O
present	O
at	O
this	O
position	O
.	O

XhoI	O
and	O
SpeI	O
restriction	O
sites	O
were	O
introduced	O
via	O
the	O
primers	O
.	O

5	O
'	O
-	O
Rapid	O
amplification	O
of	O
cDNA	O
ends	O
analysis	O
(	O
RACE	O
)	O

Briefly	O
,	O
exponential	O
growing	O
cells	O
(	O
1	O
.	O
5	O
x	O
106	O
)	O
were	O
transfected	O
with	O
5	O
microl	O
LipofectAMINE	O
,	O
6	O
microl	O
PLUS	O
reagent	O
and	O
the	O
required	O
amount	O
of	O
plasmid	O
DNA	O
in	O
a	O
final	O
volume	O
of	O
1	O
ml	O
Opti	O
-	O
MEM	O
.	O

For	O
supershift	O
experiments	O
,	O
2	O
microg	O
Sp1	S-Biological_Molecule
antibody	O
(	O
sc	O
-	O
59x	O
,	O
Santa	O
Cruz	O
Biotechnology	O
)	O
or	O
Sp3	S-Biological_Molecule
antibody	O
(	O
sc	O
-	O
644x	O
,	O
Santa	O
Cruz	O
Biotechnology	O
)	O
were	O
added	O
to	O
the	O
preincubation	O
mixture	O
and	O
preincubation	O
time	O
was	O
extended	O
to	O
30	O
min	O
.	O

Taq	B-Biological_Molecule
polymerase	E-Biological_Molecule
(	O
Qiagen	O
)	O
was	O
used	O
together	O
with	O
the	O
following	O
cycle	O
conditions	O
:	O
one	O
cycle	O
94degreesC	O
for	O
2	O
min	O
;	O
30	O
cycles	O
94degreesC	O
for	O
30	O
s	O
,	O
60degreesC	O
for	O
60	O
s	O
,	O
72degreesC	O
for	O
2	O
min	O
;	O
one	O
cycle	O
72degreesC	O
for	O
10	O
min	O
.	O

PCR	O
conditions	O
were	O
the	O
same	O
as	O
for	O
the	O
A3G	S-Biological_Molecule
promoter	O
sequence	O
,	O
with	O
the	O
exception	O
that	O
annealing	O
temperature	O
was	O
decreased	O
to	O
55degreesC	O
.	O

Forty	O
-	O
eight	O
hours	O
after	O
transfection	O
,	O
HeLa	O
cells	O
were	O
harvested	O
for	O
detection	O
of	O
Sp1	S-Biological_Molecule
and	O
Sp3	S-Biological_Molecule
proteins	O
.	O

Further	O
confirmation	O
of	O
the	O
specificity	O
of	O
these	O
DNA	O
-	O
protein	O
complexes	O
was	O
demonstrated	O
by	O
the	O
inability	O
of	O
the	O
unlabeled	O
APO	O
-	O
Sp1	O
/	O
3mut	O
probe	O
to	O
abolish	O
binding	O
(	O
Figure	O
6A	O
,	O
lanes	O
12	O
and	O
13	O
)	O
.	O

In	O
order	O
to	O
characterize	O
the	O
complexes	O
,	O
we	O
performed	O
supershift	O
experiments	O
using	O
Sp1	S-Biological_Molecule
-	O
and	O
Sp3	S-Biological_Molecule
-	O
specific	O
antibodies	O
.	O

Silencing	O
of	O
Sp1	S-Biological_Molecule
and	O
Sp3	S-Biological_Molecule
reduces	O
A3G	S-Biological_Molecule
promoter	O
activity	O

Thus	O
,	O
the	O
induction	O
we	O
observed	O
was	O
most	O
likely	O
mediated	O
by	O
the	O
described	O
interferon	O
-	O
responsive	O
elements	O
.	O

The	O
transcriptional	O
potency	O
of	O
the	O
GC	O
-	O
box	O
was	O
further	O
demonstrated	O
by	O
cloning	O
it	O
upstream	O
of	O
an	O
SV40	O
promoter	O
.	O

This	O
resulted	O
in	O
a	O
4	O
-	O
fold	O
enhanced	O
transcription	O
rate	O
.	O

In	O
addition	O
,	O
the	O
binding	O
of	O
Sp1	S-Biological_Molecule
and	O
Sp3	S-Biological_Molecule
to	O
the	O
endogenous	O
A3G	S-Biological_Molecule
promoter	O
was	O
demonstrated	O
by	O
a	O
chromatin	O
immunoprecipitation	O
assay	O
.	O

This	O
can	O
be	O
explained	O
by	O
the	O
remaining	O
low	O
amounts	O
of	O
Sp1	S-Biological_Molecule
/	O
Sp3	S-Biological_Molecule
proteins	O
which	O
can	O
be	O
seen	O
in	O
the	O
western	O
blot	O
analysis	O
.	O

A3F	S-Biological_Molecule
only	O
differs	O
in	O
16	O
nt	O
from	O
the	O
560	O
nt	O
upstream	O
of	O
the	O
TSS	O
of	O
A3G	S-Biological_Molecule
(	O
GenBank	O
(	O
TM	O
)	O
DQ146365	O
and	O
DQ147772	O
)	O
.	O

In	O
A3	O
.	O
01	O
T	O
cells	O
,	O
the	O
A3G	S-Biological_Molecule
promoter	O
appears	O
constitutively	O
active	O
and	O
is	O
not	O
inducible	O
by	O
TPA	O
,	O
type	O
I	O
or	O
II	O
interferons	O
or	O
by	O
HIV	O
-	O
1	O
proteins	O
.	O

Introns	O
are	O
removed	O
,	O
but	O
their	O
positions	O
are	O
indicated	O
.	O

A	O
putative	O
Sp1	O
/	O
Sp3	O
consensus	O
site	O
(	O
gray	O
square	O
)	O
is	O
depicted	O
.	O

Numbers	O
on	O
the	O
x	O
-	O
axis	O
refer	O
to	O
the	O
length	O
of	O
the	O
A3G	S-Biological_Molecule
promoter	O
fragments	O
in	O
bp	O
.	O

(	O
D	O
)	O
HepG2	O
cells	O
were	O
used	O
for	O
transfection	O
.	O

Protein	O
kinase	O
D	O
enzymes	O
are	O
dispensable	O
for	O
proliferation	O
,	O
survival	O
and	O
antigen	O
receptor	O
-	O
regulated	O
NFkappaB	O
activity	O
in	O
vertebrate	O
B	O
-	O
cells	O

In	O
particular	O
,	O
PKDs	O
have	O
been	O
widely	O
linked	O
to	O
the	O
activation	O
of	O
the	O
NFkappaB	O
transcription	O
factor	O
and	O
in	O
regulating	O
cell	O
survival	O
during	O
oxidative	O
stress	O
[	O
17	O
,	O
21	O
-	O
23	O
]	O
.	O

Another	O
recently	O
proposed	O
PKD1	S-Biological_Molecule
substrate	O
is	O
HSP27	S-Biological_Molecule
[	O
24	O
]	O
,	O
a	O
small	O
heat	O
shock	O
protein	O
involved	O
in	O
regulating	O
cell	O
migration	O
and	O
cell	O
survival	O
[	O
25	O
]	O
.	O

The	O
generation	O
,	O
culture	O
and	O
activation	O
of	O
PKD1	S-Biological_Molecule
-	O
/	O
-	O
,	O
PKD3	S-Biological_Molecule
-	O
/	O
-	O
and	O
PKD1	S-Biological_Molecule
/	O
3	S-Biological_Molecule
-	O
/	O
-	O
knockout	O
DT40	O
B	O
cell	O
lines	O
have	O
been	O
described	O
previously	O
[	O
1	O
]	O
.	O

DT40	O
B	O
cells	O
express	O
two	O
PKD	O
isoforms	O
,	O
PKD1	S-Biological_Molecule
and	O
PKD3	S-Biological_Molecule
,	O
and	O
as	O
previously	O
described	O
we	O
have	O
recently	O
generated	O
DT40	O
B	O
cell	O
lines	O
that	O
lack	O
expression	O
of	O
either	O
PKD1	S-Biological_Molecule
or	O
PKD3	S-Biological_Molecule
or	O
both	O
enzymes	O
[	O
1	O
]	O
.	O

However	O
,	O
BCR	O
-	O
and	O
phorbol	O
ester	O
-	O
induced	O
phosphorylation	O
of	O
HSP27	S-Biological_Molecule
on	O
S82	O
was	O
abolished	O
in	O
B	O
cells	O
that	O
lacked	O
both	O
PKD1	S-Biological_Molecule
and	O
PKD3	S-Biological_Molecule
(	O
Fig	O
.	O
1C	O
)	O
.	O

4Protein	O
kinase	O
D	O
serine	O
kinases	O
have	O
been	O
proposed	O
to	O
regulate	O
diverse	O
cellular	O
functions	O
including	O
the	O
phosphorylation	O
and	O
nuclear	O
localisation	O
of	O
class	O
II	O
HDACs	O
and	O
the	O
phosphorylation	O
of	O
HSP27	S-Biological_Molecule
.	O

Recently	O
,	O
it	O
was	O
shown	O
that	O
T	B-Biological_Molecule
-	I-Biological_Molecule
bet	E-Biological_Molecule
directly	O
modulates	O
GATA3	S-Biological_Molecule
function	O
,	O
suggesting	O
that	O
transcription	O
factors	O
compete	O
in	O
the	O
early	O
differentiation	O
phase	O
of	O
T	O
cells	O
,	O
potentially	O
integrating	O
environmental	O
signals	O
to	O
finally	O
imprint	O
the	O
T	O
cell	O
phenotype	O
[	O
4	O
,	O
5	O
]	O
.	O

Naturally	O
occurring	O
,	O
thymus	O
-	O
derived	O
Treg	O
(	O
nTreg	O
)	O
cells	O
are	O
generated	O
in	O
the	O
thymus	O
and	O
are	O
assumed	O
to	O
protect	O
against	O
the	O
activity	O
of	O
autoreactive	O
T	O
cells	O
in	O
the	O
periphery	O
.	O

These	O
induced	O
Treg	O
(	O
iTreg	O
)	O
cells	O
were	O
reported	O
to	O
express	O
FOXP3	S-Biological_Molecule
[	O
10	O
]	O
.	O

The	O
exact	O
mechanisms	O
of	O
iTreg	O
generation	O
are	O
unclear	O
,	O
but	O
T	O
cell	O
receptor	O
(	O
TCR	O
)	O
triggering	O
has	O
been	O
shown	O
to	O
induce	O
FOXP3	S-Biological_Molecule
expression	O
and	O
suppressive	O
cells	O
in	O
human	O
[	O
11	O
,	O
12	O
]	O
,	O
however	O
the	O
phenotype	O
appears	O
to	O
be	O
of	O
transient	O
nature	O
[	O
13	O
,	O
14	O
]	O
.	O

In	O
contrast	O
,	O
Th2	O
cells	O
stimulated	O
under	O
the	O
same	O
conditions	O
did	O
not	O
increase	O
FOXP3	S-Biological_Molecule
expression	O
.	O

Th2	O
cells	O
are	O
known	O
to	O
produce	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
upon	O
activation	O
,	O
which	O
may	O
interact	O
with	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
signaling	O
and	O
thus	O
prevent	O
FOXP3	S-Biological_Molecule
induction	O
.	O

Low	O
levels	O
of	O
GATA3	S-Biological_Molecule
were	O
induced	O
also	O
in	O
the	O
absence	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
,	O
as	O
it	O
was	O
previously	O
observed	O
[	O
3	O
]	O
.	O

Of	O
note	O
,	O
GATA3	S-Biological_Molecule
was	O
also	O
induced	O
in	O
the	O
presence	O
of	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
at	O
high	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
concentration	O
(	O
Figure	O
5A	O
and	O
5B	O
)	O
.	O

The	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
-	O
mediated	O
prevention	O
of	O
FOXP3	S-Biological_Molecule
expression	O
was	O
not	O
caused	O
by	O
interferences	O
of	O
the	O
receptor	O
signaling	O
,	O
because	O
the	O
phosphorylation	O
of	O
SMAD2	S-Biological_Molecule
or	O
STAT6	S-Biological_Molecule
was	O
not	O
affected	O
by	O
the	O
addition	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
and	O
/	O
or	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
,	O
which	O
demonstrates	O
that	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
as	O
well	O
as	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
signaling	O
were	O
functional	O
under	O
these	O
conditions	O
(	O
Figure	O
5C	O
)	O
.	O

Increasing	O
amounts	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
increase	O
intracellular	O
GATA3	S-Biological_Molecule
,	O
whereas	O
FOXP3	S-Biological_Molecule
decreased	O
,	O
which	O
is	O
consistent	O
with	O
the	O
mRNA	O
analysis	O
(	O
Figure	O
5D	O
)	O
.	O

In	O
conclusion	O
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
negatively	O
regulates	O
the	O
natural	O
or	O
inducible	O
Treg	O
cell	O
turnover	O
not	O
only	O
in	O
vitro	O
but	O
also	O
in	O
vivo	O
.	O

In	O
fact	O
both	O
populations	O
showed	O
similarly	O
enhanced	O
proliferation	O
(	O
Figure	O
6A	O
)	O
.	O

The	O
thymic	O
selection	O
into	O
the	O
CD4	S-Biological_Molecule
lineage	O
is	O
largely	O
intact	O
in	O
DO11	O
.	O
10xCD2	S-Biological_Molecule
-	O
GATA3	S-Biological_Molecule
(	O
RW	O
Hendriks	O
,	O
unpublished	O
data	O
)	O
.	O

These	O
mice	O
develop	O
lymphomas	O
at	O
an	O
older	O
age	O
,	O
but	O
signs	O
of	O
autoimmune	O
disease	O
were	O
not	O
described	O
[	O
22	O
]	O
.	O

In	O
contrast	O
,	O
naive	O
T	O
cells	O
could	O
efficiently	O
up	O
-	O
regulate	O
FOXP3	S-Biological_Molecule
when	O
treated	O
with	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
to	O
induce	O
iTreg	O
cells	O
[	O
10	O
,	O
28	O
-	O
34	O
]	O
,	O
suggesting	O
that	O
FOXP3	S-Biological_Molecule
plays	O
an	O
important	O
role	O
in	O
the	O
early	O
differentiation	O
process	O
and	O
may	O
act	O
in	O
a	O
way	O
similar	O
to	O
that	O
known	O
for	O
the	O
Th1	O
/	O
Th2	O
decision	O
factors	O
T	B-Biological_Molecule
-	I-Biological_Molecule
bet	E-Biological_Molecule
and	O
GATA3	S-Biological_Molecule
.	O

This	O
commitment	O
is	O
characterized	O
by	O
competitive	O
expression	O
of	O
these	O
factors	O
[	O
35	O
,	O
36	O
]	O
,	O
which	O
we	O
also	O
observed	O
in	O
differentiating	O
FOXP3	S-Biological_Molecule
+	O
iTreg	O
cells	O
including	O
a	O
phase	O
of	O
co	O
-	O
expression	O
,	O
which	O
turns	O
into	O
nonoverlapping	O
expression	O
upon	O
completed	O
differentiation	O
.	O

To	O
prove	O
the	O
inhibitory	O
effect	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
on	O
inducible	O
or	O
natural	O
Treg	O
commitment	O
in	O
vivo	O
,	O
we	O
treated	O
mice	O
with	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
and	O
anti	O
-	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
.	O

In	O
those	O
experiments	O
,	O
the	O
concentrations	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
used	O
were	O
low	O
,	O
and	O
as	O
we	O
also	O
observed	O
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
at	O
low	O
concentration	O
slightly	O
enhanced	O
FOXP3	S-Biological_Molecule
expression	O
.	O

In	O
fact	O
,	O
GATA3	S-Biological_Molecule
-	O
inducing	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
concentrations	O
repressed	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
-	O
mediated	O
FOXP3	S-Biological_Molecule
expression	O
,	O
whereas	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
as	O
well	O
as	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
signaling	O
were	O
intact	O
.	O

This	O
inhibitory	O
effect	O
of	O
GATA3	S-Biological_Molecule
was	O
further	O
confirmed	O
in	O
BALB	O
/	O
c	O
transgenic	O
mice	O
,	O
expressing	O
GATA3	S-Biological_Molecule
in	O
T	O
cells	O
(	O
DO11	O
.	O
10	O
:	O
CD2	S-Biological_Molecule
-	O
GATA3	S-Biological_Molecule
transgenic	O
mice	O
)	O
.	O

Strikingly	O
,	O
the	O
DO11	O
.	O
10	O
:	O
CD2	S-Biological_Molecule
-	O
GATA3	S-Biological_Molecule
mice	O
do	O
have	O
peripheral	O
FOXP3	S-Biological_Molecule
+	O
cells	O
,	O
which	O
however	O
displayed	O
a	O
10	O
%	O
-	O
25	O
%	O
lower	O
frequency	O
compared	O
to	O
wild	O
-	O
type	O
DO11	O
.	O
10	O
mice	O
.	O

Therefore	O
,	O
the	O
role	O
of	O
GATA3	S-Biological_Molecule
appears	O
to	O
be	O
tissue	O
specific	O
and	O
cannot	O
be	O
generalized	O
.	O

Site	O
-	O
specific	O
mutation	O
of	O
this	O
site	O
increased	O
the	O
activity	O
of	O
the	O
promoter	O
constructs	O
,	O
thus	O
revealing	O
the	O
repressive	O
nature	O
of	O
this	O
GATA	O
element	O
in	O
memory	O
T	O
cells	O
,	O
which	O
naturally	O
express	O
GATA3	S-Biological_Molecule
,	O
whereas	O
no	O
difference	O
was	O
seen	O
in	O
naive	O
T	O
cells	O
,	O
which	O
do	O
not	O
express	O
GATA3	S-Biological_Molecule
.	O

Mice	O
were	O
housed	O
under	O
specific	O
pathogen	O
-	O
free	O
conditions	O
and	O
all	O
animal	O
studies	O
were	O
performed	O
according	O
to	O
institutional	O
and	O
state	O
guidelines	O
.	O

Quantitative	O
PCR	O
of	O
murine	O
samples	O
was	O
performed	O
with	O
Brilliant	O
SYBR	O
Green	O
QPCR	O
master	O
mix	O
(	O
Stratagene	O
)	O
and	O
the	O
following	O
primers	O
:	O
Ubiquitin	B-Biological_Molecule
C	E-Biological_Molecule
,	O
5	O
'	O
-	O
AGG	O
TCA	O
AAC	O
AGG	O
AAG	O
ACA	O
GAC	O
GTA	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
TCACACCCAAGAACAAGCACA	O
-	O
3	O
'	O
;	O
Smad	B-Biological_Molecule
-	I-Biological_Molecule
7	E-Biological_Molecule
,	O
5	O
'	O
-	O
GAA	O
ACC	O
GGG	O
GGA	O
ACG	O
AAT	O
TAT	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
CGC	O
GAG	O
TCT	O
TCT	O
CCT	O
CCC	O
A	O
-	O
3	O
'	O
;	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
ss1	E-Biological_Molecule
,	O
5	O
'	O
-	O
TGA	O
CGT	O
CAC	O
TGG	O
AGT	O
TGT	O
ACG	O
G	O
-	O
3	O
'	O
and	O
5	O
'	O
-	O
GGT	O
TCA	O
TGT	O
CAT	O
GGA	O
TGG	O
TGC	O
-	O
3	O
'	O
.	O

In	O
vitro	O
T	O
cell	O
differentiation	O
.	O

3	O
.	O
5	O
mug	O
of	O
the	O
FOXP3	S-Biological_Molecule
promoter	O
luciferase	S-Biological_Molecule
reporter	O
vector	O
and	O
0	O
.	O
5	O
mug	O
phRL	O
-	O
TK	O
were	O
added	O
to	O
3	O
x	O
106	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
resuspended	O
in	O
100	O
muL	O
of	O
Nucleofector	O
solution	O
(	O
Amaxa	O
Biosystems	O
)	O
and	O
electroporated	O
using	O
the	O
U	O
-	O
15	O
program	O
of	O
the	O
Nucleofector	O
.	O

Data	O
were	O
normalized	O
by	O
the	O
activity	O
of	O
renilla	O
luciferase	S-Biological_Molecule
.	O

RNA	O
was	O
isolated	O
using	O
the	O
RNeasy	O
Mini	O
Kit	O
(	O
Qiagen	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
protocol	O
.	O

CD4	S-Biological_Molecule
+	O
CD45RA	S-Biological_Molecule
+	O
cells	O
were	O
cultured	O
in	O
AIMV	O
medium	O
and	O
transduced	O
with	O
20	O
nM	O
,	O
10	O
nM	O
,	O
or	O
500	O
nM	O
of	O
full	O
-	O
length	O
or	O
truncated	O
GATA3	S-Biological_Molecule
over	O
the	O
course	O
of	O
4	O
h	O
.	O

FOXP3	S-Biological_Molecule
expression	O
was	O
measured	O
after	O
5	O
d	O
by	O
intracellular	O
staining	O
.	O

The	O
PCR	O
products	O
were	O
visualized	O
using	O
an	O
ethidium	O
bromide	O
gel	O
.	O

Insoluble	O
material	O
was	O
removed	O
by	O
centrifugation	O
.	O

The	O
supernatant	O
was	O
diluted	O
1	O
:	O
3	O
with	O
buffer	O
D	O
(	O
as	O
buffer	O
C	O
,	O
but	O
without	O
NaCl	O
)	O
.	O

The	O
phenotype	O
of	O
these	O
cells	O
was	O
confirmed	O
by	O
FACS	O
and	O
proliferation	O
analysis	O
(	O
Figure	O
S1	O
)	O
.	O

(	O
C	O
)	O
Similarly	O
,	O
a	O
Th2	O
clone	O
(	O
BR8	O
)	O
,	O
CRTH2	S-Biological_Molecule
+	O
Th2	O
cells	O
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
-	O
secreting	O
cells	O
,	O
and	O
memory	O
T	O
cells	O
(	O
CD45RO	S-Biological_Molecule
)	O
were	O
stained	O
for	O
FOXP3	S-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
.	O

(	O
B	O
)	O
Intracellular	O
GATA3	S-Biological_Molecule
and	O
FOXP3	S-Biological_Molecule
staining	O
is	O
shown	O
after	O
exposure	O
of	O
CD4	S-Biological_Molecule
+	O
CD45RA	S-Biological_Molecule
+	O
T	O
cells	O
to	O
differentiating	O
conditions	O
as	O
in	O
part	O
A	O
of	O
the	O
figure	O
.	O

After	O
1	O
h	O
,	O
cell	O
lysates	O
were	O
prepared	O
and	O
analyzed	O
by	O
Western	O
blot	O
for	O
phosphorylated	O
SMAD2	S-Biological_Molecule
and	O
STAT6	S-Biological_Molecule
.	O

(	O
A	O
)	O
Jurkat	O
,	O
Th2	O
cells	O
,	O
and	O
human	O
primary	O
CD4	S-Biological_Molecule
cells	O
were	O
transfected	O
with	O
an	O
empty	O
vector	O
(	O
pGL3	O
basic	O
)	O
or	O
a	O
vector	O
containing	O
the	O
putative	O
FOXP3	S-Biological_Molecule
promoter	O
region	O
fused	O
to	O
the	O
luciferase	S-Biological_Molecule
reporter	O
gene	O
.	O

The	O
oligonucleotides	O
-	O
transcription	O
factor	O
complexes	O
were	O
separated	O
on	O
a	O
SDS	O
-	O
PAGE	O
gel	O
.	O

Total	O
nuclear	O
extracts	O
were	O
also	O
run	O
as	O
controls	O
.	O

Suppression	O
of	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
Nuclear	O
Import	O
and	O
Phosphorylation	O
:	O
A	O
Novel	O
Mechanism	O
of	O
Corticosteroid	O
Action	O
in	O
Allergic	O
Disease	O

IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
13	E-Biological_Molecule
regulate	O
the	O
expression	O
of	O
IgE	O
from	O
B	O
lymphocytes	O
,	O
whereas	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
plays	O
a	O
key	O
role	O
in	O
eosinophilic	O
inflammation	O
[	O
1	O
]	O
.	O

However	O
,	O
the	O
molecular	O
basis	O
for	O
the	O
inhibition	O
of	O
Th2	O
cytokines	O
by	O
corticosteroids	O
is	O
not	O
well	O
understood	O
,	O
because	O
the	O
genes	O
encoding	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
,	O
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
13	E-Biological_Molecule
do	O
not	O
have	O
any	O
recognisable	O
GRE	O
sequence	O
[	O
29	O
]	O
and	O
are	O
only	O
partly	O
regulated	O
by	O
NF	O
-	O
kappaB	O
in	O
human	O
cells	O
[	O
30	O
]	O
-	O
[	O
32	O
]	O
.	O

Seven	O
patients	O
with	O
mild	O
asthma	O
entered	O
the	O
study	O
and	O
were	O
randomized	O
to	O
receive	O
a	O
single	O
inhalation	O
of	O
FP	O
(	O
100	O
and	O
500	O
microg	O
)	O
or	O
a	O
matched	O
placebo	O
control	O
via	O
a	O
spacer	O
chamber	O
,	O
and	O
the	O
other	O
treatment	O
was	O
given	O
after	O
a	O
wash	O
-	O
out	O
period	O
of	O
at	O
least	O
6	O
d	O
.	O

Blood	O
was	O
taken	O
for	O
preparation	O
of	O
PBMCs	O
at	O
1	O
and	O
2	O
h	O
after	O
drug	O
administration	O
.	O

All	O
patients	O
gave	O
informed	O
consent	O
and	O
the	O
study	O
was	O
approved	O
by	O
the	O
Ethics	O
Committee	O
of	O
the	O
Royal	O
Brompton	O
and	O
Harefield	O
Hospitals	O
NHS	O
Trust	O
.	O

Next	O
,	O
0	O
.	O
5	O
microg	O
of	O
total	O
RNA	O
was	O
reversed	O
transcribed	O
using	O
the	O
avian	O
myeloblastosis	O
virus	O
RT	O
(	O
Promega	O
,	O
Southampton	O
,	O
UK	O
)	O
.	O

Primers	O
for	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
were	O
from	O
Sigma	O
-	O
Genosys	O
(	O
Cambridge	O
,	O
UK	O
)	O
.	O

After	O
1	O
h	O
incubation	O
,	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
(	O
100	O
ng	O
/	O
ml	O
in	O
TBS	O
)	O
from	O
stimulated	O
or	O
unstimulated	O
cells	O
were	O
added	O
to	O
the	O
importin	O
-	O
alpha	O
-	O
coated	O
wells	O
.	O

Immunofluorescence	O
Staining	O

Immunofluorescence	O
staining	O
was	O
performed	O
as	O
previously	O
described	O
[	O
34	O
]	O
.	O

After	O
three	O
washes	O
in	O
phosphate	O
-	O
buffered	O
saline	O
(	O
PBS	O
)	O
,	O
cells	O
were	O
incubated	O
with	O
tetrarhodamine	O
isothiocyanate	O
-	O
conjugated	O
goat	O
anti	O
-	O
rabbit	O
antibody	O
(	O
Dako	O
)	O
.	O

Positive	O
clones	O
were	O
confirmed	O
by	O
digestion	O
and	O
size	O
analysis	O
by	O
1	O
%	O
agarose	O
gel	O
electrophoresis	O
and	O
by	O
sequencing	O
.	O

The	O
medium	O
was	O
subsequently	O
changed	O
to	O
1	O
%	O
RPMI	O
for	O
24	O
h	O
before	O
transfected	O
cells	O
were	O
added	O
to	O
anti	O
-	O
CD3	O
/	O
CD28	O
treated	O
wells	O
and	O
live	O
cell	O
videomicroscopy	O
performed	O
.	O

Time	O
-	O
Lapse	O
Microscopy	O

Photographs	O
were	O
taken	O
at	O
0	O
,	O
30	O
,	O
60	O
,	O
120	O
,	O
and	O
240	O
min	O
.	O

Briefly	O
,	O
immunoblots	O
were	O
scanned	O
and	O
gates	O
were	O
drawn	O
tightly	O
around	O
each	O
band	O
.	O

Background	O
values	O
from	O
each	O
lane	O
were	O
subtracted	O
to	O
normalize	O
each	O
measurement	O
.	O

We	O
also	O
confirmed	O
a	O
clear	O
separation	O
of	O
nuclear	O
and	O
cytosolic	O
fractions	O
as	O
indicated	O
by	O
histone	O
H1	O
and	O
MEK	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
markers	O
(	O
Figure	O
1B	O
)	O
.	O

This	O
concentration	O
is	O
close	O
to	O
peak	O
plasma	O
levels	O
obtained	O
from	O
asthmatic	O
patients	O
treated	O
with	O
inhaled	O
FP	O
(	O
500	O
microg	O
)	O
[	O
27	O
]	O
.	O

Inhaled	O
FP	O
(	O
500	O
microg	O
)	O
treatment	O
of	O
seven	O
steroid	O
-	O
naive	O
asthma	O
patients	O
significantly	O
reduced	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
-	O
importin	O
-	O
alpha	O
interaction	O
in	O
vivo	O
in	O
a	O
time	O
-	O
dependent	O
manner	O
.	O

This	O
effect	O
may	O
be	O
direct	O
,	O
through	O
competition	O
for	O
importin	O
-	O
alpha	O
or	O
associated	O
molecules	O
,	O
or	O
secondary	O
to	O
an	O
effect	O
on	O
p38	O
MAPK	O
-	O
mediated	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
phosphorylation	O
via	O
rapid	O
induction	O
of	O
MKP	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
.	O

We	O
report	O
here	O
a	O
rapid	O
induction	O
of	O
MKP	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
mRNA	O
following	O
stimulation	O
of	O
cells	O
with	O
relatively	O
high	O
concentrations	O
of	O
FP	O
.	O

The	O
location	O
of	O
the	O
serine	O
residue	O
(	O
s	O
)	O
of	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
that	O
are	O
phosphorylated	O
by	O
p38	O
MAPK	O
are	O
currently	O
unknown	O
,	O
but	O
a	O
bioinformatics	O
search	O
(	O
Motif	O
Scanner	O
,	O
http	O
:	O
/	O
/	O
scansite	O
.	O
mit	O
.	O
edu	O
/	O
motifscan	O
_	O
seq	O
.	O
phtml	O
)	O
indicates	O
at	O
least	O
three	O
potential	O
p38	O
MAPK	O
-	O
sensitive	O
serine	O
residues	O
.	O

However	O
,	O
it	O
is	O
likely	O
that	O
the	O
higher	O
concentrations	O
of	O
FP	O
in	O
the	O
airways	O
after	O
inhaled	O
administration	O
would	O
be	O
effective	O
in	O
inhibiting	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
in	O
airway	O
T	O
cells	O
of	O
asthma	O
patients	O
.	O

In	O
summary	O
,	O
our	O
data	O
provide	O
evidence	O
for	O
a	O
novel	O
action	O
of	O
corticosteroids	O
:	O
suppression	O
of	O
allergic	O
inflammation	O
through	O
a	O
rapid	O
inhibitory	O
effect	O
on	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
nuclear	O
translocation	O
by	O
preferential	O
binding	O
to	O
the	O
shared	O
nuclear	O
import	O
protein	O
importin	O
-	O
alpha	O
and	O
by	O
a	O
second	O
mechanism	O
involving	O
increased	O
synthesis	O
of	O
MKP	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
which	O
inhibits	O
p38	O
MAPK	O
,	O
thus	O
preventing	O
the	O
phosphorylation	O
of	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
that	O
is	O
necessary	O
for	O
nuclear	O
translocation	O
of	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
.	O

(	O
A	O
)	O
Anti	O
-	O
CD3	O
/	O
CD28	O
treatment	O
of	O
HuT	O
-	O
78	O
cells	O
results	O
in	O
translocation	O
of	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
from	O
the	O
cytoplasm	O
to	O
the	O
nucleus	O
within	O
30	O
min	O
.	O

(	O
E	O
)	O
FP	O
(	O
10	O
nM	O
)	O
reduces	O
the	O
ability	O
of	O
anti	O
-	O
CD3	O
/	O
CD28	O
-	O
stimulated	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
to	O
associate	O
with	O
the	O
native	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
5	E-Biological_Molecule
promoter	O
60	O
min	O
after	O
stimulation	O
.	O

(	O
A	O
)	O
Western	O
blot	O
analysis	O
demonstrates	O
a	O
time	O
-	O
(	O
at	O
10	O
-	O
8	O
M	O
FP	O
)	O
and	O
concentration	O
-	O
(	O
at	O
60	O
min	O
after	O
stimulation	O
)	O
dependent	O
induction	O
of	O
FP	O
-	O
activated	O
GR	S-Biological_Molecule
interaction	O
with	O
importin	O
-	O
alpha	O
(	O
Imp	O
-	O
alpha	O
)	O
.	O

A	O
positive	O
control	O
for	O
GR	S-Biological_Molecule
association	O
with	O
importin	O
is	O
shown	O
.	O

(	O
D	O
)	O
FP	O
induced	O
MKP	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
mRNA	O
in	O
a	O
concentration	O
-	O
dependent	O
manner	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
compared	O
to	O
no	O
activated	O
GR	S-Biological_Molecule
.	O

*	O
p	O
<	O
0	O
.	O
05	O
compared	O
to	O
control	O
.	O

#	O
p	O
<	O
0	O
.	O
05	O
compared	O
to	O
stimulated	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
-	O
importin	O
binding	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
,	O
*	O
*	O
p	O
<	O
0	O
.	O
01	O
between	O
groups	O
.	O

Fluticasone	O
propionate	O
does	O
not	O
affect	O
GATA	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
nuclear	O
export	O
.	O

The	O
individual	O
values	O
for	O
each	O
treatment	O
are	O
presented	O
graphically	O
.	O

The	O
results	O
shown	O
in	O
(	O
E	O
)	O
are	O
representative	O
of	O
samples	O
from	O
two	O
participants	O
.	O

Degraded	O
Carrageenan	O
Causing	O
Colitis	O
in	O
Rats	O
Induces	O
TNF	S-Biological_Molecule
Secretion	O
and	O
ICAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
Upregulation	O
in	O
Monocytes	O
through	O
NF	O
-	O
kappaB	O
Activation	O

Also	O
,	O
dCGN	O
stimulated	O
monocyte	O
aggregation	O
in	O
vitro	O
that	O
was	O
prevented	O
by	O
incubation	O
with	O
anti	O
-	O
ICAM	O
-	O
1	O
antibody	O
.	O

Native	O
CGN	O
is	O
thought	O
to	O
be	O
harmless	O
and	O
is	O
widely	O
used	O
as	O
a	O
food	O
additive	O
to	O
improve	O
texture	O
.	O

Whereas	O
the	O
effects	O
of	O
native	O
and	O
dCGN	O
on	O
intestinal	O
inflammation	O
have	O
been	O
extensively	O
analyzed	O
in	O
animal	O
models	O
,	O
only	O
few	O
studies	O
have	O
been	O
conducted	O
using	O
human	O
cell	O
lines	O
.	O

Macrophage	O
infiltration	O
and	O
accumulation	O
is	O
a	O
common	O
characteristic	O
of	O
intestinal	O
diseases	O
[	O
17	O
]	O
.	O

Preparation	O
of	O
Degraded	O
Carrageenan	O

Male	O
Wistar	O
rats	O
(	O
150	O
g	O
average	O
weight	O
)	O
were	O
housed	O
under	O
standard	O
conditions	O
and	O
fed	O
ad	O
libitum	O
with	O
standard	O
rodent	O
laboratory	O
chow	O
.	O

An	O
additional	O
group	O
of	O
four	O
rats	O
were	O
maintained	O
on	O
regular	O
tap	O
water	O
(	O
control	O
group	O
)	O
.	O

[	O
24	O
]	O
.	O

One	O
unit	O
of	O
MPO	O
activity	O
corresponds	O
to	O
the	O
degradation	O
of	O
1	O
micromol	O
of	O
peroxide	O
per	O
minute	O
at	O
25degreesC	O
.	O

Cell	O
DNA	O
content	O
was	O
then	O
analyzed	O
by	O
flow	O
cytometry	O
using	O
an	O
EPICS	O
XL2	O
(	O
Beckman	O
-	O
Coulter	O
)	O
.	O

Peripheral	O
Blood	O
Monocytes	O
or	O
THP	O
-	O
1	O
cells	O
were	O
exposed	O
to	O
complete	O
medium	O
in	O
the	O
presence	O
or	O
absence	O
of	O
carrageenan	O
for	O
36	O
h	O
.	O

Biologically	O
active	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
/	O
beta	S-Biological_Molecule
in	O
tissue	O
culture	O
supernatant	O
was	O
measured	O
using	O
the	O
WEHI	O
164	O
clone	O
13	O
-	O
cell	O
killing	O
assay	O
[	O
29	O
]	O
.	O

cDNA	O
was	O
generated	O
on	O
1	O
microg	O
of	O
total	O
RNA	O
in	O
a	O
reaction	O
volume	O
of	O
20	O
microl	O
,	O
using	O
M	O
-	O
MLV	O
reverse	O
transcriptase	O
(	O
Invitrogen	O
)	O
.	O

cDNA	O
for	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
was	O
amplified	O
for	O
35	O
cycles	O
using	O
the	O
oligos	O
:	O
sense	O
5	O
'	O
-	O
AAGCCTGTAGCCCATGTTGT	O
-	O
3	O
'	O
and	O
antisense	O
5	O
'	O
-	O
CAGATAGATGGGCTCATACC	O
-	O
3	O
'	O
.	O

Membranes	O
were	O
subsequently	O
probed	O
with	O
the	O
corresponding	O
antibody	O
in	O
blocking	O
buffer	O
,	O
overnight	O
.	O

Histological	O
examination	O
revealed	O
various	O
degrees	O
of	O
mucosal	O
inflammation	O
.	O

These	O
symptoms	O
were	O
totally	O
absent	O
in	O
the	O
colon	O
of	O
control	O
rats	O
(	O
Fig	O
.	O
1E	O
)	O
.	O

In	O
order	O
to	O
study	O
the	O
effect	O
of	O
dCGN	O
on	O
the	O
expression	O
of	O
cell	O
surface	O
antigens	O
,	O
PBM	O
and	O
THP	O
-	O
1	O
cells	O
were	O
incubated	O
for	O
36	O
h	O
in	O
the	O
presence	O
and	O
absence	O
of	O
dCGN	O
.	O

The	O
increase	O
in	O
surface	O
ICAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
expression	O
and	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
production	O
by	O
monocytes	O
correlated	O
with	O
an	O
upregulation	O
of	O
mRNA	O
for	O
these	O
molecules	O
.	O

These	O
assays	O
also	O
allowed	O
us	O
to	O
determine	O
what	O
NF	B-Biological_Molecule
-	I-Biological_Molecule
kappaB	I-Biological_Molecule
subunits	E-Biological_Molecule
were	O
activated	O
by	O
dCGN	O
.	O

In	O
agreement	O
with	O
the	O
previous	O
data	O
,	O
FACS	O
analysis	O
of	O
nuclei	O
from	O
THP	O
-	O
1	O
cells	O
showed	O
that	O
there	O
was	O
a	O
basal	O
level	O
of	O
nuclear	O
NF	O
-	O
kappaB	O
(	O
Fig	O
.	O
7D	O
)	O
.	O

These	O
degraded	O
CGN	O
may	O
also	O
have	O
a	O
possible	O
carcinogenic	O
effect	O
[	O
4	O
]	O
,	O
[	O
6	O
]	O
-	O
[	O
8	O
]	O
;	O
however	O
this	O
is	O
still	O
controversial	O
.	O

This	O
macrophage	O
accumulation	O
was	O
not	O
due	O
to	O
cell	O
proliferation	O
because	O
dCGN	O
inhibited	O
THP	O
-	O
1	O
monocytes	O
proliferation	O
in	O
vitro	O
.	O

Degraded	O
CGN	O
induced	O
a	O
robust	O
production	O
of	O
TNF	S-Biological_Molecule
by	O
monocytes	O
.	O

Surprisingly	O
,	O
monocyte	O
activation	O
by	O
dCGN	O
to	O
produce	O
TNF	S-Biological_Molecule
was	O
much	O
stronger	O
than	O
the	O
activation	O
induced	O
by	O
LPS	O
,	O
an	O
inflammatory	O
factor	O
considered	O
to	O
be	O
among	O
the	O
most	O
potent	O
stimuli	O
for	O
leukocyte	O
activation	O
.	O

It	O
is	O
noteworthy	O
that	O
neutralizing	O
antibody	O
to	O
CD14	O
only	O
partially	O
(	O
<	O
40	O
%	O
)	O
inhibited	O
dCGN	O
-	O
induced	O
TNF	S-Biological_Molecule
secretion	O
(	O
not	O
shown	O
)	O
.	O

Indeed	O
,	O
dCGN	O
induced	O
NF	O
-	O
kappaB	O
activation	O
as	O
shown	O
by	O
degradation	O
of	O
IkappaBalpha	S-Biological_Molecule
,	O
translocation	O
of	O
p65	S-Biological_Molecule
and	O
p50	S-Biological_Molecule
sub	O
-	O
units	O
to	O
the	O
nucleus	O
and	O
by	O
activation	O
of	O
an	O
NF	O
-	O
kappaB	O
-	O
responsive	O
luciferase	S-Biological_Molecule
reporter	O
plasmid	O
.	O

Such	O
relationship	O
between	O
NF	O
-	O
kB	O
activation	O
and	O
cell	O
cycle	O
regulation	O
has	O
been	O
reported	O
in	O
normal	O
human	O
epidermal	O
cells	O
[	O
50	O
]	O
.	O

This	O
higher	O
expression	O
of	O
ICAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
resulted	O
in	O
formation	O
of	O
cell	O
aggregates	O
similar	O
to	O
those	O
observed	O
in	O
patients	O
with	O
Crohn	O
'	O
s	O
disease	O
.	O

These	O
results	O
suggest	O
that	O
,	O
although	O
CGN	O
is	O
widely	O
used	O
as	O
a	O
food	O
additive	O
,	O
its	O
degraded	O
forms	O
have	O
an	O
important	O
effect	O
on	O
monocytes	O
characteristic	O
of	O
an	O
inflammatory	O
phenotype	O
.	O

B	O
:	O
Kinetics	O
of	O
TNF	S-Biological_Molecule
release	O
induced	O
by	O
nothing	O
(	O
control	O
;	O
black	O
diamonds	O
)	O
,	O
0	O
.	O
1	O
mg	O
/	O
ml	O
10	O
kDa	O
dCGN	O
(	O
black	O
triangles	O
)	O
,	O
0	O
.	O
1	O
mg	O
/	O
ml	O
40	O
kDa	O
dCGN	O
(	O
black	O
squares	O
)	O
,	O
or	O
10	O
microg	O
/	O
ml	O
LPS	O
(	O
open	O
squares	O
)	O
.	O

Cells	O
were	O
observed	O
by	O
phase	O
contrast	O
inverse	O
microscopy	O
at	O
150X	O
magnification	O
.	O

Degraded	O
CGN	O
stimulated	O
ICAM	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
gene	O
expression	O
in	O
monocytes	O
.	O

Nuclei	O
isolated	O
from	O
THP	O
-	O
1	O
cells	O
were	O
fluorescence	O
-	O
stained	O
for	O
NF	O
-	O
kappaB	O
p50	S-Biological_Molecule
subunit	O
or	O
NF	O
-	O
kappaB	O
p65	S-Biological_Molecule
subunit	O
before	O
(	O
filled	O
area	O
)	O
or	O
after	O
cells	O
were	O
treated	O
with	O
1	O
mg	O
/	O
ml	O
of	O
10	O
kDa	O
dCGN	O
(	O
C10	O
)	O
,	O
or	O
with	O
1	O
mg	O
/	O
ml	O
of	O
40	O
kDa	O
dCGN	O
(	O
C40	O
)	O
for	O
30	O
minutes	O
at	O
37degreesC	O
.	O

RUNX1	S-Biological_Molecule
plays	O
an	O
important	O
role	O
in	O
hematopoiesis	O
during	O
development	O
,	O
and	O
RUNX3	S-Biological_Molecule
has	O
important	O
functions	O
in	O
thymogenesis	O
and	O
neurogenesis	O
(	O
Wang	O
et	O
al	O
.	O
,	O
1996	O
;	O
Inoue	O
et	O
al	O
.	O
,	O
2002	O
;	O
Levanon	O
et	O
al	O
.	O
,	O
2002	O
)	O
.	O

To	O
determine	O
whether	O
RUNX1	S-Biological_Molecule
and	O
RUNX3	S-Biological_Molecule
are	O
also	O
expressed	O
in	O
human	O
T	O
reg	O
cells	O
in	O
vivo	O
,	O
we	O
isolated	O
peripheral	O
blood	O
CD4	S-Biological_Molecule
+	O
CD127	S-Biological_Molecule
-	O
CD25high	S-Biological_Molecule
T	O
reg	O
cells	O
and	O
compared	O
them	O
with	O
CD4	S-Biological_Molecule
+	O
CD127	S-Biological_Molecule
+	O
CD25	S-Biological_Molecule
-	O
T	O
cells	O
.	O

Transcription	O
element	O
search	O
system	O
analysis	O
of	O
the	O
human	O
FOXP3	S-Biological_Molecule
promoter	O
predicted	O
3	O
putative	O
RUNX	O
binding	O
sites	O
at	O
333	O
,	O
287	O
,	O
and	O
53	O
bp	O
upstream	O
of	O
the	O
transcription	O
start	O
site	O
(	O
TSS	O
)	O
.	O

All	O
three	O
binding	O
sites	O
are	O
conserved	O
between	O
human	O
,	O
mouse	O
,	O
and	O
rat	O
(	O
Fig	O
.	O
S4	O
)	O
.	O

Cell	O
lysates	O
were	O
obtained	O
from	O
HEK293T	O
cells	O
that	O
had	O
been	O
transiently	O
transfected	O
with	O
RUNX1	S-Biological_Molecule
or	O
RUNX3	S-Biological_Molecule
expression	O
vectors	O
.	O

CBFbeta	S-Biological_Molecule
,	O
a	O
common	O
cofactor	O
of	O
all	O
RUNX	S-Biological_Molecule
proteins	O
,	O
stabilizes	O
and	O
increases	O
the	O
binding	O
of	O
the	O
runt	O
domain	O
to	O
target	O
DNA	O
sequences	O
.	O

Even	O
though	O
Cbfb	S-Biological_Molecule
-	O
deficient	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
had	O
impaired	O
induction	O
of	O
Foxp3	S-Biological_Molecule
after	O
stimulation	O
with	O
anti	O
-	O
CD3	S-Biological_Molecule
/	O
28	S-Biological_Molecule
mAbs	O
and	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
,	O
sufficient	O
numbers	O
of	O
Foxp3	S-Biological_Molecule
+	O
cells	O
could	O
be	O
generated	O
to	O
permit	O
analysis	O
of	O
their	O
suppressive	O
activity	O
.	O

Cells	O
were	O
cultured	O
under	O
T	O
reg	O
conditions	O
,	O
and	O
then	O
mixed	O
with	O
CFSE	O
-	O
labeled	O
autologous	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
and	O
stimulated	O
with	O
anti	O
-	O
CD3	S-Biological_Molecule
mAb	O
.	O

TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
promotes	O
or	O
inhibits	O
the	O
proliferation	O
,	O
differentiation	O
,	O
and	O
survival	O
of	O
a	O
wide	O
array	O
of	O
different	O
cells	O
.	O

These	O
data	O
in	O
mice	O
confirm	O
the	O
human	O
data	O
that	O
RUNX	S-Biological_Molecule
proteins	O
play	O
an	O
important	O
role	O
for	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
-	O
dependent	O
FOXP3	S-Biological_Molecule
induction	O
,	O
as	O
well	O
as	O
in	O
the	O
suppressive	O
capacity	O
of	O
iT	O
reg	O
cells	O
.	O

Cbfb	S-Biological_Molecule
-	O
deficient	O
nT	O
reg	O
cells	O
progressively	O
lose	O
Foxp3	S-Biological_Molecule
upon	O
division	O
,	O
and	O
there	O
is	O
no	O
evidence	O
of	O
increased	O
death	O
of	O
Cbfb	S-Biological_Molecule
-	O
deficient	O
nT	O
reg	O
cells	O
in	O
that	O
study	O
.	O

Polymorphisms	O
that	O
alter	O
RUNX1	S-Biological_Molecule
binding	O
to	O
other	O
genes	O
have	O
also	O
been	O
described	O
in	O
rheumatoid	O
arthritis	O
linkage	O
at	O
5q31	O
in	O
Japanese	O
patients	O
(	O
Tokuhiro	O
et	O
al	O
.	O
,	O
2003	O
)	O
and	O
in	O
a	O
psoriasis	O
linkage	O
at	O
17q25	O
(	O
Prokunina	O
et	O
al	O
.	O
,	O
2002	O
;	O
Helms	O
et	O
al	O
.	O
,	O
2003	O
)	O
.	O

Runx	S-Biological_Molecule
proteins	O
also	O
play	O
an	O
essential	O
role	O
during	O
T	O
lymphocyte	O
differentiation	O
in	O
the	O
thymus	O
(	O
Taniuchi	O
et	O
al	O
.	O
,	O
2002	O
)	O
.	O

The	O
interaction	O
of	O
Foxp3	S-Biological_Molecule
and	O
NFAT	O
is	O
dependent	O
on	O
their	O
cooperative	O
binding	O
to	O
DNA	O
(	O
Wu	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

In	O
conclusion	O
,	O
our	O
findings	O
elucidate	O
the	O
role	O
of	O
RUNX	S-Biological_Molecule
proteins	O
in	O
iT	O
reg	O
cell	O
development	O
and	O
function	O
.	O

Mice	O
.	O

Human	O
PBMCs	O
were	O
isolated	O
by	O
Ficoll	O
(	O
Biochrom	O
)	O
density	O
gradient	O
centrifugation	O
and	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
were	O
then	O
isolated	O
using	O
the	O
Dynal	O
CD4	S-Biological_Molecule
+	O
Isolation	O
kit	S-Biological_Molecule
(	O
Invitrogen	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

For	O
Th1	O
differentiation	O
conditions	O
,	O
cells	O
were	O
stimulated	O
with	O
the	O
following	O
:	O
40	O
ng	O
/	O
ml	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
,	O
5	O
microg	O
/	O
ml	O
anti	O
-	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
,	O
and	O
25	O
ng	O
/	O
ml	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
12	E-Biological_Molecule
(	O
R	O
&	O
D	O
Systems	O
)	O
.	O

For	O
Th2	O
conditions	O
,	O
cells	O
were	O
stimulated	O
with	O
the	O
following	O
:	O
40	O
ng	O
/	O
ml	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
,	O
25	O
ng	O
/	O
ml	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
,	O
and	O
5	O
microg	O
/	O
ml	O
anti	O
-	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
12	E-Biological_Molecule
(	O
R	O
&	O
D	O
Systems	O
)	O
.	O

For	O
T	O
reg	O
cell	O
conditions	O
,	O
cells	O
were	O
stimulated	O
with	O
the	O
following	O
:	O
40	O
ng	O
/	O
ml	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
,	O
5	O
ng	O
/	O
ml	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
,	O
5	O
microg	O
/	O
ml	O
anti	O
-	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
12	E-Biological_Molecule
,	O
5	O
microg	O
/	O
ml	O
anti	O
-	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
.	O

RUNX1	S-Biological_Molecule
-	O
binding	O
antibodies	O
were	O
detected	O
by	O
using	O
Alexa	O
Fluor	O
633	O
-	O
conjugated	O
goat	O
anti	O
-	O
rabbit	O
IgG	O
and	O
RUNX3	S-Biological_Molecule
-	O
binding	O
antibodies	O
were	O
detected	O
by	O
using	O
Alexa	O
Fluor	O
532	O
-	O
conjugated	O
goat	O
anti	O
-	O
mouse	O
IgG1	O
.	O

A	O
total	O
of	O
4	O
x	O
105	O
CD4	S-Biological_Molecule
+	O
cells	O
(	O
CFSE	O
-	O
loaded	O
CD25	S-Biological_Molecule
-	O
plus	O
Foxp3	B-Biological_Molecule
-	I-Biological_Molecule
GFP	E-Biological_Molecule
+	O
)	O
was	O
mixed	O
with	O
105	O
APCs	O
+	O
1	O
microg	O
/	O
ml	O
anti	O
-	O
CD3	S-Biological_Molecule
mAb	O
per	O
well	O
of	O
a	O
96	O
well	O
round	O
bottom	O
plate	O
.	O

Transfections	O
and	O
reporter	O
gene	O
assays	O
.	O

The	O
prepared	O
cDNAs	O
were	O
amplified	O
using	O
SYBR	O
green	O
PCR	O
master	O
mix	O
(	O
Fermentas	O
)	O
according	O
to	O
the	O
recommendations	O
of	O
the	O
manufacturer	O
in	O
an	O
ABI	O
PRISM	O
7000	O
Sequence	O
Detection	O
System	O
(	O
Applied	O
Biosystems	O
)	O
.	O

Relative	O
quantification	O
and	O
calculation	O
of	O
the	O
range	O
of	O
confidence	O
was	O
performed	O
using	O
the	O
comparative	O
deltadeltaCT	O
method	O
(	O
Applied	O
Biosystems	O
)	O
.	O

For	O
analysis	O
of	O
human	O
FOXP3	S-Biological_Molecule
expression	O
on	O
the	O
single	O
-	O
cell	O
level	O
,	O
cells	O
were	O
first	O
stained	O
with	O
the	O
monoclonal	O
CD4	S-Biological_Molecule
mAb	O
(	O
Beckman	O
Coulter	O
)	O
,	O
and	O
after	O
fixation	O
and	O
permeabilization	O
,	O
they	O
were	O
incubated	O
with	O
anti	O
-	O
human	O
Foxp3	S-Biological_Molecule
-	O
Alexa	O
Fluor	O
488	O
antibody	O
(	O
BioLegend	O
)	O
based	O
on	O
the	O
manufacturer	O
'	O
s	O
recommendations	O
and	O
subjected	O
to	O
FACS	O
(	O
EPICS	O
XL	O
-	O
MCL	O
;	O
Beckman	O
Coulter	O
)	O
.	O

DNA	O
-	O
bound	O
proteins	O
were	O
collected	O
with	O
streptavidin	O
-	O
agarose	O
beads	O
,	O
washed	O
with	O
HKMG	O
buffer	O
,	O
and	O
finally	O
resuspended	O
in	O
NuPAGE	O
loading	O
buffer	O
(	O
Invitrogen	O
Life	O
Technologies	O
)	O
,	O
heated	O
to	O
70degreesC	O
for	O
10	O
min	O
,	O
and	O
separated	O
on	O
a	O
NuPAGE	O
4	O
-	O
12	O
%	O
Bis	O
-	O
Tris	O
gel	O
(	O
Invitrogen	O
Life	O
Technologies	O
)	O
.	O

The	O
wells	O
were	O
washed	O
4	O
times	O
with	O
HKMG	O
buffer	O
before	O
adding	O
the	O
substrate	O
reagent	O
(	O
R	O
&	O
D	O
Systems	O
)	O
.	O

Human	O
naive	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
were	O
cultured	O
either	O
with	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
only	O
or	O
with	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
,	O
anti	O
-	O
CD2	S-Biological_Molecule
/	O
3	S-Biological_Molecule
/	O
28	S-Biological_Molecule
,	O
and	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
for	O
72	O
h	O
,	O
and	O
protein	O
-	O
DNA	O
complexes	O
were	O
fixed	O
by	O
cross	O
-	O
linking	O
with	O
formaldehyde	O
in	O
a	O
final	O
concentration	O
of	O
1	O
.	O
42	O
%	O
for	O
15	O
min	O
.	O

Online	O
supplemental	O
material	O
.	O

The	O
precipitated	O
oligonucleotide	O
-	O
transcription	O
factor	O
complexes	O
were	O
separated	O
by	O
SDS	O
-	O
PAGE	O
and	O
identified	O
by	O
Western	O
blotting	O
with	O
anti	O
-	O
RUNX1	S-Biological_Molecule
and	O
anti	O
-	O
RUNX3	S-Biological_Molecule
antibodies	O
.	O

Bars	O
show	O
the	O
mean	O
luciferase	S-Biological_Molecule
activity	O
+	O
/	O
-	O
SD	O
measured	O
as	O
arbitrary	O
light	O
units	O
of	O
three	O
independent	O
experiments	O
.	O

(	O
A	O
)	O
FACS	O
-	O
purified	O
naive	O
CD4	S-Biological_Molecule
+	O
CD8	S-Biological_Molecule
-	O
T	O
cells	O
from	O
CbfbF	S-Biological_Molecule
/	O
F	O
CD4	B-Biological_Molecule
-	I-Biological_Molecule
cre	E-Biological_Molecule
and	O
control	O
CbfbF	S-Biological_Molecule
/	O
+	O
CD4	B-Biological_Molecule
-	I-Biological_Molecule
cre	E-Biological_Molecule
mice	O
were	O
activated	O
in	O
vitro	O
with	O
anti	O
-	O
CD3	S-Biological_Molecule
/	O
28	S-Biological_Molecule
mAb	O
,	O
50	O
U	O
/	O
ml	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
,	O
+	O
/	O
-	O
10	O
nM	O
retinoic	O
acid	O
(	O
RA	O
)	O
,	O
and	O
increasing	O
concentrations	O
of	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
.	O

(	O
B	O
)	O
Naive	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
from	O
Cbfb	S-Biological_Molecule
CD4	B-Biological_Molecule
-	I-Biological_Molecule
cre	E-Biological_Molecule
or	O
control	O
mice	O
(	O
harboring	O
a	O
Foxp3	S-Biological_Molecule
-	O
IRES	O
-	O
GFP	S-Biological_Molecule
allele	O
)	O
were	O
adoptively	O
transferred	O
into	O
Rag	S-Biological_Molecule
-	O
deficient	O
mice	O
(	O
5	O
x	O
106	O
cells	O
per	O
transfer	O
)	O
.	O

The	O
data	O
from	O
four	O
sets	O
of	O
mice	O
is	O
shown	O
in	O
C	O
.	O

Statistical	O
analysis	O
was	O
performed	O
with	O
Mann	O
-	O
Whitney	O
U	O
test	O
.	O

*	O
,	O
P	O
<	O
0	O
.	O
05	O
between	O
groups	O
.	O

After	O
3	O
d	O
,	O
Foxp3	B-Biological_Molecule
-	I-Biological_Molecule
GFP	E-Biological_Molecule
+	O
cells	O
were	O
FACS	O
-	O
sorted	O
and	O
mixed	O
with	O
CFSE	O
-	O
loaded	O
naive	O
CD45	B-Biological_Molecule
.	I-Biological_Molecule
1	E-Biological_Molecule
+	O
CD4	S-Biological_Molecule
+	O
cells	O
at	O
the	O
indicated	O
ratios	O
.	O

These	O
were	O
then	O
incubated	O
with	O
inactivated	O
splenocytes	O
and	O
anti	O
-	O
CD3	S-Biological_Molecule
mAb	O
.	O

The	O
median	O
division	O
number	O
(	O
of	O
the	O
naive	O
CD45	B-Biological_Molecule
.	I-Biological_Molecule
1	E-Biological_Molecule
+	O
CD4	S-Biological_Molecule
+	O
cells	O
in	O
the	O
cultures	O
containing	O
Foxp3	B-Biological_Molecule
-	I-Biological_Molecule
GFP	E-Biological_Molecule
+	O
cells	O
)	O
is	O
indicated	O
in	O
each	O
of	O
the	O
histograms	O
.	O

IKKbeta	S-Biological_Molecule
phosphorylation	O
regulates	O
RPS3	S-Biological_Molecule
nuclear	O
translocation	O
and	O
NF	O
-	O
kappaB	O
function	O
duringEscherichia	O
coliO157	O
:	O
H7	O
infection	O

However	O
,	O
it	O
is	O
unknown	O
how	O
RPS3	S-Biological_Molecule
nuclear	O
translocation	O
is	O
regulated	O
.	O

Thus	O
,	O
the	O
IKKbeta	S-Biological_Molecule
-	O
dependent	O
modification	O
of	O
a	O
specific	O
amino	O
acid	O
in	O
RPS3	S-Biological_Molecule
promotes	O
specific	O
NF	O
-	O
kappaB	O
functions	O
that	O
underlie	O
the	O
molecular	O
pathogenetic	O
mechanisms	O
of	O
E	O
.	O
coli	O
O157	O
:	O
H7	O
.	O

The	O
best	O
-	O
known	O
mammalian	O
NF	O
-	O
kappaB	O
subunits	O
are	O
Rel	O
proteins	O
,	O
including	O
RelA	S-Biological_Molecule
(	O
p65	S-Biological_Molecule
)	O
,	O
RelB	S-Biological_Molecule
,	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Rel	E-Biological_Molecule
,	O
p50	S-Biological_Molecule
,	O
and	O
p52	S-Biological_Molecule
(	O
refs	O
.	O
4	O
,	O
5	O
)	O
.	O

We	O
next	O
examined	O
resting	O
Jurkat	O
cells	O
and	O
detected	O
a	O
modest	O
endogenous	O
IKKbeta	S-Biological_Molecule
-	O
RPS3	S-Biological_Molecule
interaction	O
(	O
Fig	O
.	O
1d	O
)	O
,	O
potentially	O
accounting	O
for	O
the	O
basal	O
NF	O
-	O
kappaB	O
transcription	O
required	O
for	O
cell	O
proliferation	O
and	O
survival	O
.	O

Immunoblotting	O
of	O
nuclear	O
fractions	O
confirmed	O
that	O
full	O
expression	O
of	O
IKKbeta	S-Biological_Molecule
,	O
but	O
not	O
IKKalpha	S-Biological_Molecule
,	O
was	O
necessary	O
for	O
activation	O
-	O
induced	O
RPS3	S-Biological_Molecule
nuclear	O
translocation	O
(	O
Fig	O
.	O
2b	O
)	O
.	O

Consistent	O
with	O
this	O
notion	O
,	O
RPS3	S-Biological_Molecule
association	O
with	O
importin	O
-	O
alpha	O
,	O
but	O
not	O
importin	O
-	O
beta	O
,	O
was	O
enhanced	O
in	O
TNF	O
-	O
stimulated	O
cells	O
(	O
Fig	O
.	O
3a	O
)	O
.	O

Therefore	O
,	O
we	O
examined	O
whether	O
RPS3	S-Biological_Molecule
binding	O
to	O
importin	O
-	O
alpha	O
is	O
essential	O
for	O
nuclear	O
translocation	O
during	O
NF	O
-	O
kappaB	O
activation	O
.	O

We	O
discovered	O
that	O
GST	B-Biological_Molecule
-	I-Biological_Molecule
RPS3	E-Biological_Molecule
could	O
be	O
phosphorylated	O
by	O
IKKbeta	S-Biological_Molecule
,	O
but	O
not	O
IKKalpha	S-Biological_Molecule
,	O
in	O
vitro	O
(	O
Fig	O
.	O
4a	O
,	O
compare	O
lanes	O
4	O
and	O
7	O
)	O
.	O

Phosphorylation	O
of	O
RPS3	S-Biological_Molecule
and	O
its	O
NF	O
-	O
kappaB	O
function	O

While	O
expressing	O
RPS3	S-Biological_Molecule
S209A	O
had	O
no	O
impact	O
on	O
p65	S-Biological_Molecule
nuclear	O
translocation	O
,	O
it	O
substantially	O
attenuated	O
p65	S-Biological_Molecule
recruitment	O
(	O
Fig	O
.	O
5e	O
)	O
.	O

There	O
was	O
no	O
significant	O
Flag	B-Biological_Molecule
-	I-Biological_Molecule
RPS3	E-Biological_Molecule
or	O
p65	S-Biological_Molecule
recruitment	O
to	O
ACTB	S-Biological_Molecule
promoter	O
lacking	O
kappaB	O
sites	O
(	O
Fig	O
.	O
5e	O
)	O
,	O
suggesting	O
the	O
recruitment	O
was	O
kappaB	O
site	O
-	O
specific	O
.	O

Thus	O
,	O
the	O
recruitment	O
of	O
RPS3	S-Biological_Molecule
as	O
well	O
as	O
the	O
contingent	O
recruitment	O
of	O
p65	S-Biological_Molecule
to	O
key	O
promoters	O
depended	O
on	O
S209	O
.	O

In	O
uninfected	O
cells	O
,	O
TNF	S-Biological_Molecule
-	O
treatment	O
stimulated	O
a	O
~	O
7	O
-	O
fold	O
increase	O
in	O
RPS3	S-Biological_Molecule
S209	O
phosphorylation	O
,	O
peaking	O
at	O
30	O
minutes	O
(	O
Fig	O
.	O
6d	O
)	O
.	O

Indeed	O
,	O
these	O
genes	O
were	O
only	O
modestly	O
upregulated	O
in	O
cells	O
infected	O
with	O
wild	O
-	O
type	O
E	O
.	O
coli	O
O157	O
:	O
H7	O
,	O
but	O
significantly	O
induced	O
in	O
cells	O
infected	O
with	O
either	O
deltanleH1	S-Biological_Molecule
or	O
deltaescN	S-Biological_Molecule
strains	O
(	O
Fig	O
.	O
6e	O
)	O
.	O

In	O
contrast	O
,	O
deleting	O
nleH1	S-Biological_Molecule
had	O
no	O
impact	O
on	O
the	O
expression	O
of	O
RPS3	O
-	O
independent	O
genes	O
,	O
including	O
CD25	S-Biological_Molecule
and	O
TNFSF13B	S-Biological_Molecule
(	O
Supplementary	O
Fig	O
.	O
12	O
)	O
.	O

Piglets	O
infected	O
with	O
deltanleH1	S-Biological_Molecule
displayed	O
clinical	O
disease	O
consistent	O
with	O
a	O
robust	O
inflammatory	O
response	O
,	O
but	O
with	O
reduced	O
bacterial	O
colonization	O
and	O
little	O
diarrhea9	O
.	O

To	O
examine	O
whether	O
the	O
kinase	O
activity	O
is	O
required	O
for	O
NleH1	S-Biological_Molecule
to	O
inhibit	O
IKKbeta	S-Biological_Molecule
phosphorlyation	O
of	O
RPS3	S-Biological_Molecule
on	O
S209	O
,	O
we	O
ectopically	O
expressing	O
either	O
wild	O
-	O
type	O
or	O
K159A	O
NleH1	S-Biological_Molecule
in	O
293T	O
cells	O
.	O

RPS3	S-Biological_Molecule
nuclear	O
accumulation	O
was	O
substantially	O
retarded	O
by	O
infecting	O
cells	O
with	O
wild	O
-	O
type	O
E	O
.	O
coli	O
O157	O
:	O
H7	O
(	O
Fig	O
.	O
7d	O
)	O
.	O

The	O
bacterial	O
effector	O
NleH1	S-Biological_Molecule
specifically	O
binds	O
to	O
RPS3	S-Biological_Molecule
once	O
injected	O
into	O
host	O
cells	O
and	O
profoundly	O
suppresses	O
NF	O
-	O
kappaB	O
and	O
its	O
attendant	O
protective	O
immune	O
responses9	O
.	O

These	O
data	O
provide	O
new	O
insights	O
into	O
the	O
poorly	O
understood	O
action	O
mechanism	O
for	O
most	O
T3SS	O
effectors	O
.	O

By	O
selectively	O
inhibiting	O
RPS3	S-Biological_Molecule
and	O
its	O
attendant	O
NF	O
-	O
kappaB	O
function	O
with	O
NleH1	S-Biological_Molecule
,	O
the	O
pathogen	O
achieves	O
the	O
ability	O
to	O
increase	O
colonization	O
and	O
diarrhea	O
yet	O
limiting	O
the	O
mortality	O
of	O
the	O
host	O
.	O

Cells	O
and	O
Reagents	O

Bacterially	O
purified	O
glutathione	O
S	O
-	O
transferase	O
(	O
GST	O
)	O
,	O
GST	O
-	O
IkappaBalpha	O
(	O
1	O
-	O
54	O
)	O
,	O
wild	O
type	O
,	O
mutant	O
GST	B-Biological_Molecule
-	I-Biological_Molecule
RPS3	E-Biological_Molecule
,	O
or	O
RPS3	S-Biological_Molecule
proteins	O
were	O
used	O
as	O
substrates	O
.	O

The	O
in	O
vitro	O
kinase	O
assay	O
was	O
performed	O
as	O
previously	O
described29	O
.	O

Briefly	O
,	O
enzyme	O
(	O
100	O
ng	O
)	O
and	O
substrate	O
(	O
2	O
mug	O
)	O
were	O
co	O
-	O
incubated	O
in	O
IKK	O
reaction	O
buffer	O
(	O
25	O
mM	O
Tris	O
-	O
HCl	O
[	O
pH	O
8	O
.	O
0	O
]	O
,	O
50	O
mM	O
KCl	O
,	O
10	O
mM	O
MgCl2	O
,	O
1	O
mM	O
DTT	O
,	O
1	O
mM	O
Na3VO4	O
,	O
1	O
mM	O
ATP	O
)	O
or	O
NleH1	O
reaction	O
buffer	O
(	O
50	O
mM	O
Tris	O
-	O
HCl	O
[	O
pH	O
7	O
.	O
6	O
]	O
,	O
5	O
mM	O
MgCl2	O
,	O
1	O
mM	O
DTT	O
,	O
1	O
mM	O
ATP	O
)	O
with	O
0	O
.	O
5	O
muCi	O
32P	O
-	O
gamma	O
-	O
ATP	O
(	O
GE	O
Healthcare	O
)	O
added	O
at	O
37	O
degreesC	O
for	O
30	O
min	O
.	O

GST	O
or	O
GST	B-Biological_Molecule
-	I-Biological_Molecule
RPS3	E-Biological_Molecule
was	O
incubated	O
with	O
recombinant	O
IKKbeta	S-Biological_Molecule
protein	O
as	O
described	O
above	O
in	O
an	O
in	O
vitro	O
kinase	O
assay	O
reaction	O
conducted	O
without	O
32P	O
-	O
gamma	O
-	O
ATP	O
labeling	O
.	O

The	O
corresponding	O
protein	O
fragments	O
were	O
excised	O
and	O
subjected	O
to	O
trypsin	O
digestion	O
and	O
LC	O
-	O
MS	O
/	O
MS	O
at	O
the	O
Yale	O
Cancer	O
Center	O
Mass	O
Spectrometry	O
Resource	O
(	O
New	O
Haven	O
,	O
CT	O
)	O
.	O

Briefly	O
,	O
cells	O
were	O
cotransfected	O
at	O
a	O
ratio	O
of	O
10	O
:	O
1	O
with	O
various	O
promoter	O
-	O
driven	O
firefly	O
luciferase	S-Biological_Molecule
constructs	O
to	O
the	O
Renilla	O
luciferase	S-Biological_Molecule
pTKRL	O
plasmid	O
,	O
together	O
with	O
indicated	O
plasmids	O
.	O

Blots	O
were	O
blocked	O
in	O
5	O
%	O
bovine	O
serum	O
albumin	S-Biological_Molecule
in	O
0	O
.	O
1	O
%	O
Tris	O
buffered	O
saline	O
-	O
Tween	O
20	O
(	O
TBS	O
-	O
T	O
)	O
,	O
and	O
probed	O
with	O
specific	O
antibodies	O
as	O
described	O
previously46	O
.	O

The	O
amount	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
present	O
in	O
supernatants	O
collected	O
from	O
Jurkat	O
cell	O
culture	O
was	O
measured	O
using	O
a	O
Human	O
Interleukin	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
ELISA	O
Ready	O
-	O
SET	O
-	O
Go	O
kit	S-Biological_Molecule
(	O
eBioscience	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

Persistent	O
activation	O
of	O
NF	O
-	O
kappaB	O
occurs	O
in	O
human	O
immunodeficiency	O
virus	O
-	O
1	O
(	O
HIV	O
-	O
1	O
)	O
-	O
infected	O
monocytes	O
,	O
macrophages	O
and	O
microglia	O
,	O
and	O
enhances	O
the	O
expression	O
of	O
NF	O
-	O
kappaB	O
-	O
responsive	O
genes	O
,	O
including	O
pro	O
-	O
inflammatory	O
cytokines	O
,	O
cell	O
adhesion	O
molecules	O
and	O
chemokines	O
(	O
23	O
-	O
25	O
)	O
.	O

Following	O
gene	O
transfection	O
or	O
protein	O
transduction	O
,	O
Tat	S-Biological_Molecule
induced	O
the	O
IKK	O
activity	O
and	O
proteasomal	O
degradation	O
of	O
IkappaB	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
(	O
48	O
)	O
,	O
and	O
increased	O
the	O
p65	S-Biological_Molecule
transcriptional	O
activity	O
by	O
inhibiting	O
the	O
SIRT	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
-	O
mediated	O
deacetylation	O
of	O
p65	S-Biological_Molecule
Lys310	O
(	O
49	O
)	O
.	O

We	O
previously	O
found	O
that	O
IkappaB	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
binds	O
to	O
Tat	S-Biological_Molecule
and	O
promotes	O
the	O
nuclear	O
export	O
of	O
the	O
viral	O
transactivator	O
(	O
50	O
,	O
51	O
)	O
.	O

The	O
plasmids	O
pcDNA	O
-	O
3xHA	B-Biological_Molecule
-	I-Biological_Molecule
IkappaB	I-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
,	O
p3xFLAG	O
-	O
CMV	O
-	O
Tat	S-Biological_Molecule
,	O
p3xFLAG	O
-	O
CMV	O
-	O
Tat	B-Biological_Molecule
C	I-Biological_Molecule
(	I-Biological_Molecule
22	I-Biological_Molecule
,	I-Biological_Molecule
25	I-Biological_Molecule
,	I-Biological_Molecule
27	I-Biological_Molecule
)	I-Biological_Molecule
A	E-Biological_Molecule
,	O
p3xFLAG	O
-	O
CMV	O
-	O
Tat	B-Biological_Molecule
R	I-Biological_Molecule
(	I-Biological_Molecule
49	I-Biological_Molecule
,	I-Biological_Molecule
52	I-Biological_Molecule
,	I-Biological_Molecule
53	I-Biological_Molecule
,	I-Biological_Molecule
55	I-Biological_Molecule
,	I-Biological_Molecule
56	I-Biological_Molecule
,	I-Biological_Molecule
57	I-Biological_Molecule
)	I-Biological_Molecule
A	E-Biological_Molecule
,	O
pGEX	O
-	O
2T	O
-	O
Tat	S-Biological_Molecule
,	O
pGEX	O
-	O
2T	O
-	O
Tat	B-Biological_Molecule
C	I-Biological_Molecule
(	I-Biological_Molecule
22	I-Biological_Molecule
,	I-Biological_Molecule
25	I-Biological_Molecule
,	I-Biological_Molecule
27	I-Biological_Molecule
)	I-Biological_Molecule
A	E-Biological_Molecule
and	O
pGEX	O
-	O
2T	O
-	O
Tat	B-Biological_Molecule
R	I-Biological_Molecule
(	I-Biological_Molecule
49	I-Biological_Molecule
,	I-Biological_Molecule
52	I-Biological_Molecule
,	I-Biological_Molecule
53	I-Biological_Molecule
,	I-Biological_Molecule
55	I-Biological_Molecule
,	I-Biological_Molecule
56	I-Biological_Molecule
,	I-Biological_Molecule
57	I-Biological_Molecule
)	I-Biological_Molecule
A	E-Biological_Molecule
were	O
previously	O
described	O
(	O
50	O
)	O
.	O

The	O
plasmids	O
pRc	O
/	O
CMV	O
-	O
3xHA	B-Biological_Molecule
-	I-Biological_Molecule
p65	E-Biological_Molecule
,	O
pRc	O
/	O
CMV	O
-	O
3xHA	B-Biological_Molecule
-	I-Biological_Molecule
p65deltaC	E-Biological_Molecule
(	O
1	O
-	O
318	O
)	O
,	O
pRc	O
/	O
CMV	O
-	O
3xHA	B-Biological_Molecule
-	I-Biological_Molecule
p65deltaN	E-Biological_Molecule
(	O
122	O
-	O
551	O
)	O
,	O
p3xFLAG	O
-	O
CMV	O
-	O
Tat	B-Biological_Molecule
T	I-Biological_Molecule
,	I-Biological_Molecule
N	I-Biological_Molecule
(	I-Biological_Molecule
23	I-Biological_Molecule
,	I-Biological_Molecule
24	I-Biological_Molecule
)	I-Biological_Molecule
A	E-Biological_Molecule
,	O
p3xFLAG	O
-	O
CMV	O
-	O
Tat	B-Biological_Molecule
K	I-Biological_Molecule
(	I-Biological_Molecule
50	I-Biological_Molecule
,	I-Biological_Molecule
51	I-Biological_Molecule
)	I-Biological_Molecule
A	E-Biological_Molecule
,	O
pGEX	O
-	O
2T	O
-	O
Tat	B-Biological_Molecule
T	I-Biological_Molecule
,	I-Biological_Molecule
N	I-Biological_Molecule
(	I-Biological_Molecule
23	I-Biological_Molecule
,	I-Biological_Molecule
24	I-Biological_Molecule
)	I-Biological_Molecule
A	E-Biological_Molecule
,	O
pGEX	O
-	O
2T	O
-	O
Tat	B-Biological_Molecule
K	I-Biological_Molecule
(	I-Biological_Molecule
50	I-Biological_Molecule
,	I-Biological_Molecule
51	I-Biological_Molecule
)	I-Biological_Molecule
A	E-Biological_Molecule
and	O
pNL4	O
-	O
3	O
.	O
FLAG	O
-	O
Tat	S-Biological_Molecule
.	O
R	O
-	O
E	O
-	O
were	O
generated	O
as	O
described	O
in	O
Supplementary	O
Data	O
.	O

Media	O
were	O
supplemented	O
with	O
10	O
%	O
heat	O
-	O
inactivated	O
fetal	O
calf	O
serum	O
and	O
2	O
mM	O
l	O
-	O
glutamine	O
(	O
Lonza	O
Cologne	O
AG	O
,	O
Germany	O
)	O
.	O

Pseudotyped	O
virions	O
and	O
single	O
round	O
infection	O

IKK	O
activity	O
was	O
evaluated	O
in	O
cytosolic	O
extracts	O
using	O
the	O
HTScan	O
IKK	O
kinase	O
assay	O
kit	O
(	O
Cell	O
Signaling	O
Technology	O
,	O
Danvers	O
,	O
MA	O
,	O
USA	O
)	O
.	O

Immunoprecipitation	O
,	O
GST	S-Biological_Molecule
-	O
pull	O
down	O
,	O
and	O
production	O
of	O
GST	S-Biological_Molecule
proteins	O
in	O
Escherichia	O
coli	O
strain	O
BL21	O
were	O
performed	O
as	O
previously	O
reported	O
(	O
50	O
)	O
.	O

Real	O
-	O
time	O
PCR	O

Cells	O
were	O
fixed	O
by	O
adding	O
formaldehyde	O
(	O
Sigma	O
-	O
Aldrich	O
)	O
at	O
the	O
final	O
concentration	O
of	O
1	O
%	O
.	O

Nuclei	O
were	O
pelletted	O
(	O
1000	O
x	O
g	O
,	O
5	O
min	O
)	O
,	O
and	O
resuspended	O
in	O
sonication	O
buffer	O
(	O
50	O
mM	O
Tris	O
-	O
HCl	O
pH	O
8	O
.	O
0	O
,	O
1	O
%	O
SDS	O
,	O
10	O
mM	O
EDTA	O
)	O
.	O

Immunoprecipitations	O
were	O
carried	O
out	O
at	O
4degreesC	O
overnight	O
and	O
immune	O
complexes	O
were	O
collected	O
with	O
protein	B-Biological_Molecule
G	E-Biological_Molecule
agarose	O
beads	O
,	O
washed	O
five	O
times	O
with	O
low	O
salt	O
buffer	O
(	O
20	O
mM	O
Tris	O
-	O
HCl	O
pH	O
8	O
.	O
0	O
,	O
0	O
.	O
1	O
%	O
SDS	O
,	O
1	O
%	O
Triton	O
X	O
-	O
100	O
,	O
2	O
mM	O
EDTA	O
,	O
150	O
mM	O
NaCl	O
)	O
,	O
four	O
times	O
with	O
high	O
salt	O
buffer	O
(	O
20	O
mM	O
Tris	O
-	O
HCl	O
pH	O
8	O
.	O
0	O
,	O
0	O
.	O
1	O
%	O
SDS	O
,	O
1	O
%	O
Triton	O
X	O
-	O
100	O
,	O
2	O
mM	O
EDTA	O
,	O
500	O
mM	O
NaCl	O
)	O
,	O
once	O
with	O
TE	O
buffer	O
(	O
10	O
mM	O
Tris	O
-	O
HCl	O
pH	O
8	O
.	O
0	O
,	O
1	O
mM	O
EDTA	O
)	O
,	O
and	O
extracted	O
in	O
TE	O
buffer	O
containing	O
2	O
%	O
SDS	O
.	O

Consistently	O
,	O
the	O
IKK	O
activation	O
started	O
at	O
5	O
min	O
,	O
and	O
turned	O
off	O
at	O
30	O
min	O
independently	O
of	O
the	O
presence	O
of	O
Tat	S-Biological_Molecule
(	O
Figure	O
2C	O
)	O
.	O

These	O
results	O
indicated	O
that	O
the	O
arginine	O
-	O
rich	O
domain	O
of	O
Tat	S-Biological_Molecule
was	O
involved	O
in	O
the	O
binding	O
to	O
IkappaB	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
,	O
which	O
was	O
consistent	O
with	O
previous	O
observations	O
(	O
50	O
,	O
51	O
)	O
.	O

The	O
transcriptional	O
regulation	O
of	O
MIP	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
has	O
been	O
poorly	O
characterized	O
.	O

By	O
ChIP	O
,	O
Tat	S-Biological_Molecule
bound	O
to	O
the	O
NF	O
-	O
kappaB	O
-	O
responsive	O
promoters	O
,	O
and	O
not	O
to	O
the	O
GAPDH	S-Biological_Molecule
and	O
ACTB	S-Biological_Molecule
promoters	O
,	O
with	O
loss	O
of	O
binding	O
following	O
p65	S-Biological_Molecule
RNA	O
interference	O
(	O
Figure	O
5I	O
)	O
,	O
suggesting	O
that	O
Tat	S-Biological_Molecule
occupancy	O
occurred	O
via	O
p65	S-Biological_Molecule
interaction	O
.	O

Based	O
on	O
the	O
evidence	O
that	O
Tat	S-Biological_Molecule
enhanced	O
the	O
transcriptional	O
activity	O
of	O
the	O
p65	S-Biological_Molecule
subunit	O
of	O
NF	O
-	O
kappaB	O
(	O
49	O
,	O
63	O
,	O
64	O
)	O
,	O
and	O
physically	O
interacted	O
with	O
the	O
IkappaB	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
repressor	O
(	O
50	O
,	O
51	O
)	O
,	O
we	O
investigated	O
the	O
possibility	O
that	O
Tat	S-Biological_Molecule
could	O
activate	O
NF	O
-	O
kappaB	O
via	O
direct	O
interaction	O
with	O
IkappaB	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
and	O
p65	S-Biological_Molecule
.	O

Several	O
inflammatory	O
cytokines	O
under	O
the	O
transcriptional	O
control	O
of	O
NF	O
-	O
kappaB	O
are	O
hyper	O
-	O
expressed	O
in	O
HIV	O
-	O
1	O
infected	O
individuals	O
,	O
including	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
(	O
66	O
,	O
67	O
)	O
,	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
(	O
68	O
)	O
,	O
and	O
MIP	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
(	O
57	O
-	O
62	O
,	O
69	O
-	O
71	O
)	O
.	O

Densitometry	O
values	O
(	O
D	O
)	O
of	O
the	O
bands	O
were	O
expressed	O
as	O
fold	O
increase	O
above	O
the	O
control	O
(	O
lane	O
1	O
)	O
.	O

Real	O
-	O
time	O
PCR	O
was	O
performed	O
with	O
primers	O
specific	O
for	O
the	O
indicated	O
promoters	O
.	O

(	O
E	O
)	O
U937	O
cells	O
(	O
5	O
x	O
107	O
)	O
were	O
infected	O
with	O
HXB2	O
-	O
pseudotyped	O
NL4	O
-	O
3	O
.	O
FLAG	B-Biological_Molecule
-	I-Biological_Molecule
Tat	E-Biological_Molecule
.	O
R	O
-	O
E	O
-	O
virions	O
,	O
or	O
left	O
uninfected	O
.	O

Twenty	O
-	O
four	O
-	O
hour	O
post	O
-	O
infection	O
,	O
total	O
RNA	O
was	O
analysed	O
for	O
MIP	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
expression	O
by	O
real	O
-	O
time	O
PCR	O
.	O

Hematopoeitic	O
cells	O
appear	O
to	O
be	O
the	O
predominant	O
source	O
of	O
inflammasome	O
-	O
induced	O
pro	O
-	O
inflammatory	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
in	O
CF	O
.	O

PBMCs	O
derived	O
from	O
CF	O
subjects	O
display	O
preserved	O
inflammasome	O
activation	O
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
secretion	O
in	O
response	O
to	O
the	O
major	O
CF	O
pathogen	O
Pseudomonas	O
aeruginosa	O
.	O

In	O
CF	O
,	O
airway	O
epithelial	O
cells	O
have	O
been	O
shown	O
to	O
produce	O
an	O
exaggerated	O
pro	O
-	O
inflammatory	O
cytokine	O
response	O
to	O
stimulation	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
.	O

CD14	O
positive	O
monocytes	O
from	O
CF	O
patients	O
and	O
healthy	O
controls	O
showed	O
a	O
significant	O
increase	O
in	O
caspase	O
-	O
1	O
activation	O
upon	O
stimulation	O
with	O
LPS	O
+	O
ATP	O
,	O
PAO1	O
,	O
and	O
LPS	O
+	O
Poly	O
(	O
dA	O
:	O
dT	O
)	O
(	O
Fig	O
.	O
4a	O
)	O
but	O
this	O
activation	O
was	O
not	O
different	O
between	O
CF	O
and	O
control	O
subjects	O
(	O
Fig	O
.	O
4b	O
)	O
.	O

Dependency	O
of	O
these	O
responses	O
on	O
NF	O
-	O
kappaB	O
was	O
confirmed	O
by	O
pharmacologic	O
inhibition	O
of	O
NF	O
-	O
kappaB	O
using	O
the	O
Bay11	O
-	O
7082	O
inhibitor	O
of	O
IkappaBalpha	S-Biological_Molecule
phosphorylation	O
,	O
which	O
significantly	O
reduced	O
NF	O
-	O
kappaB	O
/	O
AP	O
-	O
1	O
activation	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
(	O
Fig	O
.	O
6d	O
)	O
and	O
the	O
subsequent	O
production	O
of	O
IL	O
-	O
8	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
(	O
Fig	O
.	O
6e	O
)	O
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
(	O
P	O
<	O
0	O
.	O
001	O
)	O
(	O
Fig	O
.	O
6f	O
)	O
in	O
response	O
to	O
both	O
heat	O
-	O
killed	O
and	O
live	O
PAO1	O
.	O

Overall	O
these	O
results	O
confirm	O
that	O
NF	O
-	O
kappaB	O
is	O
an	O
important	O
modulator	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
production	O
and	O
that	O
increased	O
activation	O
of	O
NF	O
-	O
kappaB	O
augments	O
inflammasome	O
-	O
mediated	O
production	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
.	O

To	O
determine	O
whether	O
CFTR	O
dysfunction	O
alters	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
production	O
,	O
THP	O
-	O
1	O
cells	O
and	O
PBMCs	O
from	O
CF	O
patients	O
and	O
healthy	O
controls	O
were	O
treated	O
with	O
the	O
CFTR	O
inhibitor	O
,	O
CFTRinh172	O
,	O
prior	O
to	O
simulation	O
with	O
live	O
P	O
.	O
aeruginosa	O
.	O

Cells	O
deficient	O
in	O
CFTR	O
are	O
thought	O
to	O
exhibit	O
an	O
increased	O
basal	O
level	O
of	O
NF	O
-	O
kappaB	O
activity	O
,	O
which	O
leads	O
to	O
increased	O
pro	O
-	O
inflammatory	O
cytokine	O
production	O
including	O
an	O
increased	O
availability	O
of	O
pro	O
-	O
IL	O
-	O
1beta	O
for	O
cleavage	O
and	O
secretion	O
.	O

However	O
,	O
as	O
monocytes	O
and	O
other	O
PBMCs	O
express	O
CFTR	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
and	O
produce	O
large	O
amounts	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
,	O
they	O
are	O
adequate	O
models	O
to	O
examine	O
the	O
effects	O
of	O
CFTR	O
function	O
on	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
production	O
.	O

Furthermore	O
,	O
we	O
find	O
little	O
evidence	O
to	O
support	O
an	O
increased	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
inflammatory	O
response	O
to	O
NF	O
-	O
kappaB	O
/	O
Inflammasome	O
stimulation	O
in	O
CF	O
patients	O
.	O

Cell	O
Culture	O

THP1	O
-	O
XBlue	O
cells	O
stably	O
express	O
a	O
secreted	O
embryonic	O
alkaline	O
phosphatase	O
(	O
SEAP	O
)	O
reporter	O
inducible	O
by	O
NF	O
-	O
kappaB	O
and	O
AP	O
-	O
1	O
(	O
Invivogen	O
)	O
.	O

Cells	O
were	O
washed	O
with	O
PBS	O
and	O
allowed	O
to	O
rest	O
a	O
further	O
42	O
hours	O
prior	O
to	O
stimulation	O
.	O

Blots	O
were	O
blocked	O
for	O
1	O
hour	O
at	O
room	O
temperature	O
and	O
probed	O
overnight	O
at	O
4degreesC	O
for	O
pro	O
-	O
IL	O
-	O
1beta	O
(	O
Santa	O
Cruz	O
)	O
,	O
IkappaBalpha	S-Biological_Molecule
(	O
Cell	O
Signaling	O
)	O
,	O
or	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
actin	E-Biological_Molecule
(	O
Cell	O
Signaling	O
)	O
.	O

To	O
prepare	O
heat	O
-	O
killed	O
bacteria	O
,	O
live	O
PAO1	O
was	O
resuspended	O
in	O
PBS	O
to	O
an	O
optical	O
density	O
of	O
0	O
.	O
5	O
and	O
heated	O
at	O
60degreesC	O
for	O
1	O
hour	O
.	O

(	O
G	O
)	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
and	O
(	O
H	O
)	O
IL	O
-	O
8	O
levels	O
were	O
measured	O
at	O
24	O
hours	O
.	O

PBMCs	O
from	O
CF	O
patients	O
(	O
n	O
=	O
15	O
)	O
and	O
controls	O
(	O
n	O
=	O
13	O
)	O
were	O
treated	O
with	O
CFTRinh172	O
(	O
10	O
microM	O
)	O
for	O
18	O
hours	O
prior	O
to	O
stimulation	O
with	O
live	O
PAO1	O
(	O
MOI	O
=	O
1	O
)	O
.	O

(	O
C	O
)	O
Monocytes	O
from	O
controls	O
(	O
n	O
=	O
3	O
)	O
were	O
differentiated	O
into	O
macrophages	O
.	O

The	O
suppressor	O
of	O
cytokine	O
signaling	O
(	O
SOCS	O
)	O
proteins	O
have	O
been	O
identified	O
as	O
a	O
family	O
of	O
endogenous	O
JAK	O
kinase	O
inhibitors	O
that	O
can	O
act	O
in	O
classic	O
feedback	O
inhibition	O
loops	O
,	O
but	O
their	O
roles	O
as	O
the	O
mediators	O
of	O
crosstalk	O
inhibition	O
by	O
opposing	O
cytokine	O
signaling	O
pathways	O
have	O
been	O
clarified	O
[	O
7	O
]	O
.	O

The	O
continuing	O
emergence	O
of	O
activated	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
,	O
even	O
though	O
few	O
in	O
number	O
,	O
may	O
be	O
crucial	O
in	O
sustaining	O
the	O
activation	O
of	O
macrophages	O
and	O
synovial	O
fibroblasts	O
through	O
cell	O
surface	O
signaling	O
by	O
means	O
of	O
cell	O
surface	O
CD69	S-Biological_Molecule
and	O
CD11	S-Biological_Molecule
,	O
as	O
well	O
as	O
the	O
release	O
of	O
proinflammatory	O
Th1	O
cytokines	O
such	O
as	O
interferon	B-Biological_Molecule
gamma	E-Biological_Molecule
(	B-Biological_Molecule
IFN	I-Biological_Molecule
)	I-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
17	E-Biological_Molecule
[	O
21	O
,	O
22	O
]	O
.	O

CD4	S-Biological_Molecule
+	O
T	O
cells	O
were	O
purified	O
from	O
PBMC	O
by	O
positive	O
selection	O
using	O
anti	O
-	O
CD4	S-Biological_Molecule
mAb	O
-	O
coated	O
magnetic	O
beads	O
(	O
Miltenyi	O
Biotec	O
,	O
Gladbach	O
,	O
Germany	O
)	O
,	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

The	O
levels	O
of	O
SOCS1	S-Biological_Molecule
and	O
SOCS3	S-Biological_Molecule
expression	O
were	O
determined	O
by	O
normalizing	O
relative	O
to	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
actin	E-Biological_Molecule
expression	O
.	O

CD4	S-Biological_Molecule
+	O
T	O
cells	O
were	O
stimulated	O
for	O
20	O
min	O
by	O
the	O
indicated	O
concentrations	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
at	O
a	O
density	O
of	O
5	O
x	O
105	O
cells	O
in	O
0	O
.	O
5	O
ml	O
culture	O
medium	O
with	O
10	O
%	O
FCS	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

Similarly	O
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
production	O
was	O
not	O
affected	O
by	O
1	O
ng	O
/	O
ml	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
in	O
RA	O
patients	O
(	O
percentage	O
decrease	O
,	O
-	O
2	O
.	O
1	O
+	O
/	O
-	O
13	O
.	O
8	O
%	O
)	O
,	O
while	O
it	O
was	O
significantly	O
reduced	O
in	O
healthy	O
controls	O
(	O
61	O
.	O
1	O
+	O
/	O
-	O
13	O
.	O
7	O
%	O
;	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Taken	O
together	O
,	O
these	O
results	O
indicate	O
that	O
RA	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
become	O
less	O
susceptible	O
to	O
the	O
immunoregulatory	O
effect	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
during	O
the	O
active	O
phase	O
.	O

Increased	O
expression	O
of	O
cell	O
surface	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10R1	E-Biological_Molecule
on	O
RA	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O

IL	B-Biological_Molecule
-	I-Biological_Molecule
10R1	E-Biological_Molecule
expression	O
plays	O
a	O
critical	O
role	O
in	O
cellular	O
responses	O
to	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
[	O
29	O
]	O
.	O

Defective	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
-	O
mediated	O
STAT3	S-Biological_Molecule
phosphorylation	O
in	O
RA	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O

STAT3	S-Biological_Molecule
phosphorylation	O
was	O
augmented	O
only	O
when	O
activated	O
by	O
as	O
much	O
as	O
10	O
ng	O
/	O
ml	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
.	O

Since	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
is	O
also	O
abundant	O
in	O
sera	O
of	O
active	O
RA	O
patients	O
,	O
frequently	O
detected	O
at	O
>	O
1	O
ng	O
/	O
ml	O
[	O
27	O
]	O
,	O
we	O
examined	O
whether	O
persistent	O
exposure	O
of	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
to	O
high	O
concentrations	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
in	O
the	O
blood	O
circulation	O
was	O
responsible	O
for	O
their	O
sustained	O
STAT3	S-Biological_Molecule
activation	O
and	O
resistance	O
to	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
inhibition	O
in	O
active	O
RA	O
.	O

Normal	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
were	O
thus	O
incubated	O
for	O
20	O
min	O
with	O
culture	O
medium	O
containing	O
30	O
%	O
serum	O
from	O
active	O
RA	O
patients	O
and	O
neutralizing	O
anti	O
-	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
antibody	O
or	O
control	O
antibody	O
,	O
and	O
STAT	O
phosphorylation	O
was	O
examined	O
by	O
western	O
blot	O
analysis	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
found	O
that	O
PB	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
from	O
patients	O
with	O
active	O
RA	O
,	O
in	O
the	O
presence	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
,	O
are	O
able	O
to	O
produce	O
higher	O
levels	O
of	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
after	O
CD3	O
and	O
CD28	S-Biological_Molecule
costimulation	O
than	O
normal	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
.	O

This	O
impaired	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
signaling	O
is	O
probably	O
induced	O
by	O
chronic	O
exposure	O
to	O
immune	O
complexes	O
in	O
vivo	O
,	O
because	O
both	O
cell	O
surface	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10R1	E-Biological_Molecule
expression	O
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
-	O
induced	O
Jak1	S-Biological_Molecule
activation	O
are	O
suppressed	O
in	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
-	O
primed	O
macrophages	O
by	O
a	O
protein	O
kinase	O
C	O
-	O
dependent	O
pathway	O
following	O
ligation	O
of	O
the	O
IgG	O
Fc	O
gamma	O
receptor	O
[	O
14	O
]	O
.	O

In	O
addition	O
,	O
the	O
involvement	O
of	O
other	O
essential	O
proinflammatory	O
cytokines	O
in	O
this	O
process	O
was	O
suggested	O
by	O
our	O
preliminary	O
experiments	O
demonstrating	O
that	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
-	O
mediated	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
inhibition	O
in	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
was	O
reduced	O
by	O
pretreatment	O
with	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
and	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
,	O
although	O
less	O
effectively	O
than	O
by	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
(	O
data	O
not	O
shown	O
)	O
.	O

Furthermore	O
,	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
produced	O
by	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
themselves	O
could	O
be	O
responsible	O
for	O
impaired	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
signaling	O
in	O
the	O
ST	O
,	O
because	O
T	O
-	O
cell	O
infiltrates	O
produce	O
both	O
cytokines	O
[	O
34	O
,	O
35	O
]	O
.	O

The	O
T	O
-	O
cell	O
-	O
inhibitory	O
effect	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
may	O
therefore	O
be	O
modulated	O
complicatedly	O
upon	O
exposure	O
to	O
an	O
inflammatory	O
environment	O
in	O
RA	O
joints	O
,	O
where	O
many	O
cytokines	O
are	O
present	O
substantially	O
[	O
10	O
]	O
.	O

More	O
recently	O
,	O
high	O
levels	O
of	O
activated	O
STAT3	S-Biological_Molecule
,	O
thought	O
to	O
be	O
induced	O
mainly	O
by	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
,	O
have	O
been	O
detected	O
in	O
the	O
ST	O
,	O
and	O
STAT3	S-Biological_Molecule
activation	O
has	O
been	O
shown	O
to	O
be	O
involved	O
in	O
synovial	O
fibroblast	O
proliferation	O
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
production	O
[	O
37	O
]	O
.	O

Furthermore	O
,	O
the	O
significance	O
of	O
persistent	O
STAT3	S-Biological_Molecule
signaling	O
in	O
Th1	O
-	O
cell	O
-	O
dominated	O
autoimmune	O
arthritis	O
has	O
been	O
suggested	O
by	O
studies	O
of	O
the	O
gp130F759	S-Biological_Molecule
/	O
F759	O
mice	O
,	O
in	O
which	O
the	O
Src	O
homology	O
phosphatase	O
-	O
2	O
binding	O
site	O
of	O
gp130	S-Biological_Molecule
(	O
the	O
transmembrane	B-Biological_Molecule
glycoprotein	I-Biological_Molecule
beta	I-Biological_Molecule
subunit	I-Biological_Molecule
of	I-Biological_Molecule
the	I-Biological_Molecule
IL	I-Biological_Molecule
-	I-Biological_Molecule
6	I-Biological_Molecule
family	I-Biological_Molecule
cytokine	I-Biological_Molecule
receptor	E-Biological_Molecule
)	O
,	O
tyrosine	O
759	O
,	O
was	O
mutated	O
to	O
phenylalanine	O
[	O
39	O
]	O
.	O

Increased	O
SOCS1	S-Biological_Molecule
expression	O
in	O
RA	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
may	O
therefore	O
be	O
associated	O
with	O
both	O
the	O
impaired	O
responsiveness	O
to	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
and	O
to	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
-	O
mediated	O
STAT3	S-Biological_Molecule
activation	O
,	O
and	O
defective	O
SOCS3	S-Biological_Molecule
expression	O
may	O
be	O
responsible	O
for	O
persistent	O
STAT3	S-Biological_Molecule
activation	O
in	O
response	O
to	O
serum	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
.	O

IL	B-Biological_Molecule
-	I-Biological_Molecule
12	E-Biological_Molecule
-	O
induced	O
STAT4	S-Biological_Molecule
activation	O
is	O
inhibited	O
by	O
SOCS3	S-Biological_Molecule
induction	O
in	O
Th2	O
cells	O
,	O
whereas	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
-	O
induced	O
STAT6	S-Biological_Molecule
signaling	O
is	O
diminished	O
by	O
SOCS1	S-Biological_Molecule
induction	O
in	O
Th1	O
cells	O
.	O

More	O
specific	O
therapy	O
targeting	O
STAT3	S-Biological_Molecule
activation	O
will	O
be	O
awaited	O
;	O
for	O
example	O
,	O
the	O
induction	O
of	O
the	O
SOCS3	S-Biological_Molecule
gene	O
,	O
the	O
efficacy	O
of	O
which	O
has	O
been	O
demonstrated	O
in	O
animal	O
models	O
[	O
37	O
]	O
.	O

Increased	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
17	E-Biological_Molecule
production	O
via	O
a	O
phosphoinositide	O
3	O
-	O
kinase	O
/	O
Akt	S-Biological_Molecule
and	O
nuclear	O
factor	O
?	O
B	O
-	O
dependent	O
pathway	O
in	O
patients	O
with	O
rheumatoid	O
arthritis	O

Rheumatoid	O
arthritis	O
(	O
RA	O
)	O
is	O
characterized	O
by	O
infiltrations	O
of	O
macrophages	O
and	O
T	O
cells	O
into	O
the	O
joint	O
,	O
and	O
synovial	O
hyperplasia	O
.	O

Proinflammatory	O
cytokines	O
released	O
from	O
these	O
cells	O
are	O
known	O
to	O
be	O
important	O
in	O
the	O
destruction	O
of	O
joints	O
in	O
RA	O
[	O
1	O
]	O
.	O

This	O
paradox	O
has	O
questioned	O
the	O
role	O
of	O
T	O
cells	O
in	O
the	O
pathogenesis	O
of	O
RA	O
[	O
3	O
]	O
.	O

Cell	O
suspension	O
(	O
1	O
ml	O
)	O
was	O
dispensed	O
into	O
24	O
-	O
well	O
multi	O
-	O
well	O
plates	O
(	O
Nunc	O
,	O
Roskilde	O
,	O
Denmark	O
)	O
,	O
and	O
incubated	O
for	O
24	O
hours	O
at	O
37degreesC	O
in	O
5	O
%	O
CO2	O
.	O

After	O
incubation	O
for	O
24	O
hours	O
(	O
unless	O
otherwise	O
stated	O
)	O
,	O
cell	O
-	O
free	O
media	O
were	O
collected	O
and	O
stored	O
at	O
-	O
20degreesC	O
until	O
assayed	O
.	O

Cells	O
were	O
diluted	O
in	O
2	O
.	O
5	O
ml	O
of	O
FBS	O
staining	O
buffer	O
,	O
pelleted	O
,	O
resuspended	O
in	O
500	O
mul	O
and	O
magnetically	O
separated	O
,	O
usually	O
on	O
an	O
AutoMACS	O
magnet	O
fitted	O
with	O
a	O
MACS	O
MS	O
column	O
.	O

In	O
brief	O
,	O
a	O
96	O
-	O
well	O
plate	O
(	O
Nunc	O
)	O
was	O
coated	O
with	O
4	O
mug	O
/	O
ml	O
monoclonal	O
antibodies	O
against	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
17	E-Biological_Molecule
(	O
R	O
&	O
D	O
Systems	O
)	O
at	O
4degreesC	O
overnight	O
.	O

PCR	O
amplification	O
of	O
cDNA	O
aliquots	O
was	O
performed	O
by	O
adding	O
2	O
.	O
5	O
mM	O
dNTPs	O
,	O
2	O
.	O
5	O
U	O
of	O
Taq	S-Biological_Molecule
DNA	O
polymerase	O
(	O
Takara	O
)	O
and	O
0	O
.	O
25	O
muM	O
of	O
sense	O
and	O
antisense	O
primers	O
.	O

For	O
western	O
hybridization	O
,	O
membrane	O
was	O
preincubated	O
with	O
0	O
.	O
1	O
%	O
skimmed	O
milk	O
in	O
TBS	O
-	O
T	O
buffer	O
(	O
0	O
.	O
1	O
%	O
Tween	O
20	O
in	O
Tris	O
-	O
buffered	O
saline	O
)	O
at	O
room	O
temperature	O
for	O
2	O
hours	O
,	O
then	O
primary	O
antibodies	O
against	O
Akt	S-Biological_Molecule
,	O
phosphorylated	O
Akt	S-Biological_Molecule
and	O
IkappaB	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
(	O
Cell	O
Signaling	O
Technology	O
Inc	O
.	O
,	O
Beverly	O
,	O
MA	O
,	O
USA	O
)	O
,	O
diluted	O
1	O
:	O
1000	O
in	O
5	O
%	O
BSA	O
/	O
TBS	O
-	O
T	O
,	O
were	O
added	O
and	O
incubated	O
overnight	O
at	O
4degreesC	O
.	O

Statistical	O
analysis	O

Because	O
RA	O
PBMC	O
include	O
several	O
cell	O
types	O
in	O
addition	O
to	O
T	O
cells	O
,	O
some	O
inflammatory	O
cytokines	O
released	O
from	O
macrophages	O
and	O
other	O
lymphocytes	O
might	O
have	O
affected	O
the	O
production	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
17	E-Biological_Molecule
from	O
T	O
cells	O
.	O

The	O
calcineurin	S-Biological_Molecule
inhibitors	O
cyclosporin	O
A	O
and	O
FK506	O
also	O
downregulated	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
17	E-Biological_Molecule
secretion	O
as	O
well	O
as	O
the	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
p38	O
inhibitor	O
SB203580	O
did	O
,	O
whereas	O
rapamycin	O
and	O
PD98059	O
had	O
no	O
effect	O
on	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
17	E-Biological_Molecule
levels	O
(	O
Fig	O
.	O
3	O
)	O
.	O

IL	B-Biological_Molecule
-	I-Biological_Molecule
17	E-Biological_Molecule
mRNA	O
expression	O
in	O
RA	O
PBMC	O

IL	B-Biological_Molecule
-	I-Biological_Molecule
17	E-Biological_Molecule
is	O
produced	O
mainly	O
by	O
activated	O
CD4	S-Biological_Molecule
+	O
T	O
cells	O
,	O
especially	O
for	O
Th1	O
/	O
Th0	O
cells	O
,	O
not	O
the	O
Th2	O
phenotype	O
[	O
26	O
]	O
.	O

In	O
view	O
of	O
the	O
fact	O
that	O
NF	O
-	O
kappaB	O
was	O
also	O
activated	O
by	O
anti	O
-	O
CD3	O
/	O
anti	O
-	O
CD28	S-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
15	E-Biological_Molecule
or	O
mitogens	O
in	O
our	O
experiments	O
,	O
it	O
is	O
most	O
likely	O
that	O
the	O
NF	O
-	O
kappaB	O
pathway	O
is	O
also	O
actively	O
involved	O
in	O
the	O
induction	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
17	E-Biological_Molecule
in	O
RA	O
PBMC	O
.	O

We	O
have	O
detected	O
a	O
more	O
pronounced	O
production	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
17	E-Biological_Molecule
from	O
RA	O
PBMC	O
in	O
response	O
to	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
15	E-Biological_Molecule
and	O
MCP	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
as	O
well	O
as	O
stimulation	O
by	O
anti	O
-	O
CD3	O
/	O
anti	O
-	O
CD28	S-Biological_Molecule
.	O

Sox6	S-Biological_Molecule
Directly	O
Silences	O
Epsilon	B-Biological_Molecule
Globin	E-Biological_Molecule
Expression	O
in	O
Definitive	O
Erythropoiesis	O

In	O
mice	O
,	O
erythropoiesis	O
originates	O
in	O
the	O
embryonic	O
yolk	O
sac	O
where	O
primitive	O
erythroid	O
cells	O
express	O
epsilony	S-Biological_Molecule
and	O
betah	B-Biological_Molecule
-	I-Biological_Molecule
1	I-Biological_Molecule
globins	E-Biological_Molecule
[	O
22	O
]	O
.	O

In	O
addition	O
to	O
playing	O
an	O
important	O
role	O
in	O
the	O
development	O
of	O
the	O
central	O
nervous	O
system	O
[	O
8	O
-	O
11	O
]	O
,	O
cartilage	O
[	O
6	O
,	O
12	O
,	O
13	O
]	O
,	O
and	O
muscle	O
[	O
14	O
,	O
15	O
]	O
,	O
it	O
was	O
shown	O
that	O
Sox6	S-Biological_Molecule
is	O
upregulated	O
in	O
long	O
-	O
term	O
hematopoiesis	O
stem	O
cells	O
(	O
LT	O
-	O
HSC	O
)	O
compared	O
with	O
multipotent	O
progenitors	O
of	O
adult	O
mouse	O
bone	O
marrow	O
lineage	O
[	O
28	O
]	O
.	O

The	O
epsilony	B-Biological_Molecule
globin	E-Biological_Molecule
gene	O
was	O
initially	O
identified	O
as	O
an	O
upregulated	O
transcript	O
in	O
the	O
p100H	O
mouse	O
using	O
subtractive	O
hybridization	O
to	O
identify	O
Sox6	S-Biological_Molecule
downstream	O
targets	O
.	O

These	O
data	O
indicate	O
that	O
Sox6	S-Biological_Molecule
acts	O
to	O
repress	O
the	O
epsilony	S-Biological_Molecule
promoter	O
at	O
the	O
transcriptional	O
level	O
.	O

Deletion	O
analysis	O
of	O
the	O
epsilony	S-Biological_Molecule
promoter	O
,	O
as	O
shown	O
in	O
Figure	O
2C	O
,	O
defined	O
a	O
region	O
(	O
-	O
63	O
to	O
-	O
37	O
)	O
within	O
the	O
epsilony	S-Biological_Molecule
proximal	O
promoter	O
that	O
is	O
critical	O
for	O
Sox6	S-Biological_Molecule
repression	O
.	O

Analysis	O
of	O
this	O
short	O
region	O
reveals	O
two	O
Sox	O
/	O
Sox6	O
consensus	O
binding	O
sites	O
[	O
5	O
]	O
(	O
Figure	O
3A	O
)	O
.	O

The	O
36	O
-	O
bp	O
probe	O
was	O
shifted	O
by	O
the	O
tagged	O
Sox6	S-Biological_Molecule
protein	O
.	O

Consistent	O
with	O
the	O
EMSA	O
results	O
,	O
the	O
mutant	O
epsilony	S-Biological_Molecule
promoter	O
reporter	O
constructs	O
(	O
with	O
either	O
one	O
or	O
both	O
Sox	O
/	O
Sox6	O
binding	O
sites	O
mutagenized	O
)	O
do	O
not	O
result	O
in	O
significant	O
promoter	O
repression	O
in	O
transfection	O
studies	O
(	O
Figure	O
3F	O
)	O
.	O

Thus	O
,	O
both	O
sites	O
are	O
required	O
for	O
maximal	O
repression	O
of	O
epsilony	S-Biological_Molecule
by	O
Sox6	S-Biological_Molecule
,	O
but	O
not	O
to	O
the	O
same	O
degree	O
.	O

Figure	O
4	O
shows	O
that	O
the	O
epsilony	S-Biological_Molecule
proximal	O
promoter	O
is	O
readily	O
immunoprecipitated	O
with	O
Sox6	S-Biological_Molecule
antibody	O
in	O
both	O
MEL	O
cells	O
and	O
liver	O
cells	O
.	O

The	O
above	O
data	O
(	O
Figures	O
3	O
and	O
4	O
)	O
clearly	O
indicate	O
that	O
Sox6	S-Biological_Molecule
acts	O
as	O
a	O
repressor	O
of	O
the	O
epsilony	S-Biological_Molecule
gene	O
by	O
directly	O
binding	O
to	O
the	O
epsilony	S-Biological_Molecule
promoter	O
,	O
probably	O
as	O
a	O
dimer	O
.	O

Furthermore	O
,	O
in	O
situ	O
hybridization	O
shows	O
that	O
Sox6	S-Biological_Molecule
is	O
highly	O
transcribed	O
in	O
12	O
.	O
5	O
-	O
dpc	O
liver	O
,	O
but	O
not	O
in	O
yolk	O
sac	O
blood	O
islands	O
at	O
7	O
.	O
5	O
dpc	O
(	O
Figure	O
6B	O
)	O
.	O

This	O
alteration	O
is	O
noted	O
as	O
early	O
as	O
14	O
.	O
5	O
dpc	O
.	O

In	O
this	O
report	O
,	O
we	O
show	O
that	O
Sox6	S-Biological_Molecule
is	O
a	O
novel	O
factor	O
in	O
the	O
complicated	O
regulation	O
mechanism	O
of	O
globin	O
genes	O
.	O

Like	O
epsilony	S-Biological_Molecule
,	O
levels	O
of	O
zeta	S-Biological_Molecule
and	O
betah1	S-Biological_Molecule
are	O
dramatically	O
higher	O
in	O
mutant	O
mice	O
at	O
15	O
.	O
5	O
dpc	O
.	O

A	O
2	O
.	O
5	O
-	O
kb	O
SstI	O
/	O
XhoI	O
fragment	O
of	O
muLCRbeta	O
9	O
.	O
3	O
(	O
micro	O
LCR	O
;	O
[	O
31	O
]	O
)	O
was	O
then	O
inserted	O
upstream	O
of	O
the	O
epsilony	S-Biological_Molecule
promoter	O
in	O
the	O
above	O
pGL3	O
Basic	O
plasmid	O
,	O
resulting	O
in	O
a	O
reporter	O
construct	O
in	O
which	O
luciferase	S-Biological_Molecule
expression	O
is	O
driven	O
by	O
the	O
epsilony	S-Biological_Molecule
promoter	O
.	O

Primers	O
for	O
cDNA	O
PCR	O
amplification	O
of	O
globin	O
genes	O
were	O
obtained	O
from	O
Primerbank	O
[	O
51	O
]	O
.	O

For	O
epsilony	B-Biological_Molecule
globin	E-Biological_Molecule
:	O
MHB1666	O
,	O
5	O
'	O
TGGCCTGTGGAGTAAGGTCAA3	O
'	O
;	O
and	O
MHB1667	O
,	O
5	O
'	O
GAAGCAGAGGACAAGTTCCCA3	O
'	O
.	O

18	O
.	O
5	O
-	O
dpc	O
embryos	O
were	O
exsanguinated	O
and	O
peripheral	O
blood	O
smears	O
were	O
prepared	O
from	O
both	O
mutant	O
and	O
WT	O
mice	O
.	O

Images	O
were	O
obtained	O
with	O
Nikon	O
Labophot	O
-	O
2	O
microscope	O
.	O

Blots	O
were	O
washed	O
with	O
0	O
.	O
2x	O
SSC	O
,	O
1	O
%	O
SDS	O
at	O
60	O
degreesC	O
prior	O
to	O
exposure	O
to	O
X	O
-	O
ray	O
film	O
(	O
Kodak	O
,	O
Rochester	O
,	O
New	O
York	O
,	O
United	O
States	O
)	O
at	O
-	O
80	O
degreesC	O
for	O
6	O
d	O
.	O

Glucan	O
phosphate	O
induced	O
significant	O
binding	O
to	O
a	O
known	O
NFIL	O
-	O
6	O
site	O
and	O
a	O
new	O
NFAT	O
site	O
within	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1RA	E-Biological_Molecule
promoter	O
,	O
which	O
was	O
confirmed	O
by	O
inhibition	O
experiments	O
.	O

When	O
applied	O
in	O
combination	O
with	O
either	O
LPS	O
or	O
TSST	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
at	O
the	O
same	O
time	O
points	O
,	O
we	O
detected	O
that	O
glucan	O
phosphate	O
elevated	O
the	O
LPS	O
-	O
and	O
the	O
TSST	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
-	O
induced	O
DNA	O
binding	O
of	O
NFkappaB	O
,	O
NFIL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
and	O
NFAT	S-Biological_Molecule
,	O
leading	O
to	O
a	O
synergistic	O
increase	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1RA	E-Biological_Molecule
.	O

Further	O
,	O
glucan	O
phosphate	O
modulated	O
the	O
TSST	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
-	O
induced	O
inflammatory	O
response	O
via	O
reduction	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
.	O

Because	O
of	O
the	O
potential	O
effect	O
of	O
beta	O
-	O
1	O
to	O
3	O
-	O
D	O
-	O
glucan	O
on	O
cytokine	O
production	O
[	O
12	O
,	O
16	O
-	O
19	O
]	O
,	O
TNFalpha	S-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1RA	E-Biological_Molecule
were	O
measured	O
as	O
well	O
as	O
IFNgamma	S-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
12	E-Biological_Molecule
and	O
TGFbeta1	S-Biological_Molecule
.	O

A	O
supershift	O
,	O
conducted	O
for	O
an	O
NFkappaB	O
consensus	O
site	O
from	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
promoter	O
,	O
demonstrated	O
a	O
GP	O
-	O
induced	O
predominant	O
binding	O
of	O
NFkappaB	O
p65	S-Biological_Molecule
and	O
to	O
a	O
lesser	O
degree	O
of	O
p50	S-Biological_Molecule
(	O
Fig	O
.	O
1A	O
)	O
.	O

(	O
i	O
)	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule

(	O
ii	O
)	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule

Pharmacological	O
inhibitors	O
were	O
used	O
to	O
demonstrate	O
that	O
the	O
transcription	O
factor	O
sites	O
within	O
the	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1RA	E-Biological_Molecule
promoter	O
are	O
relevant	O
for	O
the	O
induction	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1RA	E-Biological_Molecule
by	O
GP	O
.	O

Water	O
soluble	O
phosphorylated	O
beta	O
-	O
1	O
to	O
3	O
-	O
D	O
-	O
glucan	O
(	O
GP	O
)	O
was	O
prepared	O
as	O
done	O
before	O
[	O
20	O
]	O
.	O

Preparation	O
of	O
nuclear	O
extracts	O
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSA	O
)	O

[	O
27	O
]	O
and	O
modified	O
for	O
our	O
experimental	O
setup	O
[	O
56	O
]	O
.	O

B	O
,	O
Decreased	O
DNA	O
binding	O
of	O
NFkappaB	O
following	O
GP	O
+	O
TSST	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
compared	O
to	O
TSST	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
GP	O
,	O
or	O
TSST	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
/	O
GP	O
.	O

At	O
18	O
h	O
and	O
24	O
h	O
there	O
was	O
a	O
marked	O
reduction	O
in	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
production	O
following	O
GP	O
+	O
TSST	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
when	O
compared	O
to	O
TSST	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
(	O
*	O
=	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Binding	O
was	O
enhanced	O
for	O
GP	O
+	O
LPS	O
and	O
GP	O
+	O
TSST	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
when	O
compared	O
to	O
LPS	O
,	O
TSST	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
GP	O
,	O
GP	O
/	O
LPS	O
calc	O
.	O
or	O
GP	O
/	O
TSST	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
calc	O
.	O
,	O
respectively	O
(	O
*	O
=	O
p	O
<	O
0	O
.	O
05	O
;	O
*	O
*	O
=	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

The	O
rats	O
were	O
assigned	O
randomly	O
to	O
three	O
groups	O
:	O
normal	O
group	O
(	O
N	O
,	O
n	O
=	O
10	O
,	O
without	O
any	O
treatment	O
)	O
,	O
normal	O
saline	O
control	O
(	O
S	O
,	O
n	O
=	O
40	O
,	O
intra	O
-	O
cerebral	O
injection	O
of	O
normal	O
saline	O
as	O
control	O
)	O
and	O
intra	O
-	O
cerebral	O
hemorrhage	O
group	O
(	O
ICH	O
,	O
n	O
=	O
40	O
)	O
.	O

Five	O
rats	O
in	O
each	O
group	O
at	O
each	O
time	O
point	O
were	O
sacrificed	O
by	O
over	O
dose	O
injection	O
of	O
Ketamine	O
.	O

Rats	O
were	O
anesthetized	O
with	O
intra	O
-	O
peritoneal	O
sodium	O
pentobarbital	O
(	O
60	O
mg	O
/	O
kg	O
)	O
.	O

The	O
primary	O
antibody	O
employed	O
was	O
rabbit	O
anti	O
-	O
TLR4	O
(	O
WuHan	O
,	O
BA1717	O
)	O
.	O

The	O
biotinylated	O
secondary	O
antibody	O
and	O
antibody	O
-	O
biotin	O
-	O
avidin	S-Biological_Molecule
-	O
peroxidase	O
complexes	O
(	O
ABC	O
reagent	O
,	O
SC	O
-	O
2018	O
)	O
were	O
obtained	O
from	O
Santa	O
Cruz	O
Biotechnology	O
Inc	O
.	O

Cellular	O
proteins	O
were	O
prepared	O
from	O
ICH	O
cerebral	O
hemispheres	O
,	O
electrophoresed	O
with	O
SDS	O
-	O
polyacrylamide	O
gel	O
and	O
transferred	O
onto	O
Hybond	O
ECL	O
membranes	O
(	O
Amersham	O
Pharmacia	O
,	O
Piscataway	O
,	O
NJ	O
)	O
.	O

A	O
super	O
shift	O
assay	O
using	O
antibodies	O
to	O
P65	S-Biological_Molecule
and	O
P50	S-Biological_Molecule
was	O
performed	O
to	O
confirm	O
NFkappaB	O
binding	O
specificity	O
as	O
previously	O
described	O
.	O

In	O
the	O
saline	O
control	O
group	O
,	O
the	O
TLR4	S-Biological_Molecule
mRNA	O
slightly	O
increased	O
,	O
but	O
was	O
not	O
significantly	O
different	O
from	O
normal	O
group	O
.	O

To	O
explore	O
the	O
distribution	O
of	O
TLR4	S-Biological_Molecule
protein	O
,	O
the	O
TLR4	S-Biological_Molecule
was	O
detected	O
by	O
immunohistochemistry	O
(	O
IHC	O
)	O
.	O

3	O
.	O
4	O
.	O

The	O
mortality	O
of	O
ICH	O
is	O
higher	O
than	O
that	O
of	O
ischemic	O
stroke	O
.	O

However	O
,	O
how	O
the	O
inflammatory	O
responses	O
is	O
activated	O
and	O
regulated	O
in	O
the	O
brain	O
tissue	O
after	O
ICH	O
is	O
unclear	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
established	O
the	O
rat	O
model	O
of	O
experimental	O
ICH	O
and	O
detected	O
the	O
TLR4	S-Biological_Molecule
mRNA	O
and	O
protein	O
.	O

Activation	O
of	O
TLR4	S-Biological_Molecule
stimulates	O
IkappaBalpha	S-Biological_Molecule
phosphorylation	O
and	O
degradation	O
,	O
resulting	O
in	O
nuclear	O
translocation	O
of	O
NFkappaB	O
,	O
which	O
initiates	O
transcription	O
of	O
genes	O
associated	O
with	O
innate	O
immune	O
responses	O
and	O
inflammation	O
[	O
5	O
,	O
6	O
]	O
.	O

Infiltration	O
of	O
cells	O
of	O
the	O
innate	O
and	O
adaptive	O
immune	O
system	O
into	O
the	O
joint	O
space	O
drives	O
the	O
local	O
production	O
of	O
proinflammatory	O
T	O
-	O
helper	O
type	O
1	O
and	O
T	O
-	O
helper	O
type	O
17	O
cytokines	O
,	O
chemokines	O
,	O
and	O
matrix	O
metalloproteinases	O
by	O
infiltrating	O
monocytes	O
and	O
synovial	O
cells	O
.	O

In	O
addition	O
,	O
TNF	S-Biological_Molecule
and	O
IL	O
-	O
1	O
are	O
themselves	O
very	O
potent	O
activators	O
of	O
NF	O
-	O
kappaB	O
(	O
reviewed	O
in	O
[	O
2	O
,	O
3	O
]	O
)	O
.	O

TNF	S-Biological_Molecule
and	O
IL	O
-	O
1	O
are	O
both	O
very	O
potent	O
activators	O
of	O
NF	O
-	O
kappaB	O
and	O
it	O
can	O
be	O
expected	O
that	O
NF	O
-	O
kappaB	O
activation	O
by	O
these	O
cytokines	O
mediates	O
most	O
of	O
their	O
pro	O
-	O
inflammatory	O
activities	O
in	O
RA	O
(	O
reviewed	O
in	O
[	O
3	O
]	O
)	O
.	O

NF	O
-	O
kappaB	O
proteins	O
are	O
sequestered	O
in	O
the	O
cytoplasm	O
as	O
latent	O
complexes	O
by	O
inhibitory	O
proteins	O
referred	O
to	O
as	O
inhibitor	O
of	O
NF	O
-	O
kappaB	O
(	O
IkappaB	O
)	O
proteins	O
,	O
which	O
prevent	O
NF	O
-	O
kappaB	O
nuclear	O
translocation	O
and	O
DNA	O
binding	O
[	O
19	O
]	O
.	O

TRIF	S-Biological_Molecule
also	O
recruits	O
TRAF6	S-Biological_Molecule
[	O
25	O
]	O
and	O
RIP1	S-Biological_Molecule
[	O
26	O
]	O
via	O
a	O
direct	O
interaction	O
.	O

Recently	O
,	O
the	O
disruption	O
of	O
interactions	O
between	O
E2	O
ubiquitin	O
conjugating	O
enzymes	O
(	O
Ubc13	S-Biological_Molecule
and	O
Ubc5hc	S-Biological_Molecule
)	O
and	O
E3	O
ubiquitin	O
ligases	O
(	O
TRAF6	S-Biological_Molecule
,	O
TRAF2	S-Biological_Molecule
and	O
cIAP1	S-Biological_Molecule
/	O
2	S-Biological_Molecule
)	O
were	O
described	O
as	O
another	O
important	O
mechanism	O
used	O
by	O
A20	S-Biological_Molecule
to	O
downregulate	O
NF	O
-	O
kappaB	O
signalling	O
[	O
42	O
]	O
.	O

Interestingly	O
,	O
A20	S-Biological_Molecule
expression	O
is	O
itself	O
regulated	O
by	O
NF	O
-	O
kappaB	O
[	O
50	O
]	O
,	O
implicating	O
A20	S-Biological_Molecule
in	O
the	O
negative	O
feedback	O
regulation	O
of	O
NF	O
-	O
kappaB	O
signalling	O
.	O

Recently	O
,	O
Elsby	O
and	O
colleagues	O
functionally	O
evaluated	O
in	O
vitro	O
the	O
regulatory	O
ability	O
of	O
RA	O
-	O
associated	O
SNP	O
variants	O
on	O
A20	S-Biological_Molecule
promoter	O
activity	O
,	O
and	O
could	O
show	O
repressed	O
A20	S-Biological_Molecule
transcription	O
for	O
some	O
of	O
the	O
SNPs	O
investigated	O
[	O
53	O
]	O
.	O

A20	S-Biological_Molecule
-	O
binding	O
inhibitors	O
of	O
NF	O
-	O
kappaB	O

Functional	O
ABIN	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
is	O
expressed	O
in	O
humans	O
,	O
but	O
mice	O
only	O
express	O
a	O
truncated	B-Biological_Molecule
and	I-Biological_Molecule
inactive	I-Biological_Molecule
form	E-Biological_Molecule
lacking	O
the	O
crucial	O
ubiquitin	O
-	O
binding	O
domain	O
[	O
57	O
]	O
.	O

Mice	O
with	O
a	O
genetic	O
deficiency	O
of	O
CYLD	S-Biological_Molecule
have	O
aberrant	O
osteoclast	O
differentiation	O
and	O
develop	O
severe	O
osteoporosis	O
.	O

TRAF1	S-Biological_Molecule
-	O
deficient	O
dendritic	O
cells	O
,	O
however	O
,	O
show	O
attenuated	O
responses	O
to	O
secondary	O
stimulation	O
by	O
TRAF2	S-Biological_Molecule
-	O
dependent	O
factors	O
,	O
suggesting	O
a	O
positive	O
regulatory	O
role	O
in	O
these	O
cells	O
.	O

Moreover	O
,	O
miR	B-Biological_Molecule
-	I-Biological_Molecule
155	E-Biological_Molecule
was	O
shown	O
to	O
promote	O
TNF	S-Biological_Molecule
production	O
,	O
a	O
key	O
process	O
in	O
the	O
pathogenesis	O
of	O
RA	O
[	O
87	O
]	O
.	O

In	O
addition	O
,	O
given	O
the	O
number	O
of	O
miRNAs	O
in	O
humans	O
and	O
the	O
multiple	O
mRNAs	O
they	O
target	O
,	O
intense	O
complexity	O
can	O
be	O
expected	O
.	O

miR	O
-	O
146	O
is	O
thought	O
to	O
negatively	O
regulate	O
TLR	O
signalling	O
by	O
inhibiting	O
expression	O
of	O
IRAK1	S-Biological_Molecule
and	O
TRAF6	S-Biological_Molecule
.	O

A20	O
(	O
Tnfaip3	S-Biological_Molecule
)	O
Deficiency	O
in	O
Myeloid	O
Cells	O
Protects	O
against	O
Influenza	O
A	O
Virus	O
Infection	O

Here	O
we	O
used	O
myeloid	O
cell	O
specific	O
A20	O
knockout	O
mice	O
to	O
examine	O
the	O
role	O
of	O
the	O
ubiquitin	O
-	O
editing	O
protein	O
A20	O
in	O
the	O
response	O
of	O
myeloid	O
cells	O
to	O
IAV	O
infection	O
.	O

The	O
presence	O
of	O
viral	O
nucleic	O
acids	O
,	O
such	O
as	O
viral	O
RNA	O
and	O
DNA	O
,	O
viral	O
replication	O
intermediates	O
and	O
viral	O
transcription	O
products	O
,	O
can	O
be	O
sensed	O
by	O
specific	O
intracellular	O
PRRs	O
[	O
3	O
]	O
.	O

Emergence	O
of	O
drug	O
-	O
resistant	O
strains	O
of	O
influenza	O
viruses	O
with	O
pandemic	O
potential	O
underscores	O
the	O
importance	O
of	O
developing	O
novel	O
antiviral	O
strategies	O
.	O

TLR3	S-Biological_Molecule
and	O
RIG	B-Biological_Molecule
-	I-Biological_Molecule
I	E-Biological_Molecule
have	O
been	O
implicated	O
as	O
sensors	O
of	O
IAV	O
infection	O
[	O
10	O
]	O
-	O
[	O
12	O
]	O
.	O

In	O
addition	O
,	O
well	O
characterized	O
ubiquitin	O
ligases	O
such	O
as	O
TRAF6	S-Biological_Molecule
[	O
25	O
]	O
,	O
[	O
26	O
]	O
and	O
TRAF3	S-Biological_Molecule
[	O
27	O
]	O
mediate	O
respectively	O
NF	O
-	O
kappaB	O
and	O
IRF3	S-Biological_Molecule
activation	O
upon	O
RIG	B-Biological_Molecule
-	I-Biological_Molecule
I	E-Biological_Molecule
stimulation	O
.	O

A20	O
is	O
an	O
ubiquitin	O
-	O
editing	O
enzyme	O
belonging	O
to	O
the	O
OTU	O
-	O
domain	O
family	O
of	O
DUBs	O
.	O

Interestingly	O
,	O
A20	O
also	O
harbors	O
atypical	O
zinc	O
finger	O
dependent	O
K48	O
-	O
specific	O
E3	O
ubiquitin	O
ligase	O
activity	O
.	O

Unlike	O
IRF3	S-Biological_Molecule
,	O
IRF7	S-Biological_Molecule
is	O
not	O
or	O
weakly	O
expressed	O
under	O
naive	O
conditions	O
and	O
IRF7	S-Biological_Molecule
protein	O
levels	O
are	O
rapidly	O
upregulated	O
upon	O
virus	O
-	O
induced	O
IRF3	S-Biological_Molecule
activation	O
[	O
54	O
]	O
,	O
[	O
55	O
]	O
.	O

As	O
expected	O
,	O
poly	O
(	O
I	O
:	O
C	O
)	O
transfection	O
induced	O
the	O
rapid	O
expression	O
of	O
A20	O
in	O
wild	O
type	O
,	O
but	O
not	O
in	O
A20myel	O
-	O
KO	O
BMDM	O
(	O
figure	O
1B	O
,	O
upper	O
panel	O
)	O
.	O

To	O
test	O
whether	O
A20	O
directly	O
controls	O
IAV	O
-	O
induced	O
gene	O
expression	O
in	O
alveolar	O
macrophages	O
,	O
we	O
isolated	O
these	O
cells	O
from	O
lungs	O
of	O
A20myel	O
-	O
KO	O
and	O
control	O
littermates	O
and	O
infected	O
them	O
in	O
vitro	O
with	O
IAV	O
X	O
-	O
47	O
.	O

Consistent	O
with	O
the	O
higher	O
KC	S-Biological_Molecule
and	O
MIP	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
levels	O
in	O
A20myel	O
-	O
KO	O
mice	O
,	O
the	O
number	O
of	O
neutrophils	O
(	O
CD11b	O
+	O
Ly6C	O
+	O
Ly6G	O
+	O
F4	B-Biological_Molecule
/	I-Biological_Molecule
80	E-Biological_Molecule
-	O
)	O
that	O
were	O
recruited	O
in	O
the	O
bronchoalveolar	O
spaces	O
upon	O
IAV	O
infection	O
was	O
clearly	O
higher	O
throughout	O
infection	O
in	O
A20myel	O
-	O
KO	O
mice	O
compared	O
to	O
control	O
animals	O
(	O
figure	O
3D	O
)	O
.	O

A	O
clear	O
increase	O
in	O
CD8	O
+	O
T	O
cells	O
could	O
be	O
detected	O
at	O
day	O
7	O
and	O
10	O
post	O
infection	O
,	O
but	O
no	O
differences	O
were	O
observed	O
between	O
A20myel	O
-	O
KO	O
and	O
wild	O
type	O
mice	O
(	O
figure	O
S2A	O
and	O
figure	O
S2C	O
)	O
.	O

This	O
was	O
associated	O
with	O
a	O
selective	O
enhancement	O
of	O
neutrophil	O
recruitment	O
to	O
the	O
bronchoalveolar	O
compartment	O
,	O
and	O
resulted	O
in	O
improved	O
viral	O
clearance	O
later	O
on	O
during	O
infection	O
.	O

However	O
,	O
the	O
selective	O
effect	O
of	O
A20	O
deficiency	O
on	O
neutrophil	O
recruitment	O
,	O
without	O
altering	O
inflammatory	O
monocyte	O
(	O
Ly6C	O
+	O
CD11b	O
+	O
)	O
recruitment	O
,	O
further	O
support	O
the	O
idea	O
that	O
monocytes	O
and	O
not	O
neutrophils	O
are	O
major	O
contributors	O
to	O
IAV	O
-	O
associated	O
immunopathology	O
and	O
lethality	O
[	O
78	O
]	O
.	O

However	O
,	O
this	O
does	O
not	O
exclude	O
an	O
additional	O
effect	O
of	O
A20	O
on	O
other	O
signaling	O
pathways	O
that	O
may	O
contribute	O
to	O
proinflammatory	O
gene	O
expression	O
.	O

In	O
this	O
context	O
,	O
it	O
was	O
recently	O
shown	O
that	O
A20	O
cooperates	O
with	O
the	O
ubiquitin	O
-	O
binding	O
proteins	O
TAX1BP1	O
and	O
ABIN1	S-Biological_Molecule
to	O
to	O
disrupt	O
the	O
TRAF3	O
-	O
TBK1	O
-	O
IKKepsilon	O
complex	O
,	O
thereby	O
negatively	O
affecting	O
K63	O
-	O
polyubiquitination	O
of	O
TBK1	S-Biological_Molecule
and	O
IKKepsilon	S-Biological_Molecule
,	O
and	O
their	O
ability	O
to	O
activity	O
IRF3	S-Biological_Molecule
[	O
81	O
]	O
,	O
[	O
82	O
]	O
.	O

The	O
identification	O
of	O
these	O
substrates	O
will	O
be	O
the	O
topic	O
of	O
future	O
investigations	O
in	O
our	O
laboratory	O
.	O

Also	O
small	O
compound	O
inhibitors	O
of	O
A20	O
might	O
be	O
an	O
interesting	O
alternative	O
.	O

All	O
efforts	O
were	O
made	O
to	O
ameliorate	O
suffering	O
of	O
animals	O
.	O

To	O
determine	O
pulmonary	O
viral	O
titers	O
,	O
median	O
tissue	O
culture	O
infectious	O
dose	O
(	O
TCID50	O
)	O
was	O
measured	O
as	O
follows	O
:	O
lungs	O
were	O
homogenized	O
with	O
a	O
Polytron	O
homogenizer	O
(	O
Kinematica	O
)	O
in	O
PBS	O
.	O

Cells	O
and	O
transfection	O

Nuclear	O
and	O
cytoplasmic	O
lysates	O
were	O
prepared	O
by	O
resuspending	O
cells	O
in	O
B1	O
(	O
10	O
mM	O
Hepes	O
pH	O
7	O
.	O
5	O
,	O
10	O
mM	O
KCl	O
,	O
1	O
mM	O
MgCl2	O
,	O
5	O
%	O
glycerol	O
,	O
0	O
.	O
5	O
mM	O
EDTA	O
and	O
0	O
.	O
1	O
mM	O
EGTA	O
supplemented	O
with	O
protease	O
and	O
phosphatase	O
inhibitors	O
)	O
for	O
15	O
min	O
at	O
4degreesC	O
.	O

Detection	O
of	O
MCP	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
KC	S-Biological_Molecule
,	O
TNF	S-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
and	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
in	O
BAL	O
fluid	O
was	O
performed	O
using	O
Bioplex	O
(	O
BioRad	O
)	O
technology	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

Results	O
are	O
expressed	O
as	O
the	O
mean	O
+	O
/	O
-	O
SEM	O
.	O

Quantification	O
of	O
band	O
density	O
for	O
nuclear	O
p65	S-Biological_Molecule
and	O
IRF3	S-Biological_Molecule
is	O
shown	O
in	O
bar	O
graphs	O
(	O
expressed	O
as	O
relative	O
density	O
compared	O
to	O
the	O
first	O
lane	O
;	O
=	O
time	O
0	O
)	O
.	O

A20	O
deficiency	O
in	O
myeloid	O
cells	O
protects	O
against	O
IAV	O
lung	O
infection	O
.	O

(	O
D	O
)	O
.	O

Status	O
epilepticus	O
(	O
SE	O
)	O
induces	O
severe	O
vasogenic	O
edema	O
in	O
the	O
piriform	O
cortex	O
(	O
PC	O
)	O
accompanied	O
by	O
neuronal	O
and	O
astroglial	O
damages	O
.	O

SE	O
was	O
induced	O
by	O
pilocarpine	O
in	O
rats	O
that	O
were	O
intracerebroventricularly	O
infused	O
with	O
saline	O
-	O
,	O
and	O
soluble	O
TNF	B-Biological_Molecule
p55	I-Biological_Molecule
receptor	E-Biological_Molecule
(	O
sTNFp55R	S-Biological_Molecule
)	O
prior	O
to	O
SE	O
induction	O
.	O

SE	O
also	O
induces	O
severe	O
vasogenic	O
edema	O
in	O
the	O
PC	O
accompanied	O
by	O
neuronal	O
and	O
astroglial	O
damages	O
[	O
5	O
-	O
8	O
]	O
.	O

The	O
vasogenic	O
edema	O
results	O
from	O
dysfunction	O
of	O
endothelial	O
cells	O
and	O
the	O
blood	O
-	O
brain	O
barrier	O
(	O
BBB	O
)	O
.	O

Loss	O
of	O
BBB	O
integrity	O
is	O
not	O
only	O
due	O
to	O
an	O
abrupt	O
increase	O
in	O
the	O
intraluminal	O
pressure	O
but	O
also	O
influenced	O
by	O
the	O
properties	O
of	O
cerebral	O
tissue	O
.	O

Animal	O
protocols	O
were	O
approved	O
by	O
the	O
Institutional	O
Animal	O
Care	O
and	O
Use	O
Committee	O
of	O
Hallym	O
University	O
.	O

In	O
addition	O
,	O
we	O
have	O
made	O
all	O
efforts	O
to	O
minimize	O
the	O
number	O
of	O
animals	O
used	O
and	O
their	O
suffering	O
.	O

Rats	O
were	O
divided	O
into	O
two	O
groups	O
:	O
vehicle	O
(	O
saline	O
)	O
-	O
treated	O
and	O
soluble	O
TNFp55	B-Biological_Molecule
receptor	E-Biological_Molecule
(	O
sTNFp55R	S-Biological_Molecule
,	O
50	O
mug	O
/	O
ml	O
;	O
Sigma	O
-	O
Aldrich	O
Co	O
.	O
,	O
St	O
.	O
Louis	O
,	O
MO	O
)	O
-	O
treated	O
groups	O
.	O

Three	O
days	O
after	O
surgery	O
,	O
rats	O
were	O
treated	O
with	O
pilocarpine	O
(	O
380	O
mg	O
/	O
kg	O
,	O
i	O
.	O
p	O
.	O
;	O
Sigma	O
-	O
Aldrich	O
Co	O
.	O
,	O
St	O
.	O
Louis	O
,	O
MO	O
)	O
at	O
20	O
min	O
after	O
methylscopolamine	O
(	O
5	O
mg	O
/	O
kg	O
,	O
i	O
.	O
p	O
.	O
;	O
Sigma	O
-	O
Aldrich	O
Co	O
.	O
,	O
St	O
.	O
Louis	O
,	O
MO	O
)	O
.	O

The	O
rats	O
were	O
then	O
observed	O
3	O
-	O
4	O
hours	O
a	O
day	O
in	O
the	O
vivarium	O
for	O
general	O
behavior	O
and	O
occurrence	O
of	O
spontaneous	O
seizures	O
.	O

Immunohistochemistry	O

For	O
negative	O
controls	O
,	O
rat	O
hippocampal	O
tissues	O
were	O
incubated	O
with	O
1	O
mug	O
of	O
the	O
antibody	O
that	O
was	O
preincubated	O
with	O
1	O
mug	O
of	O
purified	O
peptide	O
for	O
1	O
hr	O
at	O
room	O
temperature	O
or	O
incubated	O
with	O
pre	O
-	O
immune	O
serum	O
instead	O
of	O
the	O
primary	O
antibody	O
.	O

For	O
nuclei	O
counterstaining	O
,	O
we	O
used	O
Vectashield	O
mounting	O
medium	O
with	O
DAPI	O
(	O
Vector	O
,	O
Burlingame	O
,	O
CA	O
)	O
.	O

In	O
our	O
previous	O
[	O
18	O
,	O
25	O
]	O
and	O
preliminary	O
data	O
,	O
neuronal	O
damage	O
was	O
first	O
detectable	O
at	O
3	O
days	O
after	O
SE	O
.	O

An	O
optical	O
fractionator	O
was	O
used	O
to	O
estimate	O
cell	O
numbers	O
.	O

The	O
optical	O
fractionator	O
(	O
a	O
combination	O
of	O
performing	O
counting	O
with	O
the	O
optical	O
dissector	O
,	O
with	O
fractionator	O
sampling	O
)	O
is	O
a	O
stereological	O
method	O
based	O
on	O
a	O
properly	O
designed	O
systematic	O
random	O
sampling	O
method	O
that	O
by	O
definition	O
yields	O
unbiased	O
estimates	O
of	O
population	O
number	O
.	O

One	O
day	O
to	O
1	O
week	O
after	O
SE	O
,	O
both	O
TNFp55R	S-Biological_Molecule
and	O
TNFp75R	S-Biological_Molecule
immunoreactivities	O
were	O
significantly	O
reduced	O
in	O
astrocytes	O
,	O
not	O
in	O
endothelial	O
cells	O
,	O
due	O
to	O
massive	O
astroglial	O
loss	O
(	O
data	O
not	O
shown	O
)	O
[	O
5	O
,	O
7	O
,	O
8	O
,	O
20	O
]	O
.	O

In	O
contrast	O
,	O
p65	S-Biological_Molecule
-	O
Thr435	O
phosphorylation	O
was	O
increased	O
in	O
endothelial	O
cells	O
(	O
not	O
astrocytes	O
)	O
within	O
the	O
PC	O
of	O
saline	O
-	O
infused	O
animals	O
12	O
hr	O
after	O
SE	O
(	O
Figure	O
5A	O
)	O
.	O

Furthermore	O
,	O
neutrophil	O
infiltration	O
showed	O
a	O
direct	O
proportion	O
to	O
the	O
area	O
of	O
vasogenic	O
edema	O
,	O
with	O
a	O
linear	O
coefficient	O
of	O
correlation	O
of	O
0	O
.	O
8631	O
(	O
p	O
<	O
0	O
.	O
05	O
,	O
Figure	O
6E	O
)	O
.	O

Therefore	O
,	O
our	O
findings	O
indicate	O
that	O
SE	O
-	O
induced	O
neutrophil	O
infiltration	O
into	O
the	O
PC	O
may	O
be	O
correlated	O
to	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
-	O
mediated	O
vasogenic	O
edema	O
formation	O
.	O

MIP	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
is	O
a	O
powerful	O
chemokine	S-Biological_Molecule
that	O
contributes	O
to	O
recruitment	O
of	O
neutrophils	O
[	O
27	O
]	O
.	O

p65	S-Biological_Molecule
phosphorylation	O
of	O
NF	O
-	O
kappaB	O
enhances	O
its	O
transactivation	O
potential	O
,	O
and	O
p65	S-Biological_Molecule
phosphorylation	O
occurs	O
in	O
either	O
the	O
cytoplasm	O
or	O
the	O
nucleus	O
[	O
30	O
]	O
.	O

Indeed	O
,	O
neutralization	O
of	O
SMI	O
-	O
71	O
in	O
vivo	O
leads	O
to	O
widening	O
of	O
intercellular	O
junctions	O
between	O
endothelial	O
cells	O
and	O
swelling	O
of	O
perivascular	O
astrocytic	O
processes	O
[	O
34	O
]	O
,	O
although	O
SMI	O
-	O
71	O
is	O
not	O
localized	O
at	O
endothelial	O
cell	O
junctions	O
[	O
35	O
-	O
38	O
]	O
.	O

Furthermore	O
,	O
sTNFp55R	S-Biological_Molecule
infusion	O
effectively	O
inhibited	O
p65	S-Biological_Molecule
-	O
Ser276	O
and	O
p65	S-Biological_Molecule
-	O
Ser311phosphorylation	O
in	O
astrocytes	O
following	O
SE	O
.	O

Neutrophil	O
infiltration	O
into	O
brain	O
parenchyma	O
is	O
transiently	O
observed	O
during	O
the	O
acute	O
phase	O
of	O
SE	O
(	O
4	O
-	O
36	O
hr	O
after	O
SE	O
)	O
and	O
disappears	O
thereafter	O
[	O
20	O
]	O
.	O

In	O
the	O
PC	O
,	O
however	O
,	O
neither	O
a	O
P2X7	O
receptor	O
agonist	O
/	O
antagonist	O
nor	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1Ra	E-Biological_Molecule
(	O
an	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	I-Biological_Molecule
antagonist	E-Biological_Molecule
)	O
infusion	O
could	O
not	O
affect	O
leukocyte	O
infiltration	O
.	O

(	O
A	O
)	O
TNF	B-Biological_Molecule
-	I-Biological_Molecule
alpha	E-Biological_Molecule
immunoreactivity	O
in	O
Ox	O
-	O
42	O
-	O
positive	O
microglia	O
(	O
arrows	O
)	O
.	O

Bar	O
=	O
12	O
.	O
5	O
mum	O
.	O

(	O
B	O
)	O
MIP	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
expression	O
in	O
the	O
PC	O
1	O
day	O
after	O
SE	O
.	O

The	O
expression	O
and	O
activity	O
of	O
MMP9	S-Biological_Molecule
were	O
also	O
elevated	O
.	O

And	O
the	O
subsequent	O
inflammation	O
leads	O
to	O
secondary	O
damage	O
not	O
only	O
in	O
brain	O
but	O
also	O
in	O
other	O
organs	O
[	O
2	O
-	O
4	O
]	O
.	O

Following	O
decapitation	O
,	O
the	O
cortices	O
were	O
dissected	O
out	O
,	O
and	O
the	O
meninges	O
and	O
associated	O
blood	O
vessels	O
were	O
removed	O
.	O

After	O
incubation	O
for	O
1	O
h	O
,	O
the	O
supernatant	O
was	O
transferred	O
to	O
a	O
new	O
flask	O
or	O
dish	O
(	O
Costar	O
,	O
USA	O
)	O
for	O
depleting	O
the	O
residual	O
epithelial	O
cells	O
.	O

Then	O
the	O
flasks	O
or	O
dishes	O
were	O
shaken	O
at	O
150	O
rpm	O
for	O
4	O
h	O
to	O
deplete	O
the	O
microglia	O
and	O
less	O
adherent	O
cells	O
from	O
the	O
cultures	O
.	O

2	O
.	O
4	O
.	O

The	O
nuclear	O
proteins	O
were	O
extracted	O
with	O
buffer	O
containing	O
20	O
mM	O
HEPES	O
(	O
pH	O
7	O
.	O
9	O
)	O
,	O
0	O
.	O
4	O
mM	O
NaCl	O
,	O
1	O
.	O
0	O
mM	O
EDTA	O
,	O
1	O
.	O
0	O
mM	O
EGTA	O
,	O
1	O
.	O
0	O
mM	O
DTT	O
,	O
and	O
1	O
.	O
0	O
mM	O
phenylmethylsulfonyl	O
fluoride	O
.	O

Levels	O
of	O
NF	O
-	O
kappaB	O
DNA	O
binding	O
activity	O
were	O
quantified	O
by	O
software	O
ImageJ	O
.	O

The	O
cDNA	O
was	O
stored	O
in	O
-	O
20degreesC	O
.	O

The	O
blots	O
were	O
washed	O
three	O
times	O
in	O
the	O
washing	O
buffer	O
and	O
covered	O
with	O
the	O
horseradish	O
peroxidase	O
-	O
linked	O
secondary	O
antibody	O
at	O
a	O
1	O
:	O
2000	O
dilution	O
for	O
1	O
h	O
.	O

Briefly	O
,	O
prepared	O
the	O
standard	O
and	O
created	O
the	O
standard	O
dilution	O
for	O
building	O
standard	O
curve	O
.	O

Then	O
samples	O
and	O
biotinconjugate	O
were	O
added	O
to	O
microwell	O
strips	O
.	O

Gelatin	O
zymography	O
was	O
performed	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
(	O
Genmed	O
Scientifics	O
Inc	O
,	O
MA	O
,	O
USA	O
)	O
.	O

After	O
rinsing	O
in	O
water	O
,	O
each	O
gel	O
was	O
stained	O
with	O
Coomassie	O
blue	O
for	O
1	O
h	O
and	O
destained	O
in	O
50	O
%	O
methanol	O
.	O

P	O
values	O
<	O
0	O
.	O
05	O
were	O
considered	O
to	O
be	O
significant	O
.	O

Cell	O
death	O
was	O
detected	O
by	O
microscope	O
and	O
CCK	O
-	O
8	O
analysis	O
at	O
24	O
h	O
after	O
scratch	O
.	O

Expression	O
of	O
Proinflammatory	O
Cytokines	O
Was	O
Elevated	O
in	O
Nrf2	O
Knockout	O
Astrocytes	O
after	O
Scratch	O
Injury	O

3	O
.	O
4	O
.	O

The	O
present	O
study	O
demonstrated	O
that	O
scratch	O
injury	O
induced	O
the	O
upregulation	O
of	O
NF	O
-	O
kappaB	O
DNA	O
binding	O
activity	O
and	O
overexpression	O
of	O
TNF	O
-	O
alpha	O
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
,	O
and	O
MMP9	S-Biological_Molecule
in	O
cultured	O
astrocytes	O
.	O

Our	O
previous	O
study	O
has	O
proved	O
the	O
augmentation	O
of	O
Nrf2	O
in	O
brain	O
tissue	O
after	O
TBI	O
[	O
17	O
]	O
.	O

Enhanced	O
level	O
of	O
Nrf2	O
activates	O
transcription	O
of	O
a	O
group	O
of	O
antioxidant	O
genes	O
,	O
such	O
as	O
heme	B-Biological_Molecule
oxygenase	I-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
(	O
HO	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
)	O
and	O
NAD	O
(	O
P	O
)	O
H	O
:	O
quinone	O
oxidoreductase	O
-	O
1	O
(	O
NQO1	O
)	O
,	O
which	O
would	O
subsequently	O
reduce	O
the	O
damage	O
in	O
brain	O
[	O
18	O
]	O
.	O

Postinjury	O
administration	O
of	O
SFN	O
,	O
an	O
inducer	O
of	O
Nrf2	O
,	O
significantly	O
improves	O
spatial	O
memory	O
of	O
rat	O
and	O
decreases	O
the	O
immunoreactivity	O
for	O
4	O
-	O
Hydroxynonenal	O
(	O
4	O
-	O
HNE	O
)	O
,	O
a	O
marker	O
of	O
lipid	O
peroxidation	O
,	O
in	O
the	O
cortex	O
and	O
the	O
CA3	O
subfield	O
of	O
hippocampus	O
after	O
TBI	O
[	O
19	O
]	O
.	O

In	O
view	O
of	O
the	O
fact	O
that	O
Nrf2	O
is	O
a	O
transcription	O
factor	O
which	O
should	O
take	O
function	O
mainly	O
in	O
nucleus	O
,	O
it	O
can	O
be	O
reasoned	O
that	O
astrocytes	O
may	O
be	O
one	O
kind	O
of	O
respondent	O
cells	O
in	O
activation	O
of	O
Nrf2	O
-	O
ARE	O
pathway	O
after	O
TBI	O
.	O

In	O
conclusion	O
,	O
depletion	O
of	O
Nrf2	O
induced	O
the	O
activation	O
of	O
NF	O
-	O
kappaB	O
and	O
the	O
expression	O
of	O
TNF	O
-	O
alpha	O
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1beta	E-Biological_Molecule
,	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
,	O
and	O
MMP9	S-Biological_Molecule
resulting	O
in	O
more	O
cell	O
deaths	O
in	O
astrocytes	O
after	O
scratch	O
injury	O
.	O

Thus	O
,	O
the	O
innate	O
immune	O
response	O
to	O
MTb	O
infection	O
induces	O
NFAT5	S-Biological_Molecule
gene	O
and	O
protein	O
expression	O
,	O
and	O
NFAT5	S-Biological_Molecule
plays	O
a	O
crucial	O
role	O
in	O
MTb	O
regulation	O
of	O
HIV	O
-	O
1	O
replication	O
via	O
a	O
direct	O
interaction	O
with	O
the	O
viral	O
promoter	O
.	O

These	O
findings	O
also	O
demonstrate	O
a	O
general	O
role	O
for	O
NFAT5	S-Biological_Molecule
in	O
TLR	O
-	O
and	O
MTb	O
-	O
mediated	O
control	O
of	O
gene	O
expression	O
.	O

Furthermore	O
,	O
inflammatory	O
cytokines	O
and	O
chemokines	O
produced	O
by	O
the	O
human	O
host	O
in	O
response	O
to	O
MTb	O
infection	O
activate	O
signal	O
transduction	O
pathways	O
in	O
CD4	S-Biological_Molecule
T	O
cells	O
and	O
monocytic	O
cells	O
that	O
also	O
result	O
in	O
transcriptional	O
activation	O
of	O
the	O
HIV	O
-	O
1	O
LTR	O
[	O
4	O
]	O
-	O
[	O
6	O
]	O
.	O

Notably	O
,	O
HIV	O
-	O
1	O
comprises	O
several	O
subtypes	O
,	O
and	O
the	O
LTR	O
of	O
each	O
subtype	O
is	O
unique	O
with	O
respect	O
to	O
the	O
number	O
and	O
organization	O
of	O
activator	O
binding	O
sites	O
.	O

By	O
contrast	O
,	O
HIV	O
-	O
1	O
subtypes	O
C	O
and	O
E	O
,	O
which	O
have	O
spread	O
disproportionately	O
in	O
TB	O
-	O
burdened	O
sub	O
-	O
Saharan	O
Africa	O
and	O
southeast	O
Asia	O
,	O
have	O
three	O
and	O
one	O
NF	O
-	O
kappaB	O
binding	O
sites	O
,	O
respectively	O
[	O
1	O
]	O
,	O
[	O
28	O
]	O
-	O
[	O
30	O
]	O
.	O

Cells	O
were	O
incubated	O
at	O
37degreesC	O
for	O
16	O
hours	O
after	O
which	O
they	O
were	O
stimulated	O
with	O
10	O
microg	O
/	O
ml	O
MTb	O
CDC1551	O
lysate	O
or	O
left	O
unstimulated	O
for	O
8	O
hours	O
.	O

Quantitative	O
DNase	B-Biological_Molecule
I	E-Biological_Molecule
footprinting	O

Quantitative	O
DNase	B-Biological_Molecule
I	E-Biological_Molecule
footprinting	O
was	O
performed	O
as	O
previously	O
described	O
[	O
31	O
]	O
.	O

The	O
plasmid	O
encoding	O
the	O
full	O
-	O
length	O
infectious	O
molecular	O
clone	O
of	O
HIV	O
-	O
1Lai	O
was	O
obtained	O
from	O
the	O
NIH	O
AIDS	O
Reagent	O
and	O
Reference	O
Program	O
.	O

The	O
infectious	O
molecular	O
clone	O
of	O
HIV	O
-	O
198IN22	O
was	O
constructed	O
using	O
DNA	O
extracted	O
from	O
PBMC	O
that	O
were	O
infected	O
with	O
a	O
primary	O
isolate	O
of	O
HIV	O
-	O
198IN22	O
.	O

The	O
lentiviral	O
plasmid	O
pLKO	O
.	O
1	O
expressing	O
shRNA	S-Biological_Molecule
targeting	O
human	O
MyD88	S-Biological_Molecule
was	O
purchased	O
from	O
Open	O
Biosystems	O
(	O
www	O
.	O
openbiosystems	O
.	O
com	O
)	O
and	O
was	O
validated	O
in	O
our	O
laboratory	O
.	O

shRNA	O
targeting	O
human	O
IRAK1	S-Biological_Molecule
(	O
forward	O
primer	O
5	O
'	O
-	O
CCGGAGCAGCTGTCCAGGTTTCGTCTCATAAAACCTGGACAGCTGCTCCTTTTTG	O
-	O
3	O
'	O
,	O
reverse	O
primer	O
5	O
'	O
-	O
AATTCAAAAAGGAGCAGCTGTCCAGGTTTTATGAGACGAAACCTGGACAGCTGCT	O
-	O
3	O
'	O
mRNA	O
(	O
IRAK1	S-Biological_Molecule
mRNA	O
target	O
sequence	O
is	O
underlined	O
)	O
and	O
human	O
TRAF6	S-Biological_Molecule
(	O
forward	O
primer	O
5	O
'	O
-	O
CCGGAGAAACCTGTTGTGATTCGTCTCATAAATCACAACAGGTTTCTCCTTTTTG	O
-	O
3	O
'	O
,	O
reverse	O
primer	O
5	O
'	O
-	O
AATTCAAAAAGGAGAAACCTGTTGTGATTTATGAGACGAATCACAACAGGTTTCT	O
-	O
3	O
'	O
(	O
TRAF6	S-Biological_Molecule
mRNA	O
target	O
sequence	O
is	O
underlined	O
)	O
were	O
designed	O
in	O
our	O
laboratory	O
and	O
were	O
cloned	O
into	O
the	O
pLKO	O
.	O
1	O
plasmid	O
.	O

Bacteria	O
were	O
then	O
plated	O
,	O
washed	O
with	O
PBS	O
,	O
resuspended	O
in	O
PBS	O
,	O
and	O
passed	O
through	O
a	O
5	O
microm	O
filter	O
to	O
ensure	O
that	O
the	O
bacteria	O
were	O
in	O
a	O
single	O
cell	O
suspension	O
.	O

Extracts	O
were	O
boiled	O
for	O
5	O
min	O
in	O
1x	O
Laemmli	O
sample	O
buffer	O
with	O
5	O
%	O
v	O
/	O
v	O
2	O
-	O
mercaptoethanol	O
and	O
proteins	O
were	O
separated	O
by	O
SDS	O
-	O
PAGE	O
.	O

The	O
blot	O
was	O
again	O
washed	O
3x5	O
min	O
in	O
TBST	O
and	O
developed	O
with	O
SuperSignal	O
West	O
Pico	O
Chemiluminescent	O
Reagent	O
(	O
Pierce	O
)	O
.	O

As	O
shown	O
in	O
Figure	O
2A	O
,	O
stimulation	O
with	O
MTb	O
lysate	O
significantly	O
increased	O
NFAT5	S-Biological_Molecule
mRNA	O
levels	O
at	O
24	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
48	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
hours	O
,	O
whereas	O
infection	O
with	O
viable	O
or	O
heat	O
-	O
inactivated	O
HIV	O
-	O
1	O
isolates	O
did	O
not	O
increase	O
NFAT5	S-Biological_Molecule
mRNA	O
levels	O
(	O
Figure	O
2A	O
)	O
.	O

As	O
shown	O
in	O
Figure	O
2	O
,	O
transfection	O
of	O
the	O
siRNA	O
specific	O
for	O
NFAT5	S-Biological_Molecule
reduces	O
NFAT5	S-Biological_Molecule
mRNA	O
levels	O
in	O
both	O
MTb	O
-	O
uninfected	O
(	O
p	O
=	O
0	O
.	O
048	O
)	O
and	O
MTb	O
-	O
infected	O
(	O
p	O
=	O
0	O
.	O
021	O
)	O
MDM	O
as	O
compared	O
to	O
transfection	O
of	O
control	O
GFP	S-Biological_Molecule
siRNA	O
into	O
MTb	O
-	O
uninfected	O
or	O
-	O
infected	O
MDM	O
(	O
Figure	O
2B	O
)	O
.	O

We	O
also	O
created	O
a	O
double	O
NF	O
-	O
kappaB	O
site	O
mutant	O
virus	O
(	O
HIV	O
-	O
1Lai	O
/	O
Bal	O
-	O
env	S-Biological_Molecule
-	O
kappaB	O
I	O
+	O
II	O
-	O
Mut	O
)	O
in	O
order	O
to	O
test	O
the	O
impact	O
of	O
complete	O
disruption	O
of	O
NF	O
-	O
kappaB	O
binding	O
to	O
the	O
HIV	O
-	O
1	O
LTR	O
on	O
MTb	O
regulation	O
.	O

However	O
,	O
recombinant	O
NFAT5	S-Biological_Molecule
binding	O
to	O
the	O
single	O
and	O
the	O
double	O
NF	O
-	O
kappaB	O
mutant	O
LTRs	O
was	O
not	O
impaired	O
and	O
indeed	O
appeared	O
enhanced	O
(	O
compare	O
lanes	O
2	O
-	O
5	O
to	O
lanes	O
7	O
-	O
20	O
of	O
Figure	O
3D	O
)	O
.	O

None	O
of	O
the	O
mutations	O
completely	O
abolished	O
viral	O
induction	O
by	O
MTb	O
co	O
-	O
infection	O
.	O

However	O
,	O
the	O
replication	O
of	O
each	O
mutant	O
virus	O
was	O
impaired	O
to	O
a	O
more	O
significant	O
extent	O
in	O
the	O
context	O
of	O
MTb	O
co	O
-	O
infection	O
,	O
consistent	O
with	O
important	O
roles	O
for	O
both	O
NF	O
-	O
kappaB	O
and	O
NFAT5	S-Biological_Molecule
in	O
MTb	O
-	O
induced	O
HIV	O
-	O
1	O
replication	O
.	O

Subtype	O
C	O
LTRs	O
generally	O
have	O
three	O
functional	O
NF	O
-	O
kappaB	O
sites	O
in	O
their	O
LTRs	O
,	O
and	O
subtype	O
C	O
is	O
the	O
predominant	O
viral	O
subtype	O
in	O
the	O
African	O
and	O
Asian	O
HIV	O
-	O
1	O
epidemics	O
where	O
MTb	O
co	O
-	O
infection	O
is	O
extremely	O
common	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
,	O
[	O
28	O
]	O
,	O
[	O
52	O
]	O
.	O

We	O
thus	O
next	O
extended	O
our	O
analysis	O
of	O
the	O
role	O
of	O
NFAT5	S-Biological_Molecule
in	O
MTb	O
/	O
HIV	O
-	O
1	O
co	O
-	O
infection	O
to	O
a	O
subtype	O
C	O
isolate	O
.	O

To	O
begin	O
to	O
decipher	O
the	O
cellular	O
mechanisms	O
underlying	O
NFAT5	S-Biological_Molecule
-	O
dependent	O
,	O
MTb	O
-	O
induced	O
HIV	O
-	O
1	O
replication	O
,	O
we	O
next	O
investigated	O
the	O
requirement	O
for	O
specific	O
signaling	O
molecules	O
in	O
the	O
TLR	O
pathway	O
that	O
are	O
required	O
for	O
MTb	O
stimulation	O
of	O
NFAT5	S-Biological_Molecule
gene	O
expression	O
.	O

The	O
adaptor	O
molecule	O
MyD88	S-Biological_Molecule
transmits	O
signals	O
upon	O
TLR2	S-Biological_Molecule
ligation	O
(	O
reviewed	O
in	O
[	O
53	O
]	O
)	O
.	O

Thus	O
,	O
MTb	O
regulation	O
of	O
NFAT5	S-Biological_Molecule
is	O
dependent	O
upon	O
MyD88	S-Biological_Molecule
.	O

Indeed	O
,	O
in	O
response	O
to	O
hypertonic	O
stress	O
,	O
NFAT5	S-Biological_Molecule
binds	O
to	O
the	O
aldose	B-Biological_Molecule
reductase	E-Biological_Molecule
(	O
AR	S-Biological_Molecule
)	O
promoter	O
and	O
induces	O
rapid	O
hyperacetylation	O
of	O
histones	O
H3	O
and	O
H4	O
[	O
76	O
]	O
.	O

Furthermore	O
,	O
we	O
have	O
shown	O
that	O
MTb	O
stimulation	O
of	O
NFAT5	S-Biological_Molecule
depends	O
on	O
TLR	O
pathway	O
signaling	O
molecules	O
,	O
including	O
MyD88	S-Biological_Molecule
,	O
IRAK1	S-Biological_Molecule
,	O
and	O
TRAF6	S-Biological_Molecule
.	O

Quantitative	O
DNaseI	S-Biological_Molecule
footprinting	O
analysis	O
is	O
shown	O
of	O
nucleotides	O
-	O
262	O
to	O
+	O
4	O
from	O
HIV	O
-	O
1Lai	O
/	O
Bal	O
-	O
env	S-Biological_Molecule
-	O
WT	O
,	O
HIV	O
-	O
1Lai	O
/	O
Bal	O
-	O
env	S-Biological_Molecule
-	O
kappaB	O
I	O
-	O
Mut	O
,	O
HIV	O
-	O
1Lai	O
/	O
Bal	O
-	O
env	S-Biological_Molecule
-	O
kappaB	O
II	O
-	O
Mut	O
,	O
and	O
HIV	O
-	O
1Lai	O
/	O
Bal	O
-	O
env	S-Biological_Molecule
-	O
kappaB	O
I	O
+	O
II	O
-	O
Mut	O
and	O
increasing	O
concentrations	O
of	O
recombinant	O
NF	O
-	O
kappaB	O
(	O
p50	S-Biological_Molecule
/	O
p65	S-Biological_Molecule
)	O
(	O
25	O
ng	O
,	O
100	O
ng	O
,	O
and	O
500	O
ng	O
)	O
.	O

MTb	O
-	O
induced	O
HIV	O
-	O
1	O
replication	O
in	O
PBMC	O
depends	O
on	O
binding	O
of	O
NFAT5	S-Biological_Molecule
and	O
NF	O
-	O
kappaB	O
to	O
the	O
LTR	O
.	O

Viral	O
p24	S-Biological_Molecule
levels	O
in	O
culture	O
supernatants	O
were	O
measured	O
at	O
days	O
4	O
,	O
7	O
and	O
12	O
post	O
-	O
infection	O
.	O

Disruption	O
of	O
NF	O
-	O
kappaB	O
or	O
NFAT5	O
sites	O
in	O
the	O
LTR	O
inhibits	O
MTb	O
-	O
induced	O
HIV	O
-	O
1	O
replication	O
in	O
MDM	O
.	O

Disruption	O
of	O
the	O
NFAT5	O
site	O
in	O
HIV	O
-	O
1	O
subtype	O
C	O
significantly	O
impairs	O
MTb	O
-	O
induced	O
viral	O
replication	O
.	O

Mutations	O
were	O
introduced	O
into	O
the	O
3	O
'	O
LTR	O
of	O
the	O
HIV	O
-	O
198IN22	O
-	O
WT	O
proviral	O
sequence	O
.	O

Moreover	O
,	O
infiltration	O
of	O
CD8	O
+	O
cytotoxic	O
T	O
cell	O
and	O
CD57	O
+	O
natural	O
killer	O
cells	O
was	O
significantly	O
increased	O
in	O
melanoma	O
tumor	O
and	O
spleen	O
tissue	O
of	O
CCR5	S-Biological_Molecule
-	O
/	O
-	O
mice	O
compared	O
to	O
that	O
of	O
CCR5	S-Biological_Molecule
+	O
/	O
+	O
mice	O
.	O

Because	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1Ra	E-Biological_Molecule
has	O
been	O
shown	O
to	O
inhibit	O
tumor	O
progression	O
by	O
promoting	O
antitumor	O
immune	O
responses	O
and	O
by	O
enhancing	O
the	O
activity	O
of	O
chemotherapy	O
,	O
numerous	O
studies	O
have	O
examined	O
the	O
ability	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1Ra	E-Biological_Molecule
to	O
block	O
tumor	O
progression	O
.	O

Induction	O
of	O
Apoptotic	O
Cell	O
Death	O
and	O
Inhibition	O
of	O
the	O
Expression	O
of	O
Anti	O
-	O
apoptotic	O
Proteins	O
in	O
CCR5	S-Biological_Molecule
-	O
/	O
-	O
Mice	O

To	O
see	O
whether	O
inhibition	O
of	O
NF	O
-	O
kappaB	O
activity	O
results	O
in	O
the	O
induction	O
of	O
apoptotic	O
cell	O
death	O
and	O
expression	O
of	O
NF	O
-	O
kappaB	O
target	O
apoptotic	O
cell	O
death	O
regulatory	O
protein	O
,	O
the	O
levels	O
of	O
apoptotic	O
cell	O
death	O
and	O
expression	O
of	O
apoptotic	O
cell	O
death	O
regulatory	O
proteins	O
were	O
assessed	O
.	O

Consistent	O
with	O
the	O
immunohistochemical	O
data	O
,	O
Western	O
blot	O
analysis	O
of	O
tumor	O
proteins	O
showed	O
greater	O
increased	O
levels	O
of	O
cleaved	O
caspase	O
-	O
3	O
,	O
cleaved	O
caspase	O
-	O
9	O
,	O
cleaved	O
PARP	O
and	O
Bax	O
,	O
whereas	O
the	O
levels	O
of	O
Bcl	O
-	O
2	O
and	O
C	B-Biological_Molecule
-	I-Biological_Molecule
IAP1	E-Biological_Molecule
were	O
significantly	O
decreased	O
in	O
CCR5	S-Biological_Molecule
-	O
/	O
-	O
mice	O
tissues	O
(	O
Figure	O
3D	O
)	O
.	O

To	O
analyze	O
the	O
cell	O
phenotype	O
change	O
in	O
CCR5	S-Biological_Molecule
-	O
/	O
-	O
mice	O
and	O
CCR5	S-Biological_Molecule
+	O
/	O
+	O
mice	O
by	O
inoculation	O
of	O
the	O
melanoma	O
cell	O
,	O
lymphocytes	O
were	O
isolated	O
from	O
the	O
tumor	O
and	O
spleen	O
tissues	O
.	O

The	O
B	O
,	O
CD3	O
T	O
,	O
CD4	S-Biological_Molecule
T	O
,	O
CD	O
8	O
T	O
and	O
NK	O
cell	O
portion	O
of	O
the	O
CCR5	S-Biological_Molecule
-	O
/	O
-	O
mice	O
spleen	O
were	O
61	O
.	O
3	O
%	O
,	O
33	O
.	O
4	O
%	O
,	O
17	O
.	O
6	O
%	O
,	O
9	O
.	O
2	O
%	O
and	O
0	O
.	O
6	O
%	O
,	O
respectively	O
compared	O
to	O
38	O
.	O
3	O
%	O
,	O
5	O
.	O
9	O
%	O
,	O
4	O
.	O
0	O
%	O
,	O
1	O
.	O
0	O
%	O
and	O
3	O
.	O
9	O
%	O
of	O
the	O
CCR5	S-Biological_Molecule
+	O
/	O
+	O
mice	O
(	O
Figure	O
5D	O
)	O
.	O

We	O
found	O
that	O
the	O
levels	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1Ra	E-Biological_Molecule
were	O
significantly	O
elevated	O
in	O
the	O
tumor	O
tissues	O
of	O
CCR5	S-Biological_Molecule
-	O
/	O
-	O
mice	O
inoculated	O
with	O
B16	O
melanoma	O
cells	O
.	O

In	O
contrast	O
,	O
IL	O
-	O
23	O
,	O
a	O
tumor	O
growth	O
promoting	O
cytokine	O
,	O
increased	O
NF	O
-	O
kappaB	O
and	O
immune	O
cell	O
infiltration	O
in	O
oral	O
tumor	O
[	O
51	O
]	O
.	O

These	O
data	O
indicate	O
that	O
NF	O
-	O
kappaB	O
could	O
be	O
involved	O
in	O
the	O
cytokine	O
mediated	O
anti	O
-	O
tumor	O
activities	O
of	O
immune	O
cells	O
.	O

The	O
3	O
-	O
methylcholatrene	O
-	O
induced	O
tumor	O
incidence	O
was	O
reduced	O
in	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1alpha	E-Biological_Molecule
knockout	O
mice	O
,	O
but	O
increased	O
in	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
1Ra	E-Biological_Molecule
mice	O
with	O
concomitant	O
maturation	O
of	O
NK	O
cells	O
and	O
anti	O
-	O
tumor	O
immunity	O
[	O
52	O
]	O
.	O

Sections	O
(	O
4	O
microm	O
thick	O
)	O
were	O
stained	O
with	O
H	O
&	O
E	O
and	O
analyzed	O
by	O
immunohistochemistry	O
.	O

A	O
flow	O
cytometric	O
analysis	O
was	O
performed	O
on	O
a	O
FACSAria	O
flow	O
cytometry	O
(	O
BD	O
Biosciences	O
)	O
,	O
and	O
the	O
data	O
were	O
analyzed	O
using	O
the	O
WinMDI	O
statistical	O
software	O
(	O
Scripps	O
,	O
La	O
Jolla	O
,	O
CA	O
,	O
USA	O
)	O
.	O

A	O
-	O
C	O
,	O
Tumor	O
images	O
,	O
volumes	O
,	O
and	O
weights	O
.	O

Decrease	O
of	O
NF	O
-	O
kappaB	O
activity	O
in	O
tumor	O
tissue	O
of	O
CCR5	S-Biological_Molecule
-	O
/	O
-	O
mice	O
.	O

C	O
,	O
Immunolfluorescence	O
analysis	O
of	O
p50	S-Biological_Molecule
confirmed	O
that	O
the	O
intensities	O
of	O
nuclear	O
staining	O
for	O
p50	S-Biological_Molecule
were	O
decreased	O
in	O
the	O
tumor	O
tissues	O
of	O
CCR5	S-Biological_Molecule
-	O
/	O
-	O
mice	O
.	O

Each	O
band	O
is	O
representative	O
of	O
three	O
independent	O
experimental	O
results	O
.	O

Induction	O
of	O
the	O
infiltration	O
of	O
CD8	O
+	O
T	O
cells	O
and	O
NK	O
cells	O
into	O
tumor	O
,	O
and	O
increase	O
in	O
spleen	O
of	O
CCR5	S-Biological_Molecule
-	O
/	O
-	O
mice	O
.	O

We	O
show	O
that	O
Akt	O
kinase	O
activity	O
is	O
critical	O
for	O
necroptosis	O
in	O
L929	O
cells	O
and	O
plays	O
a	O
key	O
role	O
in	O
TNFalpha	S-Biological_Molecule
production	O
.	O

A	O
complex	O
consisting	O
of	O
two	O
related	O
Ser	O
/	O
Thr	O
kinases	O
,	O
RIP1	S-Biological_Molecule
and	O
RIP3	S-Biological_Molecule
,	O
plays	O
a	O
critical	O
role	O
in	O
the	O
initiation	O
of	O
necroptosis	O
in	O
multiple	O
systems	O
[	O
7	O
]	O
,	O
[	O
8	O
]	O
,	O
[	O
9	O
]	O
.	O

For	O
example	O
,	O
the	O
transcription	O
factor	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Jun	E-Biological_Molecule
,	O
a	O
key	O
cellular	O
target	O
of	O
JNK	O
activity	O
,	O
was	O
one	O
of	O
the	O
hits	O
in	O
the	O
genome	O
wide	O
siRNA	O
screen	O
[	O
10	O
]	O
.	O

We	O
found	O
that	O
the	O
Akt	O
pathway	O
serves	O
as	O
a	O
critical	O
link	O
between	O
RIP1	S-Biological_Molecule
kinase	O
and	O
JNK	O
activation	O
in	O
L929	O
cells	O
.	O

It	O
has	O
been	O
established	O
that	O
mouse	O
fibrosarcoma	O
L929	O
cells	O
undergo	O
necroptotic	O
cell	O
death	O
following	O
stimulation	O
with	O
TNFalpha	S-Biological_Molecule
[	O
10	O
]	O
,	O
[	O
17	O
]	O
.	O

To	O
understand	O
the	O
activation	O
of	O
Akt	O
and	O
JNK	O
under	O
necroptotic	O
conditions	O
,	O
we	O
examined	O
the	O
changes	O
in	O
Akt	O
and	O
JNK	O
phosphorylation	O
at	O
9	O
hrs	O
post	O
zVAD	O
.	O
fmk	O
and	O
TNFalpha	S-Biological_Molecule
stimulation	O
.	O

In	O
contrast	O
,	O
activation	O
of	O
JNK	O
by	O
TNFalpha	S-Biological_Molecule
followed	O
different	O
kinetics	O
from	O
zVAD	O
.	O
fmk	O
-	O
induced	O
changes	O
.	O

TNFalpha	S-Biological_Molecule
treatment	O
caused	O
an	O
early	O
and	O
robust	O
increase	O
in	O
the	O
phosphorylation	O
of	O
JNK	O
and	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Jun	E-Biological_Molecule
.	O

Secondly	O
,	O
we	O
saw	O
that	O
the	O
ability	O
of	O
the	O
Akt	O
inhibitor	O
to	O
protect	O
cells	O
from	O
necroptosis	O
rapidly	O
declined	O
after	O
6	O
hrs	O
of	O
stimulation	O
with	O
zVAD	O
.	O
fmk	O
,	O
TNFalpha	S-Biological_Molecule
or	O
bFGF	S-Biological_Molecule
/	O
zVAD	O
.	O
fmk	O
and	O
no	O
protection	O
was	O
observed	O
when	O
the	O
inhibitor	O
was	O
added	O
at	O
9	O
hrs	O
(	O
Fig	O
.	O
4B	O
,	O
C	O
)	O
.	O

Both	O
pre	O
-	O
addition	O
and	O
delayed	O
addition	O
of	O
PD173074	O
fully	O
prevented	O
necroptosis	O
(	O
Fig	O
.	O
4E	O
)	O
.	O

In	O
the	O
case	O
of	O
pFoxO1	S-Biological_Molecule
we	O
occasionally	O
observed	O
a	O
shift	O
in	O
migration	O
rather	O
than	O
an	O
increase	O
in	O
band	O
intensity	O
(	O
e	O
.	O
g	O
.	O
comparing	O
Fig	O
.	O
5A	O
and	O
B	O
)	O
,	O
suggesting	O
that	O
phosphorylation	O
events	O
in	O
addition	O
to	O
Thr24	O
take	O
place	O
during	O
necroptosis	O
.	O

We	O
found	O
that	O
inhibition	O
of	O
mTORC1	O
by	O
rapamycin	O
,	O
an	O
inhibitor	O
of	O
the	O
mTOR	O
co	O
-	O
factor	O
Raptor	S-Biological_Molecule
[	O
29	O
]	O
,	O
protected	O
cells	O
from	O
necroptosis	O
(	O
Fig	O
.	O
5C	O
)	O
.	O

RIP1	S-Biological_Molecule
kinase	O
,	O
Akt	O
,	O
mTORC1	O
and	O
JNK	O
control	O
the	O
upregulation	O
of	O
TNFalpha	S-Biological_Molecule
accompanying	O
necroptosis	O
.	O

[	O
10	O
]	O
have	O
recently	O
reported	O
that	O
the	O
induction	O
of	O
necroptosis	O
by	O
zVAD	O
.	O
fmk	O
in	O
L929	O
cells	O
is	O
associated	O
with	O
increased	O
synthesis	O
of	O
TNFalpha	S-Biological_Molecule
,	O
which	O
potentiates	O
cell	O
death	O
.	O

S6C	O
.	O

Further	O
analysis	O
suggested	O
that	O
both	O
Akt	O
and	O
mTORC1	O
contribute	O
to	O
the	O
upregulation	O
of	O
TNFalpha	S-Biological_Molecule
mRNA	O
during	O
necroptosis	O
as	O
both	O
small	O
-	O
molecule	O
inhibition	O
and	O
siRNA	O
knockdown	O
of	O
Akt	O
and	O
mTOR	O
reduced	O
TNFalpha	S-Biological_Molecule
mRNA	O
levels	O
in	O
necroptotic	O
cells	O
(	O
Fig	O
.	O
6B	O
,	O
C	O
,	O
D	O
)	O
.	O

Knockdown	O
of	O
Akt	O
isoforms	O
Akt1	S-Biological_Molecule
and	O
Akt2	S-Biological_Molecule
or	O
inhibition	O
of	O
Akt	O
prominently	O
suppressed	O
the	O
necroptosis	O
dependent	O
increase	O
in	O
JNK	O
and	O
c	B-Biological_Molecule
-	I-Biological_Molecule
Jun	E-Biological_Molecule
phosphorylation	O
(	O
Fig	O
.	O
6E	O
,	O
S6D	O
,	O
E	O
)	O
suggesting	O
that	O
Akt	O
may	O
provide	O
a	O
link	O
between	O
RIP1	S-Biological_Molecule
and	O
JNK	O
activation	O
.	O

Expression	O
of	O
Constitutively	O
Active	O
Akt	O
,	O
Rescues	O
Necroptosis	O
Under	O
Serum	O
Free	O
Conditions	O

Constitutively	O
active	O
Akt1	S-Biological_Molecule
(	O
Myr	B-Biological_Molecule
-	I-Biological_Molecule
Akt	E-Biological_Molecule
)	O
was	O
generated	O
as	O
previously	O
described	O
[	O
37	O
]	O
by	O
the	O
addition	O
of	O
a	O
myristoylation	O
signal	O
which	O
provides	O
constitutive	O
localization	O
to	O
the	O
plasma	O
membrane	O
and	O
by	O
the	O
deletion	O
of	O
the	O
auto	O
-	O
inhibitory	O
PH	O
domain	O
(	O
Fig	O
.	O
7A	O
)	O
resulting	O
in	O
an	O
Akt	O
that	O
is	O
active	O
under	O
serum	O
free	O
.	O

This	O
allowed	O
us	O
to	O
examine	O
the	O
effects	O
of	O
other	O
Akt	O
mutations	O
on	O
necroptosis	O
.	O

As	O
expected	O
,	O
the	O
S473D	B-Biological_Molecule
mutant	E-Biological_Molecule
,	O
which	O
was	O
phosphorylated	O
on	O
Thr308	O
after	O
the	O
addition	O
of	O
zVAD	O
,	O
displayed	O
only	O
slightly	O
reduced	O
activity	O
,	O
while	O
S473A	S-Biological_Molecule
was	O
significantly	O
less	O
active	O
in	O
all	O
aspects	O
of	O
necroptosis	O
.	O

Our	O
model	O
,	O
based	O
on	O
these	O
results	O
,	O
is	O
that	O
necroptosis	O
-	O
specific	O
Thr308	O
phosphorylation	O
provides	O
a	O
critical	O
link	O
between	O
necroptotic	O
machinery	O
and	O
Akt	O
kinase	O
,	O
allowing	O
Akt	O
to	O
phosphorylate	O
substrates	O
during	O
necroptosis	O
,	O
promote	O
TNFalpha	S-Biological_Molecule
synthesis	O
,	O
JNK	O
activation	O
and	O
eventual	O
cell	O
death	O
.	O

Similar	O
to	O
L929	O
cells	O
,	O
a	O
RIP1	S-Biological_Molecule
kinase	O
dependent	O
increase	O
in	O
the	O
phosphorylation	O
of	O
Thr308	O
on	O
Akt	O
occurred	O
during	O
necroptosis	O
(	O
Fig	O
.	O
8B	O
,	O
D	O
,	O
F	O
)	O
in	O
these	O
cell	O
types	O
.	O

Model	O
of	O
RIP1	S-Biological_Molecule
,	O
Akt	O
and	O
JNK	O
Dependent	O
Signaling	O
in	O
Necroptotic	O
L929	O
Cells	O

It	O
did	O
not	O
,	O
however	O
,	O
lead	O
to	O
a	O
reduction	O
in	O
TNFalpha	S-Biological_Molecule
production	O
or	O
cell	O
death	O
(	O
Fig	O
.	O
S10C	O
,	O
D	O
,	O
F	O
,	O
G	O
)	O
,	O
suggesting	O
that	O
earlier	O
data	O
with	O
SP600125	O
protection	O
(	O
Fig	O
.	O
2	O
)	O
could	O
reflect	O
off	O
-	O
target	O
effects	O
of	O
this	O
molecule	O
,	O
rather	O
than	O
JNK	O
inhibition	O
.	O

The	O
first	O
input	O
,	O
which	O
is	O
induced	O
by	O
growth	O
factors	O
,	O
leads	O
to	O
the	O
plasma	O
membrane	O
localization	O
of	O
Akt	O
.	O

Expression	O
of	O
constitutively	O
active	O
membrane	O
-	O
targeted	O
Myr	B-Biological_Molecule
-	I-Biological_Molecule
Akt	E-Biological_Molecule
overcomes	O
this	O
requirement	O
.	O

One	O
possibility	O
is	O
that	O
RIP1	S-Biological_Molecule
kinase	O
inhibits	O
a	O
phosphatase	O
that	O
targets	O
Thr308	O
.	O

Furthermore	O
,	O
mutating	O
these	O
residues	O
to	O
Ala	O
in	O
Myr	B-Biological_Molecule
-	I-Biological_Molecule
Akt	E-Biological_Molecule
leads	O
to	O
the	O
loss	O
of	O
its	O
ability	O
to	O
promote	O
necroptosis	O
.	O

While	O
there	O
are	O
some	O
recent	O
examples	O
of	O
mTORC1	O
-	O
dependent	O
regulation	O
of	O
JNK	O
,	O
e	O
.	O
g	O
.	O
following	O
ER	O
stress	O
[	O
46	O
]	O
,	O
the	O
exact	O
mechanisms	O
during	O
necroptosis	O
remain	O
to	O
be	O
established	O
.	O

Two	O
recent	O
papers	O
showed	O
that	O
the	O
loss	O
of	O
control	O
over	O
RIP1	S-Biological_Molecule
/	O
RIP3	S-Biological_Molecule
kinase	O
activities	O
by	O
FADD	S-Biological_Molecule
and	O
caspase	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
in	O
epithelial	O
cells	O
unleashes	O
a	O
feed	O
forward	O
cycle	O
of	O
necroptosis	O
and	O
TNFalpha	S-Biological_Molecule
production	O
,	O
resulting	O
in	O
the	O
development	O
of	O
intestinal	O
inflammation	O
in	O
mice	O
and	O
,	O
possibly	O
,	O
in	O
patients	O
with	O
Crohn	O
'	O
s	O
disease	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
.	O

Mutant	O
versions	O
of	O
Myr	B-Biological_Molecule
-	I-Biological_Molecule
Akt1	E-Biological_Molecule
were	O
generated	O
using	O
the	O
same	O
strategy	O
.	O

Lung	O
fibroblasts	O
were	O
a	O
generous	O
gift	O
of	O
Dr	O
.	O
Philip	O
Tsichlis	O
(	O
Tufts	O
University	O
)	O
[	O
53	O
]	O
.	O

Cells	O
were	O
seeded	O
into	O
white	O
clear	O
bottom	O
96	O
well	O
plates	O
at	O
the	O
density	O
of	O
1x104	O
cells	O
/	O
well	O
and	O
treated	O
as	O
described	O
for	O
western	O
blot	O
experiments	O
.	O

Western	O
Blot	O

After	O
24	O
-	O
48	O
hr	O
,	O
cells	O
were	O
stimulated	O
with	O
30	O
microM	O
zVAD	O
.	O
fmk	O
or	O
10	O
ng	O
/	O
ml	O
mouse	O
TNFalpha	S-Biological_Molecule
.	O

After	O
brief	O
sonication	O
,	O
cell	O
lysates	O
were	O
spun	O
down	O
for	O
15	O
min	O
at	O
14	O
,	O
000xrpm	O
.	O

1	O
microL	O
of	O
cDNA	O
was	O
used	O
with	O
500	O
pM	O
primers	O
in	O
qPCR	O
reactions	O
.	O

Reactions	O
were	O
performs	O
using	O
SYBRGreen	O
2xMaster	O
mix	O
(	O
SABiosciences	O
)	O
in	O
a	O
LightCycler480	O
(	O
Roche	O
)	O
.	O

ELISAOne	O
Assay	O

Primary	O
antibody	O
to	O
pan	O
-	O
Akt	O
was	O
incubated	O
overnight	O
at	O
4degreesC	O
.	O

Viability	O
was	O
measured	O
24	O
hr	O
after	O
activation	O
of	O
necroptosis	O
.	O

In	O
all	O
graphs	O
,	O
average	O
+	O
/	O
-	O
SD	O
was	O
plotted	O
.	O

(	O
C	O
)	O
Necroptosis	O
was	O
induced	O
by	O
zVAD	O
.	O
fmk	O
or	O
TNFalpha	S-Biological_Molecule
in	O
L929	O
cell	O
in	O
the	O
presence	O
of	O
inhibitors	O
of	O
Akt	O
(	O
Akt	O
inh	O
.	O
VIII	O
)	O
and	O
mTOR	O
(	O
rapamycin	O
,	O
Torin	O
-	O
1	O
and	O
PI	O
-	O
103	O
)	O
.	O

(	O
D	O
)	O
L929	O
cells	O
with	O
mTOR	O
siRNA	O
knockdown	O
were	O
harvested	O
for	O
western	O
blot	O
or	O
treated	O
with	O
zVAD	O
.	O
fmk	O
or	O
TNFalpha	S-Biological_Molecule
for	O
24	O
hrs	O
.	O

(	O
B	O
)	O
Necroptosis	O
was	O
induced	O
by	O
zVAD	O
.	O
fmk	O
or	O
TNFalpha	S-Biological_Molecule
in	O
cells	O
treated	O
with	O
Nec	O
-	O
1	O
,	O
rapamycin	O
(	O
rapa	O
)	O
,	O
or	O
Akt	O
inh	O
.	O

(	O
C	O
-	O
F	O
)	O
L929	O
cells	O
with	O
siRNA	O
knockdown	O
of	O
Akt	O
isoforms	O
(	O
C	O
,	O
E	O
)	O
or	O
mTOR	O
(	O
D	O
,	O
F	O
)	O
were	O
stimulated	O
with	O
zVAD	O
.	O
fmk	O
or	O
TNFalpha	S-Biological_Molecule
for	O
9	O
hr	O
,	O
followed	O
by	O
qRT	O
-	O
PCR	O
analysis	O
of	O
mTNFalpha	S-Biological_Molecule
(	O
C	O
,	O
D	O
)	O
or	O
western	O
blot	O
(	O
E	O
,	O
F	O
)	O
.	O

(	O
D	O
)	O
L929	O
cells	O
,	O
stably	O
infected	O
with	O
Myr	O
-	O
Akt	O
and	O
Myr	O
-	O
Akt	O
K179KM	O
,	O
were	O
stimulated	O
with	O
zVAD	O
.	O
fmk	O
for	O
9	O
hr	O
under	O
serum	O
free	O
conditions	O
.	O

Model	O
of	O
RIP1	S-Biological_Molecule
,	O
Akt	O
and	O
JNK	O
dependent	O
signaling	O
in	O
necroptotic	O
L929	O
cells	O
.	O

Downstream	O
from	O
Akt	O
,	O
JNK	O
activation	O
leads	O
to	O
TNFalpha	S-Biological_Molecule
synthesis	O
.	O

High	O
expression	O
of	O
MGMT	S-Biological_Molecule
or	O
loss	O
of	O
MMR	O
contributes	O
significantly	O
to	O
TMZ	O
resistance	O
in	O
many	O
clinical	O
cases	O
(	O
Pollack	O
et	O
al	O
.	O
,	O
2006	O
;	O
Hegi	O
et	O
al	O
.	O
,	O
2008	O
;	O
Sarkaria	O
et	O
al	O
.	O
,	O
2008	O
)	O
.	O

MicroRNA	B-Biological_Molecule
-	I-Biological_Molecule
21	E-Biological_Molecule
is	O
considered	O
as	O
a	O
pro	O
-	O
survival	O
factor	O
for	O
cancer	O
cells	O
(	O
Li	O
et	O
al	O
.	O
,	O
2012	O
)	O
.	O

Interferon	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
(	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
)	O
,	O
levetiracetam	O
(	O
LEV	O
)	O
,	O
resveratrol	O
,	O
and	O
valproic	O
acid	O
(	O
VAP	O
)	O
increase	O
the	O
sensitivity	O
of	O
TMZ	O
through	O
MGMT	S-Biological_Molecule
-	O
dependent	O
or	O
-	O
independent	O
mechanisms	O
(	O
Nakada	O
et	O
al	O
.	O
,	O
2012	O
)	O
.	O

p53	S-Biological_Molecule
mutants	O
are	O
considered	O
as	O
unfavorable	O
factors	O
for	O
the	O
effectiveness	O
in	O
radiotherapy	O
and	O
TMZ	O
treatment	O
in	O
glioma	O
cells	O
(	O
Gjerset	O
et	O
al	O
.	O
,	O
1995	O
;	O
Hirose	O
et	O
al	O
.	O
,	O
2001	O
;	O
Squatrito	O
et	O
al	O
.	O
,	O
2010	O
;	O
Blough	O
et	O
al	O
.	O
,	O
2011	O
)	O
.	O

Loss	O
of	O
functional	O
p53	S-Biological_Molecule
confers	O
sensitivity	O
to	O
TMZ	O
in	O
glioma	O
cells	O
,	O
whereas	O
wild	O
type	O
p53	S-Biological_Molecule
increases	O
the	O
TMZ	O
resistance	O
(	O
Blough	O
et	O
al	O
.	O
,	O
2011	O
)	O
.	O

Activated	O
WWOX	S-Biological_Molecule
binds	O
wild	O
type	O
p53	S-Biological_Molecule
with	O
Ser46	O
phosphorylation	O
(	O
Chang	O
et	O
al	O
.	O
,	O
2005b	O
)	O
.	O

UV	O
irradiation	O
enhances	O
the	O
binding	O
interactions	O
.	O

Preliminary	O
studies	O
from	O
our	O
screening	O
of	O
chemicals	O
have	O
selected	O
certain	O
small	O
molecules	O
that	O
induce	O
apoptosis	O
of	O
many	O
types	O
of	O
cancer	O
cells	O
(	O
Lu	O
et	O
al	O
.	O
,	O
unpublished	O
)	O
.	O

We	O
have	O
shown	O
the	O
role	O
of	O
WWOX	S-Biological_Molecule
in	O
controlling	O
cell	O
migration	O
and	O
metabolic	O
alterations	O
,	O
and	O
discussed	O
the	O
effects	O
of	O
WWOX	S-Biological_Molecule
deficiency	O
and	O
TMZ	O
resistance	O
in	O
cancer	O
cells	O
.	O

In	O
response	O
to	O
TGF	B-Biological_Molecule
-	I-Biological_Molecule
beta1	E-Biological_Molecule
,	O
WWOX	S-Biological_Molecule
binds	O
Hyal	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
and	O
forms	O
a	O
complex	O
,	O
followed	O
by	O
relocating	O
to	O
the	O
nucleus	O
and	O
enhancing	O
the	O
SMAD	O
-	O
driven	O
promoter	O
activity	O
.	O

In	O
addition	O
,	O
we	O
compared	O
the	O
DNA	O
sequence	O
of	O
the	O
murine	O
5	O
'	O
flanking	O
sequence	O
with	O
the	O
sequence	O
of	O
the	O
human	O
gene	O
for	O
homologous	O
functional	O
regulatory	O
elements	O
and	O
identified	O
several	O
regulatory	O
cis	O
-	O
acting	O
elements	O
in	O
the	O
human	O
SERPINB2	S-Biological_Molecule
promoter	O
conserved	O
in	O
the	O
mouse	O
.	O

Importantly	O
,	O
both	O
constitutive	O
and	O
LPS	O
-	O
induced	O
SerpinB2	S-Biological_Molecule
expression	O
was	O
severely	O
abrogated	O
in	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBP	I-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
-	O
null	O
mouse	O
embryonic	O
fibroblasts	O
(	O
MEFs	O
)	O
and	O
primary	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBP	I-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
-	O
deficient	O
peritoneal	O
macrophages	O
.	O

The	O
inflammatory	O
response	O
is	O
a	O
double	O
-	O
edged	O
sword	O
.	O

Over	O
the	O
past	O
decade	O
,	O
intracellular	O
roles	O
for	O
SerpinB2	S-Biological_Molecule
in	O
cell	O
survival	O
[	O
11	O
]	O
-	O
[	O
17	O
]	O
,	O
proliferation	O
and	O
differentiation	O
[	O
18	O
]	O
-	O
[	O
21	O
]	O
,	O
signal	O
transduction	O
[	O
15	O
]	O
;	O
[	O
22	O
]	O
;	O
[	O
23	O
]	O
and	O
innate	O
immunity	O
[	O
24	O
]	O
-	O
[	O
28	O
]	O
,	O
have	O
been	O
described	O
.	O

Our	O
previously	O
published	O
data	O
indicated	O
that	O
SerpinB2	S-Biological_Molecule
is	O
distinctly	O
regulated	O
from	O
other	O
LPS	O
-	O
inducible	O
genes	O
in	O
terms	O
of	O
kinetics	O
,	O
LPS	O
dose	O
response	O
and	O
sensitivity	O
to	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
co	O
-	O
stimulation	O
[	O
4	O
]	O
;	O
however	O
,	O
the	O
cis	O
-	O
acting	O
elements	O
in	O
the	O
SerpinB2	S-Biological_Molecule
promoter	O
responsible	O
for	O
LPS	O
-	O
dependent	O
transcription	O
in	O
macrophages	O
and	O
the	O
specific	O
LPS	O
-	O
responsive	O
transcription	O
factors	O
that	O
bind	O
the	O
SerpinB2	S-Biological_Molecule
promoter	O
were	O
not	O
defined	O
.	O

This	O
sequence	O
was	O
deposited	O
in	O
GenBank	O
/	O
EMBL	O
/	O
DDBJ	O
Data	O
Bank	O
with	O
Accession	O
No	O
.	O

Luciferase	S-Biological_Molecule
activity	O
was	O
determined	O
and	O
normalized	O
to	O
that	O
of	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
galactosidase	E-Biological_Molecule
[	O
38	O
]	O
using	O
the	O
Luciferase	S-Biological_Molecule
Assay	O
System	O
and	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
Galactosidase	E-Biological_Molecule
Enzyme	O
Assay	O
System	O
Kits	O
,	O
respectively	O
(	O
Promega	O
)	O
.	O

Electrophoretic	O
Mobility	O
Shift	O
Assays	O

A	O
similar	O
strong	O
induction	O
of	O
LPS	O
-	O
inducible	O
SerpinB2	S-Biological_Molecule
mRNA	O
expression	O
has	O
been	O
reported	O
previously	O
in	O
murine	O
peritoneal	O
macrophages	O
and	O
human	O
peripheral	O
blood	O
mononuclear	O
cells	O
[	O
4	O
]	O
;	O
[	O
32	O
]	O
.	O

To	O
investigate	O
regulatory	O
elements	O
between	O
-	O
539	O
and	O
-	O
189	O
essential	O
for	O
LPS	O
-	O
inducible	O
transcription	O
,	O
several	O
candidate	O
binding	O
sites	O
for	O
transcription	O
factors	O
previously	O
reported	O
to	O
mediate	O
LPS	O
-	O
inducible	O
transcription	O
in	O
other	O
genes	O
[	O
57	O
]	O
were	O
targeted	O
by	O
nucleotide	O
substitution	O
designed	O
to	O
disrupt	O
transcription	O
factor	O
binding	O
to	O
the	O
pGLmP	O
-	O
539	O
murine	O
SerpinB2	B-Biological_Molecule
promoter	I-Biological_Molecule
-	I-Biological_Molecule
luciferase	I-Biological_Molecule
reporter	I-Biological_Molecule
gene	E-Biological_Molecule
construct	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

Four	O
bands	O
of	O
different	O
mobilities	O
,	O
representing	O
DNA	O
-	O
nuclear	O
protein	O
complexes	O
were	O
detected	O
(	O
Fig	O
.	O
5A	O
)	O
.	O

C	B-Biological_Molecule
/	I-Biological_Molecule
EBP	I-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
is	O
a	O
LPS	O
-	O
induced	O
Nuclear	O
Factor	O
that	O
Binds	O
to	O
the	O
C	O
/	O
EBP	O
Element	O
of	O
the	O
SerpinB2	S-Biological_Molecule
Proximal	O
Promoter	O

C	B-Biological_Molecule
/	I-Biological_Molecule
EBP	I-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
Promotes	O
LPS	O
-	O
inducible	O
Murine	O
SerpinB2	S-Biological_Molecule
Proximal	O
Promoter	O
Activity	O

Since	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBP	I-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
binds	O
to	O
the	O
SerpinB2	S-Biological_Molecule
proximal	O
promoter	O
in	O
an	O
LPS	O
-	O
inducible	O
manner	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
we	O
wanted	O
to	O
address	O
the	O
question	O
of	O
whether	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBP	I-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
was	O
an	O
essential	O
factor	O
for	O
driving	O
transcription	O
from	O
the	O
SerpinB2	S-Biological_Molecule
promoter	O
in	O
cells	O
in	O
response	O
to	O
LPS	O
.	O

Phosphorylation	O
of	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBP	I-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
at	O
Serine	O
64	O
negatively	O
Regulates	O
LPS	O
-	O
stimulated	O
SerpinB2	S-Biological_Molecule
Promoter	O
Activity	O

Pro	O
-	O
inflammatory	O
stimuli	O
,	O
such	O
as	O
the	O
bacterial	O
endotoxin	O
LPS	O
,	O
stimulate	O
macrophages	O
to	O
mount	O
an	O
anti	O
-	O
pathogenic	O
response	O
which	O
involves	O
massive	O
induction	O
of	O
the	O
pro	O
-	O
survival	O
factor	O
SerpinB2	S-Biological_Molecule
.	O

In	O
contrast	O
to	O
the	O
pattern	O
of	O
incremental	O
increases	O
in	O
PMA	O
-	O
induced	O
transcriptional	O
activity	O
conferred	O
by	O
regions	O
of	O
the	O
murine	O
SerpinB2	S-Biological_Molecule
promoter	O
containing	O
these	O
sites	O
,	O
most	O
of	O
the	O
LPS	O
-	O
inducible	O
response	O
is	O
dependent	O
upon	O
cis	O
-	O
acting	O
regulatory	O
sequences	O
in	O
the	O
region	O
between	O
nucleotides	O
-	O
189	O
and	O
-	O
539	O
.	O

Additionally	O
,	O
CREB	O
has	O
been	O
shown	O
to	O
control	O
transcription	O
of	O
the	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBP	I-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
gene	O
[	O
67	O
]	O
.	O

C	B-Biological_Molecule
/	I-Biological_Molecule
EBP	I-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
,	O
like	O
SerpinB2	S-Biological_Molecule
,	O
plays	O
an	O
important	O
role	O
in	O
inflammation	O
,	O
as	O
it	O
is	O
upregulated	O
by	O
LPS	O
and	O
a	O
host	O
of	O
other	O
inflammatory	O
cytokines	O
[	O
59	O
]	O
;	O
[	O
62	O
]	O
.	O

In	O
recent	O
years	O
it	O
has	O
become	O
apparent	O
that	O
persistent	O
infection	O
is	O
integrally	O
linked	O
to	O
chronic	O
inflammation	O
and	O
cancer	O
,	O
and	O
immune	O
cells	O
such	O
as	O
macrophages	O
can	O
either	O
promote	O
or	O
attenuate	O
cancer	O
progression	O
[	O
2	O
]	O
;	O
[	O
74	O
]	O
-	O
[	O
76	O
]	O
.	O

Importantly	O
,	O
we	O
were	O
able	O
to	O
uncover	O
a	O
previously	O
unknown	O
role	O
for	O
C	O
/	O
EBP	O
-	O
betaS64	O
in	O
negatively	O
regulating	O
SerpinB2	S-Biological_Molecule
promoter	O
activity	O
.	O

Cells	O
were	O
either	O
left	O
untreated	O
or	O
treated	O
with	O
100	O
ng	O
/	O
ml	O
LPS	O
or	O
40	O
ng	O
/	O
ml	O
PMA	O
for	O
16	O
hrs	O
.	O

Shown	O
is	O
the	O
relative	O
luciferase	S-Biological_Molecule
reporter	O
gene	O
activity	O
following	O
treatment	O
.	O

(	O
C	O
)	O
DNA	O
sequence	O
conservation	O
between	O
the	O
human	O
and	O
murine	O
SerpinB2	S-Biological_Molecule
5	O
'	O
flanking	O
regions	O
.	O

The	O
location	O
of	O
the	O
5	O
'	O
ends	O
of	O
the	O
-	O
539	O
,	O
-	O
189	O
and	O
-	O
87	O
reporter	O
constructs	O
is	O
also	O
shown	O
.	O

Human	O
CEBPB	O
shRNA	O
serves	O
as	O
the	O
non	O
-	O
silencing	O
control	O
since	O
it	O
does	O
not	O
target	O
the	O
murine	O
Cebpb	S-Biological_Molecule
sequence	O
[	O
38	O
]	O
.	O

The	O
results	O
represent	O
the	O
mean	O
and	O
SEM	O
of	O
two	O
independent	O
experiments	O
performed	O
in	O
duplicate	O
or	O
triplicate	O
.	O

Cebpb	S-Biological_Molecule
-	O
/	O
-	O
MEFs	O
were	O
co	O
-	O
transfected	O
with	O
expression	O
plasmids	O
encoding	O
wild	O
-	O
type	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBP	I-Biological_Molecule
-	I-Biological_Molecule
beta	E-Biological_Molecule
or	O
the	O
indicated	O
C	B-Biological_Molecule
/	I-Biological_Molecule
EBP	I-Biological_Molecule
-	I-Biological_Molecule
beta	I-Biological_Molecule
phospho	I-Biological_Molecule
-	I-Biological_Molecule
acceptor	I-Biological_Molecule
mutants	E-Biological_Molecule
,	O
along	O
with	O
the	O
pGLmP	O
-	O
539	O
SerpinB2	B-Biological_Molecule
promoter	I-Biological_Molecule
-	I-Biological_Molecule
luciferase	I-Biological_Molecule
reporter	E-Biological_Molecule
and	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
galactosidase	I-Biological_Molecule
reporter	E-Biological_Molecule
plasmids	O
,	O
and	O
stimulated	O
with	O
LPS	O
for	O
4	O
hrs	O
.	O

Luciferase	S-Biological_Molecule
activity	O
was	O
quantified	O
and	O
normalized	O
to	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
galactosidase	E-Biological_Molecule
activity	O
.	O

However	O
,	O
during	O
each	O
phase	O
of	O
the	O
disease	O
,	O
low	O
levels	O
of	O
TGF	O
-	O
beta	O
RII	O
were	O
detected	O
when	O
compared	O
with	O
the	O
hematopoietic	O
cells	O
of	O
normal	O
donors	O
.	O

The	O
leukemia	O
cell	O
lines	O
K562	O
and	O
HL	O
-	O
60	O
had	O
no	O
detectable	O
TGF	O
-	O
beta	O
RII	O
mRNA	O
.	O

Leukemic	O
K562	O
,	O
U937	O
and	O
HL60	O
cells	O
expressed	O
Glut	O
-	O
1	O
transporter	O
protein	O
.	O

In	O
contrast	O
,	O
tunicamycin	S-Chemical_Compound
had	O
little	O
effect	O
on	O
the	O
viability	O
and	O
MTT	S-Chemical_Compound
responses	O
of	O
the	O
cells	O
used	O
.	O

However	O
,	O
the	O
expression	O
of	O
nm23	O
-	O
H1	O
gene	O
product	O
in	O
the	O
metastatic	O
sites	O
have	O
not	O
been	O
studied	O
in	O
detail	O
.	O

The	O
positive	O
staining	O
of	O
nm23	O
-	O
H1	O
gene	O
product	O
in	O
primary	O
cancers	O
and	O
metastatic	O
lymph	O
nodes	O
were	O
observed	O
in	O
56	O
.	O
5	O
and	O
67	O
.	O
4	O
%	O
,	O
respectively	O
.	O

No	O
correlations	O
were	O
found	O
between	O
the	O
nm23	O
-	O
H1	O
gene	O
product	O
expression	O
in	O
lung	O
cancers	O
and	O
the	O
patients	O
survival	O
.	O

In	O
contrast	O
,	O
bFGF	O
mRNA	O
was	O
not	O
altered	O
by	O
alinidine	S-Chemical_Compound
treatment	O
.	O

Vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
is	O
known	O
to	O
be	O
operative	O
in	O
the	O
pathogenesis	O
of	O
diabetic	O
retinopathy	O
.	O

In	O
vivo	O
nuclear	O
magnetic	O
resonance	O
analysis	O
of	O
tumor	O
blood	O
flow	O
in	O
linomide	S-Chemical_Compound
-	O
treated	O
animals	O
showed	O
localization	O
of	O
blood	O
vessels	O
almost	O
exclusively	O
to	O
the	O
periphery	O
of	O
the	O
poorly	O
vascularized	O
tumors	O
with	O
a	O
significant	O
reduction	O
of	O
both	O
vascular	O
functionality	O
and	O
vasodilation	O
.	O

The	O
second	O
most	O
prevalent	O
urological	O
malignancy	O
in	O
middle	O
aged	O
and	O
elderly	O
men	O
is	O
bladder	O
cancer	O
,	O
with	O
90	O
%	O
of	O
the	O
cases	O
being	O
transitional	O
cell	O
carcinomas	O
.	O

However	O
,	O
the	O
mechanism	O
(	O
s	O
)	O
by	O
which	O
ciprofloxacin	S-Chemical_Compound
elicits	O
its	O
biological	O
effects	O
on	O
bladder	O
cancer	O
cells	O
is	O
not	O
well	O
documented	O
.	O

Recent	O
studies	O
revealed	O
that	O
p21WAF1	O
protects	O
cells	O
from	O
apoptosis	O
by	O
arresting	O
them	O
in	O
G1	O
and	O
further	O
binds	O
to	O
pro	O
-	O
caspase	O
-	O
3	O
,	O
preventing	O
its	O
activation	O
and	O
thus	O
,	O
inhibiting	O
the	O
apoptotic	O
cascade	O
.	O

These	O
changes	O
originate	O
from	O
increased	O
peritoneal	O
surface	O
area	O
,	O
but	O
the	O
morphologic	O
and	O
molecular	O
mechanisms	O
involved	O
remain	O
unknown	O
.	O

The	O
biologic	O
relevance	O
of	O
increased	O
NOS	O
in	O
long	O
-	O
term	O
PD	O
was	O
demonstrated	O
by	O
enhanced	O
nitrotyrosine	S-Chemical_Compound
immunoreactivity	O
and	O
a	O
significant	O
increase	O
in	O
vascular	O
density	O
and	O
endothelial	O
area	O
in	O
the	O
peritoneum	O
.	O

Despite	O
these	O
suggestive	O
observations	O
,	O
no	O
formal	O
proof	O
is	O
as	O
yet	O
available	O
for	O
the	O
concept	O
that	O
angiogenesis	O
is	O
a	O
physiologic	O
event	O
that	O
occurs	O
all	O
over	O
the	O
mature	O
mammalian	O
integument	O
whenever	O
hair	O
follicles	O
switch	O
from	O
resting	O
(	O
telogen	O
)	O
to	O
active	O
growth	O
(	O
anagen	O
)	O
.	O

At	O
other	O
times	O
,	O
both	O
the	O
metastases	O
and	O
the	O
primary	O
tumor	O
may	O
spontaneously	O
regress	O
without	O
treatment	O
.	O

MATERIALS	O
AND	O
METHODS	O
:	O
Human	O
neuroblastoma	O
cells	O
and	O
human	O
Chang	O
hepatocytes	O
are	O
grown	O
in	O
a	O
noncontact	O
,	O
coculture	O
system	O
.	O

All	O
data	O
are	O
reported	O
as	O
means	O
+	O
/	O
-	O
SEM	O
.	O

Previously	O
we	O
demonstrated	O
that	O
N1	O
(	O
ic	O
)	O
and	O
N2	O
(	O
ic	O
)	O
could	O
transform	O
E1A	O
immortalized	O
baby	O
rat	O
kidney	O
cells	O
(	O
RKE	O
)	O
in	O
vitro	O
.	O

RESULTS	O
:	O
No	O
correlation	O
was	O
found	O
between	O
tumor	O
prognosis	O
and	O
EGFR	O
,	O
ICAM	O
-	O
1	O
or	O
Fas	O
.	O

All	O
of	O
the	O
4	O
tumors	O
that	O
were	O
CD40	O
-	O
negative	O
,	O
were	O
stage	O
I	O
tumors	O
,	O
without	O
any	O
evidence	O
of	O
regional	O
or	O
distant	O
metastasis	O
.	O

The	O
differences	O
in	O
IL	O
-	O
12	O
levels	O
were	O
unremarkable	O
.	O

Pretreatment	O
IL	O
levels	O
were	O
not	O
associated	O
with	O
outcome	O
.	O

Expression	O
of	O
wild	O
-	O
type	O
VASP	O
induces	O
marked	O
membrane	O
ruffling	O
and	O
formation	O
of	O
prominent	O
stress	O
fibers	O
in	O
bovine	O
aortic	O
endothelial	O
cells	O
.	O

uPAR	O
is	O
also	O
coexpressed	O
with	O
caveolin	O
and	O
members	O
of	O
the	O
integrin	O
adhesion	O
receptor	O
superfamily	O
.	O

Onconase	S-Chemical_Compound
similarly	O
inhibited	O
proliferation	O
in	O
all	O
three	O
cell	O
lines	O
(	O
IC	O
(	O
50	O
)	O
=	O
0	O
.	O
3	O
-	O
1	O
.	O
0	O
microM	O
)	O
while	O
(	B-Chemical_Compound
-	I-Chemical_Compound
4	I-Chemical_Compound
)	I-Chemical_Compound
rhEDN	E-Chemical_Compound
was	O
more	O
effective	O
on	O
immortalized	O
HUVEC	O
cell	O
lines	O
(	O
IC	O
(	O
50	O
)	O
=	O
0	O
.	O
02	O
-	O
0	O
.	O
06	O
microM	O
)	O
than	O
on	O
primary	O
HUVECs	O
(	O
IC	O
(	O
50	O
)	O
>	O
0	O
.	O
1	O
microM	O
)	O
.	O

However	O
,	O
it	O
is	O
not	O
sufficient	O
for	O
the	O
immortalization	O
of	O
MEF	O
,	O
and	O
MEF	O
-	O
LMP1	O
(	O
TRADD	O
)	O
cells	O
eventually	O
enter	O
growth	O
arrest	O
.	O

IL	O
-	O
12	O
inhibition	O
of	O
endothelial	O
cell	O
functions	O
and	O
angiogenesis	O
depends	O
on	O
lymphocyte	O
-	O
endothelial	O
cell	O
cross	O
-	O
talk	O
.	O

The	O
soluble	O
factors	O
they	O
release	O
in	O
its	O
presence	O
arrest	O
the	O
cycle	O
of	O
endothelial	O
cells	O
(	O
EC	O
)	O
,	O
inhibit	O
in	O
vitro	O
angiogenesis	O
,	O
negatively	O
modulate	O
the	O
production	O
of	O
matrix	O
metalloproteinase	O
-	O
9	O
,	O
and	O
the	O
ability	O
of	O
EC	O
to	O
adhere	O
to	O
vitronectin	O
and	O
up	O
-	O
regulate	O
ICAM	O
-	O
1	O
and	O
VCAM	O
-	O
1	O
expression	O
.	O

To	O
elucidate	O
the	O
biological	O
role	O
of	O
the	O
endogenous	O
angiogenesis	O
inhibitor	O
thrombospondin	O
-	O
2	O
(	O
TSP	O
-	O
2	O
)	O
during	O
multistep	O
carcinogenesis	O
,	O
we	O
subjected	O
TSP	O
-	O
2	O
-	O
deficient	O
and	O
wild	O
-	O
type	O
mice	O
to	O
a	O
chemical	O
skin	O
carcinogenesis	O
regimen	O
.	O

Although	O
antibodies	O
to	O
PAI	O
-	O
1	O
did	O
not	O
affect	O
the	O
adhesion	O
of	O
HT1080	O
cells	O
to	O
vitronectin	O
,	O
the	O
antibody	O
to	O
uPA	O
reduced	O
their	O
attachment	O
.	O

The	O
interaction	O
of	O
VEGF	O
and	O
its	O
receptors	O
at	O
gene	O
and	O
protein	O
levels	O
in	O
neuroblastoma	O
remains	O
widely	O
unknown	O
.	O

Whereas	O
the	O
ligands	O
were	O
increased	O
in	O
stages	O
III	O
and	O
IV	O
,	O
the	O
receptors	O
were	O
upregulated	O
in	O
stage	O
III	O
only	O
.	O

CONCLUSIONS	O
:	O
VEGF	O
-	O
A	O
(	O
165	O
)	O
is	O
one	O
of	O
the	O
major	O
angiogenesis	O
regulators	O
among	O
the	O
ligands	O
'	O
family	O
of	O
VEGF	O
,	O
whereas	O
its	O
receptors	O
KDR	O
,	O
and	O
most	O
probably	O
Flt	O
-	O
1	O
,	O
may	O
contribute	O
to	O
a	O
poor	O
prognosis	O
(	O
angiogenic	O
)	O
phenotype	O
,	O
as	O
indicated	O
by	O
their	O
upregulated	O
MRNA	O
levels	O
in	O
stage	O
III	O
neuroblastoma	O
.	O

Hypoxia	O
-	O
inducible	O
factor	O
1	O
activation	O
by	O
aerobic	O
glycolysis	O
implicates	O
the	O
Warburg	O
effect	O
in	O
carcinogenesis	O
.	O

Granulocyte	O
colony	O
-	O
stimulating	O
factor	O
(	O
G	O
-	O
CSF	O
)	O
has	O
had	O
a	O
major	O
impact	O
on	O
the	O
management	O
of	O
"	O
severe	O
chronic	O
neutropenia	O
"	O
(	O
SCN	O
)	O
,	O
a	O
collective	O
term	O
referring	O
to	O
congenital	O
,	O
idiopathic	O
,	O
or	O
cyclic	O
neutropenia	O
.	O

What	O
was	O
observed	O
,	O
however	O
,	O
was	O
the	O
multistep	O
acquisition	O
of	O
aberrant	O
cellular	O
genetic	O
changes	O
in	O
marrow	O
cells	O
from	O
patients	O
who	O
transformed	O
,	O
including	O
activating	O
ras	O
oncogene	O
mutations	O
,	O
clonal	O
cytogenetic	O
abnormalities	O
,	O
and	O
G	O
-	O
CSF	O
receptor	O
mutations	O
.	O

Since	O
congenital	O
neutropenia	O
and	O
SDS	O
are	O
inherited	O
forms	O
of	O
bone	O
marrow	O
failure	O
,	O
G	O
-	O
CSF	O
may	O
accelerate	O
the	O
propensity	O
for	O
MDS	O
/	O
AML	O
in	O
the	O
genetically	O
altered	O
stem	O
and	O
progenitor	O
cells	O
,	O
especially	O
in	O
those	O
with	O
G	O
-	O
CSF	O
receptor	O
and	O
ras	O
mutations	O
(	O
82	O
%	O
and	O
50	O
%	O
of	O
patients	O
who	O
transform	O
,	O
respectively	O
)	O
.	O

Cancer	O
cells	O
secrete	O
soluble	O
factors	O
which	O
can	O
induce	O
proliferation	O
and	O
migration	O
of	O
capillary	O
endothelial	O
cells	O
.	O

Reduced	O
oxygen	S-Chemical_Compound
tension	O
has	O
been	O
shown	O
to	O
increase	O
VEGF	O
production	O
by	O
induction	O
of	O
the	O
transcription	O
factor	O
hypoxia	O
inducible	O
factor	O
1	O
alpha	O
(	O
HIF	O
-	O
1alpha	O
)	O
.	O

The	O
mechanisms	O
by	O
which	O
hypoxic	O
tumor	O
environments	O
induce	O
HIF	O
-	O
1alpha	O
and	O
VEGF	O
expression	O
are	O
largely	O
unknown	O
.	O

T	O
-	O
antigen	O
-	O
mediated	O
sensitization	O
occurred	O
independently	O
of	O
retinoblastoma	O
protein	O
or	O
p53	O
and	O
p300	O
binding	O
.	O

Proof	O
of	O
principle	O
of	O
the	O
combined	O
diagnosis	O
/	O
treatment	O
system	O
design	O
for	O
performing	O
dye	O
-	O
enhanced	O
photocoagulation	O
(	O
DEP	O
)	O
in	O
the	O
clinical	O
setting	O
and	O
determination	O
of	O
the	O
minimum	O
DEP	O
laser	O
energy	O
needed	O
to	O
close	O
CNV	O
FVs	O
was	O
made	O
in	O
11	O
AMD	O
patients	O
requiring	O
treatment	O
of	O
CNV	O
,	O
but	O
for	O
whom	O
other	O
treatment	O
was	O
not	O
appropriate	O
.	O

After	O
acquiring	O
and	O
interpreting	O
diagnostic	O
angiograms	O
and	O
repositioning	O
a	O
patient	O
in	O
front	O
of	O
the	O
device	O
,	O
feeder	O
vessel	O
DEP	O
and	O
treatment	O
evaluation	O
required	O
15	O
to	O
20	O
minutes	O
.	O

In	O
addition	O
to	O
direct	O
effects	O
on	O
mammary	O
epithelial	O
cells	O
,	O
including	O
decreased	O
proliferation	O
and	O
induction	O
of	O
apoptosis	O
,	O
CLA	S-Chemical_Compound
may	O
exert	O
its	O
effects	O
indirectly	O
by	O
inhibiting	O
the	O
differentiation	O
of	O
mammary	O
stromal	O
cells	O
to	O
an	O
endothelial	O
cell	O
type	O
.	O

In	O
contrast	O
,	O
pellets	O
from	O
the	O
CLA	S-Chemical_Compound
-	O
fed	O
animals	O
contained	O
fewer	O
infiltrating	O
cells	O
,	O
which	O
formed	O
limited	O
branching	O
cellular	O
networks	O
,	O
the	O
majority	O
of	O
which	O
had	O
collapsed	O
lumen	O
and	O
no	O
RBCs	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrate	O
that	O
overexpression	O
of	O
TIMP	O
-	O
3	O
can	O
inhibit	O
angiogenesis	O
and	O
associated	O
tumor	O
growth	O
,	O
and	O
that	O
the	O
antiangiogenic	O
effects	O
of	O
TIMP	O
-	O
3	O
appear	O
to	O
be	O
mediated	O
through	O
the	O
inhibition	O
of	O
functional	O
capillary	O
morphogenesis	O
.	O

Looking	O
for	O
mechanisms	O
linking	O
Brn	O
-	O
3a	O
to	O
carcinogenesis	O
,	O
we	O
discuss	O
the	O
role	O
of	O
this	O
transcription	O
factor	O
in	O
influencing	O
Bcl	O
-	O
2	O
/	O
p53	O
antagonism	O
and	O
Bcl	O
-	O
2	O
/	O
VEGF	O
induction	O
of	O
tumor	O
angiogenesis	O
,	O
concluding	O
this	O
review	O
with	O
a	O
proposal	O
for	O
the	O
oncogenic	O
nature	O
of	O
Brn	O
-	O
3a	O
.	O

Keratinocyte	O
progenitor	O
cells	O
from	O
TPA	S-Chemical_Compound
-	O
treated	O
Tg	O
.	O
AC	O
mice	O
were	O
isolated	O
with	O
fluorescence	O
-	O
activated	O
cell	O
sorting	O
and	O
expression	O
was	O
analyzed	O
using	O
cDNA	O
microarray	O
technology	O
.	O

These	O
data	O
suggest	O
that	O
c	O
-	O
FLIP	O
may	O
play	O
a	O
critical	O
role	O
in	O
regulating	O
Fas	O
-	O
mediated	O
apoptosis	O
in	O
prostate	O
cancer	O
cells	O
and	O
that	O
modulation	O
of	O
c	O
-	O
FLIP	O
may	O
enhance	O
Fas	O
signaling	O
based	O
therapies	O
.	O

Therefore	O
,	O
understanding	O
these	O
signaling	O
mechanisms	O
may	O
provide	O
us	O
with	O
novel	O
ways	O
to	O
develop	O
strategies	O
for	O
treating	O
clinical	O
diseases	O
induced	O
by	O
these	O
cytokines	O
.	O

Glucose	S-Chemical_Compound
deprivation	O
-	O
mediated	O
sensitization	O
to	O
apoptosis	O
was	O
prevented	O
in	O
MCF	O
-	O
7	O
cells	O
overexpressing	O
BCL	O
-	O
2	O
.	O

Arteriogenesis	O
:	O
the	O
development	O
and	O
growth	O
of	O
collateral	O
arteries	O
.	O

The	O
term	O
"	O
arteriogenesis	O
"	O
was	O
introduced	O
to	O
differentiate	O
the	O
formation	O
of	O
collateral	O
arteries	O
from	O
angiogenesis	O
,	O
which	O
mainly	O
occurs	O
in	O
the	O
ischemic	O
,	O
collateral	O
flow	O
-	O
dependent	O
tissue	O
.	O

The	O
contribution	O
of	O
ischemia	O
to	O
arteriogenesis	O
is	O
still	O
unclear	O
,	O
but	O
arteriogenesis	O
clearly	O
can	O
occur	O
in	O
the	O
absence	O
of	O
any	O
significant	O
ischemia	O
.	O

Bee	O
venom	O
induces	O
apoptosis	O
and	O
inhibits	O
expression	O
of	O
cyclooxygenase	O
-	O
2	O
mRNA	O
in	O
human	O
lung	O
cancer	O
cell	O
line	O
NCI	O
-	O
H1299	O
.	O

To	O
investigate	O
whether	O
bee	O
venom	O
(	O
BV	O
)	O
induces	O
apoptosis	O
,	O
the	O
3	B-Chemical_Compound
-	I-Chemical_Compound
(	I-Chemical_Compound
4	I-Chemical_Compound
,	I-Chemical_Compound
5	I-Chemical_Compound
-	I-Chemical_Compound
dimethylthiazol	I-Chemical_Compound
-	I-Chemical_Compound
2	I-Chemical_Compound
-	I-Chemical_Compound
yl	I-Chemical_Compound
)	I-Chemical_Compound
-	I-Chemical_Compound
2	I-Chemical_Compound
,	I-Chemical_Compound
5	I-Chemical_Compound
-	I-Chemical_Compound
diphenyltetrazolium	I-Chemical_Compound
bromide	E-Chemical_Compound
assay	O
,	O
terminal	O
deoxynucleotidyl	O
transferase	O
-	O
mediated	O
dUTP	S-Chemical_Compound
nick	O
end	O
-	O
labeling	O
assay	O
,	O
4	B-Chemical_Compound
,	I-Chemical_Compound
6	I-Chemical_Compound
-	I-Chemical_Compound
diamidino	I-Chemical_Compound
-	I-Chemical_Compound
2	I-Chemical_Compound
-	I-Chemical_Compound
phenylindole	E-Chemical_Compound
staining	O
,	O
flow	O
cytometric	O
analysis	O
,	O
and	O
DNA	O
fragmentation	O
assay	O
were	O
performed	O
on	O
NCI	O
-	O
H1299	O
lung	O
cancer	O
cells	O
treated	O
with	O
BV	O
.	O

Histological	O
examination	O
of	O
ovarian	O
corrosion	O
casts	O
indicated	O
that	O
NS	B-Chemical_Compound
-	I-Chemical_Compound
398	E-Chemical_Compound
inhibited	O
the	O
establishment	O
of	O
luteal	O
capillary	O
vessels	O
following	O
the	O
injection	O
of	O
hCG	O
.	O

In	O
cultured	O
b	O
.	O
END5	O
cells	O
the	O
tumor	O
necrosis	O
factor	O
alpha	O
-	O
induced	O
up	O
-	O
regulation	O
of	O
intercellular	O
adhesion	O
molecule	O
1	O
and	O
vascular	O
cell	O
adhesion	O
molecule	O
1	O
was	O
reduced	O
in	O
ECs	O
that	O
were	O
preincubated	O
with	O
basic	O
fibroblast	O
growth	O
factor	O
or	O
vascular	O
endothelial	O
growth	O
factor	O
.	O

Truncated	O
galectin	O
-	O
3	O
inhibits	O
tumor	O
growth	O
and	O
metastasis	O
in	O
orthotopic	O
nude	O
mouse	O
model	O
of	O
human	O
breast	O
cancer	O
.	O

Vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
,	O
a	O
recently	O
identified	O
growth	O
factor	O
with	O
significant	O
angiogenic	O
properties	O
,	O
may	O
be	O
a	O
major	O
tumor	O
angiogenesis	O
regulator	O
.	O

Under	O
conditions	O
mimicking	O
the	O
injection	O
environment	O
,	O
the	O
lipoplex	S-Chemical_Compound
-	O
serum	O
interaction	O
was	O
strongly	O
dependent	O
on	O
helper	O
lipid	S-Chemical_Compound
and	O
ionic	O
strength	O
:	O
lipoplexes	S-Chemical_Compound
prepared	O
in	O
150	O
mM	O
NaCl	O
or	O
lipoplexes	S-Chemical_Compound
with	O
high	O
(	O
greater	O
than	O
33	O
mol	O
%	O
)	O
cholesterol	S-Chemical_Compound
were	O
found	O
to	O
aggregate	O
immediately	O
.	O

Retinopathy	O
is	O
the	O
most	O
common	O
microvascular	O
diabetes	O
complication	O
and	O
represents	O
a	O
major	O
threat	O
to	O
the	O
eyesight	O
.	O

PEDF	O
is	O
an	O
important	O
negative	O
regulator	O
of	O
angiogenic	O
activity	O
of	O
aqueous	O
humor	O
.	O

These	O
data	O
indicate	O
that	O
endogenous	O
IL	O
-	O
1	O
is	O
a	O
mediator	O
of	O
ischaemic	O
and	O
excitotoxic	O
brain	O
damage	O
,	O
and	O
that	O
inhibitors	O
of	O
IL	O
-	O
1	O
action	O
may	O
be	O
of	O
therapeutic	O
value	O
in	O
the	O
treatment	O
of	O
acute	O
or	O
chronic	O
neuronal	O
death	O
.	O

The	O
activity	O
of	O
the	O
Tie1	O
promoter	O
is	O
suppressed	O
by	O
shear	O
stress	O
and	O
by	O
tumor	O
necrosis	O
factor	O
alpha	O
.	O

Cells	O
cannot	O
survive	O
extended	O
severe	O
ischemia	O
but	O
may	O
be	O
able	O
to	O
adapt	O
to	O
a	O
moderate	O
condition	O
where	O
diffusion	O
to	O
and	O
from	O
bordering	O
nonischemic	O
regions	O
sustains	O
vital	O
functions	O
.	O

Lipid	S-Chemical_Compound
/	O
cholesterol	S-Chemical_Compound
-	O
lowering	O
agents	O
,	O
diet	O
and	O
antiplatelet	O
adherence	O
(	O
aspirin	S-Chemical_Compound
)	O
therapy	O
may	O
help	O
slow	O
the	O
progression	O
of	O
vessel	O
disease	O
in	O
some	O
instances	O
;	O
but	O
surgical	O
reconstruction	O
may	O
be	O
the	O
only	O
option	O
in	O
advanced	O
stages	O
,	O
and	O
even	O
this	O
is	O
not	O
always	O
an	O
option	O
.	O

During	O
the	O
last	O
decade	O
,	O
a	O
significant	O
body	O
of	O
evidence	O
has	O
accumulated	O
,	O
indicating	O
that	O
expression	O
of	O
the	O
components	O
of	O
the	O
IGF	O
system	O
are	O
regulated	O
by	O
multiple	O
factors	O
,	O
including	O
growth	O
factors	O
,	O
cytokines	O
,	O
lipoproteins	O
,	O
reactive	B-Chemical_Compound
oxygen	I-Chemical_Compound
species	E-Chemical_Compound
,	O
and	O
hemodynamic	O
forces	O
.	O

Microvascular	O
density	O
and	O
vascular	O
endothelial	O
growth	O
factor	O
immunoreactivity	O
as	O
predictors	O
of	O
regional	O
lymph	O
node	O
metastasis	O
from	O
betel	O
-	O
associated	O
oral	O
squamous	O
cell	O
carcinoma	O
.	O

Malignant	O
cells	O
often	O
display	O
defects	O
in	O
autophagy	O
,	O
an	O
evolutionarily	O
conserved	O
pathway	O
for	O
degrading	O
long	O
-	O
lived	O
proteins	O
and	O
cytoplasmic	O
organelles	O
.	O

Effects	O
of	O
dietary	O
folate	S-Chemical_Compound
on	O
ulcerative	O
colitis	O
-	O
associated	O
colorectal	O
carcinogenesis	O
in	O
the	O
interleukin	O
2	O
-	O
and	O
beta	O
(	O
2	O
)	O
-	O
microglobulin	O
-	O
deficient	O
mice	O
.	O

Most	O
Group	O
I	O
compounds	O
except	O
doxorubicin	S-Chemical_Compound
(	O
which	O
induced	O
DNA	O
fragmentation	O
less	O
effectively	O
than	O
others	O
)	O
activated	O
caspase	O
3	O
more	O
efficiently	O
than	O
Group	O
II	O
compounds	O
.	O

Caspase	O
8	O
(	O
involved	O
in	O
non	O
-	O
mitochondrial	O
extrinsic	O
pathway	O
)	O
and	O
caspase	O
9	O
(	O
involved	O
in	O
mitochondrial	O
intrinsic	O
pathway	O
)	O
were	O
also	O
activated	O
,	O
but	O
to	O
a	O
much	O
lesser	O
extent	O
.	O

This	O
chapter	O
focuses	O
on	O
the	O
morphology	O
of	O
blood	O
vessel	O
formation	O
in	O
and	O
around	O
the	O
early	O
central	O
nervous	O
system	O
(	O
CNS	O
,	O
i	O
.	O
e	O
.	O
,	O
brain	O
and	O
spinal	O
cord	O
)	O
of	O
avian	O
embryos	O
.	O

Here	O
we	O
report	O
that	O
a	O
candidate	O
tumour	O
suppressor	O
gene	O
,	O
ING4	O
,	O
is	O
involved	O
in	O
regulating	O
brain	O
tumour	O
growth	O
and	O
angiogenesis	O
.	O

Subsequently	O
this	O
activity	O
was	O
separated	O
into	O
TGFbeta	O
and	O
TGFalpha	O
an	O
EGF	O
receptor	O
ligand	O
.	O

Similar	O
results	O
have	O
been	O
obtained	O
with	O
tumor	O
cell	O
lines	O
and	O
experimental	O
animal	O
models	O
.	O

Thus	O
stage	O
specific	O
duality	O
of	O
function	O
is	O
the	O
emerging	O
paradigm	O
for	O
the	O
role	O
of	O
TGFbeta1	O
in	O
cancer	O
.	O

Lactoferrin	O
enhances	O
Fas	O
expression	O
and	O
apoptosis	O
in	O
the	O
colon	O
mucosa	O
of	O
azoxymethane	S-Chemical_Compound
-	O
treated	O
rats	O
.	O

Pak1	O
-	O
DLC1	O
interaction	O
plays	O
an	O
essential	O
role	O
in	O
cell	O
survival	O
,	O
which	O
depends	O
on	O
Pak1	O
'	O
s	O
phosphorylation	O
of	O
DLC1	O
on	O
Ser88	O
.	O

Matrix	O
metalloproteinase	O
activity	O
,	O
determined	O
using	O
a	O
quenched	O
fluorescence	O
substrate	O
assay	O
,	O
increased	O
during	O
early	O
healing	O
(	O
3	O
-	O
8	O
weeks	O
)	O
compared	O
to	O
controls	O
,	O
and	O
then	O
decreased	O
between	O
24	O
and	O
36	O
weeks	O
after	O
surgery	O
(	O
p	O
less	O
than	O
0	O
.	O
05	O
until	O
24	O
weeks	O
,	O
Mann	O
-	O
Whitney	O
U	O
-	O
test	O
)	O
.	O

Tissue	O
inhibitor	O
of	O
metalloproteinase	O
-	O
1	O
staining	O
was	O
relatively	O
sparse	O
but	O
was	O
significantly	O
increased	O
until	O
8	O
weeks	O
after	O
surgery	O
.	O

We	O
hypothesized	O
that	O
IGF	O
-	O
1	O
-	O
transfected	O
smooth	O
muscle	O
cells	O
(	O
SMCs	O
)	O
would	O
enhance	O
cell	O
survival	O
and	O
improve	O
engraftment	O
after	O
cell	O
transplantation	O
.	O

IGF	O
-	O
1	O
-	O
transfected	O
cells	O
demonstrated	O
greater	O
cell	O
proliferation	O
,	O
stimulated	O
angiogenesis	O
,	O
and	O
decreased	O
caspase	O
-	O
3	O
activity	O
after	O
simulated	O
ischemia	O
and	O
reperfusion	O
(	O
P	O
less	O
than	O
0	O
.	O
05	O
for	O
all	O
groups	O
compared	O
with	O
vector	O
or	O
cell	O
controls	O
)	O
.	O

OBJECTIVE	O
:	O
To	O
investigate	O
the	O
expression	O
of	O
PTEN	O
and	O
loss	O
of	O
heterozygosity	O
(	O
LOH	O
)	O
of	O
its	O
epigenetic	O
microsatellite	O
in	O
gastric	O
carcinoma	O
and	O
explore	O
their	O
roles	O
in	O
progression	O
of	O
gastric	O
carcinoma	O
.	O

There	O
was	O
positive	O
correlation	O
between	O
PTEN	O
mRNA	O
expression	O
and	O
LOH	O
of	O
microsatellites	O
in	O
advanced	O
gastric	O
carcinomas	O
.	O

Granulocyte	O
-	O
macrophage	O
colony	O
-	O
stimulating	O
factor	O
and	O
interleukin	O
-	O
3	O
enhance	O
the	O
incorporation	O
of	O
cytosine	B-Chemical_Compound
arabinoside	E-Chemical_Compound
into	O
the	O
DNA	O
of	O
leukemic	O
blasts	O
and	O
the	O
cytotoxic	O
effect	O
on	O
clonogenic	O
cells	O
from	O
patients	O
with	O
acute	O
myeloid	O
leukemia	O
.	O

After	O
GM	O
-	O
CSF	O
or	O
IL	O
-	O
3	O
,	O
a	O
1	O
.	O
2	O
-	O
to	O
2	O
.	O
4	O
-	O
fold	O
increase	O
in	O
S	O
-	O
phase	O
cells	O
was	O
observed	O
in	O
nine	O
of	O
14	O
GM	O
-	O
CSF	O
and	O
seven	O
of	O
11	O
IL	O
-	O
3	O
cases	O
.	O

Prolonged	O
silencing	O
of	O
both	O
MCTs	O
reduced	O
viability	O
by	O
75	O
%	O
individually	O
and	O
92	O
%	O
in	O
combination	O
,	O
as	O
measured	O
by	O
both	O
phenotypic	O
and	O
flow	O
cytometric	O
analyses	O
.	O

Hypoxia	O
-	O
activated	O
functional	O
HIF	O
-	O
1	O
protein	O
binds	O
to	O
hypoxia	O
-	O
responsive	O
elements	O
(	O
HRE	O
)	O
in	O
the	O
enhancers	O
of	O
several	O
genes	O
including	O
VEGF	O
,	O
the	O
major	O
player	O
in	O
angiogenesis	O
,	O
and	O
initiates	O
their	O
mRNA	O
expression	O
.	O

The	O
molecular	O
mechanisms	O
regulating	O
the	O
gene	O
expression	O
under	O
hypoxic	O
conditions	O
could	O
increase	O
the	O
therapeutic	O
window	O
of	O
tumor	O
-	O
specific	O
delivery	O
systems	O
.	O

EXPERIMENTAL	O
DESIGN	O
:	O
In	O
this	O
study	O
all	O
of	O
the	O
major	O
members	O
of	O
the	O
matrix	O
metalloproteinase	O
(	O
MMP	O
-	O
1	O
,	O
MMP	O
-	O
2	O
,	O
MMP	O
-	O
3	O
,	O
MMP	O
-	O
7	O
,	O
MMP	O
-	O
9	O
,	O
MMP	O
-	O
13	O
,	O
MT1	O
-	O
MMP	O
and	O
MT2	O
-	O
MMP	O
)	O
/	O
tissue	O
inhibitor	O
of	O
matrix	O
metalloproteinase	O
(	O
TIMP	O
-	O
1	O
,	O
TIMP	O
-	O
2	O
,	O
and	O
TIMP	O
-	O
3	O
)	O
system	O
have	O
been	O
investigated	O
by	O
immunohistochemistry	O
in	O
a	O
series	O
(	O
n	O
=	O
90	O
)	O
of	O
stage	O
III	O
(	O
Dukes	O
'	O
C	O
)	O
colorectal	O
cancers	O
.	O

2	B-Chemical_Compound
-	I-Chemical_Compound
methoxyestradiol	E-Chemical_Compound
inhibits	O
hypoxia	O
-	O
inducible	O
factor	O
1alpha	O
,	O
tumor	O
growth	O
,	O
and	O
angiogenesis	O
and	O
augments	O
paclitaxel	S-Chemical_Compound
efficacy	O
in	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
.	O

HIF	O
-	O
2alpha	O
expression	O
in	O
human	O
fetal	O
paraganglia	O
and	O
neuroblastoma	O
:	O
relation	O
to	O
sympathetic	O
differentiation	O
,	O
glucose	S-Chemical_Compound
deficiency	O
,	O
and	O
hypoxia	O
.	O

HIF	O
-	O
2alpha	O
was	O
detected	O
in	O
hypoxic	O
and	O
in	O
well	O
-	O
oxygenized	O
neuroblastoma	O
cells	O
and	O
tissue	O
,	O
presumably	O
reflecting	O
their	O
embryonic	O
features	O
.	O

Expression	O
and	O
purification	O
of	O
the	O
catalytic	O
domain	O
of	O
human	O
vascular	O
endothelial	O
growth	O
factor	O
receptor	O
2	O
for	O
inhibitor	O
screening	O
.	O

Treatment	O
of	O
NIH3T3	O
/	O
KDR	O
cells	O
with	O
TKI	B-Chemical_Compound
-	I-Chemical_Compound
31	E-Chemical_Compound
blocked	O
VEGF	O
-	O
induced	O
phosphorylation	O
of	O
KDR	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

These	O
results	O
indicate	O
that	O
the	O
INK4B	O
locus	O
,	O
similarly	O
to	O
INK4A	O
-	O
ARF	O
,	O
harbors	O
two	O
different	O
splicing	O
variants	O
that	O
can	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
both	O
the	O
p53	O
and	O
retinoblastoma	O
pathways	O
,	O
the	O
two	O
major	O
molecular	O
pathways	O
in	O
tumor	O
suppression	O
.	O

Rofecoxib	S-Chemical_Compound
as	O
adjunctive	O
therapy	O
for	O
haemophilic	O
arthropathy	O
.	O

These	O
properties	O
make	O
such	O
agents	O
potentially	O
useful	O
as	O
adjunctive	O
therapy	O
in	O
haemophilia	O
.	O

There	O
is	O
only	O
one	O
prior	O
report	O
describing	O
rofecoxib	S-Chemical_Compound
treatment	O
in	O
a	O
single	O
haemophilia	O
patient	O
.	O

The	O
safety	O
and	O
efficacy	O
of	O
rofecoxib	S-Chemical_Compound
treatment	O
were	O
determined	O
based	O
on	O
subjective	O
patient	O
reports	O
and	O
physical	O
examinations	O
during	O
follow	O
-	O
up	O
clinic	O
visits	O
.	O

All	O
courses	O
were	O
evaluated	O
for	O
safety	O
and	O
31	O
for	O
efficacy	O
.	O

Thalidomide	S-Chemical_Compound
and	O
angiostatin	O
inhibit	O
tumor	O
growth	O
in	O
a	O
murine	O
xenograft	O
model	O
of	O
human	O
cervical	O
cancer	O
.	O

Mice	O
that	O
received	O
either	O
IR	O
or	O
TEMF	O
had	O
significantly	O
fewer	O
lung	O
metastatic	O
sites	O
and	O
slower	O
tumor	O
growth	O
than	O
did	O
untreated	O
mice	O
.	O

The	O
adenomatous	O
polyposis	O
coli	O
(	O
APC	O
)	O
gene	O
,	O
whose	O
mutations	O
are	O
responsible	O
for	O
familial	O
adenomatous	O
polyposis	O
,	O
is	O
a	O
major	O
negative	O
controller	O
of	O
the	O
Wnt	O
/	O
beta	O
-	O
catenin	O
pathway	O
.	O

To	O
investigate	O
the	O
dose	O
-	O
dependent	O
effects	O
of	O
APC	O
protein	O
in	O
suppressing	O
intestinal	O
tumorigenesis	O
,	O
we	O
constructed	O
mutant	O
mice	O
carrying	O
hypomorphic	O
Apc	O
alleles	O
Apc	O
(	O
neoR	O
)	O
and	O
Apc	O
(	O
neoF	O
)	O
whose	O
expression	O
levels	O
were	O
reduced	O
to	O
20	O
%	O
and	O
10	O
%	O
of	O
the	O
wild	O
type	O
,	O
respectively	O
.	O

Like	O
in	O
Apc	O
(	O
Delta716	O
)	O
mice	O
,	O
loss	O
of	O
the	O
wild	O
-	O
type	O
Apc	O
allele	O
was	O
confirmed	O
for	O
all	O
polyps	O
examined	O
in	O
the	O
Apc	O
(	O
neoR	O
)	O
and	O
Apc	O
(	O
neoF	O
)	O
mice	O
.	O

We	O
further	O
estimated	O
the	O
threshold	O
of	O
APC	O
protein	O
level	O
that	O
forms	O
one	O
polyp	O
per	O
mouse	O
as	O
approximately	O
15	O
%	O
of	O
the	O
wild	O
type	O
.	O

Domain	O
5	O
of	O
cleaved	O
high	O
molecular	O
weight	O
kininogen	O
inhibits	O
endothelial	O
cell	O
migration	O
through	O
Akt	O
.	O

Effect	O
of	O
thalidomide	S-Chemical_Compound
affecting	O
VEGF	O
secretion	O
,	O
cell	O
migration	O
,	O
adhesion	O
and	O
capillary	O
tube	O
formation	O
of	O
human	O
endothelial	O
EA	O
.	O
hy	O
926	O
cells	O
.	O

Additional	O
analysis	O
of	O
the	O
mechanism	O
of	O
action	O
of	O
Go6976	S-Chemical_Compound
(	O
RT	O
-	O
PCR	O
,	O
Western	O
blots	O
,	O
and	O
immunohistochemistry	O
)	O
of	O
the	O
changes	O
in	O
the	O
phosphorylated	O
and	O
nonphosphorylated	O
forms	O
of	O
PKCalpha	O
in	O
the	O
cell	O
membrane	O
and	O
cytoplasm	O
confirmed	O
the	O
specificity	O
of	O
PKCalpha	O
inhibition	O
by	O
Go6976	S-Chemical_Compound
.	O

In	O
this	O
study	O
,	O
we	O
applied	O
a	O
proteomics	O
strategy	O
to	O
identify	O
novel	O
proteins	O
involved	O
in	O
ECM	O
modeling	O
that	O
are	O
regulated	O
by	O
LRP	O
-	O
1	O
.	O

L	B-Chemical_Compound
-	I-Chemical_Compound
Carnitine	E-Chemical_Compound
ameliorates	O
methotrexate	S-Chemical_Compound
-	O
induced	O
oxidative	O
organ	O
injury	O
and	O
inhibits	O
leukocyte	O
death	O
.	O

Similarly	O
,	O
flow	O
cytometric	O
measurements	O
revealed	O
that	O
leukocyte	O
apoptosis	O
was	O
increased	O
in	O
MTX	S-Chemical_Compound
-	O
treated	O
animals	O
,	O
while	O
L	B-Chemical_Compound
-	I-Chemical_Compound
Car	E-Chemical_Compound
reversed	O
these	O
effects	O
.	O

A	O
role	O
for	O
NF	O
-	O
kappaB	O
in	O
cancer	O
cells	O
appears	O
to	O
involve	O
regulation	O
of	O
cell	O
proliferation	O
,	O
control	O
of	O
apoptosis	O
,	O
promotion	O
of	O
angiogenesis	O
,	O
and	O
stimulation	O
of	O
invasion	O
/	O
metastasis	O
.	O

Analysis	O
of	O
Runx2	O
-	O
expressing	O
lymphomas	O
reveals	O
a	O
consistently	O
low	O
rate	O
of	O
apoptosis	O
,	O
in	O
contrast	O
to	O
lymphomas	O
of	O
MYC	O
mice	O
which	O
are	O
often	O
highly	O
apoptotic	O
.	O

The	O
low	O
apoptosis	O
phenotype	O
is	O
dominant	O
in	O
Runx2	O
/	O
MYC	O
tumors	O
,	O
indicating	O
that	O
Runx2	O
confers	O
a	O
potent	O
survival	O
advantage	O
to	O
MYC	O
-	O
expressing	O
tumor	O
cells	O
.	O

Our	O
results	O
show	O
that	O
Runx2	O
and	O
MYC	O
overcome	O
distinct	O
"	O
fail	O
-	O
safe	O
"	O
responses	O
and	O
that	O
their	O
selection	O
as	O
collaborating	O
genes	O
is	O
due	O
to	O
their	O
ability	O
to	O
neutralize	O
each	O
other	O
'	O
s	O
negative	O
growth	O
effect	O
.	O

In	O
cervical	O
cancer	O
cells	O
,	O
paclitaxel	S-Chemical_Compound
induced	O
apoptosis	O
through	O
an	O
intrinsic	O
pathway	O
with	O
prior	O
G2	O
/	O
M	O
arrest	O
.	O

Hyperfibrinogenemia	O
is	O
associated	O
with	O
lymphatic	O
as	O
well	O
as	O
hematogenous	O
metastasis	O
and	O
worse	O
clinical	O
outcome	O
in	O
T2	O
gastric	O
cancer	O
.	O

Our	O
aim	O
is	O
to	O
verify	O
the	O
alterations	O
in	O
the	O
HRK	O
gene	O
in	O
primary	O
central	O
nervous	O
system	O
lymphomas	O
(	O
PCNSLs	O
)	O
.	O

For	O
patients	O
with	O
limb	O
threatening	O
ischaemia	O
the	O
only	O
option	O
for	O
relief	O
of	O
rest	O
pain	O
or	O
gangraena	O
is	O
amputation	O
.	O

The	O
data	O
support	O
the	O
concept	O
that	O
a	O
positive	O
relationship	O
exists	O
between	O
the	O
density	O
of	O
blood	O
vessels	O
and	O
the	O
formation	O
of	O
bone	O
.	O

METHODS	O
:	O
Immunohistochemistry	O
was	O
used	O
to	O
determine	O
the	O
distribution	O
of	O
opticin	O
in	O
normal	O
human	O
CBE	O
,	O
and	O
in	O
hyperplastic	O
and	O
neoplastic	O
CBE	O
lesions	O
.	O

Because	O
of	O
this	O
,	O
and	O
the	O
virtual	O
explosion	O
of	O
interest	O
in	O
pomegranate	O
as	O
a	O
medicinal	O
and	O
nutritional	O
product	O
that	O
has	O
followed	O
,	O
this	O
review	O
is	O
accordingly	O
launched	O
.	O

The	O
tree	O
/	O
fruit	O
can	O
be	O
divided	O
into	O
several	O
anatomical	O
compartments	O
:	O
(	O
1	O
)	O
seed	O
,	O
(	O
2	O
)	O
juice	O
,	O
(	O
3	O
)	O
peel	O
,	O
(	O
4	O
)	O
leaf	O
,	O
(	O
5	O
)	O
flower	O
,	O
(	O
6	O
)	O
bark	O
,	O
and	O
(	O
7	O
)	O
roots	O
,	O
each	O
of	O
which	O
has	O
interesting	O
pharmacologic	O
activity	O
.	O

To	O
test	O
the	O
hypothesis	O
that	O
20	B-Chemical_Compound
-	I-Chemical_Compound
HETE	E-Chemical_Compound
increases	O
endothelial	O
cell	O
(	O
EC	O
)	O
proliferation	O
via	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
,	O
we	O
studied	O
the	O
effects	O
of	O
WIT003	S-Chemical_Compound
[	O
20	B-Chemical_Compound
-	I-Chemical_Compound
hydroxyeicosa	I-Chemical_Compound
-	I-Chemical_Compound
5	I-Chemical_Compound
(	I-Chemical_Compound
Z	I-Chemical_Compound
)	I-Chemical_Compound
,	I-Chemical_Compound
14	I-Chemical_Compound
(	I-Chemical_Compound
Z	I-Chemical_Compound
)	I-Chemical_Compound
-	I-Chemical_Compound
dienoic	I-Chemical_Compound
acid	E-Chemical_Compound
]	O
,	O
a	O
20	B-Chemical_Compound
-	I-Chemical_Compound
HETE	E-Chemical_Compound
analog	O
on	O
human	O
macrovascular	O
or	O
microvascular	O
EC	O
.	O

We	O
have	O
reported	O
important	O
benefits	O
and	O
survival	O
with	O
an	O
immunotherapy	O
schedule	O
in	O
patients	O
with	O
endocrine	O
-	O
dependent	O
breast	O
cancer	O
and	O
distant	O
metastases	O
.	O

In	O
32	O
evaluated	O
breast	O
cancer	O
patients	O
with	O
endocrine	O
-	O
dependent	O
distant	O
metastases	O
treated	O
with	O
a	O
new	O
immunotherapy	O
schedule	O
(	O
cyclic	O
administration	O
of	O
beta	O
-	O
interferon	O
and	O
interleukin	O
-	O
2	O
)	O
,	O
cellular	O
immunity	O
,	O
cytokines	O
and	O
CRP	O
were	O
related	O
to	O
the	O
clinical	O
course	O
.	O

Interleukin	O
-	O
2	O
administration	O
was	O
followed	O
by	O
a	O
significant	O
increase	O
in	O
total	O
lymphocytes	O
,	O
CD4	O
+	O
,	O
CD8	O
+	O
,	O
CD16	O
+	O
56	O
+	O
(	O
NK	O
)	O
cells	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
12	O
,	O
and	O
CRP	O
(	O
from	O
P	O
<	O
0	O
.	O
04	O
to	O
P	O
<	O
0	O
.	O
000	O
)	O
but	O
no	O
change	O
in	O
IL	O
-	O
10	O
and	O
TGFbeta1	O
during	O
clinical	O
benefit	O
.	O

Trib1	O
and	O
Evi1	O
were	O
up	O
-	O
regulated	O
due	O
to	O
retroviral	O
insertions	O
,	O
and	O
coexpression	O
of	O
these	O
genes	O
significantly	O
accelerated	O
the	O
onset	O
of	O
Hoxa9	O
/	O
Meis1	O
-	O
induced	O
AML	O
,	O
suggesting	O
that	O
Trib1	O
and	O
Evi1	O
are	O
the	O
key	O
collaborators	O
.	O

These	O
results	O
demonstrate	O
the	O
importance	O
of	O
specific	O
oncogene	O
interaction	O
in	O
myeloid	O
leukemogenesis	O
.	O

Papilloma	O
formation	O
was	O
observed	O
in	O
both	O
the	O
DMBA	S-Chemical_Compound
-	O
TPA	S-Chemical_Compound
-	O
and	O
DMBA	S-Chemical_Compound
-	O
Cum	B-Chemical_Compound
-	I-Chemical_Compound
OOH	E-Chemical_Compound
-	O
exposed	O
animals	O
,	O
whereas	O
skin	O
carcinomas	O
were	O
found	O
only	O
in	O
the	O
DMBA	S-Chemical_Compound
-	O
Cum	B-Chemical_Compound
-	I-Chemical_Compound
OOH	E-Chemical_Compound
-	O
treated	O
mice	O
.	O

John	O
'	O
s	O
wort	O
(	O
Hypericum	O
perforatum	O
)	O
,	O
has	O
emerged	O
as	O
key	O
player	O
not	O
only	O
in	O
the	O
antidepressant	O
activity	O
of	O
the	O
plant	O
but	O
also	O
as	O
an	O
inhibitor	O
of	O
bacteria	O
lymphocyte	O
and	O
tumor	O
cell	O
proliferation	O
,	O
and	O
matrix	O
proteinases	O
.	O

PMN	O
-	O
triggered	O
angiogenesis	O
is	O
also	O
blocked	O
by	O
both	O
local	O
injection	O
and	O
daily	O
i	O
.	O
p	O
.	O
administration	O
of	O
the	O
Hyp	S-Chemical_Compound
salt	O
in	O
an	O
interleukin	O
-	O
8	O
-	O
induced	O
murine	O
model	O
.	O

These	O
results	O
indicate	O
that	O
Hyp	S-Chemical_Compound
is	O
a	O
powerful	O
anti	O
-	O
inflammatory	O
compound	O
with	O
therapeutic	O
potential	O
,	O
and	O
they	O
elucidate	O
mechanistic	O
keys	O
.	O

Because	O
failure	O
of	O
endothelial	O
cell	O
apoptosis	O
might	O
lead	O
to	O
intimal	O
proliferation	O
and	O
lack	O
of	O
reversibility	O
of	O
PHT	O
,	O
we	O
investigated	O
this	O
and	O
other	O
key	O
markers	O
of	O
vasoactivity	O
and	O
angiogenesis	O
in	O
subjects	O
with	O
PHT	O
and	O
CHD	O
.	O

RESULTS	O
:	O
The	O
antiapoptotic	O
protein	O
Bcl	O
-	O
2	O
was	O
highly	O
expressed	O
by	O
pulmonary	O
endothelial	O
cells	O
in	O
all	O
cases	O
of	O
irreversible	O
PHT	O
but	O
in	O
no	O
cases	O
of	O
reversible	O
PHT	O
,	O
nor	O
in	O
control	O
patients	O
(	O
p	O
less	O
than	O
0	O
.	O
001	O
)	O
.	O

Intimal	O
proliferation	O
was	O
present	O
in	O
10	O
of	O
11	O
irreversible	O
PHT	O
cases	O
,	O
but	O
never	O
observed	O
in	O
reversible	O
PHT	O
(	O
p	O
less	O
than	O
0	O
.	O
001	O
)	O
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
Tsg101	O
is	O
highly	O
expressed	O
in	O
a	O
subset	O
of	O
invasive	O
human	O
breast	O
cancers	O
.	O

Consequently	O
,	O
we	O
examined	O
by	O
immunohistochemistry	O
,	O
using	O
the	O
avidin	O
-	O
biotin	S-Chemical_Compound
-	O
peroxidase	O
method	O
,	O
Bcl	O
-	O
xL	O
,	O
Bax	O
,	O
and	O
p53	O
expression	O
in	O
56	O
samples	O
of	O
primary	O
oral	O
squamous	O
cell	O
carcinoma	O
and	O
in	O
22	O
matched	O
pairs	O
of	O
primary	O
and	O
metastatic	O
tumors	O
.	O

We	O
found	O
positive	O
Bcl	O
-	O
xL	O
,	O
Bax	O
,	O
and	O
p53	O
immunostaining	O
in	O
44	O
.	O
6	O
%	O
,	O
28	O
.	O
6	O
%	O
,	O
and	O
58	O
.	O
9	O
%	O
of	O
the	O
studied	O
primary	O
tumors	O
and	O
in	O
63	O
.	O
6	O
%	O
,	O
45	O
.	O
5	O
%	O
,	O
and	O
72	O
.	O
7	O
%	O
of	O
lymph	O
node	O
metastases	O
,	O
respectively	O
.	O

An	O
antibody	O
directed	O
against	O
PDGF	O
receptor	O
beta	O
enhances	O
the	O
antitumor	O
and	O
the	O
anti	O
-	O
angiogenic	O
activities	O
of	O
an	O
anti	O
-	O
VEGF	O
receptor	O
2	O
antibody	O
.	O

The	O
antibody	O
also	O
blocks	O
ligand	O
-	O
stimulated	O
activation	O
of	O
PDGFRbeta	O
and	O
downstream	O
signaling	O
molecules	O
,	O
including	O
Akt	O
and	O
MAPK	O
p42	O
/	O
44	O
,	O
in	O
tumor	O
cells	O
.	O

Treatment	O
with	O
the	O
combination	O
of	O
1B3	S-Chemical_Compound
and	O
DC101	S-Chemical_Compound
in	O
BxPC	O
-	O
3	O
xenograft	O
-	O
bearing	O
mice	O
resulted	O
in	O
tumor	O
regression	O
in	O
58	O
%	O
of	O
mice	O
compared	O
to	O
that	O
in	O
18	O
%	O
of	O
mice	O
treated	O
with	O
DC101	S-Chemical_Compound
alone	O
.	O

We	O
show	O
that	O
HIF	O
-	O
1alpha	O
and	O
VEGF	O
are	O
increased	O
through	O
A3	O
adenosine	O
receptor	O
stimulation	O
,	O
whereas	O
the	O
effects	O
on	O
IL	O
-	O
8	O
are	O
mediated	O
via	O
the	O
A2B	O
subtype	O
.	O

There	O
is	O
comparatively	O
less	O
evidence	O
to	O
support	O
the	O
use	O
of	O
other	O
treatment	O
modalities	O
for	O
relief	O
of	O
symptoms	O
in	O
intermittent	O
claudication	O
,	O
but	O
there	O
is	O
considerable	O
interest	O
in	O
therapeutic	O
angiogenesis	O
to	O
promote	O
new	O
vessel	O
formation	O
and	O
enhance	O
collateralisation	O
of	O
the	O
lower	O
limb	O
using	O
recombinant	O
growth	O
factor	O
proteins	O
or	O
gene	O
transfer	O
strategies	O
.	O

In	O
agreement	O
,	O
induced	O
overexpression	O
of	O
VEGF	O
-	O
C	O
in	O
LAPC	O
-	O
9	O
enhanced	O
tumor	O
lymphangiogenesis	O
leading	O
to	O
the	O
development	O
of	O
metastatic	O
lesions	O
.	O

The	O
mean	O
BCVA	O
increased	O
from	O
20	O
/	O
76	O
to	O
20	O
/	O
64	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
Ang1	O
halts	O
the	O
ability	O
of	O
VEGF	O
to	O
induce	O
the	O
phosphorylation	O
-	O
dependent	O
redistribution	O
of	O
the	O
adhesion	O
molecule	O
VE	O
-	O
cadherin	O
,	O
thereby	O
rescuing	O
the	O
endothelial	O
barrier	O
function	O
.	O

We	O
did	O
not	O
found	O
any	O
mutation	O
in	O
de	O
novo	O
BCR	O
-	O
ABL	O
+	O
ALLs	O
or	O
lymphoid	O
BC	O
CML	O
.	O

Emergence	O
of	O
the	O
RUNX1	O
mutations	O
was	O
detected	O
at	O
diagnosis	O
or	O
before	O
the	O
acquisition	O
of	O
trisomy	O
21	O
during	O
disease	O
progression	O
.	O

PATIENTS	O
AND	O
METHODS	O
:	O
Twenty	O
-	O
one	O
patients	O
with	O
radiation	O
retinopathy	O
(	O
edema	O
,	O
hemorrhages	O
,	O
capillary	O
dropout	O
,	O
and	O
neovascularization	O
)	O
and	O
a	O
subjective	O
or	O
objective	O
loss	O
of	O
vision	O
were	O
treated	O
.	O

RESULTS	O
:	O
Bevacizumab	S-Chemical_Compound
treatment	O
was	O
followed	O
by	O
reductions	O
in	O
retinal	O
hemorrhage	O
,	O
exudation	O
,	O
and	O
edema	O
.	O

CONCLUSIONS	O
:	O
Intravitreal	O
bevacizumab	S-Chemical_Compound
can	O
be	O
used	O
to	O
treat	O
radiation	O
retinopathy	O
.	O

We	O
hypothesized	O
that	O
signaling	O
through	O
multiple	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
kinase	O
(	O
MKK	O
)	O
pathways	O
is	O
essential	O
for	O
the	O
growth	O
and	O
vascularization	O
of	O
soft	O
-	O
tissue	O
sarcomas	O
,	O
which	O
are	O
malignant	O
tumors	O
derived	O
from	O
mesenchymal	O
tissues	O
.	O

Nucleotide	O
sequence	O
analysis	O
of	O
a	O
3116bp	O
cDNA	O
clone	O
revealed	O
a	O
2682	O
-	O
bp	O
-	O
long	O
open	O
reading	O
frame	O
capable	O
of	O
directing	O
the	O
synthesis	O
of	O
a	O
894	O
amino	O
acid	O
polypeptide	O
.	O

The	O
UFO	O
proto	O
-	O
oncogene	O
maps	O
to	O
human	O
chromosome	O
19q13	O
.	O
1	O
and	O
is	O
transcribed	O
into	O
two	O
5	O
.	O
0	O
kb	O
and	O
3	O
.	O
2	O
kb	O
mRNAs	O
in	O
human	O
bone	O
marrow	O
and	O
human	O
tumor	O
cell	O
lines	O
.	O

Proteomic	O
comparison	O
of	O
nasopharyngeal	O
cancer	O
cell	O
lines	O
C666	O
-	O
1	O
and	O
NP69	O
identifies	O
down	O
-	O
regulation	O
of	O
annexin	O
II	O
and	O
beta2	O
-	O
tubulin	O
for	O
nasopharyngeal	O
carcinoma	O
.	O

OBJECTIVES	O
:	O
To	O
compare	O
the	O
proteomic	O
expression	O
profile	O
between	O
an	O
Epstein	O
-	O
Barr	O
virus	O
-	O
associated	O
NPC	O
cell	O
line	O
(	O
C666	O
-	O
1	O
)	O
and	O
a	O
normal	O
NP	O
cell	O
line	O
(	O
NP69	O
)	O
.	O

After	O
confirming	O
the	O
results	O
in	O
agar	O
-	O
processed	O
cell	O
lines	O
,	O
annexin	O
II	O
and	O
beta	O
(	O
2	O
)	O
-	O
tubulin	O
expression	O
were	O
found	O
to	O
be	O
lower	O
in	O
tumor	O
cells	O
than	O
in	O
adjacent	O
normal	O
epithelial	O
cells	O
in	O
100	O
%	O
and	O
90	O
%	O
of	O
the	O
patients	O
'	O
specimens	O
,	O
respectively	O
.	O

Proprotein	O
convertases	O
are	O
serine	O
endoproteases	O
implicated	O
in	O
the	O
proteolytic	O
processing	O
of	O
a	O
large	O
variety	O
of	O
regulatory	O
proteins	O
.	O

An	O
important	O
role	O
of	O
proprotein	O
convertases	O
in	O
tumorigenic	O
processes	O
has	O
been	O
suggested	O
by	O
various	O
studies	O
.	O

Moreover	O
,	O
the	O
lymph	O
nodes	O
close	O
to	O
the	O
salivary	O
glands	O
were	O
enlarged	O
,	O
and	O
histology	O
showed	O
that	O
they	O
had	O
activated	O
follicles	O
.	O

Furthermore	O
,	O
the	O
expression	O
of	O
M2	O
-	O
PK	O
-	O
binding	O
peptide	O
aptamers	O
moderately	O
reduced	O
the	O
growth	O
of	O
immortalized	O
NIH3T3	O
cell	O
populations	O
by	O
decelerating	O
cell	O
proliferation	O
,	O
but	O
without	O
affecting	O
apoptotic	O
cell	O
death	O
.	O

Moreover	O
,	O
the	O
M2	O
-	O
PK	O
-	O
binding	O
peptide	O
aptamers	O
also	O
reduced	O
the	O
proliferation	O
rate	O
of	O
human	O
U	O
-	O
2	O
OS	O
osteosarcoma	O
cells	O
.	O

To	O
examine	O
the	O
mechanism	O
by	O
which	O
ethanol	S-Chemical_Compound
influences	O
angiogenesis	O
in	O
wounds	O
,	O
we	O
employed	O
two	O
different	O
in	O
vitro	O
angiogenesis	O
assays	O
to	O
determine	O
whether	O
acute	O
ethanol	S-Chemical_Compound
exposure	O
(	O
100	O
mg	O
/	O
dl	O
)	O
would	O
have	O
long	O
-	O
lasting	O
effects	O
on	O
VEGF	O
-	O
induced	O
capillary	O
network	O
formation	O
.	O

Histological	O
examination	O
revealed	O
cystic	O
or	O
angiomatoid	O
spaces	O
of	O
various	O
sizes	O
lined	O
by	O
cuboidal	O
,	O
low	O
-	O
columnar	O
,	O
or	O
flattened	O
epithelioid	O
cells	O
with	O
vacuolated	O
cytoplasm	O
and	O
round	O
to	O
oval	O
nuclei	O
.	O

Contemporary	O
perspectives	O
on	O
vital	O
pulp	O
therapy	O
:	O
views	O
from	O
the	O
endodontists	O
and	O
pediatric	O
dentists	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
whether	O
upregulation	O
of	O
PTEN	O
gene	O
by	O
transfection	O
wild	O
-	O
type	O
PTEN	O
gene	O
to	O
ovarian	O
cancer	O
cells	O
can	O
inhibit	O
growth	O
and	O
migration	O
and	O
to	O
explore	O
the	O
potential	O
for	O
PTEN	O
gene	O
therapy	O
of	O
ovarian	O
cancers	O
.	O

Malignancy	O
in	O
cancer	O
is	O
associated	O
with	O
aerobic	O
glycolysis	O
(	O
Warburg	O
effect	O
)	O
evidenced	O
by	O
increased	O
trapping	O
of	O
[	B-Chemical_Compound
(	I-Chemical_Compound
18	I-Chemical_Compound
)	I-Chemical_Compound
F	I-Chemical_Compound
]	I-Chemical_Compound
deoxyglucose	E-Chemical_Compound
(	O
FdG	S-Chemical_Compound
)	O
in	O
patients	O
imaged	O
by	O
positron	O
emission	O
tomography	O
(	O
PET	O
)	O
.	O

A	O
connection	O
between	O
CAM	O
and	O
adipose	O
tissue	O
vessels	O
was	O
evidenced	O
by	O
immunohistochemistry	O
,	O
with	O
recruitment	O
of	O
both	O
avian	O
and	O
human	O
endothelial	O
cells	O
.	O

BACKGROUND	O
:	O
M	O
-	O
CSF	O
recruits	O
mononuclear	O
phagocytes	O
which	O
regulate	O
processes	O
such	O
as	O
angiogenesis	O
and	O
metastases	O
in	O
tumors	O
.	O

VEGF	O
is	O
a	O
potent	O
activator	O
of	O
angiogenesis	O
as	O
it	O
promotes	O
endothelial	O
cell	O
proliferation	O
and	O
new	O
blood	O
vessel	O
formation	O
.	O

Further	O
analysis	O
revealed	O
that	O
M	O
-	O
CSF	O
induced	O
VEGF	O
through	O
the	O
MAPK	O
/	O
ERK	O
signaling	O
pathway	O
via	O
the	O
transcription	O
factor	O
,	O
Sp1	O
.	O

Inhibition	O
of	O
NF	O
-	O
kappaB	O
significantly	O
reduced	O
transcript	O
levels	O
and	O
autocrine	O
production	O
of	O
BMP	O
-	O
2	O
by	O
rhTNF	O
-	O
alpha	O
stimulated	O
C4	O
-	O
2B	O
cells	O
and	O
to	O
a	O
lesser	O
extent	O
by	O
the	O
parental	O
LNCaP	O
cells	O
.	O

A	O
novel	O
integrin	O
alpha5beta1	O
antagonistic	O
peptide	O
,	O
A5	O
-	O
1	O
,	O
screened	O
by	O
Protein	O
Chip	O
system	O
as	O
a	O
potent	O
angiogenesis	O
inhibitor	O
.	O

Electrical	O
stimulation	O
(	O
ES	O
)	O
has	O
been	O
recommended	O
as	O
a	O
adjunctive	O
therapy	O
,	O
however	O
optimal	O
treatment	O
paradigms	O
have	O
not	O
been	O
established	O
.	O

VEGF	O
and	O
COL	O
-	O
IV	O
levels	O
were	O
found	O
to	O
be	O
significantly	O
higher	O
for	O
pattern	O
A	O
(	O
110	O
mus	O
pulse	O
width	O
)	O
compared	O
to	O
pattern	O
B	O
(	O
5	O
mus	O
pulse	O
width	O
)	O
at	O
14	O
days	O
,	O
implying	O
that	O
pattern	O
A	O
may	O
be	O
more	O
effective	O
at	O
promoting	O
angiogenesis	O
.	O

All	O
wounds	O
were	O
fully	O
re	O
-	O
epithelialized	O
by	O
10	O
days	O
post	O
-	O
injury	O
.	O

The	O
early	O
closure	O
of	O
all	O
wounds	O
implies	O
that	O
the	O
rabbit	O
ear	O
model	O
may	O
not	O
be	O
valid	O
for	O
chronic	O
wound	O
studies	O
.	O

Ang	O
-	O
1	O
has	O
been	O
shown	O
to	O
induce	O
the	O
migration	O
and	O
sprouting	O
of	O
endothelial	O
cells	O
,	O
and	O
coexpression	O
of	O
Ang	O
-	O
1	O
and	O
VEGF	O
enhanced	O
angiogenesis	O
.	O

Effect	O
of	O
transplanted	O
mesenchymal	O
stem	O
cells	O
from	O
rats	O
of	O
different	O
ages	O
on	O
the	O
improvement	O
of	O
heart	O
function	O
after	O
acute	O
myocardial	O
infarction	O
.	O

The	O
present	O
study	O
was	O
designed	O
to	O
investigate	O
the	O
effect	O
of	O
transplanted	O
MSCs	O
from	O
rats	O
of	O
different	O
ages	O
on	O
the	O
improvement	O
of	O
heart	O
function	O
after	O
AMI	O
.	O

CONCLUSIONS	O
:	O
Young	O
donor	O
-	O
derived	O
MSCs	O
can	O
improve	O
heart	O
function	O
significantly	O
through	O
angiogenesis	O
and	O
decreasing	O
cardiomyocyte	O
apoptosis	O
when	O
transplanted	O
to	O
the	O
infarcted	O
area	O
.	O

Immunostaining	O
and	O
Western	O
blot	O
revealed	O
a	O
more	O
significant	O
PTEN	O
downregulation	O
in	O
PTEN	O
-	O
methylated	O
CCMs	O
in	O
comparison	O
to	O
PTEN	O
-	O
unmethylated	O
CCMs	O
.	O

Chondrocyte	O
-	O
DegraPol	O
in	O
Oxygent	S-Chemical_Compound
group	O
presented	O
lower	O
glycosaminoglycan	S-Chemical_Compound
value	O
(	O
0	O
.	O
03	O
+	O
/	O
-	O
0	O
.	O
00	O
vs	O
.	O
0	O
.	O
13	O
+	O
/	O
-	O
0	O
.	O
00	O
,	O
p	O
less	O
than	O
0	O
.	O
05	O
)	O
;	O
histology	O
slides	O
showed	O
poor	O
acid	O
mucopolysaccharides	S-Chemical_Compound
formation	O
.	O

Semaphorins	O
and	O
their	O
cognate	O
receptors	O
,	O
Plexins	O
and	O
neuropilins	O
,	O
are	O
involved	O
in	O
neuronal	O
pathfinding	O
,	O
immune	O
function	O
,	O
and	O
tumor	O
progression	O
through	O
effects	O
on	O
blood	O
vessel	O
growth	O
and	O
cell	O
migration	O
.	O

Functional	O
studies	O
showed	O
that	O
Sema7A	O
stimulates	O
cytoskeletal	O
reorganization	O
in	O
human	O
melanocytes	O
,	O
resulting	O
in	O
adhesion	O
and	O
dendrite	O
formation	O
.	O

Molecular	O
analysis	O
of	O
genetic	O
instability	O
caused	O
by	O
chronic	O
inflammation	O
.	O

PTTG	O
overexpression	O
promotes	O
lymph	O
node	O
metastasis	O
in	O
human	O
esophageal	O
squamous	O
cell	O
carcinoma	O
.	O

However	O
,	O
mechanism	O
(	O
s	O
)	O
by	O
which	O
VEGFR2	O
signaling	O
and	O
trafficking	O
is	O
coordinated	O
are	O
not	O
clear	O
.	O

Here	O
,	O
we	O
have	O
tested	O
endocytic	O
Rab	O
GTPases	O
for	O
regulation	O
of	O
VEGFR2	O
trafficking	O
and	O
signaling	O
linked	O
to	O
endothelial	O
cell	O
migration	O
.	O

CONCLUSIONS	O
:	O
Rab5a	O
and	O
Rab7a	O
regulate	O
VEGFR2	O
trafficking	O
toward	O
early	O
and	O
late	O
endosomes	O
.	O

This	O
suggests	O
that	O
FOXO3a	O
is	O
a	O
potential	O
suppressor	O
of	O
carcinogenic	O
damage	O
in	O
LAC	O
.	O

Since	O
Akt	O
phosphorylates	O
Chk1	O
-	O
Ser	O
(	O
280	O
)	O
,	O
the	O
effect	O
of	O
Erbb2	O
on	O
phosphatidyl	O
inositol	O
-	O
3	O
-	O
kinase	O
(	O
PI3K	O
)	O
/	O
Akt	O
signaling	O
during	O
UV	O
-	O
induced	O
cell	O
cycle	O
arrest	O
was	O
determined	O
.	O

TRAP	O
-	O
activated	O
platelets	O
stimulated	O
a	O
dose	O
-	O
dependent	O
increase	O
in	O
SKOV3	O
cell	O
invasion	O
.	O

Mice	O
with	O
EC	O
-	O
specific	O
deletion	O
of	O
Dicer	O
,	O
a	O
key	O
enzyme	O
for	O
generating	O
miRNAs	O
,	O
display	O
defective	O
postnatal	O
angiogenesis	O
.	O

METHODS	O
:	O
Bovine	O
aortic	O
endothelial	O
cells	O
(	O
ECs	O
)	O
were	O
cultured	O
.	O

CONCLUSIONS	O
:	O
Our	O
study	O
provides	O
new	O
candidate	O
genes	O
for	O
the	O
esophageal	O
cancer	O
microenvironment	O
.	O

Such	O
activity	O
was	O
abolished	O
in	O
mechanically	O
stimulated	O
mouse	O
MRTF	O
-	O
A	O
(	O
-	O
/	O
-	O
)	O
cells	O
or	O
upon	O
inhibition	O
of	O
CREB	O
-	O
binding	O
protein	O
(	O
CBP	O
)	O
histone	O
acetyltransferase	O
(	O
HAT	O
)	O
either	O
pharmacologically	O
or	O
by	O
siRNAs	O
.	O

We	O
demonstrate	O
for	O
the	O
first	O
time	O
that	O
ERK5	O
signaling	O
not	O
only	O
is	O
involved	O
in	O
EC	O
survival	O
and	O
stress	O
response	O
but	O
also	O
controls	O
migration	O
and	O
morphology	O
of	O
EC	O
.	O

EPOX	S-Chemical_Compound
inhibits	O
angiogenesis	O
by	O
degradation	O
of	O
Mcl	O
-	O
1	O
through	O
ERK	O
inactivation	O
.	O

Our	O
results	O
suggest	O
that	O
EPOX	S-Chemical_Compound
is	O
a	O
novel	O
antiangiogenic	O
agent	O
,	O
making	O
it	O
a	O
promising	O
lead	O
compound	O
for	O
further	O
development	O
in	O
the	O
treatment	O
of	O
angiogenesis	O
-	O
related	O
pathologies	O
.	O

Targeting	O
angiogenesis	O
:	O
progress	O
with	O
anti	O
-	O
VEGF	O
treatment	O
with	O
large	O
molecules	O
.	O

Metronomic	O
5	B-Chemical_Compound
-	I-Chemical_Compound
fluorouracil	E-Chemical_Compound
,	O
oxaliplatin	S-Chemical_Compound
and	O
irinotecan	S-Chemical_Compound
in	O
colorectal	O
cancer	O
.	O

On	O
the	O
contrary	O
,	O
metronomic	O
5	B-Chemical_Compound
-	I-Chemical_Compound
FU	E-Chemical_Compound
+	O
L	B-Chemical_Compound
-	I-Chemical_Compound
OHP	E-Chemical_Compound
+	O
CPT	B-Chemical_Compound
-	I-Chemical_Compound
11	E-Chemical_Compound
therapy	O
did	O
not	O
affect	O
the	O
microvascular	O
count	O
.	O

Collectively	O
,	O
our	O
results	O
provide	O
strong	O
biochemical	O
and	O
genetic	O
evidence	O
of	O
a	O
central	O
role	O
for	O
alpha2beta1	O
integrin	O
in	O
experimental	O
and	O
developmental	O
angiogenesis	O
.	O

Because	O
islet	O
inflammation	O
may	O
originate	O
from	O
endothelial	O
cells	O
,	O
we	O
assessed	O
the	O
expression	O
of	O
selected	O
genes	O
involved	O
in	O
endothelial	O
cell	O
activation	O
in	O
islets	O
from	O
a	O
spontaneous	O
model	O
of	O
type	O
2	O
diabetes	O
,	O
the	O
Goto	O
-	O
Kakizaki	O
(	O
GK	O
)	O
rat	O
.	O

Furthermore	O
,	O
GK	O
rats	O
were	O
treated	O
s	O
.	O
c	O
twice	O
daily	O
with	O
IL	B-Chemical_Compound
-	I-Chemical_Compound
1Ra	E-Chemical_Compound
(	O
Kineret	S-Chemical_Compound
,	O
Amgen	O
,	O
100	O
mg	O
/	O
kg	O
/	O
day	O
)	O
or	O
saline	S-Chemical_Compound
,	O
from	O
4	O
weeks	O
of	O
age	O
onwards	O
(	O
onset	O
of	O
diabetes	O
)	O
.	O

Thus	O
,	O
metabolically	O
-	O
altered	O
islet	O
endothelium	O
might	O
affect	O
the	O
beta	O
-	O
cell	O
microenvironment	O
and	O
contribute	O
to	O
progressive	O
type	O
2	O
diabetic	O
beta	O
-	O
cell	O
dysfunction	O
in	O
GK	O
rats	O
.	O

CONCLUSION	O
:	O
Osteopontin	O
siRNA	O
can	O
inhibit	O
U251	O
cells	O
invasion	O
via	O
the	O
down	O
-	O
regulation	O
of	O
uPA	O
,	O
MMP	O
-	O
2	O
and	O
MMP	O
-	O
9	O
levels	O
,	O
and	O
promote	O
apoptosis	O
through	O
induction	O
of	O
Bax	O
expression	O
and	O
inhibition	O
of	O
Bcl	O
2	O
level	O
.	O

Measurements	O
of	O
respiration	O
,	O
CO2	S-Chemical_Compound
and	O
lactate	S-Chemical_Compound
production	O
,	O
and	O
changes	O
in	O
the	O
levels	O
of	O
various	O
key	O
metabolites	O
of	O
the	O
glycolytic	O
sequence	O
and	O
tricarboxylic	B-Chemical_Compound
acid	E-Chemical_Compound
cycle	O
were	O
made	O
on	O
five	O
lines	O
of	O
rodent	O
ascites	O
tumor	O
cells	O
(	O
two	O
strains	O
of	O
Ehrlich	O
ascites	O
tumor	O
cells	O
,	O
Krebs	O
II	O
carcinoma	O
,	O
AS	O
-	O
30D	O
carcinoma	O
,	O
and	O
L1210	O
cells	O
)	O
incubated	O
aerobically	O
in	O
the	O
presence	O
of	O
uniformly	O
labeled	O
D	B-Chemical_Compound
-	I-Chemical_Compound
[	I-Chemical_Compound
14C	I-Chemical_Compound
]	I-Chemical_Compound
glucose	E-Chemical_Compound
.	O

In	O
parallel	O
,	O
we	O
assessed	O
several	O
human	O
melanoma	O
biopsy	O
samples	O
and	O
found	O
again	O
that	O
AKT2	O
was	O
the	O
predominantly	O
activated	O
AKT	O
in	O
these	O
human	O
melanoma	O
biopsies	O
.	O

Bolus	O
incubation	O
was	O
carried	O
out	O
to	O
determine	O
effects	O
of	O
doxorubicin	S-Chemical_Compound
accumulated	O
during	O
the	O
first	O
3h	O
,	O
whereas	O
continuous	O
incubation	O
allowed	O
further	O
(	O
continuous	O
)	O
exposure	O
to	O
doxorubicin	S-Chemical_Compound
.	O

In	O
contrast	O
,	O
continuous	O
(	O
24h	O
)	O
treatment	O
with	O
doxorubicin	S-Chemical_Compound
reduced	O
the	O
number	O
of	O
living	O
cells	O
with	O
no	O
parallel	O
raise	O
in	O
the	O
amount	O
of	O
dead	O
cells	O
.	O

METHODS	O
:	O
Primary	O
lung	O
cancers	O
(	O
n	O
=	O
269	O
)	O
and	O
non	O
neoplastic	O
lung	O
tissue	O
(	O
n	O
=	O
35	O
)	O
were	O
tested	O
for	O
LDH5	O
expression	O
by	O
immunohistochemistry	O
using	O
a	O
polyclonal	O
LDH5	O
antibody	O
(	O
ab53010	O
)	O
.	O

Furthermore	O
,	O
LDH5	O
correlates	O
positively	O
with	O
the	O
prognostic	O
marker	O
TKTL1	O
.	O

Telomere	O
/	O
telomerase	O
interplay	O
in	O
virus	O
-	O
driven	O
and	O
virus	O
-	O
independent	O
lymphomagenesis	O
:	O
pathogenic	O
and	O
clinical	O
implications	O
.	O

Adenovirus	O
5	O
early	O
region	O
1A	O
(	O
E1A	O
)	O
has	O
been	O
shown	O
to	O
exhibit	O
high	O
tumor	O
suppressor	O
activity	O
,	O
and	O
gene	O
therapy	O
using	O
E1A	O
has	O
been	O
tested	O
in	O
clinical	O
trials	O
.	O

Constitutively	O
nuclear	O
FOXO3a	O
localization	O
predicts	O
poor	O
survival	O
and	O
promotes	O
Akt	O
phosphorylation	O
in	O
breast	O
cancer	O
.	O

Brk1	O
is	O
required	O
for	O
cell	O
proliferation	O
and	O
cell	O
transformation	O
by	O
oncogenes	O
.	O

When	O
the	O
patients	O
were	O
divided	O
into	O
two	O
groups	O
according	O
to	O
their	O
alpha	O
-	O
SMA	O
expression	O
using	O
a	O
cutoff	O
point	O
at	O
the	O
mean	O
value	O
of	O
8	O
.	O
48	O
%	O
,	O
the	O
high	O
alpha	O
-	O
SMA	O
group	O
had	O
a	O
significantly	O
poorer	O
overall	O
survival	O
rate	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Multivariate	O
analysis	O
demonstrated	O
that	O
alpha	O
-	O
SMA	O
and	O
lymph	O
node	O
metastasis	O
were	O
identified	O
as	O
independent	O
predictive	O
factors	O
of	O
metastasis	O
.	O

Furthermore	O
,	O
interaction	O
of	O
fibroblasts	O
and	O
high	O
invasive	O
melanoma	O
cells	O
with	O
soluble	O
recombinant	O
DC	O
-	O
9	O
resulted	O
in	O
enhanced	O
expression	O
of	O
MMP	O
-	O
1	O
and	O
MMP	O
-	O
2	O
.	O

Such	O
evidence	O
indicates	O
that	O
MTSS1	O
as	O
a	O
multiple	O
functional	O
molecular	O
player	O
and	O
has	O
an	O
important	O
role	O
in	O
development	O
,	O
carcinogenesis	O
and	O
metastasis	O
.	O

sVAP	O
-	O
1	O
levels	O
were	O
assayed	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

This	O
decrease	O
persisted	O
for	O
the	O
remaining	O
2	O
weeks	O
of	O
treatment	O
.	O

We	O
performed	O
comparative	O
proteomic	O
and	O
pathway	O
analysis	O
of	O
four	O
human	O
metastatic	O
HCC	O
cell	O
lines	O
to	O
identify	O
metastasis	O
-	O
associated	O
proteins	O
.	O

Using	O
a	O
combination	O
of	O
two	O
dimensional	O
electrophoresis	O
(	O
2	O
-	O
DE	O
)	O
and	O
MALDI	O
-	O
TOF	O
mass	O
spectrometry	O
,	O
a	O
total	O
of	O
125	O
proteins	O
and	O
their	O
post	O
-	O
translational	O
modification	O
forms	O
or	O
isoforms	O
were	O
found	O
to	O
be	O
differentially	O
expressed	O
in	O
the	O
cell	O
lines	O
.	O

Meanwhile	O
,	O
knockdown	O
of	O
HDGF	O
,	O
an	O
up	O
-	O
regulated	O
protein	O
and	O
a	O
target	O
of	O
NF	O
-	O
kappaB	O
,	O
induced	O
cell	O
apoptosis	O
in	O
the	O
metastatic	O
HCC	O
cells	O
.	O

OBJECTIVE	O
:	O
To	O
determine	O
the	O
expression	O
and	O
clinical	O
significance	O
of	O
Merlin	O
protein	O
in	O
non	O
-	O
small	O
cell	O
lung	O
cancer	O
(	O
NSCLC	O
)	O
.	O

Using	O
recombinant	O
viruses	O
that	O
lack	O
only	O
one	O
member	O
of	O
the	O
cluster	O
,	O
we	O
now	O
show	O
that	O
all	O
three	O
BHRF1	O
miRNAs	O
contribute	O
to	O
B	O
-	O
cell	O
transformation	O
.	O

Sunitinib	S-Chemical_Compound
induces	O
apoptosis	O
in	O
pheochromocytoma	O
tumor	O
cells	O
by	O
inhibiting	O
VEGFR2	O
/	O
Akt	O
/	O
mTOR	O
/	O
S6K1	O
pathways	O
through	O
modulation	O
of	O
Bcl	O
-	O
2	O
and	O
BAD	O
.	O

Development	O
of	O
a	O
mouse	O
model	O
for	O
lymph	O
node	O
metastasis	O
with	O
endometrial	O
cancer	O
.	O

Curcumin	S-Chemical_Compound
(	O
1	B-Chemical_Compound
,	I-Chemical_Compound
7	I-Chemical_Compound
-	I-Chemical_Compound
bis	I-Chemical_Compound
(	I-Chemical_Compound
4	I-Chemical_Compound
-	I-Chemical_Compound
hydroxy	I-Chemical_Compound
-	I-Chemical_Compound
3	I-Chemical_Compound
-	I-Chemical_Compound
methoxyphenyl	I-Chemical_Compound
)	I-Chemical_Compound
-	I-Chemical_Compound
1	I-Chemical_Compound
,	I-Chemical_Compound
6	I-Chemical_Compound
-	I-Chemical_Compound
heptadiene	I-Chemical_Compound
-	I-Chemical_Compound
3	I-Chemical_Compound
,	I-Chemical_Compound
5	I-Chemical_Compound
-	I-Chemical_Compound
dione	E-Chemical_Compound
)	O
,	O
is	O
extracted	O
from	O
the	O
plant	O
Curcuma	O
longa	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
evaluated	O
the	O
effects	O
of	O
curcumin	S-Chemical_Compound
on	O
human	O
mammary	O
epithelial	O
carcinoma	O
MCF	O
-	O
7	O
cells	O
.	O

PTHrP	O
drives	O
breast	O
tumor	O
initiation	O
,	O
progression	O
,	O
and	O
metastasis	O
in	O
mice	O
and	O
is	O
a	O
potential	O
therapy	O
target	O
.	O

Aquaporins	O
in	O
human	O
breast	O
cancer	O
:	O
identification	O
and	O
involvement	O
in	O
carcinogenesis	O
of	O
breast	O
cancer	O
.	O

BACKGROUND	O
AND	O
OBJECTIVES	O
:	O
Aquaporins	O
(	O
AQPs	O
)	O
play	O
important	O
roles	O
in	O
water	S-Chemical_Compound
and	O
glycerol	S-Chemical_Compound
transport	O
.	O

RESULTS	O
:	O
AQP1	O
,	O
3	O
-	O
5	O
,	O
and	O
10	O
-	O
12	O
were	O
expressed	O
in	O
human	O
breast	O
cancer	O
and	O
/	O
or	O
normal	O
breast	O
tissues	O
,	O
and	O
AQP1	O
and	O
3	O
-	O
5	O
exhibited	O
differential	O
expression	O
.	O

AQP4	O
was	O
expressed	O
in	O
the	O
cell	O
membrane	O
and	O
cytoplasm	O
and	O
was	O
detected	O
markedly	O
stronger	O
in	O
normal	O
than	O
in	O
cancer	O
tissues	O
.	O

Selective	O
inhibition	O
of	O
nuclear	O
factor	O
-	O
kappaB	O
by	O
nuclear	B-Chemical_Compound
factor	I-Chemical_Compound
-	I-Chemical_Compound
kappaB	I-Chemical_Compound
essential	I-Chemical_Compound
modulator	I-Chemical_Compound
-	I-Chemical_Compound
binding	I-Chemical_Compound
domain	I-Chemical_Compound
peptide	E-Chemical_Compound
suppresses	O
the	O
metastasis	O
of	O
highly	O
metastatic	O
oral	O
squamous	O
cell	O
carcinoma	O
.	O

Nuclear	O
factor	O
-	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
activation	O
contributes	O
to	O
the	O
development	O
of	O
metastasis	O
,	O
thus	O
leading	O
to	O
a	O
poor	O
prognosis	O
in	O
many	O
cancers	O
,	O
including	O
OSCC	O
.	O

Highly	O
metastatic	O
tumors	O
with	O
beta	O
-	O
catenin	O
stabilization	O
are	O
very	O
similar	O
to	O
a	O
subset	O
of	O
human	O
melanomas	O
.	O

CONCLUSION	O
:	O
The	O
up	O
-	O
regulation	O
of	O
HER2	O
and	O
B	O
(	O
1	O
)	O
R	O
in	O
precursor	O
lesions	O
of	O
gallbladder	O
carcinoma	O
suggests	O
cross	O
-	O
talk	O
between	O
these	O
two	O
receptors	O
that	O
may	O
be	O
of	O
importance	O
in	O
the	O
modulation	O
of	O
cell	O
proliferation	O
in	O
gallbladder	O
carcinogenesis	O
.	O

Expression	O
of	O
basic	O
fibroblast	O
growth	O
factor	O
in	O
normal	O
human	O
tissues	O
.	O

The	O
presence	O
of	O
bFGF	O
in	O
the	O
extracellular	O
compartment	O
of	O
a	O
diverse	O
variety	O
of	O
organs	O
may	O
play	O
a	O
role	O
in	O
angiogenesis	O
.	O

The	O
activation	O
of	O
Na	B-Chemical_Compound
+	E-Chemical_Compound
transport	O
is	O
due	O
to	O
the	O
exchange	O
of	O
protons	S-Chemical_Compound
formed	O
via	O
glucose	S-Chemical_Compound
conversion	O
into	O
lactate	S-Chemical_Compound
for	O
Na	B-Chemical_Compound
+	E-Chemical_Compound
,	O
i	O
.	O
e	O
.	O
,	O
to	O
the	O
stimulation	O
of	O
the	O
Na	B-Chemical_Compound
+	E-Chemical_Compound
/	O
H	B-Chemical_Compound
+	E-Chemical_Compound
-	O
antiport	O
.	O

Experimental	O
results	O
and	O
theoretical	O
calculations	O
suggest	O
that	O
in	O
glucose	S-Chemical_Compound
-	O
containing	O
medium	O
the	O
Na	B-Chemical_Compound
+	E-Chemical_Compound
transport	O
increases	O
from	O
0	O
.	O
75	O
to	O
1	O
.	O
78	O
pmol	O
/	O
hour	O
per	O
cell	O
.	O

In	O
synchronized	O
cultures	O
at	O
the	O
beginning	O
of	O
the	O
mitotic	O
cycle	O
,	O
the	O
bulk	O
of	O
ATP	S-Chemical_Compound
resynthesized	O
via	O
glycolysis	O
is	O
utilized	O
for	O
the	O
synthesis	O
of	O
biopolymers	O
,	O
whereas	O
that	O
at	O
the	O
end	O
of	O
the	O
S	O
-	O
phase	O
and	O
in	O
the	O
G2	O
-	O
phase	O
is	O
utilized	O
for	O
cation	S-Chemical_Compound
transport	O
across	O
plasma	O
membranes	O
.	O

Metastatic	O
spread	O
of	O
malignant	O
tumor	O
appears	O
to	O
correlate	O
with	O
activation	O
of	O
the	O
fibrolytic	O
system	O
.	O

The	O
ras	O
-	O
encoded	O
proteins	O
are	O
similar	O
to	O
regulatory	O
G	O
-	O
proteins	O
and	O
are	O
candidates	O
for	O
the	O
unknown	O
G	O
-	O
protein	O
that	O
modulates	O
phosphatidylinositol	S-Chemical_Compound
(	O
PI	S-Chemical_Compound
)	O
turnover	O
.	O

Ha	O
-	O
ras	O
cells	O
also	O
show	O
less	O
binding	O
of	O
phorbol	B-Chemical_Compound
ester	E-Chemical_Compound
than	O
control	O
cells	O
,	O
suggesting	O
that	O
elevation	O
of	O
DG	S-Chemical_Compound
causes	O
partial	O
down	O
-	O
regulation	O
in	O
addition	O
to	O
activation	O
of	O
protein	O
kinase	O
C	O
.	O

Epidermal	O
growth	O
factor	O
(	O
EGF	O
)	O
binds	O
with	O
high	O
affinity	O
and	O
specificity	O
to	O
a	O
single	O
site	O
on	O
the	O
external	O
domain	O
of	O
its	O
transmembrane	O
receptor	O
to	O
activate	O
the	O
tyrosine	O
protein	O
kinase	O
activity	O
of	O
its	O
cytoplasmic	O
portion	O
.	O

In	O
these	O
conditions	O
,	O
the	O
rates	O
of	O
oxygen	S-Chemical_Compound
uptake	O
,	O
the	O
CO2	S-Chemical_Compound
evolution	O
and	O
the	O
changes	O
in	O
the	O
redox	O
states	O
of	O
cytochromes	O
indicate	O
that	O
glucose	S-Chemical_Compound
is	O
preferred	O
by	O
Ehrlich	O
ascites	O
tumour	O
cells	O
as	O
energy	O
substrate	O
.	O

In	O
contrast	O
,	O
the	O
response	O
of	O
cells	O
to	O
long	O
-	O
term	O
treatment	O
with	O
PDBu	S-Chemical_Compound
was	O
significantly	O
different	O
depending	O
upon	O
the	O
initial	O
growth	O
state	O
of	O
the	O
cells	O
.	O

Suppression	O
and	O
re	O
-	O
expression	O
of	O
transformed	O
phenotype	O
in	O
hybrids	O
of	O
HA	O
-	O
ras	O
-	O
1	O
-	O
transformed	O
rat	O
-	O
1	O
cells	O
and	O
early	O
-	O
passage	O
rat	O
embryonic	O
fibroblasts	O
.	O

The	O
increased	O
transport	O
rate	O
is	O
a	O
consequence	O
of	O
an	O
increased	O
number	O
of	O
transporters	O
in	O
the	O
transformed	O
cells	O
.	O

In	O
contrast	O
,	O
at	O
least	O
some	O
of	O
these	O
sites	O
were	O
not	O
methylated	O
in	O
DNA	O
from	O
the	O
B	O
-	O
cells	O
expressing	O
high	O
levels	O
of	O
DR	O
alpha	O
mRNA	O
.	O

Uncultured	O
peripheral	O
blood	O
T	O
-	O
cells	O
from	O
human	O
T	O
-	O
cell	O
leukemia	O
-	O
lymphoma	O
virus	O
-	O
infected	O
individuals	O
expressed	O
DR	O
antigens	O
at	O
a	O
low	O
level	O
,	O
and	O
the	O
DR	O
alpha	O
locus	O
was	O
partially	O
unmethylated	O
.	O

These	O
data	O
thus	O
indicate	O
that	O
the	O
effects	O
on	O
hemostasis	O
of	O
the	O
drugs	O
examined	O
can	O
contribute	O
only	O
marginally	O
to	O
their	O
antimetastatic	O
action	O
,	O
since	O
more	O
pronounced	O
effects	O
on	O
hemostasis	O
have	O
been	O
shown	O
to	O
be	O
required	O
to	O
significantly	O
affect	O
metastasis	O
formation	O
.	O

These	O
data	O
support	O
a	O
possible	O
role	O
for	O
tumor	O
cell	O
TGF	O
-	O
beta	O
in	O
the	O
progression	O
of	O
mammary	O
carcinomas	O
by	O
suppressing	O
host	O
immune	O
surveillance	O
.	O

Assays	O
of	O
electrophoretic	O
mobility	O
,	O
DNA	O
-	O
binding	O
specificity	O
,	O
and	O
antigenicity	O
indicated	O
that	O
Stat3	O
or	O
a	O
closely	O
related	O
STAT	O
family	O
member	O
was	O
constitutively	O
activated	O
by	O
the	O
Src	O
oncoprotein	O
.	O

Human	O
umbilical	O
vein	O
endothelial	O
cells	O
(	O
HUVECs	O
)	O
and	O
rat	O
aorta	O
smooth	O
muscle	O
cells	O
(	O
RASMCs	O
)	O
infected	O
with	O
AdCMV	O
.	O
VEGF165	O
(	O
5	O
and	O
20	O
plaque	O
-	O
forming	O
units	O
[	O
pfu	O
]	O
per	O
cell	O
)	O
demonstrated	O
VEGF	O
mRNA	O
expression	O
and	O
protein	O
secretion	O
into	O
the	O
supernatant	O
.	O

To	O
evaluate	O
the	O
ability	O
of	O
AdCMV	O
.	O
VEGF165	O
to	O
function	O
in	O
vivo	O
,	O
either	O
AdCMV	O
.	O

Lysates	O
of	O
cells	O
from	O
the	O
granulocyte	O
-	O
macrophage	O
colony	O
-	O
stimulating	O
factor	O
(	O
GM	O
-	O
CSF	O
)	O
-	O
dependent	O
myeloid	O
leukemic	O
cell	O
line	O
TF1	O
were	O
separated	O
into	O
high	O
molecular	O
weight	O
(	O
HMW	O
)	O
pellets	O
of	O
intact	O
DNA	O
and	O
supernatants	O
of	O
fragmented	O
low	O
MW	O
(	O
LMW	O
)	O
DNA	O
,	O
and	O
the	O
DNA	O
purified	O
from	O
these	O
fractions	O
was	O
quantified	O
.	O

The	O
neoplastic	O
transformation	O
of	O
cultured	O
rat	O
liver	O
epithelial	O
cells	O
by	O
various	O
means	O
has	O
consistently	O
been	O
associated	O
with	O
the	O
development	O
of	O
resistance	O
to	O
the	O
mito	O
-	O
inhibitory	O
effect	O
of	O
transforming	O
growth	O
factor	O
beta	O
(	O
TGF	O
-	O
beta	O
)	O
,	O
suggesting	O
that	O
such	O
phenotype	O
plays	O
a	O
mechanistic	O
role	O
during	O
the	O
transformation	O
of	O
these	O
cells	O
.	O

The	O
control	O
WB	O
cells	O
in	O
continuous	O
culture	O
slowly	O
developed	O
TGF	O
-	O
beta	O
resistance	O
.	O

Both	O
basal	O
(	O
2	O
.	O
3	O
+	O
/	O
-	O
0	O
.	O
2	O
mumol	O
/	O
100	O
g	O
/	O
minute	O
,	O
P	O
=	O
0	O
.	O
061	O
)	O
and	O
insulin	O
-	O
stimulated	O
(	O
8	O
.	O
5	O
+	O
/	O
-	O
1	O
.	O
9	O
mumol	O
/	O
100	O
g	O
/	O
minute	O
,	O
P	O
=	O
0	O
.	O
055	O
)	O
skeletal	O
arm	O
muscle	O
glucose	S-Chemical_Compound
uptake	O
rates	O
were	O
higher	O
in	O
control	O
subjects	O
than	O
in	O
patients	O
.	O

Whole	O
body	O
glucose	S-Chemical_Compound
use	O
was	O
55	O
%	O
lower	O
in	O
patients	O
than	O
in	O
control	O
subjects	O
(	O
17	O
+	O
/	O
-	O
3	O
mumol	O
/	O
kg	O
/	O
minute	O
versus	O
38	O
+	O
/	O
-	O
3	O
mumol	O
/	O
kg	O
/	O
minute	O
,	O
P	O
=	O
0	O
.	O
002	O
)	O
,	O
consistent	O
with	O
insulin	O
resistance	O
in	O
cancer	O
.	O

1	B-Chemical_Compound
-	I-Chemical_Compound
Tetradecylpyrrolidine	I-Chemical_Compound
N	I-Chemical_Compound
-	I-Chemical_Compound
oxide	E-Chemical_Compound
(	O
TPNO	S-Chemical_Compound
)	O
,	O
one	O
of	O
the	O
most	O
active	O
compounds	O
,	O
immediately	O
after	O
addition	O
to	O
the	O
suspension	O
of	O
Ehrlich	O
cells	O
in	O
an	O
ice	O
bath	O
,	O
decreased	O
the	O
level	O
of	O
ATP	S-Chemical_Compound
to	O
the	O
same	O
extent	O
over	O
the	O
whole	O
concentration	O
range	O
.	O

More	O
recent	O
data	O
have	O
demonstrated	O
the	O
existence	O
of	O
two	O
human	O
nm23	O
gene	O
homologues	O
,	O
nm23	O
-	O
H1	O
and	O
nm23	O
-	O
H2	O
,	O
and	O
have	O
shown	O
that	O
deletion	O
of	O
nm23	O
-	O
H1	O
alleles	O
occurs	O
in	O
some	O
colon	O
carcinomas	O
associated	O
with	O
poor	O
prognosis	O
.	O

PURPOSE	O
:	O
This	O
study	O
was	O
designed	O
to	O
reconcile	O
our	O
previous	O
findings	O
with	O
the	O
recent	O
report	O
of	O
nm23	O
-	O
H1	O
allelic	O
deletion	O
in	O
human	O
colon	O
cancers	O
associated	O
with	O
poor	O
prognosis	O
.	O

Expression	O
of	O
nm23	O
-	O
H1	O
mRNA	O
increased	O
in	O
33	O
of	O
41	O
colon	O
tumors	O
,	O
and	O
expression	O
of	O
nm23	O
-	O
H2	O
mRNA	O
was	O
elevated	O
in	O
28	O
of	O
41	O
colon	O
tumors	O
relative	O
to	O
that	O
in	O
matched	O
normal	O
mucosa	O
.	O

Rearrangement	O
of	O
the	O
c	O
-	O
myc	O
gene	O
was	O
common	O
in	O
the	O
plasmacytomas	O
,	O
implying	O
a	O
synergistic	O
role	O
for	O
myc	O
and	O
bcl	O
-	O
2	O
in	O
their	O
etiology	O
,	O
but	O
was	O
not	O
detected	O
in	O
the	O
lymphomas	O
.	O

Tumorigenic	O
activity	O
of	O
rho	O
genes	O
from	O
Aplysia	O
californica	O
.	O

Furthermore	O
,	O
in	O
comparison	O
with	O
native	O
OPN	O
,	O
thrombin	O
-	O
cleaved	O
OPN	O
stimulated	O
a	O
greater	O
rate	O
of	O
EC	O
migration	O
in	O
vitro	O
,	O
which	O
was	O
additive	O
to	O
the	O
increased	O
migration	O
associated	O
with	O
induction	O
of	O
alpha	O
v	O
beta	O
3	O
.	O

Thus	O
,	O
these	O
data	O
demonstrate	O
cooperative	O
mechanisms	O
for	O
VPF	O
/	O
VEGF	O
regulation	O
of	O
EC	O
migration	O
involving	O
the	O
alphavbeta3	O
integrin	O
,	O
the	O
alphavbeta3	O
ligand	O
OPN	O
,	O
and	O
thrombin	O
cleavage	O
of	O
OPN	O
.	O

Indeed	O
,	O
adjuvant	O
tamoxifen	S-Chemical_Compound
significantly	O
prolonged	O
DFS	O
and	O
OAS	O
in	O
c	O
-	O
erbB2	O
-	O
negative	O
cases	O
,	O
whereas	O
it	O
had	O
no	O
effect	O
on	O
DFS	O
and	O
OAS	O
in	O
c	O
-	O
erbB2	O
-	O
positive	O
patients	O
.	O

It	O
is	O
believed	O
that	O
the	O
role	O
of	O
the	O
E1B	O
-	O
55kDa	O
protein	O
in	O
transformation	O
is	O
to	O
protect	O
against	O
p53	O
-	O
dependent	O
apoptosis	O
by	O
binding	O
to	O
and	O
inactivating	O
p53	O
.	O

Non	O
-	O
invasive	O
grading	O
of	O
primary	O
brain	O
tumours	O
:	O
results	O
of	O
a	O
comparative	O
study	O
between	O
SPET	O
with	O
123I	B-Chemical_Compound
-	I-Chemical_Compound
alpha	I-Chemical_Compound
-	I-Chemical_Compound
methyl	I-Chemical_Compound
tyrosine	E-Chemical_Compound
and	O
PET	O
with	O
18F	B-Chemical_Compound
-	I-Chemical_Compound
deoxyglucose	E-Chemical_Compound
.	O

18F	B-Chemical_Compound
-	I-Chemical_Compound
FDG	E-Chemical_Compound
and	O
123I	B-Chemical_Compound
-	I-Chemical_Compound
IMT	E-Chemical_Compound
uptake	O
was	O
quantified	O
as	O
ratios	O
between	O
the	O
uptake	O
by	O
the	O
tumour	O
and	O
contralateral	O
regions	O
of	O
reference	O
.	O

However	O
,	O
high	O
expression	O
of	O
WT1	O
correlates	O
with	O
poor	O
prognosis	O
in	O
acute	O
leukemia	O
.	O

This	O
study	O
was	O
aimed	O
to	O
investigate	O
whether	O
there	O
is	O
selective	O
expression	O
of	O
these	O
cytolytic	O
markers	O
in	O
the	O
putative	O
NK	O
-	O
cell	O
lymphomas	O
and	O
whether	O
there	O
is	O
correlation	O
with	O
zonal	O
tumor	O
cell	O
death	O
in	O
these	O
tumors	O
.	O

The	O
only	O
CD8	O
+	O
CD56	O
+	O
postthymic	O
T	O
-	O
cell	O
lymphoma	O
also	O
expressed	O
all	O
three	O
cytolytic	O
markers	O
,	O
two	O
CD8	O
-	O
ALCL	O
expressed	O
TIA1	O
;	O
other	O
postthymic	O
T	O
-	O
cell	O
,	O
T	O
-	O
lymphoblastic	O
,	O
and	O
B	O
-	O
cell	O
lymphomas	O
were	O
consistently	O
negative	O
.	O

Since	O
both	O
cell	O
lines	O
remained	O
non	O
-	O
tumorigenic	O
in	O
nude	O
mice	O
,	O
these	O
properties	O
indicate	O
that	O
they	O
attained	O
a	O
premalignant	O
phenotype	O
.	O

Interestingly	O
,	O
under	O
normal	O
conditions	O
muscle	O
cells	O
express	O
only	O
a	O
approximately	O
5	O
.	O
5	O
-	O
kb	O
type	O
II	O
HK	O
RNA	O
transcript	O
.	O

A	O
significant	O
amount	O
of	O
type	O
I	O
HK	O
RNA	O
was	O
also	O
found	O
expressed	O
in	O
cancer	O
cell	O
lines	O
.	O

Homeobox	O
genes	O
in	O
hematopoiesis	O
and	O
leukemogenesis	O
.	O

Moreover	O
,	O
U	O
-	O
995	O
(	O
30	O
micrograms	O
/	O
ml	O
)	O
markedly	O
prevented	O
collagenase	O
-	O
induced	O
collagenolysis	O
.	O

Nitric	O
oxide	O
synthase	O
inhibition	O
results	O
in	O
synergistic	O
anti	O
-	O
tumour	O
activity	O
with	O
melphalan	S-Chemical_Compound
and	O
tumour	O
necrosis	O
factor	O
alpha	O
-	O
based	O
isolated	O
limb	O
perfusions	O
.	O

Nitric	B-Chemical_Compound
oxide	E-Chemical_Compound
(	O
NO	S-Chemical_Compound
)	O
is	O
an	O
important	O
molecule	O
in	O
regulating	O
tumour	O
blood	O
flow	O
and	O
stimulating	O
tumour	O
angiogenesis	O
.	O

An	O
additional	O
anti	O
-	O
tumour	O
effect	O
was	O
demonstrated	O
when	O
L	B-Chemical_Compound
-	I-Chemical_Compound
NAME	E-Chemical_Compound
was	O
added	O
to	O
the	O
synergistic	O
combination	O
of	O
melphalan	S-Chemical_Compound
and	O
TNF	O
(	O
responses	O
increased	O
from	O
70	O
to	O
100	O
%	O
)	O
.	O

Administration	O
of	O
exogenous	O
polyamines	O
prevented	O
ACA	S-Chemical_Compound
-	O
induced	O
apoptosis	O
represented	O
by	O
a	O
reduction	O
in	O
the	O
number	O
of	O
apoptotic	O
bodies	O
and	O
also	O
caused	O
reduction	O
in	O
the	O
induced	O
caspase	O
-	O
3	O
-	O
like	O
protease	O
activity	O
at	O
8	O
h	O
.	O

Although	O
the	O
importance	O
of	O
VEGF	O
-	O
A	O
has	O
been	O
shown	O
in	O
renal	O
carcinomas	O
,	O
the	O
contribution	O
of	O
these	O
new	O
ligands	O
in	O
kidney	O
tumors	O
is	O
not	O
clear	O
.	O

We	O
have	O
,	O
therefore	O
,	O
measured	O
the	O
mRNA	O
level	O
of	O
VEGF	O
-	O
B	O
and	O
VEGF	O
-	O
C	O
together	O
with	O
their	O
receptors	O
by	O
RNase	O
protection	O
assay	O
(	O
RPA	O
)	O
in	O
26	O
normal	O
kidney	O
samples	O
and	O
45	O
renal	O
cell	O
cancers	O
.	O

Activated	O
Hck	O
and	O
membrane	O
-	O
anchored	O
Cbl	O
are	O
present	O
in	O
similar	O
subcellular	O
localizations	O
and	O
co	O
-	O
immunoprecipitate	O
,	O
suggesting	O
that	O
their	O
interaction	O
is	O
required	O
for	O
subsequent	O
ubiquitination	O
and	O
degradation	O
.	O

Transfection	O
with	O
hTERT	O
alone	O
,	O
led	O
to	O
the	O
immortalization	O
of	O
two	O
out	O
of	O
three	O
cultures	O
of	O
bone	O
marrow	O
-	O
derived	O
ECs	O
(	O
BMECs	O
)	O
.	O

One	O
hTERT	O
transduced	O
BMEC	O
culture	O
underwent	O
a	O
long	O
proliferative	O
lag	O
before	O
resuming	O
proliferation	O
.	O

RESULTS	O
:	O
In	O
all	O
,	O
67	O
vascular	O
abnormalities	O
were	O
found	O
by	O
indocyanine	B-Chemical_Compound
green	E-Chemical_Compound
angiography	O
and	O
only	O
22	O
by	O
fluorescein	S-Chemical_Compound
angiography	O
;	O
this	O
finding	O
was	O
statistically	O
significant	O
(	O
P	O
less	O
than	O
0	O
.	O
0001	O
)	O
.	O

However	O
,	O
in	O
rap1GAPII	O
-	O
expressing	O
cells	O
,	O
ephrin	O
-	O
B1	O
did	O
not	O
induce	O
membrane	O
spreading	O
,	O
probably	O
due	O
to	O
instability	O
of	O
the	O
focal	O
complex	O
.	O

These	O
results	O
indicated	O
that	O
Crk	O
plays	O
a	O
critical	O
role	O
in	O
Rac1	O
-	O
induced	O
membrane	O
ruffling	O
and	O
Rap1	O
-	O
mediated	O
nascent	O
focal	O
complex	O
stabilization	O
contributing	O
to	O
ephrin	O
-	O
B1	O
-	O
induced	O
human	O
aortic	O
endothelial	O
cells	O
migration	O
.	O

Treatment	O
with	O
the	O
antiangiogenic	O
reagent	O
TNP	B-Chemical_Compound
-	I-Chemical_Compound
470	E-Chemical_Compound
suppressed	O
postoperative	O
progression	O
of	O
pulmonary	O
metastasis	O
.	O

The	O
current	O
data	O
also	O
suggest	O
that	O
administration	O
of	O
antiangiogenic	O
reagents	O
can	O
prevent	O
progression	O
of	O
pulmonary	O
metastasis	O
in	O
osteosarcoma	O
postoperatively	O
.	O

Cloning	O
and	O
characterization	O
of	O
the	O
latent	O
membrane	O
protein	O
(	O
LMP	O
)	O
of	O
a	O
specific	O
Epstein	O
-	O
Barr	O
virus	O
variant	O
derived	O
from	O
the	O
nasopharyngeal	O
carcinoma	O
in	O
the	O
Taiwanese	O
population	O
.	O

One	O
of	O
the	O
clones	O
(	O
clone	O
1510	O
)	O
contained	O
the	O
gene	O
encoding	O
latent	O
membrane	O
protein	O
(	O
LMP	O
)	O
.	O

Balb	O
/	O
c	O
3T3	O
cells	O
carrying	O
this	O
NPC	O
-	O
LMP	O
gene	O
showed	O
a	O
transformed	O
cell	O
morphology	O
and	O
were	O
tumorigenic	O
in	O
nude	O
mice	O
.	O

HYPOTHESIS	O
:	O
We	O
speculate	O
that	O
there	O
is	O
a	O
burst	O
of	O
angiogenesis	O
of	O
distant	O
dormant	O
micrometastases	O
after	O
surgery	O
in	O
approximately	O
20	O
%	O
of	O
premenopausal	O
node	O
-	O
positive	O
patients	O
.	O

Vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
in	O
seizures	O
:	O
a	O
double	O
-	O
edged	O
sword	O
.	O

However	O
,	O
VEGF	O
has	O
also	O
been	O
shown	O
to	O
be	O
neuroprotective	O
across	O
several	O
experimental	O
paradigms	O
,	O
and	O
hence	O
could	O
potentially	O
protect	O
vulnerable	O
cells	O
from	O
damage	O
associated	O
with	O
seizures	O
.	O

METHODS	O
:	O
Four	O
hundred	O
eighty	O
-	O
four	O
consecutive	O
eyes	O
of	O
446	O
patients	O
treated	O
with	O
PDT	O
from	O
January	O
1	O
,	O
2001	O
,	O
to	O
June	O
30	O
,	O
2002	O
,	O
were	O
identified	O
from	O
billing	O
records	O
.	O

CONCLUSIONS	O
:	O
Despite	O
a	O
small	O
sample	O
size	O
and	O
limited	O
length	O
of	O
follow	O
-	O
up	O
,	O
this	O
study	O
shows	O
that	O
visual	O
acuity	O
on	O
average	O
can	O
remain	O
stable	O
for	O
at	O
least	O
12	O
months	O
after	O
PDT	O
of	O
juxtafoveal	O
lesions	O
.	O

Expression	O
of	O
DCC	O
and	O
netrin	O
-	O
1	O
in	O
normal	O
human	O
endometrium	O
and	O
its	O
implication	O
in	O
endometrial	O
carcinogenesis	O
.	O

CONCLUSION	O
:	O
Our	O
observations	O
suggest	O
that	O
DCC	O
/	O
netrin	O
-	O
1	O
signaling	O
may	O
commit	O
cells	O
to	O
the	O
transition	O
of	O
endometrial	O
gland	O
architecture	O
or	O
function	O
from	O
a	O
proliferating	O
to	O
a	O
secretory	O
phase	O
.	O

Group	O
2	O
was	O
treated	O
by	O
Enoxaparine	B-Chemical_Compound
Na	E-Chemical_Compound
,	O
group	O
3	O
received	O
HBO	S-Chemical_Compound
therapy	O
,	O
and	O
group	O
4	O
was	O
given	O
both	O
enoxaparine	B-Chemical_Compound
Na	E-Chemical_Compound
and	O
HBO	S-Chemical_Compound
treatment	O
.	O

Statistically	O
significant	O
differences	O
were	O
observed	O
between	O
groups	O
1	O
and	O
4	O
and	O
between	O
groups	O
1	O
and	O
3	O
regarding	O
the	O
hydroxyproline	O
content	O
of	O
the	O
abdominal	O
wounds	O
.	O

Vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
and	O
its	O
receptors	O
are	O
key	O
regulators	O
of	O
the	O
process	O
of	O
angiogenesis	O
,	O
which	O
makes	O
them	O
attractive	O
therapeutic	O
targets	O
.	O

Thrombospondin	O
is	O
a	O
potent	O
inhibitor	O
of	O
angiogenesis	O
and	O
might	O
therefore	O
be	O
important	O
in	O
controlling	O
tumour	O
growth	O
.	O

To	O
address	O
this	O
question	O
,	O
we	O
used	O
the	O
proteomic	O
approach	O
of	O
tandem	O
affinity	O
purification	O
to	O
identify	O
cellular	O
proteins	O
that	O
are	O
in	O
complex	O
with	O
E7	O
,	O
and	O
identified	O
the	O
600	O
-	O
kDa	O
protein	O
,	O
p600	O
,	O
as	O
a	O
binding	O
partner	O
of	O
E7	O
.	O

Additionally	O
,	O
knockdown	O
of	O
p600	O
reduced	O
transformation	O
of	O
cells	O
expressing	O
both	O
BPV	O
-	O
1	O
E6	O
and	O
E7	O
,	O
as	O
well	O
as	O
E6	O
alone	O
,	O
suggesting	O
that	O
the	O
ability	O
of	O
E7	O
to	O
transformed	O
cells	O
is	O
mediated	O
,	O
at	O
least	O
in	O
part	O
,	O
through	O
its	O
ability	O
to	O
bind	O
p600	O
.	O

Besides	O
TGFbeta	O
and	O
RTK	O
/	O
Ras	O
signaling	O
,	O
autocrine	O
factors	O
and	O
Wnt	O
-	O
,	O
Notch	O
-	O
,	O
Hedgehog	O
-	O
and	O
NF	O
-	O
kappaB	O
-	O
dependent	O
pathways	O
were	O
found	O
to	O
contribute	O
to	O
EMT	O
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
murine	O
bone	O
marrow	O
contains	O
endothelial	O
progenitors	O
,	O
which	O
arise	O
from	O
a	O
cell	O
with	O
self	O
-	O
renewing	O
capacity	O
,	O
and	O
can	O
integrate	O
into	O
tumor	O
microvasculature	O
,	O
albeit	O
at	O
a	O
very	O
low	O
frequency	O
.	O

Histopathological	O
development	O
of	O
gastric	O
tumors	O
induced	O
by	O
N	B-Chemical_Compound
-	I-Chemical_Compound
methyl	I-Chemical_Compound
-	I-Chemical_Compound
N	I-Chemical_Compound
'	I-Chemical_Compound
-	I-Chemical_Compound
nitro	I-Chemical_Compound
-	I-Chemical_Compound
N	I-Chemical_Compound
-	I-Chemical_Compound
nitrosoguanidine	E-Chemical_Compound
in	O
rats	O
.	O

Changes	O
of	O
bile	O
reflux	O
to	O
the	O
stomach	O
was	O
observed	O
endoscopically	O
at	O
24	O
weeks	O
as	O
well	O
as	O
the	O
development	O
of	O
gastric	O
mucosal	O
erosions	O
.	O

The	O
c	O
-	O
myc	O
oncogene	O
encodes	O
for	O
a	O
transcriptional	O
factor	O
involved	O
in	O
many	O
cellular	O
processes	O
such	O
as	O
proliferation	O
,	O
differentiation	O
and	O
apoptosis	O
.	O

We	O
defined	O
the	O
role	O
of	O
c	O
-	O
Myc	O
in	O
cancer	O
cell	O
sensitivity	O
to	O
vinblastine	S-Chemical_Compound
(	O
VLB	S-Chemical_Compound
)	O
using	O
human	O
colon	O
cancer	O
cells	O
:	O
LoVo	O
wild	O
-	O
type	O
or	O
transfected	O
with	O
a	O
plasmid	O
containing	O
the	O
human	O
c	O
-	O
myc	O
gene	O
in	O
antisense	O
orientation	O
(	O
LoVo	O
-	O
mycANS	O
)	O
.	O

Moreover	O
,	O
the	O
downregulation	O
of	O
c	O
-	O
myc	O
oncogene	O
by	O
an	O
antisense	O
strategy	O
might	O
represent	O
a	O
useful	O
goal	O
for	O
improving	O
the	O
efficacy	O
of	O
this	O
anti	O
-	O
neoplastic	O
drug	O
family	O
.	O

However	O
,	O
in	O
N	O
-	O
ras	O
-	O
transformed	O
cell	O
clones	O
,	O
RA	S-Chemical_Compound
-	O
induced	O
expression	O
of	O
these	O
homeobox	O
genes	O
is	O
delayed	O
.	O

The	O
median	O
response	O
duration	O
was	O
8	O
.	O
2	O
months	O
.	O

Many	O
studies	O
on	O
carcinogenesis	O
carried	O
out	O
early	O
in	O
the	O
last	O
century	O
are	O
united	O
on	O
the	O
consensus	O
that	O
cancer	O
is	O
a	O
genetic	O
disease	O
.	O

Recent	O
advances	O
in	O
stem	O
cell	O
biology	O
added	O
the	O
new	O
concept	O
that	O
cancer	O
originates	O
from	O
a	O
single	O
cancer	O
-	O
initiating	O
cell	O
.	O

These	O
findings	O
reveal	O
a	O
previously	O
unrecognized	O
regulatory	O
role	O
for	O
Ang	O
II	O
on	O
sFlt	O
-	O
1	O
expression	O
in	O
murine	O
and	O
human	O
pregnancy	O
and	O
suggest	O
that	O
elevated	O
sFlt	O
-	O
1	O
levels	O
in	O
preeclampsia	O
may	O
be	O
caused	O
by	O
a	O
dysregulation	O
of	O
the	O
local	O
renin	O
/	O
angiotensin	O
system	O
.	O

After	O
24	O
h	O
treatment	O
with	O
80	O
microM	O
magnolol	S-Chemical_Compound
in	O
serum	O
-	O
containing	O
medium	O
,	O
about	O
50	O
%	O
of	O
the	O
cells	O
exhibited	O
apoptotic	O
features	O
and	O
20	O
%	O
necrotic	O
features	O
.	O

Furthermore	O
,	O
inhibition	O
of	O
PARP	O
activity	O
,	O
but	O
not	O
of	O
caspase	O
activity	O
,	O
completely	O
prevented	O
magnolol	S-Chemical_Compound
-	O
induced	O
necrosis	O
,	O
suggesting	O
the	O
notion	O
that	O
it	O
might	O
be	O
caused	O
by	O
depletion	O
of	O
intracellular	O
ATP	S-Chemical_Compound
levels	O
due	O
to	O
PARP	O
activation	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
two	O
independent	O
downstream	O
signal	O
pathways	O
,	O
DCN	O
/	O
EGFR	O
/	O
ERK1	O
/	O
2	O
and	O
DCN	O
/	O
EGFR	O
/	O
phosphoinositide	O
-	O
3	O
kinase	O
/	O
AKT	O
,	O
mediate	O
up	O
-	O
regulation	O
and	O
activation	O
of	O
transcription	O
factors	O
of	O
VEGF	O
such	O
as	O
HIF1alpha	O
,	O
Stat3	O
,	O
and	O
Sp1	O
and	O
increase	O
VEGF	O
transcription	O
and	O
angiogenesis	O
in	O
MCE	O
cells	O
.	O

METHODS	O
:	O
Grafted	O
animals	O
for	O
corneal	O
survival	O
analysis	O
were	O
assigned	O
to	O
receive	O
either	O
spironolactone	S-Chemical_Compound
suspension	O
(	O
orally	O
,	O
100	O
mg	O
/	O
kg	O
/	O
day	O
,	O
n	O
=	O
7	O
)	O
,	O
phosphate	B-Chemical_Compound
-	I-Chemical_Compound
buffered	I-Chemical_Compound
saline	E-Chemical_Compound
(	O
PBS	S-Chemical_Compound
,	O
orally	O
,	O
same	O
volume	O
as	O
spironolactone	S-Chemical_Compound
,	O
n	O
=	O
9	O
)	O
or	O
remained	O
untreated	O
(	O
n	O
=	O
16	O
)	O
.	O

In	O
a	O
multivariate	O
analysis	O
D2	O
-	O
40	O
+	O
was	O
the	O
strongest	O
predictor	O
for	O
ALNM	O
with	O
an	O
odds	O
ratio	O
of	O
3	O
.	O
489	O
and	O
a	O
P	O
-	O
value	O
of	O
P	O
=	O
0	O
.	O
0003	O
,	O
followed	O
only	O
by	O
T	O
-	O
stage	O
and	O
grading	O
with	O
odds	O
ratios	O
of	O
3	O
.	O
167	O
and	O
1	O
.	O
953	O
and	O
P	O
-	O
values	O
P	O
=	O
0	O
.	O
0003	O
and	O
P	O
=	O
0	O
.	O
0352	O
.	O

Among	O
these	O
are	O
vascular	O
endothelial	O
growth	O
factor	O
-	O
A	O
(	O
VEGF	O
-	O
A	O
)	O
,	O
the	O
key	O
angiogenic	O
stimulant	O
,	O
and	O
VEGF	O
-	O
C	O
,	O
a	O
primary	O
mediator	O
of	O
lymphangiogenesis	O
.	O

In	O
vivo	O
,	O
cediranib	S-Chemical_Compound
(	O
6	O
mg	O
/	O
kg	O
/	O
d	O
)	O
prevented	O
angiogenesis	O
and	O
lymphangiogenesis	O
induced	O
by	O
VEGF	O
-	O
E	O
-	O
expressing	O
and	O
VEGF	O
-	O
C156S	O
-	O
expressing	O
adenoviruses	O
,	O
respectively	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
artemisinin	S-Chemical_Compound
on	O
tumor	O
growth	O
,	O
lymphangiogenesis	O
,	O
metastasis	O
and	O
survival	O
in	O
mouse	O
Lewis	O
lung	O
carcinoma	O
(	O
LLC	O
)	O
models	O
.	O

Bevacizumab	S-Chemical_Compound
and	O
irinotecan	S-Chemical_Compound
therapy	O
in	O
glioblastoma	O
multiforme	O
:	O
a	O
series	O
of	O
13	O
cases	O
.	O

OBJECT	O
:	O
Endothelial	O
proliferation	O
has	O
been	O
recognized	O
as	O
a	O
marker	O
of	O
high	O
-	O
grade	O
or	O
aggressive	O
glioma	O
.	O

Bevacizumab	S-Chemical_Compound
is	O
a	O
humanized	O
immunoglobulin	O
G1	O
monoclonal	O
antibody	O
to	O
vascular	O
endothelial	O
growth	O
factor	O
that	O
has	O
been	O
shown	O
to	O
have	O
activity	O
in	O
malignant	O
gliomas	O
when	O
combined	O
with	O
irinotecan	S-Chemical_Compound
.	O

The	O
median	O
time	O
to	O
disease	O
progression	O
while	O
on	O
treatment	O
was	O
24	O
weeks	O
.	O

Six	O
of	O
the	O
8	O
patients	O
whose	O
disease	O
progressed	O
have	O
died	O
.	O

Blockade	O
of	O
angiogenesis	O
is	O
an	O
important	O
approach	O
for	O
cancer	O
treatment	O
and	O
prevention	O
.	O

Vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
is	O
one	O
of	O
the	O
most	O
critical	O
factors	O
that	O
induce	O
angiogenesis	O
and	O
has	O
thus	O
become	O
an	O
attractive	O
target	O
for	O
antiangiogenesis	O
treatment	O
.	O

We	O
found	O
that	O
GSE	O
could	O
directly	O
inhibit	O
the	O
kinase	O
activity	O
of	O
purified	O
VEGF	O
receptor	O
2	O
,	O
a	O
novel	O
activity	O
of	O
GSE	O
that	O
has	O
not	O
been	O
characterized	O
.	O

Consistent	O
with	O
the	O
in	O
vitro	O
data	O
,	O
GSE	O
treatment	O
of	O
tumor	O
-	O
bearing	O
mice	O
led	O
to	O
concomitant	O
reduction	O
of	O
blood	O
vessel	O
density	O
and	O
phosphorylation	O
of	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
.	O

In	O
the	O
current	O
study	O
,	O
the	O
impact	O
of	O
VEGF	O
expression	O
on	O
the	O
response	O
of	O
tumors	O
to	O
the	O
VEGFR2	O
associated	O
tyrosine	O
kinase	O
inhibitor	O
vandetanib	S-Chemical_Compound
was	O
evaluated	O
.	O

RESULTS	O
:	O
Vandetanib	S-Chemical_Compound
treatment	O
had	O
no	O
effect	O
on	O
tumor	O
cell	O
clonogenic	O
cell	O
survival	O
in	O
vitro	O
but	O
doses	O
>	O
or	O
=	O
10	O
nM	O
significantly	O
reduced	O
endothelial	O
cell	O
migration	O
.	O

We	O
previously	O
showed	O
that	O
disruption	O
of	O
TGF	O
-	O
beta	O
signaling	O
by	O
dominant	O
-	O
negative	O
TGF	O
-	O
beta	O
type	O
II	O
receptor	O
in	O
a	O
diffuse	O
-	O
type	O
gastric	O
carcinoma	O
model	O
accelerated	O
tumor	O
growth	O
through	O
induction	O
of	O
tumor	O
angiogenesis	O
by	O
decreased	O
expression	O
of	O
the	O
anti	O
-	O
angiogenic	O
factor	O
thrombospondin	O
(	O
TSP	O
)	O
-	O
1	O
.	O

Induction	O
of	O
TSP	O
-	O
1	O
mRNA	O
by	O
TGF	O
-	O
beta	O
was	O
attenuated	O
by	O
c	O
-	O
Ski	O
in	O
vitro	O
,	O
and	O
expression	O
of	O
TSP	O
-	O
1	O
mRNA	O
was	O
decreased	O
in	O
tumors	O
expressing	O
c	O
-	O
Ski	O
in	O
vivo	O
.	O

We	O
determined	O
that	O
lacZ	O
was	O
uniformly	O
expressed	O
in	O
the	O
endothelium	O
of	O
transgenic	O
embryos	O
but	O
was	O
markedly	O
downregulated	O
postnatally	O
.	O

The	O
DSCR1s	O
promoter	O
was	O
similarly	O
induced	O
in	O
the	O
endothelium	O
of	O
tumor	O
xenografts	O
.	O

beta2	O
-	O
glycoprotein	O
I	O
(	O
beta2GPI	O
)	O
is	O
proteolytically	O
cleaved	O
by	O
plasmin	O
in	O
its	O
domain	O
V	O
(	O
nicked	O
beta2GPI	O
)	O
,	O
resulting	O
in	O
binding	O
to	O
plasminogen	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
found	O
significant	O
binding	O
of	O
nicked	O
beta2GPI	O
to	O
AS4	O
.	O
5	O
(	O
K	O
(	O
D	O
)	O
=	O
3	O
.	O
27	O
x	O
10	O
(	O
6	O
)	O
M	O
(	O
-	O
1	O
)	O
)	O
.	O

OBJECTIVE	O
:	O
To	O
investigate	O
the	O
effect	O
of	O
vascular	O
bundle	O
implantation	O
in	O
autogenous	O
bone	O
graft	O
on	O
angiogenesis	O
.	O

METHODS	O
:	O
Thirty	O
-	O
six	O
New	O
Zealand	O
white	O
rabbits	O
were	O
evaluated	O
in	O
this	O
study	O
.	O

Each	O
bone	O
was	O
placed	O
in	O
masseter	O
muscle	O
separately	O
.	O

Multiple	O
myeloma	O
,	O
an	O
incurable	O
plasma	O
cell	O
malignancy	O
,	O
is	O
characterized	O
by	O
altered	O
cellular	O
metabolism	O
and	O
resistance	O
to	O
apoptosis	O
.	O

Vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
-	O
induced	O
receptor	O
phosphorylation	O
is	O
the	O
crucial	O
step	O
for	O
initiating	O
downstream	O
signaling	O
pathways	O
that	O
lead	O
to	O
angiogenesis	O
or	O
related	O
pathophysiological	O
outcomes	O
.	O

Compared	O
with	O
CSC	O
-	O
low	O
tumors	O
,	O
CSC	O
-	O
high	O
tumors	O
exhibited	O
increased	O
microvessel	O
density	O
and	O
blood	O
perfusion	O
and	O
induced	O
increased	O
mobilization	O
and	O
tumor	O
recruitment	O
of	O
bone	O
marrow	O
-	O
derived	O
endothelial	O
progenitor	O
cells	O
(	O
EPC	O
)	O
.	O

Recent	O
studies	O
have	O
demonstrated	O
that	O
tumor	O
cells	O
treated	O
with	O
antibodies	O
specific	O
for	O
beta	O
(	O
2	O
)	O
-	O
microglobulin	O
(	O
beta	O
(	O
2	O
)	O
M	O
)	O
or	O
major	O
histocompatibility	O
complex	O
(	O
MHC	O
)	O
class	O
I	O
molecules	O
undergo	O
apoptosis	O
in	O
vitro	O
and	O
in	O
vivo	O
(	O
mouse	O
models	O
)	O
.	O

However	O
,	O
although	O
beta	O
(	O
2	O
)	O
M	O
and	O
MHC	O
class	O
I	O
are	O
expressed	O
on	O
normal	O
hematopoietic	O
cells	O
,	O
which	O
is	O
a	O
potential	O
safety	O
concern	O
,	O
the	O
monoclonal	O
antibodies	O
were	O
selective	O
to	O
tumor	O
cells	O
and	O
did	O
not	O
damage	O
normal	O
cells	O
in	O
vitro	O
or	O
in	O
human	O
-	O
like	O
mouse	O
models	O
.	O

Ploidy	O
analysis	O
was	O
carried	O
out	O
on	O
39	O
EOGCs	O
and	O
immunohistochemistry	O
of	O
CDC4	O
/	O
FBXW7	O
and	O
its	O
substrates	O
c	O
-	O
myc	O
,	O
c	O
-	O
jun	O
,	O
Notch	O
and	O
cyclin	O
E	O
was	O
performed	O
on	O
204	O
gastric	O
carcinomas	O
using	O
tissue	O
microarrays	O
(	O
TMAs	O
)	O
.	O

The	O
results	O
showed	O
0	O
.	O
01	O
mM	O
GA	S-Chemical_Compound
induced	O
the	O
same	O
level	O
of	O
cell	O
toxicity	O
as	O
4	O
.	O
0mM	O
PCA	S-Chemical_Compound
.	O

Our	O
data	O
suggest	O
that	O
p	B-Chemical_Compound
-	I-Chemical_Compound
XSC	E-Chemical_Compound
inhibits	O
multiple	O
signaling	O
pathways	O
in	O
prostate	O
cancer	O
,	O
likely	O
accounting	O
for	O
the	O
downstream	O
effects	O
on	O
proliferation	O
and	O
apoptosis	O
.	O

TB4	O
expression	O
in	O
B16F10	O
cells	O
was	O
increased	O
by	O
hypoxia	O
conditioning	O
in	O
a	O
time	O
-	O
dependent	O
manner	O
.	O

Activation	O
of	O
PKA	O
(	O
cAMP	O
-	O
dependent	O
protein	O
kinase	O
)	O
by	O
androgen	S-Chemical_Compound
increased	O
phosphorylation	O
of	O
CREB	O
[	O
CRE	O
(	O
cAMP	O
-	O
response	O
element	O
)	O
-	O
binding	O
protein	O
]	O
,	O
which	O
in	O
turn	O
bound	O
to	O
CRE	O
on	O
the	O
promoter	O
of	O
the	O
HK2	O
gene	O
resulting	O
in	O
transcriptional	O
activation	O
of	O
the	O
HK2	O
gene	O
.	O

The	O
activated	O
PI3K	O
(	O
phosphoinositide	O
3	O
-	O
kinase	O
)	O
/	O
Akt	O
signalling	O
pathway	O
in	O
LNCaP	O
cells	O
contributes	O
to	O
the	O
phosphorylation	O
of	O
PFKFB2	O
at	O
Ser466	O
and	O
Ser483	O
,	O
resulting	O
in	O
the	O
constitutive	O
activation	O
of	O
PFK	O
-	O
2	O
(	O
6	O
-	O
phosphofructo	O
-	O
2	O
-	O
kinase	O
)	O
activity	O
.	O

Our	O
earlier	O
studies	O
showed	O
that	O
DATS	S-Chemical_Compound
induced	O
apoptosis	O
in	O
human	O
colon	O
cancer	O
HT29	O
and	O
colo	O
205	O
cell	O
lines	O
in	O
vitro	O
.	O

However	O
,	O
there	O
is	O
no	O
report	O
to	O
show	O
that	O
DATS	S-Chemical_Compound
induced	O
apoptosis	O
in	O
vitro	O
and	O
inhibited	O
CT26	O
cancer	O
cells	O
in	O
vivo	O
on	O
a	O
murine	O
allograft	O
animal	O
model	O
.	O

Thus	O
,	O
DATS	S-Chemical_Compound
may	O
represent	O
a	O
colon	O
cancer	O
preventive	O
agent	O
and	O
can	O
be	O
used	O
in	O
the	O
future	O
.	O

The	O
expression	O
of	O
HMGA2	O
modulates	O
the	O
expression	O
of	O
hTERT	O
,	O
resulting	O
in	O
cells	O
with	O
enhanced	O
telomerase	O
activities	O
and	O
increased	O
telomere	O
length	O
.	O

These	O
findings	O
are	O
potentially	O
clinically	O
relevant	O
,	O
because	O
HMGA2	O
expression	O
is	O
reported	O
to	O
be	O
upregulated	O
in	O
a	O
number	O
of	O
human	O
cancers	O
as	O
telomere	O
maintenance	O
is	O
essential	O
for	O
tumorigenesis	O
.	O

Finally	O
,	O
we	O
discuss	O
future	O
directions	O
for	O
identifying	O
the	O
appropriate	O
patients	O
for	O
therapy	O
,	O
developing	O
reliable	O
markers	O
of	O
efficacy	O
of	O
treatment	O
,	O
and	O
combating	O
resistance	O
to	O
Hedgehog	O
pathway	O
inhibitors	O
.	O

Promoter	O
hypermethylation	O
of	O
APC	O
was	O
observed	O
in	O
54	O
.	O
65	O
per	O
cent	O
(	O
47	O
of	O
86	O
)	O
of	O
cases	O
.	O

Although	O
5	B-Chemical_Compound
-	I-Chemical_Compound
FU	E-Chemical_Compound
is	O
often	O
used	O
for	O
the	O
treatment	O
of	O
oral	O
carcinoma	O
,	O
there	O
has	O
not	O
been	O
any	O
investigation	O
into	O
the	O
expression	O
of	O
these	O
enzymes	O
in	O
metastatic	O
lymph	O
nodes	O
or	O
of	O
their	O
roles	O
in	O
the	O
effectiveness	O
of	O
5	B-Chemical_Compound
-	I-Chemical_Compound
FU	E-Chemical_Compound
in	O
treating	O
lymph	O
node	O
-	O
metastatic	O
cancer	O
.	O

CD82	O
expression	O
was	O
significantly	O
reduced	O
in	O
lymph	O
node	O
metastases	O
.	O

The	O
different	O
tumorigenic	O
potential	O
of	O
SV40	O
in	O
WAP	O
-	O
T	O
and	O
WAP	O
-	O
mutCK1delta	O
/	O
WAP	O
-	O
T	O
tumors	O
was	O
also	O
reflected	O
by	O
a	O
significantly	O
different	O
expression	O
of	O
various	O
genes	O
known	O
to	O
be	O
involved	O
in	O
tumor	O
progression	O
,	O
specifically	O
of	O
those	O
involved	O
in	O
wnt	O
-	O
signaling	O
and	O
DNA	O
repair	O
.	O

Osteonectin	O
is	O
one	O
of	O
the	O
major	O
non	O
-	O
collagenous	O
proteins	O
of	O
bone	O
.	O

High	O
osteonectin	O
expression	O
was	O
correlated	O
with	O
high	O
lung	O
colonization	O
.	O

We	O
found	O
that	O
the	O
severity	O
of	O
vascular	O
abnormalities	O
correlated	O
positively	O
with	O
the	O
severity	O
of	O
histologic	O
epithelial	O
lesions	O
;	O
this	O
finding	O
is	O
consistent	O
with	O
colposcopic	O
results	O
.	O

Glycolysis	O
and	O
glutaminolysis	O
in	O
perifused	O
Ehrlich	O
ascites	O
tumour	O
cells	O
.	O

At	O
intervals	O
of	O
four	O
to	O
14	O
days	O
,	O
the	O
animals	O
were	O
challenged	O
by	O
intrastromal	O
inoculation	O
with	O
10	O
,	O
000	O
plaque	O
-	O
forming	O
units	O
of	O
viable	O
HSV	O
.	O

Although	O
contaminating	O
kinases	O
were	O
detectable	O
in	O
the	O
immune	O
complexes	O
,	O
at	O
least	O
the	O
p53	O
molecules	O
were	O
phosphorylated	O
in	O
vitro	O
in	O
a	O
more	O
specific	O
way	O
.	O

Finally	O
,	O
anti	O
-	O
p53	O
monoclonal	O
antibodies	O
only	O
slightly	O
affected	O
in	O
vitro	O
phosphorylation	O
reactions	O
,	O
whereas	O
a	O
p53	O
molecule	O
from	O
a	O
simian	O
virus	O
40	O
-	O
free	O
,	O
chemically	O
transformed	O
human	O
cell	O
line	O
was	O
not	O
phosphorylated	O
in	O
vitro	O
under	O
any	O
condition	O
tested	O
.	O

Parental	O
NIH	O
3T3	O
-	O
derived	O
cells	O
had	O
both	O
72	O
kDa	O
and	O
92	O
kDa	O
gelatinase	O
activities	O
,	O
and	O
LTA	O
-	O
derived	O
cells	O
had	O
either	O
aberrantly	O
sized	O
approximately	O
90	O
kDa	O
activity	O
alone	O
or	O
neither	O
enzyme	O
activity	O
.	O

Our	O
results	O
suggest	O
that	O
a	O
key	O
change	O
in	O
the	O
metastatic	O
hybrids	O
,	O
relative	O
to	O
non	O
-	O
metastatic	O
parental	O
LTA	O
cells	O
,	O
is	O
induction	O
of	O
expression	O
of	O
72	O
kDa	O
type	O
IV	O
collagenase	O
.	O

Neoplastic	O
progression	O
of	O
human	O
colorectal	O
cancer	O
is	O
associated	O
with	O
overexpression	O
of	O
the	O
stromelysin	O
-	O
3	O
and	O
BM	O
-	O
40	O
/	O
SPARC	O
genes	O
.	O

The	O
ST3	O
and	O
BM	O
-	O
40	O
/	O
SPARC	O
transcripts	O
were	O
overexpressed	O
in	O
primary	O
colorectal	O
cancers	O
and	O
their	O
liver	O
metastases	O
compared	O
to	O
non	O
-	O
neoplastic	O
mucosa	O
.	O

31P	S-Chemical_Compound
MR	O
spectra	O
showed	O
that	O
phosphocreatine	S-Chemical_Compound
was	O
present	O
in	O
H5	O
spheroids	O
but	O
not	O
in	O
H4	O
spheroids	O
or	O
tumors	O
.	O

RNA	O
and	O
DNA	O
viruses	O
can	O
be	O
transforming	O
and	O
tumourigenic	O
agents	O
.	O

The	O
detection	O
of	O
increased	O
abundance	O
of	O
EGF	O
-	O
R	O
or	O
Her	O
-	O
2	O
/	O
neu	O
proteins	O
in	O
human	O
tumours	O
can	O
provide	O
additional	O
information	O
on	O
the	O
disease	O
-	O
free	O
survival	O
and	O
overall	O
survival	O
for	O
patients	O
with	O
breast	O
,	O
ovarian	O
,	O
endometrial	O
or	O
cervical	O
cancer	O
.	O

This	O
transporter	O
was	O
expressed	O
on	O
the	O
cell	O
membrane	O
and	O
in	O
the	O
cytoplasm	O
of	O
the	O
tumor	O
cells	O
,	O
but	O
exhibited	O
marked	O
intratumoral	O
and	O
intertumoral	O
variability	O
in	O
the	O
proportions	O
of	O
positive	O
cells	O
and	O
the	O
intensity	O
of	O
staining	O
.	O

Staining	O
of	O
the	O
normal	O
mammary	O
epithelium	O
,	O
if	O
present	O
,	O
was	O
much	O
lower	O
than	O
observed	O
in	O
tumor	O
cells	O
from	O
the	O
same	O
patient	O
.	O

In	O
all	O
cases	O
,	O
the	O
somatostatin	O
receptors	O
were	O
localized	O
in	O
veins	O
,	O
particularly	O
in	O
the	O
smooth	O
-	O
muscle	O
cell	O
layer	O
.	O

In	O
invasive	O
NM	O
-	O
e	O
-	O
ras	O
-	O
MAC1	O
cells	O
,	O
where	O
E	O
-	O
cadherin	O
was	O
partially	O
downregulated	O
by	O
specific	O
antisense	O
RNA	O
,	O
syndecan	O
-	O
1	O
expression	O
was	O
suppressed	O
.	O

Metastasis	O
-	O
associated	O
5T4	O
antigen	O
disrupts	O
cell	O
-	O
cell	O
contacts	O
and	O
induces	O
cellular	O
motility	O
in	O
epithelial	O
cells	O
.	O

Thus	O
,	O
5T4	O
molecules	O
can	O
deliver	O
signals	O
through	O
both	O
the	O
extracellular	O
and	O
intracellular	O
domains	O
,	O
and	O
the	O
resultant	O
effects	O
are	O
consistent	O
with	O
a	O
role	O
for	O
5T4	O
molecules	O
in	O
invasion	O
processes	O
.	O

Consequently	O
,	O
increased	O
adhesion	O
of	O
cancer	O
cells	O
to	O
endothelial	O
cells	O
was	O
observed	O
by	O
the	O
treatment	O
of	O
carcinostatic	O
agents	O
.	O

Levels	O
of	O
uPA	O
,	O
urokinase	O
-	O
plasminogen	O
activator	O
receptor	O
(	O
uPAR	O
)	O
and	O
plasminogen	O
activator	O
inhibitor	O
-	O
1	O
(	O
PAI	O
-	O
1	O
)	O
were	O
measured	O
semiquantitatively	O
in	O
paraffin	O
sections	O
of	O
tumours	O
from	O
147	O
patients	O
with	O
NSCLC	O
.	O

uPA	O
and	O
uPAR	O
levels	O
were	O
not	O
significantly	O
associated	O
with	O
tumour	O
staging	O
or	O
survival	O
.	O

Although	O
evidence	O
suggesting	O
a	O
role	O
for	O
FAK	O
in	O
morphogenesis	O
is	O
accumulating	O
,	O
current	O
uncertainties	O
regarding	O
its	O
cytoplasmic	O
location	O
and	O
its	O
molecular	O
interactions	O
in	O
vivo	O
make	O
it	O
difficult	O
to	O
reach	O
definitive	O
conclusions	O
regarding	O
the	O
significance	O
of	O
its	O
contributions	O
to	O
developmental	O
processes	O
.	O
The	O
characteristics	O
of	O
HPCs	O
in	O
PET	O
described	O
herein	O
for	O
the	O
first	O
time	O
offer	O
additional	O
diagnostic	O
criteria	O
and	O
may	O
help	O
especially	O
to	O
differentiate	O
these	O
tumors	O
from	O
meningiomas	O
.	O

A	O
reduction	O
in	O
alpha	O
-	O
catenin	O
expression	O
and	O
p53	O
overexpression	O
correlated	O
to	O
lymph	O
node	O
metastases	O
,	O
respectively	O
.	O

Tumour	O
-	O
specific	O
distribution	O
of	O
BRCA1	O
promoter	O
region	O
methylation	O
supports	O
a	O
pathogenetic	O
role	O
in	O
breast	O
and	O
ovarian	O
cancer	O
.	O

The	O
role	O
of	O
BRCA1	O
in	O
sporadic	O
breast	O
and	O
ovarian	O
cancers	O
remains	O
elusive	O
.	O

We	O
suggest	O
that	O
the	O
rarity	O
of	O
observed	O
BRCA1	O
mutations	O
in	O
sporadic	O
breast	O
and	O
ovarian	O
cancer	O
is	O
due	O
to	O
the	O
greater	O
likelihood	O
of	O
BRCA1	O
inactivation	O
by	O
non	O
-	O
mutational	O
mechanisms	O
such	O
as	O
methylation	O
.	O

Activation	O
of	O
MybER	O
both	O
prevented	O
the	O
growth	O
arrest	O
induced	O
by	O
interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
)	O
and	O
rapidly	O
restored	O
c	O
-	O
myc	O
expression	O
in	O
nearly	O
terminal	O
differentiated	O
cells	O
that	O
had	O
been	O
exposed	O
to	O
IL	O
-	O
6	O
for	O
3	O
days	O
.	O

In	O
addition	O
,	O
the	O
endostatin	O
vector	O
treatment	O
completely	O
prevented	O
the	O
formation	O
of	O
pulmonary	O
micrometastases	O
in	O
Lewis	O
lung	O
carcinoma	O
(	O
P	O
=	O
0	O
.	O
0001	O
)	O
.	O

Hypermethylation	O
and	O
loss	O
of	O
final	O
sigma	O
expression	O
are	O
the	O
most	O
consistent	O
molecular	O
alterations	O
in	O
breast	O
cancer	O
identified	O
so	O
far	O
.	O

A	O
cohort	O
of	O
unspecified	O
mesodermal	O
cells	O
differentiates	O
into	O
primitive	O
endothelial	O
cells	O
,	O
which	O
migrate	O
to	O
and	O
occupy	O
positions	O
within	O
the	O
stereotypical	O
blueprint	O
of	O
the	O
primitive	O
vasculature	O
.	O

The	O
expression	O
of	O
VEGF	O
and	O
p53	O
protein	O
in	O
these	O
SCC	O
was	O
examined	O
immunohistochemically	O
.	O

RESULTS	O
:	O
VEGF	O
expression	O
was	O
observed	O
in	O
58	O
.	O
3	O
%	O
,	O
and	O
p53	O
protein	O
expression	O
was	O
observed	O
in	O
61	O
.	O
7	O
%	O
of	O
the	O
60	O
patients	O
.	O

The	O
5	O
-	O
yr	O
survival	O
rate	O
in	O
patients	O
with	O
the	O
coexpression	O
was	O
poorer	O
than	O
in	O
the	O
other	O
patients	O
.	O

Neoplastic	O
transformation	O
and	O
tumorigenesis	O
associated	O
with	O
overexpression	O
of	O
phospholipase	O
D	O
isozymes	O
in	O
cultured	O
murine	O
fibroblasts	O
.	O

Both	O
PLD1	O
and	O
PLD2	O
also	O
induced	O
an	O
up	O
-	O
regulation	O
of	O
the	O
activity	O
of	O
matrix	O
metalloprotease	O
-	O
9	O
as	O
detected	O
by	O
zymograms	O
.	O

Troponin	O
I	O
(	O
TnI	O
)	O
is	O
a	O
novel	O
cartilage	O
-	O
derived	O
angiogenesis	O
inhibitor	O
,	O
first	O
demonstrated	O
by	O
Moses	O
et	O
al	O
.	O

(	O
1999	O
,	O
Proc	O
.	O
Natl	O
.	O
Acad	O
.	O
Sci	O
.	O
USA	O
2645	O
-	O
2650	O
)	O
to	O
inhibit	O
endothelial	O
cell	O
proliferation	O
and	O
angiogenesis	O
,	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
,	O
and	O
to	O
inhibit	O
metastasis	O
of	O
a	O
wide	O
variety	O
of	O
tumors	O
in	O
vivo	O
.	O

We	O
further	O
support	O
this	O
hypothesis	O
by	O
providing	O
the	O
first	O
evidence	O
that	O
TnI	O
can	O
act	O
on	O
nonendothelial	O
as	O
well	O
as	O
endothelial	O
cells	O
and	O
by	O
demonstrating	O
that	O
this	O
inhibitory	O
action	O
is	O
specific	O
for	O
the	O
bFGF	O
receptor	O
on	O
the	O
target	O
cells	O
.	O

The	O
implication	O
of	O
the	O
small	O
GTPase	O
RhoA	O
in	O
TSH	O
-	O
mediated	O
proliferation	O
of	O
FRTL	O
-	O
5	O
rat	O
thyroid	O
cells	O
has	O
been	O
previously	O
demonstrated	O
.	O

Interestingly	O
,	O
FRTL	O
-	O
5	O
-	O
RhoA	O
QL	O
cells	O
express	O
less	O
Tg	O
and	O
TTF	O
-	O
1	O
than	O
wild	O
-	O
type	O
FRTL	O
-	O
5	O
(	O
FRTL	O
-	O
5	O
-	O
vector	O
)	O
or	O
FRTL	O
-	O
5	O
-	O
RhoA	O
N19	O
,	O
suggesting	O
a	O
loss	O
at	O
the	O
differentiation	O
stage	O
.	O

Taken	O
together	O
,	O
these	O
results	O
show	O
for	O
the	O
first	O
time	O
that	O
active	O
RhoA	O
is	O
able	O
to	O
transform	O
FRTL	O
-	O
5	O
cells	O
and	O
that	O
this	O
effect	O
is	O
coupled	O
to	O
a	O
loss	O
of	O
thyroid	O
differentiation	O
due	O
to	O
impaired	O
TTF	O
-	O
1	O
activity	O
.	O

RESULTS	O
:	O
There	O
was	O
no	O
significant	O
difference	O
in	O
the	O
median	O
PE	O
level	O
between	O
AML	O
/	O
MDS	O
patients	O
and	O
the	O
normal	O
controls	O
.	O

Nevertheless	O
,	O
patients	O
who	O
achieved	O
complete	O
remission	O
(	O
CR	O
)	O
had	O
a	O
significantly	O
lower	O
median	O
PE	O
level	O
compared	O
to	O
those	O
who	O
did	O
not	O
.	O

In	O
multivariate	O
analysis	O
,	O
PE	O
was	O
found	O
to	O
be	O
a	O
significant	O
(	O
P	O
=	O
0	O
.	O
03	O
)	O
predictor	O
of	O
overall	O
survival	O
(	O
OS	O
)	O
with	O
adjustment	O
of	O
the	O
other	O
baseline	O
covariates	O
,	O
including	O
patient	O
age	O
,	O
history	O
of	O
antecedent	O
hematologic	O
disorders	O
,	O
and	O
the	O
use	O
of	O
protective	O
environments	O
.	O

Absent	O
staining	O
of	O
beta	O
-	O
catenin	O
was	O
associated	O
with	O
lymph	O
node	O
metastasis	O
.	O

An	O
intracellular	O
complex	O
containing	O
NRP1	O
and	O
KDR	O
was	O
immunoprecipitated	O
from	O
EC	O
by	O
anti	O
-	O
NRP1	O
antibodies	O
only	O
in	O
the	O
presence	O
of	O
VEGF165	O
.	O

In	O
1997	O
,	O
the	O
PTEN	O
gene	O
(	O
phosphatase	O
and	O
tensin	O
homolog	O
deleted	O
on	O
chromosome	O
10	O
)	O
was	O
identified	O
as	O
a	O
tumor	O
suppressor	O
gene	O
on	O
the	O
long	O
arm	O
of	O
chromosome	O
10	O
.	O

Furthermore	O
,	O
the	O
possibility	O
of	O
selective	O
targeting	O
of	O
PTEN	O
mutant	O
tumor	O
cells	O
by	O
specific	O
pharmacologic	O
inhibitors	O
of	O
members	O
of	O
the	O
Pten	O
/	O
PI3K	O
/	O
Akt	O
pathway	O
opens	O
up	O
new	O
perspectives	O
for	O
a	O
targeted	O
molecular	O
therapy	O
of	O
malignant	O
gliomas	O
.	O

TTF	O
-	O
1	O
immunohistochemistry	O
could	O
focus	O
the	O
search	O
for	O
the	O
primary	O
tumor	O
for	O
patients	O
presenting	O
with	O
brain	O
metastasis	O
as	O
the	O
initial	O
manifestation	O
.	O

For	O
this	O
reason	O
,	O
formalin	S-Chemical_Compound
-	O
fixed	O
,	O
paraffin	S-Chemical_Compound
-	O
embedded	O
specimens	O
from	O
130	O
patients	O
with	O
squamous	O
cell	O
lung	O
carcinomas	O
were	O
analyzed	O
by	O
immunohistochemistry	O
.	O

In	O
a	O
first	O
step	O
,	O
proteins	O
were	O
selected	O
which	O
showed	O
a	O
relationship	O
to	O
lymph	O
node	O
involvement	O
.	O

We	O
have	O
investigated	O
the	O
expression	O
of	O
the	O
CD40	O
-	O
CD154	O
system	O
in	O
24	O
primary	O
cultures	O
derived	O
from	O
renal	O
cell	O
carcinomas	O
,	O
its	O
correlation	O
with	O
tumor	O
stage	O
and	O
its	O
potential	O
functional	O
significance	O
.	O

CD154	O
,	O
but	O
not	O
CD40	O
expression	O
,	O
significantly	O
correlated	O
with	O
tumor	O
stage	O
.	O

Together	O
,	O
these	O
studies	O
define	O
a	O
novel	O
p53	O
-	O
survivin	O
signaling	O
pathway	O
activated	O
by	O
DNA	O
damage	O
that	O
results	O
in	O
down	O
-	O
regulation	O
of	O
survivin	O
,	O
cell	O
cycle	O
arrest	O
,	O
and	O
apoptosis	O
.	O

FGFR1	O
and	O
FGFR2	O
were	O
present	O
on	O
explants	O
.	O

Heating	O
and	O
protease	O
treatment	O
of	O
the	O
stimulants	O
reduced	O
the	O
VEGF	O
enhancing	O
levels	O
in	O
Ve	O
and	O
OMP	O
in	O
vitro	O
.	O

NF	O
-	O
kappaB	O
/	O
Rel	O
transcriptional	O
pathway	O
:	O
implications	O
in	O
pancreatic	O
cancer	O
.	O

The	O
polyester	S-Chemical_Compound
prostheses	O
utilized	O
were	O
polyester	S-Chemical_Compound
flat	O
(	O
PF	O
)	O
and	O
polyester	S-Chemical_Compound
soft	O
three	O
-	O
dimensional	O
(	O
PS	O
)	O
;	O
the	O
PP	O
mesh	O
utilized	O
was	O
Marlex	O
.	O

Furthermore	O
,	O
we	O
show	O
that	O
p53	O
is	O
activated	O
in	O
virally	O
infected	O
cells	O
to	O
evoke	O
an	O
apoptotic	O
response	O
and	O
that	O
p53	O
is	O
critical	O
for	O
antiviral	O
defence	O
of	O
the	O
host	O
.	O

Our	O
study	O
reveals	O
a	O
hitherto	O
unrecognized	O
link	O
between	O
p53	O
and	O
IFN	O
-	O
alpha	O
/	O
beta	O
in	O
tumour	O
suppression	O
and	O
antiviral	O
immunity	O
,	O
which	O
may	O
have	O
therapeutic	O
implications	O
.	O

It	O
also	O
promotes	O
endothelial	O
differentiation	O
into	O
capillary	O
-	O
like	O
structures	O
in	O
an	O
in	O
vitro	O
assay	O
and	O
is	O
angiogenic	O
in	O
the	O
chick	O
chorionallantoic	O
membrane	O
.	O

BX471	S-Chemical_Compound
(	O
R	B-Chemical_Compound
-	I-Chemical_Compound
N	I-Chemical_Compound
-	I-Chemical_Compound
[	I-Chemical_Compound
5	I-Chemical_Compound
-	I-Chemical_Compound
chloro	I-Chemical_Compound
-	I-Chemical_Compound
2	I-Chemical_Compound
-	I-Chemical_Compound
[	I-Chemical_Compound
2	I-Chemical_Compound
-	I-Chemical_Compound
[	I-Chemical_Compound
4	I-Chemical_Compound
(	I-Chemical_Compound
4	I-Chemical_Compound
-	I-Chemical_Compound
fluorophenyl	I-Chemical_Compound
)	I-Chemical_Compound
methyl	I-Chemical_Compound
]	I-Chemical_Compound
-	I-Chemical_Compound
2	I-Chemical_Compound
-	I-Chemical_Compound
methyl	I-Chemical_Compound
-	I-Chemical_Compound
1	I-Chemical_Compound
-	I-Chemical_Compound
piperazinyl	I-Chemical_Compound
]	I-Chemical_Compound
-	I-Chemical_Compound
2	I-Chemical_Compound
-	I-Chemical_Compound
oxoethoxy	I-Chemical_Compound
]	I-Chemical_Compound
phenyl	I-Chemical_Compound
]	I-Chemical_Compound
urea	I-Chemical_Compound
hydrochloric	I-Chemical_Compound
acid	I-Chemical_Compound
salt	E-Chemical_Compound
)	O
,	O
a	O
CCR1	O
antagonist	O
,	O
inhibits	O
angiogenic	O
properties	O
of	O
CCL16	O
,	O
whereas	O
blocking	O
of	O
CCR8	O
or	O
desensitizing	O
CCR2	O
,	O
which	O
are	O
both	O
well	O
known	O
receptors	O
for	O
CCL16	O
,	O
did	O
not	O
abolish	O
endothelial	O
activation	O
.	O

In	O
all	O
cases	O
,	O
there	O
was	O
complete	O
concordance	O
between	O
the	O
effects	O
of	O
hypoxia	O
and	O
AdCA5	O
.	O

These	O
results	O
indicate	O
that	O
HIF	O
-	O
1	O
functions	O
as	O
a	O
master	O
regulator	O
of	O
angiogenesis	O
by	O
controlling	O
the	O
expression	O
of	O
multiple	O
angiogenic	O
growth	O
factors	O
and	O
that	O
adenovirus	O
-	O
mediated	O
expression	O
of	O
a	O
constitutively	O
active	O
form	O
of	O
HIF	O
-	O
1alpha	O
is	O
sufficient	O
to	O
induce	O
angiogenesis	O
in	O
nonischemic	O
tissue	O
of	O
an	O
adult	O
animal	O
.	O

However	O
,	O
the	O
expression	O
level	O
of	O
E	O
-	O
cadherin	O
had	O
an	O
inverse	O
relationship	O
with	O
both	O
differentiation	O
level	O
of	O
the	O
tumor	O
and	O
lymphatic	O
vessel	O
invasion	O
(	O
p	O
=	O
0	O
.	O
0430	O
and	O
0	O
.	O
0320	O
,	O
respectively	O
)	O
.	O

Nuclear	O
translocation	O
of	O
a	O
clusterin	O
isoform	O
is	O
associated	O
with	O
induction	O
of	O
anoikis	O
in	O
SV40	O
-	O
immortalized	O
human	O
prostate	O
epithelial	O
cells	O
.	O

We	O
quantified	O
CYR61	O
,	O
CTGF	O
,	O
WISP	O
-	O
1	O
,	O
and	O
NOV	O
mRNA	O
expression	O
levels	O
in	O
samples	O
from	O
sixty	O
-	O
six	O
primary	O
gliomas	O
and	O
five	O
normal	O
brain	O
samples	O
using	O
quantitative	O
real	O
-	O
time	O
PCR	O
assay	O
.	O

In	O
contrast	O
to	O
CYR61	O
and	O
CTGF	O
,	O
no	O
significant	O
association	O
was	O
found	O
between	O
expression	O
of	O
either	O
WISP	O
-	O
1	O
or	O
NOV	O
versus	O
any	O
of	O
the	O
pathological	O
features	O
.	O

Agents	O
that	O
inhibit	O
Hsp90	O
function	O
hold	O
significant	O
promise	O
in	O
cancer	O
therapy	O
.	O

Concentrations	O
achieved	O
in	O
vivo	O
in	O
tumors	O
lead	O
to	O
single	O
-	O
agent	O
anti	O
-	O
tumor	O
activity	O
at	O
non	O
-	O
toxic	O
doses	O
.	O

Fifty	O
distinct	O
different	O
protein	O
spots	O
were	O
analyzed	O
with	O
online	O
LC	O
-	O
ESI	O
-	O
MS	O
/	O
MS	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
(	O
1	O
)	O
whether	O
expression	O
of	O
COX	O
-	O
2	O
and	O
PPARgamma	O
is	O
associated	O
with	O
ovarian	O
carcinogenesis	O
and	O
progression	O
of	O
ovarian	O
tumours	O
and	O
(	O
2	O
)	O
whether	O
COX	O
-	O
2	O
expression	O
is	O
controlled	O
through	O
ligand	O
-	O
mediated	O
activation	O
of	O
PPARgamma	O
in	O
ovarian	O
carcinoma	O
cells	O
.	O

For	O
this	O
purpose	O
,	O
the	O
presence	O
of	O
COX	O
-	O
2	O
and	O
PPARgamma	O
was	O
immunohistochemically	O
examined	O
in	O
71	O
epithelial	O
ovarian	O
carcinomas	O
,	O
18	O
borderline	O
tumours	O
and	O
23	O
benign	O
tumours	O
and	O
the	O
levels	O
of	O
COX	O
-	O
2	O
and	O
PPARgamma	O
proteins	O
were	O
determined	O
by	O
enzyme	O
immunoassay	O
in	O
four	O
benign	O
tumours	O
,	O
three	O
borderline	O
tumours	O
and	O
12	O
carcinomas	O
.	O

The	O
frequency	O
of	O
COX	O
-	O
2	O
and	O
PPARgamma	O
detection	O
was	O
significantly	O
increased	O
and	O
decreased	O
as	O
lesions	O
progressed	O
to	O
carcinoma	O
,	O
respectively	O
.	O

These	O
aspects	O
of	O
OPN	O
biology	O
are	O
important	O
in	O
tumorigenesis	O
.	O

RESULTS	O
:	O
The	O
mean	O
Rentrop	O
collateral	O
score	O
was	O
higher	O
in	O
Group	O
1	O
than	O
in	O
Group	O
2	O
(	O
2	O
.	O
39	O
+	O
/	O
-	O
1	O
.	O
07	O
vs	O
.	O
1	O
.	O
76	O
+	O
/	O
-	O
0	O
.	O
76	O
,	O
respectively	O
,	O
p	O
less	O
than	O
0	O
.	O
001	O
)	O
.	O

CONCLUSIONS	O
:	O
We	O
have	O
shown	O
that	O
patients	O
with	O
PDR	O
have	O
a	O
lower	O
coronary	O
collateral	O
score	O
than	O
patients	O
without	O
DR	O
.	O

VEGFR1	O
-	O
positive	O
haematopoietic	O
bone	O
marrow	O
progenitors	O
initiate	O
the	O
pre	O
-	O
metastatic	O
niche	O
.	O

These	O
findings	O
demonstrate	O
a	O
requirement	O
for	O
VEGFR1	O
+	O
haematopoietic	O
progenitors	O
in	O
the	O
regulation	O
of	O
metastasis	O
,	O
and	O
suggest	O
that	O
expression	O
patterns	O
of	O
fibronectin	O
and	O
VEGFR1	O
+	O
VLA	O
-	O
4	O
+	O
clusters	O
dictate	O
organ	O
-	O
specific	O
tumour	O
spread	O
.	O

We	O
therefore	O
set	O
out	O
to	O
determine	O
whether	O
the	O
few	O
cells	O
that	O
express	O
vGPCR	O
in	O
established	O
tumors	O
represent	O
an	O
appropriate	O
therapeutic	O
target	O
for	O
the	O
treatment	O
of	O
patients	O
with	O
preexisting	O
Kaposi	O
'	O
s	O
sarcoma	O
.	O

Mechanisms	O
of	O
pericyte	O
recruitment	O
in	O
tumour	O
angiogenesis	O
:	O
a	O
new	O
role	O
for	O
metalloproteinases	O
.	O

Finally	O
,	O
dominant	O
-	O
negative	O
inhibition	O
of	O
Mitf	O
resulted	O
in	O
profound	O
resistance	O
of	O
melanocytes	O
and	O
melanoma	O
cells	O
to	O
HGF	O
-	O
dependent	O
matrix	O
invasion	O
,	O
suggesting	O
a	O
physiologic	O
role	O
for	O
this	O
pathway	O
in	O
melanocytic	O
development	O
and	O
melanoma	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
activation	O
of	O
the	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
5	O
(	O
STAT5	O
)	O
plays	O
an	O
essential	O
role	O
in	O
leukemogenesis	O
mediated	O
through	O
constitutive	O
activated	O
protein	O
tyrosine	O
kinases	O
(	O
PTK	O
)	O
.	O

Ba	O
/	O
F3	O
cells	O
transformed	O
to	O
growth	O
factor	O
independence	O
by	O
various	O
oncogenic	O
PTKs	O
(	O
TEL	O
/	O
JAK2	O
,	O
TEL	O
/	O
TRKC	O
,	O
TEL	O
/	O
ABL	O
,	O
BCR	O
/	O
ABL	O
,	O
FLT3	O
-	O
ITD	O
,	O
and	O
H4	O
/	O
PDGFbetaR	O
)	O
show	O
abundant	O
expression	O
of	O
PIM	O
-	O
1	O
and	O
PIM	O
-	O
2	O
.	O

96	O
,	O
2811	O
-	O
2816	O
.	O

This	O
ectopic	O
ATP	O
synthase	O
catalyzes	O
ATP	S-Chemical_Compound
synthesis	O
and	O
is	O
inhibited	O
by	O
angiostatin	O
over	O
a	O
wide	O
pH	O
range	O
.	O

An	O
angiostatin	B-Chemical_Compound
-	I-Chemical_Compound
mimetic	E-Chemical_Compound
activity	O
has	O
recently	O
been	O
observed	O
using	O
a	O
polyclonal	O
antibody	O
against	O
the	O
beta	O
catalytic	O
subunit	O
of	O
ATP	O
synthase	O
.	O

Hepatitis	O
B	O
virus	O
(	O
HBV	O
)	O
is	O
strongly	O
associated	O
with	O
the	O
development	O
of	O
HCC	O
in	O
people	O
chronically	O
infected	O
with	O
the	O
virus	O
,	O
but	O
the	O
mechanism	O
of	O
viral	O
involvement	O
remains	O
unclear	O
.	O

Restriction	O
fragment	O
length	O
polymorphism	O
studies	O
demonstrated	O
that	O
the	O
loss	O
of	O
one	O
copy	O
of	O
portions	O
of	O
chromosome	O
17	O
occurred	O
in	O
10	O
(	O
53	O
%	O
)	O
of	O
the	O
19	O
patients	O
.	O

MATERIALS	O
AND	O
METHODS	O
:	O
Porous	O
PLGA	S-Chemical_Compound
microspheres	O
having	O
primary	O
amine	O
groups	O
on	O
the	O
surface	O
were	O
prepared	O
using	O
an	O
oil	O
-	O
in	O
-	O
water	O
(	O
O	O
/	O
W	O
)	O
single	O
emulsion	O
method	O
using	O
Pluronic	O
F	O
-	O
127	O
as	O
an	O
extractable	O
porogen	O
.	O

The	O
amount	O
of	O
conjugated	O
amine	O
group	O
onto	O
the	O
microspheres	O
was	O
1	O
.	O
93	O
+	O
/	O
-	O
0	O
.	O
01	O
nmol	O
/	O
mg	O
-	O
microspheres	O
,	O
while	O
the	O
amount	O
of	O
heparin	S-Chemical_Compound
was	O
95	O
.	O
8	O
pmol	O
/	O
mg	O
-	O
microspheres	O
.	O

In	O
some	O
cancers	O
,	O
syndecan	O
expression	O
has	O
been	O
shown	O
to	O
regulate	O
tumor	O
cell	O
function	O
(	O
e	O
.	O
g	O
.	O
proliferation	O
,	O
adhesion	O
,	O
and	O
motility	O
)	O
and	O
serve	O
as	O
a	O
prognostic	O
marker	O
for	O
tumor	O
progression	O
and	O
patient	O
survival	O
.	O

The	O
CCAAT	O
/	O
enhancer	O
-	O
binding	O
protein	O
beta	O
(	O
C	O
/	O
EBPbeta	O
)	O
transcription	O
factor	O
has	O
been	O
associated	O
with	O
several	O
cancer	O
models	O
.	O

In	O
this	O
study	O
,	O
the	O
expression	O
of	O
C	O
/	O
EBPbeta	O
was	O
analysed	O
in	O
a	O
series	O
of	O
90	O
gastric	O
carcinomas	O
(	O
GCs	O
)	O
.	O

In	O
normal	O
gastric	O
mucosa	O
,	O
C	O
/	O
EBPbeta	O
expression	O
was	O
restricted	O
to	O
cells	O
in	O
the	O
proliferative	O
zone	O
.	O

The	O
3	O
-	O
D	O
organization	O
of	O
these	O
extracellular	O
components	O
distinguishes	O
the	O
Surgisis	O
mesh	O
from	O
synthetic	O
materials	O
and	O
is	O
associated	O
with	O
constructive	O
tissue	O
remodelling	O
instead	O
of	O
scar	O
tissue	O
.	O

Common	O
features	O
of	O
this	O
ECM	O
-	O
assisted	O
tissue	O
remodelling	O
include	O
angiogenesis	O
,	O
recruitment	O
of	O
circulating	O
progenitor	O
cells	O
and	O
constructive	O
remodelling	O
of	O
damaged	O
tissue	O
structures	O
.	O

The	O
average	O
IMVD	O
had	O
statistical	O
difference	O
in	O
histological	O
grading	O
(	O
P	O
less	O
than	O
0	O
.	O
01	O
)	O
,	O
and	O
analysis	O
by	O
one	O
to	O
one	O
,	O
the	O
average	O
IMVD	O
had	O
statistical	O
difference	O
between	O
high	O
and	O
median	O
grading	O
.	O

The	O
effect	O
of	O
swainsonine	S-Chemical_Compound
(	O
active	O
compound	O
of	O
locoweed	O
and	O
a	O
potential	O
anticancer	O
drug	O
)	O
on	O
vascular	O
development	O
showed	O
no	O
differences	O
in	O
sinusoidal	O
diameters	O
at	O
7	O
weeks	O
,	O
but	O
a	O
decrease	O
in	O
capillary	O
density	O
was	O
noted	O
.	O

Strikingly	O
,	O
Tip30	O
deletion	O
promotes	O
proliferation	O
of	O
primary	O
MECs	O
and	O
results	O
in	O
rapid	O
immortalization	O
of	O
MECs	O
in	O
vitro	O
relative	O
to	O
wild	O
-	O
type	O
cells	O
.	O

Together	O
,	O
these	O
results	O
suggest	O
that	O
Tip30	O
is	O
an	O
intrinsic	O
and	O
negative	O
regulator	O
of	O
MEC	O
proliferation	O
partly	O
through	O
the	O
inhibition	O
of	O
Wisp2	O
and	O
Igf	O
-	O
1	O
expression	O
,	O
and	O
its	O
absence	O
in	O
the	O
mammary	O
gland	O
may	O
predispose	O
MECs	O
to	O
neoplastic	O
transformation	O
.	O

Unlike	O
wounds	O
,	O
however	O
,	O
that	O
turn	O
off	O
VPF	O
production	O
after	O
healing	O
,	O
tumors	O
did	O
not	O
turn	O
off	O
their	O
VPF	O
production	O
and	O
instead	O
continued	O
to	O
make	O
large	O
amounts	O
of	O
VPF	O
,	O
allowing	O
malignant	O
cells	O
to	O
continue	O
to	O
induce	O
new	O
blood	O
vessels	O
and	O
so	O
to	O
grow	O
and	O
spread	O
.	O

The	O
transforming	O
growth	O
factor	O
beta	O
(	O
TGFbeta	O
)	O
family	O
has	O
critical	O
roles	O
in	O
the	O
regulation	O
of	O
fertility	O
.	O

Using	O
tissue	O
-	O
specific	O
ablation	O
in	O
mice	O
,	O
we	O
deleted	O
the	O
BR	O
-	O
SMADs	O
from	O
somatic	O
cells	O
of	O
ovaries	O
and	O
testes	O
.	O

DESIGN	O
:	O
Paraffin	S-Chemical_Compound
-	O
embedded	O
sections	O
of	O
37	O
breast	O
carcinomas	O
were	O
immunostained	O
for	O
survivin	O
,	O
bcl	O
-	O
2	O
,	O
bcl	O
-	O
x	O
,	O
and	O
bax	O
.	O

G45	O
antibody	O
treatment	O
induced	O
SCC	O
tumor	O
apoptosis	O
,	O
decreased	O
SCC	O
tumor	O
proliferation	O
,	O
and	O
markedly	O
impaired	O
human	O
SCC	O
tumorigenesis	O
in	O
vivo	O
without	O
affecting	O
normal	O
tissue	O
adhesion	O
.	O

These	O
results	O
show	O
a	O
remarkable	O
selectivity	O
of	O
expression	O
and	O
function	O
for	O
laminin	O
-	O
332	O
G45	O
in	O
human	O
SCC	O
tumorigenesis	O
and	O
implicate	O
it	O
as	O
a	O
specific	O
target	O
for	O
anticancer	O
therapy	O
.	O

Angiogenesis	O
plays	O
an	O
important	O
role	O
in	O
many	O
types	O
of	O
cancer	O
.	O

However	O
,	O
the	O
role	O
of	O
IL	O
-	O
8	O
in	O
non	O
-	O
Hodgkin	O
'	O
s	O
lymphoma	O
(	O
NHL	O
)	O
has	O
not	O
been	O
fully	O
determined	O
.	O

We	O
developed	O
reference	O
intervals	O
for	O
serum	O
and	O
urine	O
IL	O
-	O
8	O
level	O
in	O
131	O
control	O
individuals	O
.	O

The	O
importance	O
of	O
NO	S-Chemical_Compound
in	O
the	O
vasculature	O
is	O
demonstrated	O
by	O
several	O
experimental	O
conditions	O
,	O
such	O
as	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
-	O
induced	O
angiogenesis	O
.	O

Thus	O
,	O
the	O
NO	S-Chemical_Compound
metabolic	O
pathway	O
in	O
endothelial	O
cells	O
could	O
be	O
one	O
of	O
the	O
main	O
contributing	O
factors	O
for	O
angiogenesis	O
.	O

METHODS	O
:	O
Transplant	O
tumor	O
model	O
was	O
induced	O
by	O
subcutaneous	O
inoculation	O
of	O
2	O
x	O
10	O
(	O
6	O
)	O
Lewis	O
lung	O
cancer	O
(	O
LLC	O
)	O
cells	O
into	O
the	O
back	O
of	O
C57BL	O
/	O
6	O
mice	O
.	O

CONCLUSION	O
:	O
Endostatin	O
gene	O
therapy	O
mediated	O
by	O
adenoviral	O
vector	O
efficiently	O
induces	O
expression	O
of	O
endostatin	O
in	O
vivo	O
,	O
and	O
inhibits	O
the	O
growth	O
and	O
metastasis	O
of	O
tumor	O
.	O

This	O
pathway	O
will	O
continue	O
to	O
be	O
a	O
focus	O
of	O
investigation	O
,	O
particularly	O
with	O
respect	O
to	O
targeted	O
experimental	O
chemotherapeutics	O
.	O

Furthermore	O
,	O
we	O
have	O
searched	O
for	O
the	O
underlying	O
mechanisms	O
of	O
apoptosis	O
by	O
demonstrating	O
apoptosis	O
-	O
related	O
genes	O
.	O

RESULTS	O
:	O
Our	O
results	O
revealed	O
that	O
docetaxel	S-Chemical_Compound
and	O
ATRA	S-Chemical_Compound
were	O
synergistically	O
cytotoxic	O
and	O
apoptotic	O
in	O
DU	O
-	O
145	O
cells	O
,	O
in	O
a	O
dose	O
-	O
and	O
time	O
dependent	O
manner	O
.	O

CONCLUSION	O
:	O
In	O
conclusion	O
,	O
we	O
strongly	O
suggest	O
that	O
docetaxel	S-Chemical_Compound
and	O
ATRA	S-Chemical_Compound
combination	O
is	O
a	O
good	O
candidate	O
for	O
this	O
challenging	O
era	O
of	O
daily	O
oncologic	O
practice	O
.	O

The	O
pro	O
-	O
angiogenic	O
capacities	O
of	O
perlecan	O
that	O
involve	O
proliferative	O
and	O
migratory	O
signals	O
in	O
response	O
to	O
bound	O
growth	O
factors	O
will	O
be	O
explored	O
,	O
as	O
well	O
as	O
the	O
anti	O
-	O
angiogenic	O
signals	O
resulting	O
from	O
interactions	O
between	O
the	O
C	O
-	O
terminal	O
domain	O
known	O
as	O
endorepellin	O
and	O
integrins	O
that	O
control	O
adhesion	O
of	O
cells	O
to	O
the	O
extracellular	O
matrix	O
.	O

Additional	O
mechanistic	O
studies	O
further	O
suggested	O
that	O
the	O
ability	O
of	O
circulating	O
cancer	O
cells	O
to	O
extravasate	O
to	O
surrounding	O
lung	O
tissues	O
was	O
linked	O
to	O
the	O
activation	O
of	O
the	O
vascular	O
endothelium	O
via	O
one	O
or	O
more	O
Galpha	O
(	O
i	O
)	O
-	O
coupled	O
receptors	O
.	O

Inhibition	O
of	O
energy	O
-	O
producing	O
pathways	O
of	O
HepG2	O
cells	O
by	O
3	B-Chemical_Compound
-	I-Chemical_Compound
bromopyruvate	E-Chemical_Compound
.	O

This	O
compound	O
inhibits	O
cellular	O
ATP	S-Chemical_Compound
production	O
owing	O
to	O
its	O
action	O
on	O
glycolysis	O
and	O
oxidative	O
phosphorylation	O
;	O
however	O
,	O
the	O
specific	O
metabolic	O
steps	O
and	O
mechanisms	O
of	O
3	B-Chemical_Compound
-	I-Chemical_Compound
BrPA	E-Chemical_Compound
action	O
in	O
human	O
hepatocellular	O
carcinomas	O
,	O
particularly	O
its	O
effects	O
on	O
mitochondrial	O
energetics	O
,	O
are	O
poorly	O
understood	O
.	O

The	O
activity	O
of	O
mitochondrial	O
hexokinase	O
was	O
not	O
inhibited	O
by	O
150	O
microM	O
3	B-Chemical_Compound
-	I-Chemical_Compound
BrPA	E-Chemical_Compound
,	O
but	O
this	O
concentration	O
caused	O
more	O
than	O
70	O
%	O
inhibition	O
of	O
GAPDH	O
(	O
glyceraldehyde	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
)	O
and	O
3	O
-	O
phosphoglycerate	O
kinase	O
activities	O
.	O

The	O
activity	O
of	O
succinate	O
dehydrogenase	O
was	O
inhibited	O
by	O
70	O
%	O
by	O
3	B-Chemical_Compound
-	I-Chemical_Compound
BrPA	E-Chemical_Compound
treatment	O
.	O

CONCLUSION	O
:	O
This	O
study	O
identifies	O
specific	O
components	O
of	O
the	O
Robo	O
signaling	O
apparatus	O
that	O
work	O
together	O
to	O
guide	O
directional	O
migration	O
of	O
endothelial	O
cells	O
.	O

Several	O
cell	O
types	O
in	O
a	O
tissue	O
secrete	O
IL	O
-	O
8	O
.	O

An	O
anti	B-Chemical_Compound
-	I-Chemical_Compound
IL	I-Chemical_Compound
-	I-Chemical_Compound
8	I-Chemical_Compound
Ab	E-Chemical_Compound
inhibited	O
endothelial	O
cell	O
proliferation	O
induced	O
by	O
cancer	O
cell	O
produced	O
IL	O
-	O
8	O
and	O
tumors	O
with	O
low	O
IL	O
-	O
8	O
levels	O
exhibited	O
decreased	O
angiogenesis	O
.	O

In	O
contrast	O
,	O
KATO	O
III	O
cells	O
expressed	O
membrane	O
CXCR4	O
.	O

In	O
these	O
cells	O
,	O
SDF	O
-	O
1alpha	O
-	O
induced	O
migration	O
was	O
observed	O
and	O
was	O
blocked	O
by	O
AMD3100	S-Chemical_Compound
,	O
a	O
specific	O
inhibitor	O
of	O
CXCR4	O
.	O

SDF	O
-	O
1alpha	O
induced	O
rapid	O
phosphorylation	O
of	O
Erk1	O
/	O
2	O
MAPK	O
but	O
did	O
not	O
promote	O
phosphorylation	O
of	O
Stat3	O
or	O
Akt	O
.	O

Gastric	O
cancer	O
tissue	O
samples	O
expressed	O
CXCR4	O
with	O
variable	O
intensities	O
.	O

Macrophages	O
can	O
be	O
activated	O
in	O
a	O
classical	O
or	O
alternative	O
manner	O
in	O
parallel	O
with	O
the	O
T	O
(	O
H	O
)	O
1	O
/	O
T	O
(	O
H	O
)	O
2	O
dichotomy	O
,	O
respectively	O
.	O

Newly	O
formed	O
bone	O
densities	O
were	O
also	O
found	O
to	O
be	O
higher	O
in	O
these	O
2	O
groups	O
.	O

Correspondingly	O
,	O
Ang	O
-	O
2	O
manipulatory	O
therapies	O
have	O
been	O
shown	O
to	O
exert	O
protumorigenic	O
as	O
well	O
as	O
antitumorigenic	O
effects	O
.	O

The	O
selected	O
peptide	O
was	O
tested	O
for	O
the	O
antitumor	O
activity	O
against	O
mildly	O
aggressive	O
xenografted	O
prostate	O
carcinoma	O
and	O
highly	O
aggressive	O
renal	O
cell	O
carcinoma	O
.	O

To	O
verify	O
that	O
P18	O
acts	O
in	O
the	O
same	O
manner	O
as	O
PEDF	O
,	O
we	O
used	O
immunohistochemistry	O
to	O
measure	O
PEDF	O
targets	O
,	O
vascular	O
endothelial	O
growth	O
factor	O
receptor	O
2	O
,	O
and	O
CD95	O
ligand	O
expression	O
in	O
P18	O
-	O
treated	O
vasculature	O
.	O

RESULTS	O
:	O
P14	O
and	O
P18	O
blocked	O
endothelial	O
cell	O
chemotaxis	O
;	O
P18	O
and	O
P23	O
induced	O
apoptosis	O
.	O

The	O
concept	O
of	O
the	O
neurovascular	O
unit	O
emphasizes	O
that	O
common	O
signals	O
and	O
substrates	O
underlie	O
the	O
physiology	O
and	O
pathophysiology	O
of	O
neuronal	O
and	O
endothelial	O
compartments	O
in	O
brain	O
.	O

CONCLUSION	O
:	O
These	O
results	O
suggested	O
that	O
cisplatin	S-Chemical_Compound
induced	O
a	O
reduction	O
of	O
endothelial	O
cell	O
migration	O
through	O
an	O
inhibition	O
of	O
MMP2	O
activity	O
by	O
downstream	O
signal	O
transduction	O
pathways	O
independent	O
of	O
JNK	O
and	O
p38	O
MAPK	O
activation	O
.	O

Expanded	O
polytetrafluoroethylene	S-Chemical_Compound
(	O
ePTFE	S-Chemical_Compound
)	O
vascular	O
grafts	O
were	O
coated	O
with	O
perlecan	O
and	O
tested	O
in	O
an	O
ovine	O
carotid	O
interposition	O
model	O
for	O
a	O
period	O
of	O
6	O
weeks	O
and	O
assessed	O
using	O
light	O
and	O
scanning	O
microscopy	O
.	O

These	O
processes	O
are	O
regulated	O
by	O
numerous	O
pro	O
-	O
angiogenic	O
and	O
anti	O
-	O
angiogenic	O
growth	O
factors	O
.	O

Other	O
anti	O
-	O
angiogenic	O
therapies	O
alter	O
the	O
immune	O
response	O
and	O
endogeneous	O
angiogenesis	O
inhibitor	O
levels	O
.	O

Undoubtedly	O
,	O
blood	O
vessels	O
growth	O
regulation	O
is	O
a	O
vital	O
aspect	O
in	O
health	O
and	O
disease	O
.	O

One	O
limitation	O
of	O
these	O
approaches	O
,	O
however	O
,	O
may	O
be	O
the	O
failure	O
to	O
normalize	O
myocardial	O
perfusion	O
,	O
due	O
to	O
the	O
concomitant	O
presence	O
or	O
small	O
of	O
resistance	O
vessel	O
disease	O
.	O

We	O
report	O
a	O
novel	O
strategy	O
to	O
engineer	O
and	O
express	O
stable	O
and	O
soluble	O
human	O
recombinant	O
polyvalent	O
/	O
polyspecific	O
fusion	O
proteins	O
.	O

Using	O
a	O
human	O
recombinant	O
antibody	O
(	O
scFv	O
)	O
specific	O
for	O
the	O
angiogenesis	O
marker	O
domain	O
B	O
of	O
fibronectin	O
,	O
interleukin	O
2	O
,	O
and	O
an	O
scFv	O
able	O
to	O
neutralize	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
,	O
we	O
expressed	O
various	O
biologically	O
active	O
uteroglobin	O
fusion	O
proteins	O
.	O

Netrin	O
-	O
1	O
up	O
-	O
regulation	O
in	O
inflammatory	O
bowel	O
diseases	O
is	O
required	O
for	O
colorectal	O
cancer	O
progression	O
.	O

Moreover	O
,	O
we	O
demonstrate	O
that	O
this	O
inflammation	O
-	O
driven	O
netrin	O
-	O
1	O
up	O
-	O
regulation	O
is	O
causal	O
for	O
colorectal	O
cancer	O
development	O
as	O
interference	O
with	O
netrin	O
-	O
1	O
autocrine	O
loop	O
in	O
a	O
mouse	O
model	O
for	O
ulcerative	O
colitis	O
-	O
associated	O
colorectal	O
cancer	O
,	O
while	O
showing	O
no	O
effect	O
on	O
inflammation	O
,	O
inhibits	O
colorectal	O
cancer	O
progression	O
.	O

INTRODUCTION	O
:	O
Increased	O
angiogenesis	O
in	O
bone	O
marrow	O
is	O
one	O
of	O
the	O
characteristics	O
of	O
chronic	O
myeloid	O
leukaemia	O
(	O
CML	O
)	O
,	O
a	O
clonal	O
myeloproliferative	O
disorder	O
that	O
expresses	O
a	O
chimeric	O
bcr	O
/	O
abl	O
protein	O
.	O

Vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
is	O
one	O
of	O
the	O
most	O
potent	O
and	O
a	O
specific	O
regulator	O
of	O
angiogenesis	O
which	O
principally	O
targets	O
endothelial	O
cells	O
and	O
regulates	O
several	O
of	O
their	O
functions	O
,	O
including	O
mitogenesis	O
,	O
permeability	O
and	O
migration	O
.	O

OBJECTIVE	O
:	O
The	O
aim	O
of	O
this	O
study	O
was	O
the	O
follow	O
-	O
up	O
of	O
VEGF	O
expression	O
during	O
the	O
course	O
of	O
CML	O
.	O

CONCLUSION	O
:	O
Immunohistochemically	O
confirmed	O
significance	O
of	O
the	O
expression	O
of	O
VEGF	O
in	O
dependence	O
of	O
the	O
CML	O
stage	O
could	O
be	O
of	O
clinical	O
importance	O
in	O
deciding	O
on	O
the	O
timing	O
therapy	O
.	O

Aberrant	O
expression	O
of	O
Evi	O
-	O
1	O
has	O
been	O
frequently	O
found	O
in	O
myeloid	O
leukemia	O
,	O
and	O
is	O
associated	O
with	O
a	O
poor	O
patient	O
survival	O
.	O

Overexpression	O
of	O
Evi	O
-	O
1	O
increased	O
Pbx1	O
expression	O
in	O
hematopoietic	O
stem	O
/	O
progenitor	O
cells	O
.	O

Relevant	O
differentially	O
expressed	O
genes	O
were	O
validated	O
by	O
either	O
quantitative	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
or	O
immunohistochemistry	O
on	O
tissue	O
microarrays	O
.	O

Finally	O
,	O
we	O
identified	O
FGF13	O
as	O
a	O
new	O
prognostic	O
marker	O
that	O
predicted	O
poorer	O
outcome	O
in	O
patients	O
who	O
were	O
clinically	O
considered	O
free	O
from	O
disease	O
.	O

Activity	O
of	O
several	O
transcriptional	O
factors	O
located	O
downstream	O
in	O
the	O
Akt	O
pathway	O
was	O
also	O
tested	O
,	O
and	O
constitutive	O
activation	O
of	O
adenosine	O
3	O
'	O
,	O
5	O
'	O
-	O
monophosphate	O
response	O
element	O
-	O
binding	O
protein	O
(	O
CREB	O
)	O
by	O
ICAM	O
-	O
3	O
was	O
detected	O
.	O

Knowledge	O
of	O
14	O
-	O
3	O
-	O
3zeta	O
and	O
beta	O
-	O
catenin	O
expression	O
and	O
clinical	O
significance	O
in	O
the	O
same	O
tumor	O
tissues	O
is	O
limited	O
.	O

Specimens	O
of	O
NSCLC	O
and	O
adjacent	O
normal	O
lung	O
tissues	O
were	O
collected	O
from	O
110	O
patients	O
.	O

The	O
expression	O
of	O
14	O
-	O
3	O
-	O
3zeta	O
was	O
upregulated	O
in	O
stage	O
I	O
NSCLC	O
.	O

Expression	O
of	O
KISS1	O
and	O
MMP	O
-	O
9	O
in	O
non	O
-	O
small	O
cell	O
lung	O
cancer	O
and	O
their	O
relations	O
to	O
metastasis	O
and	O
survival	O
.	O

Evaluation	O
of	O
VEGF	O
expression	O
level	O
with	O
the	O
same	O
tissues	O
was	O
used	O
to	O
establish	O
the	O
antigenic	O
profiles	O
,	O
and	O
the	O
marker	O
of	O
CD34	O
staining	O
was	O
used	O
as	O
an	O
indicator	O
of	O
microvessel	O
density	O
(	O
MVD	O
)	O
.	O

The	O
neural	O
stem	O
cell	O
fate	O
determinant	O
TLX	O
plays	O
a	O
pivotal	O
role	O
in	O
neurogenesis	O
in	O
the	O
adult	O
brain	O
by	O
maintaining	O
neural	O
stem	O
cells	O
.	O

Increased	O
TLX	O
expression	O
was	O
observed	O
in	O
a	O
number	O
of	O
glioma	O
cells	O
and	O
glioma	O
stem	O
cells	O
,	O
and	O
correlated	O
with	O
poor	O
survival	O
of	O
patients	O
with	O
gliomas	O
.	O

We	O
show	O
here	O
that	O
constitutively	O
active	O
STAT3	O
acts	O
as	O
a	O
master	O
regulator	O
of	O
cell	O
metabolism	O
,	O
inducing	O
aerobic	O
glycolysis	O
and	O
down	O
-	O
regulating	O
mitochondrial	O
activity	O
both	O
in	O
primary	O
fibroblasts	O
and	O
in	O
STAT3	O
-	O
dependent	O
tumour	O
cell	O
lines	O
.	O

KISS1	O
methylation	O
was	O
associated	O
with	O
low	O
KISS1	O
transcript	O
expression	O
by	O
quantitative	O
RT	O
-	O
PCR	O
(	O
P	O
=	O
0	O
.	O
037	O
)	O
.	O

Low	O
transcript	O
expression	O
alone	O
(	O
P	O
=	O
0	O
.	O
003	O
)	O
or	O
combined	O
with	O
methylation	O
(	O
P	O
=	O
0	O
.	O
019	O
)	O
was	O
associated	O
with	O
poor	O
disease	O
-	O
specific	O
survival	O
(	O
n	O
=	O
205	O
)	O
.	O

Multikinase	O
inhibitor	O
sorafenib	S-Chemical_Compound
inhibits	O
proliferation	O
and	O
angiogenesis	O
of	O
tumors	O
by	O
suppressing	O
the	O
Raf	O
/	O
MEK	O
/	O
ERK	O
signaling	O
pathway	O
and	O
VEGF	O
receptor	O
tyrosine	O
kinase	O
.	O

To	O
examine	O
the	O
mechanisms	O
underlying	O
the	O
relative	O
resistance	O
in	O
HCC	O
,	O
we	O
investigated	O
the	O
role	O
of	O
autophagy	O
,	O
an	O
evolutionarily	O
conserved	O
self	O
-	O
digestion	O
pathway	O
,	O
in	O
hepatoma	O
cells	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

This	O
induction	O
was	O
due	O
to	O
activation	O
of	O
autophagic	O
flux	O
,	O
as	O
there	O
was	O
further	O
increase	O
in	O
LC3	O
-	O
II	O
expression	O
upon	O
treatment	O
with	O
lysosomal	O
inhibitors	O
,	O
clear	O
decline	O
of	O
the	O
autophagy	O
substrate	O
p62	O
,	O
and	O
an	O
mRFP	O
-	O
GFP	O
-	O
LC3	O
fluorescence	O
change	O
in	O
sorafenib	S-Chemical_Compound
-	O
treated	O
hepatoma	O
cells	O
.	O

Concomitant	O
inhibition	O
of	O
autophagy	O
may	O
be	O
an	O
attractive	O
strategy	O
for	O
unlocking	O
the	O
antitumor	O
potential	O
of	O
sorafenib	S-Chemical_Compound
in	O
HCC	O
.	O

These	O
results	O
suggest	O
that	O
desensitization	O
of	O
certain	O
agonist	O
-	O
induced	O
inositol	B-Chemical_Compound
phospholipid	E-Chemical_Compound
responses	O
in	O
ras	O
-	O
transformed	O
cells	O
is	O
a	O
consequence	O
of	O
increased	O
cell	O
proliferation	O
and	O
associated	O
amplification	O
in	O
C	O
-	O
kinase	O
activity	O
and	O
is	O
an	O
indirect	O
consequence	O
of	O
transformation	O
by	O
ras	O
.	O

Because	O
AR	O
-	O
ARD1	O
interaction	O
facilitated	O
the	O
AR	O
binding	O
to	O
its	O
targeted	O
promoters	O
for	O
gene	O
transcription	O
,	O
we	O
propose	O
that	O
ARD1	O
functions	O
as	O
a	O
unique	O
AR	O
regulator	O
and	O
forms	O
a	O
positive	O
feedback	O
loop	O
for	O
AR	O
-	O
dependent	O
prostate	O
tumorigenesis	O
.	O

Although	O
AID	O
activity	O
is	O
focused	O
at	O
Immunoglobulin	O
(	O
Ig	O
)	O
gene	O
loci	O
,	O
it	O
also	O
targets	O
a	O
wide	O
array	O
of	O
non	O
-	O
Ig	O
genes	O
including	O
oncogenes	O
associated	O
with	O
lymphomas	O
.	O

However	O
,	O
the	O
frequency	O
of	O
the	O
p	O
.	O
Val600Lys	O
mutation	O
was	O
higher	O
than	O
in	O
most	O
other	O
studies	O
and	O
comprised	O
almost	O
one	O
-	O
third	O
of	O
all	O
BRAF	O
mutations	O
in	O
our	O
cohort	O
(	O
27	O
/	O
89	O
,	O
30	O
%	O
)	O
.	O

The	O
virus	O
-	O
altered	O
cells	O
continued	O
to	O
proliferate	O
in	O
the	O
presence	O
of	O
high	O
levels	O
of	O
extracellular	O
calcium	S-Chemical_Compound
but	O
exhibited	O
alterations	O
in	O
normal	O
keratinocyte	O
terminal	O
differentiation	O
that	O
appear	O
to	O
be	O
specific	O
to	O
the	O
particular	O
oncogene	O
.	O

The	O
'	O
angiostatic	O
'	O
steroids	O
17	B-Chemical_Compound
hydroxyprogesterone	E-Chemical_Compound
and	O
epicortisol	S-Chemical_Compound
were	O
tested	O
because	O
of	O
their	O
lack	O
of	O
glucocorticoid	S-Chemical_Compound
and	O
mineralocorticoid	S-Chemical_Compound
effects	O
and	O
their	O
structural	O
similarity	O
to	O
glucocorticoids	S-Chemical_Compound
.	O

The	O
mutant	O
which	O
retains	O
only	O
the	O
central	O
region	O
of	O
the	O
v	O
-	O
fos	O
protein	O
(	O
Met111	O
-	O
Ile206	O
)	O
have	O
both	O
activities	O
,	O
but	O
the	O
mutants	O
which	O
have	O
deletions	O
in	O
this	O
region	O
,	O
and	O
one	O
of	O
the	O
mutants	O
that	O
has	O
a	O
four	O
amino	O
acid	O
insertion	O
in	O
it	O
,	O
lost	O
both	O
activities	O
.	O

The	O
direct	O
addition	O
of	O
all	B-Chemical_Compound
-	I-Chemical_Compound
trans	I-Chemical_Compound
-	I-Chemical_Compound
RA	E-Chemical_Compound
to	O
conditioned	O
medium	O
had	O
no	O
effect	O
on	O
secreted	O
collagenase	O
activity	O
.	O

The	O
apparent	O
molecular	O
weights	O
of	O
the	O
collagenolytic	O
enzymes	O
were	O
determined	O
by	O
electrophoresis	O
of	O
cell	O
extracts	O
and	O
concentrated	O
conditioned	O
medium	O
in	O
type	O
IV	O
collagen	O
-	O
embedded	O
polyacrylamide	S-Chemical_Compound
gels	O
followed	O
by	O
renaturation	O
and	O
activation	O
of	O
the	O
enzymes	O
within	O
the	O
gels	O
.	O

These	O
two	O
enzymes	O
were	O
also	O
found	O
to	O
have	O
specificity	O
for	O
gelatin	O
.	O

The	O
results	O
suggest	O
that	O
in	O
this	O
strain	O
,	O
the	O
malate	S-Chemical_Compound
-	O
citrate	S-Chemical_Compound
shuttle	O
is	O
not	O
an	O
effective	O
pathway	O
for	O
transferring	O
glycolytic	O
reducing	O
equivalents	O
from	O
cytosol	O
to	O
mitochondria	O
.	O

Moreover	O
,	O
in	O
the	O
presence	O
of	O
glucose	S-Chemical_Compound
,	O
the	O
malate	S-Chemical_Compound
-	O
citrate	S-Chemical_Compound
cycle	O
did	O
not	O
appear	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
glutaminolytic	O
process	O
.	O

These	O
results	O
suggest	O
that	O
there	O
is	O
cell	O
type	O
specificity	O
for	O
oncogene	O
activation	O
during	O
in	O
vitro	O
rat	O
bladder	O
transformation	O
initiated	O
by	O
a	O
single	O
carcinogen	O
and	O
that	O
ras	O
gene	O
activation	O
is	O
not	O
a	O
necessary	O
step	O
in	O
urothelial	O
transformation	O
in	O
vitro	O
.	O

As	O
in	O
prior	O
studies	O
,	O
there	O
were	O
significant	O
vascular	O
volume	O
differences	O
between	O
DMBA	S-Chemical_Compound
and	O
DMBA	S-Chemical_Compound
+	O
radiation	O
groups	O
of	O
tumor	O
-	O
bearing	O
cheek	O
pouches	O
.	O

Now	O
,	O
by	O
competition	O
experiments	O
with	O
a	O
panel	O
of	O
different	O
unlabelled	O
cells	O
we	O
show	O
that	O
the	O
VCSA	O
expressed	O
on	O
RSV	O
-	O
transformed	O
hamster	O
fibroblasts	O
is	O
a	O
complex	O
of	O
at	O
least	O
three	O
distinct	O
antigenic	O
specificities	O
:	O
(	O
1	O
)	O
one	O
expressed	O
on	O
all	O
RSV	O
-	O
transformed	O
fibroblasts	O
,	O
regardless	O
their	O
species	O
and	O
the	O
subgroup	O
or	O
strain	O
of	O
the	O
transforming	O
virus	O
;	O
(	O
2	O
)	O
one	O
cross	O
-	O
reacting	O
with	O
a	O
cell	O
-	O
surface	O
antigen	O
(	O
CSA	O
)	O
expressed	O
at	O
various	O
degrees	O
on	O
untransformed	O
avian	O
fibroblasts	O
,	O
but	O
not	O
on	O
mammalian	O
fibroblasts	O
;	O
(	O
3	O
)	O
one	O
species	O
-	O
specific	O
,	O
present	O
only	O
on	O
RSV	O
-	O
transformed	O
hamster	O
fibroblasts	O
.	O

N	B-Chemical_Compound
-	I-Chemical_Compound
(	I-Chemical_Compound
Phosphonacetyl	I-Chemical_Compound
)	I-Chemical_Compound
-	I-Chemical_Compound
L	I-Chemical_Compound
-	I-Chemical_Compound
aspartate	E-Chemical_Compound
(	O
PALA	S-Chemical_Compound
)	O
suppressed	O
the	O
growth	O
of	O
Ehrlich	O
ascites	O
tumour	O
cells	O
in	O
vivo	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Cancer	O
progression	O
and	O
p53	O
.	O

p53	O
-	O
deficient	O
cancers	O
are	O
often	O
unstable	O
,	O
aggressive	O
,	O
and	O
resistant	O
to	O
therapy	O
.	O

Daily	O
i	O
.	O
v	O
.	O
injections	O
of	O
HAH	B-Chemical_Compound
-	I-Chemical_Compound
cortisol	E-Chemical_Compound
at	O
doses	O
causing	O
no	O
apparent	O
toxicity	O
retarded	O
the	O
growth	O
of	O
solid	O
s	O
.	O
c	O
.	O

In	O
conclusion	O
,	O
HAH	B-Chemical_Compound
-	I-Chemical_Compound
cortisol	E-Chemical_Compound
represents	O
the	O
prototype	O
of	O
a	O
new	O
class	O
of	O
angiogenesis	O
inhibitors	O
for	O
the	O
treatment	O
of	O
cancer	O
and	O
other	O
angiogenic	O
diseases	O
.	O

These	O
results	O
highlight	O
the	O
importance	O
of	O
selenoperoxidase	O
action	O
in	O
the	O
glutathione	S-Chemical_Compound
cycle	O
as	O
a	O
means	O
by	O
which	O
tumor	O
cells	O
cope	O
with	O
hydroperoxide	S-Chemical_Compound
stress	O
.	O

Appearance	O
of	O
tumorous	O
phenotypes	O
in	O
goldfish	O
erythrophores	O
transfected	O
with	O
ras	O
,	O
src	O
,	O
and	O
myc	O
oncogenes	O
and	O
spontaneous	O
differentiation	O
of	O
the	O
transformants	O
in	O
vitro	O
.	O

The	O
end	O
result	O
in	O
individuals	O
surviving	O
burn	O
shock	O
is	O
immunosuppression	O
,	O
with	O
increased	O
susceptibility	O
to	O
potentially	O
fatal	O
systemic	O
burn	O
wound	O
or	O
pulmonary	O
sepsis	O
.	O

Endothelialization	O
was	O
present	O
at	O
anastomotic	O
sites	O
,	O
but	O
other	O
areas	O
were	O
covered	O
with	O
fresh	O
thrombi	O
.	O

Such	O
cases	O
may	O
be	O
considered	O
either	O
examples	O
of	O
a	O
single	O
primary	O
carcinoma	O
with	O
metastasis	O
or	O
as	O
synchronous	O
primary	O
neoplasms	O
.	O

The	O
distinction	O
between	O
these	O
two	O
possibilities	O
is	O
made	O
based	O
on	O
clinicopathologic	O
observations	O
,	O
and	O
therefore	O
may	O
not	O
be	O
definitive	O
.	O

Molecular	O
biology	O
of	O
cervical	O
cancer	O
and	O
its	O
precursors	O
.	O

It	O
is	O
now	O
known	O
that	O
specific	O
types	O
of	O
human	O
papillomaviruses	O
(	O
HPV	O
)	O
are	O
the	O
principal	O
etiologic	O
agents	O
for	O
both	O
cervical	O
cancer	O
and	O
its	O
precursors	O
.	O

Additional	O
cofactors	O
and	O
mutational	O
events	O
may	O
be	O
important	O
in	O
the	O
pathogenesis	O
of	O
invasive	O
cervical	O
cancers	O
and	O
may	O
include	O
chromosomal	O
rearrangements	O
,	O
loss	O
of	O
constitutional	O
heterozygosity	O
,	O
and	O
proto	O
-	O
oncogene	O
activation	O
.	O

Rats	O
that	O
were	O
irradiated	O
twice	O
(	O
single	O
fractions	O
at	O
0	O
and	O
24	O
hours	O
after	O
implantation	O
)	O
did	O
not	O
show	O
a	O
significant	O
decrease	O
in	O
the	O
neovascularization	O
of	O
the	O
irradiated	O
implant	O
compared	O
with	O
the	O
contralateral	O
control	O
implant	O
.	O

Interestingly	O
,	O
neovascularization	O
of	O
the	O
implants	O
irradiated	O
with	O
10	O
fractions	O
(	O
3000	O
cGy	O
)	O
was	O
not	O
significantly	O
decreased	O
compared	O
with	O
irradiation	O
with	O
three	O
fractions	O
(	O
900	O
cGy	O
)	O
.	O

Irradiation	O
delivered	O
before	O
implantation	O
(	O
900	O
cGy	O
)	O
inhibited	O
neovascularization	O
significantly	O
less	O
than	O
the	O
same	O
dose	O
administered	O
after	O
implantation	O
.	O

The	O
results	O
of	O
this	O
study	O
suggest	O
that	O
a	O
subclinical	O
cumulative	O
dose	O
of	O
900	O
cGy	O
is	O
the	O
threshold	O
for	O
impaired	O
tissue	O
revascularization	O
provided	O
that	O
treatment	O
is	O
delivered	O
immediately	O
after	O
implantation	O
over	O
a	O
48	O
-	O
hour	O
interval	O
.	O

Tumours	O
from	O
younger	O
patients	O
had	O
a	O
higher	O
grade	O
of	O
angiogenesis	O
(	O
P	O
=	O
0	O
.	O
05	O
)	O
.	O

Apart	O
from	O
the	O
vascular	O
grade	O
,	O
none	O
of	O
the	O
other	O
factors	O
examined	O
was	O
statistically	O
related	O
to	O
lymph	O
node	O
metastasis	O
(	O
P	O
less	O
than	O
0	O
.	O
0001	O
)	O
.	O

Excluding	O
N	O
-	O
stage	O
,	O
vascular	O
grade	O
was	O
the	O
only	O
independent	O
prognostic	O
factor	O
(	O
P	O
=	O
0	O
.	O
007	O
)	O
.	O

The	O
integration	O
of	O
vascular	O
grading	O
in	O
clinical	O
trials	O
on	O
adjuvant	O
chemotherapy	O
and	O
/	O
or	O
radiotherapy	O
could	O
substantially	O
contribute	O
in	O
defining	O
groups	O
of	O
operable	O
patients	O
who	O
might	O
benefit	O
from	O
cytotoxic	O
treatment	O
.	O

Groups	O
3	O
and	O
4	O
were	O
vitamin	B-Chemical_Compound
E	E-Chemical_Compound
and	O
untreated	O
controls	O
.	O

Fas	O
-	O
mediated	O
cell	O
death	O
was	O
examined	O
in	O
MCF	O
-	O
10AT	O
preneoplastic	O
human	O
breast	O
epithelial	O
cells	O
.	O

DNA	O
fragmentation	O
occurred	O
in	O
response	O
to	O
anti	O
-	O
Fas	O
treatment	O
.	O

On	O
day	O
41	O
,	O
rats	O
were	O
killed	O
and	O
tumor	O
nodules	O
were	O
counted	O
.	O

On	O
the	O
other	O
hand	O
cancer	O
cells	O
overexpress	O
insulin	O
-	O
like	O
growth	O
factors	O
and	O
their	O
receptors	O
which	O
mimic	O
many	O
activities	O
of	O
insulin	O
.	O

Our	O
experiments	O
demonstrate	O
that	O
insulin	O
-	O
like	O
growth	O
factor	O
I	O
indeed	O
induces	O
hexokinase	O
gene	O
expression	O
in	O
a	O
concentration	O
and	O
time	O
dependent	O
manner	O
in	O
two	O
cancer	O
cell	O
lines	O
we	O
studied	O
.	O

STUDY	O
DESIGN	O
:	O
Thirty	O
-	O
three	O
archival	O
cytologic	O
specimens	O
from	O
eight	O
patients	O
with	O
histologically	O
confirmed	O
malignant	O
mesothelioma	O
and	O
13	O
from	O
patients	O
with	O
metastatic	O
serous	O
effusions	O
were	O
destained	O
and	O
then	O
immunostained	O
with	O
anticalretinin	O
antiserum	O
.	O

Infiltration	O
of	O
dendritic	O
cells	O
correlated	O
negatively	O
with	O
distant	O
lymph	O
node	O
metastases	O
,	O
clinical	O
stage	O
,	O
and	O
peritoneal	O
invasion	O
.	O

Twenty	O
-	O
one	O
percent	O
of	O
clinically	O
unaffected	O
family	O
members	O
had	O
elevated	O
levels	O
of	O
bFGF	O
,	O
and	O
13	O
%	O
of	O
patients	O
with	O
EBS	O
had	O
elevated	O
levels	O
of	O
bFGF	O
.	O

CONCLUSIONS	O
:	O
We	O
have	O
found	O
that	O
patients	O
with	O
RDEB	O
have	O
elevated	O
levels	O
of	O
bFGF	O
,	O
which	O
may	O
contribute	O
to	O
increased	O
fibroblast	O
collagenase	O
and	O
the	O
development	O
of	O
squamous	O
cell	O
carcinoma	O
.	O

At	O
3	O
weeks	O
,	O
the	O
endogenous	O
blood	O
supply	O
of	O
both	O
the	O
control	O
and	O
the	O
experimental	O
fat	O
pads	O
was	O
isolated	O
and	O
ligated	O
,	O
and	O
the	O
composite	O
fat	O
/	O
muscle	O
flap	O
was	O
transferred	O
to	O
the	O
chest	O
wall	O
.	O

Careful	O
selection	O
of	O
patients	O
may	O
be	O
necessary	O
before	O
designing	O
therapeutic	O
strategies	O
using	O
either	O
p53	O
or	O
E2F	O
-	O
1	O
as	O
a	O
therapeutic	O
tools	O
for	O
glioma	O
patients	O
.	O

Protective	O
function	O
of	O
von	O
Hippel	O
-	O
Lindau	O
protein	O
against	O
impaired	O
protein	O
processing	O
in	O
renal	O
carcinoma	O
cells	O
.	O

Thus	O
,	O
pVHL	O
appears	O
to	O
participate	O
in	O
the	O
elimination	O
of	O
misprocessed	O
proteins	O
,	O
such	O
as	O
those	O
arising	O
in	O
the	O
cell	O
due	O
to	O
the	O
unavailability	O
of	O
glucose	S-Chemical_Compound
or	O
to	O
other	O
stresses	O
.	O
Clustering	O
algorithms	O
group	O
genes	O
by	O
similarities	O
in	O
expression	O
patterns	O
,	O
based	O
on	O
the	O
assumption	O
that	O
co	O
-	O
expressed	O
genes	O
share	O
common	O
function	O
or	O
regulation	O
[	O
3	O
,	O
4	O
]	O
;	O
however	O
,	O
clustering	O
solely	O
by	O
co	O
-	O
expression	O
patterns	O
may	O
not	O
reveal	O
a	O
considerable	O
amount	O
of	O
information	O
contained	O
in	O
array	O
data	O
.	O

This	O
process	O
ultimately	O
identifies	O
significant	O
clusters	O
of	O
co	O
-	O
expressed	O
gene	O
neighbors	O
that	O
likely	O
share	O
common	O
function	O
or	O
regulation	O
.	O

We	O
compared	O
data	O
generated	O
before	O
and	O
after	O
neighbor	O
clustering	O
to	O
show	O
that	O
this	O
method	O
provides	O
a	O
more	O
comprehensive	O
view	O
of	O
transcription	O
by	O
:	O
(	O
1	O
)	O
identifying	O
more	O
differentially	O
expressed	O
genes	O
than	O
even	O
traditional	O
,	O
rigorous	O
statistical	O
analyses	O
;	O
(	O
2	O
)	O
reconstructing	O
intact	O
biological	O
pathways	O
that	O
statistical	O
significance	O
analysis	O
could	O
not	O
reconstruct	O
;	O
and	O
(	O
3	O
)	O
providing	O
preliminary	O
insight	O
and	O
clues	O
about	O
the	O
function	O
or	O
regulation	O
of	O
uncharacterized	O
genes	O
by	O
associating	O
their	O
co	O
-	O
expression	O
with	O
physically	O
proximate	O
,	O
functionally	O
defined	O
genes	O
.	O

SF370	O
contains	O
one	O
inducible	O
prophage	O
(	O
370	O
.	O
1	O
)	O
and	O
three	O
defective	O
prophages	O
(	O
370	O
.	O
2	O
,	O
370	O
.	O
3	O
,	O
and	O
370	O
.	O
4	O
)	O
that	O
produce	O
no	O
infectious	O
phage	O
[	O
39	O
]	O
.	O

We	O
identified	O
11	O
differentially	O
expressed	O
phage	O
370	O
.	O
2	O
genes	O
,	O
suggesting	O
that	O
this	O
defective	O
phage	O
is	O
not	O
transcriptionally	O
silent	O
(	O
Table	O
1	O
)	O
.	O

The	O
speH	O
gene	O
encodes	O
a	O
mitogenic	O
exotoxin	O
[	O
38	O
]	O
reportedly	O
induced	O
during	O
polymorphonuclear	O
leukocyte	O
phagocytosis	O
[	O
8	O
]	O
but	O
not	O
implicated	O
previously	O
in	O
adherence	O
.	O

The	O
significant	O
upregulation	O
of	O
the	O
speH	O
gene	O
during	O
adherence	O
suggests	O
that	O
the	O
gene	O
product	O
may	O
function	O
instead	O
during	O
a	O
subsequent	O
stage	O
of	O
infection	O
.	O

To	O
overcome	O
these	O
limitations	O
and	O
to	O
extract	O
more	O
functional	O
information	O
from	O
the	O
array	O
dataset	O
(	O
including	O
more	O
complete	O
biological	O
pathways	O
)	O
,	O
we	O
developed	O
the	O
neighbor	O
clustering	O
algorithms	O
to	O
combine	O
the	O
physical	O
position	O
of	O
genes	O
on	O
the	O
streptococcal	O
chromosome	O
with	O
gene	O
expression	O
data	O
.	O

Of	O
the	O
309	O
qualifying	O
clusters	O
(	O
Table	O
S5	O
)	O
,	O
197	O
(	O
63	O
.	O
8	O
%	O
)	O
were	O
composed	O
entirely	O
of	O
known	O
,	O
functionally	O
defined	O
genes	O
;	O
however	O
,	O
26	O
(	O
13	O
%	O
)	O
of	O
these	O
were	O
incorrectly	O
assembled	O
,	O
as	O
they	O
contained	O
known	O
genes	O
that	O
are	O
functionally	O
unrelated	O
.	O

We	O
measured	O
the	O
performance	O
of	O
our	O
algorithm	O
by	O
examining	O
whether	O
it	O
identified	O
gene	O
groupings	O
known	O
to	O
be	O
functionally	O
related	O
(	O
Type	O
I	O
clusters	O
)	O
.	O

Only	O
four	O
(	O
16	O
%	O
)	O
of	O
25	O
Type	O
I	O
clusters	O
(	O
spy0080	O
-	O
0081	O
,	O
spy1236	O
-	O
1237	O
,	O
spy1707	O
-	O
1711	O
,	O
spy2041	O
-	O
2042	O
)	O
could	O
have	O
been	O
identified	O
in	O
entirety	O
by	O
significance	O
analysis	O
because	O
all	O
clustered	O
genes	O
exhibited	O
significant	O
differential	O
expression	O
(	O
PF	O
value	O
<	O
0	O
.	O
05	O
)	O
.	O

A	O
total	O
of	O
11	O
(	O
52	O
.	O
4	O
%	O
)	O
of	O
the	O
remaining	O
21	O
clusters	O
would	O
not	O
have	O
been	O
identified	O
in	O
their	O
entirety	O
without	O
GenomeCrawler	O
because	O
we	O
initially	O
identified	O
significant	O
fold	O
-	O
changes	O
in	O
only	O
a	O
subset	O
of	O
genes	O
necessary	O
to	O
encode	O
particular	O
pathways	O
or	O
loci	O
;	O
this	O
is	O
intuitively	O
unreasonable	O
if	O
all	O
genes	O
are	O
essential	O
for	O
functionality	O
.	O

GenomeCrawler	O
expanded	O
these	O
clusters	O
to	O
contain	O
more	O
genes	O
that	O
encode	O
intact	O
loci	O
(	O
Table	O
3	O
)	O
.	O

We	O
obtained	O
a	O
similar	O
result	O
for	O
the	O
eight	O
-	O
gene	O
operon	O
encoding	O
the	O
F0F1	O
-	O
type	O
proton	O
translocating	O
ATPase	O
[	O
41	O
]	O
(	O
spy0754	O
-	O
0761	O
)	O
.	O

Each	O
of	O
the	O
11	O
neighbor	O
clusters	O
that	O
could	O
have	O
been	O
only	O
partially	O
identified	O
by	O
our	O
initial	O
analysis	O
alone	O
gained	O
gene	O
members	O
after	O
application	O
of	O
the	O
algorithms	O
and	O
became	O
more	O
complete	O
sets	O
of	O
functionally	O
related	O
genes	O
than	O
initially	O
identified	O
(	O
Table	O
3	O
)	O
.	O

Recently	O
,	O
it	O
was	O
reported	O
that	O
the	O
four	O
genes	O
spanning	O
spy0127	O
-	O
0130	O
encode	O
,	O
and	O
are	O
responsible	O
for	O
,	O
the	O
formation	O
of	O
surface	O
-	O
localized	O
,	O
trypsin	O
-	O
resistant	O
pili	O
that	O
induce	O
protective	O
immunity	O
against	O
a	O
lethal	O
dose	O
of	O
group	O
A	O
streptococci	O
in	O
a	O
mouse	O
model	O
of	O
infection	O
[	O
36	O
]	O
.	O

This	O
attribute	O
may	O
be	O
particularly	O
important	O
for	O
datasets	O
in	O
which	O
the	O
relationship	O
between	O
clustered	O
genes	O
is	O
not	O
obvious	O
,	O
and	O
may	O
facilitate	O
the	O
organization	O
of	O
larger	O
datasets	O
into	O
more	O
manageable	O
packages	O
.	O

BlastP	O
analysis	O
aligned	O
the	O
spy1725	O
gene	O
product	O
,	O
which	O
has	O
homologs	O
in	O
all	O
sequenced	O
streptococcal	O
genomes	O
,	O
with	O
the	O
SP14	O
.	O
3	O
protein	O
from	O
S	O
.	O
pneumoniae	O
[	O
52	O
]	O
(	O
80	O
%	O
sequence	O
similarity	O
;	O
67	O
%	O
identity	O
)	O
.	O

Although	O
operon	O
-	O
modeling	O
methods	O
exist	O
[	O
54	O
,	O
55	O
]	O
,	O
we	O
inspected	O
clusters	O
in	O
silico	O
for	O
upstream	O
regulatory	O
elements	O
and	O
identified	O
17	O
candidates	O
,	O
including	O
clusters	O
such	O
as	O
streptolysin	O
S	O
that	O
have	O
been	O
previously	O
confirmed	O
as	O
operons	O
[	O
56	O
]	O
;	O
the	O
spy0127	O
-	O
0130	O
grouping	O
,	O
which	O
was	O
confirmed	O
as	O
an	O
operon	O
in	O
this	O
study	O
;	O
and	O
others	O
that	O
have	O
yet	O
to	O
be	O
verified	O
(	O
Table	O
S6	O
)	O
.	O

Concluding	O
Remarks	O

Neighbor	O
clustering	O
,	O
despite	O
the	O
statistical	O
framework	O
with	O
which	O
it	O
assigns	O
groupings	O
,	O
would	O
be	O
valuable	O
to	O
microarray	O
data	O
analysis	O
only	O
if	O
it	O
produced	O
biologically	O
relevant	O
data	O
.	O

Two	O
distinct	O
fimbriae	O
are	O
found	O
on	O
the	O
surface	O
of	O
the	O
organism	O
(	O
Dickinson	O
et	O
al	O
.	O
,	O
1988	O
;	O
Hamada	O
et	O
al	O
.	O
,	O
1996	O
)	O
.	O

The	O
FimA	O
protein	O
is	O
required	O
for	O
P	O
.	O
gingivalis	O
colonization	O
on	O
salivary	O
coated	O
surfaces	O
,	O
and	O
the	O
early	O
colonization	O
of	O
dental	O
plaque	O
(	O
Malek	O
et	O
al	O
.	O
,	O
1994	O
;	O
Levesque	O
et	O
al	O
.	O
,	O
2003	O
;	O
Maeda	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

Investigation	O
of	O
the	O
mechanism	O
of	O
regulation	O
of	O
fimA	O
by	O
FimR	O
indicates	O
that	O
FimR	O
does	O
not	O
bind	O
directly	O
to	O
the	O
fimA	O
promoter	O
,	O
but	O
rather	O
binds	O
to	O
the	O
promoter	O
region	O
of	O
the	O
first	O
gene	O
(	O
pg2130	O
)	O
in	O
the	O
fimA	O
cluster	O
,	O
suggesting	O
that	O
PG2130	O
is	O
the	O
FimR	O
target	O
gene	O
,	O
which	O
in	O
turn	O
regulates	O
expression	O
of	O
other	O
genes	O
in	O
the	O
fimA	O
cluster	O
,	O
including	O
the	O
fimA	O
gene	O
(	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

In	O
this	O
study	O
,	O
it	O
is	O
demonstrated	O
that	O
FimR	O
is	O
a	O
positive	O
regulator	O
of	O
Mfa1	O
expression	O
.	O

FimA	O
protein	O
was	O
not	O
detectable	O
in	O
the	O
fimR	O
-	O
mutant	O
,	O
while	O
a	O
50	O
%	O
lower	O
level	O
of	O
Mfa1	O
protein	O
was	O
found	O
in	O
the	O
fimR	O
-	O
mutant	O
compared	O
with	O
that	O
in	O
wild	O
-	O
type	O
strain	O
33277	O
.	O

Similarly	O
,	O
there	O
was	O
no	O
apparent	O
change	O
in	O
RgpA	O
production	O
in	O
the	O
fimR	O
-	O
mutant	O
,	O
which	O
was	O
detected	O
by	O
anti	O
-	O
RgpA	O
serum	O
.	O

The	O
same	O
transcriptional	O
start	O
site	O
was	O
identified	O
.	O

This	O
may	O
explain	O
the	O
much	O
tighter	O
control	O
of	O
fimA	O
expression	O
by	O
FimR	O
.	O

Data	O
of	O
this	O
study	O
suggest	O
that	O
transcription	O
of	O
the	O
mfa1	O
gene	O
originated	O
at	O
a	O
distal	O
upstream	O
transcriptional	O
start	O
site	O
and	O
read	O
through	O
the	O
promoter	O
region	O
suggested	O
by	O
Park	O
et	O
al	O
.	O

The	O
genetic	O
lesions	O
of	O
BCG	O
have	O
recently	O
been	O
determined	O
[	O
2	O
-	O
4	O
]	O
,	O
revealing	O
that	O
the	O
loss	O
of	O
region	O
of	O
difference	O
1	O
(	O
RD1	O
)	O
,	O
which	O
encodes	O
part	O
of	O
the	O
ESX	O
-	O
1	O
secretion	O
system	O
[	O
5	O
]	O
,	O
was	O
one	O
of	O
the	O
key	O
events	O
in	O
its	O
attenuation	O
.	O

To	O
evaluate	O
the	O
phenotypic	O
effect	O
of	O
the	O
different	O
SNPs	O
and	O
to	O
assess	O
their	O
potential	O
contribution	O
to	O
the	O
attenuation	O
process	O
,	O
we	O
undertook	O
functional	O
genomic	O
analyses	O
using	O
knock	O
-	O
ins	O
of	O
H37Ra	O
,	O
as	O
described	O
previously	O
[	O
18	O
]	O
.	O

However	O
,	O
as	O
already	O
observed	O
in	O
macrophages	O
,	O
integration	O
of	O
phoP	O
did	O
not	O
restore	O
levels	O
of	O
virulence	O
to	O
those	O
of	O
the	O
reference	O
strain	O
H37Rv	O
(	O
Figure	O
2	O
)	O
.	O

Groups	O
of	O
C57BL	O
/	O
6	O
mice	O
were	O
subcutaneously	O
inoculated	O
with	O
H37Rv	O
,	O
H37Ra	O
,	O
or	O
one	O
of	O
three	O
recombinant	O
H37Ra	O
strains	O
complemented	O
with	O
phoP	O
,	O
fadE5	O
,	O
or	O
rpsL	O
,	O
respectively	O
.	O

Most	O
importantly	O
,	O
the	O
various	O
strains	O
differed	O
extensively	O
in	O
their	O
potential	O
to	O
induce	O
antigen	O
specific	O
T	O
cell	O
responses	O
towards	O
ESAT	O
-	O
6	O
and	O
CFP	O
-	O
10	O
.	O

To	O
further	O
evaluate	O
the	O
involvement	O
of	O
phoP	O
and	O
the	O
ESX	O
-	O
1	O
system	O
in	O
immunogenicity	O
,	O
C57BL	O
/	O
6	O
mice	O
were	O
vaccinated	O
with	O
additional	O
strains	O
.	O

Functional	O
Characterization	O
of	O
Knock	O
-	O
In	O
Mutants	O

However	O
,	O
hardly	O
any	O
ESAT	O
-	O
6	O
was	O
present	O
in	O
the	O
culture	O
filtrates	O
of	O
these	O
cultures	O
,	O
indicating	O
that	O
these	O
strains	O
were	O
unable	O
to	O
secrete	O
ESAT	O
-	O
6	O
under	O
the	O
in	O
vitro	O
conditions	O
employed	O
in	O
spite	O
of	O
proper	O
expression	O
.	O

Analysis	O
of	O
the	O
M	O
.	O
tuberculosis	O
MT103	O
phoP	O
ko	O
strain	O
SO2	O
showed	O
strong	O
expression	O
of	O
ESAT	O
-	O
6	O
,	O
but	O
only	O
very	O
little	O
secreted	O
ESAT	O
-	O
6	O
(	O
Figure	O
5	O
)	O
.	O

Discussion	O

Finally	O
,	O
microarray	O
-	O
based	O
trancriptome	O
analysis	O
using	O
the	O
wild	O
-	O
type	O
versus	O
a	O
phoP	O
ko	O
mutant	O
of	O
H37Rv	O
has	O
provided	O
an	O
overview	O
of	O
the	O
transcriptional	O
regulation	O
linked	O
to	O
PhoP	O
[	O
21	O
]	O
.	O

It	O
is	O
not	O
clear	O
yet	O
which	O
factors	O
might	O
contribute	O
to	O
this	O
effect	O
.	O

In	O
contrast	O
,	O
Y	O
.	O
enterocolitica	O
is	O
widely	O
found	O
in	O
the	O
environment	O
and	O
mainly	O
known	O
to	O
cause	O
gastroenteritis	O
in	O
men	O
,	O
but	O
has	O
only	O
recently	O
been	O
shown	O
to	O
be	O
also	O
toxic	O
for	O
insects	O
.	O

We	O
therefore	O
decided	O
to	O
perform	O
a	O
comparative	O
study	O
of	O
the	O
genomes	O
of	O
Photorhabdus	O
luminescens	O
and	O
Yersinia	O
enterocolitica	O
.	O

However	O
,	O
Y	O
.	O
pestis	O
,	O
a	O
blood	O
-	O
borne	O
pathogen	O
and	O
the	O
etiological	O
agent	O
of	O
human	O
plague	O
,	O
has	O
long	O
been	O
known	O
to	O
be	O
transmitted	O
by	O
insects	O
,	O
specifically	O
by	O
rat	O
fleas	O
.	O

Upon	O
entering	O
an	O
insect	O
host	O
,	O
the	O
nematodes	O
release	O
the	O
bacteria	O
by	O
regurgiation	O
directly	O
into	O
the	O
insect	O
hemocoel	O
,	O
the	O
open	O
circulatory	O
system	O
of	O
the	O
insect	O
.	O

Once	O
inside	O
the	O
hemocoel	O
,	O
the	O
bacteria	O
replicate	O
rapidly	O
and	O
establish	O
a	O
lethal	O
septemica	O
in	O
the	O
host	O
by	O
the	O
production	O
of	O
virulence	O
factors	O
such	O
as	O
the	O
insecticidal	O
toxin	O
complexes	O
that	O
kill	O
the	O
insect	O
within	O
48	O
hours	O
.	O

Sensing	O
,	O
signalling	O
,	O
and	O
regulation	O
Bacteria	O
have	O
evolved	O
several	O
regulation	O
mechanisms	O
to	O
ensure	O
a	O
proper	O
answer	O
to	O
changing	O
environments	O
.	O

The	O
principal	O
biological	O
reason	O
for	O
this	O
redundancy	O
remains	O
unclear	O
.	O

2	O
,	O
and	O
include	O
PhoP	O
/	O
PhoQ	O
,	O
and	O
AstS	O
/	O
AstR	O
(	O
BvgS	O
/	O
BvgR	O
)	O
which	O
have	O
been	O
identified	O
to	O
be	O
involved	O
in	O
virulence	O
[	O
28	O
]	O
.	O

The	O
AstS	O
/	O
AstR	O
TCS	O
is	O
required	O
for	O
the	O
correct	O
timing	O
of	O
phase	O
variant	O
switching	O
in	O
P	O
.	O
luminescens	O
[	O
28	O
]	O
.	O

BvgS	O
/	O
BvgR	O
is	O
the	O
TCS	O
of	O
Y	O
.	O
enterocolitica	O
that	O
corresponds	O
to	O
AstS	O
/	O
AstR	O
.	O

In	O
the	O
genome	O
of	O
P	O
.	O
luminescens	O
,	O
two	O
genes	O
encoding	O
putative	O
AHL	S-Chemical_Compound
-	O
LuxR	O
-	O
like	O
receptors	O
,	O
plu0320	O
and	O
plu4562	O
,	O
but	O
no	O
luxI	O
genes	O
are	O
present	O
(	O
Fig	O
.	O
3	O
)	O
.	O

Instead	O
of	O
producing	O
AHLs	S-Chemical_Compound
to	O
regulate	O
quorum	O
dependent	O
genes	O
,	O
a	O
common	O
strategy	O
of	O
insect	O
-	O
colonizing	O
bacteria	O
might	O
be	O
the	O
detection	O
of	O
AHLs	S-Chemical_Compound
as	O
a	O
signal	O
for	O
the	O
presence	O
of	O
other	O
bacteria	O
such	O
as	O
those	O
colonizing	O
the	O
insect	O
intestinal	O
tract	O
or	O
living	O
in	O
soil	O
.	O

It	O
has	O
been	O
shown	O
that	O
the	O
luxS	O
pathway	O
negatively	O
controls	O
the	O
expression	O
of	O
genes	O
for	O
carbapenem	S-Chemical_Compound
antibiotic	O
biosynthesis	O
in	O
P	O
.	O
luminescens	O
[	O
41	O
]	O
.	O

Homologues	O
of	O
these	O
proteins	O
are	O
present	O
in	O
Y	O
.	O
enterocolitica	O
(	O
see	O
chapter	O
2	O
)	O
,	O
suggesting	O
their	O
possible	O
regulation	O
by	O
AI	B-Chemical_Compound
-	I-Chemical_Compound
2	E-Chemical_Compound
also	O
in	O
this	O
bacterium	O
.	O

Whether	O
they	O
sense	O
self	O
-	O
produced	O
or	O
external	O
AI	B-Chemical_Compound
-	I-Chemical_Compound
2	E-Chemical_Compound
,	O
or	O
a	O
combination	O
of	O
both	O
,	O
indicating	O
a	O
quorum	O
sensing	O
mechanism	O
or	O
a	O
regulation	O
similar	O
to	O
AHL	S-Chemical_Compound
as	O
described	O
above	O
,	O
remains	O
to	O
be	O
elucidated	O
.	O

Met	O
has	O
been	O
shown	O
to	O
bind	O
JH	O
at	O
physiological	O
concentrations	O
and	O
is	O
therefore	O
suspected	O
to	O
act	O
as	O
a	O
JH	O
receptor	O
[	O
46	O
,	O
47	O
]	O
.	O

In	O
P	O
.	O
luminescens	O
,	O
expression	O
of	O
UspA	O
has	O
been	O
shown	O
to	O
be	O
under	O
control	O
of	O
the	O
AstS	O
/	O
AstR	O
TCS	O
,	O
which	O
is	O
important	O
for	O
the	O
correct	O
timing	O
of	O
phase	O
variant	O
switching	O
[	O
28	O
]	O
.	O

A	O
GroEL	O
homologue	O
is	O
present	O
in	O
P	O
.	O
luminescens	O
(	O
Plu4134	O
)	O
which	O
the	O
P	O
.	O
luminescens	O
UspG	O
homologues	O
might	O
interact	O
with	O
.	O

This	O
pattern	O
corresponds	O
to	O
the	O
overlapping	O
life	O
cycles	O
of	O
both	O
pathogens	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Furthermore	O
,	O
two	O
proteins	O
with	O
PilZ	O
domain	O
exist	O
in	O
Y	O
.	O
enterocolitica	O
,	O
namely	O
YE3197	O
and	O
BcsA	O
(	O
YE4074	O
)	O
,	O
a	O
putative	O
cellulose	O
synthase	O
.	O

Cellulose	O
synthesis	O
in	O
bacteria	O
has	O
been	O
identified	O
to	O
be	O
important	O
for	O
the	O
protection	O
from	O
chemical	O
or	O
mechanical	O
stress	O
by	O
forming	O
a	O
hydrophobic	O
extracellular	O
matrix	O
[	O
60	O
]	O
.	O

All	O
virulence	O
factors	O
described	O
in	O
the	O
following	O
are	O
summarized	O
in	O
Fig	O
.	O

It	O
is	O
speculated	O
that	O
the	O
Tc	O
toxins	O
are	O
active	O
against	O
different	O
tissues	O
within	O
individual	O
hosts	O
,	O
namely	O
Tcb	O
against	O
hemocytes	O
and	O
Tcd	O
and	O
Tca	O
against	O
cells	O
of	O
the	O
insect	O
gut	O
.	O

Hemolysins	O
or	O
surface	O
-	O
associated	O
adhesins	O
,	O
together	O
with	O
their	O
transporters	O
,	O
are	O
sometimes	O
organized	O
as	O
two	O
-	O
partner	O
secretion	O
(	O
TPS	O
)	O
systems	O
,	O
a	O
specialized	O
mechanism	O
for	O
the	O
delivery	O
of	O
large	O
exoproteins	O
[	O
65	O
]	O
.	O

Eight	O
other	O
TPS	O
systems	O
are	O
present	O
in	O
P	O
.	O
luminescens	O
,	O
namely	O
Plu0225	O
/	O
Plu0226	O
,	O
Plu0548	O
/	O
Plu0549	O
,	O
Plu1149	O
/	O
Plu1150	O
,	O
Plu1367	O
/	O
Plu1368	O
,	O
Plu3064	O
/	O
Plu3065	O
,	O
Plu3125	O
-	O
3127	O
/	O
3128	O
,	O
Plu3667	O
/	O
Plu3668	O
,	O
and	O
Plu3718	O
/	O
Plu3719	O
,	O
and	O
further	O
three	O
genes	O
for	O
which	O
the	O
partner	O
locus	O
has	O
not	O
been	O
identified	O
(	O
Fig	O
.	O
4	O
)	O
.	O

Examples	O
are	O
SopB	O
,	O
a	O
host	O
cell	O
invasion	O
factor	O
translocated	O
via	O
the	O
type	O
-	O
III	O
secretion	O
system	O
that	O
is	O
present	O
in	O
the	O
emerging	O
human	O
pathogen	O
P	O
.	O
asymbiotica	O
,	O
but	O
not	O
in	O
the	O
insect	O
pathogen	O
P	O
.	O
luminescens	O
[	O
14	O
]	O
,	O
a	O
putative	O
effector	O
protein	O
(	O
YE2447	O
)	O
with	O
proteolytic	O
activity	O
,	O
and	O
a	O
homologue	O
of	O
SrfA	O
which	O
is	O
negatively	O
regulated	O
by	O
PhoP	O
in	O
S	O
.	O
typhimurium	O
[	O
75	O
]	O
.	O

Examples	O
of	O
those	O
factors	O
are	O
shown	O
in	O
Fig	O
.	O

In	O
P	O
.	O
luminescens	O
,	O
eleven	O
fimbrial	O
gene	O
cluster	O
have	O
been	O
identified	O
,	O
four	O
of	O
which	O
(	O
V	O
,	O
VII	O
,	O
IX	O
and	O
X	O
)	O
are	O
also	O
present	O
in	O
Y	O
.	O
enterocolitica	O
.	O

Remarkable	O
exceptions	O
are	O
the	O
toxin	O
/	O
antitoxin	O
system	O
ccdA	O
/	O
ccdB	O
,	O
the	O
tolQRAB	O
/	O
pal	O
operon	O
involved	O
in	O
group	O
A	O
colicin	O
translocation	O
,	O
and	O
a	O
colicin	O
production	O
and	O
secretion	O
system	O
(	O
Plu3168	O
/	O
Plu3869	O
;	O
YE0791	O
/	O
YE1314	O
)	O
.	O

These	O
are	O
substrate	O
-	O
specific	O
secretion	O
machineries	O
that	O
share	O
a	O
similar	O
architecture	O
and	O
secretion	O
mechanism	O
[	O
88	O
]	O
.	O

VAS	O
-	O
dependent	O
secretion	O
has	O
been	O
found	O
to	O
be	O
important	O
for	O
virulence	O
of	O
Vibrio	O
cholerae	O
[	O
92	O
]	O
as	O
well	O
as	O
for	O
Pseudomonas	O
aeruginosa	O
[	O
93	O
]	O
,	O
and	O
T6SS	O
are	O
assumed	O
to	O
play	O
a	O
major	O
role	O
in	O
virulence	O
in	O
many	O
Gram	O
-	O
negative	O
bacteria	O
[	O
91	O
]	O
.	O

Due	O
to	O
its	O
absence	O
in	O
Y	O
.	O
enterocolitica	O
,	O
Ymt	O
is	O
another	O
example	O
for	O
the	O
high	O
diversity	O
of	O
genetic	O
determinants	O
that	O
are	O
used	O
by	O
closely	O
related	O
bacterial	O
pathogens	O
to	O
interact	O
with	O
their	O
insect	O
hosts	O
.	O

There	O
are	O
several	O
other	O
exoenzymes	O
present	O
either	O
in	O
Y	O
.	O
enterocolitica	O
or	O
in	O
P	O
.	O
luminescens	O
,	O
which	O
do	O
not	O
have	O
a	O
homologue	O
counterpart	O
in	O
the	O
other	O
bacterium	O
.	O

Metabolism	O

Degradative	O
pathways	O
P	O
.	O
luminescens	O
and	O
Y	O
.	O
enterocolitica	O
share	O
loci	O
encoding	O
several	O
common	O
degradation	O
pathways	O
that	O
are	O
absent	O
in	O
E	O
.	O
coli	O
K	O
-	O
12	O
,	O
including	O
the	O
urease	O
operon	O
(	O
ureABCEFGD	O
)	O
,	O
the	O
genes	O
involved	O
in	O
myo	O
-	O
inositol	O
degradation	O
,	O
and	O
the	O
histidine	O
degradation	O
operon	O
(	O
hutHUCGI	O
)	O
.	O

We	O
recently	O
reported	O
that	O
the	O
genes	O
of	O
the	O
urease	O
operon	O
as	O
well	O
as	O
a	O
histidine	O
ammonia	S-Chemical_Compound
lyase	O
(	O
ye3021	O
/	O
plu1240	O
)	O
,	O
which	O
deaminates	O
histidine	O
to	O
urocanic	B-Chemical_Compound
acid	E-Chemical_Compound
,	O
are	O
highly	O
induced	O
in	O
Y	O
.	O
enterocolitica	O
upon	O
temperature	O
decrease	O
[	O
67	O
]	O
.	O

Beside	O
arginine	O
(	O
5	O
.	O
17	O
mumol	O
/	O
g	O
)	O
,	O
lysine	O
(	O
12	O
.	O
23	O
mumol	O
/	O
g	O
)	O
,	O
serine	O
(	O
6	O
.	O
77	O
mumol	O
/	O
g	O
)	O
and	O
proline	O
(	O
6	O
.	O
40	O
mumol	O
/	O
g	O
)	O
,	O
histidine	O
(	O
5	O
.	O
04	O
mumol	O
/	O
g	O
)	O
is	O
the	O
most	O
abundant	O
free	O
amino	O
acids	O
in	O
the	O
Hyalophora	O
gloveri	O
fat	O
body	O
[	O
98	O
]	O
.	O

Beside	O
S	O
.	O
typhimurium	O
,	O
all	O
these	O
genetic	O
determinants	O
were	O
found	O
only	O
in	O
few	O
other	O
bacteria	O
,	O
namely	O
the	O
human	O
pathogens	O
Listeria	O
monocytogenes	O
,	O
and	O
Clostridium	O
perfringens	O
[	O
101	O
]	O
.	O

Further	O
metabolic	O
genes	O
common	O
to	O
both	O
pathogens	O
are	O
dctA	O
responsible	O
for	O
transport	O
of	O
C4	B-Chemical_Compound
-	I-Chemical_Compound
dicarboxylates	E-Chemical_Compound
across	O
the	O
membrane	O
,	O
the	O
UhpABC	O
regulatory	O
system	O
controlling	O
the	O
hexose	B-Chemical_Compound
phosphate	E-Chemical_Compound
transport	O
by	O
UhpT	O
,	O
and	O
the	O
three	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
transport	O
systems	O
CorA	O
,	O
MgtA	O
and	O
MgtB	O
.	O

Another	O
gene	O
,	O
gltP	O
encoding	O
a	O
glutamate	O
-	O
aspartate	O
symporter	O
,	O
is	O
also	O
up	O
-	O
regulated	O
at	O
low	O
temperature	O
in	O
Y	O
.	O
enterocolitica	O
,	O
but	O
lacks	O
a	O
counterpart	O
in	O
P	O
.	O
luminescens	O
.	O

Genes	O
involved	O
in	O
the	O
biosynthesis	O
,	O
transport	O
and	O
regulation	O
of	O
the	O
siderophore	O
yersiniabactin	S-Chemical_Compound
are	O
clustered	O
in	O
the	O
high	O
pathogenicity	O
island	O
of	O
Y	O
.	O
enterocolitica	O
[	O
103	O
]	O
and	O
have	O
counterparts	O
in	O
P	O
.	O
luminescens	O
(	O
plu2316	O
-	O
2324	O
)	O
.	O

While	O
Y	O
.	O
enterocolitica	O
explores	O
citrate	S-Chemical_Compound
for	O
anaerobic	O
metabolism	O
,	O
it	O
is	O
most	O
likely	O
that	O
the	O
specific	O
uptake	O
of	O
citrate	S-Chemical_Compound
and	O
other	O
tricarboxylic	B-Chemical_Compound
acids	E-Chemical_Compound
by	O
TctCBA	S-Chemical_Compound
is	O
used	O
by	O
P	O
.	O
luminescens	O
upon	O
entering	O
the	O
insect	O
host	O
where	O
enough	O
citrate	S-Chemical_Compound
is	O
available	O
.	O

In	O
Yersinia	O
,	O
temperature	O
-	O
dependent	O
gene	O
expression	O
has	O
been	O
described	O
to	O
be	O
an	O
important	O
theme	O
in	O
bacterial	O
mechanisms	O
of	O
pathogenesis	O
towards	O
humans	O
[	O
116	O
]	O
.	O

By	O
data	O
mining	O
,	O
we	O
identified	O
32	O
genes	O
or	O
gene	O
loci	O
of	O
Yersinia	O
spp	O
.	O
that	O
exhibit	O
stronger	O
expression	O
with	O
temperature	O
decrease	O
(	O
Table	O
1	O
)	O
.	O

19	O
of	O
them	O
have	O
a	O
homologue	O
in	O
P	O
.	O
luminescens	O
.	O

The	O
data	O
have	O
derived	O
from	O
expression	O
profiling	O
in	O
vitro	O
and	O
cannot	O
directly	O
be	O
translated	O
to	O
the	O
in	O
vivo	O
situation	O
.	O

It	O
is	O
assumed	O
that	O
the	O
PZ	O
has	O
not	O
been	O
acquired	O
by	O
a	O
single	O
event	O
of	O
gene	O
transfer	O
,	O
but	O
through	O
a	O
series	O
of	O
independent	O
insertions	O
[	O
23	O
]	O
.	O

Those	O
adaptational	O
processes	O
must	O
be	O
precisely	O
regulated	O
by	O
the	O
bacteria	O
.	O

Staphylococcus	O
aureus	O
,	O
a	O
frequent	O
cause	O
of	O
human	O
infections	O
,	O
is	O
highly	O
resistant	O
to	O
antimicrobial	O
factors	O
of	O
the	O
innate	O
immune	O
system	O
such	O
as	O
cationic	O
antimicrobial	O
peptides	O
(	O
CAMPs	O
)	O
[	O
1	O
,	O
2	O
]	O
which	O
are	O
produced	O
by	O
epithelial	O
cells	O
and	O
neutrophils	O
[	O
3	O
,	O
4	O
]	O
.	O

Due	O
to	O
their	O
cationic	O
properties	O
,	O
CAMPs	O
can	O
easily	O
bind	O
to	O
the	O
highly	O
negatively	O
charged	O
bacterial	O
cell	O
envelope	O
and	O
inactivate	O
bacteria	O
,	O
e	O
.	O
g	O
.	O
by	O
forming	O
pores	O
in	O
the	O
bacterial	O
membrane	O
leading	O
to	O
bacterial	O
lysis	O
[	O
6	O
]	O
.	O

To	O
control	O
for	O
this	O
possibility	O
,	O
we	O
compared	O
patterns	O
of	O
membrane	O
lipids	O
from	O
log	O
-	O
phase	O
bacteria	O
by	O
thin	O
-	O
layer	O
chromatography	O
.	O

Significantly	O
less	O
bacteria	O
were	O
detected	O
in	O
the	O
kidneys	O
of	O
animals	O
,	O
which	O
had	O
been	O
infected	O
with	O
the	O
graRS	O
mutant	O
than	O
those	O
infected	O
with	O
the	O
WT	O
bacteria	O
.	O

However	O
,	O
which	O
of	O
factors	O
are	O
involved	O
in	O
pathogenesis	O
mediated	O
by	O
clinically	O
isolated	O
severe	O
invasive	O
GAS	O
remains	O
obscure	O
.	O

Epidemiological	O
and	O
pathological	O
findings	O
,	O
including	O
sporadic	O
incidents	O
of	O
severe	O
invasive	O
GAS	O
infections	O
[	O
9	O
]	O
,	O
high	O
frequency	O
of	O
severe	O
invasive	O
infections	O
in	O
immunocompromised	O
host	O
[	O
9	O
]	O
,	O
and	O
aggregation	O
of	O
bacteria	O
and	O
a	O
paucity	O
of	O
polymorphnuclear	O
neutrophils	O
(	O
PMN	O
)	O
in	O
foci	O
of	O
invasive	O
GAS	O
infection	O
[	O
10	O
]	O
suggest	O
that	O
host	O
defense	O
factors	O
play	O
an	O
important	O
role	O
in	O
the	O
onset	O
of	O
invasive	O
infections	O
.	O

These	O
data	O
may	O
participate	O
in	O
prediction	O
of	O
GAS	O
potential	O
for	O
future	O
invasive	O
infection	O
as	O
well	O
as	O
risk	O
assessment	O
of	O
patients	O
by	O
measuring	O
PMN	O
function	O
.	O

The	O
similar	O
results	O
were	O
obtained	O
when	O
opsonized	O
with	O
either	O
FCS	O
or	O
human	O
serum	O
regardless	O
of	O
complements	O
immobilization	O
(	O
data	O
not	O
shown	O
)	O
.	O

Flow	O
cytometry	O
analysis	O
suggested	O
that	O
although	O
PMN	O
was	O
detected	O
in	O
the	O
lower	O
well	O
consisted	O
of	O
IL	O
-	O
8	O
and	O
severe	O
invasive	O
GAS	O
,	O
but	O
most	O
of	O
them	O
were	O
dead	O
as	O
defined	O
by	O
propidium	B-Chemical_Compound
iodine	E-Chemical_Compound
staining	O
(	O
p	O
=	O
0	O
.	O
016	O
)	O
(	O
Figure	O
2A	O
and	O
2C	O
)	O
demonstrating	O
that	O
severe	O
invasive	O
GAS	O
affected	O
survival	O
of	O
PMN	O
and	O
its	O
migration	O
activity	O
in	O
a	O
transwell	O
system	O
.	O

PMN	O
were	O
killed	O
by	O
streptolysin	O
O	O
(	O
SLO	O
)	O
from	O
severe	O
invasive	O
GAS	O

Subcutaneous	O
inoculation	O
of	O
NIH230scpC	O
and	O
NIH230slo	O
yielded	O
the	O
local	O
infected	O
lesions	O
with	O
area	O
comparable	O
to	O
those	O
of	O
1566	O
and	O
NIH230	O
:	O
:	O
csrS	O
+	O
during	O
the	O
course	O
of	O
infection	O
(	O
Figure	O
7D	O
)	O
.	O

These	O
results	O
suggest	O
that	O
enhanced	O
expression	O
of	O
ScpC	O
and	O
SLO	O
in	O
invasive	O
GAS	O
plays	O
an	O
important	O
role	O
in	O
vivo	O
virulence	O
of	O
GAS	O
infection	O
.	O

DNase	O
activity	O
of	O
the	O
emm49	O
severe	O
invasive	O
GAS	O
was	O
lower	O
than	O
that	O
of	O
non	O
-	O
invasive	O
GAS	O
(	O
Figure	O
S1B	O
)	O
,	O
possibly	O
due	O
to	O
the	O
difference	O
of	O
emm	O
type	O
.	O

SLO	O
is	O
a	O
cholesterol	S-Chemical_Compound
-	O
binding	O
pore	O
-	O
forming	O
hemolysin	O
as	O
well	O
as	O
cytotoxic	O
for	O
other	O
cells	O
[	O
15	O
]	O
.	O

A	O
further	O
study	O
in	O
which	O
collates	O
clinical	O
with	O
bacterial	O
/	O
immunological	O
data	O
may	O
provide	O
with	O
novel	O
clues	O
for	O
early	O
diagnosis	O
and	O
therapeutics	O
of	O
invasive	O
bacterial	O
infections	O
.	O

DNA	O
-	O
mediated	O
killing	O
occurred	O
within	O
minutes	O
,	O
as	O
a	O
result	O
of	O
perturbation	O
of	O
both	O
the	O
outer	O
and	O
inner	O
membrane	O
(	O
IM	O
)	O
and	O
the	O
release	O
of	O
cytoplasmic	O
contents	O
,	O
including	O
genomic	O
DNA	O
.	O

A	O
number	O
of	O
regulatory	O
systems	O
that	O
influence	O
biofilm	O
formation	O
have	O
been	O
described	O
.	O

The	O
broad	O
-	O
spectrum	O
antimicrobial	O
activity	O
of	O
CAPs	S-Chemical_Compound
against	O
Gram	O
-	O
negative	O
and	O
Gram	O
-	O
positive	O
bacteria	O
accounts	O
for	O
their	O
role	O
as	O
an	O
essential	O
component	O
of	O
the	O
innate	O
immune	O
response	O
of	O
humans	O
,	O
animals	O
and	O
insects	O
.	O

The	O
extracellular	O
matrix	O
of	O
P	O
.	O
aeruginosa	O
biofilms	O
includes	O
extracellular	O
DNA	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
,	O
multiple	O
bacterial	O
exopolysaccharides	S-Chemical_Compound
and	O
host	O
proteins	O
[	O
4	O
]	O
,	O
[	O
52	O
]	O
.	O

Addition	O
of	O
0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
(	O
5	O
mg	O
/	O
ml	O
)	O
or	O
greater	O
extracellular	O
DNA	O
to	O
LB	O
or	O
1	O
%	O
(	O
w	O
/	O
v	O
)	O
or	O
greater	O
DNA	O
to	O
BM2	O
media	O
inhibited	O
growth	O
of	O
P	O
.	O
aeruginosa	O
(	O
Fig	O
1A	O
and	O
1B	O
)	O
.	O

To	O
determine	O
the	O
effect	O
of	O
DNA	O
on	O
membrane	O
integrity	O
,	O
microscopic	O
analysis	O
in	O
response	O
to	O
lethal	O
concentrations	O
of	O
DNA	O
and	O
relevant	O
controls	O
was	O
performed	O
.	O

PI	S-Chemical_Compound
staining	O
also	O
revealed	O
the	O
presence	O
of	O
long	O
strands	O
of	O
genomic	O
DNA	O
,	O
presumably	O
as	O
a	O
consequence	O
of	O
the	O
loss	O
of	O
membrane	O
integrity	O
,	O
cell	O
lysis	O
and	O
release	O
of	O
cytoplasmic	O
contents	O
,	O
including	O
DNA	O
(	O
Fig	O
2B	O
)	O
.	O

Protection	O
was	O
measured	O
in	O
response	O
to	O
a	O
range	O
of	O
cation	O
concentrations	O
,	O
where	O
the	O
highest	O
concentration	O
tested	O
was	O
that	O
which	O
remained	O
soluble	O
in	O
the	O
presence	O
of	O
DNA	O
(	O
3	O
.	O
125	O
-	O
25	O
mM	O
)	O
.	O

Cations	O
play	O
diverse	O
physiologically	O
important	O
roles	O
within	O
a	O
cell	O
;	O
from	O
detoxification	O
of	O
reactive	B-Chemical_Compound
oxygen	I-Chemical_Compound
species	E-Chemical_Compound
and	O
co	O
-	O
factors	O
for	O
enzymes	O
to	O
the	O
stabilization	O
of	O
macromolecules	O
within	O
the	O
cell	O
[	O
62	O
]	O
.	O

To	O
determine	O
if	O
extracellular	O
DNA	O
imposes	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
limitation	O
,	O
we	O
measured	O
the	O
gene	O
expression	O
of	O
a	O
chromosomally	O
encoded	O
transcriptional	O
lux	O
(	O
bioluminescence	O
)	O
fusion	O
to	O
PA3553	O
,	O
as	O
a	O
measure	O
of	O
the	O
CAP	S-Chemical_Compound
resistance	O
operon	O
expression	O
in	O
planktonic	O
cultures	O
.	O

P	O
.	O
aeruginosa	O
genomic	O
DNA	O
inhibited	O
growth	O
at	O
similar	O
concentrations	O
as	O
salmon	O
sperm	O
DNA	O
.	O

This	O
is	O
due	O
to	O
the	O
addition	O
of	O
excess	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
ions	O
as	O
part	O
of	O
the	O
DNAse	O
buffer	O
,	O
which	O
is	O
required	O
for	O
DNAse	O
activity	O
.	O

To	O
determine	O
if	O
DNA	O
-	O
induced	O
resistance	O
requires	O
these	O
genes	O
in	O
biofilms	O
,	O
the	O
resistance	O
phenotype	O
of	O
the	O
PA3553	O
:	O
:	O
lux	O
mutant	O
was	O
determined	O
.	O

Recently	O
,	O
a	O
novel	O
host	O
defense	O
mechanism	O
was	O
discovered	O
whereby	O
stimulated	O
neutrophils	O
ejected	O
a	O
mesh	O
-	O
like	O
net	O
of	O
intracellular	O
DNA	O
and	O
proteins	O
that	O
functions	O
to	O
trap	O
and	O
kill	O
pathogens	O
[	O
70	O
]	O
.	O

The	O
antimicrobial	O
property	O
of	O
neutrophil	O
nets	O
was	O
attributed	O
to	O
DNA	O
-	O
associated	O
histones	O
and	O
other	O
antimicrobial	O
peptides	O
[	O
70	O
]	O
.	O

It	O
has	O
previously	O
been	O
reported	O
that	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
concentrations	O
within	O
the	O
airway	O
surface	O
fluid	O
are	O
high	O
(	O
2	O
.	O
2	O
mM	O
)	O
[	O
73	O
]	O
,	O
[	O
74	O
]	O
.	O

However	O
,	O
induction	O
of	O
PA3553	O
gene	O
expression	O
does	O
not	O
occur	O
in	O
the	O
presence	O
of	O
alginate	S-Chemical_Compound
(	O
data	O
not	O
shown	O
)	O
.	O

This	O
study	O
aims	O
at	O
evaluating	O
the	O
importance	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
VicRK	O
to	O
virulence	O
of	O
the	O
horse	O
pathogen	O
Streptococcus	O
equi	O
subspecies	O
equi	O
and	O
the	O
potential	O
of	O
a	O
vicK	O
mutant	O
as	O
a	O
live	O
vaccine	O
candidate	O
using	O
mouse	O
infection	O
models	O
.	O

Intranasal	O
DeltavicK	O
infection	O
induces	O
production	O
of	O
anti	O
-	O
SeM	O
mucosal	O
IgA	O
and	O
systemic	O
IgG	O
.	O

This	O
study	O
aims	O
at	O
evaluating	O
the	O
importance	O
of	O
VicRK	O
to	O
S	O
.	O
equi	O
virulence	O
and	O
the	O
potential	O
of	O
a	O
vicK	O
deletion	O
mutant	O
as	O
a	O
live	O
vaccine	O
using	O
mouse	O
infection	O
models	O
.	O

Three	O
putative	O
DeltavicK	O
strains	O
,	O
which	O
were	O
spectinomycin	S-Chemical_Compound
-	O
resistant	O
and	O
chloramphenicol	S-Chemical_Compound
-	O
sensitive	O
,	O
were	O
obtained	O
.	O

The	O
samples	O
were	O
incubated	O
for	O
4	O
h	O
,	O
and	O
the	O
numbers	O
of	O
the	O
bacteria	O
in	O
the	O
samples	O
and	O
inocula	O
at	O
time	O
zero	O
were	O
determined	O
by	O
plating	O
.	O

The	O
spy1718	O
:	O
:	O
aad	O
mutant	O
of	O
S	O
.	O
pyogenes	O
,	O
which	O
is	O
no	O
longer	O
resistant	O
to	O
phagocytosis	O
by	O
PMNs	O
,	O
was	O
used	O
as	O
a	O
positive	O
control	O
in	O
the	O
assay	O
.	O

The	O
percentages	O
of	O
PMNs	O
with	O
associated	O
wild	O
-	O
type	O
S	O
.	O
equi	O
and	O
spy1718	O
:	O
:	O
aad	O
were	O
low	O
and	O
high	O
,	O
respectively	O
,	O
indicating	O
that	O
the	O
assay	O
worked	O
well	O
to	O
evaluate	O
resistance	O
of	O
the	O
bacteria	O
to	O
phagocytosis	O
.	O

Seven	O
of	O
the	O
8	O
mice	O
infected	O
with	O
the	O
wild	O
-	O
type	O
S	O
.	O
equi	O
strain	O
died	O
,	O
whereas	O
7	O
of	O
the	O
8	O
mice	O
inoculated	O
with	O
DeltavicK	O
survived	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

Similarly	O
,	O
these	O
4	O
mice	O
with	O
higher	O
IgA	O
levels	O
also	O
had	O
higher	O
levels	O
of	O
SeM	O
-	O
specific	O
systemic	O
IgG	O
(	O
Fig	O
.	O
5B	O
)	O
.	O

Thus	O
,	O
VicK	O
is	O
not	O
essential	O
in	O
S	O
.	O
equi	O
.	O

As	O
a	O
first	O
step	O
towards	O
understanding	O
the	O
interplay	O
between	O
a	O
pathogen	O
and	O
its	O
host	O
from	O
a	O
systems	O
biology	O
standpoint	O
,	O
we	O
focused	O
on	O
these	O
14	O
genes	O
.	O

These	O
regions	O
include	O
two	O
40	O
kb	O
stretches	O
of	O
DNA	O
termed	O
Salmonella	O
pathogenicity	O
islands	O
1	O
(	O
SPI	O
-	O
1	O
)	O
and	O
2	O
(	O
SPI	O
-	O
2	O
)	O
[	O
4	O
]	O
-	O
[	O
9	O
]	O
.	O

Salmonella	O
regulators	O
required	O
for	O
systemic	O
mouse	O
infection	O
Typhimurium	O
encodes	O
a	O
surfeit	O
of	O
regulators	O
(	O
more	O
than	O
330	O
based	O
on	O
annotation	O
cited	O
in	O
NCBI	O
)	O
presumably	O
because	O
it	O
can	O
survive	O
and	O
replicate	O
in	O
many	O
different	O
environments	O
,	O
cause	O
infection	O
in	O
diverse	O
hosts	O
,	O
and	O
can	O
use	O
multiple	O
carbon	S-Chemical_Compound
sources	O
and	O
terminal	O
electron	O
acceptors	O
.	O

BALB	O
/	O
c	O
mice	O
infection	O
to	O
eliminate	O
other	O
regulators	O
required	O
only	O
for	O
gastrointestinal	O
infection	O
or	O
persistence	O
but	O
most	O
of	O
these	O
strains	O
were	O
avirulent	O
in	O
another	O
strain	O
of	O
mice	O
(	O
129X1	O
/	O
SvJ	O
)	O
and	O
by	O
other	O
route	O
(	O
intragastric	O
)	O
of	O
infection	O
(	O
see	O
Table	O
S1	O
)	O
.	O

Even	O
at	O
the	O
shortest	O
time	O
few	O
intracellular	O
bacteria	O
were	O
recovered	O
from	O
macrophage	O
infection	O
with	O
an	O
rpoE	O
mutant	O
,	O
suggesting	O
that	O
this	O
strain	O
is	O
very	O
sensitive	O
to	O
microbicidal	O
factors	O
released	O
by	O
macrophages	O
on	O
contact	O
with	O
bacteria	O
or	O
doesn	O
'	O
t	O
get	O
internalized	O
very	O
well	O
.	O

Because	O
some	O
of	O
the	O
Typhimurium	O
regulator	O
mutants	O
survived	O
so	O
poorly	O
within	O
macrophages	O
that	O
preparing	O
mRNA	O
from	O
intracellular	O
bacteria	O
was	O
not	O
possible	O
we	O
have	O
used	O
in	O
vitro	O
growth	O
conditions	O
that	O
duplicate	O
some	O
of	O
the	O
intracellular	O
conditions	O
(	O
low	O
pH	O
,	O
minimal	O
media	O
;	O
[	O
47	O
]	O
,	O
[	O
48	O
]	O
)	O
.	O

We	O
observed	O
that	O
the	O
results	O
determined	O
by	O
these	O
two	O
methods	O
matched	O
closely	O
(	O
Figure	O
S2	O
)	O
and	O
that	O
the	O
level	O
of	O
transcription	O
of	O
ssaG	O
was	O
highest	O
when	O
Salmonella	O
was	O
grown	O
in	O
minimal	O
acidic	O
media	O
.	O

The	O
three	O
exceptions	O
were	O
spvR	O
,	O
fruR	O
,	O
and	O
rpoS	O
.	O

We	O
searched	O
for	O
additional	O
previously	O
unidentified	O
virulence	O
factors	O
encoded	O
elsewhere	O
on	O
the	O
chromosome	O
that	O
show	O
the	O
same	O
pattern	O
of	O
expression	O
as	O
those	O
located	O
within	O
SPI	O
-	O
2	O
.	O

To	O
detect	O
dependencies	O
among	O
genes	O
over	O
different	O
conditions	O
we	O
employed	O
the	O
context	O
likelihood	O
of	O
relatedness	O
algorithm	O
(	O
CLR	O
;	O
[	O
19	O
]	O
)	O
,	O
which	O
is	O
a	O
plugin	O
for	O
SEBINI	O
.	O

In	O
the	O
computed	O
network	O
multiple	O
regulators	O
act	O
both	O
directly	O
and	O
indirectly	O
to	O
control	O
SPI	O
-	O
2	O
expression	O
.	O

So	O
,	O
in	O
Figure	O
6B	O
all	O
regulatory	O
effects	O
on	O
SPI	O
-	O
2	O
have	O
been	O
removed	O
except	O
for	O
those	O
mediated	O
directly	O
by	O
slyA	O
and	O
ssrB	O
based	O
on	O
additional	O
genetic	O
data	O
as	O
described	O
below	O
.	O

The	O
consensus	O
network	O
combining	O
all	O
data	O
reported	O
in	O
this	O
study	O
includes	O
the	O
network	O
computed	O
from	O
qRT	O
-	O
PCR	O
(	O
Figure	O
6B	O
)	O
in	O
part	O
and	O
suggests	O
a	O
predictive	O
regulatory	O
cascade	O
that	O
merits	O
a	O
test	O
.	O

The	O
complementation	O
result	O
suggests	O
that	O
many	O
of	O
the	O
regulators	O
may	O
function	O
on	O
SPI	O
-	O
2	O
through	O
SlyA	O
activation	O
of	O
ssrB	O
or	O
alternatively	O
via	O
both	O
regulators	O
(	O
slyA	O
and	O
ssrB	O
)	O
acting	O
together	O
.	O

To	O
test	O
this	O
possibility	O
we	O
constructed	O
double	O
deletions	O
of	O
ssrAB	O
/	O
ompRenvZ	O
,	O
ssrAB	O
/	O
phoPQ	O
,	O
ssrAB	O
/	O
csrA	O
and	O
ssrAB	O
/	O
himD	O
.	O

Furthermore	O
there	O
was	O
a	O
clear	O
dichotomy	O
in	O
expression	O
between	O
the	O
first	O
two	O
SPI	O
-	O
2	O
operons	O
encoding	O
ssaB	O
-	O
ssaE	O
and	O
sseA	O
-	O
sseG	O
and	O
the	O
operons	O
further	O
downstream	O
(	O
ssaG	O
-	O
ssaQ	O
)	O
suggesting	O
that	O
slyA	O
may	O
act	O
at	O
different	O
sites	O
within	O
SPI	O
-	O
2	O
.	O

During	O
systemic	O
mouse	O
infection	O
,	O
Salmonella	O
processes	O
multiple	O
environmental	O
cues	O
via	O
more	O
than	O
14	O
regulators	O
We	O
performed	O
virulence	O
assays	O
on	O
83	O
regulators	O
previously	O
identified	O
as	O
required	O
for	O
Salmonella	O
enteriditis	O
virulence	O
by	O
one	O
or	O
more	O
negative	O
selection	O
experiments	O
in	O
various	O
hosts	O
including	O
calves	O
,	O
chickens	O
,	O
and	O
mice	O
[	O
13	O
]	O
,	O
[	O
21	O
]	O
-	O
[	O
23	O
]	O
.	O

This	O
operon	O
encodes	O
some	O
of	O
the	O
most	O
abundantly	O
expressed	O
proteins	O
by	O
intracellular	O
Salmonella	O
.	O

In	O
our	O
transcriptional	O
network	O
each	O
pink	O
node	O
represents	O
a	O
regulator	O
(	O
Figure	O
6	O
B	O
)	O
and	O
lines	O
represent	O
positive	O
or	O
negative	O
transcriptional	O
interactions	O
(	O
positive	O
in	O
red	O
and	O
negative	O
in	O
blue	O
)	O
.	O

For	O
SPI	O
-	O
2	O
ssrB	O
plays	O
this	O
role	O
and	O
for	O
SPI	O
-	O
1	O
hilA	O
is	O
the	O
central	O
regulator	O
.	O

It	O
is	O
possible	O
that	O
SsrB	O
can	O
be	O
phosphorylated	O
from	O
other	O
sources	O
as	O
noted	O
by	O
Walthers	O
et	O
al	O
.	O

Mutations	O
in	O
rpoE	O
,	O
smpB	O
,	O
rpoS	O
,	O
and	O
hfq	O
showed	O
only	O
small	O
decreases	O
in	O
SPI	O
-	O
2	O
gene	O
transcription	O
during	O
growth	O
in	O
minimal	O
acidic	O
media	O
but	O
some	O
of	O
them	O
showed	O
large	O
defects	O
in	O
survival	O
assays	O
performed	O
in	O
murine	O
macrophages	O
.	O

For	O
rpoE	O
and	O
rpoS	O
it	O
is	O
possible	O
that	O
the	O
environmental	O
conditions	O
that	O
distinguish	O
growth	O
in	O
minimal	O
media	O
from	O
those	O
in	O
the	O
SCV	O
inside	O
hosts	O
are	O
sensed	O
via	O
these	O
two	O
alternative	O
sigma	O
factors	O
.	O

Four	O
nucleoid	O
-	O
like	O
proteins	O
in	O
enteric	O
bacteria	O
,	O
H	O
-	O
NS	O
,	O
StpA	O
,	O
Hha	O
,	O
and	O
YdgT	O
have	O
a	O
predilection	O
for	O
binding	O
to	O
A	O
+	O
T	O
rich	O
sequences	O
and	O
repress	O
transcription	O
of	O
SPI	O
-	O
2	O
genes	O
(	O
rev	O
.	O
in	O
[	O
14	O
]	O
)	O
.	O

This	O
model	O
is	O
supported	O
by	O
SlyA	O
binding	O
sites	O
that	O
are	O
located	O
downstream	O
of	O
transcriptional	O
start	O
sites	O
[	O
31	O
]	O
,	O
[	O
86	O
]	O
,	O
which	O
is	O
unusual	O
for	O
a	O
traditional	O
transcriptional	O
activator	O
.	O

In	O
agreement	O
with	O
this	O
model	O
,	O
SlyA	O
and	O
PhoP	O
counteract	O
H	O
-	O
NS	O
silencing	O
at	O
pagC	O
[	O
85	O
]	O
,	O
[	O
87	O
]	O
.	O

Complete	O
elucidation	O
of	O
the	O
virulence	O
pathways	O
must	O
include	O
proteomic	O
studies	O
to	O
identify	O
steps	O
that	O
require	O
translational	O
regulation	O
,	O
binding	O
studies	O
to	O
distinguish	O
direct	O
from	O
indirect	O
effects	O
and	O
additional	O
regulators	O
not	O
included	O
in	O
this	O
preliminary	O
group	O
of	O
14	O
.	O

The	O
construction	O
of	O
a	O
complete	O
interaction	O
network	O
describing	O
both	O
the	O
host	O
and	O
pathogen	O
is	O
a	O
long	O
-	O
term	O
goal	O
of	O
this	O
and	O
other	O
related	O
research	O
efforts	O
.	O

Biochemical	O
analysis	O
of	O
purified	O
Rv2623	O
suggested	O
that	O
this	O
mycobacterial	O
USP	O
binds	O
ATP	S-Chemical_Compound
,	O
and	O
the	O
2	O
.	O
9	O
-	O
A	O
-	O
resolution	O
crystal	O
structure	O
revealed	O
that	O
Rv2623	O
engages	O
ATP	S-Chemical_Compound
in	O
a	O
novel	O
nucleotide	O
-	O
binding	O
pocket	O
.	O

Recrudescence	O
of	O
latent	O
bacilli	O
contributes	O
significantly	O
to	O
the	O
incidence	O
of	O
adult	O
tuberculosis	O
[	O
2	O
]	O
,	O
yet	O
the	O
physiological	O
state	O
of	O
latent	O
bacilli	O
and	O
the	O
signals	O
that	O
promote	O
dormancy	O
in	O
the	O
host	O
remain	O
incompletely	O
defined	O
.	O

The	O
rv2623	O
-	O
specific	O
allelic	O
exchange	O
construct	O
was	O
delivered	O
via	O
recombinant	O
mycobacteriophage	O
phAE159	O
and	O
transformants	O
were	O
analyzed	O
by	O
Southern	O
blot	O
,	O
confirming	O
replacement	O
of	O
rv2623	O
with	O
the	O
hyg	O
gene	O
,	O
which	O
confers	O
hygromycin	S-Chemical_Compound
resistance	O
(	O
Figure	O
1A	O
)	O
.	O

These	O
results	O
support	O
the	O
notion	O
that	O
it	O
is	O
unlikely	O
that	O
M	O
.	O
tuberculosis	O
Rv2623	O
is	O
essential	O
for	O
resistance	O
to	O
stresses	O
encountered	O
in	O
the	O
host	O
,	O
which	O
is	O
consistent	O
with	O
the	O
observed	O
in	O
vivo	O
hypervirulence	O
phenotype	O
of	O
Deltarv2623	O
.	O

On	O
the	O
basis	O
of	O
structures	O
of	O
ATP	S-Chemical_Compound
-	O
binding	O
and	O
non	O
-	O
ATP	S-Chemical_Compound
-	O
binding	O
USPs	O
,	O
a	O
G	O
-	O
2X	O
-	O
G	O
-	O
9X	O
-	O
G	O
(	O
S	O
/	O
T	O
)	O
motif	O
was	O
suggested	O
to	O
be	O
essential	O
for	O
the	O
binding	O
of	O
ATP	S-Chemical_Compound
[	O
27	O
]	O
.	O

Each	O
monomer	O
is	O
composed	O
of	O
tandem	O
USP	O
domains	O
[	O
residues	O
6	O
-	O
154	O
(	O
domain	O
1	O
)	O
,	O
155	O
-	O
294	O
(	O
domain2	O
)	O
]	O
that	O
share	O
26	O
%	O
sequence	O
identity	O
and	O
significant	O
structural	O
homology	O
(	O
residues	O
6	O
-	O
154	O
and	O
155	O
-	O
294	O
comprise	O
domains	O
1	O
and	O
2	O
,	O
respectively	O
;	O
interdomain	O
rms	O
=	O
2	O
.	O
04	O
A	O
for	O
140	O
equivalent	O
Calpha	O
'	O
s	O
)	O
.	O

Mechanistically	O
,	O
results	O
of	O
the	O
mutagenesis	O
studies	O
have	O
shown	O
that	O
Rv2623	O
regulates	O
growth	O
through	O
ATP	S-Chemical_Compound
-	O
dependent	O
function	O
.	O

Moreover	O
,	O
discontinuation	O
of	O
bfiS	O
,	O
bfmR	O
,	O
and	O
mifR	O
expression	O
in	O
established	O
biofilms	O
resulted	O
in	O
the	O
collapse	O
of	O
biofilms	O
to	O
an	O
earlier	O
developmental	O
stage	O
,	O
indicating	O
a	O
requirement	O
for	O
these	O
regulatory	O
systems	O
for	O
the	O
development	O
and	O
maintenance	O
of	O
normal	O
biofilm	O
architecture	O
.	O

Introduction	O

Biofilms	O
form	O
when	O
bacteria	O
adhere	O
to	O
surfaces	O
in	O
moist	O
environments	O
.	O

Vallet	O
et	O
al	O
.	O

This	O
raises	O
the	O
question	O
of	O
whether	O
the	O
transition	O
to	O
later	O
stages	O
of	O
biofilm	O
formation	O
,	O
which	O
coincide	O
with	O
distinct	O
phenotypes	O
compared	O
to	O
planktonic	O
and	O
initial	O
attached	O
bacterial	O
cells	O
,	O
also	O
involves	O
sensing	O
of	O
environmental	O
signal	O
(	O
s	O
)	O
and	O
requires	O
the	O
coordinated	O
transduction	O
of	O
phosphorylation	O
events	O
(	O
phosphorelays	O
)	O
.	O

Furthermore	O
,	O
we	O
report	O
the	O
identification	O
of	O
three	O
novel	O
two	O
-	O
component	O
regulatory	O
systems	O
named	O
BfiRS	O
(	O
PA4196	O
-	O
4197	O
)	O
,	O
BfmRS	O
(	O
PA4101	O
-	O
4102	O
)	O
,	O
and	O
MifRS	O
(	O
PA5511	O
-	O
5512	O
)	O
that	O
coordinate	O
phosphorylation	O
events	O
required	O
for	O
the	O
progression	O
of	O
P	O
.	O
aeruginosa	O
biofilm	O
development	O
in	O
a	O
stage	O
-	O
specific	O
manner	O
.	O

The	O
increase	O
in	O
similarity	O
between	O
the	O
planktonic	O
and	O
the	O
216	O
-	O
hr	O
-	O
old	O
biofilm	O
phosphoproteomes	O
is	O
consistent	O
with	O
previous	O
reports	O
indicating	O
that	O
cells	O
within	O
dispersion	O
-	O
stage	O
biofilms	O
are	O
returning	O
to	O
the	O
planktonic	O
mode	O
of	O
growth	O
[	O
12	O
]	O
,	O
[	O
50	O
]	O
.	O

We	O
therefore	O
also	O
purified	O
phosphorylated	O
proteins	O
using	O
metal	O
oxide	O
affinity	O
chromatography	O
(	O
MOAC	O
,	O
see	O
Fig	O
.	O
S1	O
)	O
,	O
a	O
gel	O
-	O
independent	O
approach	O
allowing	O
for	O
the	O
enrichment	O
of	O
phosphoproteins	O
independent	O
of	O
the	O
phosphorylation	O
site	O
with	O
an	O
up	O
to	O
100	O
%	O
specificity	O
[	O
51	O
]	O
,	O
[	O
52	O
]	O
,	O
followed	O
by	O
cleavable	O
isotope	O
coded	O
affinity	O
tag	O
(	O
cICAT	O
)	O
labeling	O
and	O
analysis	O
by	O
liquid	O
chromatography	O
tandem	O
mass	O
spectrometry	O
(	O
LC	O
-	O
MS	O
/	O
MS	O
)	O
.	O

Similarly	O
to	O
the	O
results	O
obtained	O
via	O
immunoblot	O
analysis	O
,	O
the	O
changes	O
in	O
phosphorylation	O
events	O
over	O
the	O
course	O
of	O
biofilm	O
development	O
detected	O
using	O
LC	O
-	O
MS	O
-	O
MS	O
analysis	O
appeared	O
to	O
be	O
stage	O
-	O
specific	O
(	O
two	O
examples	O
are	O
shown	O
in	O
Suppl	O
.	O
Fig	O
.	O
S2	O
)	O
,	O
with	O
the	O
similarity	O
to	O
the	O
planktonic	O
patterns	O
decreasing	O
from	O
72	O
%	O
in	O
8	O
hr	O
biofilms	O
to	O
38	O
%	O
in	O
144	O
hr	O
biofilms	O
(	O
Fig	O
.	O
1C	O
)	O
.	O

This	O
is	O
the	O
first	O
description	O
of	O
the	O
dynamic	O
changes	O
of	O
the	O
phosphoproteome	O
occurring	O
during	O
biofilm	O
development	O
.	O

Based	O
on	O
the	O
role	O
of	O
PA4197	O
in	O
the	O
initiation	O
of	O
biofilm	O
formation	O
,	O
we	O
named	O
the	O
PA4197	O
ORF	O
Biofilm	O
initiation	O
Sensor	O
(	O
BfiS	O
)	O
.	O

BfiS	O
is	O
an	O
unusual	O
sensor	O
that	O
harbors	O
a	O
His	O
kinase	O
A	O
domain	O
typically	O
found	O
in	O
two	O
-	O
component	O
system	O
(	O
TCS	O
)	O
sensor	O
proteins	O
,	O
a	O
Histidine	O
kinase	O
-	O
like	O
ATPase	O
domain	O
involved	O
in	O
autophosphorylation	O
but	O
also	O
in	O
protein	O
dephosphorylation	O
events	O
,	O
and	O
a	O
PAS	O
signal	O
receiver	O
domain	O
[	O
53	O
]	O
.	O

Mutant	O
biofilms	O
display	O
protein	O
and	O
phosphorylation	O
patterns	O
indicative	O
of	O
stage	O
-	O
specific	O
arrest	O
of	O
biofilm	O
development	O

4B	O
,	O
cluster	O
analysis	O
based	O
on	O
protein	O
similarity	O
confirmed	O
our	O
previous	O
findings	O
obtained	O
by	O
microscopic	O
and	O
phosphoproteome	O
analyses	O
of	O
mutant	O
biofilms	O
.	O

NtrC	O
-	O
like	O
regulators	O
belong	O
to	O
a	O
family	O
of	O
transcriptional	O
activators	O
which	O
control	O
a	O
variety	O
of	O
physiological	O
processes	O
in	O
response	O
to	O
environmental	O
signals	O
[	O
68	O
]	O
.	O

This	O
family	O
of	O
regulators	O
control	O
transcription	O
from	O
-	O
12	O
,	O
-	O
24	O
promoters	O
recognized	O
by	O
RNA	O
polymerase	O
that	O
utilizes	O
the	O
alternative	O
sigma	O
54	O
factor	O
encoded	O
by	O
rpoN	O
and	O
its	O
analogs	O
.	O

While	O
fruiting	O
body	O
formation	O
is	O
governed	O
by	O
a	O
cascade	O
of	O
RpoN	O
-	O
dependent	O
transcription	O
factors	O
in	O
starving	O
cells	O
,	O
endospore	O
formation	O
in	O
B	O
.	O
subtilis	O
requires	O
the	O
consecutive	O
activity	O
of	O
multiple	O
sigma	O
factors	O
including	O
Sigma	O
E	O
,	O
F	O
,	O
G	O
,	O
and	O
K	O
.	O

BfiR	O
harbors	O
region	O
4	O
of	O
Sigma	O
-	O
70	O
(	O
RpoD	O
)	O
-	O
like	O
sigma	O
factors	O
,	O
a	O
domain	O
involved	O
in	O
binding	O
to	O
-	O
35	O
promoter	O
elements	O
.	O

In	O
summary	O
,	O
we	O
have	O
evidence	O
of	O
three	O
novel	O
regulatory	O
systems	O
playing	O
a	O
role	O
in	O
the	O
progression	O
of	O
P	O
.	O
aeruginosa	O
biofilm	O
development	O
in	O
a	O
stage	O
-	O
specific	O
manner	O
.	O

Furthermore	O
,	O
the	O
finding	O
of	O
sequential	O
and	O
essential	O
regulatory	O
steps	O
in	O
biofilm	O
formation	O
and	O
the	O
involvement	O
of	O
at	O
least	O
two	O
sigma	O
factors	O
suggests	O
that	O
biofilm	O
development	O
is	O
analogous	O
to	O
other	O
programmed	O
developmental	O
processes	O
.	O

Many	O
Gram	O
-	O
negative	O
bacteria	O
that	O
colonize	O
host	O
animals	O
use	O
a	O
type	O
III	O
secretion	O
system	O
(	O
T3SS	O
)	O
to	O
deliver	O
effector	O
proteins	O
directly	O
into	O
host	O
cells	O
where	O
their	O
interaction	O
with	O
host	O
proteins	O
and	O
membranes	O
contribute	O
to	O
pathogenesis	O
.	O

Current	O
literature	O
groups	O
secretion	O
chaperones	O
into	O
three	O
classes	O
based	O
on	O
their	O
physical	O
interactions	O
with	O
cargo	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
.	O

SPI	O
-	O
1	O
encodes	O
a	O
T3SS	O
required	O
for	O
host	O
cell	O
invasion	O
and	O
SPI	O
-	O
2	O
encodes	O
a	O
second	O
T3SS	O
needed	O
for	O
intracellular	O
survival	O
and	O
immune	O
evasion	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
.	O

However	O
no	O
structures	O
are	O
available	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O
chaperones	O
whose	O
effector	O
repertoire	O
seems	O
considerably	O
larger	O
than	O
that	O
of	O
the	O
SPI	O
-	O
1	O
system	O
.	O

We	O
solved	O
the	O
crystal	O
structure	O
of	O
SrcA	O
and	O
performed	O
additional	O
biochemical	O
,	O
proteomic	O
and	O
in	O
vivo	O
experiments	O
that	O
revealed	O
SrcA	O
to	O
be	O
a	O
class	O
I	O
chaperone	O
required	O
for	O
bacterial	O
fitness	O
in	O
the	O
host	O
environment	O
.	O

Each	O
monomer	O
consisted	O
of	O
a	O
small	O
and	O
large	O
domain	O
.	O

As	O
expected	O
from	O
data	O
with	O
the	O
complemented	O
mutant	O
in	O
vivo	O
,	O
expression	O
of	O
srcA	O
in	O
trans	O
restored	O
effector	O
secretion	O
in	O
the	O
srcA	O
mutant	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
interaction	O
between	O
SrcA	O
and	O
SsaN	O
supports	O
an	O
emerging	O
paradigm	O
whereby	O
secretion	O
chaperones	O
bring	O
effector	O
cargo	O
to	O
the	O
T3SS	O
through	O
physical	O
interaction	O
with	O
the	O
hexameric	O
ATPase	O
at	O
the	O
base	O
of	O
the	O
apparatus	O
[	O
14	O
]	O
.	O

Due	O
to	O
low	O
G	O
+	O
C	O
base	O
content	O
compared	O
to	O
the	O
genome	O
average	O
of	O
52	O
%	O
,	O
it	O
'	O
s	O
likely	O
that	O
srcA	O
(	O
32	O
%	O
G	O
+	O
C	O
)	O
and	O
an	O
adjacent	O
gene	O
,	O
STM2137	O
(	O
37	O
%	O
G	O
+	O
C	O
)	O
,	O
were	O
acquired	O
as	O
a	O
foreign	O
islet	O
that	O
was	O
retained	O
in	O
organisms	O
containing	O
the	O
SPI	O
-	O
2	O
T3SS	O
due	O
to	O
the	O
selective	O
advantage	O
afforded	O
by	O
the	O
new	O
protein	O
interactions	O
so	O
created	O
.	O

Our	O
results	O
suggest	O
that	O
transit	O
through	O
the	O
flea	O
vector	O
induces	O
a	O
phenotype	O
that	O
enhances	O
survival	O
and	O
dissemination	O
of	O
Y	O
.	O
pestis	O
after	O
transmission	O
to	O
the	O
mammalian	O
host	O
.	O

Y	O
.	O
pestis	O
circulates	O
among	O
many	O
species	O
of	O
wild	O
rodents	O
,	O
its	O
primary	O
reservoir	O
hosts	O
,	O
via	O
flea	O
bite	O
.	O

The	O
subsequent	O
growth	O
and	O
consolidation	O
of	O
the	O
adherent	O
Y	O
.	O
pestis	O
biofilm	O
amongst	O
the	O
rows	O
of	O
cuticle	O
-	O
covered	O
spines	O
that	O
line	O
the	O
proventriculus	O
interferes	O
with	O
normal	O
blood	O
feeding	O
,	O
resulting	O
in	O
regurgitation	O
of	O
bacteria	O
and	O
transmission	O
.	O

Comparing	O
the	O
Y	O
.	O
pestis	O
gene	O
expression	O
profile	O
in	O
the	O
flea	O
to	O
those	O
of	O
in	O
vitro	O
biofilm	O
and	O
planktonic	O
cells	O
cultured	O
at	O
the	O
low	O
temperature	O
typical	O
of	O
the	O
flea	O
implicated	O
several	O
genes	O
in	O
a	O
flea	O
-	O
specific	O
adaptive	O
response	O
and	O
in	O
proventricular	O
blockage	O
.	O

During	O
the	O
first	O
week	O
after	O
being	O
ingested	O
in	O
an	O
infectious	O
blood	O
meal	O
,	O
Y	O
.	O
pestis	O
grows	O
rapidly	O
in	O
the	O
flea	O
midgut	O
to	O
form	O
large	O
bacterial	O
aggregates	O
.	O

Blockage	O
occurred	O
between	O
1	O
.	O
5	O
and	O
3	O
.	O
5	O
weeks	O
after	O
the	O
initial	O
infectious	O
blood	O
meal	O
,	O
during	O
which	O
time	O
the	O
fleas	O
fed	O
on	O
uninfected	O
mice	O
twice	O
weekly	O
.	O

Quantitative	O
RT	O
-	O
PCR	O
analysis	O
of	O
a	O
subset	O
of	O
Y	O
.	O
pestis	O
genes	O
differentially	O
expressed	O
in	O
the	O
flea	O
was	O
confirmatory	O
of	O
the	O
microarray	O
results	O
(	O
Fig	O
.	O
S2	O
)	O
.	O

Y	O
.	O
pestis	O
metabolic	O
adaptation	O
to	O
the	O
flea	O
gut	O
environment	O

The	O
central	O
role	O
of	O
the	O
L	O
-	O
glutamate	O
family	O
of	O
amino	O
acids	O
may	O
also	O
confer	O
this	O
advantage	O
in	O
the	O
flea	O
gut	O
,	O
because	O
Glu	O
and	O
Pro	O
are	O
osmoprotectants	O
.	O

Insect	O
midgut	O
epithelium	O
is	O
typified	O
by	O
multiple	O
amino	O
acid	O
transporters	O
with	O
specific	O
substrates	O
and	O
rapid	O
absorption	O
kinetics	O
,	O
but	O
different	O
amino	O
acids	O
enter	O
the	O
hemocoel	O
at	O
different	O
rates	O
and	O
amounts	O
[	O
14	O
]	O
,	O
[	O
15	O
]	O
.	O

Although	O
the	O
flea	O
gut	O
contains	O
lipid	O
derived	O
from	O
the	O
blood	O
meal	O
,	O
Y	O
.	O
pestis	O
does	O
not	O
appear	O
to	O
use	O
it	O
as	O
a	O
major	O
energy	O
source	O
.	O

Amino	O
acid	O
carbon	S-Chemical_Compound
is	O
presumably	O
funneled	O
into	O
the	O
TCA	S-Chemical_Compound
cycle	O
,	O
the	O
genes	O
for	O
which	O
are	O
highly	O
expressed	O
in	O
the	O
flea	O
(	O
Table	O
S3	O
)	O
.	O

The	O
transcriptional	O
profile	O
of	O
Y	O
.	O
pestis	O
in	O
blocked	O
fleas	O
showed	O
greater	O
similarity	O
to	O
the	O
transcriptional	O
profile	O
reported	O
for	O
E	O
.	O
coli	O
in	O
mature	O
,	O
four	O
-	O
day	O
-	O
old	O
in	O
vitro	O
biofilms	O
[	O
23	O
]	O
.	O

Although	O
genes	O
in	O
the	O
polyamine	O
transport	O
gabTpotDBC	O
locus	O
are	O
among	O
the	O
most	O
highly	O
induced	O
genes	O
in	O
the	O
flea	O
(	O
Table	O
S1	O
)	O
and	O
polyamines	S-Chemical_Compound
are	O
essential	O
for	O
Y	O
.	O
pestis	O
biofilm	O
formation	O
[	O
30	O
]	O
,	O
we	O
have	O
previously	O
reported	O
that	O
a	O
Y	O
.	O
pestis	O
Deltapot	O
mutant	O
has	O
no	O
defect	O
in	O
flea	O
infection	O
or	O
blockage	O
[	O
31	O
]	O
.	O

With	O
this	O
study	O
,	O
the	O
in	O
vivo	O
transcriptome	O
of	O
Y	O
.	O
pestis	O
in	O
blocked	O
fleas	O
and	O
in	O
the	O
rat	O
bubo	O
[	O
11	O
]	O
have	O
now	O
both	O
been	O
characterized	O
.	O

Other	O
virulence	O
and	O
transmission	O
factors	O
were	O
not	O
differentially	O
regulated	O
,	O
including	O
the	O
hms	O
genes	O
;	O
and	O
the	O
Y	O
.	O
pestis	O
plasminogen	O
activator	O
(	O
pla	O
)	O
,	O
critical	O
for	O
dissemination	O
from	O
extravascular	O
tissue	O
at	O
the	O
fleabite	O
site	O
[	O
33	O
]	O
,	O
and	O
ymt	O
were	O
highly	O
expressed	O
in	O
both	O
hosts	O
(	O
Table	O
S3	O
and	O
[	O
11	O
]	O
)	O
.	O

The	O
Y	O
.	O
pestis	O
outer	O
surface	O
protein	O
gene	O
yadB	O
,	O
recently	O
shown	O
to	O
be	O
required	O
for	O
dissemination	O
and	O
bubonic	O
plague	O
pathogenesis	O
from	O
a	O
subcutaneous	O
inoculation	O
site	O
[	O
34	O
]	O
,	O
was	O
significantly	O
upregulated	O
in	O
both	O
the	O
flea	O
and	O
the	O
bubo	O
compared	O
to	O
in	O
vitro	O
conditions	O
(	O
Tables	O
1	O
,	O
S1	O
)	O
.	O

Bacteria	O
from	O
fleas	O
showed	O
significantly	O
lower	O
levels	O
of	O
phagocytosis	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

Because	O
phoP	O
is	O
required	O
by	O
Y	O
.	O
pestis	O
to	O
produce	O
a	O
transmissible	O
infection	O
in	O
fleas	O
(	O
unpublished	O
data	O
)	O
,	O
it	O
was	O
not	O
possible	O
to	O
similarly	O
assess	O
the	O
effect	O
on	O
disease	O
transmission	O
of	O
phoP	O
induction	O
in	O
the	O
flea	O
.	O

Does	O
transit	O
through	O
the	O
flea	O
vector	O
preadapt	O
Y	O
.	O
pestis	O
to	O
resist	O
mammalian	O
innate	O
immunity	O
?	O

In	O
summary	O
,	O
Y	O
.	O
pestis	O
appears	O
to	O
be	O
prepared	O
for	O
pathogenesis	O
in	O
the	O
mammal	O
while	O
still	O
in	O
the	O
flea	O
vector	O
.	O

Transcriptome	O
Analysis	O
of	O
the	O
Brucella	O
abortus	O
BvrR	O
/	O
BvrS	O
Two	O
-	O
Component	O
Regulatory	O
System	O

Notably	O
,	O
seven	O
transcriptional	O
regulators	O
were	O
affected	O
,	O
including	O
VjbR	O
,	O
ExoR	O
and	O
OmpR	O
that	O
were	O
less	O
expressed	O
in	O
the	O
bvrR	O
mutant	O
.	O

These	O
regulatory	O
systems	O
are	O
highly	O
conserved	O
among	O
bacteria	O
and	O
widely	O
used	O
for	O
controlling	O
gene	O
expression	O
in	O
response	O
to	O
environmental	O
signals	O
.	O

B	O
.	O
abortus	O
mutants	O
in	O
this	O
system	O
were	O
more	O
susceptible	O
to	O
bactericidal	O
polycationic	O
substances	O
like	O
polymyxin	B-Chemical_Compound
B	E-Chemical_Compound
,	O
melittin	S-Chemical_Compound
or	O
poly	B-Chemical_Compound
-	I-Chemical_Compound
L	I-Chemical_Compound
-	I-Chemical_Compound
lysine	E-Chemical_Compound
,	O
and	O
displayed	O
a	O
more	O
hydrophobic	O
outer	O
membrane	O
surface	O
than	O
the	O
parental	O
strain	O
[	O
4	O
]	O
.	O

B	O
.	O
abortus	O
RNA	O
was	O
obtained	O
from	O
three	O
independent	O
cultures	O
of	O
each	O
wild	O
type	O
and	O
bvrR	O
mutant	O
cells	O
grown	O
in	O
the	O
same	O
conditions	O
.	O

Data	O
were	O
normalized	O
by	O
the	O
2	O
-	O
DeltaDeltaCt	O
method	O
[	O
9	O
]	O
using	O
the	O
IF	O
-	O
1	O
housekeeping	O
gene	O
of	O
Brucella	O
as	O
reference	O
(	O
Table	O
1	O
)	O
.	O

Interestingly	O
,	O
the	O
level	O
of	O
transcription	O
obtained	O
by	O
RT	O
-	O
PCR	O
of	O
the	O
flagellar	O
genes	O
fliM	O
(	O
BAB2	O
_	O
0124	O
)	O
and	O
motB	O
(	O
BAB2	O
_	O
1103	O
)	O
,	O
and	O
the	O
pckA	O
gene	O
(	O
BAB1	O
_	O
2091	O
)	O
were	O
the	O
highest	O
in	O
the	O
bvrR	O
mutant	O
.	O

On	O
the	O
other	O
hand	O
,	O
exoR	O
(	O
BAB1	O
_	O
0891	O
)	O
,	O
omp25a	O
(	O
BAB1	O
_	O
0722	O
)	O
,	O
hpr	O
-	O
K	O
(	O
BAB1	O
_	O
2094	O
)	O
,	O
bvrS	O
(	O
BAB1	O
_	O
2093	O
)	O
and	O
the	O
lipoproteins	O
(	O
BAB1	O
_	O
2147	O
,	O
BAB1	O
_	O
0589	O
,	O
BAB1	O
_	O
0358	O
)	O
were	O
among	O
the	O
less	O
expressed	O
genes	O
(	O
Table	O
1	O
)	O
.	O

Other	O
authors	O
[	O
29	O
]	O
suggest	O
that	O
ExoR	O
is	O
an	O
inhibitor	O
of	O
two	O
-	O
component	O
signaling	O
that	O
may	O
be	O
conserved	O
in	O
a	O
large	O
number	O
of	O
alpha	O
-	O
proteobacteria	O
.	O

In	O
order	O
to	O
investigate	O
if	O
the	O
BvrR	O
/	O
BvrS	O
controlled	O
genes	O
were	O
expressed	O
intracellularly	O
,	O
bacterial	O
RNA	O
was	O
obtained	O
from	O
B	O
.	O
abortus	O
wild	O
type	O
recovered	O
from	O
infected	O
cells	O
as	O
described	O
in	O
Material	O
and	O
Methods	O
.	O

The	O
amount	O
of	O
bacterial	O
RNA	O
was	O
not	O
enough	O
to	O
perform	O
microarray	O
hybridizations	O
.	O

The	O
horse	O
pathogen	O
Streptococcus	O
equi	O
subspecies	O
equi	O
produces	O
a	O
homologue	O
of	O
Mac	O
(	O
SeMac	O
)	O
.	O

[	O
16	O
]	O
,	O
resolved	O
by	O
SDS	O
-	O
PAGE	O
,	O
and	O
probed	O
by	O
Western	O
immunoblot	O
with	O
anti	O
-	O
SeMac	O
mouse	O
antisera	O
.	O

Due	O
to	O
the	O
unavailability	O
of	O
other	O
purified	O
subgroup	O
IgG	O
,	O
it	O
is	O
not	O
known	O
whether	O
SeMac	O
cleaves	O
the	O
other	O
IgG	O
subgroups	O
.	O

SeMac	O
and	O
GAS	O
M1	O
Mac	O
show	O
similar	O
enzymatic	O
specificity	O
(	O
Fig	O
.	O
4	O
and	O
Table	O
1	O
)	O
,	O
confirming	O
the	O
previous	O
finding	O
[	O
18	O
]	O
.	O

S	O
.	O
equi	O
is	O
a	O
horse	O
pathogen	O
.	O

The	O
fact	O
that	O
SeMac	O
does	O
not	O
inhibit	O
opsonophagocytosis	O
of	O
S	O
.	O
equi	O
by	O
horse	O
PMNs	O
indicates	O
that	O
SeMac	O
is	O
not	O
involved	O
in	O
the	O
evasion	O
of	O
the	O
acquired	O
horse	O
immunity	O
against	O
S	O
.	O
equi	O
.	O

The	O
acid	O
tolerance	O
response	O
of	O
Salmonella	O
results	O
in	O
the	O
synthesis	O
of	O
over	O
50	O
acid	O
shock	O
proteins	O
(	O
Bearson	O
et	O
al	O
.	O
,	O
1998	O
)	O
that	O
are	O
likely	O
to	O
function	O
primarily	O
when	O
variations	O
in	O
internal	O
pH	O
occur	O
,	O
i	O
.	O
e	O
.	O
when	O
Salmonella	O
experiences	O
severe	O
acidic	O
conditions	O
(	O
pH	O
approximately3	O
)	O
(	O
Foster	O
,	O
2004	O
)	O
.	O

The	O
low	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
activation	O
of	O
the	O
PmrA	O
protein	O
requires	O
PhoQ	O
,	O
a	O
protein	O
that	O
senses	O
extracellular	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
levels	O
(	O
Vescovi	O
et	O
al	O
.	O
,	O
1996	O
)	O
,	O
PhoQ	O
'	O
s	O
cognate	O
regulator	O
PhoP	O
,	O
and	O
the	O
PhoP	O
-	O
activated	O
protein	O
PmrD	O
(	O
Kox	O
et	O
al	O
.	O
,	O
2000	O
;	O
Kato	O
and	O
Groisman	O
,	O
2004	O
)	O
.	O

Here	O
we	O
show	O
that	O
PmrA	O
'	O
s	O
cognate	O
sensor	O
kinase	O
PmrB	O
is	O
required	O
for	O
responding	O
to	O
external	O
changes	O
in	O
pH	O
through	O
a	O
mechanism	O
that	O
requires	O
a	O
histidine	O
and	O
several	O
glutamic	O
acid	O
residues	O
located	O
in	O
its	O
periplasmic	O
domain	O
,	O
as	O
well	O
as	O
the	O
post	O
-	O
translational	O
activator	O
PmrD	O
protein	O
.	O

Results	O

We	O
considered	O
the	O
possibility	O
of	O
PmrA	O
being	O
phosphorylated	O
from	O
acetyl	B-Chemical_Compound
phosphate	E-Chemical_Compound
because	O
acetyl	B-Chemical_Compound
phosphate	E-Chemical_Compound
has	O
been	O
shown	O
to	O
serve	O
as	O
phosphoryl	O
donor	O
to	O
several	O
response	O
regulators	O
when	O
their	O
cognate	O
sensors	O
are	O
absent	O
(	O
see	O
Wolfe	O
,	O
2005	O
for	O
a	O
review	O
)	O
.	O

Interestingly	O
,	O
one	O
of	O
these	O
conserved	O
residues	O
was	O
a	O
histidine	O
at	O
position	O
35	O
.	O

Four	O
of	O
the	O
nine	O
conserved	O
amino	O
acids	O
in	O
the	O
periplasmic	O
domain	O
of	O
PmrB	O
are	O
glutamic	O
acid	O
residues	O
,	O
which	O
also	O
could	O
be	O
subjected	O
to	O
changes	O
in	O
protonation	O
upon	O
variations	O
in	O
the	O
pH	O
of	O
their	O
surroundings	O
.	O

Indeed	O
,	O
the	O
pKa	O
of	O
one	O
of	O
the	O
glutamic	O
acid	O
residues	O
of	O
the	O
regulatory	O
protein	O
TraM	O
is	O
approximately7	O
.	O
7	O
in	O
the	O
folded	O
protein	O
(	O
Lu	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

The	O
levels	O
of	O
phosphorylated	O
PmrA	O
are	O
determined	O
by	O
the	O
balance	O
of	O
the	O
autokinase	O
+	O
phosphotransferase	O
activity	O
of	O
PmrB	O
and	O
PmrB	O
'	O
s	O
phosphatase	O
activity	O
towards	O
phospho	O
-	O
PmrA	O
.	O

What	O
role	O
could	O
the	O
pH	O
-	O
dependent	O
activation	O
of	O
PmrA	O
-	O
regulated	O
genes	O
play	O
in	O
Salmonella	O
'	O
s	O
lifestyle	O
?	O

However	O
,	O
the	O
effects	O
of	O
Mlc	O
on	O
hilD	O
expression	O
and	O
bacterial	O
invasiveness	O
were	O
not	O
seen	O
in	O
the	O
hilE	O
mutant	O
,	O
and	O
hilE	O
expression	O
was	O
increased	O
in	O
the	O
mlc	O
mutant	O
,	O
which	O
suggests	O
that	O
Mlc	O
exerts	O
positive	O
effects	O
on	O
the	O
expression	O
of	O
SPI1	O
genes	O
by	O
reducing	O
the	O
expression	O
of	O
HilE	O
,	O
which	O
is	O
known	O
to	O
down	O
-	O
regulate	O
the	O
expression	O
of	O
SPI1	O
genes	O
through	O
direct	O
interaction	O
with	O
HilD	O
.	O

Figure	O
1C	O
shows	O
that	O
SL1344	O
killed	O
42	O
%	O
of	O
the	O
macrophages	O
,	O
whereas	O
SR1304	O
killed	O
only	O
16	O
%	O
of	O
the	O
macrophages	O
4h	O
after	O
infection	O
,	O
which	O
demonstrates	O
that	O
the	O
mlc	O
gene	O
plays	O
an	O
important	O
role	O
in	O
the	O
expression	O
of	O
genes	O
involved	O
in	O
cytotoxicity	O
.	O

To	O
identify	O
the	O
target	O
gene	O
in	O
SPI1	O
that	O
is	O
regulated	O
by	O
Mlc	O
,	O
the	O
expression	O
patterns	O
of	O
the	O
SPI1	O
-	O
regulatory	O
genes	O
,	O
which	O
include	O
hilA	O
,	O
invF	O
,	O
hilC	O
and	O
hilD	O
,	O
were	O
examined	O
by	O
primer	O
extension	O
analysis	O
of	O
total	O
RNA	O
from	O
SL1344	O
and	O
SR1304	O
grown	O
statically	O
to	O
the	O
exponential	O
phase	O
.	O

However	O
,	O
hilC	O
expression	O
was	O
unchanged	O
(	O
Figure	O
2A	O
)	O
.	O

(	O
20	O
)	O
have	O
found	O
that	O
HilE	O
plays	O
an	O
important	O
regulatory	O
role	O
in	O
the	O
expression	O
of	O
the	O
Salmonella	O
-	O
invasive	O
phenotype	O
by	O
affecting	O
hilA	O
transcription	O
through	O
direct	O
interaction	O
with	O
HilD	O
.	O

The	O
requirement	O
of	O
hilE	O
for	O
Mlc	O
function	O
was	O
reflected	O
in	O
the	O
levels	O
of	O
hilD	O
transcription	O
.	O

We	O
performed	O
a	O
primer	O
extension	O
assay	O
of	O
total	O
RNA	O
isolated	O
from	O
SL1344	O
grown	O
to	O
exponential	O
phase	O
in	O
static	O
culture	O
,	O
using	O
the	O
primer	O
described	O
by	O
Baxter	O
and	O
Jones	O
(	O
18	O
)	O
,	O
to	O
discover	O
which	O
promoter	O
is	O
regulated	O
by	O
Mlc	O
.	O

Using	O
a	O
primer	O
extension	O
assay	O
with	O
the	O
hilE5	O
primer	O
(	O
Table	O
2	O
)	O
,	O
the	O
promoter	O
of	O
hilE	O
,	O
which	O
is	O
designated	O
as	O
P3	O
,	O
was	O
newly	O
identified	O
;	O
this	O
promoter	O
initiates	O
335	O
nucleotides	O
upstream	O
of	O
the	O
translation	O
start	O
site	O
of	O
hilE	O
(	O
Figure	O
4B	O
,	O
lane	O
1	O
)	O
.	O

The	O
activity	O
of	O
the	O
purified	O
Mlc	O
-	O
His6	O
protein	O
was	O
verified	O
with	O
the	O
control	O
gel	O
mobility	O
shift	O
experiment	O
employing	O
the	O
Salmonella	O
ptsG	O
DNA	O
fragment	O
that	O
contains	O
the	O
known	O
Mlc	O
-	O
binding	O
site	O
(	O
data	O
not	O
shown	O
)	O
.	O

These	O
results	O
imply	O
that	O
multiple	O
regulatory	O
pathways	O
are	O
involved	O
in	O
the	O
regulation	O
of	O
hilE	O
and	O
hilD	O
by	O
carbohydrates	O
.	O

It	O
is	O
well	O
known	O
that	O
SPI1	O
is	O
required	O
for	O
the	O
invasion	O
of	O
host	O
cells	O
and	O
induction	O
of	O
macrophage	O
apoptosis	O
(	O
2	O
,	O
3	O
,	O
40	O
)	O
.	O

This	O
regulatory	O
cascade	O
implies	O
that	O
the	O
reduced	O
invasive	O
phenotype	O
of	O
mlc	O
mutant	O
is	O
the	O
result	O
of	O
hilD	O
repression	O
,	O
which	O
affects	O
both	O
hilA	O
and	O
invF	O
expression	O
(	O
Figures	O
1	O
and	O
2	O
)	O
.	O

However	O
,	O
this	O
length	O
of	O
5	O
'	O
-	O
UTR	O
has	O
been	O
observed	O
in	O
other	O
SPI1	O
regulators	O
.	O

The	O
results	O
presented	O
in	O
this	O
study	O
support	O
the	O
notion	O
that	O
hilE	O
expression	O
is	O
activated	O
as	O
a	O
result	O
of	O
Mlc	O
sequestration	O
by	O
unphosphorylated	O
EIICBGlc	O
in	O
the	O
presence	O
of	O
glucose	S-Chemical_Compound
.	O

Thus	O
,	O
carbon	O
metabolism	O
sensed	O
by	O
PhoB	O
/	O
R	O
may	O
also	O
affect	O
hilE	O
expression	O
(	O
22	O
)	O
,	O
and	O
this	O
may	O
be	O
one	O
of	O
the	O
reasons	O
for	O
the	O
elevated	O
hilE	O
expression	O
in	O
the	O
presence	O
of	O
carbohydrates	O
in	O
the	O
mlc	O
mutant	O
(	O
Figure	O
6A	O
)	O
.	O

The	O
effects	O
of	O
various	O
sugars	O
on	O
the	O
differential	O
regulation	O
of	O
SPI1	O
genes	O
require	O
further	O
investigation	O
to	O
understand	O
their	O
roles	O
in	O
Salmonella	O
pathogenesis	O
.	O

Further	O
sequence	O
analysis	O
revealed	O
a	O
palindrome	O
of	O
55	O
bp	O
with	O
the	O
potential	O
to	O
form	O
a	O
stem	O
-	O
loop	O
structure	O
situated	O
in	O
the	O
intergenic	O
region	O
between	O
salR	O
and	O
05SSU0942	O
,	O
which	O
may	O
function	O
as	O
a	O
transcriptional	O
terminator	O
.	O

On	O
the	O
other	O
hand	O
,	O
when	O
genomic	O
DNA	O
was	O
used	O
as	O
a	O
template	O
,	O
all	O
these	O
primer	O
pairs	O
yielded	O
the	O
expected	O
PCR	O
products	O
(	O
Fig	O
.	O
2B	O
,	O
PCR	O
)	O
.	O

Construction	O
of	O
DeltasalKR	O

To	O
check	O
this	O
suspected	O
mutant	O
,	O
Southern	O
hybridization	O
analyses	O
were	O
employed	O
using	O
probes	O
of	O
SpcR	O
gene	O
,	O
an	O
internal	O
fragment	O
of	O
salKR	O
,	O
and	O
pUC18	O
,	O
respectively	O
.	O

In	O
the	O
suspected	O
mutant	O
,	O
a	O
3	O
.	O
6	O
kb	O
restriction	O
fragment	O
hybridized	O
with	O
the	O
SpcR	O
probe	O
(	O
Fig	O
.	O
3B	O
,	O
lane	O
2	O
)	O
,	O
while	O
no	O
hybridization	O
signal	O
was	O
detected	O
when	O
the	O
internal	O
fragment	O
of	O
salKR	O
and	O
pUC18	O
served	O
as	O
the	O
probes	O
(	O
Fig	O
.	O
3C	O
and	O
3D	O
,	O
lane	O
2	O
)	O
.	O

Five	O
out	O
of	O
six	O
piglets	O
succumbed	O
to	O
the	O
lethal	O
infections	O
of	O
CDeltasalKR	O
and	O
died	O
,	O
with	O
median	O
survival	O
times	O
of	O
2	O
to	O
3	O
days	O
.	O

In	O
contrast	O
,	O
in	O
the	O
mutant	O
-	O
inoculated	O
group	O
,	O
no	O
mutant	O
bacteria	O
could	O
be	O
recovered	O
from	O
any	O
of	O
the	O
examined	O
tissue	O
specimens	O
.	O

Similarly	O
,	O
we	O
observed	O
that	O
pst	O
(	O
05SSU0451	O
)	O
is	O
down	O
-	O
regulated	O
in	O
DeltasalKR	O
whose	O
survival	O
in	O
the	O
bloodstream	O
is	O
drastically	O
affected	O
(	O
Fig	O
.	O
6	O
)	O
.	O

However	O
,	O
they	O
did	O
not	O
provide	O
sufficient	O
experimental	O
evidence	O
supporting	O
the	O
prediction	O
of	O
89K	O
PAI	O
which	O
was	O
largely	O
based	O
on	O
the	O
results	O
of	O
bioinformatical	O
analysis	O
,	O
and	O
the	O
functions	O
of	O
the	O
vast	O
majority	O
of	O
genes	O
encoding	O
within	O
the	O
89K	O
island	O
remain	O
largely	O
unknown	O
.	O

In	O
this	O
study	O
,	O
we	O
carried	O
out	O
a	O
detailed	O
structural	O
and	O
functional	O
analysis	O
of	O
a	O
unique	O
two	O
-	O
component	O
regulatory	O
system	O
designated	O
SalK	O
/	O
SalR	O
which	O
is	O
located	O
in	O
the	O
putative	O
89K	O
PAI	O
.	O

Moreover	O
,	O
PCR	O
analysis	O
using	O
primers	O
amplifying	O
the	O
salKR	O
locus	O
also	O
demonstrated	O
that	O
this	O
TCSTS	O
is	O
specific	O
to	O
Chinese	O
epidemic	O
outbreak	O
strains	O
of	O
SS2	O
(	O
data	O
not	O
shown	O
)	O
,	O
implying	O
its	O
tight	O
linkage	O
to	O
the	O
virulence	O
of	O
this	O
new	O
emerging	O
pathogenic	O
species	O
.	O

It	O
is	O
known	O
that	O
TCSTSs	O
are	O
often	O
implicated	O
in	O
the	O
regulation	O
of	O
the	O
direct	O
downstream	O
genes	O
.	O

For	O
those	O
members	O
belonging	O
to	O
putative	O
transcriptional	O
operons	O
,	O
microarray	O
results	O
showed	O
that	O
most	O
of	O
those	O
genes	O
cotranscribed	O
with	O
them	O
were	O
also	O
down	O
-	O
regulated	O
to	O
a	O
various	O
degree	O
,	O
although	O
under	O
the	O
threshold	O
of	O
2	O
.	O

Secondly	O
,	O
some	O
of	O
the	O
TCSTSs	O
of	O
S	O
.	O
pneumoniae	O
were	O
suggested	O
to	O
be	O
involved	O
in	O
key	O
processes	O
of	O
pathogenesis	O
,	O
such	O
as	O
autolysis	O
and	O
cell	O
-	O
cell	O
signaling	O
[	O
52	O
]	O
,	O
SalK	O
/	O
SalR	O
might	O
regulate	O
similar	O
processes	O
in	O
Chinese	O
SS2	O
virulent	O
isolates	O
.	O

More	O
importantly	O
,	O
accumulated	O
evidence	O
suggests	O
that	O
some	O
of	O
the	O
known	O
virulent	O
factors	O
are	O
not	O
requisite	O
for	O
the	O
full	O
virulence	O
of	O
SS2	O
,	O
as	O
the	O
absence	O
of	O
one	O
or	O
more	O
of	O
these	O
proteins	O
in	O
isolates	O
from	O
infected	O
animals	O
cannot	O
necessarily	O
be	O
associated	O
with	O
a	O
lack	O
of	O
virulence	O
[	O
53	O
]	O
-	O
[	O
56	O
]	O
.	O

Typhimurium	O
(	O
rpoS	O
,	O
rpoN	O
,	O
rpoE	O
,	O
rpoH	O
)	O
for	O
their	O
ability	O
to	O
express	O
a	O
key	O
virulence	O
gene	O
,	O
sseB	O
,	O
that	O
requires	O
SsrB	O
for	O
expression	O
and	O
whose	O
gene	O
product	O
is	O
essential	O
for	O
intracellular	O
pathogenesis	O
.	O

RpoE	O
is	O
involved	O
in	O
transcriptional	O
activity	O
of	O
a	O
subset	O
of	O
virulence	O
genes	O

Typhimurium	O
.	O

Discussion	O

When	O
we	O
examined	O
the	O
-	O
10	O
and	O
-	O
35	O
positions	O
of	O
the	O
promoters	O
studied	O
here	O
relative	O
to	O
the	O
transcriptional	O
start	O
sites	O
identified	O
previously	O
[	O
24	O
]	O
,	O
these	O
promoters	O
did	O
not	O
appear	O
to	O
contain	O
sigmaE	O
consensus	O
sequences	O
.	O

One	O
powerful	O
approach	O
to	O
dissect	O
the	O
interaction	O
between	O
pathogen	O
and	O
host	O
is	O
the	O
use	O
of	O
simple	O
infection	O
models	O
.	O

We	O
developed	O
a	O
high	O
-	O
throughput	O
killing	O
assay	O
using	O
C	O
.	O
elegans	O
as	O
a	O
host	O
,	O
which	O
will	O
be	O
appropriate	O
for	O
a	O
systematic	O
screen	O
of	O
mutant	O
libraries	O
of	O
any	O
P	O
.	O
aeruginosa	O
isolate	O
of	O
interest	O
.	O

High	O
Throughput	O
Assay	O
for	O
Nematode	O
Killing	O
by	O
P	O
.	O
aeruginosa	O
It	O
was	O
reported	O
earlier	O
that	O
relatively	O
high	O
-	O
throughput	O
screening	O
procedures	O
performed	O
on	O
plates	O
could	O
be	O
used	O
to	O
identify	O
virulence	O
factors	O
in	O
various	O
pathogens	O
such	O
as	O
Staphylococcus	O
aureus	O
[	O
32	O
]	O
,	O
P	O
.	O
aeruginosa	O
[	O
8	O
]	O
or	O
Serratia	O
marcescens	O
[	O
33	O
]	O
.	O

Evaluation	O
of	O
virulence	O
was	O
based	O
upon	O
the	O
number	O
of	O
live	O
worms	O
recovered	O
after	O
24	O
h	O
exposure	O
to	O
bacteria	O
.	O

Under	O
our	O
assay	O
conditions	O
,	O
more	O
than	O
90	O
%	O
of	O
the	O
worms	O
grown	O
on	O
E	O
.	O
coli	O
were	O
still	O
alive	O
after	O
24	O
h	O
.	O

Screening	O
the	O
TB	O
Transposon	O
Library	O
for	O
Mutants	O
Attenuated	O
in	O
Virulence	O

CheB2	O
has	O
been	O
proposed	O
to	O
be	O
an	O
essential	O
component	O
for	O
an	O
optimal	O
chemotactic	O
response	O
[	O
21	O
]	O
.	O

In	O
the	O
remaining	O
mutants	O
,	O
one	O
contained	O
a	O
transposon	O
insertion	O
in	O
PA5479	O
,	O
which	O
encodes	O
a	O
protein	O
similar	O
to	O
GltP	O
from	O
E	O
.	O
coli	O
,	O
a	O
glutamate	O
-	O
aspartate	O
carrier	O
protein	O
.	O

In	O
order	O
to	O
compare	O
our	O
liquid	O
assay	O
with	O
the	O
established	O
C	O
.	O
elegans	O
slow	O
killing	O
assay	O
,	O
we	O
compared	O
the	O
lethality	O
of	O
the	O
TB	O
strain	O
with	O
the	O
previously	O
tested	O
PA14	O
strain	O
.	O

We	O
observed	O
that	O
both	O
strains	O
kill	O
worms	O
with	O
similar	O
efficiency	O
(	O
data	O
not	O
shown	O
)	O
.	O

Each	O
of	O
the	O
12	O
group	O
1A	O
mutants	O
derived	O
from	O
TB	O
was	O
further	O
tested	O
in	O
the	O
slow	O
killing	O
assay	O
.	O

We	O
wished	O
to	O
determine	O
if	O
our	O
selected	O
mutants	O
showed	O
a	O
reduction	O
in	O
their	O
capacity	O
to	O
adhere	O
to	O
a	O
biological	O
surface	O
such	O
as	O
the	O
human	O
epithelial	O
cell	O
line	O
16HBE14o	O
-	O
.	O

Motility	O
is	O
also	O
an	O
important	O
factor	O
for	O
P	O
.	O
aeruginosa	O
colonization	O
and	O
spread	O
.	O

In	O
addition	O
,	O
we	O
engineered	O
a	O
similar	O
cheB2	O
mutation	O
in	O
the	O
P	O
.	O
aeruginosa	O
PA14	O
strain	O
,	O
yielding	O
PA140173i	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
,	O
and	O
observed	O
similar	O
virulence	O
attenuation	O
on	O
C	O
.	O
elegans	O
(	O
Figure	O
S3	O
)	O
.	O

This	O
further	O
confirmed	O
the	O
virulence	O
phenotype	O
of	O
a	O
cheB2	O
mutant	O
and	O
indicated	O
that	O
it	O
is	O
not	O
a	O
TB	O
strain	O
-	O
specific	O
trait	O
.	O

Infection	O
with	O
the	O
complemented	O
strain	O
TB0173sp2B2	O
resulted	O
in	O
60	O
%	O
dead	O
by	O
day	O
3	O
(	O
6	O
of	O
10	O
;	O
P	O
=	O
0	O
,	O
0018	O
,	O
Fisher	O
'	O
s	O
exact	O
test	O
)	O
(	O
Figure	O
4A	O
)	O
.	O

Surviving	O
mice	O
infected	O
with	O
the	O
cheB2	O
mutant	O
showed	O
a	O
significantly	O
less	O
troubled	O
body	O
condition	O
from	O
days	O
3	O
to	O
6	O
post	O
infection	O
(	O
P	O
<	O
0	O
.	O
01	O
,	O
Mann	O
-	O
Whitney	O
rank	O
test	O
)	O
than	O
surviving	O
mice	O
infected	O
with	O
the	O
wild	O
type	O
strain	O
indicating	O
that	O
the	O
former	O
group	O
recovered	O
earlier	O
than	O
the	O
latter	O
(	O
Figure	O
4B	O
)	O
.	O

It	O
is	O
worth	O
noting	O
that	O
a	O
mutant	O
affected	O
in	O
the	O
gacA	O
gene	O
,	O
previously	O
identified	O
in	O
the	O
slow	O
killing	O
assay	O
,	O
appeared	O
to	O
be	O
attenuated	O
in	O
our	O
liquid	O
-	O
based	O
killing	O
assay	O
.	O

We	O
tested	O
additional	O
virulence	O
and	O
motility	O
related	O
phenotypes	O
including	O
C	O
.	O
elegans	O
slow	O
killing	O
,	O
swarming	O
and	O
swimming	O
motility	O
,	O
or	O
adherence	O
to	O
human	O
cells	O
(	O
Table	O
1	O
)	O
.	O

The	O
cheB2	O
mutant	O
was	O
also	O
found	O
to	O
have	O
reduced	O
adhesive	O
capabilities	O
to	O
bronchial	O
epithelial	O
cells	O
(	O
Figure	O
S1	O
)	O
.	O

The	O
cheB1	O
mutant	O
virulence	O
is	O
not	O
attenuated	O
in	O
the	O
slow	O
killing	O
assay	O
.	O

Several	O
tissues	O
participate	O
in	O
a	O
coordinated	O
defense	O
against	O
microbial	O
infection	O
.	O

Secondly	O
,	O
specialized	O
hemocytes	O
participate	O
in	O
phagocytosis	O
and	O
encapsulation	O
of	O
foreign	O
intruders	O
.	O

In	O
contrast	O
,	O
the	O
Imd	O
pathway	O
mainly	O
responds	O
to	O
Gram	O
-	O
negative	O
bacterial	O
infections	O
and	O
controls	O
different	O
AMP	O
genes	O
(	O
e	O
.	O
g	O
.	O
,	O
Diptericin	O
)	O
via	O
the	O
activation	O
of	O
the	O
nuclear	O
factor	O
-	O
kappaB	O
transactivator	O
Relish	O
(	O
Rel	O
)	O
[	O
3	O
,	O
4	O
,	O
6	O
]	O
.	O

We	O
have	O
isolated	O
several	O
Erwinia	O
carotovora	O
strains	O
,	O
such	O
as	O
Ecc15	O
,	O
for	O
their	O
capacity	O
to	O
persist	O
in	O
the	O
Drosophila	O
larval	O
gut	O
and	O
to	O
trigger	O
a	O
strong	O
systemic	O
immune	O
response	O
following	O
oral	O
infection	O
[	O
8	O
]	O
.	O

Here	O
we	O
report	O
an	O
in	O
vivo	O
analysis	O
of	O
P	O
.	O
entomophila	O
virulence	O
to	O
both	O
Drosophila	O
larvae	O
and	O
adult	O
flies	O
following	O
natural	O
oral	O
infection	O
.	O

No	O
killing	O
of	O
either	O
larvae	O
or	O
adults	O
was	O
observed	O
with	O
a	O
culture	O
filtrate	O
derived	O
from	O
the	O
avirulent	O
P	O
.	O
entomophila	O
strain	O
carrying	O
a	O
Tn5	O
transposon	O
in	O
the	O
gacA	O
gene	O
[	O
9	O
]	O
.	O

The	O
protein	O
profile	O
for	O
wild	O
-	O
type	O
P	O
.	O
entomophila	O
supernantant	O
(	O
Figure	O
1C	O
,	O
lane	O
2	O
)	O
shows	O
a	O
major	O
protein	O
band	O
at	O
51	O
kDa	O
and	O
several	O
minor	O
bands	O
.	O

Studies	O
in	O
other	O
bacteria	O
have	O
shown	O
that	O
AprD	O
,	O
E	O
,	O
and	O
F	O
participate	O
in	O
the	O
elaboration	O
of	O
a	O
Type	O
I	O
transporter	O
required	O
for	O
AprA	O
secretion	O
to	O
the	O
external	O
medium	O
[	O
17	O
]	O
.	O

To	O
investigate	O
the	O
connection	O
between	O
activation	O
of	O
the	O
Imd	O
pathway	O
and	O
the	O
outcome	O
of	O
P	O
.	O
entomophila	O
infection	O
in	O
more	O
detail	O
,	O
we	O
focused	O
our	O
analysis	O
on	O
the	O
adult	O
stage	O
when	O
it	O
is	O
easier	O
to	O
monitor	O
survival	O
.	O

We	O
thus	O
compared	O
resistance	O
to	O
P	O
.	O
entomophila	O
infection	O
of	O
flies	O
that	O
were	O
previously	O
either	O
orally	O
infected	O
with	O
Ecc15	O
(	O
to	O
activate	O
a	O
local	O
immune	O
response	O
)	O
or	O
pricked	O
with	O
Ecc15	O
(	O
to	O
activate	O
a	O
systemic	O
immune	O
response	O
)	O
.	O

In	O
these	O
flies	O
,	O
the	O
Imd	O
pathway	O
was	O
not	O
constitutively	O
active	O
in	O
the	O
gut	O
but	O
could	O
be	O
induced	O
upon	O
oral	O
bacterial	O
infection	O
similarly	O
to	O
the	O
wild	O
-	O
type	O
situation	O
(	O
Figure	O
S3A	O
)	O
.	O

This	O
response	O
could	O
be	O
interpreted	O
as	O
anticipation	O
of	O
possible	O
breaching	O
of	O
the	O
gut	O
barrier	O
.	O

Since	O
gacA	O
mutants	O
did	O
not	O
persist	O
in	O
imd	O
-	O
deficient	O
mutant	O
hosts	O
,	O
we	O
speculate	O
that	O
this	O
persistence	O
-	O
promoting	O
factor	O
provides	O
general	O
protection	O
against	O
gut	O
intestinal	O
conditions	O
rather	O
than	O
a	O
specific	O
protection	O
against	O
the	O
fly	O
immune	O
response	O
.	O

The	O
genome	O
of	O
P	O
.	O
entomophila	O
contains	O
several	O
genes	O
encoding	O
putative	O
insecticidal	O
toxins	O
(	O
e	O
.	O
g	O
.	O
,	O
Tc	O
toxins	O
,	O
hemolysins	O
,	O
and	O
lipopeptides	O
)	O
.	O

We	O
have	O
developed	O
a	O
powerful	O
experimental	O
framework	O
that	O
combines	O
competitive	O
selection	O
and	O
microarray	O
-	O
based	O
genetic	O
footprinting	O
to	O
comprehensively	O
reveal	O
the	O
genetic	O
basis	O
of	O
bacterial	O
behaviors	O
.	O

Introduction	O

Results	O
/	O
Discussion	O

Quantitative	O
Analysis	O
of	O
Selection	O
within	O
the	O
Pool	O
of	O
Mutants	O

The	O
ORF	O
intensities	O
from	O
five	O
hybridizations	O
of	O
the	O
maximally	O
diverse	O
unselected	O
library	O
(	O
Dataset	O
S1	O
)	O
are	O
used	O
as	O
a	O
statistical	O
reference	O
to	O
quantify	O
the	O
degree	O
of	O
enrichment	O
or	O
depletion	O
after	O
the	O
library	O
is	O
exposed	O
to	O
a	O
selection	O
of	O
interest	O
.	O

The	O
amplification	O
of	O
transposon	O
insertion	O
sites	O
from	O
a	O
small	O
sample	O
of	O
these	O
mutants	O
showed	O
that	O
the	O
nonmotile	O
phenotype	O
is	O
the	O
result	O
of	O
a	O
single	O
gene	O
disruption	O
in	O
each	O
mutant	O
.	O

We	O
observed	O
that	O
some	O
false	O
positives	O
were	O
indeed	O
due	O
to	O
hitchhiking	O
,	O
but	O
others	O
were	O
due	O
to	O
polar	O
effects	O
of	O
transposon	O
insertions	O
on	O
downstream	O
genes	O
within	O
operons	O
.	O

Bacteriophage	O
chi	O
infects	O
E	O
.	O
coli	O
by	O
attaching	O
to	O
and	O
traveling	O
along	O
flagellar	O
filaments	O
[	O
24	O
]	O
.	O

CCW	O
flagellar	O
rotation	O
and	O
the	O
correct	O
pattern	O
of	O
grooves	O
on	O
the	O
surface	O
of	O
the	O
flagellum	O
are	O
thought	O
to	O
drive	O
chi	O
-	O
phage	O
down	O
the	O
filament	O
to	O
the	O
surface	O
of	O
the	O
membrane	O
,	O
very	O
similar	O
to	O
how	O
a	O
nut	O
follows	O
the	O
grooves	O
of	O
a	O
rotating	O
bolt	O
[	O
25	O
]	O
.	O

Because	O
the	O
genetic	O
basis	O
of	O
swarming	O
is	O
not	O
well	O
characterized	O
,	O
this	O
behavior	O
is	O
well	O
suited	O
for	O
comprehensive	O
analysis	O
using	O
our	O
approach	O
.	O

A	O
single	O
round	O
of	O
enrichment	O
consisted	O
of	O
inoculating	O
our	O
library	O
of	O
E	O
.	O
coli	O
mutants	O
onto	O
the	O
center	O
of	O
agar	O
plates	O
,	O
incubating	O
the	O
plates	O
to	O
allow	O
the	O
cells	O
to	O
migrate	O
outward	O
from	O
the	O
site	O
of	O
inoculation	O
,	O
and	O
transferring	O
bacteria	O
from	O
the	O
original	O
area	O
of	O
inoculation	O
to	O
a	O
fresh	O
plate	O
.	O

These	O
observations	O
indicate	O
that	O
the	O
chemotaxis	O
sensory	O
system	O
and	O
flagellar	O
switching	O
have	O
an	O
effect	O
on	O
,	O
but	O
are	O
not	O
critical	O
for	O
,	O
surface	O
motility	O
.	O

Novel	O
Genes	O
Implicated	O
in	O
Swimming	O
,	O
Swarming	O
,	O
and	O
chi	O
-	O
Phage	O
Infection	O

Therefore	O
,	O
while	O
rcsC	O
mutations	O
disrupt	O
the	O
RcsF	O
-	O
-	O
>	O
RcsC	O
-	O
-	O
>	O
RcsD	O
-	O
-	O
>	O
RcsB	O
phosphorelay	O
cascade	O
,	O
the	O
phosphorylation	O
of	O
RcsB	O
cannot	O
be	O
fully	O
reversed	O
in	O
the	O
absence	O
of	O
RcsC	O
phosphatase	O
activity	O
,	O
as	O
observed	O
by	O
the	O
reduced	O
flhDC	O
-	O
lacZ	O
expression	O
and	O
motility	O
exhibited	O
by	O
rcsC	O
and	O
rcsD	O
mutants	O
(	O
Figure	O
4	O
)	O
.	O

First	O
,	O
chi	O
-	O
phage	O
infectivity	O
assays	O
with	O
DeltayhjH	O
mutants	O
showed	O
comparable	O
levels	O
of	O
infection	O
to	O
cheR	O
mutants	O
(	O
which	O
exhibit	O
CCW	O
flagellar	O
rotation	O
bias	O
)	O
in	O
contrast	O
to	O
the	O
reduced	O
sensitivity	O
displayed	O
by	O
cheZ	O
mutants	O
(	O
which	O
have	O
CW	O
flagellar	O
rotation	O
bias	O
)	O
,	O
consistent	O
with	O
the	O
z	O
-	O
scores	O
of	O
our	O
chi	O
-	O
phage	O
selection	O
(	O
Figure	O
5E	O
)	O
.	O

Together	O
,	O
these	O
results	O
indicate	O
that	O
the	O
yhjH	O
gene	O
product	O
is	O
involved	O
with	O
the	O
frequency	O
of	O
flagellar	O
motor	O
switching	O
,	O
a	O
process	O
that	O
is	O
among	O
the	O
remaining	O
puzzles	O
in	O
bacterial	O
chemotaxis	O
[	O
45	O
]	O
.	O

We	O
can	O
dissect	O
the	O
genetic	O
network	O
context	O
in	O
which	O
newly	O
identified	O
genes	O
function	O
by	O
making	O
libraries	O
of	O
double	O
mutants	O
in	O
which	O
a	O
transposon	O
library	O
is	O
constructed	O
in	O
the	O
background	O
of	O
a	O
mutation	O
of	O
interest	O
.	O

In	O
a	O
genome	O
-	O
wide	O
effort	O
to	O
identify	O
suppressors	O
of	O
swimming	O
defects	O
,	O
additional	O
libraries	O
of	O
transposon	O
insertional	O
mutants	O
were	O
created	O
in	O
genetic	O
backgrounds	O
containing	O
gene	O
deletions	O
of	O
interest	O
.	O

This	O
finding	O
is	O
consistent	O
with	O
a	O
recent	O
report	O
in	O
which	O
the	O
inactivation	O
of	O
ycgR	O
was	O
observed	O
to	O
improve	O
motility	O
of	O
yhjH	O
mutants	O
[	O
48	O
]	O
.	O

Suppressor	O
mutations	O
identified	O
in	O
the	O
Deltahns	O
background	O
are	O
shown	O
and	O
discussed	O
in	O
Figure	O
S8	O
,	O
and	O
the	O
microarray	O
results	O
can	O
be	O
found	O
in	O
Dataset	O
S12	O
.	O

YegE	O
and	O
YfgF	O
both	O
contain	O
an	O
EAL	O
domain	O
C	O
-	O
terminal	O
to	O
a	O
GGDEF	O
domain	O
(	O
Figure	O
6G	O
)	O
.	O

The	O
arrangement	O
of	O
these	O
genes	O
in	O
an	O
operon	O
suggests	O
that	O
they	O
may	O
function	O
together	O
.	O

We	O
found	O
that	O
swarming	O
was	O
not	O
impaired	O
in	O
either	O
the	O
fimS	O
mutant	O
or	O
the	O
mutants	O
with	O
fimbria	O
locked	O
in	O
phase	O
ON	O
,	O
indicating	O
that	O
fimbria	O
expression	O
does	O
not	O
interfere	O
with	O
swarming	O
motility	O
(	O
Figure	O
S11C	O
)	O
.	O

ZnuA	O
and	O
ZnuC	O
are	O
part	O
of	O
a	O
high	O
-	O
affinity	O
zinc	S-Chemical_Compound
uptake	O
system	O
.	O

The	O
role	O
of	O
yfiM	O
,	O
a	O
novel	O
uncharacterized	O
gene	O
that	O
shows	O
sequence	O
similarity	O
to	O
a	O
lipoprotein	O
,	O
is	O
not	O
clear	O
at	O
this	O
point	O
.	O

Microbes	O
account	O
for	O
half	O
the	O
world	O
'	O
s	O
biomass	O
and	O
are	O
the	O
most	O
widely	O
distributed	O
organisms	O
on	O
the	O
planet	O
.	O

In	O
this	O
study	O
,	O
we	O
confirmed	O
our	O
findings	O
by	O
functional	O
analyses	O
of	O
individual	O
mutants	O
,	O
which	O
revealed	O
high	O
levels	O
of	O
sensitivity	O
and	O
low	O
rates	O
of	O
false	O
positives	O
.	O

Moreover	O
,	O
the	O
vancomycin	S-Chemical_Compound
resistance	O
phenotype	O
makes	O
this	O
strain	O
more	O
of	O
a	O
risk	O
to	O
handle	O
in	O
the	O
laboratory	O
.	O

To	O
avoid	O
these	O
issues	O
,	O
most	O
laboratories	O
use	O
strain	O
OG1	O
or	O
its	O
close	O
derivatives	O
.	O

By	O
pulsed	O
-	O
field	O
gel	O
electrophoresis	O
,	O
Murray	O
et	O
al	O
.	O

Numerous	O
factors	O
important	O
for	O
virulence	O
have	O
been	O
characterized	O
in	O
OG1RF	O
.	O

Also	O
present	O
is	O
Ace	O
,	O
a	O
member	O
of	O
the	O
MSCRAMM	O
(	O
microbial	O
surface	O
component	O
recognizing	O
adhesive	O
matrix	O
molecules	O
)	O
family	O
.	O

We	O
found	O
232	O
kb	O
of	O
OG1RF	O
unique	O
sequences	O
distributed	O
in	O
48	O
regions	O
ranging	O
from	O
101	O
bp	O
to	O
approximately	O
49	O
kb	O
in	O
length	O
(	O
Figure	O
1	O
;	O
Additional	O
data	O
file	O
1	O
)	O
.	O

Using	O
the	O
published	O
DNA	O
sequence	O
of	O
V583	O
as	O
reference	O
(	O
NC	O
_	O
004668	O
)	O
,	O
OG1RF	O
shares	O
2	O
,	O
474	O
ORFs	O
as	O
well	O
as	O
the	O
12	O
rRNA	O
genes	O
and	O
58	O
of	O
68	O
tRNA	O
genes	O
(	O
Table	O
1	O
)	O
.	O

Surprisingly	O
,	O
the	O
genomes	O
align	O
syntenically	O
,	O
as	O
shown	O
in	O
Figure	O
2	O
,	O
despite	O
the	O
fact	O
that	O
25	O
%	O
of	O
the	O
V583	O
genome	O
is	O
composed	O
of	O
mobile	O
elements	O
.	O

To	O
determine	O
the	O
distribution	O
of	O
the	O
CRISPR1	O
locus	O
in	O
E	O
.	O
faecalis	O
strains	O
,	O
16	O
isolates	O
of	O
various	O
MLST	O
types	O
were	O
tested	O
for	O
the	O
presence	O
(	O
PCR	O
with	O
primers	O
specific	O
for	O
csn1	O
and	O
cas1	O
)	O
or	O
absence	O
(	O
PCR	O
with	O
primers	O
overlapping	O
the	O
junction	O
between	O
EF0672	O
and	O
EF0673	O
)	O
of	O
the	O
CRISPR1	O
locus	O
(	O
Table	O
2	O
)	O
.	O

A	O
14	O
.	O
8	O
kb	O
region	O
inserted	O
in	O
the	O
23	O
.	O
9	O
kb	O
region	O
containing	O
fsrA	O
and	O
fsrB	O

It	O
has	O
been	O
shown	O
in	O
E	O
.	O
faecalis	O
that	O
at	O
least	O
one	O
cell	O
surface	O
protein	O
(	O
Ace	O
)	O
is	O
subject	O
to	O
domain	O
variation	O
[	O
20	O
]	O
and	O
it	O
has	O
been	O
postulated	O
that	O
domain	O
variation	O
may	O
help	O
bacteria	O
escape	O
the	O
immune	O
system	O
.	O

A	O
hypothesis	O
that	O
the	O
number	O
of	O
repeats	O
may	O
be	O
proportional	O
to	O
the	O
depth	O
of	O
the	O
peptidoglycan	O
has	O
been	O
proposed	O
[	O
32	O
]	O
.	O

OG1RF	O
does	O
not	O
contain	O
homologues	O
of	O
EF2248	O
-	O
54	O
(	O
carrying	O
instead	O
the	O
iol	O
operon	O
)	O
,	O
though	O
it	O
has	O
a	O
novel	O
WxL	O
locus	O
within	O
the	O
14	O
.	O
8	O
kb	O
unique	O
region	O
upstream	O
of	O
the	O
fsr	O
locus	O
(	O
Additional	O
data	O
file	O
2	O
)	O
.	O

When	O
compared	O
to	O
V583	O
,	O
the	O
sequence	O
identity	O
in	O
this	O
area	O
between	O
the	O
two	O
strains	O
appears	O
to	O
be	O
as	O
low	O
as	O
75	O
%	O
(	O
depicted	O
in	O
Figure	O
2	O
from	O
reference	O
[	O
5	O
]	O
)	O
.	O

More	O
analyses	O
are	O
required	O
for	O
a	O
better	O
understanding	O
of	O
the	O
number	O
,	O
frequency	O
and	O
function	O
of	O
these	O
WxL	O
domain	O
proteins	O
and	O
their	O
possible	O
relationship	O
with	O
the	O
diversity	O
of	O
E	O
.	O
faecalis	O
.	O

[	O
37	O
]	O
carry	O
these	O
two	O
genes	O
.	O

Two	O
-	O
component	O
regulatory	O
systems	O

Similarly	O
,	O
OG1RF	O
_	O
0192	O
shares	O
68	O
%	O
similarity	O
with	O
VanSG	O
and	O
VanSG2	O
.	O

The	O
iol	O
operon	O

OG1RF	O
carries	O
an	O
iol	O
operon	O
while	O
V583	O
does	O
not	O
.	O

The	O
OG1RF	O
iol	O
operon	O
appears	O
to	O
be	O
closely	O
related	O
to	O
ones	O
described	O
in	O
Clostridium	O
perfringens	O
[	O
44	O
]	O
and	O
Lactobacillus	O
casei	O
[	O
45	O
]	O
.	O

Yebra	O
et	O
al	O
.	O
reported	O
that	O
L	O
.	O
casei	O
was	O
the	O
sole	O
member	O
of	O
the	O
Lactobacillales	O
to	O
carry	O
a	O
functional	O
iol	O
operon	O
[	O
45	O
]	O
.	O

In	O
OG1RF	O
,	O
the	O
iol	O
operon	O
is	O
located	O
between	O
the	O
equivalent	O
of	O
EF2239	O
and	O
EF2352	O
when	O
compared	O
with	O
V583	O
.	O

An	O
analysis	O
of	O
the	O
G	O
+	O
C	O
content	O
of	O
OG1RF	O
unique	O
regions	O
revealed	O
several	O
loci	O
with	O
a	O
lower	O
G	O
+	O
C	O
content	O
than	O
the	O
37	O
.	O
8	O
%	O
average	O
content	O
of	O
OG1RF	O
.	O

This	O
fragment	O
appears	O
to	O
be	O
a	O
patchwork	O
composed	O
of	O
hypothetical	O
genes	O
,	O
homologues	O
of	O
Tn916	O
-	O
associated	O
genes	O
and	O
homologues	O
of	O
genes	O
from	O
other	O
Gram	O
-	O
positive	O
organisms	O
,	O
including	O
Listeria	O
,	O
E	O
.	O
faecium	O
,	O
staphylococci	O
,	O
or	O
lactococci	O
(	O
Additional	O
data	O
file	O
1	O
)	O
.	O

We	O
did	O
not	O
find	O
any	O
homologues	O
of	O
CSP	O
in	O
OG1RF	O
.	O

Two	O
homologous	O
ComDE	O
sensor	O
histidine	O
kinase	O
/	O
response	O
regulators	O
were	O
found	O
in	O
OG1RF	O
,	O
one	O
of	O
which	O
is	O
FsrC	O
/	O
FsrA	O
.	O

[	O
53	O
]	O
compared	O
nine	O
strains	O
,	O
including	O
OG1RF	O
to	O
V583	O
,	O
using	O
comparative	O
genomic	O
hybridization	O
.	O

The	O
mutation	O
leading	O
to	O
rifampicin	S-Chemical_Compound
resistance	O
was	O
identified	O
in	O
the	O
rpoB	O
gene	O
by	O
Ozawa	O
et	O
al	O
.	O

Mutations	O
in	O
this	O
region	O
have	O
been	O
associated	O
with	O
fusidic	B-Chemical_Compound
acid	E-Chemical_Compound
resistance	O
in	O
Staphylococcus	O
aureus	O
[	O
55	O
,	O
56	O
]	O
,	O
and	O
thus	O
the	O
C1368A	O
mutation	O
is	O
likely	O
the	O
cause	O
of	O
the	O
fusidic	B-Chemical_Compound
acid	E-Chemical_Compound
resistance	O
phenotype	O
in	O
OG1RF	O
.	O

However	O
,	O
at	O
comparable	O
inoculum	O
,	O
OG1RF	O
(	O
4	O
x	O
108	O
CFU	O
/	O
ml	O
)	O
showed	O
more	O
rapid	O
mortality	O
versus	O
V583	O
(	O
5	O
x	O
108	O
CFU	O
/	O
ml	O
)	O
in	O
the	O
first	O
48	O
hours	O
(	O
P	O
=	O
0	O
.	O
0034	O
;	O
Additional	O
data	O
file	O
3	O
)	O
.	O

[	O
36	O
]	O
demonstrate	O
that	O
these	O
factors	O
may	O
be	O
present	O
in	O
harmless	O
strains	O
while	O
absent	O
in	O
clinical	O
isolates	O
,	O
indicating	O
that	O
E	O
.	O
faecalis	O
virulence	O
is	O
not	O
dependent	O
on	O
any	O
single	O
virulence	O
factor	O
.	O

A	O
Naturally	O
Occurring	O
Mutation	O
in	O
ropB	O
Suppresses	O
SpeB	O
Expression	O
and	O
Reduces	O
M1T1	O
Group	O
A	O
Streptococcal	O
Systemic	O
Virulence	O

However	O
,	O
SpeB	O
has	O
also	O
been	O
shown	O
to	O
cleave	O
a	O
range	O
of	O
GAS	O
proteins	O
such	O
as	O
the	O
fibrinogen	O
-	O
binding	O
M1	O
protein	O
[	O
14	O
]	O
,	O
[	O
15	O
]	O
,	O
various	O
superantigens	O
[	O
16	O
]	O
,	O
[	O
17	O
]	O
,	O
the	O
secreted	O
plasminogen	O
activator	O
streptokinase	O
[	O
18	O
]	O
as	O
well	O
as	O
the	O
DNase	O
Sda1	O
[	O
17	O
]	O
,	O
and	O
thus	O
possibly	O
interfere	O
with	O
the	O
proven	O
virulence	O
functions	O
of	O
these	O
bacterial	O
factors	O
.	O

The	O
precise	O
role	O
(	O
s	O
)	O
of	O
SpeB	O
throughout	O
the	O
course	O
of	O
infection	O
are	O
undoubtedly	O
complex	O
,	O
and	O
not	O
surprisingly	O
,	O
different	O
studies	O
using	O
different	O
in	O
vivo	O
animal	O
models	O
have	O
produced	O
seemingly	O
contradictory	O
results	O
[	O
19	O
]	O
-	O
[	O
21	O
]	O
.	O

This	O
strain	O
-	O
specific	O
variation	O
is	O
highlighted	O
in	O
a	O
recent	O
work	O
by	O
Dmitriev	O
et	O
al	O
.	O

It	O
is	O
in	O
the	O
light	O
of	O
the	O
current	O
uncertainty	O
surrounding	O
RopB	O
and	O
its	O
role	O
in	O
virulence	O
that	O
we	O
sought	O
to	O
investigate	O
the	O
role	O
of	O
this	O
transcriptional	O
regulator	O
in	O
the	O
serotype	O
M1T1	O
GAS	O
background	O
that	O
is	O
the	O
leading	O
agent	O
of	O
severe	O
human	O
infection	O
.	O

This	O
analysis	O
begins	O
with	O
a	O
naturally	O
-	O
occuring	O
mutation	O
in	O
ropB	O
identified	O
in	O
one	O
such	O
strain	O
.	O

GAS	O
strain	O
5628	O
and	O
its	O
isogenic	O
mutants	O
5628R	O
+	O
and	O
5628RDeltaSpeB	O
were	O
grown	O
in	O
THB	O
,	O
and	O
the	O
OD600	O
was	O
measured	O
over	O
time	O
.	O

C57BL6	O
/	O
J	O
mice	O
were	O
subcutaneously	O
infected	O
with	O
the	O
SpeB	O
-	O
positive	O
strain	O
5628R	O
+	O
.	O

This	O
finding	O
reveals	O
that	O
when	O
SpeB	O
-	O
negative	O
colonies	O
are	O
selected	O
for	O
in	O
vivo	O
,	O
this	O
selection	O
is	O
predominantly	O
a	O
phenomenon	O
associated	O
with	O
CovR	O
/	O
S	O
inactivation	O
.	O

The	O
two	O
strains	O
containing	O
a	O
truncated	O
RopB	O
(	O
5628	O
and	O
5448R	O
-	O
)	O
demonstrated	O
similarly	O
reduced	O
virulence	O
compared	O
to	O
the	O
two	O
strains	O
containing	O
a	O
full	O
-	O
length	O
RopB	O
(	O
5628R	O
+	O
and	O
5448	O
)	O
(	O
Fig	O
.	O
4B	O
)	O
,	O
confirming	O
that	O
inactivation	O
of	O
RopB	O
results	O
in	O
decreased	O
virulence	O
in	O
systemic	O
infection	O
.	O

We	O
have	O
shown	O
that	O
in	O
M1T1	O
GAS	O
,	O
when	O
the	O
covR	O
/	O
S	O
locus	O
is	O
intact	O
and	O
DNase	O
Sda1	O
activity	O
is	O
unaffected	O
,	O
ropB	O
point	O
mutation	O
results	O
in	O
reduced	O
virulence	O
in	O
vivo	O
,	O
despite	O
inactivation	O
of	O
SpeB	O
activity	O
.	O

Furthermore	O
,	O
the	O
switch	O
to	O
a	O
SpeB	O
-	O
negative	O
phenotype	O
appeared	O
to	O
occur	O
exclusively	O
through	O
mutations	O
in	O
covR	O
/	O
S	O
.	O

We	O
show	O
that	O
mutants	O
of	O
hfq	O
and	O
smpB	O
directly	O
or	O
indirectly	O
modulate	O
at	O
least	O
20	O
%	O
and	O
4	O
%	O
of	O
all	O
possible	O
Salmonella	O
proteins	O
,	O
respectively	O
,	O
with	O
limited	O
correlation	O
between	O
transcription	O
and	O
protein	O
expression	O
.	O

Hfq	O
is	O
a	O
highly	O
conserved	O
protein	O
encoded	O
within	O
many	O
bacterial	O
genomes	O
and	O
at	O
least	O
one	O
archaeon	O
genome	O
[	O
7	O
]	O
,	O
[	O
8	O
]	O
.	O

In	O
bacteria	O
,	O
Hfq	O
functions	O
as	O
a	O
post	O
-	O
transcriptional	O
regulator	O
that	O
modulates	O
the	O
stability	O
and	O
translation	O
of	O
mRNAs	O
chiefly	O
by	O
facilitating	O
sRNA	O
-	O
mRNA	O
interactions	O
[	O
1	O
]	O
,	O
[	O
4	O
]	O
,	O
[	O
9	O
]	O
.	O

In	O
another	O
study	O
,	O
a	O
smpB	O
mutant	O
of	O
Salmonella	O
Typhimurium	O
exhibited	O
defects	O
in	O
intra	O
-	O
macrophage	O
survival	O
,	O
a	O
model	O
of	O
Salmonella	O
pathogenesis	O
[	O
23	O
]	O
.	O

Collectively	O
,	O
these	O
results	O
demonstrate	O
that	O
Hfq	O
and	O
SmpB	O
are	O
essential	O
for	O
regulating	O
virulence	O
by	O
controlling	O
translation	O
of	O
key	O
components	O
.	O

Zhang	O
et	O
al	O
.	O

In	O
a	O
recent	O
study	O
Sittka	O
et	O
al	O
.	O

Construction	O
and	O
growth	O
characteristics	O
of	O
mutant	O
and	O
wildtype	O
Salmonella	O
Typhimurium	O
strains	O
Hfq	O
and	O
SmpB	O
are	O
essential	O
for	O
virulence	O
in	O
a	O
variety	O
of	O
pathogenic	O
bacteria	O
including	O
Salmonella	O
Typhimurium	O
[	O
20	O
]	O
,	O
[	O
21	O
]	O
,	O
[	O
22	O
]	O
,	O
[	O
25	O
]	O
.	O

Extracellular	O
bacteria	O
were	O
removed	O
by	O
washing	O
and	O
treatment	O
with	O
gentamicin	O
.	O

The	O
differences	O
in	O
protein	O
expression	O
between	O
parent	O
and	O
isogenic	O
mutant	O
was	O
assessed	O
via	O
hypothesis	O
testing	O
,	O
specifically	O
a	O
comprehensive	O
ANOVA	O
scheme	O
included	O
in	O
the	O
computer	O
program	O
DAnTE	O
[	O
30	O
]	O
.	O

Considering	O
that	O
we	O
observe	O
36	O
%	O
(	O
1621	O
orfs	O
)	O
of	O
the	O
entire	O
Salmonella	O
proteome	O
(	O
4450	O
orfs	O
)	O
and	O
that	O
50	O
%	O
(	O
781	O
orfs	O
)	O
of	O
this	O
observed	O
proteome	O
(	O
1621	O
orfs	O
)	O
is	O
modulated	O
by	O
Hfq	O
,	O
it	O
would	O
be	O
expected	O
that	O
a	O
significant	O
portion	O
of	O
the	O
unobserved	O
Salmonella	O
proteome	O
(	O
2829	O
orfs	O
)	O
would	O
also	O
be	O
regulated	O
by	O
Hfq	O
,	O
thus	O
our	O
assertion	O
that	O
the	O
approximately20	O
%	O
value	O
may	O
very	O
well	O
represent	O
an	O
underestimation	O
.	O

This	O
category	O
encompasses	O
sub	O
-	O
categories	O
including	O
adaptations	O
to	O
atypical	O
conditions	O
,	O
cell	O
adhesion	O
,	O
pathogenesis	O
,	O
chemotaxis	O
and	O
motility	O
,	O
detoxification	O
,	O
toxin	O
production	O
and	O
resistance	O
,	O
DNA	O
transformation	O
and	O
cell	O
division	O
.	O

[	O
20	O
]	O
investigated	O
the	O
proteome	O
of	O
an	O
Deltahfq	O
mutant	O
strain	O
using	O
2D	O
gel	O
analysis	O
,	O
and	O
found	O
approximately70	O
differentially	O
expressed	O
proteins	O
in	O
early	O
stationary	O
phase	O
.	O

The	O
exception	O
was	O
the	O
SPI	O
-	O
1	O
protein	O
SipA	O
under	O
LB	O
Stat	O
growth	O
conditions	O
.	O

Our	O
proteomics	O
results	O
showed	O
that	O
HtrA	O
protein	O
levels	O
were	O
strongly	O
up	O
-	O
regulated	O
in	O
the	O
Deltahfq	O
mutant	O
relative	O
to	O
wildtype	O
in	O
LB	O
Log	O
,	O
while	O
OsmY	O
and	O
STM1513	O
were	O
strongly	O
down	O
-	O
regulated	O
in	O
the	O
Deltahfq	O
mutant	O
relative	O
to	O
wildtype	O
in	O
AMM	O
-	O
1	O
and	O
LB	O
Stat	O
respectively	O
.	O

Of	O
the	O
781	O
proteins	O
and	O
492	O
transcripts	O
regulated	O
by	O
Hfq	O
,	O
113	O
genes	O
overlapped	O
both	O
sets	O
.	O

We	O
observed	O
changes	O
in	O
expression	O
for	O
approximately50	O
%	O
of	O
the	O
observed	O
Salmonella	O
Typhimurium	O
proteome	O
based	O
on	O
an	O
ANOVA	O
analysis	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
(	O
Table	O
S1	O
)	O
.	O

The	O
proteins	O
affected	O
represent	O
a	O
broad	O
spectrum	O
of	O
Salmonella	O
proteins	O
required	O
for	O
many	O
biological	O
processes	O
including	O
general	O
metabolism	O
,	O
the	O
translational	O
machinery	O
,	O
stress	O
response	O
,	O
and	O
virulence	O
-	O
assocaited	O
processes	O
as	O
described	O
next	O
.	O

General	O
metabolism	O
Proteome	O
profiling	O
data	O
suggested	O
Hfq	O
regulates	O
nucleoside	O
(	O
DeoABC	O
)	O
and	O
nucleotide	O
metabolism	O
(	O
CarAB	O
,	O
PurUBCMHAD	O
,	O
Ndk	O
)	O
under	O
AMM	O
conditions	O
,	O
as	O
well	O
as	O
regulates	O
ribose	O
metabolism	O
and	O
transport	O
(	O
RbsABK	O
)	O
under	O
AMM	O
-	O
2	O
.	O

Hfq	O
also	O
appears	O
to	O
play	O
a	O
role	O
in	O
the	O
regulation	O
of	O
the	O
translational	O
machinery	O
itself	O
presumably	O
as	O
a	O
feedback	O
mechanism	O
to	O
maintain	O
tight	O
control	O
over	O
the	O
amount	O
of	O
ribosomal	O
synthesis	O
.	O

Among	O
the	O
SPI	O
-	O
1	O
invasion	O
proteins	O
were	O
PrgI	O
,	O
SptP	O
,	O
SipD	O
,	O
SicA	O
,	O
InvC	O
and	O
InvG	O
,	O
and	O
the	O
motility	O
proteins	O
FliC	O
,	O
FliT	O
,	O
FliB	O
,	O
CheZ	O
,	O
CheY	O
,	O
and	O
CheW	O
.	O

Propanediol	S-Chemical_Compound
utilization	O
operon	O

Both	O
microarray	O
analysis	O
and	O
confirmative	O
qRT	O
-	O
PCR	O
assays	O
showed	O
that	O
RNA	O
levels	O
were	O
unchanged	O
for	O
pduA	O
and	O
pduE	O
genes	O
in	O
the	O
Deltahfq	O
mutant	O
strain	O
compared	O
to	O
the	O
wildtype	O
strain	O
(	O
Figure	O
5	O
)	O
,	O
thus	O
showing	O
that	O
Hfq	O
represses	O
translation	O
in	O
these	O
two	O
environmental	O
conditions	O
.	O

We	O
note	O
however	O
that	O
a	O
more	O
detailed	O
and	O
rigorous	O
analysis	O
is	O
required	O
to	O
confirm	O
the	O
speculated	O
global	O
regulatory	O
role	O
of	O
SmpB	O
.	O

Nine	O
proteins	O
,	O
including	O
the	O
NADPH	S-Chemical_Compound
-	O
dependent	O
quinine	S-Chemical_Compound
oxidoreductase	O
Qor	O
,	O
TolC	O
involved	O
in	O
LPS	S-Chemical_Compound
biosynthesis	O
,	O
and	O
a	O
putative	O
hydrolase	O
YbeM	O
,	O
overlapped	O
.	O

Summary	O

Using	O
a	O
sample	O
-	O
matched	O
procedure	O
our	O
strategy	O
simultaneously	O
measures	O
changes	O
in	O
global	O
transcript	O
and	O
protein	O
abundance	O
levels	O
allowing	O
for	O
a	O
clear	O
distinction	O
between	O
the	O
transcriptional	O
and	O
post	O
-	O
transcriptional	O
effects	O
of	O
Hfq	O
or	O
SmpB	O
.	O

Furthermore	O
,	O
our	O
strategy	O
requires	O
no	O
tagging	O
and	O
or	O
isolation	O
of	O
Hfq	O
or	O
SmpB	O
precluding	O
the	O
possibility	O
of	O
spurious	O
results	O
introduced	O
by	O
tagging	O
and	O
or	O
co	O
-	O
immunoprecipitation	O
processes	O
.	O

Most	O
recently	O
high	O
-	O
throughput	O
pyrosequencing	O
(	O
HTPS	O
)	O
was	O
used	O
to	O
detect	O
message	O
and	O
sRNA	O
bound	O
to	O
Hfq	O
following	O
immunoprecipitation	O
[	O
10	O
]	O
.	O

During	O
growth	O
in	O
rich	O
media	O
approximately	O
14	O
%	O
of	O
all	O
proteins	O
observed	O
showed	O
differences	O
in	O
abundance	O
where	O
as	O
in	O
acidic	O
minimal	O
media	O
the	O
result	O
was	O
approximately21	O
%	O
.	O

Upregulation	O
of	O
genes	O
encoding	O
different	O
types	O
of	O
nutrient	O
uptake	O
systems	O
further	O
emphasized	O
the	O
differences	O
in	O
nutritional	O
requirements	O
of	O
the	O
two	O
bacteria	O
in	O
the	O
same	O
insect	O
host	O
.	O

The	O
published	O
genome	O
sequence	O
of	O
Photorhabdus	O
luminescens	O
TT01	O
strain	O
indicates	O
that	O
virulence	O
genes	O
are	O
encoded	O
within	O
a	O
number	O
of	O
pathogenicity	O
islands	O
located	O
on	O
the	O
bacterial	O
chromosome	O
[	O
4	O
,	O
5	O
]	O
.	O

[	O
16	O
]	O
identified	O
29	O
promoters	O
induced	O
by	O
P	O
.	O
luminescens	O
in	O
the	O
presence	O
of	O
isolated	O
Galleria	O
mellonella	O
homogenate	O
using	O
a	O
differential	O
fluorescence	O
induction	O
approach	O
.	O

To	O
isolate	O
bacterial	O
mRNA	O
transcripts	O
preferentially	O
induced	O
during	O
infection	O
of	O
the	O
insect	O
compared	O
to	O
the	O
culture	O
,	O
normalized	O
in	O
vivo	O
cDNAs	O
were	O
enriched	O
by	O
hybridization	O
to	O
biotinylated	O
bacterial	O
genomic	O
DNA	O
that	O
had	O
been	O
pre	O
-	O
hybridized	O
with	O
rRNA	O
operon	O
and	O
in	O
vitro	O
normalized	O
cDNAs	O
.	O

The	O
enriched	O
cDNAs	O
representing	O
in	O
vivo	O
-	O
induced	O
genes	O
,	O
which	O
were	O
either	O
lower	O
in	O
abundance	O
or	O
absent	O
in	O
48	O
h	O
in	O
vitro	O
bacterial	O
cultures	O
were	O
then	O
cloned	O
into	O
a	O
TA	O
cloning	O
vector	O
to	O
construct	O
in	O
vivo	O
enriched	O
cDNA	O
libraries	O
.	O

Only	O
a	O
small	O
number	O
of	O
transcripts	O
were	O
induced	O
in	O
both	O
bacteria	O
,	O
and	O
most	O
of	O
them	O
corresponded	O
to	O
genes	O
required	O
for	O
stress	O
response	O
.	O

In	O
X	O
.	O
koppenhoeferi	O
,	O
gene	O
trxB	O
is	O
influenced	O
by	O
arabinose	S-Chemical_Compound
and	O
selenium	S-Chemical_Compound
,	O
and	O
gene	O
znuA	O
is	O
influenced	O
by	O
etoposide	S-Chemical_Compound
(	O
see	O
Additional	O
file	O
2	O
)	O
.	O

As	O
depicted	O
in	O
the	O
conceptual	O
molecular	O
model	O
(	O
Fig	O
.	O
5	O
)	O
,	O
apart	O
from	O
a	O
relatively	O
small	O
number	O
of	O
common	O
strategies	O
used	O
by	O
P	O
.	O
temperata	O
and	O
X	O
.	O
koppenhoeferi	O
to	O
cause	O
infection	O
of	O
R	O
.	O
majalis	O
,	O
most	O
upregulated	O
genes	O
were	O
different	O
between	O
the	O
two	O
bacteria	O
,	O
suggesting	O
vastly	O
different	O
pathways	O
to	O
bring	O
about	O
infection	O
of	O
the	O
same	O
insect	O
host	O
.	O

phoP	O
has	O
been	O
previously	O
identified	O
to	O
be	O
involved	O
in	O
virulence	O
as	O
mutational	O
inactivation	O
of	O
this	O
gene	O
rendered	O
P	O
.	O
luminescens	O
avirulent	O
to	O
Spodoptera	O
littoralis	O
larvae	O
[	O
6	O
]	O
.	O

Differences	O
in	O
expression	O
of	O
virulence	O
and	O
secretion	O
related	O
genes	O
imply	O
the	O
differential	O
virulence	O
mechanisms	O
employed	O
by	O
the	O
two	O
bacteria	O
.	O

Similarly	O
,	O
induction	O
of	O
a	O
chaperone	O
protein	O
encoding	O
gene	O
dnaK	O
in	O
both	O
bacteria	O
may	O
picture	O
common	O
stress	O
responses	O
between	O
P	O
.	O
temperata	O
and	O
X	O
.	O
koppenhoeferi	O
in	O
a	O
number	O
of	O
cellular	O
processes	O
including	O
rescue	O
of	O
misfolded	O
proteins	O
and	O
control	O
of	O
the	O
activity	O
of	O
folded	O
regulatory	O
proteins	O
[	O
46	O
]	O
.	O

In	O
addition	O
to	O
ion	O
scavenging	O
systems	O
,	O
artM	O
,	O
encoding	O
a	O
putative	O
ABC	O
amino	O
acid	O
transport	O
system	O
[	O
63	O
]	O
was	O
identified	O
in	O
P	O
.	O
temperata	O
,	O
but	O
not	O
in	O
X	O
.	O
koppenhoeferi	O
.	O

Further	O
,	O
P	O
.	O
temperata	O
but	O
not	O
X	O
.	O
koppenhoeferi	O
induced	O
tolB	O
gene	O
that	O
encodes	O
a	O
Tol	O
protein	O
upon	O
insect	O
infection	O
.	O

Nearly	O
all	O
A	O
.	O
pleuropneumoniae	O
transcripts	O
could	O
be	O
detected	O
on	O
our	O
microarrays	O
,	O
and	O
150	O
genes	O
were	O
deemed	O
differentially	O
expressed	O
in	O
vivo	O
during	O
the	O
acute	O
phase	O
of	O
the	O
infection	O
.	O

These	O
transcriptional	O
profiling	O
data	O
,	O
combined	O
with	O
previous	O
comparative	O
genomic	O
hybridizations	O
performed	O
by	O
our	O
group	O
,	O
revealed	O
that	O
66	O
out	O
of	O
the	O
72	O
up	O
-	O
regulated	O
genes	O
are	O
conserved	O
amongst	O
all	O
serotypes	O
and	O
that	O
3	O
of	O
them	O
code	O
for	O
products	O
that	O
are	O
predicted	O
outer	O
membrane	O
proteins	O
(	O
genes	O
irp	O
and	O
APL	O
_	O
0959	O
,	O
predicted	O
to	O
code	O
for	O
a	O
TonB	O
-	O
dependent	O
receptor	O
and	O
a	O
filamentous	O
hemagglutinin	O
/	O
adhesin	O
respectively	O
)	O
or	O
lipoproteins	O
(	O
gene	O
APL	O
_	O
0920	O
)	O
.	O

DNA	O
microarrays	O
have	O
been	O
used	O
to	O
determine	O
the	O
complete	O
transcriptomic	O
profile	O
of	O
microorganisms	O
in	O
vitro	O
,	O
but	O
technical	O
drawbacks	O
that	O
are	O
associated	O
with	O
the	O
use	O
of	O
this	O
technique	O
in	O
vivo	O
,	O
such	O
as	O
the	O
qualitative	O
and	O
quantitative	O
recovery	O
of	O
bacterial	O
RNA	O
from	O
host	O
tissues	O
,	O
explain	O
why	O
the	O
use	O
of	O
this	O
technique	O
to	O
monitor	O
bacterial	O
infections	O
has	O
been	O
limited	O
[	O
21	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
conducted	O
in	O
vivo	O
transcript	O
profiling	O
with	O
DNA	O
microarrays	O
of	O
A	O
.	O
pleuropneumoniae	O
during	O
the	O
acute	O
phase	O
of	O
a	O
natural	O
infection	O
in	O
pigs	O
.	O

Results	O
and	O
discussion	O

As	O
anticipated	O
,	O
clusters	O
of	O
genes	O
associated	O
with	O
LPS	O
/	O
capsule	O
biosynthesis	O
and	O
toxin	O
production	O
showed	O
variations	O
.	O

AppChip2	O
was	O
designed	O
using	O
the	O
complete	O
genome	O
sequence	O
from	O
the	O
serotype	O
5b	O
reference	O
strain	O
L20	O
.	O

Out	O
of	O
these	O
28	O
genes	O
,	O
20	O
can	O
be	O
found	O
in	O
two	O
major	O
regions	O
of	O
the	O
genome	O
:	O
14	O
putative	O
ORFs	O
code	O
for	O
phage	O
structures	O
,	O
while	O
6	O
are	O
located	O
in	O
the	O
A	O
.	O
pleuropneumoniae	O
tight	O
adherence	O
(	O
tad	O
)	O
locus	O
.	O

Following	O
microarray	O
hybridization	O
and	O
analysis	O
,	O
86	O
.	O
7	O
%	O
of	O
all	O
coding	O
sequences	O
included	O
on	O
AppChip2	O
could	O
be	O
detected	O
during	O
our	O
experiments	O
,	O
and	O
150	O
genes	O
were	O
significantly	O
differentially	O
expressed	O
in	O
vivo	O
when	O
their	O
level	O
of	O
expression	O
was	O
compared	O
to	O
that	O
seen	O
in	O
vitro	O
,	O
with	O
a	O
FDR	O
of	O
4	O
.	O
25	O
%	O
over	O
the	O
course	O
of	O
three	O
hybridizations	O
:	O
72	O
of	O
these	O
were	O
up	O
-	O
regulated	O
,	O
while	O
78	O
were	O
down	O
-	O
regulated	O
.	O

A	O
large	O
number	O
of	O
genes	O
encoding	O
"	O
Hypothetical	O
/	O
Unknown	O
/	O
Unclassified	O
"	O
products	O
were	O
differentially	O
expressed	O
.	O

Five	O
of	O
these	O
were	O
up	O
-	O
regulated	O
in	O
vivo	O
(	O
sohB	O
,	O
hbpA	O
,	O
kpsF	O
,	O
apxIVA	O
,	O
phoR	O
)	O
and	O
six	O
were	O
down	O
-	O
regulated	O
(	O
nlpI	O
,	O
visC	O
,	O
proQ	O
,	O
APL	O
_	O
1456	O
,	O
APL	O
_	O
1135	O
and	O
nusG	O
)	O
.	O

Whether	O
this	O
is	O
also	O
the	O
case	O
for	O
A	O
.	O
pleuropneumoniae	O
will	O
have	O
to	O
be	O
assessed	O
.	O

c	O
)	O
Down	O
-	O
regulated	O
genes	O

Both	O
rpsK	O
and	O
rpsU	O
are	O
transcribed	O
from	O
sigma	O
70	O
promoters	O
,	O
which	O
is	O
the	O
main	O
sigma	O
factor	O
during	O
the	O
exponential	O
growth	O
phase	O
[	O
39	O
]	O
.	O

In	O
bacteria	O
,	O
Fur	O
down	O
-	O
regulates	O
the	O
transcription	O
of	O
genes	O
involved	O
in	O
iron	S-Chemical_Compound
-	O
acquisition	O
and	O
iron	S-Chemical_Compound
homeostasis	O
in	O
bacterial	O
cells	O
,	O
and	O
its	O
action	O
is	O
directly	O
linked	O
to	O
the	O
amount	O
of	O
available	O
iron	S-Chemical_Compound
,	O
as	O
it	O
requires	O
Fe2	B-Chemical_Compound
+	E-Chemical_Compound
as	O
a	O
cofactor	O
[	O
41	O
]	O
.	O

This	O
is	O
not	O
surprising	O
considering	O
that	O
there	O
is	O
extensive	O
hemorrhage	O
and	O
tissue	O
destruction	O
,	O
caused	O
most	O
probably	O
by	O
the	O
secretion	O
of	O
Apx	O
toxins	O
.	O

Hfq	O
is	O
an	O
RNA	O
chaperone	O
that	O
acts	O
as	O
a	O
post	O
-	O
transcriptional	O
riboregulator	O
[	O
44	O
]	O
.	O

The	O
down	O
-	O
regulation	O
of	O
genes	O
involved	O
in	O
capsule	O
synthesis	O
could	O
potentially	O
lead	O
to	O
the	O
production	O
of	O
a	O
thinner	O
capsule	O
on	O
the	O
surface	O
of	O
bacteria	O
,	O
thereby	O
unmasking	O
potential	O
adhesins	O
.	O

The	O
apf	O
promoter	O
was	O
shown	O
to	O
be	O
active	O
in	O
vitro	O
during	O
adhesion	O
experiments	O
to	O
primary	O
epithelial	O
cells	O
,	O
and	O
in	O
vivo	O
early	O
in	O
the	O
infection	O
process	O
[	O
49	O
]	O
.	O

Here	O
,	O
we	O
report	O
that	O
genes	O
apfB	O
and	O
apfC	O
,	O
coding	O
for	O
the	O
type	O
IV	O
pilin	O
biogenesis	O
proteins	O
ApfB	O
and	O
ApfC	O
,	O
were	O
up	O
-	O
regulated	O
in	O
vivo	O
during	O
natural	O
infection	O
by	O
an	O
A	O
.	O
pleuropneumoniae	O
isolate	O
.	O

Interestingly	O
,	O
another	O
gene	O
that	O
could	O
share	O
similar	O
functions	O
was	O
also	O
up	O
-	O
regulated	O
.	O

Two	O
operon	O
structures	O
that	O
were	O
up	O
-	O
regulated	O
in	O
vivo	O
during	O
the	O
acute	O
phase	O
of	O
the	O
disease	O
could	O
give	O
some	O
insight	O
into	O
the	O
environment	O
the	O
bacteria	O
encounters	O
in	O
the	O
host	O
,	O
and	O
are	O
the	O
main	O
reason	O
why	O
the	O
"	O
Transport	O
and	O
Binding	O
Protein	O
"	O
functional	O
class	O
is	O
so	O
prominently	O
represented	O
in	O
our	O
list	O
of	O
up	O
-	O
regulated	O
genes	O
.	O

It	O
was	O
also	O
recently	O
shown	O
that	O
catabolism	O
of	O
maltose	O
provides	O
a	O
competitive	O
advantage	O
to	O
pathogenic	O
and	O
commensal	O
E	O
.	O
coli	O
strains	O
in	O
the	O
gut	O
[	O
59	O
]	O
.	O

While	O
ascorbate	O
use	O
has	O
not	O
been	O
linked	O
to	O
bacterial	O
virulence	O
before	O
,	O
it	O
has	O
been	O
shown	O
on	O
multiple	O
occasions	O
that	O
genes	O
involved	O
in	O
anaerobic	O
metabolism	O
are	O
important	O
for	O
the	O
virulence	O
of	O
A	O
.	O
pleuropneumoniae	O
[	O
10	O
,	O
61	O
-	O
63	O
]	O
.	O

The	O
irp	O
(	O
iron	O
responsive	O
protein	O
)	O
gene	O
codes	O
for	O
a	O
predicted	O
TonB	O
-	O
dependant	O
receptor	O
,	O
possibly	O
involved	O
in	O
hemin	O
transport	O
.	O

While	O
it	O
was	O
first	O
identified	O
for	O
its	O
hemagglutination	O
properties	O
[	O
72	O
]	O
,	O
FHA	O
can	O
bind	O
carbohydrates	O
,	O
heparan	B-Chemical_Compound
sulphate	E-Chemical_Compound
and	O
integrin	O
[	O
73	O
]	O
.	O

Conclusions	O

These	O
three	O
genes	O
,	O
namely	O
fhaB	O
(	O
APL	O
_	O
0959	O
)	O
,	O
irp	O
(	O
APL	O
_	O
0919	O
)	O
and	O
APL	O
_	O
0920	O
,	O
could	O
all	O
represent	O
excellent	O
candidates	O
for	O
the	O
development	O
of	O
a	O
protective	O
cross	O
-	O
serotype	O
subunit	O
vaccine	O
against	O
A	O
.	O
pleuropneumoniae	O
.	O

To	O
survive	O
in	O
the	O
host	O
environment	O
,	O
Salmonella	O
enterica	O
uses	O
a	O
type	O
III	O
secretion	O
system	O
and	O
effector	O
proteins	O
,	O
which	O
are	O
activated	O
by	O
the	O
SsrA	O
-	O
SsrB	O
two	O
-	O
component	O
system	O
in	O
response	O
to	O
the	O
host	O
environment	O
.	O

To	O
better	O
understand	O
the	O
phenomenon	O
of	O
regulatory	O
evolution	O
in	O
S	O
.	O
enterica	O
,	O
we	O
defined	O
the	O
SsrB	O
regulon	O
and	O
asked	O
how	O
this	O
transcription	O
factor	O
interacts	O
with	O
the	O
cis	O
-	O
regulatory	O
region	O
of	O
target	O
genes	O
.	O

It	O
is	O
generally	O
accepted	O
that	O
SPI	O
-	O
2	O
was	O
acquired	O
by	O
Salmonella	O
enterica	O
after	O
divergence	O
from	O
S	O
.	O
bongori	O
,	O
providing	O
a	O
useful	O
pedigree	O
to	O
study	O
regulatory	O
evolution	O
influenced	O
by	O
SsrB	O
.	O

Next	O
,	O
we	O
performed	O
a	O
Clusters	O
of	O
Orthologous	O
Groups	O
(	O
COG	O
)	O
analysis	O
[	O
22	O
]	O
on	O
the	O
118	O
genes	O
that	O
had	O
an	O
ortholog	O
in	O
the	O
annotated	O
genome	O
of	O
S	O
.	O

From	O
this	O
analysis	O
,	O
62	O
of	O
256	O
SsrB	O
binding	O
peaks	O
(	O
24	O
.	O
3	O
%	O
)	O
occurred	O
within	O
genomic	O
islands	O
(	O
Figure	O
2B	O
)	O
.	O

To	O
generate	O
a	O
consensus	O
set	O
of	O
SsrB	O
regulated	O
genes	O
,	O
we	O
performed	O
an	O
analysis	O
to	O
identify	O
operons	O
in	O
the	O
S	O
.	O

SsrB	O
binds	O
to	O
six	O
promoters	O
within	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O

We	O
used	O
the	O
PhoP	O
response	O
regulator	O
from	O
E	O
.	O
coli	O
as	O
a	O
control	O
because	O
a	O
DNA	O
recognition	O
sequence	O
for	O
it	O
was	O
known	O
[	O
28	O
]	O
.	O

We	O
identified	O
variations	O
of	O
this	O
motif	O
within	O
footprinted	O
regions	O
of	O
SsrB	O
-	O
regulated	O
promoters	O
[	O
25	O
]	O
,	O
,	O
however	O
sequence	O
degeneracy	O
made	O
it	O
difficult	O
to	O
precisely	O
map	O
the	O
input	O
functions	O
.	O

The	O
tsetse	O
fly	O
endosymbiont	O
Sodalis	O
glossinidius	O
contains	O
the	O
Sodalis	O
Symbiosis	O
Region	O
-	O
3	O
(	O
SSR	O
-	O
3	O
)	O
that	O
is	O
similar	O
in	O
content	O
and	O
synteny	O
with	O
the	O
S	O
.	O
enterica	O
SPI	O
-	O
2	O
locus	O
[	O
31	O
]	O
.	O

We	O
aligned	O
the	O
sequences	O
of	O
the	O
five	O
mapped	O
promoters	O
in	O
SPI	O
-	O
2	O
with	O
the	O
orthologous	O
SSR	O
-	O
3	O
regions	O
to	O
identify	O
local	O
conservation	O
.	O

Interestingly	O
,	O
two	O
copies	O
of	O
the	O
palindrome	O
occur	O
upstream	O
of	O
the	O
ssrA	O
-	O
ssrB	O
operon	O
in	O
S	O
.	O

Evaluation	O
of	O
the	O
heptamer	O
motif	O
in	O
the	O
palindrome	O
showed	O
high	O
similarity	O
to	O
the	O
motifs	O
identified	O
by	O
the	O
bacterial	O
one	O
-	O
hybrid	O
screen	O
and	O
the	O
ChIP	O
-	O
on	O
-	O
chip	O
experiments	O
(	O
Figure	O
4B	O
and	O
4D	O
)	O
,	O
giving	O
us	O
confidence	O
that	O
we	O
had	O
identified	O
the	O
major	O
recognition	O
module	O
for	O
transcriptional	O
input	O
by	O
SsrB	O
.	O

In	O
accord	O
with	O
a	O
previous	O
observation	O
[	O
26	O
]	O
,	O
there	O
was	O
not	O
a	O
strict	O
requirement	O
in	O
the	O
spacing	O
between	O
the	O
SsrB	O
binding	O
site	O
and	O
the	O
downstream	O
transcriptional	O
start	O
site	O
.	O

Therefore	O
,	O
we	O
compared	O
the	O
sequences	O
generated	O
upon	O
mutation	O
against	O
a	O
consensus	O
palindrome	O
matrix	O
generated	O
from	O
all	O
SPI	O
-	O
2	O
and	O
other	O
identified	O
putative	O
elements	O
.	O

Discussion	O

By	O
using	O
a	O
genetic	O
screening	O
strategy	O
together	O
with	O
functional	O
and	O
comparative	O
genomics	O
,	O
we	O
were	O
able	O
to	O
define	O
the	O
essential	O
SsrB	O
regulatory	O
element	O
as	O
being	O
an	O
18	O
-	O
bp	O
palindrome	O
with	O
a	O
conserved	O
7	O
-	O
4	O
-	O
7	O
internal	O
organization	O
.	O

As	O
a	O
result	O
of	O
our	O
mutational	O
analyses	O
we	O
conclude	O
that	O
so	O
long	O
as	O
the	O
orientation	O
of	O
a	O
single	O
heptamer	O
of	O
the	O
palindrome	O
is	O
conserved	O
with	O
respect	O
to	O
the	O
downstream	O
gene	O
,	O
SsrB	O
is	O
tolerant	O
of	O
degeneracy	O
in	O
the	O
adjacent	O
spacer	O
and	O
heptamer	O
sequences	O
.	O

Our	O
findings	O
also	O
suggest	O
that	O
dimerization	O
is	O
likely	O
required	O
for	O
transcriptional	O
activation	O
however	O
strong	O
recognition	O
by	O
one	O
monomer	O
may	O
stabilize	O
interaction	O
of	O
a	O
second	O
monomer	O
with	O
a	O
less	O
than	O
ideal	O
sequence	O
.	O

We	O
showed	O
that	O
the	O
SsrB	O
regulatory	O
palindrome	O
is	O
also	O
present	O
in	O
the	O
orthologous	O
SSR	O
-	O
3	O
island	O
of	O
the	O
endosymbiont	O
Sodalis	O
glossinidius	O
and	O
that	O
the	O
palindrome	O
evolved	O
in	O
Sodalis	O
can	O
act	O
as	O
a	O
cis	O
regulatory	O
input	O
function	O
in	O
Salmonella	O
.	O

To	O
the	O
contrary	O
,	O
high	O
local	O
conservation	O
in	O
the	O
promoters	O
evolved	O
in	O
Salmonella	O
and	O
Sodalis	O
was	O
the	O
crux	O
in	O
defining	O
the	O
functional	O
SsrB	O
input	O
among	O
stochastic	O
noise	O
.	O

Having	O
previously	O
reported	O
that	O
M1T1	O
Streptococcus	O
pyogenes	O
become	O
hypervirulent	O
in	O
mice	O
due	O
to	O
selection	O
of	O
mutants	O
in	O
the	O
covRS	O
regulatory	O
genes	O
,	O
we	O
set	O
out	O
to	O
dissect	O
the	O
impact	O
of	O
these	O
mutations	O
in	O
vitro	O
and	O
in	O
vivo	O
from	O
the	O
impact	O
of	O
other	O
adaptive	O
events	O
.	O

This	O
difference	O
in	O
buoyancy	O
can	O
be	O
attributed	O
to	O
differences	O
in	O
proteolytic	O
activity	O
(	O
WT	O
>	O
>	O
AP	O
)	O
that	O
may	O
degrade	O
many	O
surface	O
proteins	O
,	O
including	O
pilin	O
,	O
or	O
induce	O
changes	O
in	O
the	O
surface	O
charge	O
making	O
bacterial	O
aggregates	O
more	O
compact	O
.	O

The	O
concentrations	O
of	O
viable	O
WT	O
and	O
AP	O
bacteria	O
at	O
24	O
h	O
post	O
-	O
inoculation	O
remained	O
essentially	O
the	O
same	O
:	O
1	O
-	O
5x109	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
)	O
/	O
ml	O
vs	O
.	O
approximately2x109	O
CFU	O
/	O
ml	O
inoculum	O
.	O

Multiple	O
approaches	O
to	O
microarray	O
analysis	O
show	O
statistically	O
significant	O
and	O
biologically	O
relevant	O
differences	O
between	O
the	O
WT	O
and	O
AP	O
populations	O
in	O
vitro	O
and	O
in	O
vivo	O

Many	O
of	O
these	O
genes	O
encode	O
metabolic	O
enzymes	O
(	O
e	O
.	O
g	O
.	O
,	O
carbohydrate	O
metabolism	O
,	O
arginine	O
degradation	O
,	O
and	O
pyrimidine	O
biosynthesis	O
)	O
,	O
ribosomal	O
proteins	O
(	O
mostly	O
downregulated	O
)	O
,	O
and	O
sugar	O
or	O
peptide	O
transport	O
systems	O
,	O
reflecting	O
the	O
transition	O
from	O
a	O
carbohydrate	O
-	O
rich	O
laboratory	O
medium	O
to	O
a	O
protein	O
-	O
rich	O
,	O
oxygen	S-Chemical_Compound
-	O
poor	O
subcutaneous	O
tissue	O
.	O

However	O
,	O
the	O
fold	O
-	O
change	O
in	O
SpeB	O
operon	O
transcription	O
level	O
largely	O
varied	O
across	O
the	O
four	O
experimental	O
conditions	O
,	O
ranging	O
from	O
a	O
2	O
.	O
2	O
-	O
fold	O
to	O
a	O
30	O
-	O
fold	O
downregulation	O
(	O
Table	O
3	O
)	O
.	O

NC	O
analysis	O
also	O
allowed	O
us	O
to	O
visualize	O
genomic	O
clusters	O
that	O
are	O
similarly	O
regulated	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
and	O
those	O
that	O
are	O
reciprocally	O
regulated	O
.	O

In	O
this	O
study	O
,	O
we	O
captured	O
dynamic	O
events	O
underlying	O
the	O
phenotypic	O
switch	O
resulting	O
from	O
this	O
population	O
restructuring	O
.	O

This	O
finding	O
is	O
in	O
agreement	O
with	O
studies	O
showing	O
that	O
the	O
CovRS	O
system	O
is	O
mainly	O
linked	O
to	O
the	O
regulation	O
of	O
virulence	O
factors	O
and	O
virulence	O
-	O
associated	O
pathways	O
[	O
19	O
]	O
,	O
[	O
20	O
]	O
,	O
[	O
24	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
,	O
[	O
28	O
]	O
,	O
[	O
52	O
]	O
,	O
[	O
53	O
]	O
,	O
[	O
54	O
]	O
,	O
[	O
55	O
]	O
.	O

The	O
downregulation	O
of	O
GRAB	O
makes	O
biological	O
sense	O
because	O
this	O
protein	O
binds	O
alpha	O
-	O
2	O
-	O
macroglobulin	O
in	O
blood	O
[	O
60	O
]	O
to	O
protect	O
the	O
bacteria	O
against	O
its	O
own	O
protease	O
,	O
SpeB	O
,	O
and	O
thus	O
the	O
bacteria	O
no	O
longer	O
need	O
to	O
express	O
high	O
levels	O
of	O
GRAB	O
when	O
SpeB	O
is	O
not	O
expressed	O
.	O

Finally	O
,	O
genes	O
encoding	O
the	O
antiphagocytic	O
M	O
protein	O
,	O
and	O
the	O
toxins	O
streptolysin	O
O	O
and	O
NADGH	O
were	O
among	O
few	O
genes	O
that	O
were	O
upregulated	O
in	O
all	O
conditions	O
except	O
WT	O
-	O
vitro	O
(	O
Fig	O
.	O
2	O
,	O
CC7	O
)	O
,	O
which	O
suggests	O
that	O
their	O
transcription	O
is	O
dependent	O
on	O
multiple	O
signals	O
,	O
including	O
signals	O
from	O
the	O
host	O
as	O
well	O
as	O
covS	O
-	O
dependent	O
cues	O
.	O

Although	O
our	O
microarray	O
studies	O
were	O
extensive	O
(	O
28	O
arrays	O
for	O
4	O
conditions	O
)	O
,	O
we	O
ran	O
qPCR	O
to	O
validate	O
the	O
microarray	O
findings	O
,	O
focusing	O
on	O
virulence	O
genes	O
that	O
are	O
biomarkers	O
of	O
the	O
bacterial	O
switch	O
to	O
a	O
hypervirulent	O
phenotype	O
.	O

The	O
use	O
of	O
multiple	O
microarray	O
analysis	O
strategies	O
and	O
the	O
integration	O
of	O
their	O
results	O
strengthened	O
this	O
study	O
since	O
each	O
strategy	O
has	O
advantages	O
and	O
disadvantages	O
.	O

In	O
bacteria	O
,	O
biochemical	O
pathways	O
,	O
virulence	O
systems	O
,	O
and	O
multimeric	O
proteins	O
are	O
often	O
encoded	O
next	O
to	O
each	O
other	O
by	O
chromosomally	O
contiguous	O
or	O
clustered	O
genes	O
[	O
64	O
]	O
,	O
[	O
65	O
]	O
.	O

However	O
,	O
the	O
degree	O
of	O
AP	O
invasiveness	O
might	O
vary	O
depending	O
on	O
the	O
route	O
of	O
infection	O
and	O
animal	O
model	O
[	O
15	O
]	O
.	O

This	O
dominant	O
SpeB	O
effect	O
may	O
explain	O
why	O
WT	O
bacteria	O
parish	O
in	O
vivo	O
even	O
though	O
they	O
partially	O
downregulate	O
SpeB	O
transcription	O
(	O
Table	O
3	O
)	O
.	O

This	O
study	O
is	O
a	O
first	O
step	O
towards	O
exploring	O
the	O
sociomicrobiology	O
of	O
invasive	O
GAS	O
in	O
vivo	O
.	O

Recently	O
,	O
the	O
novel	O
two	O
-	O
component	O
regulatory	O
system	O
Sak188	O
/	O
Sak189	O
was	O
identified	O
.	O

Streptococcus	O
agalactiae	O
(	O
group	O
B	O
streptococcus	O
)	O
is	O
an	O
important	O
cause	O
of	O
neonatal	O
invasive	O
infections	O
and	O
variety	O
of	O
diseases	O
in	O
human	O
and	O
animals	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

Subsequently	O
,	O
phosphoryl	O
group	O
is	O
transferred	O
to	O
RR	O
protein	O
resulting	O
in	O
conformational	O
changes	O
in	O
RR	O
molecule	O
.	O

Construction	O
of	O
the	O
strains	O
was	O
confirmed	O
by	O
PCR	O
and	O
nucleotide	O
sequencing	O
(	O
data	O
not	O
shown	O
)	O
.	O

Comparative	O
analysis	O
of	O
the	O
wild	O
-	O
type	O
strain	O
168	O
/	O
00	O
and	O
mutant	O
strains	O
revealed	O
no	O
difference	O
in	O
morphological	O
properties	O
.	O

Subsequently	O
,	O
bacterial	O
cell	O
lysates	O
and	O
secreted	O
proteins	O
after	O
2	O
hrs	O
and	O
5	O
hrs	O
of	O
growth	O
in	O
THB	O
were	O
analyzed	O
.	O

Effect	O
of	O
insertional	O
inactivation	O
on	O
transcription	O
of	O
bac	O
gene	O

In	O
vivo	O
virulent	O
properties	O
of	O
the	O
wild	O
-	O
type	O
strain	O
and	O
mutant	O
strains	O

Intraperitoneal	O
infection	O
of	O
laboratory	O
mice	O
demonstrated	O
that	O
Sak189	O
DNA	O
-	O
binding	O
response	O
regulatory	O
protein	O
is	O
important	O
for	O
virulent	O
properties	O
of	O
S	O
.	O
agalactiae	O
.	O

We	O
present	O
neighbor	O
clustering	O
,	O
a	O
new	O
computational	O
method	O
for	O
further	O
analyzing	O
bacterial	O
microarray	O
data	O
that	O
combines	O
two	O
informative	O
characteristics	O
of	O
bacterial	O
genes	O
that	O
share	O
common	O
function	O
or	O
regulation	O
:	O
(	O
1	O
)	O
similar	O
gene	O
expression	O
profiles	O
(	O
i	O
.	O
e	O
.	O
,	O
co	O
-	O
expression	O
)	O
;	O
and	O
(	O
2	O
)	O
physical	O
proximity	O
of	O
genes	O
on	O
the	O
chromosome	O
.	O

This	O
method	O
identifies	O
statistically	O
significant	O
clusters	O
of	O
co	O
-	O
expressed	O
gene	O
neighbors	O
that	O
potentially	O
share	O
common	O
function	O
or	O
regulation	O
by	O
coupling	O
statistically	O
analyzed	O
gene	O
expression	O
profiles	O
with	O
the	O
chromosomal	O
position	O
of	O
genes	O
.	O

We	O
applied	O
this	O
method	O
to	O
our	O
own	O
data	O
and	O
to	O
those	O
of	O
others	O
,	O
and	O
we	O
show	O
that	O
it	O
identified	O
a	O
greater	O
number	O
of	O
differentially	O
expressed	O
genes	O
,	O
facilitating	O
the	O
reconstruction	O
of	O
more	O
multimeric	O
proteins	O
and	O
complete	O
metabolic	O
pathways	O
than	O
would	O
have	O
been	O
possible	O
without	O
its	O
application	O
.	O

Following	O
filtering	O
and	O
normalization	O
[	O
18	O
,	O
19	O
]	O
,	O
we	O
analyzed	O
data	O
from	O
four	O
biological	O
replicates	O
[	O
16	O
]	O
with	O
robust	O
summary	O
statistics	O
[	O
20	O
]	O
,	O
Bayesian	O
statistics	O
[	O
21	O
,	O
22	O
]	O
,	O
and	O
permutation	O
algorithms	O
[	O
19	O
]	O
to	O
identify	O
genes	O
differentially	O
expressed	O
with	O
significance	O
during	O
pharyngeal	O
cell	O
adherence	O
.	O

We	O
conducted	O
TaqMan	O
(	O
qRT	O
-	O
PCR	O
)	O
analysis	O
[	O
23	O
]	O
of	O
11	O
differentially	O
expressed	O
genes	O
to	O
validate	O
selected	O
microarray	O
hybridization	O
results	O
(	O
see	O
Table	O
S2	O
for	O
genes	O
and	O
primer	O
-	O
probe	O
sequences	O
)	O
.	O

Virulence	O
Factors	O

However	O
,	O
once	O
adhered	O
,	O
our	O
data	O
suggest	O
that	O
streptococci	S-Species
downregulate	O
production	O
of	O
this	O
cytotoxin	O
,	O
presumably	O
to	O
prevent	O
further	O
host	O
tissue	O
destruction	O
that	O
could	O
interfere	O
with	O
adherence	O
.	O

The	O
speH	O
gene	O
(	O
spy1008	O
)	O
was	O
induced	O
,	O
and	O
the	O
remaining	O
genes	O
,	O
hypothetically	O
involved	O
in	O
replication	O
and	O
regulation	O
[	O
39	O
]	O
,	O
were	O
downregulated	O
.	O

A	O
total	O
of	O
56	O
of	O
the	O
original	O
79	O
significant	O
genes	O
became	O
components	O
of	O
significant	O
clusters	O
,	O
whereas	O
23	O
remained	O
unclustered	O
.	O

Each	O
of	O
the	O
11	O
neighbor	O
clusters	O
that	O
could	O
have	O
been	O
only	O
partially	O
identified	O
by	O
our	O
initial	O
analysis	O
alone	O
gained	O
gene	O
members	O
after	O
application	O
of	O
the	O
algorithms	O
and	O
became	O
more	O
complete	O
sets	O
of	O
functionally	O
related	O
genes	O
than	O
initially	O
identified	O
(	O
Table	O
3	O
)	O
.	O

Notably	O
,	O
the	O
remaining	O
ten	O
Type	O
I	O
clusters	O
were	O
composed	O
entirely	O
of	O
genes	O
that	O
individually	O
were	O
not	O
significant	O
;	O
however	O
,	O
after	O
applying	O
our	O
algorithms	O
,	O
the	O
combined	O
contribution	O
of	O
each	O
gene	O
resulted	O
in	O
a	O
significant	O
cluster	O
.	O

Based	O
on	O
the	O
Type	O
I	O
cluster	O
results	O
,	O
we	O
speculated	O
that	O
genes	O
contained	O
in	O
Type	O
II	O
clusters	O
might	O
be	O
related	O
by	O
function	O
or	O
regulation	O
.	O

We	O
note	O
,	O
however	O
,	O
that	O
despite	O
the	O
statistical	O
framework	O
with	O
which	O
groupings	O
are	O
assigned	O
,	O
experimental	O
evidence	O
is	O
necessary	O
to	O
confirm	O
functional	O
or	O
regulatory	O
relatedness	O
.	O

Together	O
with	O
the	O
identification	O
of	O
this	O
cluster	O
by	O
GenomeCrawler	O
,	O
these	O
results	O
prompted	O
us	O
to	O
study	O
this	O
cluster	O
and	O
the	O
contributions	O
of	O
the	O
gene	O
products	O
to	O
pharyngeal	O
cell	O
adherence	O
.	O

In	O
silico	O
sequence	O
inspection	O
identified	O
a	O
single	O
putative	O
promoter	O
sequence	O
upstream	O
of	O
spy0127	O
(	O
see	O
Table	O
S6	O
)	O
.	O

We	O
created	O
a	O
spy0129	O
deletion	O
mutant	O
in	O
strain	O
SF370	S-Species
(	O
SF370Deltaspy0129	O
)	O
to	O
determine	O
if	O
genes	O
contained	O
within	O
the	O
spy0127	O
-	O
0130	O
cluster	O
were	O
directly	O
involved	O
in	O
adherence	O
to	O
pharyngeal	O
cells	O
.	O

The	O
genes	O
spy1724	O
,	O
spy1722	O
,	O
spy1721	O
,	O
and	O
spy1719	O
share	O
transcriptional	O
order	O
and	O
predicted	O
function	O
with	O
homologs	O
in	O
the	O
nusA	O
-	O
infB	O
protein	O
biosynthesis	O
operon	O
of	O
Bacillus	B-Species
subtilis	E-Species
and	O
Escherichia	B-Species
coli	E-Species
[	O
51	O
]	O
.	O

We	O
applied	O
the	O
statistical	O
analysis	O
and	O
the	O
GenomeCrawler	O
algorithms	O
to	O
data	O
from	O
a	O
recently	O
published	O
streptococcal	O
microarray	O
study	O
that	O
is	O
relevant	O
for	O
comparison	O
to	O
our	O
own	O
data	O
(	O
same	O
streptococcal	B-Species
strain	E-Species
,	O
similar	O
array	O
platform	O
)	O
[	O
57	O
]	O
.	O

We	O
applied	O
the	O
GenomeCrawler	O
algorithms	O
to	O
the	O
statistically	O
analyzed	O
dataset	O
,	O
which	O
identified	O
an	O
expanded	O
group	O
of	O
genes	O
(	O
107	O
versus	O
four	O
)	O
contained	O
within	O
36	O
statistically	O
significant	O
clusters	O
(	O
PK	O
<	O
0	O
.	O
05	O
;	O
Table	O
S9	O
)	O
.	O

The	O
long	O
(	O
FimA	O
)	O
fimbriae	O
have	O
been	O
extensively	O
studied	O
.	O

Two	O
distinct	O
fimbriae	O
are	O
found	O
on	O
the	O
surface	O
of	O
the	O
organism	O
(	O
Dickinson	O
et	O
al	O
.	O
,	O
1988	O
;	O
Hamada	O
et	O
al	O
.	O
,	O
1996	O
)	O
.	O

Coadhesion	O
and	O
biofilm	O
development	O
between	O
P	B-Species
.	I-Species
gingivalis	E-Species
and	O
Streptococcus	B-Species
gordonii	E-Species
require	O
the	O
interaction	O
of	O
Mfa1	O
with	O
streptococcal	O
protein	O
SspB	O
(	O
Park	O
et	O
al	O
.	O
,	O
2005	O
)	O
.	O

The	O
authors	O
have	O
recently	O
reported	O
that	O
the	O
short	O
fimbriae	O
are	O
required	O
for	O
P	B-Species
.	I-Species
gingivalis	E-Species
cell	O
-	O
cell	O
aggregation	O
,	O
an	O
essential	O
step	O
in	O
microcolony	O
formation	O
(	O
Lin	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

In	O
a	O
nutrient	O
-	O
limited	O
medium	O
,	O
expression	O
of	O
FimA	O
and	O
Mfa1	O
are	O
inhibited	O
in	O
P	B-Species
.	I-Species
gingivalis	E-Species
,	O
whereas	O
such	O
differences	O
are	O
not	O
found	O
in	O
gingipain	O
expression	O
.	O

In	O
this	O
study	O
,	O
it	O
is	O
demonstrated	O
that	O
FimR	O
is	O
a	O
positive	O
regulator	O
of	O
Mfa1	O
expression	O
.	O

Evidence	O
is	O
provided	O
that	O
unlike	O
FimR	O
-	O
dependent	O
fimA	O
expression	O
,	O
FimR	O
regulates	O
mfa1	O
expression	O
by	O
directly	O
binding	O
to	O
the	O
promoter	O
region	O
of	O
mfa1	O
.	O

Results	O

This	O
analysis	O
suggests	O
the	O
FimS	O
/	O
FimR	O
system	O
is	O
required	O
for	O
expression	O
of	O
both	O
major	O
and	O
minor	O
fimbriae	O
.	O

Density	O
of	O
protein	O
bands	O
was	O
determined	O
by	O
UVP	O
Bioimaging	O
System	O
(	O
UVP	O
,	O
CA	O
)	O
.	O

This	O
analysis	O
revealed	O
that	O
the	O
expression	O
of	O
the	O
fimA	O
and	O
mfa1	O
genes	O
was	O
consistent	O
at	O
the	O
mRNA	O
level	O
and	O
protein	O
level	O
(	O
Fig	O
.	O
1b	O
)	O
.	O

FimA	O
protein	O
was	O
not	O
detectable	O
in	O
the	O
fimR	O
-	O
mutant	O
,	O
while	O
a	O
50	O
%	O
lower	O
level	O
of	O
Mfa1	O
protein	O
was	O
found	O
in	O
the	O
fimR	O
-	O
mutant	O
compared	O
with	O
that	O
in	O
wild	O
-	O
type	O
strain	O
33277	S-Species
.	O

The	O
same	O
transcriptional	O
start	O
site	O
was	O
identified	O
.	O

Binding	O
of	O
FimR	O
to	O
the	O
promoter	O
region	O
of	O
mfa1	O

To	O
investigate	O
the	O
role	O
of	O
phosphorylation	O
of	O
FimR	O
in	O
its	O
binding	O
to	O
the	O
mfa1	O
promoter	O
region	O
,	O
EMSA	O
experiments	O
were	O
also	O
performed	O
with	O
the	O
phosphorylated	O
rFimR	O
.	O

No	O
significant	O
difference	O
was	O
detected	O
in	O
the	O
level	O
of	O
DNA	O
binding	O
between	O
the	O
phosphorylated	O
rFimR	O
and	O
unphosphorylated	O
rFimR	O
(	O
data	O
not	O
shown	O
)	O
.	O

Although	O
most	O
target	O
genes	O
of	O
P	B-Species
.	I-Species
gingivalis	E-Species
two	O
-	O
component	O
systems	O
are	O
unknown	O
,	O
the	O
role	O
of	O
the	O
FimS	O
/	O
FimR	O
in	O
expression	O
of	O
the	O
fimA	O
gene	O
is	O
well	O
defined	O
.	O

The	O
observations	O
that	O
FimR	O
binds	O
only	O
to	O
the	O
upstream	O
promoter	O
region	O
of	O
the	O
mfa1	O
gene	O
and	O
that	O
activity	O
of	O
the	O
downstream	O
promoter	O
is	O
inhibited	O
by	O
S	B-Species
.	I-Species
gordonii	E-Species
,	O
S	B-Species
.	I-Species
sanguinis	E-Species
and	O
S	B-Species
.	I-Species
mitis	E-Species
(	O
Park	O
et	O
al	O
.	O
,	O
2006	O
)	O
imply	O
the	O
complexity	O
of	O
regulation	O
of	O
mfa1	O
expression	O
.	O

In	O
conclusion	O
,	O
P	B-Species
.	I-Species
gingivalis	E-Species
fimbriae	O
play	O
a	O
predominant	O
role	O
in	O
the	O
attachment	O
of	O
the	O
organism	O
to	O
a	O
variety	O
of	O
oral	O
surfaces	O
(	O
Lamont	O
&	O
Jenkinson	O
,	O
2000	O
;	O
Amano	O
et	O
al	O
.	O
,	O
2004	O
)	O
,	O
although	O
other	O
surface	O
proteins	O
,	O
such	O
as	O
gingipains	O
,	O
may	O
also	O
be	O
involved	O
in	O
the	O
bacterial	O
colonization	O
(	O
Tokuda	O
et	O
al	O
.	O
,	O
1996	O
;	O
Chen	O
et	O
al	O
.	O
,	O
2001	O
)	O
.	O

Despite	O
its	O
long	O
use	O
,	O
the	O
reasons	O
for	O
its	O
stable	O
attenuation	O
have	O
not	O
yet	O
been	O
elucidated	O
.	O

In	O
another	O
study	O
,	O
Pascopella	O
et	O
al	O
.	O

While	O
writing	O
this	O
article	O
,	O
the	O
whole	O
genome	O
sequence	O
of	O
H37Ra	S-Species
became	O
publicly	O
available	O
(	O
NC	O
_	O
009525	O
)	O
,	O
and	O
comparison	O
of	O
the	O
SNP	O
data	O
obtained	O
from	O
the	O
H37Ra	S-Species
strain	O
used	O
in	O
our	O
laboratory	O
(	O
Table	O
S1	O
)	O
with	O
the	O
NC	O
_	O
009525	O
data	O
,	O
showed	O
that	O
some	O
differences	O
existed	O
between	O
the	O
H37Ra	S-Species
strains	O
,	O
a	O
phenomenon	O
which	O
was	O
also	O
previously	O
observed	O
for	O
BCG	S-Species
[	O
4	O
]	O
and	O
H37Rv	S-Species
[	O
17	O
]	O
.	O

Figure	O
S1	O
shows	O
part	O
of	O
the	O
nucleotide	O
sequence	O
of	O
a	O
PCR	O
-	O
amplified	O
fragment	O
obtained	O
from	O
H37Ra	O
:	O
:	O
phoP	O
.	O

In	O
contrast	O
,	O
no	O
effects	O
on	O
the	O
virulence	O
were	O
observed	O
when	O
H37Ra	S-Species
was	O
complemented	O
with	O
fadE5	O
(	O
Figure	O
2	O
)	O
or	O
rpsL	O
(	O
unpublished	O
data	O
)	O
.	O

For	O
M	B-Species
.	I-Species
tuberculosis	E-Species
,	O
several	O
studies	O
have	O
described	O
a	O
link	O
between	O
the	O
inactivation	O
of	O
phoP	O
and	O
loss	O
of	O
virulence	O
,	O
suggesting	O
that	O
the	O
phoP	O
gene	O
is	O
required	O
for	O
intracellular	O
growth	O
of	O
M	B-Species
.	I-Species
tuberculosis	E-Species
[	O
14	O
,	O
25	O
]	O
.	O

There	O
were	O
also	O
several	O
ppe	O
genes	O
that	O
seem	O
to	O
be	O
regulated	O
by	O
phoP	O
but	O
not	O
ppe68	O
[	O
21	O
]	O
.	O

Furthermore	O
,	O
rv3614c	O
-	O
rv3616c	O
were	O
reported	O
to	O
be	O
transiently	O
upregulated	O
in	O
the	O
phagosome	O
and	O
under	O
acidic	O
stress	O
[	O
38	O
]	O
.	O

With	O
its	O
well	O
documented	O
role	O
in	O
virulence	O
and	O
strong	O
T	O
cell	O
antigenicity	O
,	O
ESAT	O
-	O
6	O
is	O
one	O
of	O
the	O
most	O
important	O
proteins	O
of	O
M	B-Species
.	I-Species
tuberculosis	E-Species
involved	O
in	O
host	O
pathogen	O
interaction	O
[	O
5	O
,	O
41	O
-	O
43	O
]	O
.	O

At	O
present	O
,	O
we	O
do	O
not	O
know	O
how	O
many	O
of	O
these	O
differences	O
actually	O
contribute	O
to	O
the	O
attenuation	O
of	O
H37Ra	S-Species
,	O
and	O
it	O
also	O
remains	O
to	O
be	O
determined	O
how	O
many	O
differences	O
exist	O
among	O
the	O
various	O
H37Ra	S-Species
strains	O
that	O
are	O
presently	O
used	O
in	O
the	O
worldwide	O
tuberculosis	O
research	O
laboratories	O
.	O

In	O
addition	O
,	O
the	O
genetic	O
overlap	O
unravelled	O
a	O
two	O
-	O
component	O
system	O
that	O
is	O
unique	O
for	O
the	O
genera	O
Photorhabdus	S-Species
and	O
Yersinia	S-Species
and	O
is	O
therefore	O
suggested	O
to	O
play	O
a	O
major	O
role	O
in	O
the	O
pathogen	O
-	O
insect	O
relationship	O
.	O

Some	O
of	O
them	O
might	O
have	O
been	O
selected	O
during	O
the	O
association	O
with	O
insects	O
and	O
then	O
adapted	O
to	O
pathogenesis	O
in	O
mammalian	O
hosts	O
.	O

Pathogenicity	O
as	O
well	O
as	O
symbiosis	O
plays	O
a	O
key	O
role	O
in	O
the	O
interaction	O
of	O
bacteria	O
with	O
their	O
hosts	O
including	O
invertebrates	O
.	O

Y	B-Species
.	I-Species
pseudotuberculosis	E-Species
,	O
in	O
contrast	O
to	O
Y	B-Species
.	I-Species
pestis	E-Species
,	O
has	O
been	O
shown	O
to	O
be	O
orally	O
toxic	O
to	O
flea	O
[	O
8	O
]	O
.	O

Furthermore	O
,	O
Y	B-Species
.	I-Species
pseudotuberculosis	E-Species
and	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
have	O
been	O
demonstrated	O
to	O
adhere	O
to	O
and	O
invade	O
cultivated	O
insect	O
cells	O
[	O
10	O
]	O
.	O

Thus	O
,	O
the	O
interaction	O
of	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
with	O
insects	O
is	O
an	O
important	O
link	O
in	O
the	O
ecological	O
range	O
of	O
bacteria	O
-	O
host	O
interactions	O
extending	O
from	O
entomopathogenic	O
to	O
humanpathogenic	O
bacteria	O
.	O

Nematode	O
reproduction	O
is	O
supported	O
by	O
the	O
bacteria	O
,	O
probably	O
by	O
providing	O
essential	O
nutrients	O
that	O
are	O
required	O
for	O
efficient	O
nematode	O
proliferation	O
[	O
16	O
]	O
.	O

Results	O
and	O
Discussion	O

Its	O
genome	O
size	O
is	O
exceeded	O
by	O
the	O
~	O
5	O
.	O
7	O
Mbp	O
genome	O
of	O
P	B-Species
.	I-Species
luminescens	E-Species
encoding	O
4839	O
putative	O
proteins	O
[	O
24	O
]	O
.	O

In	O
contrast	O
,	O
P	B-Species
.	I-Species
luminescens	E-Species
cells	O
are	O
primarily	O
restricted	O
to	O
symbiosis	O
with	O
the	O
nematode	O
species	O
H	B-Species
.	I-Species
bacteriophora	E-Species
and	O
the	O
insect	O
larvae	O
as	O
hosts	O
,	O
thus	O
encountering	O
a	O
more	O
homeostatic	O
milieu	O
.	O

The	O
putative	O
target	O
genes	O
of	O
Plu0102	O
/	O
Plu0103	O
and	O
Ye4185	O
/	O
Ye4186	O
,	O
plu0104	O
and	O
ye4187	O
,	O
respectively	O
,	O
are	O
homologues	O
and	O
encode	O
putative	O
secreted	O
proteins	O
which	O
might	O
act	O
in	O
a	O
similar	O
,	O
yet	O
unknown	O
manner	O
.	O

They	O
produce	O
membrane	O
diffusible	O
signalling	O
molecules	O
,	O
acyl	O
homoserine	O
lactones	O
(	O
AHLs	O
)	O
,	O
which	O
are	O
sensed	O
by	O
the	O
receptor	O
/	O
regulator	O
LuxR	O
when	O
exceeding	O
a	O
threshold	O
concentration	O
.	O

Y	B-Species
.	I-Species
enterocolitica	E-Species
possesses	O
a	O
typical	O
quorum	O
sensing	O
pair	O
of	O
homologues	O
,	O
YenI	O
/	O
YenR	O
(	O
YE1600	O
/	O
YE1599	O
)	O
,	O
and	O
it	O
has	O
recently	O
been	O
shown	O
that	O
swimming	O
and	O
swarming	O
motility	O
is	O
regulated	O
by	O
3	O
-	O
oxo	O
-	O
C6	O
-	O
AHL	O
and	O
C6	O
-	O
AHL	O
,	O
which	O
are	O
synthesized	O
by	O
YenI	O
[	O
34	O
]	O
.	O

The	O
DeltaluxS	O
mutant	O
also	O
showed	O
decreased	O
expression	O
of	O
virulence	O
factors	O
such	O
as	O
the	O
cytotoxic	O
protein	O
CcdB	O
,	O
the	O
hemolysin	O
secretion	O
protein	O
HlyD	O
(	O
Plu0635	O
)	O
,	O
and	O
the	O
toxin	O
ABC	O
transporter	O
subunits	O
RtxD	O
/	O
RtxB	O
.	O

It	O
is	O
discussed	O
that	O
the	O
AstS	O
/	O
AstR	O
-	O
system	O
prevents	O
or	O
delays	O
phenotypic	O
variation	O
by	O
protecting	O
the	O
cell	O
from	O
stress	O
[	O
18	O
]	O
.	O

Because	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
produces	O
the	O
corresponding	O
TCS	O
BvgS	O
/	O
BvgR	O
,	O
but	O
is	O
not	O
known	O
to	O
switch	O
to	O
another	O
phenotypic	O
variant	O
,	O
the	O
possible	O
role	O
of	O
UspA	O
in	O
global	O
regulation	O
still	O
remains	O
to	O
be	O
elucidated	O
.	O

Phenotypic	O
variation	O
and	O
thus	O
the	O
switch	O
between	O
mutualism	O
and	O
pathogenicity	O
in	O
P	B-Species
.	I-Species
luminescens	E-Species
is	O
proposed	O
to	O
be	O
regulated	O
by	O
a	O
Ner	O
-	O
like	O
and	O
a	O
HexA	O
-	O
like	O
regulator	O
that	O
repress	O
primary	O
variant	O
specific	O
genes	O
in	O
the	O
stage	O
of	O
the	O
secondary	O
variant	O
[	O
17	O
]	O
.	O

Therefore	O
,	O
an	O
UspC	O
mediated	O
stress	O
response	O
is	O
not	O
assumed	O
to	O
play	O
a	O
major	O
role	O
in	O
insect	O
pathogenicity	O
.	O

In	O
addition	O
to	O
phenotypes	O
that	O
affect	O
virulence	O
properties	O
indirectly	O
,	O
c	O
-	O
di	O
-	O
GMP	O
can	O
also	O
directly	O
regulate	O
virulence	O
factors	O
[	O
56	O
,	O
57	O
]	O
.	O

Remarkably	O
,	O
their	O
expression	O
is	O
induced	O
by	O
low	O
iron	O
concentration	O
as	O
encountered	O
in	O
the	O
insect	O
host	O
,	O
and	O
phlA	O
/	O
phlB	O
are	O
up	O
-	O
regulated	O
at	O
18degreesC	O
compared	O
to	O
28degreesC	O
in	O
Y	B-Species
.	I-Species
ruckeri	E-Species
[	O
66	O
]	O
.	O

In	O
the	O
genome	O
of	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
,	O
only	O
three	O
complete	O
TPS	O
systems	O
are	O
present	O
,	O
namely	O
YE0479	O
/	O
YE0480	O
,	O
YE2407	O
/	O
YE2408	O
,	O
(	O
YE4084	O
)	O
YE4085	O
/	O
YE4086	O
,	O
and	O
YE3454	O
which	O
lacks	O
the	O
activator	O
partner	O
.	O

Recently	O
,	O
we	O
have	O
shown	O
that	O
a	O
luciferase	O
reporter	O
insertion	O
into	O
YE0480	O
is	O
induced	O
at	O
low	O
temperature	O
[	O
67	O
]	O
,	O
indicating	O
that	O
this	O
TPS	O
system	O
might	O
contribute	O
to	O
insect	O
pathogenicity	O
and	O
possibly	O
to	O
the	O
host	O
-	O
specificity	O
of	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
.	O

The	O
P	B-Species
.	I-Species
luminescens	E-Species
genome	O
comprises	O
a	O
gene	O
cluster	O
encoding	O
RTX	O
proteins	O
,	O
namely	O
plu1330	O
-	O
1369	O
.	O

Adhesins	O
and	O
invasins	O

Defensive	O
mechanisms	O

Interestingly	O
,	O
none	O
of	O
these	O
genes	O
showed	O
significant	O
similarities	O
to	O
sequences	O
of	O
the	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
genome	O
.	O

More	O
than	O
twenty	O
colicin	O
/	O
pyocin	O
-	O
like	O
factors	O
and	O
putative	O
immunity	O
proteins	O
are	O
unique	O
to	O
P	B-Species
.	I-Species
luminescens	E-Species
in	O
comparison	O
to	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
.	O

Examples	O
are	O
the	O
product	O
of	O
plu4258	O
,	O
adjacent	O
to	O
a	O
gene	O
encoding	O
glutathione	O
transferase	O
(	O
plu4259	O
)	O
,	O
a	O
putative	O
steroid	O
monooxygenase	O
(	O
Plu4232	O
)	O
,	O
and	O
a	O
glycine	O
oxidase	O
(	O
Plu2242	O
)	O
,	O
all	O
of	O
which	O
have	O
no	O
counterparts	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
.	O

In	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
,	O
two	O
type	O
-	O
III	O
secretion	O
systems	O
(	O
T3SS	O
)	O
essential	O
for	O
virulence	O
in	O
the	O
mammalian	O
host	O
are	O
encoded	O
on	O
pYV	O
and	O
by	O
the	O
ysa	O
operon	O
(	O
YE3533	O
-	O
3561	O
)	O
[	O
23	O
,	O
82	O
]	O
.	O

Additionally	O
to	O
the	O
Sec	O
-	O
system	O
,	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
produces	O
a	O
T2SS	O
named	O
Yts1	O
,	O
which	O
has	O
been	O
found	O
to	O
be	O
important	O
for	O
virulence	O
in	O
mice	S-Species
[	O
90	O
]	O
.	O

Ymt	O
is	O
essential	O
for	O
flea	O
colonization	O
by	O
Y	B-Species
.	I-Species
pestis	E-Species
and	O
is	O
regulated	O
by	O
AHL	O
both	O
in	O
Y	B-Species
.	I-Species
pestis	E-Species
[	O
95	O
]	O
and	O
P	B-Species
.	I-Species
luminescens	E-Species
(	O
R	O
.	O
Heermann	O
,	O
unpublished	O
data	O
)	O
,	O
indicating	O
that	O
Ymt	O
is	O
also	O
required	O
for	O
insect	O
colonization	O
by	O
P	B-Species
.	I-Species
luminescens	E-Species
.	O

We	O
also	O
identified	O
two	O
proteases	O
in	O
each	O
pathogen	O
(	O
Plu4291	O
,	O
Plu0631	O
,	O
YE0320	O
,	O
and	O
YE2087	O
)	O
without	O
a	O
homologue	O
in	O
the	O
other	O
bacterium	O
.	O

Propanediol	O
degradation	O
by	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
might	O
also	O
be	O
supported	O
by	O
YE4187	O
with	O
a	O
putative	O
GlcG	O
domain	O
which	O
is	O
predicted	O
to	O
be	O
involved	O
in	O
glycolate	O
and	O
propanediol	O
utilization	O
.	O

The	O
uhpABC	O
operon	O
as	O
well	O
as	O
mgtC	O
encoding	O
the	O
Mg2	O
+	O
transport	O
ATPase	O
subunit	O
have	O
been	O
found	O
to	O
be	O
induced	O
at	O
low	O
temperature	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
[	O
67	O
]	O
,	O
indicating	O
a	O
relevance	O
for	O
these	O
metabolic	O
genes	O
for	O
P	B-Species
.	I-Species
luminescens	E-Species
and	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
during	O
insect	O
infection	O
.	O

Bacteria	O
use	O
two	O
different	O
strategies	O
to	O
acquire	O
sufficient	O
amounts	O
of	O
iron	O
,	O
namely	O
the	O
expression	O
and	O
secretion	O
of	O
high	O
-	O
affinity	O
iron	O
-	O
binding	O
compounds	O
called	O
siderophores	O
,	O
and	O
the	O
production	O
of	O
receptors	O
for	O
iron	O
carriers	O
such	O
as	O
heme	O
.	O

Interestingly	O
,	O
three	O
gene	O
loci	O
involved	O
in	O
iron	O
acquisition	O
,	O
namely	O
the	O
genes	O
encoding	O
the	O
hemin	O
storage	O
system	O
,	O
the	O
yersiniabactin	O
and	O
the	O
enterobactin	O
transporter	O
FepG	O
,	O
have	O
been	O
demonstrated	O
to	O
be	O
up	O
-	O
regulated	O
upon	O
temperature	O
decrease	O
in	O
Y	B-Species
.	I-Species
pestis	E-Species
or	O
Y	B-Species
.	I-Species
ruckeri	E-Species
,	O
respectively	O
(	O
Table	O
1	O
)	O
.	O

It	O
also	O
indicates	O
that	O
iron	O
acquisition	O
is	O
a	O
prerequisite	O
for	O
the	O
infection	O
process	O
of	O
pathogenic	O
bacteria	O
not	O
only	O
in	O
mammalian	O
,	O
but	O
also	O
in	O
invertebrate	O
hosts	O
,	O
and	O
underlines	O
the	O
suggestion	O
that	O
genetic	O
determinants	O
of	O
invertebrate	O
pathogens	O
such	O
as	O
P	B-Species
.	I-Species
luminescens	E-Species
include	O
the	O
progenitors	O
of	O
virulence	O
factors	O
against	O
vertebrates	O
[	O
79	O
,	O
106	O
]	O
.	O

The	O
TctE	O
/	O
TctD	O
system	O
is	O
the	O
only	O
TCS	O
of	O
P	B-Species
.	I-Species
luminescens	E-Species
without	O
homologue	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
(	O
see	O
section	O
"	O
Two	O
-	O
component	O
signal	O
transduction	O
"	O
,	O
Fig	O
.	O
2	O
)	O
.	O

This	O
pathogen	O
is	O
non	O
-	O
motile	O
at	O
body	O
temperature	O
,	O
and	O
a	O
connection	O
between	O
motility	O
and	O
virulence	O
is	O
well	O
-	O
documented	O
[	O
116	O
,	O
117	O
]	O
.	O

Evolution	O
of	O
pathogenicity	O

Certainly	O
,	O
the	O
question	O
whether	O
fundamental	O
differences	O
in	O
regulatory	O
networks	O
reflect	O
how	O
each	O
of	O
these	O
two	O
bacteria	O
specifically	O
interacts	O
with	O
either	O
the	O
insect	O
or	O
the	O
human	S-Species
host	O
remains	O
to	O
be	O
addressed	O
in	O
more	O
detail	O
.	O

Moreover	O
,	O
P	B-Species
.	I-Species
luminescens	E-Species
is	O
pathogenic	O
to	O
a	O
variety	O
of	O
insect	O
larvae	O
,	O
and	O
a	O
dose	O
of	O
<	O
5	O
colony	O
-	O
forming	O
units	O
directly	O
injected	O
into	O
the	O
blood	O
system	O
is	O
sufficient	O
to	O
kill	O
within	O
48	O
-	O
72	O
h	O
[	O
124	O
]	O
.	O

Summarizing	O
,	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
and	O
P	B-Species
.	I-Species
luminescens	E-Species
have	O
evolved	O
partially	O
different	O
and	O
partially	O
similar	O
and	O
therefore	O
probably	O
conserved	O
mechanisms	O
to	O
detect	O
and	O
to	O
react	O
on	O
the	O
insect	O
host	O
.	O

The	O
GraRS	O
regulatory	O
system	O
controls	O
Staphylococcus	B-Species
aureus	E-Species
susceptibility	O
to	O
antimicrobial	O
host	O
defenses	O

In	O
a	O
S	O
.	O
aureus	O
SA113	O
graRS	O
deletion	O
mutant	O
,	O
the	O
content	O
of	O
D	O
-	O
alanine	O
in	O
teichoic	O
acids	O
was	O
reduced	O
by	O
47	O
%	O
and	O
the	O
mutant	O
showed	O
reduced	O
resistance	O
to	O
various	O
antibiotics	O
including	O
polymyxin	O
B	O
,	O
gallidermin	O
,	O
and	O
vancomycin	O
[	O
10	O
,	O
13	O
]	O
.	O

The	O
characteristic	O
of	O
invasive	B-Species
GAS	E-Species
infections	O
has	O
been	O
thought	O
to	O
attribute	O
to	O
genetic	O
changes	O
in	O
bacteria	O
,	O
however	O
,	O
no	O
clear	O
evidence	O
has	O
shown	O
due	O
to	O
lack	O
of	O
an	O
intriguingly	O
study	O
using	O
serotype	O
-	O
matched	O
isolates	O
from	O
clinical	O
severe	O
invasive	B-Species
GAS	E-Species
infections	O
.	O

It	O
causes	O
a	O
wide	O
variety	O
of	O
infections	O
ranging	O
from	O
uncomplicated	O
pharyngitis	O
and	O
skin	O
infections	O
to	O
severe	O
and	O
even	O
life	O
-	O
threatening	O
manifestations	O
,	O
such	O
as	O
necrotizing	O
fasciitis	O
(	O
NF	O
)	O
and	O
streptococcal	O
toxic	O
shock	O
-	O
like	O
syndrome	O
(	O
STSS	O
)	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
,	O
with	O
high	O
mortality	O
rates	O
ranging	O
from	O
20	O
%	O
to	O
60	O
%	O
[	O
3	O
]	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
aimed	O
to	O
explore	O
the	O
crucial	O
factors	O
in	O
the	O
pathogenesis	O
of	O
severe	O
invasive	B-Species
GAS	E-Species
infections	O
in	O
the	O
context	O
of	O
PMN	O
-	O
GAS	O
relationship	O
,	O
using	O
a	O
panel	O
of	O
emm49	O
clinical	O
isolates	O
from	O
patients	S-Species
with	O
or	O
without	O
severe	O
invasive	O
infection	O
,	O
and	O
their	O
gene	O
-	O
manipulated	O
mutants	O
.	O

GAS	S-Species
isolates	O
from	O
mice	S-Species
with	O
severe	O
invasive	O
disease	O
had	O
mutations	O
in	O
csrS	O
,	O
raising	O
the	O
notion	O
that	O
CsrR	O
/	O
S	O
function	O
is	O
important	O
in	O
modulating	O
gene	O
expression	O
during	O
infection	O
.	O

However	O
,	O
as	O
shown	O
in	O
Figure	O
5B	O
,	O
the	O
csrS	O
genes	O
of	O
all	O
clinically	O
isolated	O
severe	O
invasive	B-Species
GAS	E-Species
had	O
a	O
deletion	O
,	O
a	O
point	O
mutation	O
,	O
or	O
an	O
insertion	O
,	O
thereby	O
,	O
resulting	O
in	O
the	O
creation	O
of	O
translational	O
stop	O
codons	O
(	O
NIH147	S-Species
,	O
NIH226	S-Species
,	O
NIH230	S-Species
,	O
and	O
NIH269	S-Species
)	O
or	O
in	O
a	O
mutation	O
in	O
the	O
presumed	O
kinase	O
domain	O
(	O
NIH200	S-Species
)	O
.	O

As	O
shown	O
in	O
Figure	O
7A	O
,	O
the	O
NIH230	S-Species
strain	O
caused	O
bacteremia	O
in	O
mice	S-Species
24	O
h	O
after	O
intraperitoneal	O
injection	O
whereas	O
the	O
bacteremia	O
was	O
barely	O
detected	O
in	O
mice	S-Species
infected	O
with	O
NIH230	O
:	O
:	O
csrS	O
+	O
as	O
well	O
as	O
the	O
1566	S-Species
strain	O
(	O
p	O
=	O
0	O
.	O
005	O
compared	O
with	O
non	B-Species
-	I-Species
invasive	E-Species
isolates	O
,	O
and	O
p	O
=	O
0	O
.	O
005	O
compared	O
with	O
invasive	O
isolates	O
+	O
CsrS	O
)	O
.	O

Contrarily	O
,	O
no	O
significant	O
pathological	O
alterations	O
were	O
observed	O
in	O
the	O
mice	S-Species
injected	O
with	O
the	O
1566	S-Species
and	O
NIH230	O
:	O
:	O
csrS	O
+	O
strains	O
(	O
Figure	O
7B	O
and	O
7C	O
)	O
.	O

Finally	O
,	O
we	O
assessed	O
the	O
influence	O
of	O
enhanced	O
expression	O
of	O
the	O
scpC	O
or	O
the	O
slo	O
gene	O
on	O
the	O
virulence	O
in	O
a	O
mouse	S-Species
model	O
.	O

However	O
,	O
the	O
severe	O
invasive	O
isolates	O
analyzed	O
in	O
this	O
study	O
accumulated	O
mutations	O
in	O
the	O
csrS	O
gene	O
but	O
not	O
in	O
the	O
csrR	O
gene	O
(	O
Figure	O
5B	O
and	O
data	O
not	O
shown	O
)	O
.	O

This	O
dominant	O
role	O
of	O
CsrS	O
is	O
the	O
first	O
important	O
observation	O
in	O
this	O
study	O
,	O
and	O
its	O
mutation	O
is	O
possibly	O
more	O
important	O
than	O
that	O
of	O
csrR	O
in	O
terms	O
of	O
etiopathogenesis	O
of	O
human	S-Species
severe	O
invasive	O
diseases	O
.	O

Furthermore	O
,	O
DNA	O
-	O
induced	O
expression	O
of	O
this	O
operon	O
resulted	O
in	O
up	O
to	O
2560	O
-	O
fold	O
increased	O
resistance	O
to	O
cationic	O
antimicrobial	O
peptides	O
and	O
640	O
-	O
fold	O
increased	O
resistance	O
to	O
aminoglycosides	O
,	O
but	O
had	O
no	O
effect	O
on	O
beta	O
-	O
lactam	O
and	O
fluoroquinolone	O
resistance	O
.	O

Alginate	O
production	O
has	O
been	O
shown	O
to	O
inhibit	O
phagocytic	O
killing	O
of	O
Pseudomonas	S-Species
,	O
to	O
protect	O
from	O
antibiotic	O
exposure	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
,	O
and	O
is	O
associated	O
with	O
poor	O
prognosis	O
for	O
the	O
infected	O
patients	S-Species
[	O
15	O
]	O
,	O
[	O
16	O
]	O
.	O

The	O
direct	O
observation	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
microcolonies	O
encased	O
in	O
an	O
alginate	O
matrix	O
in	O
microscopy	O
studies	O
of	O
CF	O
bronchial	O
samples	O
[	O
17	O
]	O
,	O
along	O
with	O
a	O
large	O
body	O
of	O
additional	O
in	O
vitro	O
and	O
in	O
vivo	O
data	O
[	O
7	O
]	O
,	O
[	O
18	O
]	O
-	O
[	O
21	O
]	O
suggests	O
that	O
P	B-Species
.	I-Species
aeruginosa	E-Species
forms	O
biofilms	O
in	O
the	O
lungs	O
of	O
CF	O
patients	S-Species
.	O

Although	O
the	O
basis	O
of	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
is	O
not	O
fully	O
understood	O
,	O
it	O
is	O
likely	O
that	O
multiple	O
mechanisms	O
operate	O
simultaneously	O
in	O
biofilms	O
to	O
contribute	O
to	O
antibiotic	O
resistance	O
.	O

These	O
include	O
,	O
but	O
are	O
not	O
limited	O
to	O
,	O
the	O
global	O
virulence	O
factor	O
regulator	O
GacA	O
,	O
mutation	O
of	O
which	O
results	O
in	O
a	O
10	O
-	O
fold	O
decrease	O
in	O
biofilm	O
formation	O
and	O
failure	O
to	O
form	O
microcolony	O
structures	O
[	O
33	O
]	O
.	O

Mutations	O
in	O
algR	O
,	O
a	O
response	O
regulator	O
protein	O
required	O
for	O
synthesis	O
of	O
alginate	O
,	O
which	O
is	O
a	O
major	O
component	O
of	O
the	O
matrix	O
of	O
biofilms	O
in	O
the	O
cystic	O
fibrosis	O
lung	O
[	O
1	O
]	O
results	O
in	O
a	O
P	B-Species
.	I-Species
aeruginosa	E-Species
strain	O
that	O
has	O
decreased	O
type	O
IV	O
pili	O
-	O
dependent	O
motility	O
and	O
biofilm	O
formation	O
[	O
39	O
]	O
.	O

Killing	O
was	O
dose	O
-	O
dependent	O
,	O
with	O
faster	O
killing	O
observed	O
as	O
the	O
DNA	O
concentration	O
increased	O
(	O
Fig	O
1C	O
)	O
.	O

Extracellular	O
DNA	O
induces	O
cell	O
death	O
by	O
membrane	O
perturbation	O
and	O
cell	O
lysis	O

This	O
property	O
,	O
in	O
combination	O
with	O
the	O
fast	O
-	O
killing	O
observed	O
in	O
response	O
to	O
extracellular	O
DNA	O
led	O
us	O
to	O
hypothesize	O
that	O
addition	O
of	O
exogenous	O
DNA	O
resulted	O
in	O
the	O
loss	O
of	O
membrane	O
integrity	O
through	O
cation	O
chelation	O
,	O
in	O
a	O
manner	O
similar	O
to	O
that	O
observed	O
with	O
the	O
known	O
cation	O
chelator	O
EDTA	O
[	O
58	O
]	O
.	O

PI	O
staining	O
was	O
observed	O
in	O
cells	O
exposed	O
to	O
DNA	O
and	O
EDTA	O
,	O
confirming	O
that	O
this	O
treatment	O
was	O
lethal	O
(	O
Fig	O
2B	O
)	O
.	O

PI	O
staining	O
also	O
revealed	O
the	O
presence	O
of	O
long	O
strands	O
of	O
genomic	O
DNA	O
,	O
presumably	O
as	O
a	O
consequence	O
of	O
the	O
loss	O
of	O
membrane	O
integrity	O
,	O
cell	O
lysis	O
and	O
release	O
of	O
cytoplasmic	O
contents	O
,	O
including	O
DNA	O
(	O
Fig	O
2B	O
)	O
.	O

Degradation	O
of	O
these	O
strands	O
by	O
DNAse	O
treatment	O
of	O
lysed	O
cells	O
confirmed	O
that	O
these	O
fibres	O
were	O
composed	O
of	O
DNA	O
(	O
Fig	O
S1	O
)	O
.	O

DNA	O
has	O
cation	O
chelating	O
activity	O

The	O
observation	O
that	O
DNA	O
disrupted	O
the	O
integrity	O
of	O
the	O
cell	O
envelope	O
causing	O
cell	O
lysis	O
suggested	O
that	O
DNA	O
was	O
acting	O
as	O
a	O
cation	O
chelator	O
.	O

The	O
genes	O
PA3552	O
-	O
PA3559	O
are	O
co	O
-	O
regulated	O
under	O
low	O
Mg2	O
+	O
conditions	O
and	O
are	O
thought	O
to	O
be	O
organized	O
as	O
an	O
operon	O
[	O
45	O
]	O
-	O
[	O
47	O
]	O
.	O

The	O
presence	O
of	O
DNA	O
in	O
peg	O
-	O
cultivated	O
biofilms	O
(	O
Fig	O
5A	O
)	O
,	O
grown	O
in	O
the	O
absence	O
of	O
exogenous	O
DNA	O
,	O
likely	O
contributes	O
to	O
the	O
increased	O
antibiotic	O
resistance	O
generally	O
observed	O
in	O
biofilms	O
(	O
Table	O
1	O
)	O
.	O

The	O
PA3553	O
mutant	O
also	O
displayed	O
decreased	O
DNA	O
-	O
induced	O
resistance	O
to	O
aminoglycosides	O
compared	O
to	O
PAO1	S-Species
.	O

In	O
S	B-Species
.	I-Species
typhimurium	E-Species
,	O
PhoPQ	O
regulates	O
multiple	O
LPS	O
modifications	O
that	O
decrease	O
the	O
OM	O
permeability	O
to	O
membrane	O
cationic	O
dyes	O
,	O
bile	O
salts	O
and	O
antibiotics	O
,	O
including	O
gentamicin	O
[	O
67	O
]	O
.	O

We	O
report	O
here	O
that	O
DNA	O
-	O
induces	O
aminoglycoside	O
resistance	O
in	O
P	B-Species
.	I-Species
aeruginosa	E-Species
biofilms	O
,	O
and	O
this	O
resistance	O
is	O
partially	O
dependent	O
on	O
the	O
LPS	O
modification	O
operon	O
PA3552	O
-	O
PA3559	O
.	O

While	O
previous	O
studies	O
have	O
shown	O
the	O
biofilm	O
matrix	O
to	O
function	O
as	O
a	O
diffusion	O
barrier	O
to	O
antibiotics	O
,	O
these	O
results	O
demonstrate	O
a	O
novel	O
function	O
of	O
the	O
biofilm	O
matrix	O
component	O
DNA	O
,	O
where	O
the	O
cation	O
chelating	O
properties	O
of	O
DNA	O
in	O
biofilms	O
induces	O
resistance	O
to	O
host	O
-	O
derived	O
or	O
therapeutic	O
antimicrobials	O
.	O

The	O
growth	O
curve	O
of	O
the	O
DeltavicK	O
mutant	O
in	O
THY	O
displays	O
a	O
longer	O
early	O
growth	O
phase	O
and	O
smaller	O
slope	O
in	O
the	O
exponential	O
growth	O
phase	O
than	O
that	O
of	O
the	O
parent	O
strain	O
(	O
Fig	O
.	O
2A	O
)	O
,	O
indicating	O
that	O
the	O
vicK	O
deletion	O
detrimentally	O
affects	O
S	B-Species
.	I-Species
equi	E-Species
growth	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
the	O
percentages	O
of	O
PMNs	O
associated	O
with	O
wild	O
-	O
type	O
and	O
DeltavicK	O
bacteria	O
at	O
both	O
time	O
points	O
and	O
in	O
both	O
horse	O
and	O
rabbit	O
blood	O
(	O
Fig	O
.	O
3	O
)	O
,	O
indicating	O
that	O
the	O
DeltavicK	O
mutant	O
retains	O
the	O
ability	O
of	O
S	B-Species
.	I-Species
equi	E-Species
to	O
resist	O
to	O
phagocytosis	O
by	O
PMNs	O
.	O

Seven	O
of	O
the	O
8	O
mice	S-Species
infected	O
with	O
the	O
wild	O
-	O
type	O
S	B-Species
.	I-Species
equi	E-Species
strain	O
died	O
,	O
whereas	O
7	O
of	O
the	O
8	O
mice	S-Species
inoculated	O
with	O
DeltavicK	O
survived	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

All	O
the	O
8	O
mice	S-Species
infected	O
with	O
DeltavicK	O
survived	O
,	O
whereas	O
5	O
of	O
the	O
8	O
mice	S-Species
infected	O
with	O
the	O
wild	O
-	O
type	O
S	B-Species
.	I-Species
equi	E-Species
strain	O
died	O
(	O
Fig	O
.	O
4B	O
)	O
.	O

These	O
results	O
indicate	O
that	O
the	O
vicK	O
deletion	O
significantly	O
attenuated	O
S	B-Species
.	I-Species
equi	E-Species
virulence	O
in	O
both	O
mouse	S-Species
models	O
of	O
subcutaneous	O
(	O
P	O
=	O
0	O
.	O
0066	O
)	O
and	O
nasal	O
(	O
P	O
=	O
0	O
.	O
0085	O
)	O
infections	O
.	O

Six	O
of	O
the	O
7	O
mice	S-Species
survived	O
the	O
reinfection	O
(	O
Fig	O
.	O
4A	O
)	O
,	O
suggesting	O
that	O
the	O
DeltavicK	O
infection	O
induces	O
immunity	O
against	O
S	B-Species
.	I-Species
equi	E-Species
infection	O
.	O

The	O
wild	O
-	O
type	O
sera	O
and	O
5	O
of	O
the	O
8	O
DeltavicK	O
samples	O
had	O
strong	O
immunoreactions	O
with	O
SeM38	O
-	O
260	O
in	O
Western	O
blotting	O
analysis	O
(	O
Fig	O
.	O
5C	O
)	O
.	O

As	O
a	O
first	O
step	O
towards	O
understanding	O
the	O
interplay	O
between	O
a	O
pathogen	O
and	O
its	O
host	O
from	O
a	O
systems	O
biology	O
standpoint	O
,	O
we	O
focused	O
on	O
these	O
14	O
genes	O
.	O

These	O
experiments	O
validated	O
the	O
regulatory	O
model	O
and	O
showed	O
that	O
the	O
response	O
regulator	O
SsrB	O
and	O
the	O
MarR	O
type	O
regulator	O
,	O
SlyA	O
,	O
are	O
the	O
terminal	O
regulators	O
in	O
a	O
cascade	O
that	O
integrates	O
multiple	O
signals	O
.	O

Gastrointestinal	O
infections	O
are	O
the	O
second	O
most	O
common	O
cause	O
of	O
childhood	O
mortality	O
in	O
the	O
developing	O
world	O
and	O
Typhoid	O
alone	O
(	O
caused	O
by	O
serovar	O
Typhi	S-Species
)	O
is	O
estimated	O
to	O
result	O
in	O
500	O
,	O
000	O
deaths	O
per	O
year	O
[	O
1	O
]	O
.	O

During	O
the	O
course	O
of	O
systemic	O
infection	O
in	O
mice	S-Species
,	O
bacteria	O
are	O
found	O
within	O
neutrophils	O
,	O
monocytes	O
,	O
dendritic	O
cells	O
,	O
and	O
B	O
and	O
T	O
cells	O
but	O
are	O
not	O
found	O
extracellularly	O
until	O
the	O
last	O
one	O
or	O
two	O
days	O
immediately	O
before	O
death	O
of	O
the	O
mouse	S-Species
[	O
15	O
]	O
-	O
[	O
17	O
]	O
.	O

Results	O

Salmonella	S-Species
regulators	O
required	O
for	O
systemic	O
mouse	S-Species
infection	O
Typhimurium	S-Species
encodes	O
a	O
surfeit	O
of	O
regulators	O
(	O
more	O
than	O
330	O
based	O
on	O
annotation	O
cited	O
in	O
NCBI	O
)	O
presumably	O
because	O
it	O
can	O
survive	O
and	O
replicate	O
in	O
many	O
different	O
environments	O
,	O
cause	O
infection	O
in	O
diverse	O
hosts	O
,	O
and	O
can	O
use	O
multiple	O
carbon	O
sources	O
and	O
terminal	O
electron	O
acceptors	O
.	O

Based	O
on	O
this	O
preliminary	O
screen	O
we	O
chose	O
the	O
regulators	O
spvR	O
,	O
fruR	O
,	O
himD	O
,	O
phoP	O
/	O
phoQ	O
,	O
ssrA	O
/	O
ssrB	O
,	O
slyA	O
,	O
hnr	O
,	O
rpoE	O
,	O
smpB	O
,	O
csrA	O
,	O
rpoS	O
,	O
crp	O
,	O
ompR	O
/	O
envZ	O
,	O
and	O
hfq	O
for	O
further	O
investigation	O
(	O
see	O
Figure	O
1	O
and	O
Table	O
1	O
for	O
references	O
and	O
descriptions	O
;	O
a	O
complete	O
list	O
of	O
virulence	O
phenotypes	O
is	O
provided	O
in	O
Table	O
S1	O
)	O
.	O

The	O
CI	O
test	O
identified	O
30	O
(	O
out	O
of	O
83	O
)	O
regulator	O
mutants	O
that	O
were	O
attenuated	O
in	O
comparison	O
to	O
the	O
wild	O
type	O
control	O
(	O
see	O
Table	O
S1	O
)	O
.	O

Our	O
results	O
closely	O
match	O
these	O
published	O
results	O
.	O

The	O
14	O
virulence	O
regulators	O
,	O
whose	O
absence	O
was	O
identified	O
by	O
attenuated	O
virulence	O
in	O
vivo	O
in	O
this	O
study	O
,	O
presumably	O
sense	O
specific	O
environmental	O
signals	O
within	O
the	O
host	O
and	O
respond	O
by	O
expressing	O
the	O
appropriate	O
complement	O
of	O
virulence	O
factors	O
.	O

Transcriptional	O
profiles	O
were	O
significantly	O
different	O
from	O
the	O
parent	O
for	O
known	O
virulence	O
factors	O
required	O
during	O
systemic	O
infection	O
,	O
but	O
only	O
if	O
cells	O
were	O
grown	O
in	O
acidic	O
minimal	O
media	O
(	O
AMM1	O
or	O
AMM2	O
;	O
see	O
Figure	O
3	O
;	O
complete	O
microarray	O
data	O
available	O
at	O
http	O
:	O
/	O
/	O
www	O
.	O
ohsu	O
.	O
edu	O
/	O
microbiology	O
/	O
heffron	O
/	O
r01	O
.	O
html	O
)	O
.	O

All	O
in	O
all	O
,	O
these	O
results	O
suggest	O
that	O
the	O
normal	O
function	O
of	O
each	O
of	O
the	O
14	O
regulators	O
is	O
to	O
activate	O
transcription	O
of	O
virulence	O
factors	O
necessary	O
for	O
systemic	O
infection	O
but	O
only	O
under	O
specific	O
environmental	O
conditions	O
.	O

We	O
observed	O
that	O
the	O
results	O
determined	O
by	O
these	O
two	O
methods	O
matched	O
closely	O
(	O
Figure	O
S2	O
)	O
and	O
that	O
the	O
level	O
of	O
transcription	O
of	O
ssaG	O
was	O
highest	O
when	O
Salmonella	S-Species
was	O
grown	O
in	O
minimal	O
acidic	O
media	O
.	O

Furthermore	O
,	O
Hfq	O
regulates	O
translation	O
of	O
more	O
than	O
20	O
%	O
of	O
all	O
Salmonella	S-Species
proteins	O
explaining	O
why	O
a	O
mutation	O
in	O
this	O
gene	O
has	O
such	O
a	O
dramatic	O
phenotype	O
(	O
[	O
54	O
]	O
;	O
Charles	O
Ansong	O
,	O
Hyunjin	O
Yoon	O
,	O
Steffen	O
Porwollik	O
,	O
Heather	O
Mottaz	O
-	O
Brewer	O
,	O
Briana	O
Ogata	O
-	O
Petritis	O
,	O
Navdeep	O
Jaitly	O
,	O
Joshua	O
N	O
.	O
Adkins	O
,	O
Michael	O
McClelland	O
,	O
Fred	O
Heffron	O
,	O
and	O
Richard	O
D	O
.	O
Smith	O
;	O
Global	O
systems	O
-	O
level	O
analysis	O
of	O
small	O
RNA	O
-	O
mediated	O
translational	O
regulation	O
:	O
Implications	O
for	O
virulence	O
and	O
global	O
protein	O
translation	O
;	O
Submitted	O
)	O
.	O

The	O
results	O
from	O
the	O
microarray	O
analysis	O
identified	O
many	O
genes	O
that	O
appeared	O
to	O
be	O
coordinately	O
regulated	O
including	O
all	O
SPI	O
-	O
2	O
encoded	O
genes	O
that	O
are	O
part	O
of	O
the	O
type	O
III	O
secretion	O
system	O
(	O
Table	O
S2	O
)	O
.	O

The	O
diverse	O
growth	O
conditions	O
used	O
in	O
this	O
study	O
,	O
as	O
well	O
as	O
differences	O
between	O
isogenic	O
strains	O
containing	O
mutations	O
in	O
virulence	O
regulators	O
,	O
make	O
our	O
data	O
set	O
ideal	O
for	O
this	O
type	O
of	O
analysis	O
.	O

SEBINI	O
incorporates	O
statistical	O
and	O
network	O
algorithms	O
into	O
a	O
framework	O
for	O
network	O
inference	O
[	O
55	O
]	O
,	O
[	O
56	O
]	O
.	O

A	O
recent	O
study	O
with	O
E	B-Species
.	I-Species
coli	E-Species
shows	O
that	O
the	O
CLR	O
algorithm	O
was	O
the	O
most	O
accurate	O
in	O
computing	O
the	O
correct	O
network	O
for	O
experimentally	O
verified	O
regulatory	O
interactions	O
[	O
19	O
]	O
.	O

The	O
cluster	O
analysis	O
identified	O
92	O
genes	O
that	O
are	O
co	O
-	O
regulated	O
with	O
the	O
SPI	O
-	O
2	O
encoded	O
type	O
III	O
secretion	O
system	O
but	O
not	O
located	O
within	O
SPI	O
-	O
2	O
.	O

The	O
network	O
suggests	O
that	O
both	O
slyA	O
and	O
ssrA	O
/	O
ssrB	O
could	O
coordinate	O
regulation	O
of	O
SPI	O
-	O
2	O
and	O
other	O
virulence	O
factors	O
by	O
integrating	O
signals	O
from	O
multiple	O
regulators	O
as	O
was	O
tested	O
next	O
.	O

To	O
test	O
this	O
possibility	O
we	O
constructed	O
double	O
deletions	O
of	O
ssrAB	O
/	O
ompRenvZ	O
,	O
ssrAB	O
/	O
phoPQ	O
,	O
ssrAB	O
/	O
csrA	O
and	O
ssrAB	O
/	O
himD	O
.	O

Because	O
the	O
bacteria	O
are	O
exclusively	O
intracellular	O
we	O
tested	O
the	O
hypothesis	O
that	O
replication	O
in	O
macrophages	O
could	O
be	O
a	O
surrogate	O
for	O
systemic	O
mouse	S-Species
infection	O
.	O

There	O
are	O
other	O
regulators	O
required	O
for	O
systemic	O
infection	O
in	O
BALB	B-Species
/	I-Species
c	I-Species
mice	E-Species
,	O
including	O
those	O
whose	O
absence	O
reduces	O
viability	O
without	O
a	O
compensating	O
mutation	O
(	O
hns	O
;	O
[	O
70	O
]	O
)	O
,	O
those	O
that	O
require	O
deletion	O
of	O
two	O
unlinked	O
genes	O
for	O
inactivation	O
(	O
ppGpp	O
;	O
reviewed	O
in	O
[	O
71	O
]	O
and	O
ydgT	O
/	O
hha	O
[	O
48	O
]	O
)	O
,	O
or	O
those	O
that	O
were	O
simply	O
missed	O
in	O
the	O
screens	O
(	O
STM0410	O
;	O
[	O
72	O
]	O
)	O
;	O
these	O
regulators	O
will	O
be	O
included	O
in	O
subsequent	O
analyses	O
.	O

Four	O
nucleoid	O
-	O
like	O
proteins	O
in	O
enteric	O
bacteria	O
,	O
H	O
-	O
NS	O
,	O
StpA	O
,	O
Hha	O
,	O
and	O
YdgT	O
have	O
a	O
predilection	O
for	O
binding	O
to	O
A	O
+	O
T	O
rich	O
sequences	O
and	O
repress	O
transcription	O
of	O
SPI	O
-	O
2	O
genes	O
(	O
rev	O
.	O
in	O
[	O
14	O
]	O
)	O
.	O

Mycobacterium	B-Species
tuberculosis	E-Species
Rv2623	O
regulates	O
growth	O
in	O
vitro	O
An	O
rv2623	O
-	O
deletion	O
mutant	O
of	O
the	O
virulent	O
M	B-Species
.	I-Species
tuberculosis	I-Species
Erdman	I-Species
strain	E-Species
was	O
generated	O
by	O
specialized	O
transduction	O
[	O
12	O
]	O
.	O

The	O
observation	O
that	O
Rv2623	O
modulates	O
mycobacterial	O
growth	O
in	O
vitro	O
prompted	O
us	O
to	O
examine	O
the	O
effect	O
of	O
this	O
USP	O
on	O
the	O
in	O
vivo	O
kinetics	O
of	O
M	B-Species
.	I-Species
tuberculosis	E-Species
infection	O
.	O

Moreover	O
,	O
Deltarv2623	O
-	O
infected	O
guinea	O
pigs	O
were	O
moribund	O
at	O
60	O
days	O
post	O
-	O
infection	O
,	O
while	O
those	O
challenged	O
with	O
wildtype	O
Erdman	S-Species
remained	O
relatively	O
healthy	O
,	O
providing	O
further	O
evidence	O
that	O
the	O
mutant	O
strain	O
is	O
hypervirulent	O
in	O
this	O
model	O
.	O

This	O
increase	O
in	O
lung	O
pathology	O
was	O
also	O
largely	O
reversed	O
in	O
animals	O
infected	O
with	O
the	O
complemented	O
Deltarv2623	O
attB	O
:	O
:	O
Phsp60Rv2623	O
strain	O
(	O
Figure	O
3B	O
and	O
C	O
)	O
.	O

In	O
agreement	O
with	O
the	O
survival	O
data	O
,	O
quantification	O
of	O
tissue	O
bacterial	O
burden	O
revealed	O
a	O
growth	O
advantage	O
for	O
the	O
Rv2623	O
-	O
deficient	O
mutant	O
relative	O
to	O
wildtype	O
M	B-Species
.	I-Species
tuberculosis	I-Species
Erdman	E-Species
(	O
Figure	O
4C	O
)	O
.	O

As	O
in	O
the	O
guinea	B-Species
pig	E-Species
studies	O
,	O
results	O
of	O
complementation	O
experiments	O
involving	O
the	O
reintroduction	O
of	O
a	O
single	O
copy	O
of	O
wildtype	O
rv2623	O
into	O
Deltarv2623	O
M	O
.	O
tuberculosis	O
reverses	O
the	O
hypervirulence	O
(	O
Figure	O
4C	O
)	O
exhibited	O
in	O
the	O
C3H	B-Species
/	I-Species
HeJ	E-Species
model	O
,	O
thus	O
indicating	O
that	O
the	O
observed	O
growth	O
phenotype	O
of	O
the	O
tubercle	B-Species
bacillus	E-Species
deficient	O
for	O
the	O
universal	O
stress	O
protein	O
is	O
rv2623	O
-	O
specific	O
.	O

Therefore	O
,	O
the	O
hypervirulence	O
of	O
Deltarv2623	O
in	O
guinea	B-Species
pigs	E-Species
and	O
susceptible	O
mice	S-Species
is	O
intriguing	O
;	O
if	O
Rv2623	O
provides	O
M	B-Species
.	I-Species
tuberculosis	E-Species
protection	O
against	O
stress	O
,	O
it	O
might	O
be	O
expected	O
that	O
the	O
Rv2623	O
-	O
deficient	O
mutant	O
would	O
be	O
attenuated	O
in	O
vivo	O
.	O

An	O
HPLC	O
-	O
based	O
examination	O
of	O
supernatants	O
from	O
boiled	O
samples	O
of	O
His6	O
-	O
Rv2623	O
demonstrated	O
that	O
His6	O
-	O
Rv2623	O
co	O
-	O
purifies	O
with	O
both	O
ATP	O
and	O
ADP	O
(	O
Figure	O
5	O
)	O
.	O

A	O
"	O
U	O
-	O
shaped	O
"	O
ATP	O
molecule	O
that	O
lies	O
within	O
a	O
cleft	O
near	O
the	O
monomer	O
surface	O
is	O
stabilized	O
by	O
1	O
)	O
a	O
cluster	O
of	O
hydrophobic	O
residues	O
(	O
I14	O
,	O
V41	O
,	O
H42	O
,	O
V116	O
/	O
132	O
/	O
261	O
/	O
277	O
/	O
281	O
,	O
L136	O
,	O
A175	O
)	O
that	O
forge	O
the	O
adenine	O
/	O
ribose	O
-	O
binding	O
scaffold	O
,	O
2	O
)	O
a	O
pair	O
of	O
conserved	O
L1	O
/	O
L3	O
aspartates	O
(	O
D15	O
-	O
L1	O
/	O
D167	O
-	O
L3	O
)	O
,	O
and	O
3	O
)	O
small	O
phosphoryl	O
/	O
ribosyl	O
-	O
binding	O
residues	O
within	O
the	O
G	O
-	O
2X	O
-	O
G	O
-	O
9X	O
-	O
G	O
(	O
S	O
/	O
T	O
)	O
motifs	O
that	O
comprise	O
L2	O
/	O
L4	O
(	O
G120	O
/	O
265	O
/	O
267	O
/	O
268	O
and	O
S131	O
/	O
276	O
)	O
(	O
Figures	O
6A	O
,	O
C	O
and	O
7A	O
)	O
.	O

As	O
this	O
manuscript	O
was	O
under	O
preparation	O
,	O
a	O
second	O
,	O
lower	O
resolution	O
(	O
3	O
.	O
2	O
A	O
)	O
crystal	O
form	O
of	O
Rv2623	O
(	O
PDB	O
ID	O
2JAX	O
)	O
was	O
released	O
for	O
public	O
access	O
.	O

Overlay	O
of	O
these	O
structures	O
reveals	O
very	O
considerable	O
similarity	O
for	O
the	O
residues	O
that	O
form	O
the	O
binding	O
pockets	O
and	O
the	O
associated	O
ATP	O
molecules	O
,	O
for	O
which	O
the	O
triphosphoryl	O
moieties	O
assume	O
virtually	O
indistinguishable	O
conformations	O
.	O

The	O
growth	O
-	O
regulating	O
property	O
of	O
M	B-Species
.	I-Species
tuberculosis	E-Species
Rv2623	O
is	O
dependent	O
on	O
its	O
ability	O
to	O
bind	O
ATP	O

Discussion	O

Based	O
on	O
in	O
silico	O
analyses	O
,	O
Florczyk	O
et	O
al	O
.	O
classified	O
Rv2623	O
as	O
belonging	O
to	O
a	O
novel	O
class	O
of	O
ATPases	O
[	O
52	O
]	O
,	O
although	O
formal	O
evidence	O
for	O
ATP	O
binding	O
by	O
this	O
protein	O
has	O
not	O
been	O
reported	O
.	O

It	O
has	O
been	O
proposed	O
that	O
a	O
nucleotide	O
-	O
binding	O
USP	O
from	O
M	B-Species
.	I-Species
jannaschii	E-Species
,	O
MJ0577	O
,	O
whose	O
ability	O
to	O
hydrolyze	O
ATP	O
is	O
dependent	O
on	O
interaction	O
with	O
factor	O
(	O
s	O
)	O
present	O
in	O
the	O
cell	O
extract	O
of	O
this	O
hyperthermophile	O
[	O
26	O
]	O
,	O
functions	O
as	O
a	O
molecular	O
switch	O
much	O
like	O
the	O
Ras	O
protein	O
family	O
,	O
whose	O
GTP	O
hydrolysis	O
ability	O
is	O
modulated	O
by	O
interaction	O
with	O
a	O
number	O
of	O
regulatory	O
proteins	O
[	O
53	O
]	O
,	O
[	O
54	O
]	O
,	O
[	O
55	O
]	O
.	O

The	O
fact	O
that	O
E	B-Species
.	I-Species
coli	E-Species
-	O
expressed	O
Rv2623	O
co	O
-	O
purifies	O
with	O
ADP	O
as	O
well	O
as	O
ATP	O
suggests	O
the	O
possibility	O
that	O
this	O
mycobacterial	O
USP	O
,	O
like	O
MJ0577	O
,	O
is	O
capable	O
of	O
ATP	O
hydrolysis	O
.	O

Elucidation	O
of	O
how	O
ATP	O
-	O
binding	O
and	O
,	O
potentially	O
,	O
the	O
hydrolysis	O
of	O
ATP	O
by	O
Rv2623	O
regulate	O
M	B-Species
.	I-Species
tuberculosis	E-Species
dormancy	O
-	O
signaling	O
pathways	O
will	O
likely	O
illuminate	O
the	O
mechanisms	O
by	O
which	O
the	O
tubercle	O
bacillus	O
establishes	O
persistence	O
.	O

This	O
raises	O
the	O
question	O
of	O
whether	O
the	O
transition	O
to	O
later	O
stages	O
of	O
biofilm	O
formation	O
,	O
which	O
coincide	O
with	O
distinct	O
phenotypes	O
compared	O
to	O
planktonic	O
and	O
initial	O
attached	O
bacterial	O
cells	O
,	O
also	O
involves	O
sensing	O
of	O
environmental	O
signal	O
(	O
s	O
)	O
and	O
requires	O
the	O
coordinated	O
transduction	O
of	O
phosphorylation	O
events	O
(	O
phosphorelays	O
)	O
.	O

These	O
systems	O
together	O
form	O
a	O
coordinated	O
signaling	O
network	O
that	O
regulates	O
three	O
committed	O
steps	O
of	O
the	O
P	B-Species
.	I-Species
aeruginosa	E-Species
biofilm	O
life	O
cycle	O
,	O
in	O
particular	O
the	O
transition	O
to	O
three	O
later	O
biofilm	O
developmental	O
stages	O
following	O
initial	O
attachment	O
,	O
namely	O
initiation	O
of	O
biofilm	O
formation	O
(	O
BfiRS	O
)	O
,	O
biofilm	O
maturation	O
(	O
BfmRS	O
)	O
,	O
and	O
microcolony	O
formation	O
(	O
MifRS	O
)	O
.	O

The	O
quantitative	O
mass	O
spectrometric	O
approach	O
by	O
LC	O
-	O
MS	O
/	O
MS	O
allowed	O
for	O
the	O
simultaneous	O
determination	O
of	O
peptide	O
amino	O
acid	O
sequences	O
by	O
collision	O
-	O
induced	O
dissociation	O
(	O
CID	O
)	O
in	O
the	O
MS	O
/	O
MS	O
mode	O
.	O

The	O
probable	O
TCS	O
regulatory	O
protein	O
PA5511	O
(	O
MifR	O
)	O
was	O
phosphorylated	O
following	O
72	O
hr	O
of	O
surface	O
-	O
associated	O
growth	O
.	O

This	O
may	O
be	O
due	O
to	O
detection	O
limitation	O
(	O
low	O
protein	O
concentrations	O
,	O
poor	O
protein	O
solubility	O
,	O
poor	O
ionization	O
)	O
and	O
/	O
or	O
limitation	O
in	O
the	O
number	O
of	O
phosphorylated	O
proteins	O
identified	O
(	O
see	O
Suppl	O
.	O
Tables	O
S1	O
and	O
S2	O
for	O
comparison	O
)	O
.	O

We	O
reasoned	O
that	O
if	O
protein	O
phosphorylation	O
occurs	O
in	O
sequence	O
,	O
inactivation	O
of	O
one	O
of	O
the	O
proteins	O
would	O
potentially	O
prevent	O
phosphorylation	O
of	O
the	O
other	O
proteins	O
of	O
the	O
phosphorelay	O
.	O

DeltagacS	O
biofilm	O
phosphorylation	O
patterns	O
showed	O
an	O
intermediate	O
phosphorylation	O
phenotype	O
with	O
PA4197	O
being	O
phosphorylated	O
but	O
PA4101	O
phosphorylation	O
lacking	O
(	O
not	O
shown	O
)	O
.	O

As	O
differential	O
and	O
sequential	O
phosphorylation	O
of	O
regulatory	O
proteins	O
was	O
detected	O
over	O
the	O
course	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
biofilm	O
development	O
,	O
we	O
asked	O
whether	O
inactivation	O
of	O
these	O
regulatory	O
proteins	O
would	O
alter	O
or	O
affect	O
the	O
stage	O
-	O
specific	O
progression	O
of	O
biofilm	O
formation	O
.	O

Furthermore	O
,	O
the	O
mutant	O
biofilms	O
differed	O
significantly	O
from	O
wild	O
type	O
biofilms	O
with	O
respect	O
to	O
biomass	O
,	O
surface	O
coverage	O
,	O
and	O
roughness	O
coefficient	O
.	O

Complementation	O
restored	O
biofilm	O
formation	O
to	O
wild	O
type	O
levels	O
(	O
Fig	O
.	O
2C	O
,	O
Table	O
2	O
)	O
.	O

Under	O
the	O
conditions	O
tested	O
,	O
the	O
biofilm	O
architecture	O
of	O
all	O
three	O
mutants	O
was	O
similar	O
to	O
the	O
biofilm	O
architecture	O
shown	O
in	O
Fig	O
.	O

These	O
findings	O
implied	O
that	O
the	O
novel	O
regulatory	O
proteins	O
were	O
involved	O
in	O
the	O
regulation	O
of	O
biofilm	O
formation	O
at	O
later	O
stages	O
following	O
initial	O
attachment	O
.	O

In	O
this	O
study	O
we	O
describe	O
the	O
identification	O
and	O
initial	O
characterization	O
of	O
three	O
novel	O
two	O
-	O
component	O
systems	O
(	O
TCS	O
)	O
essential	O
in	O
regulating	O
three	O
committed	O
steps	O
in	O
biofilm	O
development	O
.	O

The	O
sequential	O
phosphorylation	O
of	O
sensors	O
/	O
regulatory	O
proteins	O
is	O
reminiscent	O
of	O
a	O
regulatory	O
cascade	O
in	O
which	O
each	O
phosphorylation	O
event	O
acts	O
as	O
a	O
trigger	O
for	O
bacterial	O
biofilm	O
cells	O
to	O
transition	O
to	O
the	O
next	O
developmental	O
stage	O
(	O
Fig	O
.	O
6	O
)	O
.	O

BfiR	O
harbors	O
region	O
4	O
of	O
Sigma	O
-	O
70	O
(	O
RpoD	O
)	O
-	O
like	O
sigma	O
factors	O
,	O
a	O
domain	O
involved	O
in	O
binding	O
to	O
-	O
35	O
promoter	O
elements	O
.	O

To	O
date	O
,	O
13	O
effectors	O
have	O
been	O
identified	O
as	O
substrates	O
of	O
the	O
SPI	O
-	O
1	O
T3SS	O
and	O
21	O
effectors	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O
,	O
although	O
the	O
chaperones	O
orchestrating	O
the	O
latter	O
system	O
have	O
been	O
elusive	O
.	O

These	O
include	O
the	O
effector	O
-	O
chaperone	O
pair	O
of	O
SseF	O
-	O
SscB	O
,	O
and	O
the	O
chaperone	O
SseA	O
that	O
binds	O
translocon	O
components	O
SseD	O
and	O
SseB	O
[	O
8	O
]	O
,	O
[	O
9	O
]	O
,	O
[	O
10	O
]	O
.	O

In	O
addition	O
to	O
maintaining	O
a	O
region	O
of	O
localized	O
effector	O
unfolding	O
[	O
12	O
]	O
,	O
T3SS	O
chaperones	O
have	O
an	O
emerging	O
role	O
as	O
escorts	O
that	O
deliver	O
their	O
cargo	O
to	O
the	O
cytoplasmic	O
face	O
of	O
the	O
inner	O
membrane	O
through	O
physical	O
interactions	O
with	O
an	O
ATPase	O
.	O

Results	O

The	O
srcA	O
gene	O
is	O
not	O
located	O
in	O
the	O
vicinity	O
of	O
the	O
T3SS	O
encoded	O
by	O
SPI	O
-	O
2	O
(	O
STM1378	O
-	O
STM1425	O
)	O
,	O
but	O
is	O
713	O
genes	O
downstream	O
on	O
the	O
chromosome	O
(	O
STM	O
numbers	O
are	O
based	O
on	O
the	O
LT2	O
genome	O
and	O
ordered	O
sequentially	O
on	O
the	O
chromosome	O
beginning	O
at	O
STM0001	O
,	O
thrL	O
)	O
.	O

In	O
comparative	O
genomics	O
analyses	O
,	O
srcA	O
was	O
found	O
in	O
all	O
virulent	O
strains	O
of	O
Salmonella	B-Species
enterica	E-Species
containing	O
SPI	O
-	O
2	O
,	O
but	O
was	O
absent	O
from	O
the	O
cold	O
-	O
blooded	O
animal	O
commensal	O
,	O
S	B-Species
.	I-Species
bongori	E-Species
,	O
which	O
lacks	O
SPI	O
-	O
2	O
(	O
Table	O
S1	O
)	O
.	O

The	O
level	O
of	O
attenuation	O
of	O
the	O
srcA	O
mutant	O
was	O
generally	O
higher	O
than	O
most	O
single	O
effector	O
gene	O
mutants	O
[	O
26	O
]	O
,	O
which	O
suggested	O
to	O
us	O
that	O
SrcA	O
contributes	O
to	O
an	O
important	O
aspect	O
of	O
T3SS	O
function	O
in	O
vivo	O
.	O

Although	O
the	O
N	O
-	O
terminus	O
of	O
these	O
proteins	O
is	O
conserved	O
structurally	O
,	O
the	O
tertiary	O
structures	O
differ	O
for	O
each	O
protein	O
.	O

To	O
evaluate	O
the	O
potential	O
for	O
an	O
effector	O
-	O
binding	O
surface	O
on	O
SrcA	O
,	O
the	O
structure	O
of	O
SicP	O
in	O
complex	O
with	O
its	O
effector	O
SptP	O
was	O
aligned	O
with	O
SrcA	O
and	O
represented	O
as	O
a	O
space	O
-	O
filling	O
model	O
(	O
Fig	O
.	O
3B	O
)	O
.	O

SsaN	O
contains	O
conserved	O
amino	O
acid	O
residues	O
characteristic	O
of	O
Walker	O
-	O
A	O
and	O
Walker	O
-	O
B	O
motifs	O
of	O
P	O
-	O
loop	O
nucleoside	O
triphosphate	O
hydrolases	O
,	O
as	O
well	O
as	O
a	O
number	O
of	O
residues	O
shown	O
to	O
contribute	O
to	O
ATP	O
binding	O
or	O
ring	O
stacking	O
with	O
the	O
adenine	O
base	O
of	O
ATP	O
in	O
the	O
E	B-Species
.	I-Species
coli	E-Species
orthologue	O
,	O
EscN	O
,	O
(	O
Q412	O
,	O
E191	O
,	O
R366	O
)	O
(	O
Fig	O
.	O
S1	O
)	O
.	O

The	O
direct	O
binding	O
of	O
SsrB	O
to	O
the	O
promoter	O
region	O
upstream	O
of	O
srcA	O
,	O
along	O
with	O
SsrB	O
-	O
regulation	O
of	O
both	O
sseL	O
[	O
19	O
]	O
,	O
[	O
20	O
]	O
and	O
pipB2	O
[	O
32	O
]	O
is	O
indicative	O
of	O
multiple	O
cis	O
-	O
regulatory	O
mutation	O
events	O
that	O
have	O
allowed	O
for	O
functional	O
coordination	O
of	O
the	O
distributed	O
secretion	O
apparatus	O
,	O
chaperone	O
and	O
effector	O
cargos	O
.	O

SrcA	O
is	O
unique	O
among	O
other	O
multi	O
-	O
effector	O
chaperones	O
most	O
closely	O
related	O
to	O
it	O
in	O
that	O
it	O
is	O
unlinked	O
from	O
the	O
T3SS	O
genomic	O
island	O
.	O

Introduction	O

In	O
common	O
with	O
many	O
other	O
bacteria	O
,	O
ECM	O
synthesis	O
in	O
Y	B-Species
.	I-Species
pestis	E-Species
is	O
controlled	O
by	O
intracellular	O
levels	O
of	O
cyclic	O
di	O
-	O
GMP	O
,	O
which	O
are	O
determined	O
by	O
competing	O
activities	O
of	O
the	O
hmsT	O
diguanylate	O
cyclase	O
and	O
hmsP	O
phosphodiesterase	O
gene	O
products	O
[	O
8	O
]	O
,	O
[	O
9	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
characterized	O
the	O
Y	B-Species
.	I-Species
pestis	E-Species
transcriptome	O
in	O
blocked	O
Xenopsylla	B-Species
cheopis	I-Species
rat	I-Species
fleas	E-Species
,	O
an	O
important	O
vector	O
of	O
plague	O
to	O
humans	S-Species
.	O

This	O
provides	O
the	O
"	O
medium	O
"	O
for	O
Y	B-Species
.	I-Species
pestis	E-Species
growth	O
,	O
but	O
these	O
and	O
other	O
factors	O
such	O
as	O
pH	O
,	O
oxygen	O
tension	O
,	O
osmolarity	O
,	O
and	O
flea	S-Species
antibacterial	O
immune	O
components	O
are	O
poorly	O
defined	O
.	O

Blockage	O
occurred	O
between	O
1	O
.	O
5	O
and	O
3	O
.	O
5	O
weeks	O
after	O
the	O
initial	O
infectious	O
blood	O
meal	O
,	O
during	O
which	O
time	O
the	O
fleas	S-Species
fed	O
on	O
uninfected	O
mice	S-Species
twice	O
weekly	O
.	O

Profiles	O
of	O
the	O
exponential	O
and	O
stationary	O
phase	O
planktonic	O
cultures	O
clustered	O
most	O
closely	O
,	O
whereas	O
the	O
profiles	O
from	O
in	O
vitro	O
and	O
in	O
vivo	O
biofilm	O
growth	O
were	O
more	O
distinct	O
from	O
each	O
other	O
and	O
from	O
the	O
planktonic	O
culture	O
profiles	O
.	O

Certain	O
genes	O
whose	O
mutational	O
loss	O
resulted	O
in	O
an	O
altered	O
biofilm	O
phenotype	O
have	O
been	O
identified	O
in	O
these	O
studies	O
;	O
but	O
in	O
general	O
a	O
consistent	O
,	O
distinct	O
biofilm	O
gene	O
expression	O
profile	O
has	O
not	O
emerged	O
.	O

In	O
addition	O
to	O
the	O
known	O
temperature	O
-	O
induced	O
virulence	O
factors	O
,	O
iron	O
acquisition	O
systems	O
,	O
including	O
the	O
ybt	O
and	O
yfe	O
operons	O
that	O
are	O
required	O
for	O
virulence	O
;	O
and	O
oxidative	O
and	O
nitrosative	O
stress	O
response	O
genes	O
,	O
including	O
the	O
hmp	O
virulence	O
factor	O
,	O
are	O
highly	O
upregulated	O
in	O
the	O
rat	S-Species
bubo	O
,	O
but	O
not	O
the	O
flea	S-Species
.	O

The	O
psa	O
locus	O
is	O
regulated	O
by	O
RovA	O
[	O
36	O
]	O
.	O

Consistent	O
with	O
these	O
findings	O
,	O
rovA	O
expression	O
was	O
downregulated	O
in	O
the	O
flea	S-Species
;	O
whereas	O
expression	O
of	O
rovM	O
,	O
a	O
negative	O
regulator	O
of	O
rovA	O
[	O
37	O
]	O
,	O
was	O
upregulated	O
.	O

The	O
transcriptional	O
regulator	O
gene	O
phoP	O
of	O
the	O
PhoPQ	O
two	O
-	O
component	O
regulatory	O
system	O
and	O
the	O
PhoP	O
-	O
regulated	O
mgtC	O
gene	O
were	O
expressed	O
at	O
levels	O
>	O
2	O
-	O
fold	O
higher	O
in	O
fleas	S-Species
than	O
in	O
any	O
other	O
condition	O
(	O
Tables	O
1	O
,	O
S1	O
,	O
S3	O
)	O
.	O

However	O
,	O
deletion	O
of	O
yitR	O
or	O
yitA	O
-	O
yipB	O
(	O
y0183	O
-	O
y0191	O
)	O
does	O
not	O
affect	O
the	O
ability	O
of	O
Y	B-Species
.	I-Species
pestis	I-Species
KIM6	I-Species
+	E-Species
to	O
infect	O
or	O
block	O
fleas	S-Species
(	O
data	O
not	O
shown	O
)	O
.	O

To	O
determine	O
if	O
the	O
insecticidal	O
-	O
like	O
toxins	O
were	O
involved	O
in	O
resistance	O
to	O
phagocytosis	O
,	O
we	O
repeated	O
the	O
macrophage	O
experiments	O
with	O
a	O
Y	B-Species
.	I-Species
pestis	I-Species
DeltayitR	E-Species
mutant	O
,	O
which	O
as	O
expected	O
showed	O
greatly	O
reduced	O
expression	O
of	O
the	O
yit	O
and	O
yip	O
genes	O
in	O
vitro	O
and	O
in	O
the	O
flea	S-Species
(	O
Fig	O
.	O
4B	O
)	O
.	O

However	O
,	O
it	O
was	O
not	O
possible	O
to	O
detect	O
any	O
relatively	O
minor	O
difference	O
in	O
LD50	O
because	O
the	O
number	O
of	O
bacteria	O
transmitted	O
by	O
a	O
blocked	O
flea	S-Species
varies	O
widely	O
[	O
1	O
]	O
,	O
[	O
52	O
]	O
.	O

Coming	O
from	O
the	O
flea	S-Species
,	O
Y	B-Species
.	I-Species
pestis	E-Species
is	O
also	O
associated	O
with	O
the	O
biofilm	O
ECM	O
,	O
identical	O
or	O
closely	O
related	O
to	O
the	O
poly	O
-	O
beta	O
-	O
1	O
,	O
6	O
-	O
N	O
-	O
acetyl	O
glucosamine	O
ECM	O
of	O
staphylococcal	S-Species
biofilms	O
,	O
which	O
has	O
been	O
shown	O
to	O
provide	O
protection	O
from	O
innate	O
immune	O
components	O
[	O
55	O
]	O
,	O
[	O
56	O
]	O
.	O

Methodology	O
/	O
Principal	O
Findings	O
A	O
total	O
of	O
127	O
differentially	O
expressed	O
genes	O
were	O
found	O
:	O
83	O
were	O
over	O
expressed	O
and	O
44	O
were	O
less	O
expressed	O
in	O
the	O
bvrR	O
mutant	O
.	O

Notably	O
,	O
seven	O
transcriptional	O
regulators	O
were	O
affected	O
,	O
including	O
VjbR	O
,	O
ExoR	O
and	O
OmpR	O
that	O
were	O
less	O
expressed	O
in	O
the	O
bvrR	O
mutant	O
.	O

Conclusions	O
/	O
Significance	O
All	O
these	O
data	O
corroborate	O
the	O
impact	O
of	O
BvrR	O
/	O
BvrS	O
on	O
cell	O
envelope	O
modulation	O
,	O
confirm	O
that	O
this	O
system	O
controls	O
the	O
carbon	O
and	O
nitrogen	O
metabolism	O
,	O
and	O
suggest	O
a	O
cross	O
-	O
talk	O
among	O
some	O
regulators	O
to	O
adjust	O
the	O
Brucella	S-Species
physiology	O
to	O
the	O
shift	O
expected	O
to	O
occur	O
during	O
the	O
transit	O
from	O
the	O
extracellular	O
to	O
the	O
intracellular	O
niche	O
.	O

Introduction	O

For	O
this	O
,	O
the	O
bacterium	O
must	O
coordinate	O
an	O
intricate	O
network	O
of	O
factors	O
to	O
generate	O
a	O
suitable	O
adaptive	O
response	O
to	O
the	O
various	O
signals	O
.	O

BvrR	O
/	O
bvrS	O
mutants	O
are	O
avirulent	O
in	O
mice	S-Species
,	O
have	O
increased	O
susceptibility	O
to	O
killing	O
by	O
nonimmune	O
serum	O
,	O
show	O
reduced	O
invasiveness	O
to	O
epithelial	O
cells	O
and	O
macrophages	O
,	O
and	O
are	O
incapable	O
of	O
inhibiting	O
lysosome	O
fusion	O
and	O
of	O
intracellular	O
replication	O
[	O
4	O
]	O
.	O

This	O
evidence	O
suggests	O
an	O
altered	O
outer	O
membrane	O
structure	O
.	O

B	B-Species
.	I-Species
abortus	E-Species
RNA	O
was	O
obtained	O
from	O
three	O
independent	O
cultures	O
of	O
each	O
wild	O
type	O
and	O
bvrR	O
mutant	O
cells	O
grown	O
in	O
the	O
same	O
conditions	O
.	O

The	O
statistical	O
analysis	O
resulted	O
in	O
the	O
identification	O
of	O
a	O
total	O
of	O
127	O
genes	O
differentially	O
transcribed	O
in	O
the	O
bvrR	O
mutant	O
versus	O
the	O
wild	O
type	O
.	O

On	O
the	O
other	O
hand	O
,	O
exoR	O
(	O
BAB1	O
_	O
0891	O
)	O
,	O
omp25a	O
(	O
BAB1	O
_	O
0722	O
)	O
,	O
hpr	O
-	O
K	O
(	O
BAB1	O
_	O
2094	O
)	O
,	O
bvrS	O
(	O
BAB1	O
_	O
2093	O
)	O
and	O
the	O
lipoproteins	O
(	O
BAB1	O
_	O
2147	O
,	O
BAB1	O
_	O
0589	O
,	O
BAB1	O
_	O
0358	O
)	O
were	O
among	O
the	O
less	O
expressed	O
genes	O
(	O
Table	O
1	O
)	O
.	O

Interestingly	O
,	O
all	O
genes	O
related	O
with	O
carbohydrate	O
,	O
amino	O
or	O
fatty	O
acids	O
metabolism	O
were	O
up	O
-	O
regulated	O
in	O
the	O
bvrR	O
mutant	O
.	O

The	O
nitrite	O
reductase	O
gene	O
(	O
nirK	O
,	O
BAB2	O
_	O
0943	O
)	O
was	O
down	O
regulated	O
and	O
the	O
nitric	O
oxide	O
and	O
nitrous	O
oxide	O
reductases	O
genes	O
(	O
nor	O
C	O
,	O
BAB2	O
_	O
0955	O
;	O
nosZ	O
,	O
BAB2	O
_	O
0928	O
)	O
were	O
up	O
regulated	O
.	O

Brucella	S-Species
may	O
also	O
take	O
advantage	O
of	O
denitrification	O
to	O
cope	O
with	O
nitric	O
oxide	O
(	O
NO	O
)	O
production	O
in	O
the	O
macrophage	O
during	O
the	O
innate	O
response	O
against	O
infection	O
.	O

In	O
most	O
of	O
these	O
loci	O
,	O
upstream	O
of	O
the	O
regulatory	O
gene	O
the	O
pckA	O
is	O
divergently	O
expressed	O
(	O
Figure	O
2	O
)	O
.	O

[	O
15	O
]	O
have	O
suggested	O
that	O
in	O
Brucella	S-Species
the	O
PTS	O
could	O
interact	O
with	O
the	O
BvrS	O
sensor	O
kinase	O
,	O
which	O
in	O
turn	O
phosphorylates	O
the	O
response	O
regulator	O
.	O

Notably	O
,	O
seven	O
transcriptional	O
regulators	O
genes	O
were	O
also	O
differentially	O
expressed	O
in	O
the	O
bvrR	O
mutant	O
compared	O
to	O
parental	O
strain	O
:	O
BAB1	O
_	O
0237	O
,	O
BAB1	O
_	O
0891	O
(	O
exoR	O
)	O
,	O
BAB1	O
_	O
1397	O
,	O
BAB2	O
_	O
0118	O
(	O
vjbR	O
)	O
,	O
BAB2	O
_	O
0762	O
(	O
ompR	O
)	O
,	O
BAB2	O
_	O
1127	O
and	O
BAB2	O
_	O
1152	O
.	O

Three	O
of	O
these	O
,	O
namely	O
exoR	O
,	O
ompR	O
and	O
vjbR	O
are	O
down	O
regulated	O
and	O
have	O
been	O
previously	O
implicated	O
in	O
Brucella	S-Species
virulence	O
.	O

Most	O
of	O
the	O
genes	O
candidate	O
to	O
be	O
regulated	O
by	O
BvrR	O
/	O
BvrS	O
identified	O
in	O
our	O
microarray	O
experiments	O
can	O
be	O
involved	O
with	O
the	O
changes	O
needed	O
for	O
intracellular	O
survival	O
of	O
Brucella	S-Species
.	O

SeMac	O
was	O
characterized	O
to	O
determine	O
whether	O
SeMac	O
has	O
IgG	O
endopeptidase	O
activity	O
and	O
inhibits	O
opsonophagocytosis	O
of	O
S	B-Species
.	I-Species
equi	E-Species
by	O
horse	S-Species
PMNs	O
.	O

The	O
immunity	O
is	O
primarily	O
mediated	O
by	O
protective	O
antibodies	O
[	O
4	O
]	O
,	O
which	O
opsonize	O
and	O
thus	O
enhance	O
phagocytosis	O
of	O
S	B-Species
.	I-Species
equi	E-Species
by	O
horse	S-Species
PMNs	O
.	O

The	O
type	O
-	O
1	O
Mac	O
,	O
such	O
as	O
M1	O
Mac	O
produced	O
by	O
serotype	B-Species
M1	I-Species
GAS	E-Species
strains	O
,	O
has	O
high	O
enzymatic	O
activity	O
and	O
low	O
affinity	O
to	O
Fc	O
receptor	O
on	O
the	O
surface	O
of	O
PMNs	O
,	O
while	O
the	O
type	O
-	O
2	O
Mac	O
can	O
bind	O
to	O
the	O
Fc	O
receptor	O
and	O
has	O
lower	O
enzymatic	O
activity	O
[	O
9	O
]	O
.	O

All	O
the	O
strains	O
tested	O
had	O
the	O
mac	O
gene	O
(	O
Fig	O
.	O
2	O
)	O
.	O

To	O
assess	O
the	O
in	O
vitro	O
production	O
of	O
SeMac	O
,	O
culture	O
supernatant	O
of	O
the	O
10	O
S	B-Species
.	I-Species
equi	E-Species
strains	O
was	O
prepared	O
by	O
the	O
method	O
of	O
Lei	O
et	O
al	O
.	O

No	O
SeMac	O
was	O
detected	O
in	O
all	O
the	O
samples	O
(	O
data	O
not	O
shown	O
)	O
,	O
suggesting	O
that	O
SeMac	O
is	O
not	O
produced	O
in	O
vitro	O
.	O

SeMac	O
efficiently	O
cleaves	O
the	O
heavy	O
chain	O
of	O
human	S-Species
IgG	O
.	O

Cleavable	O
horse	S-Species
IgG1	O
has	O
PELLGG	O
,	O
while	O
the	O
non	O
-	O
cleavable	O
horse	S-Species
IgG4	O
has	O
PECLSVG	O
in	O
the	O
same	O
region	O
,	O
suggesting	O
that	O
the	O
amino	O
acid	O
sequences	O
of	O
the	O
lower	O
hinge	O
region	O
are	O
important	O
for	O
cleavability	O
by	O
SeMac	O
and	O
GAS	S-Species
Mac	O
.	O

Timoney	O
et	O
al	O
.	O
recently	O
reported	O
that	O
IdeE	O
/	O
SeMac	O
reduces	O
the	O
bactericidal	O
activity	O
of	O
isolated	O
equine	S-Species
PMNs	O
for	O
S	B-Species
.	I-Species
equi	E-Species
[	O
19	O
]	O
.	O

The	O
mac	O
gene	O
is	O
controlled	O
by	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
CovRS	O
[	O
5	O
]	O
,	O
which	O
also	O
controls	O
the	O
expression	O
of	O
many	O
virulence	O
factors	O
including	O
the	O
hyaluronic	O
capsule	O
[	O
20	O
]	O
.	O

The	O
fact	O
that	O
SeMac	O
does	O
not	O
inhibit	O
opsonophagocytosis	O
of	O
S	B-Species
.	I-Species
equi	E-Species
by	O
horse	S-Species
PMNs	O
indicates	O
that	O
SeMac	O
is	O
not	O
involved	O
in	O
the	O
evasion	O
of	O
the	O
acquired	O
horse	S-Species
immunity	O
against	O
S	B-Species
.	I-Species
equi	E-Species
.	O

This	O
suggests	O
that	O
SeMac	O
has	O
other	O
unknown	O
function	O
.	O
Here	O
we	O
report	O
that	O
this	O
activation	O
requires	O
both	O
PmrA	O
'	O
s	O
cognate	O
sensor	O
kinase	O
PmrB	O
,	O
which	O
had	O
been	O
previously	O
shown	O
to	O
respond	O
to	O
Fe3	O
+	O
and	O
Al3	O
+	O
,	O
and	O
PmrA	O
'	O
s	O
post	O
-	O
translational	O
activator	O
PmrD	O
.	O

The	O
PmrA	O
protein	O
and	O
its	O
cognate	O
sensor	O
kinase	O
PmrB	O
form	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
that	O
is	O
required	O
for	O
virulence	O
in	O
mice	S-Species
(	O
Gunn	O
et	O
al	O
.	O
,	O
2000	O
)	O
,	O
infection	O
of	O
chicken	S-Species
macrophages	O
(	O
Zhao	O
et	O
al	O
.	O
,	O
2002	O
)	O
,	O
growth	O
in	O
soil	O
(	O
Chamnongpol	O
et	O
al	O
.	O
,	O
2002	O
)	O
,	O
resistance	O
to	O
the	O
cationic	O
peptide	O
antibiotic	O
polymyxin	O
B	O
(	O
Roland	O
et	O
al	O
.	O
,	O
1993	O
)	O
and	O
resistance	O
to	O
Fe3	O
+	O
-	O
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
and	O
Al3	O
+	O
-	O
mediated	O
killing	O
(	O
Nishino	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

We	O
determined	O
that	O
the	O
regulatory	O
protein	O
PmrA	O
is	O
required	O
for	O
the	O
transcriptional	O
activation	O
in	O
response	O
to	O
mild	O
acid	O
pH	O
because	O
there	O
was	O
no	O
induction	O
of	O
the	O
three	O
investigated	O
genes	O
in	O
a	O
pmrA	O
mutant	O
(	O
Fig	O
.	O
2A	O
-	O
C	O
)	O
.	O

The	O
PmrB	O
protein	O
is	O
necessary	O
for	O
activation	O
of	O
the	O
PmrA	O
protein	O
in	O
low	O
Mg2	O
+	O
(	O
Kox	O
et	O
al	O
.	O
,	O
2000	O
;	O
Kato	O
and	O
Groisman	O
,	O
2004	O
)	O
and	O
in	O
the	O
presence	O
of	O
Fe3	O
+	O
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
,	O
consistent	O
with	O
the	O
notion	O
that	O
PmrB	O
is	O
the	O
major	O
phosphodonor	O
for	O
PmrA	O
.	O

Thus	O
,	O
we	O
determined	O
the	O
beta	O
-	O
galactosidase	O
activity	O
of	O
isogenic	O
pmrB	O
strains	O
harbouring	O
a	O
chromosomal	O
pbgP	O
-	O
lac	O
transcriptional	O
fusion	O
:	O
expression	O
was	O
approximately	O
sixfold	O
lower	O
in	O
a	O
pmrB	O
mutant	O
than	O
in	O
the	O
pmrB	O
+	O
strain	O
following	O
growth	O
at	O
pH	O
5	O
.	O
8	O
(	O
Fig	O
.	O
3	O
)	O
,	O
indicating	O
that	O
a	O
functional	O
pmrB	O
gene	O
is	O
necessary	O
for	O
a	O
normal	O
response	O
to	O
mild	O
acid	O
pH	O
.	O

In	O
agreement	O
with	O
the	O
gene	O
transcription	O
data	O
,	O
Western	O
blot	O
analysis	O
of	O
crude	O
extracts	O
using	O
anti	O
-	O
PmrD	O
antibodies	O
showed	O
that	O
the	O
PmrD	O
protein	O
was	O
produced	O
in	O
cells	O
grown	O
in	O
N	O
-	O
minimal	O
medium	O
pH	O
5	O
.	O
8	O
and	O
10	O
mM	O
MgCl2	O
but	O
not	O
in	O
cells	O
grown	O
in	O
the	O
same	O
medium	O
buffered	O
at	O
pH	O
7	O
.	O
7	O
(	O
Fig	O
.	O
4B	O
)	O
.	O

To	O
test	O
this	O
hypothesis	O
,	O
we	O
constructed	O
a	O
plasmid	O
that	O
produced	O
a	O
PmrB	O
protein	O
containing	O
a	O
single	O
histidine	O
to	O
alanine	O
substitution	O
at	O
position	O
35	O
.	O

However	O
,	O
the	O
substitution	O
of	O
this	O
residue	O
by	O
alanine	O
had	O
no	O
effect	O
on	O
the	O
response	O
to	O
mild	O
acid	O
pH	O
(	O
Fig	O
.	O
6B	O
)	O
.	O

Although	O
the	O
pKa	O
of	O
free	O
glutamic	O
acid	O
is	O
approximately4	O
,	O
which	O
is	O
well	O
below	O
the	O
range	O
of	O
pH	O
at	O
which	O
PmrA	O
-	O
activated	O
genes	O
are	O
induced	O
,	O
the	O
folding	O
of	O
a	O
protein	O
can	O
dramatically	O
change	O
the	O
pKa	O
of	O
its	O
residues	O
.	O

For	O
instance	O
,	O
the	O
pKa	O
of	O
one	O
of	O
the	O
glutamic	O
acid	O
residues	O
of	O
the	O
regulatory	O
protein	O
TraM	O
is	O
approximately7	O
.	O
7	O
(	O
Lu	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

The	O
requirement	O
of	O
periplasmic	O
PmrB	O
residues	O
in	O
the	O
mild	O
acid	O
pH	O
activation	O
of	O
PmrA	O
-	O
regulated	O
genes	O
suggests	O
that	O
this	O
signalling	O
pathway	O
responds	O
to	O
changes	O
in	O
extracytoplasmic	O
pH	O
.	O

Indeed	O
,	O
the	O
pKa	O
of	O
one	O
of	O
the	O
glutamic	O
acid	O
residues	O
of	O
the	O
regulatory	O
protein	O
TraM	O
is	O
approximately7	O
.	O
7	O
in	O
the	O
folded	O
protein	O
(	O
Lu	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

Therefore	O
,	O
it	O
is	O
plausible	O
that	O
protonation	O
/	O
deprotonation	O
of	O
one	O
or	O
more	O
of	O
the	O
glutamic	O
acids	O
in	O
the	O
periplasmic	O
domain	O
of	O
PmrB	O
could	O
occur	O
at	O
pH	O
approximately5	O
.	O
8	O
.	O

Similarly	O
,	O
cadC	O
mutants	O
have	O
been	O
isolated	O
that	O
are	O
impaired	O
in	O
the	O
ability	O
to	O
sense	O
only	O
one	O
of	O
its	O
two	O
inducing	O
signals	O
(	O
Dell	O
et	O
al	O
.	O
,	O
1994	O
)	O
.	O

Mlc	O
regulation	O
of	O
Salmonella	S-Species
pathogenicity	O
island	O
I	O
gene	O
expression	O
via	O
hilE	O
repression	O

A	O
Salmonella	O
enterica	O
serovar	O
Typhimurium	O
mlc	O
mutant	O
showed	O
reduced	O
levels	O
of	O
invasion	O
and	O
cytotoxicity	O
compared	O
to	O
the	O
wild	O
-	O
type	O
,	O
and	O
exhibited	O
reduced	O
expression	O
levels	O
of	O
hilD	O
,	O
hilA	O
and	O
invF	O
,	O
which	O
are	O
regulatory	O
genes	O
in	O
the	O
Salmonella	S-Species
pathogenicity	O
island	O
1	O
(	O
SPI1	O
)	O
.	O

Several	O
other	O
genes	O
have	O
been	O
identified	O
that	O
exert	O
positive	O
or	O
negative	O
effects	O
on	O
these	O
direct	O
regulators	O
of	O
SPI1	O
in	O
response	O
to	O
the	O
changes	O
in	O
environmental	O
conditions	O
.	O

RESULTS	O

Mutation	O
of	O
the	O
mlc	O
gene	O
reduces	O
Salmonella	S-Species
invasiveness	O
The	O
process	O
of	O
invasion	O
into	O
non	O
-	O
phagocytic	O
epithelial	O
cells	O
,	O
which	O
is	O
known	O
to	O
be	O
mediated	O
by	O
proteins	O
secreted	O
by	O
the	O
SPI1	O
-	O
encoded	O
type	O
III	O
machinery	O
(	O
3	O
)	O
,	O
is	O
an	O
important	O
initial	O
step	O
in	O
the	O
pathogenesis	O
of	O
S	B-Species
.	E-Species

S	B-Species
.	E-Species

To	O
study	O
the	O
effect	O
of	O
Mlc	O
on	O
hilE	O
expression	O
,	O
we	O
measured	O
the	O
expression	O
of	O
hilE	O
-	O
lacZY	O
on	O
the	O
low	O
-	O
copy	O
plasmid	O
pMAB69	O
,	O
which	O
contains	O
the	O
hilE	O
promoter	O
region	O
from	O
-	O
886	O
to	O
+	O
121	O
,	O
relative	O
to	O
the	O
translation	O
start	O
site	O
.	O

When	O
these	O
cells	O
were	O
grown	O
in	O
static	O
cultures	O
to	O
exponential	O
phase	O
,	O
SL1344	B-Species
-	I-Species
pMAB69	E-Species
expressed	O
28	O
.	O
9	O
+	O
/	O
-	O
3	O
.	O
5	O
Miller	O
units	O
of	O
beta	O
-	O
galactosidase	O
,	O
whereas	O
SR1304	B-Species
-	I-Species
pMAB69	E-Species
expressed	O
49	O
.	O
5	O
+	O
/	O
-	O
5	O
.	O
3	O
Miller	O
units	O
of	O
beta	O
-	O
galactosidase	O
;	O
the	O
level	O
of	O
hilE	O
expression	O
in	O
the	O
mlc	O
mutant	O
was	O
almost	O
1	O
.	O
8	O
-	O
fold	O
higher	O
than	O
that	O
in	O
the	O
wild	O
-	O
type	O
strain	O
.	O

The	O
requirement	O
of	O
hilE	O
for	O
Mlc	O
function	O
was	O
reflected	O
in	O
the	O
levels	O
of	O
hilD	O
transcription	O
.	O

Additionally	O
,	O
the	O
over	O
-	O
expression	O
of	O
HilD	O
from	O
the	O
plasmid	O
pJB3	O
containing	O
hilD	O
gene	O
under	O
the	O
control	O
of	O
a	O
lac	O
promoter	O
caused	O
the	O
induction	O
of	O
hilA	O
by	O
approximately2	O
-	O
fold	O
and	O
invF	O
by	O
approximately6	O
-	O
fold	O
irrespective	O
of	O
hilE	O
or	O
mlc	O
mutation	O
when	O
real	O
-	O
time	O
PCR	O
was	O
used	O
to	O
compare	O
the	O
expression	O
levels	O
(	O
data	O
not	O
shown	O
)	O
.	O

Since	O
HilD	O
activates	O
the	O
transcription	O
of	O
hilA	O
(	O
14	O
)	O
,	O
which	O
in	O
turn	O
can	O
activate	O
HilA	O
-	O
dependent	O
invFA	O
expression	O
(	O
10	O
)	O
,	O
and	O
directly	O
activates	O
HilC	O
/	O
D	O
-	O
dependent	O
invFD	O
expression	O
(	O
16	O
)	O
,	O
these	O
results	O
establish	O
that	O
the	O
mlc	O
mutation	O
exerts	O
a	O
negative	O
effect	O
on	O
SPI1	O
gene	O
expression	O
,	O
mainly	O
by	O
increasing	O
the	O
level	O
of	O
hilE	O
expression	O
.	O

Baxter	O
and	O
Jones	O
(	O
18	O
)	O
have	O
identified	O
two	O
independent	O
hilE	O
promoters	O
,	O
P1	O
and	O
P2	O
.	O

The	O
addition	O
of	O
cold	O
probe	O
released	O
the	O
labeled	O
probe	O
from	O
the	O
retarded	O
complex	O
(	O
Figure	O
5A	O
,	O
right	O
panel	O
)	O
,	O
which	O
indicates	O
specific	O
binding	O
of	O
Mlc	O
to	O
the	O
hilE	O
P3	O
promoter	O
DNA	O
.	O

Interestingly	O
,	O
arabinose	O
also	O
activated	O
hilE	O
,	O
albeit	O
to	O
a	O
lesser	O
degree	O
than	O
either	O
glucose	O
or	O
mannose	O
.	O

These	O
results	O
imply	O
that	O
multiple	O
regulatory	O
pathways	O
are	O
involved	O
in	O
the	O
regulation	O
of	O
hilE	O
and	O
hilD	O
by	O
carbohydrates	O
.	O

It	O
has	O
been	O
demonstrated	O
that	O
the	O
region	O
190	O
-	O
270	O
-	O
bp	O
upstream	O
of	O
the	O
hilE	O
promoter	O
is	O
required	O
for	O
the	O
activation	O
of	O
hilE	O
P2	O
expression	O
by	O
FimYZ	O
,	O
which	O
is	O
a	O
response	O
regulator	O
that	O
is	O
involved	O
in	O
the	O
expression	O
of	O
type	O
1	O
fimbriae	O
and	O
motility	O
genes	O
(	O
18	O
,	O
Figure	O
5C	O
)	O
.	O

It	O
has	O
been	O
suggested	O
that	O
glucose	O
plays	O
a	O
negative	O
role	O
in	O
the	O
expression	O
of	O
invasion	O
-	O
associated	O
genes	O
in	O
Salmonella	S-Species
.	O

In	O
addition	O
,	O
hilE	O
expression	O
was	O
also	O
increased	O
in	O
the	O
presence	O
of	O
arabinose	O
,	O
which	O
suggests	O
an	O
additional	O
regulatory	O
mechanism	O
mediated	O
by	O
arabinose	O
.	O

However	O
,	O
even	O
in	O
the	O
absence	O
of	O
PhoR	O
,	O
many	O
carbon	O
sources	O
are	O
known	O
to	O
activate	O
the	O
Pho	O
regulon	O
via	O
CreC	O
,	O
which	O
is	O
a	O
PhoR	O
homolog	O
(	O
47	O
)	O
.	O

As	O
a	O
subgroup	O
of	O
genomic	O
islands	O
(	O
GIs	O
)	O
,	O
PAI	O
usually	O
contains	O
some	O
distinct	O
genetic	O
elements	O
acquired	O
by	O
horizontal	O
gene	O
transfer	O
[	O
7	O
]	O
,	O
[	O
8	O
]	O
.	O

In	O
pathogens	O
,	O
various	O
members	O
of	O
TCSTSs	O
have	O
been	O
shown	O
to	O
play	O
critical	O
roles	O
in	O
both	O
metabolism	O
and	O
pathogenesis	O
[	O
12	O
]	O
-	O
[	O
23	O
]	O
.	O

salK	O
encodes	O
a	O
396	O
aa	O
long	O
protein	O
,	O
with	O
five	O
N	O
-	O
terminal	O
transmembrane	O
domains	O
and	O
a	O
transmitter	O
domain	O
signature	O
motif	O
in	O
the	O
C	O
-	O
terminal	O
-	O
typical	O
of	O
sensor	O
histidine	O
protein	O
kinases	O
of	O
TCSTSs	O
[	O
25	O
]	O
.	O

05SSU0945	O
,	O
situated	O
upstream	O
(	O
729	O
bp	O
long	O
intergenic	O
region	O
)	O
of	O
the	O
salKR	O
locus	O
,	O
encodes	O
a	O
94	O
aa	O
polypeptide	O
for	O
which	O
there	O
were	O
no	O
significant	O
database	O
matches	O
.	O

In	O
the	O
suspected	O
mutant	O
,	O
a	O
3	O
.	O
6	O
kb	O
restriction	O
fragment	O
hybridized	O
with	O
the	O
SpcR	O
probe	O
(	O
Fig	O
.	O
3B	O
,	O
lane	O
2	O
)	O
,	O
while	O
no	O
hybridization	O
signal	O
was	O
detected	O
when	O
the	O
internal	O
fragment	O
of	O
salKR	O
and	O
pUC18	O
served	O
as	O
the	O
probes	O
(	O
Fig	O
.	O
3C	O
and	O
3D	O
,	O
lane	O
2	O
)	O
.	O

First	O
,	O
the	O
ability	O
of	O
the	O
mutant	O
strain	O
to	O
retain	O
spectinomycin	O
resistance	O
was	O
assessed	O
.	O

As	O
shown	O
in	O
Figure	O
5	O
,	O
all	O
six	O
SPF	O
-	O
piglets	S-Species
inoculated	O
intravenously	O
with	O
WT	O
developed	O
most	O
of	O
the	O
typical	O
disease	O
symptoms	O
,	O
including	O
high	O
fever	O
,	O
limping	O
,	O
swollen	O
joints	O
,	O
shivering	O
,	O
CNS	O
failure	O
and	O
respiratory	O
failure	O
within	O
24	O
hrs	O
.	O

For	O
identifying	O
genes	O
whose	O
expression	O
was	O
significantly	O
different	O
,	O
the	O
threshold	O
for	O
the	O
expression	O
ratio	O
between	O
the	O
mutant	O
and	O
wild	O
type	O
strain	O
was	O
set	O
at	O
2	O
.	O

Although	O
these	O
genes	O
were	O
found	O
to	O
be	O
down	O
-	O
regulated	O
in	O
the	O
mutant	O
,	O
it	O
is	O
not	O
understood	O
how	O
they	O
are	O
associated	O
with	O
the	O
attenuation	O
of	O
DeltasalKR	O
.	O

As	O
shown	O
in	O
Table	O
S1	O
,	O
the	O
quantitative	O
results	O
of	O
RT	O
-	O
PCR	O
were	O
highly	O
compatible	O
to	O
the	O
microarray	O
data	O
,	O
in	O
the	O
DeltasalKR	O
mutant	O
,	O
41	O
out	O
of	O
42	O
selected	O
genes	O
(	O
97	O
.	O
6	O
%	O
)	O
were	O
confirmed	O
to	O
have	O
similar	O
transcript	O
levels	O
using	O
these	O
two	O
different	O
techniques	O
,	O
thus	O
independently	O
confirming	O
the	O
microarray	O
results	O
.	O

Bioinformatics	O
analysis	O
revealed	O
that	O
the	O
GC	O
content	O
of	O
salKR	O
is	O
far	O
less	O
than	O
that	O
of	O
89K	O
island	O
and	O
the	O
whole	O
genome	O
,	O
implying	O
that	O
this	O
TCSTS	O
is	O
of	O
foreign	O
origin	O
which	O
may	O
have	O
been	O
acquired	O
through	O
horizontal	O
gene	O
transfer	O
.	O

It	O
has	O
been	O
well	O
documented	O
that	O
horizontal	O
gene	O
transfer	O
events	O
occur	O
frequently	O
in	O
pathogens	O
[	O
45	O
]	O
-	O
[	O
47	O
]	O
,	O
and	O
some	O
of	O
them	O
have	O
been	O
implicated	O
in	O
high	O
pathogenicity	O
[	O
48	O
]	O
and	O
even	O
in	O
the	O
causation	O
of	O
severe	O
diseases	O
[	O
49	O
]	O
.	O

However	O
,	O
in	O
our	O
study	O
,	O
neither	O
microarray	O
findings	O
nor	O
further	O
analysis	O
of	O
real	O
-	O
time	O
quantitative	O
RT	O
-	O
PCR	O
revealed	O
any	O
differences	O
in	O
level	O
of	O
transcription	O
of	O
the	O
known	O
virulence	O
factors	O
(	O
CPS	O
,	O
suilysin	O
,	O
MRP	O
and	O
EF	O
)	O
between	O
the	O
wild	O
type	O
and	O
mutant	O
strain	O
.	O

Mutants	O
lacking	O
the	O
gene	O
encoding	O
the	O
alternative	O
sigma	O
factor	O
sigmaE	O
(	O
rpoE	O
)	O
are	O
also	O
highly	O
attenuated	O
for	O
intracellular	O
survival	O
,	O
pointing	O
to	O
a	O
potential	O
connection	O
with	O
the	O
SsrAB	O
regulatory	O
system	O
.	O

Background	O

Deletion	O
of	O
rseA	O
in	O
Yersinia	B-Species
pseudotuberculosis	E-Species
causes	O
elevated	O
virulence	O
effector	O
synthesis	O
and	O
secretion	O
[	O
18	O
]	O
,	O
establishing	O
links	O
between	O
alternative	O
sigma	O
factors	O
and	O
virulence	O
-	O
specific	O
regulators	O
.	O

By	O
testing	O
six	O
promoters	O
representing	O
four	O
classes	O
of	O
SsrB	O
-	O
regulated	O
promoters	O
(	O
(	O
i	O
)	O
two	O
type	O
III	O
secretion	O
structural	O
operons	O
in	O
SPI	O
-	O
2	O
,	O
(	O
ii	O
)	O
the	O
effector	O
operon	O
in	O
SPI	O
-	O
2	O
,	O
(	O
iii	O
)	O
two	O
effector	O
genes	O
unlinked	O
with	O
SPI	O
-	O
2	O
,	O
and	O
(	O
iv	O
)	O
an	O
integrated	O
virulence	O
gene	O
unlinked	O
with	O
SPI	O
-	O
2	O
)	O
we	O
demonstrate	O
that	O
RpoE	O
elicits	O
an	O
effect	O
on	O
a	O
subset	O
of	O
SsrB	O
-	O
regulated	O
genes	O
.	O

Deletion	O
of	O
rpoE	O
affects	O
a	O
subset	O
of	O
SsrB	O
-	O
regulated	O
virulence	O
genes	O
Salmonella	S-Species
virulence	O
gene	O
expression	O
is	O
coordinated	O
in	O
vivo	O
and	O
may	O
be	O
regulated	O
,	O
in	O
part	O
,	O
by	O
alternative	O
sigma	O
factor	O
(	O
s	O
)	O
in	O
order	O
to	O
quickly	O
respond	O
to	O
the	O
host	O
environment	O
.	O

RpoE	O
is	O
involved	O
in	O
transcriptional	O
activity	O
of	O
a	O
subset	O
of	O
virulence	O
genes	O

We	O
predict	O
that	O
RpoE	O
confers	O
a	O
similar	O
fine	O
-	O
tuning	O
effect	O
on	O
Salmonella	S-Species
virulence	O
gene	O
expression	O
that	O
is	O
required	O
for	O
optimal	O
within	O
-	O
host	O
fitness	O
during	O
infection	O
.	O

Also	O
necessary	O
are	O
protein	O
secretion	O
systems	O
[	O
4	O
]	O
and	O
toxins	O
required	O
for	O
cytotoxicity	O
and	O
survival	O
within	O
the	O
host	O
.	O

The	O
TB	S-Species
strain	O
belongs	O
to	O
an	O
abundant	O
clonal	O
complex	O
in	O
the	O
P	B-Species
.	I-Species
aeruginosa	E-Species
population	O
[	O
15	O
]	O
.	O

It	O
has	O
a	O
high	O
resistance	O
to	O
detergents	O
[	O
16	O
]	O
and	O
reactive	O
oxygen	O
intermediates	O
[	O
17	O
]	O
and	O
is	O
able	O
to	O
grow	O
within	O
polymorphonuclear	O
leukocytes	O
[	O
18	O
]	O
.	O

We	O
screened	O
a	O
TB	B-Species
STM	I-Species
(	I-Species
signature	I-Species
tagged	I-Species
mutagenesis	I-Species
)	I-Species
mutant	E-Species
library	O
of	O
2	O
,	O
200	O
non	O
-	O
redundant	O
clones	O
[	O
19	O
]	O
,	O
[	O
20	O
]	O
and	O
selected	O
a	O
small	O
group	O
of	O
mutants	O
,	O
significantly	O
attenuated	O
for	O
virulence	O
in	O
C	B-Species
.	I-Species
elegans	E-Species
.	O

Characterization	O
of	O
Selected	O
Attenuated	O
Mutants	O

Two	O
potential	O
regulatory	O
genes	O
were	O
found	O
.	O

We	O
recovered	O
two	O
additional	O
mutants	O
with	O
transposon	O
insertion	O
into	O
genes	O
which	O
have	O
functions	O
related	O
to	O
motility	O
.	O

The	O
adaptation	O
of	O
the	O
chemotaxis	O
system	O
in	O
response	O
to	O
changes	O
in	O
attractant	O
binding	O
is	O
dependent	O
on	O
the	O
methylation	O
state	O
of	O
the	O
MCPs	O
.	O

Another	O
interrupted	O
gene	O
,	O
PA2478	O
,	O
encodes	O
a	O
probable	O
thiol	O
:	O
disulfide	O
interchange	O
protein	O
of	O
the	O
DsbD	O
family	O
.	O

Characterization	O
of	O
the	O
cheB2	O
Mutant	O

The	O
reactions	O
were	O
performed	O
simultaneously	O
using	O
PA14	S-Species
or	O
TB	S-Species
genomic	O
DNA	O
as	O
matrix	O
.	O

The	O
swimming	O
or	O
swarming	O
motility	O
defect	O
is	O
,	O
however	O
,	O
much	O
more	O
severe	O
in	O
the	O
cheB1	O
mutant	O
as	O
compared	O
to	O
the	O
cheB2	O
mutant	O
.	O

Finally	O
,	O
we	O
used	O
a	O
chemotactic	O
assay	O
using	O
tryptone	O
as	O
chemo	O
-	O
attractant	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

The	O
liquid	O
killing	O
assay	O
by	O
contrast	O
,	O
is	O
read	O
after	O
overnight	O
feeding	O
of	O
the	O
nematodes	O
with	O
the	O
bacterial	O
strains	O
.	O

Interestingly	O
,	O
we	O
observed	O
that	O
a	O
mutation	O
in	O
the	O
cheB1	O
gene	O
yields	O
different	O
phenotypes	O
compared	O
to	O
the	O
cheB2	O
mutation	O
.	O

This	O
could	O
be	O
a	O
condition	O
to	O
set	O
the	O
function	O
of	O
the	O
Che2	O
proteins	O
and	O
allow	O
non	O
-	O
growing	O
cells	O
to	O
sense	O
and	O
respond	O
to	O
the	O
environment	O
in	O
a	O
different	O
manner	O
as	O
compared	O
to	O
fast	O
-	O
growing	O
cells	O
.	O

Inactivation	O
of	O
aprA	O
attenuated	O
both	O
the	O
capacity	O
to	O
persist	O
in	O
the	O
host	O
and	O
pathogenicity	O
.	O

Our	O
knowledge	O
of	O
the	O
Drosophila	S-Species
immune	O
response	O
is	O
mainly	O
based	O
on	O
the	O
analysis	O
of	O
host	O
reactions	O
following	O
direct	O
injection	O
of	O
non	O
-	O
pathogenic	O
bacteria	O
into	O
the	O
insect	O
hemocoel	O
.	O

All	O
of	O
these	O
proteases	O
are	O
members	O
of	O
the	O
zinc	O
metzincin	O
family	O
of	O
Type	O
I	O
-	O
secreted	O
RTX	O
proteins	O
[	O
15	O
]	O
.	O

Injection	O
of	O
pure	O
AprA	O
into	O
the	O
hemocoel	O
rapidly	O
killed	O
adult	O
flies	O
,	O
identifying	O
this	O
protein	O
as	O
a	O
bacterial	O
toxin	O
(	O
Figure	O
1E	O
)	O
.	O

In	O
P	B-Species
.	I-Species
fluorescens	E-Species
,	O
membrane	O
-	O
localized	O
anti	O
-	O
sigma	O
factor	O
PrtR	O
cleaves	O
the	O
extracytoplasmic	O
sigma	O
factor	O
PrtI	O
,	O
resulting	O
in	O
increased	O
expression	O
of	O
multiple	O
genes	O
,	O
including	O
one	O
encoding	O
for	O
a	O
metalloprotease	O
,	O
aprX	O
[	O
16	O
]	O
.	O

Studies	O
in	O
other	O
bacteria	O
have	O
shown	O
that	O
AprD	O
,	O
E	O
,	O
and	O
F	O
participate	O
in	O
the	O
elaboration	O
of	O
a	O
Type	O
I	O
transporter	O
required	O
for	O
AprA	O
secretion	O
to	O
the	O
external	O
medium	O
[	O
17	O
]	O
.	O

Using	O
the	O
same	O
assay	O
,	O
both	O
prtR	O
and	O
gacA	O
mutants	O
were	O
almost	O
avirulent	O
toward	O
Drosophila	S-Species
indicating	O
that	O
both	O
genes	O
regulate	O
other	O
virulence	O
factors	O
in	O
addition	O
to	O
AprA	O
(	O
Figure	O
2B	O
)	O
.	O

Use	O
of	O
Diptericin	O
-	O
GFP	O
or	O
lacZ	O
reporter	O
genes	O
reveals	O
strong	O
Diptericin	O
expression	O
in	O
the	O
proventriculus	O
,	O
an	O
organ	O
that	O
acts	O
as	O
a	O
valve	O
between	O
the	O
oesophagus	O
and	O
the	O
anterior	O
midgut	O
(	O
Figure	O
5B	O
)	O
.	O

The	O
results	O
described	O
above	O
were	O
corroborated	O
by	O
the	O
over	O
-	O
expression	O
of	O
Imd	O
in	O
the	O
gut	O
or	O
in	O
the	O
fat	O
body	O
using	O
specific	O
Gal4	O
drivers	O
.	O

Thus	O
,	O
we	O
next	O
compared	O
survival	O
of	O
Rel	O
flies	O
specifically	O
expressing	O
a	O
wild	O
-	O
type	O
copy	O
of	O
Rel	O
in	O
the	O
intestine	O
using	O
caudal	O
(	O
cad	O
)	O
-	O
Gal4	O
.	O

In	O
these	O
flies	O
,	O
the	O
Imd	O
pathway	O
was	O
not	O
constitutively	O
active	O
in	O
the	O
gut	O
but	O
could	O
be	O
induced	O
upon	O
oral	O
bacterial	O
infection	O
similarly	O
to	O
the	O
wild	O
-	O
type	O
situation	O
(	O
Figure	O
S3A	O
)	O
.	O

Figure	O
5E	O
shows	O
that	O
Rel	O
flies	O
expressing	O
Rel	O
in	O
the	O
gut	O
survive	O
better	O
than	O
Rel	O
mutant	O
flies	O
.	O

AprA	O
Confers	O
Protection	O
against	O
Diptericin	O

We	O
have	O
shown	O
that	O
AprA	O
protects	O
P	B-Species
.	I-Species
entomophila	E-Species
against	O
the	O
Imd	O
-	O
regulated	O
immune	O
response	O
.	O

To	O
investigate	O
a	O
possible	O
in	O
vivo	O
role	O
of	O
AprA	O
in	O
the	O
protection	O
against	O
AMPs	O
synthesized	O
in	O
the	O
gut	O
,	O
we	O
compared	O
survival	O
to	O
P	B-Species
.	I-Species
entomophila	E-Species
in	O
imd	O
-	O
deficient	O
flies	O
over	O
-	O
expressing	O
Attacin	O
A	O
or	O
Diptericin	O
ubiquitously	O
under	O
the	O
control	O
of	O
the	O
daughterless	O
Gal4	O
driver	O
(	O
daGal4	O
)	O
using	O
the	O
UAS	O
-	O
Gal4	O
system	O
(	O
referred	O
to	O
as	O
imd	O
;	O
da	O
>	O
AMP	O
,	O
Figure	O
S3B	O
)	O
.	O

This	O
strategy	O
allowed	O
us	O
to	O
study	O
the	O
contribution	O
of	O
each	O
antibacterial	O
peptide	O
to	O
the	O
defense	O
against	O
a	O
P	B-Species
.	I-Species
entomophila	E-Species
infection	O
.	O

Altogether	O
,	O
our	O
results	O
provide	O
an	O
in	O
vivo	O
demonstration	O
that	O
AprA	O
functions	O
in	O
the	O
protection	O
of	O
P	B-Species
.	I-Species
entomophila	E-Species
against	O
Drosophila	S-Species
AMPs	O
.	O

Previous	O
studies	O
revealed	O
only	O
a	O
modest	O
contribution	O
of	O
Diptericin	O
to	O
resistance	O
against	O
Gram	O
-	O
negative	O
bacteria	O
during	O
systemic	O
infection	O
[	O
22	O
]	O
.	O

This	O
can	O
be	O
compared	O
with	O
many	O
human	S-Species
pathogens	O
for	O
which	O
activation	O
of	O
an	O
inflammatory	O
response	O
represents	O
a	O
part	O
of	O
their	O
invasive	O
strategy	O
[	O
25	O
]	O
.	O

However	O
,	O
in	O
most	O
cases	O
,	O
attempts	O
to	O
evaluate	O
the	O
role	O
of	O
metalloproteases	O
in	O
virulence	O
have	O
failed	O
to	O
obtain	O
conclusive	O
results	O
with	O
respect	O
to	O
a	O
specific	O
function	O
[	O
20	O
,	O
21	O
]	O
.	O

Many	O
pseudomonads	S-Species
and	O
other	O
bacteria	O
express	O
proteases	O
similar	O
to	O
AprA	O
but	O
are	O
not	O
able	O
to	O
infect	O
Drosophila	S-Species
by	O
oral	O
ingestion	O
.	O

This	O
indicates	O
that	O
AprA	O
is	O
not	O
the	O
sole	O
virulence	O
factor	O
required	O
for	O
persistence	O
in	O
the	O
Drosophila	S-Species
gastrointestinal	O
tract	O
.	O

The	O
genome	O
of	O
P	B-Species
.	I-Species
entomophila	E-Species
contains	O
several	O
genes	O
encoding	O
putative	O
insecticidal	O
toxins	O
(	O
e	O
.	O
g	O
.	O
,	O
Tc	O
toxins	O
,	O
hemolysins	O
,	O
and	O
lipopeptides	O
)	O
.	O

A	O
Comprehensive	O
Genetic	O
Characterization	O
of	O
Bacterial	O
Motility	O

This	O
allows	O
us	O
to	O
place	O
the	O
novel	O
genes	O
within	O
the	O
context	O
of	O
signaling	O
and	O
regulatory	O
networks	O
,	O
including	O
the	O
Rcs	O
phosphorelay	O
pathway	O
and	O
the	O
cyclic	O
di	O
-	O
GMP	O
second	O
-	O
messenger	O
system	O
.	O

A	O
major	O
challenge	O
of	O
the	O
post	O
-	O
genome	O
era	O
is	O
the	O
development	O
of	O
efficient	O
and	O
comprehensive	O
methods	O
for	O
revealing	O
the	O
genetic	O
basis	O
of	O
these	O
behaviors	O
across	O
diverse	O
clades	O
,	O
especially	O
as	O
the	O
emerging	O
field	O
of	O
metagenomics	O
begins	O
to	O
reveal	O
the	O
wide	O
assortment	O
of	O
microbial	O
life	O
on	O
the	O
planet	O
[	O
1	O
]	O
.	O

An	O
impressive	O
achievement	O
of	O
20th	O
-	O
century	O
biology	O
was	O
a	O
systems	O
-	O
level	O
understanding	O
of	O
bacterial	O
chemotaxis	O
in	O
terms	O
of	O
the	O
structures	O
,	O
interactions	O
,	O
and	O
organization	O
of	O
the	O
roughly	O
50	O
constituent	O
molecular	O
components	O
[	O
2	O
-	O
4	O
]	O
.	O

The	O
direction	O
of	O
rotation	O
is	O
influenced	O
by	O
the	O
output	O
of	O
the	O
chemotaxis	O
network	O
,	O
which	O
consists	O
of	O
a	O
signal	O
transduction	O
cascade	O
that	O
allows	O
robust	O
adaptation	O
to	O
local	O
concentrations	O
of	O
ligands	O
over	O
many	O
orders	O
of	O
magnitude	O
[	O
7	O
,	O
8	O
]	O
.	O

These	O
events	O
yield	O
an	O
orderly	O
"	O
just	O
-	O
in	O
-	O
time	O
"	O
expression	O
and	O
assembly	O
of	O
the	O
flagellar	O
components	O
[	O
11	O
]	O
,	O
which	O
consist	O
of	O
a	O
basal	O
body	O
complex	O
and	O
a	O
filament	O
.	O

For	O
these	O
reasons	O
,	O
flagellar	O
-	O
mediated	O
motility	O
is	O
an	O
ideal	O
test	O
case	O
for	O
any	O
modern	O
post	O
-	O
genomic	O
approach	O
that	O
attempts	O
to	O
efficiently	O
and	O
comprehensively	O
reveal	O
the	O
genetic	O
basis	O
of	O
a	O
complex	O
bacterial	O
phenotype	O
.	O

In	O
this	O
study	O
,	O
we	O
make	O
improvements	O
on	O
a	O
microarray	O
-	O
based	O
genetic	O
footprinting	O
strategy	O
[	O
12	O
]	O
,	O
increasing	O
its	O
sensitivity	O
and	O
specificity	O
in	O
revealing	O
the	O
contribution	O
of	O
each	O
and	O
every	O
gene	O
in	O
the	O
genome	O
to	O
a	O
phenotype	O
of	O
interest	O
.	O

In	O
each	O
of	O
our	O
experiments	O
,	O
a	O
population	O
of	O
mutants	O
is	O
challenged	O
for	O
competitive	O
growth	O
under	O
a	O
selection	O
of	O
interest	O
.	O

Once	O
inoculated	O
into	O
a	O
region	O
of	O
the	O
soft	O
agar	O
,	O
bacteria	O
deplete	O
local	O
nutrients	O
and	O
chemotax	O
radially	O
outward	O
following	O
the	O
concentration	O
gradient	O
of	O
preferred	O
substrates	O
[	O
17	O
]	O
.	O

Survival	O
of	O
a	O
mutant	O
meant	O
either	O
the	O
loss	O
of	O
its	O
flagella	O
,	O
the	O
loss	O
of	O
flagellar	O
CCW	O
rotation	O
,	O
or	O
the	O
loss	O
of	O
other	O
components	O
necessary	O
for	O
infection	O
.	O

Most	O
of	O
these	O
non	O
-	O
flagellar	O
genes	O
encode	O
components	O
of	O
the	O
cell	O
envelope	O
.	O

OPG	O
mutants	O
were	O
defective	O
in	O
both	O
swimming	O
and	O
swarming	O
;	O
surprisingly	O
,	O
however	O
,	O
only	O
mutants	O
with	O
large	O
LPS	O
truncations	O
showed	O
significant	O
defects	O
in	O
these	O
behaviors	O
(	O
Figures	O
3E	O
and	O
4	O
)	O
.	O

Therefore	O
,	O
while	O
rcsC	O
mutations	O
disrupt	O
the	O
RcsF	O
-	O
-	O
>	O
RcsC	O
-	O
-	O
>	O
RcsD	O
-	O
-	O
>	O
RcsB	O
phosphorelay	O
cascade	O
,	O
the	O
phosphorylation	O
of	O
RcsB	O
cannot	O
be	O
fully	O
reversed	O
in	O
the	O
absence	O
of	O
RcsC	O
phosphatase	O
activity	O
,	O
as	O
observed	O
by	O
the	O
reduced	O
flhDC	O
-	O
lacZ	O
expression	O
and	O
motility	O
exhibited	O
by	O
rcsC	O
and	O
rcsD	O
mutants	O
(	O
Figure	O
4	O
)	O
.	O

We	O
also	O
observed	O
that	O
sensitivity	O
to	O
chi	S-Species
-	O
phage	O
was	O
higher	O
in	O
rfaI	O
mutants	O
than	O
rfaC	O
mutants	O
,	O
indicating	O
that	O
chi	S-Species
-	O
phage	O
infectivity	O
is	O
directly	O
related	O
to	O
the	O
degree	O
of	O
flhDC	O
expression	O
(	O
Figures	O
4	O
,	O
5B	O
,	O
and	O
5C	O
)	O
.	O

A	O
sample	O
of	O
suppressor	O
mutants	O
extracted	O
from	O
the	O
extreme	O
edge	O
of	O
the	O
motile	O
front	O
was	O
used	O
for	O
both	O
microarray	O
-	O
based	O
genetic	O
footprinting	O
,	O
and	O
for	O
isolation	O
of	O
individual	O
mutants	O
for	O
subsequent	O
characterization	O
.	O

Among	O
the	O
18	O
suppressor	O
mutants	O
sampled	O
at	O
random	O
from	O
the	O
DeltayhjH	O
background	O
,	O
half	O
had	O
insertions	O
in	O
different	O
regions	O
of	O
ycgR	O
,	O
a	O
gene	O
encoding	O
a	O
protein	O
of	O
unknown	O
function	O
(	O
Figure	O
6D	O
)	O
.	O

Among	O
the	O
loci	O
that	O
partially	O
suppress	O
the	O
motility	O
defect	O
of	O
DeltayhjH	O
are	O
fliZ	O
(	O
a	O
gene	O
predicted	O
to	O
be	O
a	O
regulator	O
of	O
the	O
flagellum	O
-	O
specific	O
sigma	O
factor	O
sigma28	O
)	O
,	O
yfiR	O
(	O
a	O
gene	O
identified	O
in	O
the	O
selection	O
for	O
swarming	O
motility	O
defective	O
mutants	O
)	O
,	O
and	O
three	O
additional	O
genes	O
of	O
unknown	O
function	O
:	O
yjdA	O
,	O
yjcZ	O
,	O
and	O
yegE	O
.	O

YhjH	O
contains	O
an	O
EAL	O
domain	O
,	O
and	O
expression	O
of	O
this	O
protein	O
leads	O
to	O
the	O
degradation	O
of	O
c	O
-	O
di	O
-	O
GMP	O
and	O
enhanced	O
motility	O
in	O
S	B-Species
.	I-Species
enterica	E-Species
[	O
52	O
]	O
.	O

We	O
argue	O
that	O
YfgF	O
has	O
an	O
active	O
EAL	O
domain	O
and	O
functions	O
as	O
a	O
PDE	O
based	O
on	O
three	O
observations	O
:	O
(	O
1	O
)	O
expression	O
of	O
this	O
gene	O
enhances	O
motility	O
of	O
the	O
DeltayhjH	O
strain	O
(	O
Figure	O
6E	O
)	O
;	O
(	O
2	O
)	O
the	O
amino	O
acid	O
sequence	O
of	O
YfgF	O
shows	O
similarity	O
to	O
enzymatically	O
active	O
EAL	O
domains	O
(	O
Figure	O
S10	O
)	O
;	O
and	O
(	O
3	O
)	O
the	O
amino	O
acid	O
sequence	O
lacks	O
a	O
complete	O
GGDEF	O
motif	O
needed	O
for	O
DGC	O
activity	O
(	O
data	O
not	O
shown	O
)	O
.	O

Such	O
an	O
interaction	O
may	O
explain	O
the	O
observed	O
rotational	O
bias	O
of	O
flagella	O
in	O
DeltayhjH	O
mutants	O
(	O
Figure	O
6B	O
)	O
and	O
is	O
in	O
agreement	O
with	O
our	O
finding	O
that	O
mutations	O
in	O
ycgR	O
strongly	O
suppress	O
the	O
motility	O
defects	O
of	O
DeltayhjH	O
mutants	O
(	O
Figure	O
6F	O
)	O
.	O

YfiR	O
is	O
predicted	O
to	O
be	O
a	O
periplasmic	O
protein	O
,	O
YfiB	O
shows	O
sequence	O
similarity	O
to	O
outer	O
-	O
membrane	O
porin	O
proteins	O
,	O
and	O
YfiN	O
is	O
a	O
predicted	O
inner	O
-	O
membrane	O
protein	O
with	O
GGDEF	O
and	O
HAMP	O
domains	O
.	O

According	O
to	O
this	O
model	O
,	O
the	O
transposon	O
insertion	O
library	O
should	O
harbor	O
mutants	O
that	O
perform	O
chemotaxis	O
in	O
high	O
[	O
NaCl	O
]	O
as	O
well	O
as	O
wild	O
-	O
type	O
cells	O
do	O
under	O
low	O
[	O
NaCl	O
]	O
conditions	O
.	O

A	O
non	O
-	O
piliated	O
mutant	O
produces	O
less	O
biofilm	O
than	O
the	O
parent	O
strain	O
and	O
is	O
attenuated	O
in	O
a	O
rat	S-Species
model	O
of	O
endocarditis	O
[	O
18	O
]	O
and	O
in	O
a	O
murine	S-Species
urinary	O
tract	O
infection	O
model	O
[	O
16	O
]	O
.	O

Surprisingly	O
,	O
the	O
genomes	O
align	O
syntenically	O
,	O
as	O
shown	O
in	O
Figure	O
2	O
,	O
despite	O
the	O
fact	O
that	O
25	O
%	O
of	O
the	O
V583	S-Species
genome	O
is	O
composed	O
of	O
mobile	O
elements	O
.	O

However	O
,	O
most	O
of	O
the	O
differences	O
are	O
small	O
and	O
cannot	O
be	O
visualized	O
in	O
this	O
figure	O
.	O

Both	O
OG1RF	S-Species
CRISPR	O
elements	O
are	O
composed	O
of	O
7	O
repeats	O
of	O
a	O
37	O
bp	O
palindromic	O
sequence	O
with	O
a	O
29	O
bp	O
spacer	O
.	O

The	O
repeat	O
upstream	O
of	O
cas	O
_	O
csn1	O
appears	O
to	O
have	O
degenerated	O
since	O
it	O
shares	O
only	O
23	O
bp	O
with	O
the	O
37	O
bp	O
repeat	O
cluster	O
downstream	O
of	O
the	O
last	O
gene	O
.	O

A	O
unique	O
feature	O
of	O
the	O
OG1RF	S-Species
CRISPR1	O
locus	O
is	O
the	O
presence	O
of	O
a	O
gene	O
downstream	O
of	O
the	O
element	O
,	O
which	O
encodes	O
a	O
hypothetical	O
119	O
amino	O
acid	O
transmembrane	O
protein	O
.	O

Also	O
,	O
in	O
place	O
of	O
EF3153	O
,	O
EF3154	O
,	O
and	O
EF3155	O
(	O
which	O
share	O
70	O
%	O
similarity	O
among	O
themselves	O
)	O
,	O
were	O
found	O
non	O
-	O
distantly	O
related	O
homologues	O
,	O
OG1RF	O
_	O
0209	O
and	O
OG1RF	O
_	O
0210	O
,	O
which	O
share	O
60	O
-	O
80	O
%	O
similarity	O
with	O
EF3153	O
,	O
EF3154	O
,	O
and	O
EF3155	O
.	O

However	O
,	O
the	O
order	O
of	O
the	O
genes	O
is	O
not	O
the	O
same	O
between	O
E	B-Species
.	I-Species
faecalis	E-Species
and	O
L	B-Species
.	I-Species
casei	E-Species
.	O

Since	O
we	O
did	O
not	O
identify	O
any	O
remnants	O
of	O
the	O
iol	O
operon	O
in	O
V583	S-Species
,	O
it	O
would	O
appear	O
that	O
at	O
least	O
two	O
independent	O
events	O
at	O
the	O
same	O
location	O
differentiate	O
OG1RF	S-Species
and	O
V583	S-Species
,	O
suggesting	O
that	O
it	O
is	O
a	O
hot	O
region	O
for	O
rearrangement	O
.	O

This	O
region	O
between	O
EF2239	O
and	O
EF2352	O
(	O
111	O
Kb	O
)	O
is	O
also	O
missing	O
in	O
the	O
Symbioflor	B-Species
1	E-Species
strain	O
(	O
referred	O
to	O
as	O
gap	O
2	O
)	O
[	O
5	O
]	O
.	O

The	O
possible	O
junction	O
and	O
presence	O
of	O
unique	O
sequence	O
in	O
this	O
region	O
,	O
if	O
investigated	O
,	O
was	O
not	O
mentioned	O
in	O
the	O
publication	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
this	O
region	O
contains	O
:	O
a	O
putative	O
adhesin	O
protein	O
gene	O
(	O
OG1RF	O
_	O
0039	O
)	O
at	O
one	O
end	O
of	O
the	O
fragment	O
;	O
homologues	O
of	O
14	O
Tn916	O
-	O
associated	O
genes	O
(	O
Tn916	O
_	O
2	O
to	O
Tn916	O
_	O
12	O
,	O
Tn916	O
_	O
18	O
and	O
Tn916	O
_	O
19	O
,	O
with	O
an	O
average	O
of	O
70	O
%	O
similarity	O
)	O
;	O
and	O
a	O
gene	O
encoding	O
a	O
putative	O
integrase	O
(	O
OG1RF	O
_	O
0088	O
)	O
at	O
the	O
other	O
end	O
-	O
these	O
three	O
features	O
are	O
also	O
present	O
in	O
Tn5386	O
in	O
E	B-Species
.	I-Species
faecium	I-Species
D344R	E-Species
[	O
46	O
]	O
.	O

An	O
uninterrupted	O
competence	O
operon	O
in	O
OG1RF	S-Species

In	O
V583	S-Species
,	O
the	O
fourth	O
gene	O
of	O
this	O
operon	O
(	O
corresponding	O
to	O
OG1RF	O
_	O
0148	O
)	O
is	O
interrupted	O
by	O
phage	O
4	O
(	O
EF1896	O
-	O
EF2043	O
)	O
;	O
in	O
addition	O
,	O
EF1984	O
contains	O
a	O
premature	O
stop	O
codon	O
not	O
found	O
in	O
the	O
corresponding	O
gene	O
in	O
OG1RF	S-Species
(	O
OG1RF	O
_	O
0228	O
)	O
.	O

To	O
investigate	O
the	O
possibility	O
that	O
directly	O
or	O
indirectly	O
the	O
com	O
operon	O
might	O
be	O
responsible	O
for	O
this	O
phenotype	O
,	O
we	O
also	O
evaluated	O
transformability	O
by	O
electroporation	O
.	O

When	O
compared	O
with	O
OG1RF	S-Species
,	O
transposon	O
mutants	O
[	O
12	O
]	O
in	O
the	O
OG1RF	S-Species
equivalent	O
of	O
EF2045	O
(	O
encoding	O
the	O
comGB	O
homologue	O
)	O
and	O
in	O
the	O
OG1RF	S-Species
equivalent	O
of	O
EF1986	O
(	O
encoding	O
the	O
comGF	O
homologue	O
)	O
showed	O
similar	O
levels	O
of	O
transformability	O
by	O
electroporation	O
(	O
data	O
not	O
shown	O
)	O
,	O
implying	O
that	O
the	O
difference	O
in	O
electroporation	O
efficiency	O
observed	O
between	O
OG1RF	S-Species
and	O
V583	S-Species
is	O
not	O
related	O
to	O
this	O
locus	O
.	O

Based	O
on	O
our	O
previous	O
microarray	O
data	O
,	O
the	O
Fsr	O
system	O
does	O
not	O
regulate	O
the	O
comY	O
operon	O
,	O
at	O
least	O
under	O
our	O
previously	O
used	O
conditions	O
(	O
mid	O
-	O
log	O
phase	O
growth	O
to	O
early	O
stationary	O
phase	O
in	O
brain	O
heart	O
infusion	O
(	O
BHI	O
)	O
)	O
[	O
22	O
]	O
.	O

The	O
acquisition	O
of	O
MGE	O
is	O
believed	O
to	O
be	O
an	O
important	O
mechanism	O
by	O
which	O
the	O
species	O
E	B-Species
.	I-Species
faecalis	E-Species
had	O
been	O
able	O
to	O
generate	O
genetic	O
diversity	O
and	O
,	O
thereby	O
,	O
highly	O
variable	O
phenotypes	O
[	O
4	O
]	O
.	O

[	O
36	O
]	O
demonstrate	O
that	O
these	O
factors	O
may	O
be	O
present	O
in	O
harmless	O
strains	O
while	O
absent	O
in	O
clinical	O
isolates	O
,	O
indicating	O
that	O
E	B-Species
.	I-Species
faecalis	E-Species
virulence	O
is	O
not	O
dependent	O
on	O
any	O
single	O
virulence	O
factor	O
.	O

The	O
inverse	O
allelic	O
exchange	O
was	O
also	O
performed	O
to	O
replace	O
the	O
intact	O
ropB	O
in	O
5448	S-Species
with	O
the	O
mutated	O
allele	O
from	O
5628	S-Species
.	O

While	O
the	O
M1T1	B-Species
GAS	E-Species
has	O
become	O
the	O
most	O
common	O
cause	O
of	O
streptococcal	O
pharyngitis	O
,	O
this	O
clone	O
is	O
also	O
overrepresented	O
in	O
cases	O
of	O
severe	O
invasive	O
disease	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
.	O

Studies	O
of	O
M1T1	S-Species
clinical	O
isolates	O
from	O
invasive	O
disease	O
cases	O
have	O
revealed	O
an	O
inverse	O
relationship	O
between	O
expression	O
of	O
the	O
extracellular	O
cysteine	O
protease	O
SpeB	O
and	O
clinical	O
severity	O
[	O
8	O
]	O
.	O

SpeB	O
is	O
a	O
secreted	O
cysteine	O
protease	O
initially	O
expressed	O
as	O
40	O
kDa	O
zymogen	O
which	O
is	O
then	O
converted	O
to	O
the	O
28	O
kDa	O
active	O
form	O
by	O
autocatalytic	O
processing	O
[	O
10	O
]	O
.	O

This	O
analysis	O
begins	O
with	O
a	O
naturally	O
-	O
occuring	O
mutation	O
in	O
ropB	O
identified	O
in	O
one	O
such	O
strain	O
.	O

The	O
ropB	O
mutation	O
of	O
strain	O
5628	S-Species
was	O
not	O
recapitulated	O
on	O
passage	O
in	O
the	O
mouse	S-Species
subcutaneous	O
infection	O
model	O
.	O

SpeB	O
is	O
the	O
principal	O
target	O
of	O
RopB	O
regulation	O
in	O
vivo	O

Discussion	O

Restoration	O
of	O
full	O
-	O
length	O
RopB	O
in	O
5628R	B-Species
+	E-Species
resulted	O
in	O
gaining	O
SpeB	O
expression	O
,	O
but	O
did	O
not	O
result	O
in	O
changes	O
in	O
hemolysis	O
,	O
DNase	O
activity	O
or	O
resistance	O
to	O
killing	O
by	O
neutrophils	O
.	O

Microarray	O
analysis	O
was	O
conducted	O
using	O
in	O
vivo	O
-	O
derived	O
RNA	O
,	O
since	O
the	O
transcriptome	O
of	O
bacteria	O
grown	O
in	O
vitro	O
may	O
differ	O
greatly	O
from	O
the	O
transcriptome	O
found	O
during	O
the	O
course	O
of	O
infection	O
.	O

This	O
finding	O
supported	O
the	O
in	O
vitro	O
and	O
in	O
vivo	O
data	O
that	O
suggested	O
SpeB	O
is	O
the	O
main	O
target	O
of	O
RopB	O
regulation	O
in	O
this	O
strain	O
.	O

This	O
finding	O
leads	O
to	O
the	O
conclusion	O
that	O
inactivation	O
of	O
SpeB	O
alone	O
is	O
not	O
sufficient	O
to	O
initiate	O
invasive	O
disease	O
.	O

In	O
M1T1	B-Species
GAS	E-Species
,	O
an	O
intact	O
RopB	O
and	O
efficient	O
SpeB	O
production	O
are	O
necessary	O
for	O
systemic	O
infection	O
.	O

However	O
,	O
the	O
proteins	O
regulated	O
by	O
Hfq	O
and	O
SmpB	O
are	O
not	O
as	O
clearly	O
defined	O
.	O

In	O
this	O
report	O
we	O
have	O
used	O
global	O
proteomics	O
to	O
directly	O
identify	O
proteins	O
regulated	O
by	O
Hfq	O
or	O
SmpB	O
by	O
comparing	O
protein	O
abundance	O
in	O
the	O
parent	O
and	O
isogenic	O
hfq	O
or	O
smpB	O
mutant	O
.	O

These	O
proteins	O
represent	O
a	O
broad	O
spectrum	O
of	O
Salmonella	S-Species
proteins	O
required	O
for	O
many	O
biological	O
processes	O
including	O
host	O
cell	O
invasion	O
,	O
motility	O
,	O
central	O
metabolism	O
,	O
LPS	O
biosynthesis	O
,	O
two	O
-	O
component	O
regulatory	O
systems	O
,	O
and	O
fatty	O
acid	O
metabolism	O
.	O

Post	O
-	O
transcriptional	O
regulation	O
of	O
gene	O
expression	O
by	O
small	O
noncoding	O
RNAs	O
(	O
sRNAs	O
)	O
is	O
widespread	O
in	O
both	O
prokaryotes	O
and	O
eukaryotes	O
and	O
has	O
only	O
recently	O
been	O
recognized	O
as	O
playing	O
a	O
prominent	O
role	O
in	O
the	O
regulation	O
of	O
cellular	O
processes	O
.	O

Its	O
broad	O
role	O
in	O
regulation	O
at	O
the	O
translational	O
level	O
has	O
recently	O
been	O
hinted	O
at	O
by	O
Sittka	O
and	O
co	O
-	O
workers	O
[	O
10	O
]	O
.	O

The	O
RNA	O
-	O
binding	O
protein	O
SmpB	O
specifically	O
interacts	O
with	O
the	O
sRNA	O
tmRNA	O
(	O
also	O
known	O
as	O
ssrA	O
and	O
10Sa	O
)	O
and	O
is	O
required	O
for	O
all	O
known	O
functions	O
of	O
tmRNA	O
[	O
11	O
]	O
.	O

Once	O
bound	O
,	O
tmRNA	O
adds	O
a	O
peptide	O
tag	O
to	O
the	O
nascent	O
partially	O
synthesized	O
protein	O
chain	O
which	O
targets	O
it	O
for	O
degradation	O
by	O
C	O
-	O
terminal	O
-	O
specific	O
cellular	O
proteases	O
[	O
15	O
]	O
,	O
[	O
16	O
]	O
,	O
[	O
17	O
]	O
,	O
[	O
18	O
]	O
.	O

In	O
this	O
method	O
[	O
28	O
]	O
,	O
the	O
coding	O
region	O
between	O
the	O
initiation	O
methionine	O
and	O
the	O
last	O
seven	O
amino	O
acids	O
of	O
the	O
gene	O
was	O
replaced	O
with	O
an	O
inframe	O
"	O
scar	O
"	O
sequence	O
that	O
does	O
not	O
contain	O
any	O
stop	O
codons	O
.	O

However	O
this	O
most	O
likely	O
is	O
an	O
underestimate	O
of	O
the	O
true	O
number	O
of	O
proteins	O
that	O
are	O
regulated	O
by	O
Hfq	O
,	O
if	O
accurate	O
protein	O
identifications	O
could	O
be	O
made	O
for	O
the	O
remaining	O
2829	O
orfs	O
of	O
the	O
entire	O
Salmonella	S-Species
proteome	O
(	O
4450	O
orfs	O
)	O
that	O
are	O
either	O
expressed	O
at	O
levels	O
too	O
low	O
to	O
be	O
detected	O
or	O
not	O
expressed	O
under	O
the	O
four	O
growth	O
conditions	O
employed	O
in	O
this	O
study	O
.	O

Of	O
the	O
781	O
proteins	O
and	O
492	O
transcripts	O
regulated	O
by	O
Hfq	O
,	O
113	O
genes	O
overlapped	O
both	O
sets	O
.	O

While	O
the	O
role	O
of	O
Hfq	O
as	O
a	O
global	O
regulator	O
has	O
become	O
increasingly	O
appreciated	O
over	O
the	O
past	O
few	O
years	O
,	O
the	O
actual	O
extent	O
of	O
Hfq	O
regulation	O
of	O
translation	O
remains	O
unknown	O
.	O

We	O
observed	O
changes	O
in	O
expression	O
for	O
approximately50	O
%	O
of	O
the	O
observed	O
Salmonella	B-Species
Typhimurium	E-Species
proteome	O
based	O
on	O
an	O
ANOVA	O
analysis	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
(	O
Table	O
S1	O
)	O
.	O

One	O
hallmark	O
of	O
growth	O
under	O
nutrient	O
poor	O
conditions	O
is	O
lower	O
expression	O
of	O
the	O
machinery	O
necessary	O
to	O
synthesize	O
proteins	O
,	O
including	O
tRNA	O
synthetases	O
and	O
other	O
factors	O
.	O

This	O
suggests	O
that	O
Hfq	O
normally	O
represses	O
translation	O
of	O
these	O
genes	O
under	O
conditions	O
that	O
mimics	O
the	O
intracellular	O
environment	O
(	O
AMM	O
)	O
.	O

Hfq	O
was	O
observed	O
to	O
modulate	O
numerous	O
proteins	O
involved	O
in	O
envelope	O
stress	O
under	O
AMM	O
-	O
2	O
conditions	O
,	O
including	O
FkpA	O
,	O
SurA	O
,	O
HtrA	O
,	O
NlpB	O
,	O
NmpC	O
,	O
ClpA	O
,	O
SlyD	O
,	O
RseA	O
,	O
RseB	O
,	O
RpoE	O
,	O
OmpF	O
,	O
and	O
HtpG	O
,	O
which	O
were	O
all	O
up	O
-	O
regulated	O
in	O
the	O
Deltahfq	O
mutant	O
strain	O
.	O

Recent	O
studies	O
have	O
shown	O
the	O
periplasmic	O
Cu	O
,	O
Zn	O
-	O
superoxide	O
dismutase	O
sodC	O
to	O
contribute	O
to	O
Salmonella	S-Species
virulence	O
in	O
mice	S-Species
[	O
39	O
]	O
,	O
[	O
40	O
]	O
.	O

The	O
cob	O
operon	O
is	O
required	O
for	O
the	O
de	O
novo	O
biosynthesis	O
of	O
vitamin	O
B12	O
in	O
Salmonella	B-Species
Typhimurium	E-Species
.	O

Results	O
from	O
our	O
proteomics	O
analysis	O
revealed	O
that	O
Hfq	O
regulates	O
the	O
cob	O
-	O
pdu	O
operon	O
in	O
AMM	O
-	O
2	O
(	O
Figure	O
4A	O
)	O
and	O
stationary	O
phase	O
(	O
Figure	O
4D	O
)	O
growth	O
conditions	O
,	O
with	O
several	O
products	O
of	O
the	O
cob	O
-	O
pdu	O
operon	O
exhibiting	O
increased	O
expression	O
compared	O
to	O
wild	O
type	O
.	O

We	O
note	O
however	O
that	O
a	O
more	O
detailed	O
and	O
rigorous	O
analysis	O
is	O
required	O
to	O
confirm	O
the	O
speculated	O
global	O
regulatory	O
role	O
of	O
SmpB	O
.	O

For	O
logarithmic	O
phase	O
growth	O
conditions	O
,	O
the	O
expression	O
pattern	O
of	O
242	O
proteins	O
appeared	O
to	O
exhibit	O
a	O
dependence	O
on	O
Hfq	O
,	O
while	O
37	O
proteins	O
exhibited	O
a	O
dependency	O
on	O
SmpB	O
.	O

In	O
order	O
to	O
accurately	O
characterize	O
global	O
control	O
of	O
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
level	O
it	O
is	O
essential	O
to	O
measure	O
global	O
changes	O
in	O
both	O
transcript	O
and	O
protein	O
levels	O
.	O

The	O
amount	O
of	O
translational	O
regulation	O
varied	O
with	O
growth	O
conditions	O
.	O

The	O
two	O
bacteria	O
shared	O
more	O
genes	O
in	O
stress	O
response	O
category	O
than	O
any	O
other	O
functional	O
group	O
.	O

Upregulation	O
of	O
genes	O
encoding	O
different	O
types	O
of	O
nutrient	O
uptake	O
systems	O
further	O
emphasized	O
the	O
differences	O
in	O
nutritional	O
requirements	O
of	O
the	O
two	O
bacteria	O
in	O
the	O
same	O
insect	O
host	O
.	O

P	B-Species
.	I-Species
luminescens	E-Species
produces	O
a	O
signaling	O
molecule	O
AI	O
-	O
2	O
to	O
resist	O
reactive	O
oxygen	O
species	O
[	O
8	O
]	O
and	O
phenylpropanoid	O
chemical	O
ST	O
to	O
inhibit	O
the	O
activity	O
of	O
antimicrobial	O
enzyme	O
PO	O
and	O
formation	O
of	O
melanotic	O
nodules	O
[	O
9	O
]	O
,	O
but	O
the	O
strategy	O
used	O
by	O
X	B-Species
.	I-Species
nematophila	E-Species
appears	O
to	O
be	O
that	O
of	O
suppression	O
of	O
transcripts	O
involved	O
in	O
the	O
insect	O
immune	O
response	O
[	O
10	O
-	O
12	O
]	O
.	O

They	O
were	O
selected	O
according	O
to	O
their	O
distinct	O
pathogenicity	O
in	O
insects	O
of	O
the	O
family	O
of	O
Scarabaeidae	O
-	O
S	B-Species
.	I-Species
scarabaei	E-Species
is	O
more	O
virulent	O
to	O
R	B-Species
.	I-Species
majalis	E-Species
than	O
H	B-Species
.	I-Species
bacteriophora	E-Species
.	O

In	O
addition	O
,	O
although	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
grows	O
slower	O
than	O
P	B-Species
.	I-Species
temperata	E-Species
both	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
the	O
LD50	O
and	O
LT50	O
value	O
do	O
not	O
differ	O
between	O
these	O
two	O
bacteria	O
[	O
17	O
]	O
.	O

Twenty	O
nine	O
of	O
the	O
40	O
distinct	O
P	B-Species
.	I-Species
temperata	E-Species
transcripts	O
have	O
similar	O
sequences	O
in	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
genome	O
,	O
thus	O
11	O
were	O
P	B-Species
.	I-Species
temperata	E-Species
specific	O
;	O
30	O
of	O
the	O
39	O
distinct	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
transcripts	O
share	O
sequence	O
similarity	O
with	O
P	B-Species
.	I-Species
temperata	E-Species
genome	O
,	O
thus	O
9	O
were	O
specific	O
to	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
(	O
Tables	O
1	O
and	O
2	O
)	O
.	O

Some	O
products	O
encoded	O
by	O
induced	O
genes	O
were	O
found	O
to	O
interact	O
with	O
as	O
many	O
as	O
eight	O
other	O
gene	O
products	O
in	O
the	O
network	O
.	O

The	O
pathway	O
network	O
analysis	O
indicates	O
that	O
the	O
product	O
of	O
yijC	O
may	O
function	O
as	O
a	O
repressor	O
to	O
potentially	O
control	O
the	O
expression	O
of	O
the	O
fabB	O
gene	O
,	O
which	O
in	O
turn	O
,	O
modulates	O
the	O
physical	O
properties	O
of	O
the	O
membrane	O
by	O
altering	O
the	O
level	O
of	O
unsaturated	O
fatty	O
acid	O
production	O
.	O

Further	O
,	O
genes	O
encoding	O
components	O
of	O
different	O
types	O
of	O
secretion	O
machineries	O
were	O
isolated	O
in	O
this	O
study	O
.	O

A	O
protease	O
gene	O
,	O
clpP	O
,	O
involved	O
in	O
protein	O
degradation	O
,	O
was	O
induced	O
in	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
upon	O
infection	O
.	O

Genes	O
involved	O
in	O
nutrient	O
scavenging	O

Induction	O
of	O
different	O
types	O
of	O
nutrient	O
uptake	O
systems	O
in	O
Photorhabdus	S-Species
and	O
Xenorhabdus	S-Species
further	O
emphasized	O
the	O
possible	O
differences	O
in	O
nutritional	O
requirements	O
of	O
the	O
two	O
bacteria	O
in	O
the	O
insect	O
host	O
.	O

Similarly	O
,	O
it	O
has	O
been	O
discussed	O
previously	O
that	O
histidine	O
and	O
phosphatidylethanolamine	O
,	O
the	O
possible	O
components	O
presented	O
in	O
the	O
insect	O
host	O
hemolymph	O
,	O
may	O
be	O
important	O
food	O
sources	O
used	O
by	O
P	B-Species
.	I-Species
luminescens	E-Species
for	O
growth	O
within	O
the	O
insect	O
host	O
[	O
64	O
]	O
.	O

As	O
cysteine	O
synthesis	O
gene	O
cysK	O
was	O
also	O
identified	O
from	O
P	B-Species
.	I-Species
temperata	E-Species
as	O
discussed	O
above	O
,	O
it	O
may	O
indicate	O
that	O
the	O
level	O
of	O
cysteine	O
either	O
synthesized	O
by	O
P	B-Species
.	I-Species
temperata	E-Species
or	O
acquired	O
from	O
the	O
insect	O
host	O
is	O
not	O
sufficient	O
during	O
infection	O
.	O

As	O
a	O
periplasmic	O
protein	O
,	O
TolB	O
is	O
an	O
extra	O
member	O
in	O
the	O
Tol	O
system	O
.	O

In	O
E	B-Species
.	I-Species
coli	E-Species
,	O
Tol	O
system	O
stabilizes	O
the	O
outer	O
membrane	O
structure	O
and	O
mutations	O
in	O
Tol	O
encoding	O
genes	O
result	O
in	O
hypersensitivity	O
to	O
deleterious	O
agents	O
[	O
65	O
]	O
.	O

Results	O
reveal	O
that	O
phylogenetically	O
related	O
bacteria	O
with	O
similar	O
biology	O
differ	O
dramatically	O
in	O
molecular	O
mechanisms	O
of	O
pathogenicity	O
in	O
the	O
same	O
host	O
.	O

AppChip2	S-Species
contains	O
2033	O
PCR	O
amplicons	O
based	O
on	O
the	O
genomic	O
sequence	O
of	O
App	B-Species
serotype	I-Species
5b	I-Species
strain	I-Species
L20	E-Species
,	O
representing	O
more	O
than	O
95	O
%	O
of	O
ORFs	O
greater	O
than	O
160	O
bp	O
in	O
length	O
.	O

Results	O
Transcriptional	O
profiling	O
of	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
recovered	O
from	O
the	O
lung	O
of	O
a	O
pig	S-Species
suffering	O
from	O
a	O
natural	O
infection	O
or	O
following	O
growth	O
of	O
the	O
bacterial	O
isolate	O
in	O
BHI	O
medium	O
was	O
performed	O
.	O

Our	O
results	O
indicate	O
that	O
,	O
for	O
example	O
,	O
gene	O
apxIVA	O
from	O
an	O
operon	O
coding	O
for	O
RTX	O
toxin	O
ApxIV	O
is	O
highly	O
up	O
-	O
regulated	O
in	O
vivo	O
,	O
and	O
that	O
two	O
genes	O
from	O
the	O
operon	O
coding	O
for	O
type	O
IV	O
fimbriae	O
(	O
APL	O
_	O
0878	O
and	O
APL	O
_	O
0879	O
)	O
were	O
also	O
up	O
-	O
regulated	O
.	O

Our	O
results	O
indicate	O
that	O
150	O
genes	O
are	O
differentially	O
expressed	O
during	O
the	O
acute	O
phase	O
of	O
infection	O
in	O
the	O
host	O
.	O

Results	O
and	O
discussion	O

During	O
the	O
course	O
of	O
our	O
experiments	O
,	O
we	O
were	O
able	O
to	O
collect	O
samples	O
from	O
three	O
different	O
animals	O
from	O
the	O
same	O
herd	O
,	O
before	O
antibiotherapy	O
was	O
undertaken	O
to	O
eradicate	O
the	O
infection	O
.	O

Clinical	O
signs	O
ranged	O
from	O
depression	O
to	O
respiratory	O
distress	O
,	O
while	O
macroscopic	O
observation	O
of	O
deceased	O
pigs	S-Species
revealed	O
lobar	O
fibrinohemorrhagic	O
pleuropneumonia	O
,	O
along	O
with	O
necrotic	O
lesions	O
and	O
the	O
accumulation	O
of	O
bloody	O
fluid	O
in	O
the	O
thorax	O
.	O

Only	O
28	O
genes	O
were	O
identified	O
as	O
divergent	O
/	O
absent	O
in	O
our	O
field	O
strain	O
,	O
when	O
compared	O
to	O
the	O
reference	O
serotype	O
5b	B-Species
L20	E-Species
strain	O
(	O
Table	O
1	O
)	O
.	O

Out	O
of	O
these	O
28	O
genes	O
,	O
20	O
can	O
be	O
found	O
in	O
two	O
major	O
regions	O
of	O
the	O
genome	O
:	O
14	O
putative	O
ORFs	O
code	O
for	O
phage	O
structures	O
,	O
while	O
6	O
are	O
located	O
in	O
the	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
tight	O
adherence	O
(	O
tad	O
)	O
locus	O
.	O

Some	O
genes	O
might	O
also	O
be	O
present	O
in	O
the	O
genome	O
of	O
strain	O
896	B-Species
-	I-Species
07	E-Species
and	O
absent	O
in	O
reference	O
strain	O
L20	S-Species
,	O
and	O
therefore	O
absent	O
on	O
AppChip2	S-Species
.	O

Our	O
results	O
indicated	O
that	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
could	O
easily	O
be	O
isolated	O
in	O
pure	O
culture	O
from	O
lung	O
tissues	O
of	O
all	O
animals	O
,	O
and	O
that	O
the	O
number	O
of	O
CFU	O
varied	O
from	O
1	O
x	O
106	O
to	O
1	O
x	O
107	O
per	O
gram	O
of	O
infected	O
tissue	O
.	O

Centrifugation	O
of	O
homogenized	O
samples	O
enabled	O
the	O
removal	O
of	O
most	O
cellular	O
debris	O
and	O
the	O
recovery	O
of	O
bacteria	O
.	O

In	O
vivo	O
transcript	O
profiling	O

Duplicate	O
experiments	O
showed	O
a	O
R2	O
correlation	O
factor	O
of	O
0	O
.	O
996	O
between	O
the	O
intensity	O
detected	O
for	O
the	O
Cy3	O
labelled	O
and	O
Cy5	O
labelled	O
probes	O
,	O
and	O
only	O
two	O
genes	O
seemed	O
to	O
qualify	O
as	O
obvious	O
outliers	O
(	O
data	O
not	O
shown	O
)	O
.	O

Both	O
genes	O
,	O
APL	O
_	O
1141	O
and	O
APL	O
_	O
0484	O
,	O
were	O
not	O
identified	O
as	O
differentially	O
expressed	O
during	O
the	O
course	O
of	O
a	O
natural	O
infection	O
.	O

We	O
also	O
compared	O
our	O
results	O
to	O
the	O
transcriptional	O
profile	O
of	O
a	O
virulent	O
strain	O
of	O
Pseudomonas	B-Species
aeruginosa	E-Species
,	O
another	O
lung	O
pathogen	O
,	O
isolated	O
from	O
a	O
chronically	O
infected	O
cystic	O
fibrosis	O
patient	S-Species
[	O
23	O
]	O
.	O

With	O
regards	O
to	O
their	O
possible	O
involvement	O
in	O
virulence	O
processes	O
,	O
some	O
genes	O
that	O
were	O
down	O
-	O
regulated	O
were	O
of	O
particular	O
interest	O
.	O

However	O
,	O
a	O
few	O
genes	O
involved	O
in	O
iron	O
acquisition	O
,	O
namely	O
APL	O
_	O
0096	O
,	O
APL	O
_	O
0668	O
,	O
hbpA	O
and	O
irp	O
,	O
were	O
up	O
-	O
regulated	O
.	O

Hfq	O
is	O
an	O
RNA	O
chaperone	O
that	O
acts	O
as	O
a	O
post	O
-	O
transcriptional	O
riboregulator	O
[	O
44	O
]	O
.	O

d	O
)	O
Up	O
-	O
regulated	O
genes	O

Numerous	O
genes	O
that	O
could	O
be	O
involved	O
in	O
the	O
progression	O
of	O
the	O
disease	O
were	O
identified	O
as	O
up	O
-	O
regulated	O
.	O

Adhesion	O
processes	O
are	O
essential	O
for	O
the	O
establishment	O
of	O
bacterial	O
infections	O
.	O

Genes	O
from	O
the	O
maltose	O
operon	O
,	O
involved	O
in	O
the	O
uptake	O
and	O
catabolism	O
of	O
maltose	O
[	O
56	O
]	O
,	O
were	O
up	O
-	O
regulated	O
:	O
the	O
genes	O
malP	O
,	O
malK	O
,	O
malF	O
,	O
malG	O
,	O
malQ	O
and	O
a	O
malM	O
homolog	O
(	O
APL	O
_	O
1234	O
)	O
were	O
actively	O
transcribed	O
in	O
the	O
host	O
(	O
average	O
fold	O
increase	O
of	O
3	O
.	O
1	O
)	O
,	O
and	O
gene	O
lamB1	O
,	O
which	O
codes	O
for	O
a	O
maltoporin	O
,	O
showed	O
a	O
5	O
.	O
14	O
fold	O
change	O
in	O
the	O
only	O
hybridization	O
in	O
which	O
the	O
reporter	O
wasn	O
'	O
t	O
manually	O
flagged	O
because	O
of	O
signal	O
saturation	O
.	O

The	O
irp	O
(	O
iron	O
responsive	O
protein	O
)	O
gene	O
codes	O
for	O
a	O
predicted	O
TonB	O
-	O
dependant	O
receptor	O
,	O
possibly	O
involved	O
in	O
hemin	O
transport	O
.	O

Interestingly	O
,	O
the	O
irp	O
gene	O
is	O
located	O
directly	O
next	O
to	O
APL	O
_	O
0920	O
,	O
a	O
conserved	O
lipoprotein	O
in	O
the	O
L20	S-Species
genome	O
although	O
they	O
are	O
transcribed	O
in	O
opposite	O
directions	O
.	O

These	O
three	O
genes	O
,	O
namely	O
fhaB	O
(	O
APL	O
_	O
0959	O
)	O
,	O
irp	O
(	O
APL	O
_	O
0919	O
)	O
and	O
APL	O
_	O
0920	O
,	O
could	O
all	O
represent	O
excellent	O
candidates	O
for	O
the	O
development	O
of	O
a	O
protective	O
cross	O
-	O
serotype	O
subunit	O
vaccine	O
against	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
.	O

While	O
our	O
results	O
can	O
help	O
decipher	O
some	O
of	O
the	O
adaptations	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
has	O
to	O
make	O
once	O
it	O
infects	O
the	O
host	O
,	O
much	O
more	O
research	O
is	O
necessary	O
in	O
order	O
to	O
understand	O
the	O
whole	O
picture	O
of	O
the	O
disease	O
.	O

These	O
data	O
provide	O
a	O
high	O
-	O
resolution	O
map	O
of	O
a	O
regulatory	O
network	O
and	O
the	O
underlying	O
logic	O
enabling	O
pathogen	O
adaptation	O
to	O
a	O
host	O
.	O

In	O
the	O
Salmonella	S-Species
genus	O
,	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O
is	O
found	O
only	O
in	O
pathogenic	O
serotypes	O
of	O
Salmonella	B-Species
enterica	E-Species
that	O
infect	O
warm	O
-	O
blooded	O
animals	O
and	O
is	O
absent	O
from	O
Salmonella	B-Species
bongori	E-Species
,	O
which	O
colonizes	O
cold	O
-	O
blooded	O
animals	O
[	O
18	O
]	O
.	O

This	O
included	O
almost	O
all	O
genes	O
in	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O
as	O
well	O
as	O
effector	O
genes	O
encoded	O
throughout	O
the	O
genome	O
(	O
Dataset	O
S1	O
)	O
.	O

The	O
SsrA	O
-	O
SsrB	O
system	O
was	O
acquired	O
by	O
horizontal	O
gene	O
transfer	O
into	O
the	O
S	B-Species
.	I-Species
enterica	E-Species
species	O
after	O
divergence	O
from	O
what	O
is	O
now	O
extant	O
S	B-Species
.	I-Species
bongori	E-Species
.	O

We	O
also	O
determined	O
the	O
distribution	O
of	O
down	O
-	O
regulated	O
genes	O
among	O
genomic	O
islands	O
[	O
24	O
]	O
,	O
including	O
prophages	O
,	O
pathogenicity	O
islands	O
(	O
SPI	O
-	O
islands	O
)	O
and	O
additional	O
regions	O
of	O
difference	O
(	O
ROD	O
)	O
between	O
S	B-Species
.	I-Species
enterica	E-Species
and	O
S	B-Species
.	I-Species
bongori	E-Species
(	O
Dataset	O
S2	O
)	O
.	O

From	O
this	O
,	O
the	O
133	O
down	O
-	O
regulated	O
genes	O
mapped	O
to	O
86	O
operons	O
,	O
49	O
of	O
which	O
had	O
an	O
SsrB	O
interaction	O
upstream	O
or	O
within	O
the	O
first	O
gene	O
of	O
the	O
operon	O
(	O
Table	O
2	O
)	O
.	O

Next	O
,	O
we	O
examined	O
our	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
for	O
the	O
presence	O
of	O
a	O
conserved	O
regulatory	O
motif	O
.	O

Interestingly	O
,	O
two	O
copies	O
of	O
the	O
palindrome	O
occur	O
upstream	O
of	O
the	O
ssrA	O
-	O
ssrB	O
operon	O
in	O
S	B-Species
.	E-Species

The	O
presence	O
of	O
a	O
conserved	O
palindrome	O
sequence	O
in	O
SPI	O
-	O
2	O
promoters	O
and	O
in	O
related	O
sequences	O
from	O
the	O
endosymbiont	O
S	B-Species
.	I-Species
glossinidius	E-Species
suggested	O
that	O
regulatory	O
input	O
by	O
SsrB	O
was	O
through	O
a	O
palindrome	O
sequence	O
architecture	O
.	O

However	O
,	O
the	O
orientation	O
of	O
individual	O
heptamers	O
was	O
essential	O
for	O
transcriptional	O
input	O
since	O
rewiring	O
the	O
palindrome	O
in	O
any	O
head	O
-	O
to	O
-	O
head	O
orientation	O
produced	O
negligible	O
promoter	O
activity	O
.	O

When	O
tested	O
in	O
promoter	O
activity	O
experiments	O
,	O
this	O
reporter	O
was	O
unable	O
to	O
activate	O
transcription	O
and	O
was	O
identical	O
to	O
the	O
X	O
-	O
X	O
-	O
X	O
mutant	O
construct	O
(	O
Figure	O
5D	O
)	O
.	O

To	O
examine	O
the	O
extent	O
to	O
which	O
regulatory	O
evolution	O
has	O
been	O
selective	O
for	O
this	O
genetic	O
architecture	O
,	O
we	O
created	O
a	O
position	O
weight	O
matrix	O
(	O
PWM	O
)	O
for	O
the	O
five	O
strongest	O
palindrome	O
sites	O
in	O
SPI	O
-	O
2	O
and	O
the	O
orthologous	O
sites	O
in	O
Sodalis	S-Species
SSR	O
-	O
3	O
.	O

Remarkably	O
,	O
this	O
accounted	O
for	O
17	O
of	O
22	O
SL1344	O
genome	O
-	O
encoded	O
effectors	O
translocated	O
by	O
the	O
SPI	O
-	O
2	O
-	O
encoded	O
T3SS	O
(	O
exceptions	O
are	O
chromosomal	O
steA	O
,	O
gogB	O
,	O
and	O
sseK	O
,	O
and	O
plasmid	O
-	O
encoded	O
spvB	O
and	O
spvC	O
)	O
.	O

Together	O
,	O
these	O
data	O
provide	O
compelling	O
evidence	O
for	O
the	O
identity	O
of	O
the	O
DNA	O
recognition	O
element	O
that	O
has	O
been	O
selected	O
through	O
evolution	O
to	O
co	O
-	O
regulate	O
an	O
SsrB	O
-	O
dependent	O
gene	O
program	O
involved	O
in	O
adaptation	O
to	O
a	O
host	O
.	O

This	O
regulatory	O
system	O
was	O
co	O
-	O
acquired	O
with	O
a	O
T3SS	O
encoded	O
in	O
the	O
SPI	O
-	O
2	O
pathogenicity	O
island	O
and	O
likely	O
contributed	O
to	O
immediate	O
and	O
gradual	O
phenotypic	O
diversity	O
as	O
new	O
regulatory	O
nodes	O
were	O
explored	O
and	O
acted	O
upon	O
by	O
natural	O
selection	O
.	O

The	O
SSR	O
-	O
3	O
region	O
in	O
S	B-Species
.	I-Species
glossinidius	E-Species
is	O
fully	O
conserved	O
in	O
gene	O
synteny	O
and	O
content	O
with	O
that	O
of	O
SPI	O
-	O
2	O
[	O
31	O
]	O
,	O
with	O
the	O
exception	O
of	O
two	O
effector	O
genes	O
missing	O
in	O
SSR	O
-	O
3	O
(	O
sseF	O
and	O
sseG	O
)	O
that	O
are	O
required	O
to	O
localize	O
vacuolar	O
Salmonella	S-Species
to	O
the	O
perinuclear	O
Golgi	O
in	O
host	O
cells	O
[	O
38	O
]	O
,	O
[	O
39	O
]	O
.	O

To	O
the	O
contrary	O
,	O
high	O
local	O
conservation	O
in	O
the	O
promoters	O
evolved	O
in	O
Salmonella	S-Species
and	O
Sodalis	S-Species
was	O
the	O
crux	O
in	O
defining	O
the	O
functional	O
SsrB	O
input	O
among	O
stochastic	O
noise	O
.	O

Our	O
findings	O
demonstrate	O
the	O
engagement	O
of	O
unique	O
regulatory	O
modules	O
in	O
niche	O
adaptation	O
,	O
implicate	O
a	O
critical	O
role	O
for	O
bacterial	O
genetic	O
heterogeneity	O
that	O
surpasses	O
transcriptional	O
in	O
vivo	O
adaptation	O
,	O
and	O
portray	O
the	O
dynamics	O
underlying	O
the	O
selection	O
of	O
hypervirulent	O
covS	O
mutants	O
over	O
their	O
parental	O
WT	O
cells	O
.	O

Despite	O
the	O
association	O
between	O
covS	O
mutations	O
and	O
the	O
emergence	O
of	O
the	O
hypervirulent	O
phenotype	O
of	O
M1T1	S-Species
strains	O
,	O
it	O
is	O
unclear	O
whether	O
this	O
increased	O
virulence	O
can	O
be	O
entirely	O
attributed	O
to	O
the	O
modulation	O
of	O
the	O
CovR	O
regulon	O
or	O
if	O
other	O
networks	O
are	O
also	O
perturbed	O
in	O
vivo	O
directly	O
,	O
indirectly	O
,	O
or	O
independently	O
of	O
the	O
CovRS	O
system	O
.	O

Such	O
comprehensive	O
analyses	O
highlighted	O
the	O
behavior	O
of	O
genomic	O
subsystems	O
that	O
may	O
be	O
involved	O
directly	O
or	O
indirectly	O
in	O
S	B-Species
.	I-Species
pyogenes	E-Species
niche	O
adaptation	O
and	O
pathogenesis	O
.	O

This	O
difference	O
in	O
buoyancy	O
can	O
be	O
attributed	O
to	O
differences	O
in	O
proteolytic	O
activity	O
(	O
WT	O
>	O
>	O
AP	S-Species
)	O
that	O
may	O
degrade	O
many	O
surface	O
proteins	O
,	O
including	O
pilin	O
,	O
or	O
induce	O
changes	O
in	O
the	O
surface	O
charge	O
making	O
bacterial	O
aggregates	O
more	O
compact	O
.	O

In	O
vivo	O
murine	S-Species
chamber	O
infection	O
model	O
allows	O
the	O
dissection	O
of	O
regulatory	O
vs	O
.	O
mutation	O
-	O
selection	O
events	O

Several	O
studies	O
,	O
including	O
ours	O
,	O
have	O
examined	O
phenotypic	O
,	O
proteomic	O
,	O
and	O
transcriptional	O
differences	O
between	O
WT	O
and	O
animal	O
-	O
passaged	O
M1T1	B-Species
GAS	E-Species
strains	O
[	O
For	O
example	O
,	O
11	O
,	O
12	O
,	O
13	O
,	O
16	O
,	O
26	O
,	O
27	O
,	O
37	O
]	O
,	O
but	O
none	O
attempted	O
to	O
capture	O
the	O
dynamic	O
changes	O
in	O
the	O
bacterial	O
population	O
in	O
vivo	O
.	O

Overall	O
,	O
at	O
the	O
least	O
conservative	O
statistical	O
threshold	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
the	O
transcription	O
of	O
557	O
(	O
23	O
.	O
9	O
%	O
)	O
out	O
of	O
2	O
,	O
329	O
genes	O
probed	O
in	O
the	O
microarrays	O
was	O
significantly	O
perturbed	O
(	O
up	O
or	O
down	O
,	O
at	O
one	O
or	O
more	O
conditions	O
,	O
Fig	O
.	O
S3	O
)	O
and	O
the	O
only	O
set	O
of	O
contiguous	O
genes	O
that	O
underwent	O
transcriptional	O
changes	O
at	O
all	O
tested	O
conditions	O
is	O
the	O
SpeB	O
operon	O
gene	O
set	O
(	O
CC4	O
in	O
Fig	O
.	O
2	O
)	O
.	O

However	O
,	O
the	O
fold	O
-	O
change	O
in	O
SpeB	O
operon	O
transcription	O
level	O
largely	O
varied	O
across	O
the	O
four	O
experimental	O
conditions	O
,	O
ranging	O
from	O
a	O
2	O
.	O
2	O
-	O
fold	O
to	O
a	O
30	O
-	O
fold	O
downregulation	O
(	O
Table	O
3	O
)	O
.	O

In	O
this	O
study	O
,	O
we	O
captured	O
dynamic	O
events	O
underlying	O
the	O
phenotypic	O
switch	O
resulting	O
from	O
this	O
population	O
restructuring	O
.	O

As	O
both	O
bacterial	O
variants	O
were	O
subjected	O
to	O
the	O
host	O
environment	O
,	O
they	O
underwent	O
additional	O
changes	O
in	O
gene	O
expression	O
.	O

Many	O
of	O
the	O
in	O
vivo	O
changes	O
that	O
both	O
the	O
WT	O
and	O
AP	S-Species
bacteria	O
underwent	O
are	O
suggestive	O
of	O
major	O
metabolic	O
reprogramming	O
associated	O
with	O
the	O
transition	O
from	O
a	O
saprophytic	O
lifestyle	O
in	O
the	O
carbohydrate	O
-	O
rich	O
laboratory	O
culture	O
medium	O
to	O
a	O
parasitic	O
lifestyle	O
in	O
the	O
vascularized	O
and	O
the	O
anaerobic	O
subcutaneous	O
environments	O
rich	O
in	O
peptides	O
,	O
amino	O
acids	O
,	O
nucleotides	O
,	O
and	O
different	O
types	O
of	O
complex	O
carbohydrates	O
.	O

Among	O
the	O
upregulated	O
genes	O
are	O
dipepetide	O
and	O
sucrose	O
-	O
specific	O
transporters	O
,	O
whose	O
upregulation	O
supports	O
the	O
hypothesis	O
that	O
the	O
bacteria	O
are	O
switching	O
diets	O
[	O
39	O
]	O
and	O
attempting	O
to	O
scavenge	O
nutrients	O
available	O
in	O
their	O
new	O
host	O
environment	O
.	O

Both	O
these	O
expression	O
patterns	O
suggest	O
CovS	O
-	O
dependent	O
in	O
vivo	O
signaling	O
via	O
different	O
downstream	O
pathways	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrate	O
how	O
the	O
murine	S-Species
model	O
has	O
allowed	O
us	O
to	O
finely	O
dissect	O
two	O
classes	O
of	O
events	O
affecting	O
GAS	S-Species
sociomicrobiology	O
:	O
those	O
related	O
to	O
reversible	O
transcriptional	O
adaptation	O
and	O
those	O
irreversibly	O
caused	O
by	O
the	O
covS	O
mutation	O
in	O
AP	S-Species
bacteria	O
.	O

Genes	O
in	O
neighbor	O
clusters	O
could	O
have	O
been	O
otherwise	O
overlooked	O
either	O
because	O
they	O
were	O
misannotated	O
but	O
their	O
co	O
-	O
occurrence	O
in	O
known	O
clusters	O
revealed	O
their	O
importance	O
,	O
or	O
because	O
they	O
did	O
not	O
pass	O
the	O
statistical	O
tests	O
but	O
,	O
since	O
many	O
bacterial	O
transcripts	O
are	O
polycistronic	O
,	O
the	O
expression	O
of	O
two	O
or	O
more	O
members	O
of	O
a	O
polycistron	O
strongly	O
suggests	O
that	O
the	O
whole	O
operon	O
is	O
expressed	O
.	O

In	O
fact	O
,	O
WT	O
bacteria	O
underwent	O
the	O
most	O
dramatic	O
in	O
vivo	O
transcriptional	O
reprogramming	O
(	O
Table	O
2	O
)	O
;	O
yet	O
,	O
they	O
failed	O
to	O
survive	O
since	O
after	O
five	O
to	O
seven	O
days	O
post	O
-	O
infection	O
,	O
they	O
became	O
extinct	O
,	O
and	O
only	O
AP	O
bacteria	O
could	O
be	O
isolated	O
from	O
the	O
mice	S-Species
chambers	O
[	O
16	O
]	O
.	O

Streptococcus	B-Species
agalactiae	E-Species
(	O
group	B-Species
B	I-Species
streptococcus	E-Species
)	O
is	O
an	O
important	O
cause	O
of	O
neonatal	O
invasive	O
infections	O
and	O
variety	O
of	O
diseases	O
in	O
human	S-Species
and	O
animals	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

This	O
bacterium	O
is	O
able	O
to	O
sense	O
the	O
changing	O
environmental	O
conditions	O
and	O
colonize	O
numerous	O
tissues	O
employing	O
different	O
mechanisms	O
of	O
gene	O
regulation	O
.	O

Subsequently	O
,	O
phosphoryl	O
group	O
is	O
transferred	O
to	O
RR	O
protein	O
resulting	O
in	O
conformational	O
changes	O
in	O
RR	O
molecule	O
.	O

HK06	O
/	O
RR06	O
was	O
also	O
important	O
for	O
the	O
ability	O
of	O
pneumococci	S-Species
to	O
adhere	O
to	O
epithelial	O
cells	O
in	O
vitro	O
and	O
to	O
survive	O
and	O
proliferate	O
in	O
an	O
in	O
vivo	O
mouse	S-Species
model	O
[	O
22	O
]	O
.	O

The	O
strains	O
were	O
tested	O
by	O
PCR	O
for	O
the	O
presence	O
of	O
virulence	O
gene	O
bac	O
and	O
sak188	O
and	O
sak189	O
TCS	O
genes	O
,	O
which	O
were	O
previously	O
found	O
to	O
be	O
located	O
on	O
pathogenicity	O
island	O
[	O
13	O
]	O
.	O

In	O
this	O
strain	O
,	O
the	O
bac	O
gene	O
has	O
unique	O
allele	O
with	O
the	O
closest	O
similarity	O
with	O
676a	O
and	O
676b	O
alleles	O
according	O
to	O
classification	O
of	O
Kong	O
et	O
al	O
.	O

Briefly	O
,	O
DNA	O
fragments	O
of	O
sak188	O
and	O
sak189	O
genes	O
were	O
PCR	O
amplified	O
using	O
pairs	O
of	O
primers	O
hkFor	O
,	O
hkRev	O
,	O
and	O
rrFor	O
,	O
rrRev	O
(	O
Table	O
1	O
)	O
,	O
respectively	O
.	O

Construction	O
of	O
the	O
strains	O
was	O
confirmed	O
by	O
PCR	O
and	O
nucleotide	O
sequencing	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
size	O
,	O
shape	O
and	O
color	O
of	O
the	O
colonies	O
,	O
diameter	O
of	O
zone	O
of	O
hemolysis	O
,	O
morphology	O
of	O
the	O
cells	O
and	O
the	O
chain	O
length	O
were	O
similar	O
in	O
all	O
the	O
strains	O
.	O

As	O
result	O
,	O
10	O
min	O
boiling	O
of	O
the	O
cells	O
in	O
2	O
-	O
mercaptoethanol	O
(	O
10	O
%	O
,	O
w	O
/	O
w	O
)	O
was	O
found	O
to	O
be	O
most	O
effective	O
with	O
respect	O
to	O
higher	O
yield	O
and	O
quality	O
of	O
the	O
protein	O
bands	O
observed	O
after	O
SDS	O
-	O
PAGE	O
(	O
data	O
not	O
shown	O
)	O
.	O

SDS	O
-	O
PAGE	O
of	O
secreted	O
proteins	O
did	O
not	O
reveal	O
any	O
difference	O
among	O
the	O
wild	O
-	O
type	O
strain	O
and	O
mutant	O
strains	O
(	O
data	O
not	O
shown	O
)	O
.	O

However	O
,	O
the	O
regulatory	O
mechanism	O
of	O
bac	O
gene	O
expression	O
has	O
not	O
been	O
studied	O
.	O

Similarly	O
,	O
ATP	O
-	O
binding	O
and	O
Mg2	O
+	O
-	O
binding	O
sites	O
located	O
at	O
C	O
-	O
terminal	O
end	O
of	O
Sak188	O
,	O
which	O
are	O
essential	O
for	O
phosphorylation	O
,	O
were	O
lost	O
in	O
Sak188	O
protein	O
due	O
to	O
the	O
mutagenesis	O
.	O

As	O
seen	O
from	O
the	O
Fig	O
.	O

Thus	O
,	O
we	O
can	O
conclude	O
that	O
sak188	O
and	O
bac	O
gene	O
are	O
not	O
in	O
the	O
operon	O
,	O
and	O
repression	O
of	O
bac	O
gene	O
transcription	O
in	O
sak189	O
/	O
sak188	O
double	O
mutant	O
strain	O
is	O
not	O
due	O
to	O
the	O
polar	O
effect	O
.	O

Given	O
that	O
insertional	O
inactivation	O
of	O
sak188	O
gene	O
does	O
not	O
affect	O
beta	O
-	O
antigen	O
expression	O
,	O
we	O
suggest	O
that	O
beta	O
-	O
antigen	O
expression	O
can	O
be	O
activated	O
independently	O
of	O
Sak188	O
,	O
perhaps	O
through	O
small	O
-	O
molecular	O
-	O
weight	O
phosphodonors	O
such	O
as	O
acetyl	O
phosphate	O
or	O
other	O
noncognate	O
histidine	O
kinases	O
.	O

Novel	O
Algorithms	O
Reveal	O
Streptococcal	O
Transcriptomes	O
and	O
Clues	O
about	O
Undefined	O
Genes	O

We	O
used	O
oligonucleotide	O
microarrays	O
to	O
monitor	O
(	O
in	O
vitro	O
)	O
differential	O
gene	O
expression	O
in	O
group	B-Species
A	I-Species
streptococci	E-Species
during	O
pharyngeal	O
cell	O
adherence	O
,	O
the	O
first	O
overt	O
infection	O
stage	O
.	O

We	O
present	O
neighbor	O
clustering	O
,	O
a	O
new	O
computational	O
method	O
for	O
further	O
analyzing	O
bacterial	O
microarray	O
data	O
that	O
combines	O
two	O
informative	O
characteristics	O
of	O
bacterial	O
genes	O
that	O
share	O
common	O
function	O
or	O
regulation	O
:	O
(	O
1	O
)	O
similar	O
gene	O
expression	O
profiles	O
(	O
i	O
.	O
e	O
.	O
,	O
co	O
-	O
expression	O
)	O
;	O
and	O
(	O
2	O
)	O
physical	O
proximity	O
of	O
genes	O
on	O
the	O
chromosome	O
.	O

This	O
method	O
identifies	O
statistically	O
significant	O
clusters	O
of	O
co	O
-	O
expressed	O
gene	O
neighbors	O
that	O
potentially	O
share	O
common	O
function	O
or	O
regulation	O
by	O
coupling	O
statistically	O
analyzed	O
gene	O
expression	O
profiles	O
with	O
the	O
chromosomal	O
position	O
of	O
genes	O
.	O

We	O
assessed	O
the	O
biological	O
significance	O
of	O
two	O
identified	O
genes	O
by	O
assaying	O
deletion	O
mutants	O
for	O
adherence	O
in	O
vitro	O
and	O
show	O
that	O
neighbor	O
clustering	O
indeed	O
provides	O
biologically	O
relevant	O
data	O
.	O

Neighbor	O
clustering	O
provides	O
a	O
more	O
comprehensive	O
view	O
of	O
the	O
molecular	O
responses	O
of	O
streptococci	S-Species
during	O
pharyngeal	O
cell	O
adherence	O
.	O

Introduction	O

Several	O
factors	O
,	O
however	O
,	O
limit	O
the	O
power	O
of	O
such	O
analyses	O
,	O
including	O
inadequate	O
statistical	O
analysis	O
and	O
insufficient	O
sample	O
replication	O
,	O
both	O
of	O
which	O
do	O
not	O
account	O
for	O
experimental	O
variability	O
,	O
and	O
often	O
result	O
in	O
arbitrary	O
thresholds	O
for	O
significance	O
[	O
1	O
,	O
2	O
]	O
.	O

Several	O
methods	O
are	O
available	O
to	O
organize	O
gene	O
expression	O
profiles	O
and	O
to	O
assist	O
in	O
extracting	O
functional	O
or	O
regulatory	O
gene	O
information	O
from	O
microarray	O
datasets	O
.	O

Because	O
no	O
tools	O
exist	O
to	O
interpret	O
unknown	O
gene	O
clusters	O
or	O
to	O
assess	O
their	O
significance	O
and	O
completeness	O
,	O
a	O
significant	O
portion	O
of	O
bacterial	O
expression	O
profiles	O
are	O
not	O
interpretable	O
using	O
current	O
clustering	O
methods	O
.	O

Information	O
about	O
gene	O
function	O
and	O
regulation	O
is	O
stored	O
intrinsically	O
in	O
the	O
bacterial	O
genome	O
structure	O
,	O
as	O
genes	O
with	O
common	O
function	O
or	O
regulation	O
tend	O
to	O
be	O
physically	O
proximate	O
on	O
the	O
chromosome	O
and	O
often	O
linked	O
as	O
operons	O
[	O
5	O
,	O
6	O
]	O
.	O

The	O
algorithms	O
also	O
recalculate	O
the	O
statistical	O
significance	O
of	O
each	O
gene	O
as	O
a	O
member	O
of	O
a	O
particular	O
cluster	O
,	O
as	O
well	O
as	O
the	O
significance	O
of	O
each	O
resulting	O
grouping	O
as	O
a	O
whole	O
,	O
to	O
ensure	O
accuracy	O
of	O
cluster	O
assignments	O
.	O

This	O
process	O
ultimately	O
identifies	O
significant	O
clusters	O
of	O
co	O
-	O
expressed	O
gene	O
neighbors	O
that	O
likely	O
share	O
common	O
function	O
or	O
regulation	O
.	O

We	O
used	O
this	O
approach	O
to	O
analyze	O
microarray	O
expression	O
data	O
from	O
group	B-Species
A	I-Species
streptococci	E-Species
(	O
Streptococcus	B-Species
pyogenes	E-Species
)	O
during	O
adherence	O
to	O
human	S-Species
pharyngeal	O
cells	O
,	O
the	O
first	O
overt	O
infection	O
step	O
[	O
7	O
]	O
.	O

We	O
compared	O
data	O
generated	O
before	O
and	O
after	O
neighbor	O
clustering	O
to	O
show	O
that	O
this	O
method	O
provides	O
a	O
more	O
comprehensive	O
view	O
of	O
transcription	O
by	O
:	O
(	O
1	O
)	O
identifying	O
more	O
differentially	O
expressed	O
genes	O
than	O
even	O
traditional	O
,	O
rigorous	O
statistical	O
analyses	O
;	O
(	O
2	O
)	O
reconstructing	O
intact	O
biological	O
pathways	O
that	O
statistical	O
significance	O
analysis	O
could	O
not	O
reconstruct	O
;	O
and	O
(	O
3	O
)	O
providing	O
preliminary	O
insight	O
and	O
clues	O
about	O
the	O
function	O
or	O
regulation	O
of	O
uncharacterized	O
genes	O
by	O
associating	O
their	O
co	O
-	O
expression	O
with	O
physically	O
proximate	O
,	O
functionally	O
defined	O
genes	O
.	O

Adherence	O
-	O
Mediated	O
Differential	O
Expression	O
We	O
developed	O
spotted	O
oligonucleotide	O
arrays	O
of	O
the	O
S	B-Species
.	I-Species
pyogenes	I-Species
SF370	E-Species
(	O
an	O
M1	O
serotype	O
)	O
genome	O
[	O
14	O
]	O
and	O
compared	O
the	O
transcriptomes	O
of	O
streptococci	S-Species
that	O
adhere	O
to	O
Detroit	O
562	O
human	S-Species
pharyngeal	O
cells	O
to	O
non	O
-	O
adherent	O
(	O
"	O
associated	O
"	O
)	O
streptococci	S-Species
within	O
the	O
same	O
experiment	O
.	O

This	O
analysis	O
identified	O
79	O
genes	O
(	O
4	O
%	O
of	O
the	O
genome	O
)	O
exhibiting	O
statistically	O
significant	O
fold	O
changes	O
in	O
expression	O
(	O
PF	O
value	O
<	O
0	O
.	O
05	O
)	O
during	O
adherence	O
from	O
1	O
,	O
769	O
open	O
reading	O
frames	O
represented	O
on	O
the	O
array	O
(	O
Table	O
1	O
)	O
.	O

Genes	O
demonstrating	O
upregulation	O
(	O
n	O
=	O
45	O
)	O
and	O
downregulation	O
(	O
n	O
=	O
34	O
)	O
included	O
virulence	O
factors	O
,	O
prophage	O
-	O
encoded	O
transcripts	O
,	O
metabolic	O
genes	O
,	O
and	O
transcriptional	O
regulators	O
(	O
Table	O
2	O
)	O
.	O

Undefined	O
or	O
hypothetical	O
genes	O
comprised	O
27	O
%	O
of	O
differentially	O
expressed	O
genes	O
(	O
n	O
=	O
21	O
;	O
11	O
chromosomally	O
encoded	O
genes	O
,	O
ten	O
phage	O
-	O
encoded	O
genes	O
)	O
.	O

Five	O
genes	O
chosen	O
for	O
validation	O
demonstrated	O
statistically	O
significant	O
fold	O
changes	O
in	O
expression	O
by	O
microarray	O
analysis	O
(	O
PF	O
value	O
<	O
0	O
.	O
05	O
;	O
two	O
upregulated	O
,	O
three	O
downregulated	O
)	O
.	O

We	O
averaged	O
the	O
data	O
to	O
generate	O
a	O
value	O
for	O
each	O
gene	O
,	O
creating	O
a	O
set	O
of	O
11	O
paired	O
values	O
from	O
quantitative	O
real	O
-	O
time	O
(	O
qRT	O
)	O
-	O
PCR	O
and	O
microarray	O
analyses	O
(	O
Table	O
S3	O
)	O
.	O

Virulence	O
Factors	O

The	O
initial	O
statistical	O
analysis	O
identified	O
four	O
differentially	O
expressed	O
virulence	O
genes	O
(	O
Tables	O
1	O
and	O
2	O
)	O
.	O

We	O
verified	O
the	O
differential	O
expression	O
of	O
spy2039	S-Biological_Molecule
and	O
spy0130	S-Biological_Molecule
by	O
qRT	O
-	O
PCR	O
.	O

The	O
downregulation	O
of	O
virulence	O
loci	O
during	O
presumably	O
inappropriate	O
stages	O
of	O
infection	O
was	O
not	O
surprising	O
.	O

Streptolysin	B-Biological_Molecule
O	E-Biological_Molecule
is	O
a	O
cytotoxin	O
that	O
damages	O
human	S-Species
tissue	O
and	O
increases	O
host	O
cell	O
cytotoxicity	O
[	O
7	O
,	O
25	O
]	O
.	O

Based	O
on	O
its	O
downregulation	O
during	O
adherence	O
,	O
we	O
infer	O
that	O
slo	S-Biological_Molecule
was	O
transcribed	O
during	O
pre	O
-	O
adherence	O
associations	O
,	O
perhaps	O
,	O
as	O
previously	O
reported	O
,	O
to	O
protect	O
streptococci	S-Species
from	O
phagocytic	O
killing	O
in	O
vivo	O
[	O
27	O
]	O
.	O

Although	O
few	O
studies	O
have	O
examined	O
gene	O
expression	O
patterns	O
during	O
adherence	O
,	O
SpeB	S-Biological_Molecule
production	O
(	O
as	O
detected	O
by	O
Western	O
blot	O
analysis	O
)	O
decreases	O
during	O
co	O
-	O
culture	O
with	O
human	S-Species
peripheral	O
blood	O
mononuclear	O
cells	O
[	O
30	O
]	O
and	O
in	O
a	O
mouse	S-Species
infection	O
model	O
[	O
31	O
]	O
.	O

When	O
SpeB	S-Biological_Molecule
expression	O
is	O
limited	O
,	O
several	O
streptococcal	O
proteins	O
necessary	O
for	O
adherence	O
remain	O
intact	O
[	O
24	O
,	O
32	O
,	O
33	O
]	O
;	O
thus	O
,	O
decreased	O
SpeB	S-Biological_Molecule
production	O
(	O
as	O
indicated	O
here	O
)	O
may	O
promote	O
pharyngeal	O
cell	O
attachment	O
.	O

We	O
observed	O
significant	O
upregulation	O
of	O
the	O
gene	O
spy0130	S-Biological_Molecule
,	O
encoding	O
a	O
protein	O
recently	O
found	O
to	O
be	O
associated	O
with	O
the	O
production	O
of	O
surface	O
-	O
exposed	O
pili	O
on	O
strain	O
SF370	S-Species
[	O
36	O
]	O
.	O

The	O
protein	O
shares	O
60	O
%	O
sequence	O
similarity	O
to	O
protein	B-Biological_Molecule
F	E-Biological_Molecule
,	O
suggesting	O
that	O
it	O
may	O
coordinate	O
a	O
similar	O
internalization	O
mechanism	O
or	O
may	O
be	O
involved	O
directly	O
in	O
adherence	O
(	O
discussed	O
later	O
in	O
detail	O
)	O
.	O

Taken	O
together	O
,	O
our	O
results	O
agree	O
with	O
previous	O
reports	O
on	O
SpeB	S-Biological_Molecule
production	O
during	O
host	O
cell	O
interactions	O
,	O
suggesting	O
that	O
decreased	O
expression	O
may	O
promote	O
streptococcal	O
adherence	O
(	O
by	O
preventing	O
proteolytic	O
degradation	O
of	O
key	O
virulence	O
factors	O
or	O
adhesins	O
)	O
,	O
enhance	O
internalization	O
(	O
perhaps	O
through	O
a	O
fibronectin	O
-	O
mediated	O
pathway	O
)	O
,	O
and	O
increase	O
survival	O
(	O
through	O
increased	O
pyrogenic	O
exotoxin	O
production	O
,	O
discussed	O
below	O
)	O
.	O

We	O
identified	O
11	O
differentially	O
expressed	O
phage	O
370	O
.	O
2	O
genes	O
,	O
suggesting	O
that	O
this	O
defective	O
phage	O
is	O
not	O
transcriptionally	O
silent	O
(	O
Table	O
1	O
)	O
.	O

Adherence	O
-	O
mediated	O
upregulation	O
of	O
speH	S-Biological_Molecule
is	O
likely	O
not	O
the	O
result	O
of	O
phage	O
induction	O
,	O
as	O
the	O
remaining	O
phage	O
370	O
.	O
2	O
genes	O
identified	O
in	O
our	O
analysis	O
were	O
downregulated	O
.	O

To	O
determine	O
if	O
SpeH	S-Biological_Molecule
plays	O
a	O
direct	O
role	O
in	O
the	O
adherence	O
process	O
,	O
we	O
created	O
a	O
deletion	O
mutant	O
in	O
strain	O
SF370	S-Species
(	O
SF370DeltaspeH	S-Biological_Molecule
)	O
,	O
which	O
was	O
confirmed	O
by	O
PCR	O
(	O
unpublished	O
data	O
)	O
and	O
RT	O
-	O
PCR	O
(	O
Figure	O
1A	O
)	O
and	O
tested	O
in	O
vitro	O
for	O
adherence	O
to	O
human	S-Species
pharyngeal	O
cells	O
.	O

We	O
observed	O
no	O
significant	O
difference	O
in	O
adherence	O
between	O
the	O
wild	O
-	O
type	O
(	O
SF370	S-Species
)	O
and	O
mutant	O
strains	O
(	O
Figure	O
1B	O
)	O
,	O
indicating	O
that	O
SpeH	S-Biological_Molecule
is	O
not	O
involved	O
directly	O
in	O
attachment	O
to	O
the	O
pharyngeal	O
cell	O
.	O

The	O
significant	O
upregulation	O
of	O
the	O
speH	S-Biological_Molecule
gene	O
during	O
adherence	O
suggests	O
that	O
the	O
gene	O
product	O
may	O
function	O
instead	O
during	O
a	O
subsequent	O
stage	O
of	O
infection	O
.	O

For	O
example	O
,	O
genes	O
encoding	O
proteins	O
involved	O
in	O
folate	S-Chemical_Compound
biosynthesis	O
[	O
40	O
]	O
were	O
upregulated	O
,	O
suggesting	O
that	O
certain	O
cofactors	O
that	O
may	O
be	O
necessary	O
during	O
adherence	O
were	O
unavailable	O
.	O

For	O
example	O
,	O
RopB	S-Biological_Molecule
(	O
encoded	O
by	O
spy2042	S-Biological_Molecule
)	O
,	O
a	O
member	O
of	O
the	O
Rgg	S-Biological_Molecule
family	O
of	O
response	O
regulators	O
,	O
interacts	O
with	O
a	O
number	O
of	O
regulatory	O
networks	O
throughout	O
the	O
streptococcal	O
genome	O
(	O
e	O
.	O
g	O
.	O
,	O
mga	S-Biological_Molecule
,	O
csrRS	S-Biological_Molecule
,	O
sagA	S-Biological_Molecule
,	O
and	O
fasBCA	S-Biological_Molecule
)	O
,	O
affecting	O
the	O
transcription	O
of	O
numerous	O
proteins	O
,	O
virulence	O
factors	O
,	O
and	O
two	O
-	O
component	O
regulatory	O
systems	O
[	O
42	O
,	O
43	O
]	O
.	O

Although	O
the	O
delineation	O
of	O
genes	O
influenced	O
by	O
RopB	S-Biological_Molecule
(	O
or	O
any	O
identified	O
transcriptional	O
regulator	O
)	O
is	O
beyond	O
the	O
scope	O
of	O
this	O
study	O
,	O
our	O
initial	O
analysis	O
did	O
identify	O
the	O
upregulation	O
of	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
,	O
encoded	O
by	O
spy1236	S-Biological_Molecule
-	O
1237	S-Biological_Molecule
.	O

The	O
functions	O
of	O
these	O
particular	O
loci	O
are	O
not	O
yet	O
known	O
,	O
and	O
their	O
adherence	O
-	O
mediated	O
upregulation	O
represents	O
new	O
targets	O
in	O
the	O
study	O
of	O
regulators	O
that	O
function	O
during	O
host	O
cell	O
contact	O
.	O

Because	O
the	O
genome	O
contains	O
many	O
possible	O
clusters	O
,	O
we	O
restricted	O
the	O
algorithm	O
'	O
s	O
search	O
space	O
to	O
identify	O
only	O
spatially	O
related	O
clusters	O
.	O

Because	O
individual	O
genes	O
could	O
be	O
members	O
of	O
many	O
different	O
significant	O
clusters	O
,	O
GenomeCrawler	O
then	O
applied	O
a	O
distinct	O
permutation	O
algorithm	O
to	O
calculate	O
the	O
probability	O
(	O
PC	O
)	O
that	O
a	O
gene	O
was	O
clustered	O
coincidentally	O
.	O

Calculation	O
of	O
PC	O
values	O
relies	O
on	O
Bayes	O
'	O
Theorem	O
,	O
in	O
which	O
the	O
probability	O
of	O
a	O
gene	O
'	O
s	O
log2	O
-	O
fold	O
change	O
(	O
PF	O
value	O
)	O
is	O
combined	O
with	O
the	O
cluster	O
probability	O
itself	O
(	O
PK	O
value	O
)	O
.	O

We	O
stress	O
that	O
PC	O
reflects	O
the	O
significance	O
of	O
a	O
gene	O
based	O
on	O
its	O
cluster	O
context	O
rather	O
than	O
a	O
recapitulation	O
of	O
PF	O
.	O

We	O
developed	O
a	O
plotting	O
application	O
(	O
GenomeSpyer	O
)	O
that	O
represents	O
the	O
chromosome	O
as	O
a	O
linear	O
molecule	O
to	O
visualize	O
GenomeCrawler	O
output	O
,	O
with	O
genes	O
displayed	O
on	O
the	O
x	O
-	O
axis	O
and	O
their	O
log2	O
-	O
fold	O
change	O
magnitudes	O
on	O
the	O
y	O
-	O
axis	O
.	O

Applications	O
and	O
all	O
datasets	O
are	O
available	O
for	O
download	O
at	O
http	O
:	O
/	O
/	O
www	O
.	O
rockefeller	O
.	O
edu	O
/	O
vaf	O
/	O
streparray	O
.	O
php	O
.	O

We	O
visually	O
inspected	O
the	O
resulting	O
clusters	O
and	O
disqualified	O
those	O
that	O
violated	O
our	O
neighbor	O
cluster	O
definition	O
(	O
see	O
Methods	O
for	O
details	O
)	O
.	O

All	O
output	O
prior	O
to	O
cluster	O
disqualifications	O
is	O
included	O
for	O
comparison	O
(	O
see	O
Table	O
S4	O
)	O
.	O

Of	O
the	O
309	O
qualifying	O
clusters	O
(	O
Table	O
S5	O
)	O
,	O
197	O
(	O
63	O
.	O
8	O
%	O
)	O
were	O
composed	O
entirely	O
of	O
known	O
,	O
functionally	O
defined	O
genes	O
;	O
however	O
,	O
26	O
(	O
13	O
%	O
)	O
of	O
these	O
were	O
incorrectly	O
assembled	O
,	O
as	O
they	O
contained	O
known	O
genes	O
that	O
are	O
functionally	O
unrelated	O
.	O

Because	O
we	O
did	O
not	O
incorporate	O
functional	O
annotations	O
of	O
genes	O
into	O
the	O
algorithms	O
(	O
i	O
.	O
e	O
.	O
,	O
to	O
keep	O
the	O
analysis	O
"	O
blind	O
"	O
)	O
,	O
we	O
anticipated	O
the	O
possibility	O
that	O
some	O
groupings	O
could	O
be	O
assembled	O
incorrectly	O
despite	O
the	O
statistical	O
framework	O
for	O
assigning	O
clusters	O
.	O

We	O
present	O
examples	O
of	O
Type	O
I	O
and	O
II	O
clusters	O
:	O
Type	O
I	O
clusters	O
(	O
n	O
=	O
25	O
)	O
contained	O
only	O
functionally	O
defined	O
and	O
functionally	O
related	O
genes	O
(	O
as	O
reported	O
in	O
published	O
studies	O
)	O
,	O
such	O
as	O
biological	O
pathways	O
components	O
(	O
Figures	O
2B	O
and	O
S2	O
)	O
;	O
Type	O
II	O
clusters	O
(	O
n	O
=	O
20	O
)	O
included	O
both	O
known	O
and	O
unknown	O
genes	O
(	O
Figures	O
2C	O
and	O
S3	O
)	O
.	O

Type	O
III	O
clusters	O
(	O
n	O
=	O
2	O
)	O
were	O
composed	O
entirely	O
of	O
unknown	O
genes	O
(	O
Figures	O
2D	O
and	O
S4	O
)	O
,	O
and	O
are	O
not	O
discussed	O
in	O
detail	O
.	O

Type	O
I	O
Clusters	O
:	O
Intact	O
Metabolic	O
Pathways	O
and	O
Multimeric	O
Proteins	O

We	O
measured	O
the	O
performance	O
of	O
our	O
algorithm	O
by	O
examining	O
whether	O
it	O
identified	O
gene	O
groupings	O
known	O
to	O
be	O
functionally	O
related	O
(	O
Type	O
I	O
clusters	O
)	O
.	O

Only	O
four	O
(	O
16	O
%	O
)	O
of	O
25	O
Type	O
I	O
clusters	O
(	O
spy0080	S-Biological_Molecule
-	O
0081	S-Biological_Molecule
,	O
spy1236	S-Biological_Molecule
-	O
1237	S-Biological_Molecule
,	O
spy1707	S-Biological_Molecule
-	O
1711	S-Biological_Molecule
,	O
spy2041	S-Biological_Molecule
-	O
2042	S-Biological_Molecule
)	O
could	O
have	O
been	O
identified	O
in	O
entirety	O
by	O
significance	O
analysis	O
because	O
all	O
clustered	O
genes	O
exhibited	O
significant	O
differential	O
expression	O
(	O
PF	O
value	O
<	O
0	O
.	O
05	O
)	O
.	O

GenomeCrawler	O
expanded	O
these	O
clusters	O
to	O
contain	O
more	O
genes	O
that	O
encode	O
intact	O
loci	O
(	O
Table	O
3	O
)	O
.	O

For	O
example	O
,	O
we	O
initially	O
identified	O
(	O
Table	O
1	O
)	O
the	O
significant	O
upregulation	O
of	O
three	O
of	O
the	O
five	O
known	O
gene	O
members	O
of	O
the	O
folate	S-Chemical_Compound
biosynthetic	O
pathway	O
[	O
40	O
]	O
(	O
spy1096	S-Biological_Molecule
-	O
1100	S-Biological_Molecule
)	O
,	O
but	O
GenomeCrawler	O
identified	O
a	O
significant	O
cluster	O
containing	O
all	O
five	O
genes	O
(	O
Table	O
3	O
and	O
Figure	O
2B	O
)	O
.	O

We	O
obtained	O
a	O
similar	O
result	O
for	O
the	O
eight	O
-	O
gene	O
operon	O
encoding	O
the	O
F0F1	O
-	O
type	O
proton	O
translocating	O
ATPase	O
[	O
41	O
]	O
(	O
spy0754	S-Biological_Molecule
-	O
0761	S-Biological_Molecule
)	O
.	O

Each	O
of	O
the	O
11	O
neighbor	O
clusters	O
that	O
could	O
have	O
been	O
only	O
partially	O
identified	O
by	O
our	O
initial	O
analysis	O
alone	O
gained	O
gene	O
members	O
after	O
application	O
of	O
the	O
algorithms	O
and	O
became	O
more	O
complete	O
sets	O
of	O
functionally	O
related	O
genes	O
than	O
initially	O
identified	O
(	O
Table	O
3	O
)	O
.	O

These	O
clusters	O
encompass	O
various	O
metabolic	O
processes	O
,	O
including	O
purine	O
biosynthesis	O
(	O
spy0025	S-Biological_Molecule
-	O
0028	S-Biological_Molecule
)	O
,	O
lactose	S-Chemical_Compound
metabolism	O
(	O
spy1916	S-Biological_Molecule
-	O
1923	S-Biological_Molecule
)	O
,	O
fatty	O
acid	O
biosynthesis	O
(	O
spy1743	S-Biological_Molecule
-	O
1747	S-Biological_Molecule
)	O
,	O
lipoteichoic	B-Chemical_Compound
acid	E-Chemical_Compound
synthesis	O
(	O
spy1308	S-Biological_Molecule
-	O
1312	S-Biological_Molecule
)	O
,	O
and	O
sugar	O
phosphotransferase	O
transport	O
(	O
spy1058	S-Biological_Molecule
-	O
1060	S-Biological_Molecule
)	O
[	O
14	O
]	O
,	O
suggesting	O
that	O
specific	O
changes	O
occur	O
in	O
the	O
streptococcal	O
metabolic	O
program	O
as	O
the	O
bacteria	O
adhere	O
to	O
human	S-Species
pharyngeal	O
cells	O
in	O
vitro	O
.	O

If	O
transcription	O
is	O
internally	O
disrupted	O
by	O
such	O
a	O
terminator	O
,	O
the	O
abundance	O
of	O
the	O
sagA	S-Biological_Molecule
transcript	O
may	O
be	O
much	O
greater	O
than	O
the	O
polycistronic	O
message	O
;	O
such	O
disproportionate	O
transcript	O
levels	O
would	O
affect	O
log2	O
-	O
fold	O
change	O
values	O
and	O
impact	O
the	O
statistical	O
significance	O
of	O
individual	O
genes	O
within	O
these	O
types	O
of	O
clusters	O
.	O

Thus	O
,	O
in	O
addition	O
to	O
helping	O
resolve	O
clusters	O
that	O
would	O
not	O
be	O
easily	O
recognized	O
because	O
of	O
experimental	O
technical	O
variability	O
,	O
the	O
neighbor	O
clustering	O
method	O
may	O
help	O
to	O
resolve	O
operons	O
with	O
such	O
internal	O
terminators	O
and	O
regulators	O
.	O

Curating	O
the	O
dataset	O
following	O
its	O
application	O
may	O
make	O
the	O
algorithms	O
less	O
user	O
-	O
friendly	O
;	O
however	O
,	O
the	O
elimination	O
of	O
such	O
bias	O
is	O
essential	O
for	O
this	O
type	O
of	O
analysis	O
.	O

Type	O
II	O
Clusters	O

Based	O
on	O
the	O
Type	O
I	O
cluster	O
results	O
,	O
we	O
speculated	O
that	O
genes	O
contained	O
in	O
Type	O
II	O
clusters	O
might	O
be	O
related	O
by	O
function	O
or	O
regulation	O
.	O

A	O
total	O
of	O
18	O
(	O
90	O
%	O
)	O
of	O
20	O
Type	O
II	O
clusters	O
(	O
Table	O
3	O
and	O
Figure	O
S3	O
)	O
may	O
not	O
have	O
been	O
identified	O
without	O
neighbor	O
clustering	O
:	O
eight	O
(	O
44	O
.	O
4	O
%	O
)	O
of	O
18	O
gained	O
additional	O
gene	O
members	O
;	O
the	O
remaining	O
ten	O
comprised	O
genes	O
that	O
demonstrated	O
significant	O
differential	O
expression	O
only	O
after	O
applying	O
GenomeCrawler	O
.	O

Only	O
two	O
clusters	O
(	O
spy0127	S-Biological_Molecule
-	O
0130	S-Biological_Molecule
and	O
spy1701	S-Biological_Molecule
-	O
1704	S-Biological_Molecule
)	O
could	O
have	O
been	O
identified	O
without	O
neighbor	O
clustering	O
;	O
however	O
,	O
a	O
number	O
of	O
these	O
genes	O
were	O
initially	O
annotated	O
as	O
hypothetical	O
proteins	O
,	O
so	O
a	O
potential	O
relationship	O
between	O
the	O
gene	O
members	O
may	O
not	O
have	O
been	O
readily	O
apparent	O
.	O

A	O
search	O
of	O
both	O
the	O
PFAM	O
database	O
[	O
47	O
]	O
(	O
http	O
:	O
/	O
/	O
pfam	O
.	O
wustl	O
.	O
edu	O
)	O
and	O
sortase	O
database	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
doe	O
-	O
mbi	O
.	O
ucla	O
.	O
edu	O
/	O
Services	O
/	O
Sortase	O
)	O
predicted	O
that	O
spy0129	S-Biological_Molecule
encodes	O
a	O
sortase	O
enzyme	O
,	O
which	O
are	O
transpeptidases	O
that	O
cleave	O
protein	O
substrates	O
at	O
conserved	O
C	O
-	O
terminal	O
motifs	O
(	O
often	O
LPXTG	O
)	O
and	O
then	O
anchor	O
these	O
proteins	O
to	O
the	O
bacterial	O
cell	O
wall	O
[	O
48	O
,	O
49	O
]	O
.	O

This	O
same	O
report	O
provided	O
the	O
first	O
experimental	O
evidence	O
supporting	O
the	O
sortase	S-Biological_Molecule
prediction	O
,	O
indicating	O
that	O
the	O
gene	O
product	O
of	O
spy0129	S-Biological_Molecule
is	O
responsible	O
for	O
the	O
cell	O
-	O
wall	O
sorting	O
of	O
the	O
proteins	O
encoded	O
by	O
both	O
spy0128	S-Biological_Molecule
(	O
annotated	O
as	O
a	O
Cpa	S-Biological_Molecule
homolog	O
[	O
50	O
]	O
)	O
and	O
spy0130	S-Biological_Molecule
(	O
annotated	O
as	O
a	O
protein	B-Biological_Molecule
F	E-Biological_Molecule
homolog	O
[	O
14	O
]	O
)	O
.	O

Furthermore	O
,	O
the	O
spy0128	S-Biological_Molecule
-	O
encoded	O
protein	O
is	O
the	O
structural	O
backbone	O
of	O
the	O
pili	O
,	O
and	O
the	O
gene	B-Biological_Molecule
product	E-Biological_Molecule
of	O
spy0130	S-Biological_Molecule
may	O
be	O
involved	O
in	O
stabilizing	O
the	O
structure	O
[	O
36	O
]	O
.	O

We	O
determined	O
experimentally	O
that	O
cluster	O
spy0127	S-Biological_Molecule
-	O
0130	S-Biological_Molecule
is	O
an	O
operon	O
,	O
verifying	O
both	O
related	O
function	O
and	O
regulation	O
of	O
the	O
gene	O
members	O
.	O

Reverse	O
transcription	O
of	O
SF370	S-Species
RNA	O
,	O
with	O
primer	O
combinations	O
that	O
spanned	O
all	O
four	O
genes	O
,	O
produced	O
cDNA	O
fragments	O
of	O
sizes	O
that	O
could	O
only	O
result	O
from	O
a	O
polycistronic	O
mRNA	O
template	O
(	O
Figure	O
3	O
)	O
.	O

In	O
silico	O
sequence	O
inspection	O
identified	O
a	O
single	O
putative	O
promoter	O
sequence	O
upstream	O
of	O
spy0127	S-Biological_Molecule
(	O
see	O
Table	O
S6	O
)	O
.	O

Allelic	O
Replacement	O
of	O
spy0129	S-Biological_Molecule

In	O
vitro	O
pharyngeal	O
cell	O
adherence	O
assays	O
revealed	O
that	O
the	O
SF370Deltaspy0129	S-Biological_Molecule
.	O
2	O
mutant	O
was	O
approximately	O
66	O
%	O
less	O
adherent	O
than	O
the	O
parental	O
control	O
strain	O
,	O
SF370	S-Species
(	O
Figure	O
4B	O
;	O
p	O
=	O
0	O
.	O
03	O
as	O
determined	O
by	O
the	O
Student	O
'	O
s	O
t	O
-	O
test	O
)	O
.	O

These	O
results	O
suggest	O
that	O
either	O
the	O
spy0130	S-Biological_Molecule
gene	O
product	O
is	O
involved	O
directly	O
in	O
adherence	O
,	O
or	O
that	O
due	O
to	O
the	O
elimination	O
of	O
the	O
sortase	S-Biological_Molecule
,	O
the	O
pili	O
,	O
which	O
may	O
function	O
in	O
their	O
entirety	O
as	O
adhesins	O
,	O
were	O
not	O
assembled	O
on	O
the	O
surface	O
of	O
the	O
mutant	O
.	O

BlastP	O
analysis	O
aligned	O
the	O
spy1725	S-Biological_Molecule
gene	O
product	O
,	O
which	O
has	O
homologs	O
in	O
all	O
sequenced	O
streptococcal	O
genomes	O
,	O
with	O
the	O
SP14	B-Biological_Molecule
.	I-Biological_Molecule
3	E-Biological_Molecule
protein	O
from	O
S	B-Species
.	I-Species
pneumoniae	E-Species
[	O
52	O
]	O
(	O
80	O
%	O
sequence	O
similarity	O
;	O
67	O
%	O
identity	O
)	O
.	O

The	O
spy1723	S-Biological_Molecule
gene	O
product	O
has	O
similar	O
domain	O
structure	O
to	O
the	O
YlxR	S-Biological_Molecule
protein	O
of	O
S	B-Species
.	I-Species
pneumoniae	E-Species
,	O
an	O
RNA	O
-	O
binding	O
protein	O
implicated	O
in	O
transcription	O
termination	O
[	O
53	O
]	O
.	O

These	O
results	O
indicate	O
that	O
both	O
genes	O
likely	O
encode	O
RNA	O
-	O
binding	O
proteins	O
,	O
in	O
agreement	O
with	O
their	O
functionally	O
defined	O
cluster	O
members	O
.	O

Although	O
domain	S-Biological_Molecule
and	O
homology	O
searches	O
yielded	O
the	O
functional	O
predictions	O
,	O
their	O
membership	O
within	O
a	O
protein	O
biosynthetic	O
cluster	O
provided	O
the	O
initial	O
indication	O
of	O
common	O
function	O
or	O
regulation	O
.	O

The	O
Mga	S-Biological_Molecule
regulator	O
is	O
a	O
growth	O
-	O
phase	O
mediator	O
of	O
a	O
number	O
of	O
surface	O
-	O
exposed	O
molecules	O
and	O
secreted	O
proteins	O
involved	O
in	O
colonization	O
and	O
immune	O
evasion	O
during	O
infection	O
[	O
58	O
]	O
.	O

We	O
suspect	O
that	O
this	O
discrepancy	O
results	O
from	O
different	O
normalization	O
methods	O
used	O
,	O
or	O
from	O
different	O
methods	O
that	O
were	O
applied	O
to	O
analyze	O
the	O
ratio	O
of	O
signal	O
intensities	O
between	O
sample	O
and	O
control	O
(	O
i	O
.	O
e	O
.	O
,	O
we	O
analyzed	O
the	O
ratios	O
of	O
the	O
median	O
rather	O
than	O
the	O
ratios	O
of	O
the	O
mean	O
[	O
57	O
]	O
)	O
.	O

Although	O
the	O
published	O
report	O
did	O
not	O
include	O
statistical	O
analysis	O
of	O
the	O
data	O
,	O
we	O
note	O
that	O
the	O
statistical	O
analysis	O
that	O
we	O
performed	O
identified	O
four	O
genes	O
with	O
significant	O
log2	O
-	O
fold	O
changes	O
in	O
expression	O
(	O
PF	O
<	O
0	O
.	O
05	O
;	O
Table	O
S8	O
)	O
.	O

These	O
groupings	O
included	O
clusters	O
of	O
genes	O
that	O
have	O
been	O
shown	O
previously	O
in	O
streptococci	S-Species
to	O
be	O
functionally	O
related	O
,	O
indicating	O
that	O
the	O
algorithms	O
were	O
performing	O
as	O
expected	O
.	O

GenomeCrawler	O
confirmed	O
these	O
results	O
by	O
identifying	O
both	O
groupings	O
as	O
statistically	O
significant	O
neighbor	O
clusters	O
.	O

For	O
example	O
,	O
the	O
algorithm	O
identified	O
a	O
significant	O
neighbor	O
cluster	O
spanning	O
spy0711	S-Biological_Molecule
-	O
0712	S-Biological_Molecule
.	O

However	O
,	O
these	O
results	O
provided	O
further	O
supporting	O
evidence	O
that	O
the	O
GenomeCrawler	O
algorithms	O
can	O
identify	O
(	O
1	O
)	O
a	O
larger	O
group	O
of	O
genes	O
than	O
a	O
rigorous	O
statistical	O
analysis	O
alone	O
and	O
(	O
2	O
)	O
biologically	O
relevant	O
groupings	O
in	O
other	O
microarray	O
datasets	O
,	O
even	O
if	O
they	O
contain	O
fewer	O
replicates	O
than	O
presented	O
in	O
our	O
study	O
.	O

Although	O
GenomeCrawler	O
improves	O
bacterial	O
array	O
analyses	O
,	O
it	O
has	O
limitations	O
:	O
it	O
cannot	O
identify	O
regulons	O
comprising	O
genes	O
dispersed	O
throughout	O
the	O
genome	O
by	O
virtue	O
of	O
its	O
design	O
,	O
it	O
does	O
not	O
specifically	O
interrogate	O
single	O
-	O
gene	O
operons	O
,	O
and	O
it	O
only	O
applies	O
to	O
genomes	O
with	O
available	O
and	O
accurate	O
experimental	O
information	O
(	O
expression	O
data	O
and	O
gene	O
annotations	O
)	O
.	O

Adding	O
available	O
clusters	O
of	O
orthologous	O
groups	O
(	O
COG	O
)	O
information	O
into	O
a	O
downstream	O
processing	O
step	O
could	O
decrease	O
errors	O
by	O
minimizing	O
clustering	O
of	O
unrelated	O
genes	O
.	O

Nonetheless	O
,	O
neighbor	O
clustering	O
provided	O
a	O
more	O
comprehensive	O
view	O
of	O
the	O
transcriptome	O
of	O
group	B-Species
A	I-Species
streptococci	E-Species
during	O
adherence	O
to	O
human	S-Species
pharyngeal	O
cells	O
,	O
a	O
critical	O
step	O
in	O
the	O
infection	O
program	O
of	O
this	O
organism	O
.	O

We	O
found	O
that	O
even	O
a	O
rigorous	O
statistical	O
analysis	O
of	O
well	O
-	O
replicated	O
microarray	O
data	O
produced	O
a	O
dataset	O
that	O
was	O
somewhat	O
limited	O
,	O
although	O
certainly	O
more	O
informative	O
than	O
assigning	O
arbitrary	O
thresholds	O
for	O
significance	O
.	O

As	O
described	O
in	O
other	O
microarray	O
reports	O
,	O
we	O
had	O
initially	O
identified	O
a	O
number	O
of	O
incomplete	O
biological	O
pathways	O
in	O
which	O
we	O
did	O
not	O
detect	O
the	O
differential	O
expression	O
of	O
a	O
number	O
of	O
known	O
pathway	O
members	O
.	O

Neighbor	O
clustering	O
was	O
able	O
to	O
extend	O
the	O
results	O
by	O
identifying	O
more	O
differentially	O
expressed	O
genes	O
and	O
reconstructing	O
more	O
intact	O
biological	O
pathways	O
.	O

Neighbor	O
clustering	O
,	O
despite	O
the	O
statistical	O
framework	O
with	O
which	O
it	O
assigns	O
groupings	O
,	O
would	O
be	O
valuable	O
to	O
microarray	O
data	O
analysis	O
only	O
if	O
it	O
produced	O
biologically	O
relevant	O
data	O
.	O

It	O
is	O
also	O
possible	O
that	O
GenomeCrawler	O
(	O
in	O
its	O
current	O
form	O
)	O
could	O
be	O
used	O
to	O
interrogate	O
intergenic	O
portions	O
of	O
the	O
genome	O
(	O
such	O
as	O
those	O
encoding	O
small	O
noncoding	O
RNAs	O
or	O
sRNAs	O
)	O
,	O
if	O
probes	O
representing	O
such	O
regions	O
were	O
included	O
on	O
the	O
microarray	O
,	O
and	O
experimental	O
conditions	O
were	O
designed	O
to	O
promote	O
their	O
differential	O
expression	O
.	O

Finally	O
,	O
because	O
of	O
the	O
common	O
architecture	O
of	O
bacterial	O
chromosomes	O
,	O
the	O
neighbor	O
clustering	O
algorithms	O
may	O
be	O
applicable	O
to	O
microarray	O
datasets	O
from	O
other	O
prokaryotes	O
.	O

Porphyromonas	B-Species
gingivalis	E-Species
possesses	O
two	O
distinct	O
fimbriae	O
.	O

The	O
authors	O
have	O
recently	O
demonstrated	O
that	O
both	O
fimbriae	O
are	O
required	O
for	O
formation	O
of	O
P	B-Species
.	I-Species
gingivalis	E-Species
biofilms	O
.	O

It	O
is	O
also	O
a	O
pathogen	O
that	O
may	O
be	O
involved	O
in	O
coronary	O
heart	O
disease	O
and	O
preterm	O
births	O
(	O
Boggess	O
et	O
al	O
.	O
,	O
2005	O
;	O
Brodala	O
et	O
al	O
.	O
,	O
2005	O
;	O
Chou	O
et	O
al	O
.	O
,	O
2005	O
)	O
.	O

Two	O
distinct	O
fimbriae	O
are	O
found	O
on	O
the	O
surface	O
of	O
the	O
organism	O
(	O
Dickinson	O
et	O
al	O
.	O
,	O
1988	O
;	O
Hamada	O
et	O
al	O
.	O
,	O
1996	O
)	O
.	O

The	O
long	O
(	O
major	O
)	O
filamentous	O
structure	O
is	O
comprised	O
of	O
a	O
FimA	S-Biological_Molecule
subunit	O
protein	O
encoded	O
by	O
the	O
fimA	S-Biological_Molecule
gene	O
.	O

Both	O
fimbriae	O
appear	O
to	O
be	O
involved	O
in	O
bacterial	O
pathogenicity	O
(	O
Amano	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

The	O
function	O
of	O
the	O
FimA	S-Biological_Molecule
protein	O
and	O
regulation	O
of	O
fimA	S-Biological_Molecule
expression	O
have	O
been	O
extensively	O
studied	O
.	O

The	O
FimA	S-Biological_Molecule
protein	O
is	O
required	O
for	O
P	B-Species
.	I-Species
gingivalis	E-Species
colonization	O
on	O
salivary	O
coated	O
surfaces	O
,	O
and	O
the	O
early	O
colonization	O
of	O
dental	O
plaque	O
(	O
Malek	O
et	O
al	O
.	O
,	O
1994	O
;	O
Levesque	O
et	O
al	O
.	O
,	O
2003	O
;	O
Maeda	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

Earlier	O
studies	O
by	O
the	O
authors	O
showed	O
that	O
FimA	S-Biological_Molecule
expression	O
was	O
modulated	O
by	O
environmental	O
cues	O
,	O
including	O
temperature	O
and	O
hemin	S-Chemical_Compound
concentration	O
,	O
and	O
by	O
the	O
presence	O
of	O
Streptococcus	B-Species
cristatus	E-Species
,	O
an	O
early	O
colonizer	O
of	O
dental	O
plaque	O
(	O
Xie	O
et	O
al	O
.	O
,	O
1997	O
,	O
2000b	O
)	O
.	O

FimR	S-Biological_Molecule
,	O
a	O
response	O
regulator	O
of	O
the	O
fimS	S-Biological_Molecule
/	O
fimR	S-Biological_Molecule
two	O
-	O
component	O
system	O
was	O
identified	O
,	O
and	O
FimA	S-Biological_Molecule
expression	O
was	O
found	O
to	O
be	O
dramatically	O
reduced	O
in	O
fimR	S-Biological_Molecule
mutants	O
(	O
Hayashi	O
et	O
al	O
.	O
,	O
2000	O
)	O
.	O

Investigation	O
of	O
the	O
mechanism	O
of	O
regulation	O
of	O
fimA	S-Biological_Molecule
by	O
FimR	S-Biological_Molecule
indicates	O
that	O
FimR	S-Biological_Molecule
does	O
not	O
bind	O
directly	O
to	O
the	O
fimA	S-Biological_Molecule
promoter	O
,	O
but	O
rather	O
binds	O
to	O
the	O
promoter	O
region	O
of	O
the	O
first	O
gene	O
(	O
pg2130	S-Biological_Molecule
)	O
in	O
the	O
fimA	S-Biological_Molecule
cluster	O
,	O
suggesting	O
that	O
PG2130	S-Biological_Molecule
is	O
the	O
FimR	S-Biological_Molecule
target	O
gene	O
,	O
which	O
in	O
turn	O
regulates	O
expression	O
of	O
other	O
genes	O
in	O
the	O
fimA	S-Biological_Molecule
cluster	O
,	O
including	O
the	O
fimA	S-Biological_Molecule
gene	O
(	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

The	O
short	O
fimbriae	O
(	O
Mfa1	S-Biological_Molecule
)	O
also	O
contribute	O
to	O
P	B-Species
.	I-Species
gingivalis	E-Species
colonization	O
.	O

Coadhesion	O
and	O
biofilm	O
development	O
between	O
P	B-Species
.	I-Species
gingivalis	E-Species
and	O
Streptococcus	B-Species
gordonii	E-Species
require	O
the	O
interaction	O
of	O
Mfa1	S-Biological_Molecule
with	O
streptococcal	O
protein	O
SspB	S-Biological_Molecule
(	O
Park	O
et	O
al	O
.	O
,	O
2005	O
)	O
.	O

A	O
mutant	O
with	O
a	O
deficiency	O
in	O
minor	O
fimbriae	O
binds	O
to	O
a	O
saliva	O
-	O
coated	O
surface	O
but	O
does	O
not	O
form	O
microcolonies	O
as	O
the	O
wild	O
-	O
type	O
strain	O
does	O
.	O

In	O
a	O
nutrient	O
-	O
limited	O
medium	O
,	O
expression	O
of	O
FimA	S-Biological_Molecule
and	O
Mfa1	S-Biological_Molecule
are	O
inhibited	O
in	O
P	B-Species
.	I-Species
gingivalis	E-Species
,	O
whereas	O
such	O
differences	O
are	O
not	O
found	O
in	O
gingipain	O
expression	O
.	O

A	O
recent	O
study	O
has	O
shown	O
that	O
expression	O
of	O
mfa1	S-Biological_Molecule
is	O
repressed	O
in	O
the	O
presence	O
of	O
some	O
common	O
oral	O
plaque	O
bacteria	O
such	O
as	O
S	B-Species
.	I-Species
gordonii	E-Species
,	O
Streptococcus	B-Species
sanguinis	E-Species
and	O
Streptococcus	B-Species
mitis	E-Species
(	O
Park	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

However	O
,	O
very	O
little	O
is	O
known	O
about	O
regulatory	O
mechanisms	O
of	O
mfa1	S-Biological_Molecule
expression	O
.	O

In	O
this	O
study	O
,	O
it	O
is	O
demonstrated	O
that	O
FimR	S-Biological_Molecule
is	O
a	O
positive	O
regulator	O
of	O
Mfa1	S-Biological_Molecule
expression	O
.	O

Evidence	O
is	O
provided	O
that	O
unlike	O
FimR	S-Biological_Molecule
-	O
dependent	O
fimA	S-Biological_Molecule
expression	O
,	O
FimR	S-Biological_Molecule
regulates	O
mfa1	S-Biological_Molecule
expression	O
by	O
directly	O
binding	O
to	O
the	O
promoter	O
region	O
of	O
mfa1	S-Biological_Molecule
.	O

Results	O

Role	O
of	O
FimR	S-Biological_Molecule
in	O
mfa1	S-Biological_Molecule
expression	O
The	O
fimA	S-Biological_Molecule
gene	O
is	O
the	O
only	O
gene	O
known	O
to	O
be	O
tightly	O
controlled	O
by	O
the	O
FimS	S-Biological_Molecule
/	O
FimR	S-Biological_Molecule
system	O
.	O

To	O
investigate	O
effects	O
of	O
FimR	S-Biological_Molecule
on	O
expression	O
of	O
the	O
mfa1	S-Biological_Molecule
gene	O
,	O
an	O
insertional	O
fimR	S-Biological_Molecule
mutant	O
was	O
constructed	O
by	O
allelic	O
replacement	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

This	O
result	O
is	O
consistent	O
with	O
previous	O
observations	O
(	O
Hayashi	O
et	O
al	O
.	O
,	O
2000	O
;	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

The	O
striking	O
finding	O
is	O
that	O
expression	O
of	O
the	O
mfa1	S-Biological_Molecule
gene	O
was	O
also	O
repressed	O
threefold	O
in	O
the	O
fimR	S-Biological_Molecule
-	O
mutant	O
,	O
although	O
not	O
to	O
the	O
degree	O
observed	O
with	O
the	O
fimA	S-Biological_Molecule
expression	O
.	O

To	O
determine	O
production	O
of	O
long	O
(	O
major	O
)	O
and	O
short	O
(	O
minor	O
)	O
fimbriae	O
in	O
the	O
fimR	S-Biological_Molecule
-	O
mutant	O
,	O
western	O
blotting	O
was	O
performed	O
with	O
a	O
polyclonal	O
anti	O
-	O
FimA	S-Biological_Molecule
or	O
anti	O
-	O
Mfa1	S-Biological_Molecule
antibody	O
to	O
compare	O
fimbrial	O
production	O
in	O
wild	O
-	O
type	O
strain	O
(	O
33277	S-Species
)	O
,	O
the	O
fimR	S-Biological_Molecule
-	O
mutant	O
(	O
FRE	S-Species
)	O
,	O
the	O
fimA	S-Biological_Molecule
-	O
mutant	O
(	O
FAT	S-Species
)	O
and	O
the	O
mfa1	S-Biological_Molecule
-	O
mutant	O
(	O
MFAE	S-Species
)	O
.	O

This	O
analysis	O
revealed	O
that	O
the	O
expression	O
of	O
the	O
fimA	S-Biological_Molecule
and	O
mfa1	S-Biological_Molecule
genes	O
was	O
consistent	O
at	O
the	O
mRNA	O
level	O
and	O
protein	O
level	O
(	O
Fig	O
.	O
1b	O
)	O
.	O

FimA	S-Biological_Molecule
protein	O
was	O
not	O
detectable	O
in	O
the	O
fimR	S-Biological_Molecule
-	O
mutant	O
,	O
while	O
a	O
50	O
%	O
lower	O
level	O
of	O
Mfa1	S-Biological_Molecule
protein	O
was	O
found	O
in	O
the	O
fimR	S-Biological_Molecule
-	O
mutant	O
compared	O
with	O
that	O
in	O
wild	O
-	O
type	O
strain	O
33277	S-Species
.	O

Similarly	O
,	O
there	O
was	O
no	O
apparent	O
change	O
in	O
RgpA	S-Biological_Molecule
production	O
in	O
the	O
fimR	S-Biological_Molecule
-	O
mutant	O
,	O
which	O
was	O
detected	O
by	O
anti	O
-	O
RgpA	S-Biological_Molecule
serum	O
.	O

Identification	O
of	O
the	O
transcriptional	O
start	O
site	O
of	O
the	O
mfa1	S-Biological_Molecule
gene	O

The	O
transcriptional	O
start	O
site	O
(	O
the	O
A	O
)	O
of	O
mfa1	S-Biological_Molecule
was	O
at	O
434	O
bp	O
upstream	O
from	O
the	O
potential	O
start	O
codon	O
(	O
Fig	O
.	O
2b	O
)	O
.	O

To	O
verify	O
the	O
result	O
,	O
the	O
RACE	O
experiment	O
was	O
repeated	O
with	O
mfa1	S-Biological_Molecule
-	O
specific	O
reverse	O
primers	O
MfaTSR3	O
and	O
MfaTSR4	O
located	O
at	O
237	O
bp	O
upstream	O
of	O
the	O
potential	O
start	O
codon	O
.	O

2c	O
,	O
the	O
PCR	O
product	O
was	O
generated	O
only	O
with	O
primers	O
MfaTSF1	O
(	O
corresponding	O
to	O
+	O
6	O
to	O
+	O
25	O
)	O
and	O
MfaTSR5	O
(	O
+	O
805	O
to	O
+	O
824	O
)	O
.	O

This	O
transcriptional	O
start	O
site	O
is	O
390	O
bp	O
upstream	O
of	O
the	O
site	O
previously	O
reported	O
(	O
Park	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

Binding	O
of	O
FimR	S-Biological_Molecule
to	O
the	O
promoter	O
region	O
of	O
mfa1	S-Biological_Molecule

It	O
was	O
postulated	O
that	O
different	O
mechanisms	O
might	O
be	O
involved	O
in	O
FimR	S-Biological_Molecule
-	O
mediated	O
mfa1	S-Biological_Molecule
expression	O
,	O
since	O
expression	O
regulation	O
of	O
mfa1	S-Biological_Molecule
by	O
FimR	S-Biological_Molecule
was	O
not	O
controlled	O
as	O
tightly	O
as	O
observed	O
for	O
fimA	S-Biological_Molecule
expression	O
.	O

The	O
mfa1	S-Biological_Molecule
promoter	O
(	O
positioned	O
from	O
+	O
18	O
to	O
-	O
138	O
)	O
,	O
fimA	S-Biological_Molecule
promoter	O
(	O
positioned	O
from	O
-	O
22	O
to	O
-	O
190	O
)	O
(	O
Xie	O
&	O
Lamont	O
,	O
1999	O
)	O
and	O
mfa1	S-Biological_Molecule
coding	O
DNA	O
(	O
positioned	O
from	O
+	O
1253	O
to	O
+	O
1373	O
)	O
were	O
generated	O
by	O
PCR	O
with	O
the	O
5	O
'	O
biotin	O
-	O
labeled	O
primers	O
(	O
Table	O
1	O
)	O
.	O

The	O
rHGP44	S-Biological_Molecule
protein	O
,	O
a	O
binding	O
domain	O
of	O
P	B-Species
.	I-Species
gingivalis	E-Species
gingipains	O
(	O
Xie	O
et	O
al	O
.	O
,	O
2006	O
)	O
,	O
expressed	O
in	O
the	O
same	O
system	O
and	O
purified	O
by	O
the	O
same	O
procedures	O
as	O
rFimR	S-Biological_Molecule
was	O
used	O
as	O
a	O
control	O
.	O

Cold	O
competitor	O
chase	O
experiments	O
with	O
a	O
100	O
-	O
fold	O
excess	O
of	O
unlabeled	O
DNA	O
probe	O
as	O
a	O
specific	O
competitor	O
were	O
also	O
used	O
to	O
demonstrate	O
the	O
specificity	O
of	O
rFimR	S-Biological_Molecule
binding	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

As	O
the	O
concentration	O
of	O
rFimR	S-Biological_Molecule
increased	O
,	O
the	O
retarded	O
protein	O
-	O
DNA	O
complex	O
became	O
evident	O
,	O
with	O
complete	O
loss	O
of	O
the	O
mfa1	S-Biological_Molecule
promoter	O
DNA	O
.	O

No	O
significant	O
difference	O
was	O
detected	O
in	O
the	O
level	O
of	O
DNA	O
binding	O
between	O
the	O
phosphorylated	O
rFimR	S-Biological_Molecule
and	O
unphosphorylated	O
rFimR	S-Biological_Molecule
(	O
data	O
not	O
shown	O
)	O
.	O

There	O
was	O
also	O
no	O
DNA	O
shift	O
detected	O
when	O
rFimR	S-Biological_Molecule
was	O
incubated	O
with	O
the	O
coding	O
region	O
of	O
mfa1	S-Biological_Molecule
.	O

These	O
data	O
clearly	O
show	O
that	O
FimR	S-Biological_Molecule
protein	O
can	O
bind	O
specifically	O
to	O
the	O
mfa1	S-Biological_Molecule
promoter	O
region	O
,	O
acting	O
as	O
an	O
activator	O
of	O
mfa1	S-Biological_Molecule
transcription	O
.	O

EMSA	O
experiments	O
were	O
also	O
performed	O
to	O
examine	O
whether	O
the	O
rFimR	S-Biological_Molecule
binds	O
to	O
the	O
other	O
promoter	O
region	O
identified	O
by	O
Park	O
et	O
al	O
.	O

Discussion	O

The	O
two	O
-	O
component	O
regulatory	O
system	O
is	O
a	O
major	O
mechanism	O
of	O
signal	O
transduction	O
and	O
is	O
widespread	O
in	O
bacteria	O
.	O

Although	O
most	O
target	O
genes	O
of	O
P	B-Species
.	I-Species
gingivalis	E-Species
two	O
-	O
component	O
systems	O
are	O
unknown	O
,	O
the	O
role	O
of	O
the	O
FimS	S-Biological_Molecule
/	O
FimR	S-Biological_Molecule
in	O
expression	O
of	O
the	O
fimA	S-Biological_Molecule
gene	O
is	O
well	O
defined	O
.	O

Expression	O
of	O
minor	B-Biological_Molecule
fimbriae	E-Biological_Molecule
(	O
mfa1	S-Biological_Molecule
)	O
in	O
a	O
fimR	S-Biological_Molecule
mutanthas	O
been	O
investigated	O
.	O

A	O
comparison	O
of	O
the	O
transcriptional	O
level	O
of	O
the	O
mfa1	S-Biological_Molecule
in	O
P	B-Species
.	I-Species
gingivalis	E-Species
wild	O
-	O
type	O
strain	O
and	O
in	O
the	O
fimR	S-Biological_Molecule
mutant	O
indicates	O
that	O
the	O
FimS	S-Biological_Molecule
/	O
FimR	S-Biological_Molecule
system	O
is	O
a	O
positive	O
regulator	O
for	O
the	O
mfa1	S-Biological_Molecule
gene	O
,	O
although	O
the	O
system	O
controls	O
two	O
fimbrial	O
genes	O
at	O
different	O
levels	O
.	O

The	O
previous	O
study	O
suggested	O
that	O
regulation	O
of	O
fimA	S-Biological_Molecule
expression	O
by	O
FimR	S-Biological_Molecule
is	O
through	O
a	O
regulation	O
cascade	O
involving	O
interaction	O
of	O
FimR	S-Biological_Molecule
and	O
the	O
promoter	O
region	O
of	O
the	O
first	O
gene	O
in	O
the	O
fimA	S-Biological_Molecule
cluster	O
(	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

It	O
has	O
also	O
been	O
reported	O
previously	O
that	O
the	O
transcriptional	O
activity	O
of	O
fimA	S-Biological_Molecule
was	O
reduced	O
in	O
the	O
fimA	S-Biological_Molecule
mutant	O
,	O
indicating	O
multiple	O
levels	O
of	O
control	O
of	O
fimA	S-Biological_Molecule
expression	O
in	O
P	B-Species
.	I-Species
gingivalis	E-Species
(	O
Xie	O
et	O
al	O
.	O
,	O
2000a	O
)	O
.	O

However	O
,	O
the	O
possibility	O
cannot	O
be	O
excluded	O
that	O
other	O
regulatory	O
elements	O
are	O
also	O
involved	O
in	O
expression	O
of	O
the	O
mfa1	S-Biological_Molecule
gene	O
.	O

However	O
,	O
no	O
apparent	O
difference	O
was	O
found	O
in	O
DNA	O
-	O
binding	O
affinity	O
between	O
rFimRs	S-Biological_Molecule
with	O
or	O
without	O
acetyl	B-Chemical_Compound
phosphate	E-Chemical_Compound
treatment	O
.	O

Observation	O
suggests	O
that	O
different	O
mechanisms	O
may	O
be	O
involved	O
in	O
P	B-Species
.	I-Species
gingivalis	E-Species
FimR	S-Biological_Molecule
activation	O
.	O

Activation	O
of	O
a	O
regulatory	O
protein	O
not	O
corresponding	O
to	O
phosphorylation	O
was	O
also	O
observed	O
in	O
Streptococcus	B-Species
mutans	E-Species
(	O
Biswas	O
&	O
Biswas	O
,	O
2006	O
)	O
.	O

Phosphorylation	O
of	O
CovR	S-Biological_Molecule
,	O
a	O
global	O
response	O
regulator	O
,	O
had	O
no	O
effect	O
on	O
its	O
DNA	O
-	O
binding	O
affinity	O
.	O

Data	O
of	O
this	O
study	O
suggest	O
that	O
transcription	O
of	O
the	O
mfa1	S-Biological_Molecule
gene	O
originated	O
at	O
a	O
distal	O
upstream	O
transcriptional	O
start	O
site	O
and	O
read	O
through	O
the	O
promoter	O
region	O
suggested	O
by	O
Park	O
et	O
al	O
.	O

(	O
2006	O
)	O
.	O

Moreover	O
,	O
FimR	S-Biological_Molecule
appears	O
to	O
act	O
on	O
the	O
promoter	O
region	O
identified	O
here	O
,	O
suggesting	O
that	O
this	O
promoter	O
may	O
make	O
significant	O
contributions	O
toward	O
mfa1	S-Biological_Molecule
expression	O
through	O
the	O
FimS	S-Biological_Molecule
/	O
FimR	S-Biological_Molecule
system	O
.	O

Gene	O
expression	O
under	O
the	O
control	O
of	O
two	O
promoters	O
is	O
not	O
uncommon	O
in	O
bacteria	O
.	O

In	O
E	B-Species
.	I-Species
coli	E-Species
,	O
two	O
promoters	O
direct	O
transcription	O
of	O
acs	O
encoding	O
,	O
an	O
acetate	S-Chemical_Compound
-	O
scavenging	O
enzyme	O
required	O
for	O
fitness	O
during	O
periods	O
of	O
carbon	O
starvation	O
-	O
the	O
distal	O
acsP1	S-Biological_Molecule
and	O
the	O
proximal	O
acsP2	S-Biological_Molecule
(	O
Beatty	O
et	O
al	O
.	O
,	O
2003	O
)	O
.	O

It	O
is	O
suggested	O
that	O
each	O
promoter	O
may	O
interact	O
with	O
different	O
regulatory	O
elements	O
.	O

A	O
cascade	O
regulation	O
starting	O
with	O
FimR	S-Biological_Molecule
appears	O
to	O
act	O
on	O
the	O
upstream	O
promoter	O
(	O
Nishikawa	O
et	O
al	O
.	O
,	O
2004	O
)	O
.	O

The	O
hypothesis	O
is	O
currently	O
under	O
investigation	O
.	O

In	O
conclusion	O
,	O
P	B-Species
.	I-Species
gingivalis	E-Species
fimbriae	O
play	O
a	O
predominant	O
role	O
in	O
the	O
attachment	O
of	O
the	O
organism	O
to	O
a	O
variety	O
of	O
oral	O
surfaces	O
(	O
Lamont	O
&	O
Jenkinson	O
,	O
2000	O
;	O
Amano	O
et	O
al	O
.	O
,	O
2004	O
)	O
,	O
although	O
other	O
surface	O
proteins	O
,	O
such	O
as	O
gingipains	O
,	O
may	O
also	O
be	O
involved	O
in	O
the	O
bacterial	O
colonization	O
(	O
Tokuda	O
et	O
al	O
.	O
,	O
1996	O
;	O
Chen	O
et	O
al	O
.	O
,	O
2001	O
)	O
.	O

It	O
has	O
been	O
recently	O
reported	O
by	O
the	O
authors	O
that	O
both	O
major	O
fimbriae	O
and	O
minor	O
fimbriae	O
contribute	O
to	O
the	O
formation	O
of	O
P	B-Species
.	I-Species
gingivalis	E-Species
biofilm	O
(	O
Lin	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

Major	O
fimbriae	O
are	O
required	O
for	O
initial	O
attachment	O
and	O
the	O
minor	O
fimbriae	O
appear	O
to	O
play	O
an	O
important	O
role	O
in	O
microcolony	O
formation	O
by	O
facilitating	O
cell	O
-	O
cell	O
interactions	O
.	O

Therefore	O
,	O
it	O
is	O
proposed	O
that	O
FimR	S-Biological_Molecule
can	O
be	O
an	O
attractive	O
target	O
for	O
inhibition	O
of	O
P	B-Species
.	I-Species
gingivalis	E-Species
colonization	O
.	O

Control	O
of	O
M	B-Species
.	I-Species
tuberculosis	E-Species
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
Secretion	O
and	O
Specific	O
T	O
Cell	O
Recognition	O
by	O
PhoP	S-Biological_Molecule

Two	O
of	O
the	O
most	O
widely	O
used	O
attenuated	O
strains	O
in	O
the	O
history	O
of	O
tuberculosis	O
research	O
are	O
Mycobacterium	B-Species
bovis	I-Species
BCG	E-Species
(	O
BCG	S-Species
)	O
and	O
Mycobacterium	B-Species
tuberculosis	I-Species
H37Ra	E-Species
(	O
H37Ra	S-Species
)	O
,	O
which	O
both	O
lost	O
their	O
virulence	O
during	O
in	O
vitro	O
serial	O
passage	O
.	O

Whereas	O
the	O
attenuation	O
of	O
BCG	S-Species
is	O
due	O
mainly	O
to	O
loss	O
of	O
the	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
secretion	O
system	O
,	O
ESX	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
,	O
the	O
reason	O
why	O
H37Ra	S-Species
is	O
attenuated	O
remained	O
unknown	O
.	O

Only	O
H37Ra	S-Species
"	O
knock	O
-	O
ins	O
"	O
that	O
carried	O
an	O
integrated	O
cosmid	O
with	O
the	O
wild	O
-	O
type	O
phoP	S-Biological_Molecule
gene	O
from	O
M	B-Species
.	I-Species
tuberculosis	I-Species
H37Rv	E-Species
showed	O
changes	O
in	O
colony	O
morphology	O
,	O
increased	O
virulence	O
,	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
secretion	O
,	O
and	O
induction	O
of	O
specific	O
T	O
cell	O
responses	O
,	O
whereas	O
other	O
H37Ra	S-Species
constructs	O
did	O
not	O
.	O

Among	O
the	O
different	O
possibilities	O
to	O
obtain	O
new	O
insight	O
into	O
the	O
mechanisms	O
employed	O
by	O
M	B-Species
.	I-Species
tuberculosis	E-Species
to	O
infect	O
its	O
host	O
,	O
the	O
analysis	O
of	O
attenuated	O
strains	O
is	O
one	O
promising	O
approach	O
,	O
and	O
there	O
are	O
some	O
well	O
-	O
documented	O
examples	O
of	O
laboratory	O
-	O
attenuated	O
strains	O
.	O

Another	O
famous	O
example	O
of	O
an	O
attenuated	O
strain	O
is	O
M	B-Species
.	I-Species
tuberculosis	I-Species
H37Ra	E-Species
(	O
"	O
a	O
"	O
for	O
avirulent	O
)	O
(	O
H37Ra	S-Species
)	O
.	O

This	O
strain	O
was	O
obtained	O
in	O
1934	O
by	O
serial	O
passage	O
of	O
patient	S-Species
isolate	O
M	B-Species
.	I-Species
tuberculosis	I-Species
H37	E-Species
through	O
media	O
with	O
different	O
pHs	O
[	O
6	O
]	O
and	O
since	O
then	O
has	O
been	O
widely	O
used	O
in	O
many	O
laboratories	O
in	O
the	O
world	O
.	O

As	O
H37Ra	S-Species
is	O
derived	O
from	O
the	O
same	O
parent	O
strain	O
as	O
M	B-Species
.	I-Species
tuberculosis	I-Species
H37Rv	E-Species
(	O
"	O
v	O
"	O
for	O
virulent	O
)	O
(	O
H37Rv	S-Species
)	O
,	O
the	O
sequenced	O
paradigm	O
strain	O
of	O
tuberculosis	O
research	O
[	O
7	O
]	O
,	O
genomic	O
comparisons	O
of	O
the	O
attenuated	O
and	O
virulent	O
variants	O
of	O
M	B-Species
.	I-Species
tuberculosis	I-Species
H37	E-Species
are	O
particularly	O
interesting	O
and	O
have	O
the	O
potential	O
to	O
identify	O
subtle	O
genetic	O
changes	O
that	O
might	O
be	O
responsible	O
for	O
the	O
phenotypic	O
differences	O
observed	O
between	O
the	O
two	O
strains	O
.	O

In	O
a	O
previous	O
study	O
we	O
have	O
tried	O
to	O
reveal	O
these	O
determinants	O
[	O
8	O
]	O
,	O
but	O
the	O
methods	O
employed	O
only	O
identified	O
large	O
genetic	O
polymorphisms	O
,	O
associated	O
with	O
IS6110	O
,	O
which	O
were	O
not	O
found	O
to	O
be	O
responsible	O
for	O
the	O
attenuation	O
of	O
H37Ra	S-Species
[	O
8	O
]	O
.	O

[	O
9	O
]	O
transformed	O
a	O
cosmid	O
library	O
of	O
H37Rv	S-Species
into	O
H37Ra	S-Species
and	O
then	O
selected	O
for	O
clones	O
that	O
were	O
enriched	O
on	O
passage	O
through	O
the	O
mouse	S-Species
.	O

H37Ra	S-Species
was	O
also	O
the	O
subject	O
of	O
extensive	O
micro	O
-	O
array	O
based	O
analyses	O
,	O
including	O
whole	O
genome	O
comparative	O
DNA	O
/	O
DNA	O
analyses	O
[	O
10	O
]	O
and	O
transcriptional	O
studies	O
[	O
11	O
,	O
12	O
]	O
,	O
which	O
have	O
identified	O
some	O
candidate	O
genes	O
that	O
were	O
consistently	O
downregulated	O
.	O

This	O
technique	O
has	O
previously	O
permitted	O
single	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
of	O
a	O
PA	B-Chemical_Compound
-	I-Chemical_Compound
824	E-Chemical_Compound
drug	O
resistant	O
mutant	O
strain	O
of	O
H37Rv	S-Species
to	O
be	O
detected	O
[	O
13	O
]	O
.	O

This	O
approach	O
was	O
combined	O
with	O
gene	O
"	O
knock	O
-	O
in	O
"	O
strategies	O
,	O
to	O
complement	O
selected	O
lesions	O
,	O
that	O
allowed	O
recombinant	O
H37Ra	S-Species
strains	O
to	O
be	O
engineered	O
,	O
whose	O
virulence	O
and	O
immunogenicity	O
were	O
then	O
evaluated	O
in	O
in	O
vitro	O
,	O
ex	O
vivo	O
and	O
animal	O
models	O
.	O

Microarray	O
-	O
Based	O
Comparative	O
Genome	O
Sequencing	O
of	O
M	B-Species
.	I-Species
tuberculosis	I-Species
H37Ra	E-Species
The	O
genome	O
-	O
wide	O
comparative	O
mutational	O
analysis	O
of	O
H37Ra	S-Species
and	O
H37Rv	S-Species
was	O
carried	O
out	O
by	O
NimbleGen	O
Systems	O
following	O
a	O
previously	O
published	O
method	O
[	O
13	O
]	O
.	O

By	O
this	O
combined	O
approach	O
we	O
identified	O
13	O
non	O
-	O
synonymous	O
SNPs	O
that	O
differed	O
between	O
the	O
H37Ra	S-Species
and	O
H37Rv	S-Species
strains	O
used	O
(	O
Table	O
S1	O
)	O
.	O

We	O
were	O
particularly	O
interested	O
in	O
a	O
C	O
to	O
T	O
mutation	O
responsible	O
for	O
the	O
serine	O
to	O
leucine	O
replacement	O
at	O
position	O
219	O
,	O
S219L	O
,	O
of	O
the	O
two	O
-	O
component	O
regulator	O
PhoP	S-Biological_Molecule
as	O
this	O
protein	O
is	O
well	O
known	O
for	O
its	O
involvement	O
in	O
the	O
virulent	O
phenotype	O
of	O
M	B-Species
.	I-Species
tuberculosis	E-Species
[	O
14	O
]	O
.	O

While	O
writing	O
this	O
article	O
,	O
the	O
whole	O
genome	O
sequence	O
of	O
H37Ra	S-Species
became	O
publicly	O
available	O
(	O
NC	O
_	O
009525	O
)	O
,	O
and	O
comparison	O
of	O
the	O
SNP	O
data	O
obtained	O
from	O
the	O
H37Ra	S-Species
strain	O
used	O
in	O
our	O
laboratory	O
(	O
Table	O
S1	O
)	O
with	O
the	O
NC	O
_	O
009525	O
data	O
,	O
showed	O
that	O
some	O
differences	O
existed	O
between	O
the	O
H37Ra	S-Species
strains	O
,	O
a	O
phenomenon	O
which	O
was	O
also	O
previously	O
observed	O
for	O
BCG	S-Species
[	O
4	O
]	O
and	O
H37Rv	S-Species
[	O
17	O
]	O
.	O

Nevertheless	O
,	O
the	O
S129L	O
mutation	O
in	O
PhoP	S-Biological_Molecule
,	O
which	O
we	O
consider	O
an	O
important	O
SNP	O
involved	O
in	O
the	O
attenuation	O
and	O
reduced	O
immunogenicity	O
of	O
H37Ra	S-Species
,	O
is	O
identical	O
in	O
all	O
H37Ra	S-Species
strains	O
.	O

To	O
evaluate	O
the	O
phenotypic	O
effect	O
of	O
the	O
different	O
SNPs	O
and	O
to	O
assess	O
their	O
potential	O
contribution	O
to	O
the	O
attenuation	O
process	O
,	O
we	O
undertook	O
functional	O
genomic	O
analyses	O
using	O
knock	O
-	O
ins	O
of	O
H37Ra	S-Species
,	O
as	O
described	O
previously	O
[	O
18	O
]	O
.	O

By	O
this	O
approach	O
we	O
obtained	O
appropriately	O
complemented	O
transformants	O
for	O
the	O
SNPs	O
in	O
genes	O
fadE5	S-Biological_Molecule
,	O
rpsL	S-Biological_Molecule
,	O
and	O
phoP	S-Biological_Molecule
(	O
Table	O
S1	O
)	O
,	O
using	O
cosmids	O
I230	O
,	O
I563	O
,	O
and	O
I36	O
,	O
respectively	O
.	O

Figure	O
S1	O
shows	O
part	O
of	O
the	O
nucleotide	O
sequence	O
of	O
a	O
PCR	O
-	O
amplified	O
fragment	O
obtained	O
from	O
H37Ra	O
:	O
:	O
phoP	S-Biological_Molecule
.	O

It	O
is	O
clearly	O
visible	O
that	O
at	O
nucleotide	O
position	O
656	O
of	O
phoP	S-Biological_Molecule
two	O
peaks	O
exist	O
,	O
one	O
originating	O
from	O
the	O
SNP	O
present	O
in	O
H37Ra	S-Species
and	O
one	O
from	O
the	O
integrated	O
cosmid	O
I36	O
carrying	O
the	O
H37Rv	S-Species
wild	O
-	O
type	O
copy	O
of	O
phoP	S-Biological_Molecule
.	O

Correct	O
integration	O
of	O
I36	O
was	O
also	O
confirmed	O
by	O
Southern	O
blot	O
.	O

The	O
successful	O
integration	O
of	O
the	O
cosmid	O
was	O
also	O
reflected	O
by	O
a	O
change	O
in	O
colony	O
morphology	O
that	O
is	O
shown	O
in	O
Figure	O
S3	O
.	O

Ex	O
Vivo	O
Virulence	O
Studies	O

In	O
a	O
first	O
attempt	O
to	O
determine	O
the	O
virulence	O
of	O
the	O
complemented	O
H37Ra	S-Species
knock	O
-	O
in	O
strains	O
relative	O
to	O
wild	O
-	O
type	O
H37Ra	S-Species
and	O
H37Rv	S-Species
,	O
bone	O
marrow	O
-	O
derived	O
murine	O
macrophages	O
(	O
BMM	O
)	O
were	O
infected	O
with	O
the	O
different	O
strains	O
at	O
a	O
multiplicity	O
of	O
infection	O
(	O
MOI	O
)	O
of	O
1	O
:	O
1	O
and	O
10	O
:	O
1	O
bacteria	O
per	O
cell	O
.	O

As	O
depicted	O
in	O
Figure	O
1	O
,	O
macrophages	O
were	O
able	O
to	O
control	O
ex	O
vivo	O
growth	O
of	O
H37Ra	S-Species
,	O
but	O
failed	O
to	O
control	O
growth	O
of	O
H37Rv	S-Species
,	O
confirming	O
results	O
from	O
Freeman	O
and	O
colleagues	O
[	O
20	O
]	O
.	O

When	O
H37Ra	S-Species
knock	O
-	O
ins	O
were	O
tested	O
,	O
important	O
differences	O
in	O
their	O
ex	O
vivo	O
growth	O
characteristics	O
were	O
found	O
.	O

Whereas	O
H37Ra	O
:	O
:	O
fadE5	S-Biological_Molecule
(	O
Figure	O
1	O
)	O
and	O
H37Ra	O
:	O
:	O
rpsL	S-Biological_Molecule
(	O
unpublished	O
data	O
)	O
showed	O
very	O
little	O
or	O
no	O
growth	O
over	O
the	O
7	O
-	O
d	O
period	O
,	O
the	O
H37Ra	O
:	O
:	O
phoP	S-Biological_Molecule
mutant	O
grew	O
more	O
vigorously	O
,	O
with	O
a	O
7	O
.	O
5	O
-	O
fold	O
increase	O
in	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
)	O
over	O
the	O
7	O
-	O
d	O
period	O
.	O

From	O
these	O
experiments	O
we	O
concluded	O
that	O
complementation	O
of	O
H37Ra	S-Species
with	O
the	O
phoP	S-Biological_Molecule
wild	O
-	O
type	O
copy	O
partially	O
restored	O
its	O
virulence	O
,	O
but	O
not	O
to	O
the	O
extent	O
of	O
the	O
fully	O
virulent	O
H37Rv	S-Species
strain	O
.	O

Virulence	O
Studies	O
of	O
H37Ra	S-Species
Complemented	O
Mutants	O
in	O
a	O
Mouse	S-Species
Model	O

Further	O
assessment	O
of	O
the	O
in	O
vivo	O
growth	O
of	O
different	O
H37Ra	S-Species
knock	O
-	O
in	O
strains	O
was	O
carried	O
out	O
by	O
intravenous	O
infection	O
of	O
severe	B-Species
combined	I-Species
immuno	I-Species
-	I-Species
deficient	I-Species
(	I-Species
SCID	I-Species
)	I-Species
mice	E-Species
.	O

However	O
,	O
as	O
already	O
observed	O
in	O
macrophages	O
,	O
integration	O
of	O
phoP	S-Biological_Molecule
did	O
not	O
restore	O
levels	O
of	O
virulence	O
to	O
those	O
of	O
the	O
reference	O
strain	O
H37Rv	S-Species
(	O
Figure	O
2	O
)	O
.	O

Together	O
with	O
the	O
data	O
from	O
the	O
macrophage	O
infection	O
assay	O
,	O
the	O
results	O
from	O
the	O
mouse	S-Species
infection	O
show	O
that	O
the	O
S219L	O
mutation	O
in	O
the	O
phoP	S-Biological_Molecule
gene	O
definitely	O
represents	O
one	O
genetic	O
lesion	O
that	O
contributed	O
to	O
the	O
attenuation	O
of	O
the	O
H37Ra	S-Species
strain	O
.	O

Two	O
weeks	O
after	O
vaccination	O
we	O
assessed	O
the	O
interferon	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
(	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
)	O
production	O
of	O
splenocytes	O
mounted	O
against	O
ESX	O
-	O
1	O
antigens	O
or	O
controls	O
.	O

Most	O
importantly	O
,	O
the	O
various	O
strains	O
differed	O
extensively	O
in	O
their	O
potential	O
to	O
induce	O
antigen	O
specific	O
T	O
cell	O
responses	O
towards	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
and	O
CFP	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
.	O

As	O
shown	O
in	O
Figure	O
3	O
,	O
splenocytes	O
from	O
mice	S-Species
that	O
were	O
inoculated	O
with	O
H37Rv	S-Species
produced	O
high	O
amounts	O
of	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
upon	O
stimulation	O
with	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
or	O
CFP	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
,	O
whereas	O
the	O
responses	O
of	O
H37Ra	S-Species
,	O
H37Ra	O
:	O
:	O
fadE5	S-Biological_Molecule
,	O
and	O
H37Ra	O
:	O
:	O
rpsL	S-Biological_Molecule
infected	O
mice	S-Species
were	O
extremely	O
weak	O
.	O

Exactly	O
the	O
same	O
trend	O
was	O
observed	O
when	O
a	O
highly	O
sensitive	O
T	O
cell	O
hybridoma	O
assay	O
was	O
used	O
to	O
investigate	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
secretion	O
.	O

This	O
test	O
is	O
based	O
on	O
the	O
presentation	O
of	O
the	O
immunodominant	O
epitope	O
contained	O
in	O
the	O
first	O
20	O
amino	O
acids	O
of	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
by	O
H37Ra	S-Species
,	O
recombinant	O
H37Ra	S-Species
,	O
or	O
H37Rv	S-Species
infected	O
bone	O
marrow	O
-	O
derived	O
dendritic	O
cells	O
(	O
BM	O
-	O
DC	O
)	O
to	O
an	O
ESAT	B-Species
-	I-Species
6	E-Species
-	O
specific	O
T	O
cell	O
hybridoma	O
(	O
NB11	O
)	O
,	O
restricted	O
by	O
I	O
-	O
Ab	O
.	O

To	O
further	O
evaluate	O
the	O
involvement	O
of	O
phoP	S-Biological_Molecule
and	O
the	O
ESX	O
-	O
1	O
system	O
in	O
immunogenicity	O
,	O
C57BL	B-Species
/	I-Species
6	I-Species
mice	E-Species
were	O
vaccinated	O
with	O
additional	O
strains	O
.	O

Firstly	O
,	O
we	O
constructed	O
a	O
partially	O
diploid	O
H37Ra	S-Species
knock	O
-	O
in	O
strain	O
carrying	O
cosmid	O
RD1	O
-	O
ppe68	S-Biological_Molecule
-	O
ko	O
that	O
,	O
in	O
BCG	S-Species
yields	O
the	O
greatest	O
amounts	O
of	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
expression	O
and	O
secretion	O
[	O
24	O
]	O
.	O

However	O
,	O
in	O
H37Ra	S-Species
the	O
presence	O
of	O
this	O
cosmid	O
could	O
not	O
increase	O
the	O
weak	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
and	O
CFP	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
T	O
cell	O
responses	O
(	O
Figure	O
3B	O
)	O
in	O
the	O
splenocyte	O
IFN	B-Biological_Molecule
-	I-Biological_Molecule
gamma	E-Biological_Molecule
assay	O
.	O

However	O
,	O
in	O
comparison	O
to	O
the	O
corresponding	O
MT103	S-Species
wild	O
-	O
type	O
strain	O
,	O
the	O
SO2	S-Species
strain	O
showed	O
a	O
strongly	O
reduced	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
and	O
CFP	B-Biological_Molecule
-	I-Biological_Molecule
10	E-Biological_Molecule
specific	O
T	O
cell	O
response	O
,	O
corresponding	O
to	O
a	O
similar	O
low	O
level	O
as	O
the	O
H37Ra	S-Species
strain	O
(	O
Figure	O
3B	O
)	O
.	O

The	O
western	O
blot	O
analysis	O
presented	O
in	O
Figure	O
5	O
shows	O
that	O
the	O
cell	O
lysates	O
of	O
H37Ra	S-Species
and	O
H37Ra	O
:	O
:	O
rpsL	S-Biological_Molecule
contain	O
large	O
amounts	O
of	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
,	O
indicating	O
that	O
the	O
antigen	O
is	O
properly	O
expressed	O
.	O

However	O
,	O
hardly	O
any	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
was	O
present	O
in	O
the	O
culture	O
filtrates	O
of	O
these	O
cultures	O
,	O
indicating	O
that	O
these	O
strains	O
were	O
unable	O
to	O
secrete	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
under	O
the	O
in	O
vitro	O
conditions	O
employed	O
in	O
spite	O
of	O
proper	O
expression	O
.	O

Similar	O
results	O
were	O
obtained	O
for	O
H37Ra	O
:	O
:	O
fadE5	S-Biological_Molecule
(	O
unpublished	O
data	O
)	O
.	O

In	O
a	O
previous	O
report	O
[	O
25	O
]	O
,	O
the	O
presence	O
of	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
in	O
cell	O
free	O
extracts	O
was	O
described	O
for	O
this	O
strain	O
,	O
but	O
no	O
secretion	O
assay	O
was	O
performed	O
.	O

Together	O
,	O
our	O
findings	O
correlate	O
perfectly	O
with	O
the	O
in	O
vivo	O
data	O
described	O
above	O
and	O
suggest	O
that	O
the	O
lack	O
of	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
specific	O
T	O
cell	O
recognition	O
for	O
H37Ra	S-Species
,	O
H37Ra	O
:	O
:	O
fadE5	S-Biological_Molecule
,	O
H37Ra	O
:	O
:	O
rpsL	S-Biological_Molecule
,	O
and	O
SO2	S-Species
is	O
not	O
caused	O
by	O
a	O
loss	O
of	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
expression	O
,	O
but	O
rather	O
due	O
to	O
a	O
failure	O
of	O
(	O
phoP	S-Biological_Molecule
dependent	O
)	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
secretion	O
.	O

The	O
observation	O
that	O
knocking	O
-	O
in	O
the	O
ESX	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
region	O
of	O
H37Rv	S-Species
into	O
H37Ra	S-Species
(	O
H37Ra	O
:	O
:	O
RD1	S-Biological_Molecule
-	O
ppe68	S-Biological_Molecule
-	O
ko	O
)	O
,	O
and	O
the	O
resultant	O
diploidy	O
,	O
did	O
not	O
improve	O
the	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
-	O
specific	O
T	O
cell	O
responses	O
(	O
Figure	O
3B	O
)	O
,	O
further	O
argues	O
that	O
PhoP	S-Biological_Molecule
-	O
dependent	O
ESAT	O
-	O
secretion	O
might	O
be	O
regulated	O
via	O
a	O
mechanism	O
that	O
lies	O
outside	O
the	O
RD1	O
region	O
.	O

As	O
closer	O
inspection	O
of	O
the	O
available	O
literature	O
on	O
transcriptional	O
analyses	O
of	O
a	O
H37Rv	O
-	O
phoP	S-Biological_Molecule
ko	O
strain	O
[	O
21	O
]	O
and	O
H37Ra	S-Species
[	O
12	O
]	O
suggested	O
that	O
the	O
expression	O
of	O
gene	O
cluster	O
rv3612c	S-Biological_Molecule
-	O
rv3616c	S-Biological_Molecule
is	O
reduced	O
in	O
both	O
strains	O
,	O
we	O
evaluated	O
the	O
expression	O
level	O
of	O
rv3614c	S-Biological_Molecule
in	O
H37Rv	S-Species
,	O
H37Ra	S-Species
,	O
and	O
H37Ra	O
:	O
:	O
phoP	S-Biological_Molecule
by	O
quantitative	O
real	O
time	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
.	O

In	O
previous	O
studies	O
rv3614c	S-Biological_Molecule
,	O
rv3615c	S-Biological_Molecule
,	O
rv3616c	S-Biological_Molecule
(	O
espA	S-Biological_Molecule
)	O
were	O
independently	O
shown	O
to	O
be	O
essential	O
for	O
proper	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
secretion	O
[	O
27	O
,	O
28	O
]	O
.	O

We	O
confirmed	O
the	O
trend	O
that	O
rv3614c	S-Biological_Molecule
was	O
expressed	O
much	O
lower	O
in	O
H37Ra	S-Species
compared	O
to	O
H37Rv	S-Species
by	O
qRT	O
-	O
PCR	O
(	O
Figure	O
6	O
)	O
,	O
whereas	O
expression	O
of	O
rv3614c	S-Biological_Molecule
in	O
H37Ra	O
:	O
:	O
phoP	S-Biological_Molecule
was	O
restored	O
to	O
wild	O
-	O
type	O
levels	O
,	O
suggesting	O
that	O
the	O
rv3612c	S-Biological_Molecule
-	O
rv3616c	S-Biological_Molecule
gene	O
cluster	O
is	O
regulated	O
by	O
PhoP	S-Biological_Molecule
.	O

Interestingly	O
,	O
expression	O
of	O
phoP	S-Biological_Molecule
was	O
higher	O
in	O
H37Ra	S-Species
than	O
in	O
H37Rv	S-Species
(	O
Figure	O
6	O
)	O
.	O

These	O
findings	O
are	O
consistent	O
with	O
data	O
from	O
a	O
previous	O
transcriptional	O
study	O
[	O
12	O
]	O
and	O
suggest	O
that	O
the	O
proposed	O
ability	O
of	O
PhoP	S-Biological_Molecule
to	O
downregulate	O
its	O
own	O
expression	O
[	O
22	O
]	O
is	O
affected	O
by	O
the	O
S219L	O
phoP	S-Biological_Molecule
mutation	O
[	O
29	O
]	O
.	O

They	O
also	O
indicate	O
that	O
it	O
is	O
not	O
a	O
lack	O
of	O
phoP	S-Biological_Molecule
expression	O
that	O
is	O
causing	O
the	O
phoP	S-Biological_Molecule
-	O
associated	O
effects	O
in	O
H37Ra	S-Species
.	O

Discussion	O

The	O
attenuated	O
H37Ra	S-Species
strain	O
was	O
obtained	O
at	O
the	O
Trudeau	O
Institute	O
in	O
the	O
1930s	O
in	O
an	O
attempt	O
to	O
dissociate	O
virulent	O
and	O
avirulent	O
forms	O
of	O
the	O
tubercle	B-Species
bacillus	I-Species
H37	E-Species
.	O

Steenken	O
et	O
al	O
.	O
have	O
shown	O
that	O
the	O
virulence	O
of	O
the	O
H37	S-Species
strain	O
was	O
associated	O
with	O
colony	O
morphology	O
and	O
that	O
the	O
avirulent	O
variant	O
H37Ra	S-Species
failed	O
to	O
propagate	O
in	O
an	O
ordinarily	O
susceptible	O
host	O
while	O
the	O
virulent	O
variant	O
H37Rv	S-Species
was	O
able	O
to	O
proliferate	O
[	O
6	O
]	O
.	O

For	O
M	B-Species
.	I-Species
tuberculosis	E-Species
,	O
several	O
studies	O
have	O
described	O
a	O
link	O
between	O
the	O
inactivation	O
of	O
phoP	S-Biological_Molecule
and	O
loss	O
of	O
virulence	O
,	O
suggesting	O
that	O
the	O
phoP	S-Biological_Molecule
gene	O
is	O
required	O
for	O
intracellular	O
growth	O
of	O
M	B-Species
.	I-Species
tuberculosis	E-Species
[	O
14	O
,	O
25	O
]	O
.	O

However	O
,	O
according	O
to	O
very	O
recent	O
information	O
,	O
these	O
polyketide	B-Chemical_Compound
-	I-Chemical_Compound
derived	I-Chemical_Compound
(	I-Chemical_Compound
Pks2	I-Chemical_Compound
-	I-Chemical_Compound
4	I-Chemical_Compound
)	I-Chemical_Compound
lipids	E-Chemical_Compound
do	O
not	O
have	O
a	O
strong	O
impact	O
on	O
the	O
virulence	O
of	O
M	B-Species
.	I-Species
tuberculosis	E-Species
[	O
29	O
]	O
.	O

That	O
study	O
identified	O
44	O
genes	O
in	O
the	O
phoP	S-Biological_Molecule
-	O
ko	O
strain	O
that	O
were	O
expressed	O
at	O
least	O
2	O
.	O
5	O
-	O
fold	O
lower	O
in	O
the	O
mutant	O
than	O
their	O
counterparts	O
in	O
the	O
M	B-Species
.	I-Species
tuberculosis	E-Species
wild	O
-	O
type	O
strain	O
.	O

Among	O
the	O
genes	O
expressed	O
at	O
low	O
level	O
in	O
the	O
phoP	S-Biological_Molecule
-	O
ko	O
strain	O
and	O
in	O
H37Ra	S-Species
were	O
several	O
that	O
are	O
involved	O
in	O
lipid	O
metabolism	O
;	O
for	O
example	O
,	O
the	O
polyketide	S-Chemical_Compound
synthases	O
pks2	S-Biological_Molecule
(	O
rv3825c	S-Biological_Molecule
)	O
or	O
the	O
Pks	O
-	O
associated	O
protein	O
papA1	S-Biological_Molecule
(	O
rv3824c	S-Biological_Molecule
)	O
.	O

There	O
were	O
also	O
several	O
ppe	O
genes	O
that	O
seem	O
to	O
be	O
regulated	O
by	O
phoP	S-Biological_Molecule
but	O
not	O
ppe68	S-Biological_Molecule
[	O
21	O
]	O
.	O

In	O
addition	O
,	O
NirA	S-Biological_Molecule
(	O
Rv2391	S-Biological_Molecule
)	O
,	O
a	O
putative	O
nitrite	S-Chemical_Compound
reductase	O
and	O
MmpL10	S-Biological_Molecule
-	O
FadD21	S-Biological_Molecule
(	O
Rv1183	S-Biological_Molecule
-	O
85c	S-Biological_Molecule
)	O
,	O
which	O
were	O
all	O
identified	O
by	O
TraSH	O
analysis	O
as	O
potentially	O
implicated	O
in	O
virulence	O
[	O
16	O
]	O
,	O
seem	O
to	O
be	O
regulated	O
by	O
PhoP	S-Biological_Molecule
[	O
12	O
,	O
21	O
]	O
.	O

However	O
,	O
the	O
most	O
striking	O
link	O
in	O
relation	O
to	O
our	O
results	O
on	O
phoP	S-Biological_Molecule
and	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
secretion	O
that	O
was	O
revealed	O
by	O
these	O
two	O
transcriptional	O
analyses	O
,	O
were	O
the	O
data	O
on	O
gene	O
cluster	O
rv3612c	S-Biological_Molecule
-	O
rv3616c	S-Biological_Molecule
.	O

Closer	O
inspection	O
of	O
the	O
data	O
published	O
in	O
the	O
corresponding	O
supplemental	O
materials	O
showed	O
that	O
rv3612c	S-Biological_Molecule
-	O
rv3616c	S-Biological_Molecule
were	O
strongly	O
downregulated	O
in	O
the	O
H37Rv	O
phoP	S-Biological_Molecule
ko	O
mutant	O
as	O
well	O
as	O
in	O
H37Ra	S-Species
[	O
12	O
,	O
21	O
]	O
.	O

[	O
12	O
]	O
show	O
substantial	O
differences	O
between	O
cultures	O
grown	O
in	O
roller	O
bottles	O
relative	O
to	O
cultures	O
grown	O
in	O
shake	O
flasks	O
,	O
arguing	O
that	O
this	O
gene	O
cluster	O
might	O
be	O
regulated	O
by	O
environmental	O
conditions	O
through	O
the	O
PhoP	S-Biological_Molecule
/	O
PhoR	S-Biological_Molecule
system	O
.	O

However	O
,	O
upregulation	O
of	O
phoP	S-Biological_Molecule
and	O
rv3614c	S-Biological_Molecule
-	O
rv3616c	S-Biological_Molecule
was	O
observed	O
after	O
incubation	O
of	O
M	B-Species
.	I-Species
tuberculosis	E-Species
in	O
5mM	O
H2O2	S-Chemical_Compound
[	O
37	O
]	O
.	O

Furthermore	O
,	O
rv3614c	S-Biological_Molecule
-	O
rv3616c	S-Biological_Molecule
were	O
reported	O
to	O
be	O
transiently	O
upregulated	O
in	O
the	O
phagosome	O
and	O
under	O
acidic	O
stress	O
[	O
38	O
]	O
.	O

Altogether	O
,	O
from	O
these	O
reports	O
it	O
seems	O
plausible	O
that	O
the	O
pleiotropic	O
regulator	O
PhoP	S-Biological_Molecule
is	O
involved	O
in	O
the	O
regulation	O
of	O
rv3612c	S-Biological_Molecule
-	O
rv3616c	S-Biological_Molecule
expression	O
and	O
thereby	O
influences	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
secretion	O
and	O
virulence	O
[	O
16	O
]	O
,	O
but	O
to	O
unambiguously	O
answer	O
this	O
question	O
,	O
virulence	O
tests	O
with	O
recombinant	O
H37Ra	S-Species
and	O
/	O
or	O
phoP	S-Biological_Molecule
ko	O
strains	O
that	O
express	O
rv3616c	S-Biological_Molecule
-	O
3612c	S-Biological_Molecule
under	O
a	O
constitutive	O
promoter	O
or	O
a	O
tetracycline	O
inducable	O
expression	O
system	O
[	O
39	O
]	O
will	O
be	O
needed	O
.	O

As	O
in	O
previous	O
DNA	O
/	O
DNA	O
microarray	O
analyses	O
[	O
10	O
]	O
,	O
and	O
from	O
inspection	O
of	O
the	O
very	O
recently	O
released	O
genome	O
sequence	O
of	O
H37Ra	S-Species
,	O
no	O
significant	O
differences	O
in	O
the	O
ESX	O
-	O
1	O
encoding	O
region	O
were	O
found	O
,	O
the	O
assumption	O
that	O
the	O
observed	O
lack	O
of	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
secretion	O
in	O
H37Ra	S-Species
may	O
be	O
caused	O
by	O
factors	O
outside	O
of	O
the	O
RD1	O
region	O
is	O
very	O
plausible	O
.	O

However	O
,	O
it	O
is	O
also	O
possible	O
that	O
the	O
observed	O
differences	O
may	O
be	O
caused	O
by	O
variations	O
of	O
in	O
vitro	O
culture	O
conditions	O
.	O

In	O
conclusion	O
,	O
in	O
this	O
work	O
we	O
report	O
the	O
identification	O
and	O
profound	O
consequences	O
of	O
the	O
PhoP	S-Biological_Molecule
S219L	O
mutation	O
on	O
the	O
widely	O
used	O
H37Ra	S-Species
strain	O
.	O

BLASTP	O
comparisons	O
of	O
the	O
PhoP	S-Biological_Molecule
sequence	O
showed	O
that	O
the	O
predicted	O
DNA	O
binding	O
region	O
,	O
where	O
the	O
mutation	O
occurred	O
,	O
is	O
perfectly	O
conserved	O
among	O
a	O
wide	O
range	O
of	O
actinobacteria	O
,	O
with	O
H37Ra	S-Species
being	O
the	O
only	O
strain	O
showing	O
such	O
a	O
mutation	O
.	O

It	O
should	O
be	O
mentioned	O
here	O
that	O
the	O
SO2	O
phoP	S-Biological_Molecule
ko	O
strain	O
,	O
which	O
showed	O
strong	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
expression	O
but	O
little	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	E-Biological_Molecule
secretion	O
(	O
Figure	O
5	O
)	O
,	O
induced	O
only	O
very	O
reduced	O
ESAT	B-Biological_Molecule
-	I-Biological_Molecule
6	I-Biological_Molecule
-	E-Biological_Molecule
specific	O
T	O
cell	O
responses	O
(	O
Figure	O
3	O
)	O
.	O

Comparative	O
analysis	O
of	O
the	O
Photorhabdus	B-Species
luminescens	E-Species
and	O
the	O
Yersinia	B-Species
enterocolitica	E-Species
genomes	O
:	O
uncovering	O
candidate	O
genes	O
involved	O
in	O
insect	O
pathogenicity	O

P	B-Species
.	I-Species
luminescens	E-Species
lives	O
in	O
symbiosis	O
with	O
soil	O
nematodes	O
and	O
is	O
highly	O
pathogenic	O
towards	O
insects	O
but	O
not	O
to	O
humans	S-Species
.	O

Results	O
A	O
selective	O
genome	O
comparison	O
was	O
applied	O
.	O

Proteins	O
belonging	O
to	O
the	O
class	O
of	O
two	O
-	O
component	O
regulatory	O
systems	O
,	O
quorum	O
sensing	O
,	O
universal	O
stress	O
proteins	O
,	O
and	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
signalling	O
have	O
been	O
analysed	O
.	O

The	O
interorganismic	O
synopsis	O
of	O
selected	O
regulatory	O
systems	O
uncovered	O
common	O
and	O
distinct	O
signalling	O
mechanisms	O
of	O
both	O
pathogens	O
used	O
for	O
perception	O
of	O
signals	O
within	O
the	O
insect	O
host	O
.	O

Particularly	O
,	O
a	O
new	O
class	O
of	O
LuxR	S-Biological_Molecule
-	O
like	O
regulators	O
was	O
identified	O
,	O
which	O
might	O
be	O
involved	O
in	O
detecting	O
insect	O
-	O
specific	O
molecules	O
.	O

Our	O
analysis	O
also	O
highlights	O
factors	O
of	O
both	O
pathogens	O
that	O
are	O
expressed	O
at	O
low	O
temperatures	O
as	O
encountered	O
in	O
insects	O
in	O
contrast	O
to	O
higher	O
(	O
body	O
)	O
temperature	O
,	O
providing	O
evidence	O
that	O
temperature	O
is	O
a	O
yet	O
under	O
-	O
investigated	O
environmental	O
signal	O
for	O
bacterial	O
adaptation	O
to	O
various	O
hosts	O
.	O

Background	O

We	O
therefore	O
decided	O
to	O
perform	O
a	O
comparative	O
study	O
of	O
the	O
genomes	O
of	O
Photorhabdus	B-Species
luminescens	E-Species
and	O
Yersinia	B-Species
enterocolitica	E-Species
.	O

However	O
,	O
Y	B-Species
.	I-Species
pestis	E-Species
,	O
a	O
blood	O
-	O
borne	O
pathogen	O
and	O
the	O
etiological	O
agent	O
of	O
human	S-Species
plague	O
,	O
has	O
long	O
been	O
known	O
to	O
be	O
transmitted	O
by	O
insects	O
,	O
specifically	O
by	O
rat	S-Species
fleas	O
.	O

More	O
recent	O
data	O
strongly	O
support	O
the	O
idea	O
that	O
yersiniae	O
are	O
capable	O
to	O
interact	O
with	O
insects	O
.	O

Y	B-Species
.	I-Species
pseudotuberculosis	E-Species
,	O
in	O
contrast	O
to	O
Y	B-Species
.	I-Species
pestis	E-Species
,	O
has	O
been	O
shown	O
to	O
be	O
orally	O
toxic	O
to	O
flea	O
[	O
8	O
]	O
.	O

While	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
and	O
Y	B-Species
.	I-Species
pseudotuberculosis	E-Species
have	O
diverged	O
within	O
the	O
last	O
200	O
million	O
years	O
,	O
Y	B-Species
.	I-Species
pestis	E-Species
has	O
emerged	O
from	O
Y	B-Species
.	I-Species
pseudotuberculosis	E-Species
only	O
1	O
,	O
500	O
-	O
20	O
,	O
000	O
years	O
ago	O
[	O
9	O
]	O
.	O

Interestingly	O
,	O
another	O
Photorhabdus	S-Species
species	O
,	O
P	B-Species
.	I-Species
asymbiotica	E-Species
,	O
has	O
been	O
described	O
as	O
a	O
human	S-Species
pathogen	O
.	O

It	O
is	O
assumed	O
that	O
these	O
strains	O
are	O
associated	O
with	O
spiders	O
,	O
because	O
spider	O
bites	O
where	O
attended	O
with	O
Photorhabdus	S-Species
human	S-Species
infections	O
[	O
15	O
]	O
.	O

Upon	O
entering	O
an	O
insect	O
host	O
,	O
the	O
nematodes	O
release	O
the	O
bacteria	O
by	O
regurgiation	O
directly	O
into	O
the	O
insect	O
hemocoel	O
,	O
the	O
open	O
circulatory	O
system	O
of	O
the	O
insect	O
.	O

Bioconversion	O
of	O
the	O
insect	O
'	O
s	O
body	O
by	O
P	B-Species
.	I-Species
luminescens	E-Species
produces	O
a	O
rich	O
food	O
source	O
for	O
the	O
bacteria	O
as	O
well	O
as	O
for	O
the	O
nematodes	O
.	O

Nematode	O
reproduction	O
is	O
supported	O
by	O
the	O
bacteria	O
,	O
probably	O
by	O
providing	O
essential	O
nutrients	O
that	O
are	O
required	O
for	O
efficient	O
nematode	O
proliferation	O
[	O
16	O
]	O
.	O

When	O
the	O
insect	O
cadaver	O
is	O
depleted	O
,	O
the	O
nematodes	O
and	O
bacteria	O
reassociate	O
and	O
emerge	O
from	O
the	O
carcass	O
in	O
search	O
of	O
a	O
new	O
insect	O
host	O
(	O
Fig	O
.	O
1	O
,	O
right	O
circle	O
)	O
[	O
17	O
,	O
18	O
]	O
.	O

Primary	O
variants	O
are	O
found	O
to	O
produce	O
extracellular	O
protease	O
,	O
extracellular	O
lipase	O
,	O
intracellular	O
protein	O
crystals	O
CipA	S-Biological_Molecule
and	O
CipB	S-Biological_Molecule
,	O
antibiotics	O
,	O
and	O
are	O
bioluminescent	O
.	O

Secondary	O
variants	O
lack	O
protease	O
,	O
lipase	O
and	O
antibiotic	O
activity	O
,	O
and	O
bioluminescence	O
is	O
strongly	O
decreased	O
.	O

We	O
identified	O
genes	O
and	O
the	O
corresponding	O
proteins	O
involved	O
in	O
signalling	O
,	O
regulation	O
,	O
pathogenicity	O
,	O
as	O
well	O
as	O
in	O
metabolism	O
,	O
and	O
suggest	O
their	O
possible	O
function	O
during	O
colonization	O
and	O
infection	O
of	O
non	O
-	O
mammals	O
.	O

Results	O
and	O
Discussion	O

The	O
genome	O
of	O
the	O
latter	O
strain	O
has	O
a	O
size	O
of	O
~	O
4	O
.	O
6	O
Mbp	O
and	O
encodes	O
4037	O
putative	O
proteins	O
[	O
23	O
]	O
.	O

Two	O
-	O
component	O
signal	O
transduction	O
To	O
sense	O
their	O
environment	O
and	O
to	O
react	O
rapidly	O
to	O
changing	O
surrounding	O
conditions	O
,	O
bacteria	O
have	O
evolved	O
so	O
called	O
two	O
-	O
component	O
systems	O
(	O
TCSs	O
)	O
[	O
25	O
]	O
which	O
have	O
been	O
found	O
to	O
be	O
involved	O
in	O
the	O
control	O
of	O
virulence	O
or	O
symbiosis	O
,	O
in	O
metabolite	O
utilization	O
,	O
and	O
also	O
in	O
the	O
adaptation	O
to	O
various	O
stress	O
factors	O
[	O
26	O
]	O
.	O

The	O
consisting	O
domains	O
or	O
proteins	O
can	O
also	O
be	O
organized	O
as	O
more	O
complex	O
systems	O
using	O
a	O
His	O
-	O
Asp	O
-	O
His	O
-	O
Asp	O
phosphorelay	O
.	O

The	O
number	O
of	O
TCSs	O
ranges	O
from	O
zero	O
in	O
Mycoplasma	B-Species
genitalium	E-Species
to	O
80	O
in	O
Syncheocystes	B-Species
spp	E-Species
.	O

[	O
25	O
,	O
27	O
]	O
.	O

Eighteen	O
of	O
these	O
TCSs	O
are	O
present	O
in	O
P	B-Species
.	I-Species
luminescens	E-Species
,	O
and	O
28	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
,	O
of	O
which	O
17	O
are	O
shared	O
by	O
both	O
organisms	O
(	O
Fig	O
.	O
2	O
,	O
depicted	O
in	O
grey	O
)	O
.	O

Among	O
the	O
eleven	O
TCSs	O
of	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
not	O
shared	O
by	O
P	B-Species
.	I-Species
luminescens	E-Species
are	O
duplicates	O
of	O
the	O
CitA	S-Biological_Molecule
/	O
CitB	S-Biological_Molecule
system	O
(	O
YE2505	S-Biological_Molecule
/	O
YE2506	S-Biological_Molecule
and	O
YE2654	S-Biological_Molecule
/	O
YE2655	S-Biological_Molecule
)	O
and	O
of	O
the	O
LytS	S-Biological_Molecule
/	O
LytR	S-Biological_Molecule
system	O
(	O
YE1228	S-Biological_Molecule
/	O
YE1227	S-Biological_Molecule
and	O
YE4014	S-Biological_Molecule
/	O
YE4015	S-Biological_Molecule
)	O
.	O

Both	O
sensor	O
kinases	O
Plu0102	S-Biological_Molecule
and	O
YE4185	S-Biological_Molecule
are	O
of	O
moderate	O
similarity	O
(	O
31	O
.	O
5	O
%	O
identity	O
,	O
48	O
.	O
5	O
%	O
homology	O
)	O
.	O

Therefore	O
,	O
Plu0102	S-Biological_Molecule
and	O
YE4185	S-Biological_Molecule
are	O
interesting	O
candidates	O
for	O
unravelling	O
invertebrate	O
-	O
specific	O
signals	O
.	O

The	O
putative	O
target	O
genes	O
of	O
Plu0102	S-Biological_Molecule
/	O
Plu0103	S-Biological_Molecule
and	O
Ye4185	S-Biological_Molecule
/	O
Ye4186	S-Biological_Molecule
,	O
plu0104	S-Biological_Molecule
and	O
ye4187	S-Biological_Molecule
,	O
respectively	O
,	O
are	O
homologues	O
and	O
encode	O
putative	O
secreted	O
proteins	O
which	O
might	O
act	O
in	O
a	O
similar	O
,	O
yet	O
unknown	O
manner	O
.	O

All	O
TCSs	O
present	O
in	O
both	O
organisms	O
are	O
depicted	O
in	O
grey	O
in	O
Fig	O
.	O

2	O
,	O
and	O
include	O
PhoP	S-Biological_Molecule
/	O
PhoQ	S-Biological_Molecule
,	O
and	O
AstS	S-Biological_Molecule
/	O
AstR	S-Biological_Molecule
(	O
BvgS	S-Biological_Molecule
/	O
BvgR	S-Biological_Molecule
)	O
which	O
have	O
been	O
identified	O
to	O
be	O
involved	O
in	O
virulence	O
[	O
28	O
]	O
.	O

BvgS	S-Biological_Molecule
/	O
BvgR	S-Biological_Molecule
is	O
the	O
TCS	O
of	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
that	O
corresponds	O
to	O
AstS	S-Biological_Molecule
/	O
AstR	S-Biological_Molecule
.	O

It	O
has	O
recently	O
been	O
found	O
that	O
the	O
Kdp	O
-	O
system	O
of	O
P	B-Species
.	I-Species
luminescens	E-Species
is	O
important	O
for	O
insect	O
pathogenicity	O
(	O
S	O
.	O
E	O
.	O
Reynolds	O
and	O
N	O
.	O
R	O
.	O
Waterfield	O
,	O
University	O
of	O
Bath	O
,	O
UK	O
,	O
personal	O
communication	O
)	O
.	O

Therefore	O
,	O
the	O
KdpD	S-Biological_Molecule
/	O
KdpE	S-Biological_Molecule
system	O
is	O
also	O
a	O
further	O
candidate	O
system	O
which	O
might	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
insecticidal	O
activity	O
of	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
.	O

The	O
only	O
TCS	O
of	O
P	B-Species
.	I-Species
luminescens	E-Species
absent	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
is	O
TctE	S-Biological_Molecule
/	O
TctD	S-Biological_Molecule
(	O
Fig	O
.	O
2	O
,	O
marked	O
in	O
blue	O
)	O
,	O
which	O
,	O
however	O
,	O
is	O
found	O
in	O
the	O
genomes	O
of	O
Y	B-Species
.	I-Species
intermedia	E-Species
and	O
Y	B-Species
.	I-Species
frederiksenii	E-Species
.	O

Beside	O
these	O
microorganisms	O
,	O
TctE	S-Biological_Molecule
/	O
TctD	S-Biological_Molecule
homologues	O
controlling	O
the	O
transport	O
of	O
tricarboxylic	O
acid	O
(	O
see	O
section	O
"	O
Tricarboxylate	O
utilization	O
"	O
)	O
are	O
present	O
in	O
the	O
genera	O
Salmonella	S-Species
,	O
Burkholderia	S-Species
,	O
Agrobacterium	S-Species
,	O
Bordetella	S-Species
,	O
Collinsella	S-Species
,	O
Xylella	S-Species
,	O
Xanthomonas	S-Species
,	O
and	O
Pseudomonas	S-Species
,	O
particularly	O
P	B-Species
.	I-Species
entomophila	E-Species
,	O
all	O
of	O
which	O
are	O
found	O
in	O
association	O
with	O
eukaryotes	O
.	O

In	O
comparison	O
to	O
P	B-Species
.	I-Species
luminescens	E-Species
,	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
uses	O
an	O
expanded	O
set	O
of	O
TCSs	O
,	O
possibly	O
to	O
adapt	O
to	O
its	O
various	O
hosts	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Regulation	O
by	O
AHL	S-Chemical_Compound
-	O
LuxR	S-Biological_Molecule
-	O
like	O
receptors	O
Virulence	O
,	O
bioluminescence	O
,	O
mutualism	O
,	O
antibiotic	O
production	O
and	O
biofilm	O
formation	O
are	O
often	O
regulated	O
by	O
LuxI	S-Biological_Molecule
/	O
LuxR	S-Biological_Molecule
quorum	O
sensing	O
systems	O
in	O
Gram	O
-	O
negative	O
bacteria	O
.	O

These	O
AHLs	S-Chemical_Compound
are	O
produced	O
by	O
an	O
autoinductor	O
synthase	O
named	O
LuxI	S-Biological_Molecule
.	O

Upon	O
autoinductor	O
-	O
binding	O
,	O
the	O
receptor	O
LuxR	S-Biological_Molecule
binds	O
to	O
the	O
promoter	O
/	O
operator	O
regions	O
of	O
the	O
target	O
genes	O
or	O
operons	O
,	O
resulting	O
in	O
the	O
regulation	O
of	O
gene	O
expression	O
in	O
response	O
to	O
the	O
cell	O
number	O
[	O
33	O
]	O
.	O

Y	B-Species
.	I-Species
enterocolitica	E-Species
possesses	O
a	O
typical	O
quorum	O
sensing	O
pair	O
of	O
homologues	O
,	O
YenI	S-Biological_Molecule
/	O
YenR	S-Biological_Molecule
(	O
YE1600	S-Biological_Molecule
/	O
YE1599	S-Biological_Molecule
)	O
,	O
and	O
it	O
has	O
recently	O
been	O
shown	O
that	O
swimming	O
and	O
swarming	O
motility	O
is	O
regulated	O
by	O
3	B-Chemical_Compound
-	I-Chemical_Compound
oxo	I-Chemical_Compound
-	I-Chemical_Compound
C6	I-Chemical_Compound
-	I-Chemical_Compound
AHL	E-Chemical_Compound
and	O
C6	B-Chemical_Compound
-	I-Chemical_Compound
AHL	E-Chemical_Compound
,	O
which	O
are	O
synthesized	O
by	O
YenI	S-Biological_Molecule
[	O
34	O
]	O
.	O

In	O
the	O
genome	O
of	O
P	B-Species
.	I-Species
luminescens	E-Species
,	O
two	O
genes	O
encoding	O
putative	O
AHL	S-Chemical_Compound
-	O
LuxR	S-Biological_Molecule
-	O
like	O
receptors	O
,	O
plu0320	S-Biological_Molecule
and	O
plu4562	S-Biological_Molecule
,	O
but	O
no	O
luxI	S-Biological_Molecule
genes	O
are	O
present	O
(	O
Fig	O
.	O
3	O
)	O
.	O

A	O
similar	O
function	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
might	O
be	O
provided	O
by	O
YE1026	S-Biological_Molecule
.	O

Instead	O
of	O
producing	O
AHLs	S-Chemical_Compound
to	O
regulate	O
quorum	O
dependent	O
genes	O
,	O
a	O
common	O
strategy	O
of	O
insect	O
-	O
colonizing	O
bacteria	O
might	O
be	O
the	O
detection	O
of	O
AHLs	S-Chemical_Compound
as	O
a	O
signal	O
for	O
the	O
presence	O
of	O
other	O
bacteria	O
such	O
as	O
those	O
colonizing	O
the	O
insect	O
intestinal	O
tract	O
or	O
living	O
in	O
soil	O
.	O

It	O
has	O
been	O
shown	O
that	O
the	O
luxS	S-Biological_Molecule
pathway	O
negatively	O
controls	O
the	O
expression	O
of	O
genes	O
for	O
carbapenem	S-Chemical_Compound
antibiotic	O
biosynthesis	O
in	O
P	B-Species
.	I-Species
luminescens	E-Species
[	O
41	O
]	O
.	O

Homologues	O
of	O
these	O
proteins	O
are	O
present	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
(	O
see	O
chapter	O
2	O
)	O
,	O
suggesting	O
their	O
possible	O
regulation	O
by	O
AI	B-Chemical_Compound
-	I-Chemical_Compound
2	E-Chemical_Compound
also	O
in	O
this	O
bacterium	O
.	O

Furthermore	O
,	O
the	O
P	O
.	O
luminescens	O
luxS	S-Biological_Molecule
-	O
negative	O
strain	O
exhibited	O
decreased	O
biofilm	O
formation	O
,	O
increased	O
type	O
IV	O
/	O
V	O
pilus	O
-	O
dependent	O
twitching	O
motility	O
,	O
and	O
attenuated	O
virulence	O
against	O
insect	O
larvae	O
[	O
42	O
]	O
.	O

Taken	O
together	O
,	O
a	O
similar	O
and	O
AI	B-Chemical_Compound
-	I-Chemical_Compound
2	E-Chemical_Compound
dependent	O
mechanism	O
for	O
the	O
regulation	O
of	O
insect	O
colonization	O
and	O
insect	O
pathogenicity	O
might	O
be	O
used	O
by	O
both	O
organisms	O
.	O

Whether	O
they	O
sense	O
self	O
-	O
produced	O
or	O
external	O
AI	B-Chemical_Compound
-	I-Chemical_Compound
2	E-Chemical_Compound
,	O
or	O
a	O
combination	O
of	O
both	O
,	O
indicating	O
a	O
quorum	O
sensing	O
mechanism	O
or	O
a	O
regulation	O
similar	O
to	O
AHL	S-Chemical_Compound
as	O
described	O
above	O
,	O
remains	O
to	O
be	O
elucidated	O
.	O

Regulation	O
by	O
PAS	B-Biological_Molecule
_	I-Biological_Molecule
4	E-Biological_Molecule
/	O
LuxR	S-Biological_Molecule
-	O
like	O
receptors	O

In	O
P	B-Species
.	I-Species
luminescens	E-Species
,	O
the	O
amount	O
of	O
luxR	S-Biological_Molecule
-	O
like	O
genes	O
is	O
overrepresented	O
with	O
39	O
copies	O
in	O
the	O
genome	O
.	O

Most	O
of	O
the	O
genes	O
are	O
located	O
in	O
two	O
large	O
gene	O
clusters	O
(	O
plu0918	S-Biological_Molecule
-	O
0925	S-Biological_Molecule
and	O
plu2001	S-Biological_Molecule
-	O
2019	S-Biological_Molecule
)	O
.	O

Interestingly	O
,	O
eleven	O
of	O
those	O
LuxR	S-Biological_Molecule
-	O
like	O
receptors	O
are	O
present	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
of	O
which	O
five	O
are	O
located	O
in	O
a	O
cluster	O
(	O
ye0035	S-Biological_Molecule
-	O
0039	S-Biological_Molecule
)	O
.	O

PAS	O
-	O
domains	O
have	O
been	O
suspected	O
to	O
act	O
as	O
insect	O
juvenile	O
hormone	O
(	O
JH	O
)	O
receptors	O
in	O
the	O
fruit	B-Species
fly	I-Species
Drosophila	I-Species
melanogaster	E-Species
[	O
43	O
,	O
44	O
]	O
.	O

Met	S-Biological_Molecule
has	O
been	O
shown	O
to	O
bind	O
JH	O
at	O
physiological	O
concentrations	O
and	O
is	O
therefore	O
suspected	O
to	O
act	O
as	O
a	O
JH	O
receptor	O
[	O
46	O
,	O
47	O
]	O
.	O

Therefore	O
,	O
the	O
potential	O
PAS	B-Biological_Molecule
_	I-Biological_Molecule
4	E-Biological_Molecule
/	O
LuxR	S-Biological_Molecule
-	O
like	O
receptors	O
of	O
P	B-Species
.	I-Species
luminescens	E-Species
,	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
,	O
and	O
S	B-Species
.	I-Species
glossinidius	E-Species
might	O
sense	O
JH	O
or	O
other	O
eukaryotic	O
hormones	O
of	O
the	O
insect	O
to	O
adapt	O
their	O
gene	O
expression	O
to	O
the	O
insect	O
host	O
.	O

The	O
high	O
number	O
of	O
35	O
highly	O
homologous	O
receptor	O
proteins	O
in	O
P	B-Species
.	I-Species
luminescens	E-Species
might	O
be	O
the	O
reason	O
for	O
the	O
wide	O
insect	O
host	O
spectrum	O
this	O
pathogen	O
is	O
capable	O
to	O
infect	O
.	O

Although	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
protein	O
extracts	O
confer	O
toxicity	O
against	O
M	B-Species
.	I-Species
sexta	E-Species
larvae	O
[	O
7	O
]	O
,	O
its	O
host	O
spectrum	O
still	O
remains	O
to	O
be	O
defined	O
.	O

LuxR	S-Biological_Molecule
-	O
like	O
receptors	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
with	O
a	O
yet	O
unidentified	O
signalling	O
binding	O
-	O
site	O
are	O
YE2705	S-Biological_Molecule
and	O
YE3014	S-Biological_Molecule
,	O
both	O
of	O
which	O
are	O
also	O
present	O
in	O
Y	B-Species
.	I-Species
pestis	E-Species
(	O
YPO2955	S-Biological_Molecule
and	O
YPO2593	S-Biological_Molecule
)	O
and	O
in	O
S	B-Species
.	I-Species
glossinidius	E-Species
(	O
SGP1	B-Biological_Molecule
_	I-Biological_Molecule
007	E-Biological_Molecule
,	O
SG1174	S-Biological_Molecule
,	O
SG1480	S-Biological_Molecule
,	O
and	O
SG1698	S-Biological_Molecule
)	O
,	O
but	O
not	O
in	O
P	B-Species
.	I-Species
luminescens	E-Species
(	O
Fig	O
.	O
3	O
)	O
.	O

It	O
might	O
be	O
possible	O
that	O
signalling	O
molecules	O
of	O
mammals	O
and	O
hormones	O
of	O
adult	O
insects	O
are	O
sensed	O
via	O
these	O
receptors	O
by	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
and	O
S	B-Species
.	I-Species
glossinidius	E-Species
,	O
respectively	O
,	O
hosts	O
which	O
P	B-Species
.	I-Species
luminescens	E-Species
does	O
not	O
specifically	O
interact	O
with	O
during	O
its	O
life	O
cycle	O
.	O

In	O
P	B-Species
.	I-Species
luminescens	E-Species
,	O
two	O
LuxR	S-Biological_Molecule
-	O
like	O
receptors	O
with	O
a	O
yet	O
unidentified	O
signalling	O
binding	O
site	O
are	O
present	O
,	O
Plu4274	S-Biological_Molecule
and	O
Plu1817	S-Biological_Molecule
,	O
the	O
latter	O
of	O
which	O
is	O
shared	O
by	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
(	O
YE1621	S-Biological_Molecule
)	O
,	O
but	O
not	O
by	O
S	B-Species
.	I-Species
glossinidius	E-Species
.	O

In	O
contrast	O
,	O
the	O
UspA	S-Biological_Molecule
and	O
the	O
UspE	S-Biological_Molecule
homologues	O
of	O
P	B-Species
.	I-Species
luminescens	E-Species
and	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
are	O
nearly	O
similar	O
,	O
indicating	O
that	O
an	O
identical	O
stress	O
response	O
is	O
regulated	O
by	O
these	O
proteins	O
.	O

Homologues	O
of	O
these	O
proteins	O
are	O
also	O
present	O
in	O
P	B-Species
.	I-Species
aeruginosa	E-Species
,	O
namely	O
PA4352	S-Biological_Molecule
and	O
PA3309	S-Biological_Molecule
,	O
a	O
tandem	O
-	O
type	O
Usp	O
protein	O
and	O
a	O
UspA	S-Biological_Molecule
-	O
like	O
protein	O
,	O
respectively	O
.	O

They	O
are	O
essential	O
for	O
survival	O
under	O
anaerobic	O
growth	O
and	O
therefore	O
biofilm	O
formation	O
,	O
a	O
situation	O
cells	O
are	O
exposed	O
to	O
when	O
colonizing	O
the	O
cystic	O
fibrosis	O
lung	O
in	O
hosts	O
[	O
49	O
,	O
50	O
]	O
.	O

In	O
P	B-Species
.	I-Species
luminescens	E-Species
,	O
expression	O
of	O
UspA	S-Biological_Molecule
has	O
been	O
shown	O
to	O
be	O
under	O
control	O
of	O
the	O
AstS	S-Biological_Molecule
/	O
AstR	S-Biological_Molecule
TCS	O
,	O
which	O
is	O
important	O
for	O
the	O
correct	O
timing	O
of	O
phase	O
variant	O
switching	O
[	O
28	O
]	O
.	O

It	O
is	O
discussed	O
that	O
the	O
AstS	S-Biological_Molecule
/	O
AstR	S-Biological_Molecule
-	O
system	O
prevents	O
or	O
delays	O
phenotypic	O
variation	O
by	O
protecting	O
the	O
cell	O
from	O
stress	O
[	O
18	O
]	O
.	O

Because	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
produces	O
the	O
corresponding	O
TCS	O
BvgS	S-Biological_Molecule
/	O
BvgR	S-Biological_Molecule
,	O
but	O
is	O
not	O
known	O
to	O
switch	O
to	O
another	O
phenotypic	O
variant	O
,	O
the	O
possible	O
role	O
of	O
UspA	S-Biological_Molecule
in	O
global	O
regulation	O
still	O
remains	O
to	O
be	O
elucidated	O
.	O

Phenotypic	O
variation	O
and	O
thus	O
the	O
switch	O
between	O
mutualism	O
and	O
pathogenicity	O
in	O
P	B-Species
.	I-Species
luminescens	E-Species
is	O
proposed	O
to	O
be	O
regulated	O
by	O
a	O
Ner	S-Biological_Molecule
-	O
like	O
and	O
a	O
HexA	S-Biological_Molecule
-	O
like	O
regulator	O
that	O
repress	O
primary	O
variant	O
specific	O
genes	O
in	O
the	O
stage	O
of	O
the	O
secondary	O
variant	O
[	O
17	O
]	O
.	O

In	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
,	O
the	O
transcriptional	O
repressor	O
RovM	S-Biological_Molecule
(	O
YE1343	S-Biological_Molecule
)	O
is	O
similar	O
to	O
HexA	S-Biological_Molecule
of	O
P	B-Species
.	I-Species
luminescens	E-Species
(	O
61	O
%	O
identity	O
and	O
75	O
%	O
homology	O
)	O
,	O
and	O
has	O
only	O
recently	O
been	O
shown	O
to	O
control	O
cell	O
invasion	O
,	O
virulence	O
and	O
motility	O
in	O
Y	B-Species
.	I-Species
pseudotuberculosis	E-Species
,	O
Y	B-Species
.	I-Species
pestis	E-Species
and	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
[	O
51	O
-	O
53	O
]	O
.	O

P	B-Species
.	I-Species
luminescens	E-Species
,	O
but	O
not	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
,	O
produces	O
two	O
members	O
of	O
the	O
UspFG	S-Biological_Molecule
family	O
,	O
the	O
UspG	S-Biological_Molecule
homologues	O
Plu2030	S-Biological_Molecule
and	O
Plu2032	S-Biological_Molecule
(	O
Tab	O
.	O
2	O
)	O
,	O
indicating	O
a	O
global	O
stress	O
response	O
induced	O
by	O
those	O
Usp	O
proteins	O
that	O
is	O
different	O
in	O
both	O
organisms	O
.	O

A	O
GroEL	S-Biological_Molecule
homologue	O
is	O
present	O
in	O
P	B-Species
.	I-Species
luminescens	E-Species
(	O
Plu4134	S-Biological_Molecule
)	O
which	O
the	O
P	B-Species
.	I-Species
luminescens	E-Species
UspG	S-Biological_Molecule
homologues	O
might	O
interact	O
with	O
.	O

The	O
UspA	S-Biological_Molecule
and	O
the	O
UspE	S-Biological_Molecule
homologues	O
are	O
predicted	O
here	O
to	O
be	O
relevant	O
for	O
insect	O
infection	O
,	O
whereas	O
UspC	S-Biological_Molecule
is	O
assumed	O
be	O
more	O
important	O
for	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
in	O
other	O
environments	O
/	O
hosts	O
.	O

The	O
two	O
UspG	S-Biological_Molecule
homologues	O
might	O
constitute	O
a	O
set	O
of	O
Usp	O
proteins	O
that	O
play	O
a	O
specific	O
role	O
in	O
P	B-Species
.	I-Species
luminescens	E-Species
infection	O
or	O
in	O
symbiosis	O
with	O
the	O
nematode	O
host	O
.	O

Cyclic	B-Chemical_Compound
diguanylate	E-Chemical_Compound
(	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
)	O
is	O
a	O
bacterial	O
second	O
messenger	O
that	O
activates	O
biofilm	O
formation	O
while	O
inhibiting	O
motility	O
,	O
thus	O
regulating	O
the	O
switch	O
between	O
a	O
planktonic	O
and	O
a	O
sessile	O
lifestyle	O
.	O

Proteins	O
containing	O
a	O
so	O
-	O
called	O
GGDEF	S-Biological_Molecule
domain	O
are	O
responsible	O
for	O
the	O
synthesis	O
of	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
,	O
and	O
those	O
with	O
a	O
so	O
-	O
called	O
EAL	S-Biological_Molecule
domain	O
for	O
its	O
degradation	O
.	O

The	O
expression	O
and	O
activity	O
of	O
those	O
GGDEF	S-Biological_Molecule
and	O
EAL	S-Biological_Molecule
domain	O
containing	O
proteins	O
is	O
regulated	O
by	O
factors	O
with	O
a	O
PilZ	S-Biological_Molecule
domain	O
that	O
binds	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
.	O

The	O
PilZ	S-Biological_Molecule
domain	O
is	O
found	O
as	O
a	O
stand	O
-	O
alone	O
domain	O
or	O
in	O
combination	O
with	O
GGDEF	S-Biological_Molecule
,	O
EAL	S-Biological_Molecule
and	O
other	O
domains	O
,	O
thus	O
assumed	O
to	O
function	O
also	O
as	O
an	O
allosteric	O
domain	O
to	O
control	O
other	O
regulatory	O
enzymes	O
[	O
58	O
,	O
59	O
]	O
.	O

Eleven	O
of	O
these	O
proteins	O
solely	O
contain	O
a	O
GGDEF	S-Biological_Molecule
-	O
domain	O
and	O
six	O
solely	O
an	O
EAL	S-Biological_Molecule
-	O
domain	O
,	O
and	O
both	O
domains	O
are	O
found	O
in	O
tandem	O
in	O
five	O
proteins	O
.	O

The	O
protein	O
AdrA	S-Biological_Molecule
(	O
YE3010	S-Biological_Molecule
,	O
GGDEF	S-Biological_Molecule
domain	O
)	O
is	O
annotated	O
as	O
a	O
putative	O
diguanylate	S-Chemical_Compound
cyclase	O
,	O
YE2278	S-Biological_Molecule
(	O
GGDEF	S-Biological_Molecule
+	O
EAL	S-Biological_Molecule
)	O
as	O
a	O
putative	O
phosphodiesterase	O
,	O
YE3818	S-Biological_Molecule
(	O
GGDEF	S-Biological_Molecule
)	O
as	O
a	O
putative	O
regulator	O
,	O
and	O
YE3806	S-Biological_Molecule
(	O
GGDEF	S-Biological_Molecule
+	O
EAL	S-Biological_Molecule
)	O
as	O
a	O
putative	O
exported	O
protein	O
.	O

Furthermore	O
,	O
two	O
proteins	O
with	O
PilZ	S-Biological_Molecule
domain	O
exist	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
,	O
namely	O
YE3197	S-Biological_Molecule
and	O
BcsA	S-Biological_Molecule
(	O
YE4074	S-Biological_Molecule
)	O
,	O
a	O
putative	O
cellulose	O
synthase	O
.	O

Cellulose	O
synthesis	O
in	O
bacteria	O
has	O
been	O
identified	O
to	O
be	O
important	O
for	O
the	O
protection	O
from	O
chemical	O
or	O
mechanical	O
stress	O
by	O
forming	O
a	O
hydrophobic	O
extracellular	O
matrix	O
[	O
60	O
]	O
.	O

This	O
phenomenon	O
is	O
quite	O
surprising	O
,	O
because	O
with	O
few	O
exceptions	O
such	O
as	O
Helicobacter	B-Species
pylori	E-Species
,	O
nearly	O
all	O
pathogenic	O
bacteria	O
use	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
as	O
a	O
second	O
messenger	O
.	O

Virulence	O
factors	O

We	O
compared	O
both	O
genomes	O
with	O
respect	O
to	O
genes	O
encoding	O
toxins	O
,	O
adhesins	O
or	O
invasines	O
that	O
are	O
common	O
to	O
both	O
pathogens	O
.	O

All	O
virulence	O
factors	O
described	O
in	O
the	O
following	O
are	O
summarized	O
in	O
Fig	O
.	O

The	O
respective	O
genes	O
encoding	O
four	O
high	O
molecular	O
weight	O
toxin	O
complexes	O
are	O
termed	O
tca	O
,	O
tcb	O
,	O
tcc	O
and	O
tcd	O
.	O

Further	O
experiments	O
supported	O
the	O
hypothesis	O
that	O
TccC	S-Biological_Molecule
-	O
like	O
proteins	O
might	O
act	O
as	O
universal	O
activators	O
of	O
,	O
or	O
chaperons	O
for	O
,	O
different	O
toxin	O
proteins	O
,	O
while	O
Tca	O
-	O
like	O
and	O
Tcd	O
-	O
like	O
proteins	O
contribute	O
predominantly	O
to	O
the	O
oral	O
toxicity	O
of	O
bacterial	O
supernatants	O
[	O
17	O
]	O
.	O

In	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
,	O
the	O
insecticidal	O
toxin	O
genes	O
are	O
located	O
on	O
a	O
distinct	O
genomic	O
island	O
termed	O
tc	O
-	O
PAIYe	O
of	O
21	O
kb	O
,	O
and	O
are	O
low	O
-	O
temperature	O
induced	O
[	O
7	O
]	O
.	O

Similar	O
islands	O
in	O
which	O
regulatory	O
genes	O
are	O
followed	O
by	O
three	O
tca	O
genes	O
,	O
phage	O
-	O
related	O
genes	O
and	O
one	O
or	O
two	O
tccC	S-Biological_Molecule
genes	O
,	O
are	O
present	O
in	O
the	O
genomes	O
of	O
Y	B-Species
.	I-Species
pseudotuberculosis	I-Species
IP32953	E-Species
and	O
Y	B-Species
.	I-Species
pestis	I-Species
KIM	E-Species
.	O

The	O
reason	O
for	O
the	O
over	O
-	O
represence	O
of	O
tc	O
-	O
like	O
genes	O
in	O
the	O
P	B-Species
.	I-Species
luminescens	E-Species
genome	O
might	O
reflect	O
the	O
different	O
strategies	O
followed	O
by	O
both	O
bacteria	O
within	O
insects	O
,	O
namely	O
the	O
rapid	O
killing	O
for	O
exploiting	O
the	O
victim	O
as	O
a	O
food	O
source	O
in	O
case	O
of	O
P	B-Species
.	I-Species
luminescens	E-Species
,	O
and	O
infection	O
of	O
and	O
persistance	O
within	O
the	O
invertebrate	O
host	O
as	O
possibly	O
preferred	O
by	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
.	O

Hemolysins	O
or	O
surface	O
-	O
associated	O
adhesins	O
,	O
together	O
with	O
their	O
transporters	O
,	O
are	O
sometimes	O
organized	O
as	O
two	O
-	O
partner	O
secretion	O
(	O
TPS	O
)	O
systems	O
,	O
a	O
specialized	O
mechanism	O
for	O
the	O
delivery	O
of	O
large	O
exoproteins	O
[	O
65	O
]	O
.	O

Eight	O
other	O
TPS	O
systems	O
are	O
present	O
in	O
P	B-Species
.	I-Species
luminescens	E-Species
,	O
namely	O
Plu0225	S-Biological_Molecule
/	O
Plu0226	S-Biological_Molecule
,	O
Plu0548	S-Biological_Molecule
/	O
Plu0549	S-Biological_Molecule
,	O
Plu1149	S-Biological_Molecule
/	O
Plu1150	S-Biological_Molecule
,	O
Plu1367	S-Biological_Molecule
/	O
Plu1368	S-Biological_Molecule
,	O
Plu3064	S-Biological_Molecule
/	O
Plu3065	S-Biological_Molecule
,	O
Plu3125	S-Biological_Molecule
-	O
3127	S-Biological_Molecule
/	O
3128	S-Biological_Molecule
,	O
Plu3667	S-Biological_Molecule
/	O
Plu3668	S-Biological_Molecule
,	O
and	O
Plu3718	S-Biological_Molecule
/	O
Plu3719	S-Biological_Molecule
,	O
and	O
further	O
three	O
genes	O
for	O
which	O
the	O
partner	O
locus	O
has	O
not	O
been	O
identified	O
(	O
Fig	O
.	O
4	O
)	O
.	O

FhaC	S-Biological_Molecule
which	O
belongs	O
to	O
a	O
family	O
of	O
hemolysin	O
activator	O
proteins	O
related	O
to	O
ShlA	S-Biological_Molecule
from	O
Serratia	B-Species
marcescens	E-Species
is	O
present	O
in	O
both	O
pathogens	O
and	O
also	O
induced	O
at	O
low	O
temperature	O
[	O
67	O
]	O
.	O

The	O
genome	O
sequence	O
of	O
P	B-Species
.	I-Species
luminescens	E-Species
exhibits	O
more	O
toxin	O
genes	O
than	O
found	O
in	O
any	O
other	O
bacterial	O
genome	O
sequenced	O
yet	O
,	O
including	O
the	O
genome	O
of	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
.	O

A	O
putative	O
RTX	O
-	O
family	O
toxin	O
transporter	O
is	O
common	O
to	O
both	O
pathogens	O
(	O
YE1998	S-Biological_Molecule
-	O
2000	S-Biological_Molecule
,	O
Plu0634	S-Biological_Molecule
/	O
Plu0635	S-Biological_Molecule
)	O
.	O

The	O
P	B-Species
.	I-Species
luminescens	E-Species
genome	O
comprises	O
a	O
gene	O
cluster	O
encoding	O
RTX	O
proteins	O
,	O
namely	O
plu1330	S-Biological_Molecule
-	O
1369	S-Biological_Molecule
.	O

P	B-Species
.	I-Species
luminescens	E-Species
produces	O
a	O
series	O
of	O
proteins	O
similar	O
to	O
toxins	O
that	O
have	O
been	O
identified	O
in	O
other	O
bacteria	O
,	O
but	O
are	O
absent	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
.	O

Most	O
of	O
these	O
toxins	O
probably	O
contribute	O
to	O
the	O
higher	O
insect	O
toxicity	O
of	O
P	B-Species
.	I-Species
luminescens	E-Species
against	O
the	O
tobacco	B-Species
hornworm	E-Species
in	O
comparison	O
with	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
.	O

No	O
homologues	O
of	O
the	O
Y	B-Species
.	I-Species
pestis	E-Species
gene	O
coding	O
for	O
enhancin	O
(	O
YPO0339	S-Biological_Molecule
)	O
could	O
be	O
found	O
for	O
which	O
a	O
role	O
in	O
flea	O
colonization	O
was	O
predicted	O
[	O
74	O
]	O
.	O

Toxins	O
only	O
present	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
are	O
assumed	O
to	O
play	O
a	O
major	O
role	O
in	O
its	O
pathogenicity	O
towards	O
mammalians	O
,	O
and	O
some	O
of	O
them	O
might	O
have	O
been	O
acquired	O
by	O
horizontal	O
gene	O
transfer	O
.	O

Adhesins	O
and	O
invasins	O

Further	O
invasin	O
genes	O
of	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
with	O
counterparts	O
in	O
P	B-Species
.	I-Species
luminescens	E-Species
are	O
ysaV	S-Biological_Molecule
(	O
ye3546	S-Biological_Molecule
/	O
plu3761	S-Biological_Molecule
)	O
and	O
invF	S-Biological_Molecule
(	O
ye3549	S-Biological_Molecule
/	O
plu3775	S-Biological_Molecule
)	O
.	O

Unique	O
for	O
the	O
human	S-Species
pathogen	O
in	O
comparison	O
to	O
P	B-Species
.	I-Species
luminescens	E-Species
are	O
the	O
two	O
fimbrial	O
gene	O
cluster	O
ye2664	S-Biological_Molecule
-	O
2668	S-Biological_Molecule
and	O
ye2692	S-Biological_Molecule
-	O
2700	S-Biological_Molecule
,	O
both	O
of	O
yet	O
hypothetical	O
function	O
.	O

Thus	O
,	O
invasin	O
and	O
adhesin	O
homologues	O
similar	O
in	O
the	O
two	O
pathogens	O
might	O
contribute	O
to	O
the	O
infection	O
of	O
insect	O
or	O
mammalian	O
hosts	O
,	O
but	O
candidates	O
for	O
insect	O
-	O
and	O
mammalian	O
-	O
specific	O
colonization	O
factors	O
have	O
also	O
been	O
revealed	O
by	O
the	O
genome	O
comparison	O
performed	O
here	O
.	O

Defensive	O
mechanisms	O

Interestingly	O
,	O
none	O
of	O
these	O
genes	O
showed	O
significant	O
similarities	O
to	O
sequences	O
of	O
the	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
genome	O
.	O

More	O
than	O
twenty	O
colicin	O
/	O
pyocin	O
-	O
like	O
factors	O
and	O
putative	O
immunity	O
proteins	O
are	O
unique	O
to	O
P	B-Species
.	I-Species
luminescens	E-Species
in	O
comparison	O
to	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
.	O

P	B-Species
.	I-Species
luminescens	E-Species
produces	O
proteins	O
similar	O
to	O
monooxygenases	O
,	O
dioxygenases	O
and	O
hydroxylases	O
that	O
have	O
been	O
suggested	O
to	O
play	O
a	O
role	O
in	O
rapid	O
elimination	O
of	O
insect	O
polyphenols	S-Chemical_Compound
or	O
in	O
the	O
detoxification	O
of	O
reactive	B-Chemical_Compound
oxygen	I-Chemical_Compound
species	E-Chemical_Compound
generated	O
by	O
the	O
invaded	O
host	O
[	O
24	O
]	O
.	O

Examples	O
are	O
the	O
product	O
of	O
plu4258	S-Biological_Molecule
,	O
adjacent	O
to	O
a	O
gene	O
encoding	O
glutathione	S-Chemical_Compound
transferase	O
(	O
plu4259	S-Biological_Molecule
)	O
,	O
a	O
putative	O
steroid	S-Chemical_Compound
monooxygenase	O
(	O
Plu4232	S-Biological_Molecule
)	O
,	O
and	O
a	O
glycine	O
oxidase	O
(	O
Plu2242	S-Biological_Molecule
)	O
,	O
all	O
of	O
which	O
have	O
no	O
counterparts	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
.	O

Factors	O
present	O
in	O
both	O
pathogens	O
are	O
two	O
monooxigenases	O
encoded	O
by	O
ye1945	S-Biological_Molecule
/	O
hpaC	S-Biological_Molecule
(	O
plu0974	S-Biological_Molecule
)	O
and	O
ye3394	S-Biological_Molecule
/	O
plu3599	S-Biological_Molecule
,	O
and	O
two	O
hydroxylases	O
encoded	O
by	O
ubiH	S-Biological_Molecule
(	O
ye3395	S-Biological_Molecule
/	O
plu3600	S-Biological_Molecule
)	O
and	O
ubiF	S-Biological_Molecule
(	O
ye2984	S-Biological_Molecule
/	O
plu1313	S-Biological_Molecule
)	O
.	O

Secretion	O
and	O
exoenzymes	O

In	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
,	O
two	O
type	O
-	O
III	O
secretion	O
systems	O
(	O
T3SS	O
)	O
essential	O
for	O
virulence	O
in	O
the	O
mammalian	O
host	O
are	O
encoded	O
on	O
pYV	O
and	O
by	O
the	O
ysa	O
operon	O
(	O
YE3533	S-Biological_Molecule
-	O
3561	S-Biological_Molecule
)	O
[	O
23	O
,	O
82	O
]	O
.	O

The	O
P	B-Species
.	I-Species
luminescens	E-Species
genome	O
encodes	O
one	O
T3SS	O
which	O
is	O
highly	O
similar	O
to	O
the	O
plasmid	O
-	O
encoded	O
T3SS	O
of	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
and	O
probably	O
involved	O
in	O
the	O
secretion	O
of	O
virulence	O
proteins	O
or	O
in	O
immunomodulation	O
of	O
the	O
insect	O
response	O
to	O
an	O
infection	O
.	O

Interestingly	O
,	O
the	O
T3SS	O
of	O
Y	B-Species
.	I-Species
pestis	E-Species
has	O
recently	O
been	O
demonstrated	O
to	O
translocate	O
insecticidal	O
toxins	O
,	O
providing	O
evidence	O
that	O
they	O
support	O
the	O
transmission	O
of	O
the	O
plague	O
agent	O
by	O
insects	O
[	O
83	O
]	O
.	O

The	O
P	B-Species
.	I-Species
luminescens	E-Species
Lop	O
effector	O
proteins	O
are	O
homologs	O
of	O
the	O
Yop	O
effector	O
proteins	O
of	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
[	O
85	O
]	O
.	O

The	O
LopT	S-Biological_Molecule
effector	O
protein	O
of	O
P	B-Species
.	I-Species
luminescens	E-Species
can	O
be	O
injected	O
by	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
into	O
mammal	O
cells	O
[	O
86	O
]	O
,	O
underlining	O
the	O
idea	O
that	O
both	O
T3SS	O
act	O
similarly	O
.	O

Furthermore	O
,	O
we	O
found	O
homologues	O
of	O
the	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
low	O
-	O
calcium	S-Chemical_Compound
-	O
response	O
genes	O
(	O
lcrH	S-Biological_Molecule
,	O
lcrV	S-Biological_Molecule
,	O
and	O
lrcD	S-Biological_Molecule
)	O
in	O
P	B-Species
.	I-Species
luminescens	E-Species
(	O
plu3757	S-Biological_Molecule
,	O
plu3758	S-Biological_Molecule
,	O
sctV	S-Biological_Molecule
)	O
which	O
further	O
supports	O
this	O
hypothesis	O
.	O

These	O
are	O
substrate	O
-	O
specific	O
secretion	O
machineries	O
that	O
share	O
a	O
similar	O
architecture	O
and	O
secretion	O
mechanism	O
[	O
88	O
]	O
.	O

Proteins	O
secreted	O
by	O
these	O
systems	O
are	O
mainly	O
virulence	O
determinants	O
such	O
as	O
exotoxins	O
like	O
the	O
Cholera	O
toxin	O
of	O
Vibrio	B-Species
cholerae	E-Species
,	O
pili	O
,	O
and	O
S	O
-	O
layer	O
components	O
(	O
see	O
[	O
89	O
]	O
for	O
review	O
)	O
.	O

The	O
genes	O
encoding	O
these	O
kinds	O
of	O
secretion	O
systems	O
were	O
named	O
vas	O
(	O
virulence	O
associated	O
secretion	O
)	O
,	O
and	O
homologues	O
are	O
widespread	O
in	O
Gram	O
-	O
negative	O
bacteria	O
.	O

YplA	S-Biological_Molecule
contributes	O
to	O
pathogenesis	O
of	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
in	O
a	O
mouse	S-Species
model	O
[	O
94	O
]	O
,	O
suggesting	O
a	O
role	O
in	O
virulence	O
against	O
insects	O
for	O
the	O
P	B-Species
.	I-Species
luminescens	E-Species
homologue	O
.	O

Two	O
additional	O
phospholipases	O
are	O
present	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
,	O
namely	O
PdlA	S-Biological_Molecule
(	O
YE0203	S-Biological_Molecule
)	O
and	O
PdlB	S-Biological_Molecule
(	O
YE0207	S-Biological_Molecule
)	O
,	O
the	O
latter	O
one	O
a	O
homologue	O
of	O
Plu4619	S-Biological_Molecule
.	O

This	O
overlap	O
is	O
another	O
example	O
for	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
enzymes	O
probably	O
involved	O
rather	O
in	O
the	O
association	O
with	O
invertebrates	O
than	O
in	O
pathogenicity	O
towards	O
mammalians	O
.	O

Plu1971	S-Biological_Molecule
of	O
P	B-Species
.	I-Species
luminescens	E-Species
is	O
a	O
protein	O
which	O
contains	O
two	O
phospholipase	B-Biological_Molecule
D	E-Biological_Molecule
motifs	O
.	O

Furthermore	O
,	O
it	O
shares	O
homologies	O
to	O
the	O
plasmid	O
(	O
pMT1	O
)	O
-	O
encoded	O
murine	S-Species
toxin	O
(	O
Ymt	S-Biological_Molecule
)	O
of	O
Y	B-Species
.	I-Species
pestis	E-Species
.	O

Due	O
to	O
its	O
absence	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
,	O
Ymt	S-Biological_Molecule
is	O
another	O
example	O
for	O
the	O
high	O
diversity	O
of	O
genetic	O
determinants	O
that	O
are	O
used	O
by	O
closely	O
related	O
bacterial	O
pathogens	O
to	O
interact	O
with	O
their	O
insect	O
hosts	O
.	O

Examples	O
are	O
the	O
ten	O
triacylglycerol	S-Chemical_Compound
lipases	O
of	O
P	B-Species
.	I-Species
luminescens	E-Species
or	O
the	O
three	O
identified	O
lipases	O
of	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
.	O

Further	O
examples	O
for	O
shared	O
proteases	O
are	O
another	O
Zn	O
-	O
dependent	O
protease	O
(	O
Plu0306	S-Biological_Molecule
/	O
YE4066	S-Biological_Molecule
)	O
,	O
the	O
protease	O
III	O
(	O
Plu0631	S-Biological_Molecule
/	O
YE3311	S-Biological_Molecule
)	O
,	O
and	O
DegQ	S-Biological_Molecule
/	O
DegS	S-Biological_Molecule
(	O
YE3744	S-Biological_Molecule
/	O
YE3745	S-Biological_Molecule
/	O
Plu4018	S-Biological_Molecule
/	O
Plu4022	S-Biological_Molecule
)	O
.	O

We	O
also	O
identified	O
two	O
proteases	O
in	O
each	O
pathogen	O
(	O
Plu4291	S-Biological_Molecule
,	O
Plu0631	S-Biological_Molecule
,	O
YE0320	S-Biological_Molecule
,	O
and	O
YE2087	S-Biological_Molecule
)	O
without	O
a	O
homologue	O
in	O
the	O
other	O
bacterium	O
.	O

We	O
speculate	O
that	O
these	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
proteases	O
could	O
be	O
involved	O
in	O
the	O
infection	O
process	O
in	O
mammals	O
,	O
whereas	O
the	O
P	B-Species
.	I-Species
luminescens	E-Species
proteases	O
are	O
rather	O
used	O
for	O
nutrient	O
bioconversion	O
than	O
for	O
the	O
infection	O
process	O
.	O

The	O
synthesis	O
of	O
vitamin	B-Chemical_Compound
B12	E-Chemical_Compound
that	O
occurs	O
only	O
anaerobically	O
is	O
required	O
for	O
the	O
degradation	O
of	O
1	B-Chemical_Compound
,	I-Chemical_Compound
2	I-Chemical_Compound
-	I-Chemical_Compound
propanediol	E-Chemical_Compound
by	O
the	O
products	O
of	O
the	O
pdu	O
operon	O
,	O
as	O
well	O
as	O
of	O
ethanolamine	S-Chemical_Compound
by	O
the	O
eutABC	S-Biological_Molecule
-	O
encoded	O
enzymes	O
.	O

Y	B-Species
.	I-Species
enterocolitica	E-Species
carries	O
the	O
genes	O
encoding	O
tetrathionate	S-Chemical_Compound
reductase	O
(	O
ttrABC	S-Biological_Molecule
)	O
and	O
the	O
TCS	O
TtrRS	S-Biological_Molecule
(	O
YE1613	S-Biological_Molecule
-	O
1617	S-Biological_Molecule
)	O
.	O

The	O
gene	O
clusters	O
for	O
cobalamin	S-Chemical_Compound
synthesis	O
and	O
propanediol	S-Chemical_Compound
degradation	O
are	O
located	O
on	O
a	O
40	O
-	O
kb	O
genomic	O
island	O
(	O
ye2707	S-Biological_Molecule
-	O
2750	S-Biological_Molecule
)	O
,	O
but	O
the	O
eutABC	S-Biological_Molecule
operon	O
is	O
missing	O
.	O

Propanediol	S-Chemical_Compound
degradation	O
by	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
might	O
also	O
be	O
supported	O
by	O
YE4187	S-Biological_Molecule
with	O
a	O
putative	O
GlcG	S-Biological_Molecule
domain	O
which	O
is	O
predicted	O
to	O
be	O
involved	O
in	O
glycolate	S-Chemical_Compound
and	O
propanediol	S-Chemical_Compound
utilization	O
.	O

Further	O
metabolic	O
genes	O
common	O
to	O
both	O
pathogens	O
are	O
dctA	S-Biological_Molecule
responsible	O
for	O
transport	O
of	O
C4	B-Chemical_Compound
-	I-Chemical_Compound
dicarboxylates	E-Chemical_Compound
across	O
the	O
membrane	O
,	O
the	O
UhpABC	S-Biological_Molecule
regulatory	O
system	O
controlling	O
the	O
hexose	B-Chemical_Compound
phosphate	E-Chemical_Compound
transport	O
by	O
UhpT	S-Biological_Molecule
,	O
and	O
the	O
three	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
transport	O
systems	O
CorA	S-Biological_Molecule
,	O
MgtA	S-Biological_Molecule
and	O
MgtB	S-Biological_Molecule
.	O

Furthermore	O
,	O
both	O
insecticidal	O
bacteria	O
produce	O
a	O
chitin	S-Chemical_Compound
-	O
binding	O
-	O
like	O
protein	O
(	O
Plu2352	S-Biological_Molecule
,	O
YE3576	S-Biological_Molecule
)	O
,	O
but	O
chitinase	O
-	O
like	O
proteins	O
(	O
Plu2235	S-Biological_Molecule
,	O
Plu2458	S-Biological_Molecule
and	O
Plu2461	S-Biological_Molecule
)	O
are	O
without	O
homologues	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
.	O

The	O
proteins	O
encoded	O
by	O
the	O
P	B-Species
.	I-Species
luminescens	E-Species
fecIRABCDE	S-Biological_Molecule
operon	O
are	O
similar	O
to	O
the	O
components	O
of	O
the	O
E	B-Species
.	I-Species
coli	E-Species
Fe3	B-Chemical_Compound
+	E-Chemical_Compound
-	O
dicitrate	O
transport	O
system	O
.	O

In	O
addition	O
,	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
produces	O
two	O
heme	S-Chemical_Compound
-	O
protein	O
acquisition	O
sytems	O
(	O
YE0123	S-Biological_Molecule
-	O
126	S-Biological_Molecule
,	O
YE2180	S-Biological_Molecule
-	O
2182	S-Biological_Molecule
)	O
,	O
a	O
second	O
SfuABC	S-Biological_Molecule
system	O
,	O
the	O
ferrichrome	S-Chemical_Compound
binding	O
and	O
transport	O
proteins	O
(	O
YE0730	S-Biological_Molecule
-	O
0732	S-Biological_Molecule
)	O
,	O
a	O
putative	O
siderophore	S-Chemical_Compound
(	O
YE0704	S-Biological_Molecule
)	O
,	O
and	O
a	O
hemin	S-Chemical_Compound
storage	O
system	O
(	O
YE2481	S-Biological_Molecule
-	O
2484	S-Biological_Molecule
)	O
.	O

It	O
is	O
suggested	O
that	O
the	O
photopexins	O
may	O
be	O
used	O
by	O
P	B-Species
.	I-Species
luminescens	E-Species
to	O
scavenge	O
iron	S-Chemical_Compound
containing	O
compounds	O
from	O
insects	O
[	O
105	O
]	O
.	O

It	O
also	O
indicates	O
that	O
iron	S-Chemical_Compound
acquisition	O
is	O
a	O
prerequisite	O
for	O
the	O
infection	O
process	O
of	O
pathogenic	O
bacteria	O
not	O
only	O
in	O
mammalian	O
,	O
but	O
also	O
in	O
invertebrate	O
hosts	O
,	O
and	O
underlines	O
the	O
suggestion	O
that	O
genetic	O
determinants	O
of	O
invertebrate	O
pathogens	O
such	O
as	O
P	B-Species
.	I-Species
luminescens	E-Species
include	O
the	O
progenitors	O
of	O
virulence	O
factors	O
against	O
vertebrates	O
[	O
79	O
,	O
106	O
]	O
.	O

The	O
TctE	S-Biological_Molecule
/	O
TctD	S-Biological_Molecule
system	O
is	O
the	O
only	O
TCS	O
of	O
P	B-Species
.	I-Species
luminescens	E-Species
without	O
homologue	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
(	O
see	O
section	O
"	O
Two	O
-	O
component	O
signal	O
transduction	O
"	O
,	O
Fig	O
.	O
2	O
)	O
.	O

The	O
Na	B-Chemical_Compound
+	E-Chemical_Compound
dependent	O
citrate	S-Chemical_Compound
symporter	O
CitS	S-Biological_Molecule
of	O
S	B-Species
.	I-Species
enterica	E-Species
,	O
which	O
the	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
protein	O
YE2507	S-Biological_Molecule
is	O
homologous	O
to	O
,	O
is	O
induced	O
by	O
the	O
CitA	S-Biological_Molecule
/	O
CitB	S-Biological_Molecule
system	O
for	O
fermentation	O
of	O
citrate	S-Chemical_Compound
under	O
anoxic	O
conditions	O
[	O
110	O
]	O
,	O
indicating	O
a	O
general	O
difference	O
of	O
citrate	S-Chemical_Compound
utilization	O
in	O
P	B-Species
.	I-Species
luminescens	E-Species
and	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
.	O

While	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
explores	O
citrate	S-Chemical_Compound
for	O
anaerobic	O
metabolism	O
,	O
it	O
is	O
most	O
likely	O
that	O
the	O
specific	O
uptake	O
of	O
citrate	S-Chemical_Compound
and	O
other	O
tricarboxylic	B-Chemical_Compound
acids	E-Chemical_Compound
by	O
TctCBA	S-Chemical_Compound
is	O
used	O
by	O
P	B-Species
.	I-Species
luminescens	E-Species
upon	O
entering	O
the	O
insect	O
host	O
where	O
enough	O
citrate	S-Chemical_Compound
is	O
available	O
.	O

The	O
specific	O
up	O
-	O
regulation	O
of	O
the	O
tricarboxylic	B-Chemical_Compound
acid	E-Chemical_Compound
cycle	O
(	O
TCA	O
)	O
enzymes	O
within	O
a	O
host	O
has	O
also	O
been	O
described	O
for	O
other	O
microorganisms	O
.	O

For	O
example	O
,	O
sucA	S-Biological_Molecule
encoding	O
a	O
subunit	O
of	O
alpha	B-Chemical_Compound
-	I-Chemical_Compound
ketoglutarate	E-Chemical_Compound
synthase	O
and	O
acnA	S-Biological_Molecule
encoding	O
the	O
aconitase	O
have	O
been	O
found	O
to	O
be	O
induced	O
in	O
V	B-Species
.	I-Species
cholerae	E-Species
during	O
host	O
infection	O
[	O
111	O
,	O
112	O
]	O
,	O
and	O
a	O
complete	O
TCA	S-Chemical_Compound
cycle	O
is	O
also	O
required	O
for	O
S	B-Species
.	I-Species
typhimurium	E-Species
virulence	O
[	O
113	O
]	O
.	O

Therefore	O
,	O
it	O
is	O
obvious	O
that	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
and	O
P	B-Species
.	I-Species
luminescens	E-Species
use	O
different	O
sensing	O
and	O
utilization	O
strategies	O
for	O
tricarboxylates	S-Chemical_Compound
.	O

Temperature	O
is	O
a	O
key	O
environmental	O
signal	O
to	O
enable	O
bacterial	O
adaptation	O
to	O
diverse	O
hosts	O
.	O

In	O
Yersinia	S-Species
,	O
temperature	O
-	O
dependent	O
gene	O
expression	O
has	O
been	O
described	O
to	O
be	O
an	O
important	O
theme	O
in	O
bacterial	O
mechanisms	O
of	O
pathogenesis	O
towards	O
humans	S-Species
[	O
116	O
]	O
.	O

The	O
data	O
have	O
derived	O
from	O
expression	O
profiling	O
in	O
vitro	O
and	O
cannot	O
directly	O
be	O
translated	O
to	O
the	O
in	O
vivo	O
situation	O
.	O

Recently	O
,	O
it	O
was	O
shown	O
that	O
the	O
flagellar	O
master	O
-	O
operon	O
of	O
X	B-Species
.	I-Species
nematophila	E-Species
regulates	O
the	O
expression	O
of	O
a	O
novel	O
hemolysin	O
which	O
is	O
required	O
for	O
full	O
virulence	O
of	O
X	B-Species
.	I-Species
nematophila	E-Species
against	O
insects	O
[	O
119	O
]	O
.	O

We	O
therefore	O
speculate	O
that	O
motility	O
essentially	O
contributes	O
to	O
the	O
control	O
of	O
the	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
switch	O
between	O
two	O
pathogenicity	O
phases	O
towards	O
mammalians	O
and	O
invertebrates	O
[	O
120	O
]	O
.	O

Evolution	O
of	O
pathogenicity	O

We	O
identified	O
several	O
common	O
loci	O
representing	O
ancestral	O
clusters	O
of	O
genes	O
important	O
in	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
and	O
P	B-Species
.	I-Species
luminescens	E-Species
pathogenesis	O
that	O
might	O
have	O
evolved	O
during	O
the	O
association	O
of	O
bacteria	O
with	O
invertebrates	O
,	O
the	O
so	O
-	O
called	O
"	O
pre	O
-	O
vertebrate	O
"	O
pathosphere	O
[	O
121	O
]	O
and	O
then	O
been	O
adapted	O
to	O
more	O
recent	O
pathologies	O
in	O
mammalians	O
.	O

Examples	O
are	O
yersiniabactin	S-Species
,	O
quorum	O
sensing	O
-	O
like	O
regulators	O
,	O
or	O
the	O
urease	O
operon	O
.	O

The	O
complexity	O
of	O
this	O
evolutionary	O
concept	O
is	O
also	O
demonstrated	O
by	O
the	O
fact	O
that	O
the	O
immune	O
systems	O
both	O
of	O
invertebrates	O
and	O
vertebrates	O
are	O
based	O
on	O
phagocytic	O
cells	O
that	O
are	O
attacked	O
by	O
hemolysins	O
,	O
T3SS	O
effector	O
proteins	O
,	O
and	O
many	O
other	O
toxins	O
described	O
above	O
.	O

Thus	O
,	O
it	O
can	O
not	O
be	O
excluded	O
that	O
these	O
virulence	O
factors	O
are	O
able	O
to	O
act	O
on	O
both	O
immune	O
systems	O
[	O
121	O
]	O
.	O

Thus	O
,	O
P	B-Species
.	I-Species
asymbiotica	E-Species
might	O
be	O
an	O
evolutionary	O
link	O
that	O
is	O
evolving	O
from	O
an	O
insect	O
to	O
a	O
mammal	O
-	O
pathogen	O
.	O

Another	O
example	O
that	O
might	O
enlighten	O
the	O
evolution	O
of	O
bacterial	O
pathogenicity	O
is	O
the	O
plasticity	O
zone	O
(	O
PZ	O
)	O
of	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
,	O
a	O
199	O
kb	O
key	O
locus	O
for	O
high	O
pathogenicity	O
that	O
includes	O
YAPIYe	O
,	O
secretion	O
systems	O
,	O
hydrogenase	O
loci	O
essential	O
for	O
gut	O
colonization	O
of	O
S	B-Species
.	I-Species
typhimurium	E-Species
and	O
H	B-Species
.	I-Species
pylori	E-Species
[	O
122	O
]	O
,	O
and	O
iron	S-Chemical_Compound
acquisition	O
systems	O
.	O

It	O
is	O
assumed	O
that	O
the	O
PZ	O
has	O
not	O
been	O
acquired	O
by	O
a	O
single	O
event	O
of	O
gene	O
transfer	O
,	O
but	O
through	O
a	O
series	O
of	O
independent	O
insertions	O
[	O
23	O
]	O
.	O

A	O
region	O
highly	O
similar	O
to	O
YAPIYe	O
is	O
the	O
genome	O
island	O
plu0958	S-Biological_Molecule
-	O
1166	S-Biological_Molecule
carrying	O
a	O
hemolysin	O
,	O
hypothetical	O
genes	O
,	O
the	O
toxin	O
/	O
antitoxin	O
system	O
CcdA	S-Biological_Molecule
/	O
CcdB	S-Biological_Molecule
,	O
and	O
the	O
type	O
IV	O
pilus	O
.	O

Only	O
few	O
other	O
genes	O
or	O
operons	O
of	O
the	O
PZ	O
are	O
also	O
present	O
in	O
P	B-Species
.	I-Species
luminescens	E-Species
,	O
namely	O
a	O
chitinase	O
,	O
two	O
iron	S-Chemical_Compound
acquisition	O
systems	O
,	O
and	O
three	O
ysa	O
genes	O
,	O
thus	O
confirming	O
the	O
idea	O
of	O
a	O
patchwork	O
of	O
horizontally	O
acquired	O
genes	O
within	O
the	O
PZ	O
[	O
23	O
]	O
.	O

However	O
,	O
given	O
the	O
extensive	O
transfer	O
of	O
virulence	O
factors	O
between	O
bacteria	O
,	O
the	O
history	O
of	O
pathogen	O
evolution	O
still	O
requires	O
further	O
investigation	O
.	O

The	O
comparison	O
of	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
and	O
P	B-Species
.	I-Species
luminescens	E-Species
at	O
the	O
genomic	O
level	O
performed	O
here	O
provides	O
the	O
database	O
for	O
a	O
better	O
understanding	O
of	O
the	O
genetic	O
basis	O
for	O
their	O
distinct	O
behaviour	O
towards	O
invertebrates	O
and	O
mammals	O
.	O

Y	B-Species
.	I-Species
enterocolitica	E-Species
is	O
expected	O
to	O
switch	O
between	O
two	O
pathogenicity	O
phases	O
against	O
insects	O
and	O
mammalians	O
,	O
while	O
the	O
genome	O
of	O
P	B-Species
.	I-Species
luminescens	E-Species
must	O
contain	O
the	O
modulators	O
and	O
regulators	O
necessary	O
to	O
change	O
the	O
bacterium	O
from	O
a	O
state	O
of	O
symbiosis	O
with	O
nematodes	O
to	O
pathogenicity	O
against	O
insects	O
,	O
and	O
also	O
from	O
symbiosis	O
-	O
proficient	O
primary	O
variants	O
to	O
symbiosis	O
-	O
deficient	O
secondary	O
variants	O
[	O
17	O
]	O
.	O

Those	O
adaptational	O
processes	O
must	O
be	O
precisely	O
regulated	O
by	O
the	O
bacteria	O
.	O

It	O
was	O
assumed	O
that	O
there	O
are	O
parallels	O
in	O
the	O
regulation	O
of	O
pathogenicity	O
in	O
mammals	O
and	O
insect	O
pathogens	O
[	O
41	O
,	O
123	O
]	O
.	O

However	O
,	O
molecular	O
components	O
of	O
the	O
regulatory	O
networks	O
controlling	O
pathogenicity	O
and	O
mutualism	O
have	O
recently	O
been	O
demonstrated	O
to	O
be	O
very	O
different	O
between	O
P	B-Species
.	I-Species
luminescens	E-Species
and	O
X	B-Species
.	I-Species
nematophilus	E-Species
with	O
similar	O
life	O
cycles	O
[	O
124	O
]	O
.	O

Dissecting	O
the	O
genomes	O
of	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
and	O
P	B-Species
.	I-Species
luminescens	E-Species
for	O
putative	O
key	O
regulators	O
,	O
we	O
identified	O
factor	O
groups	O
(	O
AI	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
,	O
PAS	B-Biological_Molecule
-	I-Biological_Molecule
4	E-Biological_Molecule
/	O
LuxR	S-Biological_Molecule
like	O
receptors	O
)	O
possibly	O
involved	O
in	O
pathogen	O
-	O
insect	O
association	O
only	O
,	O
those	O
with	O
members	O
contributing	O
to	O
either	O
insect	O
or	O
mammalian	O
pathogenicity	O
(	O
QS	O
,	O
TKS	O
,	O
Usp	O
)	O
,	O
and	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
signalling	O
probably	O
not	O
involved	O
in	O
regulation	O
of	O
activities	O
against	O
insects	O
.	O

Certainly	O
,	O
the	O
question	O
whether	O
fundamental	O
differences	O
in	O
regulatory	O
networks	O
reflect	O
how	O
each	O
of	O
these	O
two	O
bacteria	O
specifically	O
interacts	O
with	O
either	O
the	O
insect	O
or	O
the	O
human	S-Species
host	O
remains	O
to	O
be	O
addressed	O
in	O
more	O
detail	O
.	O

This	O
fact	O
might	O
explain	O
the	O
high	O
number	O
of	O
antibacterial	O
factors	O
directed	O
against	O
possible	O
competitors	O
that	O
are	O
going	O
to	O
colonize	O
the	O
same	O
insect	O
cadaver	O
or	O
that	O
are	O
already	O
present	O
in	O
the	O
insect	O
gut	O
flora	O
[	O
17	O
]	O
.	O

In	O
contrast	O
,	O
only	O
highly	O
concentrated	O
protein	O
extracts	O
of	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
are	O
toxic	O
for	O
M	B-Species
.	I-Species
sexta	E-Species
[	O
7	O
]	O
,	O
and	O
a	O
low	O
insect	O
larvae	O
mortality	O
has	O
been	O
observed	O
following	O
injection	O
of	O
approximately	O
3	O
.	O
5	O
x	O
106	O
Y	B-Species
.	I-Species
enterocolitica	E-Species
cells	O
into	O
the	O
hemolymph	O
(	O
T	O
.	O
M	O
.	O
Fuchs	O
,	O
unpublished	O
data	O
)	O
.	O

Up	O
to	O
the	O
present	O
time	O
,	O
we	O
are	O
far	O
away	O
from	O
understanding	O
the	O
complexity	O
of	O
bacteria	O
-	O
invertebrate	O
interactions	O
.	O

The	O
GraRS	S-Biological_Molecule
regulatory	O
system	O
controls	O
Staphylococcus	B-Species
aureus	E-Species
susceptibility	O
to	O
antimicrobial	O
host	O
defenses	O

Results	O
To	O
determine	O
the	O
impact	O
of	O
the	O
GraRS	S-Biological_Molecule
regulatory	O
system	O
on	O
resistance	O
to	O
antimicrobial	O
host	O
defense	O
mechanisms	O
and	O
virulence	O
of	O
S	B-Species
.	I-Species
aureus	E-Species
,	O
we	O
compared	O
inactivation	O
of	O
S	B-Species
.	I-Species
aureus	I-Species
SA113	I-Species
wild	I-Species
type	E-Species
and	O
its	O
isogenic	O
graRS	S-Biological_Molecule
deletion	O
mutant	O
by	O
the	O
human	O
cathelicidin	O
LL	B-Biological_Molecule
-	I-Biological_Molecule
37	E-Biological_Molecule
or	O
human	O
neutrophil	O
granulocytes	O
in	O
vitro	O
,	O
and	O
the	O
ability	O
to	O
cause	O
infection	O
in	O
vivo	O
.	O

Conclusion	O
Our	O
results	O
indicate	O
that	O
S	B-Species
.	I-Species
aureus	E-Species
can	O
regulate	O
its	O
surface	O
properties	O
in	O
order	O
to	O
overcome	O
innate	O
host	O
defenses	O
.	O

Background	O

Staphylococcus	B-Species
aureus	E-Species
,	O
a	O
frequent	O
cause	O
of	O
human	S-Species
infections	O
,	O
is	O
highly	O
resistant	O
to	O
antimicrobial	O
factors	O
of	O
the	O
innate	O
immune	O
system	O
such	O
as	O
cationic	O
antimicrobial	O
peptides	O
(	O
CAMPs	O
)	O
[	O
1	O
,	O
2	O
]	O
which	O
are	O
produced	O
by	O
epithelial	O
cells	O
and	O
neutrophils	O
[	O
3	O
,	O
4	O
]	O
.	O

These	O
peptides	O
generally	O
contain	O
10	O
-	O
50	O
amino	O
acids	O
and	O
have	O
positive	O
net	O
charges	O
[	O
5	O
]	O
.	O

S	B-Species
.	I-Species
aureus	E-Species
has	O
evolved	O
mechanisms	O
to	O
alter	O
the	O
anionic	O
charge	O
of	O
cell	O
surface	O
components	O
to	O
gain	O
resistance	O
to	O
a	O
broad	O
variety	O
of	O
cationic	O
antimicrobial	O
factors	O
such	O
as	O
CAMPs	O
[	O
7	O
]	O
,	O
phospholipase	B-Biological_Molecule
A2	E-Biological_Molecule
[	O
8	O
]	O
,	O
myeloperoxidase	S-Biological_Molecule
[	O
9	O
]	O
,	O
or	O
lysozyme	O
[	O
10	O
]	O
.	O

A	O
similar	O
reaction	O
is	O
mediated	O
by	O
products	O
of	O
the	O
dltABCD	S-Biological_Molecule
operon	O
,	O
which	O
are	O
responsible	O
for	O
attachment	O
of	O
positively	O
charged	O
D	O
-	O
alanine	O
residues	O
into	O
negatively	O
charged	O
phosphate	O
groups	O
in	O
the	O
backbone	O
of	O
teichoic	B-Chemical_Compound
acids	E-Chemical_Compound
[	O
7	O
,	O
9	O
]	O
.	O

In	O
a	O
S	O
.	O
aureus	O
SA113	O
graRS	S-Biological_Molecule
deletion	O
mutant	O
,	O
the	O
content	O
of	O
D	O
-	O
alanine	O
in	O
teichoic	B-Chemical_Compound
acids	E-Chemical_Compound
was	O
reduced	O
by	O
47	O
%	O
and	O
the	O
mutant	O
showed	O
reduced	O
resistance	O
to	O
various	O
antibiotics	O
including	O
polymyxin	B-Chemical_Compound
B	E-Chemical_Compound
,	O
gallidermin	S-Chemical_Compound
,	O
and	O
vancomycin	S-Chemical_Compound
[	O
10	O
,	O
13	O
]	O
.	O

Accordingly	O
,	O
graRS	S-Biological_Molecule
have	O
previously	O
been	O
implicated	O
in	O
regulation	O
of	O
vancomycin	S-Chemical_Compound
intermediary	O
resistance	O
[	O
14	O
]	O
.	O

As	O
the	O
dlt	O
operon	O
plays	O
a	O
key	O
role	O
in	O
S	B-Species
.	I-Species
aureus	E-Species
resistance	O
to	O
cationic	O
antimicrobial	O
host	O
molecules	O
,	O
the	O
graRS	S-Biological_Molecule
system	O
may	O
be	O
important	O
in	O
evasion	O
of	O
host	O
defense	O
mechanisms	O
such	O
as	O
cationic	O
antimicrobial	O
peptides	O
and	O
neutrophil	O
killing	O
.	O

Results	O

The	O
graRS	S-Biological_Molecule
mutant	O
bound	O
significantly	O
more	O
cytochrome	B-Biological_Molecule
c	E-Biological_Molecule
than	O
the	O
WT	O
or	O
the	O
complemented	O
mutant	O
(	O
Fig	O
.	O
1A	O
)	O
,	O
which	O
is	O
in	O
accordance	O
with	O
the	O
recently	O
described	O
reduced	O
content	O
of	O
D	O
-	O
alanine	O
residues	O
in	O
the	O
teichoic	B-Chemical_Compound
acids	E-Chemical_Compound
of	O
the	O
mutant	O
[	O
10	O
]	O
.	O

Due	O
to	O
the	O
high	O
binding	O
capacities	O
of	O
the	O
dltA	S-Biological_Molecule
and	O
the	O
dltA	S-Biological_Molecule
/	O
graRS	S-Biological_Molecule
mutant	O
we	O
modified	O
the	O
conditions	O
in	O
order	O
to	O
prevent	O
limitation	O
of	O
applied	O
cytochrome	B-Biological_Molecule
c	E-Biological_Molecule
.	O

Deletion	O
of	O
the	O
graRS	S-Biological_Molecule
genes	O
in	O
the	O
dlt	B-Species
mutant	E-Species
background	O
did	O
not	O
lead	O
to	O
further	O
increased	O
binding	O
of	O
cytochrome	B-Biological_Molecule
c	E-Biological_Molecule
compared	O
to	O
the	O
dltA	S-Biological_Molecule
mutant	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

Increased	O
binding	O
of	O
cationic	O
proteins	O
may	O
also	O
result	O
from	O
reduced	O
mprF	S-Biological_Molecule
expression	O
and	O
,	O
accordingly	O
,	O
reduced	O
lysylphosphatidylglycerol	S-Chemical_Compound
(	O
LPG	S-Chemical_Compound
)	O
content	O
.	O

The	O
amounts	O
of	O
LPG	S-Chemical_Compound
from	O
WT	O
and	O
graRS	S-Biological_Molecule
mutant	O
were	O
indistinguishable	O
(	O
data	O
not	O
shown	O
)	O
,	O
which	O
corroborates	O
recent	O
findings	O
that	O
mprF	S-Biological_Molecule
is	O
not	O
among	O
the	O
graRS	S-Biological_Molecule
-	O
regulated	O
genes	O
in	O
S	B-Species
.	I-Species
aureus	I-Species
SA113	E-Species
[	O
10	O
]	O
.	O

The	O
graRS	S-Biological_Molecule
mutant	O
is	O
more	O
susceptible	O
to	O
killing	O
by	O
LL	B-Biological_Molecule
-	I-Biological_Molecule
37	E-Biological_Molecule
and	O
human	S-Species
neutrophil	O
granulocytes	O
in	O
vitro	O
In	O
an	O
attempt	O
to	O
test	O
whether	O
the	O
increased	O
affinity	O
of	O
the	O
graRS	S-Biological_Molecule
mutant	O
to	O
cationic	O
molecules	O
leads	O
to	O
higher	O
susceptibility	O
to	O
human	S-Species
host	O
defense	O
peptides	O
,	O
we	O
compared	O
inactivation	O
of	O
WT	O
and	O
graRS	S-Biological_Molecule
mutant	O
by	O
the	O
human	S-Species
cathelicidin	O
LL	B-Biological_Molecule
-	I-Biological_Molecule
37	E-Biological_Molecule
.	O

Next	O
we	O
investigated	O
whether	O
the	O
graRS	S-Biological_Molecule
mutant	O
is	O
killed	O
faster	O
than	O
the	O
parental	O
strain	O
by	O
human	S-Species
neutrophils	O
,	O
which	O
produce	O
high	O
amounts	O
of	O
LL	B-Biological_Molecule
-	I-Biological_Molecule
37	E-Biological_Molecule
and	O
other	O
CAMPs	O
as	O
components	O
of	O
their	O
antibacterial	O
killing	O
arsenal	O
.	O

The	O
graRS	S-Biological_Molecule
mutant	O
was	O
killed	O
by	O
neutrophils	O
considerably	O
faster	O
than	O
the	O
WT	O
strain	O
.	O

Of	O
note	O
,	O
our	O
previous	O
studies	O
had	O
shown	O
that	O
altered	O
alanylation	O
of	O
teichoic	O
acids	O
does	O
not	O
affect	O
the	O
rate	O
of	O
PMN	O
phagocytosis	O
[	O
9	O
]	O
.	O

Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
graRS	S-Biological_Molecule
-	O
mediated	O
control	O
of	O
CAMP	O
resistance	O
mechanisms	O
is	O
of	O
importance	O
for	O
S	B-Species
.	I-Species
aureus	E-Species
evasion	O
from	O
neutrophil	O
killing	O
.	O

Therefore	O
female	O
BALB	B-Species
/	I-Species
c	I-Species
mice	E-Species
(	O
12	O
to	O
15	O
weeks	O
old	O
)	O
were	O
infected	O
with	O
S	B-Species
.	I-Species
aureus	E-Species
WT	O
or	O
graRS	S-Biological_Molecule
mutant	O
bacteria	O
.	O

72	O
h	O
after	O
infection	O
numbers	O
of	O
CFU	O
/	O
kidney	O
were	O
determined	O
.	O

Significantly	O
less	O
bacteria	O
were	O
detected	O
in	O
the	O
kidneys	O
of	O
animals	O
,	O
which	O
had	O
been	O
infected	O
with	O
the	O
graRS	S-Biological_Molecule
mutant	O
than	O
those	O
infected	O
with	O
the	O
WT	O
bacteria	O
.	O

Incompetence	O
of	O
Neutrophils	O
to	O
Invasive	B-Species
Group	I-Species
A	I-Species
streptococcus	E-Species
Is	O
Attributed	O
to	O
Induction	O
of	O
Plural	O
Virulence	O
Factors	O
by	O
Dysfunction	O
of	O
a	O
Regulator	O

In	O
addition	O
,	O
rare	O
outbreaks	O
of	O
invasive	O
infections	O
and	O
their	O
distinctive	O
pathology	O
in	O
which	O
infectious	O
foci	O
without	O
neutrophil	O
infiltration	O
hypothesized	O
us	O
invasive	B-Species
GAS	E-Species
could	O
evade	O
host	O
defense	O
,	O
especially	O
neutrophil	O
functions	O
.	O

Herein	O
we	O
report	O
that	O
a	O
panel	O
of	O
serotype	O
-	O
matched	O
GAS	S-Species
,	O
which	O
were	O
clinically	O
isolated	O
from	O
severe	O
invasive	O
but	O
not	O
from	O
non	O
-	O
invaive	O
infections	O
,	O
could	O
abrogate	O
functions	O
of	O
human	S-Species
polymorphnuclear	O
neutrophils	O
(	O
PMN	O
)	O
in	O
at	O
least	O
two	O
independent	O
ways	O
;	O
due	O
to	O
inducing	O
necrosis	O
to	O
PMN	O
by	O
enhanced	O
production	O
of	O
a	O
pore	O
-	O
forming	O
toxin	O
streptolysin	B-Biological_Molecule
O	E-Biological_Molecule
(	O
SLO	S-Biological_Molecule
)	O
and	O
due	O
to	O
impairment	O
of	O
PMN	O
migration	O
via	O
digesting	O
interleukin	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
,	O
a	O
PMN	O
attracting	O
chemokine	O
,	O
by	O
increased	O
production	O
of	O
a	O
serine	O
protease	O
ScpC	S-Biological_Molecule
.	O

Expression	O
of	O
genes	O
was	O
upregulated	O
by	O
a	O
loss	O
of	O
repressive	O
function	O
with	O
the	O
mutation	O
of	O
csrS	S-Biological_Molecule
gene	O
in	O
the	O
all	O
emm49	S-Biological_Molecule
severe	O
invasive	B-Species
GAS	E-Species
isolates	O
.	O

However	O
,	O
GAS	S-Species
which	O
lack	O
either	O
SLO	S-Biological_Molecule
or	O
ScpC	S-Biological_Molecule
exhibit	O
much	O
less	O
mortality	O
than	O
the	O
csrS	S-Biological_Molecule
-	O
mutated	O
parent	O
invasive	O
GAS	O
isolate	O
to	O
the	O
infected	O
mice	S-Species
.	O

Streptococcus	B-Species
pyogenes	E-Species
(	O
group	B-Species
A	I-Species
streptococcus	E-Species
;	O
GAS	S-Species
)	O
is	O
one	O
of	O
the	O
most	O
common	O
human	S-Species
pathogens	O
.	O

Several	O
streptococcal	O
virulence	O
factors	O
,	O
including	O
streptolysin	O
,	O
and	O
M	B-Biological_Molecule
protein	E-Biological_Molecule
,	O
have	O
been	O
reported	O
to	O
be	O
involved	O
in	O
these	O
diseases	O
,	O
by	O
genetic	O
studies	O
or	O
animal	O
-	O
passaged	O
models	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
,	O
[	O
4	O
]	O
-	O
[	O
6	O
]	O
.	O

The	O
strains	O
of	O
emm1	S-Biological_Molecule
genotype	O
,	O
among	O
more	O
than	O
100	O
emm	S-Biological_Molecule
genes	O
encoding	O
the	O
serotype	O
-	O
determinant	O
M	B-Biological_Molecule
protein	E-Biological_Molecule
,	O
are	O
the	O
predominant	O
cause	O
of	O
severe	O
GAS	S-Species
infections	O
in	O
Japan	O
[	O
7	O
]	O
.	O

Therefore	O
,	O
emm49	S-Biological_Molecule
GAS	O
isolated	O
from	O
invasive	O
infections	O
seems	O
to	O
acquire	O
the	O
novel	O
or	O
altered	O
virulence	O
factors	O
by	O
mutations	O
,	O
genomic	O
additions	O
,	O
or	O
deletions	O
.	O

Epidemiological	O
and	O
pathological	O
findings	O
,	O
including	O
sporadic	O
incidents	O
of	O
severe	O
invasive	B-Species
GAS	E-Species
infections	O
[	O
9	O
]	O
,	O
high	O
frequency	O
of	O
severe	O
invasive	O
infections	O
in	O
immunocompromised	O
host	O
[	O
9	O
]	O
,	O
and	O
aggregation	O
of	O
bacteria	O
and	O
a	O
paucity	O
of	O
polymorphnuclear	O
neutrophils	O
(	O
PMN	O
)	O
in	O
foci	O
of	O
invasive	B-Species
GAS	E-Species
infection	O
[	O
10	O
]	O
suggest	O
that	O
host	O
defense	O
factors	O
play	O
an	O
important	O
role	O
in	O
the	O
onset	O
of	O
invasive	O
infections	O
.	O

However	O
,	O
restricted	O
availability	O
of	O
clinical	O
isolates	O
with	O
the	O
same	O
serotypes	O
fail	O
to	O
elucidate	O
direct	O
relationship	O
between	O
definitive	O
genetic	O
changes	O
in	O
clinically	O
isolated	O
severe	O
invasive	B-Species
GAS	E-Species
and	O
the	O
lack	O
of	O
PMN	O
at	O
the	O
site	O
of	O
bacterial	O
growth	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
aimed	O
to	O
explore	O
the	O
crucial	O
factors	O
in	O
the	O
pathogenesis	O
of	O
severe	O
invasive	B-Species
GAS	E-Species
infections	O
in	O
the	O
context	O
of	O
PMN	O
-	O
GAS	O
relationship	O
,	O
using	O
a	O
panel	O
of	O
emm49	S-Biological_Molecule
clinical	O
isolates	O
from	O
patients	S-Species
with	O
or	O
without	O
severe	O
invasive	O
infection	O
,	O
and	O
their	O
gene	O
-	O
manipulated	O
mutants	O
.	O

Group	B-Species
A	I-Species
streptococcus	E-Species
isolates	O
from	O
severe	O
invasive	O
infections	O
is	O
resistant	O
to	O
killing	O
by	O
human	S-Species
PMN	O
To	O
examine	O
whether	O
emm49	S-Biological_Molecule
GAS	O
isolated	O
from	O
severe	O
invasive	O
infection	O
might	O
alter	O
human	S-Species
PMN	O
function	O
,	O
we	O
performed	O
phagocytosis	O
assay	O
in	O
vitro	O
.	O

However	O
,	O
as	O
shown	O
in	O
Figure	O
1B	O
,	O
in	O
vitro	O
killing	O
assay	O
revealed	O
that	O
PMN	O
killed	O
non	B-Species
-	I-Species
invasive	I-Species
GAS	E-Species
,	O
resulting	O
in	O
15	O
-	O
42	O
%	O
of	O
initial	O
number	O
of	O
bacteria	O
,	O
but	O
not	O
invasive	B-Species
GAS	E-Species
(	O
p	O
=	O
0	O
.	O
019	O
)	O
.	O

The	O
similar	O
results	O
were	O
obtained	O
when	O
opsonized	O
with	O
either	O
FCS	O
or	O
human	S-Species
serum	O
regardless	O
of	O
complements	O
immobilization	O
(	O
data	O
not	O
shown	O
)	O
.	O

Therefore	O
,	O
we	O
examined	O
whether	O
GAS	S-Species
clinically	O
isolated	O
from	O
severe	O
invasive	O
infections	O
could	O
affect	O
the	O
migration	O
ability	O
of	O
PMN	O
in	O
response	O
to	O
chemokines	O
.	O

PMN	O
death	O
was	O
induced	O
shortly	O
after	O
encounter	O
with	O
severe	O
invasive	B-Species
GAS	E-Species
,	O
and	O
PMN	O
were	O
not	O
in	O
apoptotic	O
death	O
because	O
of	O
low	O
frequency	O
of	O
cells	O
positive	O
for	O
annexin	B-Biological_Molecule
V	E-Biological_Molecule
(	O
data	O
not	O
shown	O
)	O
,	O
which	O
was	O
seen	O
in	O
the	O
case	O
of	O
cytolysin	S-Chemical_Compound
-	O
dependent	O
cell	O
injury	O
[	O
15	O
]	O
.	O

GAS	S-Species
produce	O
two	O
cytolysins	S-Chemical_Compound
that	O
may	O
contribute	O
to	O
pathogenesis	O
.	O

Therefore	O
,	O
to	O
know	O
the	O
mechanism	O
underlying	O
GAS	S-Species
-	O
mediated	O
killing	O
of	O
PMN	O
,	O
we	O
investigated	O
whether	O
SLO	S-Biological_Molecule
produced	O
by	O
invasive	B-Species
GAS	E-Species
affect	O
survival	O
of	O
PMN	O
in	O
an	O
in	O
vitro	O
migration	O
assay	O
system	O
.	O

Furthermore	O
,	O
an	O
SLO	S-Biological_Molecule
deficient	O
mutant	O
from	O
a	O
STSS	O
isolate	O
NIH230	S-Species
(	O
NIH230slo	S-Biological_Molecule
)	O
lost	O
the	O
killing	O
activity	O
for	O
PMN	O
(	O
Figure	O
3A	O
)	O
,	O
thereby	O
,	O
strongly	O
suggesting	O
that	O
SLO	S-Biological_Molecule
is	O
a	O
key	O
element	O
for	O
PMN	O
killing	O
mediated	O
by	O
invasive	B-Species
GAS	E-Species
.	O

Contrarily	O
,	O
SLS	S-Biological_Molecule
-	O
deficient	O
mutant	O
from	O
NIH230	S-Species
strain	O
(	O
NIH230sagA	S-Biological_Molecule
)	O
killed	O
PMN	O
,	O
as	O
efficiently	O
as	O
did	O
parent	O
strain	O
,	O
indicating	O
that	O
SLS	S-Biological_Molecule
is	O
dispensable	O
for	O
killing	O
of	O
PMN	O
mediated	O
by	O
invasive	B-Species
GAS	E-Species
.	O

SLO	S-Biological_Molecule
and	O
SLS	S-Biological_Molecule
double	O
mutant	O
GAS	O
from	O
NIH230	S-Species
strain	O
(	O
NIH230slosagA	S-Biological_Molecule
)	O
displayed	O
the	O
killing	O
activity	O
indistinguishable	O
from	O
that	O
of	O
NIH230slo	S-Biological_Molecule
,	O
confirming	O
the	O
primarily	O
role	O
of	O
SLO	S-Biological_Molecule
for	O
GAS	S-Species
-	O
mediated	O
PMN	O
killing	O
.	O

Impaired	O
migration	O
of	O
PMN	O
is	O
due	O
to	O
degradation	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
by	O
serine	O
proteinase	O
ScpC	S-Biological_Molecule

Therefore	O
,	O
we	O
quantified	O
the	O
amount	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
in	O
culture	O
before	O
and	O
after	O
co	O
-	O
culture	O
with	O
clinically	O
isolated	O
GAS	S-Species
or	O
its	B-Species
mutants	E-Species
.	O

Figure	O
4B	O
shows	O
that	O
the	O
amount	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
was	O
significantly	O
reduced	O
by	O
60	O
-	O
min	O
co	O
-	O
culture	O
with	O
NIH230	S-Species
,	O
as	O
well	O
as	O
NIH230slo	S-Biological_Molecule
,	O
but	O
not	O
with	O
non	B-Species
-	I-Species
invasive	I-Species
GAS	I-Species
1556	E-Species
.	O

Enhanced	O
expression	O
of	O
the	O
slo	S-Biological_Molecule
and	O
the	O
scpC	S-Biological_Molecule
genes	O
in	O
severe	O
invasive	B-Species
GAS	E-Species
is	O
attributed	O
to	O
mutation	O
of	O
a	O
transcriptional	O
regulator	O
CsrS	S-Biological_Molecule

Although	O
sequences	O
of	O
the	O
slo	S-Biological_Molecule
gene	O
and	O
the	O
scpC	S-Biological_Molecule
gene	O
were	O
identical	O
among	O
clinically	O
isolated	O
non	B-Species
-	I-Species
invasive	E-Species
and	O
severe	O
invasive	B-Species
GAS	E-Species
(	O
data	O
not	O
shown	O
)	O
,	O
Figure	O
5A	O
shows	O
that	O
the	O
slo	S-Biological_Molecule
and	O
the	O
scpC	S-Biological_Molecule
genes	O
were	O
expressed	O
in	O
the	O
severe	O
invasive	B-Species
GAS	E-Species
greater	O
in	O
extent	O
than	O
those	O
in	O
the	O
non	B-Species
-	I-Species
invasive	I-Species
GAS	E-Species
.	O

The	O
expression	O
of	O
the	O
other	O
virulence	O
-	O
associated	O
genes	O
,	O
such	O
as	O
IgG	S-Biological_Molecule
degrading	O
protease	O
of	O
GAS	S-Biological_Molecule
,	O
Mac	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
-	O
like	O
protein	O
(	O
mac	S-Biological_Molecule
)	O
,	O
nicotine	B-Chemical_Compound
adenine	I-Chemical_Compound
dinucleotide	E-Chemical_Compound
glycohydrolase	O
(	O
nga	S-Biological_Molecule
)	O
,	O
polysaccharide	B-Chemical_Compound
capsule	E-Chemical_Compound
production	O
(	O
hasA	S-Biological_Molecule
)	O
,	O
and	O
C5a	O
peptidase	O
(	O
scpA	S-Biological_Molecule
)	O
,	O
was	O
also	O
upregulted	O
in	O
the	O
severe	O
invasive	B-Species
GAS	E-Species
,	O
greater	O
than	O
that	O
detected	O
in	O
the	O
non	B-Species
-	I-Species
invasive	I-Species
GAS	E-Species
(	O
Figure	O
5A	O
)	O
.	O

These	O
results	O
demonstrate	O
the	O
prominent	O
changes	O
in	O
the	O
transcriptional	O
profile	O
of	O
several	O
virulence	O
-	O
associated	O
genes	O
,	O
including	O
the	O
slo	S-Biological_Molecule
and	O
the	O
scpC	S-Biological_Molecule
,	O
in	O
the	O
all	O
severe	O
invasive	B-Species
GAS	E-Species
.	O

Mutation	O
of	O
csrR	S-Biological_Molecule
or	O
csrS	S-Biological_Molecule
can	O
cause	O
significant	O
alterations	O
in	O
virulence	O
in	O
mouse	S-Species
models	O
of	O
infection	O
,	O
either	O
increasing	O
lethality	O
or	O
the	O
severity	O
of	O
localized	O
soft	O
tissue	O
lesions	O
[	O
5	O
]	O
,	O
[	O
6	O
]	O
.	O

GAS	S-Species
isolates	O
from	O
mice	S-Species
with	O
severe	O
invasive	O
disease	O
had	O
mutations	O
in	O
csrS	S-Biological_Molecule
,	O
raising	O
the	O
notion	O
that	O
CsrR	S-Biological_Molecule
/	O
S	S-Biological_Molecule
function	O
is	O
important	O
in	O
modulating	O
gene	O
expression	O
during	O
infection	O
.	O

Therefore	O
,	O
we	O
analyzed	O
the	O
linkage	O
between	O
the	O
csrS	S-Biological_Molecule
and	O
/	O
or	O
csrR	S-Biological_Molecule
genes	O
and	O
the	O
property	O
of	O
invasive	B-Species
GAS	E-Species
infection	O
by	O
sequencing	O
these	O
genes	O
in	O
the	O
emm49	S-Biological_Molecule
strains	O
used	O
in	O
this	O
study	O
.	O

The	O
nucleotide	O
sequence	O
of	O
the	O
csrR	S-Biological_Molecule
gene	O
was	O
identical	O
in	O
all	O
the	O
isolates	O
,	O
and	O
that	O
of	O
the	O
csrS	S-Biological_Molecule
gene	O
was	O
identical	O
among	O
the	O
all	O
non	B-Species
-	I-Species
invasive	I-Species
GAS	E-Species
isolates	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
csrS	S-Biological_Molecule
-	O
introduced	O
severe	O
invasive	O
GAS	O
reduced	O
the	O
expression	O
levels	O
of	O
the	O
slo	S-Biological_Molecule
and	O
the	O
scpC	S-Biological_Molecule
genes	O
,	O
comparable	O
to	O
those	O
detected	O
in	O
the	O
non	B-Species
-	I-Species
invasive	I-Species
GAS	E-Species
.	O

In	O
parallel	O
with	O
the	O
expression	O
profile	O
of	O
slo	S-Biological_Molecule
and	O
scpC	S-Biological_Molecule
in	O
the	O
severe	O
invasive	B-Species
GAS	E-Species
,	O
introduction	O
of	O
the	O
intact	O
csrS	S-Biological_Molecule
gene	O
into	O
the	O
severe	O
invasive	B-Species
GAS	E-Species
restored	O
the	O
susceptibility	O
to	O
the	O
killing	O
by	O
PMN	O
(	O
p	O
=	O
0	O
.	O
015	O
compared	O
with	O
severe	O
invasive	O
isolates	O
+	O
CsrS	S-Biological_Molecule
)	O
(	O
Figure	O
6A	O
)	O
,	O
abrogated	O
the	O
inhibition	O
of	O
PMN	O
migration	O
by	O
degradation	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
(	O
p	O
=	O
0	O
.	O
002	O
compared	O
with	O
invasive	O
isolates	O
+	O
CsrS	S-Biological_Molecule
)	O
(	O
Figure	O
4A	O
,	O
4B	O
,	O
and	O
6B	O
)	O
,	O
and	O
diminished	O
the	O
killing	O
activity	O
for	O
PMN	O
by	O
necrosis	O
(	O
p	O
=	O
0	O
.	O
00016	O
compared	O
with	O
invasive	O
isolates	O
+	O
CsrS	S-Biological_Molecule
)	O
(	O
Figure	O
3A	O
,	O
3C	O
,	O
and	O
6C	O
)	O
,	O
These	O
results	O
strongly	O
suggest	O
that	O
mutations	O
in	O
the	O
csrS	S-Biological_Molecule
gene	O
correspond	O
to	O
the	O
immunocompromized	O
activity	O
in	O
the	O
severe	O
invasive	O
isolates	O
,	O
associated	O
with	O
inhibition	O
of	O
PMN	O
recruitment	O
and	O
survival	O
.	O

In	O
order	O
to	O
elucidate	O
the	O
role	O
of	O
csrS	S-Biological_Molecule
,	O
in	O
infections	O
in	O
vivo	O
,	O
we	O
compared	O
the	O
virulence	O
of	O
GAS	S-Species
isolates	O
using	O
a	O
mouse	S-Species
model	O
which	O
infected	O
GAS	S-Species
intraperitoneally	O
.	O

Consistently	O
,	O
an	O
introduction	O
of	O
the	O
intact	O
csrS	S-Biological_Molecule
gene	O
into	O
the	O
NIH230	S-Species
strain	O
(	O
NIH230	O
:	O
:	O
csrS	B-Biological_Molecule
+	E-Biological_Molecule
)	O
reduced	O
the	O
LD50	O
value	O
to	O
the	O
level	O
observed	O
in	O
the	O
non	B-Species
-	I-Species
invasive	I-Species
strain	E-Species
.	O

These	O
results	O
indicate	O
that	O
csrS	S-Biological_Molecule
is	O
an	O
important	O
virulence	O
factor	O
in	O
the	O
mouse	S-Species
model	O
of	O
lethal	O
infections	O
.	O

As	O
shown	O
in	O
Figure	O
7A	O
,	O
the	O
NIH230	S-Species
strain	O
caused	O
bacteremia	O
in	O
mice	S-Species
24	O
h	O
after	O
intraperitoneal	O
injection	O
whereas	O
the	O
bacteremia	O
was	O
barely	O
detected	O
in	O
mice	S-Species
infected	O
with	O
NIH230	O
:	O
:	O
csrS	B-Biological_Molecule
+	E-Biological_Molecule
as	O
well	O
as	O
the	O
1566	S-Species
strain	O
(	O
p	O
=	O
0	O
.	O
005	O
compared	O
with	O
non	B-Species
-	I-Species
invasive	E-Species
isolates	O
,	O
and	O
p	O
=	O
0	O
.	O
005	O
compared	O
with	O
invasive	O
isolates	O
+	O
CsrS	S-Biological_Molecule
)	O
.	O

Histopathologically	O
,	O
in	O
the	O
mice	S-Species
injected	O
with	O
the	O
NIH230	S-Species
strain	O
,	O
bacteria	O
formed	O
clusters	O
in	O
interstitial	O
tissues	O
in	O
the	O
kidneys	O
and	O
the	O
lungs	O
,	O
accompanied	O
congestion	O
and	O
no	O
inflammatory	O
cells	O
at	O
infectious	O
foci	O
(	O
Figure	O
7B	O
,	O
7C	O
and	O
data	O
not	O
shown	O
)	O
.	O

Contrarily	O
,	O
no	O
significant	O
pathological	O
alterations	O
were	O
observed	O
in	O
the	O
mice	S-Species
injected	O
with	O
the	O
1566	S-Species
and	O
NIH230	O
:	O
:	O
csrS	B-Biological_Molecule
+	E-Biological_Molecule
strains	O
(	O
Figure	O
7B	O
and	O
7C	O
)	O
.	O

Figure	O
7D	O
shows	O
that	O
subcutaneous	O
infection	O
of	O
NIH230	S-Species
formed	O
the	O
infected	O
lesions	O
with	O
area	O
significantly	O
larger	O
than	O
those	O
of	O
1566	S-Species
and	O
NIH230	O
:	O
:	O
csrS	B-Biological_Molecule
+	E-Biological_Molecule
.	O

These	O
results	O
suggest	O
that	O
the	O
invasive	B-Species
GAS	E-Species
isolates	O
are	O
more	O
virulent	O
in	O
vivo	O
than	O
non	B-Species
-	I-Species
invasive	I-Species
GAS	E-Species
,	O
and	O
impair	O
PMN	O
function	O
in	O
vivo	O
,	O
owing	O
,	O
at	O
least	O
in	O
part	O
,	O
to	O
the	O
mutations	O
in	O
the	O
csrS	S-Biological_Molecule
gene	O
.	O

Finally	O
,	O
we	O
assessed	O
the	O
influence	O
of	O
enhanced	O
expression	O
of	O
the	O
scpC	S-Biological_Molecule
or	O
the	O
slo	S-Biological_Molecule
gene	O
on	O
the	O
virulence	O
in	O
a	O
mouse	S-Species
model	O
.	O

As	O
shown	O
in	O
Table	O
1	O
,	O
NIH230scpC	S-Biological_Molecule
and	O
NIH230slo	S-Biological_Molecule
exerted	O
the	O
LD50	O
value	O
3	O
-	O
10	O
fold	O
lower	O
than	O
that	O
of	O
the	O
non	B-Species
-	I-Species
invasive	I-Species
isolate	I-Species
1566	E-Species
,	O
but	O
10	O
-	O
30	O
fold	O
higher	O
than	O
that	O
of	O
severe	O
invasive	O
isolates	O
.	O

These	O
results	O
suggest	O
that	O
enhanced	O
expression	O
of	O
ScpC	S-Biological_Molecule
and	O
SLO	S-Biological_Molecule
in	O
invasive	B-Species
GAS	E-Species
plays	O
an	O
important	O
role	O
in	O
vivo	O
virulence	O
of	O
GAS	S-Species
infection	O
.	O

Introduction	O
of	O
the	O
intact	O
csrS	S-Biological_Molecule
gene	O
into	O
the	O
severe	O
invasive	B-Species
GAS	E-Species
restored	O
the	O
susceptibility	O
to	O
the	O
killing	O
by	O
PMN	O
and	O
abrogated	O
the	O
activity	O
for	O
inhibition	O
of	O
PMN	O
recruitment	O
and	O
survival	O
,	O
thus	O
,	O
demonstrating	O
an	O
instructional	O
role	O
of	O
the	O
loss	O
-	O
of	O
-	O
functional	O
mutations	O
in	O
csrS	S-Biological_Molecule
gene	O
for	O
the	O
evasion	O
of	O
PMN	O
functions	O
,	O
providing	O
unique	O
pathophysiology	O
of	O
invasive	O
GAS	S-Species
infections	O
.	O

Then	O
we	O
further	O
examined	O
whether	O
severe	O
invasive	O
isolates	O
of	O
other	O
than	O
emm49	S-Biological_Molecule
genotype	O
have	O
the	O
mutation	O
of	O
the	O
csrS	S-Biological_Molecule
and	O
the	O
csrR	S-Biological_Molecule
genes	O
.	O

The	O
frequency	O
of	O
the	O
mutation	O
in	O
the	O
csrS	S-Biological_Molecule
gene	O
is	O
higher	O
than	O
that	O
in	O
csrR	S-Biological_Molecule
(	O
csrS	S-Biological_Molecule
mutation	O
:	O
csrR	S-Biological_Molecule
mutation	O
=	O
59	O
:	O
19	O
)	O
(	O
manuscript	O
in	O
preparation	O
)	O
,	O
suggesting	O
the	O
csrS	S-Biological_Molecule
mutation	O
is	O
more	O
important	O
in	O
comparison	O
with	O
that	O
of	O
csrR	S-Biological_Molecule
in	O
the	O
clinical	O
isolates	O
regardless	O
of	O
emm	S-Biological_Molecule
genotypes	O
.	O

This	O
dominant	O
role	O
of	O
CsrS	S-Biological_Molecule
is	O
the	O
first	O
important	O
observation	O
in	O
this	O
study	O
,	O
and	O
its	O
mutation	O
is	O
possibly	O
more	O
important	O
than	O
that	O
of	O
csrR	S-Biological_Molecule
in	O
terms	O
of	O
etiopathogenesis	O
of	O
human	S-Species
severe	O
invasive	O
diseases	O
.	O

As	O
examples	O
,	O
SpeB	S-Biological_Molecule
[	O
22	O
]	O
and	O
SLS	S-Biological_Molecule
[	O
23	O
]	O
have	O
been	O
proposed	O
as	O
an	O
invasive	O
infection	O
-	O
associated	O
factor	O
by	O
its	O
cytotoxic	O
effect	O
,	O
however	O
,	O
speB	S-Biological_Molecule
and	O
sagA	S-Biological_Molecule
expression	O
is	O
not	O
enhanced	O
in	O
any	O
csrS	S-Biological_Molecule
-	O
mutated	O
severe	O
invasive	O
GAS	O
isolate	O
used	O
in	O
this	O
study	O
and	O
others	O
[	O
5	O
]	O
,	O
[	O
24	O
]	O
.	O

Furthermore	O
,	O
SLS	S-Biological_Molecule
hemolytic	O
activity	O
of	O
invasive	B-Species
GAS	E-Species
is	O
significantly	O
decreased	O
as	O
compared	O
with	O
non	B-Species
-	I-Species
invasive	I-Species
strains	E-Species
(	O
data	O
not	O
shown	O
)	O
and	O
SLS	S-Biological_Molecule
-	O
deletion	O
in	O
invasive	O
GAS	O
did	O
not	O
affect	O
PMN	O
survival	O
at	O
all	O
,	O
excluding	O
the	O
possibility	O
for	O
the	O
role	O
of	O
SLS	S-Biological_Molecule
in	O
PMN	O
necrosis	O
seen	O
in	O
this	O
study	O
.	O

However	O
,	O
we	O
confirmed	O
that	O
addition	O
of	O
DNase	S-Biological_Molecule
in	O
the	O
culture	O
did	O
not	O
alter	O
the	O
level	O
of	O
PI	S-Chemical_Compound
-	O
positive	O
PMN	O
,	O
meaning	O
bright	O
PI	S-Chemical_Compound
staining	O
of	O
PMN	O
is	O
not	O
due	O
to	O
release	O
of	O
NETs	O
from	O
PMN	O
(	O
Figure	O
S1A	O
)	O
.	O

These	O
suggest	O
that	O
DNase	S-Biological_Molecule
may	O
be	O
important	O
but	O
redundant	O
for	O
induction	O
of	O
invasive	O
diseases	O
.	O

Therefore	O
,	O
the	O
second	O
important	O
observation	O
in	O
the	O
present	O
study	O
is	O
that	O
an	O
essential	O
requirement	O
of	O
csrS	S-Biological_Molecule
mutation	O
for	O
invasive	O
infection	O
is	O
associated	O
with	O
increased	O
expression	O
of	O
ScpC	S-Biological_Molecule
and	O
SLO	S-Biological_Molecule
and	O
in	O
vitro	O
evasion	O
of	O
PMN	O
functions	O
,	O
though	O
we	O
do	O
not	O
exclude	O
the	O
possibility	O
that	O
other	O
CsrS	S-Biological_Molecule
-	O
regulating	O
factors	O
contribute	O
to	O
the	O
escape	O
of	O
invasive	B-Species
GAS	E-Species
from	O
host	O
defense	O
.	O

SLO	S-Biological_Molecule
and	O
ScpC	S-Biological_Molecule
independently	O
enable	O
GAS	S-Species
to	O
escape	O
from	O
PMN	O
functions	O
;	O
Present	O
data	O
using	O
clinical	O
isolated	O
GAS	S-Species
and	O
a	O
scpC	S-Biological_Molecule
-	O
deletion	O
mutant	O
(	O
Figure	O
4A	O
and	O
4B	O
)	O
show	O
that	O
enhanced	O
production	O
of	O
serine	O
proteinase	O
ScpC	S-Biological_Molecule
in	O
virulent	O
GAS	S-Species
is	O
essential	O
to	O
impair	O
PMN	O
migration	O
in	O
vitro	O
by	O
degradation	O
of	O
IL	B-Biological_Molecule
-	I-Biological_Molecule
8	E-Biological_Molecule
,	O
as	O
others	O
partially	O
have	O
demonstrated	O
[	O
17	O
]	O
-	O
[	O
19	O
]	O
.	O

The	O
present	O
study	O
also	O
uncovers	O
that	O
increased	O
activity	O
of	O
SLO	S-Biological_Molecule
from	O
invasive	O
GAS	S-Species
isolates	O
induces	O
rapid	O
and	O
extensive	O
necrosis	O
to	O
human	S-Species
PMN	O
.	O

SLO	S-Biological_Molecule
is	O
a	O
cholesterol	S-Chemical_Compound
-	O
binding	O
pore	O
-	O
forming	O
hemolysin	O
as	O
well	O
as	O
cytotoxic	O
for	O
other	O
cells	O
[	O
15	O
]	O
.	O

A	O
study	O
has	O
demonstrated	O
SLO	S-Biological_Molecule
from	O
invasive	O
GAS	S-Species
lyse	O
PMN	O
[	O
27	O
]	O
,	O
however	O
this	O
effect	O
is	O
likely	O
due	O
to	O
complement	O
activation	O
by	O
SLO	S-Biological_Molecule
[	O
28	O
]	O
or	O
PMN	O
activation	O
[	O
29	O
]	O
but	O
not	O
due	O
to	O
cytotoxity	O
of	O
SLO	S-Biological_Molecule
itself	O
as	O
judged	O
by	O
their	O
flow	O
cytometry	O
profiles	O
which	O
are	O
distinct	O
from	O
ours	O
(	O
Figure	O
2A	O
)	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
observed	O
that	O
SLO	S-Biological_Molecule
concentration	O
in	O
a	O
short	O
-	O
time	O
culture	O
with	O
severe	O
invasive	B-Species
GAS	E-Species
did	O
not	O
reach	O
the	O
threshold	O
level	O
to	O
kill	O
PMN	O
by	O
formation	O
of	O
pores	O
(	O
data	O
not	O
shown	O
)	O
and	O
that	O
PMN	O
did	O
not	O
undergo	O
necrosis	O
upon	O
incubation	O
with	O
culture	O
media	O
of	O
severe	O
invasive	B-Species
GAS	E-Species
(	O
Figure	O
3B	O
)	O
,	O
leading	O
to	O
the	O
novel	O
possibility	O
that	O
PMN	O
are	O
probably	O
killed	O
following	O
encounter	O
with	O
invasive	B-Species
GAS	E-Species
in	O
a	O
contact	O
-	O
dependent	O
manner	O
.	O

Collaboration	O
of	O
SLO	S-Biological_Molecule
with	O
other	O
toxins	O
may	O
be	O
critical	O
to	O
induce	O
PMN	O
necrosis	O
as	O
similarly	O
mechanism	O
has	O
been	O
reported	O
[	O
31	O
]	O
,	O
although	O
it	O
remains	O
to	O
be	O
examined	O
whether	O
there	O
exist	O
explore	O
interaction	O
-	O
associated	O
molecules	O
on	O
both	O
host	O
and	O
bacterial	O
membrane	O
is	O
needed	O
.	O

In	O
contrast	O
to	O
the	O
previous	O
view	O
[	O
18	O
]	O
,	O
we	O
observed	O
that	O
both	O
of	O
ScpC	S-Biological_Molecule
and	O
SLO	S-Biological_Molecule
together	O
,	O
but	O
not	O
each	O
of	O
them	O
,	O
mediated	O
sufficient	O
in	O
vivo	O
virulence	O
(	O
Table	O
1	O
)	O
,	O
thus	O
compatible	O
with	O
the	O
notion	O
that	O
plural	O
virulence	O
-	O
associated	O
factors	O
under	O
the	O
regulation	O
of	O
csrS	S-Biological_Molecule
abrogate	O
PMN	O
bactericidal	O
functions	O
and	O
induce	O
invasive	O
diseases	O
in	O
in	O
vivo	O
animal	O
model	O
.	O

Consistently	O
,	O
the	O
high	O
mortality	O
and	O
histopathological	O
findings	O
which	O
lacks	O
PMN	O
infiltration	O
in	O
mice	S-Species
tissues	O
infected	O
with	O
csrS	S-Biological_Molecule
-	O
mutated	O
GAS	O
(	O
Figure	O
7	O
)	O
are	O
similar	O
to	O
those	O
seen	O
in	O
clinical	O
invasive	B-Species
GAS	E-Species
infections	O
[	O
32	O
]	O
.	O

These	O
evidences	O
suggest	O
that	O
the	O
level	O
of	O
PMN	O
function	O
is	O
one	O
of	O
the	O
critical	O
factors	O
to	O
determine	O
the	O
threshold	O
for	O
the	O
onset	O
of	O
invasive	B-Species
GAS	E-Species
infection	O
,	O
which	O
may	O
be	O
the	O
reason	O
for	O
rare	O
outbreaks	O
of	O
invasive	B-Species
GAS	E-Species
infections	O
.	O

A	O
further	O
study	O
in	O
which	O
collates	O
clinical	O
with	O
bacterial	O
/	O
immunological	O
data	O
may	O
provide	O
with	O
novel	O
clues	O
for	O
early	O
diagnosis	O
and	O
therapeutics	O
of	O
invasive	O
bacterial	O
infections	O
.	O

Biofilms	O
are	O
surface	O
-	O
adhered	O
bacterial	O
communities	O
encased	O
in	O
an	O
extracellular	O
matrix	O
composed	O
of	O
DNA	O
,	O
bacterial	O
polysaccharides	O
and	O
proteins	O
,	O
which	O
are	O
up	O
to	O
1000	O
-	O
fold	O
more	O
antibiotic	O
resistant	O
than	O
planktonic	O
cultures	O
.	O

To	O
date	O
,	O
extracellular	O
DNA	O
has	O
been	O
shown	O
to	O
function	O
as	O
a	O
structural	O
support	O
to	O
maintain	O
Pseudomonas	B-Species
aeruginosa	E-Species
biofilm	O
architecture	O
.	O

Here	O
we	O
show	O
that	O
DNA	O
is	O
a	O
multifaceted	O
component	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
biofilms	O
.	O

At	O
physiologically	O
relevant	O
concentrations	O
,	O
extracellular	O
DNA	O
has	O
antimicrobial	O
activity	O
,	O
causing	O
cell	O
lysis	O
by	O
chelating	O
cations	O
that	O
stabilize	O
lipopolysaccharide	S-Chemical_Compound
(	O
LPS	S-Chemical_Compound
)	O
and	O
the	O
outer	O
membrane	O
(	O
OM	O
)	O
.	O

DNA	O
-	O
mediated	O
killing	O
occurred	O
within	O
minutes	O
,	O
as	O
a	O
result	O
of	O
perturbation	O
of	O
both	O
the	O
outer	O
and	O
inner	O
membrane	O
(	O
IM	O
)	O
and	O
the	O
release	O
of	O
cytoplasmic	O
contents	O
,	O
including	O
genomic	O
DNA	O
.	O

Sub	O
-	O
inhibitory	O
concentrations	O
of	O
DNA	O
created	O
a	O
cation	O
-	O
limited	O
environment	O
that	O
resulted	O
in	O
induction	O
of	O
the	O
PhoPQ	S-Biological_Molecule
-	O
and	O
PmrAB	S-Biological_Molecule
-	O
regulated	O
cationic	O
antimicrobial	O
peptide	O
resistance	O
operon	O
PA3552	S-Biological_Molecule
-	O
PA3559	S-Biological_Molecule
in	O
P	B-Species
.	I-Species
aeruginosa	E-Species
.	O

Furthermore	O
,	O
DNA	O
-	O
induced	O
expression	O
of	O
this	O
operon	O
resulted	O
in	O
up	O
to	O
2560	O
-	O
fold	O
increased	O
resistance	O
to	O
cationic	O
antimicrobial	O
peptides	O
and	O
640	O
-	O
fold	O
increased	O
resistance	O
to	O
aminoglycosides	S-Chemical_Compound
,	O
but	O
had	O
no	O
effect	O
on	O
beta	B-Chemical_Compound
-	I-Chemical_Compound
lactam	E-Chemical_Compound
and	O
fluoroquinolone	S-Chemical_Compound
resistance	O
.	O

The	O
biofilm	O
-	O
forming	O
ability	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
,	O
and	O
indeed	O
other	O
bacteria	O
,	O
is	O
thought	O
to	O
contribute	O
to	O
their	O
ability	O
to	O
thrive	O
in	O
hostile	O
host	O
environments	O
and	O
result	O
in	O
chronic	O
infection	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
.	O

Biofilms	O
are	O
multicellular	O
surface	O
-	O
associated	O
microbial	O
communities	O
encased	O
in	O
an	O
extracellular	O
matrix	O
which	O
display	O
a	O
characteristic	O
structure	O
and	O
increased	O
resistance	O
to	O
antimicrobial	O
compounds	O
and	O
environmental	O
stresses	O
.	O

As	O
acute	O
CF	O
exacerbations	O
caused	O
by	O
P	B-Species
.	I-Species
aeruginosa	E-Species
are	O
often	O
treated	O
with	O
combination	O
antibiotic	O
therapy	O
[	O
8	O
]	O
-	O
[	O
10	O
]	O
,	O
the	O
increased	O
resistance	O
of	O
biofilms	O
to	O
combination	O
antibiotics	O
is	O
of	O
direct	O
clinical	O
relevance	O
.	O

Eighty	O
five	O
percent	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
strains	O
isolated	O
from	O
the	O
lungs	O
of	O
CF	O
patients	S-Species
with	O
advanced	O
stages	O
of	O
disease	O
have	O
a	O
distinctive	O
mucoid	O
colony	O
morphology	O
[	O
11	O
]	O
.	O

This	O
mucoid	O
phenotype	O
is	O
a	O
result	O
of	O
overproduction	O
of	O
the	O
alginate	B-Chemical_Compound
exopolysaccharide	E-Chemical_Compound
(	O
EPS	S-Chemical_Compound
)	O
[	O
1	O
]	O
,	O
[	O
12	O
]	O
.	O

The	O
direct	O
observation	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
microcolonies	O
encased	O
in	O
an	O
alginate	S-Chemical_Compound
matrix	O
in	O
microscopy	O
studies	O
of	O
CF	O
bronchial	O
samples	O
[	O
17	O
]	O
,	O
along	O
with	O
a	O
large	O
body	O
of	O
additional	O
in	O
vitro	O
and	O
in	O
vivo	O
data	O
[	O
7	O
]	O
,	O
[	O
18	O
]	O
-	O
[	O
21	O
]	O
suggests	O
that	O
P	B-Species
.	I-Species
aeruginosa	E-Species
forms	O
biofilms	O
in	O
the	O
lungs	O
of	O
CF	O
patients	S-Species
.	O

The	O
mechanisms	O
of	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
are	O
distinct	O
from	O
the	O
well	O
studied	O
intrinsic	O
resistance	O
mechanisms	O
such	O
as	O
drug	O
efflux	O
,	O
drug	O
inactivation	O
,	O
membrane	O
permeability	O
and	O
target	O
site	O
alterations	O
.	O

Although	O
the	O
basis	O
of	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
is	O
not	O
fully	O
understood	O
,	O
it	O
is	O
likely	O
that	O
multiple	O
mechanisms	O
operate	O
simultaneously	O
in	O
biofilms	O
to	O
contribute	O
to	O
antibiotic	O
resistance	O
.	O

It	O
is	O
the	O
general	O
consensus	O
that	O
reduced	O
diffusion	O
through	O
the	O
biofilm	O
matrix	O
only	O
provides	O
a	O
short	O
-	O
term	O
protective	O
effect	O
and	O
does	O
not	O
play	O
a	O
significant	O
role	O
during	O
long	O
-	O
term	O
antibiotic	O
exposure	O
[	O
26	O
]	O
.	O

Despite	O
the	O
fact	O
that	O
biofilms	O
are	O
recognized	O
as	O
the	O
predominant	O
mode	O
of	O
bacterial	O
growth	O
in	O
nature	O
and	O
are	O
responsible	O
for	O
the	O
majority	O
of	O
refractory	O
bacterial	O
infections	O
[	O
19	O
]	O
,	O
little	O
is	O
known	O
regarding	O
the	O
mechanisms	O
of	O
biofilm	O
-	O
specific	O
antibiotic	O
resistance	O
.	O

Signal	O
transduction	O
systems	O
have	O
been	O
documented	O
to	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
biofilm	O
formation	O
in	O
multiple	O
bacterial	O
species	O
including	O
P	B-Species
.	I-Species
aeruginosa	E-Species
,	O
S	B-Species
.	I-Species
aureus	E-Species
,	O
E	B-Species
.	I-Species
coli	E-Species
and	O
V	B-Species
.	I-Species
fischeri	E-Species
[	O
33	O
]	O
-	O
[	O
38	O
]	O
.	O

These	O
two	O
component	O
systems	O
(	O
TCS	O
)	O
are	O
comprised	O
of	O
an	O
membrane	O
-	O
anchored	O
histidine	O
kinase	O
sensor	O
and	O
a	O
cytoplasmic	O
response	O
regulator	O
.	O

Additionally	O
,	O
the	O
hybrid	O
sensor	O
kinases	O
,	O
LadS	S-Biological_Molecule
and	O
RetS	S-Biological_Molecule
appear	O
to	O
work	O
upstream	O
of	O
GacA	S-Biological_Molecule
to	O
possibly	O
control	O
the	O
switch	O
to	O
a	O
biofilm	O
lifestyle	O
[	O
34	O
]	O
,	O
[	O
35	O
]	O
.	O

CAPs	S-Chemical_Compound
are	O
short	O
,	O
amphipathic	O
peptides	O
that	O
bind	O
to	O
and	O
disrupt	O
both	O
the	O
outer	O
and	O
cytoplasmic	O
membranes	O
resulting	O
in	O
cell	O
death	O
.	O

The	O
broad	O
-	O
spectrum	O
antimicrobial	O
activity	O
of	O
CAPs	S-Chemical_Compound
against	O
Gram	O
-	O
negative	O
and	O
Gram	O
-	O
positive	O
bacteria	O
accounts	O
for	O
their	O
role	O
as	O
an	O
essential	O
component	O
of	O
the	O
innate	O
immune	O
response	O
of	O
humans	S-Species
,	O
animals	O
and	O
insects	O
.	O

Cationic	O
peptides	O
,	O
which	O
have	O
antimicrobial	O
and	O
immunomodulatory	O
activities	O
,	O
are	O
being	O
developed	O
as	O
a	O
promising	O
new	O
class	O
of	O
therapeutically	O
relevant	O
drugs	O
[	O
42	O
]	O
.	O

In	O
P	B-Species
.	I-Species
aeruginosa	E-Species
,	O
resistance	O
to	O
CAPs	S-Chemical_Compound
is	O
inducible	O
by	O
the	O
PhoPQ	S-Biological_Molecule
and	O
PmrAB	S-Biological_Molecule
TCSs	O
,	O
both	O
of	O
which	O
are	O
activated	O
independently	O
in	O
response	O
to	O
limiting	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
[	O
43	O
]	O
-	O
[	O
46	O
]	O
.	O

Under	O
conditions	O
of	O
limiting	O
magnesium	S-Chemical_Compound
,	O
PhoP	S-Biological_Molecule
and	O
PmrA	S-Biological_Molecule
bind	O
to	O
the	O
promoter	O
of	O
the	O
CAP	S-Chemical_Compound
resistance	O
operon	O
PA3552	S-Biological_Molecule
-	O
PA3559	S-Biological_Molecule
(	O
arnBCADTEF	S-Biological_Molecule
-	O
ugd	S-Biological_Molecule
)	O
and	O
induce	O
its	O
expression	O
[	O
45	O
]	O
-	O
[	O
47	O
]	O
.	O

The	O
PhoPQ	S-Biological_Molecule
and	O
PmrAB	S-Biological_Molecule
regulatory	O
systems	O
are	O
well	O
studied	O
in	O
planktonic	O
cultures	O
and	O
have	O
been	O
shown	O
to	O
induce	O
modest	O
resistance	O
to	O
CAPs	S-Chemical_Compound
(	O
8	O
-	O
fold	O
)	O
under	O
low	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
conditions	O
[	O
45	O
]	O
.	O

However	O
,	O
while	O
the	O
PA3552	S-Biological_Molecule
-	O
PA3559	S-Biological_Molecule
operon	O
has	O
been	O
reported	O
to	O
be	O
expressed	O
in	O
biofilms	O
cultivated	O
in	O
flowcells	O
,	O
and	O
is	O
required	O
for	O
survival	O
in	O
response	O
to	O
colistin	O
treatment	O
[	O
49	O
]	O
,	O
little	O
else	O
is	O
known	O
regarding	O
these	O
systems	O
and	O
the	O
role	O
they	O
may	O
play	O
in	O
biofilm	O
-	O
associated	O
antibiotic	O
resistance	O
.	O

The	O
extracellular	O
matrix	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
biofilms	O
includes	O
extracellular	O
DNA	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
,	O
multiple	O
bacterial	O
exopolysaccharides	S-Chemical_Compound
and	O
host	O
proteins	O
[	O
4	O
]	O
,	O
[	O
52	O
]	O
.	O

It	O
has	O
been	O
reported	O
that	O
prophage	O
-	O
mediated	O
cell	O
death	O
is	O
an	O
important	O
mechanism	O
in	O
the	O
differentiation	O
and	O
dispersal	O
of	O
biofilms	O
[	O
54	O
]	O
,	O
[	O
55	O
]	O
.	O

In	O
this	O
study	O
we	O
sought	O
to	O
examine	O
if	O
the	O
presence	O
of	O
DNA	O
in	O
biofilms	O
may	O
contribute	O
to	O
biofilm	O
-	O
specific	O
antibiotic	O
resistance	O
.	O

Results	O

Addition	O
of	O
0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
(	O
5	O
mg	O
/	O
ml	O
)	O
or	O
greater	O
extracellular	O
DNA	O
to	O
LB	O
or	O
1	O
%	O
(	O
w	O
/	O
v	O
)	O
or	O
greater	O
DNA	O
to	O
BM2	O
media	O
inhibited	O
growth	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
(	O
Fig	O
1A	O
and	O
1B	O
)	O
.	O

Extracellular	O
DNA	O
induces	O
cell	O
death	O
by	O
membrane	O
perturbation	O
and	O
cell	O
lysis	O

DNA	O
is	O
a	O
highly	O
anionic	O
polymer	O
due	O
to	O
the	O
phosphates	O
in	O
the	O
deoxyribose	O
backbone	O
.	O

This	O
property	O
,	O
in	O
combination	O
with	O
the	O
fast	O
-	O
killing	O
observed	O
in	O
response	O
to	O
extracellular	O
DNA	O
led	O
us	O
to	O
hypothesize	O
that	O
addition	O
of	O
exogenous	O
DNA	O
resulted	O
in	O
the	O
loss	O
of	O
membrane	O
integrity	O
through	O
cation	O
chelation	O
,	O
in	O
a	O
manner	O
similar	O
to	O
that	O
observed	O
with	O
the	O
known	O
cation	O
chelator	O
EDTA	S-Chemical_Compound
[	O
58	O
]	O
.	O

To	O
determine	O
the	O
effect	O
of	O
DNA	O
on	O
membrane	O
integrity	O
,	O
microscopic	O
analysis	O
in	O
response	O
to	O
lethal	O
concentrations	O
of	O
DNA	O
and	O
relevant	O
controls	O
was	O
performed	O
.	O

Lipoproteins	O
are	O
lipid	O
-	O
modified	O
proteins	O
anchored	O
in	O
the	O
outer	O
leaflet	O
of	O
the	O
IM	O
or	O
the	O
inner	O
leaflet	O
of	O
the	O
OM	O
.	O

P	B-Species
.	I-Species
aeruginosa	E-Species
cells	O
producing	O
mCherry	O
fluorescent	O
membrane	O
-	O
anchored	O
lipoproteins	O
(	O
lipoChFP	O
)	O
that	O
are	O
localized	O
to	O
either	O
the	O
OM	O
or	O
IM	O
[	O
60	O
]	O
,	O
[	O
61	O
]	O
were	O
used	O
as	O
markers	O
of	O
OM	O
and	O
IM	O
integrity	O
.	O

Propidium	B-Chemical_Compound
iodide	E-Chemical_Compound
(	O
PI	S-Chemical_Compound
)	O
stains	O
extracellular	O
DNA	O
and	O
DNA	O
in	O
dead	O
cells	O
.	O

PI	S-Chemical_Compound
staining	O
also	O
revealed	O
the	O
presence	O
of	O
long	O
strands	O
of	O
genomic	O
DNA	O
,	O
presumably	O
as	O
a	O
consequence	O
of	O
the	O
loss	O
of	O
membrane	O
integrity	O
,	O
cell	O
lysis	O
and	O
release	O
of	O
cytoplasmic	O
contents	O
,	O
including	O
DNA	O
(	O
Fig	O
2B	O
)	O
.	O

The	O
DNA	O
released	O
by	O
lysed	O
cells	O
formed	O
a	O
mesh	O
-	O
like	O
coating	O
surrounding	O
and	O
connecting	O
individual	O
bacterial	O
cells	O
(	O
Fig	O
2B	O
)	O
.	O

DNA	O
has	O
cation	O
chelating	O
activity	O

The	O
rapidity	O
of	O
DNA	O
-	O
induced	O
cell	O
death	O
ruled	O
out	O
the	O
possibility	O
that	O
death	O
,	O
or	O
lack	O
of	O
growth	O
,	O
was	O
simply	O
due	O
to	O
cation	O
starvation	O
.	O

Addition	O
of	O
excess	O
cations	O
to	O
planktonic	O
cultures	O
inhibited	O
the	O
fast	O
-	O
acting	O
antimicrobial	O
effects	O
of	O
DNA	O
(	O
Fig	O
3A	O
)	O
.	O

The	O
concentration	O
at	O
which	O
maximal	O
protection	O
was	O
obtained	O
for	O
each	O
cation	O
is	O
represented	O
in	O
Fig	O
3A	O
(	O
25	O
mM	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
;	O
6	O
.	O
25	O
mM	O
Ca2	B-Chemical_Compound
+	E-Chemical_Compound
;	O
6	O
.	O
25	O
Mn2	B-Chemical_Compound
+	E-Chemical_Compound
;	O
3	O
.	O
125	O
mM	O
Zn2	B-Chemical_Compound
+	E-Chemical_Compound
)	O
.	O

Kill	O
curve	O
assays	O
indicated	O
that	O
the	O
addition	O
of	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
,	O
Ca2	B-Chemical_Compound
+	E-Chemical_Compound
or	O
Mn2	B-Chemical_Compound
+	E-Chemical_Compound
provided	O
protection	O
from	O
DNA	O
-	O
induced	O
lysis	O
,	O
however	O
,	O
the	O
addition	O
of	O
Zn2	B-Chemical_Compound
+	E-Chemical_Compound
did	O
not	O
protect	O
from	O
DNA	O
-	O
mediated	O
killing	O
(	O
Fig	O
3A	O
)	O
.	O

The	O
increased	O
protection	O
observed	O
following	O
addition	O
of	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
and	O
Ca2	B-Chemical_Compound
+	E-Chemical_Compound
is	O
likely	O
due	O
to	O
their	O
importance	O
in	O
membrane	O
integrity	O
where	O
they	O
function	O
to	O
stabilize	O
the	O
OM	O
by	O
crosslinking	O
adjacent	O
LPS	S-Chemical_Compound
molecules	O
[	O
58	O
]	O
.	O

These	O
genes	O
encode	O
an	O
LPS	S-Chemical_Compound
modification	O
pathway	O
required	O
for	O
the	O
addition	O
of	O
aminoarabinose	O
to	O
lipid	B-Chemical_Compound
A	E-Chemical_Compound
,	O
which	O
reduces	O
the	O
OM	O
permeability	O
to	O
CAPs	S-Chemical_Compound
,	O
thus	O
conferring	O
resistance	O
[	O
48	O
]	O
.	O

Addition	O
of	O
excess	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
(	O
5	O
mM	O
)	O
to	O
the	O
growth	O
medium	O
completely	O
repressed	O
the	O
expression	O
of	O
PA3553	S-Biological_Molecule
in	O
cultures	O
supplemented	O
with	O
DNA	O
,	O
except	O
at	O
the	O
highest	O
DNA	O
concentration	O
tested	O
(	O
0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
)	O
(	O
Fig	O
4B	O
)	O
.	O

A	O
similar	O
induction	O
profile	O
of	O
PA3553	S-Biological_Molecule
:	O
:	O
lux	S-Biological_Molecule
was	O
observed	O
following	O
exposure	O
to	O
high	O
molecular	O
weight	O
P	B-Species
.	I-Species
aeruginosa	E-Species
genomic	O
DNA	O
(	O
not	O
shown	O
)	O
or	O
P	B-Species
.	I-Species
aeruginosa	E-Species
genomic	O
DNA	O
that	O
was	O
mechanically	O
sheared	O
by	O
sonication	O
(	O
Fig	O
4C	O
)	O
.	O

Thus	O
,	O
the	O
ability	O
of	O
extracellular	O
DNA	O
to	O
chelate	O
magnesium	S-Chemical_Compound
is	O
independent	O
of	O
origin	O
and	O
molecular	O
weight	O
,	O
indicating	O
that	O
chelation	O
is	O
a	O
general	O
property	O
of	O
this	O
negatively	O
charged	O
polymer	O
.	O

However	O
the	O
addition	O
of	O
DNAse	O
buffer	O
to	O
cells	O
in	O
our	O
buffer	O
control	O
experiment	O
also	O
abolished	O
induction	O
of	O
PA3553	S-Biological_Molecule
.	O

Thus	O
,	O
it	O
is	O
impossible	O
to	O
determine	O
conclusively	O
if	O
DNAse	O
treatment	O
of	O
DNA	O
abolished	O
PA3553	S-Biological_Molecule
gene	O
expression	O
.	O

Expression	O
of	O
the	O
CAP	S-Chemical_Compound
resistance	O
operon	O
PA3552	S-Biological_Molecule
-	O
PA3559	S-Biological_Molecule
is	O
induced	O
in	O
biofilms	O
in	O
response	O
to	O
extracellular	O
DNA	O

Double	O
staining	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
with	O
syto9	S-Chemical_Compound
(	O
stains	O
viable	O
cells	O
green	O
)	O
and	O
the	O
extracellular	O
DNA	O
stain	O
DDAO	S-Chemical_Compound
(	O
red	O
)	O
[	O
51	O
]	O
was	O
used	O
to	O
visualize	O
DNA	O
as	O
a	O
loose	O
lattice	O
in	O
biofilms	O
formed	O
on	O
polystyrene	S-Chemical_Compound
pegs	O
after	O
24	O
h	O
(	O
Fig	O
5A	O
)	O
.	O

DNA	O
was	O
also	O
visualized	O
(	O
PI	S-Chemical_Compound
stained	O
)	O
as	O
a	O
mesh	O
-	O
like	O
DNA	O
matrix	O
in	O
1	O
day	O
-	O
old	O
peg	O
-	O
adhered	O
biofilm	O
monolayers	O
(	O
Fig	O
5B	O
)	O
,	O
which	O
resembled	O
the	O
thread	O
-	O
like	O
projections	O
of	O
genomic	O
DNA	O
observed	O
in	O
DNA	O
or	O
EDTA	S-Chemical_Compound
-	O
lysed	O
cells	O
(	O
Fig	O
2B	O
)	O
.	O

One	O
-	O
day	O
old	O
PA3553	S-Biological_Molecule
:	O
:	O
lux	S-Biological_Molecule
biofilms	O
were	O
washed	O
to	O
remove	O
non	O
-	O
adhered	O
cells	O
and	O
gene	O
expression	O
was	O
measured	O
from	O
the	O
cells	O
adhered	O
to	O
the	O
polystyrene	S-Chemical_Compound
peg	O
surface	O
.	O

PA3553	S-Biological_Molecule
gene	O
expression	O
was	O
strongly	O
induced	O
,	O
up	O
to	O
20	O
-	O
fold	O
,	O
in	O
peg	O
-	O
adhered	O
biofilms	O
,	O
with	O
the	O
highest	O
induction	O
at	O
0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
extracellular	O
DNA	O
(	O
Fig	O
6B	O
)	O
.	O

Although	O
gene	O
expression	O
was	O
measured	O
in	O
a	O
mutant	O
background	O
,	O
both	O
PAO1	S-Species
and	O
PA3553	S-Biological_Molecule
:	O
:	O
lux	S-Biological_Molecule
had	O
similar	O
biofilm	O
phenotypes	O
in	O
each	O
condition	O
tested	O
(	O
Fig	O
6A	O
)	O
.	O

DNA	O
chelation	O
of	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
,	O
Ca2	B-Chemical_Compound
+	E-Chemical_Compound
or	O
Mn2	B-Chemical_Compound
+	E-Chemical_Compound
but	O
not	O
Zn2	B-Chemical_Compound
+	E-Chemical_Compound
induces	O
PA3553	S-Biological_Molecule
expression	O

At	O
lethal	O
concentrations	O
,	O
extracellular	O
DNA	O
induced	O
cell	O
lysis	O
by	O
chelating	O
cations	O
from	O
the	O
OM	O
.	O

DNA	O
was	O
capable	O
of	O
binding	O
all	O
four	O
cations	O
at	O
similar	O
levels	O
(	O
80	O
-	O
88	O
%	O
)	O
,	O
whether	O
alone	O
(	O
Fig	O
7A	O
)	O
or	O
in	O
combination	O
(	O
data	O
not	O
shown	O
)	O
.	O

To	O
ensure	O
binding	O
was	O
specific	O
to	O
DNA	O
a	O
negative	O
control	O
was	O
included	O
.	O

The	O
P	B-Species
.	I-Species
aeruginosa	E-Species
PhoQ	S-Biological_Molecule
sensor	O
kinase	O
protein	O
has	O
been	O
shown	O
to	O
bind	O
to	O
and	O
be	O
repressed	O
by	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
and	O
Ca2	B-Chemical_Compound
+	E-Chemical_Compound
cations	O
[	O
63	O
]	O
,	O
[	O
64	O
]	O
.	O

DNA	O
-	O
enriched	O
biofilms	O
were	O
dramatically	O
more	O
resistant	O
than	O
planktonic	O
cultures	O
,	O
up	O
to	O
256	O
-	O
fold	O
,	O
and	O
this	O
resistance	O
phenotype	O
to	O
CAPs	S-Chemical_Compound
and	O
aminoglycosides	S-Chemical_Compound
was	O
also	O
observed	O
in	O
planktonic	O
cultures	O
supplemented	O
with	O
DNA	O
.	O

The	O
simple	O
addition	O
of	O
sub	O
-	O
inhibitory	O
DNA	O
amounts	O
to	O
planktonic	O
cultures	O
closely	O
simulated	O
the	O
resistance	O
-	O
inducing	O
effects	O
of	O
DNA	O
in	O
a	O
biofilm	O
(	O
Table	O
1	O
)	O
.	O

The	O
MIC	O
values	O
for	O
polymyxin	B-Chemical_Compound
B	E-Chemical_Compound
and	O
gentamicin	S-Chemical_Compound
are	O
equal	O
to	O
1	O
microg	O
/	O
ml	O
and	O
2	O
microg	O
/	O
ml	O
,	O
respectively	O
,	O
using	O
the	O
standard	O
microbroth	O
dilution	O
method	O
for	O
antimicrobial	O
susceptibility	O
testing	O
(	O
National	O
Committee	O
on	O
Clinical	O
Laboratory	O
Standards	O
(	O
NCCLS	O
)	O
protocol	O
)	O
(	O
data	O
not	O
shown	O
)	O
.	O

Thus	O
,	O
depending	O
on	O
the	O
method	O
used	O
to	O
determine	O
the	O
MIC	O
(	O
CBD	O
or	O
NCCLS	O
protocol	O
)	O
,	O
DNA	O
-	O
enriched	O
biofilms	O
can	O
be	O
up	O
to	O
2560	O
-	O
fold	O
more	O
polymyxin	B-Chemical_Compound
B	E-Chemical_Compound
resistant	O
and	O
up	O
to	O
640	O
-	O
fold	O
more	O
aminoglycoside	S-Chemical_Compound
resistant	O
than	O
planktonic	O
cultures	O
.	O

DNA	O
-	O
enriched	O
biofilms	O
did	O
not	O
show	O
an	O
increased	O
tolerance	O
to	O
ceftazidime	S-Chemical_Compound
(	O
beta	B-Chemical_Compound
-	I-Chemical_Compound
lactam	E-Chemical_Compound
)	O
or	O
ciprofloxacin	S-Chemical_Compound
(	O
fluoroquinolone	S-Chemical_Compound
)	O
(	O
data	O
not	O
shown	O
)	O
.	O

Since	O
extracellular	O
DNA	O
is	O
a	O
natural	O
matrix	O
component	O
of	O
PAO1	S-Species
biofilms	O
(	O
Fig	O
5A	O
and	O
5B	O
)	O
,	O
DNA	O
-	O
induced	O
antibiotic	O
resistance	O
is	O
likely	O
to	O
be	O
a	O
phenomenon	O
unique	O
to	O
biofilms	O
or	O
other	O
DNA	O
rich	O
environments	O
.	O

We	O
have	O
shown	O
previously	O
that	O
the	O
PA3552	S-Biological_Molecule
-	O
PA3559	S-Biological_Molecule
operon	O
is	O
required	O
for	O
resistance	O
to	O
cationic	O
antimicrobial	O
peptides	O
in	O
planktonic	O
cultures	O
grown	O
in	O
limiting	O
magnesium	S-Chemical_Compound
conditions	O
[	O
47	O
]	O
.	O

To	O
determine	O
if	O
DNA	O
-	O
induced	O
resistance	O
requires	O
these	O
genes	O
in	O
biofilms	O
,	O
the	O
resistance	O
phenotype	O
of	O
the	O
PA3553	S-Biological_Molecule
:	O
:	O
lux	S-Biological_Molecule
mutant	O
was	O
determined	O
.	O

The	O
biofilms	O
formed	O
by	O
the	O
PA3553	S-Biological_Molecule
:	O
:	O
lux	S-Biological_Molecule
mutant	O
were	O
unaltered	O
compared	O
to	O
PAO1	S-Species
biofilms	O
under	O
these	O
conditions	O
,	O
ensuring	O
that	O
the	O
difference	O
observed	O
was	O
not	O
due	O
to	O
an	O
altered	O
biofilm	O
phenotype	O
(	O
Fig	O
6B	O
)	O
.	O

The	O
CAP	S-Chemical_Compound
resistance	O
phenotype	O
of	O
biofilms	O
grown	O
in	O
limiting	O
magnesium	S-Chemical_Compound
(	O
20	O
microM	O
)	O
was	O
similar	O
to	O
biofilms	O
grown	O
in	O
DNA	O
,	O
confirming	O
that	O
DNA	O
imposes	O
a	O
magnesium	S-Chemical_Compound
limitation	O
stress	O
(	O
Table	O
2	O
)	O
.	O

Therefore	O
,	O
the	O
DNA	O
-	O
induced	O
resistance	O
of	O
biofilms	O
requires	O
both	O
the	O
cultivation	O
and	O
challenge	O
under	O
cation	O
-	O
limiting	O
conditions	O
.	O

Discussion	O

The	O
ability	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
to	O
form	O
biofilms	O
promotes	O
survival	O
of	O
the	O
bacteria	O
in	O
the	O
presence	O
of	O
antimicrobials	O
and	O
host	O
defense	O
mechanisms	O
and	O
is	O
thought	O
to	O
contribute	O
significantly	O
to	O
its	O
ability	O
to	O
survive	O
long	O
-	O
term	O
within	O
the	O
hostile	O
environment	O
of	O
chronically	O
-	O
infected	O
patients	S-Species
.	O

Understanding	O
the	O
mechanisms	O
underlying	O
antibiotic	O
resistance	O
and	O
especially	O
biofilm	O
-	O
specific	O
antimicrobial	O
resistance	O
is	O
of	O
significant	O
importance	O
in	O
the	O
development	O
of	O
new	O
treatment	O
options	O
and	O
/	O
or	O
strategies	O
.	O

As	O
an	O
intracellular	O
pathogen	O
,	O
the	O
PhoPQ	S-Biological_Molecule
system	O
of	O
Salmonella	B-Species
typhimurium	E-Species
is	O
activated	O
by	O
limiting	O
magnesium	S-Chemical_Compound
in	O
vitro	O
and	O
phoP	S-Biological_Molecule
-	O
regulated	O
genes	O
are	O
also	O
induced	O
after	O
invasion	O
of	O
macrophages	O
and	O
epithelial	O
cells	O
[	O
65	O
]	O
.	O

These	O
observations	O
suggested	O
that	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
is	O
limiting	O
within	O
host	O
cells	O
,	O
but	O
it	O
was	O
recently	O
shown	O
that	O
vacuole	O
acidification	O
and	O
low	O
pH	O
is	O
the	O
crucial	O
environmental	O
trigger	O
of	O
PhoPQ	S-Biological_Molecule
activation	O
[	O
66	O
]	O
.	O

Many	O
extracellular	O
pathogens	O
possess	O
homologs	O
of	O
the	O
cation	O
-	O
sensing	O
PhoPQ	S-Biological_Molecule
TCS	O
that	O
responds	O
to	O
magnesium	S-Chemical_Compound
limitation	O
and	O
induces	O
genes	O
necessary	O
for	O
surviving	O
this	O
environmental	O
challenge	O
[	O
65	O
]	O
.	O

However	O
,	O
to	O
date	O
the	O
identification	O
of	O
a	O
relevant	O
in	O
vivo	O
environment	O
for	O
P	B-Species
.	I-Species
aeruginosa	E-Species
which	O
is	O
cation	O
limited	O
has	O
remained	O
elusive	O
.	O

We	O
have	O
demonstrated	O
that	O
DNA	O
-	O
rich	O
environments	O
,	O
such	O
as	O
biofilms	O
,	O
are	O
cation	O
limited	O
.	O

In	O
S	B-Species
.	I-Species
typhimurium	E-Species
,	O
PhoPQ	S-Biological_Molecule
regulates	O
multiple	O
LPS	S-Chemical_Compound
modifications	O
that	O
decrease	O
the	O
OM	O
permeability	O
to	O
membrane	O
cationic	O
dyes	O
,	O
bile	O
salts	O
and	O
antibiotics	O
,	O
including	O
gentamicin	S-Chemical_Compound
[	O
67	O
]	O
.	O

We	O
report	O
here	O
that	O
DNA	O
-	O
induces	O
aminoglycoside	S-Chemical_Compound
resistance	O
in	O
P	B-Species
.	I-Species
aeruginosa	E-Species
biofilms	O
,	O
and	O
this	O
resistance	O
is	O
partially	O
dependent	O
on	O
the	O
LPS	S-Chemical_Compound
modification	O
operon	O
PA3552	S-Biological_Molecule
-	O
PA3559	S-Biological_Molecule
.	O

Previous	O
reports	O
have	O
documented	O
the	O
involvement	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
PmrAB	S-Biological_Molecule
[	O
49	O
]	O
and	O
the	O
E	B-Species
.	I-Species
coli	E-Species
PmrAB	S-Biological_Molecule
homologs	O
BasRS	S-Biological_Molecule
[	O
69	O
]	O
in	O
regulating	O
the	O
formation	O
of	O
an	O
antimicrobial	O
peptide	O
-	O
tolerant	O
subpopulation	O
within	O
biofilms	O
.	O

In	O
pure	O
culture	O
P	B-Species
.	I-Species
aeruginosa	E-Species
biofilms	O
,	O
genomic	O
DNA	O
localizes	O
throughout	O
the	O
biofilm	O
surface	O
monolayer	O
and	O
surrounds	O
the	O
mushroom	O
-	O
shaped	O
microcolonies	O
[	O
51	O
]	O
.	O

This	O
coincides	O
with	O
the	O
localization	O
of	O
a	O
CAP	S-Chemical_Compound
-	O
tolerant	O
subpopulation	O
of	O
bacteria	O
that	O
expresses	O
the	O
PA3552	S-Biological_Molecule
-	O
PA3559	S-Biological_Molecule
operon	O
along	O
the	O
surface	O
of	O
mushroom	O
-	O
structured	O
P	B-Species
.	I-Species
aeruginosa	E-Species
biofilms	O
[	O
49	O
]	O
.	O

To	O
date	O
,	O
it	O
was	O
thought	O
unlikely	O
that	O
a	O
biofilm	O
environment	O
may	O
be	O
cation	O
limited	O
.	O

Above	O
certain	O
concentrations	O
(	O
approximately0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
)	O
extracellular	O
DNA	O
inhibited	O
planktonic	O
growth	O
and	O
biofilm	O
formation	O
.	O

This	O
data	O
supports	O
the	O
hypothesis	O
that	O
the	O
release	O
of	O
genomic	O
DNA	O
by	O
lysed	O
cells	O
following	O
exposure	O
to	O
inhibitory	O
concentrations	O
of	O
extracellular	O
DNA	O
may	O
result	O
in	O
a	O
continual	O
release	O
of	O
DNA	O
by	O
dying	O
cells	O
and	O
a	O
DNA	O
gradient	O
within	O
the	O
biofilm	O
.	O

Our	O
observation	O
that	O
DNA	O
imposes	O
a	O
cation	O
gradient	O
in	O
biofilm	O
is	O
also	O
consistent	O
with	O
previous	O
reports	O
of	O
oxygen	S-Chemical_Compound
and	O
nutrient	O
gradients	O
within	O
biofilms	O
,	O
which	O
result	O
in	O
diverse	O
physiological	O
cellular	O
states	O
within	O
a	O
biofilm	O
community	O
[	O
72	O
]	O
.	O

It	O
has	O
previously	O
been	O
reported	O
that	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
concentrations	O
within	O
the	O
airway	O
surface	O
fluid	O
are	O
high	O
(	O
2	O
.	O
2	O
mM	O
)	O
[	O
73	O
]	O
,	O
[	O
74	O
]	O
.	O

However	O
,	O
sputum	O
samples	O
from	O
the	O
lungs	O
of	O
CF	O
patients	S-Species
have	O
very	O
high	O
concentrations	O
of	O
DNA	O
,	O
up	O
to	O
20	O
mg	O
/	O
ml	O
(	O
2	O
%	O
(	O
w	O
/	O
v	O
)	O
)	O
[	O
75	O
]	O
,	O
[	O
76	O
]	O
.	O

It	O
is	O
likely	O
that	O
within	O
the	O
CF	O
lung	O
,	O
localized	O
cation	O
limited	O
environments	O
exist	O
within	O
DNA	O
-	O
rich	O
microcolonies	O
.	O

Therefore	O
,	O
it	O
appears	O
that	O
there	O
are	O
multiple	O
environmental	O
signals	O
in	O
the	O
CF	O
lung	O
that	O
can	O
induce	O
the	O
expression	O
the	O
PA3552	S-Biological_Molecule
-	O
PA3559	S-Biological_Molecule
operon	O
,	O
which	O
may	O
explain	O
why	O
many	O
P	B-Species
.	I-Species
aeruginosa	E-Species
CF	O
isolates	O
show	O
LPS	S-Chemical_Compound
modifications	O
such	O
as	O
aminoarabinose	O
addition	O
to	O
lipid	B-Chemical_Compound
A	E-Chemical_Compound
[	O
78	O
]	O
.	O

As	O
many	O
P	B-Species
.	I-Species
aeruginosa	E-Species
strains	O
isolated	O
from	O
the	O
CF	O
lung	O
overproduce	O
the	O
negatively	O
charged	O
EPS	B-Chemical_Compound
alginate	E-Chemical_Compound
,	O
we	O
hypothesized	O
that	O
alginate	S-Chemical_Compound
may	O
also	O
be	O
a	O
relevant	O
in	O
vivo	O
signal	O
inducing	O
expression	O
of	O
the	O
PA3552	S-Biological_Molecule
-	O
PA3559	S-Biological_Molecule
operon	O
.	O

However	O
,	O
induction	O
of	O
PA3553	S-Biological_Molecule
gene	O
expression	O
does	O
not	O
occur	O
in	O
the	O
presence	O
of	O
alginate	S-Chemical_Compound
(	O
data	O
not	O
shown	O
)	O
.	O

Furthermore	O
,	O
these	O
findings	O
indicate	O
that	O
DNA	O
-	O
rich	O
environments	O
,	O
such	O
as	O
bacterial	O
biofilms	O
or	O
the	O
CF	O
lung	O
,	O
may	O
represent	O
the	O
natural	O
setting	O
where	O
bacterial	O
growth	O
is	O
cation	O
limited	O
,	O
and	O
highlight	O
the	O
importance	O
of	O
the	O
PhoPQ	S-Biological_Molecule
/	O
PmrAB	S-Biological_Molecule
controlled	O
response	O
and	O
LPS	S-Chemical_Compound
modifications	O
in	O
antibiotic	O
resistance	O
in	O
biofilms	O
.	O

The	O
DeltavicK	S-Biological_Molecule
mutant	O
is	O
attenuated	O
in	O
virulence	O
in	O
both	O
subcutaneous	O
and	O
intranasal	O
infections	O
in	O
mice	S-Species
.	O

DeltavicK	S-Biological_Molecule
grows	O
less	O
slowly	O
than	O
the	O
parent	O
strain	O
but	O
retains	O
the	O
ability	O
of	O
S	B-Species
.	I-Species
equi	E-Species
to	O
resist	O
to	O
phagocytosis	O
by	O
polymorphoneuclear	O
leukocytes	O
,	O
suggesting	O
that	O
the	O
vicK	S-Biological_Molecule
deletion	O
causes	O
growth	O
defect	O
.	O

Intranasal	O
DeltavicK	S-Biological_Molecule
infection	O
induces	O
production	O
of	O
anti	O
-	O
SeM	S-Biological_Molecule
mucosal	O
IgA	S-Biological_Molecule
and	O
systemic	O
IgG	S-Biological_Molecule
.	O

These	O
results	O
indicate	O
that	O
VicRK	S-Biological_Molecule
is	O
important	O
to	O
S	B-Species
.	I-Species
equi	E-Species
growth	O
and	O
virulence	O
and	O
suggest	O
that	O
DeltavicK	S-Biological_Molecule
has	O
the	O
potential	O
to	O
be	O
developed	O
as	O
a	O
live	O
S	B-Species
.	I-Species
equi	E-Species
vaccine	O
.	O

INTRODUCTION	O

Bacterial	O
pathogens	O
produce	O
many	O
two	O
-	O
component	O
regulatory	O
systems	O
to	O
regulate	O
gene	O
expression	O
by	O
specific	O
environmental	O
signals	O
[	O
1	O
]	O
.	O

The	O
regulator	O
is	O
phosphorylated	O
by	O
the	O
sensor	O
in	O
response	O
to	O
a	O
specific	O
signal	O
,	O
activating	O
or	O
repressing	O
the	O
transcription	O
of	O
target	O
genes	O
.	O

The	O
two	O
-	O
component	O
regulatory	O
system	O
VicRK	S-Biological_Molecule
or	O
YycFG	S-Biological_Molecule
is	O
specific	O
for	O
Gram	O
-	O
positive	O
bacteria	O
.	O

The	O
hyaluronic	B-Chemical_Compound
acid	E-Chemical_Compound
capsule	O
and	O
S	B-Species
.	I-Species
equi	E-Species
M	B-Biological_Molecule
-	I-Biological_Molecule
like	I-Biological_Molecule
protein	E-Biological_Molecule
(	O
SeM	S-Biological_Molecule
)	O
are	O
both	O
required	O
for	O
the	O
resistance	O
to	O
phagocytosis	O
by	O
PMNs	O
[	O
16	O
-	O
17	O
]	O
.	O

Most	O
horses	S-Species
recovered	O
from	O
strangles	O
have	O
immunity	O
against	O
S	B-Species
.	I-Species
equi	E-Species
reinfection	O
for	O
up	O
to	O
5	O
years	O
[	O
18	O
]	O
.	O

An	O
intranasal	O
vaccine	O
made	O
of	O
live	O
attenuated	O
strain	O
has	O
been	O
used	O
in	O
USA	O
,	O
which	O
lacks	O
the	O
hyaluronic	B-Chemical_Compound
acid	E-Chemical_Compound
capsule	O
,	O
and	O
various	O
adverse	O
effects	O
,	O
including	O
pharyngeal	O
lymphadenopathy	O
,	O
limb	O
edema	O
,	O
and	O
bastard	O
strangles	O
abscesses	O
,	O
have	O
been	O
reported	O
[	O
15	O
]	O
.	O

This	O
study	O
aims	O
at	O
evaluating	O
the	O
importance	O
of	O
VicRK	S-Biological_Molecule
to	O
S	B-Species
.	I-Species
equi	E-Species
virulence	O
and	O
the	O
potential	O
of	O
a	O
vicK	S-Biological_Molecule
deletion	O
mutant	O
as	O
a	O
live	O
vaccine	O
using	O
mouse	S-Species
infection	O
models	O
.	O

The	O
two	O
upstream	O
and	O
downstream	O
flanking	O
fragments	O
of	O
the	O
internal	O
vicK	S-Biological_Molecule
fragment	O
from	O
Tyr151	O
to	O
Ser427	O
to	O
be	O
deleted	O
were	O
cloned	O
at	O
the	O
upstream	O
and	O
downstream	O
ends	O
of	O
the	O
aad	S-Biological_Molecule
gene	O
,	O
respectively	O
,	O
resulting	O
in	O
suicide	O
plasmid	O
pGRV	O
-	O
DeltavicK	S-Biological_Molecule
.	O

Single	O
crossover	O
between	O
one	O
flanking	O
fragment	O
in	O
pGRV	O
-	O
DeltavicK	S-Biological_Molecule
and	O
the	O
homologous	O
region	O
in	O
the	O
genome	O
would	O
lead	O
to	O
the	O
insertion	O
of	O
the	O
whole	O
plasmid	O
into	O
S	B-Species
.	I-Species
equi	E-Species
genome	O
,	O
resulting	O
in	O
strains	O
resistant	O
to	O
both	O
spectinomycin	S-Chemical_Compound
and	O
chloramphenicol	S-Chemical_Compound
.	O

Double	O
crossoverat	O
both	O
of	O
the	O
flanking	O
fragments	O
would	O
lead	O
to	O
the	O
replacement	O
of	O
the	O
vicK	S-Biological_Molecule
internal	O
fragment	O
with	O
the	O
aad	S-Biological_Molecule
gene	O
,	O
resulting	O
in	O
vicK	S-Biological_Molecule
deletion	O
strains	O
with	O
resistance	O
only	O
to	O
spectinomycin	S-Chemical_Compound
.	O

Three	O
putative	O
DeltavicK	S-Biological_Molecule
strains	O
,	O
which	O
were	O
spectinomycin	S-Chemical_Compound
-	O
resistant	O
and	O
chloramphenicol	S-Chemical_Compound
-	O
sensitive	O
,	O
were	O
obtained	O
.	O

DNA	O
sequencing	O
confirmed	O
the	O
desired	O
deletion	O
.	O

One	O
deletion	O
strain	O
was	O
randomly	O
chosen	O
for	O
further	O
characterization	O
.	O

The	O
effect	O
of	O
the	O
deletion	O
on	O
S	B-Species
.	I-Species
equi	E-Species
growth	O
in	O
blood	O
was	O
also	O
examined	O
.	O

The	O
samples	O
were	O
incubated	O
for	O
4	O
h	O
,	O
and	O
the	O
numbers	O
of	O
the	O
bacteria	O
in	O
the	O
samples	O
and	O
inocula	O
at	O
time	O
zero	O
were	O
determined	O
by	O
plating	O
.	O

The	O
growth	O
factors	O
,	O
the	O
ratio	O
of	O
cfu	O
in	O
the	O
sample	O
at	O
4	O
h	O
over	O
cfu	O
at	O
time	O
zero	O
,	O
were	O
250	O
and	O
66	O
for	O
the	O
wild	O
type	O
and	O
DeltavicK	S-Biological_Molecule
strains	O
,	O
respectively	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

No	O
Effect	O
of	O
the	O
vicK	S-Biological_Molecule
Deletion	O
on	O
Resistance	O
of	O
S	B-Species
.	I-Species
equi	E-Species
to	O
Phagocytosis	O
by	O
PMNs	O

FITC	O
-	O
labeled	O
wild	O
-	O
type	O
S	B-Species
.	I-Species
equi	E-Species
,	O
DeltavicK	S-Biological_Molecule
mutant	O
,	O
and	O
S	O
.	O
pyogenes	O
spy1718	S-Biological_Molecule
:	O
:	O
aad	S-Biological_Molecule
mutant	O
were	O
incubated	O
with	O
heparinized	O
horse	O
or	O
rabbit	O
blood	O
for	O
5	O
and	O
15	O
min	O
,	O
and	O
percentages	O
of	O
PMNs	O
associated	O
with	O
fluorescent	O
bacteria	O
were	O
quantified	O
using	O
flow	O
cytometry	O
analysis	O
.	O

The	O
spy1718	S-Biological_Molecule
:	O
:	O
aad	S-Biological_Molecule
mutant	O
of	O
S	B-Species
.	I-Species
pyogenes	E-Species
,	O
which	O
is	O
no	O
longer	O
resistant	O
to	O
phagocytosis	O
by	O
PMNs	O
,	O
was	O
used	O
as	O
a	O
positive	O
control	O
in	O
the	O
assay	O
.	O

The	O
percentages	O
of	O
PMNs	O
with	O
associated	O
wild	O
-	O
type	O
S	B-Species
.	I-Species
equi	E-Species
and	O
spy1718	S-Biological_Molecule
:	O
:	O
aad	S-Biological_Molecule
were	O
low	O
and	O
high	O
,	O
respectively	O
,	O
indicating	O
that	O
the	O
assay	O
worked	O
well	O
to	O
evaluate	O
resistance	O
of	O
the	O
bacteria	O
to	O
phagocytosis	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
the	O
percentages	O
of	O
PMNs	O
associated	O
with	O
wild	O
-	O
type	O
and	O
DeltavicK	S-Biological_Molecule
bacteria	O
at	O
both	O
time	O
points	O
and	O
in	O
both	O
horse	O
and	O
rabbit	O
blood	O
(	O
Fig	O
.	O
3	O
)	O
,	O
indicating	O
that	O
the	O
DeltavicK	S-Biological_Molecule
mutant	O
retains	O
the	O
ability	O
of	O
S	B-Species
.	I-Species
equi	E-Species
to	O
resist	O
to	O
phagocytosis	O
by	O
PMNs	O
.	O

Group	O
of	O
8	O
mice	S-Species
were	O
subcutaneously	O
inoculated	O
with	O
1	O
.	O
1	O
x	O
108	O
cfu	O
wild	O
-	O
type	O
or	O
DeltavicK	S-Biological_Molecule
mutant	O
strains	O
.	O

The	O
infection	O
was	O
performed	O
in	O
a	O
model	O
of	O
intranasal	O
infection	O
as	O
well	O
.	O

All	O
the	O
8	O
mice	S-Species
infected	O
with	O
DeltavicK	S-Biological_Molecule
survived	O
,	O
whereas	O
5	O
of	O
the	O
8	O
mice	S-Species
infected	O
with	O
the	O
wild	O
-	O
type	O
S	B-Species
.	I-Species
equi	E-Species
strain	O
died	O
(	O
Fig	O
.	O
4B	O
)	O
.	O

To	O
test	O
whether	O
DeltavicK	S-Biological_Molecule
infection	O
confers	O
immunity	O
against	O
S	B-Species
.	I-Species
equi	E-Species
infection	O
,	O
the	O
seven	O
mice	S-Species
recovered	O
from	O
the	O
subcutaneous	O
DeltavicK	S-Biological_Molecule
infection	O
was	O
reinfected	O
subcutaneously	O
with	O
1	O
.	O
5	O
x	O
108	O
cfu	O
wild	O
-	O
type	O
S	B-Species
.	I-Species
equi	E-Species
30	O
days	O
after	O
the	O
first	O
infection	O
and	O
monitored	O
for	O
18	O
days	O
.	O

Six	O
of	O
the	O
7	O
mice	S-Species
survived	O
the	O
reinfection	O
(	O
Fig	O
.	O
4A	O
)	O
,	O
suggesting	O
that	O
the	O
DeltavicK	S-Biological_Molecule
infection	O
induces	O
immunity	O
against	O
S	B-Species
.	I-Species
equi	E-Species
infection	O
.	O

Intranasal	O
DeltavicK	S-Biological_Molecule
Infection	O
Induces	O
SeM	S-Biological_Molecule
-	O
Specific	O
Mucosal	O
IgA	S-Biological_Molecule
and	O
Systemic	O
IgG	S-Biological_Molecule

To	O
examine	O
the	O
humoral	O
immune	O
responses	O
in	O
the	O
intranasal	O
DeltavicK	S-Biological_Molecule
infection	O
,	O
nasal	O
wash	O
and	O
serum	O
samples	O
were	O
collected	O
from	O
the	O
8	O
mice	S-Species
infected	O
intranasally	O
with	O
DeltavicK	S-Biological_Molecule
and	O
3	O
surviving	O
mice	S-Species
infected	O
with	O
the	O
wild	O
-	O
type	O
S	B-Species
.	I-Species
equi	E-Species
30	O
days	O
after	O
infection	O
.	O

Half	O
of	O
the	O
nasal	O
wash	O
samples	O
from	O
the	O
mice	S-Species
infected	O
with	O
DeltavicK	S-Biological_Molecule
had	O
similar	O
levels	O
of	O
SeM38	S-Biological_Molecule
-	O
260	S-Biological_Molecule
-	O
IgA	S-Biological_Molecule
reactivity	O
with	O
those	O
from	O
the	O
mice	S-Species
infected	O
with	O
the	O
wild	O
-	O
type	O
strains	O
.	O

Western	O
blotting	O
analysis	O
was	O
used	O
to	O
confirm	O
the	O
presence	O
of	O
SeM	S-Biological_Molecule
-	O
specific	O
IgG	S-Biological_Molecule
.	O

We	O
successfully	O
deleted	O
the	O
vicK	S-Biological_Molecule
gene	O
of	O
S	B-Species
.	I-Species
equi	E-Species
.	O

Thus	O
,	O
VicK	S-Biological_Molecule
is	O
not	O
essential	O
in	O
S	B-Species
.	I-Species
equi	E-Species
.	O

However	O
,	O
the	O
DeltavicK	S-Biological_Molecule
mutant	O
is	O
attenuated	O
in	O
virulence	O
in	O
both	O
mouse	S-Species
models	O
of	O
subcutaneous	O
and	O
intranasal	O
S	B-Species
.	I-Species
equi	E-Species
infections	O
,	O
indicating	O
that	O
VicRK	S-Biological_Molecule
is	O
important	O
to	O
virulence	O
.	O

The	O
results	O
provide	O
the	O
further	O
evidence	O
for	O
the	O
importance	O
of	O
VicRK	S-Biological_Molecule
to	O
virulence	O
of	O
Gram	O
-	O
positive	O
pathogens	O
.	O

The	O
phenotypes	O
of	O
the	O
S	O
.	O
equi	O
DeltavicK	S-Biological_Molecule
mutant	O
are	O
similar	O
to	O
those	O
of	O
the	O
S	O
.	O
pyogenes	O
DeltavicK	S-Biological_Molecule
mutant	O
[	O
6	O
]	O
,	O
suggesting	O
that	O
the	O
growth	O
defect	O
phenotype	O
may	O
be	O
a	O
common	O
feature	O
of	O
the	O
vicRK	S-Biological_Molecule
mutants	O
of	O
various	O
Gram	O
-	O
positive	O
pathogens	O
.	O

The	O
DeltavicK	S-Biological_Molecule
mutant	O
appears	O
to	O
possess	O
the	O
properties	O
of	O
a	O
potential	O
live	O
vaccine	O
.	O

First	O
,	O
it	O
is	O
attenuated	O
in	O
virulence	O
in	O
the	O
mouse	S-Species
infection	O
models	O
.	O

Thirdly	O
,	O
most	O
of	O
the	O
mice	S-Species
with	O
intranasal	O
DeltavicK	S-Biological_Molecule
infection	O
produce	O
mucosal	O
IgA	S-Biological_Molecule
and	O
systemic	O
IgG	S-Biological_Molecule
specific	O
to	O
protective	O
antigen	O
SeM	S-Biological_Molecule
.	O

However	O
,	O
whether	O
DeltavicK	S-Biological_Molecule
can	O
be	O
an	O
effective	O
live	O
vaccine	O
and	O
whether	O
the	O
DeltavicK	S-Biological_Molecule
mutant	O
has	O
any	O
advantages	O
over	O
the	O
current	O
live	O
S	B-Species
.	I-Species
equi	E-Species
vaccine	O
require	O
the	O
test	O
of	O
the	O
mutant	O
in	O
horses	S-Species
since	O
S	B-Species
.	I-Species
equi	E-Species
does	O
not	O
naturally	O
infect	O
mice	S-Species
.	O

We	O
hope	O
to	O
perform	O
this	O
expensive	O
test	O
in	O
future	O
when	O
funds	O
are	O
available	O

Coordinated	O
Regulation	O
of	O
Virulence	O
during	O
Systemic	O
Infection	O
of	O
Salmonella	B-Species
enterica	I-Species
Serovar	I-Species
Typhimurium	E-Species

Overall	O
,	O
35	O
regulators	O
were	O
identified	O
whose	O
absence	O
attenuated	O
virulence	O
in	O
at	O
least	O
one	O
assay	O
,	O
and	O
of	O
those	O
,	O
14	O
regulators	O
were	O
required	O
for	O
systemic	O
mouse	S-Species
infection	O
,	O
the	O
most	O
stringent	O
virulence	O
assay	O
.	O

As	O
a	O
first	O
step	O
towards	O
understanding	O
the	O
interplay	O
between	O
a	O
pathogen	O
and	O
its	O
host	O
from	O
a	O
systems	O
biology	O
standpoint	O
,	O
we	O
focused	O
on	O
these	O
14	O
genes	O
.	O

These	O
results	O
,	O
as	O
well	O
as	O
publicly	O
available	O
transcriptional	O
profiles	O
,	O
were	O
analyzed	O
using	O
both	O
network	O
inference	O
and	O
cluster	O
analysis	O
algorithms	O
.	O

The	O
analysis	O
predicts	O
a	O
regulatory	O
network	O
in	O
which	O
all	O
14	O
regulators	O
control	O
the	O
same	O
set	O
of	O
genes	O
necessary	O
for	O
Salmonella	S-Species
to	O
cause	O
systemic	O
infection	O
.	O

These	O
experiments	O
validated	O
the	O
regulatory	O
model	O
and	O
showed	O
that	O
the	O
response	O
regulator	O
SsrB	S-Biological_Molecule
and	O
the	O
MarR	S-Biological_Molecule
type	O
regulator	O
,	O
SlyA	S-Biological_Molecule
,	O
are	O
the	O
terminal	O
regulators	O
in	O
a	O
cascade	O
that	O
integrates	O
multiple	O
signals	O
.	O

In	O
addition	O
to	O
fluid	O
and	O
electrolyte	O
loss	O
,	O
non	O
-	O
typhoidal	O
Salmonella	S-Species
often	O
results	O
in	O
septicemia	O
in	O
children	S-Species
and	O
in	O
HIV	S-Species
infected	O
adults	O
in	O
developing	O
countries	O
with	O
a	O
fatality	O
rate	O
of	O
25	O
%	O
or	O
greater	O
[	O
2	O
]	O
.	O

More	O
than	O
4	O
%	O
of	O
the	O
entire	O
genome	O
is	O
required	O
for	O
Typhimurium	S-Species
to	O
infect	O
the	O
mouse	S-Species
[	O
3	O
]	O
.	O

Numerous	O
studies	O
have	O
assigned	O
a	O
small	O
fraction	O
of	O
these	O
genes	O
to	O
specific	O
steps	O
in	O
mouse	S-Species
infection	O
but	O
most	O
are	O
still	O
a	O
mystery	O
.	O

These	O
regions	O
include	O
two	O
40	O
kb	O
stretches	O
of	O
DNA	O
termed	O
Salmonella	S-Species
pathogenicity	O
islands	O
1	O
(	O
SPI	O
-	O
1	O
)	O
and	O
2	O
(	O
SPI	O
-	O
2	O
)	O
[	O
4	O
]	O
-	O
[	O
9	O
]	O
.	O

The	O
two	O
type	O
III	O
secretion	O
systems	O
are	O
expressed	O
under	O
different	O
environmental	O
conditions	O
and	O
play	O
distinct	O
roles	O
in	O
pathogenesis	O
.	O

During	O
the	O
course	O
of	O
systemic	O
infection	O
in	O
mice	S-Species
,	O
bacteria	O
are	O
found	O
within	O
neutrophils	O
,	O
monocytes	O
,	O
dendritic	O
cells	O
,	O
and	O
B	O
and	O
T	O
cells	O
but	O
are	O
not	O
found	O
extracellularly	O
until	O
the	O
last	O
one	O
or	O
two	O
days	O
immediately	O
before	O
death	O
of	O
the	O
mouse	S-Species
[	O
15	O
]	O
-	O
[	O
17	O
]	O
.	O

Technological	O
advances	O
in	O
the	O
last	O
10	O
years	O
such	O
as	O
microarrays	O
,	O
whole	O
genome	O
sequences	O
,	O
and	O
global	O
proteomics	O
have	O
provided	O
a	O
more	O
complete	O
picture	O
of	O
gene	O
expression	O
for	O
a	O
number	O
of	O
bacteria	O
.	O

The	O
goal	O
of	O
the	O
current	O
work	O
is	O
to	O
develop	O
a	O
predictive	O
model	O
for	O
host	O
-	O
pathogen	O
interactions	O
that	O
will	O
provide	O
insight	O
into	O
how	O
Salmonella	S-Species
responds	O
to	O
specific	O
conditions	O
in	O
the	O
host	O
.	O

We	O
have	O
used	O
SEBINI	O
(	O
Software	O
Environment	O
for	O
Biological	O
Network	O
Inference	O
;	O
[	O
18	O
]	O
)	O
to	O
directly	O
compare	O
multiple	O
network	O
algorithms	O
.	O

The	O
analysis	O
of	O
our	O
data	O
provided	O
a	O
testable	O
regulatory	O
hierarchy	O
and	O
a	O
list	O
of	O
genes	O
with	O
similar	O
expression	O
profiles	O
as	O
described	O
below	O
.	O

Results	O

Salmonella	S-Species
regulators	O
required	O
for	O
systemic	O
mouse	S-Species
infection	O
Typhimurium	S-Species
encodes	O
a	O
surfeit	O
of	O
regulators	O
(	O
more	O
than	O
330	O
based	O
on	O
annotation	O
cited	O
in	O
NCBI	O
)	O
presumably	O
because	O
it	O
can	O
survive	O
and	O
replicate	O
in	O
many	O
different	O
environments	O
,	O
cause	O
infection	O
in	O
diverse	O
hosts	O
,	O
and	O
can	O
use	O
multiple	O
carbon	S-Chemical_Compound
sources	O
and	O
terminal	O
electron	O
acceptors	O
.	O

We	O
focused	O
on	O
83	O
regulators	O
presumed	O
to	O
play	O
roles	O
in	O
virulence	O
,	O
based	O
on	O
published	O
data	O
including	O
negative	O
selection	O
experiments	O
[	O
13	O
]	O
,	O
[	O
21	O
]	O
-	O
[	O
23	O
]	O
.	O

We	O
constructed	O
non	O
-	O
polar	O
in	O
-	O
frame	O
deletions	O
in	O
which	O
each	O
regulator	O
gene	O
was	O
replaced	O
with	O
a	O
"	O
scar	O
"	O
sequence	O
using	O
bacteriophage	B-Species
lambda	E-Species
-	O
mediated	O
recombination	O
[	O
24	O
]	O
,	O
[	O
25	O
]	O
.	O

For	O
the	O
two	O
-	O
component	O
regulator	O
ssrA	S-Biological_Molecule
/	O
ssrB	S-Biological_Molecule
we	O
constructed	O
in	O
-	O
frame	O
deletions	O
missing	O
ssrA	S-Biological_Molecule
,	O
ssrB	S-Biological_Molecule
or	O
both	O
;	O
for	O
the	O
other	O
two	O
two	O
-	O
component	O
regulators	O
,	O
phoP	S-Biological_Molecule
/	O
phoQ	S-Biological_Molecule
and	O
ompR	S-Biological_Molecule
/	O
envZ	S-Biological_Molecule
,	O
both	O
the	O
signal	O
sensor	O
and	O
response	O
regulator	O
were	O
deleted	O
.	O

As	O
an	O
initial	O
screen	O
two	O
4	O
-	O
6	O
weeks	O
-	O
old	O
BALB	B-Species
/	I-Species
c	I-Species
mice	E-Species
were	O
infected	O
intraperitoneally	O
(	O
i	O
.	O
p	O
.	O
)	O
with	O
200	O
colony	O
forming	O
units	O
(	O
CFU	O
)	O
of	O
each	O
deleted	O
strain	O
(	O
about	O
100x	O
the	O
LD50	O
)	O
.	O

Mutations	O
that	O
resulted	O
in	O
either	O
no	O
deaths	O
,	O
one	O
death	O
,	O
or	O
delayed	O
death	O
of	O
infected	O
mice	S-Species
were	O
retested	O
with	O
groups	O
of	O
5	O
mice	S-Species
at	O
the	O
same	O
dose	O
(	O
Figure	O
1A	O
)	O
.	O

Based	O
on	O
this	O
preliminary	O
screen	O
we	O
chose	O
the	O
regulators	O
spvR	S-Biological_Molecule
,	O
fruR	S-Biological_Molecule
,	O
himD	S-Biological_Molecule
,	O
phoP	S-Biological_Molecule
/	O
phoQ	S-Biological_Molecule
,	O
ssrA	S-Biological_Molecule
/	O
ssrB	S-Biological_Molecule
,	O
slyA	S-Biological_Molecule
,	O
hnr	S-Biological_Molecule
,	O
rpoE	S-Biological_Molecule
,	O
smpB	S-Biological_Molecule
,	O
csrA	S-Biological_Molecule
,	O
rpoS	S-Biological_Molecule
,	O
crp	S-Biological_Molecule
,	O
ompR	S-Biological_Molecule
/	O
envZ	S-Biological_Molecule
,	O
and	O
hfq	S-Biological_Molecule
for	O
further	O
investigation	O
(	O
see	O
Figure	O
1	O
and	O
Table	O
1	O
for	O
references	O
and	O
descriptions	O
;	O
a	O
complete	O
list	O
of	O
virulence	O
phenotypes	O
is	O
provided	O
in	O
Table	O
S1	O
)	O
.	O

The	O
LD50	O
for	O
each	O
of	O
the	O
mutants	O
was	O
computed	O
as	O
shown	O
in	O
Figure	O
1B	O
.	O

BALB	B-Species
/	I-Species
c	I-Species
mice	E-Species
infection	O
to	O
eliminate	O
other	O
regulators	O
required	O
only	O
for	O
gastrointestinal	O
infection	O
or	O
persistence	O
but	O
most	O
of	O
these	O
strains	O
were	O
avirulent	O
in	O
another	O
strain	O
of	O
mice	S-Species
(	O
129X1	B-Species
/	I-Species
SvJ	E-Species
)	O
and	O
by	O
other	O
route	O
(	O
intragastric	O
)	O
of	O
infection	O
(	O
see	O
Table	O
S1	O
)	O
.	O

Unlike	O
BALB	B-Species
/	I-Species
c	E-Species
,	O
129X1	B-Species
/	I-Species
SvJ	I-Species
mice	E-Species
have	O
a	O
functional	O
copy	O
of	O
Nramp1	S-Biological_Molecule
and	O
the	O
bacteria	O
persist	O
for	O
several	O
weeks	O
without	O
killing	O
the	O
mouse	S-Species
[	O
13	O
]	O
,	O
[	O
26	O
]	O
.	O

The	O
CI	O
test	O
identified	O
30	O
(	O
out	O
of	O
83	O
)	O
regulator	O
mutants	O
that	O
were	O
attenuated	O
in	O
comparison	O
to	O
the	O
wild	O
type	O
control	O
(	O
see	O
Table	O
S1	O
)	O
.	O

Salmonella	S-Species
transcription	O
profiles	O
for	O
the	O
following	O
regulators	O
have	O
already	O
been	O
reported	O
:	O
rpoE	S-Biological_Molecule
[	O
27	O
]	O
;	O
phoP	S-Biological_Molecule
/	O
phoQ	S-Biological_Molecule
[	O
28	O
]	O
;	O
ssrA	S-Biological_Molecule
/	O
ssrB	S-Biological_Molecule
[	O
29	O
]	O
;	O
csrA	S-Biological_Molecule
[	O
30	O
]	O
;	O
slyA	S-Biological_Molecule
[	O
31	O
]	O
;	O
ihf	S-Biological_Molecule
[	O
32	O
]	O
;	O
hfq	S-Biological_Molecule
[	O
33	O
]	O
.	O

To	O
validate	O
this	O
result	O
we	O
complemented	O
the	O
spvR	S-Biological_Molecule
mutation	O
in	O
trans	O
and	O
found	O
complete	O
complementation	O
in	O
mouse	S-Species
virulence	O
(	O
Figure	O
S1	O
)	O
.	O

The	O
differences	O
between	O
our	O
results	O
and	O
others	O
are	O
most	O
likely	O
related	O
to	O
the	O
different	O
strains	O
of	O
Salmonella	S-Species
used	O
in	O
the	O
studies	O
[	O
34	O
]	O
.	O

The	O
ability	O
of	O
Salmonella	S-Species
to	O
survive	O
and	O
replicate	O
in	O
macrophages	O
is	O
necessary	O
but	O
not	O
sufficient	O
for	O
mouse	S-Species
virulence	O

Previous	O
work	O
demonstrated	O
that	O
Salmonella	S-Species
mutants	O
that	O
were	O
unable	O
to	O
survive	O
within	O
elicited	O
peritoneal	O
macrophages	O
were	O
attenuated	O
for	O
virulence	O
during	O
systemic	O
mouse	S-Species
infection	O
[	O
36	O
]	O
.	O

Salmonella	S-Species
is	O
within	O
blood	O
monocytes	O
and	O
in	O
other	O
WBC	O
in	O
the	O
spleen	O
including	O
neutrophils	O
,	O
dendritic	O
cells	O
,	O
and	O
B	O
and	O
T	O
cells	O
in	O
these	O
reports	O
(	O
ibid	O
)	O
.	O

Thus	O
,	O
some	O
of	O
the	O
regulatory	O
mutations	O
described	O
here	O
may	O
affect	O
growth	O
in	O
cells	O
types	O
other	O
than	O
macrophages	O
.	O

We	O
therefore	O
wished	O
to	O
determine	O
if	O
there	O
is	O
a	O
direct	O
relationship	O
between	O
growth	O
in	O
macrophages	O
and	O
mouse	S-Species
virulence	O
.	O

In	O
these	O
studies	O
we	O
used	O
primary	O
bone	O
marrow	O
-	O
derived	O
macrophages	O
(	O
BMDM	O
)	O
from	O
the	O
same	O
strain	O
of	O
mouse	S-Species
as	O
used	O
in	O
the	O
original	O
identification	O
of	O
attenuated	O
regulatory	O
mutants	O
(	O
BALB	B-Species
/	I-Species
c	E-Species
)	O
.	O

The	O
identical	O
number	O
of	O
input	O
bacteria	O
and	O
the	O
identical	O
number	O
of	O
macrophages	O
were	O
used	O
in	O
every	O
infection	O
experiment	O
.	O

We	O
monitored	O
the	O
number	O
of	O
intracellular	O
bacteria	O
at	O
an	O
early	O
time	O
(	O
30	O
min	O
)	O
to	O
determine	O
the	O
number	O
of	O
bacteria	O
internalized	O
(	O
Figure	O
2	O
)	O
.	O

Even	O
at	O
the	O
shortest	O
time	O
few	O
intracellular	O
bacteria	O
were	O
recovered	O
from	O
macrophage	O
infection	O
with	O
an	O
rpoE	S-Biological_Molecule
mutant	O
,	O
suggesting	O
that	O
this	O
strain	O
is	O
very	O
sensitive	O
to	O
microbicidal	O
factors	O
released	O
by	O
macrophages	O
on	O
contact	O
with	O
bacteria	O
or	O
doesn	O
'	O
t	O
get	O
internalized	O
very	O
well	O
.	O

Finally	O
,	O
at	O
18	O
hrs	O
bacterial	O
numbers	O
were	O
enumerated	O
to	O
monitor	O
intracellular	O
replication	O
as	O
well	O
as	O
the	O
ability	O
to	O
withstand	O
nitrous	O
oxide	O
oxidation	O
and	O
other	O
late	O
antimicrobial	O
factors	O
[	O
39	O
]	O
,	O
[	O
40	O
]	O
.	O

Small	O
differences	O
in	O
intracellular	O
growth	O
were	O
observed	O
for	O
ssrA	S-Biological_Molecule
/	O
ssrB	S-Biological_Molecule
and	O
slyA	S-Biological_Molecule
compared	O
to	O
the	O
parent	O
although	O
larger	O
differences	O
have	O
been	O
observed	O
previously	O
[	O
43	O
]	O
-	O
[	O
45	O
]	O
perhaps	O
reflecting	O
BMDM	O
preparation	O
techniques	O
,	O
bacterial	O
strain	O
differences	O
,	O
or	O
opsonization	O
differences	O
[	O
46	O
]	O
.	O

The	O
14	O
virulence	O
regulators	O
,	O
whose	O
absence	O
was	O
identified	O
by	O
attenuated	O
virulence	O
in	O
vivo	O
in	O
this	O
study	O
,	O
presumably	O
sense	O
specific	O
environmental	O
signals	O
within	O
the	O
host	O
and	O
respond	O
by	O
expressing	O
the	O
appropriate	O
complement	O
of	O
virulence	O
factors	O
.	O

Two	O
different	O
minimal	O
media	O
conditions	O
were	O
used	O
depending	O
only	O
on	O
pre	O
-	O
growth	O
conditions	O
as	O
described	O
in	O
the	O
Materials	O
and	O
Methods	O
(	O
called	O
acidic	O
minimal	O
media	O
(	O
AMM	O
)	O
1	O
and	O
AMM2	O
here	O
)	O
;	O
these	O
conditions	O
are	O
identical	O
to	O
conditions	O
previously	O
reported	O
for	O
expression	O
of	O
SPI	O
-	O
2	O
;	O
[	O
47	O
]	O
,	O
[	O
48	O
]	O
.	O

The	O
fate	O
of	O
intracellular	O
Typhimurium	S-Species
is	O
determined	O
by	O
pre	O
-	O
growth	O
conditions	O
prior	O
to	O
macrophage	O
infection	O
and	O
for	O
that	O
reason	O
we	O
used	O
both	O
conditions	O
AMM1	O
and	O
2	O
[	O
49	O
]	O
.	O

To	O
identify	O
global	O
transcriptional	O
changes	O
for	O
each	O
regulator	O
,	O
mRNAs	O
were	O
isolated	O
from	O
each	O
strain	O
grown	O
under	O
the	O
four	O
conditions	O
,	O
converted	O
to	O
cDNA	O
,	O
and	O
used	O
to	O
probe	O
a	O
spotted	O
non	O
-	O
redundant	O
pan	O
-	O
Salmonella	S-Species
orf	O
microarray	O
using	O
hybridization	O
of	O
total	O
genomic	O
Salmonella	S-Species
DNA	O
as	O
an	O
internal	O
control	O
[	O
50	O
]	O
.	O

Each	O
microarray	O
was	O
probed	O
with	O
RNA	O
from	O
the	O
parent	O
or	O
an	O
isogenic	O
deletion	O
of	O
one	O
of	O
the	O
regulator	O
mutants	O
prepared	O
from	O
bacterial	O
cells	O
grown	O
under	O
one	O
of	O
the	O
four	O
conditions	O
.	O

In	O
all	O
there	O
were	O
4	O
biological	O
replicates	O
of	O
the	O
parent	O
strain	O
but	O
one	O
for	O
each	O
mutant	O
under	O
each	O
growth	O
condition	O
.	O

Transcriptional	O
profiles	O
were	O
significantly	O
different	O
from	O
the	O
parent	O
for	O
known	O
virulence	O
factors	O
required	O
during	O
systemic	O
infection	O
,	O
but	O
only	O
if	O
cells	O
were	O
grown	O
in	O
acidic	O
minimal	O
media	O
(	O
AMM1	O
or	O
AMM2	O
;	O
see	O
Figure	O
3	O
;	O
complete	O
microarray	O
data	O
available	O
at	O
http	O
:	O
/	O
/	O
www	O
.	O
ohsu	O
.	O
edu	O
/	O
microbiology	O
/	O
heffron	O
/	O
r01	O
.	O
html	O
)	O
.	O

Statistical	O
analysis	O
of	O
the	O
complete	O
transcriptional	O
data	O
for	O
gene	O
expression	O
in	O
AMM1	O
identified	O
at	O
least	O
237	O
genes	O
that	O
were	O
reduced	O
4	O
-	O
fold	O
or	O
more	O
in	O
common	O
comparing	O
the	O
mutations	O
to	O
the	O
parent	O
strain	O
(	O
at	O
least	O
3	O
standard	O
deviation	O
based	O
on	O
the	O
technical	O
replicates	O
)	O
.	O

All	O
in	O
all	O
,	O
these	O
results	O
suggest	O
that	O
the	O
normal	O
function	O
of	O
each	O
of	O
the	O
14	O
regulators	O
is	O
to	O
activate	O
transcription	O
of	O
virulence	O
factors	O
necessary	O
for	O
systemic	O
infection	O
but	O
only	O
under	O
specific	O
environmental	O
conditions	O
.	O

Validation	O
of	O
SPI	O
-	O
2	O
regulation	O

To	O
assess	O
the	O
effects	O
of	O
growth	O
conditions	O
on	O
expression	O
of	O
the	O
SPI	O
-	O
2	O
secretion	O
apparatus	O
we	O
constructed	O
a	O
lacZ	S-Biological_Molecule
transcriptional	O
fusion	O
to	O
ssaG	S-Biological_Molecule
,	O
a	O
component	O
of	O
the	O
secretion	O
apparatus	O
,	O
and	O
tested	O
expression	O
in	O
each	O
mutant	O
background	O
under	O
each	O
of	O
the	O
four	O
growth	O
conditions	O
.	O

At	O
the	O
same	O
time	O
we	O
determined	O
transcript	O
levels	O
via	O
quantitative	O
real	O
-	O
time	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
,	O
using	O
transcripts	O
from	O
rpoD	S-Biological_Molecule
and	O
gyrB	S-Biological_Molecule
as	O
controls	O
[	O
51	O
]	O
.	O

We	O
observed	O
that	O
the	O
results	O
determined	O
by	O
these	O
two	O
methods	O
matched	O
closely	O
(	O
Figure	O
S2	O
)	O
and	O
that	O
the	O
level	O
of	O
transcription	O
of	O
ssaG	S-Biological_Molecule
was	O
highest	O
when	O
Salmonella	S-Species
was	O
grown	O
in	O
minimal	O
acidic	O
media	O
.	O

To	O
validate	O
the	O
transcriptional	O
profiles	O
we	O
prepared	O
RNA	O
from	O
mutants	O
and	O
parent	O
bacteria	O
grown	O
in	O
acidic	O
minimal	O
medium	O
and	O
used	O
as	O
template	O
for	O
qRT	O
-	O
PCR	O
.	O

Six	O
promoters	O
have	O
been	O
identified	O
for	O
the	O
type	O
III	O
secretion	O
system	O
encoded	O
within	O
SPI	O
-	O
2	O
(	O
see	O
Figure	O
4	O
;	O
[	O
52	O
]	O
)	O
.	O

We	O
monitored	O
transcription	O
of	O
seven	O
genes	O
within	O
SPI	O
-	O
2	O
,	O
covering	O
each	O
operon	O
at	O
least	O
once	O
,	O
and	O
used	O
gyrB	S-Biological_Molecule
transcript	O
as	O
an	O
internal	O
control	O
.	O

Strains	O
containing	O
mutations	O
in	O
phoP	S-Biological_Molecule
/	O
phoQ	S-Biological_Molecule
,	O
ssrA	S-Biological_Molecule
/	O
ssrB	S-Biological_Molecule
,	O
slyA	S-Biological_Molecule
,	O
and	O
ompR	S-Biological_Molecule
/	O
envZ	S-Biological_Molecule
showed	O
at	O
least	O
100	O
-	O
fold	O
decreases	O
in	O
transcription	O
of	O
all	O
SPI	O
-	O
2	O
genes	O
(	O
Figure	O
4	O
)	O
.	O

Mutations	O
of	O
ihf	S-Biological_Molecule
(	O
himD	S-Biological_Molecule
)	O
and	O
csrA	S-Biological_Molecule
showed	O
an	O
intermediate	O
level	O
of	O
8	O
-	O
16	O
-	O
fold	O
decreased	O
transcription	O
whereas	O
hnr	S-Biological_Molecule
,	O
rpoE	S-Biological_Molecule
,	O
smpB	S-Biological_Molecule
,	O
crp	S-Biological_Molecule
and	O
hfq	S-Biological_Molecule
showed	O
a	O
modest	O
decrease	O
of	O
2	O
-	O
8	O
-	O
fold	O
.	O

Note	O
that	O
rpoE	S-Biological_Molecule
and	O
hfq	S-Biological_Molecule
mutants	O
showed	O
a	O
dramatic	O
reduction	O
in	O
macrophage	O
survival	O
,	O
but	O
little	O
difference	O
in	O
transcription	O
of	O
SPI	O
-	O
2	O
genes	O
during	O
growth	O
in	O
AMM	O
.	O

Furthermore	O
,	O
Hfq	S-Biological_Molecule
regulates	O
translation	O
of	O
more	O
than	O
20	O
%	O
of	O
all	O
Salmonella	S-Species
proteins	O
explaining	O
why	O
a	O
mutation	O
in	O
this	O
gene	O
has	O
such	O
a	O
dramatic	O
phenotype	O
(	O
[	O
54	O
]	O
;	O
Charles	O
Ansong	O
,	O
Hyunjin	O
Yoon	O
,	O
Steffen	O
Porwollik	O
,	O
Heather	O
Mottaz	O
-	O
Brewer	O
,	O
Briana	O
Ogata	O
-	O
Petritis	O
,	O
Navdeep	O
Jaitly	O
,	O
Joshua	O
N	O
.	O
Adkins	O
,	O
Michael	O
McClelland	O
,	O
Fred	O
Heffron	O
,	O
and	O
Richard	O
D	O
.	O
Smith	O
;	O
Global	O
systems	O
-	O
level	O
analysis	O
of	O
small	O
RNA	O
-	O
mediated	O
translational	O
regulation	O
:	O
Implications	O
for	O
virulence	O
and	O
global	O
protein	O
translation	O
;	O
Submitted	O
)	O
.	O

Cluster	O
analysis	O
identifies	O
additional	O
genes	O
that	O
are	O
co	O
-	O
regulated	O
with	O
known	O
virulence	O
factors	O

We	O
searched	O
for	O
additional	O
previously	O
unidentified	O
virulence	O
factors	O
encoded	O
elsewhere	O
on	O
the	O
chromosome	O
that	O
show	O
the	O
same	O
pattern	O
of	O
expression	O
as	O
those	O
located	O
within	O
SPI	O
-	O
2	O
.	O

A	O
systematic	O
way	O
of	O
identifying	O
co	O
-	O
regulation	O
is	O
with	O
one	O
of	O
several	O
computer	O
algorithms	O
that	O
group	O
genes	O
together	O
if	O
their	O
expression	O
is	O
similarly	O
changed	O
under	O
like	O
conditions	O
.	O

The	O
diverse	O
growth	O
conditions	O
used	O
in	O
this	O
study	O
,	O
as	O
well	O
as	O
differences	O
between	O
isogenic	O
strains	O
containing	O
mutations	O
in	O
virulence	O
regulators	O
,	O
make	O
our	O
data	O
set	O
ideal	O
for	O
this	O
type	O
of	O
analysis	O
.	O

In	O
addition	O
,	O
we	O
also	O
performed	O
cluster	O
analysis	O
using	O
public	O
data	O
sets	O
acquired	O
from	O
the	O
NIH	O
sponsored	O
public	O
repository	O
of	O
microarray	O
data	O
,	O
gene	O
expression	O
omnibus	O
(	O
GEO	O
)	O
.	O

We	O
chose	O
120	O
transcriptional	O
profiles	O
from	O
GEO	O
that	O
were	O
derived	O
by	O
extracting	O
RNA	O
from	O
the	O
same	O
parent	O
Salmonella	S-Species
strain	O
grown	O
under	O
a	O
wide	O
variety	O
of	O
culture	O
conditions	O
(	O
GSE2456	O
;	O
G	O
.	O
Yun	O
et	O
al	O
.	O
,	O
unpublished	O
data	O
)	O
.	O

Expression	O
profiles	O
for	O
all	O
genes	O
were	O
uploaded	O
to	O
SEBINI	O
(	O
Software	O
Environment	O
for	O
Biological	O
Network	O
Inference	O
[	O
18	O
]	O
)	O
.	O

The	O
results	O
shown	O
in	O
Figure	O
5	O
use	O
a	O
force	O
-	O
directed	O
network	O
layout	O
algorithm	O
where	O
genes	O
(	O
shown	O
as	O
small	O
colored	O
circles	O
)	O
are	O
generally	O
closer	O
together	O
when	O
their	O
statistical	O
association	O
,	O
and	O
thus	O
degree	O
of	O
predicted	O
co	O
-	O
regulation	O
,	O
is	O
stronger	O
(	O
the	O
cutoff	O
for	O
the	O
genes	O
shown	O
is	O
5	O
standard	O
deviations	O
from	O
the	O
mean	O
or	O
greater	O
;	O
p	O
<	O
.	O
0001	O
)	O
.	O

The	O
cluster	O
analysis	O
identified	O
92	O
genes	O
that	O
are	O
co	O
-	O
regulated	O
with	O
the	O
SPI	O
-	O
2	O
encoded	O
type	O
III	O
secretion	O
system	O
but	O
not	O
located	O
within	O
SPI	O
-	O
2	O
.	O

We	O
analyzed	O
expression	O
of	O
each	O
of	O
the	O
123	O
genes	O
and	O
found	O
that	O
only	O
two	O
genes	O
(	O
pepA	S-Biological_Molecule
and	O
mopB	S-Biological_Molecule
)	O
are	O
negatively	O
regulated	O
;	O
the	O
remaining	O
121	O
are	O
positively	O
regulated	O
.	O

The	O
fact	O
that	O
all	O
of	O
the	O
14	O
regulators	O
in	O
this	O
study	O
have	O
biological	O
functions	O
during	O
infection	O
suggests	O
they	O
could	O
be	O
part	O
of	O
a	O
coordinated	O
network	O
.	O

To	O
identify	O
coordinated	O
regulation	O
we	O
compared	O
expression	O
of	O
each	O
regulator	O
in	O
each	O
mutant	O
background	O
when	O
grown	O
in	O
minimal	O
acidic	O
medium	O
(	O
Figure	O
6A	O
)	O
.	O

A	O
matrix	O
with	O
14	O
mutants	O
in	O
columns	O
and	O
14	O
regulatory	O
genes	O
and	O
SPI	O
-	O
2	O
genes	O
(	O
6	O
genes	O
except	O
for	O
ssrB	S-Biological_Molecule
as	O
used	O
in	O
Figure	O
4	O
)	O
in	O
rows	O
was	O
constructed	O
based	O
on	O
qRT	O
-	O
PCR	O
data	O
and	O
z	O
-	O
scores	O
were	O
calculated	O
based	O
on	O
average	O
and	O
standard	O
deviations	O
from	O
columns	O
and	O
rows	O
.	O

A	O
network	O
among	O
regulators	O
and	O
SPI	O
-	O
2	O
was	O
mapped	O
as	O
described	O
in	O
Lee	O
et	O
al	O
.	O
by	O
sorting	O
out	O
values	O
that	O
changed	O
in	O
a	O
specific	O
mutant	O
background	O
[	O
59	O
]	O
.	O

However	O
,	O
direct	O
or	O
indirect	O
regulation	O
cannot	O
be	O
distinguished	O
without	O
additional	O
experimental	O
verification	O
.	O

So	O
,	O
in	O
Figure	O
6B	O
all	O
regulatory	O
effects	O
on	O
SPI	O
-	O
2	O
have	O
been	O
removed	O
except	O
for	O
those	O
mediated	O
directly	O
by	O
slyA	S-Biological_Molecule
and	O
ssrB	S-Biological_Molecule
based	O
on	O
additional	O
genetic	O
data	O
as	O
described	O
below	O
.	O

An	O
overall	O
network	O
was	O
also	O
generated	O
by	O
integrating	O
4	O
data	O
sets	O
;	O
two	O
CLR	O
algorithm	O
data	O
from	O
the	O
complete	O
microarray	O
results	O
and	O
GSE2456	O
public	O
microarray	O
database	O
and	O
two	O
matrix	O
analysis	O
data	O
from	O
the	O
transcription	O
profiles	O
and	O
qRT	O
-	O
PCR	O
results	O
(	O
Figure	O
S3	O
;	O
the	O
limitation	O
is	O
that	O
no	O
distinction	O
is	O
made	O
between	O
positive	O
and	O
negative	O
regulation	O
in	O
CLR	O
algorithm	O
data	O
)	O
.	O

The	O
consensus	O
network	O
combining	O
all	O
data	O
reported	O
in	O
this	O
study	O
includes	O
the	O
network	O
computed	O
from	O
qRT	O
-	O
PCR	O
(	O
Figure	O
6B	O
)	O
in	O
part	O
and	O
suggests	O
a	O
predictive	O
regulatory	O
cascade	O
that	O
merits	O
a	O
test	O
.	O

However	O
the	O
location	O
of	O
binding	O
sites	O
varies	O
suggesting	O
that	O
SsrB	S-Biological_Molecule
regulation	O
is	O
unusual	O
[	O
52	O
]	O
.	O

Some	O
of	O
the	O
14	O
regulators	O
in	O
this	O
study	O
have	O
been	O
previously	O
shown	O
to	O
directly	O
regulate	O
ssrA	S-Biological_Molecule
/	O
ssrB	S-Biological_Molecule
;	O
OmpR	S-Biological_Molecule
binding	O
to	O
PssrA	S-Biological_Molecule
/	O
ssrB	S-Biological_Molecule
[	O
60	O
]	O
,	O
[	O
61	O
]	O
;	O
SlyA	S-Biological_Molecule
binding	O
to	O
PssrA	S-Biological_Molecule
[	O
62	O
]	O
;	O
PhoP	S-Biological_Molecule
binding	O
to	O
PssrB	S-Biological_Molecule
[	O
45	O
]	O
.	O

Each	O
isogenic	O
derivative	O
was	O
transformed	O
with	O
either	O
pBAD30SsrB	S-Biological_Molecule
or	O
the	O
empty	O
vector	O
control	O
.	O

Expression	O
of	O
an	O
episomal	O
copy	O
of	O
ssrB	S-Biological_Molecule
resulted	O
in	O
expression	O
of	O
SPI	O
-	O
2	O
genes	O
in	O
each	O
mutant	O
background	O
,	O
suggesting	O
that	O
SsrB	S-Biological_Molecule
is	O
epistatic	O
to	O
other	O
regulators	O
for	O
SPI	O
-	O
2	O
transcription	O
.	O

Furthermore	O
,	O
SsrB	S-Biological_Molecule
could	O
complement	O
all	O
three	O
deletions	O
DeltassrB	S-Biological_Molecule
,	O
DeltassrA	S-Biological_Molecule
,	O
and	O
DeltassrA	S-Biological_Molecule
/	O
ssrB	S-Biological_Molecule
(	O
Figure	O
7B	O
)	O
,	O
suggesting	O
that	O
over	O
-	O
expression	O
of	O
SsrB	S-Biological_Molecule
may	O
compensate	O
for	O
differences	O
in	O
phosphorylation	O
that	O
normally	O
play	O
a	O
role	O
in	O
regulation	O
[	O
52	O
]	O
.	O

The	O
number	O
of	O
inputs	O
at	O
each	O
regulator	O
shown	O
in	O
Figure	O
6B	O
corresponds	O
to	O
the	O
number	O
of	O
regulators	O
that	O
directly	O
or	O
indirectly	O
control	O
its	O
expression	O
.	O

The	O
number	O
of	O
regulators	O
that	O
act	O
on	O
slyA	S-Biological_Molecule
was	O
surprising	O
.	O

Quantitative	O
RT	O
-	O
PCR	O
confirmed	O
that	O
slyA	S-Biological_Molecule
transcription	O
was	O
reduced	O
in	O
11	O
of	O
14	O
mutant	O
backgrounds	O
(	O
Figure	O
6A	O
)	O
.	O

The	O
construct	O
strongly	O
complemented	O
ompR	S-Biological_Molecule
/	O
envZ	S-Biological_Molecule
,	O
phoP	S-Biological_Molecule
/	O
phoQ	S-Biological_Molecule
,	O
csrA	S-Biological_Molecule
and	O
himD	S-Biological_Molecule
,	O
suggesting	O
that	O
the	O
effect	O
of	O
these	O
regulators	O
on	O
SPI	O
-	O
2	O
expression	O
may	O
be	O
indirect	O
via	O
regulation	O
of	O
slyA	S-Biological_Molecule
.	O

To	O
test	O
this	O
possibility	O
we	O
constructed	O
double	O
deletions	O
of	O
ssrAB	S-Biological_Molecule
/	O
ompRenvZ	S-Biological_Molecule
,	O
ssrAB	S-Biological_Molecule
/	O
phoPQ	S-Biological_Molecule
,	O
ssrAB	S-Biological_Molecule
/	O
csrA	S-Biological_Molecule
and	O
ssrAB	S-Biological_Molecule
/	O
himD	S-Biological_Molecule
.	O

As	O
shown	O
in	O
Figure	O
7D	O
,	O
slyA	S-Biological_Molecule
is	O
capable	O
of	O
activating	O
expression	O
of	O
SPI	O
-	O
2	O
genes	O
independently	O
of	O
ssrB	S-Biological_Molecule
,	O
ompR	S-Biological_Molecule
/	O
envZ	S-Biological_Molecule
,	O
phoP	S-Biological_Molecule
/	O
phoQ	S-Biological_Molecule
,	O
csrA	S-Biological_Molecule
and	O
himD	S-Biological_Molecule
(	O
ihf	S-Biological_Molecule
)	O
,	O
although	O
the	O
effects	O
are	O
not	O
as	O
strong	O
as	O
ssrB	S-Biological_Molecule
.	O

Furthermore	O
there	O
was	O
a	O
clear	O
dichotomy	O
in	O
expression	O
between	O
the	O
first	O
two	O
SPI	O
-	O
2	O
operons	O
encoding	O
ssaB	S-Biological_Molecule
-	O
ssaE	S-Biological_Molecule
and	O
sseA	S-Biological_Molecule
-	O
sseG	S-Biological_Molecule
and	O
the	O
operons	O
further	O
downstream	O
(	O
ssaG	S-Biological_Molecule
-	O
ssaQ	S-Biological_Molecule
)	O
suggesting	O
that	O
slyA	S-Biological_Molecule
may	O
act	O
at	O
different	O
sites	O
within	O
SPI	O
-	O
2	O
.	O

However	O
,	O
these	O
experiments	O
are	O
based	O
on	O
over	O
-	O
expression	O
of	O
slyA	S-Biological_Molecule
that	O
may	O
complicate	O
the	O
analysis	O
because	O
of	O
binding	O
to	O
sites	O
that	O
would	O
normally	O
not	O
be	O
occupied	O
.	O

Salmonella	S-Species
follows	O
a	O
short	O
course	O
of	O
infection	O
after	O
intraperitoneal	O
infection	O
,	O
as	O
we	O
have	O
used	O
here	O
,	O
passing	O
through	O
the	O
lymph	O
nodes	O
in	O
the	O
peritoneal	O
cavity	O
to	O
the	O
blood	O
stream	O
and	O
then	O
colonizing	O
and	O
replicating	O
within	O
the	O
spleen	O
and	O
liver	O
.	O

RNA	O
was	O
therefore	O
prepared	O
using	O
four	O
laboratory	O
growth	O
conditions	O
two	O
of	O
which	O
partially	O
mimic	O
the	O
intracellular	O
environment	O
(	O
acidic	O
minimal	O
media	O
)	O
.	O

We	O
compared	O
the	O
transcriptional	O
profiles	O
we	O
observed	O
using	O
laboratory	O
growth	O
conditions	O
that	O
mimic	O
intracellular	O
conditions	O
,	O
to	O
those	O
that	O
have	O
been	O
performed	O
during	O
intracellular	O
replication	O
within	O
J774	O
macrophage	O
like	O
cells	O
.	O

[	O
67	O
]	O
thus	O
providing	O
a	O
value	O
that	O
can	O
be	O
compared	O
across	O
different	O
experiments	O
.	O

As	O
the	O
expression	O
pattern	O
changes	O
with	O
time	O
after	O
infection	O
we	O
computed	O
the	O
difference	O
for	O
each	O
time	O
as	O
well	O
as	O
an	O
average	O
for	O
all	O
three	O
-	O
time	O
points	O
reported	O
(	O
4	O
,	O
8	O
,	O
and	O
12	O
hours	O
after	O
infection	O
)	O
.	O

Four	O
of	O
the	O
5	O
most	O
strongly	O
differentially	O
induced	O
genes	O
include	O
magnesium	S-Chemical_Compound
transporters	O
(	O
mgtB	S-Biological_Molecule
and	O
mgtC	S-Biological_Molecule
)	O
,	O
an	O
acid	O
shock	O
protein	O
(	O
STM1485	S-Biological_Molecule
)	O
,	O
and	O
a	O
high	O
affinity	O
phosphate	S-Chemical_Compound
transporter	O
(	O
pstS	S-Biological_Molecule
)	O
suggesting	O
that	O
the	O
acidic	O
minimal	O
media	O
we	O
used	O
may	O
not	O
be	O
low	O
enough	O
in	O
magnesium	S-Chemical_Compound
,	O
phosphate	S-Chemical_Compound
,	O
or	O
may	O
not	O
be	O
sufficiently	O
acidic	O
.	O

Examples	O
of	O
such	O
genes	O
include	O
sifA	S-Biological_Molecule
and	O
the	O
operon	O
STM3117	S-Biological_Molecule
-	O
3120	S-Biological_Molecule
.	O

The	O
nature	O
of	O
the	O
inducing	O
signal	O
(	O
s	O
)	O
that	O
results	O
in	O
expression	O
of	O
these	O
genes	O
during	O
intracellular	O
growth	O
is	O
not	O
known	O
.	O

In	O
our	O
transcriptional	O
network	O
each	O
pink	O
node	O
represents	O
a	O
regulator	O
(	O
Figure	O
6	O
B	O
)	O
and	O
lines	O
represent	O
positive	O
or	O
negative	O
transcriptional	O
interactions	O
(	O
positive	O
in	O
red	O
and	O
negative	O
in	O
blue	O
)	O
.	O

Many	O
of	O
these	O
predicted	O
relationships	O
have	O
been	O
demonstrated	O
already	O
but	O
some	O
are	O
new	O
and	O
merit	O
further	O
investigation	O
.	O

For	O
SPI	O
-	O
2	O
ssrB	S-Biological_Molecule
plays	O
this	O
role	O
and	O
for	O
SPI	O
-	O
1	O
hilA	S-Biological_Molecule
is	O
the	O
central	O
regulator	O
.	O

The	O
multiple	O
promoters	O
located	O
within	O
SPI	O
-	O
2	O
presumably	O
respond	O
to	O
differences	O
in	O
ssrB	S-Biological_Molecule
/	O
slyA	S-Biological_Molecule
activation	O
,	O
perhaps	O
establishing	O
part	O
of	O
the	O
temporal	O
order	O
of	O
expression	O
following	O
phagocytosis	O
of	O
Salmonella	S-Species
.	O

There	O
are	O
other	O
regulators	O
required	O
for	O
systemic	O
infection	O
in	O
BALB	B-Species
/	I-Species
c	I-Species
mice	E-Species
,	O
including	O
those	O
whose	O
absence	O
reduces	O
viability	O
without	O
a	O
compensating	O
mutation	O
(	O
hns	S-Biological_Molecule
;	O
[	O
70	O
]	O
)	O
,	O
those	O
that	O
require	O
deletion	O
of	O
two	O
unlinked	O
genes	O
for	O
inactivation	O
(	O
ppGpp	O
;	O
reviewed	O
in	O
[	O
71	O
]	O
and	O
ydgT	S-Biological_Molecule
/	O
hha	S-Biological_Molecule
[	O
48	O
]	O
)	O
,	O
or	O
those	O
that	O
were	O
simply	O
missed	O
in	O
the	O
screens	O
(	O
STM0410	S-Biological_Molecule
;	O
[	O
72	O
]	O
)	O
;	O
these	O
regulators	O
will	O
be	O
included	O
in	O
subsequent	O
analyses	O
.	O

There	O
have	O
been	O
several	O
studies	O
to	O
identify	O
environmental	O
factors	O
that	O
regulate	O
expression	O
of	O
the	O
type	O
III	O
secretion	O
system	O
encoded	O
within	O
SPI	O
-	O
2	O
.	O

Carbon	S-Chemical_Compound
limitation	O
,	O
low	O
concentrations	O
of	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
or	O
Ca2	B-Chemical_Compound
+	E-Chemical_Compound
[	O
73	O
]	O
,	O
and	O
acidic	O
pH	O
[	O
47	O
]	O
,	O
[	O
61	O
]	O
induce	O
SPI	O
-	O
2	O
expression	O
in	O
vitro	O
.	O

Inside	O
professional	O
phagocytic	O
cells	O
divalent	O
cation	O
concentrations	O
and	O
the	O
presence	O
of	O
defensin	O
-	O
like	O
molecules	O
signal	O
through	O
phoP	S-Biological_Molecule
/	O
phoQ	S-Biological_Molecule
[	O
74	O
]	O
,	O
[	O
75	O
]	O
,	O
and	O
acidic	O
pH	O
and	O
osmolarity	O
signal	O
through	O
ompR	S-Biological_Molecule
/	O
envZ	S-Biological_Molecule
[	O
76	O
]	O
.	O

OmpR	S-Biological_Molecule
has	O
been	O
shown	O
to	O
respond	O
to	O
acidic	O
pH	O
via	O
cadC	S-Biological_Molecule
[	O
77	O
]	O
.	O

It	O
is	O
surprising	O
that	O
over	O
-	O
expression	O
of	O
ssrB	S-Biological_Molecule
can	O
compensate	O
for	O
a	O
deletion	O
of	O
ssrA	S-Biological_Molecule
or	O
ssrA	S-Biological_Molecule
/	O
ssrB	S-Biological_Molecule
.	O

Yet	O
,	O
expression	O
of	O
ssrB	S-Biological_Molecule
without	O
ssrA	S-Biological_Molecule
results	O
in	O
expression	O
of	O
all	O
7	O
SPI	O
-	O
2	O
genes	O
examined	O
(	O
Figure	O
7A	O
)	O
.	O

Mutations	O
in	O
rpoE	S-Biological_Molecule
,	O
smpB	S-Biological_Molecule
,	O
rpoS	S-Biological_Molecule
,	O
and	O
hfq	S-Biological_Molecule
showed	O
only	O
small	O
decreases	O
in	O
SPI	O
-	O
2	O
gene	O
transcription	O
during	O
growth	O
in	O
minimal	O
acidic	O
media	O
but	O
some	O
of	O
them	O
showed	O
large	O
defects	O
in	O
survival	O
assays	O
performed	O
in	O
murine	S-Species
macrophages	O
.	O

For	O
rpoE	S-Biological_Molecule
and	O
rpoS	S-Biological_Molecule
it	O
is	O
possible	O
that	O
the	O
environmental	O
conditions	O
that	O
distinguish	O
growth	O
in	O
minimal	O
media	O
from	O
those	O
in	O
the	O
SCV	S-Species
inside	O
hosts	O
are	O
sensed	O
via	O
these	O
two	O
alternative	O
sigma	O
factors	O
.	O

Post	O
-	O
transcriptional	O
SPI	O
-	O
2	O
regulation	O
is	O
a	O
likely	O
explanation	O
for	O
the	O
large	O
intracellular	O
growth	O
defects	O
observed	O
in	O
the	O
mutant	O
smpB	S-Biological_Molecule
and	O
hfq	S-Biological_Molecule
derivatives	O
despite	O
relative	O
small	O
transcriptional	O
effects	O
.	O

Perhaps	O
these	O
regulators	O
are	O
selected	O
during	O
growth	O
in	O
other	O
cell	O
types	O
or	O
within	O
phagocytic	O
cells	O
that	O
are	O
activated	O
as	O
a	O
consequence	O
of	O
the	O
inflammatory	O
response	O
generated	O
by	O
the	O
bacteria	O
.	O

SlyA	S-Biological_Molecule
and	O
SsrA	S-Biological_Molecule
/	O
SsrB	S-Biological_Molecule
together	O
activate	O
transcription	O
of	O
the	O
SPI	O
-	O
2	O
encoded	O
secretion	O
apparatus	O

SlyA	S-Biological_Molecule
is	O
a	O
DNA	O
-	O
binding	O
protein	O
with	O
high	O
affinity	O
for	O
inverted	O
repeat	O
sequences	O
[	O
79	O
]	O
and	O
the	O
binding	O
ability	O
of	O
SlyA	S-Biological_Molecule
to	O
the	O
ssrA	S-Biological_Molecule
promoter	O
region	O
was	O
previously	O
reported	O
[	O
62	O
]	O
.	O

SPI	O
-	O
2	O
regulation	O
by	O
SsrB	S-Biological_Molecule
and	O
SlyA	S-Biological_Molecule
may	O
be	O
explained	O
in	O
a	O
similar	O
mechanism	O
where	O
both	O
SlyA	S-Biological_Molecule
and	O
SsrB	S-Biological_Molecule
counteract	O
the	O
silencing	O
activity	O
of	O
H	B-Biological_Molecule
-	I-Biological_Molecule
NS	E-Biological_Molecule
/	O
YdgT	S-Biological_Molecule
/	O
Hha	S-Biological_Molecule
by	O
competing	O
for	O
binding	O
to	O
the	O
same	O
target	O
sequences	O
or	O
by	O
altering	O
the	O
structure	O
of	O
the	O
DNA	O
to	O
promote	O
transcription	O
for	O
SPI	O
-	O
2	O
.	O

[	O
81	O
]	O
found	O
that	O
there	O
was	O
no	O
consensus	O
SsrB	S-Biological_Molecule
binding	O
site	O
or	O
distance	O
relative	O
to	O
the	O
transcription	O
start	O
sites	O
and	O
Walthers	O
(	O
ibid	O
)	O
proposes	O
that	O
different	O
promoters	O
may	O
be	O
activated	O
by	O
distinct	O
SsrB	S-Biological_Molecule
mechanisms	O
.	O

Our	O
results	O
support	O
this	O
conclusion	O
and	O
extend	O
the	O
observation	O
to	O
slyA	S-Biological_Molecule
at	O
least	O
for	O
specific	O
SPI	O
-	O
2	O
transcripts	O
.	O

Thus	O
,	O
one	O
explanation	O
for	O
the	O
transcription	O
we	O
observe	O
following	O
over	O
-	O
expression	O
of	O
ssrB	S-Biological_Molecule
or	O
slyA	S-Biological_Molecule
may	O
be	O
that	O
both	O
SlyA	S-Biological_Molecule
and	O
SsrB	S-Biological_Molecule
counteract	O
binding	O
of	O
small	O
nucleoid	O
-	O
like	O
proteins	O
including	O
both	O
H	B-Biological_Molecule
-	I-Biological_Molecule
NS	E-Biological_Molecule
and	O
YdgD	S-Biological_Molecule
/	O
Hha	S-Biological_Molecule
in	O
this	O
A	O
+	O
T	O
rich	O
SPI	O
-	O
2	O
region	O
[	O
70	O
]	O
.	O

Clustering	O
analysis	O
and	O
co	O
-	O
expression	O

The	O
complex	O
regulatory	O
network	O
suggested	O
by	O
these	O
studies	O
has	O
been	O
partially	O
confirmed	O
.	O

Complete	O
elucidation	O
of	O
the	O
virulence	O
pathways	O
must	O
include	O
proteomic	O
studies	O
to	O
identify	O
steps	O
that	O
require	O
translational	O
regulation	O
,	O
binding	O
studies	O
to	O
distinguish	O
direct	O
from	O
indirect	O
effects	O
and	O
additional	O
regulators	O
not	O
included	O
in	O
this	O
preliminary	O
group	O
of	O
14	O
.	O

In	O
this	O
study	O
,	O
cluster	O
analysis	O
was	O
used	O
to	O
identify	O
genes	O
that	O
show	O
similar	O
expression	O
profiles	O
under	O
a	O
variety	O
of	O
environmental	O
conditions	O
and	O
from	O
the	O
isogenic	O
Salmonella	S-Species
regulatory	O
mutants	O
we	O
describe	O
.	O

The	O
average	O
G	O
+	O
C	O
content	O
of	O
the	O
92	O
genes	O
outside	O
of	O
SPI	O
-	O
2	O
that	O
show	O
the	O
same	O
regulation	O
as	O
SPI	O
-	O
2	O
is	O
47	O
%	O
while	O
the	O
average	O
for	O
Salmonella	S-Species
is	O
52	O
%	O
(	O
p	O
<	O
e	O
-	O
25	O
)	O
.	O

The	O
construction	O
of	O
a	O
complete	O
interaction	O
network	O
describing	O
both	O
the	O
host	O
and	O
pathogen	O
is	O
a	O
long	O
-	O
term	O
goal	O
of	O
this	O
and	O
other	O
related	O
research	O
efforts	O
.	O

Mycobacterium	B-Species
tuberculosis	E-Species
Universal	O
Stress	O
Protein	O
Rv2623	S-Biological_Molecule
Regulates	O
Bacillary	O
Growth	O
by	O
ATP	S-Chemical_Compound
-	O
Binding	O
:	O
Requirement	O
for	O
Establishing	O
Chronic	O
Persistent	O
Infection	O

Induction	O
of	O
rv2623	S-Biological_Molecule
also	O
occurs	O
when	O
M	B-Species
.	I-Species
tuberculosis	E-Species
encounters	O
conditions	O
associated	O
with	O
growth	O
arrest	O
,	O
such	O
as	O
the	O
intracellular	O
milieu	O
of	O
macrophages	O
and	O
in	O
the	O
lungs	O
of	O
mice	S-Species
with	O
chronic	O
tuberculosis	O
.	O

Therefore	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
Rv2623	S-Biological_Molecule
regulates	O
tuberculosis	O
latency	O
.	O

We	O
observed	O
that	O
an	O
Rv2623	S-Biological_Molecule
-	O
deficient	O
mutant	O
fails	O
to	O
establish	O
chronic	O
tuberculous	O
infection	O
in	O
guinea	B-Species
pigs	E-Species
and	O
mice	S-Species
,	O
exhibiting	O
a	O
hypervirulence	O
phenotype	O
associated	O
with	O
increased	O
bacterial	O
burden	O
and	O
mortality	O
.	O

Consistent	O
with	O
this	O
in	O
vivo	O
growth	O
-	O
regulatory	O
role	O
,	O
constitutive	O
overexpression	O
of	O
rv2623	S-Biological_Molecule
attenuates	O
mycobacterial	O
growth	O
in	O
vitro	O
.	O

Biochemical	O
analysis	O
of	O
purified	O
Rv2623	S-Biological_Molecule
suggested	O
that	O
this	O
mycobacterial	O
USP	O
binds	O
ATP	S-Chemical_Compound
,	O
and	O
the	O
2	O
.	O
9	O
-	O
A	O
-	O
resolution	O
crystal	O
structure	O
revealed	O
that	O
Rv2623	S-Biological_Molecule
engages	O
ATP	S-Chemical_Compound
in	O
a	O
novel	O
nucleotide	O
-	O
binding	O
pocket	O
.	O

Structure	O
-	O
guided	O
mutagenesis	O
yielded	O
Rv2623	S-Biological_Molecule
mutants	O
with	O
reduced	O
ATP	S-Chemical_Compound
-	O
binding	O
capacity	O
.	O

We	O
propose	O
that	O
Rv2623	S-Biological_Molecule
may	O
function	O
as	O
an	O
ATP	S-Chemical_Compound
-	O
dependent	O
signaling	O
intermediate	O
in	O
a	O
pathway	O
that	O
promotes	O
persistent	O
infection	O
.	O

The	O
remaining	O
90	O
%	O
of	O
the	O
infected	O
individuals	O
are	O
asymptomatic	O
,	O
and	O
are	O
generally	O
believed	O
to	O
harbor	O
latent	O
bacilli	O
that	O
can	O
reactivate	O
to	O
cause	O
tuberculous	O
diseases	O
,	O
sometimes	O
decades	O
after	O
the	O
initial	O
infection	O
.	O

Understanding	O
the	O
dynamic	O
interaction	O
between	O
host	O
and	O
pathogen	O
during	O
the	O
establishment	O
of	O
persistent	O
M	B-Species
.	I-Species
tuberculosis	E-Species
infection	O
will	O
guide	O
the	O
design	O
of	O
novel	O
treatment	O
for	O
the	O
latently	O
infected	O
population	O
.	O

Nitric	B-Chemical_Compound
oxide	E-Chemical_Compound
(	O
NO	S-Chemical_Compound
)	O
produced	O
by	O
infected	O
macrophages	O
and	O
relative	O
hypoxia	O
are	O
signals	O
likely	O
to	O
be	O
encountered	O
within	O
tuberculous	O
lesions	O
that	O
are	O
believed	O
,	O
based	O
on	O
in	O
vitro	O
studies	O
,	O
to	O
promote	O
latency	O
by	O
prompting	O
the	O
M	B-Species
.	I-Species
tuberculosis	E-Species
dormancy	O
response	O
.	O

Among	O
this	O
set	O
of	O
genes	O
is	O
rv2623	S-Biological_Molecule
,	O
one	O
of	O
eight	O
M	B-Species
.	I-Species
tuberculosis	E-Species
genes	O
annotated	O
as	O
containing	O
the	O
universal	O
stress	O
protein	O
(	O
USP	O
)	O
domain	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
.	O

Increased	O
expression	O
of	O
rv2623	S-Biological_Molecule
was	O
also	O
observed	O
following	O
phagocytosis	O
by	O
macrophages	O
[	O
10	O
]	O
and	O
in	O
the	O
lungs	O
of	O
chronically	O
infected	O
mice	S-Species
[	O
11	O
]	O
,	O
supporting	O
a	O
functional	O
role	O
during	O
persistent	O
M	B-Species
.	I-Species
tuberculosis	E-Species
infection	O
.	O

Results	O

Mycobacterium	B-Species
tuberculosis	E-Species
Rv2623	S-Biological_Molecule
regulates	O
growth	O
in	O
vitro	O
An	O
rv2623	S-Biological_Molecule
-	O
deletion	O
mutant	O
of	O
the	O
virulent	O
M	B-Species
.	I-Species
tuberculosis	I-Species
Erdman	I-Species
strain	E-Species
was	O
generated	O
by	O
specialized	O
transduction	O
[	O
12	O
]	O
.	O

The	O
rv2623	S-Biological_Molecule
-	O
specific	O
allelic	O
exchange	O
construct	O
was	O
delivered	O
via	O
recombinant	O
mycobacteriophage	O
phAE159	O
and	O
transformants	O
were	O
analyzed	O
by	O
Southern	O
blot	O
,	O
confirming	O
replacement	O
of	O
rv2623	S-Biological_Molecule
with	O
the	O
hyg	O
gene	O
,	O
which	O
confers	O
hygromycin	S-Chemical_Compound
resistance	O
(	O
Figure	O
1A	O
)	O
.	O

However	O
,	O
the	O
in	O
vitro	O
growth	O
kinetics	O
of	O
Deltarv2623	S-Biological_Molecule
M	O
.	O
tuberculosis	O
in	O
OADC	S-Chemical_Compound
-	O
supplemented	O
Middlebrook	O
7H9	O
or	O
minimal	O
Sauton	O
'	O
s	O
medium	O
is	O
comparable	O
to	O
that	O
of	O
wildtype	O
Erdman	S-Species
up	O
to	O
14	O
days	O
post	O
-	O
inoculation	O
(	O
Figure	O
2A	O
)	O
.	O

We	O
reasoned	O
that	O
a	O
potential	O
growth	O
-	O
regulating	O
attribute	O
of	O
Rv2623	S-Biological_Molecule
might	O
be	O
masked	O
by	O
functional	O
redundancy	O
among	O
the	O
M	B-Species
.	I-Species
tuberculosis	E-Species
USP	O
homologs	O
.	O

As	O
seen	O
in	O
Figure	O
2B	O
,	O
constitutive	O
overexpression	O
of	O
M	B-Species
.	I-Species
tuberculosis	E-Species
rv2623	S-Biological_Molecule
using	O
the	O
multi	O
-	O
copy	O
plasmid	O
pMV261	O
resulted	O
in	O
growth	O
deficiency	O
of	O
the	O
recipient	O
strain	O
both	O
on	O
solid	O
medium	O
(	O
Middlebrook	O
7H10	O
agar	O
)	O
and	O
in	O
the	O
liquid	O
medium	O
-	O
based	O
BD	O
BACTEC	O
9000MB	O
system	O
.	O

These	O
results	O
strongly	O
suggest	O
that	O
M	B-Species
.	I-Species
tuberculosis	E-Species
Rv2623	S-Biological_Molecule
regulates	O
mycobacterial	O
growth	O
in	O
vitro	O
.	O

Although	O
USP	O
family	O
proteins	O
are	O
expressed	O
by	O
many	O
bacterial	O
pathogens	O
[	O
7	O
]	O
,	O
[	O
8	O
]	O
,	O
to	O
date	O
,	O
there	O
has	O
only	O
been	O
one	O
in	O
vivo	O
study	O
,	O
which	O
showed	O
that	O
a	O
Salmonella	S-Species
USP	O
promotes	O
virulence	O
in	O
mice	S-Species
[	O
17	O
]	O
.	O

The	O
observation	O
that	O
Rv2623	S-Biological_Molecule
modulates	O
mycobacterial	O
growth	O
in	O
vitro	O
prompted	O
us	O
to	O
examine	O
the	O
effect	O
of	O
this	O
USP	O
on	O
the	O
in	O
vivo	O
kinetics	O
of	O
M	B-Species
.	I-Species
tuberculosis	E-Species
infection	O
.	O

Low	O
dose	O
aerosol	O
infection	O
of	O
outbred	O
Hartley	O
guinea	B-Species
pigs	E-Species
with	O
approximately30	O
CFU	O
revealed	O
a	O
clear	O
growth	O
advantage	O
of	O
the	O
Deltarv2623	S-Biological_Molecule
mutant	O
strain	O
relative	O
to	O
wildtype	O
.	O

Finally	O
,	O
complementation	O
with	O
a	O
single	O
integrated	O
copy	O
of	O
rv2623	S-Biological_Molecule
expressed	O
from	O
a	O
constitutive	O
mycobacterial	O
promoter	O
(	O
Deltarv2623	S-Biological_Molecule
attB	S-Biological_Molecule
:	O
:	O
Phsp60Rv2623	S-Biological_Molecule
)	O
abrogated	O
the	O
growth	O
advantage	O
of	O
the	O
deletion	O
mutant	O
(	O
Figure	O
3A	O
)	O
.	O

Also	O
consistent	O
with	O
the	O
fulminate	O
disease	O
progression	O
displayed	O
by	O
Deltarv2623	S-Biological_Molecule
-	O
infected	O
guinea	O
pigs	O
are	O
the	O
more	O
severe	O
pathological	O
changes	O
observed	O
as	O
early	O
as	O
20	O
days	O
post	O
-	O
infection	O
in	O
the	O
lungs	O
of	O
these	O
animals	O
,	O
as	O
assessed	O
by	O
histopathological	O
studies	O
,	O
including	O
the	O
semi	O
-	O
quantitative	O
Total	O
Lung	O
Score	O
analysis	O
(	O
Figure	O
3B	O
and	O
Protocol	O
S1	O
)	O
.	O

Results	O
of	O
the	O
complementation	O
experiments	O
were	O
further	O
validated	O
using	O
a	O
complemented	O
strain	O
Deltarv2623	S-Biological_Molecule
attB	S-Biological_Molecule
:	O
:	O
Prv2623Rv2623	S-Biological_Molecule
,	O
whose	O
expression	O
of	O
the	O
wildtype	O
universal	O
stress	O
protein	O
is	O
driven	O
by	O
the	O
native	O
rv2623	S-Biological_Molecule
promoter	O
[	O
18	O
]	O
(	O
Figure	O
3D	O
and	O
E	O
)	O
.	O

In	O
contrast	O
to	O
the	O
result	O
of	O
the	O
guinea	B-Species
pig	E-Species
study	O
,	O
we	O
observed	O
no	O
difference	O
in	O
the	O
kinetics	O
of	O
infection	O
between	O
C57BL	B-Species
/	I-Species
6	I-Species
mice	E-Species
infected	O
with	O
wildtype	O
M	B-Species
.	I-Species
tuberculosis	E-Species
,	O
Deltarv2623	S-Biological_Molecule
,	O
or	O
the	O
attB	S-Biological_Molecule
:	O
:	O
Phsp60	S-Biological_Molecule
Rv2623	S-Biological_Molecule
complemented	O
strain	O
in	O
a	O
low	O
dose	O
aerogenic	O
model	O
[	O
19	O
]	O
,	O
as	O
assessed	O
by	O
lung	O
bacterial	O
burden	O
(	O
Figure	O
4A	O
)	O
.	O

In	O
fact	O
,	O
evidence	O
exists	O
that	O
M	B-Species
.	I-Species
tuberculosis	E-Species
triggers	O
an	O
immune	O
response	O
in	O
mice	S-Species
that	O
is	O
in	O
excess	O
of	O
that	O
required	O
for	O
controlling	O
the	O
infection	O
[	O
22	O
]	O
,	O
[	O
23	O
]	O
.	O

Thus	O
,	O
the	O
hypervirulence	O
phenotype	O
of	O
Deltarv2623	S-Biological_Molecule
observed	O
in	O
the	O
susceptible	O
guinea	B-Species
pig	E-Species
model	O
could	O
have	O
been	O
masked	O
in	O
the	O
C57BL	B-Species
/	I-Species
6	I-Species
mice	E-Species
.	O

Consequently	O
,	O
we	O
examined	O
the	O
virulence	O
of	O
Deltarv2623	S-Biological_Molecule
in	O
the	O
relatively	O
susceptible	O
C3H	B-Species
/	I-Species
HeJ	I-Species
mouse	E-Species
strain	O
[	O
24	O
]	O
.	O

Indeed	O
,	O
the	O
Deltarv2623	S-Biological_Molecule
mutant	O
was	O
markedly	O
more	O
virulent	O
relative	O
to	O
wildtype	O
Erdman	B-Species
M	I-Species
.	I-Species
tuberculosis	E-Species
following	O
aerogenic	O
infection	O
,	O
as	O
assessed	O
by	O
the	O
mean	O
survival	O
time	O
of	O
C3H	B-Species
/	I-Species
HeJ	I-Species
mice	E-Species
infected	O
with	O
these	O
strains	O
(	O
62	O
and	O
25	O
.	O
5	O
days	O
post	O
infection	O
for	O
Erdman	S-Species
-	O
and	O
Deltarv2623	S-Biological_Molecule
-	O
infected	O
mice	O
,	O
respectively	O
,	O
p	O
=	O
0	O
.	O
0014	O
;	O
Figure	O
4B	O
)	O
.	O

In	O
agreement	O
with	O
the	O
survival	O
data	O
,	O
quantification	O
of	O
tissue	O
bacterial	O
burden	O
revealed	O
a	O
growth	O
advantage	O
for	O
the	O
Rv2623	S-Biological_Molecule
-	O
deficient	O
mutant	O
relative	O
to	O
wildtype	O
M	B-Species
.	I-Species
tuberculosis	I-Species
Erdman	E-Species
(	O
Figure	O
4C	O
)	O
.	O

As	O
in	O
the	O
guinea	B-Species
pig	E-Species
studies	O
,	O
results	O
of	O
complementation	O
experiments	O
involving	O
the	O
reintroduction	O
of	O
a	O
single	O
copy	O
of	O
wildtype	O
rv2623	S-Biological_Molecule
into	O
Deltarv2623	S-Biological_Molecule
M	O
.	O
tuberculosis	O
reverses	O
the	O
hypervirulence	O
(	O
Figure	O
4C	O
)	O
exhibited	O
in	O
the	O
C3H	B-Species
/	I-Species
HeJ	E-Species
model	O
,	O
thus	O
indicating	O
that	O
the	O
observed	O
growth	O
phenotype	O
of	O
the	O
tubercle	B-Species
bacillus	E-Species
deficient	O
for	O
the	O
universal	O
stress	O
protein	O
is	O
rv2623	S-Biological_Molecule
-	O
specific	O
.	O

Effects	O
of	O
environmental	O
stress	O
on	O
growth	O
of	O
M	O
.	O
tuberculosis	O
Deltarv2623	S-Biological_Molecule
in	O
vitro	O

Although	O
the	O
functions	O
of	O
universal	O
stress	O
proteins	O
have	O
yet	O
to	O
be	O
completely	O
defined	O
,	O
there	O
is	O
evidence	O
that	O
many	O
USPs	O
play	O
differential	O
roles	O
in	O
protecting	O
microbes	O
against	O
various	O
environmental	O
stresses	O
[	O
9	O
]	O
.	O

Therefore	O
,	O
the	O
hypervirulence	O
of	O
Deltarv2623	S-Biological_Molecule
in	O
guinea	B-Species
pigs	E-Species
and	O
susceptible	O
mice	S-Species
is	O
intriguing	O
;	O
if	O
Rv2623	S-Biological_Molecule
provides	O
M	B-Species
.	I-Species
tuberculosis	E-Species
protection	O
against	O
stress	O
,	O
it	O
might	O
be	O
expected	O
that	O
the	O
Rv2623	S-Biological_Molecule
-	O
deficient	O
mutant	O
would	O
be	O
attenuated	O
in	O
vivo	O
.	O

The	O
growth	O
kinetics	O
and	O
survival	O
of	O
the	O
Deltarv2623	S-Biological_Molecule
strain	O
was	O
examined	O
under	O
various	O
stress	O
conditions	O
,	O
including	O
those	O
likely	O
to	O
be	O
present	O
during	O
M	B-Species
.	I-Species
tuberculosis	E-Species
infection	O
.	O

These	O
results	O
support	O
the	O
notion	O
that	O
it	O
is	O
unlikely	O
that	O
M	B-Species
.	I-Species
tuberculosis	E-Species
Rv2623	S-Biological_Molecule
is	O
essential	O
for	O
resistance	O
to	O
stresses	O
encountered	O
in	O
the	O
host	O
,	O
which	O
is	O
consistent	O
with	O
the	O
observed	O
in	O
vivo	O
hypervirulence	O
phenotype	O
of	O
Deltarv2623	S-Biological_Molecule
.	O

M	B-Species
.	I-Species
tuberculosis	E-Species
Rv2623	S-Biological_Molecule
is	O
a	O
nucleotide	O
-	O
binding	O
protein	O

M	B-Species
.	I-Species
tuberculosis	E-Species
Rv2623	S-Biological_Molecule
was	O
expressed	O
in	O
E	B-Species
.	I-Species
coli	E-Species
and	O
purified	O
to	O
homogeneity	O
for	O
biochemical	O
studies	O
.	O

SDS	O
-	O
PAGE	O
analysis	O
of	O
affinity	O
-	O
purified	O
His6	O
-	O
Rv2623	S-Biological_Molecule
revealed	O
a	O
single	O
band	O
that	O
approximates	O
the	O
predicted	O
molecular	O
mass	O
of	O
approximately31	O
.	O
6	O
kDa	O
,	O
which	O
was	O
identified	O
by	O
immunoblotting	O
as	O
Rv2623	S-Biological_Molecule
(	O
Figure	O
S3	O
)	O
.	O

On	O
the	O
basis	O
of	O
structures	O
of	O
ATP	S-Chemical_Compound
-	O
binding	O
and	O
non	O
-	O
ATP	S-Chemical_Compound
-	O
binding	O
USPs	O
,	O
a	O
G	O
-	O
2X	O
-	O
G	O
-	O
9X	O
-	O
G	O
(	O
S	O
/	O
T	O
)	O
motif	O
was	O
suggested	O
to	O
be	O
essential	O
for	O
the	O
binding	O
of	O
ATP	S-Chemical_Compound
[	O
27	O
]	O
.	O

The	O
presence	O
of	O
this	O
motif	O
in	O
each	O
of	O
the	O
two	O
tandem	O
USP	O
domains	O
of	O
Rv2623	S-Biological_Molecule
[	O
7	O
]	O
raised	O
the	O
possibility	O
that	O
this	O
protein	O
possesses	O
ATP	S-Chemical_Compound
binding	O
activity	O
.	O

An	O
HPLC	O
-	O
based	O
examination	O
of	O
supernatants	O
from	O
boiled	O
samples	O
of	O
His6	O
-	O
Rv2623	S-Biological_Molecule
demonstrated	O
that	O
His6	O
-	O
Rv2623	S-Biological_Molecule
co	O
-	O
purifies	O
with	O
both	O
ATP	S-Chemical_Compound
and	O
ADP	S-Chemical_Compound
(	O
Figure	O
5	O
)	O
.	O

Analysis	O
of	O
E	B-Species
.	I-Species
coli	E-Species
-	O
expressed	O
Rv2623	S-Biological_Molecule
using	O
nano	O
ESI	O
mass	O
spectrometry	O
also	O
demonstrated	O
that	O
an	O
ATP	S-Chemical_Compound
-	O
saturated	O
form	O
of	O
dimeric	O
Rv2623	S-Biological_Molecule
(	O
composed	O
of	O
2	O
bound	O
ATP	S-Chemical_Compound
molecules	O
per	O
monomer	O
)	O
constitutes	O
at	O
least	O
half	O
of	O
the	O
purified	O
sample	O
(	O
data	O
not	O
shown	O
)	O
.	O

Thus	O
,	O
Rv2623	S-Biological_Molecule
binds	O
endogenous	O
adenine	O
nucleotides	O
in	O
E	B-Species
.	I-Species
coli	E-Species
,	O
and	O
the	O
association	O
is	O
sufficiently	O
tight	O
that	O
nearly	O
75	O
%	O
of	O
the	O
nucleotide	O
binding	O
sites	O
are	O
occupied	O
upon	O
purification	O
.	O

Indeed	O
,	O
nucleotide	O
did	O
not	O
completely	O
dissociate	O
from	O
the	O
protein	O
following	O
an	O
extensive	O
,	O
two	O
-	O
week	O
dialysis	O
with	O
multiple	O
changes	O
against	O
nucleotide	O
-	O
free	O
buffer	O
(	O
approximately	O
0	O
.	O
3	O
nucleotide	O
equivalents	O
per	O
monomer	O
remain	O
)	O
.	O

It	O
is	O
conceivable	O
that	O
the	O
presence	O
of	O
ADP	S-Chemical_Compound
is	O
the	O
consequence	O
of	O
an	O
Rv2623	S-Biological_Molecule
-	O
associated	O
ATP	S-Chemical_Compound
activity	O
and	O
this	O
putative	O
ATPase	S-Chemical_Compound
function	O
is	O
currently	O
under	O
investigation	O
.	O

To	O
examine	O
the	O
biochemical	O
mechanisms	O
responsible	O
for	O
Rv2623	S-Biological_Molecule
function	O
,	O
we	O
determined	O
the	O
crystal	O
structure	O
of	O
wild	O
-	O
type	O
Rv2623	S-Biological_Molecule
at	O
a	O
resolution	O
of	O
2	O
.	O
9	O
A	O
.	O

The	O
structure	O
reveals	O
a	O
compact	O
,	O
2	O
-	O
fold	O
symmetric	O
dimer	O
.	O

Each	O
domain	O
possesses	O
a	O
pair	O
of	O
conserved	O
betaalphabeta	O
motifs	O
(	O
domain	O
1	O
:	O
beta1	O
-	O
L1	O
-	O
alpha1	O
-	O
beta2	O
,	O
beta4	O
-	O
L2	O
-	O
alpha4	O
-	O
beta5	O
;	O
domain	O
2	O
:	O
beta6	O
-	O
L3	O
-	O
alpha5	O
-	O
beta7	O
,	O
beta9	O
-	O
L4	O
-	O
alpha8	O
-	O
beta10	O
)	O
that	O
encompass	O
four	O
loops	O
(	O
designated	O
L1	O
-	O
L4	O
)	O
responsible	O
for	O
ATP	S-Chemical_Compound
recognition	O
(	O
Figure	O
6A	O
and	O
C	O
)	O
.	O

A	O
"	O
U	O
-	O
shaped	O
"	O
ATP	S-Chemical_Compound
molecule	O
that	O
lies	O
within	O
a	O
cleft	O
near	O
the	O
monomer	O
surface	O
is	O
stabilized	O
by	O
1	O
)	O
a	O
cluster	O
of	O
hydrophobic	O
residues	O
(	O
I14	O
,	O
V41	O
,	O
H42	O
,	O
V116	O
/	O
132	O
/	O
261	O
/	O
277	O
/	O
281	O
,	O
L136	O
,	O
A175	O
)	O
that	O
forge	O
the	O
adenine	O
/	O
ribose	O
-	O
binding	O
scaffold	O
,	O
2	O
)	O
a	O
pair	O
of	O
conserved	O
L1	O
/	O
L3	O
aspartates	O
(	O
D15	O
-	O
L1	O
/	O
D167	O
-	O
L3	O
)	O
,	O
and	O
3	O
)	O
small	O
phosphoryl	O
/	O
ribosyl	O
-	O
binding	O
residues	O
within	O
the	O
G	O
-	O
2X	O
-	O
G	O
-	O
9X	O
-	O
G	O
(	O
S	O
/	O
T	O
)	O
motifs	O
that	O
comprise	O
L2	O
/	O
L4	O
(	O
G120	O
/	O
265	O
/	O
267	O
/	O
268	O
and	O
S131	O
/	O
276	O
)	O
(	O
Figures	O
6A	O
,	O
C	O
and	O
7A	O
)	O
.	O

Dimerization	O
of	O
Rv2623	S-Biological_Molecule
occurs	O
along	O
a	O
2	O
-	O
fold	O
axis	O
orthogonal	O
to	O
the	O
intramonomer	O
dyad	O
and	O
juxtaposes	O
ATP	S-Chemical_Compound
binding	O
pockets	O
from	O
opposing	O
monomers	O
(	O
Figure	O
6B	O
)	O
.	O

Phylogenomic	O
analysis	O
places	O
Rv2623	S-Biological_Molecule
in	O
a	O
Uniprot	O
/	O
TrEMBL	O
family	O
(	O
Q5YVE7	O
)	O
of	O
370	O
tandem	O
-	O
domain	O
USPs	O
,	O
and	O
a	O
113	O
-	O
member	O
subfamily	O
(	O
N631	O
)	O
that	O
consists	O
almost	O
exclusively	O
of	O
actinobacterial	O
representatives	O
(	O
Text	O
S1	O
)	O
.	O

As	O
this	O
manuscript	O
was	O
under	O
preparation	O
,	O
a	O
second	O
,	O
lower	O
resolution	O
(	O
3	O
.	O
2	O
A	O
)	O
crystal	O
form	O
of	O
Rv2623	S-Biological_Molecule
(	O
PDB	O
ID	O
2JAX	O
)	O
was	O
released	O
for	O
public	O
access	O
.	O

To	O
gain	O
insight	O
into	O
the	O
ATP	S-Chemical_Compound
-	O
binding	O
mode	O
(	O
s	O
)	O
exhibited	O
by	O
Rv2623	S-Biological_Molecule
,	O
the	O
structural	O
features	O
of	O
the	O
ATP	S-Chemical_Compound
-	O
binding	O
pocket	O
of	O
domains	O
1	O
/	O
2	O
were	O
compared	O
to	O
the	O
monomer	O
fold	O
of	O
the	O
representative	O
ATP	S-Chemical_Compound
-	O
binding	O
USP	O
,	O
MJ0577	S-Biological_Molecule
(	O
PDBID	O
1MJH	O
)	O
[	O
26	O
]	O
.	O

Relatively	O
subtle	O
structural	O
and	O
phylogenetic	O
differences	O
that	O
exist	O
between	O
the	O
ATP	S-Chemical_Compound
-	O
binding	O
pockets	O
might	O
nevertheless	O
confer	O
divergent	O
binding	O
and	O
/	O
or	O
regulatory	O
properties	O
to	O
the	O
tandem	O
domains	O
.	O

Generation	O
and	O
analysis	O
of	O
ATP	S-Chemical_Compound
-	O
binding	O
-	O
deficient	O
Rv2623	S-Biological_Molecule
mutants	O

Similarly	O
,	O
extension	O
of	O
the	O
D15	O
side	O
chain	O
to	O
glutamate	O
was	O
also	O
predicted	O
to	O
interfere	O
with	O
the	O
ATP	S-Chemical_Compound
-	O
binding	O
conformation	O
(	O
Figure	O
7A	O
)	O
.	O

HPLC	O
analysis	O
of	O
nucleotides	O
extracted	O
from	O
Rv2623D15E	S-Biological_Molecule
and	O
Rv2623G117A	S-Biological_Molecule
revealed	O
that	O
the	O
mutant	O
proteins	O
are	O
indeed	O
deficient	O
in	O
ATP	S-Chemical_Compound
-	O
binding	O
,	O
exhibiting	O
approximately34	O
%	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
approximately29	O
%	O
(	O
p	O
=	O
0	O
.	O
0018	O
)	O
of	O
the	O
amount	O
of	O
ATP	S-Chemical_Compound
bound	O
by	O
wild	O
-	O
type	O
Rv2623	S-Biological_Molecule
,	O
respectively	O
(	O
Figure	O
7B	O
)	O
.	O

Likewise	O
,	O
following	O
an	O
overnight	O
incubation	O
with	O
[	O
alpha	O
-	O
33P	O
]	O
ATP	S-Chemical_Compound
at	O
4degreesC	O
,	O
the	O
amount	O
of	O
protein	O
-	O
bound	O
radioactivity	O
,	O
which	O
represented	O
a	O
very	O
small	O
fraction	O
of	O
the	O
total	O
ATP	S-Chemical_Compound
binding	O
sites	O
,	O
was	O
significantly	O
less	O
for	O
the	O
mutant	O
proteins	O
than	O
wild	O
-	O
type	O
Rv2623	S-Biological_Molecule
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
growth	O
-	O
regulating	O
property	O
of	O
M	B-Species
.	I-Species
tuberculosis	E-Species
Rv2623	S-Biological_Molecule
is	O
dependent	O
on	O
its	O
ability	O
to	O
bind	O
ATP	S-Chemical_Compound

Results	O
of	O
these	O
studies	O
demonstrated	O
that	O
while	O
overexpression	O
of	O
wildtype	O
Rv2623	S-Biological_Molecule
retards	O
the	O
growth	O
of	O
the	O
recipient	O
strain	O
relative	O
to	O
cells	O
transformed	O
with	O
vector	O
alone	O
,	O
growth	O
of	O
the	O
strains	O
overexpressing	O
ATP	S-Chemical_Compound
-	O
binding	O
-	O
deficient	O
mutant	O
Rv2623	S-Biological_Molecule
are	O
only	O
minimally	O
affected	O
by	O
overexpression	O
as	O
assessed	O
by	O
spotting	O
serial	O
dilutions	O
of	O
the	O
cultures	O
of	O
the	O
appropriate	O
strains	O
onto	O
solid	O
Middlebrook	O
7H10	O
agar	O
(	O
data	O
not	O
shown	O
)	O
as	O
well	O
as	O
by	O
monitoring	O
the	O
time	O
to	O
detection	O
using	O
the	O
BD	O
BACTEC	O
9000MB	O
system	O
(	O
Figure	O
8A	O
)	O
.	O

The	O
distinct	O
effects	O
exhibited	O
by	O
the	O
wild	B-Species
type	E-Species
and	O
the	O
G117A	S-Species
and	O
D15E	B-Species
mutants	E-Species
defective	O
in	O
ATP	S-Chemical_Compound
binding	O
suggests	O
a	O
direct	O
correlation	O
between	O
growth	O
attenuation	O
and	O
ATP	S-Chemical_Compound
binding	O
(	O
Figure	O
7B	O
)	O
.	O

To	O
examine	O
whether	O
the	O
effects	O
of	O
overexpression	O
of	O
Rv2623	S-Biological_Molecule
on	O
M	B-Species
.	I-Species
smegmatis	E-Species
are	O
operative	O
in	O
virulent	O
M	B-Species
.	I-Species
tuberculosis	E-Species
,	O
the	O
growth	O
kinetics	O
of	O
the	O
Erdman	S-Species
strain	O
overexpressing	O
wildtype	O
Rv2623	S-Biological_Molecule
,	O
as	O
well	O
as	O
the	O
Rv2623G117A	S-Biological_Molecule
and	O
the	O
Rv2623D15E	S-Biological_Molecule
mutant	O
proteins	O
,	O
were	O
evaluated	O
in	O
vitro	O
using	O
the	O
BACTEC	O
9000MB	O
system	O
(	O
Figure	O
8B	O
)	O
.	O

Furthermore	O
,	O
this	O
growth	O
attenuation	O
is	O
not	O
observed	O
in	O
M	B-Species
.	I-Species
tuberculosis	E-Species
strains	O
overexpressing	O
the	O
G117A	O
or	O
the	O
D15E	O
mutant	O
Rv2623	S-Biological_Molecule
(	O
Figure	O
8B	O
)	O
.	O

Discussion	O

Despite	O
the	O
significance	O
of	O
M	B-Species
.	I-Species
tuberculosis	E-Species
latency	O
in	O
pathogenesis	O
,	O
the	O
mechanisms	O
by	O
which	O
the	O
tubercle	B-Species
bacillus	E-Species
establishes	O
and	O
maintains	O
the	O
latent	O
state	O
remain	O
incompletely	O
defined	O
.	O

Indeed	O
,	O
it	O
has	O
been	O
shown	O
that	O
both	O
the	O
cognate	O
sensor	O
histidine	O
kinase	O
DosS	S-Biological_Molecule
(	O
a	O
member	O
of	O
the	O
dormancy	O
regulon	O
)	O
as	O
well	O
as	O
an	O
"	O
orphan	O
"	O
kinase	O
,	O
DosT	S-Biological_Molecule
,	O
functioning	O
as	O
redox	O
and	O
hypoxia	O
sensors	O
,	O
respectively	O
;	O
can	O
regulate	O
DosR	S-Biological_Molecule
activity	O
,	O
and	O
that	O
O2	S-Chemical_Compound
,	O
NO	S-Chemical_Compound
,	O
and	O
CO	S-Chemical_Compound
can	O
modulate	O
the	O
activity	O
of	O
these	O
two	O
kinases	O
via	O
interaction	O
with	O
a	O
haem	O
prosthetic	O
group	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
,	O
[	O
30	O
]	O
,	O
[	O
31	O
]	O
,	O
[	O
32	O
]	O
.	O

There	O
are	O
eight	O
genes	O
in	O
the	O
M	B-Species
.	I-Species
tuberculosis	E-Species
genome	O
annotated	O
to	O
encode	O
USP	O
family	O
proteins	O
[	O
7	O
]	O
.	O

We	O
studied	O
the	O
M	B-Species
.	I-Species
tuberculosis	E-Species
USP	O
rv2623	S-Biological_Molecule
because	O
it	O
is	O
one	O
of	O
the	O
most	O
highly	O
induced	O
genes	O
in	O
the	O
dormancy	O
regulon	O
when	O
bacilli	S-Species
are	O
subjected	O
to	O
hypoxia	O
and	O
nitrosative	O
stress	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
,	O
[	O
36	O
]	O
,	O
[	O
37	O
]	O
.	O

More	O
important	O
,	O
rv2623	S-Biological_Molecule
was	O
also	O
shown	O
to	O
be	O
up	O
-	O
regulated	O
when	O
the	O
tubercle	B-Species
bacillus	E-Species
is	O
internalized	O
by	O
human	S-Species
and	O
mouse	S-Species
macrophages	O
[	O
10	O
]	O
,	O
[	O
38	O
]	O
as	O
well	O
as	O
in	O
the	O
lungs	O
of	O
mice	S-Species
with	O
persistent	O
M	B-Species
.	I-Species
tuberculosis	E-Species
infection	O
[	O
11	O
]	O
.	O

These	O
latter	O
observations	O
suggest	O
that	O
the	O
induction	O
of	O
rv2623	S-Biological_Molecule
may	O
have	O
biological	O
relevance	O
.	O

The	O
precise	O
mechanisms	O
by	O
which	O
Rv2623	S-Biological_Molecule
expression	O
is	O
regulated	O
remain	O
to	O
be	O
defined	O
.	O

Recent	O
transcriptional	O
analysis	O
of	O
Rv2623	S-Biological_Molecule
,	O
while	O
confirming	O
the	O
essentiality	O
of	O
the	O
two	O
18	O
bp	O
palindromic	O
DosR	S-Biological_Molecule
-	O
binding	O
motifs	O
that	O
are	O
present	O
in	O
the	O
promoter	O
region	O
of	O
this	O
gene	O
[	O
38	O
]	O
for	O
induction	O
of	O
Rv2623	S-Biological_Molecule
under	O
low	O
oxygen	S-Chemical_Compound
conditions	O
,	O
also	O
demonstrated	O
the	O
presence	O
of	O
additional	O
regulatory	O
elements	O
within	O
the	O
rv2623	S-Biological_Molecule
5	O
'	O
-	O
untranslated	O
region	O
[	O
18	O
]	O
.	O

The	O
M	B-Species
.	I-Species
tuberculosis	E-Species
dormancy	O
response	O
features	O
a	O
dramatic	O
decrease	O
in	O
metabolic	O
activity	O
,	O
resulting	O
in	O
a	O
rapid	O
decrease	O
in	O
bacterial	O
replication	O
[	O
39	O
]	O
.	O

Therefore	O
,	O
it	O
is	O
possible	O
that	O
deficiency	O
in	O
certain	O
members	O
of	O
the	O
dormancy	O
regulon	O
could	O
result	O
in	O
inability	O
of	O
the	O
tubercle	O
bacillus	O
to	O
enter	O
a	O
latent	O
state	O
in	O
the	O
infected	O
host	O
,	O
leading	O
to	O
unrestrained	O
growth	O
and	O
thus	O
,	O
hypervirulence	O
.	O

However	O
,	O
DosR	S-Biological_Molecule
deficiency	O
has	O
also	O
been	O
reported	O
to	O
have	O
no	O
effect	O
on	O
M	B-Species
.	I-Species
tuberculosis	E-Species
virulence	O
or	O
to	O
lead	O
to	O
an	O
attenuated	O
phenotype	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
.	O

The	O
discrepancies	O
regarding	O
M	B-Species
.	I-Species
tuberculosis	E-Species
virulence	O
in	O
these	O
DosR	S-Biological_Molecule
studies	O
are	O
unclear	O
,	O
but	O
could	O
be	O
due	O
to	O
differences	O
in	O
experimental	O
systems	O
employed	O
.	O

Results	O
of	O
the	O
complementation	O
studies	O
indicate	O
that	O
the	O
phenotype	O
is	O
Rv2623	S-Biological_Molecule
-	O
specific	O
.	O

This	O
growth	O
-	O
regulating	O
phenomenon	O
is	O
echoed	O
by	O
the	O
observation	O
that	O
ectopic	O
overexpression	O
of	O
Rv2623	S-Biological_Molecule
results	O
in	O
attenuation	O
of	O
mycobacterial	O
growth	O
.	O

Together	O
,	O
these	O
data	O
strongly	O
suggest	O
that	O
the	O
M	B-Species
.	I-Species
tuberculosis	E-Species
USP	O
Rv2623	S-Biological_Molecule
has	O
the	O
ability	O
to	O
regulate	O
growth	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
and	O
is	O
required	O
for	O
the	O
establishment	O
of	O
a	O
persistent	O
infection	O
.	O

Bioinformatic	O
and	O
experimental	O
evidence	O
suggest	O
that	O
nucleotide	O
-	O
binding	O
capacity	O
represents	O
a	O
discriminating	O
biochemical	O
feature	O
that	O
facilitates	O
USP	O
protein	O
classification	O
.	O

Putative	O
functional	O
differences	O
between	O
USPs	O
are	O
implied	O
by	O
their	O
assignment	O
to	O
two	O
subclasses	O
:	O
one	O
whose	O
members	O
do	O
not	O
bind	O
ATP	S-Chemical_Compound
and	O
another	O
whose	O
constituents	O
bind	O
and	O
hydrolyze	O
adenine	O
nucleotide	O
substrates	O
[	O
8	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
,	O
[	O
45	O
]	O
,	O
[	O
46	O
]	O
.	O

A	O
structural	O
comparison	O
between	O
the	O
prototypic	O
members	O
of	O
the	O
two	O
subclasses	O
,	O
the	O
non	O
-	O
ATP	S-Chemical_Compound
-	O
binding	O
UspA	S-Biological_Molecule
homolog	O
(	O
H	B-Species
.	I-Species
influenzae	E-Species
,	O
PDB	O
ID	O
1JMV	O
)	O
and	O
the	O
ATP	S-Chemical_Compound
-	O
binding	O
USP	O
,	O
MJ0577	S-Biological_Molecule
(	O
M	B-Species
.	I-Species
jannaschii	E-Species
,	O
PDB	O
ID	O
1MJH	O
)	O
revealed	O
that	O
while	O
both	O
proteins	O
exhibit	O
a	O
similar	O
fold	O
,	O
conserved	O
glycine	O
residues	O
within	O
the	O
ATP	S-Chemical_Compound
-	O
binding	O
loop	O
of	O
the	O
latter	O
are	O
substituted	O
with	O
bulky	O
amino	O
acids	O
that	O
preclude	O
ATP	S-Chemical_Compound
recognition	O
in	O
the	O
former	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
.	O

Specific	O
roles	O
for	O
USP	O
family	O
proteins	O
are	O
just	O
beginning	O
to	O
be	O
characterized	O
,	O
and	O
early	O
functional	O
classifications	O
have	O
been	O
informed	O
by	O
ATP	S-Chemical_Compound
-	O
binding	O
capacity	O
[	O
9	O
]	O
.	O

Based	O
on	O
in	O
silico	O
analyses	O
,	O
Florczyk	O
et	O
al	O
.	O
classified	O
Rv2623	S-Biological_Molecule
as	O
belonging	O
to	O
a	O
novel	O
class	O
of	O
ATPases	S-Chemical_Compound
[	O
52	O
]	O
,	O
although	O
formal	O
evidence	O
for	O
ATP	S-Chemical_Compound
binding	O
by	O
this	O
protein	O
has	O
not	O
been	O
reported	O
.	O

Furthermore	O
,	O
given	O
that	O
the	O
attenuated	O
growth	O
phenotype	O
caused	O
by	O
overexpression	O
of	O
Rv2623	S-Biological_Molecule
could	O
be	O
abrogated	O
by	O
mutations	O
that	O
interfere	O
with	O
the	O
binding	O
of	O
this	O
protein	O
to	O
its	O
nucleotide	O
substrate	O
,	O
it	O
is	O
likely	O
that	O
the	O
mycobacterial	O
growth	O
-	O
regulatory	O
faculty	O
of	O
Rv2623	S-Biological_Molecule
is	O
mediated	O
by	O
an	O
ATP	S-Chemical_Compound
-	O
dependent	O
function	O
.	O

In	O
summary	O
,	O
the	O
results	O
of	O
the	O
present	O
study	O
have	O
revealed	O
that	O
the	O
M	B-Species
.	I-Species
tuberculosis	E-Species
USP	O
Rv2623	S-Biological_Molecule
has	O
the	O
ability	O
to	O
regulate	O
mycobacterial	O
growth	O
,	O
as	O
evident	O
by	O
the	O
in	O
vivo	O
hypervirulence	O
phenotype	O
of	O
Deltarv2623	S-Biological_Molecule
,	O
which	O
fails	O
to	O
establish	O
a	O
persistent	O
infection	O
in	O
susceptible	O
hosts	O
,	O
as	O
well	O
as	O
the	O
growth	O
attenuation	O
observed	O
in	O
mycobacteria	O
overexpressing	O
this	O
USP	O
.	O

The	O
latent	O
state	O
allows	O
persistence	O
in	O
infected	O
individuals	O
of	O
tubercle	B-Species
bacilli	E-Species
that	O
can	O
reactivate	O
to	O
cause	O
active	O
disease	O
and	O
to	O
disseminate	O
when	O
the	O
immune	O
status	O
of	O
the	O
host	O
is	O
compromised	O
.	O

As	O
a	O
result	O
,	O
Rv2623	S-Biological_Molecule
may	O
contribute	O
significantly	O
to	O
the	O
propagation	O
of	O
the	O
tubercle	O
bacillus	O
in	O
the	O
human	S-Species
host	O
and	O
the	O
difficulties	O
in	O
eradicating	O
tuberculosis	O
.	O

Mechanistically	O
,	O
results	O
of	O
the	O
mutagenesis	O
studies	O
have	O
shown	O
that	O
Rv2623	S-Biological_Molecule
regulates	O
growth	O
through	O
ATP	S-Chemical_Compound
-	O
dependent	O
function	O
.	O

Clearly	O
,	O
much	O
remains	O
to	O
be	O
learned	O
regarding	O
how	O
the	O
ATP	S-Chemical_Compound
-	O
dependent	O
function	O
of	O
Rv2623	S-Biological_Molecule
contributes	O
to	O
growth	O
regulation	O
.	O

It	O
has	O
been	O
proposed	O
that	O
a	O
nucleotide	O
-	O
binding	O
USP	O
from	O
M	B-Species
.	I-Species
jannaschii	E-Species
,	O
MJ0577	S-Biological_Molecule
,	O
whose	O
ability	O
to	O
hydrolyze	O
ATP	S-Chemical_Compound
is	O
dependent	O
on	O
interaction	O
with	O
factor	O
(	O
s	O
)	O
present	O
in	O
the	O
cell	O
extract	O
of	O
this	O
hyperthermophile	O
[	O
26	O
]	O
,	O
functions	O
as	O
a	O
molecular	O
switch	O
much	O
like	O
the	O
Ras	O
protein	O
family	O
,	O
whose	O
GTP	S-Chemical_Compound
hydrolysis	O
ability	O
is	O
modulated	O
by	O
interaction	O
with	O
a	O
number	O
of	O
regulatory	O
proteins	O
[	O
53	O
]	O
,	O
[	O
54	O
]	O
,	O
[	O
55	O
]	O
.	O

The	O
fact	O
that	O
E	B-Species
.	I-Species
coli	E-Species
-	O
expressed	O
Rv2623	S-Biological_Molecule
co	O
-	O
purifies	O
with	O
ADP	S-Chemical_Compound
as	O
well	O
as	O
ATP	S-Chemical_Compound
suggests	O
the	O
possibility	O
that	O
this	O
mycobacterial	O
USP	O
,	O
like	O
MJ0577	S-Biological_Molecule
,	O
is	O
capable	O
of	O
ATP	S-Chemical_Compound
hydrolysis	O
.	O

Experiments	O
designed	O
to	O
investigate	O
the	O
potential	O
ATP	S-Chemical_Compound
-	O
hydrolyzing	O
activity	O
of	O
Rv2623	S-Biological_Molecule
are	O
currently	O
underway	O
.	O

A	O
Novel	O
Signaling	O
Network	O
Essential	O
for	O
Regulating	O
Pseudomonas	B-Species
aeruginosa	E-Species
Biofilm	O
Development	O

The	O
important	O
human	S-Species
pathogen	O
Pseudomonas	B-Species
aeruginosa	E-Species
has	O
been	O
linked	O
to	O
numerous	O
biofilm	O
-	O
related	O
chronic	O
infections	O
.	O

These	O
two	O
-	O
component	O
systems	O
become	O
sequentially	O
phosphorylated	O
during	O
biofilm	O
formation	O
.	O

Inactivation	O
of	O
bfiS	S-Biological_Molecule
,	O
bfmR	S-Biological_Molecule
,	O
and	O
mifR	S-Biological_Molecule
arrested	O
biofilm	O
formation	O
at	O
the	O
transition	O
to	O
the	O
irreversible	O
attachment	O
,	O
maturation	O
-	O
1	O
and	O
-	O
2	O
stages	O
,	O
respectively	O
,	O
as	O
indicated	O
by	O
analyses	O
of	O
biofilm	O
architecture	O
,	O
and	O
protein	O
and	O
phosphoprotein	O
patterns	O
.	O

Interestingly	O
,	O
inactivation	O
did	O
not	O
affect	O
planktonic	O
growth	O
,	O
motility	O
,	O
polysaccharide	O
production	O
,	O
or	O
initial	O
attachment	O
.	O

Introduction	O

Biofilms	O
form	O
when	O
bacteria	O
adhere	O
to	O
surfaces	O
in	O
moist	O
environments	O
.	O

Biofilm	O
-	O
associated	O
microorganisms	O
have	O
been	O
shown	O
to	O
colonize	O
a	O
wide	O
variety	O
of	O
medical	O
devices	O
and	O
have	O
been	O
implicated	O
in	O
over	O
80	O
%	O
of	O
chronic	O
inflammatory	O
and	O
infectious	O
diseases	O
including	O
chronic	O
otitis	O
media	O
,	O
native	O
valve	O
endocarditis	O
,	O
gastrointestinal	O
ulcers	O
,	O
urinary	O
tract	O
and	O
middle	O
ear	O
infections	O
,	O
and	O
chronic	O
lung	O
infections	O
in	O
cystic	O
fibrosis	O
(	O
CF	O
)	O
patients	S-Species
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

In	O
addition	O
,	O
P	B-Species
.	I-Species
aeruginosa	E-Species
causes	O
a	O
variety	O
of	O
diseases	O
in	O
individuals	O
predisposed	O
to	O
infections	O
as	O
the	O
result	O
of	O
severe	O
burns	O
,	O
wounds	O
,	O
urinary	O
tract	O
or	O
corneal	O
injury	O
,	O
or	O
immunocompromised	O
status	O
[	O
5	O
]	O
-	O
[	O
8	O
]	O
.	O

This	O
is	O
supported	O
by	O
the	O
finding	O
that	O
various	O
microorganisms	O
,	O
including	O
P	B-Species
.	I-Species
aeruginosa	E-Species
have	O
been	O
shown	O
to	O
form	O
biofilms	O
in	O
a	O
stage	O
-	O
specific	O
and	O
coordinated	O
manner	O
.	O

Vallet	O
et	O
al	O
.	O

In	O
contrast	O
,	O
type	B-Species
IV	I-Species
pili	E-Species
and	O
flagella	B-Species
deletion	I-Species
mutants	E-Species
exhibited	O
reduced	O
attachment	O
indicating	O
that	O
attachment	O
and	O
biofilm	O
formation	O
are	O
mediated	O
by	O
extracellular	O
appendages	O
[	O
12	O
]	O
,	O
[	O
15	O
]	O
-	O
[	O
17	O
]	O
.	O

These	O
are	O
the	O
wsp	O
chemosensory	O
signal	O
transduction	O
pathway	O
[	O
25	O
]	O
and	O
a	O
genetic	O
pathway	O
composed	O
of	O
the	O
phosphodiesterase	O
BifA	S-Biological_Molecule
,	O
the	O
inner	O
membrane	O
-	O
localized	O
diguanylate	O
cyclase	O
SadC	S-Biological_Molecule
and	O
the	O
cytoplasmic	O
protein	O
SadB	S-Biological_Molecule
[	O
20	O
]	O
,	O
[	O
21	O
]	O
,	O
[	O
33	O
]	O
.	O

Both	O
are	O
involved	O
in	O
the	O
reciprocal	O
cyclic	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
-	O
dependent	O
regulation	O
of	O
Pel	S-Biological_Molecule
and	O
Psl	S-Biological_Molecule
exopolysaccharide	O
production	O
as	O
P	B-Species
.	I-Species
aeruginosa	E-Species
transitions	O
from	O
a	O
planktonic	O
to	O
a	O
surface	O
associated	O
lifestyle	O
.	O

Both	O
Pel	S-Biological_Molecule
and	O
Psl	S-Biological_Molecule
exopolysaccharides	O
contribute	O
to	O
the	O
overall	O
architecture	O
of	O
biofilms	O
and	O
are	O
essential	O
for	O
surface	O
interaction	O
and	O
biofilm	O
initiation	O
[	O
34	O
]	O
,	O
[	O
35	O
]	O
.	O

Expression	O
of	O
the	O
pel	S-Biological_Molecule
and	O
psl	S-Biological_Molecule
genes	O
is	O
coordinated	O
by	O
the	O
global	O
regulator	O
RetS	S-Biological_Molecule
,	O
a	O
hybrid	O
sensor	O
kinase	O
-	O
response	O
regulator	O
protein	O
,	O
that	O
plays	O
a	O
key	O
role	O
in	O
the	O
reciprocal	O
regulation	O
of	O
virulence	O
factors	O
and	O
biofilm	O
formation	O
required	O
for	O
acute	O
versus	O
chronic	O
infection	O
[	O
36	O
]	O
.	O

This	O
multi	O
-	O
component	O
switch	O
thus	O
orchestrates	O
the	O
transition	O
from	O
the	O
planktonic	O
to	O
the	O
biofilm	O
mode	O
of	O
growth	O
by	O
P	B-Species
.	I-Species
aeruginosa	E-Species
via	O
phosphorylation	O
events	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
GacA	S-Biological_Molecule
/	O
GacS	S-Biological_Molecule
[	O
36	O
]	O
-	O
[	O
38	O
]	O
.	O

This	O
raises	O
the	O
question	O
of	O
whether	O
the	O
transition	O
to	O
later	O
stages	O
of	O
biofilm	O
formation	O
,	O
which	O
coincide	O
with	O
distinct	O
phenotypes	O
compared	O
to	O
planktonic	O
and	O
initial	O
attached	O
bacterial	O
cells	O
,	O
also	O
involves	O
sensing	O
of	O
environmental	O
signal	O
(	O
s	O
)	O
and	O
requires	O
the	O
coordinated	O
transduction	O
of	O
phosphorylation	O
events	O
(	O
phosphorelays	O
)	O
.	O

Furthermore	O
,	O
we	O
report	O
the	O
identification	O
of	O
three	O
novel	O
two	O
-	O
component	O
regulatory	O
systems	O
named	O
BfiRS	S-Biological_Molecule
(	O
PA4196	S-Biological_Molecule
-	O
4197	S-Biological_Molecule
)	O
,	O
BfmRS	S-Biological_Molecule
(	O
PA4101	S-Biological_Molecule
-	O
4102	S-Biological_Molecule
)	O
,	O
and	O
MifRS	S-Biological_Molecule
(	O
PA5511	S-Biological_Molecule
-	O
5512	S-Biological_Molecule
)	O
that	O
coordinate	O
phosphorylation	O
events	O
required	O
for	O
the	O
progression	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
biofilm	O
development	O
in	O
a	O
stage	O
-	O
specific	O
manner	O
.	O

The	O
formation	O
of	O
biofilms	O
has	O
been	O
proposed	O
to	O
be	O
controlled	O
in	O
response	O
to	O
environmental	O
signals	O
[	O
39	O
]	O
.	O

Given	O
that	O
protein	O
phosphorylation	O
is	O
a	O
common	O
modification	O
system	O
used	O
in	O
signal	O
transduction	O
that	O
changes	O
the	O
function	O
of	O
proteins	O
in	O
response	O
to	O
environmental	O
stimuli	O
[	O
38	O
]	O
,	O
we	O
chose	O
a	O
phosphoproteomic	O
approach	O
for	O
the	O
detection	O
and	O
identification	O
of	O
regulatory	O
pathways	O
active	O
following	O
the	O
transition	O
to	O
the	O
surface	O
attached	O
mode	O
of	O
growth	O
.	O

Immunoblots	O
of	O
whole	O
cell	O
extracts	O
obtained	O
from	O
planktonic	O
cells	O
and	O
biofilm	O
cells	O
representing	O
five	O
developmental	O
stages	O
(	O
reversibly	O
and	O
irreversibly	O
attached	O
cells	O
,	O
maturation	O
-	O
1	O
and	O
-	O
2	O
and	O
dispersion	O
stage	O
;	O
following	O
8	O
,	O
24	O
,	O
72	O
,	O
144	O
,	O
and	O
216	O
hr	O
of	O
growth	O
,	O
respectively	O
,	O
see	O
[	O
12	O
]	O
,	O
[	O
50	O
]	O
for	O
timing	O
of	O
biofilm	O
stages	O
)	O
were	O
thus	O
analyzed	O
for	O
the	O
presence	O
of	O
planktonic	O
-	O
and	O
biofilm	O
-	O
specific	O
phosphorylation	O
events	O
.	O

Additional	O
stage	O
-	O
specific	O
events	O
were	O
detected	O
for	O
biofilms	O
differing	O
in	O
age	O
.	O

For	O
instance	O
,	O
8	O
hr	O
and	O
24	O
hr	O
old	O
biofilms	O
displayed	O
23	O
and	O
21	O
phosphorylation	O
events	O
,	O
respectively	O
,	O
not	O
detected	O
at	O
any	O
other	O
stage	O
.	O

Regardless	O
of	O
the	O
biofilm	O
developmental	O
stage	O
,	O
7	O
phosphorylation	O
events	O
were	O
detected	O
that	O
were	O
absent	O
in	O
planktonic	O
cells	O
(	O
Fig	O
.	O
1A	O
,	O
biofilm	O
-	O
specific	O
events	O
)	O
.	O

In	O
both	O
modes	O
of	O
growth	O
,	O
26	O
proteins	O
were	O
constitutively	O
phosphorylated	O
.	O

In	O
addition	O
to	O
biofilm	O
stage	O
-	O
specific	O
phosphorylation	O
of	O
proteins	O
,	O
protein	O
phosphorylation	O
events	O
were	O
detectable	O
at	O
more	O
than	O
one	O
biofilm	O
growth	O
stage	O
indicating	O
that	O
the	O
transition	O
to	O
surface	O
-	O
associated	O
growth	O
coincides	O
with	O
distinct	O
protein	O
phosphorylation	O
and	O
dephosphorylation	O
events	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

Furthermore	O
,	O
evidence	O
of	O
proteins	O
being	O
dephosphorylated	O
over	O
the	O
course	O
of	O
biofilm	O
formation	O
was	O
detected	O
.	O

Multiple	O
proteins	O
were	O
found	O
to	O
be	O
dephosphorylated	O
at	O
either	O
a	O
single	O
or	O
at	O
multiple	O
stages	O
over	O
the	O
course	O
of	O
biofilm	O
formation	O
and	O
maturation	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

The	O
reduced	O
similarity	O
in	O
phosphorylation	O
events	O
between	O
biofilms	O
and	O
planktonic	O
cells	O
was	O
mainly	O
due	O
to	O
biofilm	O
specific	O
phosphorylation	O
events	O
detected	O
at	O
one	O
or	O
more	O
stages	O
of	O
development	O
.	O

Dispersion	O
-	O
stage	O
biofilms	O
(	O
216	O
-	O
hr	O
-	O
old	O
)	O
shared	O
43	O
%	O
similarity	O
with	O
the	O
phosphorylation	O
patterns	O
of	O
planktonically	O
-	O
grown	O
P	B-Species
.	I-Species
aeruginosa	E-Species
cells	O
(	O
not	O
shown	O
)	O
.	O

Similarly	O
to	O
the	O
results	O
obtained	O
via	O
immunoblot	O
analysis	O
,	O
the	O
changes	O
in	O
phosphorylation	O
events	O
over	O
the	O
course	O
of	O
biofilm	O
development	O
detected	O
using	O
LC	O
-	O
MS	O
-	O
MS	O
analysis	O
appeared	O
to	O
be	O
stage	O
-	O
specific	O
(	O
two	O
examples	O
are	O
shown	O
in	O
Suppl	O
.	O
Fig	O
.	O
S2	O
)	O
,	O
with	O
the	O
similarity	O
to	O
the	O
planktonic	O
patterns	O
decreasing	O
from	O
72	O
%	O
in	O
8	O
hr	O
biofilms	O
to	O
38	O
%	O
in	O
144	O
hr	O
biofilms	O
(	O
Fig	O
.	O
1C	O
)	O
.	O

The	O
overall	O
stage	O
-	O
specific	O
(	O
de	O
)	O
phosphorylation	O
events	O
as	O
well	O
as	O
the	O
differences	O
in	O
the	O
phosphoproteome	O
were	O
similar	O
to	O
those	O
detected	O
by	O
immunoblot	O
analysis	O
using	O
anti	O
-	O
Ser	O
/	O
Thr	O
antibodies	O
.	O

This	O
is	O
the	O
first	O
description	O
of	O
the	O
dynamic	O
changes	O
of	O
the	O
phosphoproteome	O
occurring	O
during	O
biofilm	O
development	O
.	O

Identification	O
of	O
regulatory	O
proteins	O
involved	O
in	O
sensing	O
environmental	O
signals	O
associated	O
with	O
planktonic	O
and	O
biofilm	O
growth	O

Fig	O
.	O

We	O
thus	O
identified	O
48	O
proteins	O
that	O
were	O
differentially	O
phosphorylated	O
at	O
one	O
or	O
more	O
biofilm	O
developmental	O
stage	O
including	O
elongation	O
factors	O
,	O
ribosomal	O
proteins	O
,	O
several	O
enzymes	O
including	O
reductases	O
and	O
GMP	O
synthase	O
,	O
sigma	O
factor	O
RpoD	S-Biological_Molecule
(	O
Suppl	O
.	O
Table	O
S1	O
)	O
and	O
11	O
regulatory	O
proteins	O
(	O
Table	O
1	O
)	O
.	O

The	O
majority	O
of	O
regulatory	O
proteins	O
found	O
to	O
be	O
uniquely	O
phosphorylated	O
during	O
planktonic	O
growth	O
were	O
transcriptional	O
regulators	O
,	O
while	O
with	O
the	O
exception	O
of	O
PA2096	S-Biological_Molecule
,	O
all	O
regulatory	O
proteins	O
found	O
to	O
be	O
phosphorylated	O
during	O
surface	O
attached	O
growth	O
were	O
identified	O
as	O
belonging	O
to	O
two	O
-	O
component	O
systems	O
(	O
TCS	O
)	O
(	O
Table	O
1	O
)	O
.	O

The	O
reason	O
for	O
the	O
difference	O
in	O
the	O
timing	O
of	O
phosphorylation	O
between	O
sensor	O
and	O
response	O
regulator	O
is	O
unclear	O
.	O

The	O
probable	O
TCS	O
regulatory	O
protein	O
PA5511	S-Biological_Molecule
(	O
MifR	S-Biological_Molecule
)	O
was	O
phosphorylated	O
following	O
72	O
hr	O
of	O
surface	O
-	O
associated	O
growth	O
.	O

Neither	O
the	O
cognate	O
sensory	O
protein	O
PA5512	S-Biological_Molecule
nor	O
the	O
response	O
regulator	O
PA4196	S-Biological_Molecule
were	O
identified	O
in	O
this	O
study	O
.	O

As	O
PA4197	S-Biological_Molecule
,	O
PA4101	S-Biological_Molecule
and	O
GacS	S-Biological_Molecule
were	O
all	O
phosphorylated	O
by	O
24	O
hr	O
of	O
biofilm	O
growth	O
,	O
we	O
asked	O
whether	O
the	O
three	O
proteins	O
are	O
modified	O
simultaneously	O
or	O
in	O
a	O
sequential	O
manner	O
.	O

DeltagacS	S-Biological_Molecule
biofilm	O
phosphorylation	O
patterns	O
showed	O
an	O
intermediate	O
phosphorylation	O
phenotype	O
with	O
PA4197	S-Biological_Molecule
being	O
phosphorylated	O
but	O
PA4101	S-Biological_Molecule
phosphorylation	O
lacking	O
(	O
not	O
shown	O
)	O
.	O

PA5511	S-Biological_Molecule
was	O
not	O
detected	O
in	O
any	O
of	O
the	O
mutant	O
biofilms	O
analyzed	O
(	O
Suppl	O
.	O
Fig	O
.	O
S3	O
)	O
.	O

The	O
findings	O
suggest	O
that	O
phosphorylation	O
of	O
regulatory	O
proteins	O
occurs	O
in	O
a	O
sequential	O
(	O
but	O
probably	O
indirect	O
)	O
manner	O
over	O
the	O
course	O
of	O
biofilm	O
formation	O
.	O

PA4101	S-Biological_Molecule
expression	O
was	O
detected	O
to	O
be	O
biofilm	O
-	O
specific	O
,	O
while	O
PA4197	S-Biological_Molecule
and	O
PA5511	S-Biological_Molecule
were	O
constitutively	O
expressed	O
regardless	O
of	O
the	O
mode	O
of	O
growth	O
(	O
Suppl	O
.	O
Fig	O
.	O
S4	O
)	O
.	O

We	O
therefore	O
focused	O
on	O
biofilm	O
-	O
specific	O
regulatory	O
proteins	O
.	O

Under	O
the	O
conditions	O
tested	O
,	O
wild	O
type	O
P	B-Species
.	I-Species
aeruginosa	E-Species
biofilms	O
reached	O
maturity	O
following	O
144	O
hr	O
of	O
growth	O
as	O
characterized	O
by	O
biofilms	O
being	O
composed	O
of	O
large	O
microcolonies	O
exceeding	O
100	O
microm	O
in	O
diameter	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

However	O
,	O
in	O
contrast	O
to	O
PA4197	S-Biological_Molecule
mutant	O
biofilms	O
,	O
PA4101	S-Biological_Molecule
mutant	O
biofilms	O
demonstrated	O
the	O
formation	O
of	O
some	O
cellular	O
aggregates	O
which	O
were	O
less	O
than	O
10	O
microm	O
in	O
height	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

Complementation	O
of	O
both	O
PA4101	S-Biological_Molecule
and	O
PA4197	S-Biological_Molecule
mutants	O
restored	O
biofilm	O
formation	O
to	O
wild	O
type	O
levels	O
(	O
Fig	O
.	O
2C	O
,	O
Table	O
2	O
)	O
.	O

These	O
results	O
allowed	O
us	O
to	O
firmly	O
conclude	O
that	O
the	O
mutant	O
biofilm	O
phenotypes	O
are	O
caused	O
by	O
a	O
defect	O
in	O
the	O
PA4197	S-Biological_Molecule
and	O
PA4101	S-Biological_Molecule
ORF	O
.	O

Based	O
on	O
the	O
role	O
of	O
PA4197	S-Biological_Molecule
in	O
the	O
initiation	O
of	O
biofilm	O
formation	O
,	O
we	O
named	O
the	O
PA4197	S-Biological_Molecule
ORF	O
Biofilm	O
initiation	O
Sensor	O
(	O
BfiS	O
)	O
.	O

BfiS	S-Biological_Molecule
is	O
an	O
unusual	O
sensor	O
that	O
harbors	O
a	O
His	O
kinase	O
A	O
domain	O
typically	O
found	O
in	O
two	O
-	O
component	O
system	O
(	O
TCS	O
)	O
sensor	O
proteins	O
,	O
a	O
Histidine	O
kinase	O
-	O
like	O
ATPase	O
domain	O
involved	O
in	O
autophosphorylation	O
but	O
also	O
in	O
protein	O
dephosphorylation	O
events	O
,	O
and	O
a	O
PAS	O
signal	O
receiver	O
domain	O
[	O
53	O
]	O
.	O

The	O
cognate	O
response	O
regulator	O
BfiR	S-Biological_Molecule
(	O
PA4196	S-Biological_Molecule
)	O
harbors	O
a	O
CheY	O
-	O
like	O
signal	O
receiver	O
domain	O
and	O
a	O
LuxR	S-Biological_Molecule
-	O
like	O
DNA	O
binding	O
domain	O
,	O
which	O
is	O
also	O
present	O
in	O
the	O
quorum	O
-	O
sensing	O
regulatory	O
proteins	O
LasR	S-Biological_Molecule
,	O
RhlR	S-Biological_Molecule
,	O
and	O
QscR	S-Biological_Molecule
and	O
in	O
response	O
regulators	O
with	O
established	O
roles	O
in	O
biofilm	O
formation	O
(	O
GacA	S-Biological_Molecule
,	O
RocA1	S-Biological_Molecule
/	O
SadA	S-Biological_Molecule
)	O
[	O
53	O
]	O
.	O

The	O
cognate	O
sensor	O
BfmS	S-Biological_Molecule
(	O
PA4102	S-Biological_Molecule
)	O
is	O
unusual	O
in	O
that	O
it	O
lacks	O
an	O
autophosphorylation	O
site	O
typically	O
found	O
in	O
sensor	O
kinases	O
[	O
53	O
]	O
.	O

As	O
shown	O
in	O
Table	O
1	O
,	O
the	O
probable	O
TCS	O
regulatory	O
protein	O
PA5511	S-Biological_Molecule
was	O
phosphorylated	O
following	O
72	O
hr	O
of	O
surface	O
-	O
associated	O
growth	O
.	O

PA5511	S-Biological_Molecule
mutant	O
biofilms	O
grown	O
for	O
144	O
hr	O
lacked	O
clusters	O
and	O
microcolonies	O
typically	O
found	O
in	O
wild	O
type	O
biofilms	O
following	O
72	O
-	O
144	O
hr	O
of	O
growth	O
(	O
Fig	O
.	O
2A	O
-	O
B	O
)	O
.	O

MifR	S-Biological_Molecule
harbors	O
a	O
CheY	S-Biological_Molecule
-	O
like	O
receiver	O
and	O
a	O
sigma	B-Biological_Molecule
-	I-Biological_Molecule
54	E-Biological_Molecule
interaction	O
domain	O
[	O
53	O
]	O
.	O

The	O
protein	O
is	O
on	O
average	O
30	O
-	O
50	O
%	O
identical	O
to	O
known	O
P	B-Species
.	I-Species
aeruginosa	E-Species
NtrC	S-Biological_Molecule
-	O
like	O
enhancer	O
binding	O
proteins	O
including	O
PilR	S-Biological_Molecule
,	O
FleQ	S-Biological_Molecule
,	O
FleR	S-Biological_Molecule
,	O
AlgB	S-Biological_Molecule
,	O
CbrB	S-Biological_Molecule
,	O
and	O
NtrC	S-Biological_Molecule
[	O
53	O
]	O
,	O
[	O
54	O
]	O
.	O

The	O
cognate	O
sensor	O
(	O
MifS	S-Biological_Molecule
,	O
PA5512	S-Biological_Molecule
)	O
is	O
a	O
typical	O
sensor	O
kinase	O
harboring	O
both	O
a	O
His	O
kinase	O
A	O
and	O
a	O
His	O
kinase	O
-	O
like	O
ATPase	O
domain	O
[	O
53	O
]	O
.	O

Under	O
the	O
conditions	O
tested	O
,	O
the	O
biofilm	O
architecture	O
of	O
all	O
three	O
mutants	O
was	O
similar	O
to	O
the	O
biofilm	O
architecture	O
shown	O
in	O
Fig	O
.	O

In	O
addition	O
,	O
no	O
difference	O
in	O
transcript	O
abundance	O
,	O
as	O
determined	O
by	O
semi	O
-	O
quantitative	O
RT	O
-	O
PCR	O
,	O
of	O
genes	O
involved	O
in	O
Pel	S-Biological_Molecule
and	O
Psl	S-Biological_Molecule
polysaccharide	O
biosynthesis	O
compared	O
to	O
wild	O
type	O
was	O
detected	O
(	O
not	O
shown	O
)	O
.	O

However	O
,	O
a	O
DeltagacS	S-Biological_Molecule
mutant	O
showed	O
10	O
-	O
fold	O
reduced	O
initial	O
attachment	O
compared	O
to	O
the	O
wild	O
type	O
(	O
not	O
shown	O
)	O
,	O
consistent	O
with	O
previous	O
findings	O
by	O
Parkins	O
and	O
colleagues	O
[	O
65	O
]	O
.	O

Since	O
MifR	S-Biological_Molecule
was	O
detected	O
to	O
be	O
phosphorylated	O
following	O
72	O
hr	O
of	O
biofilm	O
growth	O
(	O
Table	O
1	O
)	O
,	O
our	O
findings	O
indicate	O
that	O
phosphorylation	O
of	O
MifR	S-Biological_Molecule
is	O
essential	O
for	O
the	O
progression	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
biofilms	O
from	O
the	O
maturation	O
-	O
1	O
stage	O
(	O
72	O
hr	O
)	O
to	O
the	O
maturation	O
-	O
2	O
stage	O
(	O
144	O
hr	O
)	O
.	O

To	O
exclude	O
the	O
possibility	O
that	O
the	O
DeltabfiS	S-Biological_Molecule
,	O
DeltabfmR	S-Biological_Molecule
,	O
and	O
DeltamifR	S-Biological_Molecule
mutant	O
biofilms	O
may	O
have	O
disaggregated	O
prematurely	O
,	O
the	O
formation	O
of	O
mutant	O
biofilms	O
was	O
monitored	O
daily	O
by	O
confocal	O
microscopy	O
over	O
a	O
period	O
of	O
144	O
hr	O
.	O

The	O
DeltabfiS	S-Biological_Molecule
and	O
DeltabfmR	S-Biological_Molecule
biofilms	O
resembled	O
wild	O
type	O
biofilms	O
with	O
respect	O
to	O
biomass	O
and	O
overall	O
architecture	O
at	O
the	O
24	O
hr	O
time	O
point	O
(	O
see	O
Fig	O
.	O
2A	O
-	O
B	O
)	O
.	O

However	O
,	O
while	O
wild	O
type	O
biofilms	O
continued	O
to	O
mature	O
/	O
develop	O
upon	O
prolonged	O
incubation	O
(	O
see	O
Fig	O
.	O
2A	O
)	O
,	O
no	O
additional	O
biomass	O
accumulation	O
or	O
alteration	O
in	O
architecture	O
was	O
observed	O
for	O
DeltabfiS	S-Biological_Molecule
and	O
DeltabfmR	S-Biological_Molecule
biofilms	O
post	O
24	O
hr	O
of	O
growth	O
.	O

Furthermore	O
,	O
for	O
DeltamifR	S-Biological_Molecule
biofilms	O
,	O
the	O
progression	O
of	O
biofilm	O
formation	O
was	O
indistinguishable	O
from	O
wild	O
type	O
P	B-Species
.	I-Species
aeruginosa	E-Species
biofilm	O
formation	O
for	O
the	O
first	O
72	O
hr	O
of	O
growth	O
.	O

The	O
findings	O
clearly	O
indicate	O
that	O
inactivation	O
of	O
these	O
novel	O
regulatory	O
proteins	O
did	O
not	O
cause	O
biofilm	O
disaggregation	O
.	O

Instead	O
,	O
our	O
findings	O
suggested	O
that	O
the	O
mutant	O
biofilms	O
were	O
incapable	O
of	O
progressing	O
from	O
the	O
initial	O
attachment	O
stage	O
to	O
more	O
mature	O
biofilm	O
stages	O
.	O

Since	O
GacS	S-Biological_Molecule
was	O
found	O
to	O
be	O
phosphorylated	O
in	O
a	O
BfiS	S-Biological_Molecule
-	O
dependent	O
manner	O
following	O
8	O
hrs	O
of	O
growth	O
,	O
we	O
asked	O
whether	O
a	O
DeltagacS	S-Biological_Molecule
mutant	O
forms	O
biofilms	O
similar	O
in	O
architecture	O
to	O
DeltabfiS	S-Biological_Molecule
biofilms	O
.	O

At	O
both	O
time	O
points	O
,	O
DeltagacS	S-Biological_Molecule
biofilms	O
not	O
only	O
exceeded	O
the	O
average	O
microcolony	O
size	O
typically	O
seen	O
for	O
wild	O
type	O
biofilms	O
of	O
the	O
same	O
age	O
,	O
but	O
also	O
the	O
biomass	O
and	O
thickness	O
of	O
wild	O
type	O
biofilms	O
at	O
more	O
mature	O
ages	O
(	O
Fig	O
.	O
3	O
,	O
Table	O
2	O
)	O
.	O

Continued	O
growth	O
for	O
more	O
than	O
72	O
hr	O
,	O
however	O
,	O
resulted	O
in	O
the	O
disaggregation	O
of	O
DeltagacS	S-Biological_Molecule
mutant	O
biofilms	O
as	O
indicated	O
by	O
the	O
presence	O
of	O
large	O
,	O
detached	O
clusters	O
floating	O
in	O
the	O
bulk	O
liquid	O
,	O
and	O
a	O
significantly	O
reduced	O
attached	O
biofilm	O
biomass	O
and	O
biofilm	O
thickness	O
(	O
Fig	O
.	O
3	O
,	O
Table	O
2	O
)	O
.	O

These	O
findings	O
suggest	O
that	O
GacS	S-Biological_Molecule
may	O
play	O
a	O
dual	O
role	O
in	O
regulating	O
biofilm	O
formation	O
,	O
which	O
in	O
turn	O
may	O
be	O
dependent	O
on	O
the	O
phosphorylation	O
status	O
of	O
GacS	S-Biological_Molecule
(	O
Table	O
1	O
)	O
.	O

Mutant	O
biofilms	O
display	O
protein	O
and	O
phosphorylation	O
patterns	O
indicative	O
of	O
stage	O
-	O
specific	O
arrest	O
of	O
biofilm	O
development	O

Based	O
on	O
qualitative	O
and	O
quantitative	O
analyses	O
,	O
BfiS	S-Biological_Molecule
(	O
PA4197	S-Biological_Molecule
)	O
and	O
BfmR	S-Biological_Molecule
(	O
PA4101	S-Biological_Molecule
)	O
mutant	O
biofilm	O
architecture	O
appeared	O
to	O
be	O
the	O
result	O
of	O
arrested	O
biofilm	O
formation	O
following	O
initial	O
attachment	O
,	O
while	O
inactivation	O
of	O
MifR	S-Biological_Molecule
(	O
PA5511	S-Biological_Molecule
)	O
coincided	O
with	O
biofilms	O
impaired	O
in	O
microcolony	O
formation	O
at	O
the	O
maturation	O
-	O
1	O
stage	O
.	O

The	O
phosphoproteomes	O
were	O
analyzed	O
using	O
two	O
approaches	O
,	O
(	O
i	O
)	O
immunoblot	O
analysis	O
of	O
whole	O
biofilm	O
cell	O
extracts	O
and	O
(	O
ii	O
)	O
LC	O
-	O
MS	O
/	O
MS	O
analysis	O
in	O
conjunction	O
with	O
cICAT	O
labeling	O
following	O
MOAC	O
purification	O
.	O

This	O
is	O
in	O
contrast	O
to	O
the	O
phosphoproteome	O
of	O
144	O
-	O
hr	O
-	O
old	O
P	B-Species
.	I-Species
aeruginosa	E-Species
wild	O
type	O
biofilms	O
,	O
which	O
was	O
62	O
-	O
65	O
%	O
different	O
from	O
that	O
of	O
planktonic	O
cells	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

Furthermore	O
,	O
both	O
mutant	O
biofilms	O
failed	O
to	O
exhibit	O
phosphorylation	O
events	O
typically	O
observed	O
during	O
normal	O
biofilm	O
development	O
following	O
144	O
hr	O
of	O
growth	O
(	O
see	O
Fig	O
.	O
1	O
,	O
Suppl	O
.	O
Table	O
S2	O
)	O
.	O

Instead	O
,	O
DeltabfiS	S-Biological_Molecule
biofilms	O
exhibited	O
stage	O
-	O
specific	O
phosphorylation	O
events	O
typically	O
detected	O
in	O
8	O
-	O
hr	O
-	O
and	O
24	O
-	O
hr	O
-	O
old	O
wild	O
type	O
biofilms	O
:	O
the	O
Ser	O
/	O
Thr	O
phosphoproteome	O
contained	O
15	O
out	O
of	O
23	O
phosphorylated	O
proteins	O
and	O
2	O
out	O
of	O
21	O
phosphorylated	O
proteins	O
that	O
are	O
specific	O
for	O
8	O
-	O
hr	O
-	O
and	O
24	O
-	O
hr	O
-	O
old	O
wild	O
type	O
biofilms	O
,	O
respectively	O
(	O
see	O
Fig	O
.	O
1	O
,	O
Suppl	O
.	O
Table	O
S2	O
)	O
.	O

Furthermore	O
,	O
DeltamifR	S-Biological_Molecule
biofilms	O
exhibited	O
8	O
out	O
of	O
27	O
maturation	O
-	O
1	O
specific	O
protein	O
phosphorylation	O
events	O
,	O
and	O
only	O
16	O
out	O
of	O
37	O
maturation	O
-	O
2	O
phosphorylation	O
events	O
(	O
Suppl	O
.	O
Table	O
S2	O
,	O
see	O
Fig	O
.	O
1	O
)	O
.	O

DeltabfiS	S-Biological_Molecule
biofilms	O
were	O
more	O
similar	O
to	O
24	O
-	O
hr	O
-	O
old	O
wild	O
type	O
biofilms	O
than	O
to	O
wild	O
type	O
biofilms	O
at	O
more	O
mature	O
stages	O
.	O

Based	O
on	O
analyses	O
of	O
biofilm	O
architecture	O
,	O
as	O
well	O
as	O
of	O
protein	O
production	O
and	O
phosphorylation	O
patterns	O
,	O
our	O
findings	O
indicate	O
that	O
DeltabfiS	S-Biological_Molecule
biofilms	O
are	O
arrested	O
in	O
the	O
transition	O
from	O
reversible	O
to	O
the	O
irreversible	O
attachment	O
stage	O
(	O
8	O
hr	O
to	O
24	O
-	O
hr	O
-	O
old	O
biofilms	O
,	O
respectively	O
)	O
.	O

Inactivation	O
of	O
MifR	S-Biological_Molecule
appeared	O
to	O
result	O
in	O
the	O
arrest	O
of	O
biofilm	O
development	O
in	O
the	O
transition	O
between	O
the	O
maturation	O
-	O
1	O
and	O
-	O
2	O
stages	O
(	O
72	O
to	O
144	O
hr	O
)	O
while	O
DeltabfmR	S-Biological_Molecule
biofilms	O
were	O
arrested	O
in	O
the	O
transition	O
between	O
irreversible	O
attachment	O
to	O
maturation	O
-	O
1	O
stage	O
.	O

Expression	O
of	O
bfiS	S-Biological_Molecule
,	O
bfmR	S-Biological_Molecule
,	O
and	O
mifR	S-Biological_Molecule
is	O
required	O
for	O
maintenance	O
of	O
normal	O
biofilm	O
architecture	O
while	O
loss	O
of	O
expression	O
results	O
in	O
biofilm	O
architecture	O
collapse	O

Our	O
observations	O
indicated	O
that	O
BfiS	S-Biological_Molecule
(	O
PA4197	S-Biological_Molecule
)	O
,	O
BfmR	S-Biological_Molecule
(	O
PA4101	S-Biological_Molecule
)	O
and	O
MifR	S-Biological_Molecule
(	O
PA5511	S-Biological_Molecule
)	O
are	O
essential	O
in	O
the	O
stage	O
-	O
specific	O
development	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
biofilm	O
formation	O
.	O

To	O
determine	O
whether	O
these	O
regulatory	O
proteins	O
are	O
only	O
essential	O
during	O
biofilm	O
formation	O
or	O
are	O
also	O
necessary	O
for	O
the	O
maintenance	O
of	O
established	O
biofilms	O
,	O
we	O
asked	O
whether	O
inactivation	O
of	O
these	O
regulatory	O
proteins	O
in	O
mature	O
biofilms	O
would	O
affect	O
biofilm	O
architecture	O
.	O

For	O
DeltabfiS	S-Biological_Molecule
and	O
DeltabfmR	S-Biological_Molecule
mutant	O
biofilms	O
,	O
biofilm	O
disaggregation	O
was	O
noticeable	O
as	O
early	O
as	O
24	O
hr	O
post	O
arabinose	S-Chemical_Compound
removal	O
(	O
not	O
shown	O
)	O
.	O

The	O
collapse	O
was	O
apparent	O
by	O
significant	O
reduction	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
of	O
biofilm	O
variables	O
including	O
biofilm	O
biomass	O
and	O
thickness	O
,	O
which	O
further	O
decreased	O
upon	O
continued	O
incubation	O
(	O
Fig	O
.	O
5	O
,	O
Table	O
3	O
)	O
.	O

In	O
contrast	O
,	O
no	O
reduction	O
of	O
the	O
wild	O
type	O
biofilm	O
architecture	O
was	O
observed	O
(	O
Fig	O
.	O
5	O
,	O
Table	O
3	O
)	O
.	O

Discussion	O

Evidence	O
showing	O
that	O
biofilm	O
development	O
is	O
a	O
coordinated	O
series	O
of	O
events	O
coinciding	O
with	O
distinct	O
phenotypes	O
has	O
led	O
to	O
the	O
assumption	O
that	O
the	O
formation	O
of	O
biofilms	O
is	O
a	O
regulated	O
progression	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
,	O
[	O
66	O
]	O
.	O

However	O
,	O
biofilm	O
development	O
has	O
been	O
considered	O
to	O
be	O
distinct	O
from	O
other	O
developmental	O
processes	O
including	O
the	O
programmed	O
differentiation	O
seen	O
in	O
spore	O
formation	O
in	O
Bacillus	B-Species
subtilis	E-Species
or	O
fruiting	O
body	O
formation	O
in	O
Myxococcus	B-Species
xanthus	E-Species
[	O
11	O
]	O
,	O
mainly	O
because	O
no	O
regulatory	O
pathways	O
have	O
yet	O
been	O
identified	O
that	O
are	O
responsible	O
for	O
regulating	O
committed	O
steps	O
in	O
the	O
formation	O
of	O
biofilms	O
with	O
the	O
exception	O
of	O
attachment	O
.	O

In	O
this	O
study	O
we	O
describe	O
the	O
identification	O
and	O
initial	O
characterization	O
of	O
three	O
novel	O
two	O
-	O
component	O
systems	O
(	O
TCS	O
)	O
essential	O
in	O
regulating	O
three	O
committed	O
steps	O
in	O
biofilm	O
development	O
.	O

Mutation	O
in	O
these	O
regulatory	O
pathways	O
did	O
not	O
affect	O
initial	O
attachment	O
,	O
motility	O
,	O
or	O
Pel	S-Biological_Molecule
and	O
Psl	S-Biological_Molecule
polysaccharide	O
production	O
,	O
but	O
instead	O
arrested	O
biofilm	O
development	O
in	O
the	O
transition	O
from	O
reversible	O
to	O
irreversible	O
attachment	O
[	O
8	O
hr	O
to	O
24	O
hr	O
,	O
BfiRS	S-Biological_Molecule
(	O
PA4196	S-Biological_Molecule
-	O
4197	S-Biological_Molecule
)	O
]	O
,	O
from	O
initial	O
attachment	O
to	O
the	O
maturation	O
-	O
1	O
stage	O
[	O
(	O
24	O
hr	O
to	O
72	O
hr	O
,	O
BfmRS	S-Biological_Molecule
(	O
PA4101	S-Biological_Molecule
-	O
4102	S-Biological_Molecule
)	O
]	O
,	O
and	O
following	O
the	O
maturation	O
-	O
1	O
stage	O
[	O
72	O
hr	O
to	O
144	O
hr	O
,	O
MifRS	S-Biological_Molecule
(	O
PA5511	S-Biological_Molecule
-	O
5512	S-Biological_Molecule
)	O
]	O
(	O
Fig	O
.	O
6	O
)	O
.	O

Furthermore	O
,	O
the	O
phosphorylation	O
of	O
these	O
two	O
-	O
component	O
systems	O
occurred	O
in	O
sequence	O
with	O
BfiS	S-Biological_Molecule
being	O
phosphorylated	O
first	O
,	O
followed	O
by	O
GacS	S-Biological_Molecule
,	O
and	O
lastly	O
,	O
MifR	S-Biological_Molecule
(	O
Table	O
1	O
,	O
Fig	O
.	O
6	O
)	O
.	O

Furthermore	O
,	O
the	O
novel	O
TCS	O
systems	O
described	O
here	O
appear	O
to	O
be	O
linked	O
via	O
GacS	S-Biological_Molecule
to	O
the	O
multicomponent	O
system	O
RetS	S-Biological_Molecule
/	O
LadS	S-Biological_Molecule
/	O
GacAS	S-Biological_Molecule
/	O
RsmA	S-Biological_Molecule
essential	O
for	O
regulating	O
the	O
switch	O
between	O
the	O
planktonic	O
and	O
the	O
sessile	O
mode	O
of	O
growth	O
.	O

Since	O
inactivation	O
of	O
each	O
TCS	O
system	O
resulted	O
in	O
altered	O
or	O
arrested	O
biofilms	O
which	O
failed	O
to	O
exhibit	O
stage	O
-	O
specific	O
protein	O
production	O
and	O
phosphorylation	O
events	O
(	O
Figs	O
.	O
1	O
,	O
4	O
,	O
Suppl	O
.	O
Table	O
S2	O
)	O
,	O
it	O
is	O
likely	O
that	O
the	O
mutant	O
biofilms	O
in	O
turn	O
do	O
not	O
produce	O
the	O
necessary	O
signal	O
(	O
s	O
)	O
to	O
activate	O
or	O
phosphorylate	O
TCS	O
system	O
(	O
s	O
)	O
that	O
are	O
further	O
downstream	O
.	O

Thus	O
,	O
it	O
is	O
likely	O
that	O
inactivation	O
of	O
one	O
TCS	O
system	O
(	O
in	O
)	O
directly	O
results	O
in	O
altered	O
or	O
arrested	O
phosphorylation	O
patterns	O
and	O
thus	O
,	O
lack	O
of	O
phosphorylation	O
of	O
downstream	O
TCS	O
systems	O
(	O
as	O
observed	O
here	O
)	O
.	O

This	O
is	O
even	O
more	O
important	O
as	O
this	O
biofilm	O
collapse	O
was	O
observed	O
under	O
two	O
different	O
nutritional	O
conditions	O
,	O
when	O
grown	O
on	O
minimal	O
medium	O
using	O
either	O
glutamate	S-Chemical_Compound
or	O
citrate	S-Chemical_Compound
as	O
a	O
sole	O
carbon	S-Chemical_Compound
source	O
(	O
see	O
also	O
Figs	O
.	O
2	O
and	O
5	O
for	O
comparison	O
of	O
LB	O
and	O
glutamate	O
minimal	O
medium	O
)	O
.	O

The	O
novelty	O
of	O
these	O
TCS	O
is	O
further	O
supported	O
by	O
the	O
finding	O
that	O
a	O
search	O
for	O
BfiS	S-Biological_Molecule
(	O
PA4197	S-Biological_Molecule
)	O
and	O
BfmR	S-Biological_Molecule
(	O
PA4101	S-Biological_Molecule
)	O
homologues	O
using	O
BLAST	O
(	O
http	O
:	O
/	O
/	O
blast	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
Blast	O
.	O
cgi	O
)	O
and	O
BLINK	O
(	O
precomputed	O
BLAST	O
,	O
[	O
53	O
]	O
)	O
,	O
did	O
not	O
reveal	O
any	O
proteins	O
that	O
have	O
been	O
previously	O
characterized	O
in	O
the	O
literature	O
.	O

However	O
,	O
BfiS	S-Biological_Molecule
-	O
like	O
sensory	O
proteins	O
with	O
identities	O
ranging	O
between	O
28	O
-	O
68	O
%	O
were	O
detected	O
in	O
a	O
variety	O
of	O
Gram	O
-	O
negative	O
bacteria	O
,	O
in	O
particular	O
in	O
alpha	O
-	O
,	O
beta	O
-	O
,	O
and	O
gamma	O
-	O
proteobacteria	O
(	O
Suppl	O
.	O
Table	O
S3	O
)	O
.	O

MifR	S-Biological_Molecule
homologues	O
harboring	O
a	O
sigma	O
-	O
54	O
binding	O
domain	O
are	O
present	O
in	O
both	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacteria	O
including	O
M	B-Species
.	I-Species
xanthus	E-Species
(	O
Suppl	O
.	O
Table	O
S3	O
)	O
.	O

NtrC	S-Biological_Molecule
-	O
like	O
regulators	O
belong	O
to	O
a	O
family	O
of	O
transcriptional	O
activators	O
which	O
control	O
a	O
variety	O
of	O
physiological	O
processes	O
in	O
response	O
to	O
environmental	O
signals	O
[	O
68	O
]	O
.	O

This	O
family	O
of	O
regulators	O
control	O
transcription	O
from	O
-	O
12	O
,	O
-	O
24	O
promoters	O
recognized	O
by	O
RNA	B-Biological_Molecule
polymerase	E-Biological_Molecule
that	O
utilizes	O
the	O
alternative	O
sigma	O
54	O
factor	O
encoded	O
by	O
rpoN	S-Biological_Molecule
and	O
its	O
analogs	O
.	O

At	O
least	O
8	O
NtrC	S-Biological_Molecule
-	O
like	O
transcriptional	O
regulators	O
are	O
involved	O
in	O
coordinating	O
M	B-Species
.	I-Species
xanthus	E-Species
fruiting	O
body	O
formation	O
at	O
distinct	O
stages	O
of	O
the	O
developmental	O
process	O
[	O
69	O
]	O
-	O
[	O
71	O
]	O
.	O

Their	O
activity	O
is	O
regulated	O
by	O
posttranslational	O
processes	O
,	O
either	O
by	O
cleaving	O
the	O
precursor	O
molecules	O
or	O
by	O
sequestration	O
of	O
sigma	O
factors	O
by	O
"	O
anti	O
-	O
sigma	O
factor	O
"	O
proteins	O
in	O
response	O
to	O
intercellular	O
cues	O
,	O
and	O
compartmentalization	O
[	O
68	O
]	O
,	O
[	O
73	O
]	O
.	O

Based	O
on	O
domain	O
structure	O
,	O
two	O
TCS	O
regulatory	O
proteins	O
identified	O
here	O
regulate	O
genes	O
controlled	O
by	O
the	O
sigma	O
factors	O
RpoD	S-Biological_Molecule
and	O
RpoN	S-Biological_Molecule
[	O
53	O
]	O
,	O
[	O
74	O
]	O
,	O
[	O
75	O
]	O
.	O

BfiR	S-Biological_Molecule
harbors	O
region	O
4	O
of	O
Sigma	B-Biological_Molecule
-	I-Biological_Molecule
70	E-Biological_Molecule
(	O
RpoD	S-Biological_Molecule
)	O
-	O
like	O
sigma	O
factors	O
,	O
a	O
domain	O
involved	O
in	O
binding	O
to	O
-	O
35	O
promoter	O
elements	O
.	O

These	O
results	O
are	O
consistent	O
with	O
the	O
idea	O
that	O
biofilm	O
development	O
by	O
P	B-Species
.	I-Species
aeruginosa	E-Species
is	O
orchestrated	O
by	O
a	O
regulatory	O
cascade	O
(	O
Fig	O
.	O
6	O
)	O
that	O
is	O
analogous	O
to	O
other	O
developmental	O
systems	O
including	O
spore	O
formation	O
in	O
B	B-Species
.	I-Species
subtilis	E-Species
or	O
fruiting	O
body	O
formation	O
in	O
M	B-Species
.	I-Species
xanthus	E-Species
,	O
requiring	O
the	O
consecutive	O
action	O
of	O
at	O
least	O
two	O
sigma	O
factors	O
and	O
three	O
two	O
-	O
component	O
regulatory	O
systems	O
in	O
response	O
to	O
environmental	O
signals	O
.	O

In	O
summary	O
,	O
we	O
have	O
evidence	O
of	O
three	O
novel	O
regulatory	O
systems	O
playing	O
a	O
role	O
in	O
the	O
progression	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
biofilm	O
development	O
in	O
a	O
stage	O
-	O
specific	O
manner	O
.	O

While	O
our	O
study	O
did	O
not	O
result	O
in	O
the	O
identification	O
of	O
RetS	S-Biological_Molecule
or	O
LadS	S-Biological_Molecule
,	O
we	O
identified	O
GacS	S-Biological_Molecule
by	O
two	O
different	O
approaches	O
and	O
confirmed	O
GacS	S-Biological_Molecule
phosphorylation	O
by	O
immunoblot	O
analysis	O
(	O
Table	O
1	O
)	O
.	O

GacS	S-Biological_Molecule
acts	O
as	O
a	O
suppressor	O
of	O
RetS	S-Biological_Molecule
(	O
and	O
vice	O
versa	O
)	O
with	O
RetS	S-Biological_Molecule
regulating	O
the	O
suppressor	O
activity	O
of	O
the	O
membrane	O
-	O
bound	O
sensor	O
GacS	S-Biological_Molecule
by	O
directly	O
modulating	O
its	O
phosphorylation	O
state	O
[	O
38	O
]	O
.	O

The	O
finding	O
is	O
consistent	O
with	O
our	O
observation	O
of	O
GacS	S-Biological_Molecule
playing	O
a	O
dual	O
role	O
in	O
biofilm	O
formation	O
,	O
with	O
phosphorylation	O
acting	O
as	O
a	O
switch	O
in	O
the	O
function	O
of	O
GacS	S-Biological_Molecule
(	O
Fig	O
.	O
3	O
,	O
Table	O
2	O
)	O
:	O
GacS	S-Biological_Molecule
participates	O
in	O
the	O
planktonic	O
/	O
biofilm	O
switch	O
in	O
its	O
non	O
-	O
phosphorylated	O
state	O
,	O
but	O
limits	O
/	O
regulates	O
the	O
rate	O
of	O
biomass	O
accumulation	O
and	O
biofilm	O
development	O
when	O
phosphorylated	O
.	O

Since	O
phosphorylation	O
of	O
GacS	S-Biological_Molecule
occurred	O
following	O
8	O
hr	O
of	O
surface	O
attached	O
growth	O
(	O
Table	O
1	O
)	O
and	O
since	O
RetS	S-Biological_Molecule
directly	O
modulates	O
the	O
phosphorylation	O
state	O
of	O
GacS	S-Biological_Molecule
[	O
38	O
]	O
,	O
the	O
findings	O
may	O
suggest	O
that	O
RetS	S-Biological_Molecule
only	O
remains	O
functional	O
for	O
a	O
period	O
of	O
8	O
hours	O
during	O
initial	O
attachment	O
after	O
which	O
RetS	S-Biological_Molecule
is	O
rendered	O
non	O
-	O
functional	O
.	O

Furthermore	O
,	O
the	O
finding	O
of	O
sequential	O
and	O
essential	O
regulatory	O
steps	O
in	O
biofilm	O
formation	O
and	O
the	O
involvement	O
of	O
at	O
least	O
two	O
sigma	O
factors	O
suggests	O
that	O
biofilm	O
development	O
is	O
analogous	O
to	O
other	O
programmed	O
developmental	O
processes	O
.	O

However	O
,	O
in	O
contrast	O
to	O
known	O
developmental	O
processes	O
,	O
our	O
findings	O
suggest	O
that	O
both	O
two	O
-	O
component	O
regulatory	O
systems	O
and	O
sigma	O
factor	O
dependent	O
response	O
regulators	O
are	O
key	O
components	O
of	O
the	O
transcriptional	O
and	O
regulatory	O
machinery	O
that	O
coordinate	O
gene	O
expression	O
during	O
P	B-Species
.	I-Species
aeruginosa	E-Species
biofilm	O
development	O
.	O

A	O
suite	O
of	O
T3SS	O
-	O
associated	O
chaperone	O
proteins	O
bind	O
cargo	O
in	O
the	O
bacterial	O
cytosol	O
,	O
establishing	O
protein	O
interaction	O
networks	O
needed	O
for	O
effector	O
translocation	O
into	O
host	S-Species
cells	O
.	O

In	O
Salmonella	B-Species
enterica	I-Species
serovar	I-Species
Typhimurium	E-Species
,	O
a	O
T3SS	O
encoded	O
in	O
a	O
large	O
genomic	O
island	O
(	O
SPI	O
-	O
2	O
)	O
is	O
required	O
for	O
intracellular	O
infection	O
,	O
but	O
the	O
chaperone	O
complement	O
required	O
for	O
effector	O
translocation	O
by	O
this	O
system	O
is	O
not	O
known	O
.	O

Crystallographic	O
analysis	O
of	O
SrcA	S-Biological_Molecule
at	O
a	O
resolution	O
of	O
2	O
.	O
5	O
A	O
revealed	O
a	O
dimer	O
similar	O
to	O
the	O
CesT	S-Biological_Molecule
chaperone	O
from	O
enteropathogenic	O
E	B-Species
.	I-Species
coli	E-Species
but	O
lacking	O
a	O
17	O
-	O
amino	O
acid	O
extension	O
at	O
the	O
carboxyl	S-Chemical_Compound
terminus	O
.	O

Further	O
biochemical	O
and	O
quantitative	O
proteomics	O
data	O
revealed	O
three	O
protein	O
interactions	O
with	O
SrcA	S-Biological_Molecule
,	O
including	O
two	O
effector	O
cargos	O
(	O
SseL	S-Biological_Molecule
and	O
PipB2	S-Biological_Molecule
)	O
and	O
the	O
type	O
III	O
-	O
associated	O
ATPase	O
,	O
SsaN	S-Biological_Molecule
,	O
that	O
increases	O
the	O
efficiency	O
of	O
effector	O
translocation	O
.	O

Introduction	O

Many	O
Gram	O
-	O
negative	O
bacteria	O
that	O
colonize	O
host	S-Species
animals	O
use	O
a	O
type	O
III	O
secretion	O
system	O
(	O
T3SS	O
)	O
to	O
deliver	O
effector	O
proteins	O
directly	O
into	O
host	S-Species
cells	O
where	O
their	O
interaction	O
with	O
host	S-Species
proteins	O
and	O
membranes	O
contribute	O
to	O
pathogenesis	O
.	O

These	O
chaperones	O
often	O
have	O
common	O
physical	O
features	O
such	O
as	O
low	O
molecular	O
weight	O
(	O
<	O
15	O
kDa	O
)	O
,	O
an	O
acidic	O
isoelectric	O
point	O
and	O
a	O
predicted	O
amphipathic	O
helix	O
at	O
the	O
carboxyl	S-Chemical_Compound
terminus	O
.	O

Class	O
I	O
chaperones	O
bind	O
to	O
translocated	O
effector	O
proteins	O
at	O
a	O
chaperone	O
binding	O
domain	O
(	O
CBD	O
)	O
located	O
in	O
the	O
amino	S-Chemical_Compound
terminus	O
of	O
the	O
effector	O
.	O

Class	O
II	O
chaperones	O
bind	O
to	O
translocon	O
proteins	O
that	O
make	O
up	O
the	O
secretion	O
pore	O
in	O
the	O
host	O
target	O
membrane	O
and	O
class	O
III	O
chaperones	O
bind	O
the	O
extracellular	O
filament	O
proteins	O
(	O
or	O
flagellin	O
rod	O
in	O
the	O
orthologous	O
flagellar	O
system	O
)	O
that	O
polymerize	O
into	O
a	O
helical	O
structure	O
following	O
secretion	O
from	O
the	O
bacterial	O
cell	O
.	O

To	O
date	O
,	O
13	O
effectors	O
have	O
been	O
identified	O
as	O
substrates	O
of	O
the	O
SPI	O
-	O
1	O
T3SS	O
and	O
21	O
effectors	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O
,	O
although	O
the	O
chaperones	O
orchestrating	O
the	O
latter	O
system	O
have	O
been	O
elusive	O
.	O

Whereas	O
80	O
%	O
of	O
the	O
effectors	O
of	O
the	O
SPI	O
-	O
1	O
system	O
have	O
defined	O
chaperones	O
,	O
only	O
two	O
effector	O
-	O
chaperone	O
interactions	O
are	O
known	O
for	O
the	O
SPI	O
-	O
2	O
system	O
.	O

These	O
include	O
the	O
effector	O
-	O
chaperone	O
pair	O
of	O
SseF	S-Biological_Molecule
-	O
SscB	S-Biological_Molecule
,	O
and	O
the	O
chaperone	O
SseA	S-Biological_Molecule
that	O
binds	O
translocon	O
components	O
SseD	S-Biological_Molecule
and	O
SseB	S-Biological_Molecule
[	O
8	O
]	O
,	O
[	O
9	O
]	O
,	O
[	O
10	O
]	O
.	O

Crystal	O
structures	O
have	O
been	O
determined	O
for	O
three	O
chaperones	O
that	O
coordinate	O
translocation	O
of	O
effectors	O
through	O
the	O
SPI	O
-	O
1	O
T3SS	O
(	O
InvB	S-Biological_Molecule
[	O
11	O
]	O
,	O
SicP	S-Biological_Molecule
[	O
12	O
]	O
and	O
SigE	S-Biological_Molecule
[	O
13	O
]	O
)	O
.	O

However	O
no	O
structures	O
are	O
available	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O
chaperones	O
whose	O
effector	O
repertoire	O
seems	O
considerably	O
larger	O
than	O
that	O
of	O
the	O
SPI	O
-	O
1	O
system	O
.	O

These	O
data	O
reveal	O
structural	O
and	O
biochemical	O
insight	O
into	O
a	O
T3SS	O
secretion	O
chaperone	O
required	O
for	O
intracellular	O
pathogenesis	O
of	O
Salmonella	S-Species
.	O

Results	O

This	O
gene	O
was	O
also	O
down	O
regulated	O
in	O
Salmonella	S-Species
mutants	O
lacking	O
the	O
SsrA	S-Biological_Molecule
sensor	O
kinase	O
[	O
20	O
]	O
,	O
and	O
was	O
predicted	O
to	O
encode	O
a	O
possible	O
chaperone	O
in	O
a	O
bioinformatics	O
-	O
based	O
screen	O
[	O
23	O
]	O
.	O

The	O
srcA	S-Biological_Molecule
gene	O
is	O
not	O
located	O
in	O
the	O
vicinity	O
of	O
the	O
T3SS	O
encoded	O
by	O
SPI	O
-	O
2	O
(	O
STM1378	S-Biological_Molecule
-	O
STM1425	S-Biological_Molecule
)	O
,	O
but	O
is	O
713	O
genes	O
downstream	O
on	O
the	O
chromosome	O
(	O
STM	O
numbers	O
are	O
based	O
on	O
the	O
LT2	O
genome	O
and	O
ordered	O
sequentially	O
on	O
the	O
chromosome	O
beginning	O
at	O
STM0001	O
,	O
thrL	S-Biological_Molecule
)	O
.	O

This	O
analysis	O
revealed	O
a	O
strong	O
SsrB	S-Biological_Molecule
binding	O
site	O
spanning	O
10	O
syntenic	O
probes	O
within	O
the	O
intergenic	O
region	O
(	O
IGR	O
)	O
upstream	O
of	O
srcA	S-Biological_Molecule
,	O
that	O
together	O
with	O
the	O
transcriptional	O
data	O
corroborated	O
a	O
direct	O
regulatory	O
role	O
for	O
SsrB	S-Biological_Molecule
on	O
srcA	S-Biological_Molecule
expression	O
(	O
Fig	O
.	O
1A	S-Biological_Molecule
)	O
.	O

In	O
whole	O
cell	O
lysates	O
,	O
SrcA	S-Biological_Molecule
protein	O
was	O
reduced	O
approximately10	O
-	O
fold	O
in	O
DeltassrB	S-Species
cells	O
compared	O
to	O
wild	O
type	O
(	O
Fig	O
.	O
1B	O
)	O
and	O
the	O
protein	O
was	O
not	O
detected	O
in	O
the	O
secreted	O
fraction	O
from	O
wild	O
type	O
cells	O
(	O
Fig	O
.	O
1C	O
)	O
,	O
consistent	O
with	O
the	O
expected	O
properties	O
of	O
a	O
T3SS	O
chaperone	O
.	O

SrcA	S-Biological_Molecule
contributes	O
to	O
Salmonella	S-Species
fitness	O
in	O
an	O
animal	O
host	S-Species

Most	O
SsrB	S-Biological_Molecule
-	O
regulated	O
gene	O
products	O
contribute	O
to	O
the	O
intracellular	O
survival	O
of	O
Salmonella	S-Species
in	O
a	O
host	S-Species
.	O

In	O
comparative	O
genomics	O
analyses	O
,	O
srcA	S-Biological_Molecule
was	O
found	O
in	O
all	O
virulent	O
strains	O
of	O
Salmonella	B-Species
enterica	E-Species
containing	O
SPI	O
-	O
2	O
,	O
but	O
was	O
absent	O
from	O
the	O
cold	O
-	O
blooded	O
animal	O
commensal	O
,	O
S	B-Species
.	I-Species
bongori	E-Species
,	O
which	O
lacks	O
SPI	O
-	O
2	O
(	O
Table	O
S1	O
)	O
.	O

The	O
level	O
of	O
attenuation	O
of	O
the	O
srcA	S-Biological_Molecule
mutant	O
was	O
generally	O
higher	O
than	O
most	O
single	O
effector	O
gene	O
mutants	O
[	O
26	O
]	O
,	O
which	O
suggested	O
to	O
us	O
that	O
SrcA	S-Biological_Molecule
contributes	O
to	O
an	O
important	O
aspect	O
of	O
T3SS	O
function	O
in	O
vivo	O
.	O

Crystal	O
structure	O
of	O
SrcA	S-Biological_Molecule

The	O
structure	O
was	O
solved	O
by	O
molecular	O
replacement	O
using	O
an	O
initial	O
model	O
based	O
on	O
CesT	S-Biological_Molecule
(	O
PDB	B-Biological_Molecule
1K3E	E-Biological_Molecule
)	O
[	O
13	O
]	O
.	O

SrcA	S-Biological_Molecule
crystallized	O
in	O
space	O
group	O
C2	O
with	O
two	O
molecules	O
related	O
by	O
a	O
2	O
-	O
fold	O
symmetry	O
axis	O
in	O
each	O
asymmetric	O
unit	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

The	O
smaller	O
domain	O
formed	O
by	O
alpha1	O
and	O
the	O
extended	O
loop	O
region	O
preceding	O
beta1	O
adopts	O
a	O
distinct	O
conformation	O
in	O
each	O
subunit	O
.	O

A	O
structure	O
similarity	O
search	O
with	O
SrcA	S-Biological_Molecule
revealed	O
proteins	O
identified	O
as	O
T3SS	O
secretion	O
chaperones	O
.	O

CesT	S-Biological_Molecule
and	O
SicP	S-Biological_Molecule
were	O
the	O
most	O
structurally	O
similar	O
to	O
SrcA	S-Biological_Molecule
,	O
aligning	O
with	O
RMSD	O
of	O
1	O
.	O
8	O
A	O
and	O
2	O
.	O
2	O
A	O
respectively	O
.	O

With	O
the	O
exception	O
of	O
CesT	S-Biological_Molecule
,	O
SrcA	S-Biological_Molecule
has	O
weak	O
overall	O
sequence	O
identity	O
(	O
<	O
20	O
%	O
)	O
with	O
other	O
T3SS	O
chaperones	O
.	O

Most	O
of	O
these	O
conserved	O
sites	O
are	O
located	O
in	O
the	O
alpha2	O
-	O
interface	O
helix	O
and	O
in	O
strands	O
beta4	O
and	O
beta5	O
that	O
help	O
stabilize	O
this	O
interface	O
.	O

Although	O
the	O
N	O
-	O
terminus	O
of	O
these	O
proteins	O
is	O
conserved	O
structurally	O
,	O
the	O
tertiary	O
structures	O
differ	O
for	O
each	O
protein	O
.	O

In	O
CesT	S-Biological_Molecule
,	O
alpha1	O
and	O
beta1	O
adopt	O
an	O
extended	O
conformation	O
while	O
the	O
equivalent	O
domain	O
in	O
SicP	S-Biological_Molecule
remains	O
closely	O
packed	O
against	O
the	O
dimerization	O
domain	O
[	O
12	O
]	O
.	O

A	O
comparison	O
of	O
the	O
SrcA	S-Biological_Molecule
dimer	O
interface	O
with	O
other	O
class	O
I	O
chaperone	O
family	O
members	O
indicates	O
the	O
overall	O
similarity	O
of	O
quaternary	O
structure	O
shared	O
between	O
SrcA	S-Biological_Molecule
,	O
CesT	S-Biological_Molecule
and	O
SicP	S-Biological_Molecule
(	O
Fig	O
.	O
3A	O
)	O
.	O

This	O
is	O
in	O
contrast	O
to	O
the	O
class	O
II	O
chaperone	O
interface	O
of	O
Spa15	S-Biological_Molecule
,	O
which	O
despite	O
having	O
similar	O
tertiary	O
structure	O
to	O
SrcA	S-Biological_Molecule
adopts	O
a	O
distinct	O
dimer	O
interface	O
.	O

A	O
structural	O
alignment	O
of	O
SrcA	S-Biological_Molecule
and	O
Spa15	S-Biological_Molecule
generated	O
through	O
alignment	O
of	O
single	O
monomers	O
shows	O
the	O
relative	O
difference	O
in	O
subunit	O
orientation	O
between	O
SrcA	S-Biological_Molecule
and	O
Spa15	S-Biological_Molecule
reflected	O
by	O
the	O
positions	O
of	O
each	O
monomer	O
in	O
the	O
dimer	O
configuration	O
.	O

These	O
unique	O
orientations	O
produce	O
an	O
80degrees	O
rotational	O
offset	O
between	O
respective	O
subunits	O
and	O
could	O
be	O
expected	O
to	O
influence	O
the	O
mode	O
of	O
effector	O
interactions	O
utilized	O
by	O
these	O
proteins	O
.	O

Binding	O
of	O
SptP	S-Biological_Molecule
occurs	O
primarily	O
in	O
the	O
N	O
-	O
terminus	O
of	O
SicP	S-Biological_Molecule
[	O
12	O
]	O
,	O
which	O
is	O
similar	O
to	O
the	O
effector	O
binding	O
surface	O
for	O
SrcA	S-Biological_Molecule
predicted	O
in	O
silico	O
.	O

To	O
address	O
this	O
biochemically	O
we	O
purified	O
SrcA	S-Biological_Molecule
and	O
the	O
predicted	O
ATPase	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O
,	O
SsaN	S-Biological_Molecule
,	O
and	O
performed	O
binding	O
experiments	O
and	O
gel	O
filtration	O
chromatography	O
of	O
the	O
protein	O
mixtures	O
.	O

SsaN	S-Biological_Molecule
contains	O
conserved	O
amino	O
acid	O
residues	O
characteristic	O
of	O
Walker	O
-	O
A	O
and	O
Walker	O
-	O
B	O
motifs	O
of	O
P	O
-	O
loop	O
nucleoside	B-Biological_Molecule
triphosphate	I-Biological_Molecule
hydrolases	E-Biological_Molecule
,	O
as	O
well	O
as	O
a	O
number	O
of	O
residues	O
shown	O
to	O
contribute	O
to	O
ATP	S-Chemical_Compound
binding	O
or	O
ring	O
stacking	O
with	O
the	O
adenine	S-Chemical_Compound
base	O
of	O
ATP	S-Chemical_Compound
in	O
the	O
E	B-Species
.	I-Species
coli	E-Species
orthologue	O
,	O
EscN	S-Biological_Molecule
,	O
(	O
Q412	O
,	O
E191	O
,	O
R366	O
)	O
(	O
Fig	O
.	O
S1	O
)	O
.	O

When	O
SrcA	S-Biological_Molecule
was	O
mixed	O
with	O
SsaN	S-Biological_Molecule
,	O
a	O
new	O
protein	O
complex	O
of	O
high	O
molecular	O
weight	O
was	O
observed	O
,	O
along	O
with	O
diminished	O
peaks	O
corresponding	O
to	O
the	O
SrcA	S-Biological_Molecule
dimer	O
and	O
SsaN	S-Biological_Molecule
monomer	O
(	O
Fig	O
.	O
4C	O
)	O
.	O

This	O
new	O
complex	O
elutes	O
with	O
a	O
Stokes	O
radius	O
consistent	O
with	O
an	O
apparent	O
molecular	O
mass	O
of	O
approximately600	O
kDa	O
.	O

SrcA	S-Biological_Molecule
binds	O
effector	O
cargo	O
destined	O
for	O
the	O
SPI	O
-	O
2	O
T3SS	O

First	O
,	O
we	O
used	O
stable	O
isotope	O
labeling	O
of	O
amino	O
acids	O
in	O
cell	O
culture	O
(	O
SILAC	O
)	O
[	O
28	O
]	O
in	O
conjunction	O
with	O
quantitative	O
mass	O
spectrometry	O
-	O
based	O
proteomics	O
to	O
identify	O
cargo	O
immunoprecipitated	O
with	O
SrcA	S-Biological_Molecule
from	O
Salmonella	S-Species
.	O

For	O
this	O
series	O
of	O
experiments	O
we	O
constructed	O
a	O
mutant	O
in	O
which	O
the	O
srcA	S-Biological_Molecule
gene	O
was	O
replaced	O
on	O
the	O
chromosome	O
with	O
srcA	S-Biological_Molecule
-	O
FLAG	O
to	O
enable	O
immunoprecipitation	O
from	O
cell	O
lysates	O
.	O

Peptides	O
originating	O
from	O
wild	O
type	O
cells	O
contained	O
heavy	O
atom	O
-	O
substituted	O
lysine	O
and	O
arginine	O
such	O
that	O
putative	O
SrcA	S-Biological_Molecule
cargo	O
proteins	O
would	O
generate	O
low	O
heavy	O
:	O
light	O
SILAC	O
peptide	O
ratios	O
from	O
the	O
complex	O
mixtures	O
(	O
Fig	O
.	O
5A	O
)	O
.	O

SseL	S-Biological_Molecule
was	O
immunoprecipitated	O
specifically	O
along	O
with	O
SrcA	S-Biological_Molecule
-	O
FLAG	O
with	O
a	O
SILAC	O
ratio	O
of	O
0	O
.	O
08	O
,	O
whereas	O
additional	O
abundant	O
proteins	O
displayed	O
SILAC	O
ratios	O
closer	O
to	O
approximately1	O
(	O
OmpF	S-Biological_Molecule
is	O
shown	O
,	O
Fig	O
.	O
5B	O
)	O
(	O
mean	O
SILAC	O
ratio	O
of	O
all	O
other	O
peptides	O
identified	O
was	O
0	O
.	O
93	O
(	O
Dataset	O
S1	O
)	O
.	O

Secondly	O
,	O
to	O
verify	O
the	O
mass	O
spectrometry	O
data	O
and	O
to	O
identify	O
other	O
possible	O
effector	O
cargo	O
,	O
we	O
examined	O
the	O
secretion	O
profiles	O
of	O
wild	O
type	O
cells	O
and	O
an	O
srcA	S-Biological_Molecule
mutant	O
that	O
each	O
expressed	O
HA	O
-	O
tagged	O
effector	O
genes	O
,	O
the	O
products	O
of	O
which	O
are	O
secreted	O
by	O
the	O
SPI	O
-	O
2	O
-	O
encoded	O
T3SS	O
.	O

Using	O
this	O
approach	O
SseL	S-Biological_Molecule
-	O
HA	O
and	O
PipB2	S-Biological_Molecule
-	O
HA	O
were	O
depleted	O
from	O
the	O
secreted	O
protein	O
fraction	O
of	O
srcA	S-Biological_Molecule
mutant	O
cells	O
(	O
Fig	O
.	O
5C	O
)	O
but	O
reached	O
similar	O
levels	O
in	O
the	O
bacterial	O
cytoplasm	O
(	O
Fig	O
.	O
5D	O
)	O
.	O

As	O
expected	O
from	O
data	O
with	O
the	O
complemented	O
mutant	O
in	O
vivo	O
,	O
expression	O
of	O
srcA	S-Biological_Molecule
in	O
trans	O
restored	O
effector	O
secretion	O
in	O
the	O
srcA	S-Biological_Molecule
mutant	O
(	O
data	O
not	O
shown	O
)	O
.	O

SrcA	S-Biological_Molecule
is	O
required	O
for	O
PipB2	S-Biological_Molecule
-	O
dependent	O
centrifugal	O
displacement	O
of	O
the	O
Salmonella	S-Species
-	O
containing	O
vacuole	O

To	O
further	O
show	O
a	O
role	O
for	O
SrcA	S-Biological_Molecule
in	O
chaperoning	O
PipB2	S-Biological_Molecule
,	O
we	O
set	O
up	O
experiments	O
to	O
test	O
whether	O
deleting	O
srcA	S-Biological_Molecule
would	O
phenocopy	O
DeltapipB2	S-Species
cells	O
for	O
PipB2	S-Biological_Molecule
-	O
dependent	O
centrifugal	O
displacement	O
of	O
the	O
Salmonella	S-Species
containing	O
vacuole	O
(	O
SCV	O
)	O
in	O
epithelial	O
cells	O
,	O
an	O
event	O
linked	O
to	O
cell	O
-	O
to	O
-	O
cell	O
transfer	O
during	O
infection	O
in	O
vitro	O
[	O
29	O
]	O
.	O

By	O
24	O
h	O
after	O
infection	O
SCVs	O
containing	O
wild	O
type	O
bacteria	O
were	O
displaced	O
centrifugally	O
towards	O
the	O
cell	O
periphery	O
whereas	O
SCVs	O
containing	O
either	O
pipB2	S-Biological_Molecule
or	O
srcA	S-Biological_Molecule
mutant	O
bacteria	O
remained	O
juxtaposed	O
to	O
the	O
nucleus	O
(	O
Fig	O
.	O
6A	O
)	O
.	O

Typhimurium	S-Species
that	O
is	O
integrated	O
functionally	O
with	O
the	O
T3SS	O
encoded	O
by	O
SPI	O
-	O
2	O
,	O
a	O
system	O
well	O
described	O
for	O
its	O
role	O
in	O
immune	O
subversion	O
and	O
intracellular	O
infection	O
during	O
host	S-Species
colonization	O
.	O

Consistent	O
with	O
other	O
class	O
I	O
secretion	O
chaperones	O
,	O
SrcA	S-Biological_Molecule
has	O
extensive	O
electronegative	O
charge	O
distributed	O
over	O
the	O
surface	O
of	O
the	O
molecule	O
.	O

The	O
exact	O
function	O
of	O
this	O
charge	O
distribution	O
is	O
not	O
known	O
,	O
but	O
data	O
from	O
other	O
systems	O
suggests	O
a	O
docking	O
recognition	O
function	O
with	O
other	O
components	O
of	O
the	O
type	O
III	O
apparatus	O
,	O
possibly	O
the	O
T3SS	O
-	O
accociated	O
ATPase	O
.	O

For	O
instance	O
,	O
electronegative	O
surface	O
residues	O
on	O
the	O
SigE	S-Biological_Molecule
chaperone	O
in	O
the	O
SPI	O
-	O
1	O
-	O
encoded	O
T3SS	O
negatively	O
affect	O
cargo	O
secretion	O
,	O
but	O
not	O
cargo	O
stability	O
[	O
30	O
]	O
.	O

In	O
enteropathogenic	O
E	B-Species
.	I-Species
coli	E-Species
,	O
a	O
surface	O
-	O
exposed	O
electronegative	O
residue	O
in	O
the	O
CesT	S-Biological_Molecule
chaperone	O
(	O
Glu142	O
)	O
likewise	O
contributes	O
to	O
Tir	S-Biological_Molecule
secretion	O
but	O
not	O
Tir	S-Biological_Molecule
binding	O
[	O
16	O
]	O
,	O
suggesting	O
a	O
role	O
in	O
either	O
targeting	O
bound	O
cargo	O
to	O
the	O
T3SS	O
or	O
in	O
the	O
secretion	O
process	O
itself	O
.	O

Thus	O
,	O
it	O
is	O
likely	O
that	O
other	O
surface	O
charged	O
residues	O
of	O
SrcA	S-Biological_Molecule
are	O
involved	O
in	O
these	O
functions	O
or	O
that	O
SrcA	S-Biological_Molecule
targets	O
effector	O
cargo	O
to	O
the	O
secretion	O
apparatus	O
through	O
a	O
mechanism	O
distinct	O
from	O
CesT	S-Biological_Molecule
.	O

The	O
interface	O
for	O
the	O
SrcA	S-Biological_Molecule
homodimer	O
is	O
extensive	O
and	O
is	O
more	O
in	O
keeping	O
with	O
the	O
structural	O
features	O
of	O
single	O
-	O
effector	O
class	O
IA	O
chaperones	O
(	O
approximately1100	O
-	O
1300	O
A2	O
)	O
compared	O
to	O
the	O
reduced	O
dimer	O
interface	O
of	O
Spa15	S-Biological_Molecule
,	O
a	O
multi	O
-	O
cargo	O
class	O
IB	O
chaperone	O
from	O
Shigella	S-Species
[	O
31	O
]	O
.	O

Similar	O
to	O
CesT	S-Biological_Molecule
and	O
SicP	S-Biological_Molecule
,	O
the	O
dimer	O
interface	O
of	O
SrcA	S-Biological_Molecule
adopts	O
a	O
parallel	O
configuration	O
when	O
comparing	O
alpha2	O
helices	O
of	O
opposing	O
subunits	O
.	O

In	O
contrast	O
,	O
the	O
subunits	O
of	O
Spa15	S-Biological_Molecule
undergo	O
a	O
significant	O
relative	O
rotation	O
(	O
80degrees	O
)	O
about	O
the	O
alpha2	O
-	O
axis	O
resulting	O
in	O
a	O
different	O
interface	O
.	O

These	O
features	O
may	O
relate	O
to	O
biological	O
function	O
in	O
the	O
SPI2	O
T3SS	O
and	O
/	O
or	O
in	O
vetting	O
effector	O
cargo	O
amongst	O
the	O
>	O
30	O
effectors	O
identified	O
in	O
Salmonella	S-Species
.	O

Implications	O
for	O
type	O
III	O
secretion	O
function	O

The	O
interaction	O
between	O
SrcA	S-Biological_Molecule
and	O
SsaN	S-Biological_Molecule
supports	O
an	O
emerging	O
paradigm	O
whereby	O
secretion	O
chaperones	O
bring	O
effector	O
cargo	O
to	O
the	O
T3SS	O
through	O
physical	O
interaction	O
with	O
the	O
hexameric	O
ATPase	O
at	O
the	O
base	O
of	O
the	O
apparatus	O
[	O
14	O
]	O
.	O

Our	O
work	O
shows	O
the	O
first	O
chaperone	O
-	O
ATPase	O
interaction	O
for	O
a	O
T3SS	O
functioning	O
from	O
within	O
an	O
intracellular	O
vacuolar	O
compartment	O
and	O
supports	O
this	O
interaction	O
as	O
a	O
more	O
generalize	O
feature	O
of	O
type	O
III	O
secretion	O
function	O
.	O

Conversely	O
,	O
these	O
genes	O
are	O
absent	O
from	O
S	B-Species
.	I-Species
bongori	E-Species
,	O
which	O
lacks	O
the	O
SPI	O
-	O
2	O
-	O
encoded	O
T3SS	O
.	O

The	O
expression	O
of	O
srcA	S-Biological_Molecule
is	O
coordinated	O
with	O
T3SS	O
transcriptional	O
activity	O
via	O
the	O
SsrA	S-Biological_Molecule
-	O
SsrB	S-Biological_Molecule
two	O
-	O
component	O
regulatory	O
system	O
encoded	O
in	O
SPI	O
-	O
2	O
.	O

Due	O
to	O
low	O
G	O
+	O
C	O
base	O
content	O
compared	O
to	O
the	O
genome	O
average	O
of	O
52	O
%	O
,	O
it	O
'	O
s	O
likely	O
that	O
srcA	S-Biological_Molecule
(	O
32	O
%	O
G	O
+	O
C	O
)	O
and	O
an	O
adjacent	O
gene	O
,	O
STM2137	S-Biological_Molecule
(	O
37	O
%	O
G	O
+	O
C	O
)	O
,	O
were	O
acquired	O
as	O
a	O
foreign	O
islet	O
that	O
was	O
retained	O
in	O
organisms	O
containing	O
the	O
SPI	O
-	O
2	O
T3SS	O
due	O
to	O
the	O
selective	O
advantage	O
afforded	O
by	O
the	O
new	O
protein	O
interactions	O
so	O
created	O
.	O

SseK2	S-Biological_Molecule
is	O
also	O
regulated	O
by	O
the	O
SsrA	S-Biological_Molecule
-	O
SsrB	S-Biological_Molecule
two	O
-	O
component	O
system	O
but	O
compared	O
to	O
SseK1	S-Biological_Molecule
,	O
it	O
is	O
translocated	O
in	O
much	O
less	O
abundance	O
into	O
host	O
cells	O
[	O
33	O
]	O
.	O

Given	O
its	O
genetic	O
neighborhood	O
,	O
srcA	S-Biological_Molecule
appears	O
to	O
be	O
a	O
genetic	O
acquisition	O
separate	O
from	O
SPI	O
-	O
2	O
that	O
functionally	O
links	O
some	O
effectors	O
to	O
the	O
T3SS	O
apparatus	O
via	O
the	O
ATPase	O
.	O

The	O
role	O
of	O
horizontal	O
gene	O
transfer	O
and	O
regulatory	O
evolution	O
in	O
allowing	O
for	O
uncoupling	O
of	O
chaperones	O
,	O
effectors	O
and	O
the	O
T3SS	O
has	O
many	O
possible	O
implications	O
for	O
T3SS	O
function	O
,	O
including	O
plasticity	O
in	O
chaperone	O
-	O
effector	O
interaction	O
networks	O
,	O
expansion	O
of	O
effector	O
repertoires	O
,	O
and	O
alterations	O
to	O
the	O
kinetics	O
and	O
hierarchical	O
delivery	O
of	O
effectors	O
to	O
a	O
host	O
cell	O
.	O

These	O
events	O
may	O
improve	O
host	O
adaptability	O
or	O
even	O
expand	O
the	O
host	O
range	O
of	O
bacteria	O
that	O
acquire	O
and	O
integrate	O
new	O
functional	O
secretion	O
chaperones	O
.	O

Transit	O
through	O
the	O
Flea	S-Species
Vector	O
Induces	O
a	O
Pretransmission	O
Innate	O
Immunity	O
Resistance	O
Phenotype	O
in	O
Yersinia	B-Species
pestis	E-Species

Y	B-Species
.	I-Species
pestis	E-Species
exhibits	O
a	O
distinct	O
life	O
stage	O
in	O
the	O
flea	S-Species
,	O
where	O
it	O
grows	O
in	O
the	O
form	O
of	O
a	O
cohesive	O
biofilm	O
that	O
promotes	O
transmission	O
.	O

These	O
factors	O
are	O
not	O
produced	O
in	O
the	O
low	O
-	O
temperature	O
environment	O
of	O
the	O
flea	S-Species
,	O
however	O
,	O
suggesting	O
that	O
Y	B-Species
.	I-Species
pestis	E-Species
is	O
vulnerable	O
to	O
the	O
initial	O
encounter	O
with	O
innate	O
immune	O
cells	O
at	O
the	O
flea	S-Species
bite	O
site	O
.	O

Y	B-Species
.	I-Species
pestis	E-Species
from	O
infected	O
fleas	S-Species
were	O
more	O
resistant	O
to	O
phagocytosis	O
by	O
macrophages	O
than	O
in	O
vitro	O
-	O
grown	O
bacteria	O
,	O
in	O
part	O
attributable	O
to	O
a	O
cluster	O
of	O
insecticidal	O
-	O
like	O
toxin	O
genes	O
that	O
were	O
highly	O
expressed	O
only	O
in	O
the	O
flea	S-Species
.	O

Our	O
results	O
suggest	O
that	O
transit	O
through	O
the	O
flea	S-Species
vector	O
induces	O
a	O
phenotype	O
that	O
enhances	O
survival	O
and	O
dissemination	O
of	O
Y	B-Species
.	I-Species
pestis	E-Species
after	O
transmission	O
to	O
the	O
mammalian	O
host	S-Species
.	O

To	O
date	O
,	O
only	O
three	O
transmission	O
factors	O
(	O
genes	O
specifically	O
required	O
to	O
produce	O
a	O
transmissible	O
infection	O
in	O
the	O
flea	S-Species
)	O
have	O
been	O
characterized	O
.	O

After	O
being	O
taken	O
up	O
in	O
a	O
blood	O
meal	O
,	O
Y	B-Species
.	I-Species
pestis	E-Species
proliferates	O
in	O
the	O
lumen	O
of	O
the	O
flea	S-Species
midgut	O
to	O
form	O
cohesive	O
multicellular	O
biofilm	O
aggregates	O
.	O

In	O
some	O
infected	O
fleas	S-Species
,	O
the	O
proventricular	O
valve	O
between	O
the	O
midgut	O
and	O
esophagus	O
is	O
colonized	O
.	O

Fleas	S-Species
with	O
a	O
completely	O
blocked	O
proventriculus	O
make	O
prolonged	O
,	O
repeated	O
attempts	O
to	O
feed	O
,	O
increasing	O
the	O
opportunities	O
for	O
transmission	O
.	O

Formation	O
of	O
a	O
Y	B-Species
.	I-Species
pestis	E-Species
biofilm	O
in	O
vitro	O
and	O
in	O
the	O
flea	S-Species
proventriculus	O
depends	O
on	O
synthesis	O
of	O
an	O
extracellular	O
polysaccharide	O
matrix	O
(	O
ECM	O
)	O
that	O
is	O
synthesized	O
only	O
at	O
temperatures	O
below	O
26degreesC	O
[	O
3	O
]	O
,	O
[	O
7	O
]	O
.	O

Bacterial	O
adhesins	O
are	O
typically	O
required	O
for	O
initial	O
adherence	O
and	O
autoaggregation	O
in	O
biofilm	O
development	O
[	O
10	O
]	O
,	O
but	O
such	O
factors	O
have	O
yet	O
to	O
be	O
identified	O
in	O
Y	B-Species
.	I-Species
pestis	E-Species
.	O

In	O
a	O
previous	O
study	O
,	O
we	O
reported	O
the	O
in	O
vivo	O
gene	O
expression	O
profile	O
of	O
Y	B-Species
.	I-Species
pestis	E-Species
during	O
bubonic	O
plague	O
in	O
rats	S-Species
[	O
11	O
]	O
.	O

In	O
addition	O
,	O
comparing	O
the	O
gene	O
expression	O
patterns	O
in	O
the	O
flea	S-Species
and	O
in	O
the	O
rat	S-Species
bubo	O
confirmed	O
that	O
distinct	O
subsets	O
of	O
genes	O
are	O
differentially	O
expressed	O
during	O
the	O
Y	B-Species
.	I-Species
pestis	E-Species
life	O
cycle	O
.	O

Notably	O
,	O
several	O
genes	O
with	O
known	O
or	O
predicted	O
roles	O
in	O
protection	O
against	O
the	O
mammalian	O
innate	O
immune	O
system	O
and	O
in	O
pathogenesis	O
were	O
upregulated	O
in	O
the	O
flea	S-Species
,	O
suggesting	O
that	O
transit	O
through	O
the	O
insect	O
vector	O
preinduces	O
a	O
phenotype	O
that	O
enhances	O
Y	B-Species
.	I-Species
pestis	E-Species
survival	O
and	O
dissemination	O
in	O
the	O
mammal	O
after	O
flea	S-Species
-	O
borne	O
transmission	O
.	O

Transcriptional	O
profile	O
of	O
Y	B-Species
.	I-Species
pestis	E-Species
in	O
the	O
flea	S-Species
Little	O
is	O
known	O
about	O
the	O
environmental	O
conditions	O
in	O
the	O
flea	S-Species
digestive	O
tract	O
,	O
how	O
Y	B-Species
.	I-Species
pestis	E-Species
adapts	O
to	O
them	O
,	O
or	O
the	O
physiological	O
state	O
of	O
the	O
bacteria	O
at	O
transmission	O
when	O
they	O
exit	O
the	O
flea	S-Species
and	O
enter	O
the	O
mammal	O
.	O

Flea	S-Species
proteases	O
,	O
lipases	O
,	O
and	O
other	O
digestive	O
enzymes	O
begin	O
to	O
process	O
the	O
blood	O
meal	O
in	O
the	O
midgut	O
immediately	O
after	O
feeding	O
,	O
yielding	O
amino	O
acids	O
and	O
peptides	O
,	O
glycerol	S-Chemical_Compound
,	O
fatty	O
acids	O
,	O
and	O
simple	O
carbohydrates	O
[	O
12	O
]	O
.	O

During	O
the	O
first	O
week	O
after	O
being	O
ingested	O
in	O
an	O
infectious	O
blood	O
meal	O
,	O
Y	B-Species
.	I-Species
pestis	E-Species
grows	O
rapidly	O
in	O
the	O
flea	S-Species
midgut	O
to	O
form	O
large	O
bacterial	O
aggregates	O
.	O

Bacterial	O
load	O
peaks	O
at	O
about	O
106	O
cells	O
per	O
flea	S-Species
as	O
the	O
Y	B-Species
.	I-Species
pestis	E-Species
biofilm	O
accumulates	O
in	O
the	O
proventriculus	O
to	O
cause	O
blockage	O
,	O
and	O
then	O
plateaus	O
[	O
2	O
]	O
,	O
[	O
3	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
determined	O
the	O
Y	B-Species
.	I-Species
pestis	E-Species
gene	O
expression	O
profile	O
in	O
infective	O
,	O
blocked	O
fleas	S-Species
,	O
in	O
which	O
the	O
proventriculus	O
was	O
occluded	O
with	O
a	O
mature	O
bacterial	O
biofilm	O
.	O

Quantitative	O
RT	O
-	O
PCR	O
analysis	O
of	O
a	O
subset	O
of	O
Y	B-Species
.	I-Species
pestis	E-Species
genes	O
differentially	O
expressed	O
in	O
the	O
flea	S-Species
was	O
confirmatory	O
of	O
the	O
microarray	O
results	O
(	O
Fig	O
.	O
S2	O
)	O
.	O

Of	O
the	O
214	O
genes	O
upregulated	O
in	O
the	O
flea	S-Species
gut	O
compared	O
to	O
all	O
in	O
vitro	O
conditions	O
,	O
78	O
are	O
metabolic	O
genes	O
,	O
60	O
of	O
which	O
are	O
involved	O
in	O
uptake	O
and	O
catabolism	O
of	O
amino	O
acids	O
and	O
carbohydrates	O
(	O
Table	O
S1	O
)	O
.	O

The	O
degradation	O
of	O
these	O
amino	O
acids	O
gives	O
rise	O
to	O
L	O
-	O
glutamate	O
and	O
the	O
TCA	S-Chemical_Compound
cycle	O
intermediates	O
succinate	S-Chemical_Compound
,	O
formate	S-Chemical_Compound
,	O
and	O
alpha	B-Chemical_Compound
-	I-Chemical_Compound
ketoglutarate	E-Chemical_Compound
.	O

The	O
gabD	S-Biological_Molecule
and	O
gabT	S-Biological_Molecule
genes	O
involved	O
in	O
the	O
production	O
of	O
succinate	S-Chemical_Compound
from	O
gamma	B-Chemical_Compound
-	I-Chemical_Compound
aminobutyrate	E-Chemical_Compound
(	O
GABA	S-Chemical_Compound
)	O
,	O
another	O
member	O
of	O
the	O
L	O
-	O
glutamate	O
group	O
,	O
were	O
also	O
highly	O
induced	O
in	O
the	O
flea	S-Species
.	O

The	O
gabD	S-Biological_Molecule
gene	O
functions	O
to	O
produce	O
succinate	S-Chemical_Compound
from	O
both	O
GABA	S-Chemical_Compound
and	O
hydroxyphenylacetate	S-Chemical_Compound
(	O
HPA	S-Chemical_Compound
)	O
,	O
an	O
aromatic	O
degradation	O
product	O
of	O
Tyr	O
and	O
Phe	O
;	O
and	O
the	O
HPA	B-Biological_Molecule
transport	E-Biological_Molecule
(	O
hpaX	S-Biological_Molecule
)	O
and	O
catabolism	O
(	O
hpaCBIFHDE	S-Biological_Molecule
)	O
genes	O
of	O
Y	B-Species
.	I-Species
pestis	E-Species
were	O
also	O
highly	O
upregulated	O
in	O
the	O
flea	S-Species
gut	O
(	O
Table	O
S1	O
,	O
Fig	O
.	O
2	O
)	O
.	O

As	O
Y	B-Species
.	I-Species
pestis	E-Species
does	O
not	O
have	O
homologs	O
of	O
genes	O
required	O
to	O
produce	O
GABA	S-Chemical_Compound
or	O
HPA	S-Chemical_Compound
,	O
these	O
metabolites	O
may	O
be	O
taken	O
up	O
from	O
the	O
flea	S-Species
digestive	O
tract	O
.	O

Alternatively	O
,	O
the	O
gabD	S-Biological_Molecule
and	O
gabT	S-Biological_Molecule
gene	O
products	O
might	O
act	O
in	O
the	O
reverse	O
direction	O
to	O
synthesize	O
GABA	S-Chemical_Compound
,	O
which	O
has	O
osmoprotective	O
properties	O
[	O
13	O
]	O
.	O

Interestingly	O
,	O
both	O
glutamate	S-Chemical_Compound
and	O
GABA	S-Chemical_Compound
are	O
important	O
neurotransmitters	O
at	O
the	O
neuromuscular	O
junction	O
of	O
insects	O
,	O
and	O
the	O
concentration	O
of	O
glutamate	O
is	O
very	O
low	O
in	O
insect	O
hemolymph	O
,	O
suggesting	O
that	O
it	O
is	O
converted	O
to	O
glutamine	O
before	O
it	O
is	O
absorbed	O
[	O
14	O
]	O
.	O

Thus	O
,	O
Y	B-Species
.	I-Species
pestis	E-Species
metabolism	O
in	O
the	O
flea	S-Species
may	O
reflect	O
the	O
available	O
pool	O
of	O
amino	O
acids	O
in	O
the	O
midgut	O
.	O

Only	O
the	O
genes	O
encoding	O
for	O
chitobiose	B-Biological_Molecule
phosphotransferase	E-Biological_Molecule
(	O
PTS	S-Biological_Molecule
)	O
uptake	O
and	O
utilization	O
systems	O
(	O
chbBC	S-Biological_Molecule
;	O
chbF	S-Biological_Molecule
)	O
,	O
and	O
for	O
a	O
PTS	O
system	O
of	O
unknown	O
specificity	O
(	O
frwBCD	S-Biological_Molecule
)	O
were	O
significantly	O
upregulated	O
in	O
the	O
flea	S-Species
[	O
16	O
]	O
,	O
[	O
17	O
]	O
.	O

Chitobiose	S-Biological_Molecule
could	O
be	O
present	O
in	O
the	O
flea	S-Species
gut	O
due	O
to	O
turnover	O
of	O
the	O
chitin	O
layer	O
on	O
the	O
proventricular	O
spines	O
.	O

Expression	O
of	O
the	O
glucose	S-Chemical_Compound
PTS	O
system	O
was	O
only	O
slightly	O
increased	O
relative	O
to	O
LB	O
cultures	O
,	O
and	O
other	O
PTS	O
systems	O
were	O
downregulated	O
(	O
Table	O
S2	O
)	O
.	O

Glycolytic	O
pathways	O
were	O
not	O
upregulated	O
in	O
the	O
flea	S-Species
;	O
instead	O
,	O
available	O
hexoses	S-Chemical_Compound
and	O
the	O
gluconeogenesis	O
pathway	O
may	O
be	O
used	O
to	O
synthesize	O
polysaccharide	O
components	O
required	O
for	O
cell	O
growth	O
.	O

Upregulation	O
of	O
the	O
actP	S-Biological_Molecule
and	O
acs	S-Biological_Molecule
genes	O
in	O
the	O
flea	S-Species
,	O
which	O
direct	O
the	O
uptake	O
of	O
acetate	S-Chemical_Compound
and	O
its	O
conversion	O
to	O
acetyl	B-Chemical_Compound
-	I-Chemical_Compound
CoA	E-Chemical_Compound
,	O
also	O
suggests	O
that	O
insufficient	O
acetyl	B-Chemical_Compound
-	I-Chemical_Compound
CoA	E-Chemical_Compound
is	O
produced	O
by	O
glycolysis	O
to	O
potentiate	O
the	O
TCA	S-Chemical_Compound
cycle	O
.	O

The	O
switch	O
from	O
acetate	S-Chemical_Compound
secretion	O
to	O
acetate	S-Chemical_Compound
uptake	O
is	O
typical	O
of	O
growth	O
in	O
a	O
glucose	O
-	O
limited	O
,	O
amino	O
acid	O
rich	O
environment	O
[	O
18	O
]	O
.	O

In	O
contrast	O
to	O
hexose	S-Chemical_Compound
uptake	O
systems	O
,	O
Y	B-Species
.	I-Species
pestis	E-Species
genes	O
that	O
encode	O
permeases	S-Biological_Molecule
for	O
the	O
pentoses	B-Chemical_Compound
ribose	E-Chemical_Compound
,	O
xylose	S-Chemical_Compound
,	O
and	O
arabinose	S-Chemical_Compound
were	O
induced	O
in	O
the	O
flea	S-Species
gut	O
.	O

Acquisition	O
of	O
pentoses	S-Chemical_Compound
from	O
the	O
environment	O
may	O
be	O
important	O
because	O
Y	B-Species
.	I-Species
pestis	E-Species
does	O
not	O
possess	O
glucose	B-Biological_Molecule
6	I-Biological_Molecule
-	I-Biological_Molecule
phosphate	I-Biological_Molecule
dehydrogenase	E-Biological_Molecule
activity	O
,	O
the	O
first	O
step	O
of	O
the	O
pentose	B-Chemical_Compound
phosphate	E-Chemical_Compound
pathway	O
[	O
19	O
]	O
.	O

None	O
of	O
the	O
fatty	O
acid	O
uptake	O
or	O
catabolism	O
genes	O
were	O
upregulated	O
in	O
the	O
flea	S-Species
compared	O
to	O
growth	O
in	O
LB	O
.	O

However	O
,	O
genes	O
for	O
glycerol	S-Chemical_Compound
and	O
glycerol	B-Chemical_Compound
-	I-Chemical_Compound
3	I-Chemical_Compound
-	I-Chemical_Compound
phosphate	E-Chemical_Compound
uptake	O
and	O
utilization	O
were	O
upregulated	O
,	O
suggesting	O
that	O
flea	S-Species
digestion	O
products	O
derived	O
from	O
blood	O
glycerolipids	S-Chemical_Compound
may	O
be	O
used	O
by	O
Y	B-Species
.	I-Species
pestis	E-Species
.	O

Amino	O
acid	O
carbon	S-Chemical_Compound
is	O
presumably	O
funneled	O
into	O
the	O
TCA	S-Chemical_Compound
cycle	O
,	O
the	O
genes	O
for	O
which	O
are	O
highly	O
expressed	O
in	O
the	O
flea	S-Species
(	O
Table	O
S3	O
)	O
.	O

Y	B-Species
.	I-Species
pestis	E-Species
genes	O
involved	O
in	O
infection	O
and	O
biofilm	O
formation	O
in	O
the	O
flea	S-Species

Several	O
studies	O
comparing	O
the	O
transcriptional	O
profiles	O
of	O
Escherichia	B-Species
coli	E-Species
and	O
other	O
gram	O
negative	O
bacteria	O
during	O
biofilm	O
and	O
planktonic	O
growth	O
in	O
vitro	O
have	O
been	O
published	O
[	O
20	O
]	O
,	O
[	O
21	O
]	O
,	O
[	O
22	O
]	O
,	O
[	O
23	O
]	O
.	O

However	O
,	O
Y	B-Species
.	I-Species
pestis	E-Species
is	O
constitutively	O
nonmotile	O
,	O
and	O
synthesis	O
of	O
the	O
Hms	O
-	O
dependent	O
biofilm	O
ECM	O
is	O
regulated	O
post	O
-	O
translationally	O
[	O
26	O
]	O
.	O

In	O
addition	O
to	O
yidE	S-Biological_Molecule
and	O
cpxP	S-Biological_Molecule
,	O
other	O
Y	B-Species
.	I-Species
pestis	E-Species
predicted	O
adhesins	O
and	O
components	O
of	O
an	O
ESR	O
were	O
upregulated	O
in	O
the	O
flea	S-Species
.	O

The	O
Y	B-Species
.	I-Species
pestis	E-Species
homologs	O
of	O
Pseudomonas	B-Species
aeruginosa	E-Species
cupA1	S-Biological_Molecule
and	O
cupA3	S-Biological_Molecule
in	O
a	O
predicted	O
fimbrial	O
biosynthesis	O
operon	O
and	O
yapL	S-Biological_Molecule
,	O
a	O
predicted	O
autotransporter	O
adhesin	O
similar	O
to	O
E	B-Species
.	I-Species
coli	E-Species
tibA	S-Biological_Molecule
,	O
were	O
specifically	O
upregulated	O
in	O
the	O
flea	S-Species
(	O
Table	O
S1	O
)	O
.	O

The	O
cupA	S-Biological_Molecule
fimbrial	O
locus	O
and	O
tibA	S-Biological_Molecule
are	O
important	O
for	O
surface	O
adherence	O
and	O
for	O
biofilm	O
formation	O
in	O
P	B-Species
.	I-Species
aeruginosa	E-Species
and	O
E	B-Species
.	I-Species
coli	E-Species
,	O
respectively	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
.	O

These	O
genes	O
were	O
also	O
found	O
to	O
be	O
upregulated	O
in	O
mature	O
E	B-Species
.	I-Species
coli	E-Species
biofilms	O
[	O
23	O
]	O
,	O
suggesting	O
that	O
the	O
three	O
prominent	O
ESR	O
systems	O
are	O
important	O
for	O
integrating	O
signals	O
required	O
for	O
survival	O
in	O
a	O
biofilm	O
.	O

Because	O
homologs	O
of	O
the	O
yidE	S-Biological_Molecule
,	O
cpxP	S-Biological_Molecule
,	O
tibA	S-Biological_Molecule
(	O
yapL	S-Biological_Molecule
)	O
,	O
cupA	B-Biological_Molecule
fimbriae	E-Biological_Molecule
,	O
and	O
pspABC	S-Biological_Molecule
genes	O
were	O
upregulated	O
in	O
the	O
flea	S-Species
and	O
have	O
been	O
shown	O
to	O
be	O
involved	O
in	O
biofilm	O
formation	O
in	O
other	O
bacteria	O
[	O
23	O
]	O
,	O
[	O
27	O
]	O
,	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
,	O
we	O
made	O
a	O
series	O
of	O
Y	B-Species
.	I-Species
pestis	E-Species
strains	O
containing	O
deletions	O
of	O
these	O
loci	O
.	O

However	O
,	O
the	O
single	O
loss	O
of	O
any	O
of	O
these	O
genes	O
did	O
not	O
result	O
in	O
a	O
noticeable	O
defect	O
in	O
biofilm	O
formation	O
in	O
vitro	O
,	O
or	O
in	O
flea	S-Species
infection	O
or	O
blockage	O
(	O
data	O
not	O
shown	O
)	O
.	O

These	O
genes	O
may	O
contribute	O
to	O
biofilm	O
formation	O
,	O
but	O
are	O
not	O
individually	O
essential	O
for	O
this	O
phenotype	O
.	O

This	O
is	O
likely	O
due	O
to	O
the	O
fact	O
that	O
Y	B-Species
.	I-Species
pestis	E-Species
is	O
able	O
to	O
synthesize	O
polyamines	S-Chemical_Compound
de	O
novo	O
.	O

Differential	O
gene	O
expression	O
during	O
the	O
Y	B-Species
.	I-Species
pestis	E-Species
life	O
cycle	O

Other	O
virulence	O
and	O
transmission	O
factors	O
were	O
not	O
differentially	O
regulated	O
,	O
including	O
the	O
hms	O
genes	O
;	O
and	O
the	O
Y	B-Biological_Molecule
.	I-Biological_Molecule
pestis	I-Biological_Molecule
plasminogen	I-Biological_Molecule
activator	E-Biological_Molecule
(	O
pla	S-Biological_Molecule
)	O
,	O
critical	O
for	O
dissemination	O
from	O
extravascular	O
tissue	O
at	O
the	O
fleabite	O
site	O
[	O
33	O
]	O
,	O
and	O
ymt	S-Biological_Molecule
were	O
highly	O
expressed	O
in	O
both	O
hosts	S-Species
(	O
Table	O
S3	O
and	O
[	O
11	O
]	O
)	O
.	O

The	O
Y	B-Species
.	I-Species
pestis	E-Species
outer	O
surface	O
protein	O
gene	O
yadB	S-Biological_Molecule
,	O
recently	O
shown	O
to	O
be	O
required	O
for	O
dissemination	O
and	O
bubonic	O
plague	O
pathogenesis	O
from	O
a	O
subcutaneous	O
inoculation	O
site	O
[	O
34	O
]	O
,	O
was	O
significantly	O
upregulated	O
in	O
both	O
the	O
flea	S-Species
and	O
the	O
bubo	O
compared	O
to	O
in	O
vitro	O
conditions	O
(	O
Tables	O
1	O
,	O
S1	O
)	O
.	O

Expression	O
of	O
genes	O
in	O
the	O
pH	O
6	O
antigen	O
locus	O
(	O
psaEFABC	S-Biological_Molecule
)	O
,	O
responsible	O
for	O
the	O
synthesis	O
and	O
transport	O
of	O
the	O
PsaA	S-Biological_Molecule
fimbriae	O
that	O
enhance	O
resistance	O
to	O
phagocytosis	O
by	O
macrophages	O
[	O
35	O
]	O
,	O
[	O
36	O
]	O
,	O
were	O
higher	O
in	O
the	O
bubo	O
than	O
the	O
flea	S-Species
,	O
although	O
the	O
usher	O
protein	O
gene	O
psaC	S-Biological_Molecule
was	O
upregulated	O
in	O
the	O
flea	S-Species
compared	O
to	O
in	O
vitro	O
growth	O
(	O
Tables	O
1	O
,	O
S1	O
)	O
.	O

The	O
transcriptional	O
regulator	O
gene	O
phoP	S-Biological_Molecule
of	O
the	O
PhoPQ	S-Biological_Molecule
two	O
-	O
component	O
regulatory	O
system	O
and	O
the	O
PhoP	S-Biological_Molecule
-	O
regulated	O
mgtC	S-Biological_Molecule
gene	O
were	O
expressed	O
at	O
levels	O
>	O
2	O
-	O
fold	O
higher	O
in	O
fleas	S-Species
than	O
in	O
any	O
other	O
condition	O
(	O
Tables	O
1	O
,	O
S1	O
,	O
S3	O
)	O
.	O

The	O
PhoPQ	S-Biological_Molecule
system	O
is	O
induced	O
in	O
low	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
or	O
low	O
pH	O
environments	O
,	O
or	O
by	O
exposure	O
to	O
CAMPs	O
[	O
41	O
]	O
,	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
.	O

The	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
concentration	O
and	O
pH	O
of	O
the	O
flea	S-Species
digestive	O
tract	O
have	O
not	O
been	O
defined	O
,	O
so	O
the	O
inducing	O
stimulus	O
is	O
unknown	O
,	O
but	O
CAMPs	O
are	O
induced	O
and	O
secreted	O
into	O
the	O
gut	O
by	O
blood	O
feeding	O
insects	O
when	O
they	O
take	O
a	O
blood	O
meal	O
containing	O
bacteria	O
[	O
44	O
]	O
,	O
[	O
45	O
]	O
.	O

X	B-Species
.	I-Species
cheopis	I-Species
fleas	E-Species
encode	O
homologs	O
of	O
the	O
insect	O
CAMPs	O
cecropin	S-Biological_Molecule
and	O
defensin	S-Biological_Molecule
,	O
and	O
mount	O
an	O
inducible	O
antibacterial	O
response	O
to	O
infection	O
(	O
unpublished	O
data	O
)	O
.	O

Despite	O
the	O
upregulation	O
of	O
phoP	S-Biological_Molecule
in	O
the	O
flea	S-Species
,	O
with	O
the	O
notable	O
exception	O
of	O
mgtC	S-Biological_Molecule
there	O
was	O
little	O
correlation	O
between	O
predicted	O
PhoP	S-Biological_Molecule
-	O
regulated	O
genes	O
in	O
vitro	O
and	O
genes	O
upregulated	O
in	O
the	O
flea	S-Species
[	O
39	O
]	O
,	O
[	O
46	O
]	O
,	O
[	O
47	O
]	O
.	O

Differential	O
regulation	O
of	O
members	O
of	O
the	O
PhoP	O
regulon	O
may	O
occur	O
depending	O
on	O
the	O
inducing	O
stimulus	O
,	O
however	O
[	O
48	O
]	O
.	O

Soon	O
after	O
transmission	O
,	O
Y	B-Species
.	I-Species
pestis	E-Species
would	O
be	O
expected	O
to	O
encounter	O
rapidly	O
-	O
responding	O
phagocytic	O
cells	O
in	O
the	O
dermis	O
.	O

To	O
assess	O
the	O
overall	O
effect	O
of	O
the	O
flea	S-Species
-	O
specific	O
phenotype	O
on	O
this	O
encounter	O
,	O
we	O
compared	O
the	O
interaction	O
of	O
Y	B-Species
.	I-Species
pestis	E-Species
recovered	O
from	O
infected	O
fleas	S-Species
and	O
from	O
in	O
vitro	O
cultures	O
with	O
murine	S-Species
bone	O
marrow	O
macrophages	O
.	O

Bacteria	O
from	O
fleas	S-Species
showed	O
significantly	O
lower	O
levels	O
of	O
phagocytosis	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

We	O
previously	O
reported	O
that	O
the	O
genes	O
for	O
these	O
Tc	O
-	O
like	O
proteins	O
are	O
highly	O
expressed	O
in	O
fleas	S-Species
,	O
but	O
that	O
their	O
products	O
are	O
nontoxic	O
to	O
fleas	S-Species
[	O
49	O
]	O
.	O

yitR	S-Biological_Molecule
,	O
a	O
LysR	O
-	O
type	O
regulator	O
that	O
activates	O
the	O
Tc	O
-	O
like	O
yit	O
genes	O
[	O
50	O
]	O
,	O
was	O
upregulated	O
>	O
10	O
-	O
fold	O
in	O
the	O
flea	S-Species
,	O
but	O
its	O
expression	O
was	O
not	O
detected	O
in	O
the	O
rat	S-Species
bubo	O
(	O
Table	O
1	O
)	O
.	O

The	O
specific	O
induction	O
in	O
the	O
flea	S-Species
of	O
yitR	S-Biological_Molecule
and	O
genes	O
in	O
the	O
adjacent	O
Tc	O
-	O
like	O
yit	O
and	O
yip	O
loci	O
suggests	O
that	O
they	O
are	O
involved	O
in	O
adaptation	O
to	O
and	O
colonization	O
of	O
the	O
flea	S-Species
.	O

To	O
determine	O
if	O
the	O
insecticidal	O
-	O
like	O
toxins	O
were	O
involved	O
in	O
resistance	O
to	O
phagocytosis	O
,	O
we	O
repeated	O
the	O
macrophage	O
experiments	O
with	O
a	O
Y	B-Species
.	I-Species
pestis	I-Species
DeltayitR	E-Species
mutant	O
,	O
which	O
as	O
expected	O
showed	O
greatly	O
reduced	O
expression	O
of	O
the	O
yit	O
and	O
yip	O
genes	O
in	O
vitro	O
and	O
in	O
the	O
flea	S-Species
(	O
Fig	O
.	O
4B	O
)	O
.	O

Loss	O
of	O
yitR	S-Biological_Molecule
significantly	O
reduced	O
the	O
increased	O
resistance	O
to	O
phagocytosis	O
of	O
Y	B-Species
.	I-Species
pestis	E-Species
isolated	O
from	O
infected	O
fleas	S-Species
(	O
Fig	O
.	O
4C	O
)	O
.	O

On	O
average	O
,	O
the	O
mice	S-Species
challenged	O
with	O
Y	B-Species
.	I-Species
pestis	I-Species
DeltayitR	I-Species
-	I-Species
infected	I-Species
fleas	E-Species
,	O
both	O
those	O
that	O
developed	O
disease	O
and	O
those	O
that	O
did	O
not	O
,	O
received	O
a	O
higher	O
cumulative	O
number	O
of	O
bites	O
from	O
blocked	O
fleas	S-Species
than	O
the	O
mice	S-Species
challenged	O
with	O
Y	B-Species
.	I-Species
pestis	E-Species
-	O
infected	O
fleas	S-Species
,	O
but	O
this	O
difference	O
was	O
not	O
statistically	O
significant	O
(	O
Fig	O
.	O
5	O
)	O
.	O

Because	O
phoP	S-Biological_Molecule
is	O
required	O
by	O
Y	B-Species
.	I-Species
pestis	E-Species
to	O
produce	O
a	O
transmissible	O
infection	O
in	O
fleas	S-Species
(	O
unpublished	O
data	O
)	O
,	O
it	O
was	O
not	O
possible	O
to	O
similarly	O
assess	O
the	O
effect	O
on	O
disease	O
transmission	O
of	O
phoP	S-Biological_Molecule
induction	O
in	O
the	O
flea	S-Species
.	O

Our	O
results	O
indicate	O
that	O
Y	B-Species
.	I-Species
pestis	E-Species
entering	O
the	O
mammal	O
from	O
an	O
infective	O
flea	S-Species
is	O
relatively	O
resistant	O
to	O
macrophages	O
,	O
as	O
well	O
as	O
PMNs	O
[	O
7	O
]	O
;	O
a	O
vector	O
-	O
specific	O
phenotype	O
that	O
is	O
not	O
related	O
to	O
the	O
T3SS	O
or	O
capsule	O
.	O

Finally	O
,	O
the	O
major	O
essential	O
virulence	O
factors	O
yadBC	S-Biological_Molecule
and	O
pla	S-Biological_Molecule
,	O
essential	O
for	O
Y	B-Species
.	I-Species
pestis	E-Species
dissemination	O
from	O
the	O
dermis	O
,	O
were	O
maximally	O
or	O
very	O
highly	O
expressed	O
in	O
the	O
flea	S-Species
(	O
Tables	O
1	O
,	O
S3	O
)	O
.	O

In	O
summary	O
,	O
Y	B-Species
.	I-Species
pestis	E-Species
appears	O
to	O
be	O
prepared	O
for	O
pathogenesis	O
in	O
the	O
mammal	O
while	O
still	O
in	O
the	O
flea	S-Species
vector	O
.	O

Increased	O
resistance	O
to	O
innate	O
immunity	O
that	O
is	O
preinduced	O
in	O
the	O
flea	S-Species
vector	O
may	O
be	O
critical	O
to	O
productive	O
transmission	O
because	O
blocked	O
fleas	S-Species
transmit	O
relatively	O
few	O
bacteria	O
,	O
often	O
below	O
the	O
LD50	O
of	O
Y	B-Species
.	I-Species
pestis	E-Species
grown	O
in	O
vitro	O
at	O
<	O
28degreesC	O
[	O
1	O
]	O
,	O
[	O
52	O
]	O
.	O

Two	O
operons	O
,	O
the	O
phosphotransferase	O
system	O
and	O
the	O
maltose	O
transport	O
system	O
,	O
were	O
down	O
-	O
regulated	O
.	O

Ten	O
genes	O
related	O
with	O
carbon	S-Chemical_Compound
metabolism	O
(	O
pckA	S-Biological_Molecule
and	O
fumB	S-Biological_Molecule
among	O
others	O
)	O
were	O
up	O
-	O
regulated	O
in	O
the	O
bvrR	S-Biological_Molecule
mutant	O
,	O
and	O
denitrification	O
genes	O
(	O
nirK	S-Biological_Molecule
,	O
norC	S-Biological_Molecule
and	O
nosZ	S-Biological_Molecule
)	O
were	O
also	O
regulated	O
.	O

Notably	O
,	O
seven	O
transcriptional	O
regulators	O
were	O
affected	O
,	O
including	O
VjbR	S-Biological_Molecule
,	O
ExoR	S-Biological_Molecule
and	O
OmpR	S-Biological_Molecule
that	O
were	O
less	O
expressed	O
in	O
the	O
bvrR	S-Biological_Molecule
mutant	O
.	O

These	O
regulatory	O
systems	O
are	O
highly	O
conserved	O
among	O
bacteria	O
and	O
widely	O
used	O
for	O
controlling	O
gene	O
expression	O
in	O
response	O
to	O
environmental	O
signals	O
.	O

In	O
response	O
to	O
stimuli	O
,	O
the	O
sensor	O
kinase	O
autophosphorylates	O
,	O
then	O
transfers	O
its	O
phosphate	S-Chemical_Compound
to	O
its	O
cognate	O
response	O
regulator	O
to	O
control	O
the	O
transcription	O
of	O
target	O
genes	O
[	O
1	O
]	O
.	O

Up	O
to	O
now	O
,	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
is	O
the	O
best	O
characterized	O
two	O
-	O
component	O
regulatory	O
system	O
of	O
Brucella	S-Species
[	O
2	O
]	O
-	O
[	O
4	O
]	O
.	O

BvrS	S-Biological_Molecule
is	O
a	O
membrane	O
-	O
bound	O
homodimeric	O
protein	O
that	O
has	O
three	O
conserved	O
regions	O
frequently	O
found	O
in	O
members	O
of	O
the	O
histidine	O
protein	O
kinase	O
superfamily	O
:	O
an	O
amino	O
-	O
terminal	O
periplasmic	O
sensing	O
domain	O
with	O
transmembrane	O
segments	O
,	O
a	O
cytoplasmic	O
dimerisation	O
domain	O
with	O
a	O
specific	O
His	O
residue	O
,	O
and	O
the	O
carboxy	O
-	O
terminal	O
ATP	S-Chemical_Compound
-	O
binding	O
kinase	O
domain	O
[	O
5	O
]	O
.	O

As	O
demonstrated	O
for	O
other	O
two	O
-	O
component	O
systems	O
,	O
multiple	O
genes	O
are	O
expected	O
to	O
be	O
under	O
the	O
control	O
of	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
[	O
1	O
]	O
.	O

B	B-Species
.	I-Species
abortus	I-Species
mutants	E-Species
in	O
this	O
system	O
were	O
more	O
susceptible	O
to	O
bactericidal	O
polycationic	O
substances	O
like	O
polymyxin	B-Chemical_Compound
B	E-Chemical_Compound
,	O
melittin	S-Chemical_Compound
or	O
poly	B-Chemical_Compound
-	I-Chemical_Compound
L	I-Chemical_Compound
-	I-Chemical_Compound
lysine	E-Chemical_Compound
,	O
and	O
displayed	O
a	O
more	O
hydrophobic	O
outer	O
membrane	O
surface	O
than	O
the	O
parental	O
strain	O
[	O
4	O
]	O
.	O

Later	O
studies	O
demonstrated	O
that	O
the	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
system	O
regulates	O
transcription	O
of	O
at	O
least	O
two	O
major	O
outer	O
membrane	O
proteins	O
,	O
Omp22	S-Biological_Molecule
(	O
Omp3b	S-Biological_Molecule
)	O
and	O
Omp25a	S-Biological_Molecule
(	O
Omp3a	S-Biological_Molecule
)	O
.	O

Changes	O
in	O
non	O
-	O
protein	O
envelope	O
molecules	O
such	O
as	O
lipid	B-Chemical_Compound
A	E-Chemical_Compound
underacylation	O
and	O
increased	O
LPS	S-Chemical_Compound
acyl	O
-	O
chain	O
fluidity	O
have	O
been	O
also	O
found	O
in	O
these	O
mutants	O
[	O
3	O
]	O
.	O

Our	O
results	O
link	O
the	O
regulation	O
of	O
carbon	S-Chemical_Compound
and	O
nitrogen	S-Chemical_Compound
metabolism	O
to	O
the	O
expression	O
of	O
cell	O
envelope	O
components	O
and	O
suggest	O
the	O
existence	O
of	O
a	O
complex	O
regulatory	O
network	O
with	O
the	O
interplay	O
of	O
several	O
transcriptional	O
regulators	O
.	O

The	O
ORFeome	O
-	O
based	O
Brucella	S-Species
whole	O
-	O
genome	O
DNA	O
microarray	O
used	O
in	O
this	O
study	O
has	O
been	O
previously	O
validated	O
for	O
the	O
analysis	O
of	O
gene	O
expression	O
under	O
any	O
experimental	O
conditions	O
[	O
7	O
]	O
.	O

A	O
change	O
in	O
gene	O
expression	O
was	O
considered	O
both	O
statistically	O
and	O
biologically	O
significant	O
if	O
the	O
p	O
-	O
value	O
was	O
less	O
than	O
0	O
.	O
01	O
.	O

Twenty	O
three	O
%	O
of	O
the	O
differentially	O
transcribed	O
genes	O
(	O
30	O
)	O
encoded	O
for	O
hypothetical	O
proteins	O
.	O

For	O
genes	O
of	O
annotated	O
function	O
,	O
59	O
appeared	O
to	O
be	O
up	O
regulated	O
and	O
38	O
down	O
regulated	O
in	O
the	O
bvrR	S-Biological_Molecule
mutant	O
.	O

Total	O
RNA	O
from	O
both	O
Brucella	S-Species
strains	O
were	O
reverse	O
transcribed	O
into	O
cDNA	O
.	O

Interestingly	O
,	O
the	O
level	O
of	O
transcription	O
obtained	O
by	O
RT	O
-	O
PCR	O
of	O
the	O
flagellar	O
genes	O
fliM	S-Biological_Molecule
(	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
0124	E-Biological_Molecule
)	O
and	O
motB	S-Biological_Molecule
(	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
1103	E-Biological_Molecule
)	O
,	O
and	O
the	O
pckA	S-Biological_Molecule
gene	O
(	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
2091	E-Biological_Molecule
)	O
were	O
the	O
highest	O
in	O
the	O
bvrR	S-Biological_Molecule
mutant	O
.	O

On	O
the	O
other	O
hand	O
,	O
exoR	S-Biological_Molecule
(	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
0891	E-Biological_Molecule
)	O
,	O
omp25a	S-Biological_Molecule
(	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
0722	E-Biological_Molecule
)	O
,	O
hpr	B-Biological_Molecule
-	I-Biological_Molecule
K	E-Biological_Molecule
(	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
2094	E-Biological_Molecule
)	O
,	O
bvrS	S-Biological_Molecule
(	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
2093	E-Biological_Molecule
)	O
and	O
the	O
lipoproteins	O
(	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
2147	E-Biological_Molecule
,	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
0589	E-Biological_Molecule
,	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
0358	E-Biological_Molecule
)	O
were	O
among	O
the	O
less	O
expressed	O
genes	O
(	O
Table	O
1	O
)	O
.	O

These	O
results	O
confirmed	O
a	O
good	O
correlation	O
between	O
microarray	O
and	O
RT	O
-	O
PCR	O
data	O
,	O
thus	O
validating	O
the	O
model	O
.	O

These	O
observations	O
led	O
to	O
the	O
hypothesis	O
that	O
the	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
system	O
is	O
involved	O
in	O
cell	O
envelope	O
changes	O
required	O
for	O
adaptation	O
to	O
the	O
intracellular	O
environment	O
.	O

Our	O
microarray	O
results	O
demonstrated	O
several	O
genes	O
directly	O
involved	O
in	O
cell	O
envelope	O
or	O
outer	O
membrane	O
biogenesis	O
differentially	O
expressed	O
in	O
the	O
bvrR	S-Biological_Molecule
mutant	O
.	O

These	O
data	O
confirm	O
that	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
regulates	O
bacterial	O
envelope	O
changes	O
that	O
could	O
modify	O
surface	O
properties	O
relevant	O
for	O
Brucella	S-Species
virulence	O
[	O
6	O
]	O
.	O

One	O
of	O
the	O
remarkable	O
findings	O
observed	O
in	O
our	O
microarray	O
analysis	O
was	O
that	O
several	O
genes	O
related	O
with	O
metabolism	O
were	O
also	O
differentially	O
expressed	O
.	O

Interestingly	O
,	O
all	O
genes	O
related	O
with	O
carbohydrate	O
,	O
amino	O
or	O
fatty	O
acids	O
metabolism	O
were	O
up	O
-	O
regulated	O
in	O
the	O
bvrR	S-Biological_Molecule
mutant	O
.	O

These	O
included	O
the	O
first	O
enzyme	O
in	O
gluconeogenesis	O
(	O
pckA	S-Biological_Molecule
,	O
phosphoenolpyruvate	S-Chemical_Compound
carboxykinase	O
,	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
2091	E-Biological_Molecule
)	O
,	O
four	O
genes	O
involved	O
in	O
TCA	O
cycle	O
and	O
pyruvate	S-Chemical_Compound
metabolism	O
(	O
fumB	S-Biological_Molecule
,	O
fumarate	S-Chemical_Compound
hydratase	O
,	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
0977	E-Biological_Molecule
;	O
lpdA	S-Biological_Molecule
,	O
dihydrolipoamide	S-Chemical_Compound
dehydrogenase	O
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
0712	E-Biological_Molecule
;	O
pyruvate	S-Chemical_Compound
dehydrogenase	O
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
0032	E-Biological_Molecule
;	O
acetyl	B-Chemical_Compound
-	I-Chemical_Compound
CoA	E-Chemical_Compound
acetyltransferase	O
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
0443	E-Biological_Molecule
)	O
,	O
three	O
genes	O
involved	O
in	O
amino	O
or	O
fatty	O
acid	O
metabolism	O
(	O
aldehyde	S-Chemical_Compound
dehydrogenases	O
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
1130	E-Biological_Molecule
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
1114	E-Biological_Molecule
;	O
hydroxymethylglutaryl	B-Chemical_Compound
-	I-Chemical_Compound
CoA	E-Chemical_Compound
lyase	O
,	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
0017	E-Biological_Molecule
)	O
,	O
and	O
two	O
genes	O
involve	O
in	O
benzoate	S-Chemical_Compound
degradation	O
(	O
pcaC	S-Biological_Molecule
,	O
carboxymuconolactone	S-Chemical_Compound
decarboxylase	O
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
0597	E-Biological_Molecule
;	O
pcaI	S-Biological_Molecule
,	O
coenzyme	O
A	O
transferase	O
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
0604	E-Biological_Molecule
)	O
.	O

Ten	O
of	O
these	O
genes	O
,	O
including	O
malK	S-Biological_Molecule
,	O
malG	S-Biological_Molecule
,	O
malF	S-Biological_Molecule
,	O
malE	S-Biological_Molecule
and	O
an	O
iclR	S-Biological_Molecule
regulator	O
,	O
were	O
down	O
-	O
regulated	O
suggesting	O
that	O
the	O
complete	O
operon	O
was	O
negatively	O
regulated	O
in	O
the	O
bvrR	S-Biological_Molecule
mutant	O
.	O

Although	O
it	O
has	O
been	O
showed	O
that	O
the	O
mutants	O
in	O
the	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
system	O
have	O
no	O
obvious	O
defects	O
with	O
regard	O
to	O
the	O
ability	O
to	O
grow	O
on	O
standard	O
media	O
[	O
4	O
]	O
,	O
our	O
microarray	O
results	O
suggests	O
that	O
the	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
system	O
controls	O
elements	O
directly	O
involved	O
in	O
adjusting	O
the	O
Brucella	S-Species
metabolism	O
to	O
the	O
nutrient	O
shift	O
expected	O
to	O
occur	O
during	O
the	O
transit	O
to	O
the	O
intracellular	O
niche	O
.	O

As	O
show	O
in	O
Figure	O
3	O
,	O
growth	O
of	O
the	O
bvrR	S-Biological_Molecule
mutant	O
was	O
significantly	O
reduced	O
in	O
minimal	O
media	O
.	O

The	O
nitrite	O
reductase	O
gene	O
(	O
nirK	S-Biological_Molecule
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
0943	E-Biological_Molecule
)	O
was	O
down	O
regulated	O
and	O
the	O
nitric	B-Chemical_Compound
oxide	E-Chemical_Compound
and	O
nitrous	B-Chemical_Compound
oxide	E-Chemical_Compound
reductases	O
genes	O
(	O
nor	B-Biological_Molecule
C	E-Biological_Molecule
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
0955	E-Biological_Molecule
;	O
nosZ	S-Biological_Molecule
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
0928	E-Biological_Molecule
)	O
were	O
up	O
regulated	O
.	O

Brucella	S-Species
may	O
also	O
take	O
advantage	O
of	O
denitrification	O
to	O
cope	O
with	O
nitric	B-Chemical_Compound
oxide	E-Chemical_Compound
(	O
NO	S-Chemical_Compound
)	O
production	O
in	O
the	O
macrophage	O
during	O
the	O
innate	O
response	O
against	O
infection	O
.	O

Interestingly	O
,	O
our	O
experiments	O
to	O
study	O
the	O
intracellular	O
transcriptional	O
level	O
of	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
controlled	O
genes	O
(	O
see	O
below	O
)	O
showed	O
that	O
whereas	O
norC	S-Biological_Molecule
was	O
induced	O
intracellularly	O
,	O
nirK	S-Biological_Molecule
and	O
nosZ	S-Biological_Molecule
were	O
less	O
expressed	O
.	O

Genes	O
encoding	O
proteins	O
related	O
to	O
the	O
PTS	O
,	O
including	O
a	O
HPr	S-Biological_Molecule
Ser	O
-	O
kinase	O
,	O
an	O
EIIA	O
permease	O
of	O
the	O
mannose	S-Chemical_Compound
family	O
and	O
a	O
HPr	S-Biological_Molecule
homologue	O
precede	O
those	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
.	O

In	O
most	O
of	O
these	O
loci	O
,	O
upstream	O
of	O
the	O
regulatory	O
gene	O
the	O
pckA	S-Biological_Molecule
is	O
divergently	O
expressed	O
(	O
Figure	O
2	O
)	O
.	O

In	O
alpha	O
-	O
proteobacteria	O
,	O
it	O
has	O
been	O
proposed	O
that	O
HPr	S-Biological_Molecule
might	O
control	O
the	O
phosphorylation	O
state	O
of	O
the	O
transcription	O
regulator	O
[	O
12	O
]	O
-	O
[	O
14	O
]	O
.	O

In	O
this	O
regard	O
,	O
Letesson	O
and	O
col	O
.	O

Then	O
,	O
the	O
BvrR	S-Biological_Molecule
could	O
control	O
transcription	O
of	O
the	O
pckA	S-Biological_Molecule
gene	O
,	O
which	O
encodes	O
an	O
essential	O
control	O
enzyme	O
of	O
the	O
gluconeogenesis	O
and	O
Krebs	O
cycle	O
.	O

A	O
link	O
between	O
carbon	S-Chemical_Compound
and	O
nitrogen	S-Chemical_Compound
metabolism	O
,	O
PTS	O
and	O
two	O
-	O
component	O
regulatory	O
systems	O
have	O
been	O
proposed	O
for	O
some	O
bacteria	O
[	O
18	O
]	O
,	O
and	O
our	O
microarray	O
results	O
strongly	O
suggest	O
that	O
same	O
relationship	O
could	O
be	O
made	O
for	O
Brucella	S-Species
.	O

BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
and	O
the	O
expression	O
of	O
other	O
transcriptional	O
regulators	O

Notably	O
,	O
seven	O
transcriptional	O
regulators	O
genes	O
were	O
also	O
differentially	O
expressed	O
in	O
the	O
bvrR	S-Biological_Molecule
mutant	O
compared	O
to	O
parental	O
strain	O
:	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
0237	E-Biological_Molecule
,	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
0891	E-Biological_Molecule
(	O
exoR	S-Biological_Molecule
)	O
,	O
BAB1	B-Biological_Molecule
_	I-Biological_Molecule
1397	E-Biological_Molecule
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
0118	E-Biological_Molecule
(	O
vjbR	S-Biological_Molecule
)	O
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
0762	E-Biological_Molecule
(	O
ompR	S-Biological_Molecule
)	O
,	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
1127	E-Biological_Molecule
and	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
1152	E-Biological_Molecule
.	O

Three	O
of	O
these	O
,	O
namely	O
exoR	S-Biological_Molecule
,	O
ompR	S-Biological_Molecule
and	O
vjbR	S-Biological_Molecule
are	O
down	O
regulated	O
and	O
have	O
been	O
previously	O
implicated	O
in	O
Brucella	S-Species
virulence	O
.	O

Moreover	O
,	O
it	O
has	O
been	O
demonstrated	O
that	O
VjbR	S-Biological_Molecule
controls	O
the	O
synthesis	O
of	O
exopolysaccharides	O
and	O
the	O
productions	O
of	O
several	O
OMPs	O
,	O
some	O
of	O
which	O
are	O
also	O
involved	O
in	O
virulence	O
[	O
22	O
]	O
.	O

Interestingly	O
,	O
our	O
results	O
also	O
showed	O
that	O
the	O
expression	O
of	O
vjbR	S-Biological_Molecule
was	O
also	O
induced	O
intracellularly	O
(	O
see	O
below	O
)	O
.	O

All	O
these	O
data	O
suggest	O
that	O
VjbR	S-Biological_Molecule
,	O
similarly	O
to	O
the	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
system	O
,	O
is	O
involved	O
in	O
the	O
control	O
of	O
outer	O
membrane	O
composition	O
and	O
virulence	O
.	O

In	O
addition	O
,	O
DeJong	O
and	O
col	O
[	O
20	O
]	O
have	O
demonstrated	O
that	O
among	O
the	O
promoters	O
which	O
expression	O
is	O
dependent	O
of	O
the	O
VjbR	S-Biological_Molecule
regulator	O
,	O
is	O
the	O
ompR	S-Biological_Molecule
gene	O
,	O
the	O
regulator	O
of	O
the	O
OmpR	S-Biological_Molecule
/	O
EnvZ	S-Biological_Molecule
two	O
component	O
system	O
.	O

E	B-Species
.	I-Species
coli	E-Species
OmpR	S-Biological_Molecule
/	O
EnvZ	S-Biological_Molecule
system	O
controls	O
the	O
transcription	O
of	O
the	O
outer	O
membrane	O
porins	O
OmpF	S-Biological_Molecule
and	O
OmpC	S-Biological_Molecule
in	O
response	O
to	O
osmolarity	O
[	O
23	O
]	O
.	O

Moreover	O
,	O
a	O
systematically	O
transcriptome	O
analysis	O
of	O
all	O
two	O
component	O
regulatory	O
systems	O
in	O
E	B-Species
.	I-Species
coli	E-Species
has	O
demonstrated	O
that	O
the	O
OmpR	S-Biological_Molecule
/	O
EnvZ	S-Biological_Molecule
system	O
also	O
controls	O
the	O
metabolism	O
of	O
amino	O
acids	O
,	O
flagellar	O
synthesis	O
and	O
nutrient	O
transport	O
[	O
24	O
]	O
.	O

The	O
two	O
-	O
regulatory	O
systems	O
ChvG	S-Biological_Molecule
(	O
ExoS	S-Biological_Molecule
)	O
/	O
ChvI	S-Biological_Molecule
in	O
S	B-Species
.	I-Species
meliloti	E-Species
and	O
A	B-Species
.	I-Species
tumefaciens	E-Species
posses	O
a	O
high	O
level	O
of	O
identity	O
with	O
the	O
Brucella	S-Species
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
[	O
25	O
]	O
,	O
[	O
26	O
]	O
.	O

Chaves	O
-	O
Olarte	O
et	O
al	O
have	O
reported	O
that	O
B	B-Species
.	I-Species
abortus	E-Species
bvrS	S-Biological_Molecule
mutant	O
complemented	O
with	O
the	O
ExoS	S-Biological_Molecule
protein	O
recuperated	O
the	O
ability	O
to	O
invade	O
and	O
replicated	O
successfully	O
in	O
HeLa	O
and	O
macrophage	O
cells	O
[	O
27	O
]	O
,	O
suggesting	O
that	O
the	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
system	O
is	O
functionally	O
interchangeable	O
with	O
the	O
ExoS	S-Biological_Molecule
/	O
ChvI	S-Biological_Molecule
system	O
.	O

It	O
has	O
been	O
described	O
in	O
S	B-Species
.	I-Species
meliloti	E-Species
that	O
exoR	S-Biological_Molecule
gene	O
encodes	O
a	O
global	O
regulator	O
of	O
transcription	O
and	O
that	O
ExoR	S-Biological_Molecule
interacts	O
genetically	O
with	O
both	O
ExoS	S-Biological_Molecule
and	O
ChvI	S-Biological_Molecule
and	O
inhibits	O
ExoS	S-Biological_Molecule
/	O
ChvI	S-Biological_Molecule
activity	O
[	O
29	O
]	O
,	O
[	O
30	O
]	O
.	O

Further	O
analysis	O
indicated	O
that	O
both	O
the	O
ExoR	S-Biological_Molecule
protein	O
and	O
the	O
ExoS	S-Biological_Molecule
/	O
ChvI	S-Biological_Molecule
two	O
-	O
component	O
regulatory	O
system	O
are	O
involved	O
in	O
the	O
regulation	O
of	O
both	O
polysaccharides	O
and	O
flagellum	O
biosynthesis	O
[	O
31	O
]	O
.	O

Other	O
authors	O
[	O
29	O
]	O
suggest	O
that	O
ExoR	S-Biological_Molecule
is	O
an	O
inhibitor	O
of	O
two	O
-	O
component	O
signaling	O
that	O
may	O
be	O
conserved	O
in	O
a	O
large	O
number	O
of	O
alpha	O
-	O
proteobacteria	O
.	O

Based	O
on	O
all	O
these	O
findings	O
,	O
obvious	O
comparison	O
about	O
the	O
function	O
of	O
all	O
these	O
regulators	O
in	O
Brucella	S-Species
could	O
be	O
made	O
.	O

Virulence	O
and	O
the	O
adaptation	O
to	O
intracellular	O
growth	O

Our	O
microarray	O
results	O
demonstrated	O
that	O
at	O
least	O
127	O
genes	O
were	O
differentially	O
expressed	O
in	O
the	O
bvrR	S-Biological_Molecule
mutant	O
.	O

Although	O
this	O
general	O
expression	O
changes	O
could	O
explain	O
the	O
complete	O
loss	O
of	O
virulence	O
of	O
these	O
mutants	O
,	O
it	O
was	O
remarkable	O
the	O
presence	O
among	O
them	O
of	O
ten	O
genes	O
,	O
in	O
addition	O
to	O
bvrS	S-Biological_Molecule
,	O
whose	O
products	O
are	O
already	O
known	O
to	O
be	O
associated	O
with	O
Brucella	S-Species
virulence	O
[	O
10	O
]	O
,	O
[	O
11	O
]	O
,	O
[	O
33	O
]	O
,	O
[	O
34	O
]	O
.	O

In	O
order	O
to	O
investigate	O
if	O
the	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
controlled	O
genes	O
were	O
expressed	O
intracellularly	O
,	O
bacterial	O
RNA	O
was	O
obtained	O
from	O
B	B-Species
.	I-Species
abortus	E-Species
wild	O
type	O
recovered	O
from	O
infected	O
cells	O
as	O
described	O
in	O
Material	O
and	O
Methods	O
.	O

The	O
amount	O
of	O
bacterial	O
RNA	O
was	O
not	O
enough	O
to	O
perform	O
microarray	O
hybridizations	O
.	O

The	O
results	O
showed	O
significant	O
differences	O
in	O
the	O
expression	O
of	O
at	O
least	O
fifteen	O
genes	O
controlled	O
by	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
.	O

On	O
the	O
other	O
hand	O
,	O
two	O
genes	O
for	O
cell	O
envelope	O
proteins	O
(	O
omp25d	S-Biological_Molecule
and	O
one	O
lipoprotein	O
)	O
and	O
three	O
denitrification	O
genes	O
(	O
norC	S-Biological_Molecule
,	O
nirK	S-Biological_Molecule
and	O
glutaminase	O
BAB2	B-Biological_Molecule
_	I-Biological_Molecule
0863	E-Biological_Molecule
)	O
were	O
less	O
expressed	O
intracellularly	O
.	O

In	O
conclusion	O
,	O
all	O
these	O
results	O
and	O
previous	O
findings	O
support	O
the	O
proposal	O
that	O
BvrR	S-Biological_Molecule
/	O
BvrS	S-Biological_Molecule
controls	O
a	O
significantly	O
broad	O
set	O
of	O
phenotypes	O
and	O
define	O
an	O
important	O
and	O
coordinate	O
gateway	O
between	O
the	O
free	O
-	O
living	O
and	O
intracellular	O
states	O
of	O
Brucella	S-Species
.	O

However	O
,	O
30	O
of	O
the	O
genes	O
differentially	O
expressed	O
in	O
the	O
bvrR	S-Biological_Molecule
mutant	O
compared	O
with	O
the	O
parental	O
strain	O
have	O
a	O
yet	O
uncharacterized	O
function	O
.	O

IgG	B-Biological_Molecule
Endopeptidase	E-Biological_Molecule
SeMac	S-Biological_Molecule
does	O
not	O
Inhibit	O
Opsonophagocytosis	O
of	O
Streptococcus	B-Species
equi	I-Species
Subspecies	I-Species
equi	E-Species
by	O
Horse	S-Species
Polymorphonuclear	O
Leukocytes	O

The	O
secreted	O
Mac	S-Biological_Molecule
protein	O
made	O
by	O
group	B-Species
A	I-Species
Streptococcus	E-Species
(	O
GAS	S-Species
)	O
inhibits	O
opsonophagocytosis	O
of	O
GAS	S-Biological_Molecule
by	O
human	S-Species
polymorphonuclear	O
leukocytes	O
(	O
PMNs	O
)	O
.	O

This	O
protein	O
also	O
has	O
the	O
endopeptidase	O
activity	O
against	O
human	S-Species
immunoglobulin	B-Biological_Molecule
G	E-Biological_Molecule
(	O
IgG	S-Biological_Molecule
)	O
,	O
and	O
the	O
Cys94	O
,	O
His262	O
and	O
Asp284	O
are	O
critical	O
for	O
the	O
enzymatic	O
activity	O
.	O

The	O
horse	S-Species
pathogen	O
Streptococcus	B-Species
equi	I-Species
subspecies	I-Species
equi	E-Species
produces	O
a	O
homologue	O
of	O
Mac	S-Biological_Molecule
(	O
SeMac	S-Biological_Molecule
)	O
.	O

The	O
gene	O
was	O
cloned	O
and	O
recombinant	O
SeMac	S-Biological_Molecule
was	O
overexpressed	O
in	O
Escherichia	B-Species
coli	E-Species
and	O
purified	O
to	O
homogeneity	O
.	O

Mice	S-Species
with	O
experimental	O
S	B-Species
.	I-Species
equi	E-Species
infection	O
and	O
horses	S-Species
with	O
strangles	O
caused	O
by	O
S	B-Species
.	I-Species
equi	E-Species
seroconverted	O
to	O
SeMac	S-Biological_Molecule
,	O
indicating	O
that	O
SeMac	S-Biological_Molecule
is	O
produced	O
in	O
vivo	O
during	O
infection	O
.	O

However	O
,	O
the	O
protein	O
just	O
cleaves	O
a	O
small	O
fraction	O
,	O
which	O
may	O
be	O
IgG1	S-Biological_Molecule
only	O
,	O
of	O
horse	S-Species
IgG	S-Biological_Molecule
.	O

Replacement	O
of	O
Cys102	O
with	O
Ser	O
or	O
His272	O
with	O
Ala	O
abolishes	O
the	O
enzymatic	O
activity	O
of	O
SeMac	S-Biological_Molecule
,	O
and	O
the	O
Asp294Ala	O
mutation	O
greatly	O
decreases	O
the	O
enzymatic	O
activity	O
.	O

There	O
is	O
massive	O
infiltration	O
of	O
polymorphonuclear	O
leukocytes	O
(	O
PMNs	O
)	O
to	O
the	O
infection	O
site	O
.	O

However	O
,	O
S	B-Species
.	I-Species
equi	E-Species
effectively	O
evades	O
the	O
horse	S-Species
innate	O
immunity	O
by	O
being	O
resistant	O
to	O
phagocytosis	O
by	O
PMNs	O
.	O

To	O
survive	O
in	O
hosts	O
,	O
bacterial	O
pathogens	O
have	O
evolved	O
multiple	O
mechanisms	O
to	O
evade	O
host	O
defense	O
.	O

We	O
found	O
that	O
GAS	S-Species
produces	O
a	O
secreted	O
Mac	S-Biological_Molecule
protein	O
(	O
also	O
known	O
as	O
IdeE	S-Biological_Molecule
)	O
,	O
which	O
inhibits	O
opsonophagocytosis	O
of	O
GAS	S-Species
by	O
human	S-Species
PMNs	O
[	O
5	O
]	O
.	O

The	O
type	O
-	O
1	O
Mac	S-Biological_Molecule
,	O
such	O
as	O
M1	O
Mac	S-Biological_Molecule
produced	O
by	O
serotype	B-Species
M1	I-Species
GAS	E-Species
strains	O
,	O
has	O
high	O
enzymatic	O
activity	O
and	O
low	O
affinity	O
to	O
Fc	B-Biological_Molecule
receptor	E-Biological_Molecule
on	O
the	O
surface	O
of	O
PMNs	O
,	O
while	O
the	O
type	O
-	O
2	O
Mac	S-Biological_Molecule
can	O
bind	O
to	O
the	O
Fc	B-Biological_Molecule
receptor	E-Biological_Molecule
and	O
has	O
lower	O
enzymatic	O
activity	O
[	O
9	O
]	O
.	O

In	O
this	O
study	O
,	O
SeMac	S-Biological_Molecule
was	O
prepared	O
and	O
characterized	O
.	O

S	B-Species
.	I-Species
equi	E-Species
Mac	S-Biological_Molecule
Gene	O
S	B-Species
.	I-Species
equi	E-Species
genome	O
encodes	O
a	O
Mac	S-Biological_Molecule
homologue	O
SeMac	S-Biological_Molecule
.	O

To	O
test	O
whether	O
other	O
S	B-Species
.	I-Species
equi	E-Species
strains	O
have	O
the	O
mac	S-Biological_Molecule
gene	O
,	O
10	O
S	B-Species
.	I-Species
equi	E-Species
isolates	O
representing	O
various	O
geographic	O
locations	O
were	O
tested	O
with	O
PCR	O
using	O
mac	S-Biological_Molecule
-	O
specific	O
primers	O
.	O

All	O
the	O
strains	O
tested	O
had	O
the	O
mac	S-Biological_Molecule
gene	O
(	O
Fig	O
.	O
2	O
)	O
.	O

DNA	O
sequencing	O
found	O
that	O
the	O
mac	S-Biological_Molecule
gene	O
is	O
100	O
%	O
conserved	O
in	O
DNA	O
sequence	O
in	O
these	O
strains	O
.	O

[	O
16	O
]	O
,	O
resolved	O
by	O
SDS	O
-	O
PAGE	O
,	O
and	O
probed	O
by	O
Western	O
immunoblot	O
with	O
anti	O
-	O
SeMac	S-Biological_Molecule
mouse	S-Species
antisera	O
.	O

No	O
SeMac	S-Biological_Molecule
was	O
detected	O
in	O
all	O
the	O
samples	O
(	O
data	O
not	O
shown	O
)	O
,	O
suggesting	O
that	O
SeMac	S-Biological_Molecule
is	O
not	O
produced	O
in	O
vitro	O
.	O

To	O
test	O
whether	O
SeMac	S-Biological_Molecule
is	O
produced	O
in	O
vivo	O
during	O
S	B-Species
.	I-Species
equi	E-Species
infection	O
,	O
the	O
presence	O
of	O
SeMac	S-Biological_Molecule
-	O
specific	O
antibody	O
was	O
assessed	O
by	O
Western	O
immunoblot	O
analysis	O
with	O
convalescent	O
sera	O
from	O
3	O
horses	S-Species
suffered	O
from	O
strangles	O
and	O
mice	S-Species
with	O
experimental	O
S	B-Species
.	I-Species
equi	E-Species
infection	O
.	O

Endopeptidase	O
Activity	O
of	O
SeMac	S-Biological_Molecule
against	O
Horse	S-Species
IgG1	S-Biological_Molecule
and	O
Human	S-Species
IgG	S-Biological_Molecule

GAS	S-Species
Mac	S-Biological_Molecule
can	O
cleave	O
the	O
heavy	O
chain	O
of	O
human	S-Species
IgG	S-Biological_Molecule
at	O
the	O
lower	O
hinge	O
region	O
between	O
Fab	O
and	O
Fc	O
fragments	O
.	O

SeMac	S-Biological_Molecule
possesses	O
putative	O
catalytic	O
residues	O
of	O
Cys102	O
,	O
His272	O
,	O
and	O
Asp294	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Purified	O
recombinant	O
SeMac	S-Biological_Molecule
and	O
GAS	S-Species
Mac	S-Biological_Molecule
were	O
then	O
tested	O
for	O
activity	O
to	O
cleave	O
horse	S-Species
IgG	S-Biological_Molecule
.	O

To	O
test	O
this	O
possibility	O
,	O
available	O
horse	S-Species
IgG1	S-Biological_Molecule
and	O
a	O
mixture	O
of	O
IgG1	S-Biological_Molecule
and	O
IgG4	S-Biological_Molecule
were	O
treated	O
with	O
SeMac	S-Biological_Molecule
or	O
GAS	S-Species
Mac	S-Biological_Molecule
.	O

SeMac	S-Biological_Molecule
or	O
GAS	S-Species
Mac	S-Biological_Molecule
cleaved	O
a	O
small	O
portion	O
of	O
the	O
IgG1	S-Biological_Molecule
/	O
IgG4	S-Biological_Molecule
mixture	O
,	O
but	O
not	O
IgG4	S-Biological_Molecule
.	O

Therefore	O
,	O
the	O
Mac	S-Biological_Molecule
proteins	O
can	O
cleave	O
IgG1	S-Biological_Molecule
but	O
not	O
IgG4	S-Biological_Molecule
.	O

Due	O
to	O
the	O
unavailability	O
of	O
other	O
purified	O
subgroup	O
IgG	S-Biological_Molecule
,	O
it	O
is	O
not	O
known	O
whether	O
SeMac	S-Biological_Molecule
cleaves	O
the	O
other	O
IgG	S-Biological_Molecule
subgroups	O
.	O

A	O
whole	O
blood	O
based	O
phagocytosis	O
assay	O
[	O
13	O
,	O
14	O
]	O
was	O
used	O
to	O
test	O
whether	O
SeMac	S-Biological_Molecule
inhibits	O
opsonophagocytosis	O
of	O
S	B-Species
.	I-Species
equi	E-Species
by	O
horse	S-Species
PMNs	O
.	O

Percentage	O
of	O
PMNs	O
with	O
phagocytosed	O
S	B-Species
.	I-Species
equi	E-Species
was	O
determined	O
by	O
flow	O
cytometry	O
.	O

As	O
expected	O
,	O
percentage	O
of	O
PMNs	O
with	O
phagocytosed	O
S	B-Species
.	I-Species
equi	E-Species
with	O
the	O
serum	O
treatment	O
was	O
significantly	O
higher	O
than	O
that	O
for	O
S	B-Species
.	I-Species
equi	E-Species
without	O
serum	O
treatment	O
.	O

But	O
the	O
inclusion	O
of	O
SeMac	S-Biological_Molecule
in	O
the	O
assay	O
did	O
not	O
affect	O
opsonophagocytosis	O
of	O
S	B-Species
.	I-Species
equi	E-Species
(	O
Fig	O
.	O
5A	O
)	O
,	O
suggesting	O
that	O
SeMac	S-Biological_Molecule
does	O
not	O
inhibit	O
opsonophagocytosis	O
of	O
S	B-Species
.	I-Species
equi	E-Species
by	O
horse	S-Species
PMNs	O
.	O

To	O
test	O
this	O
idea	O
,	O
the	O
phagocytosis	O
assay	O
was	O
repeated	O
using	O
GAS	S-Species
and	O
human	S-Species
blood	O
.	O

These	O
results	O
suggest	O
that	O
IgG	B-Biological_Molecule
endopeptidase	E-Biological_Molecule
activity	O
of	O
SeMac	S-Biological_Molecule
is	O
critical	O
for	O
inhibition	O
of	O
phagocytosis	O
.	O

In	O
this	O
study	O
we	O
describe	O
that	O
SeMac	S-Biological_Molecule
is	O
a	O
cysteine	B-Biological_Molecule
endopeptidase	E-Biological_Molecule
with	O
limited	O
activity	O
against	O
horse	S-Species
IgG	S-Biological_Molecule
and	O
is	O
unable	O
to	O
inhibit	O
opsonophagocytosis	O
of	O
S	B-Species
.	I-Species
equi	E-Species
by	O
horse	S-Species
PMNs	O
in	O
a	O
whole	O
blood	O
assay	O
.	O

SeMac	S-Biological_Molecule
efficiently	O
cleaves	O
the	O
heavy	O
chain	O
of	O
human	S-Species
IgG	S-Biological_Molecule
.	O

Thus	O
,	O
like	O
GAS	S-Species
M1	O
Mac	S-Biological_Molecule
[	O
7	O
,	O
8	O
]	O
,	O
SeMac	S-Biological_Molecule
is	O
a	O
cysteine	B-Biological_Molecule
endopeptidase	E-Biological_Molecule
.	O

The	O
peptide	O
fragment	O
,	O
PELLGG	O
,	O
in	O
the	O
lower	O
hinge	O
region	O
is	O
proposed	O
to	O
bind	O
to	O
the	O
active	O
site	O
of	O
Mac	S-Biological_Molecule
[	O
9	O
]	O
,	O
and	O
the	O
cleavage	O
occurs	O
between	O
the	O
two	O
Gly	O
residues	O
(	O
Table	O
1	O
)	O
.	O

These	O
horse	S-Species
IgG	S-Biological_Molecule
antibodies	O
that	O
cannot	O
be	O
cleaved	O
by	O
SeMac	S-Biological_Molecule
thus	O
still	O
can	O
mediate	O
the	O
opsonophagocytosis	O
of	O
S	B-Species
.	I-Species
equi	E-Species
.	O

SeMac	S-Biological_Molecule
and	O
GAS	S-Species
M1	O
Mac	S-Biological_Molecule
show	O
similar	O
enzymatic	O
specificity	O
(	O
Fig	O
.	O
4	O
and	O
Table	O
1	O
)	O
,	O
confirming	O
the	O
previous	O
finding	O
[	O
18	O
]	O
.	O

SeMac	S-Biological_Molecule
can	O
cleave	O
human	S-Species
IgG	S-Biological_Molecule
and	O
inhibit	O
the	O
opsonophagocytosis	O
of	O
GAS	S-Species
by	O
human	S-Species
PMNs	O
,	O
but	O
it	O
has	O
limited	O
enzymatic	O
activity	O
against	O
horse	S-Species
IgG	S-Biological_Molecule
and	O
is	O
unable	O
to	O
inhibit	O
opsonophagocytosis	O
of	O
S	B-Species
.	I-Species
equi	E-Species
by	O
horse	S-Species
PMNs	O
.	O

SeMac	S-Biological_Molecule
is	O
not	O
produced	O
in	O
vitro	O
,	O
whereas	O
GAS	S-Species
Mac	S-Biological_Molecule
is	O
[	O
16	O
]	O
.	O

The	O
hyaluronic	O
capsule	O
of	O
S	B-Species
.	I-Species
equi	E-Species
is	O
highly	O
produced	O
in	O
vitro	O
.	O

This	O
suggestion	O
is	O
supported	O
by	O
only	O
29	O
%	O
DNA	O
sequence	O
identity	O
between	O
S	B-Species
.	I-Species
equi	E-Species
and	O
M1	O
GAS	S-Species
in	O
the	O
upstream	O
region	O
of	O
the	O
semac	S-Biological_Molecule
and	O
mac	S-Biological_Molecule
genes	O
.	O

The	O
fact	O
that	O
SeMac	S-Biological_Molecule
does	O
not	O
inhibit	O
opsonophagocytosis	O
of	O
S	B-Species
.	I-Species
equi	E-Species
by	O
horse	S-Species
PMNs	O
indicates	O
that	O
SeMac	S-Biological_Molecule
is	O
not	O
involved	O
in	O
the	O
evasion	O
of	O
the	O
acquired	O
horse	S-Species
immunity	O
against	O
S	B-Species
.	I-Species
equi	E-Species
.	O

Acid	O
pH	O
activation	O
of	O
the	O
PmrA	S-Biological_Molecule
/	O
PmrB	S-Biological_Molecule
two	O
-	O
component	O
regulatory	O
system	O
of	O
Salmonella	B-Species
enterica	E-Species

However	O
,	O
little	O
is	O
known	O
about	O
the	O
identity	O
of	O
the	O
gene	O
products	O
that	O
sense	O
fluctuations	O
in	O
extracytoplasmic	O
pH	O
.	O

Substitution	O
of	O
a	O
conserved	O
histidine	O
or	O
of	O
either	O
one	O
of	O
four	O
conserved	O
glutamic	O
acid	O
residues	O
in	O
the	O
periplasmic	O
domain	O
of	O
PmrB	S-Biological_Molecule
severely	O
decreased	O
or	O
abolished	O
the	O
mild	O
acid	O
-	O
promoted	O
transcription	O
of	O
PmrA	S-Biological_Molecule
-	O
activated	O
genes	O
.	O

Wild	O
-	O
type	O
Salmonella	S-Species
grown	O
at	O
pH	O
5	O
.	O
8	O
were	O
>	O
100	O
000	O
-	O
fold	O
more	O
resistant	O
to	O
polymyxin	B-Chemical_Compound
B	E-Chemical_Compound
than	O
organisms	O
grown	O
at	O
pH	O
7	O
.	O
7	O
.	O

Our	O
results	O
suggest	O
that	O
protonation	O
of	O
the	O
PmrB	S-Biological_Molecule
periplasmic	O
histidine	O
and	O
/	O
or	O
of	O
the	O
glutamic	O
acid	O
residues	O
activate	O
the	O
PmrA	S-Biological_Molecule
protein	O
,	O
and	O
that	O
mild	O
acid	O
promotes	O
cellular	O
changes	O
resulting	O
in	O
polymyxin	B-Chemical_Compound
B	E-Chemical_Compound
resistance	O
.	O

Free	O
-	O
living	O
organisms	O
often	O
encounter	O
wide	O
variations	O
in	O
the	O
pH	O
of	O
their	O
surroundings	O
.	O

Thus	O
,	O
pH	O
may	O
act	O
as	O
a	O
signal	O
that	O
triggers	O
cellular	O
responses	O
designed	O
to	O
cope	O
with	O
a	O
new	O
environment	O
.	O

Moreover	O
,	O
Salmonella	S-Species
has	O
been	O
recovered	O
from	O
soil	O
and	O
water	O
(	O
Winfield	O
and	O
Groisman	O
,	O
2003	O
)	O
where	O
the	O
pH	O
can	O
be	O
significantly	O
low	O
.	O

While	O
growth	O
in	O
acidic	O
conditions	O
has	O
been	O
shown	O
to	O
promote	O
changes	O
in	O
the	O
gene	O
expression	O
profiles	O
of	O
several	O
bacterial	O
species	O
(	O
Tucker	O
et	O
al	O
.	O
,	O
2002	O
;	O
McGowan	O
et	O
al	O
.	O
,	O
2003	O
;	O
Weinrick	O
et	O
al	O
.	O
,	O
2004	O
;	O
Leaphart	O
et	O
al	O
.	O
,	O
2006	O
)	O
,	O
less	O
is	O
known	O
about	O
the	O
identity	O
of	O
the	O
molecule	O
(	O
s	O
)	O
that	O
sense	O
extracytoplasmic	O
fluctuations	O
in	O
pH	O
and	O
the	O
mechanisms	O
by	O
which	O
such	O
sensors	O
promote	O
changes	O
in	O
gene	O
expression	O
.	O

While	O
other	O
PmrA	S-Biological_Molecule
-	O
regulated	O
genes	O
have	O
been	O
identified	O
(	O
Marchal	O
et	O
al	O
.	O
,	O
2004	O
;	O
Tamayo	O
et	O
al	O
.	O
,	O
2005	O
)	O
,	O
their	O
biochemical	O
activities	O
and	O
the	O
role	O
(	O
s	O
)	O
that	O
they	O
play	O
in	O
Salmonella	S-Species
'	O
s	O
life	O
remain	O
unknown	O
.	O

PmrD	S-Biological_Molecule
binds	O
to	O
the	O
phosphorylated	O
form	O
of	O
PmrA	S-Biological_Molecule
protecting	O
it	O
from	O
dephosphorylation	O
by	O
PmrB	S-Biological_Molecule
(	O
Kato	O
and	O
Groisman	O
,	O
2004	O
)	O
.	O

All	O
three	O
genes	O
were	O
expressed	O
when	O
cells	O
were	O
grown	O
in	O
media	O
buffered	O
at	O
pH	O
5	O
.	O
8	O
but	O
not	O
at	O
pH	O
7	O
.	O
7	O
(	O
Fig	O
.	O
2A	O
-	O
C	O
)	O
,	O
in	O
agreement	O
with	O
previous	O
results	O
(	O
Soncini	O
and	O
Groisman	O
,	O
1996	O
)	O
.	O

A	O
similar	O
induction	O
of	O
pbgP	S-Biological_Molecule
transcription	O
was	O
found	O
when	O
MES	S-Chemical_Compound
was	O
used	O
as	O
the	O
buffering	O
agent	O
in	O
the	O
media	O
at	O
pH	O
5	O
.	O
8	O
instead	O
of	O
Bis	B-Chemical_Compound
-	I-Chemical_Compound
Tris	E-Chemical_Compound
(	O
data	O
not	O
shown	O
)	O
,	O
indicating	O
that	O
the	O
mild	O
acid	O
effect	O
on	O
gene	O
expression	O
was	O
not	O
due	O
to	O
a	O
particular	O
buffering	O
system	O
.	O

To	O
rule	O
out	O
this	O
possibility	O
,	O
we	O
treated	O
the	O
culture	O
medium	O
with	O
Chelex	B-Chemical_Compound
100	E-Chemical_Compound
resin	O
,	O
an	O
agent	O
known	O
to	O
chelate	O
polyvalent	O
metal	O
ions	O
that	O
does	O
not	O
affect	O
Salmonella	S-Species
growth	O
.	O

We	O
determined	O
that	O
Chelex	B-Chemical_Compound
100	E-Chemical_Compound
was	O
effective	O
at	O
chelating	O
iron	S-Chemical_Compound
because	O
expression	O
of	O
the	O
pmrA	S-Biological_Molecule
-	O
independent	O
iron	S-Chemical_Compound
-	O
repressed	O
iroA	S-Biological_Molecule
gene	O
(	O
Hall	O
and	O
Foster	O
,	O
1996	O
)	O
was	O
induced	O
to	O
higher	O
levels	O
in	O
cultures	O
treated	O
with	O
Chelex	B-Chemical_Compound
100	E-Chemical_Compound
(	O
Fig	O
.	O
2D	O
)	O
.	O

We	O
determined	O
that	O
the	O
regulatory	O
protein	O
PmrA	S-Biological_Molecule
is	O
required	O
for	O
the	O
transcriptional	O
activation	O
in	O
response	O
to	O
mild	O
acid	O
pH	O
because	O
there	O
was	O
no	O
induction	O
of	O
the	O
three	O
investigated	O
genes	O
in	O
a	O
pmrA	S-Biological_Molecule
mutant	O
(	O
Fig	O
.	O
2A	O
-	O
C	O
)	O
.	O

Thus	O
,	O
we	O
determined	O
the	O
beta	O
-	O
galactosidase	O
activity	O
of	O
isogenic	O
pmrB	S-Biological_Molecule
strains	O
harbouring	O
a	O
chromosomal	O
pbgP	S-Biological_Molecule
-	O
lac	O
transcriptional	O
fusion	O
:	O
expression	O
was	O
approximately	O
sixfold	O
lower	O
in	O
a	O
pmrB	S-Biological_Molecule
mutant	O
than	O
in	O
the	O
pmrB	S-Biological_Molecule
+	O
strain	O
following	O
growth	O
at	O
pH	O
5	O
.	O
8	O
(	O
Fig	O
.	O
3	O
)	O
,	O
indicating	O
that	O
a	O
functional	O
pmrB	S-Biological_Molecule
gene	O
is	O
necessary	O
for	O
a	O
normal	O
response	O
to	O
mild	O
acid	O
pH	O
.	O

This	O
suggested	O
that	O
PmrA	S-Biological_Molecule
could	O
become	O
phosphorylated	O
from	O
another	O
phosphodonor	O
(	O
s	O
)	O
when	O
PmrB	S-Biological_Molecule
is	O
not	O
present	O
.	O

In	O
contrast	O
,	O
a	O
strain	O
lacking	O
the	O
ability	O
to	O
synthesize	O
acetyl	B-Chemical_Compound
phosphate	E-Chemical_Compound
but	O
with	O
a	O
functional	O
pmrB	S-Biological_Molecule
gene	O
exhibited	O
wild	O
-	O
type	O
pbgP	S-Biological_Molecule
expression	O
levels	O
(	O
Fig	O
.	O
3	O
)	O
,	O
implying	O
that	O
under	O
normal	O
conditions	O
(	O
i	O
.	O
e	O
.	O
when	O
a	O
functional	O
pmrB	S-Biological_Molecule
gene	O
is	O
present	O
)	O
acetyl	O
phosphate	O
does	O
not	O
contribute	O
to	O
PmrA	S-Biological_Molecule
phosphorylation	O
.	O

The	O
PhoP	S-Biological_Molecule
-	O
activated	O
PmrD	S-Biological_Molecule
protein	O
favours	O
the	O
phosphorylated	O
state	O
of	O
the	O
PmrA	S-Biological_Molecule
protein	O
(	O
Fig	O
.	O
1	O
)	O
(	O
Kato	O
and	O
Groisman	O
,	O
2004	O
)	O
.	O

Thus	O
,	O
we	O
tested	O
the	O
possibility	O
of	O
PmrD	S-Biological_Molecule
participating	O
in	O
the	O
PmrA	S-Biological_Molecule
-	O
dependent	O
response	O
to	O
acidic	O
conditions	O
,	O
and	O
thus	O
contributing	O
to	O
the	O
pbgP	S-Biological_Molecule
transcription	O
remaining	O
in	O
a	O
pmrB	S-Biological_Molecule
mutant	O
.	O

Expression	O
of	O
the	O
pbgP	S-Biological_Molecule
gene	O
was	O
abolished	O
in	O
a	O
pmrB	S-Biological_Molecule
pmrD	S-Biological_Molecule
double	O
mutant	O
(	O
Fig	O
.	O
3	O
)	O
indicating	O
that	O
both	O
genes	O
are	O
necessary	O
to	O
activate	O
PmrA	S-Biological_Molecule
under	O
acidic	O
conditions	O
.	O

These	O
results	O
imply	O
that	O
the	O
pmrD	S-Biological_Molecule
gene	O
was	O
being	O
expressed	O
even	O
though	O
the	O
media	O
contained	O
10	O
mM	O
MgCl2	S-Chemical_Compound
,	O
a	O
concentration	O
known	O
to	O
repress	O
transcription	O
of	O
PhoP	S-Biological_Molecule
-	O
activated	O
genes	O
(	O
Soncini	O
et	O
al	O
.	O
,	O
1996	O
)	O
.	O

Growth	O
at	O
pH	O
5	O
.	O
8	O
resulted	O
in	O
pmrD	S-Biological_Molecule
transcript	O
levels	O
that	O
were	O
approximately3	O
.	O
5	O
-	O
fold	O
higher	O
than	O
in	O
organisms	O
grown	O
at	O
pH	O
7	O
.	O
7	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

In	O
agreement	O
with	O
the	O
gene	O
transcription	O
data	O
,	O
Western	O
blot	O
analysis	O
of	O
crude	O
extracts	O
using	O
anti	O
-	O
PmrD	S-Biological_Molecule
antibodies	O
showed	O
that	O
the	O
PmrD	S-Biological_Molecule
protein	O
was	O
produced	O
in	O
cells	O
grown	O
in	O
N	O
-	O
minimal	O
medium	O
pH	O
5	O
.	O
8	O
and	O
10	O
mM	O
MgCl2	S-Chemical_Compound
but	O
not	O
in	O
cells	O
grown	O
in	O
the	O
same	O
medium	O
buffered	O
at	O
pH	O
7	O
.	O
7	O
(	O
Fig	O
.	O
4B	O
)	O
.	O

To	O
examine	O
this	O
hypothesis	O
,	O
we	O
tested	O
a	O
Salmonella	S-Species
strain	O
with	O
a	O
chromosomal	O
pbgP	S-Biological_Molecule
-	O
lac	O
fusion	O
,	O
deleted	O
for	O
the	O
chromosomal	O
copy	O
of	O
the	O
pmrB	S-Biological_Molecule
gene	O
and	O
harbouring	O
a	O
plasmid	O
expressing	O
a	O
PmrB	S-Biological_Molecule
protein	O
lacking	O
its	O
periplasmic	O
domain	O
for	O
its	O
ability	O
to	O
promote	O
pbgP	S-Biological_Molecule
expression	O
in	O
response	O
to	O
different	O
signals	O
.	O

There	O
was	O
no	O
pbgP	S-Biological_Molecule
expression	O
in	O
cells	O
grown	O
at	O
pH	O
5	O
.	O
8	O
(	O
Fig	O
.	O
5B	O
)	O
or	O
in	O
the	O
presence	O
of	O
Fe3	B-Chemical_Compound
+	E-Chemical_Compound
(	O
Fig	O
.	O
5D	O
)	O
,	O
which	O
is	O
in	O
contrast	O
to	O
the	O
normal	O
activation	O
in	O
response	O
to	O
low	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
(	O
Fig	O
.	O
5C	O
)	O
.	O

Together	O
,	O
these	O
results	O
argue	O
in	O
favour	O
of	O
the	O
notion	O
that	O
PmrB	S-Biological_Molecule
senses	O
extracellular	O
pH	O
besides	O
its	O
previously	O
described	O
ligands	O
Fe3	B-Chemical_Compound
+	E-Chemical_Compound
and	O
Al3	B-Chemical_Compound
+	E-Chemical_Compound
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
.	O

Interestingly	O
,	O
one	O
of	O
these	O
conserved	O
residues	O
was	O
a	O
histidine	O
at	O
position	O
35	O
.	O

We	O
considered	O
the	O
possibility	O
that	O
a	O
second	O
histidine	O
at	O
position	O
57	O
could	O
be	O
involved	O
in	O
sensing	O
acid	O
despite	O
the	O
fact	O
that	O
this	O
residue	O
was	O
only	O
partially	O
conserved	O
across	O
species	O
(	O
Fig	O
.	O
6A	O
)	O
.	O

Although	O
the	O
pKa	O
of	O
free	O
glutamic	O
acid	O
is	O
approximately4	O
,	O
which	O
is	O
well	O
below	O
the	O
range	O
of	O
pH	O
at	O
which	O
PmrA	S-Biological_Molecule
-	O
activated	O
genes	O
are	O
induced	O
,	O
the	O
folding	O
of	O
a	O
protein	O
can	O
dramatically	O
change	O
the	O
pKa	O
of	O
its	O
residues	O
.	O

For	O
instance	O
,	O
the	O
pKa	O
of	O
one	O
of	O
the	O
glutamic	O
acid	O
residues	O
of	O
the	O
regulatory	O
protein	O
TraM	S-Biological_Molecule
is	O
approximately7	O
.	O
7	O
(	O
Lu	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

Therefore	O
,	O
we	O
hypothesized	O
that	O
one	O
or	O
more	O
of	O
the	O
glutamates	O
might	O
be	O
required	O
for	O
pH	O
sensing	O
.	O

Strains	O
expressing	O
the	O
mutant	O
PmrB	S-Biological_Molecule
proteins	O
could	O
express	O
pbgP	S-Biological_Molecule
normally	O
in	O
response	O
to	O
the	O
low	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
signal	O
(	O
Fig	O
.	O
6C	O
)	O
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
,	O
indicating	O
that	O
mutations	O
in	O
residues	O
of	O
the	O
periplasmic	O
domain	O
of	O
PmrB	S-Biological_Molecule
do	O
not	O
impair	O
the	O
enzymatic	O
activity	O
of	O
the	O
cytoplasmic	O
domain	O
of	O
the	O
PmrB	S-Biological_Molecule
protein	O
.	O

These	O
results	O
indicate	O
that	O
the	O
periplasmic	O
glutamates	O
are	O
required	O
for	O
responding	O
to	O
mild	O
acid	O
pH	O
.	O

What	O
role	O
could	O
the	O
mild	O
acid	O
pH	O
-	O
dependent	O
activation	O
of	O
PmrA	S-Biological_Molecule
-	O
regulated	O
genes	O
play	O
in	O
Salmonella	S-Species
'	O
s	O
lifestyle	O
?	O

In	O
fact	O
,	O
the	O
survival	O
of	O
wild	O
-	O
type	O
cells	O
to	O
a	O
challenge	O
with	O
polymyxin	B-Chemical_Compound
B	E-Chemical_Compound
was	O
100	O
000	O
-	O
fold	O
higher	O
when	O
they	O
were	O
grown	O
at	O
pH	O
5	O
.	O
8	O
than	O
when	O
grown	O
at	O
pH	O
7	O
.	O
7	O
(	O
Fig	O
.	O
7	O
)	O
.	O

Discussion	O

We	O
have	O
established	O
that	O
the	O
sensor	O
kinase	O
PmrB	S-Biological_Molecule
is	O
the	O
primary	O
sensor	O
that	O
activates	O
the	O
PmrA	S-Biological_Molecule
protein	O
when	O
Salmonella	S-Species
experiences	O
mild	O
acid	O
pH	O
,	O
resulting	O
in	O
transcription	O
of	O
PmrA	S-Biological_Molecule
-	O
activated	O
genes	O
(	O
Fig	O
.	O
1	O
)	O
.	O

The	O
requirement	O
of	O
periplasmic	O
PmrB	S-Biological_Molecule
residues	O
in	O
the	O
mild	O
acid	O
pH	O
activation	O
of	O
PmrA	S-Biological_Molecule
-	O
regulated	O
genes	O
suggests	O
that	O
this	O
signalling	O
pathway	O
responds	O
to	O
changes	O
in	O
extracytoplasmic	O
pH	O
.	O

For	O
example	O
,	O
the	O
eukaryotic	O
G	O
-	O
protein	O
coupled	O
receptor	O
OGR1	S-Biological_Molecule
is	O
inactive	O
at	O
pH	O
7	O
.	O
8	O
and	O
fully	O
active	O
at	O
pH	O
6	O
.	O
8	O
suggesting	O
that	O
the	O
pH	O
sensing	O
mechanism	O
involves	O
protonation	O
of	O
several	O
extracytoplasmic	O
histidines	O
(	O
Ludwig	O
et	O
al	O
.	O
,	O
2003	O
)	O
,	O
which	O
is	O
in	O
agreement	O
with	O
the	O
pKa	O
of	O
free	O
histidine	O
of	O
approximately6	O
.	O

Therefore	O
,	O
regulation	O
of	O
PmrB	S-Biological_Molecule
activity	O
may	O
involve	O
protonation	O
of	O
one	O
or	O
more	O
of	O
these	O
amino	O
acids	O
.	O

Even	O
though	O
protonation	O
of	O
the	O
glutamic	O
acid	O
residues	O
may	O
seem	O
unlikely	O
given	O
the	O
fact	O
that	O
the	O
pKa	O
of	O
free	O
glutamic	O
acid	O
is	O
approximately4	O
,	O
protein	O
folding	O
can	O
change	O
the	O
pKa	O
of	O
its	O
residues	O
(	O
Tanford	O
and	O
Roxby	O
,	O
1972	O
)	O
.	O

Indeed	O
,	O
the	O
pKa	O
of	O
one	O
of	O
the	O
glutamic	O
acid	O
residues	O
of	O
the	O
regulatory	O
protein	O
TraM	S-Biological_Molecule
is	O
approximately7	O
.	O
7	O
in	O
the	O
folded	O
protein	O
(	O
Lu	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

The	O
CadC	S-Biological_Molecule
protein	O
of	O
E	B-Species
.	I-Species
coli	E-Species
,	O
for	O
example	O
,	O
is	O
activated	O
by	O
exogenous	O
lysine	O
besides	O
acid	O
pH	O
(	O
Dell	O
et	O
al	O
.	O
,	O
1994	O
)	O
.	O

Furthermore	O
,	O
the	O
ability	O
to	O
sense	O
two	O
different	O
compounds	O
has	O
also	O
recently	O
been	O
shown	O
to	O
be	O
genetically	O
distinguishable	O
in	O
the	O
bacterial	O
chemoreceptor	O
Tcp	S-Biological_Molecule
(	O
Iwama	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

What	O
role	O
could	O
the	O
pH	O
-	O
dependent	O
activation	O
of	O
PmrA	S-Biological_Molecule
-	O
regulated	O
genes	O
play	O
in	O
Salmonella	S-Species
'	O
s	O
lifestyle	O
?	O

Indeed	O
,	O
when	O
grown	O
at	O
pH	O
5	O
.	O
8	O
wild	O
-	O
type	O
Salmonella	S-Species
were	O
100	O
000	O
-	O
fold	O
more	O
resistant	O
to	O
polymyxin	B-Chemical_Compound
B	E-Chemical_Compound
than	O
when	O
grown	O
at	O
pH	O
7	O
.	O
7	O
(	O
Fig	O
.	O
7	O
)	O
.	O

On	O
the	O
other	O
hand	O
,	O
although	O
mild	O
acid	O
(	O
pH	O
6	O
.	O
0	O
)	O
per	O
se	O
,	O
i	O
.	O
e	O
.	O
even	O
in	O
the	O
presence	O
of	O
high	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
,	O
promotes	O
LPS	S-Chemical_Compound
modifications	O
(	O
Gibbons	O
et	O
al	O
.	O
,	O
2005	O
)	O
,	O
the	O
low	O
pH	O
signal	O
may	O
also	O
act	O
synergistically	O
with	O
the	O
low	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
signal	O
in	O
vivo	O
because	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
deprivation	O
alone	O
is	O
not	O
sufficient	O
to	O
provide	O
all	O
the	O
LPS	S-Chemical_Compound
modifications	O
seen	O
in	O
Salmonella	S-Species
when	O
present	O
inside	O
macrophages	O
(	O
Gibbons	O
et	O
al	O
.	O
,	O
2005	O
)	O
.	O

A	O
Salmonella	O
enterica	O
serovar	O
Typhimurium	O
mlc	S-Biological_Molecule
mutant	O
showed	O
reduced	O
levels	O
of	O
invasion	O
and	O
cytotoxicity	O
compared	O
to	O
the	O
wild	O
-	O
type	O
,	O
and	O
exhibited	O
reduced	O
expression	O
levels	O
of	O
hilD	S-Biological_Molecule
,	O
hilA	S-Biological_Molecule
and	O
invF	S-Biological_Molecule
,	O
which	O
are	O
regulatory	O
genes	O
in	O
the	O
Salmonella	S-Species
pathogenicity	O
island	O
1	O
(	O
SPI1	O
)	O
.	O

However	O
,	O
the	O
effects	O
of	O
Mlc	S-Biological_Molecule
on	O
hilD	S-Biological_Molecule
expression	O
and	O
bacterial	O
invasiveness	O
were	O
not	O
seen	O
in	O
the	O
hilE	S-Biological_Molecule
mutant	O
,	O
and	O
hilE	S-Biological_Molecule
expression	O
was	O
increased	O
in	O
the	O
mlc	S-Biological_Molecule
mutant	O
,	O
which	O
suggests	O
that	O
Mlc	S-Biological_Molecule
exerts	O
positive	O
effects	O
on	O
the	O
expression	O
of	O
SPI1	O
genes	O
by	O
reducing	O
the	O
expression	O
of	O
HilE	S-Biological_Molecule
,	O
which	O
is	O
known	O
to	O
down	O
-	O
regulate	O
the	O
expression	O
of	O
SPI1	O
genes	O
through	O
direct	O
interaction	O
with	O
HilD	S-Biological_Molecule
.	O

We	O
found	O
that	O
the	O
two	O
known	O
promoters	O
of	O
hilE	S-Biological_Molecule
were	O
not	O
modulated	O
by	O
Mlc	S-Biological_Molecule
,	O
and	O
we	O
identified	O
a	O
third	O
promoter	O
,	O
designated	O
P3	O
,	O
which	O
was	O
repressed	O
by	O
Mlc	S-Biological_Molecule
.	O

The	O
gel	O
mobility	O
shift	O
assay	O
and	O
footprinting	O
analysis	O
revealed	O
that	O
Mlc	S-Biological_Molecule
repressed	O
hilE	S-Biological_Molecule
in	O
a	O
direct	O
manner	O
by	O
binding	O
to	O
two	O
distinct	O
sites	O
in	O
the	O
hilE	S-Biological_Molecule
P3	O
promoter	O
region	O
.	O

Based	O
on	O
these	O
results	O
,	O
we	O
propose	O
that	O
Mlc	S-Biological_Molecule
functions	O
to	O
sense	O
the	O
availability	O
of	O
sugars	O
and	O
is	O
linked	O
to	O
virulence	O
gene	O
regulation	O
by	O
its	O
ability	O
to	O
control	O
hilE	S-Biological_Molecule
expression	O
in	O
Salmonella	S-Species
.	O

Salmonella	B-Species
enterica	I-Species
serovar	I-Species
Typhimurium	E-Species
is	O
a	O
facultative	O
intracellular	O
pathogen	O
that	O
initiates	O
disease	O
,	O
which	O
is	O
normally	O
limited	O
to	O
gastroenteritis	O
in	O
humans	S-Species
.	O

However	O
,	O
this	O
bacterium	O
causes	O
systemic	O
disease	O
in	O
mice	S-Species
and	O
has	O
been	O
used	O
as	O
an	O
animal	O
model	O
of	O
typhoid	O
fever	O
.	O

Since	O
Salmonella	S-Species
is	O
acquired	O
usually	O
by	O
oral	O
ingestion	O
of	O
contaminated	O
materials	O
,	O
a	O
key	O
step	O
in	O
the	O
infection	O
process	O
is	O
passage	O
across	O
the	O
intestinal	O
epithelium	O
by	O
invasion	O
of	O
M	O
cells	O
in	O
Peyer	O
'	O
s	O
patches	O
(	O
1	O
)	O
.	O

SPI1	O
contains	O
at	O
least	O
37	O
genes	O
,	O
which	O
encode	O
various	O
components	O
of	O
the	O
type	O
III	O
secretion	O
systems	O
(	O
T3SSs	O
)	O
,	O
its	O
regulators	O
and	O
its	O
secreted	O
effectors	O
(	O
3	O
)	O
.	O

The	O
effector	O
proteins	O
mediate	O
actin	O
cytoskeleton	O
rearrangement	O
,	O
in	O
the	O
form	O
of	O
large	O
membrane	O
ruffles	O
,	O
which	O
engulf	O
the	O
bacteria	O
into	O
the	O
host	O
cell	O
(	O
4	O
,	O
5	O
)	O
.	O

Although	O
many	O
factors	O
and	O
a	O
complex	O
mechanism	O
related	O
to	O
environmental	O
stimuli	O
are	O
involved	O
in	O
the	O
modulation	O
of	O
SPI1	O
genes	O
,	O
they	O
are	O
thought	O
to	O
converge	O
on	O
the	O
activation	O
of	O
several	O
transcriptional	O
regulators	O
encoded	O
within	O
SPI1	O
,	O
such	O
as	O
HilA	S-Biological_Molecule
,	O
HilC	S-Biological_Molecule
,	O
HilD	S-Biological_Molecule
and	O
InvF	S-Biological_Molecule
(	O
7	O
-	O
9	O
)	O
.	O

The	O
expression	O
of	O
invF	S-Biological_Molecule
leads	O
to	O
the	O
induction	O
of	O
several	O
effector	O
genes	O
encoded	O
both	O
within	O
SPI1	O
(	O
sic	O
/	O
sip	O
operon	O
)	O
and	O
outside	O
SPI1	O
(	O
sigD	S-Biological_Molecule
/	O
sopB	S-Biological_Molecule
and	O
sopE	S-Biological_Molecule
)	O
,	O
with	O
SicA	S-Biological_Molecule
as	O
a	O
co	O
-	O
factor	O
(	O
11	O
)	O
.	O

HilC	S-Biological_Molecule
and	O
HilD	S-Biological_Molecule
,	O
which	O
are	O
members	O
of	O
the	O
AraC	S-Biological_Molecule
/	O
XylS	S-Biological_Molecule
family	O
,	O
have	O
been	O
postulated	O
to	O
act	O
as	O
a	O
derepressor	O
of	O
hilA	S-Biological_Molecule
expression	O
by	O
counteracting	O
the	O
action	O
of	O
negative	O
regulatory	O
elements	O
at	O
the	O
hilA	S-Biological_Molecule
promoter	O
(	O
12	O
,	O
13	O
)	O
.	O

Similar	O
to	O
HilC	S-Biological_Molecule
and	O
HilD	S-Biological_Molecule
,	O
RtsA	S-Biological_Molecule
activates	O
the	O
expression	O
of	O
SPI1	O
genes	O
by	O
binding	O
upstream	O
of	O
the	O
master	O
regulatory	O
gene	O
,	O
hilA	S-Biological_Molecule
,	O
to	O
induce	O
its	O
expression	O
(	O
9	O
,	O
17	O
)	O
.	O

Using	O
two	O
-	O
hybrid	O
analysis	O
,	O
it	O
has	O
been	O
shown	O
that	O
HilE	S-Biological_Molecule
interacts	O
with	O
HilD	S-Biological_Molecule
,	O
which	O
suggests	O
that	O
HilE	S-Biological_Molecule
represses	O
hilA	S-Biological_Molecule
expression	O
by	O
inhibiting	O
the	O
activity	O
of	O
HilD	S-Biological_Molecule
through	O
a	O
protein	O
-	O
protein	O
interaction	O
(	O
19	O
,	O
20	O
)	O
.	O

The	O
phosphoenolpyruvate	S-Chemical_Compound
:	O
sugar	O
phosphotransferase	O
system	O
(	O
PTS	O
)	O
is	O
the	O
major	O
sugar	O
transport	O
system	O
in	O
many	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacterial	O
species	O
.	O

Therefore	O
,	O
it	O
seemed	O
possible	O
that	O
Mlc	S-Biological_Molecule
also	O
affects	O
the	O
virulence	O
of	O
Salmonella	S-Species
.	O

In	O
the	O
present	O
study	O
,	O
a	O
Salmonella	O
Typhimurium	O
mlc	S-Biological_Molecule
mutant	O
was	O
constructed	O
to	O
investigate	O
the	O
contribution	O
of	O
Mlc	S-Biological_Molecule
to	O
the	O
virulence	O
phenotype	O
.	O

We	O
examined	O
the	O
ability	O
of	O
an	O
mlc	S-Biological_Molecule
mutant	O
,	O
SR1304	S-Species
,	O
to	O
invade	O
cultured	O
HEp	B-Species
-	I-Species
2	E-Species
and	O
HeLa	O
epithelial	O
cells	O
.	O

When	O
the	O
Salmonella	S-Species
bacteria	O
were	O
grown	O
in	O
static	O
cultures	O
to	O
the	O
exponential	O
phase	O
(	O
SPI1	O
-	O
inducing	O
condition	O
)	O
,	O
the	O
invasiveness	O
of	O
SR1304	S-Species
for	O
both	O
epithelial	O
cell	O
lines	O
was	O
reduced	O
by	O
about	O
3	O
-	O
fold	O
,	O
compared	O
to	O
that	O
of	O
SL1344	S-Species
(	O
Figure	O
1A	O
and	O
B	O
)	O
.	O

S	B-Species
.	E-Species

Typhimurium	S-Species
induces	O
the	O
apoptosis	O
of	O
infected	O
macrophages	O
.	O

This	O
process	O
is	O
rapid	O
,	O
specific	O
and	O
depends	O
on	O
the	O
T3SS	O
encoded	O
within	O
SPI1	O
(	O
33	O
,	O
34	O
)	O
.	O

Figure	O
1C	O
shows	O
that	O
SL1344	S-Species
killed	O
42	O
%	O
of	O
the	O
macrophages	O
,	O
whereas	O
SR1304	S-Species
killed	O
only	O
16	O
%	O
of	O
the	O
macrophages	O
4h	O
after	O
infection	O
,	O
which	O
demonstrates	O
that	O
the	O
mlc	S-Biological_Molecule
gene	O
plays	O
an	O
important	O
role	O
in	O
the	O
expression	O
of	O
genes	O
involved	O
in	O
cytotoxicity	O
.	O

When	O
the	O
number	O
of	O
intracellular	O
bacteria	O
were	O
measured	O
at	O
2	O
and	O
18h	O
post	O
-	O
infection	O
,	O
the	O
degree	O
of	O
replication	O
was	O
similar	O
for	O
SL1344	S-Species
and	O
SR1304	S-Species
(	O
Figure	O
1D	O
)	O
.	O

Collectively	O
,	O
these	O
results	O
suggest	O
that	O
the	O
main	O
target	O
of	O
Mlc	S-Biological_Molecule
action	O
in	O
Salmonella	S-Species
virulence	O
is	O
SPI1	O
,	O
which	O
is	O
known	O
to	O
encode	O
various	O
genes	O
that	O
are	O
required	O
for	O
Salmonella	S-Species
invasion	O
of	O
host	O
cells	O
.	O

The	O
expression	O
levels	O
of	O
hilA	S-Biological_Molecule
,	O
invF	S-Biological_Molecule
and	O
hilD	S-Biological_Molecule
,	O
but	O
not	O
of	O
hilC	S-Biological_Molecule
,	O
are	O
decreased	O
in	O
the	O
mlc	S-Biological_Molecule
mutant	O

To	O
identify	O
the	O
target	O
gene	O
in	O
SPI1	O
that	O
is	O
regulated	O
by	O
Mlc	S-Biological_Molecule
,	O
the	O
expression	O
patterns	O
of	O
the	O
SPI1	O
-	O
regulatory	O
genes	O
,	O
which	O
include	O
hilA	S-Biological_Molecule
,	O
invF	S-Biological_Molecule
,	O
hilC	S-Biological_Molecule
and	O
hilD	S-Biological_Molecule
,	O
were	O
examined	O
by	O
primer	O
extension	O
analysis	O
of	O
total	O
RNA	O
from	O
SL1344	S-Species
and	O
SR1304	S-Species
grown	O
statically	O
to	O
the	O
exponential	O
phase	O
.	O

The	O
transcriptional	O
start	O
sites	O
of	O
these	O
genes	O
have	O
been	O
reported	O
previously	O
(	O
12	O
,	O
16	O
,	O
35	O
,	O
36	O
)	O
.	O

SR1304	S-Species
exhibited	O
a	O
>	O
10	O
-	O
fold	O
reduction	O
in	O
hilA	S-Biological_Molecule
and	O
HilA	S-Biological_Molecule
-	O
dependent	O
invF	S-Biological_Molecule
(	O
invFA	S-Biological_Molecule
)	O
expression	O
,	O
and	O
about	O
a	O
3	O
-	O
fold	O
reduction	O
in	O
hilD	S-Biological_Molecule
and	O
HilC	S-Biological_Molecule
/	O
D	S-Biological_Molecule
-	O
dependent	O
invF	S-Biological_Molecule
(	O
invFD	S-Biological_Molecule
)	O
expression	O
,	O
compared	O
to	O
SL1344	S-Species
.	O

Mlc	S-Biological_Molecule
modulates	O
the	O
expression	O
of	O
SPI1	O
genes	O
by	O
repressing	O
hilE	S-Biological_Molecule

Subsequently	O
,	O
we	O
studied	O
whether	O
hilE	S-Biological_Molecule
expression	O
was	O
affected	O
by	O
Mlc	S-Biological_Molecule
.	O

Baxter	O
et	O
al	O
.	O

When	O
these	O
cells	O
were	O
grown	O
in	O
static	O
cultures	O
to	O
exponential	O
phase	O
,	O
SL1344	B-Species
-	I-Species
pMAB69	E-Species
expressed	O
28	O
.	O
9	O
+	O
/	O
-	O
3	O
.	O
5	O
Miller	O
units	O
of	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
galactosidase	E-Biological_Molecule
,	O
whereas	O
SR1304	B-Species
-	I-Species
pMAB69	E-Species
expressed	O
49	O
.	O
5	O
+	O
/	O
-	O
5	O
.	O
3	O
Miller	O
units	O
of	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
galactosidase	E-Biological_Molecule
;	O
the	O
level	O
of	O
hilE	S-Biological_Molecule
expression	O
in	O
the	O
mlc	S-Biological_Molecule
mutant	O
was	O
almost	O
1	O
.	O
8	O
-	O
fold	O
higher	O
than	O
that	O
in	O
the	O
wild	O
-	O
type	O
strain	O
.	O

The	O
hilE	S-Biological_Molecule
mRNA	O
level	O
measured	O
by	O
real	O
-	O
time	O
PCR	O
also	O
revealed	O
that	O
hilE	S-Biological_Molecule
expression	O
was	O
increased	O
in	O
SR1304	S-Species
by	O
about	O
2	O
-	O
fold	O
(	O
Figure	O
3A	O
)	O
.	O

The	O
role	O
of	O
HilE	S-Biological_Molecule
in	O
the	O
regulation	O
of	O
SPI1	O
gene	O
expression	O
by	O
Mlc	S-Biological_Molecule
was	O
further	O
studied	O
by	O
comparing	O
the	O
invasive	O
abilities	O
of	O
the	O
hilE	S-Biological_Molecule
and	O
hilE	S-Biological_Molecule
/	O
mlc	S-Biological_Molecule
mutant	O
strains	O
of	O
Salmonella	S-Species
.	O

Invasiveness	O
for	O
HEp	O
-	O
2	O
cells	O
was	O
reduced	O
to	O
39	O
.	O
1	O
%	O
of	O
the	O
wild	O
-	O
type	O
level	O
by	O
mlc	S-Biological_Molecule
mutation	O
,	O
whereas	O
it	O
was	O
increased	O
by	O
1	O
.	O
57	O
-	O
fold	O
by	O
hilE	S-Biological_Molecule
mutation	O
(	O
Figure	O
3B	O
)	O
.	O

The	O
requirement	O
of	O
hilE	S-Biological_Molecule
for	O
Mlc	S-Biological_Molecule
function	O
was	O
reflected	O
in	O
the	O
levels	O
of	O
hilD	S-Biological_Molecule
transcription	O
.	O

While	O
hilD	S-Biological_Molecule
expression	O
was	O
reduced	O
in	O
the	O
mlc	S-Biological_Molecule
mutant	O
,	O
it	O
was	O
slightly	O
higher	O
than	O
the	O
wild	O
-	O
type	O
level	O
in	O
both	O
the	O
hilE	S-Biological_Molecule
and	O
hilE	S-Biological_Molecule
/	O
mlc	S-Biological_Molecule
mutant	O
strains	O
(	O
Figure	O
3C	O
)	O
.	O

Additionally	O
,	O
the	O
over	O
-	O
expression	O
of	O
HilD	S-Biological_Molecule
from	O
the	O
plasmid	O
pJB3	O
containing	O
hilD	S-Biological_Molecule
gene	O
under	O
the	O
control	O
of	O
a	O
lac	O
promoter	O
caused	O
the	O
induction	O
of	O
hilA	S-Biological_Molecule
by	O
approximately2	O
-	O
fold	O
and	O
invF	S-Biological_Molecule
by	O
approximately6	O
-	O
fold	O
irrespective	O
of	O
hilE	S-Biological_Molecule
or	O
mlc	S-Biological_Molecule
mutation	O
when	O
real	O
-	O
time	O
PCR	O
was	O
used	O
to	O
compare	O
the	O
expression	O
levels	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
hilE	S-Biological_Molecule
P3	O
promoter	O
is	O
repressed	O
by	O
Mlc	S-Biological_Molecule

Baxter	O
and	O
Jones	O
(	O
18	O
)	O
have	O
identified	O
two	O
independent	O
hilE	S-Biological_Molecule
promoters	O
,	O
P1	O
and	O
P2	O
.	O

The	O
transcriptional	O
start	O
site	O
of	O
one	O
transcript	O
,	O
designated	O
P1	O
,	O
agreed	O
with	O
the	O
previous	O
report	O
,	O
although	O
the	O
promoter	O
activity	O
was	O
very	O
low	O
under	O
the	O
conditions	O
used	O
in	O
our	O
experiment	O
(	O
Figure	O
4A	O
)	O
.	O

However	O
,	O
the	O
activities	O
of	O
the	O
two	O
promoters	O
were	O
not	O
changed	O
by	O
mlc	S-Biological_Molecule
mutation	O
.	O

Mlc	S-Biological_Molecule
directly	O
represses	O
hilE	S-Biological_Molecule
by	O
binding	O
to	O
the	O
P3	O
promoter	O

The	O
addition	O
of	O
cold	O
probe	O
released	O
the	O
labeled	O
probe	O
from	O
the	O
retarded	O
complex	O
(	O
Figure	O
5A	O
,	O
right	O
panel	O
)	O
,	O
which	O
indicates	O
specific	O
binding	O
of	O
Mlc	S-Biological_Molecule
to	O
the	O
hilE	S-Biological_Molecule
P3	O
promoter	O
DNA	O
.	O

The	O
precise	O
locations	O
of	O
the	O
Mlc	S-Biological_Molecule
-	O
binding	O
sites	O
were	O
determined	O
by	O
DNase	O
I	O
footprinting	O
with	O
His	O
-	O
tagged	O
Mlc	S-Biological_Molecule
.	O

Two	O
Mlc	S-Biological_Molecule
-	O
binding	O
sites	O
,	O
one	O
at	O
position	O
-	O
10	O
to	O
+	O
12	O
(	O
Mlc	S-Biological_Molecule
1	O
)	O
and	O
the	O
other	O
at	O
position	O
-	O
86	O
to	O
-	O
108	O
(	O
Mlc	S-Biological_Molecule
2	O
)	O
with	O
respect	O
to	O
the	O
transcriptional	O
start	O
site	O
of	O
hilE	S-Biological_Molecule
P3	O
,	O
were	O
identified	O
(	O
Figure	O
5B	O
)	O
.	O

Inspection	O
of	O
the	O
DNA	O
sequences	O
at	O
these	O
sites	O
showed	O
high	O
-	O
level	O
homology	O
with	O
the	O
known	O
consensus	O
Mlc	S-Biological_Molecule
-	O
binding	O
sequence	O
,	O
which	O
has	O
the	O
conserved	O
TT	O
-	O
9bp	O
-	O
AA	O
motif	O
and	O
an	O
AT	O
-	O
rich	O
region	O
at	O
positions	O
+	O
/	O
-	O
7	O
to	O
+	O
/	O
-	O
11	O
,	O
showing	O
imperfect	O
dyad	O
symmetry	O
(	O
38	O
)	O
(	O
Figure	O
5C	O
)	O
.	O

These	O
results	O
clearly	O
demonstrate	O
that	O
Mlc	S-Biological_Molecule
can	O
regulate	O
directly	O
the	O
hilE	S-Biological_Molecule
P3	O
promoter	O
by	O
binding	O
to	O
the	O
promoter	O
.	O

Sugars	O
that	O
induce	O
the	O
Mlc	S-Biological_Molecule
regulon	O
repress	O
hilD	S-Biological_Molecule
expression	O
by	O
activating	O
hilE	S-Biological_Molecule

Sequestration	O
of	O
Mlc	S-Biological_Molecule
by	O
the	O
unphosphorylated	O
form	O
of	O
glucose	O
permease	O
,	O
enzyme	O
IICBGlc	S-Biological_Molecule
,	O
is	O
known	O
to	O
displace	O
Mlc	S-Biological_Molecule
from	O
its	O
DNA	O
-	O
binding	O
sites	O
,	O
thereby	O
allowing	O
transcription	O
of	O
its	O
target	O
genes	O
(	O
25	O
-	O
27	O
)	O
.	O

SL1344	S-Species
and	O
SR1304	S-Species
carrying	O
either	O
pMAB69	O
(	O
hilE	S-Biological_Molecule
-	O
lacZY	S-Biological_Molecule
)	O
or	O
pJB5	O
(	O
hilD	S-Biological_Molecule
-	O
lacZY	S-Biological_Molecule
)	O
were	O
cultivated	O
in	O
TB	O
that	O
was	O
buffered	O
to	O
pH	O
7	O
.	O
0	O
with	O
0	O
.	O
1M	O
MOPS	S-Chemical_Compound
,	O
to	O
minimize	O
pH	O
effects	O
arising	O
from	O
growth	O
in	O
the	O
presence	O
of	O
the	O
various	O
carbon	O
sources	O
.	O

Interestingly	O
,	O
arabinose	S-Chemical_Compound
also	O
activated	O
hilE	S-Biological_Molecule
,	O
albeit	O
to	O
a	O
lesser	O
degree	O
than	O
either	O
glucose	S-Chemical_Compound
or	O
mannose	S-Chemical_Compound
.	O

In	O
the	O
absence	O
of	O
sugars	O
,	O
the	O
mlc	S-Biological_Molecule
mutation	O
increased	O
hilE	S-Biological_Molecule
expression	O
1	O
.	O
5	O
-	O
fold	O
,	O
with	O
a	O
concomitant	O
reduction	O
in	O
hilD	S-Biological_Molecule
expression	O
.	O

The	O
genetic	O
evidence	O
to	O
date	O
is	O
consistent	O
with	O
a	O
regulatory	O
cascade	O
of	O
transcriptional	O
activation	O
,	O
in	O
which	O
HilD	S-Biological_Molecule
,	O
HilA	S-Biological_Molecule
and	O
InvF	S-Biological_Molecule
act	O
sequentially	O
to	O
activate	O
SPI1	O
expression	O
.	O

In	O
brief	O
,	O
HilD	S-Biological_Molecule
binds	O
directly	O
to	O
sites	O
upstream	O
of	O
hilA	S-Biological_Molecule
and	O
invFD	S-Biological_Molecule
and	O
acts	O
as	O
an	O
activator	O
(	O
14	O
,	O
16	O
,	O
36	O
)	O
.	O

The	O
2	O
-	O
3	O
-	O
fold	O
decrease	O
in	O
hilD	S-Biological_Molecule
expression	O
caused	O
by	O
the	O
mlc	S-Biological_Molecule
mutation	O
is	O
sufficient	O
to	O
account	O
for	O
the	O
nearly	O
10	O
-	O
fold	O
decrease	O
in	O
hilA	S-Biological_Molecule
and	O
invFA	S-Biological_Molecule
transcription	O
,	O
owing	O
to	O
the	O
nature	O
of	O
the	O
feed	O
-	O
forward	O
regulatory	O
loop	O
,	O
in	O
that	O
moderate	O
effects	O
on	O
HilD	S-Biological_Molecule
production	O
are	O
amplified	O
(	O
9	O
)	O
.	O

This	O
may	O
be	O
partly	O
due	O
to	O
the	O
expression	O
of	O
hilC	S-Biological_Molecule
,	O
a	O
de	O
-	O
repressor	O
of	O
hilA	S-Biological_Molecule
,	O
which	O
was	O
not	O
reduced	O
in	O
the	O
mlc	S-Biological_Molecule
mutant	O
(	O
Figure	O
2A	O
)	O
.	O

The	O
two	O
Mlc	S-Biological_Molecule
-	O
binding	O
sites	O
in	O
hilE	S-Biological_Molecule
P3	O
identified	O
by	O
the	O
gel	O
mobility	O
shift	O
assay	O
and	O
DNase	O
I	O
footprinting	O
analysis	O
show	O
high	O
-	O
level	O
homology	O
with	O
the	O
known	O
consensus	O
Mlc	S-Biological_Molecule
-	O
binding	O
sequences	O
;	O
additionally	O
,	O
the	O
two	O
Mlc	S-Biological_Molecule
-	O
binding	O
sites	O
are	O
separated	O
by	O
98nt	O
,	O
as	O
is	O
the	O
case	O
for	O
other	O
promoters	O
that	O
have	O
two	O
Mlc	S-Biological_Molecule
-	O
binding	O
sites	O
(	O
41	O
)	O
.	O

The	O
transcriptional	O
start	O
site	O
of	O
the	O
hilE	S-Biological_Molecule
P3	O
promoter	O
lies	O
335nt	O
upstream	O
of	O
the	O
ATG	O
start	O
codon	O
of	O
hilE	S-Biological_Molecule
(	O
Figures	O
4B	O
and	O
5C	O
)	O
.	O

It	O
is	O
unusual	O
that	O
the	O
5	O
'	O
-	O
untranslated	O
region	O
(	O
UTR	O
)	O
of	O
mRNA	O
is	O
more	O
than	O
300nt	O
in	O
bacteria	O
(	O
42	O
)	O
.	O

However	O
,	O
this	O
length	O
of	O
5	O
'	O
-	O
UTR	O
has	O
been	O
observed	O
in	O
other	O
SPI1	O
regulators	O
.	O

The	O
addition	O
of	O
excess	O
glucose	S-Chemical_Compound
to	O
the	O
culture	O
medium	O
results	O
in	O
the	O
reduction	O
of	O
cell	O
association	O
by	O
S	B-Species
.	E-Species

Typhimurium	S-Species
(	O
44	O
)	O
.	O

We	O
observed	O
a	O
2	O
-	O
fold	O
activation	O
of	O
hilE	S-Biological_Molecule
and	O
concomitant	O
repression	O
of	O
hilD	S-Biological_Molecule
in	O
the	O
presence	O
of	O
glucose	S-Chemical_Compound
or	O
mannose	S-Chemical_Compound
,	O
which	O
are	O
known	O
inducers	O
of	O
the	O
Mlc	S-Biological_Molecule
regulon	O
,	O
when	O
TB	O
was	O
used	O
(	O
Figure	O
6	O
)	O
.	O

In	O
addition	O
,	O
hilE	S-Biological_Molecule
expression	O
was	O
also	O
increased	O
in	O
the	O
presence	O
of	O
arabinose	S-Chemical_Compound
,	O
which	O
suggests	O
an	O
additional	O
regulatory	O
mechanism	O
mediated	O
by	O
arabinose	S-Chemical_Compound
.	O

Interestingly	O
,	O
carbohydrate	O
regulation	O
of	O
hilE	S-Biological_Molecule
and	O
hilD	S-Biological_Molecule
expression	O
in	O
the	O
mlc	S-Biological_Molecule
mutant	O
created	O
a	O
different	O
story	O
.	O

It	O
has	O
been	O
suggested	O
that	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
PhoR	S-Biological_Molecule
-	O
PhoB	S-Biological_Molecule
leads	O
to	O
increased	O
hilE	S-Biological_Molecule
P2	O
expression	O
and	O
subsequent	O
repression	O
of	O
hilA	S-Biological_Molecule
and	O
invasion	O
genes	O
(	O
7	O
,	O
18	O
)	O
.	O

The	O
PhoR	S-Biological_Molecule
sensor	O
kinase	O
phosphorylates	O
PhoB	S-Biological_Molecule
when	O
extracellular	O
Pi	S-Chemical_Compound
levels	O
are	O
low	O
,	O
and	O
the	O
phosphorylated	O
PhoB	S-Biological_Molecule
then	O
binds	O
and	O
activates	O
the	O
promoters	O
in	O
the	O
Pho	O
regulon	O
.	O

However	O
,	O
even	O
in	O
the	O
absence	O
of	O
PhoR	S-Biological_Molecule
,	O
many	O
carbon	O
sources	O
are	O
known	O
to	O
activate	O
the	O
Pho	O
regulon	O
via	O
CreC	S-Biological_Molecule
,	O
which	O
is	O
a	O
PhoR	S-Biological_Molecule
homolog	O
(	O
47	O
)	O
.	O

Thus	O
,	O
carbon	O
metabolism	O
sensed	O
by	O
PhoB	S-Biological_Molecule
/	O
R	S-Biological_Molecule
may	O
also	O
affect	O
hilE	S-Biological_Molecule
expression	O
(	O
22	O
)	O
,	O
and	O
this	O
may	O
be	O
one	O
of	O
the	O
reasons	O
for	O
the	O
elevated	O
hilE	S-Biological_Molecule
expression	O
in	O
the	O
presence	O
of	O
carbohydrates	O
in	O
the	O
mlc	S-Biological_Molecule
mutant	O
(	O
Figure	O
6A	O
)	O
.	O

Recently	O
,	O
Teplitski	O
et	O
al	O
.	O

It	O
is	O
known	O
that	O
S	B-Species
.	E-Species

We	O
propose	O
that	O
Salmonella	S-Species
can	O
use	O
the	O
glucose	S-Chemical_Compound
concentration	O
of	O
the	O
mammalian	O
intestinal	O
tract	O
as	O
one	O
of	O
many	O
signals	O
for	O
the	O
regulation	O
of	O
invasion	O
genes	O
.	O

SalK	S-Biological_Molecule
/	O
SalR	S-Biological_Molecule
,	O
a	O
Two	O
-	O
Component	O
Signal	O
Transduction	O
System	O
,	O
Is	O
Essential	O
for	O
Full	O
Virulence	O
of	O
Highly	O
Invasive	O
Streptococcus	B-Species
suis	I-Species
Serotype	I-Species
2	E-Species

Methodology	O
/	O
Principal	O
Findings	O
89K	O
is	O
a	O
newly	O
predicted	O
pathogenicity	O
island	O
(	O
PAI	O
)	O
which	O
is	O
specific	O
to	O
Chinese	O
epidemic	O
strains	O
isolated	O
from	O
these	O
two	O
SS2	S-Species
outbreaks	O
.	O

Functional	O
complementation	O
of	O
salKR	S-Biological_Molecule
into	O
the	O
isogenic	O
mutant	O
DeltasalKR	S-Biological_Molecule
restored	O
its	O
soaring	O
pathogenicity	O
.	O

Colonization	O
experiments	O
showed	O
that	O
the	O
DeltasalKR	S-Biological_Molecule
mutant	O
could	O
not	O
colonize	O
any	O
susceptible	O
tissue	O
of	O
piglets	S-Species
when	O
administered	O
alone	O
.	O

Bactericidal	O
assays	O
demonstrated	O
that	O
resistance	O
of	O
the	O
mutant	O
to	O
polymorphonuclear	O
leukocyte	O
(	O
PMN	O
)	O
-	O
mediated	O
killing	O
was	O
greatly	O
decreased	O
.	O

Expression	O
microarray	O
analysis	O
exhibited	O
a	O
transcription	O
profile	O
alteration	O
of	O
26	O
various	O
genes	O
down	O
-	O
regulated	O
in	O
the	O
DeltasalKR	S-Biological_Molecule
mutant	O
.	O

Conclusions	O
/	O
Significance	O
These	O
findings	O
suggest	O
that	O
SalK	S-Biological_Molecule
/	O
SalR	S-Biological_Molecule
is	O
requisite	O
for	O
the	O
full	O
virulence	O
of	O
ethnic	O
Chinese	O
isolates	O
of	O
highly	O
pathogenic	O
SS2	S-Species
,	O
thus	O
providing	O
experimental	O
evidence	O
for	O
the	O
validity	O
of	O
this	O
bioinformatically	O
predicted	O
PAI	O
.	O

A	O
key	O
feature	O
of	O
these	O
two	O
Chinese	O
outbreaks	O
is	O
the	O
prevalence	O
of	O
a	O
toxic	O
shock	O
-	O
like	O
syndrome	O
manifesting	O
itself	O
as	O
acute	O
high	O
fever	O
,	O
multiple	O
organ	O
failures	O
,	O
short	O
course	O
of	O
disease	O
and	O
high	O
lethality	O
[	O
5	O
]	O
.	O

Despite	O
the	O
growing	O
significance	O
of	O
such	O
infections	O
,	O
little	O
is	O
known	O
about	O
the	O
factors	O
that	O
govern	O
the	O
physiological	O
responses	O
of	O
this	O
emerging	O
organism	O
,	O
especially	O
the	O
genetic	O
repertoire	O
that	O
the	O
streptococcus	O
employs	O
to	O
cause	O
the	O
toxic	O
shock	O
-	O
like	O
syndrome	O
.	O

However	O
,	O
this	O
bioinformatically	O
predicted	O
candidate	O
PAI	O
needs	O
experimental	O
validation	O
and	O
its	O
linkage	O
to	O
SS2	S-Species
-	O
related	O
high	O
pathogenicity	O
remains	O
unknown	O
.	O

A	O
wide	O
range	O
of	O
molecular	O
machineries	O
such	O
as	O
quorum	O
sensing	O
,	O
TCSTS	O
,	O
and	O
ABC	O
transporters	O
,	O
are	O
often	O
involved	O
in	O
a	O
putative	O
PAI	O
,	O
whereby	O
the	O
PAI	O
responds	O
to	O
environmental	O
signals	O
and	O
fulfills	O
its	O
critical	O
functions	O
contributing	O
to	O
the	O
virulence	O
in	O
pathogens	O
[	O
8	O
]	O
-	O
[	O
10	O
]	O
.	O

Further	O
bioinformatics	O
analysis	O
of	O
the	O
89K	O
island	O
revealed	O
a	O
distinct	O
two	O
-	O
component	O
signal	O
transduction	O
system	O
(	O
TCSTS	O
)	O
encoded	O
therein	O
appears	O
to	O
be	O
orthologous	O
to	O
the	O
SalK	S-Biological_Molecule
/	O
SalR	S-Biological_Molecule
system	O
of	O
S	B-Species
.	I-Species
salivarius	E-Species
,	O
a	O
salivaricin	O
regulated	O
TCSTS	O
[	O
11	O
]	O
.	O

Up	O
until	O
now	O
,	O
only	O
one	O
orphan	O
response	O
regulator	O
,	O
RevS	S-Biological_Molecule
,	O
has	O
been	O
found	O
to	O
be	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
SS2	S-Species
[	O
24	O
]	O
.	O

Results	O

On	O
the	O
negative	O
strand	O
of	O
89K	O
,	O
peptides	O
encoded	O
by	O
05SSU0944	S-Biological_Molecule
and	O
05SSU0943	S-Biological_Molecule
exhibit	O
27	O
%	O
and	O
41	O
%	O
amino	O
acid	O
sequence	O
identity	O
with	O
the	O
SalK	S-Biological_Molecule
and	O
the	O
SalR	S-Biological_Molecule
proteins	O
of	O
Streptococcus	B-Species
salivarius	E-Species
,	O
respectively	O
,	O
forming	O
a	O
TCSTS	O
belonging	O
to	O
the	O
Nar	S-Biological_Molecule
/	O
LuxR	S-Biological_Molecule
family	O
.	O

Notably	O
,	O
the	O
average	O
GC	O
content	O
of	O
salKR	S-Biological_Molecule
,	O
29	O
.	O
9	O
%	O
,	O
is	O
much	O
less	O
than	O
that	O
of	O
both	O
89K	O
and	O
the	O
whole	O
genome	O
of	O
05ZYH33	S-Species
(	O
36	O
.	O
8	O
%	O
and	O
41	O
.	O
1	O
%	O
,	O
respectively	O
)	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

salK	S-Biological_Molecule
encodes	O
a	O
396	O
aa	O
long	O
protein	O
,	O
with	O
five	O
N	O
-	O
terminal	O
transmembrane	O
domains	O
and	O
a	O
transmitter	O
domain	O
signature	O
motif	O
in	O
the	O
C	O
-	O
terminal	O
-	O
typical	O
of	O
sensor	O
histidine	O
protein	O
kinases	O
of	O
TCSTSs	O
[	O
25	O
]	O
.	O

As	O
some	O
TCSTS	O
gene	O
pairs	O
are	O
adjacent	O
to	O
the	O
genes	O
that	O
they	O
control	O
,	O
the	O
genetic	O
structure	O
of	O
the	O
salKR	S-Biological_Molecule
locus	O
and	O
its	O
flanking	O
genes	O
was	O
defined	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

The	O
salK	S-Biological_Molecule
coding	O
region	O
overlaps	O
that	O
of	O
salR	S-Biological_Molecule
by	O
20	O
base	O
pairs	O
(	O
bp	O
)	O
,	O
and	O
no	O
putative	O
promoter	O
or	O
transcriptional	O
terminator	O
could	O
be	O
identified	O
within	O
either	O
gene	O
.	O

A	O
putative	O
promoter	O
located	O
approximately	O
50	O
bp	O
upstream	O
from	O
the	O
TTG	O
initiation	O
codon	O
of	O
salK	S-Biological_Molecule
,	O
was	O
predicted	O
using	O
the	O
online	O
server	O
of	O
Neutral	O
Network	O
Promoter	O
Prediction	O
.	O

Further	O
sequence	O
analysis	O
revealed	O
a	O
palindrome	O
of	O
55	O
bp	O
with	O
the	O
potential	O
to	O
form	O
a	O
stem	O
-	O
loop	O
structure	O
situated	O
in	O
the	O
intergenic	O
region	O
between	O
salR	S-Biological_Molecule
and	O
05SSU0942	S-Biological_Molecule
,	O
which	O
may	O
function	O
as	O
a	O
transcriptional	O
terminator	O
.	O

05SSU0945	S-Biological_Molecule
,	O
situated	O
upstream	O
(	O
729	O
bp	O
long	O
intergenic	O
region	O
)	O
of	O
the	O
salKR	S-Biological_Molecule
locus	O
,	O
encodes	O
a	O
94	O
aa	O
polypeptide	O
for	O
which	O
there	O
were	O
no	O
significant	O
database	O
matches	O
.	O

Transcriptional	O
Analysis	O
of	O
the	O
salKR	S-Biological_Molecule
Locus	O
and	O
its	O
Flanking	O
Sequences	O

2B	O
,	O
RT	O
-	O
PCR	O
products	O
were	O
obtained	O
with	O
five	O
pairs	O
of	O
the	O
primers	O
(	O
P3	O
/	O
P4	O
,	O
P5	O
/	O
P6	O
,	O
P7	O
/	O
P8	O
,	O
P9	O
/	O
P10	O
and	O
P13	O
/	O
P14	O
)	O
,	O
but	O
not	O
with	O
the	O
other	O
three	O
primer	O
pairs	O
(	O
P1	O
/	O
P2	O
,	O
P11	O
/	O
P12	O
and	O
P15	O
/	O
P16	O
)	O
.	O

Construction	O
of	O
DeltasalKR	S-Biological_Molecule

Positive	O
transformants	O
were	O
first	O
screened	O
on	O
THB	O
agar	O
plates	O
under	O
the	O
selective	O
pressure	O
of	O
spectinomycin	S-Chemical_Compound
.	O

To	O
check	O
this	O
suspected	O
mutant	O
,	O
Southern	O
hybridization	O
analyses	O
were	O
employed	O
using	O
probes	O
of	O
SpcR	S-Biological_Molecule
gene	O
,	O
an	O
internal	O
fragment	O
of	O
salKR	S-Biological_Molecule
,	O
and	O
pUC18	O
,	O
respectively	O
.	O

In	O
a	O
single	O
cross	O
-	O
over	O
mutant	O
which	O
was	O
set	O
as	O
the	O
reference	O
,	O
both	O
the	O
SpcR	S-Biological_Molecule
and	O
pUC18	O
probe	O
hybridized	O
with	O
a	O
6	O
.	O
1	O
kb	O
Cla	O
I	O
restriction	O
fragment	O
(	O
Fig	O
.	O
3B	O
and	O
3D	O
,	O
lane	O
3	O
)	O
,	O
and	O
the	O
salKR	S-Biological_Molecule
probe	O
hybridized	O
with	O
a	O
4	O
.	O
0	O
kb	O
fragment	O
(	O
Fig	O
.	O
3C	O
,	O
lane	O
3	O
)	O
,	O
indicating	O
that	O
this	O
strain	O
had	O
pUC	O
:	O
:	O
salKR	S-Biological_Molecule
integrated	O
into	O
its	O
chromosome	O
by	O
a	O
single	O
cross	O
-	O
over	O
event	O
at	O
the	O
3	O
'	O
-	O
flanking	O
region	O
of	O
the	O
salKR	S-Biological_Molecule
genes	O
(	O
Fig	O
.	O
3A	O
,	O
III	O
)	O
.	O

Additionally	O
,	O
the	O
allelic	O
replacement	O
of	O
the	O
wild	O
-	O
type	O
salKR	S-Biological_Molecule
genes	O
by	O
the	O
SpcR	S-Biological_Molecule
cassette	O
in	O
the	O
suspected	O
mutant	O
was	O
also	O
confirmed	O
by	O
multiple	O
-	O
PCR	O
analysis	O
and	O
sequencing	O
with	O
primers	O
specific	O
to	O
genomic	O
regions	O
lying	O
out	O
the	O
homologous	O
left	O
and	O
right	O
arms	O
(	O
Fig	O
.	O
3A	O
and	O
3E	O
)	O
.	O

Role	O
of	O
SalK	S-Biological_Molecule
/	O
SalR	S-Biological_Molecule
in	O
Virulence	O

The	O
spectinomycin	S-Chemical_Compound
resistance	O
phenotype	O
was	O
stable	O
in	O
DeltasalKR	S-Biological_Molecule
during	O
in	O
vitro	O
culture	O
(	O
data	O
not	O
shown	O
)	O
.	O

Finally	O
,	O
cell	O
morphology	O
and	O
ultrastructure	O
of	O
these	O
two	O
strains	O
were	O
examined	O
under	O
light	O
microscope	O
and	O
transmission	O
electron	O
microscope	O
respectively	O
,	O
however	O
,	O
no	O
significant	O
differences	O
were	O
found	O
(	O
Fig	O
.	O
4	O
)	O
.	O

An	O
experimental	O
infection	O
model	O
in	O
piglets	S-Species
was	O
designed	O
to	O
assess	O
the	O
role	O
of	O
SalK	S-Biological_Molecule
/	O
SalR	S-Biological_Molecule
in	O
virulence	O
.	O

As	O
shown	O
in	O
Figure	O
5	O
,	O
all	O
six	O
SPF	O
-	O
piglets	S-Species
inoculated	O
intravenously	O
with	O
WT	O
developed	O
most	O
of	O
the	O
typical	O
disease	O
symptoms	O
,	O
including	O
high	O
fever	O
,	O
limping	O
,	O
swollen	O
joints	O
,	O
shivering	O
,	O
CNS	O
failure	O
and	O
respiratory	O
failure	O
within	O
24	O
hrs	O
.	O

Wherein	O
the	O
six	O
piglets	S-Species
challenged	O
with	O
the	O
DeltasalKR	S-Biological_Molecule
mutant	O
were	O
all	O
alive	O
and	O
symptom	O
-	O
free	O
during	O
the	O
entire	O
course	O
monitored	O
.	O

The	O
experiments	O
of	O
functional	O
complementation	O
with	O
the	O
complemented	O
strain	O
CDeltasalKR	S-Biological_Molecule
showed	O
clearly	O
that	O
the	O
reintroduction	O
of	O
salKR	S-Biological_Molecule
into	O
DeltasalKR	S-Biological_Molecule
restored	O
its	O
high	O
pathogenicity	O
.	O

Five	O
out	O
of	O
six	O
piglets	S-Species
succumbed	O
to	O
the	O
lethal	O
infections	O
of	O
CDeltasalKR	S-Biological_Molecule
and	O
died	O
,	O
with	O
median	O
survival	O
times	O
of	O
2	O
to	O
3	O
days	O
.	O

The	O
last	O
one	O
recovered	O
from	O
serious	O
clinical	O
symptoms	O
and	O
survived	O
at	O
the	O
experiments	O
end	O
.	O

To	O
better	O
evaluate	O
the	O
virulence	O
attenuation	O
of	O
DeltasalKR	S-Biological_Molecule
,	O
colonization	O
experiments	O
were	O
carried	O
out	O
.	O

As	O
shown	O
in	O
Table	O
1	O
,	O
wild	O
-	O
type	O
bacteria	O
were	O
found	O
in	O
all	O
of	O
the	O
SS2	S-Species
specific	O
tissues	O
of	O
WT	O
-	O
infected	O
piglets	S-Species
,	O
including	O
heart	O
,	O
lung	O
,	O
liver	O
,	O
kidney	O
,	O
spleen	O
,	O
tonsil	O
,	O
brain	O
,	O
blood	O
,	O
joints	O
and	O
so	O
on	O
.	O

In	O
contrast	O
,	O
in	O
the	O
mutant	O
-	O
inoculated	O
group	O
,	O
no	O
mutant	O
bacteria	O
could	O
be	O
recovered	O
from	O
any	O
of	O
the	O
examined	O
tissue	O
specimens	O
.	O

We	O
anticipated	O
that	O
the	O
DeltasalKR	S-Biological_Molecule
mutant	O
is	O
still	O
able	O
to	O
colonize	O
these	O
organs	O
,	O
is	O
just	O
due	O
to	O
the	O
WT	O
-	O
mediated	O
impairment	O
of	O
host	O
defense	O
against	O
SS2	S-Species
infection	O
in	O
these	O
tissues	O
.	O

Decreased	O
Resistance	O
of	O
DeltasalKR	S-Biological_Molecule
to	O
PMN	O
-	O
Mediated	O
Killing	O

Together	O
with	O
the	O
wild	O
type	O
strain	O
,	O
DeltasalKR	S-Biological_Molecule
was	O
subjected	O
to	O
PMN	O
-	O
mediated	O
killing	O
assays	O
.	O

However	O
,	O
DeltasalKR	S-Biological_Molecule
had	O
a	O
higher	O
mortality	O
rate	O
than	O
that	O
of	O
WT	O
,	O
which	O
means	O
that	O
DeltasalKR	S-Biological_Molecule
was	O
less	O
able	O
to	O
resist	O
killing	O
by	O
PMNs	O
,	O
key	O
mediators	O
of	O
innate	O
immunity	O
.	O

To	O
gain	O
further	O
insights	O
into	O
the	O
network	O
/	O
circuit	O
mediated	O
by	O
SalK	S-Biological_Molecule
/	O
SalR	S-Biological_Molecule
,	O
whole	O
-	O
genome	O
DNA	O
microarray	O
was	O
applied	O
to	O
reveal	O
the	O
differential	O
transcription	O
profiles	O
between	O
DeltasalKR	S-Biological_Molecule
and	O
WT	O
[	O
13	O
]	O
,	O
[	O
19	O
]	O
.	O

In	O
total	O
,	O
the	O
absence	O
of	O
SalK	S-Biological_Molecule
/	O
SalR	S-Biological_Molecule
led	O
to	O
decreased	O
expression	O
of	O
26	O
genes	O
spread	O
throughout	O
the	O
genome	O
(	O
i	O
.	O
e	O
.	O
1	O
.	O
2	O
%	O
of	O
the	O
2194	O
tested	O
)	O
.	O

Furthermore	O
,	O
orotidine	B-Chemical_Compound
-	I-Chemical_Compound
5	I-Chemical_Compound
-	I-Chemical_Compound
phosphate	E-Chemical_Compound
decarboxylase	O
(	O
05SSU1009	S-Biological_Molecule
)	O
,	O
a	O
newly	O
identified	O
pathogenesis	O
-	O
related	O
protein	O
in	O
Vibrio	B-Species
vulnificus	E-Species
[	O
31	O
]	O
,	O
was	O
also	O
found	O
to	O
be	O
repressed	O
greatly	O
in	O
DeltasalKR	S-Biological_Molecule
.	O

Daigle	O
et	O
al	O
.	O

Genes	O
revolved	O
in	O
recombination	O
/	O
repair	O
and	O
transcription	O

Although	O
these	O
genes	O
were	O
found	O
to	O
be	O
down	O
-	O
regulated	O
in	O
the	O
mutant	O
,	O
it	O
is	O
not	O
understood	O
how	O
they	O
are	O
associated	O
with	O
the	O
attenuation	O
of	O
DeltasalKR	S-Biological_Molecule
.	O

Genes	O
encoding	O
proteins	O
of	O
unknown	O
function	O

Several	O
membrane	O
proteins	O
such	O
as	O
05SSU0677	S-Biological_Molecule
and	O
05SSU1912	S-Biological_Molecule
were	O
also	O
repressed	O
in	O
DeltasalKR	S-Biological_Molecule
.	O

It	O
is	O
well	O
documented	O
that	O
surface	O
proteins	O
or	O
cell	O
wall	O
-	O
anchored	O
proteins	O
are	O
usually	O
thought	O
to	O
contribute	O
to	O
the	O
immunogenicity	O
[	O
33	O
]	O
,	O
[	O
34	O
]	O
,	O
invasiveness	O
[	O
35	O
]	O
-	O
[	O
37	O
]	O
,	O
and	O
even	O
pathogenesis	O
[	O
38	O
]	O
,	O
[	O
39	O
]	O
of	O
pathogens	O
.	O

Moreover	O
,	O
it	O
should	O
be	O
noted	O
that	O
numerous	O
proteins	O
of	O
unknown	O
function	O
are	O
also	O
depressed	O
in	O
DeltasalKR	S-Biological_Molecule
,	O
which	O
may	O
in	O
part	O
lead	O
to	O
the	O
virulence	O
loss	O
of	O
the	O
mutant	O
via	O
some	O
thus	O
-	O
far	O
-	O
unknown	O
mechanisms	O
.	O

As	O
shown	O
in	O
Table	O
S1	O
,	O
the	O
quantitative	O
results	O
of	O
RT	O
-	O
PCR	O
were	O
highly	O
compatible	O
to	O
the	O
microarray	O
data	O
,	O
in	O
the	O
DeltasalKR	S-Biological_Molecule
mutant	O
,	O
41	O
out	O
of	O
42	O
selected	O
genes	O
(	O
97	O
.	O
6	O
%	O
)	O
were	O
confirmed	O
to	O
have	O
similar	O
transcript	O
levels	O
using	O
these	O
two	O
different	O
techniques	O
,	O
thus	O
independently	O
confirming	O
the	O
microarray	O
results	O
.	O

Discussion	O

Very	O
recently	O
,	O
Chen	O
et	O
al	O
.	O

[	O
6	O
]	O
reported	O
a	O
candidate	O
PAI	O
of	O
approximately89	O
kb	O
in	O
the	O
epidemic	O
outbreak	O
strains	O
of	O
SS2	S-Species
infections	O
in	O
China	O
,	O
gave	O
some	O
genomic	O
clues	O
for	O
elucidating	O
molecular	O
pathways	O
by	O
which	O
SS2	S-Species
behaved	O
so	O
aggressively	O
.	O

In	O
this	O
study	O
,	O
we	O
carried	O
out	O
a	O
detailed	O
structural	O
and	O
functional	O
analysis	O
of	O
a	O
unique	O
two	O
-	O
component	O
regulatory	O
system	O
designated	O
SalK	S-Biological_Molecule
/	O
SalR	S-Biological_Molecule
which	O
is	O
located	O
in	O
the	O
putative	O
89K	O
PAI	O
.	O

It	O
has	O
been	O
well	O
documented	O
that	O
horizontal	O
gene	O
transfer	O
events	O
occur	O
frequently	O
in	O
pathogens	O
[	O
45	O
]	O
-	O
[	O
47	O
]	O
,	O
and	O
some	O
of	O
them	O
have	O
been	O
implicated	O
in	O
high	O
pathogenicity	O
[	O
48	O
]	O
and	O
even	O
in	O
the	O
causation	O
of	O
severe	O
diseases	O
[	O
49	O
]	O
.	O

Suilysin	S-Chemical_Compound
,	O
a	O
known	O
virulence	O
factor	O
,	O
was	O
believed	O
to	O
be	O
introduced	O
into	O
SS2	S-Species
via	O
lateral	O
gene	O
transfer	O
[	O
43	O
]	O
.	O

Moreover	O
,	O
PCR	O
analysis	O
using	O
primers	O
amplifying	O
the	O
salKR	S-Biological_Molecule
locus	O
also	O
demonstrated	O
that	O
this	O
TCSTS	O
is	O
specific	O
to	O
Chinese	O
epidemic	O
outbreak	O
strains	O
of	O
SS2	S-Species
(	O
data	O
not	O
shown	O
)	O
,	O
implying	O
its	O
tight	O
linkage	O
to	O
the	O
virulence	O
of	O
this	O
new	O
emerging	O
pathogenic	O
species	O
.	O

Colonization	O
analysis	O
also	O
revealed	O
the	O
incapability	O
of	O
the	O
DeltasalKR	S-Biological_Molecule
mutant	O
to	O
colonize	O
any	O
susceptible	O
tissue	O
of	O
piglets	S-Species
when	O
administered	O
alone	O
.	O

These	O
results	O
indicate	O
definitely	O
that	O
SalK	S-Biological_Molecule
/	O
SalR	S-Biological_Molecule
plays	O
a	O
critical	O
role	O
in	O
the	O
pathogenicity	O
of	O
SS2	S-Species
.	O

We	O
consider	O
that	O
the	O
partial	O
complementation	O
observed	O
in	O
the	O
piglets	S-Species
infection	O
model	O
is	O
inherent	O
to	O
the	O
pleiotropic	O
role	O
of	O
this	O
regulatory	O
system	O
which	O
makes	O
it	O
difficult	O
to	O
restore	O
the	O
fine	O
tuning	O
of	O
gene	O
expression	O
as	O
in	O
the	O
wild	O
-	O
type	O
strain	O
.	O

Results	O
of	O
real	O
-	O
time	O
quantitative	O
RT	O
-	O
PCR	O
also	O
confirmed	O
that	O
,	O
in	O
the	O
complemented	O
strain	O
CDeltasalKR	S-Biological_Molecule
,	O
only	O
partial	O
genes	O
identified	O
as	O
down	O
-	O
regulated	O
in	O
the	O
mutant	O
rebounded	O
to	O
comparative	O
transcript	O
levels	O
of	O
the	O
wild	O
-	O
type	O
strain	O
.	O

Those	O
unrecovered	O
genes	O
were	O
probably	O
irrelavent	O
to	O
the	O
bacterial	O
virulence	O
of	O
SS2	S-Species
.	O

However	O
,	O
genes	O
immediately	O
flanking	O
the	O
salKR	S-Biological_Molecule
locus	O
were	O
identified	O
as	O
transcriptionally	O
unaffected	O
by	O
the	O
disruption	O
of	O
the	O
salKR	S-Biological_Molecule
genes	O
.	O

For	O
those	O
members	O
belonging	O
to	O
putative	O
transcriptional	O
operons	O
,	O
microarray	O
results	O
showed	O
that	O
most	O
of	O
those	O
genes	O
cotranscribed	O
with	O
them	O
were	O
also	O
down	O
-	O
regulated	O
to	O
a	O
various	O
degree	O
,	O
although	O
under	O
the	O
threshold	O
of	O
2	O
.	O

Further	O
investigation	O
of	O
other	O
transcriptional	O
alterations	O
observed	O
in	O
the	O
microarray	O
data	O
will	O
be	O
required	O
for	O
a	O
better	O
understanding	O
of	O
pathogenesis	O
of	O
this	O
highly	O
pathogenic	O
pathogen	O
.	O

First	O
,	O
some	O
pathogenic	O
determinants	O
are	O
environmentally	O
regulated	O
and	O
induced	O
at	O
specific	O
stages	O
of	O
the	O
infection	O
process	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
.	O

Secondly	O
,	O
some	O
of	O
the	O
TCSTSs	O
of	O
S	B-Species
.	I-Species
pneumoniae	E-Species
were	O
suggested	O
to	O
be	O
involved	O
in	O
key	O
processes	O
of	O
pathogenesis	O
,	O
such	O
as	O
autolysis	O
and	O
cell	O
-	O
cell	O
signaling	O
[	O
52	O
]	O
,	O
SalK	S-Biological_Molecule
/	O
SalR	S-Biological_Molecule
might	O
regulate	O
similar	O
processes	O
in	O
Chinese	O
SS2	S-Species
virulent	O
isolates	O
.	O

S	B-Species
.	I-Species
enterica	I-Species
serovar	I-Species
Typhimurium	I-Species
mutants	E-Species
lacking	O
the	O
ssrAB	S-Biological_Molecule
genes	O
are	O
avirulent	O
in	O
mice	S-Species
,	O
highlighting	O
the	O
importance	O
of	O
this	O
regulatory	O
system	O
in	O
vivo	O
.	O

Results	O
In	O
this	O
study	O
we	O
demonstrate	O
that	O
RpoE	S-Biological_Molecule
is	O
involved	O
in	O
fine	O
-	O
tuning	O
the	O
expression	O
of	O
a	O
subset	O
of	O
SsrB	S-Biological_Molecule
-	O
regulated	O
genes	O
found	O
in	O
the	O
Salmonella	S-Species
pathogenicity	O
island	O
-	O
2	O
(	O
SPI	O
-	O
2	O
)	O
genetic	O
locus	O
that	O
encodes	O
a	O
horizontally	O
acquired	O
type	O
III	O
secretion	O
system	O
,	O
and	O
unlinked	O
genes	O
integrated	O
into	O
this	O
regulon	O
that	O
are	O
required	O
for	O
virulence	O
in	O
host	O
animals	O
.	O

Background	O

Salmonella	B-Species
enterica	E-Species
are	O
enteric	O
pathogens	O
that	O
acquired	O
a	O
type	O
III	O
secretion	O
system	O
(	O
T3SS	O
)	O
through	O
horizontal	O
gene	O
transfer	O
of	O
a	O
genomic	O
island	O
termed	O
Salmonella	O
Pathogenicity	O
Island	O
2	O
(	O
SPI	O
-	O
2	O
)	O
[	O
1	O
,	O
2	O
]	O
.	O

SPI	O
-	O
2	O
also	O
has	O
genes	O
,	O
ssrA	S-Biological_Molecule
and	O
ssrB	S-Biological_Molecule
,	O
which	O
code	O
for	O
SsrAB	S-Biological_Molecule
,	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
needed	O
for	O
expression	O
of	O
the	O
T3SS	O
[	O
6	O
,	O
7	O
]	O
.	O

SsrB	S-Biological_Molecule
regulates	O
the	O
expression	O
of	O
SPI	O
-	O
2	O
encoded	O
substrate	O
effectors	O
including	O
ssaB	S-Biological_Molecule
,	O
as	O
well	O
as	O
several	O
integrated	O
virulence	O
effectors	O
such	O
as	O
sseL	S-Biological_Molecule
[	O
8	O
]	O
and	O
srfN	S-Biological_Molecule
[	O
9	O
]	O
that	O
are	O
encoded	O
elsewhere	O
on	O
the	O
chromosome	O
but	O
that	O
have	O
integrated	O
into	O
the	O
SsrB	S-Biological_Molecule
regulon	O
.	O

Mutants	O
lacking	O
ssrAB	S-Biological_Molecule
are	O
unable	O
to	O
survive	O
within	O
macrophages	O
and	O
are	O
avirulent	O
in	O
mice	S-Species
[	O
1	O
]	O
.	O

Alternative	O
sigma	O
factors	O
coordinate	O
gene	O
expression	O
in	O
response	O
to	O
environmental	O
cues	O
sensed	O
by	O
the	O
bacterium	O
.	O

Sigma	O
factors	O
have	O
a	O
specific	O
recognition	O
motif	O
at	O
the	O
-	O
35	O
and	O
-	O
10	O
positions	O
and	O
function	O
to	O
concentrate	O
RNA	O
polymerase	O
at	O
a	O
subset	O
of	O
promoters	O
[	O
10	O
]	O
.	O

SsrB	S-Biological_Molecule
-	O
regulated	O
translocated	O
effectors	O
protect	O
S	B-Species
.	E-Species

Typhimurium	S-Species
against	O
host	O
cell	O
defences	O
such	O
as	O
oxidative	O
stress	O
and	O
antimicrobial	O
peptides	O
that	O
perturb	O
bacterial	O
membrane	O
integrity	O
and	O
provide	O
a	O
stimulus	O
for	O
sigmaE	S-Biological_Molecule
release	O
[	O
4	O
,	O
12	O
-	O
15	O
]	O
.	O

Although	O
proficient	O
at	O
cellular	O
invasion	O
,	O
rpoE	S-Species
or	O
ssrB	S-Biological_Molecule
mutants	O
are	O
highly	O
attenuated	O
for	O
intracellular	O
survival	O
in	O
both	O
cultured	O
cells	O
and	O
animal	O
hosts	O
[	O
16	O
]	O
.	O

Deletion	O
of	O
rseA	S-Biological_Molecule
in	O
Yersinia	B-Species
pseudotuberculosis	E-Species
causes	O
elevated	O
virulence	O
effector	O
synthesis	O
and	O
secretion	O
[	O
18	O
]	O
,	O
establishing	O
links	O
between	O
alternative	O
sigma	O
factors	O
and	O
virulence	O
-	O
specific	O
regulators	O
.	O

Taken	O
together	O
,	O
a	O
connection	O
between	O
sigmaE	O
and	O
SsrB	S-Biological_Molecule
is	O
suggested	O
from	O
the	O
available	O
literature	O
,	O
however	O
the	O
role	O
of	O
sigmaE	O
in	O
activating	O
SsrB	S-Biological_Molecule
-	O
regulated	O
genes	O
has	O
not	O
been	O
studied	O
.	O

By	O
testing	O
six	O
promoters	O
representing	O
four	O
classes	O
of	O
SsrB	S-Biological_Molecule
-	O
regulated	O
promoters	O
(	O
(	O
i	O
)	O
two	O
type	O
III	O
secretion	O
structural	O
operons	O
in	O
SPI	O
-	O
2	O
,	O
(	O
ii	O
)	O
the	O
effector	O
operon	O
in	O
SPI	O
-	O
2	O
,	O
(	O
iii	O
)	O
two	O
effector	O
genes	O
unlinked	O
with	O
SPI	O
-	O
2	O
,	O
and	O
(	O
iv	O
)	O
an	O
integrated	O
virulence	O
gene	O
unlinked	O
with	O
SPI	O
-	O
2	O
)	O
we	O
demonstrate	O
that	O
RpoE	S-Biological_Molecule
elicits	O
an	O
effect	O
on	O
a	O
subset	O
of	O
SsrB	S-Biological_Molecule
-	O
regulated	O
genes	O
.	O

This	O
effect	O
was	O
bidirectional	O
depending	O
on	O
the	O
promoter	O
and	O
was	O
downstream	O
of	O
ssrB	S-Biological_Molecule
expression	O
itself	O
,	O
since	O
deletion	O
of	O
rpoE	S-Biological_Molecule
had	O
no	O
effect	O
on	O
SsrB	S-Biological_Molecule
levels	O
in	O
the	O
mutant	O
cells	O
.	O

Results	O

To	O
date	O
,	O
no	O
sigma	O
factor	O
has	O
been	O
identified	O
as	O
regulating	O
SsrB	S-Biological_Molecule
-	O
dependent	O
virulence	O
genes	O
.	O

To	O
start	O
,	O
we	O
first	O
screened	O
four	O
alternative	O
sigma	O
factor	O
mutants	O
of	O
S	B-Species
.	E-Species

For	O
an	O
rpoH	S-Biological_Molecule
deletion	O
,	O
this	O
strain	O
was	O
only	O
viable	O
at	O
temperatures	O
below	O
30degreesC	O
.	O

Since	O
SPI	O
-	O
2	O
gene	O
activation	O
is	O
integrated	O
into	O
a	O
thermosensing	O
circuit	O
[	O
19	O
]	O
we	O
were	O
unable	O
to	O
test	O
the	O
role	O
of	O
sigmaH	S-Biological_Molecule
in	O
this	O
study	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
this	O
screen	O
,	O
rpoS	S-Biological_Molecule
deletion	O
resulted	O
in	O
a	O
slight	O
increase	O
in	O
SseB	S-Biological_Molecule
levels	O
(	O
Figure	O
1A	O
)	O
indicating	O
a	O
role	O
for	O
RpoS	S-Biological_Molecule
in	O
the	O
repression	O
of	O
SPI	O
-	O
2	O
.	O

Both	O
rpoE	S-Biological_Molecule
and	O
rpoN	S-Biological_Molecule
deletions	O
resulted	O
in	O
decreased	O
SseB	S-Biological_Molecule
levels	O
with	O
a	O
more	O
pronounced	O
effect	O
in	O
the	O
rpoE	S-Biological_Molecule
deletion	O
.	O

An	O
unmarked	O
in	O
-	O
frame	O
deletion	O
of	O
rpoE	S-Biological_Molecule
was	O
then	O
generated	O
in	O
S	B-Species
.	E-Species

Typhimurium	B-Species
strain	I-Species
SL1344	E-Species
and	O
we	O
verified	O
that	O
this	O
in	O
-	O
frame	O
deletion	O
had	O
the	O
same	O
effect	O
on	O
SseB	S-Biological_Molecule
as	O
the	O
rpoE	S-Biological_Molecule
:	O
:	O
cat	S-Biological_Molecule
mutant	O
used	O
previously	O
(	O
Figure	O
1B	O
)	O
.	O

To	O
do	O
this	O
we	O
examined	O
the	O
levels	O
of	O
SseL	B-Biological_Molecule
-	I-Biological_Molecule
2HA	E-Biological_Molecule
,	O
SifA	B-Biological_Molecule
-	I-Biological_Molecule
2HA	E-Biological_Molecule
and	O
SrfN	B-Biological_Molecule
-	I-Biological_Molecule
2HA	E-Biological_Molecule
expressed	O
from	O
their	O
endogenous	O
promoters	O
under	O
SPI	O
-	O
2	O
inducing	O
conditions	O
(	O
Figure	O
1C	O
)	O
.	O

Consistent	O
with	O
the	O
results	O
for	O
SseB	S-Biological_Molecule
,	O
there	O
was	O
a	O
decrease	O
in	O
SifA	B-Biological_Molecule
-	I-Biological_Molecule
2HA	E-Biological_Molecule
levels	O
in	O
DeltarpoE	S-Biological_Molecule
compared	O
to	O
wild	O
type	O
,	O
although	O
deletion	O
of	O
rpoE	S-Biological_Molecule
did	O
not	O
have	O
an	O
effect	O
on	O
SseL	B-Biological_Molecule
-	I-Biological_Molecule
2HA	E-Biological_Molecule
.	O

Relative	O
to	O
its	O
expression	O
in	O
wild	O
type	O
cells	O
,	O
the	O
level	O
of	O
SrfN	B-Biological_Molecule
-	I-Biological_Molecule
2HA	E-Biological_Molecule
was	O
reproducibly	O
increased	O
in	O
the	O
DeltarpoE	S-Biological_Molecule
cells	O
,	O
suggesting	O
a	O
role	O
for	O
sigmaE	O
in	O
the	O
repression	O
of	O
SrfN	S-Biological_Molecule
,	O
although	O
it	O
is	O
unlikely	O
that	O
this	O
is	O
through	O
a	O
direct	O
mechanism	O
.	O

RpoE	S-Biological_Molecule
is	O
involved	O
in	O
transcriptional	O
activity	O
of	O
a	O
subset	O
of	O
virulence	O
genes	O

In	O
order	O
to	O
confirm	O
the	O
effect	O
of	O
sigmaE	S-Biological_Molecule
on	O
the	O
expression	O
of	O
a	O
broad	O
range	O
of	O
SsrB	S-Biological_Molecule
-	O
regulated	O
virulence	O
genes	O
,	O
we	O
used	O
wild	O
type	O
and	O
DeltarpoE	S-Biological_Molecule
cells	O
and	O
integrated	O
into	O
the	O
chromosome	O
individually	O
six	O
single	O
-	O
copy	O
transcriptional	O
fusions	O
representing	O
promoters	O
for	O
four	O
classes	O
of	O
SsrB	S-Biological_Molecule
-	O
dependent	O
genes	O
or	O
operons	O
(	O
(	O
i	O
)	O
type	O
III	O
secretion	O
effector	O
operon	O
(	O
sseA	S-Biological_Molecule
)	O
;	O
(	O
ii	O
)	O
structural	O
operon	O
I	O
(	O
ssaB	S-Biological_Molecule
)	O
;	O
(	O
iii	O
)	O
structural	O
operon	O
II	O
(	O
ssaG	S-Biological_Molecule
)	O
;	O
(	O
iv	O
and	O
v	O
)	O
effectors	O
encoded	O
outside	O
of	O
SPI	O
-	O
2	O
(	O
sseL	S-Biological_Molecule
and	O
sifA	S-Biological_Molecule
)	O
;	O
and	O
(	O
vi	O
)	O
integrated	O
virulence	O
genes	O
unlinked	O
to	O
SPI	O
-	O
2	O
(	O
srfN	S-Biological_Molecule
)	O
[	O
9	O
]	O
.	O

The	O
activity	O
of	O
each	O
promoter	O
was	O
measured	O
using	O
a	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
galactosidase	E-Biological_Molecule
assay	O
during	O
exponential	O
growth	O
.	O

Although	O
DeltarpoE	S-Biological_Molecule
was	O
observed	O
to	O
have	O
a	O
slightly	O
prolonged	O
lag	O
phase	O
relative	O
to	O
wild	O
type	O
cells	O
under	O
these	O
experimental	O
conditions	O
,	O
at	O
later	O
time	O
points	O
the	O
mutant	O
grew	O
similarly	O
to	O
wild	O
type	O
.	O

In	O
wild	O
type	O
cells	O
,	O
promoter	O
activity	O
from	O
all	O
the	O
transcriptional	O
fusions	O
was	O
high	O
,	O
as	O
expected	O
,	O
because	O
LPM	O
medium	O
is	O
highly	O
inducing	O
for	O
SsrB	S-Biological_Molecule
activity	O
[	O
21	O
]	O
.	O

Together	O
,	O
these	O
data	O
indicate	O
that	O
sigmaE	S-Biological_Molecule
can	O
have	O
a	O
variable	O
and	O
bidirectional	O
effect	O
on	O
SsrB	S-Biological_Molecule
-	O
regulated	O
virulence	O
genes	O
.	O

The	O
effect	O
of	O
RpoE	S-Biological_Molecule
on	O
virulence	O
genes	O
is	O
downstream	O
of	O
ssrB	S-Biological_Molecule
expression	O

The	O
variable	O
effects	O
of	O
rpoE	S-Biological_Molecule
deletion	O
on	O
SsrB	S-Biological_Molecule
-	O
regulated	O
effectors	O
suggested	O
that	O
RpoE	S-Biological_Molecule
might	O
direct	O
transcription	O
downstream	O
of	O
ssrB	S-Biological_Molecule
expression	O
.	O

To	O
test	O
this	O
,	O
we	O
replaced	O
the	O
ssrB	S-Biological_Molecule
gene	O
in	O
DeltarpoE	S-Biological_Molecule
and	O
wild	O
type	O
cells	O
with	O
an	O
ssrB	S-Biological_Molecule
:	O
:	O
FLAG	O
allele	O
[	O
19	O
]	O
and	O
examined	O
the	O
levels	O
of	O
SsrB	S-Biological_Molecule
protein	O
in	O
the	O
strains	O
by	O
western	O
blot	O
.	O

Together	O
these	O
data	O
establish	O
a	O
role	O
for	O
RpoE	S-Biological_Molecule
in	O
the	O
fine	O
-	O
tuning	O
of	O
virulence	O
gene	O
expression	O
in	O
S	B-Species
.	E-Species

Typhimurium	S-Species
.	O

Instead	O
they	O
appeared	O
to	O
have	O
consensus	O
sites	O
for	O
sigma70	S-Biological_Molecule
.	O

Due	O
to	O
the	O
high	O
degree	O
of	O
conservation	O
in	O
sigma	O
factor	O
binding	O
sequences	O
,	O
sigmaE	O
may	O
not	O
be	O
directly	O
regulating	O
SsrB	S-Biological_Molecule
-	O
dependent	O
promoters	O
.	O

The	O
lack	O
of	O
a	O
canonical	O
sigmaE	O
sequence	O
at	O
these	O
promoters	O
suggests	O
that	O
another	O
regulatory	O
gene	O
may	O
be	O
epistatic	O
to	O
sigmaE	O
or	O
that	O
these	O
promoters	O
encode	O
functional	O
,	O
but	O
non	O
-	O
canonical	O
sigmaE	O
-	O
binding	O
sites	O
due	O
to	O
their	O
horizontal	O
acquisition	O
and	O
gradual	O
integration	O
into	O
the	O
sigmaE	O
regulatory	O
network	O
.	O

This	O
integration	O
may	O
help	O
Salmonella	S-Species
coordinate	O
expression	O
of	O
the	O
virulence	O
-	O
associated	O
T3SS	O
in	O
response	O
to	O
host	O
factors	O
that	O
compromise	O
bacterial	O
membrane	O
integrity	O
(	O
Figure	O
4	O
)	O
.	O

This	O
mechanism	O
would	O
activate	O
a	O
restorative	O
sigmaE	O
pathway	O
,	O
which	O
is	O
consistent	O
with	O
the	O
enhanced	O
susceptibility	O
of	O
rpoE	S-Biological_Molecule
mutants	O
to	O
oxidative	O
stress	O
and	O
antimicrobial	O
peptides	O
[	O
13	O
,	O
15	O
,	O
16	O
]	O
,	O
both	O
of	O
which	O
perturb	O
membrane	O
integrity	O
in	O
vivo	O
.	O

Although	O
there	O
is	O
no	O
evidence	O
that	O
sigmaE	O
can	O
directly	O
repress	O
transcription	O
,	O
the	O
negative	O
effect	O
on	O
two	O
promoters	O
observed	O
here	O
might	O
be	O
due	O
to	O
an	O
intermediate	O
RpoE	S-Biological_Molecule
-	O
regulated	O
repressor	O
or	O
compensatory	O
effect	O
where	O
loss	O
of	O
rpoE	S-Biological_Molecule
increases	O
the	O
relative	O
abundance	O
of	O
another	O
sigma	O
factor	O
that	O
can	O
directly	O
activate	O
the	O
ssaG	S-Biological_Molecule
and	O
srfN	S-Biological_Molecule
promoters	O
.	O

Unlinking	O
ssrAB	S-Biological_Molecule
transcription	O
from	O
the	O
sigmaE	O
regulon	O
would	O
be	O
advantageous	O
to	O
the	O
cell	O
to	O
prevent	O
commitment	O
to	O
a	O
virulence	O
gene	O
expression	O
program	O
in	O
response	O
to	O
envelope	O
stress	O
not	O
associated	O
with	O
infection	O
.	O

Conclusion	O

Pseudomonas	B-Species
aeruginosa	E-Species
is	O
an	O
opportunistic	O
human	S-Species
pathogen	O
that	O
causes	O
infections	O
in	O
a	O
variety	O
of	O
animal	O
and	O
plant	O
hosts	O
.	O

Caenorhabditis	B-Species
elegans	E-Species
is	O
a	O
simple	O
model	O
with	O
which	O
one	O
can	O
identify	O
bacterial	O
virulence	O
genes	O
.	O

The	O
selected	O
mutants	O
had	O
insertions	O
in	O
regulatory	O
genes	O
,	O
such	O
as	O
a	O
histidine	O
kinase	O
sensor	O
of	O
two	O
-	O
component	O
systems	O
and	O
a	O
member	O
of	O
the	O
AraC	S-Biological_Molecule
family	O
,	O
or	O
in	O
genes	O
involved	O
in	O
adherence	O
or	O
chemotaxis	O
.	O

The	O
cheB2	S-Biological_Molecule
mutant	O
was	O
tested	O
in	O
a	O
murine	S-Species
lung	O
infection	O
model	O
and	O
found	O
to	O
have	O
a	O
highly	O
attenuated	O
virulence	O
.	O

In	O
P	B-Species
.	I-Species
aeruginosa	E-Species
,	O
the	O
main	O
player	O
in	O
chemotaxis	O
and	O
mobility	O
is	O
the	O
chemotactic	O
gene	O
cluster	O
I	O
,	O
including	O
cheB1	S-Biological_Molecule
.	O

We	O
conclude	O
that	O
the	O
virulence	O
defect	O
of	O
the	O
cheB2	S-Biological_Molecule
mutant	O
is	O
not	O
linked	O
with	O
a	O
global	O
motility	O
defect	O
but	O
that	O
instead	O
the	O
cheB2	S-Biological_Molecule
gene	O
is	O
involved	O
in	O
a	O
specific	O
chemotactic	O
response	O
,	O
which	O
takes	O
place	O
during	O
infection	O
and	O
is	O
required	O
for	O
P	B-Species
.	I-Species
aeruginosa	E-Species
pathogenicity	O
.	O

Introduction	O

The	O
ubiquitous	O
Gram	O
-	O
negative	O
bacterium	O
Pseudomonas	B-Species
aeruginosa	E-Species
is	O
an	O
opportunistic	O
pathogen	O
able	O
to	O
infect	O
a	O
broad	O
range	O
of	O
animals	O
and	O
plants	O
hosts	O
including	O
humans	S-Species
.	O

Also	O
necessary	O
are	O
protein	O
secretion	O
systems	O
[	O
4	O
]	O
and	O
toxins	O
required	O
for	O
cytotoxicity	O
and	O
survival	O
within	O
the	O
host	O
.	O

P	B-Species
.	I-Species
aeruginosa	E-Species
is	O
capable	O
of	O
killing	O
C	B-Species
.	I-Species
elegans	E-Species
in	O
several	O
distinct	O
ways	O
.	O

Nematodes	O
exposed	O
to	O
PA14	S-Species
grown	O
on	O
nematode	O
growth	O
media	O
(	O
NGM	O
)	O
,	O
succumb	O
to	O
"	O
slow	O
killing	O
"	O
.	O

Finally	O
,	O
C	B-Species
.	I-Species
elegans	E-Species
death	O
,	O
called	O
red	O
death	O
,	O
is	O
observed	O
in	O
response	O
to	O
PAO1	S-Species
grown	O
on	O
phosphate	S-Chemical_Compound
-	O
depleted	O
medium	O
in	O
conjunction	O
with	O
physiological	O
stress	O
on	O
the	O
nematodes	O
[	O
10	O
]	O
.	O

It	O
is	O
known	O
that	O
the	O
P	B-Species
.	I-Species
aeruginosa	I-Species
isolates	I-Species
PA14	E-Species
and	O
PAO1	S-Species
show	O
genomic	O
diversity	O
.	O

Individual	O
genes	O
and	O
even	O
entire	O
genomic	O
islands	O
have	O
been	O
lost	O
from	O
laboratory	O
isolates	O
when	O
compared	O
to	O
pathogenic	O
strains	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
the	O
P	B-Species
.	I-Species
aeruginosa	I-Species
strain	I-Species
TBCF10839	E-Species
(	O
TB	S-Species
)	O
,	O
which	O
was	O
isolated	O
from	O
a	O
Cystic	O
Fibrosis	O
(	O
CF	O
)	O
patient	S-Species
[	O
14	O
]	O
.	O

The	O
TB	S-Species
strain	O
belongs	O
to	O
an	O
abundant	O
clonal	O
complex	O
in	O
the	O
P	B-Species
.	I-Species
aeruginosa	E-Species
population	O
[	O
15	O
]	O
.	O

Increasing	O
throughput	O
in	O
an	O
assay	O
such	O
that	O
an	O
entire	O
genome	O
can	O
readily	O
be	O
scanned	O
in	O
a	O
short	O
time	O
period	O
is	O
an	O
important	O
advance	O
.	O

Our	O
protocol	O
is	O
based	O
on	O
a	O
standard	O
killing	O
assay	O
and	O
makes	O
use	O
of	O
a	O
Biosorter	O
to	O
distribute	O
nematodes	O
into	O
the	O
wells	O
of	O
microtitre	O
plates	O
in	O
a	O
fully	O
automated	O
manner	O
.	O

The	O
cheB2	S-Biological_Molecule
gene	O
belongs	O
to	O
the	O
P	B-Species
.	I-Species
aeruginosa	E-Species
chemotaxis	O
che2	O
gene	O
cluster	O
(	O
cluster	O
II	O
,	O
PA0180	S-Biological_Molecule
-	O
PA0173	S-Biological_Molecule
)	O
(	O
Figure	O
1	O
)	O
[	O
21	O
]	O
.	O

P	B-Species
.	I-Species
aeruginosa	E-Species
has	O
multiple	O
copies	O
of	O
chemotaxis	O
genes	O
arranged	O
in	O
five	O
clusters	O
(	O
Figure	O
1	O
)	O
[	O
22	O
]	O
.	O

The	O
wsp	O
genes	O
contained	O
in	O
cluster	O
III	O
(	O
PA3708	S-Biological_Molecule
-	O
PA3702	S-Biological_Molecule
)	O
have	O
been	O
proposed	O
to	O
contribute	O
to	O
bacterial	O
biofilm	O
formation	O
[	O
25	O
]	O
,	O
whereas	O
the	O
cluster	O
IV	O
(	O
Pil	O
-	O
Chp	O
system	O
,	O
PA0408	S-Biological_Molecule
-	O
PA0417	S-Biological_Molecule
)	O
has	O
been	O
shown	O
to	O
be	O
involved	O
in	O
twitching	O
motility	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
.	O

In	O
Escherichia	B-Species
coli	E-Species
,	O
the	O
loss	O
of	O
CheB	O
leads	O
decreased	O
receptor	O
sensitivity	O
,	O
due	O
to	O
an	O
inability	O
to	O
reset	O
the	O
MCP	O
'	O
s	O
[	O
30	O
]	O
.	O

This	O
modification	O
leaves	O
the	O
chemotactic	O
pathway	O
in	O
active	O
states	O
causing	O
clockwise	O
rotation	O
of	O
the	O
flagella	O
and	O
continuous	O
tumbling	O
instead	O
of	O
runs	O
and	O
tumbles	O
.	O

It	O
has	O
been	O
reported	O
previously	O
in	O
Salmonella	B-Species
typhimurium	E-Species
that	O
a	O
loss	O
of	O
proper	O
chemotaxis	O
control	O
through	O
a	O
cheB	O
mutation	O
,	O
leads	O
to	O
a	O
'	O
tumbly	O
'	O
swimming	O
phenotype	O
and	O
a	O
strong	O
reduction	O
in	O
the	O
isolates	O
ability	O
to	O
invade	O
human	S-Species
epithelial	O
HEP2	O
cells	O
as	O
well	O
as	O
a	O
reduction	O
in	O
infectivity	O
in	O
a	O
mouse	S-Species
ligated	O
-	O
loop	O
model	O
[	O
31	O
]	O
.	O

In	O
our	O
study	O
we	O
further	O
compare	O
the	O
phenotypes	O
of	O
cheB2	S-Biological_Molecule
and	O
cheB1	S-Biological_Molecule
mutants	O
and	O
propose	O
that	O
the	O
cheB2	S-Biological_Molecule
gene	O
has	O
a	O
specific	O
role	O
during	O
infection	O
,	O
which	O
is	O
essential	O
for	O
pathogenesis	O
.	O

Results	O

High	O
Throughput	O
Assay	O
for	O
Nematode	O
Killing	O
by	O
P	B-Species
.	I-Species
aeruginosa	E-Species
It	O
was	O
reported	O
earlier	O
that	O
relatively	O
high	O
-	O
throughput	O
screening	O
procedures	O
performed	O
on	O
plates	O
could	O
be	O
used	O
to	O
identify	O
virulence	O
factors	O
in	O
various	O
pathogens	O
such	O
as	O
Staphylococcus	B-Species
aureus	E-Species
[	O
32	O
]	O
,	O
P	B-Species
.	I-Species
aeruginosa	E-Species
[	O
8	O
]	O
or	O
Serratia	B-Species
marcescens	E-Species
[	O
33	O
]	O
.	O

Here	O
,	O
we	O
developed	O
a	O
high	O
throughput	O
screening	O
method	O
,	O
in	O
which	O
C	B-Species
.	I-Species
elegans	E-Species
killing	O
is	O
assessed	O
in	O
a	O
liquid	O
assay	O
and	O
which	O
allows	O
a	O
quick	O
selection	O
of	O
attenuated	O
candidates	O
within	O
large	O
transposon	O
libraries	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
.	O

We	O
filled	O
96	O
well	O
plates	O
with	O
the	O
medium	O
and	O
inoculated	O
the	O
bacterial	O
strains	O
to	O
be	O
tested	O
.	O

Under	O
our	O
assay	O
conditions	O
,	O
more	O
than	O
90	O
%	O
of	O
the	O
worms	O
grown	O
on	O
E	B-Species
.	I-Species
coli	E-Species
were	O
still	O
alive	O
after	O
24	O
h	O
.	O

In	O
contrast	O
,	O
more	O
than	O
50	O
%	O
of	O
the	O
worms	O
were	O
killed	O
within	O
24	O
h	O
when	O
cultured	O
with	O
any	O
one	O
of	O
three	O
isolates	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
,	O
PA14	S-Species
,	O
PAO1	S-Species
and	O
TB	S-Species
(	O
data	O
not	O
shown	O
)	O
.	O

C	B-Species
.	I-Species
elegans	E-Species
infection	O
using	O
this	O
mutant	O
in	O
the	O
liquid	O
assay	O
resulted	O
in	O
only	O
40	O
%	O
killing	O
at	O
24	O
h	O
,	O
whereas	O
95	O
%	O
killing	O
was	O
observed	O
with	O
the	O
parental	O
PA14	S-Species
strain	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
order	O
to	O
screen	O
a	O
large	O
number	O
of	O
bacterial	O
isolates	O
more	O
rapidly	O
,	O
the	O
assay	O
was	O
automated	O
using	O
the	O
COPAS	O
(	O
Complex	O
Object	O
Parametric	O
Analyzer	O
and	O
Sorter	O
)	O
Biosort	O
system	O
(	O
Union	O
Biometrica	O
)	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
unionbio	O
.	O
com	O
/	O
)	O
.	O

The	O
sorter	O
is	O
able	O
to	O
dispatch	O
systematically	O
a	O
fixed	O
number	O
of	O
worms	O
of	O
a	O
precise	O
developmental	O
stage	O
,	O
into	O
each	O
well	O
of	O
a	O
microtitre	O
plate	O
.	O

A	O
signature	O
tagged	O
mutagenesis	O
(	O
STM	O
)	O
library	O
was	O
previously	O
generated	O
in	O
the	O
virulent	O
P	B-Species
.	I-Species
aeruginosa	I-Species
CF	I-Species
isolate	E-Species
,	O
TB	S-Species
,	O
using	O
the	O
plasposon	O
vector	O
pTnModOGm	O
[	O
20	O
]	O
,	O
[	O
35	O
]	O
.	O

This	O
pre	O
-	O
screening	O
eliminated	O
clones	O
that	O
might	O
have	O
exhibited	O
attenuated	O
virulence	O
based	O
upon	O
reduced	O
growth	O
or	O
viability	O
,	O
rather	O
than	O
loss	O
of	O
a	O
specific	O
virulence	O
function	O
.	O

Each	O
mutant	O
was	O
tested	O
at	O
least	O
four	O
times	O
using	O
this	O
assay	O
.	O

Within	O
group	O
1	O
,	O
the	O
12	O
most	O
highly	O
attenuated	O
isolates	O
,	O
classified	O
as	O
group	O
1A	O
(	O
0	O
.	O
4	O
%	O
of	O
the	O
total	O
library	O
)	O
,	O
were	O
further	O
studied	O
.	O

Characterization	O
of	O
Selected	O
Attenuated	O
Mutants	O

Genomic	O
DNA	O
was	O
recovered	O
from	O
the	O
12	O
group	O
1A	O
isolates	O
.	O

The	O
transposon	O
insertion	O
site	O
was	O
determined	O
through	O
direct	O
genomic	O
DNA	O
sequencing	O
,	O
using	O
primers	O
located	O
upstream	O
from	O
each	O
transposon	O
inverted	O
repeat	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

The	O
genes	O
identified	O
are	O
shown	O
in	O
Table	O
1	O
.	O

We	O
recovered	O
two	O
additional	O
mutants	O
with	O
transposon	O
insertion	O
into	O
genes	O
which	O
have	O
functions	O
related	O
to	O
motility	O
.	O

Secondly	O
,	O
we	O
found	O
an	O
insertion	O
in	O
PA0173	S-Biological_Molecule
(	O
cheB2	S-Biological_Molecule
)	O
,	O
one	O
of	O
four	O
cheB	O
gene	O
homologues	O
in	O
the	O
P	B-Species
.	I-Species
aeruginosa	E-Species
genome	O
sequence	O
.	O

PA0173	S-Biological_Molecule
lies	O
within	O
the	O
chemotactic	O
gene	O
cluster	O
II	O
found	O
in	O
the	O
PAO1	S-Species
genome	O
(	O
Figure	O
1	O
)	O
[	O
21	O
]	O
.	O

The	O
adaptation	O
of	O
the	O
chemotaxis	O
system	O
in	O
response	O
to	O
changes	O
in	O
attractant	O
binding	O
is	O
dependent	O
on	O
the	O
methylation	O
state	O
of	O
the	O
MCPs	O
.	O

Another	O
interrupted	O
gene	O
,	O
PA2478	S-Biological_Molecule
,	O
encodes	O
a	O
probable	O
thiol	O
:	O
disulfide	O
interchange	O
protein	O
of	O
the	O
DsbD	O
family	O
.	O

We	O
observed	O
that	O
both	O
strains	O
kill	O
worms	O
with	O
similar	O
efficiency	O
(	O
data	O
not	O
shown	O
)	O
.	O

Each	O
of	O
the	O
12	O
group	O
1A	O
mutants	O
derived	O
from	O
TB	S-Species
was	O
further	O
tested	O
in	O
the	O
slow	O
killing	O
assay	O
.	O

The	O
parental	O
TB	S-Species
isolate	O
is	O
able	O
to	O
kill	O
50	O
%	O
of	O
exposed	O
nematodes	O
in	O
the	O
slow	O
killing	O
assay	O
within	O
3	O
days	O
.	O

Seven	O
of	O
the	O
twelve	O
group	O
1A	O
isolates	O
showed	O
significant	O
virulence	O
attenuation	O
(	O
Table	O
1	O
)	O
.	O

Phenotypic	O
Analysis	O
of	O
Selected	O
TB	B-Species
mutants	E-Species

It	O
has	O
been	O
shown	O
that	O
adherence	O
is	O
an	O
essential	O
first	O
step	O
in	O
the	O
process	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
colonization	O
,	O
allowing	O
the	O
bacteria	O
to	O
persist	O
,	O
expand	O
in	O
numbers	O
and	O
develop	O
a	O
biofilm	O
or	O
establish	O
intimate	O
contact	O
with	O
host	O
cells	O
[	O
45	O
]	O
,	O
[	O
46	O
]	O
.	O

We	O
wished	O
to	O
determine	O
if	O
our	O
selected	O
mutants	O
showed	O
a	O
reduction	O
in	O
their	O
capacity	O
to	O
adhere	O
to	O
a	O
biological	O
surface	O
such	O
as	O
the	O
human	S-Species
epithelial	O
cell	O
line	O
16HBE14o	O
-	O
.	O

In	O
addition	O
to	O
TB4953s	S-Species
(	O
motB	S-Biological_Molecule
,	O
p	O
<	O
0	O
.	O
0001	O
)	O
and	O
TB0173s	S-Species
(	O
cheB2	S-Biological_Molecule
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
that	O
presented	O
strongly	O
reduced	O
adherence	O
,	O
five	O
other	O
clones	O
were	O
significantly	O
affected	O
in	O
their	O
adherence	O
to	O
cells	O
when	O
compared	O
to	O
the	O
parental	O
TB	S-Species
isolate	O
(	O
Figure	O
S1	O
and	O
Table	O
1	O
)	O
.	O

These	O
mutants	O
were	O
TB2588s	S-Species
(	O
araC	S-Biological_Molecule
-	O
like	O
,	O
PA2588	S-Biological_Molecule
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
TB4380s	S-Species
(	O
colS	S-Biological_Molecule
-	O
like	O
,	O
PA4380	S-Biological_Molecule
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
TB3080s	S-Species
(	O
hypothetical	O
,	O
PA3080	S-Biological_Molecule
,	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
TB2769s	S-Species
(	O
hypothetical	O
,	O
PA2769	S-Biological_Molecule
,	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
TB5479s	S-Species
(	O
gltP	S-Biological_Molecule
-	O
like	O
,	O
PA5479	S-Biological_Molecule
,	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Motility	O
is	O
also	O
an	O
important	O
factor	O
for	O
P	B-Species
.	I-Species
aeruginosa	E-Species
colonization	O
and	O
spread	O
.	O

We	O
evaluated	O
each	O
of	O
the	O
twelve	O
attenuated	O
mutants	O
for	O
both	O
swarming	O
and	O
swimming	O
motility	O
(	O
data	O
not	O
shown	O
,	O
Table	O
1	O
and	O
Figure	O
2	O
)	O
.	O

The	O
TB0173s	S-Species
(	O
cheB2	S-Biological_Molecule
)	O
(	O
Figure	O
2	O
and	O
Table	O
1	O
)	O
and	O
TB4953s	S-Species
(	O
motB	S-Biological_Molecule
)	O
(	O
Table	O
1	O
)	O
mutants	O
showed	O
a	O
reduction	O
in	O
swimming	O
and	O
swarming	O
motility	O
,	O
respectively	O
.	O

Furthermore	O
,	O
the	O
mutants	O
TB0260s	S-Species
(	O
hypothetical	O
,	O
PA0260	S-Biological_Molecule
)	O
and	O
TB5479s	S-Species
(	O
gltP	S-Biological_Molecule
-	O
like	O
)	O
had	O
a	O
significant	O
reduction	O
in	O
swimming	O
motility	O
(	O
Table	O
1	O
)	O
whereas	O
the	O
mutants	O
TB2588s	S-Species
(	O
araC	S-Biological_Molecule
-	O
like	O
)	O
and	O
TB3080s	S-Species
(	O
hypothetical	O
)	O
had	O
a	O
significant	O
reduction	O
in	O
swarming	O
motility	O
(	O
Table	O
1	O
)	O
.	O

Characterization	O
of	O
the	O
cheB2	S-Biological_Molecule
Mutant	O

We	O
chose	O
to	O
further	O
characterize	O
the	O
TB0173s	S-Species
mutant	O
(	O
cheB2	S-Biological_Molecule
)	O
,	O
as	O
this	O
isolate	O
was	O
affected	O
in	O
all	O
phenotypes	O
tested	O
and	O
thus	O
exhibited	O
a	O
general	O
motility	O
and	O
virulence	O
defect	O
(	O
Table	O
1	O
)	O
.	O

A	O
series	O
of	O
8	O
PCR	O
reactions	O
were	O
performed	O
using	O
oligonucleotides	O
based	O
on	O
the	O
nucleotide	O
sequence	O
obtained	O
from	O
the	O
PA14	S-Species
genome	O
sequence	O
(	O
Table	O
S1	O
)	O
.	O

Each	O
paired	O
reaction	O
set	O
(	O
TB	S-Species
/	O
PA14	S-Species
)	O
resulted	O
in	O
products	O
running	O
at	O
the	O
same	O
migratory	O
rate	O
within	O
the	O
1	O
.	O
5	O
%	O
agarose	O
gel	O
(	O
data	O
not	O
shown	O
)	O
.	O

These	O
results	O
show	O
that	O
there	O
is	O
little	O
difference	O
between	O
the	O
two	O
isolates	O
,	O
TB	S-Species
and	O
PA14	S-Species
,	O
with	O
regards	O
the	O
overall	O
organization	O
of	O
the	O
che2	O
chromosomal	O
region	O
.	O

To	O
validate	O
that	O
the	O
loss	O
of	O
virulence	O
and	O
other	O
phenotypic	O
changes	O
observed	O
with	O
the	O
TB	S-Species
strain	O
were	O
a	O
result	O
of	O
the	O
transposon	O
disruption	O
of	O
the	O
cheB2	S-Biological_Molecule
gene	O
,	O
we	O
generated	O
a	O
new	O
mutant	O
by	O
interrupting	O
the	O
cheB2	S-Biological_Molecule
gene	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

Both	O
cheB2	S-Biological_Molecule
mutants	O
,	O
TB0173s	S-Species
and	O
TB0173i	S-Species
,	O
required	O
at	O
least	O
one	O
additional	O
day	O
,	O
as	O
compared	O
to	O
TB	S-Species
,	O
to	O
kill	O
50	O
%	O
of	O
exposed	O
nematodes	O
.	O

We	O
reintroduced	O
,	O
in	O
the	O
cheB2	S-Biological_Molecule
mutant	O
,	O
the	O
wild	O
-	O
type	O
cheB2	S-Biological_Molecule
gene	O
using	O
an	O
integration	O
-	O
proficient	O
vector	O
,	O
mini	O
-	O
CTX1	O
[	O
47	O
]	O
.	O

This	O
vector	O
contains	O
the	O
phiCTX	O
attachment	O
site	O
allowing	O
integration	O
of	O
exogenous	O
DNA	O
fragments	O
at	O
the	O
attB	O
site	O
within	O
the	O
genome	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
.	O

The	O
cheB2	S-Biological_Molecule
gene	O
was	O
cloned	O
into	O
the	O
mini	O
-	O
CTX1	O
,	O
yielding	O
CTXp2B2	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

This	O
construct	O
was	O
introduced	O
into	O
the	O
cheB2	S-Biological_Molecule
mutant	O
,	O
TB0173s	S-Species
,	O
generating	O
the	O
TB0173sp2B2	S-Species
strain	O
.	O

As	O
shown	O
in	O
Figure	O
3B	O
the	O
virulence	O
was	O
restored	O
in	O
the	O
complemented	O
cheB2	S-Biological_Molecule
mutant	O
TB0173sp2B2	O
(	O
p	O
<	O
0	O
.	O
009	O
)	O
,	O
whereas	O
the	O
cheB2	S-Biological_Molecule
mutant	O
strain	O
TB0173sCTX	O
(	O
p	O
<	O
0	O
.	O
005	O
)	O
remained	O
fully	O
attenuated	O
.	O

A	O
cheB1	S-Biological_Molecule
Mutant	O
Is	O
not	O
Attenuated	O
for	O
C	B-Species
.	I-Species
elegans	E-Species
Virulence	O

We	O
thus	O
investigated	O
the	O
fate	O
of	O
a	O
cheB1	S-Biological_Molecule
mutant	O
in	O
a	O
similar	O
assay	O
.	O

The	O
cheB1	S-Biological_Molecule
mutant	O
was	O
used	O
to	O
feed	O
C	B-Species
.	I-Species
elegans	E-Species
in	O
the	O
slow	O
killing	O
assay	O
and	O
the	O
survival	O
percentage	O
was	O
compared	O
to	O
those	O
obtained	O
when	O
using	O
the	O
cheB2	S-Biological_Molecule
mutant	O
or	O
the	O
parental	O
TB	S-Species
strain	O
(	O
Figure	O
3C	O
)	O
.	O

Interestingly	O
,	O
the	O
cheB1	S-Biological_Molecule
mutant	O
showed	O
no	O
significant	O
reduction	O
in	O
C	B-Species
.	I-Species
elegans	E-Species
killing	O
when	O
compared	O
to	O
the	O
parental	O
TB	S-Species
strain	O
,	O
with	O
only	O
36	O
%	O
of	O
the	O
worms	O
alive	O
after	O
4	O
days	O
post	O
infection	O
.	O

This	O
is	O
in	O
contrast	O
to	O
the	O
loss	O
of	O
virulence	O
in	O
the	O
original	O
cheB2	S-Biological_Molecule
mutant	O
(	O
TB0173s	S-Species
)	O
and	O
the	O
insertional	O
cheB2	S-Biological_Molecule
mutant	O
TB0173i	O
.	O

The	O
swimming	O
or	O
swarming	O
motility	O
defect	O
is	O
,	O
however	O
,	O
much	O
more	O
severe	O
in	O
the	O
cheB1	S-Biological_Molecule
mutant	O
as	O
compared	O
to	O
the	O
cheB2	S-Biological_Molecule
mutant	O
.	O

Finally	O
,	O
we	O
used	O
a	O
chemotactic	O
assay	O
using	O
tryptone	O
as	O
chemo	O
-	O
attractant	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

The	O
parental	O
TB	S-Species
strain	O
was	O
able	O
to	O
move	O
towards	O
the	O
attractant	O
(	O
an	O
increase	O
of	O
slightly	O
more	O
than	O
half	O
a	O
log	O
of	O
bacteria	O
over	O
45	O
min	O
)	O
and	O
the	O
TB0173s	S-Species
strain	O
(	O
cheB2	S-Biological_Molecule
mutant	O
)	O
was	O
also	O
capable	O
of	O
chemotaxis	O
,	O
even	O
though	O
much	O
reduced	O
as	O
compared	O
to	O
TB	S-Species
(	O
Figure	O
S4	O
)	O
.	O

We	O
further	O
tested	O
the	O
virulence	O
of	O
the	O
cheB2	S-Biological_Molecule
mutant	O
TB0173s	O
in	O
a	O
mouse	S-Species
model	O
of	O
lung	O
infection	O
,	O
utilizing	O
the	O
view	O
-	O
controlled	O
intratracheal	O
infection	O
protocol	O
[	O
48	O
]	O
.	O

Infection	O
with	O
the	O
wild	O
type	O
resulted	O
in	O
50	O
%	O
dead	O
animals	O
(	O
5	O
of	O
10	O
)	O
by	O
day	O
5	O
compared	O
to	O
10	O
%	O
deaths	O
for	O
the	O
TB0173s	O
cheB2	S-Biological_Molecule
mutant	O
(	O
1	O
of	O
10	O
;	O
P	O
=	O
0	O
.	O
036	O
,	O
Fisher	O
'	O
s	O
exact	O
test	O
)	O
.	O

Surviving	O
mice	S-Species
infected	O
with	O
the	O
cheB2	S-Biological_Molecule
mutant	O
showed	O
a	O
significantly	O
less	O
troubled	O
body	O
condition	O
from	O
days	O
3	O
to	O
6	O
post	O
infection	O
(	O
P	O
<	O
0	O
.	O
01	O
,	O
Mann	O
-	O
Whitney	O
rank	O
test	O
)	O
than	O
surviving	O
mice	S-Species
infected	O
with	O
the	O
wild	O
type	O
strain	O
indicating	O
that	O
the	O
former	O
group	O
recovered	O
earlier	O
than	O
the	O
latter	O
(	O
Figure	O
4B	O
)	O
.	O

In	O
contrast	O
,	O
the	O
TB0173s	O
cheB2	S-Biological_Molecule
mutant	O
had	O
caused	O
markedly	O
reduced	O
inflammation	O
and	O
very	O
little	O
PMN	O
infiltration	O
(	O
Figure	O
5B	O
)	O
.	O

Growth	O
conditions	O
and	O
host	O
-	O
pathogen	O
interactions	O
affect	O
the	O
physiology	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
via	O
complex	O
regulatory	O
networks	O
,	O
which	O
in	O
turn	O
control	O
an	O
arsenal	O
of	O
virulence	O
factors	O
[	O
52	O
]	O
,	O
[	O
53	O
]	O
,	O
[	O
54	O
]	O
,	O
[	O
55	O
]	O
.	O

This	O
method	O
was	O
automated	O
using	O
the	O
COPAS	O
Biosort	O
worm	O
sorting	O
system	O
,	O
which	O
greatly	O
reduced	O
the	O
time	O
required	O
to	O
perform	O
the	O
assay	O
.	O

Under	O
slow	O
killing	O
conditions	O
(	O
Figure	O
3	O
)	O
the	O
TB	S-Species
strain	O
requires	O
approximately	O
three	O
days	O
to	O
kill	O
50	O
%	O
of	O
a	O
given	O
worm	O
population	O
,	O
and	O
up	O
to	O
8	O
days	O
to	O
kill	O
all	O
the	O
worms	O
in	O
a	O
population	O
of	O
50	O
nematodes	O
.	O

Most	O
of	O
our	O
selected	O
mutants	O
were	O
impaired	O
in	O
at	O
least	O
one	O
of	O
the	O
additional	O
tested	O
phenotypes	O
.	O

One	O
of	O
the	O
identified	O
mutants	O
showed	O
reductions	O
in	O
all	O
aspects	O
of	O
virulence	O
we	O
tested	O
.	O

As	O
many	O
as	O
26	O
MCPs	O
have	O
been	O
identified	O
in	O
P	B-Species
.	I-Species
aeruginosa	E-Species
[	O
56	O
]	O
,	O
and	O
it	O
has	O
been	O
proposed	O
that	O
the	O
CheB2	S-Biological_Molecule
protein	O
functions	O
at	O
least	O
with	O
McpB	S-Biological_Molecule
[	O
57	O
]	O
.	O

Interestingly	O
,	O
we	O
observed	O
that	O
a	O
mutation	O
in	O
the	O
cheB1	S-Biological_Molecule
gene	O
yields	O
different	O
phenotypes	O
compared	O
to	O
the	O
cheB2	S-Biological_Molecule
mutation	O
.	O

Moreover	O
,	O
it	O
shows	O
more	O
severe	O
motility	O
defect	O
than	O
the	O
cheB2	S-Biological_Molecule
mutant	O
.	O

Finally	O
,	O
in	O
chemotaxis	O
assays	O
using	O
tryptone	O
as	O
chemo	O
-	O
attractant	O
,	O
we	O
observed	O
that	O
,	O
while	O
the	O
cheB1	S-Biological_Molecule
mutant	O
was	O
strongly	O
affected	O
,	O
the	O
cheB2	S-Biological_Molecule
mutant	O
had	O
a	O
mild	O
phenotype	O
.	O

Schuster	O
and	O
collaborators	O
have	O
reported	O
that	O
the	O
cluster	O
II	O
genes	O
are	O
induced	O
during	O
stationary	O
phase	O
,	O
are	O
regulated	O
by	O
quorum	O
sensing	O
and	O
that	O
RpoS	S-Biological_Molecule
,	O
the	O
stationary	O
phase	O
RNA	O
polymerase	O
sigma	O
factor	O
,	O
plays	O
a	O
role	O
in	O
controlling	O
cheB2	S-Biological_Molecule
gene	O
expression	O
[	O
58	O
]	O
.	O

RsmA	S-Biological_Molecule
works	O
in	O
conjunction	O
with	O
small	O
non	O
-	O
coding	O
RNA	O
to	O
regulate	O
the	O
expression	O
of	O
multiple	O
virulence	O
genes	O
,	O
including	O
the	O
quorum	O
sensing	O
lasI	S-Biological_Molecule
and	O
rhlI	S-Biological_Molecule
genes	O
[	O
60	O
]	O
.	O

Finally	O
,	O
using	O
fluorescent	O
protein	O
-	O
tagged	O
CheY	S-Biological_Molecule
and	O
CheA	S-Biological_Molecule
,	O
it	O
was	O
shown	O
that	O
the	O
Che1	O
proteins	O
(	O
cluster	O
I	O
)	O
localized	O
to	O
the	O
flagellated	O
pole	O
throughout	O
growth	O
[	O
61	O
]	O
.	O

While	O
the	O
Che1	O
proteins	O
are	O
still	O
found	O
as	O
bacterial	O
cells	O
entered	O
stationary	O
phase	O
,	O
a	O
patch	O
of	O
Che2	O
proteins	O
begins	O
to	O
co	O
-	O
localize	O
with	O
the	O
Che1	O
proteins	O
at	O
that	O
stage	O
.	O

This	O
might	O
indicate	O
that	O
during	O
stationary	O
phase	O
,	O
the	O
chemotactic	O
response	O
will	O
be	O
different	O
than	O
the	O
one	O
observed	O
with	O
exponentially	O
growing	O
cells	O
and	O
the	O
function	O
of	O
the	O
Che2	O
cluster	O
,	O
even	O
though	O
currently	O
unknown	O
,	O
might	O
be	O
to	O
respond	O
to	O
particular	O
stimuli	O
encountered	O
at	O
that	O
stage	O
.	O

It	O
has	O
been	O
shown	O
that	O
a	O
cheW	S-Biological_Molecule
mutant	O
in	O
Helicobacter	B-Species
pylori	E-Species
is	O
unable	O
to	O
establish	O
a	O
normal	O
long	O
-	O
term	O
infection	O
in	O
mice	S-Species
,	O
remaining	O
only	O
in	O
one	O
portion	O
of	O
the	O
stomach	O
.	O

It	O
is	O
a	O
possibility	O
that	O
within	O
a	O
host	O
,	O
the	O
cluster	O
II	O
che	O
genes	O
of	O
P	B-Species
.	I-Species
aeruginosa	E-Species
might	O
play	O
a	O
similar	O
role	O
in	O
sensing	O
particular	O
conditions	O
during	O
infection	O
.	O

Flies	O
orally	O
infected	O
with	O
P	B-Species
.	I-Species
entomophila	E-Species
rapidly	O
succumb	O
despite	O
the	O
induction	O
of	O
both	O
local	O
and	O
systemic	O
immune	O
responses	O
,	O
indicating	O
that	O
this	O
bacterium	O
has	O
developed	O
specific	O
strategies	O
to	O
escape	O
the	O
fly	O
immune	O
response	O
.	O

We	O
demonstrate	O
that	O
AprA	S-Biological_Molecule
,	O
an	O
abundant	O
secreted	O
metalloprotease	O
produced	O
by	O
P	B-Species
.	I-Species
entomophila	E-Species
,	O
is	O
an	O
important	O
virulence	O
factor	O
.	O

Our	O
study	O
also	O
reveals	O
that	O
the	O
major	O
contribution	O
to	O
the	O
fly	O
defense	O
against	O
P	B-Species
.	I-Species
entomophila	E-Species
is	O
provided	O
by	O
the	O
local	O
,	O
rather	O
than	O
the	O
systemic	O
immune	O
response	O
.	O

More	O
precisely	O
,	O
our	O
data	O
points	O
to	O
an	O
important	O
role	O
for	O
the	O
antimicrobial	O
peptide	O
Diptericin	S-Biological_Molecule
against	O
orally	O
infectious	O
Gram	O
-	O
negative	O
bacteria	O
,	O
emphasizing	O
the	O
critical	O
role	O
of	O
local	O
antimicrobial	O
peptide	O
expression	O
against	O
food	O
-	O
borne	O
pathogens	O
.	O

Introduction	O

Host	O
-	O
pathogen	O
interactions	O
are	O
complex	O
relationships	O
in	O
which	O
the	O
success	O
of	O
each	O
organism	O
depends	O
on	O
its	O
ability	O
to	O
overcome	O
the	O
other	O
.	O

In	O
recent	O
years	O
,	O
Drosophila	S-Species
has	O
emerged	O
as	O
a	O
powerful	O
model	O
for	O
the	O
study	O
of	O
host	O
-	O
pathogen	O
interactions	O
[	O
1	O
,	O
2	O
]	O
.	O

Firstly	O
,	O
epithelia	O
,	O
such	O
as	O
alimentary	O
tract	O
and	O
tracheae	O
,	O
are	O
the	O
first	O
line	O
of	O
defense	O
against	O
pathogens	O
and	O
produce	O
both	O
antimicrobial	O
peptides	O
(	O
AMPs	O
)	O
and	O
reactive	B-Chemical_Compound
oxygen	I-Chemical_Compound
species	E-Chemical_Compound
.	O

Secondly	O
,	O
specialized	O
hemocytes	O
participate	O
in	O
phagocytosis	O
and	O
encapsulation	O
of	O
foreign	O
intruders	O
.	O

Several	O
genetic	O
studies	O
have	O
demonstrated	O
the	O
regulation	O
of	O
AMP	O
synthesis	O
by	O
the	O
Toll	S-Biological_Molecule
and	O
immune	O
-	O
deficient	O
(	O
Imd	S-Biological_Molecule
)	O
pathways	O
.	O

The	O
Toll	S-Biological_Molecule
pathway	O
is	O
mainly	O
activated	O
by	O
Gram	O
-	O
positive	O
bacteria	O
and	O
fungi	O
,	O
and	O
controls	O
,	O
to	O
a	O
large	O
extent	O
,	O
the	O
expression	O
of	O
AMPs	O
(	O
e	O
.	O
g	O
.	O
,	O
Drosomycin	S-Biological_Molecule
)	O
through	O
the	O
nuclear	O
factor	O
-	O
kappaB	O
transactivators	O
Dif	S-Biological_Molecule
and	O
Dorsal	S-Biological_Molecule
.	O

In	O
contrast	O
,	O
the	O
Imd	S-Biological_Molecule
pathway	O
mainly	O
responds	O
to	O
Gram	O
-	O
negative	O
bacterial	O
infections	O
and	O
controls	O
different	O
AMP	O
genes	O
(	O
e	O
.	O
g	O
.	O
,	O
Diptericin	S-Biological_Molecule
)	O
via	O
the	O
activation	O
of	O
the	O
nuclear	O
factor	O
-	O
kappaB	O
transactivator	O
Relish	S-Biological_Molecule
(	O
Rel	S-Biological_Molecule
)	O
[	O
3	O
,	O
4	O
,	O
6	O
]	O
.	O

In	O
addition	O
,	O
the	O
Imd	S-Biological_Molecule
pathway	O
plays	O
a	O
predominant	O
role	O
in	O
the	O
regulation	O
of	O
AMPs	O
in	O
the	O
alimentary	O
tract	O
and	O
tracheal	O
epithelia	O
[	O
7	O
]	O
.	O

One	O
limitation	O
associated	O
with	O
this	O
approach	O
is	O
that	O
it	O
bypasses	O
the	O
initial	O
steps	O
of	O
naturally	O
occurring	O
infections	O
,	O
including	O
bacterial	O
colonization	O
and	O
persistence	O
and	O
host	O
local	O
immune	O
responses	O
.	O

Septic	O
injury	O
is	O
probably	O
of	O
little	O
consequence	O
in	O
nature	O
,	O
unlike	O
oral	O
infection	O
upon	O
ingestion	O
.	O

In	O
addition	O
,	O
the	O
response	O
to	O
non	O
-	O
pathogenic	O
microorganisms	O
does	O
not	O
necessarily	O
reflect	O
a	O
natural	O
host	O
reaction	O
to	O
a	O
real	O
pathogen	O
.	O

Importantly	O
,	O
in	O
contrast	O
to	O
Ecc15	S-Species
,	O
P	B-Species
.	I-Species
entomophila	E-Species
is	O
highly	O
pathogenic	O
for	O
Drosophila	S-Species
as	O
well	O
as	O
for	O
species	O
from	O
a	O
different	O
insect	O
order	O
(	O
Lepidoptera	O
)	O
.	O

The	O
genome	O
sequence	O
of	O
P	B-Species
.	I-Species
entomophila	E-Species
has	O
been	O
completed	O
and	O
reveals	O
the	O
existence	O
of	O
a	O
large	O
set	O
of	O
genes	O
encoding	O
putative	O
virulence	O
factors	O
such	O
as	O
proteases	O
,	O
lipases	O
,	O
toxins	O
,	O
alginate	O
synthesis	O
,	O
and	O
adhesion	O
factors	O
[	O
10	O
]	O
.	O

Transposon	O
mutagenesis	O
of	O
P	B-Species
.	I-Species
entomophila	E-Species
allowed	O
us	O
to	O
identify	O
several	O
regulatory	O
genes	O
required	O
to	O
infect	O
or	O
to	O
kill	O
Drosophila	S-Species
.	O

Among	O
them	O
we	O
identified	O
the	O
GacS	S-Biological_Molecule
/	O
GacA	S-Biological_Molecule
two	O
-	O
component	O
regulatory	O
system	O
which	O
,	O
in	O
Pseudomonas	B-Species
fluorescens	E-Species
,	O
has	O
been	O
well	O
characterized	O
and	O
demonstrated	O
to	O
be	O
an	O
essential	O
regulator	O
of	O
virulence	O
[	O
11	O
]	O
.	O

P	O
.	O
entomophila	O
gacA	S-Biological_Molecule
mutants	O
are	O
non	O
-	O
pathogenic	O
and	O
fail	O
to	O
trigger	O
a	O
systemic	O
immune	O
response	O
after	O
ingestion	O
,	O
indicating	O
that	O
the	O
GacS	S-Biological_Molecule
/	O
GacA	S-Biological_Molecule
two	O
-	O
component	O
system	O
regulates	O
important	O
bacterial	O
virulence	O
effectors	O
required	O
to	O
infect	O
and	O
kill	O
flies	O
[	O
9	O
]	O
.	O

Results	O

P	B-Species
.	I-Species
entomophila	E-Species
Secretes	O
an	O
Abundant	O
Protease	O
A	O
common	O
strategy	O
used	O
by	O
bacterial	O
pathogens	O
is	O
to	O
secrete	O
toxins	O
and	O
other	O
virulence	O
factors	O
that	O
damage	O
host	O
tissues	O
.	O

Figure	O
1A	O
shows	O
that	O
a	O
concentrated	O
P	B-Species
.	I-Species
entomophila	E-Species
culture	O
filtrate	O
had	O
a	O
moderate	O
but	O
significant	O
effect	O
on	O
Drosophila	S-Species
larvae	O
survival	O
following	O
ingestion	O
.	O

Although	O
the	O
filtrate	O
did	O
not	O
kill	O
adult	O
flies	O
after	O
feeding	O
(	O
unpublished	O
data	O
)	O
,	O
it	O
was	O
highly	O
toxic	O
by	O
direct	O
injection	O
into	O
the	O
hemocoel	O
(	O
Figure	O
1B	O
)	O
.	O

These	O
data	O
suggested	O
that	O
P	B-Species
.	I-Species
entomophila	E-Species
secreted	O
one	O
or	O
more	O
factors	O
with	O
toxic	O
activity	O
under	O
the	O
control	O
of	O
the	O
GacS	S-Biological_Molecule
/	O
GacA	S-Biological_Molecule
two	O
-	O
component	O
system	O
.	O

In	O
an	O
attempt	O
to	O
identify	O
the	O
factor	O
(	O
s	O
)	O
responsible	O
for	O
toxicity	O
,	O
we	O
analyzed	O
the	O
proteins	O
present	O
in	O
the	O
supernatant	O
.	O

The	O
protein	O
profile	O
for	O
wild	O
-	O
type	O
P	B-Species
.	I-Species
entomophila	E-Species
supernantant	O
(	O
Figure	O
1C	O
,	O
lane	O
2	O
)	O
shows	O
a	O
major	O
protein	O
band	O
at	O
51	O
kDa	O
and	O
several	O
minor	O
bands	O
.	O

We	O
subsequently	O
purified	O
this	O
protease	O
,	O
termed	O
AprA	S-Biological_Molecule
,	O
to	O
homogeneity	O
from	O
the	O
P	B-Species
.	I-Species
entomophila	E-Species
supernatant	O
by	O
anion	O
exchange	O
chromatography	O
followed	O
by	O
size	O
exclusion	O
chromatography	O
(	O
Figure	O
1D	O
)	O
.	O

Feeding	O
of	O
larvae	O
with	O
high	O
concentrations	O
(	O
1	O
.	O
5	O
mg	O
/	O
ml	O
)	O
of	O
AprA	S-Biological_Molecule
led	O
to	O
modest	O
lethality	O
(	O
unpublished	O
data	O
)	O
,	O
recapitulating	O
the	O
properties	O
of	O
the	O
P	B-Species
.	I-Species
entomophila	E-Species
supernatant	O
.	O

In	O
P	B-Species
.	I-Species
fluorescens	E-Species
,	O
membrane	O
-	O
localized	O
anti	O
-	O
sigma	O
factor	O
PrtR	S-Biological_Molecule
cleaves	O
the	O
extracytoplasmic	O
sigma	O
factor	O
PrtI	S-Biological_Molecule
,	O
resulting	O
in	O
increased	O
expression	O
of	O
multiple	O
genes	O
,	O
including	O
one	O
encoding	O
for	O
a	O
metalloprotease	O
,	O
aprX	S-Biological_Molecule
[	O
16	O
]	O
.	O

Interestingly	O
,	O
both	O
prtR	S-Biological_Molecule
mutants	O
(	O
CL25	S-Species
and	O
CU1	S-Species
)	O
displayed	O
a	O
secreted	O
protein	O
profile	O
identical	O
to	O
the	O
wild	O
-	O
type	O
strain	O
except	O
for	O
a	O
marked	O
decrease	O
of	O
AprA	S-Biological_Molecule
(	O
Figure	O
1C	O
,	O
lanes	O
4	O
and	O
5	O
)	O
.	O

Measurement	O
of	O
in	O
vitro	O
protease	O
activity	O
with	O
azocasein	O
revealed	O
that	O
the	O
gacA	S-Biological_Molecule
mutant	O
secretes	O
no	O
detectable	O
protease	O
activity	O
and	O
that	O
prtR	S-Biological_Molecule
mutants	O
retain	O
only	O
30	O
%	O
of	O
wild	O
-	O
type	O
supernatant	O
activity	O
,	O
thus	O
indicating	O
a	O
role	O
for	O
PrtR	S-Biological_Molecule
in	O
the	O
regulation	O
of	O
P	B-Species
.	I-Species
entomophila	E-Species
protease	O
secretion	O
(	O
Figure	O
1F	O
)	O
.	O

The	O
P	O
.	O
entomophila	O
aprA	S-Biological_Molecule
Mutant	O
Displays	O
Attenuated	O
Pathogenicity	O

We	O
inactivated	O
the	O
aprA	S-Biological_Molecule
gene	O
by	O
inserting	O
a	O
tetracycline	S-Chemical_Compound
resistance	O
cassette	O
by	O
a	O
double	O
homologous	O
recombination	O
event	O
.	O

To	O
analyze	O
the	O
in	O
vivo	O
contribution	O
of	O
AprA	S-Biological_Molecule
to	O
P	B-Species
.	I-Species
entomophila	E-Species
virulence	O
,	O
we	O
performed	O
a	O
survival	O
analysis	O
of	O
Drosophila	S-Species
larvae	O
and	O
adults	O
after	O
oral	O
infection	O
with	O
various	O
P	B-Species
.	I-Species
entomophila	E-Species
derivatives	O
.	O

Similarly	O
,	O
the	O
aprA	S-Biological_Molecule
mutant	O
showed	O
reduced	O
pathogenicity	O
after	O
oral	O
infection	O
of	O
adult	O
flies	O
(	O
Figure	O
S1	O
)	O
.	O

Using	O
the	O
same	O
assay	O
,	O
both	O
prtR	S-Biological_Molecule
and	O
gacA	S-Biological_Molecule
mutants	O
were	O
almost	O
avirulent	O
toward	O
Drosophila	S-Species
indicating	O
that	O
both	O
genes	O
regulate	O
other	O
virulence	O
factors	O
in	O
addition	O
to	O
AprA	S-Biological_Molecule
(	O
Figure	O
2B	O
)	O
.	O

Whereas	O
the	O
wild	O
-	O
type	O
P	B-Species
.	I-Species
entomophila	E-Species
titer	O
remained	O
high	O
,	O
aprA	S-Biological_Molecule
bacterial	O
levels	O
decreased	O
significantly	O
with	O
time	O
(	O
Figure	O
3A	O
,	O
not	O
shown	O
for	O
larvae	O
)	O
.	O

However	O
,	O
aprA	S-Biological_Molecule
gut	O
persistence	O
remained	O
higher	O
than	O
that	O
of	O
gacA	S-Biological_Molecule
mutants	O
.	O

We	O
could	O
not	O
exclude	O
that	O
the	O
aprA	S-Biological_Molecule
mutant	O
phenotype	O
was	O
due	O
to	O
polar	O
effects	O
of	O
the	O
insertion	O
in	O
the	O
operon	O
upon	O
expression	O
of	O
apr	B-Biological_Molecule
I	E-Biological_Molecule
,	O
D	S-Biological_Molecule
,	O
E	S-Biological_Molecule
,	O
and	O
F	S-Biological_Molecule
.	O

The	O
aprA	S-Biological_Molecule
Mutant	O
Retains	O
the	O
Capacity	O
to	O
Trigger	O
an	O
Immune	O
Response	O
and	O
to	O
Induce	O
Food	O
-	O
Uptake	O
Cessation	O

In	O
addition	O
to	O
its	O
pathogenicity	O
,	O
P	B-Species
.	I-Species
entomophila	E-Species
infection	O
provokes	O
a	O
food	O
-	O
uptake	O
cessation	O
in	O
larvae	O
and	O
triggers	O
an	O
immune	O
response	O
in	O
both	O
larvae	O
and	O
adults	O
[	O
9	O
]	O
.	O

In	O
contrast	O
,	O
P	B-Species
.	I-Species
entomophila	E-Species
-	O
infected	O
larvae	O
show	O
only	O
a	O
pale	O
blue	O
coloration	O
indicating	O
that	O
infected	O
larvae	O
cease	O
to	O
ingest	O
food	O
.	O

Diptericin	S-Biological_Molecule
was	O
expressed	O
at	O
a	O
wild	O
-	O
type	O
level	O
following	O
oral	O
infection	O
with	O
the	O
aprA	S-Biological_Molecule
and	O
prtR	S-Biological_Molecule
mutants	O
,	O
but	O
no	O
expression	O
was	O
detected	O
in	O
the	O
case	O
of	O
the	O
gacA	S-Biological_Molecule
mutant	O
(	O
Figures	O
2C	O
and	O
5A	O
)	O
.	O

Observation	O
of	O
green	B-Biological_Molecule
fluorescent	I-Biological_Molecule
protein	E-Biological_Molecule
(	O
GFP	S-Biological_Molecule
)	O
fluorescence	O
in	O
infected	O
larvae	O
carrying	O
a	O
Diptericin	S-Biological_Molecule
-	O
GFP	S-Biological_Molecule
reporter	O
gene	O
confirmed	O
that	O
prtR	S-Biological_Molecule
and	O
aprA	S-Biological_Molecule
mutants	O
elicited	O
an	O
immune	O
response	O
,	O
whereas	O
gacA	S-Biological_Molecule
mutants	O
failed	O
to	O
do	O
so	O
(	O
unpublished	O
data	O
)	O
.	O

The	O
data	O
presented	O
above	O
clearly	O
indicate	O
that	O
AprA	S-Biological_Molecule
is	O
a	O
major	O
virulence	O
factor	O
of	O
P	B-Species
.	I-Species
entomophila	E-Species
that	O
promotes	O
bacterial	O
persistence	O
and	O
killing	O
of	O
the	O
host	O
,	O
but	O
that	O
other	O
virulence	O
factors	O
controlled	O
by	O
gacA	S-Biological_Molecule
and	O
prtR	S-Biological_Molecule
exist	O
.	O

It	O
also	O
reveals	O
that	O
P	B-Species
.	I-Species
entomophila	E-Species
virulence	O
is	O
multi	O
-	O
factorial	O
with	O
a	O
clear	O
distinction	O
between	O
factors	O
that	O
promote	O
pathogenicity	O
and	O
those	O
that	O
trigger	O
the	O
immune	O
response	O
.	O

The	O
observation	O
that	O
both	O
factors	O
are	O
under	O
the	O
control	O
of	O
the	O
GacS	S-Biological_Molecule
/	O
GacA	S-Biological_Molecule
,	O
confirmed	O
that	O
this	O
two	O
-	O
component	O
system	O
is	O
the	O
master	O
regulator	O
of	O
P	B-Species
.	I-Species
entomophila	E-Species
virulence	O
.	O

Virulence	O
factors	O
allow	O
pathogens	O
to	O
survive	O
in	O
the	O
hostile	O
environment	O
of	O
the	O
host	O
,	O
to	O
escape	O
the	O
immune	O
system	O
,	O
or	O
to	O
establish	O
a	O
biotope	O
where	O
they	O
can	O
proliferate	O
by	O
altering	O
host	O
functions	O
.	O

The	O
observation	O
that	O
P	B-Species
.	I-Species
entomophila	E-Species
persistence	O
in	O
flies	O
and	O
larvae	O
is	O
lower	O
in	O
aprA	S-Biological_Molecule
mutants	O
clearly	O
indicates	O
that	O
the	O
AprA	S-Biological_Molecule
protease	O
promotes	O
bacterial	O
persistence	O
in	O
the	O
Drosophila	S-Species
gut	O
.	O

Whereas	O
the	O
titer	O
of	O
gacA	S-Biological_Molecule
mutants	O
decreased	O
with	O
time	O
,	O
we	O
observed	O
that	O
the	O
aprA	S-Biological_Molecule
derivative	O
persisted	O
at	O
a	O
level	O
similar	O
to	O
wild	O
-	O
type	O
bacteria	O
in	O
Rel	S-Biological_Molecule
-	O
deficient	O
mutant	O
flies	O
and	O
larvae	O
(	O
Figure	O
3A	O
and	O
3B	O
,	O
and	O
unpublished	O
data	O
)	O
.	O

P	B-Species
.	I-Species
entomophila	E-Species
infection	O
triggers	O
Imd	S-Biological_Molecule
pathway	O
activation	O
within	O
hours	O
.	O

To	O
determine	O
at	O
which	O
time	O
Imd	S-Biological_Molecule
was	O
required	O
to	O
impede	O
P	B-Species
.	I-Species
entomophila	E-Species
infection	O
,	O
we	O
monitored	O
survival	O
to	O
P	B-Species
.	I-Species
entomophila	E-Species
in	O
flies	O
in	O
which	O
the	O
Imd	S-Biological_Molecule
pathway	O
was	O
artificially	O
activated	O
in	O
a	O
time	O
-	O
dependent	O
manner	O
.	O

It	O
further	O
suggests	O
that	O
P	B-Species
.	I-Species
entomophila	E-Species
is	O
sensitive	O
to	O
immune	O
defenses	O
during	O
a	O
short	O
time	O
frame	O
and	O
subsequently	O
becomes	O
insensitive	O
.	O

Since	O
P	B-Species
.	I-Species
entomophila	E-Species
is	O
pathogenic	O
under	O
normal	O
wild	O
-	O
type	O
conditions	O
,	O
it	O
may	O
overcome	O
the	O
immune	O
response	O
by	O
establishing	O
a	O
niche	O
in	O
the	O
gut	O
before	O
the	O
Imd	S-Biological_Molecule
pathway	O
is	O
activated	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
in	O
agreement	O
with	O
the	O
results	O
described	O
above	O
,	O
persistence	O
of	O
both	O
the	O
aprA	S-Biological_Molecule
mutant	O
and	O
wild	O
-	O
type	O
bacteria	O
was	O
significantly	O
altered	O
in	O
fly	O
lines	O
over	O
-	O
expressing	O
the	O
Imd	S-Biological_Molecule
pathway	O
,	O
and	O
that	O
aprA	S-Biological_Molecule
mutants	O
survived	O
less	O
than	O
wild	O
-	O
type	O
bacteria	O
(	O
Figure	O
4B	O
)	O
.	O

Local	O
,	O
but	O
Not	O
Systemic	O
Immunity	O
,	O
Contributes	O
to	O
Resistance	O
against	O
Oral	O
Infection	O
with	O
P	B-Species
.	I-Species
entomophila	E-Species

P	B-Species
.	I-Species
entomophila	E-Species
,	O
but	O
not	O
the	O
gacA	S-Biological_Molecule
derivative	O
,	O
rapidly	O
activates	O
both	O
the	O
local	O
and	O
systemic	O
Imd	S-Biological_Molecule
-	O
dependent	O
immune	O
responses	O
in	O
Drosophila	S-Species
adults	O
,	O
which	O
can	O
be	O
demonstrated	O
using	O
RT	O
-	O
qPCR	O
with	O
fat	O
body	O
and	O
gut	O
extracts	O
(	O
Figure	O
5A	O
)	O
.	O

This	O
suggests	O
a	O
critical	O
role	O
of	O
this	O
organ	O
in	O
the	O
elimination	O
of	O
bacteria	O
.	O

We	O
thus	O
compared	O
resistance	O
to	O
P	B-Species
.	I-Species
entomophila	E-Species
infection	O
of	O
flies	O
that	O
were	O
previously	O
either	O
orally	O
infected	O
with	O
Ecc15	S-Species
(	O
to	O
activate	O
a	O
local	O
immune	O
response	O
)	O
or	O
pricked	O
with	O
Ecc15	S-Species
(	O
to	O
activate	O
a	O
systemic	O
immune	O
response	O
)	O
.	O

The	O
rationale	O
behind	O
this	O
experiment	O
is	O
based	O
on	O
previous	O
observations	O
that	O
an	O
oral	O
infection	O
with	O
Ecc15	S-Species
triggers	O
a	O
local	O
,	O
but	O
not	O
a	O
systemic	O
immune	O
response	O
at	O
the	O
adult	O
stage	O
(	O
our	O
unpublished	O
data	O
)	O
[	O
8	O
]	O
.	O

Figure	O
5C	O
shows	O
that	O
a	O
prior	O
infection	O
with	O
Ecc15	S-Species
protected	O
flies	O
against	O
a	O
subsequent	O
P	B-Species
.	I-Species
entomophila	E-Species
infection	O
only	O
when	O
Ecc15	S-Species
was	O
administrated	O
orally	O
,	O
indicating	O
that	O
the	O
local	O
,	O
but	O
not	O
the	O
systemic	O
immune	O
response	O
,	O
plays	O
an	O
important	O
role	O
in	O
P	B-Species
.	I-Species
entomophila	E-Species
clearance	O
.	O

We	O
used	O
the	O
evf	S-Biological_Molecule
-	O
deficient	O
derivative	O
because	O
this	O
bacterium	O
triggers	O
a	O
local	O
immune	O
response	O
without	O
persisting	O
in	O
the	O
gut	O
.	O

This	O
experiment	O
shows	O
that	O
wild	O
-	O
type	O
,	O
but	O
not	O
Rel	S-Biological_Molecule
flies	O
previously	O
infected	O
with	O
Ecc15	O
evf	S-Biological_Molecule
-	O
,	O
resisted	O
a	O
second	O
challenge	O
by	O
P	B-Species
.	I-Species
entomophila	E-Species
(	O
Figure	O
5D	O
)	O
.	O

This	O
demonstrates	O
that	O
the	O
protection	O
was	O
indeed	O
due	O
to	O
Imd	S-Biological_Molecule
pathway	O
activation	O
in	O
the	O
gut	O
.	O

However	O
,	O
the	O
previous	O
results	O
did	O
not	O
address	O
whether	O
the	O
Imd	S-Biological_Molecule
pathway	O
induced	O
during	O
the	O
course	O
of	O
a	O
natural	O
P	B-Species
.	I-Species
entomophila	E-Species
infection	O
contributes	O
to	O
fly	O
resistance	O
to	O
P	B-Species
.	I-Species
entomophila	E-Species
.	O

These	O
flies	O
lack	O
a	O
functional	O
Imd	S-Biological_Molecule
pathway	O
except	O
in	O
the	O
gut	O
where	O
cad	O
-	O
Gal4	S-Biological_Molecule
is	O
expressed	O
.	O

In	O
these	O
flies	O
,	O
the	O
Imd	S-Biological_Molecule
pathway	O
was	O
not	O
constitutively	O
active	O
in	O
the	O
gut	O
but	O
could	O
be	O
induced	O
upon	O
oral	O
bacterial	O
infection	O
similarly	O
to	O
the	O
wild	O
-	O
type	O
situation	O
(	O
Figure	O
S3A	O
)	O
.	O

Figure	O
5E	O
shows	O
that	O
Rel	S-Biological_Molecule
flies	O
expressing	O
Rel	S-Biological_Molecule
in	O
the	O
gut	O
survive	O
better	O
than	O
Rel	S-Biological_Molecule
mutant	O
flies	O
.	O

We	O
have	O
shown	O
that	O
AprA	S-Biological_Molecule
protects	O
P	B-Species
.	I-Species
entomophila	E-Species
against	O
the	O
Imd	S-Biological_Molecule
-	O
regulated	O
immune	O
response	O
.	O

This	O
immune	O
pathway	O
regulates	O
the	O
expression	O
of	O
several	O
AMP	O
genes	O
,	O
as	O
well	O
as	O
many	O
other	O
immune	O
genes	O
.	O

Previous	O
studies	O
indicated	O
that	O
Attacin	B-Biological_Molecule
A	E-Biological_Molecule
and	O
Diptericin	S-Biological_Molecule
are	O
the	O
AMP	O
genes	O
most	O
strongly	O
induced	O
in	O
the	O
gut	O
following	O
ingestion	O
of	O
infectious	O
bacteria	O
[	O
7	O
]	O
.	O

It	O
has	O
also	O
been	O
suggested	O
that	O
proteases	O
homologous	O
to	O
AprA	S-Biological_Molecule
in	O
other	O
bacterial	O
species	O
degrade	O
AMPs	O
in	O
vitro	O
,	O
thereby	O
enabling	O
pathogens	O
to	O
withstand	O
the	O
attack	O
of	O
the	O
host	O
immune	O
system	O
[	O
20	O
,	O
21	O
]	O
.	O

This	O
strategy	O
allowed	O
us	O
to	O
study	O
the	O
contribution	O
of	O
each	O
antibacterial	O
peptide	O
to	O
the	O
defense	O
against	O
a	O
P	B-Species
.	I-Species
entomophila	E-Species
infection	O
.	O

Ubiquitous	O
expression	O
of	O
Attacin	B-Biological_Molecule
A	E-Biological_Molecule
and	O
Diptericin	S-Biological_Molecule
with	O
the	O
da	O
-	O
Gal4	S-Biological_Molecule
driver	O
greatly	O
increased	O
the	O
resistance	O
of	O
imd	S-Biological_Molecule
mutant	O
flies	O
(	O
Figure	O
6A	O
)	O
.	O

Importantly	O
,	O
it	O
also	O
reveals	O
for	O
the	O
first	O
time	O
a	O
major	O
contribution	O
of	O
Diptericin	S-Biological_Molecule
to	O
host	O
defense	O
,	O
which	O
was	O
not	O
previously	O
detected	O
using	O
systemic	O
injection	O
of	O
microbes	O
[	O
22	O
]	O
.	O

Figure	O
6B	O
shows	O
that	O
the	O
aprA	S-Biological_Molecule
mutant	O
persisted	O
less	O
well	O
than	O
wild	O
-	O
type	O
bacteria	O
in	O
imd	O
flies	O
over	O
-	O
expressing	O
Diptericin	S-Biological_Molecule
.	O

Altogether	O
,	O
our	O
results	O
provide	O
an	O
in	O
vivo	O
demonstration	O
that	O
AprA	S-Biological_Molecule
functions	O
in	O
the	O
protection	O
of	O
P	B-Species
.	I-Species
entomophila	E-Species
against	O
Drosophila	S-Species
AMPs	O
.	O

Discussion	O

Pathogens	O
have	O
developed	O
a	O
plethora	O
of	O
strategies	O
that	O
allow	O
them	O
to	O
exploit	O
host	O
resources	O
and	O
resist	O
the	O
attacks	O
of	O
the	O
host	O
immune	O
response	O
.	O

To	O
study	O
how	O
flies	O
deal	O
with	O
infections	O
in	O
a	O
natural	O
context	O
,	O
we	O
investigated	O
the	O
interactions	O
between	O
Drosophila	S-Species
and	O
a	O
newly	O
identified	O
entomopathogen	O
,	O
P	B-Species
.	I-Species
entomophila	E-Species
.	O

Local	O
Expression	O
of	O
AMP	O
Genes	O
Plays	O
a	O
Major	O
Role	O
against	O
Food	O
-	O
Borne	O
Infections	O
The	O
use	O
of	O
GFP	S-Biological_Molecule
reporter	O
transgenes	O
in	O
Drosophila	S-Species
has	O
revealed	O
that	O
,	O
in	O
addition	O
to	O
the	O
fat	O
body	O
,	O
AMP	O
genes	O
can	O
be	O
expressed	O
in	O
several	O
barrier	O
epithelia	O
that	O
are	O
in	O
direct	O
contact	O
with	O
microorganisms	O
from	O
the	O
environment	O
[	O
7	O
,	O
23	O
]	O
.	O

The	O
present	O
study	O
demonstrates	O
a	O
key	O
role	O
for	O
the	O
local	O
Imd	S-Biological_Molecule
immune	O
response	O
in	O
the	O
gut	O
against	O
oral	O
infection	O
by	O
bacterial	O
pathogens	O
.	O

The	O
Imd	S-Biological_Molecule
pathway	O
regulates	O
a	O
large	O
number	O
of	O
immune	O
genes	O
including	O
those	O
encoding	O
AMPs	O
;	O
and	O
two	O
peptides	O
,	O
Diptericin	S-Biological_Molecule
and	O
Attacin	S-Biological_Molecule
,	O
are	O
preferentially	O
synthesized	O
following	O
bacterial	O
infection	O
in	O
the	O
digestive	O
tract	O
of	O
Drosophila	S-Species
[	O
7	O
]	O
.	O

It	O
is	O
also	O
possible	O
that	O
Diptericin	S-Biological_Molecule
could	O
reach	O
high	O
concentration	O
levels	O
in	O
restricted	O
areas	O
of	O
the	O
Drosophila	S-Species
gut	O
such	O
as	O
the	O
proventriculus	O
and	O
thus	O
be	O
more	O
effective	O
against	O
pathogens	O
than	O
in	O
other	O
body	O
compartments	O
.	O

Our	O
study	O
suggests	O
that	O
Diptericin	S-Biological_Molecule
expression	O
in	O
the	O
anterior	O
gut	O
provides	O
an	O
efficient	O
early	O
barrier	O
allowing	O
Drosophila	S-Species
to	O
rapidly	O
eliminate	O
most	O
ingested	O
bacteria	O
.	O

Finally	O
,	O
it	O
remains	O
surprising	O
that	O
P	B-Species
.	I-Species
entomophila	E-Species
infection	O
triggers	O
a	O
systemic	O
immune	O
response	O
that	O
has	O
no	O
overt	O
function	O
against	O
the	O
bacteria	O
that	O
remain	O
in	O
the	O
gut	O
lumen	O
.	O

This	O
response	O
could	O
be	O
interpreted	O
as	O
anticipation	O
of	O
possible	O
breaching	O
of	O
the	O
gut	O
barrier	O
.	O

Alternatively	O
,	O
our	O
results	O
suggest	O
the	O
possibility	O
that	O
bacteria	O
such	O
as	O
P	B-Species
.	I-Species
entomophila	E-Species
may	O
subvert	O
insect	O
host	O
defenses	O
by	O
triggering	O
this	O
systemic	O
response	O
.	O

This	O
can	O
be	O
compared	O
with	O
many	O
human	S-Species
pathogens	O
for	O
which	O
activation	O
of	O
an	O
inflammatory	O
response	O
represents	O
a	O
part	O
of	O
their	O
invasive	O
strategy	O
[	O
25	O
]	O
.	O

Proteases	O
,	O
especially	O
metalloproteases	O
,	O
are	O
also	O
known	O
to	O
contribute	O
to	O
virulence	O
in	O
some	O
pathogenic	O
bacteria	O
including	O
Pseudomonas	B-Species
aeruginosa	E-Species
,	O
S	B-Species
.	I-Species
marcescens	E-Species
,	O
and	O
Bacillus	B-Species
thuringiensis	E-Species
[	O
20	O
,	O
21	O
,	O
26	O
]	O
.	O

Molecular	O
mechanisms	O
for	O
pathogenesis	O
attributed	O
to	O
these	O
proteases	O
include	O
degradation	O
of	O
structural	O
matrices	O
and	O
destruction	O
of	O
proteins	O
involved	O
in	O
host	O
protective	O
functions	O
such	O
as	O
AMPs	O
or	O
complement	O
factors	O
.	O

However	O
,	O
in	O
most	O
cases	O
,	O
attempts	O
to	O
evaluate	O
the	O
role	O
of	O
metalloproteases	O
in	O
virulence	O
have	O
failed	O
to	O
obtain	O
conclusive	O
results	O
with	O
respect	O
to	O
a	O
specific	O
function	O
[	O
20	O
,	O
21	O
]	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
S	B-Species
.	I-Species
marcescens	E-Species
,	O
another	O
potent	O
oral	O
pathogen	O
of	O
Drosophila	S-Species
,	O
also	O
expresses	O
a	O
protease	O
that	O
can	O
degrade	O
AMPs	O
in	O
vitro	O
[	O
12	O
]	O
.	O

However	O
,	O
in	O
the	O
absence	O
of	O
a	O
Serratia	B-Species
protease	I-Species
mutant	E-Species
,	O
the	O
in	O
vivo	O
relevance	O
of	O
the	O
protease	O
is	O
not	O
yet	O
established	O
.	O

We	O
cannot	O
exclude	O
that	O
AprA	S-Biological_Molecule
degrades	O
other	O
immune	O
effectors	O
or	O
participates	O
directly	O
as	O
a	O
toxic	O
factor	O
by	O
degrading	O
the	O
gut	O
epithelium	O
or	O
the	O
peritrophic	O
matrix	O
.	O

In	O
B	B-Species
.	I-Species
thuringiensis	E-Species
,	O
it	O
has	O
been	O
proposed	O
that	O
the	O
protease	O
InhA2	S-Biological_Molecule
participates	O
in	O
the	O
degradation	O
of	O
the	O
gut	O
,	O
thus	O
facilitating	O
the	O
action	O
of	O
the	O
Cry	S-Biological_Molecule
toxins	O
[	O
27	O
,	O
28	O
]	O
.	O

The	O
observation	O
that	O
injection	O
of	O
AprA	S-Biological_Molecule
into	O
the	O
hemocoel	O
is	O
lethal	O
to	O
adult	O
flies	O
supports	O
the	O
hypothesis	O
of	O
additional	O
roles	O
for	O
the	O
protease	O
in	O
bacterial	O
pathogenesis	O
.	O

However	O
,	O
oral	O
ingestion	O
of	O
purified	O
AprA	S-Biological_Molecule
induces	O
only	O
low	O
levels	O
of	O
lethality	O
,	O
indicating	O
that	O
AprA	S-Biological_Molecule
alone	O
is	O
not	O
sufficient	O
to	O
kill	O
the	O
host	O
via	O
this	O
route	O
of	O
entry	O
,	O
and	O
other	O
factors	O
participate	O
in	O
oral	O
toxicity	O
.	O

In	O
a	O
gacA	S-Biological_Molecule
mutant	O
background	O
,	O
AprA	S-Biological_Molecule
synthesis	O
is	O
not	O
restored	O
when	O
a	O
plasmid	O
with	O
the	O
aprA	S-Biological_Molecule
locus	O
is	O
expressed	O
in	O
trans	O
(	O
unpublished	O
data	O
)	O
,	O
which	O
is	O
in	O
agreement	O
with	O
post	O
-	O
transcriptional	O
regulation	O
of	O
aprA	S-Biological_Molecule
by	O
gacA	S-Biological_Molecule
via	O
the	O
two	O
small	O
non	O
-	O
coding	O
RNAs	O
RsmY	S-Biological_Molecule
and	O
RsmZ	S-Biological_Molecule
[	O
11	O
]	O
.	O

As	O
opposed	O
to	O
the	O
pleiotropic	O
effects	O
of	O
GacS	S-Biological_Molecule
/	O
GacA	S-Biological_Molecule
,	O
PrtR	S-Biological_Molecule
appears	O
to	O
be	O
a	O
more	O
specific	O
regulator	O
of	O
aprA	S-Biological_Molecule
expression	O
in	O
P	B-Species
.	I-Species
entomophila	E-Species
,	O
reminiscent	O
of	O
aprX	S-Biological_Molecule
regulation	O
in	O
P	B-Species
.	I-Species
fluorescens	E-Species
[	O
32	O
]	O
.	O

Many	O
pseudomonads	S-Species
and	O
other	O
bacteria	O
express	O
proteases	O
similar	O
to	O
AprA	S-Biological_Molecule
but	O
are	O
not	O
able	O
to	O
infect	O
Drosophila	S-Species
by	O
oral	O
ingestion	O
.	O

The	O
difference	O
in	O
pathogenicity	O
exhibited	O
by	O
gacA	S-Biological_Molecule
,	O
prtR	S-Biological_Molecule
,	O
and	O
aprA	S-Biological_Molecule
mutants	O
underlines	O
the	O
complexity	O
of	O
P	B-Species
.	I-Species
entomophila	E-Species
virulence	O
factors	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
GacS	S-Biological_Molecule
/	O
GacA	S-Biological_Molecule
two	O
-	O
component	O
system	O
regulates	O
one	O
or	O
several	O
genes	O
that	O
promote	O
bacterial	O
survival	O
in	O
the	O
gut	O
.	O

Since	O
gacA	S-Biological_Molecule
mutants	O
did	O
not	O
persist	O
in	O
imd	O
-	O
deficient	O
mutant	O
hosts	O
,	O
we	O
speculate	O
that	O
this	O
persistence	O
-	O
promoting	O
factor	O
provides	O
general	O
protection	O
against	O
gut	O
intestinal	O
conditions	O
rather	O
than	O
a	O
specific	O
protection	O
against	O
the	O
fly	O
immune	O
response	O
.	O

Food	O
-	O
uptake	O
cessation	O
or	O
blockage	O
in	O
insects	O
is	O
induced	O
by	O
several	O
other	O
entomopathogenic	O
bacteria	O
including	O
S	B-Species
.	I-Species
entomophila	E-Species
and	O
Yersinia	B-Species
pestis	E-Species
,	O
enabling	O
persistence	O
in	O
the	O
digestive	O
tract	O
of	O
their	O
insect	O
hosts	O
[	O
35	O
,	O
36	O
]	O
.	O

This	O
observation	O
suggests	O
that	O
peristaltic	O
movements	O
of	O
the	O
gut	O
may	O
also	O
play	O
an	O
important	O
role	O
in	O
the	O
elimination	O
of	O
bacteria	O
,	O
and	O
that	O
entomopathogens	O
have	O
developed	O
strategies	O
to	O
abrogate	O
these	O
movements	O
.	O

Determining	O
the	O
cause	O
of	O
this	O
food	O
-	O
uptake	O
cessation	O
and	O
its	O
possible	O
link	O
to	O
the	O
persistence	O
-	O
promoting	O
factor	O
will	O
be	O
essential	O
for	O
the	O
elucidation	O
of	O
the	O
initial	O
events	O
involved	O
in	O
gut	O
colonization	O
.	O

This	O
confirms	O
the	O
existence	O
of	O
other	O
bacterial	O
virulence	O
factors	O
.	O

Therefore	O
,	O
it	O
remains	O
to	O
be	O
determined	O
whether	O
the	O
strategies	O
developed	O
by	O
P	B-Species
.	I-Species
entomophila	E-Species
to	O
persist	O
in	O
the	O
larval	O
gut	O
and	O
to	O
kill	O
its	O
host	O
involves	O
genes	O
related	O
to	O
those	O
identified	O
in	O
other	O
entomopathogenic	O
bacteria	O
and	O
how	O
the	O
different	O
factors	O
contribute	O
to	O
pathogenesis	O
.	O

Application	O
of	O
this	O
method	O
to	O
Escherichia	B-Species
coli	E-Species
motility	O
identifies	O
95	O
%	O
of	O
the	O
known	O
flagellar	O
and	O
chemotaxis	O
genes	O
,	O
and	O
reveals	O
three	O
dozen	O
novel	O
loci	O
that	O
,	O
to	O
varying	O
degrees	O
and	O
through	O
diverse	O
mechanisms	O
,	O
affect	O
motility	O
.	O

This	O
allows	O
us	O
to	O
place	O
the	O
novel	O
genes	O
within	O
the	O
context	O
of	O
signaling	O
and	O
regulatory	O
networks	O
,	O
including	O
the	O
Rcs	O
phosphorelay	O
pathway	O
and	O
the	O
cyclic	B-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
second	O
-	O
messenger	O
system	O
.	O

These	O
behaviors	O
are	O
contingent	O
on	O
sophisticated	O
sensory	O
systems	O
that	O
maximize	O
fitness	O
in	O
the	O
complex	O
and	O
highly	O
dynamic	O
environments	O
where	O
physical	O
,	O
chemical	O
,	O
and	O
biological	O
parameters	O
change	O
on	O
many	O
different	O
time	O
scales	O
.	O

Modern	O
genetic	O
and	O
molecular	O
studies	O
have	O
largely	O
focused	O
on	O
a	O
limited	O
repertoire	O
of	O
behaviors	O
of	O
a	O
few	O
model	O
organisms	O
in	O
the	O
non	O
-	O
native	O
context	O
of	O
the	O
laboratory	O
.	O

Chemotaxis	O
,	O
the	O
capacity	O
to	O
move	O
up	O
and	O
down	O
chemical	O
gradients	O
,	O
is	O
widespread	O
in	O
the	O
bacterial	O
world	O
.	O

An	O
impressive	O
achievement	O
of	O
20th	O
-	O
century	O
biology	O
was	O
a	O
systems	O
-	O
level	O
understanding	O
of	O
bacterial	O
chemotaxis	O
in	O
terms	O
of	O
the	O
structures	O
,	O
interactions	O
,	O
and	O
organization	O
of	O
the	O
roughly	O
50	O
constituent	O
molecular	O
components	O
[	O
2	O
-	O
4	O
]	O
.	O

When	O
the	O
filament	O
rotates	O
in	O
the	O
counterclockwise	O
(	O
CCW	O
)	O
direction	O
,	O
as	O
viewed	O
from	O
outside	O
the	O
cell	O
,	O
a	O
helical	O
wave	O
travels	O
down	O
the	O
filament	O
away	O
from	O
the	O
cell	O
body	O
.	O

The	O
direction	O
of	O
rotation	O
is	O
influenced	O
by	O
the	O
output	O
of	O
the	O
chemotaxis	O
network	O
,	O
which	O
consists	O
of	O
a	O
signal	O
transduction	O
cascade	O
that	O
allows	O
robust	O
adaptation	O
to	O
local	O
concentrations	O
of	O
ligands	O
over	O
many	O
orders	O
of	O
magnitude	O
[	O
7	O
,	O
8	O
]	O
.	O

When	O
cells	O
detect	O
an	O
increase	O
in	O
the	O
concentration	O
of	O
an	O
attractant	O
,	O
tumbling	O
is	O
suppressed	O
so	O
as	O
to	O
allow	O
cells	O
to	O
migrate	O
towards	O
the	O
source	O
through	O
the	O
statistical	O
strategy	O
of	O
a	O
biased	O
random	O
walk	O
[	O
9	O
]	O
.	O

These	O
events	O
yield	O
an	O
orderly	O
"	O
just	O
-	O
in	O
-	O
time	O
"	O
expression	O
and	O
assembly	O
of	O
the	O
flagellar	O
components	O
[	O
11	O
]	O
,	O
which	O
consist	O
of	O
a	O
basal	O
body	O
complex	O
and	O
a	O
filament	O
.	O

The	O
identification	O
of	O
the	O
molecular	O
components	O
and	O
their	O
organization	O
into	O
the	O
two	O
dominant	O
modules	O
-	O
the	O
chemotaxis	O
network	O
and	O
the	O
flagellum	O
/	O
basal	O
body	O
/	O
motor	O
system	O
-	O
took	O
the	O
better	O
part	O
of	O
40	O
years	O
and	O
the	O
work	O
of	O
dozens	O
of	O
laboratories	O
.	O

To	O
fully	O
identify	O
the	O
genetic	O
determinants	O
for	O
this	O
phenotype	O
,	O
a	O
library	O
of	O
transposon	O
-	O
mutagenized	O
cells	O
was	O
functionally	O
enriched	O
en	O
masse	O
for	O
impaired	O
swimming	O
and	O
surface	O
-	O
mediated	O
swarming	O
motility	O
.	O

Further	O
characterization	O
of	O
these	O
novel	O
genes	O
revealed	O
that	O
they	O
impair	O
motility	O
through	O
diverse	O
mechanisms	O
such	O
as	O
disrupting	O
signaling	O
through	O
phosphorelay	O
cascades	O
,	O
altering	O
concentrations	O
of	O
the	O
recently	O
appreciated	O
cyclic	B-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
(	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
)	O
second	O
messenger	O
,	O
and	O
by	O
mechanisms	O
that	O
have	O
yet	O
to	O
be	O
revealed	O
.	O

Subsequent	O
genome	O
-	O
wide	O
epistasis	O
analyses	O
allow	O
us	O
to	O
organize	O
the	O
discovered	O
loci	O
into	O
signaling	O
and	O
regulatory	O
pathways	O
.	O

Results	O
/	O
Discussion	O

Our	O
approach	O
combines	O
genetic	O
footprinting	O
[	O
13	O
]	O
with	O
microarray	O
hybridization	O
[	O
14	O
]	O
in	O
order	O
to	O
monitor	O
,	O
in	O
parallel	O
,	O
the	O
relative	O
abundances	O
of	O
transposon	O
-	O
mutagenized	O
cells	O
throughout	O
a	O
competitive	O
selection	O
experiment	O
[	O
12	O
]	O
.	O

Given	O
the	O
reduced	O
target	O
specificity	O
and	O
a	O
genome	O
of	O
approximately	O
4	O
,	O
300	O
genes	O
,	O
the	O
mutagenesis	O
of	O
our	O
library	O
is	O
saturating	O
with	O
an	O
average	O
of	O
approximately100	O
independent	O
insertions	O
within	O
each	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
.	O

In	O
each	O
of	O
our	O
experiments	O
,	O
a	O
population	O
of	O
mutants	O
is	O
challenged	O
for	O
competitive	O
growth	O
under	O
a	O
selection	O
of	O
interest	O
.	O

Each	O
mutant	O
within	O
the	O
population	O
is	O
uniquely	O
defined	O
by	O
the	O
local	O
sequence	O
flanking	O
the	O
transposon	O
insertion	O
site	O
.	O

The	O
series	O
of	O
molecular	O
manipulations	O
detailed	O
in	O
Figure	O
S1	O
allow	O
the	O
amplification	O
of	O
roughly	O
200	O
base	O
pairs	O
flanking	O
each	O
transposon	O
insertion	O
site	O
in	O
a	O
population	O
in	O
parallel	O
.	O

As	O
a	O
consequence	O
of	O
selection	O
,	O
individual	O
insertional	O
mutants	O
can	O
increase	O
or	O
decrease	O
in	O
abundance	O
during	O
the	O
course	O
of	O
an	O
experiment	O
,	O
and	O
these	O
relative	O
changes	O
can	O
be	O
monitored	O
by	O
comparing	O
genome	O
-	O
wide	O
hybridization	O
values	O
before	O
and	O
after	O
selection	O
.	O

To	O
determine	O
the	O
degree	O
to	O
which	O
each	O
gene	O
contributes	O
to	O
fitness	O
under	O
a	O
particular	O
selection	O
,	O
we	O
quantify	O
the	O
extent	O
of	O
enrichment	O
or	O
depletion	O
of	O
all	O
transposon	O
insertions	O
within	O
a	O
gene	O
after	O
a	O
selection	O
is	O
imposed	O
.	O

We	O
assign	O
the	O
total	O
hybridization	O
signal	O
for	O
each	O
ORF	O
on	O
the	O
array	O
as	O
the	O
sum	O
of	O
contributions	O
from	O
all	O
the	O
mutants	O
that	O
harbor	O
an	O
insertion	O
somewhere	O
within	O
or	O
in	O
close	O
proximity	O
to	O
the	O
ORF	O
.	O

ORFs	O
that	O
harbor	O
deleterious	O
mutations	O
during	O
the	O
selection	O
will	O
have	O
negative	O
z	O
-	O
scores	O
(	O
corresponding	O
to	O
depletion	O
)	O
,	O
whereas	O
ORFs	O
that	O
harbor	O
relatively	O
favorable	O
mutations	O
during	O
the	O
selection	O
will	O
have	O
positive	O
z	O
-	O
scores	O
(	O
corresponding	O
to	O
enrichment	O
)	O
.	O

Genetic	O
Basis	O
of	O
Swimming	O
Motility	O
and	O
Chemotaxis	O

Semi	O
-	O
solid	O
tryptone	O
agar	O
provides	O
a	O
robust	O
setting	O
for	O
studying	O
E	B-Species
.	I-Species
coli	E-Species
chemotaxis	O
.	O

Once	O
inoculated	O
into	O
a	O
region	O
of	O
the	O
soft	O
agar	O
,	O
bacteria	O
deplete	O
local	O
nutrients	O
and	O
chemotax	O
radially	O
outward	O
following	O
the	O
concentration	O
gradient	O
of	O
preferred	O
substrates	O
[	O
17	O
]	O
.	O

To	O
systematically	O
and	O
completely	O
identify	O
the	O
genetic	O
determinants	O
for	O
swimming	O
motility	O
,	O
approximately107	O
cells	O
of	O
the	O
mutant	O
library	O
were	O
functionally	O
enriched	O
en	O
masse	O
for	O
an	O
impaired	O
ability	O
to	O
swim	O
through	O
soft	O
agar	O
.	O

The	O
percentage	O
of	O
nonmotile	O
mutants	O
was	O
determined	O
after	O
each	O
stage	O
of	O
enrichment	O
by	O
a	O
clonal	O
plating	O
assay	O
and	O
,	O
after	O
five	O
stages	O
,	O
96	O
%	O
of	O
the	O
mutants	O
showed	O
an	O
impaired	O
ability	O
to	O
swim	O
(	O
Figure	O
S3	O
)	O
.	O

The	O
amplification	O
of	O
transposon	O
insertion	O
sites	O
from	O
a	O
small	O
sample	O
of	O
these	O
mutants	O
showed	O
that	O
the	O
nonmotile	O
phenotype	O
is	O
the	O
result	O
of	O
a	O
single	O
gene	O
disruption	O
in	O
each	O
mutant	O
.	O

As	O
expected	O
,	O
the	O
vast	O
majority	O
of	O
these	O
disruptions	O
occurred	O
in	O
previously	O
known	O
flagellar	O
or	O
chemotaxis	O
genes	O
(	O
Table	O
S3	O
)	O
.	O

However	O
,	O
even	O
in	O
this	O
small	O
sample	O
,	O
we	O
found	O
transposon	O
insertions	O
in	O
genes	O
without	O
a	O
previously	O
known	O
role	O
in	O
motility	O
.	O

To	O
obtain	O
a	O
genome	O
-	O
wide	O
catalog	O
of	O
loci	O
involved	O
in	O
swimming	O
motility	O
,	O
we	O
applied	O
our	O
microarray	O
-	O
based	O
genetic	O
footprinting	O
assay	O
to	O
the	O
population	O
of	O
mutants	O
at	O
the	O
end	O
of	O
the	O
enrichments	O
.	O

However	O
,	O
of	O
the	O
115	O
ORFs	O
with	O
z	O
-	O
scores	O
greater	O
than	O
12	O
,	O
49	O
are	O
known	O
flagellar	O
and	O
chemotaxis	O
genes	O
.	O

Since	O
the	O
microarray	O
contained	O
52	O
out	O
of	O
the	O
total	O
of	O
54	O
known	O
motility	O
genes	O
[	O
18	O
]	O
,	O
the	O
chance	O
likelihood	O
of	O
observing	O
this	O
level	O
of	O
enrichment	O
was	O
extremely	O
low	O
(	O
p	O
<	O
10	O
-	O
76	O
)	O
.	O

We	O
confirmed	O
this	O
expectation	O
by	O
showing	O
that	O
deletions	O
of	O
fliT	S-Biological_Molecule
and	O
aer	S-Biological_Molecule
did	O
not	O
affect	O
motility	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
neutral	O
behavior	O
of	O
the	O
fliT	S-Biological_Molecule
mutation	O
is	O
not	O
surprising	O
since	O
fliT	S-Biological_Molecule
null	O
strains	O
were	O
found	O
to	O
make	O
functional	O
flagella	O
in	O
S	B-Species
.	I-Species
enterica	E-Species
[	O
19	O
]	O
.	O

In	O
addition	O
,	O
it	O
has	O
been	O
reported	O
that	O
fliT	S-Biological_Molecule
mutations	O
enhance	O
expression	O
of	O
class	O
2	O
flagellar	O
operons	O
[	O
20	O
]	O
because	O
FliT	S-Biological_Molecule
acts	O
as	O
a	O
negative	O
regulator	O
of	O
these	O
operons	O
by	O
binding	O
to	O
and	O
inhibiting	O
the	O
activity	O
of	O
FlhDC	S-Biological_Molecule
[	O
21	O
]	O
.	O

The	O
protein	O
encoded	O
by	O
aer	O
mediates	O
oxygen	S-Chemical_Compound
and	O
redox	O
sensing	O
,	O
and	O
as	O
such	O
shares	O
overlapping	O
function	O
with	O
the	O
Tsr	S-Biological_Molecule
receptor	O
[	O
22	O
]	O
.	O

Remarkably	O
,	O
the	O
selection	O
results	O
revealed	O
many	O
genes	O
with	O
high	O
z	O
-	O
scores	O
without	O
a	O
previously	O
known	O
role	O
in	O
motility	O
.	O

To	O
minimize	O
such	O
false	O
positives	O
,	O
we	O
demanded	O
that	O
a	O
candidate	O
motility	O
gene	O
obtain	O
a	O
z	O
-	O
score	O
above	O
12	O
in	O
at	O
least	O
two	O
of	O
the	O
three	O
replicate	O
selections	O
(	O
Datasets	O
S2	O
,	O
S3	O
,	O
and	O
S4	O
)	O
.	O

We	O
observed	O
that	O
some	O
false	O
positives	O
were	O
indeed	O
due	O
to	O
hitchhiking	O
,	O
but	O
others	O
were	O
due	O
to	O
polar	O
effects	O
of	O
transposon	O
insertions	O
on	O
downstream	O
genes	O
within	O
operons	O
.	O

However	O
,	O
the	O
number	O
of	O
false	O
positives	O
can	O
be	O
driven	O
lower	O
by	O
decreasing	O
the	O
cycles	O
of	O
selection	O
,	O
increasing	O
the	O
number	O
of	O
replicates	O
,	O
or	O
by	O
focusing	O
on	O
genes	O
with	O
relatively	O
high	O
z	O
-	O
scores	O
.	O

In	O
the	O
sections	O
that	O
follow	O
,	O
we	O
explore	O
the	O
manner	O
in	O
which	O
the	O
validated	O
newly	O
identified	O
genes	O
affect	O
motility	O
.	O

Bacteriophage	O
chi	S-Species
infects	O
E	B-Species
.	I-Species
coli	E-Species
by	O
attaching	O
to	O
and	O
traveling	O
along	O
flagellar	O
filaments	O
[	O
24	O
]	O
.	O

The	O
library	O
of	O
transposon	O
insertional	O
mutants	O
was	O
exposed	O
to	O
chi	S-Species
-	O
phage	O
in	O
an	O
environment	O
conducive	O
to	O
motility	O
(	O
Figure	O
2A	O
)	O
.	O

Figure	O
2B	O
shows	O
the	O
distribution	O
of	O
z	O
-	O
scores	O
after	O
library	O
selection	O
upon	O
exposure	O
to	O
bacteriophage	O
chi	S-Species
,	O
and	O
the	O
complete	O
microarray	O
results	O
for	O
duplicate	O
selections	O
can	O
be	O
found	O
in	O
Datasets	O
S5	O
and	O
S6	O
.	O

As	O
expected	O
,	O
insertional	O
mutations	O
in	O
flagellar	O
genes	O
conferred	O
resistance	O
to	O
chi	S-Species
-	O
phage	O
infection	O
.	O

This	O
is	O
to	O
be	O
expected	O
,	O
since	O
null	O
mutations	O
in	O
these	O
genes	O
do	O
not	O
entirely	O
abolish	O
CCW	O
flagellar	O
rotation	O
.	O

The	O
only	O
exception	O
among	O
the	O
che	O
genes	O
is	O
cheZ	S-Biological_Molecule
,	O
whose	O
z	O
-	O
score	O
of	O
+	O
8	O
.	O
7	O
indicates	O
a	O
CW	O
flagellar	O
rotation	O
bias	O
and	O
reduced	O
susceptibility	O
to	O
chi	S-Species
-	O
phage	O
infection	O
.	O

Therefore	O
,	O
in	O
the	O
absence	O
of	O
CheZ	S-Biological_Molecule
,	O
CheY	S-Biological_Molecule
is	O
maintained	O
in	O
the	O
phosphorylated	O
state	O
,	O
"	O
locking	O
"	O
flagellar	O
rotation	O
in	O
the	O
CW	O
direction	O
,	O
and	O
hence	O
minimizing	O
infection	O
by	O
chi	S-Species
-	O
phage	O
.	O

The	O
role	O
these	O
structures	O
play	O
in	O
chi	S-Species
-	O
phage	O
infection	O
and	O
the	O
impact	O
they	O
have	O
on	O
motility	O
are	O
discussed	O
in	O
a	O
separate	O
section	O
below	O
.	O

Genetic	O
Basis	O
of	O
Swarming	O
Motility	O

Swarming	O
is	O
exhibited	O
by	O
many	O
flagellated	O
bacteria	O
,	O
and	O
is	O
defined	O
as	O
a	O
coordinated	O
multicellular	O
migration	O
across	O
a	O
solid	O
surface	O
by	O
morphologically	O
differentiated	O
cells	O
[	O
28	O
]	O
.	O

Confocal	O
fluorescence	O
microscopy	O
shows	O
swarming	O
cells	O
aligning	O
themselves	O
lengthwise	O
and	O
moving	O
coordinately	O
in	O
groups	O
,	O
forming	O
"	O
rafts	O
"	O
(	O
Movie	O
S1	O
)	O
.	O

In	O
this	O
context	O
,	O
the	O
cells	O
appear	O
to	O
execute	O
smooth	O
swimming	O
behavior	O
almost	O
exclusively	O
,	O
in	O
contrast	O
to	O
the	O
extensive	O
switching	O
back	O
and	O
forth	O
seen	O
during	O
chemotaxis	O
.	O

Aside	O
from	O
the	O
requirement	O
for	O
flagella	O
,	O
other	O
aspects	O
of	O
the	O
behavior	O
are	O
poorly	O
understood	O
.	O

Because	O
the	O
genetic	O
basis	O
of	O
swarming	O
is	O
not	O
well	O
characterized	O
,	O
this	O
behavior	O
is	O
well	O
suited	O
for	O
comprehensive	O
analysis	O
using	O
our	O
approach	O
.	O

A	O
single	O
round	O
of	O
enrichment	O
consisted	O
of	O
inoculating	O
our	O
library	O
of	O
E	B-Species
.	I-Species
coli	E-Species
mutants	O
onto	O
the	O
center	O
of	O
agar	O
plates	O
,	O
incubating	O
the	O
plates	O
to	O
allow	O
the	O
cells	O
to	O
migrate	O
outward	O
from	O
the	O
site	O
of	O
inoculation	O
,	O
and	O
transferring	O
bacteria	O
from	O
the	O
original	O
area	O
of	O
inoculation	O
to	O
a	O
fresh	O
plate	O
.	O

After	O
twenty	O
rounds	O
of	O
daily	O
successive	O
transfers	O
(	O
Figure	O
3A	O
)	O
,	O
more	O
than	O
90	O
%	O
of	O
the	O
population	O
exhibited	O
a	O
defect	O
in	O
swarming	O
(	O
Figure	O
S5	O
)	O
.	O

As	O
expected	O
,	O
the	O
selection	O
results	O
were	O
dominated	O
by	O
flagellar	O
and	O
chemotaxis	O
genes	O
(	O
Figure	O
3B	O
)	O
.	O

While	O
mutants	O
with	O
a	O
defect	O
in	O
the	O
flagellar	O
apparatus	O
did	O
not	O
swarm	O
,	O
chemotaxis	O
mutants	O
formed	O
swarming	O
patterns	O
as	O
finger	O
-	O
like	O
projections	O
,	O
in	O
contrast	O
to	O
the	O
more	O
uniform	O
swarming	O
patterns	O
generated	O
by	O
the	O
wild	O
-	O
type	O
parent	O
strain	O
(	O
Figure	O
3C	O
)	O
.	O

These	O
observations	O
indicate	O
that	O
the	O
chemotaxis	O
sensory	O
system	O
and	O
flagellar	O
switching	O
have	O
an	O
effect	O
on	O
,	O
but	O
are	O
not	O
critical	O
for	O
,	O
surface	O
motility	O
.	O

Novel	O
Genes	O
Implicated	O
in	O
Swimming	O
,	O
Swarming	O
,	O
and	O
chi	O
-	O
Phage	O
Infection	O

For	O
example	O
,	O
of	O
the	O
20	O
non	O
-	O
flagellar	O
genes	O
revealed	O
to	O
affect	O
swimming	O
motility	O
,	O
twelve	O
encode	O
constituents	O
of	O
the	O
inner	O
membrane	O
and	O
periplasmic	O
space	O
.	O

Surprisingly	O
,	O
while	O
mutants	O
with	O
deletions	O
of	O
rcsD	S-Biological_Molecule
,	O
sdaC	S-Biological_Molecule
,	O
tatA	S-Biological_Molecule
,	O
and	O
yhjH	S-Biological_Molecule
were	O
impaired	O
in	O
swimming	O
,	O
these	O
mutants	O
swarmed	O
normally	O
(	O
unpublished	O
data	O
)	O
.	O

Interrogation	O
of	O
genes	O
with	O
high	O
z	O
-	O
scores	O
in	O
the	O
enrichment	O
for	O
mutants	O
incapable	O
of	O
swarming	O
identified	O
two	O
additional	O
genes	O
that	O
impact	O
surface	O
motility	O
:	O
hns	S-Biological_Molecule
,	O
encoding	O
a	O
global	O
transcriptional	O
regulator	O
,	O
and	O
yfiR	S-Biological_Molecule
,	O
encoding	O
a	O
predicted	O
periplasmic	O
protein	O
of	O
unknown	O
function	O
.	O

In	O
-	O
frame	O
deletions	O
of	O
these	O
genes	O
abolished	O
swarming	O
;	O
however	O
,	O
while	O
the	O
Deltahns	S-Biological_Molecule
mutant	O
showed	O
a	O
severe	O
swimming	O
defect	O
,	O
the	O
swimming	O
motility	O
of	O
the	O
DeltayfiR	S-Biological_Molecule
mutant	O
was	O
only	O
mildly	O
impaired	O
(	O
Figures	O
3D	O
and	O
4	O
)	O
.	O

Among	O
the	O
loci	O
exhibiting	O
high	O
z	O
-	O
scores	O
after	O
chi	O
-	O
phage	O
selection	O
were	O
the	O
rfa	O
and	O
mdo	O
gene	O
clusters	O
responsible	O
for	O
the	O
structural	O
assembly	O
of	O
lipopolysaccharides	S-Chemical_Compound
(	O
LPS	S-Chemical_Compound
)	O
and	O
osmoregulated	B-Chemical_Compound
periplasmic	I-Chemical_Compound
glucans	E-Chemical_Compound
(	O
OPG	S-Chemical_Compound
)	O
.	O

Genes	O
involved	O
with	O
the	O
synthesis	O
of	O
LPS	S-Chemical_Compound
and	O
OPG	S-Chemical_Compound
precursors	O
(	O
hldD	S-Biological_Molecule
,	O
hldE	S-Biological_Molecule
,	O
galU	S-Biological_Molecule
,	O
gmhA	S-Biological_Molecule
,	O
gmhB	S-Biological_Molecule
,	O
and	O
pgm	S-Biological_Molecule
)	O
were	O
also	O
highly	O
abundant	O
after	O
chi	S-Species
-	O
phage	O
selection	O
.	O

To	O
investigate	O
this	O
possibility	O
,	O
we	O
introduced	O
flhDC	S-Biological_Molecule
-	O
lacZ	S-Biological_Molecule
translational	O
fusions	O
in	O
the	O
deletion	O
strains	O
and	O
performed	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
galactosidase	E-Biological_Molecule
assays	O
.	O

Surprisingly	O
,	O
a	O
large	O
fraction	O
of	O
the	O
mutants	O
tested	O
showed	O
significant	O
reduction	O
in	O
flhDC	S-Biological_Molecule
-	O
lacZ	S-Biological_Molecule
expression	O
values	O
relative	O
to	O
the	O
wild	O
-	O
type	O
strain	O
,	O
demonstrating	O
that	O
the	O
motility	O
defects	O
can	O
be	O
partly	O
attributed	O
to	O
reduced	O
expression	O
of	O
the	O
flhDC	S-Biological_Molecule
operon	O
.	O

In	O
addition	O
,	O
we	O
noticed	O
that	O
LPS	S-Chemical_Compound
mutants	O
varied	O
widely	O
in	O
flhDC	S-Biological_Molecule
expression	O
and	O
that	O
the	O
repression	O
of	O
this	O
operon	O
,	O
and	O
the	O
corresponding	O
motility	O
defect	O
,	O
were	O
related	O
to	O
the	O
degree	O
of	O
LPS	S-Chemical_Compound
truncation	O
(	O
Figure	O
4	O
)	O
.	O

LPS	S-Chemical_Compound
and	O
OPG	S-Chemical_Compound
Mutations	O
Impair	O
Motility	O
by	O
Repressing	O
Flagellar	O
Gene	O
Expression	O
through	O
the	O
Rcs	O
Signaling	O
Pathway	O

To	O
determine	O
the	O
role	O
of	O
the	O
Rcs	O
signaling	O
pathway	O
in	O
LPS	S-Chemical_Compound
/	O
OPG	S-Chemical_Compound
mediated	O
repression	O
of	O
motility	O
,	O
we	O
disrupted	O
each	O
of	O
the	O
components	O
of	O
the	O
Rcs	O
system	O
in	O
most	O
of	O
our	O
LPS	S-Chemical_Compound
and	O
OPG	S-Chemical_Compound
mutants	O
.	O

We	O
found	O
that	O
deletion	O
of	O
rcsB	S-Biological_Molecule
,	O
rcsD	S-Biological_Molecule
,	O
or	O
rcsF	S-Biological_Molecule
was	O
sufficient	O
to	O
rescue	O
motility	O
in	O
both	O
LPS	S-Chemical_Compound
and	O
OPG	S-Chemical_Compound
mutants	O
(	O
Figure	O
S6	O
)	O
,	O
providing	O
strong	O
evidence	O
that	O
perturbations	O
in	O
these	O
structures	O
repress	O
motility	O
by	O
signaling	O
through	O
the	O
Rcs	O
pathway	O
.	O

This	O
observation	O
is	O
consistent	O
with	O
the	O
dual	O
functional	O
role	O
of	O
RcsC	S-Biological_Molecule
as	O
both	O
kinase	O
and	O
phosphatase	O
,	O
moving	O
phosphates	S-Chemical_Compound
both	O
to	O
and	O
away	O
from	O
RcsB	S-Biological_Molecule
via	O
RcsD	S-Biological_Molecule
,	O
and	O
that	O
RcsB	S-Biological_Molecule
remains	O
phosphorylated	O
in	O
rcsC	S-Biological_Molecule
null	O
mutants	O
[	O
38	O
,	O
39	O
]	O
.	O

This	O
conclusion	O
is	O
further	O
supported	O
by	O
the	O
dramatic	O
reduction	O
in	O
swimming	O
motility	O
by	O
rcsC137	S-Biological_Molecule
mutants	O
(	O
Figure	O
S7	O
)	O
,	O
in	O
which	O
the	O
rcsC137	S-Biological_Molecule
gene	O
product	O
has	O
lost	O
its	O
phosphatase	O
activity	O
[	O
40	O
]	O
.	O

The	O
chi	O
-	O
phage	O
selection	O
results	O
suggest	O
that	O
LPS	S-Chemical_Compound
and	O
OPG	S-Chemical_Compound
are	O
necessary	O
for	O
infection	O
.	O

However	O
,	O
since	O
functional	O
flagella	O
are	O
a	O
prerequisite	O
for	O
chi	S-Species
-	O
phage	O
infection	O
,	O
we	O
sought	O
to	O
determine	O
whether	O
defects	O
in	O
LPS	S-Chemical_Compound
and	O
OPG	S-Chemical_Compound
affect	O
chi	S-Species
-	O
phage	O
infection	O
directly	O
or	O
whether	O
the	O
observed	O
selection	O
results	O
are	O
primarily	O
due	O
to	O
reduced	O
flagellar	O
expression	O
.	O

To	O
evaluate	O
the	O
necessity	O
of	O
LPS	S-Chemical_Compound
and	O
OPG	S-Chemical_Compound
for	O
phage	O
infection	O
,	O
we	O
needed	O
mutants	O
that	O
were	O
defective	O
in	O
these	O
structures	O
but	O
still	O
synthesized	O
functional	O
flagella	O
and	O
were	O
motile	O
.	O

An	O
flhD	S-Biological_Molecule
mutant	O
was	O
used	O
as	O
a	O
chi	S-Species
-	O
phage	O
-	O
resistant	O
control	O
and	O
,	O
as	O
expected	O
,	O
showed	O
no	O
sensitivity	O
,	O
whereas	O
chi	S-Species
-	O
phage	O
multiplied	O
rapidly	O
in	O
the	O
presence	O
of	O
the	O
wild	O
-	O
type	O
strain	O
(	O
Figure	O
5A	O
)	O
.	O

Both	O
OPG	S-Chemical_Compound
and	O
LPS	S-Chemical_Compound
mutants	O
showed	O
decreased	O
sensitivity	O
to	O
chi	S-Species
-	O
phage	O
,	O
and	O
the	O
decrease	O
in	O
sensitivity	O
was	O
eliminated	O
by	O
introducing	O
DeltarcsF	S-Biological_Molecule
deletions	O
,	O
indicating	O
that	O
OPG	S-Chemical_Compound
and	O
LPS	S-Chemical_Compound
are	O
not	O
directly	O
required	O
for	O
chi	S-Species
-	O
phage	O
infection	O
(	O
Figures	O
5B	O
-	O
D	O
)	O
.	O

We	O
also	O
observed	O
that	O
sensitivity	O
to	O
chi	S-Species
-	O
phage	O
was	O
higher	O
in	O
rfaI	S-Biological_Molecule
mutants	O
than	O
rfaC	S-Biological_Molecule
mutants	O
,	O
indicating	O
that	O
chi	S-Species
-	O
phage	O
infectivity	O
is	O
directly	O
related	O
to	O
the	O
degree	O
of	O
flhDC	S-Biological_Molecule
expression	O
(	O
Figures	O
4	O
,	O
5B	O
,	O
and	O
5C	O
)	O
.	O

In	O
a	O
previous	O
study	O
,	O
the	O
swarming	O
deficiency	O
of	O
LPS	O
mutants	O
had	O
suggested	O
an	O
essential	O
role	O
for	O
LPS	O
in	O
swarming	O
behavior	O
[	O
41	O
]	O
.	O

To	O
test	O
whether	O
such	O
a	O
direct	O
role	O
exists	O
,	O
we	O
interrogated	O
our	O
collection	O
of	O
LPS	S-Chemical_Compound
and	O
OPG	S-Chemical_Compound
mutants	O
for	O
swarming	O
proficiency	O
.	O

yhjH	S-Biological_Molecule
Affects	O
Flagellar	O
Motor	O
Bias	O

Mutations	O
in	O
yhjH	S-Biological_Molecule
were	O
recently	O
found	O
to	O
impair	O
swimming	O
motility	O
[	O
42	O
]	O
.	O

Surprisingly	O
,	O
this	O
gene	O
showed	O
a	O
negative	O
z	O
-	O
score	O
of	O
-	O
8	O
after	O
bacteriophage	O
chi	O
selection	O
,	O
indicating	O
that	O
this	O
mutant	O
is	O
impaired	O
in	O
swimming	O
motility	O
but	O
may	O
show	O
increased	O
susceptibility	O
to	O
chi	S-Species
-	O
phage	O
infection	O
relative	O
to	O
the	O
wild	O
-	O
type	O
strain	O
.	O

Electron	O
microscopy	O
of	O
DeltayhjH	S-Biological_Molecule
mutants	O
showed	O
the	O
appearance	O
of	O
flagella	O
,	O
and	O
light	O
microscopy	O
showed	O
vigorous	O
cellular	O
movement	O
(	O
unpublished	O
data	O
)	O
,	O
indicating	O
that	O
the	O
flagella	O
are	O
capable	O
of	O
rotating	O
;	O
still	O
,	O
this	O
mutant	O
exhibited	O
severe	O
impairment	O
in	O
swimming	O
(	O
Figure	O
1C	O
)	O
.	O

To	O
determine	O
whether	O
the	O
absence	O
of	O
yhjH	S-Biological_Molecule
alters	O
the	O
direction	O
of	O
flagellar	O
rotation	O
,	O
several	O
functional	O
studies	O
were	O
performed	O
.	O

Second	O
,	O
while	O
DeltayhjH	S-Biological_Molecule
mutants	O
are	O
impaired	O
in	O
swimming	O
motility	O
,	O
they	O
did	O
not	O
show	O
a	O
measurable	O
defect	O
in	O
swarming	O
(	O
Figure	O
6A	O
)	O
,	O
which	O
is	O
in	O
agreement	O
with	O
our	O
finding	O
that	O
flagellar	O
motor	O
switching	O
is	O
not	O
critical	O
for	O
swarming	O
.	O

In	O
a	O
final	O
functional	O
test	O
,	O
individual	O
cells	O
of	O
four	O
different	O
strains	O
-	O
wild	O
-	O
type	O
cells	O
and	O
mutants	O
with	O
yhjH	S-Biological_Molecule
,	O
cheR	S-Biological_Molecule
,	O
and	O
cheZ	S-Biological_Molecule
deletions	O
-	O
were	O
tethered	O
to	O
a	O
microscope	O
slide	O
and	O
the	O
frequency	O
of	O
flagellar	O
rotation	O
switching	O
was	O
measured	O
using	O
computer	O
tracking	O
software	O
in	O
a	O
fashion	O
similar	O
to	O
Block	O
et	O
al	O
.	O

[	O
44	O
]	O
.	O

This	O
finding	O
is	O
consistent	O
with	O
the	O
chi	S-Species
-	O
phage	O
selection	O
results	O
.	O

Tether	O
assays	O
with	O
DeltayhjH	S-Biological_Molecule
DeltacheZ	S-Biological_Molecule
double	O
mutants	O
showed	O
flagellar	O
rotation	O
indistinguishable	O
from	O
cheZ	S-Biological_Molecule
single	O
mutants	O
(	O
unpublished	O
data	O
)	O
,	O
indicating	O
that	O
null	O
mutations	O
in	O
cheZ	S-Biological_Molecule
are	O
epistatic	O
to	O
null	O
mutations	O
in	O
yhjH	S-Biological_Molecule
.	O

Genome	O
-	O
Wide	O
Identification	O
of	O
Genetic	O
Interactions	O

The	O
identification	O
of	O
novel	O
genes	O
that	O
influence	O
the	O
expression	O
of	O
a	O
phenotype	O
is	O
only	O
the	O
first	O
step	O
towards	O
understanding	O
its	O
genetic	O
basis	O
.	O

We	O
can	O
dissect	O
the	O
genetic	O
network	O
context	O
in	O
which	O
newly	O
identified	O
genes	O
function	O
by	O
making	O
libraries	O
of	O
double	O
mutants	O
in	O
which	O
a	O
transposon	O
library	O
is	O
constructed	O
in	O
the	O
background	O
of	O
a	O
mutation	O
of	O
interest	O
.	O

Systematic	O
analyses	O
of	O
such	O
interactions	O
in	O
yeast	S-Species
[	O
46	O
,	O
47	O
]	O
are	O
providing	O
a	O
wealth	O
of	O
knowledge	O
about	O
gene	O
function	O
and	O
pathway	O
organization	O
.	O

Secondary	O
insertional	O
mutations	O
were	O
observed	O
to	O
suppress	O
motility	O
defects	O
in	O
Deltahns	S-Biological_Molecule
and	O
DeltayhjH	S-Biological_Molecule
genetic	O
backgrounds	O
(	O
Figures	O
6C	O
and	O
S8A	O
)	O
.	O

Among	O
the	O
18	O
suppressor	O
mutants	O
sampled	O
at	O
random	O
from	O
the	O
DeltayhjH	S-Biological_Molecule
background	O
,	O
half	O
had	O
insertions	O
in	O
different	O
regions	O
of	O
ycgR	S-Biological_Molecule
,	O
a	O
gene	O
encoding	O
a	O
protein	O
of	O
unknown	O
function	O
(	O
Figure	O
6D	O
)	O
.	O

This	O
finding	O
is	O
consistent	O
with	O
a	O
recent	O
report	O
in	O
which	O
the	O
inactivation	O
of	O
ycgR	S-Biological_Molecule
was	O
observed	O
to	O
improve	O
motility	O
of	O
yhjH	S-Biological_Molecule
mutants	O
[	O
48	O
]	O
.	O

The	O
other	O
half	O
of	O
DeltayhjH	S-Biological_Molecule
suppressor	O
mutations	O
were	O
found	O
to	O
contain	O
insertions	O
within	O
the	O
intergenic	O
region	O
between	O
the	O
divergently	O
transcribed	O
genes	O
yfgF	S-Biological_Molecule
and	O
yfgG	S-Biological_Molecule
,	O
which	O
encode	O
gene	O
products	O
of	O
unknown	O
function	O
.	O

P1	O
transduction	O
of	O
this	O
insertion	O
to	O
the	O
DeltayhjH	S-Biological_Molecule
isogenic	O
background	O
confirmed	O
the	O
ability	O
of	O
the	O
insertion	O
to	O
suppress	O
the	O
motility	O
defect	O
(	O
unpublished	O
data	O
)	O
.	O

However	O
,	O
deletions	O
of	O
either	O
yfgF	S-Biological_Molecule
or	O
yfgG	S-Biological_Molecule
produced	O
no	O
measurable	O
difference	O
in	O
motility	O
in	O
the	O
DeltayhjH	S-Biological_Molecule
background	O
(	O
Figure	O
S9	O
)	O
.	O

Conversely	O
,	O
overexpression	O
of	O
yfgF	S-Biological_Molecule
(	O
but	O
not	O
yfgG	S-Biological_Molecule
)	O
was	O
found	O
to	O
suppress	O
the	O
motility	O
defect	O
of	O
DeltayhjH	S-Biological_Molecule
mutants	O
(	O
Figure	O
6E	O
)	O
.	O

Microarray	O
-	O
based	O
genetic	O
footprinting	O
of	O
the	O
entire	O
pool	O
of	O
mutants	O
extracted	O
from	O
the	O
motile	O
front	O
guided	O
the	O
identification	O
of	O
five	O
additional	O
suppressor	O
mutations	O
(	O
Figure	O
6F	O
;	O
Dataset	O
S11	O
)	O
.	O

Among	O
the	O
loci	O
that	O
partially	O
suppress	O
the	O
motility	O
defect	O
of	O
DeltayhjH	S-Biological_Molecule
are	O
fliZ	S-Biological_Molecule
(	O
a	O
gene	O
predicted	O
to	O
be	O
a	O
regulator	O
of	O
the	O
flagellum	O
-	O
specific	O
sigma	O
factor	O
sigma28	S-Biological_Molecule
)	O
,	O
yfiR	S-Biological_Molecule
(	O
a	O
gene	O
identified	O
in	O
the	O
selection	O
for	O
swarming	O
motility	O
defective	O
mutants	O
)	O
,	O
and	O
three	O
additional	O
genes	O
of	O
unknown	O
function	O
:	O
yjdA	S-Biological_Molecule
,	O
yjcZ	S-Biological_Molecule
,	O
and	O
yegE	S-Biological_Molecule
.	O

Further	O
studies	O
are	O
underway	O
to	O
explore	O
the	O
functional	O
relationship	O
between	O
yhjH	S-Biological_Molecule
and	O
these	O
suppressor	O
mutations	O
.	O

The	O
mechanisms	O
by	O
which	O
deletion	O
of	O
yegE	S-Biological_Molecule
and	O
overexpression	O
of	O
yfgF	S-Biological_Molecule
suppress	O
the	O
motility	O
defect	O
of	O
DeltayhjH	S-Biological_Molecule
mutants	O
are	O
discussed	O
in	O
the	O
next	O
section	O
.	O

Suppressor	O
mutations	O
identified	O
in	O
the	O
Deltahns	S-Biological_Molecule
background	O
are	O
shown	O
and	O
discussed	O
in	O
Figure	O
S8	O
,	O
and	O
the	O
microarray	O
results	O
can	O
be	O
found	O
in	O
Dataset	O
S12	O
.	O

The	O
Role	O
of	O
the	O
C	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
Second	O
-	O
Messenger	O
System	O
in	O
Swimming	O
and	O
Swarming	O
Motility	O

Based	O
on	O
sequence	O
homology	O
,	O
YhjH	S-Biological_Molecule
,	O
YfgF	S-Biological_Molecule
,	O
and	O
YegE	S-Biological_Molecule
belong	O
to	O
the	O
newly	O
identified	O
and	O
highly	O
prevalent	O
family	O
of	O
proteins	O
that	O
function	O
in	O
the	O
turnover	O
of	O
bis	B-Chemical_Compound
-	I-Chemical_Compound
(	I-Chemical_Compound
3	I-Chemical_Compound
'	I-Chemical_Compound
-	I-Chemical_Compound
5	I-Chemical_Compound
'	I-Chemical_Compound
)	I-Chemical_Compound
-	I-Chemical_Compound
cyclic	I-Chemical_Compound
dimeric	I-Chemical_Compound
guanosine	I-Chemical_Compound
monophosphate	E-Chemical_Compound
(	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
)	O
,	O
which	O
is	O
a	O
second	O
messenger	O
involved	O
in	O
the	O
regulation	O
of	O
a	O
wide	O
variety	O
of	O
bacterial	O
behaviors	O
[	O
49	O
]	O
.	O

Synthesis	O
of	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
is	O
catalyzed	O
by	O
diguanylate	O
cyclases	O
(	O
DGC	O
)	O
and	O
its	O
degradation	O
is	O
regulated	O
by	O
phosphodiesterases	O
(	O
PDE	O
)	O
.	O

YhjH	S-Biological_Molecule
contains	O
an	O
EAL	S-Biological_Molecule
domain	O
,	O
and	O
expression	O
of	O
this	O
protein	O
leads	O
to	O
the	O
degradation	O
of	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
and	O
enhanced	O
motility	O
in	O
S	B-Species
.	I-Species
enterica	E-Species
[	O
52	O
]	O
.	O

YegE	S-Biological_Molecule
and	O
YfgF	S-Biological_Molecule
both	O
contain	O
an	O
EAL	S-Biological_Molecule
domain	O
C	O
-	O
terminal	O
to	O
a	O
GGDEF	S-Biological_Molecule
domain	O
(	O
Figure	O
6G	O
)	O
.	O

In	O
addition	O
,	O
several	O
GGDEF	S-Biological_Molecule
/	O
EAL	S-Biological_Molecule
composite	O
proteins	O
were	O
found	O
to	O
exhibit	O
either	O
DGC	O
or	O
PDE	O
activity	O
[	O
53	O
,	O
54	O
]	O
.	O

Based	O
on	O
the	O
known	O
antagonistic	O
effects	O
of	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
on	O
motility	O
[	O
52	O
]	O
and	O
by	O
following	O
several	O
lines	O
of	O
reasoning	O
,	O
we	O
hypothesized	O
the	O
dominant	O
enzymatic	O
activities	O
of	O
the	O
GGDEF	S-Biological_Molecule
and	O
EAL	S-Biological_Molecule
domains	O
in	O
YfgF	S-Biological_Molecule
and	O
YegE	S-Biological_Molecule
.	O

We	O
argue	O
that	O
YfgF	S-Biological_Molecule
has	O
an	O
active	O
EAL	S-Biological_Molecule
domain	O
and	O
functions	O
as	O
a	O
PDE	O
based	O
on	O
three	O
observations	O
:	O
(	O
1	O
)	O
expression	O
of	O
this	O
gene	O
enhances	O
motility	O
of	O
the	O
DeltayhjH	S-Biological_Molecule
strain	O
(	O
Figure	O
6E	O
)	O
;	O
(	O
2	O
)	O
the	O
amino	O
acid	O
sequence	O
of	O
YfgF	S-Biological_Molecule
shows	O
similarity	O
to	O
enzymatically	O
active	O
EAL	S-Biological_Molecule
domains	O
(	O
Figure	O
S10	O
)	O
;	O
and	O
(	O
3	O
)	O
the	O
amino	O
acid	O
sequence	O
lacks	O
a	O
complete	O
GGDEF	S-Biological_Molecule
motif	O
needed	O
for	O
DGC	O
activity	O
(	O
data	O
not	O
shown	O
)	O
.	O

Based	O
on	O
these	O
observations	O
,	O
we	O
propose	O
that	O
deleting	O
yegE	S-Biological_Molecule
and	O
over	O
-	O
expressing	O
yfgF	S-Biological_Molecule
suppress	O
the	O
motility	O
defect	O
of	O
the	O
DeltayhjH	S-Biological_Molecule
strain	O
by	O
reducing	O
the	O
intracellular	O
levels	O
of	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
(	O
Figure	O
7	O
)	O
.	O

E	B-Species
.	I-Species
coli	E-Species
has	O
19	O
genes	O
encoding	O
proteins	O
with	O
GGDEF	S-Biological_Molecule
domains	O
[	O
55	O
]	O
.	O

However	O
,	O
the	O
results	O
of	O
the	O
genome	O
-	O
wide	O
screen	O
for	O
suppressors	O
of	O
the	O
DeltayhjH	S-Biological_Molecule
motility	O
defect	O
reveals	O
that	O
this	O
is	O
not	O
the	O
case	O
(	O
Table	O
S2	O
)	O
.	O

The	O
manner	O
in	O
which	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
alters	O
motility	O
at	O
the	O
molecular	O
level	O
is	O
currently	O
unknown	O
.	O

However	O
,	O
it	O
has	O
been	O
reported	O
that	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
binds	O
to	O
the	O
PilZ	S-Biological_Molecule
domain	O
of	O
the	O
aforementioned	O
YcgR	S-Biological_Molecule
protein	O
[	O
48	O
]	O
.	O

It	O
is	O
hypothesized	O
that	O
YcgR	S-Biological_Molecule
undergoes	O
a	O
conformational	O
change	O
upon	O
binding	O
to	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
,	O
and	O
that	O
the	O
YcgR	S-Biological_Molecule
-	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
complex	O
impairs	O
motility	O
through	O
a	O
protein	O
-	O
protein	O
interaction	O
with	O
the	O
flagellar	O
motor	O
[	O
57	O
]	O
.	O

In	O
addition	O
to	O
its	O
effects	O
on	O
swimming	O
,	O
we	O
found	O
evidence	O
that	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
signaling	O
also	O
plays	O
a	O
role	O
in	O
swarming	O
motility	O
.	O

As	O
stated	O
previously	O
,	O
mutations	O
in	O
yfiR	S-Biological_Molecule
strongly	O
abolish	O
swarming	O
motility	O
.	O

YfiR	S-Biological_Molecule
is	O
predicted	O
to	O
be	O
a	O
periplasmic	O
protein	O
,	O
YfiB	S-Biological_Molecule
shows	O
sequence	O
similarity	O
to	O
outer	O
-	O
membrane	O
porin	O
proteins	O
,	O
and	O
YfiN	S-Biological_Molecule
is	O
a	O
predicted	O
inner	O
-	O
membrane	O
protein	O
with	O
GGDEF	S-Biological_Molecule
and	O
HAMP	S-Biological_Molecule
domains	O
.	O

The	O
observations	O
that	O
the	O
DeltayhjH	S-Biological_Molecule
mutant	O
is	O
impaired	O
in	O
swimming	O
but	O
indistinguishable	O
from	O
the	O
wild	O
-	O
type	O
strain	O
in	O
swarming	O
,	O
while	O
in	O
contrast	O
the	O
DeltayfiR	S-Biological_Molecule
strain	O
cannot	O
swarm	O
and	O
is	O
only	O
mildly	O
impaired	O
in	O
swimming	O
,	O
support	O
the	O
notion	O
that	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
signaling	O
pathways	O
are	O
temporally	O
and	O
/	O
or	O
spatially	O
separated	O
,	O
as	O
recently	O
suggested	O
by	O
others	O
[	O
58	O
,	O
59	O
]	O
.	O

The	O
abundance	O
of	O
fimE	S-Biological_Molecule
and	O
fimB	S-Biological_Molecule
mutants	O
in	O
the	O
enrichment	O
for	O
nonmotile	O
mutants	O
suggested	O
a	O
role	O
for	O
type	O
1	O
fimbriae	O
in	O
swimming	O
motility	O
.	O

By	O
randomly	O
sampling	O
mutants	O
impaired	O
for	O
motility	O
and	O
sequencing	O
the	O
region	O
of	O
DNA	O
adjacent	O
to	O
the	O
transposon	O
,	O
we	O
identified	O
a	O
mutant	O
with	O
a	O
reduced	O
ability	O
to	O
swim	O
with	O
an	O
insertion	O
within	O
fimS	S-Biological_Molecule
.	O

This	O
observation	O
is	O
confirmed	O
by	O
comparing	O
the	O
motility	O
of	O
the	O
fimS	S-Biological_Molecule
mutant	O
to	O
phase	O
ON	O
fimB	S-Biological_Molecule
-	O
fimE	S-Biological_Molecule
-	O
double	O
mutants	O
(	O
Figure	O
S11B	O
)	O
.	O

The	O
basis	O
for	O
motility	O
suppression	O
by	O
constitutive	O
fimbriae	O
expression	O
remains	O
unclear	O
;	O
however	O
,	O
we	O
observed	O
that	O
hyper	O
-	O
fimbriated	O
cells	O
tend	O
to	O
have	O
,	O
on	O
average	O
,	O
fewer	O
flagella	O
compared	O
to	O
their	O
afimbriated	O
counterparts	O
(	O
Figure	O
S11D	O
)	O
.	O

This	O
may	O
reflect	O
competing	O
demands	O
for	O
resources	O
and	O
/	O
or	O
surface	O
area	O
for	O
synthesis	O
and	O
assembly	O
of	O
these	O
extracellular	O
appendages	O
.	O

Some	O
of	O
these	O
environmental	O
influences	O
may	O
be	O
due	O
to	O
direct	O
physicochemical	O
perturbations	O
to	O
chemotaxis	O
or	O
flagellar	O
function	O
.	O

We	O
reasoned	O
that	O
null	O
mutations	O
in	O
components	O
of	O
such	O
upstream	O
signaling	O
pathways	O
would	O
alleviate	O
repression	O
of	O
chemotaxis	O
under	O
high	O
[	O
NaCl	O
]	O
conditions	O
.	O

As	O
can	O
be	O
seen	O
in	O
Figure	O
S12A	O
,	O
this	O
is	O
in	O
fact	O
what	O
we	O
observe	O
since	O
,	O
during	O
the	O
same	O
time	O
interval	O
,	O
some	O
members	O
from	O
the	O
transposon	O
mutant	O
library	O
travel	O
significantly	O
further	O
away	O
from	O
the	O
site	O
of	O
inoculation	O
than	O
do	O
the	O
homogeneous	O
population	O
of	O
wild	O
-	O
type	O
cells	O
.	O

Microarray	O
-	O
based	O
genetic	O
footprinting	O
of	O
these	O
mutants	O
provided	O
quantitative	O
genome	O
-	O
wide	O
readout	O
of	O
the	O
population	O
(	O
Dataset	O
S13	O
)	O
.	O

The	O
selection	O
results	O
revealed	O
that	O
mutants	O
harboring	O
insertions	O
in	O
five	O
genes	O
(	O
ompR	S-Biological_Molecule
,	O
envZ	S-Biological_Molecule
,	O
znuA	S-Biological_Molecule
,	O
znuC	S-Biological_Molecule
,	O
and	O
yfiM	S-Biological_Molecule
)	O
were	O
the	O
most	O
abundant	O
.	O

The	O
microarray	O
results	O
were	O
confirmed	O
by	O
showing	O
that	O
individual	O
strains	O
with	O
mutations	O
in	O
these	O
genes	O
showed	O
increased	O
motility	O
in	O
high	O
[	O
NaCl	O
]	O
relative	O
to	O
the	O
wild	O
-	O
type	O
strain	O
(	O
Figure	O
S12B	O
)	O
.	O

EnvZ	S-Biological_Molecule
is	O
the	O
sensor	O
kinase	O
that	O
phosphorylates	O
OmpR	S-Biological_Molecule
,	O
a	O
DNA	O
-	O
binding	O
regulatory	O
protein	O
,	O
under	O
conditions	O
of	O
high	O
osmolarity	O
[	O
67	O
]	O
.	O

ZnuA	S-Biological_Molecule
and	O
ZnuC	S-Biological_Molecule
are	O
part	O
of	O
a	O
high	O
-	O
affinity	O
zinc	S-Chemical_Compound
uptake	O
system	O
.	O

Conclusions	O
and	O
Summary	O

Microbes	O
account	O
for	O
half	O
the	O
world	O
'	O
s	O
biomass	O
and	O
are	O
the	O
most	O
widely	O
distributed	O
organisms	O
on	O
the	O
planet	O
.	O

Yet	O
most	O
of	O
our	O
genetic	O
understanding	O
of	O
bacterial	O
behavior	O
comes	O
from	O
the	O
tiny	O
fraction	O
of	O
microbes	O
studied	O
in	O
the	O
laboratory	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
established	O
a	O
powerful	O
framework	O
for	O
the	O
efficient	O
and	O
comprehensive	O
identification	O
of	O
the	O
genetic	O
basis	O
of	O
complex	O
bacterial	O
behaviors	O
.	O

The	O
power	O
of	O
this	O
approach	O
lies	O
in	O
the	O
rapid	O
and	O
parallel	O
manner	O
in	O
which	O
positive	O
and	O
negative	O
genetic	O
contributions	O
can	O
be	O
mapped	O
to	O
any	O
phenotype	O
after	O
competitive	O
selection	O
.	O

In	O
this	O
study	O
,	O
we	O
confirmed	O
our	O
findings	O
by	O
functional	O
analyses	O
of	O
individual	O
mutants	O
,	O
which	O
revealed	O
high	O
levels	O
of	O
sensitivity	O
and	O
low	O
rates	O
of	O
false	O
positives	O
.	O

In	O
addition	O
,	O
we	O
have	O
shown	O
that	O
the	O
same	O
method	O
can	O
be	O
used	O
to	O
quickly	O
and	O
thoroughly	O
explore	O
the	O
genetic	O
interactions	O
between	O
a	O
single	O
locus	O
and	O
all	O
other	O
genetic	O
loci	O
in	O
the	O
genome	O
.	O

These	O
interactions	O
correspond	O
to	O
important	O
network	O
-	O
level	O
concepts	O
;	O
for	O
example	O
,	O
the	O
flow	O
of	O
information	O
within	O
signal	O
transduction	O
pathways	O
and	O
second	O
-	O
messenger	O
systems	O
such	O
as	O
c	B-Chemical_Compound
-	I-Chemical_Compound
di	I-Chemical_Compound
-	I-Chemical_Compound
GMP	E-Chemical_Compound
.	O

Enterococci	S-Species
have	O
emerged	O
over	O
the	O
past	O
few	O
decades	O
as	O
the	O
second	O
to	O
third	O
most	O
common	O
cause	O
of	O
nosocomial	O
infections	O
,	O
including	O
urinary	O
tract	O
and	O
soft	O
tissue	O
infections	O
,	O
bacteremia	O
,	O
and	O
endocarditis	O
[	O
1	O
-	O
3	O
]	O
.	O

Entecococcal	O
infections	O
are	O
predominantly	O
caused	O
by	O
E	B-Species
.	I-Species
faecalis	E-Species
and	O
E	B-Species
.	I-Species
faecium	E-Species
.	O

To	O
differentiate	O
the	O
two	O
faces	O
of	O
this	O
organism	O
,	O
genome	O
-	O
wide	O
comparisons	O
are	O
necessary	O
.	O

Although	O
hundreds	O
of	O
microbial	O
genomes	O
have	O
been	O
sequenced	O
,	O
only	O
two	O
E	B-Species
.	I-Species
faecalis	E-Species
genomes	O
have	O
been	O
reported	O
(	O
V583	S-Species
as	O
a	O
clinical	O
isolate	O
[	O
4	O
]	O
and	O
Symbioflor	B-Species
1	E-Species
as	O
a	O
commensal	O
isolate	O
[	O
5	O
]	O
)	O
,	O
but	O
only	O
the	O
V583	S-Species
genome	O
has	O
been	O
made	O
publicly	O
available	O
.	O

OG1RF	S-Species
is	O
a	O
rifampicin	S-Chemical_Compound
and	O
fusidic	O
acid	O
resistant	O
derivative	O
of	O
OG1	S-Species
[	O
8	O
,	O
9	O
]	O
.	O

Multilocus	O
sequence	O
typing	O
(	O
MLST	O
)	O
showed	O
that	O
OG1RF	S-Species
is	O
clonally	O
distinct	O
from	O
V583	S-Species
(	O
differs	O
in	O
six	O
out	O
of	O
seven	O
alleles	O
of	O
housekeeping	O
genes	O
)	O
[	O
11	O
]	O
and	O
characterization	O
of	O
regions	O
flanking	O
transposon	O
insertions	O
in	O
OG1RF	S-Species
suggested	O
that	O
approximately	O
10	O
%	O
of	O
their	O
sequences	O
differed	O
[	O
12	O
]	O
.	O

OG1	S-Species
and	O
its	O
derivatives	O
have	O
been	O
successfully	O
used	O
over	O
the	O
past	O
20	O
years	O
in	O
various	O
animal	O
models	O
,	O
starting	O
with	O
the	O
demonstration	O
that	O
it	O
can	O
cause	O
caries	O
in	O
germ	O
-	O
free	O
rats	S-Species
[	O
7	O
]	O
,	O
and	O
later	O
to	O
characterize	O
factors	O
important	O
for	O
E	B-Species
.	I-Species
faecalis	E-Species
virulence	O
in	O
a	O
mouse	S-Species
model	O
of	O
peritonitis	O
[	O
13	O
]	O
,	O
a	O
rabbit	S-Species
model	O
of	O
endophthalmitis	O
[	O
14	O
]	O
,	O
a	O
rat	S-Species
model	O
of	O
endocarditis	O
[	O
15	O
]	O
and	O
in	O
a	O
mouse	S-Species
urinary	O
tract	O
infection	O
model	O
[	O
16	O
]	O
.	O

OG1RF	S-Species
was	O
also	O
shown	O
to	O
be	O
as	O
virulent	O
as	O
V583	S-Species
in	O
the	O
model	O
host	O
Caenorhabditis	B-Species
elegans	E-Species
[	O
17	O
]	O
.	O

Numerous	O
factors	O
important	O
for	O
virulence	O
have	O
been	O
characterized	O
in	O
OG1RF	S-Species
.	O

A	O
recently	O
described	O
example	O
are	O
the	O
Ebp	O
pili	O
,	O
whose	O
subunits	O
are	O
encoded	O
by	O
the	O
ebp	O
operon	O
[	O
18	O
]	O
and	O
whose	O
genes	O
are	O
regulated	O
by	O
EbpR	S-Biological_Molecule
[	O
19	O
]	O
.	O

Also	O
present	O
is	O
Ace	S-Biological_Molecule
,	O
a	O
member	O
of	O
the	O
MSCRAMM	O
(	O
microbial	O
surface	O
component	O
recognizing	O
adhesive	O
matrix	O
molecules	O
)	O
family	O
.	O

Thus	O
,	O
we	O
analyzed	O
the	O
sequence	O
of	O
E	B-Species
.	I-Species
faecalis	I-Species
OG1RF	E-Species
.	O

The	O
unique	O
regions	O
were	O
then	O
characterized	O
further	O
.	O

General	O
genome	O
features	O
The	O
complete	O
circular	O
chromosome	O
of	O
OG1RF	S-Species
was	O
found	O
to	O
be	O
2	O
,	O
739	O
,	O
625	O
bp	O
with	O
an	O
average	O
G	O
+	O
C	O
content	O
of	O
37	O
.	O
8	O
%	O
.	O

[	O
10	O
]	O
showed	O
only	O
minor	O
variations	O
(	O
primarily	O
an	O
overestimation	O
of	O
30	O
kb	O
for	O
the	O
Sfi	B-Biological_Molecule
I	E-Biological_Molecule
fragment	O
E	O
,	O
540	O
kb	O
versus	O
509	O
kb	O
predicted	O
from	O
the	O
sequence	O
;	O
Figure	O
1	O
)	O
.	O

The	O
10	O
missing	O
tRNA	O
are	O
localized	O
in	O
a	O
region	O
in	O
V583	S-Species
that	O
has	O
been	O
replaced	O
in	O
OG1RF	S-Species
by	O
a	O
49	O
kb	O
region	O
(	O
see	O
below	O
)	O
.	O

Some	O
of	O
the	O
major	O
insertions	O
/	O
deletions	O
in	O
the	O
two	O
genomes	O
are	O
shown	O
in	O
Figure	O
2	O
,	O
such	O
as	O
the	O
absence	O
of	O
the	O
pathogenicity	O
island	O
(	O
PAI	O
)	O
in	O
OG1RF	S-Species
and	O
the	O
presence	O
of	O
an	O
approximately	O
49	O
kb	O
fragment	O
unique	O
to	O
OG1RF	S-Species
.	O

Overall	O
,	O
we	O
found	O
64	O
areas	O
of	O
divergence	O
between	O
the	O
genomes	O
that	O
can	O
be	O
divided	O
into	O
3	O
classes	O
:	O
an	O
additional	O
sequence	O
present	O
in	O
OG1RF	S-Species
when	O
compared	O
with	O
V583	S-Species
;	O
a	O
sequence	O
replacement	O
where	O
a	O
sequence	O
in	O
OG1RF	S-Species
differs	O
from	O
the	O
sequence	O
in	O
V583	S-Species
;	O
and	O
the	O
absence	O
of	O
a	O
sequence	O
from	O
OG1RF	S-Species
when	O
compared	O
with	O
V583	S-Species
.	O

Both	O
OG1RF	S-Species
CRISPR	O
elements	O
are	O
composed	O
of	O
7	O
repeats	O
of	O
a	O
37	O
bp	O
palindromic	O
sequence	O
with	O
a	O
29	O
bp	O
spacer	O
.	O

The	O
CRISPR1	O
-	O
associated	O
proteins	O
belong	O
to	O
the	O
Nmeni	O
subtype	O
[	O
28	O
]	O
.	O

The	O
four	O
cas	O
genes	O
encode	O
Cas	B-Biological_Molecule
_	I-Biological_Molecule
csn1	E-Biological_Molecule
(	O
possible	O
endonuclease	O
)	O
,	O
Cas1	S-Biological_Molecule
(	O
novel	O
nuclease	O
)	O
,	O
Cas2	S-Biological_Molecule
(	O
conserved	O
hypothetical	O
protein	O
)	O
,	O
and	O
Cas	B-Biological_Molecule
_	I-Biological_Molecule
csn2	E-Biological_Molecule
(	O
conserved	O
hypothetical	O
protein	O
)	O
.	O

To	O
determine	O
the	O
distribution	O
of	O
the	O
CRISPR1	O
locus	O
in	O
E	B-Species
.	I-Species
faecalis	E-Species
strains	O
,	O
16	O
isolates	O
of	O
various	O
MLST	O
types	O
were	O
tested	O
for	O
the	O
presence	O
(	O
PCR	O
with	O
primers	O
specific	O
for	O
csn1	S-Biological_Molecule
and	O
cas1	S-Biological_Molecule
)	O
or	O
absence	O
(	O
PCR	O
with	O
primers	O
overlapping	O
the	O
junction	O
between	O
EF0672	S-Biological_Molecule
and	O
EF0673	S-Biological_Molecule
)	O
of	O
the	O
CRISPR1	O
locus	O
(	O
Table	O
2	O
)	O
.	O

Nakayama	O
et	O
al	O
.	O

Loss	O
of	O
the	O
fsr	O
regulatory	O
components	O
results	O
in	O
a	O
gelatinase	O
-	O
negative	O
phenotype	O
under	O
routine	O
test	O
conditions	O
despite	O
the	O
fact	O
that	O
these	O
strains	O
still	O
carry	O
the	O
gelE	S-Biological_Molecule
gene	O
[	O
23	O
,	O
29	O
]	O
.	O

In	O
a	O
more	O
recent	O
analysis	O
of	O
relationships	O
between	O
various	O
E	B-Species
.	I-Species
faecalis	E-Species
strains	O
,	O
the	O
23	O
.	O
9	O
kb	O
region	O
was	O
not	O
detected	O
in	O
86	O
%	O
of	O
the	O
strains	O
of	O
the	O
clonal	O
complex	O
(	O
CC	O
)	O
2	O
,	O
58	O
%	O
of	O
the	O
CC9	S-Species
strains	O
,	O
nor	O
in	O
any	O
of	O
the	O
CC8	S-Species
strains	O
[	O
31	O
]	O
.	O

The	O
Symbioflor	B-Species
1	E-Species
strain	O
,	O
used	O
as	O
a	O
probiotic	O
,	O
is	O
one	O
representative	O
of	O
the	O
7	O
.	O
4	O
%	O
of	O
E	B-Species
.	I-Species
faecalis	E-Species
isolates	O
that	O
are	O
missing	O
the	O
gelE	S-Biological_Molecule
gene	O
in	O
addition	O
to	O
the	O
23	O
.	O
9	O
kb	O
region	O
[	O
5	O
,	O
30	O
]	O
.	O

A	O
hypothesis	O
that	O
the	O
number	O
of	O
repeats	O
may	O
be	O
proportional	O
to	O
the	O
depth	O
of	O
the	O
peptidoglycan	O
has	O
been	O
proposed	O
[	O
32	O
]	O
.	O

Another	O
family	O
of	O
E	B-Species
.	I-Species
faecalis	E-Species
surface	O
proteins	O
includes	O
the	O
newly	O
described	O
WxL	O
domain	O
surface	O
proteins	O
.	O

Siezen	O
et	O
al	O
.	O

[	O
33	O
]	O
reported	O
a	O
novel	O
gene	O
cluster	O
encoding	O
exclusively	O
cell	O
-	O
surface	O
proteins	O
that	O
is	O
conserved	O
in	O
a	O
subgroup	O
of	O
Gram	O
-	O
positive	O
bacteria	O
.	O

Each	O
gene	O
cluster	O
has	O
at	O
least	O
one	O
member	O
of	O
three	O
gene	O
families	O
:	O
a	O
gene	O
encoding	O
a	O
small	O
LPxTG	O
protein	O
(	O
approximately	O
120	O
amino	O
acids	O
)	O
;	O
a	O
gene	O
encoding	O
a	O
member	O
of	O
the	O
DUF916	O
transmembrane	O
protein	O
family	O
;	O
and	O
a	O
gene	O
encoding	O
a	O
WxL	O
domain	O
surface	O
protein	O
.	O

OG1RF	S-Species
does	O
not	O
contain	O
homologues	O
of	O
EF2248	S-Biological_Molecule
-	O
54	S-Biological_Molecule
(	O
carrying	O
instead	O
the	O
iol	O
operon	O
)	O
,	O
though	O
it	O
has	O
a	O
novel	O
WxL	O
locus	O
within	O
the	O
14	O
.	O
8	O
kb	O
unique	O
region	O
upstream	O
of	O
the	O
fsr	O
locus	O
(	O
Additional	O
data	O
file	O
2	O
)	O
.	O

Also	O
,	O
in	O
place	O
of	O
EF3153	S-Biological_Molecule
,	O
EF3154	S-Biological_Molecule
,	O
and	O
EF3155	S-Biological_Molecule
(	O
which	O
share	O
70	O
%	O
similarity	O
among	O
themselves	O
)	O
,	O
were	O
found	O
non	O
-	O
distantly	O
related	O
homologues	O
,	O
OG1RF	B-Biological_Molecule
_	I-Biological_Molecule
0209	E-Biological_Molecule
and	O
OG1RF	B-Biological_Molecule
_	I-Biological_Molecule
0210	E-Biological_Molecule
,	O
which	O
share	O
60	O
-	O
80	O
%	O
similarity	O
with	O
EF3153	S-Biological_Molecule
,	O
EF3154	S-Biological_Molecule
,	O
and	O
EF3155	S-Biological_Molecule
.	O

[	O
36	O
]	O
,	O
other	O
loci	O
,	O
including	O
the	O
EF3153	S-Biological_Molecule
and	O
EF3248	S-Biological_Molecule
loci	O
,	O
were	O
not	O
detected	O
in	O
the	O
majority	O
of	O
these	O
strains	O
.	O

In	O
addition	O
,	O
it	O
appears	O
that	O
the	O
EF3248	S-Biological_Molecule
locus	O
diverges	O
in	O
the	O
Symbioflor	B-Species
1	E-Species
strain	O
.	O

When	O
compared	O
to	O
V583	S-Species
,	O
the	O
sequence	O
identity	O
in	O
this	O
area	O
between	O
the	O
two	O
strains	O
appears	O
to	O
be	O
as	O
low	O
as	O
75	O
%	O
(	O
depicted	O
in	O
Figure	O
2	O
from	O
reference	O
[	O
5	O
]	O
)	O
.	O

However	O
,	O
because	O
the	O
Symbioflor	B-Species
1	E-Species
genome	O
sequence	O
is	O
not	O
currently	O
available	O
,	O
it	O
was	O
not	O
possible	O
to	O
compare	O
their	O
respective	O
sequences	O
in	O
more	O
detail	O
.	O

Since	O
these	O
proteins	O
are	O
located	O
at	O
the	O
surface	O
of	O
the	O
cell	O
,	O
the	O
low	O
level	O
of	O
homology	O
shared	O
between	O
them	O
may	O
be	O
the	O
result	O
of	O
antigenic	O
variation	O
.	O

In	O
OG1RF	S-Species
,	O
the	O
region	O
that	O
would	O
encode	O
the	O
cps	O
operon	O
is	O
only	O
59	O
bp	O
in	O
length	O
and	O
has	O
no	O
homology	O
with	O
V583	S-Species
.	O

Thus	O
,	O
while	O
V583	S-Species
and	O
OG1RF	S-Species
share	O
much	O
similarity	O
between	O
their	O
surface	O
components	O
,	O
there	O
are	O
unique	O
differences	O
that	O
could	O
potentially	O
be	O
important	O
in	O
affecting	O
the	O
behavior	O
of	O
the	O
strains	O
and	O
might	O
be	O
useful	O
for	O
strain	O
typing	O
.	O

Two	O
-	O
component	O
regulatory	O
systems	O

OG1RF	S-Species
lacks	O
four	O
two	O
-	O
component	O
systems	O
found	O
in	O
V583	S-Species
.	O

These	O
are	O
histidine	B-Biological_Molecule
kinase	E-Biological_Molecule
-	O
response	O
regulator	O
(	O
HK	S-Biological_Molecule
-	O
RR	B-Biological_Molecule
)	I-Biological_Molecule
08	E-Biological_Molecule
,	O
HK	S-Biological_Molecule
-	O
RR12	S-Biological_Molecule
located	O
in	O
the	O
PAI	O
,	O
HK	S-Biological_Molecule
-	O
RR16	S-Biological_Molecule
and	O
the	O
vanB	S-Biological_Molecule
regulatory	O
system	O
HK	S-Biological_Molecule
-	O
RR11	S-Biological_Molecule
[	O
38	O
]	O
.	O

OG1RF	B-Biological_Molecule
_	I-Biological_Molecule
0193	E-Biological_Molecule
shares	O
82	O
%	O
similarity	O
with	O
VanRG	S-Biological_Molecule
and	O
81	O
%	O
similarity	O
with	O
VanRG2	S-Biological_Molecule
.	O

A	O
gene	O
(	O
OG1RF	B-Biological_Molecule
_	I-Biological_Molecule
0191	E-Biological_Molecule
)	O
encoding	O
an	O
M15	S-Biological_Molecule
family	O
muramoyl	O
pentapeptide	O
carboxypeptidase	O
is	O
located	O
downstream	O
of	O
these	O
two	O
-	O
component	O
regulatory	O
genes	O
(	O
Figure	O
4a	O
)	O
.	O

The	O
predicted	O
carboxypeptidase	O
(	O
OG1RF	B-Biological_Molecule
_	I-Biological_Molecule
0191	E-Biological_Molecule
)	O
shares	O
69	O
%	O
similarity	O
over	O
179	O
amino	O
acids	O
with	O
EF2297	S-Biological_Molecule
,	O
a	O
membrane	O
-	O
associated	O
D	O
,	O
D	O
-	O
carboxypeptidase	O
encoded	O
by	O
the	O
vanB	S-Biological_Molecule
operon	O
in	O
V583	S-Species
.	O

The	O
iol	O
operon	O

OG1RF	S-Species
carries	O
an	O
iol	O
operon	O
while	O
V583	S-Species
does	O
not	O
.	O

This	O
operon	O
encodes	O
the	O
factors	O
necessary	O
for	O
the	O
degradation	O
of	O
myo	B-Chemical_Compound
-	I-Chemical_Compound
inositol	E-Chemical_Compound
into	O
glyceraldehyde	B-Chemical_Compound
-	I-Chemical_Compound
3P	E-Chemical_Compound
.	O

Many	O
soil	O
and	O
plant	O
micro	O
-	O
organisms	O
,	O
including	O
Bacillus	B-Species
subtilis	E-Species
[	O
41	O
]	O
(	O
first	O
iol	O
operon	O
identified	O
)	O
,	O
Klebsiella	S-Species
spp	O
.	O

The	O
OG1RF	S-Species
iol	O
operon	O
appears	O
to	O
be	O
closely	O
related	O
to	O
ones	O
described	O
in	O
Clostridium	B-Species
perfringens	E-Species
[	O
44	O
]	O
and	O
Lactobacillus	B-Species
casei	E-Species
[	O
45	O
]	O
.	O

In	O
L	B-Species
.	I-Species
casei	E-Species
,	O
the	O
myo	B-Chemical_Compound
-	I-Chemical_Compound
inositol	E-Chemical_Compound
operon	O
consists	O
of	O
ten	O
genes	O
with	O
an	O
upstream	O
divergent	O
regulator	O
gene	O
,	O
iolR	S-Biological_Molecule
.	O

To	O
investigate	O
whether	O
the	O
iol	O
operon	O
was	O
'	O
inserted	O
into	O
'	O
or	O
'	O
removed	O
from	O
'	O
a	O
putative	O
ancestral	O
strain	O
,	O
the	O
sequences	O
surrounding	O
the	O
iol	O
genes	O
were	O
examined	O
.	O

The	O
possible	O
junction	O
and	O
presence	O
of	O
unique	O
sequence	O
in	O
this	O
region	O
,	O
if	O
investigated	O
,	O
was	O
not	O
mentioned	O
in	O
the	O
publication	O
.	O

Nonetheless	O
,	O
preliminary	O
analysis	O
of	O
other	O
strains	O
'	O
genotypes	O
in	O
this	O
area	O
seemed	O
to	O
confirm	O
the	O
hypothesis	O
of	O
a	O
hot	O
region	O
for	O
rearrangement	O
(	O
data	O
not	O
shown	O
)	O
.	O

An	O
analysis	O
of	O
the	O
G	O
+	O
C	O
content	O
of	O
OG1RF	S-Species
unique	O
regions	O
revealed	O
several	O
loci	O
with	O
a	O
lower	O
G	O
+	O
C	O
content	O
than	O
the	O
37	O
.	O
8	O
%	O
average	O
content	O
of	O
OG1RF	S-Species
.	O

This	O
fragment	O
appears	O
to	O
be	O
a	O
patchwork	O
composed	O
of	O
hypothetical	O
genes	O
,	O
homologues	O
of	O
Tn916	S-Biological_Molecule
-	O
associated	O
genes	O
and	O
homologues	O
of	O
genes	O
from	O
other	O
Gram	O
-	O
positive	O
organisms	O
,	O
including	O
Listeria	O
,	O
E	B-Species
.	I-Species
faecium	E-Species
,	O
staphylococci	S-Species
,	O
or	O
lactococci	S-Species
(	O
Additional	O
data	O
file	O
1	O
)	O
.	O

However	O
,	O
the	O
approximately	O
49	O
kb	O
fragment	O
lacks	O
an	O
excisase	O
gene	O
and	O
the	O
probable	O
lantibiotic	O
ABC	O
transporter	O
genes	O
present	O
in	O
Tn5386	S-Biological_Molecule
.	O

An	O
uninterrupted	O
competence	O
operon	O
in	O
OG1RF	S-Species

OG1RF	S-Species
contains	O
what	O
appears	O
to	O
be	O
an	O
intact	O
competence	O
operon	O
while	O
that	O
of	O
V583	S-Species
appears	O
to	O
be	O
non	O
-	O
functional	O
.	O

For	O
example	O
,	O
the	O
homologue	O
in	O
OG1RF	S-Species
of	O
EF2046	S-Biological_Molecule
shares	O
61	O
%	O
similarity	O
with	O
ComYA	O
and	O
the	O
OG1RF	S-Species
homologue	O
of	O
EF2045	S-Biological_Molecule
is	O
55	O
%	O
similar	O
to	O
ComYB	O
.	O

In	O
V583	S-Species
,	O
the	O
fourth	O
gene	O
of	O
this	O
operon	O
(	O
corresponding	O
to	O
OG1RF	B-Biological_Molecule
_	I-Biological_Molecule
0148	E-Biological_Molecule
)	O
is	O
interrupted	O
by	O
phage	O
4	O
(	O
EF1896	S-Biological_Molecule
-	O
EF2043	S-Biological_Molecule
)	O
;	O
in	O
addition	O
,	O
EF1984	S-Biological_Molecule
contains	O
a	O
premature	O
stop	O
codon	O
not	O
found	O
in	O
the	O
corresponding	O
gene	O
in	O
OG1RF	S-Species
(	O
OG1RF	B-Biological_Molecule
_	I-Biological_Molecule
0228	E-Biological_Molecule
)	O
.	O

Natural	O
competence	O
has	O
not	O
been	O
reported	O
for	O
E	B-Species
.	I-Species
faecalis	E-Species
.	O

We	O
have	O
also	O
noted	O
that	O
V583	S-Species
is	O
less	O
transformable	O
by	O
electroporation	O
than	O
OG1RF	S-Species
.	O

To	O
investigate	O
the	O
possibility	O
that	O
directly	O
or	O
indirectly	O
the	O
com	O
operon	O
might	O
be	O
responsible	O
for	O
this	O
phenotype	O
,	O
we	O
also	O
evaluated	O
transformability	O
by	O
electroporation	O
.	O

When	O
compared	O
with	O
OG1RF	S-Species
,	O
transposon	O
mutants	O
[	O
12	O
]	O
in	O
the	O
OG1RF	S-Species
equivalent	O
of	O
EF2045	S-Biological_Molecule
(	O
encoding	O
the	O
comGB	O
homologue	O
)	O
and	O
in	O
the	O
OG1RF	S-Species
equivalent	O
of	O
EF1986	S-Biological_Molecule
(	O
encoding	O
the	O
comGF	O
homologue	O
)	O
showed	O
similar	O
levels	O
of	O
transformability	O
by	O
electroporation	O
(	O
data	O
not	O
shown	O
)	O
,	O
implying	O
that	O
the	O
difference	O
in	O
electroporation	O
efficiency	O
observed	O
between	O
OG1RF	S-Species
and	O
V583	S-Species
is	O
not	O
related	O
to	O
this	O
locus	O
.	O

The	O
other	O
ComDE	O
homology	O
is	O
that	O
with	O
a	O
two	O
-	O
component	O
system	O
unique	O
to	O
OG1RF	S-Species
(	O
OG1RF	B-Biological_Molecule
_	I-Biological_Molecule
0199	E-Biological_Molecule
and	O
OG1RF	B-Biological_Molecule
_	I-Biological_Molecule
0198	E-Biological_Molecule
,	O
respectively	O
)	O
that	O
lies	O
on	O
a	O
4	O
,	O
706	O
bp	O
unique	O
fragment	O
that	O
maps	O
between	O
EF3114	S-Biological_Molecule
and	O
EF3115	S-Biological_Molecule
in	O
V583	S-Species
.	O

This	O
fragment	O
also	O
carries	O
two	O
genes	O
(	O
OG1RF	B-Biological_Molecule
_	I-Biological_Molecule
0200	E-Biological_Molecule
and	O
OG1RF	B-Biological_Molecule
_	I-Biological_Molecule
0201	E-Biological_Molecule
)	O
encoding	O
homologues	O
of	O
the	O
YhaQ	S-Biological_Molecule
and	O
YhaP	S-Biological_Molecule
sodium	S-Chemical_Compound
efflux	O
ATP	S-Chemical_Compound
-	O
binding	O
cassette	O
efflux	O
/	O
transporter	O
proteins	O
(	O
Figure	O
4b	O
)	O
.	O

Although	O
they	O
are	O
potential	O
elements	O
of	O
a	O
secretion	O
apparatus	O
,	O
these	O
two	O
proteins	O
do	O
not	O
share	O
any	O
homology	O
at	O
the	O
protein	O
level	O
with	O
the	O
competence	O
secretion	O
apparatus	O
ComAB	O
of	O
S	B-Species
.	I-Species
pneumoniae	E-Species
[	O
51	O
]	O
nor	O
CslAB	O
from	O
S	B-Species
.	I-Species
mutans	E-Species
[	O
52	O
]	O
.	O

Searching	O
for	O
a	O
possible	O
CSP	O
in	O
the	O
vicinity	O
of	O
these	O
genes	O
,	O
we	O
identified	O
a	O
small	O
ORF	O
encoding	O
50	O
amino	O
acids	O
between	O
yhaP	S-Biological_Molecule
and	O
OG1RF199	S-Biological_Molecule
and	O
another	O
encoding	O
20	O
amino	O
acids	O
downstream	O
of	O
OG1RF198	S-Biological_Molecule
.	O

More	O
analysis	O
will	O
be	O
required	O
to	O
determine	O
if	O
there	O
are	O
conditions	O
in	O
which	O
the	O
OG1RF	S-Species
com	O
operon	O
is	O
expressed	O
and	O
to	O
determine	O
whether	O
or	O
not	O
this	O
two	O
-	O
component	O
system	O
is	O
involved	O
in	O
competence	O
.	O

Limited	O
presence	O
of	O
mobile	O
elements	O

By	O
probing	O
a	O
microarray	O
of	O
the	O
V583	O
genome	O
and	O
plasmids	O
with	O
OG1RF	S-Species
genomic	O
DNA	O
,	O
we	O
previously	O
estimated	O
that	O
only	O
75	O
%	O
of	O
V583	S-Species
ORFs	O
were	O
also	O
present	O
in	O
OG1RF	S-Species
[	O
22	O
]	O
.	O

[	O
53	O
]	O
compared	O
nine	O
strains	O
,	O
including	O
OG1RF	S-Species
to	O
V583	S-Species
,	O
using	O
comparative	O
genomic	O
hybridization	O
.	O

In	O
these	O
results	O
,	O
OG1RF	S-Species
appears	O
to	O
carry	O
a	O
few	O
genes	O
included	O
in	O
the	O
PAI	O
,	O
and	O
a	O
few	O
prophage	O
genes	O
.	O

The	O
mutation	O
leading	O
to	O
rifampicin	S-Chemical_Compound
resistance	O
was	O
identified	O
in	O
the	O
rpoB	S-Biological_Molecule
gene	O
by	O
Ozawa	O
et	O
al	O
.	O

The	O
mutation	O
also	O
affected	O
the	O
clumping	O
phenotype	O
of	O
traA	S-Biological_Molecule
mutants	O
and	O
this	O
effect	O
appears	O
to	O
be	O
specific	O
for	O
the	O
pAM373	O
system	O
[	O
54	O
]	O
.	O

All	O
of	O
the	O
other	O
22	O
differences	O
in	O
rpoB	S-Biological_Molecule
between	O
OG1RF	S-Species
and	O
V583	S-Species
are	O
synonymous	O
.	O

Fusidic	B-Chemical_Compound
acid	E-Chemical_Compound
resistance	O
is	O
associated	O
with	O
mutation	O
(	O
s	O
)	O
in	O
the	O
fusA	S-Biological_Molecule
gene	O
,	O
which	O
encodes	O
elongation	B-Biological_Molecule
factor	I-Biological_Molecule
G	E-Biological_Molecule
.	O

We	O
compared	O
fusA	S-Biological_Molecule
from	O
OG1RF	S-Species
with	O
that	O
in	O
V583	S-Species
and	O
identified	O
two	O
differences	O
(	O
C1368A	O
and	O
T1992C	O
)	O
.	O

Mutations	O
in	O
this	O
region	O
have	O
been	O
associated	O
with	O
fusidic	B-Chemical_Compound
acid	E-Chemical_Compound
resistance	O
in	O
Staphylococcus	B-Species
aureus	E-Species
[	O
55	O
,	O
56	O
]	O
,	O
and	O
thus	O
the	O
C1368A	O
mutation	O
is	O
likely	O
the	O
cause	O
of	O
the	O
fusidic	B-Chemical_Compound
acid	E-Chemical_Compound
resistance	O
phenotype	O
in	O
OG1RF	S-Species
.	O

Virulence	O
and	O
biofilm	O
comparisons	O
of	O
OG1RF	S-Species
with	O
V583	S-Species

When	O
compared	O
in	O
the	O
mouse	S-Species
peritonitis	O
model	O
,	O
the	O
LD50	O
values	O
of	O
V583	S-Species
in	O
different	O
determinations	O
were	O
lower	O
(	O
4	O
.	O
8	O
x	O
107	O
to	O
1	O
.	O
1	O
x	O
108	O
colony	O
forming	O
units	O
(	O
CFU	O
)	O
/	O
ml	O
)	O
than	O
the	O
LD50	O
values	O
of	O
OG1RF	S-Species
(	O
1	O
.	O
2	O
x	O
108	O
to	O
4	O
.	O
8	O
x	O
108	O
CFU	O
/	O
ml	O
)	O
.	O

However	O
,	O
at	O
comparable	O
inoculum	O
,	O
OG1RF	S-Species
(	O
4	O
x	O
108	O
CFU	O
/	O
ml	O
)	O
showed	O
more	O
rapid	O
mortality	O
versus	O
V583	S-Species
(	O
5	O
x	O
108	O
CFU	O
/	O
ml	O
)	O
in	O
the	O
first	O
48	O
hours	O
(	O
P	O
=	O
0	O
.	O
0034	O
;	O
Additional	O
data	O
file	O
3	O
)	O
.	O

In	O
a	O
urinary	O
tract	O
infection	O
model	O
administering	O
mixed	O
equal	O
inocula	O
of	O
V583	S-Species
and	O
OG1RF	S-Species
,	O
OG1RF	S-Species
significantly	O
outnumbered	O
V583	S-Species
in	O
kidney	O
with	O
geometric	O
means	O
of	O
1	O
.	O
3	O
x	O
104	O
CFU	O
/	O
gm	O
for	O
OG1RF	S-Species
versus	O
1	O
.	O
9	O
x	O
102	O
CFU	O
/	O
gm	O
for	O
V583	S-Species
(	O
P	O
=	O
0	O
.	O
0005	O
)	O
;	O
in	O
urinary	O
bladder	O
homogenates	O
,	O
the	O
geometric	O
mean	O
CFU	O
/	O
gm	O
was	O
1	O
.	O
7	O
x	O
103	O
for	O
OG1RF	S-Species
versus	O
6	O
.	O
6	O
x	O
101	O
for	O
V583	S-Species
(	O
P	O
=	O
0	O
.	O
003	O
;	O
Figure	O
7a	O
)	O
.	O

Conclusion	O

E	B-Species
.	I-Species
faecalis	I-Species
OG1RF	E-Species
carries	O
a	O
number	O
of	O
unique	O
loci	O
compared	O
to	O
V583	S-Species
.	O

[	O
36	O
]	O
demonstrate	O
that	O
these	O
factors	O
may	O
be	O
present	O
in	O
harmless	O
strains	O
while	O
absent	O
in	O
clinical	O
isolates	O
,	O
indicating	O
that	O
E	B-Species
.	I-Species
faecalis	E-Species
virulence	O
is	O
not	O
dependent	O
on	O
any	O
single	O
virulence	O
factor	O
.	O

It	O
may	O
be	O
that	O
these	O
clonal	O
complexes	O
are	O
not	O
more	O
virulent	O
per	O
se	O
,	O
as	O
defined	O
in	O
the	O
assays	O
described	O
here	O
,	O
but	O
rather	O
are	O
better	O
able	O
to	O
survive	O
and	O
/	O
or	O
colonize	O
hospitalized	O
patients	S-Species
,	O
taking	O
advantage	O
of	O
factors	O
that	O
predispose	O
to	O
nosocomial	O
infections	O
such	O
as	O
urinary	O
or	O
venous	O
catheters	O
,	O
or	O
mucositis	O
,	O
among	O
others	O
.	O

A	O
Naturally	O
Occurring	O
Mutation	O
in	O
ropB	S-Biological_Molecule
Suppresses	O
SpeB	S-Biological_Molecule
Expression	O
and	O
Reduces	O
M1T1	S-Species
Group	O
A	O
Streptococcal	O
Systemic	O
Virulence	O

However	O
,	O
the	O
role	O
of	O
SpeB	S-Biological_Molecule
in	O
the	O
course	O
of	O
infection	O
is	O
still	O
unclear	O
.	O

In	O
this	O
study	O
we	O
utilize	O
a	O
SpeB	S-Biological_Molecule
-	O
negative	O
M1T1	O
clinical	O
isolate	O
,	O
5628	S-Species
,	O
with	O
a	O
naturally	O
occurring	O
mutation	O
in	O
the	O
gene	O
encoding	O
the	O
regulator	O
RopB	S-Biological_Molecule
,	O
to	O
elucidate	O
the	O
role	O
of	O
RopB	S-Biological_Molecule
and	O
SpeB	S-Biological_Molecule
in	O
systemic	O
virulence	O
.	O

Allelic	O
exchange	O
mutagenesis	O
was	O
used	O
to	O
replace	O
the	O
mutated	O
ropB	S-Biological_Molecule
allele	O
in	O
5628	S-Species
with	O
the	O
intact	O
allele	O
from	O
the	O
well	O
characterized	O
isolate	O
5448	S-Species
.	O

The	O
inverse	O
allelic	O
exchange	O
was	O
also	O
performed	O
to	O
replace	O
the	O
intact	O
ropB	S-Biological_Molecule
in	O
5448	S-Species
with	O
the	O
mutated	O
allele	O
from	O
5628	S-Species
.	O

An	O
intact	O
ropB	S-Biological_Molecule
was	O
found	O
to	O
be	O
essential	O
for	O
SpeB	S-Biological_Molecule
expression	O
.	O

These	O
data	O
show	O
that	O
an	O
intact	O
RopB	S-Biological_Molecule
and	O
efficient	O
SpeB	S-Biological_Molecule
production	O
are	O
necessary	O
for	O
systemic	O
infection	O
with	O
GAS	S-Species
.	O

Streptococcus	B-Species
pyogenes	E-Species
(	O
group	B-Species
A	I-Species
streptococcus	E-Species
;	O
GAS	S-Species
)	O
is	O
a	O
Gram	O
-	O
positive	O
,	O
human	S-Species
-	O
specific	O
pathogen	O
responsible	O
for	O
over	O
500	O
,	O
000	O
deaths	O
each	O
year	O
[	O
1	O
]	O
.	O

Severe	O
invasive	O
GAS	S-Species
infections	O
such	O
as	O
necrotizing	O
fasciitis	O
account	O
for	O
approximately	O
30	O
%	O
of	O
these	O
deaths	O
,	O
and	O
the	O
incidence	O
of	O
such	O
acute	O
conditions	O
has	O
been	O
on	O
the	O
rise	O
since	O
the	O
mid	O
1980	O
'	O
s	O
[	O
2	O
]	O
.	O

While	O
the	O
M1T1	B-Species
GAS	E-Species
has	O
become	O
the	O
most	O
common	O
cause	O
of	O
streptococcal	O
pharyngitis	O
,	O
this	O
clone	O
is	O
also	O
overrepresented	O
in	O
cases	O
of	O
severe	O
invasive	O
disease	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
.	O

Studies	O
of	O
M1T1	S-Species
clinical	O
isolates	O
from	O
invasive	O
disease	O
cases	O
have	O
revealed	O
an	O
inverse	O
relationship	O
between	O
expression	O
of	O
the	O
extracellular	O
cysteine	O
protease	O
SpeB	S-Biological_Molecule
and	O
clinical	O
severity	O
[	O
8	O
]	O
.	O

SpeB	S-Biological_Molecule
is	O
a	O
secreted	O
cysteine	O
protease	O
initially	O
expressed	O
as	O
40	O
kDa	O
zymogen	O
which	O
is	O
then	O
converted	O
to	O
the	O
28	O
kDa	O
active	O
form	O
by	O
autocatalytic	O
processing	O
[	O
10	O
]	O
.	O

SpeB	S-Biological_Molecule
is	O
known	O
to	O
cleave	O
numerous	O
host	O
proteins	O
including	O
components	O
of	O
the	O
extracellular	O
matrix	O
,	O
cytokine	O
precursors	O
,	O
immunoglobulins	O
and	O
antimicrobial	O
peptides	O
[	O
11	O
]	O
-	O
[	O
13	O
]	O
,	O
which	O
could	O
interfere	O
with	O
host	O
immune	O
functions	O
.	O

However	O
,	O
SpeB	S-Biological_Molecule
has	O
also	O
been	O
shown	O
to	O
cleave	O
a	O
range	O
of	O
GAS	S-Species
proteins	O
such	O
as	O
the	O
fibrinogen	B-Biological_Molecule
-	I-Biological_Molecule
binding	I-Biological_Molecule
M1	I-Biological_Molecule
protein	E-Biological_Molecule
[	O
14	O
]	O
,	O
[	O
15	O
]	O
,	O
various	O
superantigens	O
[	O
16	O
]	O
,	O
[	O
17	O
]	O
,	O
the	O
secreted	O
plasminogen	B-Biological_Molecule
activator	I-Biological_Molecule
streptokinase	E-Biological_Molecule
[	O
18	O
]	O
as	O
well	O
as	O
the	O
DNase	O
Sda1	S-Biological_Molecule
[	O
17	O
]	O
,	O
and	O
thus	O
possibly	O
interfere	O
with	O
the	O
proven	O
virulence	O
functions	O
of	O
these	O
bacterial	O
factors	O
.	O

The	O
precise	O
role	O
(	O
s	O
)	O
of	O
SpeB	S-Biological_Molecule
throughout	O
the	O
course	O
of	O
infection	O
are	O
undoubtedly	O
complex	O
,	O
and	O
not	O
surprisingly	O
,	O
different	O
studies	O
using	O
different	O
in	O
vivo	O
animal	O
models	O
have	O
produced	O
seemingly	O
contradictory	O
results	O
[	O
19	O
]	O
-	O
[	O
21	O
]	O
.	O

RopB	S-Biological_Molecule
is	O
a	O
GAS	S-Species
transcriptional	O
regulator	O
that	O
has	O
been	O
shown	O
to	O
be	O
essential	O
for	O
expression	O
of	O
SpeB	S-Biological_Molecule
and	O
binds	O
directly	O
to	O
the	O
promoter	O
region	O
of	O
speB	S-Biological_Molecule
[	O
23	O
]	O
,	O
[	O
24	O
]	O
.	O

In	O
studies	O
performed	O
in	O
different	O
GAS	S-Species
serotype	O
strains	O
,	O
RopB	S-Biological_Molecule
has	O
variably	O
been	O
suggested	O
to	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
other	O
GAS	S-Species
genes	O
including	O
those	O
associated	O
with	O
metabolism	O
of	O
non	O
-	O
glucose	O
carbohydrates	O
and	O
amino	O
acids	O
[	O
25	O
]	O
,	O
[	O
26	O
]	O
,	O
response	O
to	O
thermal	O
and	O
oxidative	O
stress	O
[	O
25	O
]	O
,	O
[	O
27	O
]	O
and	O
the	O
expression	O
of	O
virulence	O
factors	O
including	O
DNases	O
(	O
MF	B-Biological_Molecule
-	I-Biological_Molecule
1	E-Biological_Molecule
and	O
MF	B-Biological_Molecule
-	I-Biological_Molecule
3	E-Biological_Molecule
)	O
and	O
hemolysins	O
(	O
streptolysin	B-Biological_Molecule
S	E-Biological_Molecule
and	O
streptolysin	B-Biological_Molecule
O	E-Biological_Molecule
)	O
[	O
26	O
]	O
,	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
.	O

For	O
example	O
,	O
separate	O
studies	O
have	O
shown	O
ropB	S-Biological_Molecule
mutation	O
to	O
have	O
either	O
no	O
effect	O
on	O
hemolysis	O
and	O
DNase	O
activity	O
or	O
,	O
alternatively	O
,	O
to	O
increase	O
expression	O
of	O
hemolysin	O
and	O
DNase	O
-	O
encoding	O
genes	O
and	O
the	O
associated	O
phenotypic	O
activities	O
[	O
23	O
]	O
,	O
[	O
26	O
]	O
.	O

This	O
strain	O
-	O
specific	O
variation	O
is	O
highlighted	O
in	O
a	O
recent	O
work	O
by	O
Dmitriev	O
et	O
al	O
.	O

This	O
analysis	O
begins	O
with	O
a	O
naturally	O
-	O
occuring	O
mutation	O
in	O
ropB	S-Biological_Molecule
identified	O
in	O
one	O
such	O
strain	O
.	O

Sequence	O
analysis	O
of	O
clinical	O
isolate	O
5628	S-Species
reveals	O
intact	O
speB	S-Biological_Molecule
and	O
covR	S-Biological_Molecule
/	O
S	S-Biological_Molecule
but	O
mutation	O
in	O
ropB	S-Biological_Molecule
M1T1	B-Species
GAS	E-Species
clinical	O
isolate	O
5628	S-Species
was	O
found	O
on	O
screening	O
to	O
lack	O
SpeB	S-Biological_Molecule
activity	O
by	O
azocasein	O
assay	O
.	O

DNA	O
sequencing	O
was	O
performed	O
using	O
primers	O
listed	O
in	O
Table	O
1	O
.	O

The	O
truncation	O
of	O
RopB	S-Biological_Molecule
suggested	O
that	O
this	O
may	O
be	O
the	O
cause	O
of	O
lack	O
of	O
SpeB	S-Biological_Molecule
expression	O
in	O
this	O
strain	O
.	O

Western	O
blot	O
detected	O
SpeB	S-Biological_Molecule
in	O
overnight	O
culture	O
supernatants	O
of	O
5628R	B-Species
+	E-Species
,	O
containing	O
the	O
intact	O
ropB	S-Biological_Molecule
allele	O
,	O
but	O
not	O
in	O
the	O
clinical	O
isolate	O
5628	S-Species
nor	O
the	O
isogenic	O
mutant	O
5628RDeltaSpeB	S-Biological_Molecule
,	O
containing	O
the	O
intact	O
ropB	S-Biological_Molecule
allele	O
but	O
lacking	O
speB	S-Biological_Molecule
(	O
Fig	O
.	O
1B	O
)	O
.	O

These	O
data	O
demonstrated	O
that	O
the	O
ropB	S-Biological_Molecule
point	O
mutation	O
was	O
indeed	O
responsible	O
for	O
the	O
lack	O
of	O
SpeB	S-Biological_Molecule
expression	O
in	O
the	O
clinical	O
isolate	O
5628	S-Species
.	O

RopB	S-Biological_Molecule
mutation	O
does	O
not	O
affect	O
bacterial	O
growth	O
,	O
hemolysis	O
,	O
DNase	O
activity	O
or	O
resistance	O
to	O
neutrophil	O
killing	O

GAS	B-Species
strain	I-Species
5628	E-Species
and	O
its	O
isogenic	O
mutants	O
5628R	B-Species
+	E-Species
and	O
5628RDeltaSpeB	S-Biological_Molecule
were	O
grown	O
in	O
THB	O
,	O
and	O
the	O
OD600	O
was	O
measured	O
over	O
time	O
.	O

No	O
significant	O
difference	O
was	O
found	O
among	O
the	O
growth	O
rates	O
of	O
the	O
three	O
bacterial	O
strains	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

No	O
significant	O
difference	O
was	O
seen	O
in	O
hemolytic	O
activity	O
among	O
strains	O
containing	O
the	O
WT	O
or	O
mutated	O
ropB	S-Biological_Molecule
allele	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

Extracellular	O
DNase	O
activity	O
of	O
mid	O
-	O
log	O
phase	O
bacteria	O
and	O
GAS	S-Species
resistance	O
to	O
neutrophil	O
killing	O
were	O
also	O
unaffected	O
by	O
mutation	O
in	O
ropB	S-Biological_Molecule
(	O
Fig	O
.	O
2C	O
and	O
2D	O
)	O
.	O

Three	O
days	O
post	O
-	O
infection	O
,	O
bacteria	O
were	O
recovered	O
from	O
the	O
lesion	O
and	O
screened	O
for	O
SpeB	S-Biological_Molecule
status	O
using	O
the	O
skim	O
-	O
milk	O
agar	O
method	O
.	O

This	O
finding	O
reveals	O
that	O
when	O
SpeB	S-Biological_Molecule
-	O
negative	O
colonies	O
are	O
selected	O
for	O
in	O
vivo	O
,	O
this	O
selection	O
is	O
predominantly	O
a	O
phenomenon	O
associated	O
with	O
CovR	S-Biological_Molecule
/	O
S	S-Biological_Molecule
inactivation	O
.	O

SpeB	S-Biological_Molecule
is	O
the	O
principal	O
target	O
of	O
RopB	S-Biological_Molecule
regulation	O
in	O
vivo	O

Microarray	O
analysis	O
was	O
performed	O
on	O
in	O
vivo	O
-	O
derived	O
RNA	O
from	O
the	O
well	O
characterized	O
GAS	B-Species
strain	I-Species
5448	E-Species
and	O
its	O
derivative	O
5448R	B-Species
-	E-Species
,	O
containing	O
the	O
mutated	O
ropB	S-Biological_Molecule
allele	O
from	O
5628	S-Species
.	O

Fourty	O
-	O
seven	O
genes	O
were	O
found	O
to	O
be	O
down	O
-	O
regulated	O
and	O
52	O
genes	O
were	O
found	O
to	O
be	O
up	O
-	O
regulated	O
in	O
5448R	O
-	O
greater	O
than	O
2	O
-	O
fold	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

In	O
addition	O
to	O
the	O
SpeB	S-Biological_Molecule
operon	O
,	O
genes	O
of	O
the	O
streptolysin	B-Biological_Molecule
S	E-Biological_Molecule
operon	O
were	O
also	O
found	O
to	O
be	O
strongly	O
down	O
-	O
regulated	O
in	O
the	O
ropB	S-Biological_Molecule
mutant	O
strain	O
.	O

Apart	O
from	O
the	O
gene	O
encoding	O
the	O
superantigen	O
SmeZ	S-Biological_Molecule
,	O
there	O
was	O
an	O
absence	O
of	O
virulence	O
-	O
related	O
genes	O
found	O
to	O
be	O
strongly	O
up	O
-	O
regulated	O
in	O
the	O
strain	O
5448R	B-Species
-	E-Species
,	O
which	O
expressed	O
the	O
truncated	O
RopB	S-Biological_Molecule
.	O

GAS	B-Species
strain	I-Species
5628R	I-Species
+	E-Species
expressing	O
a	O
full	O
length	O
RopB	S-Biological_Molecule
showed	O
increased	O
virulence	O
compared	O
to	O
the	O
strain	O
5628	S-Species
with	O
a	O
truncated	O
RopB	S-Biological_Molecule
(	O
Figure	O
4A	O
)	O
.	O

Strain	O
5628RDeltaSpeB	S-Biological_Molecule
containing	O
a	O
full	O
-	O
length	O
RopB	S-Biological_Molecule
but	O
lacking	O
SpeB	S-Biological_Molecule
also	O
showed	O
reduced	O
virulence	O
,	O
suggesting	O
that	O
the	O
reduced	O
virulence	O
of	O
5628	S-Species
may	O
primarily	O
result	O
from	O
the	O
lack	O
of	O
SpeB	S-Biological_Molecule
expression	O
in	O
this	O
strain	O
.	O

Virulence	O
was	O
also	O
examined	O
in	O
an	O
intravenous	O
model	O
of	O
systemic	O
infection	O
.	O

The	O
well	O
characterized	O
strain	O
5448	S-Species
and	O
its	O
isogenic	O
mutant	O
5448R	B-Species
-	E-Species
,	O
containing	O
the	O
ropB	S-Biological_Molecule
allele	O
from	O
5628	S-Species
,	O
were	O
further	O
included	O
to	O
examine	O
the	O
effect	O
of	O
this	O
allelic	O
variation	O
in	O
a	O
well	O
-	O
characterized	O
virulent	O
strain	O
of	O
GAS	S-Species
.	O

Discussion	O

In	O
the	O
globally	O
-	O
disseminated	O
clonal	O
M1T1	S-Species
serotype	O
associated	O
with	O
epidemic	O
invasive	O
GAS	S-Species
infection	O
,	O
an	O
inverse	O
relationship	O
has	O
been	O
found	O
between	O
SpeB	S-Biological_Molecule
activity	O
and	O
clinical	O
disease	O
severity	O
[	O
8	O
]	O
.	O

Recently	O
,	O
we	O
and	O
others	O
have	O
found	O
a	O
connection	O
between	O
inactivation	O
of	O
SpeB	S-Biological_Molecule
through	O
mutation	O
in	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
covR	S-Biological_Molecule
/	O
S	S-Biological_Molecule
and	O
development	O
of	O
invasive	O
disease	O
in	O
the	O
murine	S-Species
model	O
[	O
37	O
]	O
,	O
[	O
38	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
investigated	O
a	O
second	O
mechanism	O
of	O
inactivation	O
of	O
SpeB	S-Biological_Molecule
,	O
namely	O
through	O
truncation	O
of	O
the	O
regulator	O
RopB	S-Biological_Molecule
.	O

We	O
have	O
shown	O
that	O
in	O
M1T1	B-Species
GAS	E-Species
,	O
when	O
the	O
covR	S-Biological_Molecule
/	O
S	S-Biological_Molecule
locus	O
is	O
intact	O
and	O
DNase	O
Sda1	S-Biological_Molecule
activity	O
is	O
unaffected	O
,	O
ropB	S-Biological_Molecule
point	O
mutation	O
results	O
in	O
reduced	O
virulence	O
in	O
vivo	O
,	O
despite	O
inactivation	O
of	O
SpeB	S-Biological_Molecule
activity	O
.	O

The	O
SpeB	S-Biological_Molecule
-	O
negative	O
,	O
serotype	O
M1T1	O
clinical	O
isolate	O
5628	O
was	O
used	O
to	O
investigate	O
the	O
role	O
of	O
RopB	S-Biological_Molecule
in	O
virulence	O
.	O

The	O
M1T1	B-Species
strain	I-Species
5628	E-Species
contains	O
a	O
point	O
mutation	O
in	O
the	O
ropB	S-Biological_Molecule
gene	O
that	O
results	O
in	O
a	O
truncation	O
of	O
the	O
last	O
110	O
amino	O
acids	O
of	O
the	O
280	O
amino	O
acid	O
protein	O
.	O

RopB	S-Biological_Molecule
mutation	O
in	O
this	O
particular	O
strain	O
does	O
not	O
result	O
in	O
the	O
kind	O
of	O
global	O
phenotypic	O
change	O
found	O
with	O
covR	S-Biological_Molecule
/	O
S	S-Biological_Molecule
mutation	O
where	O
differential	O
expression	O
was	O
observed	O
of	O
multiple	O
genes	O
encoding	O
virulence	O
determinants	O
,	O
including	O
sic	S-Biological_Molecule
,	O
ska	S-Biological_Molecule
,	O
slo	S-Biological_Molecule
,	O
speA	S-Biological_Molecule
,	O
speJ	S-Biological_Molecule
,	O
scpC	S-Biological_Molecule
and	O
the	O
hyaluronic	O
acid	O
synthesis	O
operon	O
[	O
37	O
]	O
which	O
were	O
all	O
unaffected	O
in	O
the	O
ropB	S-Biological_Molecule
mutant	O
examined	O
in	O
this	O
work	O
.	O

Recently	O
,	O
we	O
have	O
demonstrated	O
that	O
WT	O
,	O
SpeB	S-Biological_Molecule
-	O
positive	O
bacteria	O
undergo	O
a	O
phase	O
-	O
shift	O
to	O
a	O
SpeB	S-Biological_Molecule
-	O
negative	O
phenotype	O
after	O
subcutaneous	O
infection	O
of	O
mice	S-Species
[	O
17	O
]	O
.	O

Of	O
the	O
down	O
-	O
regulated	O
genes	O
in	O
CovR	S-Biological_Molecule
/	O
S	S-Biological_Molecule
mutant	O
strains	O
,	O
SpeB	S-Biological_Molecule
would	O
appear	O
to	O
be	O
one	O
of	O
the	O
most	O
important	O
due	O
to	O
its	O
ability	O
to	O
degrade	O
many	O
host	O
and	O
self	O
-	O
proteins	O
.	O

Furthermore	O
,	O
the	O
switch	O
to	O
a	O
SpeB	S-Biological_Molecule
-	O
negative	O
phenotype	O
appeared	O
to	O
occur	O
exclusively	O
through	O
mutations	O
in	O
covR	S-Biological_Molecule
/	O
S	S-Biological_Molecule
.	O

This	O
result	O
suggests	O
that	O
covR	S-Biological_Molecule
/	O
S	S-Biological_Molecule
mutations	O
are	O
the	O
predominant	O
method	O
of	O
phenotypic	O
switching	O
in	O
GAS	S-Species
and	O
that	O
ropB	S-Biological_Molecule
mutation	O
is	O
not	O
readily	O
selected	O
for	O
in	O
vivo	O
.	O

This	O
finding	O
supported	O
the	O
in	O
vitro	O
and	O
in	O
vivo	O
data	O
that	O
suggested	O
SpeB	S-Biological_Molecule
is	O
the	O
main	O
target	O
of	O
RopB	S-Biological_Molecule
regulation	O
in	O
this	O
strain	O
.	O

Virulence	O
studies	O
utilizing	O
systemic	O
models	O
of	O
infection	O
showed	O
that	O
a	O
full	O
-	O
length	O
RopB	S-Biological_Molecule
was	O
required	O
for	O
virulence	O
.	O

These	O
data	O
illustrate	O
the	O
necessity	O
for	O
an	O
intact	O
RopB	S-Biological_Molecule
for	O
full	O
virulence	O
in	O
vivo	O
.	O

In	O
addition	O
,	O
the	O
strain	O
5628RDeltaSpeB	S-Biological_Molecule
expressing	O
an	O
intact	O
RopB	S-Biological_Molecule
but	O
lacking	O
SpeB	S-Biological_Molecule
showed	O
similarly	O
reduced	O
virulence	O
to	O
the	O
strain	O
with	O
a	O
truncated	O
RopB	S-Biological_Molecule
.	O

Of	O
note	O
,	O
the	O
additional	O
virulence	O
factors	O
streptokinase	S-Biological_Molecule
and	O
M1	S-Biological_Molecule
protein	O
,	O
are	O
both	O
up	O
-	O
regulated	O
in	O
covR	S-Biological_Molecule
/	O
S	S-Biological_Molecule
mutant	O
M1T1	O
strains	O
[	O
37	O
]	O
,	O
but	O
not	O
in	O
the	O
ropB	S-Biological_Molecule
mutant	O
under	O
investigation	O
in	O
this	O
study	O
.	O

Streptokinase	S-Biological_Molecule
and	O
M1	S-Biological_Molecule
protein	O
are	O
believed	O
to	O
play	O
a	O
role	O
in	O
the	O
accumulation	O
of	O
host	O
plasmin	O
at	O
the	O
GAS	S-Species
cell	O
surface	O
,	O
a	O
process	O
which	O
is	O
thought	O
to	O
accentuate	O
invasive	O
disease	O
[	O
5	O
]	O
,	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
.	O

In	O
M1T1	B-Species
GAS	E-Species
,	O
an	O
intact	O
RopB	S-Biological_Molecule
and	O
efficient	O
SpeB	S-Biological_Molecule
production	O
are	O
necessary	O
for	O
systemic	O
infection	O
.	O

A	O
mutation	O
in	O
any	O
one	O
of	O
these	O
three	O
genes	O
,	O
csrA	S-Biological_Molecule
,	O
hfq	S-Biological_Molecule
,	O
and	O
smpB	S-Biological_Molecule
,	O
in	O
Salmonella	S-Species
is	O
attenuated	O
for	O
mouse	S-Species
virulence	O
and	O
unable	O
to	O
survive	O
in	O
macrophages	O
.	O

CsrA	S-Biological_Molecule
has	O
a	O
clearly	O
defined	O
specificity	O
based	O
on	O
binding	O
to	O
a	O
specific	O
mRNA	O
sequence	O
to	O
inhibit	O
translation	O
.	O

However	O
,	O
the	O
proteins	O
regulated	O
by	O
Hfq	S-Biological_Molecule
and	O
SmpB	S-Biological_Molecule
are	O
not	O
as	O
clearly	O
defined	O
.	O

In	O
this	O
report	O
we	O
have	O
used	O
global	O
proteomics	O
to	O
directly	O
identify	O
proteins	O
regulated	O
by	O
Hfq	S-Biological_Molecule
or	O
SmpB	S-Biological_Molecule
by	O
comparing	O
protein	O
abundance	O
in	O
the	O
parent	O
and	O
isogenic	O
hfq	S-Biological_Molecule
or	O
smpB	S-Biological_Molecule
mutant	O
.	O

From	O
these	O
same	O
samples	O
we	O
also	O
prepared	O
RNA	O
for	O
microarray	O
analysis	O
to	O
determine	O
if	O
alteration	O
of	O
protein	O
expression	O
was	O
mediated	O
post	O
-	O
transcriptionally	O
.	O

These	O
proteins	O
represent	O
a	O
broad	O
spectrum	O
of	O
Salmonella	S-Species
proteins	O
required	O
for	O
many	O
biological	O
processes	O
including	O
host	O
cell	O
invasion	O
,	O
motility	O
,	O
central	O
metabolism	O
,	O
LPS	S-Chemical_Compound
biosynthesis	O
,	O
two	O
-	O
component	O
regulatory	O
systems	O
,	O
and	O
fatty	O
acid	O
metabolism	O
.	O

Our	O
results	O
represent	O
one	O
of	O
the	O
first	O
global	O
analyses	O
of	O
post	O
-	O
transcriptional	O
regulons	O
in	O
any	O
organism	O
and	O
suggest	O
that	O
regulation	O
at	O
the	O
translational	O
level	O
is	O
widespread	O
and	O
plays	O
an	O
important	O
role	O
in	O
virulence	O
regulation	O
and	O
environmental	O
adaptation	O
for	O
Salmonella	S-Species
.	O

Introduction	O

tmRNA	S-Biological_Molecule
functions	O
as	O
a	O
part	O
of	O
the	O
translational	O
quality	O
control	O
process	O
,	O
recognizing	O
and	O
binding	O
to	O
ribosomes	O
that	O
become	O
stalled	O
.	O

Usually	O
classified	O
as	O
a	O
housekeeping	O
or	O
repair	O
system	O
,	O
a	O
role	O
for	O
tmRNA	S-Biological_Molecule
as	O
a	O
regulatory	O
sRNA	O
has	O
been	O
recently	O
suggested	O
.	O

Ranquet	O
and	O
Gottesman	O
[	O
19	O
]	O
report	O
that	O
the	O
sRNA	O
tmRNA	S-Biological_Molecule
plays	O
a	O
regulatory	O
role	O
in	O
gene	O
expression	O
and	O
is	O
required	O
for	O
the	O
correct	O
high	O
-	O
level	O
translation	O
of	O
RpoS	S-Biological_Molecule
.	O

Recent	O
reports	O
suggest	O
that	O
both	O
Hfq	S-Biological_Molecule
and	O
SmpB	S-Biological_Molecule
play	O
essential	O
roles	O
in	O
bacterial	O
pathogenesis	O
.	O

In	O
another	O
study	O
,	O
a	O
smpB	S-Biological_Molecule
mutant	O
of	O
Salmonella	B-Species
Typhimurium	E-Species
exhibited	O
defects	O
in	O
intra	O
-	O
macrophage	O
survival	O
,	O
a	O
model	O
of	O
Salmonella	S-Species
pathogenesis	O
[	O
23	O
]	O
.	O

More	O
recently	O
mutation	O
of	O
tmRNA	S-Biological_Molecule
was	O
shown	O
to	O
be	O
responsible	O
for	O
a	O
marked	O
reduction	O
in	O
Salmonella	B-Species
Typhimurium	E-Species
virulence	O
in	O
BALB	B-Species
/	I-Species
c	I-Species
mice	E-Species
[	O
24	O
]	O
.	O

Identifying	O
what	O
proteins	O
are	O
actually	O
regulated	O
by	O
Hfq	S-Biological_Molecule
and	O
SmpB	S-Biological_Molecule
is	O
an	O
important	O
step	O
in	O
understanding	O
the	O
impact	O
of	O
post	O
-	O
transcriptional	O
gene	O
regulation	O
in	O
Enterobacteria	S-Species
and	O
more	O
specifically	O
how	O
Hfq	S-Biological_Molecule
and	O
SmpB	S-Biological_Molecule
control	O
Salmonella	S-Species
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
/	O
translational	O
level	O
and	O
the	O
role	O
that	O
this	O
may	O
play	O
in	O
Salmonella	S-Species
pathogenesis	O
.	O

Zhang	O
et	O
al	O
.	O

In	O
a	O
recent	O
study	O
Sittka	O
et	O
al	O
.	O

[	O
10	O
]	O
used	O
high	O
-	O
throughput	O
pyrosequencing	O
(	O
HTPS	O
)	O
to	O
detect	O
potential	O
targets	O
of	O
an	O
epitope	O
tagged	O
-	O
Hfq	S-Biological_Molecule
protein	O
co	O
-	O
immunoprecipitated	O
with	O
commercially	O
available	O
antibodies	O
,	O
overcoming	O
the	O
limitations	O
of	O
the	O
previous	O
strategy	O
;	O
the	O
need	O
for	O
custom	O
microarrays	O
and	O
specialized	O
antibodies	O
.	O

In	O
another	O
study	O
[	O
27	O
]	O
microarray	O
analysis	O
was	O
used	O
to	O
identify	O
changes	O
in	O
gene	O
expression	O
resulting	O
from	O
lack	O
of	O
Hfq	S-Biological_Molecule
,	O
thus	O
providing	O
potential	O
new	O
target	O
genes	O
for	O
sRNA	O
regulation	O
.	O

In	O
addition	O
,	O
it	O
is	O
clear	O
that	O
a	O
transcriptional	O
analysis	O
solely	O
can	O
not	O
distinguish	O
between	O
transcriptional	O
and	O
translational	O
/	O
post	O
-	O
transcriptional	O
regulatory	O
effects	O
.	O

Here	O
,	O
we	O
performed	O
sample	O
-	O
matched	O
global	O
proteomics	O
and	O
transcriptional	O
analyses	O
together	O
with	O
cellular	O
assays	O
and	O
animal	O
studies	O
to	O
begin	O
to	O
understand	O
how	O
Hfq	S-Biological_Molecule
and	O
SmpB	S-Biological_Molecule
control	O
Salmonella	S-Species
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
level	O
and	O
the	O
role	O
that	O
this	O
may	O
play	O
in	O
Salmonella	S-Species
pathogenesis	O
.	O

The	O
extent	O
of	O
global	O
regulation	O
of	O
translation	O
is	O
much	O
greater	O
than	O
previously	O
thought	O
[	O
10	O
]	O
,	O
with	O
profound	O
effects	O
in	O
all	O
stages	O
of	O
Salmonella	S-Species
'	O
s	O
life	O
cycle	O
including	O
a	O
variety	O
of	O
house	O
keeping	O
pathways	O
and	O
known	O
and	O
novel	O
virulence	O
factors	O
,	O
in	O
part	O
explaining	O
the	O
requirement	O
of	O
both	O
translational	O
regulators	O
for	O
virulence	O
in	O
Salmonella	S-Species
.	O

This	O
study	O
represents	O
one	O
of	O
the	O
first	O
comparative	O
global	O
analyses	O
of	O
post	O
-	O
transcriptional	O
regulation	O
in	O
any	O
organism	O
;	O
the	O
data	O
suggest	O
post	O
-	O
transcriptional	O
regulation	O
is	O
widespread	O
and	O
plays	O
an	O
important	O
role	O
in	O
virulence	O
regulation	O
and	O
environmental	O
adaptation	O
for	O
Salmonella	S-Species
.	O

In	O
this	O
method	O
[	O
28	O
]	O
,	O
the	O
coding	O
region	O
between	O
the	O
initiation	O
methionine	O
and	O
the	O
last	O
seven	O
amino	O
acids	O
of	O
the	O
gene	O
was	O
replaced	O
with	O
an	O
inframe	O
"	O
scar	O
"	O
sequence	O
that	O
does	O
not	O
contain	O
any	O
stop	O
codons	O
.	O

Functional	O
disruption	O
of	O
the	O
hfq	S-Biological_Molecule
and	O
smpB	S-Biological_Molecule
mutant	O
derivatives	O
was	O
first	O
confirmed	O
by	O
PCR	O
analysis	O
after	O
which	O
the	O
mutants	O
were	O
P22	O
transduced	O
to	O
a	O
new	O
genetic	O
background	O
to	O
avoid	O
the	O
possibility	O
of	O
secondary	O
mutations	O
.	O

Mutants	O
that	O
lacked	O
either	O
of	O
these	O
proteins	O
showed	O
impaired	O
growth	O
phenotype	O
in	O
acidic	O
minimal	O
media	O
(	O
AMM	O
)	O
.	O

These	O
results	O
suggest	O
SmpB	S-Biological_Molecule
and	O
Hfq	S-Biological_Molecule
are	O
involved	O
in	O
broad	O
cellular	O
functions	O
,	O
including	O
growth	O
rate	O
regulation	O
.	O

To	O
directly	O
assess	O
the	O
role	O
of	O
Hfq	S-Biological_Molecule
and	O
SmpB	S-Biological_Molecule
in	O
Salmonella	B-Species
Typhimurium	E-Species
pathogenesis	O
,	O
BALB	B-Species
/	I-Species
c	I-Species
mice	E-Species
were	O
infected	O
intraperitoneally	O
with	O
200	O
cfu	O
of	O
either	O
Deltahfq	S-Biological_Molecule
mutant	O
strain	O
,	O
DeltasmpB	S-Biological_Molecule
mutant	O
strain	O
or	O
wildtype	O
strain	O
and	O
monitored	O
for	O
21	O
days	O
(	O
Figure	O
1	O
)	O
.	O

Mice	S-Species
infected	O
with	O
wildtype	O
strain	O
exhibited	O
typical	O
symptoms	O
of	O
infection	O
and	O
died	O
at	O
around	O
six	O
days	O
.	O

These	O
results	O
are	O
similar	O
to	O
those	O
in	O
previous	O
reports	O
[	O
20	O
]	O
,	O
[	O
23	O
]	O
.	O

Intracellular	O
survival	O
/	O
replication	O
results	O
(	O
Figure	O
2	O
)	O
are	O
consistent	O
with	O
earlier	O
reports	O
that	O
suggest	O
Deltahfq	S-Biological_Molecule
and	O
DeltasmpB	S-Biological_Molecule
Salmonella	O
Typhimurium	O
mutant	O
strains	O
are	O
essential	O
for	O
intra	O
-	O
macrophage	O
proliferation	O
[	O
22	O
]	O
,	O
[	O
23	O
]	O
,	O
[	O
25	O
]	O
.	O

The	O
differences	O
in	O
protein	O
expression	O
between	O
parent	O
and	O
isogenic	O
mutant	O
was	O
assessed	O
via	O
hypothesis	O
testing	O
,	O
specifically	O
a	O
comprehensive	O
ANOVA	O
scheme	O
included	O
in	O
the	O
computer	O
program	O
DAnTE	O
[	O
30	O
]	O
.	O

When	O
compared	O
to	O
the	O
entire	O
Salmonella	S-Species
proteome	O
of	O
4450	O
annotated	O
open	O
reading	O
frames	O
(	O
orf	O
;	O
[	O
31	O
]	O
)	O
,	O
781	O
proteins	O
represents	O
approximately20	O
%	O
of	O
the	O
entire	O
Salmonella	S-Species
genome	O
.	O

This	O
is	O
in	O
agreement	O
with	O
a	O
recent	O
study	O
that	O
found	O
that	O
Hfq	S-Biological_Molecule
affects	O
18	O
%	O
of	O
the	O
Salmonella	S-Species
genome	O
[	O
10	O
]	O
.	O

That	O
is	O
,	O
not	O
every	O
deregulated	O
protein	O
in	O
the	O
hfq	S-Biological_Molecule
mutant	O
strain	O
is	O
necessarily	O
directly	O
regulated	O
by	O
Hfq	S-Biological_Molecule
.	O

We	O
report	O
that	O
Hfq	S-Biological_Molecule
directly	O
or	O
indirectly	O
modulates	O
approximately20	O
%	O
of	O
the	O
Salmonella	S-Species
genome	O
.	O

However	O
this	O
most	O
likely	O
is	O
an	O
underestimate	O
of	O
the	O
true	O
number	O
of	O
proteins	O
that	O
are	O
regulated	O
by	O
Hfq	S-Biological_Molecule
,	O
if	O
accurate	O
protein	O
identifications	O
could	O
be	O
made	O
for	O
the	O
remaining	O
2829	O
orfs	O
of	O
the	O
entire	O
Salmonella	S-Species
proteome	O
(	O
4450	O
orfs	O
)	O
that	O
are	O
either	O
expressed	O
at	O
levels	O
too	O
low	O
to	O
be	O
detected	O
or	O
not	O
expressed	O
under	O
the	O
four	O
growth	O
conditions	O
employed	O
in	O
this	O
study	O
.	O

Considering	O
that	O
we	O
observe	O
36	O
%	O
(	O
1621	O
orfs	O
)	O
of	O
the	O
entire	O
Salmonella	S-Species
proteome	O
(	O
4450	O
orfs	O
)	O
and	O
that	O
50	O
%	O
(	O
781	O
orfs	O
)	O
of	O
this	O
observed	O
proteome	O
(	O
1621	O
orfs	O
)	O
is	O
modulated	O
by	O
Hfq	S-Biological_Molecule
,	O
it	O
would	O
be	O
expected	O
that	O
a	O
significant	O
portion	O
of	O
the	O
unobserved	O
Salmonella	S-Species
proteome	O
(	O
2829	O
orfs	O
)	O
would	O
also	O
be	O
regulated	O
by	O
Hfq	S-Biological_Molecule
,	O
thus	O
our	O
assertion	O
that	O
the	O
approximately20	O
%	O
value	O
may	O
very	O
well	O
represent	O
an	O
underestimation	O
.	O

Craig	O
Venter	O
Institute	O
(	O
JCVI	O
)	O
functional	O
categories	O
[	O
32	O
]	O
showed	O
that	O
Hfq	S-Biological_Molecule
modulated	O
the	O
expression	O
of	O
>	O
/	O
=	O
40	O
%	O
of	O
the	O
observed	O
proteins	O
in	O
15	O
of	O
the	O
19	O
functional	O
categories	O
annotated	O
for	O
Salmonella	S-Species
(	O
Table	O
1	O
)	O
.	O

This	O
category	O
encompasses	O
sub	O
-	O
categories	O
including	O
adaptations	O
to	O
atypical	O
conditions	O
,	O
cell	O
adhesion	O
,	O
pathogenesis	O
,	O
chemotaxis	O
and	O
motility	O
,	O
detoxification	O
,	O
toxin	O
production	O
and	O
resistance	O
,	O
DNA	O
transformation	O
and	O
cell	O
division	O
.	O

[	O
20	O
]	O
investigated	O
the	O
proteome	O
of	O
an	O
Deltahfq	S-Biological_Molecule
mutant	O
strain	O
using	O
2D	O
gel	O
analysis	O
,	O
and	O
found	O
approximately70	O
differentially	O
expressed	O
proteins	O
in	O
early	O
stationary	O
phase	O
.	O

[	O
20	O
]	O
and	O
hence	O
one	O
would	O
expect	O
minimal	O
variability	O
in	O
a	O
cross	O
-	O
comparison	O
between	O
both	O
studies	O
under	O
these	O
two	O
growth	O
conditions	O
.	O

The	O
exception	O
was	O
the	O
SPI	O
-	O
1	O
protein	O
SipA	S-Biological_Molecule
under	O
LB	O
Stat	O
growth	O
conditions	O
.	O

However	O
under	O
SPI	O
-	O
1	O
inducing	O
conditions	O
(	O
LB	O
Log	O
)	O
regulation	O
of	O
SPI	O
-	O
1	O
proteins	O
by	O
Hfq	S-Biological_Molecule
was	O
generally	O
consistent	O
with	O
the	O
literature	O
.	O

To	O
extend	O
our	O
validation	O
of	O
the	O
proteomics	O
results	O
we	O
also	O
directly	O
analyzed	O
protein	O
levels	O
by	O
Western	O
blot	O
analysis	O
of	O
selected	O
proteins	O
based	O
on	O
our	O
proteomics	O
results	O
.	O

Our	O
proteomics	O
results	O
showed	O
that	O
HtrA	S-Biological_Molecule
protein	O
levels	O
were	O
strongly	O
up	O
-	O
regulated	O
in	O
the	O
Deltahfq	S-Biological_Molecule
mutant	O
relative	O
to	O
wildtype	O
in	O
LB	O
Log	O
,	O
while	O
OsmY	S-Biological_Molecule
and	O
STM1513	S-Biological_Molecule
were	O
strongly	O
down	O
-	O
regulated	O
in	O
the	O
Deltahfq	S-Biological_Molecule
mutant	O
relative	O
to	O
wildtype	O
in	O
AMM	O
-	O
1	O
and	O
LB	O
Stat	O
respectively	O
.	O

As	O
transcript	O
levels	O
are	O
often	O
equated	O
to	O
protein	O
expression	O
levels	O
,	O
it	O
was	O
of	O
particular	O
interest	O
to	O
determine	O
whether	O
genes	O
that	O
showed	O
significant	O
changes	O
in	O
protein	O
expression	O
also	O
exhibited	O
significant	O
changes	O
in	O
transcript	O
levels	O
.	O

Examination	O
of	O
transcript	O
levels	O
using	O
microarray	O
analysis	O
(	O
>	O
/	O
=	O
2	O
-	O
fold	O
change	O
)	O
revealed	O
a	O
more	O
modest	O
effect	O
on	O
Salmonella	S-Species
transcription	O
,	O
with	O
approximately11	O
%	O
(	O
492	O
genes	O
)	O
and	O
approximately8	O
%	O
(	O
370	O
genes	O
)	O
of	O
the	O
Salmonella	B-Species
Typhimurium	E-Species
genome	O
(	O
4550	O
genes	O
;	O
[	O
31	O
]	O
)	O
under	O
control	O
of	O
Hfq	S-Biological_Molecule
and	O
SmpB	S-Biological_Molecule
,	O
respectively	O
(	O
Table	O
S4	O
)	O
.	O

The	O
result	O
for	O
hfq	S-Biological_Molecule
transcriptional	O
analysis	O
is	O
in	O
general	O
agreement	O
with	O
previous	O
studies	O
for	O
Salmonella	S-Species
[	O
10	O
]	O
and	O
Pseudomonas	B-Species
aeruginosa	E-Species
[	O
33	O
]	O
where	O
approximately20	O
%	O
and	O
approximately15	O
%	O
of	O
all	O
genes	O
,	O
respectively	O
,	O
were	O
regulated	O
by	O
Hfq	S-Biological_Molecule
,	O
but	O
slightly	O
higher	O
than	O
the	O
number	O
of	O
Hfq	S-Biological_Molecule
-	O
dependent	O
genes	O
reported	O
for	O
E	B-Species
.	I-Species
coli	E-Species
[	O
27	O
]	O
and	O
Vibrio	B-Species
cholerae	E-Species
[	O
21	O
]	O
,	O
approximately6	O
%	O
each	O
.	O

Of	O
the	O
781	O
proteins	O
and	O
492	O
transcripts	O
regulated	O
by	O
Hfq	S-Biological_Molecule
,	O
113	O
genes	O
overlapped	O
both	O
sets	O
.	O

Hfq	S-Biological_Molecule
control	O
of	O
biological	O
processes	O

While	O
the	O
role	O
of	O
Hfq	S-Biological_Molecule
as	O
a	O
global	O
regulator	O
has	O
become	O
increasingly	O
appreciated	O
over	O
the	O
past	O
few	O
years	O
,	O
the	O
actual	O
extent	O
of	O
Hfq	S-Biological_Molecule
regulation	O
of	O
translation	O
remains	O
unknown	O
.	O

General	O
metabolism	O
Proteome	O
profiling	O
data	O
suggested	O
Hfq	S-Biological_Molecule
regulates	O
nucleoside	O
(	O
DeoABC	S-Biological_Molecule
)	O
and	O
nucleotide	O
metabolism	O
(	O
CarAB	S-Biological_Molecule
,	O
PurUBCMHAD	S-Biological_Molecule
,	O
Ndk	S-Biological_Molecule
)	O
under	O
AMM	O
conditions	O
,	O
as	O
well	O
as	O
regulates	O
ribose	O
metabolism	O
and	O
transport	O
(	O
RbsABK	S-Biological_Molecule
)	O
under	O
AMM	O
-	O
2	O
.	O

Hfq	S-Biological_Molecule
also	O
appears	O
to	O
play	O
a	O
significant	O
role	O
in	O
central	O
metabolism	O
based	O
on	O
observed	O
differential	O
regulation	O
of	O
numerous	O
proteins	O
involved	O
in	O
glycolysis	O
/	O
gluconeogenesis	O
,	O
the	O
TCA	S-Chemical_Compound
pathway	O
,	O
pyruvate	S-Chemical_Compound
decarboxylation	O
and	O
the	O
pentose	O
phosphate	O
shunt	O
(	O
see	O
Table	O
S1	O
)	O
.	O

Examination	O
of	O
the	O
transcript	O
levels	O
of	O
the	O
corresponding	O
genes	O
showed	O
no	O
significant	O
change	O
in	O
mRNA	O
expression	O
levels	O
relative	O
to	O
wildtype	O
,	O
suggesting	O
that	O
Hfq	S-Biological_Molecule
provides	O
most	O
of	O
the	O
control	O
of	O
these	O
pathways	O
for	O
the	O
growth	O
conditions	O
monitored	O
.	O

Translation	O

Several	O
ribosomal	O
proteins	O
including	O
RpsM	S-Biological_Molecule
,	O
RpsG	S-Biological_Molecule
,	O
RpmD	S-Biological_Molecule
,	O
and	O
RplN	S-Biological_Molecule
exhibited	O
a	O
marked	O
reduction	O
in	O
both	O
protein	O
and	O
mRNA	O
levels	O
in	O
the	O
Deltahfq	S-Biological_Molecule
mutant	O
strain	O
compared	O
to	O
the	O
wildtype	O
under	O
LB	O
Stat	O
growth	O
condition	O
.	O

One	O
hallmark	O
of	O
growth	O
under	O
nutrient	O
poor	O
conditions	O
is	O
lower	O
expression	O
of	O
the	O
machinery	O
necessary	O
to	O
synthesize	O
proteins	O
,	O
including	O
tRNA	O
synthetases	O
and	O
other	O
factors	O
.	O

In	O
fact	O
all	O
of	O
the	O
aminoacyl	O
-	O
tRNA	O
synthetases	O
(	O
IleS	S-Biological_Molecule
,	O
ProS	S-Biological_Molecule
,	O
CysS	S-Biological_Molecule
,	O
GlnS	S-Biological_Molecule
,	O
AspS	S-Biological_Molecule
,	O
ArgS	S-Biological_Molecule
,	O
GltX	S-Biological_Molecule
,	O
AlaS	S-Biological_Molecule
,	O
TrpS	S-Biological_Molecule
,	O
GlyS	S-Biological_Molecule
,	O
GlyQ	S-Biological_Molecule
)	O
observed	O
were	O
up	O
-	O
regulated	O
in	O
the	O
Deltahfq	S-Biological_Molecule
mutant	O
relative	O
to	O
the	O
wild	O
type	O
without	O
a	O
concurrent	O
change	O
in	O
transcription	O
.	O

This	O
suggests	O
that	O
Hfq	S-Biological_Molecule
normally	O
represses	O
translation	O
of	O
these	O
genes	O
under	O
conditions	O
that	O
mimics	O
the	O
intracellular	O
environment	O
(	O
AMM	O
)	O
.	O

Hfq	S-Biological_Molecule
was	O
observed	O
to	O
modulate	O
numerous	O
proteins	O
involved	O
in	O
envelope	O
stress	O
under	O
AMM	O
-	O
2	O
conditions	O
,	O
including	O
FkpA	S-Biological_Molecule
,	O
SurA	S-Biological_Molecule
,	O
HtrA	S-Biological_Molecule
,	O
NlpB	S-Biological_Molecule
,	O
NmpC	S-Biological_Molecule
,	O
ClpA	S-Biological_Molecule
,	O
SlyD	S-Biological_Molecule
,	O
RseA	S-Biological_Molecule
,	O
RseB	S-Biological_Molecule
,	O
RpoE	S-Biological_Molecule
,	O
OmpF	S-Biological_Molecule
,	O
and	O
HtpG	S-Biological_Molecule
,	O
which	O
were	O
all	O
up	O
-	O
regulated	O
in	O
the	O
Deltahfq	S-Biological_Molecule
mutant	O
strain	O
.	O

Proteins	O
involved	O
in	O
oxidative	O
stress	O
(	O
NarY	S-Biological_Molecule
,	O
Qor	S-Biological_Molecule
,	O
Dps	S-Biological_Molecule
,	O
WraB	S-Biological_Molecule
,	O
OxyR	S-Biological_Molecule
,	O
GrxA	S-Biological_Molecule
,	O
Gor	S-Biological_Molecule
,	O
GrxB	S-Biological_Molecule
,	O
KatG	S-Biological_Molecule
,	O
KatE	S-Biological_Molecule
,	O
SodC	S-Biological_Molecule
,	O
SodB	S-Biological_Molecule
,	O
AhpF	S-Biological_Molecule
)	O
;	O
acid	O
stress	O
(	O
CadA	S-Biological_Molecule
)	O
;	O
and	O
starvation	O
(	O
SspA	S-Biological_Molecule
,	O
SspB	S-Biological_Molecule
)	O
were	O
all	O
also	O
differentially	O
regulated	O
by	O
Hfq	S-Biological_Molecule
(	O
Table	O
S1	O
)	O
.	O

Many	O
of	O
these	O
genes	O
are	O
required	O
for	O
virulence	O
as	O
discussed	O
in	O
more	O
detail	O
below	O
.	O

For	O
example	O
rpoE	S-Biological_Molecule
has	O
been	O
shown	O
to	O
be	O
required	O
for	O
the	O
virulence	O
of	O
Salmonella	B-Species
Typhimurium	E-Species
[	O
35	O
]	O
.	O

Two	O
RpoE	S-Biological_Molecule
-	O
regulated	O
genes	O
,	O
htrA	S-Biological_Molecule
and	O
surA	S-Biological_Molecule
,	O
have	O
also	O
been	O
shown	O
to	O
be	O
involved	O
in	O
Salmonella	S-Species
virulence	O
[	O
35	O
]	O
,	O
[	O
36	O
]	O
,	O
[	O
37	O
]	O
.	O

Recent	O
studies	O
have	O
shown	O
the	O
periplasmic	O
Cu	S-Chemical_Compound
,	O
Zn	S-Chemical_Compound
-	O
superoxide	O
dismutase	O
sodC	S-Biological_Molecule
to	O
contribute	O
to	O
Salmonella	S-Species
virulence	O
in	O
mice	S-Species
[	O
39	O
]	O
,	O
[	O
40	O
]	O
.	O

LPS	S-Chemical_Compound
(	O
lipopolysaccharide	S-Chemical_Compound
)	O
has	O
long	O
been	O
known	O
as	O
an	O
essential	O
component	O
of	O
virulence	O
of	O
Gram	O
negative	O
pathogens	O
and	O
,	O
more	O
recently	O
,	O
the	O
agonist	O
for	O
toll	O
like	O
receptor	O
4	O
.	O

LpxA	S-Biological_Molecule
and	O
LpxD	S-Biological_Molecule
involved	O
in	O
Lipid	O
A	O
synthesis	O
,	O
TolC	S-Biological_Molecule
involved	O
in	O
LPS	O
Core	O
completion	O
,	O
as	O
well	O
as	O
proteins	O
involved	O
in	O
O	O
-	O
antigen	O
synthesis	O
(	O
RfbACKMGJU	S-Biological_Molecule
)	O
,	O
appeared	O
as	O
up	O
-	O
regulated	O
in	O
the	O
Deltahfq	S-Biological_Molecule
mutant	O
strain	O
suggesting	O
that	O
Hfq	S-Biological_Molecule
may	O
normally	O
down	O
regulate	O
expression	O
within	O
the	O
host	O
.	O

Complementary	O
transcriptional	O
analysis	O
revealed	O
no	O
change	O
in	O
the	O
corresponding	O
mRNA	O
levels	O
relative	O
to	O
the	O
wildtype	O
.	O

Reduced	O
expression	O
of	O
LPS	S-Chemical_Compound
and	O
alterations	O
in	O
LPS	S-Chemical_Compound
modification	O
has	O
been	O
reported	O
for	O
intracellular	O
Salmonella	S-Species
[	O
41	O
]	O
,	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
.	O

Our	O
results	O
suggest	O
Hfq	S-Biological_Molecule
plays	O
a	O
role	O
in	O
the	O
post	O
-	O
transcriptional	O
regulation	O
of	O
several	O
two	O
component	O
systems	O
including	O
three	O
that	O
have	O
been	O
shown	O
to	O
be	O
essential	O
for	O
virulence	O
in	O
a	O
variety	O
of	O
animal	O
models	O
;	O
SsrA	S-Biological_Molecule
/	O
B	S-Biological_Molecule
,	O
PhoP	S-Biological_Molecule
/	O
Q	S-Biological_Molecule
,	O
and	O
OmpR	S-Biological_Molecule
/	O
EnvZ	O
.	O

Two	O
component	O
systems	O
are	O
widespread	O
methods	O
of	O
sensing	O
external	O
conditions	O
and	O
responding	O
by	O
altering	O
gene	O
expression	O
in	O
prokaryotes	O
,	O
eukaryotes	O
and	O
archaea	O
.	O

Well	O
known	O
two	O
component	O
regulators	O
respond	O
to	O
osmolarity	O
,	O
nitrogen	S-Chemical_Compound
and	O
oxygen	S-Chemical_Compound
limitation	O
[	O
44	O
]	O
,	O
[	O
45	O
]	O
.	O

Microarray	O
analysis	O
showed	O
no	O
effect	O
on	O
transcription	O
of	O
these	O
genes	O
.	O

Salmonella	S-Species
motility	O
enhances	O
cell	O
contact	O
thereby	O
increasing	O
host	O
cell	O
invasion	O
.	O

A	O
recent	O
study	O
showed	O
that	O
an	O
Deltahfq	S-Biological_Molecule
mutant	O
that	O
was	O
non	O
-	O
motile	O
exhibited	O
an	O
invasion	O
defect	O
[	O
20	O
]	O
.	O

Consistent	O
with	O
this	O
previous	O
study	O
,	O
we	O
observed	O
reduced	O
expression	O
of	O
SPI	O
-	O
1	O
invasion	O
proteins	O
and	O
numerous	O
motility	O
proteins	O
in	O
the	O
Deltahfq	S-Biological_Molecule
mutant	O
strain	O
primarily	O
in	O
the	O
log	O
phase	O
growth	O
condition	O
compared	O
to	O
the	O
wildtype	O
strain	O
.	O

Propanediol	S-Chemical_Compound
,	O
derived	O
from	O
rhamnose	S-Chemical_Compound
and	O
fucose	S-Chemical_Compound
catabolism	O
,	O
is	O
degraded	O
by	O
products	O
of	O
the	O
propanediol	S-Chemical_Compound
utilization	O
(	O
pdu	O
)	O
operon	O
(	O
immediately	O
adjacent	O
to	O
the	O
cob	O
operon	O
)	O
in	O
a	O
vitamin	B-Chemical_Compound
B12	E-Chemical_Compound
dependent	O
manner	O
.	O

This	O
allows	O
Salmonella	B-Species
Typhimurium	E-Species
to	O
grow	O
using	O
propanediol	S-Chemical_Compound
as	O
a	O
sole	O
carbon	S-Chemical_Compound
source	O
and	O
because	O
it	O
is	O
required	O
for	O
growth	O
in	O
macrophages	O
this	O
may	O
be	O
the	O
preferred	O
intracellular	O
metabolite	O
[	O
47	O
]	O
.	O

Western	O
blot	O
analysis	O
of	O
PduA	S-Biological_Molecule
and	O
PduE	S-Biological_Molecule
relative	O
protein	O
levels	O
validated	O
results	O
from	O
the	O
proteomics	O
analysis	O
(	O
Figures	O
4B	O
,	O
4C	O
and	O
4E	O
,	O
4F	O
)	O
.	O

The	O
strong	O
regulation	O
of	O
Pdu	O
protein	O
expression	O
by	O
Hfq	S-Biological_Molecule
suggests	O
the	O
pdu	O
operon	O
to	O
be	O
a	O
potential	O
target	O
of	O
sRNA	O
regulation	O
and	O
that	O
correct	O
coordinate	O
expression	O
may	O
be	O
essential	O
for	O
activity	O
.	O

The	O
normal	O
function	O
of	O
SmpB	S-Biological_Molecule
is	O
in	O
quality	O
control	O
to	O
free	O
ribosomes	O
stalled	O
on	O
defective	O
mRNAs	O
[	O
11	O
]	O
,	O
[	O
16	O
]	O
.	O

However	O
,	O
results	O
from	O
our	O
global	O
proteomics	O
analysis	O
indicate	O
that	O
SmpB	S-Biological_Molecule
directly	O
or	O
indirectly	O
modulates	O
the	O
expression	O
of	O
at	O
least	O
4	O
%	O
of	O
the	O
entire	O
Salmonella	B-Species
Typhimurium	E-Species
proteome	O
determined	O
from	O
ANOVA	O
analysis	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
(	O
Table	O
S1	O
)	O
.	O

The	O
majority	O
of	O
genes	O
encoding	O
these	O
proteins	O
showed	O
no	O
changes	O
in	O
mRNA	O
level	O
thus	O
it	O
is	O
interesting	O
to	O
speculate	O
an	O
additional	O
role	O
for	O
SmpB	S-Biological_Molecule
as	O
a	O
general	O
post	O
-	O
transcriptional	O
/	O
translational	O
regulator	O
in	O
Salmonella	B-Species
Typhimurium	E-Species
.	O

We	O
note	O
however	O
that	O
a	O
more	O
detailed	O
and	O
rigorous	O
analysis	O
is	O
required	O
to	O
confirm	O
the	O
speculated	O
global	O
regulatory	O
role	O
of	O
SmpB	O
.	O

Proteins	O
involved	O
in	O
motility	O
in	O
Salmonella	B-Species
Typhimurium	E-Species
also	O
showed	O
down	O
-	O
regulation	O
during	O
growth	O
in	O
LB	O
media	O
.	O

This	O
set	O
of	O
proteins	O
included	O
the	O
chemotaxis	O
proteins	O
CheZ	S-Biological_Molecule
,	O
CheY	S-Biological_Molecule
,	O
CheW	S-Biological_Molecule
,	O
CheA	S-Biological_Molecule
and	O
Tsr	S-Biological_Molecule
as	O
well	O
as	O
the	O
flagellar	O
proteins	O
FliC	S-Biological_Molecule
,	O
FliD	S-Biological_Molecule
,	O
FliG	S-Biological_Molecule
and	O
FljB	S-Biological_Molecule
.	O

This	O
suggests	O
that	O
a	O
more	O
thorough	O
examination	O
of	O
the	O
role	O
of	O
SmpB	S-Biological_Molecule
in	O
the	O
regulation	O
of	O
cell	O
motility	O
and	O
histidine	O
biosynthesis	O
is	O
warranted	O
.	O

We	O
were	O
interested	O
in	O
determining	O
whether	O
there	O
was	O
overlap	O
in	O
translational	O
regulation	O
between	O
Hfq	S-Biological_Molecule
and	O
SmpB	S-Biological_Molecule
i	O
.	O
e	O
.	O
,	O
the	O
extent	O
of	O
cross	O
-	O
talk	O
or	O
level	O
of	O
co	O
-	O
ordination	O
if	O
any	O
between	O
these	O
two	O
translational	O
regulators	O
(	O
Table	O
S1	O
)	O
.	O

For	O
logarithmic	O
phase	O
growth	O
conditions	O
,	O
the	O
expression	O
pattern	O
of	O
242	O
proteins	O
appeared	O
to	O
exhibit	O
a	O
dependence	O
on	O
Hfq	S-Biological_Molecule
,	O
while	O
37	O
proteins	O
exhibited	O
a	O
dependency	O
on	O
SmpB	S-Biological_Molecule
.	O

Twenty	O
proteins	O
overlapped	O
both	O
sets	O
,	O
including	O
the	O
motility	O
proteins	O
FliC	S-Biological_Molecule
,	O
CheA	S-Biological_Molecule
,	O
CheZ	S-Biological_Molecule
and	O
Tsr	S-Biological_Molecule
.	O

Under	O
stationary	O
phase	O
growth	O
conditions	O
270	O
proteins	O
appeared	O
to	O
be	O
under	O
control	O
of	O
Hfq	S-Biological_Molecule
and	O
27	O
proteins	O
under	O
control	O
of	O
SmpB	S-Biological_Molecule
.	O

Of	O
the	O
390	O
proteins	O
regulated	O
by	O
Hfq	S-Biological_Molecule
and	O
50	O
proteins	O
regulated	O
by	O
SmpB	S-Biological_Molecule
in	O
growth	O
in	O
AMM	O
-	O
2	O
,	O
15	O
proteins	O
were	O
co	O
-	O
regulated	O
by	O
both	O
Hfq	S-Biological_Molecule
and	O
SmpB	S-Biological_Molecule
,	O
including	O
the	O
invasion	O
protein	O
PrgI	S-Biological_Molecule
,	O
MdoH	S-Biological_Molecule
involved	O
in	O
the	O
synthesis	O
of	O
membrane	O
-	O
derived	O
oligosaccharide	O
,	O
and	O
a	O
putative	O
periplasmic	O
protein	O
CreA	S-Biological_Molecule
.	O

Under	O
growth	O
in	O
AMM	O
-	O
1	O
267	O
proteins	O
appeared	O
regulated	O
by	O
Hfq	S-Biological_Molecule
and	O
the	O
expression	O
pattern	O
of	O
86	O
proteins	O
exhibited	O
a	O
dependence	O
on	O
SmpB	S-Biological_Molecule
.	O

Twenty	O
four	O
of	O
these	O
proteins	O
were	O
co	O
-	O
regulated	O
by	O
both	O
Hfq	S-Biological_Molecule
and	O
SmpB	S-Biological_Molecule
.	O

Summary	O

Using	O
a	O
sample	O
-	O
matched	O
procedure	O
our	O
strategy	O
simultaneously	O
measures	O
changes	O
in	O
global	O
transcript	O
and	O
protein	O
abundance	O
levels	O
allowing	O
for	O
a	O
clear	O
distinction	O
between	O
the	O
transcriptional	O
and	O
post	O
-	O
transcriptional	O
effects	O
of	O
Hfq	S-Biological_Molecule
or	O
SmpB	S-Biological_Molecule
.	O

Furthermore	O
,	O
our	O
strategy	O
requires	O
no	O
tagging	O
and	O
or	O
isolation	O
of	O
Hfq	S-Biological_Molecule
or	O
SmpB	S-Biological_Molecule
precluding	O
the	O
possibility	O
of	O
spurious	O
results	O
introduced	O
by	O
tagging	O
and	O
or	O
co	O
-	O
immunoprecipitation	O
processes	O
.	O

Previous	O
attempts	O
to	O
identify	O
processes	O
/	O
targets	O
regulated	O
by	O
Hfq	S-Biological_Molecule
,	O
and	O
thus	O
targets	O
of	O
sRNA	O
regulation	O
,	O
have	O
relied	O
on	O
transcript	O
-	O
centric	O
approaches	O
.	O

The	O
result	O
of	O
this	O
work	O
was	O
very	O
surprising	O
namely	O
that	O
Hfq	S-Biological_Molecule
bound	O
to	O
20	O
%	O
of	O
all	O
Salmonella	S-Species
mRNA	O
transcripts	O
and	O
at	O
least	O
64	O
small	O
RNA	O
molecules	O
.	O

One	O
possible	O
criticism	O
of	O
this	O
work	O
is	O
that	O
the	O
RNA	O
co	O
-	O
immunoprecipitated	O
with	O
Hfq	S-Biological_Molecule
may	O
be	O
brought	O
down	O
simply	O
because	O
Hfq	S-Biological_Molecule
strongly	O
binds	O
to	O
RNA	O
molecules	O
and	O
that	O
the	O
binding	O
is	O
somewhat	O
non	O
-	O
specific	O
.	O

Our	O
efforts	O
presented	O
here	O
support	O
the	O
conclusions	O
of	O
that	O
study	O
and	O
suggest	O
that	O
an	O
even	O
larger	O
number	O
of	O
Salmonella	S-Species
proteins	O
are	O
translationally	O
regulated	O
than	O
the	O
20	O
%	O
suggested	O
by	O
these	O
authors	O
,	O
when	O
accessed	O
across	O
a	O
larger	O
number	O
of	O
growth	O
conditions	O
.	O

These	O
results	O
have	O
been	O
validated	O
by	O
Western	O
blotting	O
to	O
a	O
number	O
of	O
proteins	O
.	O

The	O
amount	O
of	O
translational	O
regulation	O
varied	O
with	O
growth	O
conditions	O
.	O

During	O
growth	O
in	O
rich	O
media	O
approximately	O
14	O
%	O
of	O
all	O
proteins	O
observed	O
showed	O
differences	O
in	O
abundance	O
where	O
as	O
in	O
acidic	O
minimal	O
media	O
the	O
result	O
was	O
approximately21	O
%	O
.	O

These	O
results	O
may	O
explain	O
the	O
very	O
high	O
LD50	O
of	O
the	O
hfq	S-Biological_Molecule
mutant	O
strain	O
(	O
>	O
109	O
i	O
.	O
p	O
.	O
)	O
and	O
its	O
growth	O
defect	O
even	O
in	O
rich	O
media	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
in	O
adaptive	O
evolution	O
experiments	O
using	O
a	O
chemostat	O
to	O
continuously	O
alter	O
grow	O
conditions	O
often	O
results	O
in	O
changes	O
in	O
Hfq	S-Biological_Molecule
(	O
Bernard	O
Palsson	O
,	O
UCSD	O
,	O
personal	O
communication	O
)	O
.	O

It	O
has	O
long	O
been	O
known	O
that	O
many	O
proteins	O
are	O
transcriptionally	O
regulated	O
.	O

These	O
results	O
and	O
the	O
results	O
recently	O
described	O
by	O
Sittka	O
et	O
al	O
.	O

[	O
10	O
]	O
demonstrate	O
that	O
post	O
-	O
transcriptional	O
/	O
translational	O
regulation	O
plays	O
as	O
large	O
a	O
role	O
in	O
controlling	O
the	O
myriad	O
of	O
bacterial	O
processes	O
as	O
does	O
transcriptional	O
regulation	O
.	O

It	O
is	O
the	O
precisely	O
this	O
ability	O
to	O
rapidly	O
adjust	O
to	O
changing	O
conditions	O
in	O
less	O
time	O
than	O
it	O
takes	O
to	O
make	O
an	O
RNA	O
molecule	O
that	O
makes	O
this	O
a	O
pivotal	O
regulatory	O
process	O
.	O

Comparative	O
in	O
vivo	O
gene	O
expression	O
of	O
the	O
closely	O
related	O
bacteria	O
Photorhabdus	B-Species
temperata	E-Species
and	O
Xenorhabdus	B-Species
koppenhoeferi	E-Species
upon	O
infection	O
of	O
the	O
same	O
insect	O
host	O
,	O
Rhizotrogus	B-Species
majalis	E-Species

We	O
studied	O
in	O
vivo	O
gene	O
expression	O
in	O
Photorhabdus	B-Species
temperata	E-Species
and	O
Xenorhabdus	B-Species
koppenhoeferi	E-Species
upon	O
infection	O
of	O
the	O
white	O
grub	O
Rhizotrogus	B-Species
majalis	E-Species
using	O
selective	O
capture	O
of	O
transcribed	O
sequences	O
technique	O
.	O

Results	O
A	O
total	O
of	O
40	O
genes	O
in	O
P	B-Species
.	I-Species
temperata	E-Species
and	O
39	O
in	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
were	O
found	O
to	O
be	O
upregulated	O
in	O
R	B-Species
.	I-Species
majalis	E-Species
hemolymph	O
at	O
24	O
h	O
post	O
infection	O
.	O

The	O
two	O
bacteria	O
shared	O
more	O
genes	O
in	O
stress	O
response	O
category	O
than	O
any	O
other	O
functional	O
group	O
.	O

Lipopolysaccharide	S-Chemical_Compound
synthesis	O
gene	O
lpsE	S-Biological_Molecule
was	O
induced	O
in	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
but	O
not	O
in	O
P	B-Species
.	I-Species
temperata	E-Species
.	O

Except	O
tcaC	S-Biological_Molecule
and	O
hemolysin	O
related	O
genes	O
,	O
other	O
virulence	O
genes	O
were	O
different	O
between	O
the	O
two	O
bacteria	O
.	O

Photorhabdus	B-Species
temperata	E-Species
displayed	O
upregulation	O
of	O
genes	O
encoding	O
siderophore	O
-	O
dependent	O
iron	S-Chemical_Compound
uptake	O
system	O
,	O
but	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
upregulated	O
genes	O
encoding	O
siderophore	O
-	O
independent	O
ion	O
uptake	O
system	O
.	O

Further	O
analyses	O
identified	O
possible	O
mechanistic	O
associations	O
between	O
the	O
identified	O
gene	O
products	O
in	O
metabolic	O
pathways	O
,	O
providing	O
an	O
interactive	O
model	O
of	O
pathogenesis	O
for	O
each	O
bacterium	O
species	O
.	O

Conclusion	O
This	O
study	O
identifies	O
set	O
of	O
genes	O
induced	O
in	O
P	B-Species
.	I-Species
temperata	E-Species
and	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
upon	O
infection	O
of	O
R	B-Species
.	I-Species
majalis	E-Species
,	O
and	O
highlights	O
differences	O
in	O
molecular	O
features	O
used	O
by	O
these	O
two	O
closely	O
related	O
bacteria	O
to	O
promote	O
their	O
pathogenicity	O
in	O
the	O
same	O
insect	O
host	O
.	O

Background	O

They	O
naturally	O
colonize	O
intestines	O
of	O
the	O
nematode	O
infective	O
juveniles	O
which	O
invade	O
susceptible	O
insects	O
to	O
release	O
the	O
bacteria	O
into	O
the	O
hemolymph	O
.	O

The	O
bacteria	O
multiply	O
in	O
the	O
hemolymph	O
,	O
killing	O
the	O
insect	O
host	O
within	O
24	O
-	O
48	O
h	O
and	O
converting	O
the	O
cadaver	O
into	O
a	O
food	O
source	O
suitable	O
for	O
nematode	O
growth	O
and	O
reproduction	O
.	O

After	O
1	O
-	O
3	O
rounds	O
of	O
nematode	O
reproduction	O
,	O
the	O
bacteria	O
recolonize	O
the	O
emerging	O
infective	O
juveniles	O
ensuring	O
their	O
transmission	O
to	O
a	O
new	O
host	O
[	O
1	O
]	O
.	O

The	O
published	O
genome	O
sequence	O
of	O
Photorhabdus	B-Species
luminescens	I-Species
TT01	E-Species
strain	O
indicates	O
that	O
virulence	O
genes	O
are	O
encoded	O
within	O
a	O
number	O
of	O
pathogenicity	O
islands	O
located	O
on	O
the	O
bacterial	O
chromosome	O
[	O
4	O
,	O
5	O
]	O
.	O

The	O
two	O
bacteria	O
differ	O
in	O
mechanisms	O
by	O
which	O
they	O
evade	O
host	O
immune	O
responses	O
.	O

For	O
example	O
,	O
in	O
Photorhabdus	S-Species
,	O
mutational	O
inactivation	O
of	O
phoP	S-Biological_Molecule
gene	O
results	O
in	O
increased	O
sensitivity	O
to	O
insect	O
immune	O
response	O
and	O
decreased	O
virulence	O
towards	O
insects	O
[	O
6	O
,	O
7	O
]	O
,	O
while	O
in	O
X	B-Species
.	I-Species
nematophila	E-Species
,	O
phoPQ	S-Biological_Molecule
mutants	O
are	O
more	O
susceptible	O
to	O
immune	O
response	O
but	O
are	O
fully	O
virulent	O
[	O
3	O
]	O
.	O

P	B-Species
.	I-Species
luminescens	E-Species
produces	O
a	O
signaling	O
molecule	O
AI	B-Biological_Molecule
-	I-Biological_Molecule
2	E-Biological_Molecule
to	O
resist	O
reactive	B-Chemical_Compound
oxygen	I-Chemical_Compound
species	E-Chemical_Compound
[	O
8	O
]	O
and	O
phenylpropanoid	O
chemical	O
ST	O
to	O
inhibit	O
the	O
activity	O
of	O
antimicrobial	O
enzyme	O
PO	O
and	O
formation	O
of	O
melanotic	O
nodules	O
[	O
9	O
]	O
,	O
but	O
the	O
strategy	O
used	O
by	O
X	B-Species
.	I-Species
nematophila	E-Species
appears	O
to	O
be	O
that	O
of	O
suppression	O
of	O
transcripts	O
involved	O
in	O
the	O
insect	O
immune	O
response	O
[	O
10	O
-	O
12	O
]	O
.	O

In	O
addition	O
,	O
P	B-Species
.	I-Species
luminescens	E-Species
encodes	O
a	O
type	O
III	O
secretion	O
system	O
and	O
one	O
of	O
the	O
effectors	O
,	O
LopT	S-Biological_Molecule
,	O
suppresses	O
phagocytosis	O
and	O
reduces	O
nodulation	O
by	O
haemocytes	O
[	O
13	O
,	O
14	O
]	O
.	O

However	O
,	O
the	O
genomes	O
of	O
Xenorhabdus	B-Species
bovienii	E-Species
and	O
X	B-Species
.	I-Species
nematophila	E-Species
do	O
not	O
show	O
homologues	O
of	O
LopT	S-Biological_Molecule
or	O
a	O
dedicated	O
type	O
III	O
secretion	O
system	O
[	O
3	O
]	O
,	O
and	O
Xenorhabdus	S-Species
likely	O
uses	O
flagellar	O
regulatory	O
cascade	O
to	O
control	O
cellular	O
immunity	O
[	O
15	O
]	O
.	O

Despite	O
the	O
identification	O
of	O
the	O
above	O
regulatory	O
and	O
virulence	O
factors	O
from	O
Photorhabdus	S-Species
and	O
Xenorhabdus	S-Species
,	O
the	O
full	O
profiles	O
of	O
genes	O
expressed	O
during	O
insect	O
infection	O
by	O
these	O
two	O
closely	O
related	O
bacteria	O
are	O
unknown	O
.	O

Munch	O
et	O
al	O
.	O

[	O
16	O
]	O
identified	O
29	O
promoters	O
induced	O
by	O
P	B-Species
.	I-Species
luminescens	E-Species
in	O
the	O
presence	O
of	O
isolated	O
Galleria	B-Species
mellonella	E-Species
homogenate	O
using	O
a	O
differential	O
fluorescence	O
induction	O
approach	O
.	O

However	O
,	O
treatment	O
with	O
insect	O
homogenate	O
might	O
neglect	O
physicochemical	O
parameters	O
as	O
inducers	O
which	O
could	O
result	O
in	O
different	O
sets	O
of	O
genes	O
being	O
upregulated	O
during	O
natural	O
infection	O
of	O
live	O
insects	O
.	O

However	O
,	O
unlike	O
their	O
nematode	O
partners	O
,	O
both	O
bacterial	O
species	O
are	O
highly	O
virulent	O
to	O
Rhizotrogus	B-Species
majalis	E-Species
.	O

We	O
hypothesize	O
that	O
the	O
two	O
bacteria	O
species	O
will	O
use	O
both	O
common	O
and	O
distinct	O
molecular	O
mechanisms	O
during	O
infection	O
of	O
the	O
same	O
insect	O
host	O
.	O

Results	O

Isolation	O
of	O
bacterial	O
transcripts	O
induced	O
in	O
Rhizotrogus	B-Species
majalis	E-Species
To	O
isolate	O
bacterial	O
genes	O
induced	O
upon	O
infection	O
,	O
total	O
RNA	O
was	O
isolated	O
from	O
live	O
grubs	O
at	O
24	O
h	O
post	O
injection	O
with	O
P	B-Species
.	I-Species
temperata	E-Species
or	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
,	O
as	O
well	O
as	O
from	O
48	O
h	O
log	O
-	O
phase	O
bacterial	O
cultures	O
grown	O
in	O
Brain	O
Heart	O
Infusion	O
(	O
BHI	O
)	O
broth	O
that	O
were	O
used	O
to	O
inject	O
R	B-Species
.	I-Species
majalis	E-Species
.	O

Random	O
-	O
primed	O
bacterial	O
cDNAs	O
were	O
normalized	O
by	O
hybridization	O
to	O
biotinylated	O
bacterial	O
genomic	O
DNA	O
that	O
had	O
been	O
blocked	O
beforehand	O
using	O
bacterial	O
ribosomal	O
RNA	O
operon	O
,	O
resulting	O
in	O
sampling	O
of	O
bacterial	O
mRNA	O
transcripts	O
apart	O
from	O
its	O
ribosomal	O
and	O
insect	O
transcripts	O
.	O

To	O
isolate	O
bacterial	O
mRNA	O
transcripts	O
preferentially	O
induced	O
during	O
infection	O
of	O
the	O
insect	O
compared	O
to	O
the	O
culture	O
,	O
normalized	O
in	O
vivo	O
cDNAs	O
were	O
enriched	O
by	O
hybridization	O
to	O
biotinylated	O
bacterial	O
genomic	O
DNA	O
that	O
had	O
been	O
pre	O
-	O
hybridized	O
with	O
rRNA	O
operon	O
and	O
in	O
vitro	O
normalized	O
cDNAs	O
.	O

The	O
enriched	O
cDNAs	O
representing	O
in	O
vivo	O
-	O
induced	O
genes	O
,	O
which	O
were	O
either	O
lower	O
in	O
abundance	O
or	O
absent	O
in	O
48	O
h	O
in	O
vitro	O
bacterial	O
cultures	O
were	O
then	O
cloned	O
into	O
a	O
TA	O
cloning	O
vector	O
to	O
construct	O
in	O
vivo	O
enriched	O
cDNA	O
libraries	O
.	O

Out	O
of	O
these	O
,	O
the	O
clones	O
(	O
150	O
for	O
P	B-Species
.	I-Species
temperata	E-Species
and	O
140	O
for	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
)	O
that	O
showed	O
stronger	O
signal	O
upon	O
hybridization	O
with	O
in	O
vivo	O
-	O
derived	O
cDNAs	O
compared	O
to	O
in	O
vitro	O
-	O
derived	O
cDNAs	O
(	O
Fig	O
.	O
1	O
)	O
were	O
sequenced	O
and	O
analyzed	O
using	O
the	O
non	O
-	O
redundant	O
algorithms	O
of	O
BLAST	O
in	O
NCBI	O
and	O
database	O
of	O
Xenorhabdus	B-Species
Genomes	E-Species
.	O

These	O
sequenced	O
clones	O
were	O
therefore	O
considered	O
to	O
represent	O
reliable	O
transcripts	O
specifically	O
expressed	O
in	O
P	B-Species
.	I-Species
temperata	E-Species
or	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
after	O
24	O
h	O
infection	O
of	O
R	B-Species
.	I-Species
majalis	E-Species
.	O

For	O
both	O
bacteria	O
,	O
each	O
isolated	O
transcript	O
was	O
identified	O
at	O
least	O
twice	O
from	O
the	O
sequenced	O
clones	O
.	O

The	O
coverage	O
of	O
in	O
vivo	O
enriched	O
libraries	O
was	O
then	O
evaluated	O
using	O
Analytic	O
Rarefaction	O
according	O
to	O
the	O
redundancy	O
of	O
each	O
identical	O
transcript	O
in	O
the	O
sequenced	O
clones	O
.	O

As	O
indicated	O
by	O
the	O
rarefaction	O
curves	O
(	O
Fig	O
.	O
2	O
)	O
,	O
saturation	O
was	O
achieved	O
for	O
the	O
sequenced	O
clones	O
,	O
indicating	O
that	O
most	O
of	O
representative	O
genes	O
in	O
the	O
in	O
vivo	O
enriched	O
cDNA	O
libraries	O
were	O
identified	O
.	O

Totally	O
,	O
we	O
isolated	O
40	O
different	O
sequences	O
from	O
P	B-Species
.	I-Species
temperata	E-Species
(	O
Table	O
1	O
)	O
and	O
39	O
from	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
(	O
Table	O
2	O
)	O
.	O

Genes	O
involved	O
in	O
metabolism	O
constitute	O
about	O
25	O
%	O
to	O
33	O
%	O
of	O
the	O
total	O
number	O
of	O
in	O
vivo	O
-	O
induced	O
genes	O
(	O
Fig	O
.	O
3	O
)	O
,	O
showing	O
large	O
numbers	O
of	O
metabolic	O
changes	O
during	O
insect	O
infection	O
.	O

Also	O
gyrase	B-Biological_Molecule
A	E-Biological_Molecule
gene	O
,	O
a	O
prokaryotic	O
housekeeping	O
gene	O
,	O
was	O
not	O
detected	O
from	O
the	O
enriched	O
in	O
vivo	O
cDNAs	O
,	O
but	O
was	O
detected	O
in	O
all	O
other	O
cDNA	O
populations	O
including	O
in	O
vitro	O
and	O
in	O
vivo	O
cDNAs	O
before	O
and	O
after	O
normalization	O
,	O
indicating	O
that	O
only	O
differentially	O
expressed	O
genes	O
were	O
captured	O
after	O
enrichment	O
.	O

Twenty	O
nine	O
of	O
the	O
40	O
distinct	O
P	B-Species
.	I-Species
temperata	E-Species
transcripts	O
have	O
similar	O
sequences	O
in	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
genome	O
,	O
thus	O
11	O
were	O
P	B-Species
.	I-Species
temperata	E-Species
specific	O
;	O
30	O
of	O
the	O
39	O
distinct	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
transcripts	O
share	O
sequence	O
similarity	O
with	O
P	B-Species
.	I-Species
temperata	E-Species
genome	O
,	O
thus	O
9	O
were	O
specific	O
to	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
(	O
Tables	O
1	O
and	O
2	O
)	O
.	O

Further	O
,	O
the	O
level	O
of	O
changes	O
in	O
the	O
transcripts	O
exclusively	O
induced	O
in	O
one	O
or	O
the	O
other	O
bacterium	O
during	O
infection	O
of	O
R	B-Species
.	I-Species
majalis	E-Species
was	O
determined	O
by	O
quantitative	O
real	O
-	O
time	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
on	O
following	O
representative	O
genes	O
:	O
cysK	S-Biological_Molecule
,	O
def	S-Biological_Molecule
,	O
dnaB	S-Biological_Molecule
,	O
lysR	S-Biological_Molecule
,	O
pchC	S-Biological_Molecule
,	O
pckA	S-Biological_Molecule
,	O
phoP	S-Biological_Molecule
,	O
ptst1	S-Biological_Molecule
,	O
sctL	S-Biological_Molecule
,	O
selD	S-Biological_Molecule
,	O
tolB	S-Biological_Molecule
and	O
virB	S-Biological_Molecule
from	O
P	B-Species
.	I-Species
temperata	E-Species
,	O
and	O
aceK	S-Biological_Molecule
,	O
clpP	S-Biological_Molecule
,	O
cobJ	S-Biological_Molecule
,	O
dacC	S-Biological_Molecule
,	O
dld	S-Biological_Molecule
,	O
malF	S-Biological_Molecule
,	O
res	S-Biological_Molecule
,	O
rtxC	S-Biological_Molecule
,	O
tilS	S-Biological_Molecule
,	O
virH	S-Biological_Molecule
,	O
xhlA	S-Biological_Molecule
,	O
and	O
xkst4	S-Biological_Molecule
from	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
.	O

qRT	O
-	O
PCR	O
results	O
displayed	O
consistence	O
with	O
the	O
SCOTS	O
assay	O
.	O

Most	O
tested	O
genes	O
displayed	O
6	O
-	O
16	O
fold	O
induction	O
in	O
qRT	O
-	O
PCR	O
assays	O
,	O
and	O
a	O
few	O
genes	O
including	O
sctL	S-Biological_Molecule
,	O
phoP	S-Biological_Molecule
,	O
rtxC	S-Biological_Molecule
and	O
clpP	S-Biological_Molecule
exhibited	O
about	O
3	O
-	O
fold	O
induction	O
(	O
Fig	O
.	O
4	O
)	O
.	O

Analysis	O
of	O
biological	O
associations	O
of	O
in	O
vivo	O
-	O
induced	O
genes	O

To	O
understand	O
the	O
function	O
and	O
interactions	O
of	O
the	O
identified	O
gene	O
products	O
,	O
interactive	O
networks	O
were	O
built	O
to	O
provide	O
an	O
overview	O
of	O
how	O
gene	O
products	O
relate	O
to	O
each	O
other	O
by	O
leveraging	O
databases	O
of	O
published	O
literature	O
.	O

Using	O
PathwayStudio	O
(	O
Ariadne	O
,	O
Rockville	O
,	O
MD	O
,	O
USA	O
)	O
program	O
,	O
we	O
were	O
able	O
to	O
distill	O
all	O
published	O
information	O
about	O
biological	O
relationships	O
of	O
bacterial	O
homologs	O
of	O
the	O
identified	O
genes	O
.	O

Based	O
on	O
this	O
analysis	O
,	O
the	O
biological	O
significance	O
of	O
each	O
gene	O
was	O
inferred	O
.	O

Linkage	O
between	O
proteins	O
shows	O
how	O
upregulated	O
genes	O
may	O
influence	O
other	O
genes	O
or	O
gene	O
products	O
.	O

For	O
example	O
,	O
gene	O
rpoB	S-Biological_Molecule
,	O
induced	O
in	O
both	O
bacteria	O
,	O
interacts	O
with	O
many	O
gene	O
products	O
,	O
suggesting	O
its	O
overall	O
importance	O
during	O
insect	O
infection	O
(	O
see	O
Additional	O
files	O
1	O
and	O
2	O
)	O
.	O

Other	O
identified	O
genes	O
with	O
multiple	O
connections	O
to	O
different	O
gene	O
products	O
were	O
different	O
between	O
P	B-Species
.	I-Species
temperata	E-Species
and	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
,	O
indicating	O
distinct	O
biological	O
processes	O
used	O
by	O
the	O
two	O
bacteria	O
for	O
insect	O
infection	O
.	O

For	O
example	O
,	O
regulation	O
of	O
genes	O
yncB	S-Biological_Molecule
and	O
purH	S-Biological_Molecule
in	O
P	B-Species
.	I-Species
temperata	E-Species
are	O
influenced	O
by	O
aromatic	O
compounds	O
and	O
formate	S-Chemical_Compound
,	O
respectively	O
(	O
see	O
Additional	O
file	O
1	O
)	O
.	O

Some	O
products	O
encoded	O
by	O
induced	O
genes	O
were	O
found	O
to	O
interact	O
with	O
as	O
many	O
as	O
eight	O
other	O
gene	O
products	O
in	O
the	O
network	O
.	O

For	O
example	O
,	O
P	B-Species
.	I-Species
temperata	E-Species
pckA	S-Biological_Molecule
and	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
aceE	S-Biological_Molecule
both	O
influence	O
8	O
other	O
genes	O
in	O
the	O
network	O
(	O
see	O
Additional	O
file	O
3	O
)	O
.	O

As	O
a	O
whole	O
,	O
the	O
protein	O
networks	O
of	O
the	O
identified	O
genes	O
were	O
different	O
for	O
the	O
two	O
bacteria	O
except	O
that	O
NAD	O
synthetase	O
gene	O
nadE	S-Biological_Molecule
was	O
found	O
to	O
be	O
common	O
to	O
both	O
bacteria	O
.	O

Our	O
gene	O
expression	O
data	O
reveal	O
similarities	O
and	O
differences	O
in	O
molecular	O
mechanisms	O
of	O
pathogenicity	O
by	O
the	O
two	O
bacteria	O
with	O
apparently	O
similar	O
biology	O
.	O

Genes	O
involved	O
in	O
cell	O
structure	O
modification	O
As	O
the	O
physical	O
contact	O
between	O
bacteria	O
and	O
their	O
host	O
is	O
accomplished	O
by	O
the	O
outer	O
surface	O
,	O
the	O
bacterial	O
cell	O
envelope	O
is	O
crucial	O
for	O
communication	O
and	O
interaction	O
with	O
host	O
cells	O
during	O
infection	O
.	O

Genes	O
involved	O
in	O
the	O
synthesis	O
of	O
outer	O
membrane	O
proteins	O
(	O
skp	S-Biological_Molecule
in	O
P	B-Species
.	I-Species
temperata	E-Species
and	O
ompF	S-Biological_Molecule
in	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
)	O
and	O
flagella	O
(	O
fliA	S-Biological_Molecule
in	O
P	B-Species
.	I-Species
temperata	E-Species
and	O
fliM	S-Biological_Molecule
in	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
)	O
were	O
induced	O
in	O
both	O
bacteria	O
,	O
indicating	O
the	O
importance	O
of	O
surface	O
proteins	O
in	O
this	O
bacteria	O
-	O
insect	O
interface	O
.	O

Gene	O
dacC	S-Biological_Molecule
encoding	O
a	O
peptidoglycan	O
synthesis	O
enzyme	O
D	O
-	O
alanyl	O
-	O
D	O
-	O
alanine	O
carboxypeptidase	O
was	O
induced	O
in	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
but	O
not	O
in	O
P	B-Species
.	I-Species
temperata	E-Species
,	O
implying	O
that	O
peptidoglycan	O
undergoes	O
structural	O
alterations	O
in	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
that	O
probably	O
add	O
to	O
its	O
fitness	O
when	O
residing	O
in	O
the	O
host	O
.	O

PhoP	S-Biological_Molecule
and	O
CpxR	S-Biological_Molecule
are	O
dual	O
transcriptional	O
regulators	O
that	O
are	O
activated	O
in	O
response	O
to	O
environmental	O
stimuli	O
and	O
then	O
act	O
to	O
modulate	O
activity	O
of	O
other	O
genes	O
[	O
23	O
,	O
24	O
]	O
.	O

Responding	O
to	O
low	O
Mg2	B-Chemical_Compound
+	E-Chemical_Compound
levels	O
,	O
phoP	S-Biological_Molecule
expression	O
is	O
auto	O
-	O
regulated	O
by	O
PhoP	S-Biological_Molecule
and	O
PhoQ	S-Biological_Molecule
proteins	O
and	O
phoQ	S-Biological_Molecule
is	O
constitutive	O
[	O
25	O
]	O
.	O

Auto	O
-	O
regulation	O
of	O
phoP	S-Biological_Molecule
likely	O
regulates	O
expression	O
of	O
other	O
genes	O
that	O
mediate	O
various	O
cellular	O
functions	O
such	O
as	O
LPS	S-Chemical_Compound
modification	O
,	O
cell	O
structure	O
[	O
26	O
]	O
,	O
and	O
type	O
III	O
secretion	O
systems	O
[	O
27	O
]	O
.	O

Similarly	O
,	O
the	O
regulatory	O
protein	O
CpxR	S-Biological_Molecule
can	O
be	O
activated	O
in	O
response	O
to	O
signals	O
associated	O
with	O
growth	O
and	O
metabolic	O
pathways	O
[	O
28	O
]	O
.	O

Sometimes	O
,	O
CpxR	S-Biological_Molecule
acts	O
to	O
modulate	O
other	O
transcriptional	O
factors	O
[	O
30	O
]	O
.	O

Although	O
there	O
is	O
no	O
evidence	O
showing	O
links	O
between	O
phoP	S-Biological_Molecule
/	O
cpxR	S-Biological_Molecule
and	O
other	O
isolated	O
genes	O
,	O
overexpression	O
of	O
these	O
two	O
response	O
regulator	O
genes	O
may	O
possibly	O
relate	O
to	O
genes	O
involved	O
in	O
stress	O
responses	O
(	O
gshB	S-Biological_Molecule
,	O
gor	S-Biological_Molecule
,	O
msrA	S-Biological_Molecule
and	O
surA	S-Biological_Molecule
)	O
,	O
cell	O
structure	O
(	O
skp	S-Biological_Molecule
,	O
dacC	S-Biological_Molecule
and	O
ompF	S-Biological_Molecule
)	O
and	O
type	O
III	O
secretion	O
systems	O
(	O
sctL	S-Biological_Molecule
)	O
identified	O
in	O
this	O
study	O
.	O

Further	O
,	O
in	O
P	B-Species
.	I-Species
temperata	E-Species
,	O
lysR	S-Biological_Molecule
gene	O
encoding	O
a	O
transcriptional	O
activator	O
protein	O
was	O
found	O
to	O
be	O
upregulated	O
during	O
infection	O
of	O
R	B-Species
.	I-Species
majalis	E-Species
,	O
while	O
two	O
genes	O
yijC	S-Biological_Molecule
and	O
rseA	S-Biological_Molecule
encoding	O
transcriptional	O
repressors	O
were	O
identified	O
in	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
.	O

The	O
pathway	O
network	O
analysis	O
indicates	O
that	O
the	O
product	O
of	O
yijC	S-Biological_Molecule
may	O
function	O
as	O
a	O
repressor	O
to	O
potentially	O
control	O
the	O
expression	O
of	O
the	O
fabB	S-Biological_Molecule
gene	O
,	O
which	O
in	O
turn	O
,	O
modulates	O
the	O
physical	O
properties	O
of	O
the	O
membrane	O
by	O
altering	O
the	O
level	O
of	O
unsaturated	O
fatty	O
acid	O
production	O
.	O

Besides	O
transcriptional	O
regulatory	O
genes	O
,	O
gene	O
tilS	S-Biological_Molecule
,	O
encoding	O
a	O
putative	O
cell	O
cycle	O
protein	O
[	O
4	O
]	O
,	O
was	O
induced	O
in	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
.	O

However	O
,	O
none	O
of	O
these	O
regulatory	O
factors	O
were	O
identified	O
in	O
P	B-Species
.	I-Species
luminescens	E-Species
exposed	O
to	O
G	B-Species
.	I-Species
mellonella	E-Species
homogenate	O
in	O
a	O
previous	O
study	O
[	O
16	O
]	O
,	O
suggesting	O
that	O
regulation	O
of	O
these	O
factors	O
either	O
depends	O
on	O
host	O
(	O
R	B-Species
.	I-Species
majalis	E-Species
not	O
G	B-Species
.	I-Species
mellonella	E-Species
)	O
or	O
bacteria	O
themselves	O
.	O

Genes	O
involved	O
in	O
virulence	O
and	O
secretion	O

Subsequently	O
,	O
bacterial	O
virulence	O
factors	O
actively	O
contribute	O
to	O
a	O
successful	O
infection	O
by	O
colonization	O
of	O
and	O
toxicity	O
towards	O
the	O
insect	O
host	O
.	O

Among	O
the	O
virulence	O
genes	O
identified	O
in	O
this	O
study	O
,	O
tcaC	S-Biological_Molecule
was	O
identified	O
to	O
be	O
induced	O
in	O
both	O
P	B-Species
.	I-Species
temperata	E-Species
and	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
during	O
infection	O
of	O
R	B-Species
.	I-Species
majalis	E-Species
.	O

The	O
tca	O
gene	O
family	O
encodes	O
four	O
toxin	O
complexes	O
TcaA	S-Biological_Molecule
,	O
TcaB	S-Biological_Molecule
,	O
TcaC	S-Biological_Molecule
and	O
TcaD	S-Biological_Molecule
[	O
33	O
]	O
,	O
and	O
has	O
been	O
found	O
in	O
several	O
bacterial	O
pathogens	O
including	O
P	B-Species
.	I-Species
luminescens	E-Species
,	O
Yersinia	S-Species
and	O
Xenorhabdus	S-Species
[	O
34	O
]	O
.	O

Interestingly	O
,	O
Tca	O
toxin	O
encoding	O
genes	O
were	O
also	O
found	O
to	O
be	O
induced	O
in	O
a	O
related	O
species	O
P	B-Species
.	I-Species
luminescens	E-Species
treated	O
with	O
the	O
homogenate	O
of	O
G	B-Species
.	I-Species
mellonella	E-Species
[	O
16	O
]	O
.	O

[	O
36	O
]	O
.	O

Induction	O
of	O
gene	O
pplA	S-Biological_Molecule
,	O
encoding	O
a	O
phospholipase	O
,	O
in	O
P	B-Species
.	I-Species
temperata	E-Species
is	O
expected	O
to	O
contribute	O
to	O
its	O
faster	O
growth	O
rate	O
[	O
37	O
]	O
compared	O
to	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
in	O
R	B-Species
.	I-Species
majalis	E-Species
.	O

Further	O
,	O
genes	O
encoding	O
components	O
of	O
different	O
types	O
of	O
secretion	O
machineries	O
were	O
isolated	O
in	O
this	O
study	O
.	O

Notably	O
,	O
in	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
,	O
virH	S-Biological_Molecule
with	O
sequence	O
similarity	O
to	O
a	O
gene	O
encoding	O
putative	O
toxin	O
secretion	O
transporter	O
in	O
Vibrio	B-Species
cholera	E-Species
,	O
was	O
upregulated	O
during	O
infection	O
of	O
R	B-Species
.	I-Species
majalis	E-Species
.	O

Compared	O
to	O
all	O
other	O
functional	O
classes	O
,	O
more	O
stress	O
response	O
genes	O
were	O
identified	O
to	O
be	O
shared	O
by	O
P	B-Species
.	I-Species
temperata	E-Species
and	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
,	O
suggesting	O
common	O
themes	O
in	O
adaptation	O
to	O
host	O
-	O
imposed	O
stresses	O
.	O

Similarly	O
,	O
induction	O
of	O
a	O
chaperone	O
protein	O
encoding	O
gene	O
dnaK	S-Biological_Molecule
in	O
both	O
bacteria	O
may	O
picture	O
common	O
stress	O
responses	O
between	O
P	B-Species
.	I-Species
temperata	E-Species
and	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
in	O
a	O
number	O
of	O
cellular	O
processes	O
including	O
rescue	O
of	O
misfolded	O
proteins	O
and	O
control	O
of	O
the	O
activity	O
of	O
folded	O
regulatory	O
proteins	O
[	O
46	O
]	O
.	O

The	O
glutathione	S-Chemical_Compound
synthetase	O
gene	O
gshB	S-Biological_Molecule
which	O
mediates	O
condensation	O
of	O
gamma	O
-	O
glutamylcysteine	O
and	O
glycine	O
to	O
form	O
glutathione	S-Chemical_Compound
[	O
47	O
,	O
48	O
]	O
was	O
induced	O
in	O
P	B-Species
.	I-Species
temperata	E-Species
,	O
but	O
glutathione	S-Chemical_Compound
reductase	O
gene	O
gor	O
which	O
reduces	O
glutathione	B-Chemical_Compound
disulfide	E-Chemical_Compound
to	O
the	O
sulfhydryl	O
form	O
of	O
glutathione	S-Chemical_Compound
[	O
47	O
,	O
48	O
]	O
was	O
induced	O
in	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
.	O

Glutathione	S-Chemical_Compound
plays	O
a	O
major	O
role	O
in	O
protection	O
against	O
oxidative	O
stress	O
and	O
in	O
detoxification	O
of	O
hazardous	O
chemicals	O
or	O
heavy	O
metals	O
[	O
49	O
]	O
.	O

Further	O
,	O
as	O
Photorhabdus	S-Species
and	O
Xenorhabdus	S-Species
bacteria	O
can	O
switch	O
their	O
phenotypes	O
upon	O
insect	O
infection	O
,	O
we	O
speculate	O
that	O
upregulation	O
of	O
transposase	O
genes	O
in	O
both	O
bacteria	O
may	O
contribute	O
to	O
genetic	O
variability	O
for	O
better	O
adaptation	O
and	O
survival	O
in	O
a	O
particular	O
niche	O
[	O
50	O
]	O
.	O

Apart	O
from	O
the	O
common	O
mechanisms	O
handling	O
stresses	O
,	O
gene	O
msrA	S-Biological_Molecule
encoding	O
a	O
peptide	O
methionine	O
sulfoxide	O
reductase	O
was	O
unique	O
to	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
.	O

As	O
an	O
important	O
antioxidant	O
enzyme	O
,	O
peptide	O
methionine	O
sulfoxide	O
reductase	O
mediates	O
the	O
repair	O
of	O
proteins	O
damaged	O
by	O
sulfoxidation	O
of	O
methionine	O
residues	O
[	O
51	O
,	O
52	O
]	O
.	O

Three	O
genes	O
,	O
aceE	S-Biological_Molecule
,	O
aceK	S-Biological_Molecule
and	O
dld	S-Biological_Molecule
,	O
whose	O
products	O
catalyze	O
subsequent	O
steps	O
of	O
the	O
glyoxylate	S-Chemical_Compound
pathway	O
[	O
53	O
]	O
,	O
were	O
induced	O
in	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
.	O

In	O
contrast	O
,	O
two	O
genes	O
kdgK	S-Biological_Molecule
and	O
pckA	S-Biological_Molecule
involved	O
in	O
energy	O
metabolism	O
in	O
the	O
TCA	S-Chemical_Compound
cycle	O
were	O
upregulated	O
in	O
P	B-Species
.	I-Species
temperata	E-Species
[	O
54	O
,	O
55	O
]	O
.	O

Induction	O
of	O
different	O
amino	O
acid	O
biosynthetic	O
genes	O
may	O
suggest	O
the	O
differences	O
in	O
amino	O
acid	O
requirements	O
in	O
the	O
two	O
bacteria	O
during	O
infection	O
.	O

Induction	O
of	O
cysK	S-Biological_Molecule
gene	O
in	O
P	B-Species
.	I-Species
temperata	E-Species
suggests	O
that	O
cysteine	O
may	O
be	O
required	O
when	O
growing	O
in	O
the	O
insect	O
,	O
but	O
lysine	O
may	O
be	O
needed	O
for	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
as	O
lysC	S-Biological_Molecule
gene	O
was	O
induced	O
.	O

Isolation	O
of	O
P	B-Species
.	I-Species
temperata	E-Species
def	O
,	O
encoding	O
an	O
amino	O
acid	O
tRNA	O
synthesis	O
enzyme	O
N	O
-	O
formylmethionylaminoacyl	O
-	O
tRNA	O
deformylase	O
,	O
may	O
reflect	O
the	O
importance	O
of	O
specific	O
amino	O
acids	O
involved	O
in	O
the	O
translation	O
process	O
during	O
growth	O
in	O
the	O
insect	O
host	O
.	O

Genes	O
involved	O
in	O
protein	O
synthesis	O
and	O
degradation	O
can	O
also	O
be	O
distinguished	O
between	O
the	O
two	O
bacteria	O
.	O

A	O
protease	O
gene	O
,	O
clpP	S-Biological_Molecule
,	O
involved	O
in	O
protein	O
degradation	O
,	O
was	O
induced	O
in	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
upon	O
infection	O
.	O

In	O
fact	O
proteases	O
have	O
been	O
identified	O
as	O
virulence	O
factors	O
in	O
some	O
other	O
bacterial	O
pathogens	O
[	O
59	O
]	O
.	O

The	O
signal	O
peptidase	O
II	O
encoded	O
by	O
lspA	S-Biological_Molecule
gene	O
induced	O
in	O
P	B-Species
.	I-Species
temperata	E-Species
belongs	O
to	O
a	O
class	O
of	O
aspartyl	O
proteases	O
.	O

Since	O
the	O
product	O
of	O
lspA	S-Biological_Molecule
has	O
been	O
suggested	O
as	O
an	O
important	O
virulence	O
factor	O
operating	O
via	O
maturation	O
of	O
several	O
lipoproteins	O
[	O
60	O
]	O
,	O
we	O
postulate	O
that	O
the	O
product	O
of	O
lspA	S-Biological_Molecule
may	O
play	O
a	O
pathological	O
role	O
in	O
P	B-Species
.	I-Species
temperata	E-Species
by	O
cleaving	O
some	O
core	O
proteins	O
and	O
thus	O
influencing	O
bacterial	O
life	O
cycle	O
in	O
the	O
insect	O
host	O
.	O

In	O
addition	O
to	O
ion	O
scavenging	O
systems	O
,	O
artM	S-Biological_Molecule
,	O
encoding	O
a	O
putative	O
ABC	O
amino	O
acid	O
transport	O
system	O
[	O
63	O
]	O
was	O
identified	O
in	O
P	B-Species
.	I-Species
temperata	E-Species
,	O
but	O
not	O
in	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
.	O

Besides	O
transporting	O
L	O
-	O
arginine	O
across	O
the	O
inner	O
membrane	O
[	O
63	O
]	O
,	O
the	O
pathway	O
network	O
reveals	O
that	O
the	O
product	O
of	O
artM	S-Biological_Molecule
participates	O
in	O
cystine	O
transport	O
(	O
see	O
Additional	O
file	O
1	O
)	O
,	O
suggesting	O
that	O
this	O
gene	O
may	O
also	O
mediate	O
cystine	O
amino	O
acid	O
acquisition	O
.	O

As	O
cysteine	O
synthesis	O
gene	O
cysK	S-Biological_Molecule
was	O
also	O
identified	O
from	O
P	B-Species
.	I-Species
temperata	E-Species
as	O
discussed	O
above	O
,	O
it	O
may	O
indicate	O
that	O
the	O
level	O
of	O
cysteine	O
either	O
synthesized	O
by	O
P	B-Species
.	I-Species
temperata	E-Species
or	O
acquired	O
from	O
the	O
insect	O
host	O
is	O
not	O
sufficient	O
during	O
infection	O
.	O

Interestingly	O
,	O
X	B-Species
.	I-Species
koppenhoeferi	E-Species
seems	O
to	O
require	O
sugar	O
as	O
malF	S-Biological_Molecule
gene	O
which	O
is	O
involved	O
in	O
uptake	O
for	O
maltose	S-Chemical_Compound
and	O
lactose	S-Chemical_Compound
was	O
upregulated	O
.	O

As	O
a	O
periplasmic	B-Biological_Molecule
protein	E-Biological_Molecule
,	O
TolB	S-Biological_Molecule
is	O
an	O
extra	O
member	O
in	O
the	O
Tol	O
system	O
.	O

In	O
E	B-Species
.	I-Species
coli	E-Species
,	O
Tol	O
system	O
stabilizes	O
the	O
outer	O
membrane	O
structure	O
and	O
mutations	O
in	O
Tol	O
encoding	O
genes	O
result	O
in	O
hypersensitivity	O
to	O
deleterious	O
agents	O
[	O
65	O
]	O
.	O

Genes	O
with	O
unknown	O
function	O

Many	O
virulence	O
factors	O
are	O
involved	O
in	O
the	O
pathogenesis	O
,	O
namely	O
capsular	O
polysaccharides	O
,	O
RTX	O
toxins	O
,	O
LPS	S-Chemical_Compound
and	O
many	O
iron	S-Chemical_Compound
acquisition	O
systems	O
.	O

In	O
order	O
to	O
identify	O
genes	O
that	O
are	O
expressed	O
in	O
vivo	O
during	O
a	O
natural	O
infection	O
,	O
we	O
undertook	O
transcript	O
profiling	O
experiments	O
with	O
an	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
DNA	O
microarray	O
,	O
after	O
recovery	O
of	O
bacterial	O
mRNAs	O
from	O
serotype	B-Species
5b	E-Species
-	O
infected	O
porcine	O
lungs	O
.	O

Results	O
Transcriptional	O
profiling	O
of	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
recovered	O
from	O
the	O
lung	O
of	O
a	O
pig	S-Species
suffering	O
from	O
a	O
natural	O
infection	O
or	O
following	O
growth	O
of	O
the	O
bacterial	O
isolate	O
in	O
BHI	O
medium	O
was	O
performed	O
.	O

An	O
RNA	O
extraction	O
protocol	O
combining	O
beadbeating	O
and	O
hot	O
-	O
acid	O
-	O
phenol	O
was	O
developed	O
in	O
order	O
to	O
maximize	O
bacterial	O
mRNA	O
yields	O
and	O
quality	O
following	O
total	O
RNA	O
extraction	O
from	O
lung	O
lesions	O
.	O

Nearly	O
all	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
transcripts	O
could	O
be	O
detected	O
on	O
our	O
microarrays	O
,	O
and	O
150	O
genes	O
were	O
deemed	O
differentially	O
expressed	O
in	O
vivo	O
during	O
the	O
acute	O
phase	O
of	O
the	O
infection	O
.	O

These	O
transcriptional	O
profiling	O
data	O
,	O
combined	O
with	O
previous	O
comparative	O
genomic	O
hybridizations	O
performed	O
by	O
our	O
group	O
,	O
revealed	O
that	O
66	O
out	O
of	O
the	O
72	O
up	O
-	O
regulated	O
genes	O
are	O
conserved	O
amongst	O
all	O
serotypes	O
and	O
that	O
3	O
of	O
them	O
code	O
for	O
products	O
that	O
are	O
predicted	O
outer	O
membrane	O
proteins	O
(	O
genes	O
irp	S-Biological_Molecule
and	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
0959	E-Biological_Molecule
,	O
predicted	O
to	O
code	O
for	O
a	O
TonB	O
-	O
dependent	O
receptor	O
and	O
a	O
filamentous	B-Biological_Molecule
hemagglutinin	E-Biological_Molecule
/	O
adhesin	S-Biological_Molecule
respectively	O
)	O
or	O
lipoproteins	O
(	O
gene	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
0920	E-Biological_Molecule
)	O
.	O

Transmission	O
occurs	O
through	O
aerosol	O
or	O
close	O
contact	O
with	O
infected	O
animals	O
or	O
asymptomatic	O
carriers	O
,	O
and	O
can	O
affect	O
pigs	S-Species
of	O
all	O
ages	O
[	O
2	O
]	O
.	O

Animals	O
that	O
survive	O
the	O
infection	O
often	O
become	O
healthy	O
carriers	O
,	O
and	O
develop	O
localized	O
necrotizing	O
lesions	O
associated	O
with	O
pleuritis	O
[	O
3	O
]	O
.	O

Fifteen	O
different	O
serotypes	O
can	O
be	O
identified	O
based	O
on	O
differences	O
in	O
capsular	O
polysaccharides	O
.	O

While	O
serotypes	O
1	O
to	O
12	O
and	O
15	O
usually	O
belong	O
to	O
biotype	O
1	O
,	O
which	O
contains	O
strains	O
that	O
are	O
NAD	O
-	O
dependent	O
,	O
serotypes	O
13	O
and	O
14	O
are	O
usually	O
NAD	O
-	O
independent	O
and	O
belong	O
to	O
biotype	O
2	O
[	O
4	O
]	O
.	O

Despite	O
years	O
of	O
research	O
,	O
mechanisms	O
involved	O
in	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
pathogenicity	O
are	O
still	O
not	O
fully	O
understood	O
.	O

In	O
order	O
to	O
gain	O
new	O
insight	O
into	O
the	O
disease	O
,	O
researchers	O
have	O
relied	O
on	O
techniques	O
that	O
allow	O
for	O
the	O
identification	O
of	O
genes	O
expressed	O
in	O
bacteria	O
during	O
infection	O
of	O
the	O
host	O
[	O
11	O
]	O
,	O
namely	O
In	O
Vivo	O
Expression	O
Technology	O
(	O
IVET	O
)	O
,	O
Signature	O
Tagged	O
Mutagenesis	O
(	O
STM	O
)	O
and	O
Selective	O
Capture	O
of	O
Transcribed	O
Sequences	O
(	O
SCOTS	O
)	O
.	O

First	O
,	O
an	O
IVET	O
experiment	O
with	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
led	O
to	O
the	O
identification	O
of	O
10	O
loci	O
(	O
termed	O
ivi	O
)	O
transcribed	O
in	O
vivo	O
[	O
12	O
]	O
and	O
highlighted	O
the	O
importance	O
of	O
genes	O
involved	O
in	O
branched	O
-	O
chain	O
amino	O
acid	O
(	O
BCAA	O
)	O
synthesis	O
[	O
13	O
,	O
14	O
]	O
.	O

Later	O
,	O
over	O
the	O
course	O
of	O
two	O
STM	O
experiments	O
conducted	O
with	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
,	O
nearly	O
3000	O
mutants	O
were	O
screened	O
in	O
vivo	O
[	O
15	O
,	O
16	O
]	O
.	O

Both	O
experiments	O
showed	O
that	O
iron	S-Chemical_Compound
acquisition	O
was	O
highly	O
important	O
for	O
the	O
virulence	O
of	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
,	O
with	O
the	O
identification	O
of	O
mutants	O
impaired	O
for	O
the	O
ExbB	S-Biological_Molecule
-	O
ExbD	S-Biological_Molecule
-	O
TonB	S-Biological_Molecule
energy	O
-	O
transducing	O
system	O
.	O

The	O
HlyX	S-Biological_Molecule
regulon	O
was	O
characterized	O
recently	O
,	O
and	O
iron	S-Chemical_Compound
-	O
regulated	O
protein	O
B	O
(	O
FrpB	S-Biological_Molecule
)	O
was	O
identified	O
as	O
a	O
potentially	O
important	O
virulence	O
factor	O
up	O
-	O
regulated	O
when	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
is	O
grown	O
in	O
oxygen	S-Chemical_Compound
-	O
deprived	O
environments	O
[	O
20	O
]	O
.	O

Although	O
these	O
in	O
vivo	O
studies	O
have	O
been	O
very	O
valuable	O
in	O
gaining	O
a	O
better	O
understanding	O
of	O
the	O
mechanisms	O
involved	O
in	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
pathogenesis	O
,	O
limitations	O
associated	O
with	O
the	O
techniques	O
used	O
lead	O
only	O
to	O
a	O
partial	O
overview	O
of	O
the	O
transcriptional	O
events	O
taking	O
place	O
in	O
vivo	O
.	O

DNA	O
microarrays	O
have	O
been	O
used	O
to	O
determine	O
the	O
complete	O
transcriptomic	O
profile	O
of	O
microorganisms	O
in	O
vitro	O
,	O
but	O
technical	O
drawbacks	O
that	O
are	O
associated	O
with	O
the	O
use	O
of	O
this	O
technique	O
in	O
vivo	O
,	O
such	O
as	O
the	O
qualitative	O
and	O
quantitative	O
recovery	O
of	O
bacterial	O
RNA	O
from	O
host	O
tissues	O
,	O
explain	O
why	O
the	O
use	O
of	O
this	O
technique	O
to	O
monitor	O
bacterial	O
infections	O
has	O
been	O
limited	O
[	O
21	O
]	O
.	O

While	O
various	O
cell	O
culture	O
,	O
ex	O
-	O
vivo	O
or	O
mouse	S-Species
infection	O
models	O
have	O
been	O
used	O
,	O
in	O
vivo	O
experiments	O
can	O
provide	O
more	O
accurate	O
information	O
on	O
bacterial	O
adaptation	O
and	O
virulence	O
when	O
the	O
natural	O
host	O
is	O
studied	O
.	O

Our	O
results	O
indicate	O
that	O
150	O
genes	O
are	O
differentially	O
expressed	O
during	O
the	O
acute	O
phase	O
of	O
infection	O
in	O
the	O
host	O
.	O

Results	O
and	O
discussion	O

Animal	O
samples	O
While	O
working	O
with	O
samples	O
from	O
commercial	O
herds	O
means	O
that	O
we	O
are	O
working	O
with	O
disease	O
cases	O
that	O
are	O
representative	O
of	O
what	O
is	O
really	O
happening	O
in	O
the	O
field	O
,	O
it	O
also	O
means	O
that	O
limited	O
amounts	O
of	O
material	O
is	O
available	O
.	O

Two	O
animals	O
died	O
as	O
a	O
result	O
of	O
the	O
infection	O
,	O
and	O
were	O
sampled	O
a	O
few	O
hours	O
after	O
death	O
.	O

Those	O
samples	O
were	O
not	O
used	O
for	O
the	O
microarray	O
experiments	O
since	O
significant	O
transcriptomic	O
changes	O
might	O
have	O
occurred	O
between	O
the	O
time	O
of	O
death	O
and	O
the	O
time	O
of	O
sampling	O
.	O

The	O
last	O
animal	O
was	O
euthanized	O
on	O
site	O
by	O
a	O
veterinarian	O
,	O
and	O
sampled	O
less	O
than	O
5	O
minutes	O
after	O
death	O
.	O

While	O
it	O
can	O
be	O
argued	O
that	O
different	O
animals	O
might	O
react	O
differently	O
to	O
an	O
infection	O
by	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
,	O
and	O
therefore	O
elicit	O
different	O
transcriptional	O
changes	O
in	O
the	O
pathogen	O
,	O
we	O
are	O
confident	O
that	O
the	O
results	O
that	O
were	O
obtained	O
reflect	O
accurately	O
the	O
conditions	O
encountered	O
by	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
in	O
its	O
natural	O
host	O
following	O
acute	O
infection	O
.	O

Macroscopic	O
and	O
microscopic	O
observations	O

Clinical	O
signs	O
and	O
macroscopic	O
and	O
microscopic	O
examinations	O
were	O
consistent	O
with	O
acute	O
porcine	O
pleuropneumonia	O
.	O

Clinical	O
signs	O
ranged	O
from	O
depression	O
to	O
respiratory	O
distress	O
,	O
while	O
macroscopic	O
observation	O
of	O
deceased	O
pigs	S-Species
revealed	O
lobar	O
fibrinohemorrhagic	O
pleuropneumonia	O
,	O
along	O
with	O
necrotic	O
lesions	O
and	O
the	O
accumulation	O
of	O
bloody	O
fluid	O
in	O
the	O
thorax	O
.	O

The	O
infectious	O
field	O
strain	O
that	O
was	O
isolated	O
from	O
the	O
lung	O
tissues	O
was	O
named	O
896	O
-	O
07	O
,	O
and	O
serotyping	O
analysis	O
showed	O
that	O
it	O
belongs	O
to	O
serotype	B-Species
5b	E-Species
,	O
one	O
of	O
the	O
most	O
prevalent	O
in	O
North	O
America	O
[	O
4	O
]	O
.	O

Comparative	O
genomic	O
hybridizations	O

CGH	O
experiments	O
conducted	O
previously	O
in	O
our	O
laboratory	O
have	O
shown	O
that	O
the	O
majority	O
of	O
genes	O
in	O
the	O
reference	O
5b	B-Species
L20	E-Species
strain	O
were	O
conserved	O
in	O
reference	O
strains	O
and	O
fresh	O
field	O
isolates	O
.	O

In	O
order	O
to	O
validate	O
its	O
use	O
to	O
assess	O
transcriptomic	O
events	O
taking	O
place	O
with	O
our	O
infectious	O
field	O
strain	O
during	O
the	O
infection	O
,	O
we	O
first	O
used	O
it	O
to	O
analyze	O
the	O
gene	O
content	O
of	O
the	O
896	B-Species
-	I-Species
07	E-Species
field	O
strain	O
.	O

The	O
CGH	O
data	O
obtained	O
with	O
strain	O
896	B-Species
-	I-Species
07	E-Species
was	O
added	O
to	O
that	O
obtained	O
with	O
other	O
field	O
and	O
reference	O
strains	O
[	O
25	O
]	O
in	O
order	O
to	O
generate	O
a	O
strain	O
dendogram	O
(	O
Figure	O
2	O
)	O
.	O

The	O
same	O
clusters	O
as	O
those	O
observed	O
previously	O
could	O
be	O
found	O
in	O
our	O
dendrogram	O
[	O
25	O
]	O
.	O

Only	O
28	O
genes	O
were	O
identified	O
as	O
divergent	O
/	O
absent	O
in	O
our	O
field	O
strain	O
,	O
when	O
compared	O
to	O
the	O
reference	O
serotype	O
5b	B-Species
L20	E-Species
strain	O
(	O
Table	O
1	O
)	O
.	O

This	O
represents	O
only	O
1	O
.	O
43	O
%	O
of	O
all	O
the	O
genes	O
(	O
1954	O
)	O
that	O
are	O
represented	O
on	O
AppChip2	S-Species
[	O
25	O
]	O
.	O

The	O
other	O
important	O
locus	O
for	O
gene	O
divergence	O
/	O
absence	O
was	O
composed	O
of	O
phage	O
-	O
related	O
features	O
,	O
and	O
these	O
were	O
shown	O
to	O
be	O
divergent	O
during	O
inter	O
and	O
intra	O
-	O
serotype	O
comparisons	O
in	O
previous	O
experiments	O
[	O
25	O
]	O
.	O

RNA	O
extraction	O

This	O
size	O
of	O
beads	O
is	O
too	O
large	O
to	O
lyse	O
bacterial	O
cells	O
(	O
Biospec	O
,	O
personal	O
communication	O
)	O
.	O

Following	O
homogenization	O
,	O
serial	O
dilutions	O
of	O
the	O
resulting	O
supernatant	O
were	O
plated	O
in	O
order	O
to	O
determine	O
an	O
approximate	O
number	O
of	O
CFU	O
per	O
gram	O
of	O
tissue	O
.	O

Our	O
results	O
indicated	O
that	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
could	O
easily	O
be	O
isolated	O
in	O
pure	O
culture	O
from	O
lung	O
tissues	O
of	O
all	O
animals	O
,	O
and	O
that	O
the	O
number	O
of	O
CFU	O
varied	O
from	O
1	O
x	O
106	O
to	O
1	O
x	O
107	O
per	O
gram	O
of	O
infected	O
tissue	O
.	O

Nevertheless	O
,	O
the	O
MicrobENRICH	O
kit	O
was	O
still	O
used	O
to	O
remove	O
any	O
possible	O
trace	O
of	O
remaining	O
eukaryotic	O
RNA	O
,	O
and	O
treatments	O
with	O
TurboDNase	O
removed	O
traces	O
of	O
contaminating	O
DNA	O
.	O

We	O
propose	O
that	O
this	O
combination	O
of	O
techniques	O
could	O
prove	O
useful	O
in	O
isolating	O
pathogens	O
from	O
other	O
tissues	O
as	O
well	O
.	O

Duplicate	O
experiments	O
showed	O
a	O
R2	O
correlation	O
factor	O
of	O
0	O
.	O
996	O
between	O
the	O
intensity	O
detected	O
for	O
the	O
Cy3	O
labelled	O
and	O
Cy5	O
labelled	O
probes	O
,	O
and	O
only	O
two	O
genes	O
seemed	O
to	O
qualify	O
as	O
obvious	O
outliers	O
(	O
data	O
not	O
shown	O
)	O
.	O

Both	O
genes	O
,	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
1141	E-Biological_Molecule
and	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
0484	E-Biological_Molecule
,	O
were	O
not	O
identified	O
as	O
differentially	O
expressed	O
during	O
the	O
course	O
of	O
a	O
natural	O
infection	O
.	O

While	O
designing	O
the	O
microarray	O
experiments	O
,	O
growth	O
in	O
BHI	O
medium	O
to	O
an	O
optical	O
density	O
of	O
0	O
.	O
3	O
at	O
a	O
600	O
nm	O
wavelenght	O
was	O
chosen	O
as	O
our	O
reference	O
condition	O
.	O

This	O
condition	O
was	O
not	O
only	O
chosen	O
for	O
practical	O
reasons	O
,	O
but	O
also	O
to	O
fulfill	O
two	O
precise	O
objectives	O
:	O
first	O
,	O
to	O
allow	O
for	O
the	O
identification	O
of	O
genes	O
that	O
,	O
while	O
important	O
to	O
the	O
infection	O
process	O
,	O
have	O
not	O
been	O
identified	O
previously	O
in	O
vitro	O
in	O
rich	O
medium	O
,	O
and	O
second	O
,	O
to	O
allow	O
comparison	O
of	O
the	O
results	O
obtained	O
in	O
vivo	O
to	O
those	O
obtained	O
in	O
our	O
laboratory	O
in	O
other	O
growth	O
conditions	O
by	O
keeping	O
the	O
same	O
reference	O
[	O
28	O
-	O
30	O
]	O
.	O

Working	O
with	O
a	O
limited	O
amount	O
of	O
biological	O
material	O
meant	O
that	O
only	O
one	O
time	O
-	O
point	O
in	O
the	O
infection	O
could	O
be	O
investigated	O
.	O

In	O
the	O
acute	O
stage	O
of	O
porcine	O
pleuropneumonia	O
,	O
bacteria	O
are	O
likely	O
in	O
the	O
exponential	O
phase	O
of	O
growth	O
.	O

This	O
is	O
also	O
the	O
case	O
in	O
the	O
control	O
condition	O
.	O

The	O
transcriptome	O
of	O
A	B-Species
.	I-Species
pleuropneumonia	E-Species
is	O
certainly	O
very	O
different	O
when	O
the	O
infection	O
is	O
in	O
the	O
chronic	O
stage	O
.	O

Therefore	O
,	O
while	O
our	O
results	O
are	O
an	O
accurate	O
representation	O
of	O
the	O
transcriptomic	O
events	O
that	O
occur	O
in	O
vivo	O
during	O
the	O
acute	O
phase	O
of	O
the	O
infection	O
process	O
as	O
compared	O
to	O
those	O
occuring	O
in	O
vitro	O
in	O
a	O
rich	O
culture	O
medium	O
,	O
events	O
occuring	O
earlier	O
of	O
later	O
in	O
the	O
infection	O
process	O
cannot	O
be	O
inferred	O
.	O

A	O
large	O
number	O
of	O
genes	O
encoding	O
"	O
Hypothetical	O
/	O
Unknown	O
/	O
Unclassified	O
"	O
products	O
were	O
differentially	O
expressed	O
.	O

Three	O
of	O
these	O
are	O
involved	O
in	O
surface	O
structures	O
,	O
namely	O
LPS	O
and	O
capsule	O
,	O
biosynthesis	O
(	O
genes	O
kpsF	S-Biological_Molecule
,	O
cps5b	S-Biological_Molecule
and	O
cpxC	S-Biological_Molecule
)	O
,	O
and	O
two	O
others	O
are	O
found	O
in	O
phage	O
-	O
associated	O
regions	O
(	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
0512	E-Biological_Molecule
and	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
0524	E-Biological_Molecule
)	O
.	O

a	O
)	O
Validation	O
of	O
microarray	O
results	O
by	O
qRT	O
-	O
PCR	O
In	O
order	O
to	O
confirm	O
results	O
obtained	O
using	O
the	O
AppChip2	S-Species
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
microarray	O
,	O
eleven	O
genes	O
were	O
selected	O
for	O
qRT	O
-	O
PCR	O
analysis	O
.	O

Five	O
of	O
these	O
were	O
up	O
-	O
regulated	O
in	O
vivo	O
(	O
sohB	S-Biological_Molecule
,	O
hbpA	S-Biological_Molecule
,	O
kpsF	S-Biological_Molecule
,	O
apxIVA	S-Biological_Molecule
,	O
phoR	S-Biological_Molecule
)	O
and	O
six	O
were	O
down	O
-	O
regulated	O
(	O
nlpI	S-Biological_Molecule
,	O
visC	S-Biological_Molecule
,	O
proQ	S-Biological_Molecule
,	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
1456	E-Biological_Molecule
,	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
1135	E-Biological_Molecule
and	O
nusG	S-Biological_Molecule
)	O
.	O

These	O
genes	O
represented	O
a	O
large	O
range	O
of	O
log2	O
ratio	O
values	O
.	O

In	O
all	O
cases	O
,	O
microarray	O
results	O
were	O
supported	O
by	O
those	O
obtained	O
by	O
qRT	O
-	O
PCR	O
:	O
all	O
genes	O
that	O
were	O
identified	O
as	O
up	O
-	O
regulated	O
using	O
the	O
AppChip2	S-Species
also	O
showed	O
up	O
-	O
regulation	O
following	O
qRT	O
-	O
PCR	O
analysis	O
,	O
and	O
the	O
same	O
was	O
true	O
for	O
selected	O
down	O
-	O
regulated	O
genes	O
(	O
Figure	O
4	O
)	O
.	O

b	O
)	O
Comparison	O
with	O
other	O
in	O
vivo	O
studies	O

Among	O
previous	O
in	O
vivo	O
experiments	O
that	O
were	O
conducted	O
with	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
,	O
the	O
one	O
that	O
was	O
closest	O
to	O
ours	O
in	O
terms	O
of	O
experimental	O
conditions	O
and	O
results	O
was	O
by	O
Baltes	O
et	O
al	O
[	O
18	O
]	O
.	O

These	O
include	O
3	O
genes	O
already	O
identified	O
by	O
Baltes	O
et	O
al	O
.	O
using	O
SCOTS	O
at	O
the	O
end	O
of	O
the	O
acute	O
stage	O
of	O
the	O
disease	O
[	O
18	O
]	O
:	O
fucI	S-Biological_Molecule
,	O
encoding	O
the	O
L	B-Chemical_Compound
-	I-Chemical_Compound
fucose	E-Chemical_Compound
isomerase	O
,	O
nrdD	S-Biological_Molecule
,	O
encoding	O
an	O
anaerobic	B-Chemical_Compound
ribonucleoside	I-Chemical_Compound
triphosphate	E-Chemical_Compound
reductase	O
,	O
and	O
apxIVA	S-Biological_Molecule
,	O
encoding	O
the	O
ApxIVA	S-Biological_Molecule
toxin	O
structural	O
protein	O
.	O

The	O
latter	O
,	O
the	O
gene	O
encoding	O
the	O
recently	O
discovered	O
fourth	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
Apx	O
toxin	O
[	O
31	O
]	O
,	O
had	O
only	O
been	O
detected	O
in	O
vivo	O
[	O
32	O
-	O
34	O
]	O
until	O
it	O
was	O
discovered	O
recently	O
that	O
it	O
is	O
also	O
up	O
-	O
regulated	O
after	O
contact	O
with	O
broncho	O
-	O
alveolar	O
lavage	O
fluids	O
[	O
30	O
]	O
.	O

Finally	O
,	O
the	O
last	O
gene	O
that	O
was	O
up	O
-	O
regulated	O
in	O
our	O
study	O
and	O
identified	O
in	O
another	O
in	O
vivo	O
study	O
is	O
nanE	S-Biological_Molecule
,	O
which	O
codes	O
for	O
a	O
putative	O
N	B-Chemical_Compound
-	I-Chemical_Compound
acetylmannosamine	I-Chemical_Compound
-	I-Chemical_Compound
6	I-Chemical_Compound
-	I-Chemical_Compound
phosphate	E-Chemical_Compound
2	O
-	O
epimerase	O
,	O
an	O
enzyme	O
involved	O
in	O
the	O
use	O
of	O
N	B-Chemical_Compound
-	I-Chemical_Compound
acetylneuraminate	E-Chemical_Compound
and	O
N	B-Chemical_Compound
-	I-Chemical_Compound
acetylmannosamine	E-Chemical_Compound
as	O
carbon	S-Chemical_Compound
sources	O
[	O
35	O
]	O
.	O

The	O
differences	O
between	O
our	O
results	O
and	O
those	O
obtained	O
in	O
other	O
in	O
vivo	O
studies	O
can	O
be	O
easily	O
explained	O
:	O
while	O
the	O
second	O
SCOTS	O
experiment	O
was	O
conducted	O
with	O
animals	O
suffering	O
from	O
chronic	O
infections	O
[	O
10	O
]	O
,	O
a	O
condition	O
which	O
differs	O
greatly	O
from	O
our	O
field	O
case	O
,	O
the	O
STM	O
and	O
IVET	O
techniques	O
do	O
not	O
provide	O
a	O
"	O
snap	O
-	O
shot	O
"	O
of	O
the	O
transcriptome	O
at	O
a	O
precise	O
time	O
point	O
during	O
the	O
infection	O
process	O
.	O

While	O
STM	O
and	O
IVET	O
can	O
theoretically	O
provide	O
a	O
global	O
overview	O
of	O
transcriptomic	O
events	O
,	O
the	O
experiments	O
conducted	O
with	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
are	O
not	O
likely	O
to	O
have	O
achieved	O
this	O
goal	O
.	O

[	O
15	O
]	O
were	O
likely	O
not	O
saturating	O
.	O

STM	O
relies	O
on	O
transposon	O
mutagenesis	O
,	O
and	O
there	O
are	O
some	O
insertional	O
hot	O
spots	O
in	O
the	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
genome	O
[	O
16	O
]	O
.	O

There	O
were	O
no	O
striking	O
similarities	O
when	O
comparing	O
the	O
functions	O
of	O
differentially	O
expressed	O
genes	O
in	O
both	O
studies	O
.	O

As	O
with	O
Son	O
et	O
al	O
.	O
,	O
we	O
noticed	O
that	O
few	O
of	O
the	O
landmark	O
virulence	O
genes	O
in	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
were	O
up	O
-	O
regulated	O
in	O
vivo	O
.	O

Well	O
-	O
characterized	O
iron	O
acquisition	O
genes	O
such	O
as	O
those	O
coding	O
for	O
the	O
hemoglobin	O
receptor	O
HgbA	S-Biological_Molecule
(	O
despite	O
the	O
important	O
hemorrhage	O
noticed	O
in	O
the	O
infected	O
lungs	O
)	O
and	O
the	O
genes	O
coding	O
for	O
transferrin	O
binding	O
proteins	O
TbpA	S-Biological_Molecule
and	O
TbpB	S-Biological_Molecule
did	O
no	O
show	O
differential	O
expression	O
,	O
nor	O
did	O
genes	O
involved	O
in	O
anaerobic	O
respiration	O
.	O

While	O
in	O
the	O
latter	O
case	O
it	O
can	O
be	O
argued	O
that	O
the	O
environmental	O
conditions	O
encountered	O
during	O
the	O
acute	O
infection	O
might	O
explain	O
why	O
differential	O
expression	O
of	O
these	O
gene	O
transcripts	O
was	O
not	O
observed	O
,	O
it	O
could	O
also	O
be	O
hypothesized	O
that	O
years	O
of	O
evolution	O
of	O
the	O
field	O
strain	O
in	O
nature	O
might	O
have	O
led	O
to	O
the	O
loss	O
of	O
some	O
regulatory	O
mechanisms	O
that	O
could	O
still	O
be	O
present	O
in	O
well	O
-	O
characterized	O
laboratory	O
strains	O
,	O
thereby	O
leading	O
to	O
the	O
constitutive	O
expression	O
of	O
some	O
important	O
virulence	O
genes	O
.	O

c	O
)	O
Down	O
-	O
regulated	O
genes	O

Not	O
much	O
is	O
known	O
,	O
however	O
,	O
about	O
the	O
regulation	O
of	O
these	O
transcriptional	O
units	O
.	O

This	O
would	O
probably	O
indicate	O
that	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
has	O
a	O
slower	O
metabolism	O
and	O
replication	O
rate	O
in	O
vivo	O
than	O
when	O
it	O
is	O
growing	O
in	O
a	O
rich	O
culture	O
medium	O
.	O

With	O
regards	O
to	O
their	O
possible	O
involvement	O
in	O
virulence	O
processes	O
,	O
some	O
genes	O
that	O
were	O
down	O
-	O
regulated	O
were	O
of	O
particular	O
interest	O
.	O

The	O
Fur	S-Biological_Molecule
transcriptional	O
regulator	O
,	O
which	O
represses	O
transcription	O
of	O
genes	O
associated	O
with	O
iron	S-Chemical_Compound
acquisition	O
[	O
40	O
]	O
,	O
showed	O
a	O
2	O
.	O
6	O
fold	O
down	O
-	O
regulation	O
in	O
transcription	O
.	O

In	O
E	B-Species
.	I-Species
coli	E-Species
,	O
Fur	S-Biological_Molecule
also	O
regulates	O
its	O
own	O
level	O
of	O
expression	O
.	O

Iron	S-Chemical_Compound
restriction	O
if	O
often	O
thought	O
to	O
be	O
an	O
important	O
signal	O
for	O
bacteria	O
,	O
and	O
has	O
often	O
been	O
linked	O
with	O
the	O
expression	O
of	O
virulence	O
factors	O
such	O
as	O
toxins	O
[	O
42	O
]	O
.	O

Therefore	O
,	O
it	O
would	O
seem	O
that	O
the	O
in	O
vivo	O
environment	O
towards	O
the	O
end	O
of	O
the	O
acute	O
phase	O
of	O
pleuropneumonia	O
is	O
not	O
iron	S-Chemical_Compound
-	O
restricted	O
for	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
.	O

This	O
is	O
not	O
surprising	O
considering	O
that	O
there	O
is	O
extensive	O
hemorrhage	O
and	O
tissue	O
destruction	O
,	O
caused	O
most	O
probably	O
by	O
the	O
secretion	O
of	O
Apx	O
toxins	O
.	O

However	O
,	O
a	O
few	O
genes	O
involved	O
in	O
iron	S-Chemical_Compound
acquisition	O
,	O
namely	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
0096	E-Biological_Molecule
,	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
0668	E-Biological_Molecule
,	O
hbpA	S-Biological_Molecule
and	O
irp	S-Biological_Molecule
,	O
were	O
up	O
-	O
regulated	O
.	O

The	O
role	O
of	O
Hfq	S-Biological_Molecule
,	O
a	O
Sm	O
-	O
like	O
protein	O
,	O
has	O
been	O
investigated	O
with	O
greater	O
interest	O
over	O
the	O
last	O
decade	O
since	O
it	O
was	O
shown	O
that	O
it	O
is	O
involved	O
in	O
the	O
function	O
of	O
small	O
RNAs	O
(	O
sRNAs	O
)	O
[	O
45	O
]	O
.	O

Also	O
of	O
interest	O
was	O
the	O
down	O
-	O
regulation	O
of	O
the	O
cps5b	S-Biological_Molecule
(	O
-	O
2	O
.	O
21	O
fold	O
)	O
and	O
cpxC	S-Biological_Molecule
(	O
-	O
1	O
.	O
82	O
fold	O
)	O
genes	O
,	O
involved	O
respectively	O
in	O
the	O
biosynthesis	O
of	O
capsular	O
polysaccharide	O
and	O
in	O
the	O
export	O
of	O
these	O
polysaccharides	O
.	O

Down	O
-	O
regulation	O
of	O
cpxABC	S-Biological_Molecule
,	O
involved	O
in	O
capsule	O
biosynthesis	O
,	O
has	O
also	O
been	O
observed	O
during	O
planktonic	O
life	O
in	O
liquid	O
medium	O
in	O
contact	O
with	O
porcine	O
lung	O
epithelial	O
cells	O
[	O
9	O
]	O
.	O

The	O
down	O
-	O
regulation	O
of	O
genes	O
involved	O
in	O
capsule	O
synthesis	O
could	O
potentially	O
lead	O
to	O
the	O
production	O
of	O
a	O
thinner	O
capsule	O
on	O
the	O
surface	O
of	O
bacteria	O
,	O
thereby	O
unmasking	O
potential	O
adhesins	O
.	O

d	O
)	O
Up	O
-	O
regulated	O
genes	O

Gene	O
sohB	S-Biological_Molecule
has	O
the	O
highest	O
observed	O
fold	O
change	O
(	O
5	O
.	O
39x	O
)	O
and	O
codes	O
for	O
a	O
putative	O
secreted	O
serine	O
protease	O
that	O
seems	O
to	O
be	O
well	O
conserved	O
in	O
other	O
pathogenic	O
bacteria	O
,	O
such	O
as	O
Haemophilus	B-Species
parasuis	E-Species
,	O
Neisseria	B-Species
meningitidis	E-Species
and	O
N	B-Species
.	I-Species
gonorrhoeae	E-Species
.	O

In	O
the	O
lungs	O
,	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
causes	O
extensive	O
tissue	O
damage	O
that	O
could	O
result	O
from	O
the	O
combined	O
action	O
of	O
Apx	O
toxins	O
and	O
secreted	O
proteases	O
[	O
48	O
]	O
.	O

Here	O
,	O
we	O
report	O
that	O
genes	O
apfB	S-Biological_Molecule
and	O
apfC	S-Biological_Molecule
,	O
coding	O
for	O
the	O
type	O
IV	O
pilin	O
biogenesis	O
proteins	O
ApfB	S-Biological_Molecule
and	O
ApfC	S-Biological_Molecule
,	O
were	O
up	O
-	O
regulated	O
in	O
vivo	O
during	O
natural	O
infection	O
by	O
an	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
isolate	O
.	O

Interestingly	O
,	O
another	O
gene	O
that	O
could	O
share	O
similar	O
functions	O
was	O
also	O
up	O
-	O
regulated	O
.	O

APL	B-Biological_Molecule
_	I-Biological_Molecule
0220	E-Biological_Molecule
codes	O
for	O
a	O
member	O
of	O
the	O
CscG	S-Biological_Molecule
superfamily	O
of	O
proteins	O
involved	O
in	O
the	O
assembly	O
of	O
curli	O
fibers	O
.	O

Curli	O
fibers	O
are	O
important	O
for	O
biofilm	O
formation	O
in	O
numerous	O
pathogens	O
,	O
including	O
E	B-Species
.	I-Species
coli	E-Species
and	O
Salmonella	B-Species
enteritidis	E-Species
,	O
and	O
are	O
involved	O
in	O
the	O
first	O
steps	O
of	O
attachment	O
.	O

Neither	O
of	O
these	O
two	O
other	O
genes	O
shares	O
homology	O
with	O
known	O
csc	O
genes	O
.	O

Finally	O
,	O
the	O
kpsF	S-Biological_Molecule
gene	O
,	O
coding	O
for	O
an	O
arabinose	O
-	O
5	O
-	O
phosphate	O
isomerase	O
,	O
should	O
also	O
be	O
mentioned	O
since	O
it	O
is	O
involved	O
in	O
the	O
pathway	O
responsible	O
for	O
the	O
synthesis	O
of	O
2	B-Chemical_Compound
-	I-Chemical_Compound
keto	I-Chemical_Compound
-	I-Chemical_Compound
3deozyoctulosonic	I-Chemical_Compound
acid	E-Chemical_Compound
(	O
Kdo	S-Chemical_Compound
)	O
,	O
which	O
is	O
present	O
in	O
the	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
LPS	S-Chemical_Compound
core	O
oligosaccharide	O
[	O
52	O
]	O
and	O
capsule	O
of	O
serotype	B-Species
5	E-Species
[	O
53	O
]	O
.	O

Studies	O
in	O
our	O
laboratory	O
have	O
shown	O
that	O
it	O
is	O
the	O
core	O
oligosaccharide	O
that	O
is	O
responsible	O
for	O
the	O
previously	O
observed	O
LPS	S-Chemical_Compound
-	O
associated	O
adhesion	O
mechanism	O
[	O
54	O
,	O
55	O
]	O
.	O

Genes	O
from	O
the	O
maltose	O
operon	O
,	O
involved	O
in	O
the	O
uptake	O
and	O
catabolism	O
of	O
maltose	S-Chemical_Compound
[	O
56	O
]	O
,	O
were	O
up	O
-	O
regulated	O
:	O
the	O
genes	O
malP	S-Biological_Molecule
,	O
malK	S-Biological_Molecule
,	O
malF	O
,	O
malG	S-Biological_Molecule
,	O
malQ	S-Biological_Molecule
and	O
a	O
malM	S-Biological_Molecule
homolog	O
(	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
1234	E-Biological_Molecule
)	O
were	O
actively	O
transcribed	O
in	O
the	O
host	O
(	O
average	O
fold	O
increase	O
of	O
3	O
.	O
1	O
)	O
,	O
and	O
gene	O
lamB1	S-Biological_Molecule
,	O
which	O
codes	O
for	O
a	O
maltoporin	S-Biological_Molecule
,	O
showed	O
a	O
5	O
.	O
14	O
fold	O
change	O
in	O
the	O
only	O
hybridization	O
in	O
which	O
the	O
reporter	O
wasn	O
'	O
t	O
manually	O
flagged	O
because	O
of	O
signal	O
saturation	O
.	O

It	O
was	O
also	O
recently	O
shown	O
that	O
catabolism	O
of	O
maltose	O
provides	O
a	O
competitive	O
advantage	O
to	O
pathogenic	O
and	O
commensal	O
E	B-Species
.	I-Species
coli	E-Species
strains	O
in	O
the	O
gut	O
[	O
59	O
]	O
.	O

In	O
E	B-Species
.	I-Species
coli	E-Species
,	O
these	O
genes	O
are	O
responsible	O
for	O
the	O
transport	O
and	O
utilization	O
of	O
ascorbate	O
in	O
anaerobic	O
conditions	O
[	O
60	O
]	O
.	O

While	O
ascorbate	O
use	O
has	O
not	O
been	O
linked	O
to	O
bacterial	O
virulence	O
before	O
,	O
it	O
has	O
been	O
shown	O
on	O
multiple	O
occasions	O
that	O
genes	O
involved	O
in	O
anaerobic	O
metabolism	O
are	O
important	O
for	O
the	O
virulence	O
of	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
[	O
10	O
,	O
61	O
-	O
63	O
]	O
.	O

In	O
pigs	S-Species
lungs	O
,	O
following	O
extensive	O
infection	O
and	O
tissue	O
destruction	O
,	O
the	O
bacteria	O
are	O
likely	O
to	O
face	O
oxygen	O
deprivation	O
.	O

The	O
phosphoenolpyruvate	S-Chemical_Compound
carboxylase	O
and	O
fumarate	S-Chemical_Compound
reductase	O
subunit	O
C	O
,	O
respectively	O
encoded	O
by	O
genes	O
pepC	S-Biological_Molecule
and	O
frdC	S-Biological_Molecule
,	O
are	O
also	O
required	O
during	O
anaerobic	O
growth	O
.	O

However	O
,	O
neither	O
of	O
these	O
changes	O
were	O
deemed	O
statistically	O
significant	O
.	O

This	O
suggests	O
that	O
HlyX	S-Biological_Molecule
is	O
probably	O
not	O
highly	O
expressed	O
during	O
the	O
acute	O
phase	O
of	O
the	O
disease	O
caused	O
by	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
.	O

Two	O
genes	O
coding	O
for	O
proteins	O
with	O
regulatory	O
functions	O
were	O
found	O
to	O
be	O
up	O
-	O
regulated	O
.	O

The	O
phoR	S-Biological_Molecule
gene	O
codes	O
for	O
the	O
phosphate	O
regulon	O
PhoR	S-Biological_Molecule
sensing	O
protein	O
,	O
located	O
in	O
the	O
inner	O
membrane	O
.	O

In	O
E	B-Species
.	I-Species
coli	E-Species
,	O
this	O
protein	O
is	O
part	O
of	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
that	O
responds	O
to	O
periplasmic	O
orthophosphate	O
concentration	O
variations	O
[	O
65	O
]	O
.	O

Numerous	O
phoR	S-Biological_Molecule
,	O
phoB	S-Biological_Molecule
(	O
the	O
other	O
component	O
of	O
the	O
two	O
-	O
component	O
system	O
)	O
and	O
pts	O
(	O
the	O
phosphate	O
transport	O
genes	O
genetically	O
and	O
functionally	O
linked	O
to	O
phoBR	S-Biological_Molecule
)	O
mutants	O
were	O
found	O
to	O
be	O
less	O
virulent	O
or	O
avirulent	O
when	O
compared	O
to	O
wild	O
-	O
type	O
strains	O
,	O
with	O
phenotypes	O
such	O
as	O
increased	O
sensitivity	O
to	O
serum	O
,	O
acidity	O
and	O
cationic	O
antimicrobial	O
peptides	O
[	O
66	O
]	O
and	O
reduced	O
colonization	O
[	O
67	O
]	O
.	O

A	B-Species
.	I-Species
pleuropneumoniae	I-Species
strain	I-Species
L20	E-Species
harbours	O
an	O
operon	O
composed	O
of	O
the	O
genes	O
ptsSCAB	S-Biological_Molecule
-	O
phoBR	S-Biological_Molecule
.	O

Although	O
only	O
phoR	S-Biological_Molecule
was	O
deemed	O
significantly	O
up	O
-	O
regulated	O
,	O
all	O
other	O
genes	O
showed	O
levels	O
of	O
variations	O
ranging	O
from	O
a	O
1	O
.	O
5	O
-	O
to	O
2	O
-	O
fold	O
increase	O
.	O

Since	O
it	O
seems	O
unlikely	O
that	O
porcine	O
lungs	O
are	O
devoid	O
of	O
phosphate	O
,	O
the	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
PhoBR	S-Biological_Molecule
system	O
might	O
be	O
important	O
in	O
order	O
to	O
adapt	O
correctly	O
to	O
changing	O
conditions	O
inside	O
the	O
host	O
.	O

However	O
,	O
the	O
L20	S-Species
cpxA	S-Biological_Molecule
homolog	O
seems	O
to	O
either	O
be	O
truncated	O
,	O
or	O
found	O
on	O
two	O
separate	O
gene	O
loci	O
.	O

Three	O
genes	O
satisfied	O
those	O
criteria	O
:	O
two	O
that	O
are	O
coding	O
for	O
outer	O
membrane	O
proteins	O
(	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
0959	E-Biological_Molecule
and	O
irp	S-Biological_Molecule
)	O
,	O
and	O
one	O
coding	O
for	O
a	O
lipoprotein	O
(	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
0920	E-Biological_Molecule
)	O
(	O
see	O
Additional	O
file	O
1	O
)	O
.	O

The	O
irp	S-Biological_Molecule
(	O
iron	B-Biological_Molecule
responsive	I-Biological_Molecule
protein	E-Biological_Molecule
)	O
gene	O
codes	O
for	O
a	O
predicted	O
TonB	S-Biological_Molecule
-	O
dependant	O
receptor	O
,	O
possibly	O
involved	O
in	O
hemin	O
transport	O
.	O

In	O
Histophilus	B-Species
somni	E-Species
,	O
the	O
FhaB	S-Biological_Molecule
homolog	O
is	O
thought	O
to	O
also	O
have	O
an	O
important	O
role	O
in	O
biofilm	O
formation	O
in	O
cases	O
of	O
myocarditis	O
caused	O
by	O
this	O
micro	O
-	O
organism	O
[	O
75	O
]	O
.	O

The	O
three	O
proteins	O
that	O
are	O
encoded	O
by	O
genes	O
fhaB	S-Biological_Molecule
,	O
irp	S-Biological_Molecule
and	O
APL	B-Biological_Molecule
_	I-Biological_Molecule
0920	E-Biological_Molecule
have	O
all	O
these	O
features	O
,	O
and	O
might	O
therefore	O
represent	O
good	O
candidates	O
to	O
include	O
in	O
future	O
cross	O
-	O
serotype	O
vaccines	O
against	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
.	O

These	O
vaccines	O
have	O
been	O
successfully	O
used	O
to	O
prevent	O
whopping	O
cough	O
and	O
have	O
contributed	O
to	O
a	O
considerable	O
decrease	O
in	O
the	O
number	O
of	O
cases	O
registered	O
per	O
year	O
[	O
76	O
]	O
.	O

Conclusions	O

By	O
comparing	O
our	O
results	O
to	O
those	O
obtained	O
following	O
comparative	O
genomics	O
and	O
proteomics	O
experiments	O
,	O
we	O
were	O
able	O
to	O
identify	O
three	O
genes	O
that	O
were	O
conserved	O
in	O
tested	O
reference	O
strains	O
and	O
in	O
fresh	O
field	O
isolates	O
of	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
,	O
and	O
these	O
were	O
also	O
predicted	O
to	O
code	O
for	O
outer	O
membrane	O
proteins	O
or	O
lipoproteins	O
.	O

While	O
our	O
results	O
can	O
help	O
decipher	O
some	O
of	O
the	O
adaptations	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
has	O
to	O
make	O
once	O
it	O
infects	O
the	O
host	O
,	O
much	O
more	O
research	O
is	O
necessary	O
in	O
order	O
to	O
understand	O
the	O
whole	O
picture	O
of	O
the	O
disease	O
.	O

The	O
acute	O
stage	O
and	O
the	O
chronic	O
stage	O
of	O
the	O
disease	O
are	O
probably	O
highly	O
different	O
conditions	O
,	O
and	O
it	O
would	O
be	O
interesting	O
in	O
future	O
works	O
to	O
compare	O
our	O
present	O
data	O
with	O
the	O
transcriptomic	O
profile	O
of	O
A	B-Species
.	I-Species
pleuropneumoniae	E-Species
during	O
a	O
chronic	O
infection	O
.	O

Identification	O
of	O
the	O
Regulatory	O
Logic	O
Controlling	O
Salmonella	S-Species
Pathoadaptation	O
by	O
the	O
SsrA	S-Biological_Molecule
-	O
SsrB	S-Biological_Molecule
Two	O
-	O
Component	O
System	O

Regulatory	O
evolution	O
,	O
in	O
which	O
non	O
-	O
coding	O
DNA	O
is	O
mutated	O
to	O
create	O
new	O
regulatory	O
nodes	O
,	O
also	O
contributes	O
to	O
this	O
diversity	O
to	O
allow	O
niche	O
adaptation	O
and	O
the	O
evolution	O
of	O
pathogenesis	O
.	O

To	O
survive	O
in	O
the	O
host	O
environment	O
,	O
Salmonella	B-Species
enterica	E-Species
uses	O
a	O
type	O
III	O
secretion	O
system	O
and	O
effector	O
proteins	O
,	O
which	O
are	O
activated	O
by	O
the	O
SsrA	S-Biological_Molecule
-	O
SsrB	S-Biological_Molecule
two	O
-	O
component	O
system	O
in	O
response	O
to	O
the	O
host	O
environment	O
.	O

To	O
better	O
understand	O
the	O
phenomenon	O
of	O
regulatory	O
evolution	O
in	O
S	B-Species
.	I-Species
enterica	E-Species
,	O
we	O
defined	O
the	O
SsrB	S-Biological_Molecule
regulon	O
and	O
asked	O
how	O
this	O
transcription	O
factor	O
interacts	O
with	O
the	O
cis	O
-	O
regulatory	O
region	O
of	O
target	O
genes	O
.	O

Using	O
ChIP	O
-	O
on	O
-	O
chip	O
,	O
cDNA	O
hybridization	O
,	O
and	O
comparative	O
genomics	O
analyses	O
,	O
we	O
describe	O
the	O
SsrB	S-Biological_Molecule
-	O
dependent	O
regulon	O
of	O
ancestral	O
and	O
horizontally	O
acquired	O
genes	O
.	O

Further	O
,	O
we	O
used	O
a	O
genetic	O
screen	O
and	O
computational	O
analyses	O
integrating	O
experimental	O
data	O
from	O
S	B-Species
.	I-Species
enterica	E-Species
and	O
sequence	O
data	O
from	O
an	O
orthologous	O
regulatory	O
system	O
in	O
the	O
insect	O
endosymbiont	O
,	O
Sodalis	B-Species
glossinidius	E-Species
,	O
to	O
identify	O
the	O
conserved	O
yet	O
flexible	O
palindrome	O
sequence	O
that	O
defines	O
DNA	O
recognition	O
by	O
SsrB	S-Biological_Molecule
.	O

Mutational	O
analysis	O
of	O
a	O
representative	O
promoter	O
validated	O
this	O
palindrome	O
as	O
the	O
minimal	O
architecture	O
needed	O
for	O
regulatory	O
input	O
by	O
SsrB	S-Biological_Molecule
.	O

Silencing	O
of	O
horizontally	O
-	O
acquired	O
genes	O
by	O
DNA	O
binding	O
proteins	O
like	O
H	B-Biological_Molecule
-	I-Biological_Molecule
NS	E-Biological_Molecule
is	O
one	O
way	O
some	O
incoming	O
genes	O
are	O
initially	O
controlled	O
[	O
2	O
]	O
,	O
[	O
3	O
]	O
,	O
which	O
can	O
then	O
be	O
subject	O
to	O
regulatory	O
evolution	O
by	O
mutating	O
cis	O
-	O
regulatory	O
operator	O
regions	O
to	O
select	O
for	O
optional	O
gene	O
expression	O
.	O

The	O
eventual	O
promoter	O
architecture	O
selected	O
to	O
deploy	O
virulence	O
genes	O
is	O
often	O
modular	O
and	O
should	O
reflect	O
a	O
design	O
that	O
maximizes	O
organismal	O
fitness	O
while	O
limiting	O
fitness	O
trade	O
-	O
offs	O
and	O
antagonistic	O
pleiotropy	O
[	O
4	O
]	O
.	O

SsrA	S-Biological_Molecule
-	O
SsrB	S-Biological_Molecule
is	O
another	O
two	O
-	O
component	O
regulatory	O
system	O
co	O
-	O
inherited	O
by	O
genetic	O
linkage	O
with	O
the	O
SPI	O
-	O
2	O
locus	O
that	O
is	O
essential	O
for	O
gene	O
expression	O
in	O
SPI	O
-	O
2	O
[	O
14	O
]	O
-	O
[	O
16	O
]	O
.	O

SsrA	S-Biological_Molecule
is	O
a	O
sensor	O
kinase	O
activated	O
in	O
the	O
host	O
environment	O
that	O
phosphorylates	O
the	O
SsrB	S-Biological_Molecule
response	O
regulator	O
to	O
create	O
an	O
active	O
transcription	O
factor	O
needed	O
for	O
spatiotemporal	O
control	O
of	O
virulence	O
genes	O
[	O
13	O
]	O
,	O
[	O
17	O
]	O
.	O

In	O
the	O
Salmonella	S-Species
genus	O
,	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O
is	O
found	O
only	O
in	O
pathogenic	O
serotypes	O
of	O
Salmonella	B-Species
enterica	E-Species
that	O
infect	O
warm	O
-	O
blooded	O
animals	O
and	O
is	O
absent	O
from	O
Salmonella	B-Species
bongori	E-Species
,	O
which	O
colonizes	O
cold	O
-	O
blooded	O
animals	O
[	O
18	O
]	O
.	O

It	O
is	O
generally	O
accepted	O
that	O
SPI	O
-	O
2	O
was	O
acquired	O
by	O
Salmonella	B-Species
enterica	E-Species
after	O
divergence	O
from	O
S	B-Species
.	I-Species
bongori	E-Species
,	O
providing	O
a	O
useful	O
pedigree	O
to	O
study	O
regulatory	O
evolution	O
influenced	O
by	O
SsrB	S-Biological_Molecule
.	O

We	O
recently	O
demonstrated	O
the	O
evolutionary	O
significance	O
of	O
cis	O
-	O
regulatory	O
mutations	O
for	O
pathoadaptation	O
of	O
Salmonella	B-Species
enterica	I-Species
serovar	I-Species
Typhimurium	E-Species
(	O
S	B-Species
.	I-Species
Typhimurium	E-Species
)	O
to	O
an	O
animal	O
host	O
[	O
19	O
]	O
.	O

Our	O
focus	O
was	O
on	O
SsrB	S-Biological_Molecule
because	O
of	O
its	O
broad	O
conservation	O
among	O
the	O
pathogenic	O
Salmonellae	S-Species
and	O
its	O
essentiality	O
for	O
animal	O
infection	O
,	O
suggesting	O
it	O
coordinates	O
fundamental	O
aspects	O
of	O
Salmonella	S-Species
pathogenesis	O
beyond	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O
.	O

In	O
this	O
study	O
we	O
investigated	O
how	O
regulatory	O
evolution	O
assimilates	O
horizontally	O
acquired	O
and	O
ancestral	O
genes	O
into	O
the	O
SsrB	S-Biological_Molecule
regulon	O
on	O
a	O
genome	O
-	O
wide	O
scale	O
using	O
an	O
integrated	O
set	O
of	O
experimental	O
methods	O
.	O

Results	O

Transcriptional	O
profiling	O
of	O
an	O
ssrB	S-Biological_Molecule
mutant	O
To	O
begin	O
to	O
understand	O
regulatory	O
evolution	O
and	O
network	O
expansion	O
of	O
the	O
SsrB	S-Biological_Molecule
response	O
regulator	O
,	O
we	O
profiled	O
the	O
transcriptome	O
of	O
an	O
ssrB	S-Biological_Molecule
mutant	O
and	O
compared	O
it	O
to	O
S	B-Species
.	E-Species

This	O
included	O
almost	O
all	O
genes	O
in	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O
as	O
well	O
as	O
effector	O
genes	O
encoded	O
throughout	O
the	O
genome	O
(	O
Dataset	O
S1	O
)	O
.	O

Typhimurium	B-Species
strain	I-Species
LT2	E-Species
[	O
23	O
]	O
.	O

The	O
majority	O
of	O
functions	O
in	O
the	O
latter	O
groups	O
are	O
in	O
transport	O
,	O
secretion	O
,	O
and	O
trafficking	O
of	O
cellular	O
components	O
in	O
addition	O
to	O
protein	O
and	O
membrane	O
modification	O
.	O

The	O
SsrA	S-Biological_Molecule
-	O
SsrB	S-Biological_Molecule
system	O
was	O
acquired	O
by	O
horizontal	O
gene	O
transfer	O
into	O
the	O
S	B-Species
.	I-Species
enterica	E-Species
species	O
after	O
divergence	O
from	O
what	O
is	O
now	O
extant	O
S	B-Species
.	I-Species
bongori	E-Species
.	O

As	O
such	O
,	O
S	B-Species
.	I-Species
bongori	E-Species
has	O
evolved	O
in	O
the	O
absence	O
of	O
SsrA	S-Biological_Molecule
-	O
SsrB	S-Biological_Molecule
and	O
its	O
regulatory	O
architecture	O
has	O
not	O
been	O
influenced	O
by	O
it	O
.	O

To	O
expand	O
on	O
this	O
,	O
we	O
used	O
a	O
reciprocal	O
BLAST	O
-	O
based	O
analysis	O
and	O
identified	O
47	O
orthologs	O
in	O
S	B-Species
.	I-Species
bongori	E-Species
among	O
the	O
133	O
genes	O
whose	O
transcription	O
was	O
down	O
-	O
regulated	O
in	O
an	O
ssrB	S-Biological_Molecule
mutant	O
(	O
Table	O
1	O
)	O
.	O

In	O
DeltassrB	S-Biological_Molecule
cells	O
,	O
the	O
mean	O
fold	O
-	O
change	O
of	O
the	O
orthologous	O
genes	O
(	O
-	O
6	O
.	O
1	O
-	O
fold	O
)	O
was	O
subtler	O
than	O
for	O
the	O
S	B-Species
.	I-Species
enterica	E-Species
-	O
specific	O
gene	O
set	O
(	O
mean	O
-	O
21	O
.	O
2	O
-	O
fold	O
)	O
,	O
which	O
included	O
the	O
T3SS	O
and	O
associated	O
effector	O
genes	O
(	O
Dataset	O
S1	O
)	O
.	O

We	O
also	O
determined	O
the	O
distribution	O
of	O
down	O
-	O
regulated	O
genes	O
among	O
genomic	O
islands	O
[	O
24	O
]	O
,	O
including	O
prophages	O
,	O
pathogenicity	O
islands	O
(	O
SPI	O
-	O
islands	O
)	O
and	O
additional	O
regions	O
of	O
difference	O
(	O
ROD	O
)	O
between	O
S	B-Species
.	I-Species
enterica	E-Species
and	O
S	B-Species
.	I-Species
bongori	E-Species
(	O
Dataset	O
S2	O
)	O
.	O

For	O
this	O
we	O
used	O
a	O
BLAST	O
-	O
based	O
comparison	O
of	O
genome	O
-	O
wide	O
synteny	O
between	O
S	B-Species
.	E-Species

Typhimurium	S-Species
and	O
S	B-Species
.	I-Species
bongori	E-Species
and	O
identified	O
50	O
ROD	O
that	O
included	O
17	O
previously	O
reported	O
SPI	O
-	O
islands	O
and	O
prophages	O
.	O

Genome	O
-	O
wide	O
SsrB	S-Biological_Molecule
interactions	O

To	O
examine	O
SsrB	S-Biological_Molecule
allocation	O
on	O
the	O
chromosome	O
in	O
vivo	O
,	O
we	O
isolated	O
functional	O
SsrB	S-Biological_Molecule
-	O
DNA	O
interactions	O
using	O
chromatin	O
immunoprecipitation	O
and	O
examined	O
the	O
bound	O
DNA	O
by	O
chip	O
analysis	O
(	O
ChIP	O
-	O
on	O
-	O
chip	O
)	O
using	O
an	O
S	B-Species
.	E-Species

With	O
this	O
method	O
,	O
we	O
identified	O
256	O
significant	O
interaction	O
peaks	O
distributed	O
throughout	O
the	O
genome	O
that	O
were	O
enriched	O
under	O
SsrB	S-Biological_Molecule
-	O
activating	O
conditions	O
and	O
with	O
interaction	O
scores	O
three	O
standard	O
deviations	O
greater	O
than	O
the	O
mean	O
probe	O
score	O
(	O
Figure	O
2A	O
and	O
Table	O
1	O
)	O
.	O

Typhimurium	B-Species
SL1344	E-Species
.	O

From	O
this	O
analysis	O
,	O
62	O
of	O
256	O
SsrB	S-Biological_Molecule
binding	O
peaks	O
(	O
24	O
.	O
3	O
%	O
)	O
occurred	O
within	O
genomic	O
islands	O
(	O
Figure	O
2B	O
)	O
.	O

In	O
order	O
to	O
rigorously	O
evaluate	O
our	O
genome	O
-	O
wide	O
functional	O
genomics	O
data	O
,	O
we	O
compared	O
it	O
against	O
traditional	O
biochemical	O
experiments	O
describing	O
SsrB	S-Biological_Molecule
-	O
DNA	O
interactions	O
at	O
the	O
SPI	O
-	O
2	O
locus	O
.	O

Previous	O
data	O
reported	O
SsrB	S-Biological_Molecule
footprints	O
upstream	O
of	O
6	O
genes	O
in	O
SPI	O
-	O
2	O
:	O
ssrA	S-Biological_Molecule
,	O
ssrB	S-Biological_Molecule
,	O
ssaB	S-Biological_Molecule
,	O
sseA	S-Biological_Molecule
,	O
ssaG	S-Biological_Molecule
,	O
and	O
ssaM	S-Biological_Molecule
[	O
25	O
]	O
,	O
[	O
26	O
]	O
.	O

Our	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
showed	O
discrete	O
SsrB	S-Biological_Molecule
binding	O
at	O
all	O
of	O
these	O
promoters	O
except	O
for	O
the	O
promoter	O
reported	O
to	O
be	O
between	O
ssrA	S-Biological_Molecule
and	O
ssrB	S-Biological_Molecule
[	O
25	O
]	O
(	O
Figure	O
3	O
)	O
.	O

We	O
attempted	O
to	O
verify	O
functional	O
activity	O
at	O
this	O
site	O
,	O
but	O
could	O
not	O
using	O
transcriptional	O
fusions	O
(	O
data	O
not	O
shown	O
)	O
.	O

Our	O
data	O
also	O
identified	O
three	O
additional	O
SsrB	S-Biological_Molecule
binding	O
peaks	O
upstream	O
of	O
sseA	S-Biological_Molecule
,	O
within	O
the	O
CDS	O
of	O
ssaJ	S-Biological_Molecule
,	O
and	O
in	O
the	O
IGR	O
upstream	O
of	O
ssaR	S-Biological_Molecule
(	O
Figure	O
3	O
)	O
.	O

Functional	O
interactions	O
were	O
confirmed	O
for	O
sseA	S-Biological_Molecule
and	O
ssaR	S-Biological_Molecule
in	O
subsequent	O
reporter	O
experiments	O
described	O
below	O
.	O

Identification	O
of	O
a	O
functional	O
DNA	O
element	O
for	O
SsrB	S-Biological_Molecule
binding	O

We	O
fused	O
the	O
DNA	O
binding	O
domain	O
of	O
SsrB	S-Biological_Molecule
(	O
SsrBc	S-Biological_Molecule
)	O
to	O
the	O
alpha	O
-	O
subunit	O
of	O
RNA	O
polymerase	O
and	O
screened	O
a	O
prey	O
library	O
of	O
approximately108	O
DNA	O
molecules	O
previously	O
counter	O
-	O
selected	O
against	O
self	O
-	O
activation	O
(	O
Figure	O
4A	O
)	O
.	O

From	O
189	O
unique	O
sequences	O
isolated	O
for	O
SsrBc	S-Biological_Molecule
,	O
over	O
80	O
%	O
contained	O
a	O
degenerate	O
consensus	O
motif	O
,	O
mCCyTA	O
(	O
Figure	O
4B	O
)	O
.	O

In	O
control	O
screens	O
with	O
the	O
PhoP	S-Biological_Molecule
-	O
alphaNTD	S-Biological_Molecule
fusion	O
,	O
the	O
PhoP	S-Biological_Molecule
box	O
sequence	O
(	O
G	O
/	O
T	O
)	O
GTTTA	O
was	O
identified	O
in	O
11	O
%	O
of	O
sequenced	O
preys	O
(	O
12	O
/	O
109	O
,	O
data	O
not	O
shown	O
)	O
but	O
this	O
sequence	O
was	O
never	O
captured	O
by	O
SsrB	S-Biological_Molecule
-	O
alphaNTD	S-Biological_Molecule
and	O
vice	O
versa	O
,	O
demonstrating	O
specificity	O
of	O
the	O
bacterial	O
one	O
-	O
hybrid	O
system	O
for	O
prokaryotic	O
regulatory	O
proteins	O
.	O

Next	O
,	O
we	O
examined	O
our	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
for	O
the	O
presence	O
of	O
a	O
conserved	O
regulatory	O
motif	O
.	O

We	O
extracted	O
sequence	O
data	O
from	O
the	O
local	O
maxima	O
of	O
the	O
256	O
binding	O
peaks	O
and	O
analyzed	O
the	O
sequences	O
with	O
the	O
computational	O
program	O
MDscan	O
[	O
30	O
]	O
.	O

Using	O
the	O
highest	O
-	O
ranking	O
probes	O
to	O
generate	O
an	O
initial	O
prediction	O
followed	O
by	O
lower	O
-	O
ranking	O
probes	O
for	O
refinement	O
,	O
this	O
analysis	O
identified	O
motifs	O
that	O
represented	O
either	O
the	O
forward	O
or	O
the	O
reverse	O
complement	O
of	O
the	O
consensus	O
sequence	O
ACmTTA	O
,	O
which	O
shares	O
consensus	O
with	O
the	O
motif	O
identified	O
in	O
the	O
bacterial	O
one	O
-	O
hybrid	O
screen	O
(	O
Figure	O
4B	O
)	O
.	O

We	O
identified	O
variations	O
of	O
this	O
motif	O
within	O
footprinted	O
regions	O
of	O
SsrB	S-Biological_Molecule
-	O
regulated	O
promoters	O
[	O
25	O
]	O
,	O
,	O
however	O
sequence	O
degeneracy	O
made	O
it	O
difficult	O
to	O
precisely	O
map	O
the	O
input	O
functions	O
.	O

Typhimurium	S-Species
SPI	O
-	O
2	O
and	O
the	O
Sodalis	B-Species
glossinidius	E-Species
SSR	O
-	O
3	O
region	O

Gene	O
conservation	O
includes	O
the	O
entire	O
T3SS	O
structural	O
module	O
extending	O
to	O
the	O
regulatory	O
genes	O
ssrA	S-Biological_Molecule
-	O
ssrB	S-Biological_Molecule
and	O
all	O
other	O
genes	O
except	O
the	O
effectors	O
sseF	S-Biological_Molecule
and	O
sseG	S-Biological_Molecule
,	O
which	O
are	O
not	O
present	O
in	O
Sodalis	S-Species
SSR	O
-	O
3	O
.	O

Interestingly	O
,	O
two	O
copies	O
of	O
the	O
palindrome	O
occur	O
upstream	O
of	O
the	O
ssrA	S-Biological_Molecule
-	O
ssrB	S-Biological_Molecule
operon	O
in	O
S	B-Species
.	E-Species

In	O
accord	O
with	O
a	O
previous	O
observation	O
[	O
26	O
]	O
,	O
there	O
was	O
not	O
a	O
strict	O
requirement	O
in	O
the	O
spacing	O
between	O
the	O
SsrB	S-Biological_Molecule
binding	O
site	O
and	O
the	O
downstream	O
transcriptional	O
start	O
site	O
.	O

SsrB	S-Biological_Molecule
directs	O
transcriptional	O
input	O
using	O
a	O
flexible	O
palindrome	O
architecture	O

The	O
presence	O
of	O
a	O
conserved	O
palindrome	O
sequence	O
in	O
SPI	O
-	O
2	O
promoters	O
and	O
in	O
related	O
sequences	O
from	O
the	O
endosymbiont	O
S	B-Species
.	I-Species
glossinidius	E-Species
suggested	O
that	O
regulatory	O
input	O
by	O
SsrB	S-Biological_Molecule
was	O
through	O
a	O
palindrome	O
sequence	O
architecture	O
.	O

However	O
,	O
other	O
lines	O
of	O
evidence	O
suggested	O
that	O
the	O
recognition	O
site	O
architecture	O
was	O
flexible	O
in	O
nature	O
:	O
(	O
i	O
)	O
our	O
bacterial	O
one	O
-	O
hybrid	O
screen	O
isolated	O
functional	O
single	O
hexamer	O
sequences	O
,	O
(	O
ii	O
)	O
the	O
SsrB	S-Biological_Molecule
footprint	O
at	O
the	O
naturally	O
evolved	O
sseA	S-Biological_Molecule
promoter	O
within	O
SPI	O
-	O
2	O
[	O
26	O
]	O
contained	O
only	O
one	O
reasonably	O
well	O
-	O
conserved	O
heptamer	O
,	O
and	O
(	O
iii	O
)	O
degenerate	O
or	O
non	O
-	O
ideal	O
palindromes	O
exist	O
in	O
the	O
genome	O
.	O

We	O
chose	O
the	O
ssaG	S-Biological_Molecule
promoter	O
for	O
these	O
experiments	O
because	O
16	O
of	O
18	O
bases	O
were	O
identical	O
between	O
SPI	O
-	O
2	O
and	O
SSR	O
-	O
3	O
from	O
S	B-Species
.	I-Species
glossinidius	E-Species
,	O
differing	O
only	O
in	O
the	O
4	O
-	O
bp	O
spacer	O
between	O
heptamers	O
(	O
Figure	O
4C	O
)	O
.	O

Precise	O
deletion	O
of	O
the	O
entire	O
18	O
-	O
bp	O
palindrome	O
lead	O
to	O
approximately10	O
%	O
residual	O
activity	O
in	O
wild	O
-	O
type	O
cells	O
,	O
which	O
was	O
reduced	O
to	O
less	O
than	O
1	O
%	O
in	O
an	O
ssrB	S-Biological_Molecule
mutant	O
(	O
Figure	O
5C	O
)	O
.	O

Assessment	O
of	O
reporter	O
activity	O
for	O
this	O
construct	O
in	O
addition	O
to	O
wild	O
-	O
type	O
constructs	O
in	O
wild	O
-	O
type	O
and	O
ssrB	S-Biological_Molecule
mutant	O
backgrounds	O
showed	O
a	O
similar	O
level	O
of	O
activity	O
to	O
the	O
ssrB	S-Biological_Molecule
mutant	O
(	O
Figure	O
5D	O
)	O
.	O

Therefore	O
,	O
we	O
compared	O
the	O
sequences	O
generated	O
upon	O
mutation	O
against	O
a	O
consensus	O
palindrome	O
matrix	O
generated	O
from	O
all	O
SPI	O
-	O
2	O
and	O
other	O
identified	O
putative	O
elements	O
.	O

The	O
7	O
'	O
-	O
4	O
-	O
X	O
,	O
X	O
-	O
4	O
-	O
7	O
'	O
'	O
and	O
7	O
'	O
-	O
X	O
-	O
7	O
'	O
'	O
mutations	O
introduced	O
a	O
number	O
of	O
base	O
transitions	O
and	O
transversions	O
never	O
occurring	O
in	O
the	O
matrix	O
,	O
however	O
the	O
modified	O
7	O
base	O
pair	O
heptamer	O
retained	O
4	O
-	O
5	O
naturally	O
-	O
occurring	O
bases	O
along	O
with	O
the	O
unchanged	O
wild	O
-	O
type	O
sequence	O
in	O
the	O
other	O
heptamer	O
(	O
Figure	O
S2	O
)	O
.	O

To	O
test	O
this	O
,	O
we	O
created	O
an	O
additional	O
ectopic	O
transcriptional	O
fusion	O
construct	O
in	O
which	O
the	O
left	O
half	O
(	O
7	O
'	O
)	O
of	O
the	O
palindrome	O
was	O
mutated	O
to	O
bases	O
never	O
occurring	O
in	O
the	O
consensus	O
matrix	O
.	O

Salmonella	O
SsrB	S-Biological_Molecule
and	O
the	O
Sodalis	S-Species
ortholog	O
(	O
SG1279	S-Biological_Molecule
)	O
are	O
69	O
%	O
identical	O
and	O
81	O
%	O
similar	O
at	O
the	O
amino	O
acid	O
level	O
.	O

Typhimurium	S-Species
and	O
an	O
ssrB	S-Biological_Molecule
mutant	O
.	O

The	O
transcriptional	O
activity	O
from	O
a	O
wild	O
-	O
type	O
Sodalis	S-Species
palindrome	O
sequence	O
was	O
high	O
,	O
but	O
was	O
completely	O
abolished	O
in	O
an	O
ssrB	S-Biological_Molecule
mutant	O
and	O
in	O
experiments	O
where	O
only	O
the	O
palindrome	O
sequence	O
was	O
precisely	O
deleted	O
(	O
Figure	O
5D	O
)	O
.	O

These	O
experiments	O
demonstrated	O
a	O
functional	O
role	O
for	O
the	O
conserved	O
palindrome	O
in	O
Sodalis	S-Species
and	O
the	O
requirement	O
for	O
SsrB	S-Biological_Molecule
for	O
transcriptional	O
activation	O
.	O

The	O
above	O
results	O
identified	O
the	O
conserved	O
,	O
yet	O
flexible	O
,	O
palindrome	O
sequence	O
defining	O
DNA	O
recognition	O
by	O
SsrB	S-Biological_Molecule
.	O

To	O
examine	O
the	O
extent	O
to	O
which	O
regulatory	O
evolution	O
has	O
been	O
selective	O
for	O
this	O
genetic	O
architecture	O
,	O
we	O
created	O
a	O
position	O
weight	O
matrix	O
(	O
PWM	O
)	O
for	O
the	O
five	O
strongest	O
palindrome	O
sites	O
in	O
SPI	O
-	O
2	O
and	O
the	O
orthologous	O
sites	O
in	O
Sodalis	S-Species
SSR	O
-	O
3	O
.	O

We	O
then	O
searched	O
for	O
representative	O
candidates	O
of	O
this	O
motif	O
in	O
the	O
S	B-Species
.	E-Species

Typhimurium	S-Species
genome	O
using	O
the	O
simple	O
scoring	O
algorithm	O
MotifLocator	O
[	O
45	O
]	O
,	O
[	O
46	O
]	O
.	O

This	O
analysis	O
recovered	O
the	O
motifs	O
upstream	O
of	O
ssaB	S-Biological_Molecule
,	O
ssaG	S-Biological_Molecule
,	O
ssaM	S-Biological_Molecule
,	O
and	O
ssaR	S-Biological_Molecule
that	O
were	O
used	O
to	O
generate	O
the	O
PWM	O
.	O

We	O
identified	O
24	O
palindromes	O
co	O
-	O
occurring	O
with	O
ChIP	O
-	O
on	O
-	O
chip	O
peaks	O
upstream	O
of	O
24	O
different	O
SsrB	S-Biological_Molecule
-	O
regulated	O
genes	O
or	O
operons	O
.	O

Applying	O
a	O
stringent	O
threshold	O
to	O
the	O
output	O
allowed	O
us	O
to	O
identify	O
two	O
groups	O
-	O
genes	O
with	O
high	O
-	O
scoring	O
upstream	O
palindromes	O
(	O
ssaB	S-Biological_Molecule
,	O
ssaG	S-Biological_Molecule
,	O
ssaM	S-Biological_Molecule
,	O
ssaR	S-Biological_Molecule
,	O
sopD2	S-Biological_Molecule
,	O
sifA	S-Biological_Molecule
,	O
sifB	S-Biological_Molecule
,	O
sseK2	S-Biological_Molecule
,	O
sseK3	S-Biological_Molecule
,	O
sseL	S-Biological_Molecule
,	O
sseA	S-Biological_Molecule
'	O
,	O
steC	S-Biological_Molecule
,	O
and	O
srcA	S-Biological_Molecule
)	O
and	O
those	O
with	O
medium	O
-	O
scoring	O
palindromes	O
(	O
0	O
.	O
7	O
-	O
0	O
.	O
8	O
threshold	O
;	O
ssrA	S-Biological_Molecule
,	O
STM1633	S-Biological_Molecule
,	O
sseI	S-Biological_Molecule
,	O
slrP	S-Biological_Molecule
sspH2	S-Biological_Molecule
,	O
pipB	S-Biological_Molecule
,	O
sseJ	S-Biological_Molecule
,	O
pipB2	S-Biological_Molecule
,	O
srfN	S-Biological_Molecule
,	O
sseA	S-Biological_Molecule
and	O
steB	S-Biological_Molecule
)	O
(	O
Figure	O
6A	O
and	O
Dataset	O
S4	O
)	O
(	O
sseA	S-Biological_Molecule
'	O
denotes	O
the	O
SsrB	S-Biological_Molecule
palindrome	O
sequence	O
upstream	O
of	O
sseA	S-Biological_Molecule
that	O
falls	O
within	O
the	O
ssaE	S-Biological_Molecule
CDS	O
,	O
while	O
sseA	S-Biological_Molecule
refers	O
to	O
the	O
SsrB	S-Biological_Molecule
-	O
footprinted	O
IGR	O
site	O
with	O
only	O
one	O
conserved	O
heptamer	O
defined	O
in	O
Figure	O
4C	O
)	O
.	O

These	O
genes	O
either	O
lacked	O
an	O
upstream	O
ChIP	O
peak	O
above	O
our	O
3	O
-	O
standard	O
deviation	O
cut	O
-	O
off	O
(	O
sseK	S-Biological_Molecule
)	O
or	O
had	O
such	O
a	O
peak	O
but	O
did	O
not	O
reach	O
statistical	O
significance	O
in	O
our	O
transcriptional	O
profiling	O
experiments	O
(	O
steA	S-Biological_Molecule
,	O
gogB	S-Biological_Molecule
)	O
.	O

Our	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
revealed	O
three	O
additional	O
strong	O
SsrB	S-Biological_Molecule
binding	O
peaks	O
within	O
SPI	O
-	O
2	O
:	O
one	O
in	O
the	O
IGR	O
directly	O
upstream	O
of	O
ssaR	S-Biological_Molecule
,	O
a	O
second	O
within	O
the	O
CDS	O
for	O
ssaJ	S-Biological_Molecule
,	O
and	O
a	O
third	O
within	O
the	O
CDS	O
for	O
ssaE	S-Biological_Molecule
that	O
would	O
be	O
predicted	O
to	O
influence	O
transcription	O
of	O
the	O
downstream	O
effector	O
/	O
chaperone	O
operon	O
beginning	O
with	O
sseA	S-Biological_Molecule
.	O

The	O
analysis	O
described	O
above	O
recovered	O
SsrB	S-Biological_Molecule
palindrome	O
sequences	O
at	O
the	O
sseA	S-Biological_Molecule
'	O
and	O
ssaR	S-Biological_Molecule
locations	O
prompting	O
further	O
validation	O
of	O
these	O
sites	O
.	O

For	O
the	O
IGR	O
palindrome	O
upstream	O
of	O
ssaR	S-Biological_Molecule
,	O
we	O
tested	O
both	O
a	O
chromosome	O
-	O
integrated	O
transcriptional	O
fusion	O
and	O
an	O
autonomous	O
episomal	O
reporter	O
.	O

In	O
wild	O
-	O
type	O
cells	O
these	O
reporters	O
were	O
as	O
active	O
as	O
other	O
SPI	O
-	O
2	O
promoters	O
,	O
whereas	O
promoter	O
activity	O
was	O
abrogated	O
in	O
DeltassrB	S-Biological_Molecule
cells	O
,	O
implicating	O
this	O
IGR	O
as	O
a	O
functional	O
promoter	O
for	O
ssaR	S-Biological_Molecule
(	O
Figure	O
6B	O
and	O
Figure	O
S4	O
)	O
.	O

We	O
next	O
tested	O
the	O
function	O
of	O
the	O
intragenic	O
palindrome	O
within	O
ssaE	S-Biological_Molecule
(	O
sseA	S-Biological_Molecule
'	O
)	O
.	O

These	O
experiments	O
showed	O
that	O
the	O
sseA	S-Biological_Molecule
'	O
sequence	O
contributes	O
approximately	O
75	O
%	O
of	O
transcriptional	O
output	O
at	O
the	O
sseA	S-Biological_Molecule
promoter	O
(	O
Figure	O
6C	O
)	O
,	O
since	O
deleting	O
the	O
single	O
heptamer	O
in	O
the	O
sseA	S-Biological_Molecule
IGR	O
had	O
little	O
effect	O
on	O
transcriptional	O
output	O
in	O
any	O
of	O
the	O
strain	O
backgrounds	O
.	O

These	O
reporter	O
data	O
are	O
in	O
line	O
with	O
the	O
respective	O
binding	O
scores	O
for	O
the	O
ChIP	O
-	O
on	O
-	O
chip	O
interaction	O
peaks	O
(	O
Figure	O
3	O
)	O
and	O
the	O
sequence	O
similarity	O
for	O
these	O
elements	O
with	O
respect	O
to	O
the	O
consensus	O
palindrome	O
(	O
Figure	O
6A	O
and	O
Figure	O
4D	O
)	O
.	O

Together	O
,	O
these	O
data	O
provide	O
compelling	O
evidence	O
for	O
the	O
identity	O
of	O
the	O
DNA	O
recognition	O
element	O
that	O
has	O
been	O
selected	O
through	O
evolution	O
to	O
co	O
-	O
regulate	O
an	O
SsrB	S-Biological_Molecule
-	O
dependent	O
gene	O
program	O
involved	O
in	O
adaptation	O
to	O
a	O
host	O
.	O

Discussion	O

A	O
good	O
example	O
of	O
this	O
is	O
acquisition	O
of	O
type	O
III	O
secretion	O
by	O
mutualists	O
and	O
pathogenic	O
bacteria	O
enabling	O
new	O
colonization	O
strategies	O
within	O
a	O
host	O
[	O
33	O
]	O
,	O
[	O
34	O
]	O
.	O

This	O
regulatory	O
system	O
was	O
co	O
-	O
acquired	O
with	O
a	O
T3SS	O
encoded	O
in	O
the	O
SPI	O
-	O
2	O
pathogenicity	O
island	O
and	O
likely	O
contributed	O
to	O
immediate	O
and	O
gradual	O
phenotypic	O
diversity	O
as	O
new	O
regulatory	O
nodes	O
were	O
explored	O
and	O
acted	O
upon	O
by	O
natural	O
selection	O
.	O

Extensive	O
work	O
has	O
been	O
reported	O
on	O
the	O
characterization	O
of	O
SsrB	S-Biological_Molecule
dependent	O
genes	O
,	O
including	O
functional	O
evaluation	O
of	O
genes	O
encoded	O
within	O
SPI	O
-	O
2	O
in	O
addition	O
to	O
genome	O
-	O
wide	O
transcriptional	O
studies	O
[	O
14	O
]	O
,	O
[	O
15	O
]	O
.	O

Direct	O
profiling	O
of	O
SsrB	S-Biological_Molecule
-	O
DNA	O
interactions	O
using	O
ChIP	O
-	O
on	O
-	O
chip	O
was	O
used	O
to	O
identify	O
SsrB	S-Biological_Molecule
binding	O
sites	O
in	O
the	O
genome	O
.	O

In	O
both	O
cases	O
these	O
input	O
sites	O
were	O
found	O
to	O
be	O
functional	O
.	O

As	O
a	O
result	O
of	O
our	O
mutational	O
analyses	O
we	O
conclude	O
that	O
so	O
long	O
as	O
the	O
orientation	O
of	O
a	O
single	O
heptamer	O
of	O
the	O
palindrome	O
is	O
conserved	O
with	O
respect	O
to	O
the	O
downstream	O
gene	O
,	O
SsrB	S-Biological_Molecule
is	O
tolerant	O
of	O
degeneracy	O
in	O
the	O
adjacent	O
spacer	O
and	O
heptamer	O
sequences	O
.	O

While	O
we	O
were	O
able	O
to	O
identify	O
a	O
number	O
of	O
limited	O
palindrome	O
-	O
like	O
sequences	O
from	O
our	O
bacterial	O
one	O
-	O
hybrid	O
screen	O
,	O
this	O
tolerance	O
in	O
addition	O
to	O
the	O
library	O
size	O
required	O
to	O
pull	O
out	O
an	O
18	O
-	O
bp	O
palindrome	O
in	O
large	O
numbers	O
may	O
explain	O
why	O
we	O
isolated	O
functional	O
single	O
heptamer	O
sequences	O
and	O
why	O
degenerate	O
palindromes	O
naturally	O
exist	O
in	O
the	O
genome	O
.	O

Our	O
findings	O
also	O
suggest	O
that	O
dimerization	O
is	O
likely	O
required	O
for	O
transcriptional	O
activation	O
however	O
strong	O
recognition	O
by	O
one	O
monomer	O
may	O
stabilize	O
interaction	O
of	O
a	O
second	O
monomer	O
with	O
a	O
less	O
than	O
ideal	O
sequence	O
.	O

The	O
finding	O
that	O
a	O
flexible	O
palindromic	O
sequence	O
can	O
be	O
selective	O
for	O
SsrB	S-Biological_Molecule
input	O
raises	O
many	O
interesting	O
questions	O
around	O
the	O
nature	O
of	O
regulatory	O
evolution	O
.	O

The	O
ability	O
to	O
use	O
a	O
short	O
functional	O
half	O
-	O
site	O
adjacent	O
to	O
an	O
uncharacterized	O
threshold	O
level	O
of	O
tolerated	O
bases	O
would	O
reduce	O
the	O
period	O
of	O
neutral	O
evolution	O
required	O
to	O
generate	O
an	O
inverted	O
repeat	O
sequence	O
twice	O
the	O
length	O
[	O
37	O
]	O
,	O
and	O
would	O
limit	O
the	O
loss	O
of	O
intermediate	O
variations	O
to	O
drift	O
while	O
a	O
more	O
desirable	O
palindrome	O
is	O
created	O
by	O
regulatory	O
evolution	O
.	O

We	O
showed	O
that	O
the	O
SsrB	S-Biological_Molecule
regulatory	O
palindrome	O
is	O
also	O
present	O
in	O
the	O
orthologous	O
SSR	O
-	O
3	O
island	O
of	O
the	O
endosymbiont	O
Sodalis	B-Species
glossinidius	E-Species
and	O
that	O
the	O
palindrome	O
evolved	O
in	O
Sodalis	S-Species
can	O
act	O
as	O
a	O
cis	O
regulatory	O
input	O
function	O
in	O
Salmonella	S-Species
.	O

Thus	O
,	O
in	O
addition	O
to	O
supporting	O
a	O
pathogenic	O
lifestyle	O
within	O
a	O
host	O
in	O
Salmonella	S-Species
,	O
it	O
seems	O
probable	O
that	O
this	O
common	O
promoter	O
architecture	O
may	O
direct	O
the	O
activation	O
of	O
the	O
SSR	O
-	O
3	O
T3SS	O
of	O
S	B-Species
.	I-Species
glossinidius	E-Species
in	O
its	O
endosymbiotic	O
relationship	O
with	O
the	O
tsetse	B-Species
fly	E-Species
host	O
,	O
although	O
we	O
acknowledge	O
this	O
requires	O
experimental	O
validation	O
.	O

The	O
SSR	O
-	O
3	O
region	O
in	O
S	B-Species
.	I-Species
glossinidius	E-Species
is	O
fully	O
conserved	O
in	O
gene	O
synteny	O
and	O
content	O
with	O
that	O
of	O
SPI	O
-	O
2	O
[	O
31	O
]	O
,	O
with	O
the	O
exception	O
of	O
two	O
effector	O
genes	O
missing	O
in	O
SSR	O
-	O
3	O
(	O
sseF	S-Biological_Molecule
and	O
sseG	S-Biological_Molecule
)	O
that	O
are	O
required	O
to	O
localize	O
vacuolar	O
Salmonella	S-Species
to	O
the	O
perinuclear	O
Golgi	O
in	O
host	O
cells	O
[	O
38	O
]	O
,	O
[	O
39	O
]	O
.	O

To	O
the	O
contrary	O
,	O
high	O
local	O
conservation	O
in	O
the	O
promoters	O
evolved	O
in	O
Salmonella	S-Species
and	O
Sodalis	S-Species
was	O
the	O
crux	O
in	O
defining	O
the	O
functional	O
SsrB	S-Biological_Molecule
input	O
among	O
stochastic	O
noise	O
.	O

This	O
analysis	O
revealed	O
strong	O
palindrome	O
sequence	O
conservation	O
in	O
five	O
promoters	O
identified	O
in	O
SPI	O
-	O
2	O
and	O
in	O
the	O
orthologous	O
sequences	O
in	O
Sodalis	S-Species
SSR	O
-	O
3	O
.	O

Among	O
palindrome	O
-	O
containing	O
promoters	O
,	O
the	O
ssrA	S-Biological_Molecule
promoter	O
is	O
exceptional	O
for	O
two	O
reasons	O
:	O
a	O
lack	O
of	O
conservation	O
between	O
Salmonella	S-Species
and	O
Sodalis	S-Species
,	O
and	O
the	O
evolution	O
of	O
tandem	O
palindromes	O
in	O
Salmonella	S-Species
.	O

One	O
possible	O
interpretation	O
of	O
this	O
divergent	O
regulatory	O
architecture	O
in	O
front	O
of	O
ssrA	S-Biological_Molecule
might	O
relate	O
to	O
bacterial	O
lifestyle	O
.	O

The	O
endosymbiotic	O
relationship	O
of	O
Sodalis	O
with	O
the	O
tsetse	B-Species
fly	E-Species
-	O
where	O
long	O
-	O
term	O
vertical	O
transmission	O
has	O
ostensibly	O
been	O
formative	O
in	O
shaping	O
regulatory	O
circuitry	O
at	O
certain	O
promoters	O
-	O
may	O
obviate	O
the	O
need	O
for	O
rapid	O
transcriptional	O
surge	O
,	O
leading	O
to	O
regulatory	O
drift	O
or	O
selection	O
against	O
positive	O
feedback	O
.	O

Microevolution	O
of	O
Group	B-Species
A	I-Species
Streptococci	E-Species
In	O
Vivo	O
:	O
Capturing	O
Regulatory	O
Networks	O
Engaged	O
in	O
Sociomicrobiology	O
,	O
Niche	O
Adaptation	O
,	O
and	O
Hypervirulence	O

Having	O
previously	O
reported	O
that	O
M1T1	B-Species
Streptococcus	I-Species
pyogenes	E-Species
become	O
hypervirulent	O
in	O
mice	S-Species
due	O
to	O
selection	O
of	O
mutants	O
in	O
the	O
covRS	S-Biological_Molecule
regulatory	O
genes	O
,	O
we	O
set	O
out	O
to	O
dissect	O
the	O
impact	O
of	O
these	O
mutations	O
in	O
vitro	O
and	O
in	O
vivo	O
from	O
the	O
impact	O
of	O
other	O
adaptive	O
events	O
.	O

In	O
contrast	O
to	O
the	O
virulence	O
-	O
associated	O
differences	O
between	O
WT	O
and	O
AP	S-Species
bacteria	O
,	O
Phenotype	O
Microarray	O
analysis	O
showed	O
minor	O
in	O
vitro	O
phenotypic	O
differences	O
between	O
the	O
two	O
isogenic	O
variants	O
.	O

Our	O
findings	O
demonstrate	O
the	O
engagement	O
of	O
unique	O
regulatory	O
modules	O
in	O
niche	O
adaptation	O
,	O
implicate	O
a	O
critical	O
role	O
for	O
bacterial	O
genetic	O
heterogeneity	O
that	O
surpasses	O
transcriptional	O
in	O
vivo	O
adaptation	O
,	O
and	O
portray	O
the	O
dynamics	O
underlying	O
the	O
selection	O
of	O
hypervirulent	O
covS	S-Biological_Molecule
mutants	O
over	O
their	O
parental	O
WT	O
cells	O
.	O

Introduction	O

Group	B-Species
A	I-Species
streptococci	E-Species
(	O
GAS	S-Species
)	O
are	O
human	S-Species
pathogens	O
that	O
infect	O
over	O
700	O
million	O
children	O
and	O
adults	O
each	O
year	O
[	O
1	O
]	O
.	O

Among	O
the	O
various	O
GAS	S-Species
serotypes	O
,	O
the	O
globally	O
disseminated	O
M1T1	S-Species
clonal	O
strain	O
remains	O
the	O
most	O
frequently	O
isolated	O
from	O
cases	O
of	O
invasive	O
and	O
non	O
-	O
invasive	O
infections	O
[	O
2	O
]	O
,	O
[	O
3	O
]	O
,	O
and	O
although	O
disease	O
severity	O
partially	O
depends	O
on	O
host	O
genetic	O
factors	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
,	O
[	O
6	O
]	O
,	O
M1T1	B-Species
GAS	E-Species
possesses	O
unique	O
genomic	O
features	O
that	O
contribute	O
to	O
its	O
evolutionary	O
fitness	O
[	O
7	O
]	O
,	O
[	O
8	O
]	O
,	O
[	O
9	O
]	O
,	O
[	O
10	O
]	O
.	O

Among	O
these	O
features	O
is	O
the	O
ability	O
of	O
M1T1	S-Species
bacteria	O
to	O
switch	O
to	O
a	O
hypervirulent	O
phenotype	O
associated	O
with	O
invasive	O
diseases	O
in	O
vivo	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
,	O
a	O
phenomenon	O
that	O
is	O
not	O
fully	O
understood	O
and	O
whose	O
specificity	O
to	O
the	O
M1	S-Species
serotype	O
remains	O
to	O
be	O
established	O
[	O
15	O
]	O
.	O

We	O
previously	O
reported	O
that	O
virulent	O
representatives	O
of	O
M1T1	B-Species
GAS	E-Species
,	O
with	O
the	O
phenotype	O
SpeBhi	S-Biological_Molecule
/	O
SpeA	S-Biological_Molecule
-	O
/	O
Sda1low	S-Biological_Molecule
,	O
irreversibly	O
switch	O
to	O
the	O
hypervirulent	O
SpeB	S-Biological_Molecule
-	O
/	O
SpeA	S-Biological_Molecule
+	O
/	O
Sda1high	S-Biological_Molecule
phenotype	O
after	O
>	O
/	O
=	O
3	O
days	O
in	O
vivo	O
[	O
12	O
]	O
,	O
[	O
16	O
]	O
and	O
that	O
the	O
parent	O
phenotype	O
vanishes	O
by	O
day	O
7	O
post	O
-	O
infection	O
[	O
16	O
]	O
.	O

CovR	S-Biological_Molecule
regulatory	O
activity	O
is	O
thought	O
to	O
be	O
triggered	O
when	O
the	O
protein	O
is	O
phosphorylated	O
at	O
D53	O
[	O
21	O
]	O
,	O
possibly	O
by	O
acetyl	B-Chemical_Compound
phosphate	E-Chemical_Compound
[	O
22	O
]	O
,	O
[	O
23	O
]	O
.	O

This	O
complexity	O
is	O
further	O
magnified	O
by	O
the	O
reported	O
strain	O
-	O
specific	O
differences	O
in	O
the	O
impact	O
of	O
CovS	S-Biological_Molecule
on	O
pathogenesis	O
[	O
24	O
]	O
,	O
by	O
the	O
finding	O
that	O
phosphorylated	O
CovR	S-Biological_Molecule
has	O
different	O
affinities	O
to	O
different	O
streptococcal	O
promoters	O
[	O
21	O
]	O
,	O
and	O
by	O
the	O
possibility	O
that	O
CovR	S-Biological_Molecule
promoter	O
binding	O
may	O
be	O
modulated	O
by	O
kinases	O
or	O
phosphatases	O
other	O
than	O
CovS	S-Biological_Molecule
[	O
25	O
]	O
.	O

In	O
accordance	O
with	O
these	O
biochemical	O
findings	O
,	O
we	O
and	O
others	O
have	O
reported	O
that	O
some	O
covS	S-Biological_Molecule
mutations	O
generate	O
hypervirulent	O
isolates	O
associated	O
with	O
invasive	O
forms	O
of	O
streptococcal	O
infection	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
28	O
]	O
.	O

One	O
of	O
the	O
most	O
striking	O
outcomes	O
of	O
these	O
mutations	O
is	O
the	O
constitutive	O
repression	O
of	O
a	O
gene	O
encoding	O
the	O
key	O
GAS	S-Species
cysteine	O
protease	O
,	O
SpeB	S-Biological_Molecule
,	O
which	O
remodels	O
the	O
host	O
-	O
pathogen	O
interface	O
[	O
29	O
]	O
by	O
differentially	O
degrading	O
bacterial	O
surface	O
and	O
secreted	O
proteins	O
[	O
12	O
]	O
,	O
[	O
30	O
]	O
,	O
[	O
31	O
]	O
as	O
well	O
as	O
host	O
proteins	O
[	O
32	O
]	O
,	O
[	O
33	O
]	O
,	O
[	O
34	O
]	O
.	O

One	O
of	O
these	O
preserved	O
factors	O
is	O
the	O
highly	O
potent	O
DNase	O
,	O
Sda1	S-Biological_Molecule
,	O
which	O
destroys	O
neutrophil	O
extracellular	O
traps	O
,	O
NETs	O
[	O
36	O
]	O
,	O
protecting	O
the	O
bacteria	O
from	O
neutrophil	O
killing	O
,	O
promoting	O
bacterial	O
invasion	O
,	O
and	O
facilitating	O
human	S-Species
plasminogen	S-Biological_Molecule
-	O
mediated	O
bacterial	O
dissemination	O
into	O
normally	O
sterile	O
sites	O
,	O
which	O
results	O
in	O
invasive	O
infections	O
[	O
14	O
]	O
.	O

Despite	O
the	O
association	O
between	O
covS	S-Biological_Molecule
mutations	O
and	O
the	O
emergence	O
of	O
the	O
hypervirulent	O
phenotype	O
of	O
M1T1	S-Species
strains	O
,	O
it	O
is	O
unclear	O
whether	O
this	O
increased	O
virulence	O
can	O
be	O
entirely	O
attributed	O
to	O
the	O
modulation	O
of	O
the	O
CovR	S-Biological_Molecule
regulon	O
or	O
if	O
other	O
networks	O
are	O
also	O
perturbed	O
in	O
vivo	O
directly	O
,	O
indirectly	O
,	O
or	O
independently	O
of	O
the	O
CovRS	S-Biological_Molecule
system	O
.	O

To	O
address	O
these	O
issues	O
and	O
improve	O
our	O
understanding	O
of	O
the	O
gene	O
regulatory	O
impact	O
of	O
mutational	O
and	O
adaptive	O
events	O
contributing	O
to	O
the	O
hypervirulent	O
phenotype	O
of	O
M1T1	S-Species
strains	O
,	O
we	O
analyzed	O
differences	O
in	O
growth	O
requirements	O
,	O
transcriptome	O
profiles	O
,	O
and	O
regulatory	O
circuits	O
of	O
the	O
virulent	O
(	O
WT	O
)	O
and	O
hypervirulent	O
(	O
AP	S-Species
)	O
phenotypes	O
of	O
the	O
M1T1	S-Species
strain	O
both	O
in	O
vitro	O
and	O
during	O
initial	O
in	O
vivo	O
infection	O
.	O

Such	O
comprehensive	O
analyses	O
highlighted	O
the	O
behavior	O
of	O
genomic	O
subsystems	O
that	O
may	O
be	O
involved	O
directly	O
or	O
indirectly	O
in	O
S	B-Species
.	I-Species
pyogenes	E-Species
niche	O
adaptation	O
and	O
pathogenesis	O
.	O

For	O
example	O
,	O
AP	S-Species
bacteria	O
grew	O
better	O
than	O
WT	O
bacteria	O
in	O
the	O
presence	O
of	O
N	B-Chemical_Compound
-	I-Chemical_Compound
acetyl	I-Chemical_Compound
-	I-Chemical_Compound
neuraminic	I-Chemical_Compound
acid	E-Chemical_Compound
,	O
and	O
were	O
more	O
sensitive	O
to	O
four	O
antimicrobials	O
(	O
out	O
of	O
373	O
screened	O
in	O
PM	O
)	O
,	O
including	O
the	O
calcium	O
-	O
specific	O
metal	O
chelator	O
EGTA	S-Chemical_Compound
,	O
the	O
lipophilic	O
chelator	O
5	B-Chemical_Compound
-	I-Chemical_Compound
chloro	I-Chemical_Compound
-	I-Chemical_Compound
7	I-Chemical_Compound
-	I-Chemical_Compound
iodo	I-Chemical_Compound
-	I-Chemical_Compound
8	I-Chemical_Compound
-	I-Chemical_Compound
hydroxyquinoline	E-Chemical_Compound
,	O
and	O
the	O
antibiotics	O
tobramycin	S-Chemical_Compound
and	O
cefotaxime	S-Chemical_Compound
(	O
Table	O
1	O
)	O
.	O

Minimal	O
media	O
are	O
not	O
optimal	O
for	O
the	O
expression	O
of	O
GAS	S-Species
proteins	O
,	O
which	O
may	O
explain	O
why	O
GAS	S-Species
failed	O
to	O
grow	O
at	O
many	O
of	O
the	O
PM	O
conditions	O
(	O
Fig	O
.	O
S1	O
)	O
and	O
why	O
fewer	O
phenotypic	O
differences	O
were	O
observed	O
between	O
WT	O
and	O
AP	S-Species
bacteria	O
than	O
transcriptomic	O
differences	O
(	O
see	O
below	O
)	O
.	O

Because	O
bacteria	O
recovered	O
from	O
animals	O
and	O
cultured	O
in	O
the	O
laboratory	O
are	O
likely	O
to	O
have	O
reprogrammed	O
many	O
regulatory	O
networks	O
to	O
re	O
-	O
adapt	O
to	O
the	O
in	O
vitro	O
growth	O
conditions	O
,	O
transcriptome	O
profiling	O
of	O
these	O
bacteria	O
may	O
not	O
reflect	O
their	O
actual	O
in	O
vivo	O
gene	O
expression	O
and	O
regulation	O
.	O

In	O
this	O
study	O
,	O
we	O
designed	O
and	O
performed	O
in	O
vivo	O
passage	O
experiments	O
in	O
which	O
equal	O
loads	O
of	O
in	O
vitro	O
-	O
grown	O
WT	O
and	O
AP	S-Species
bacteria	O
were	O
separately	O
inoculated	O
into	O
murine	S-Species
subcutaneous	O
chambers	O
[	O
16	O
]	O
and	O
collected	O
by	O
needle	O
aspiration	O
after	O
24	O
h	O
,	O
a	O
time	O
sufficient	O
for	O
the	O
bacteria	O
to	O
sense	O
the	O
host	O
environment	O
and	O
transcriptionally	O
respond	O
to	O
it	O
,	O
but	O
not	O
long	O
enough	O
to	O
allow	O
detectable	O
restructuring	O
of	O
the	O
bacterial	O
community	O
and	O
selection	O
of	O
mutants	O
.	O

The	O
concentrations	O
of	O
viable	O
WT	O
and	O
AP	S-Species
bacteria	O
at	O
24	O
h	O
post	O
-	O
inoculation	O
remained	O
essentially	O
the	O
same	O
:	O
1	O
-	O
5x109	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
)	O
/	O
ml	O
vs	O
.	O
approximately2x109	O
CFU	O
/	O
ml	O
inoculum	O
.	O

For	O
transcriptional	O
profiling	O
,	O
we	O
followed	O
a	O
cyclic	O
,	O
two	O
-	O
color	O
design	O
and	O
performed	O
28	O
oligonucleotide	O
microarray	O
hybridization	O
experiments	O
representing	O
technical	O
and	O
biological	O
replicates	O
of	O
the	O
four	O
cell	O
states	O
under	O
investigation	O
:	O
WT	O
grown	O
in	O
vitro	O
(	O
WT	O
-	O
vitro	O
)	O
,	O
WT	O
grown	O
in	O
vivo	O
(	O
WT	O
-	O
vivo	O
)	O
,	O
AP	S-Species
grown	O
in	O
vitro	O
(	O
AP	S-Species
-	O
vitro	O
)	O
,	O
and	O
AP	S-Species
grown	O
in	O
vivo	O
(	O
AP	S-Species
-	O
vivo	O
)	O
,	O
Fig	O
.	O

Multiple	O
approaches	O
to	O
microarray	O
analysis	O
show	O
statistically	O
significant	O
and	O
biologically	O
relevant	O
differences	O
between	O
the	O
WT	O
and	O
AP	S-Species
populations	O
in	O
vitro	O
and	O
in	O
vivo	O

To	O
gain	O
biologically	O
relevant	O
knowledge	O
from	O
the	O
transcriptome	O
studies	O
without	O
compromising	O
statistical	O
significance	O
,	O
we	O
interrogated	O
the	O
data	O
using	O
multiple	O
strategies	O
that	O
had	O
been	O
developed	O
for	O
microarray	O
analysis	O
and	O
visualization	O
,	O
taking	O
into	O
consideration	O
the	O
strengths	O
and	O
limitations	O
of	O
each	O
strategy	O
.	O

This	O
pathovivogram	O
highlights	O
the	O
transcriptional	O
patterns	O
that	O
distinguish	O
WT	O
from	O
AP	S-Species
bacteria	O
regardless	O
of	O
their	O
growth	O
habitat	O
(	O
pathogram	O
,	O
Fig	O
2	O
.	O
CC4	O
-	O
CC6	O
and	O
CC8	O
-	O
CC10	O
)	O
,	O
and	O
the	O
transcriptional	O
patterns	O
that	O
are	O
shared	O
by	O
WT	O
-	O
vitro	O
and	O
AP	S-Species
-	O
vitro	O
bacteria	O
but	O
that	O
differentiate	O
them	O
from	O
their	O
corresponding	O
in	O
vivo	O
samples	O
(	O
vivogram	O
,	O
Fig	O
.	O
2	O
,	O
CC1	O
-	O
CC3	O
)	O
.	O

The	O
patterns	O
in	O
clusters	O
CC1	O
-	O
CC3	O
describe	O
those	O
gene	O
sets	O
whose	O
transcription	O
was	O
turned	O
on	O
(	O
CC1	O
-	O
CC2	O
)	O
or	O
off	O
(	O
CC3	O
)	O
to	O
drive	O
the	O
bacterial	O
adaptation	O
to	O
the	O
host	O
environment	O
,	O
but	O
are	O
not	O
primarily	O
related	O
to	O
bacterial	O
pathogenesis	O
.	O

Such	O
transition	O
is	O
bound	O
to	O
have	O
major	O
downstream	O
effects	O
on	O
the	O
bacterial	O
virulence	O
gene	O
expression	O
[	O
38	O
]	O
,	O
[	O
39	O
]	O
,	O
[	O
40	O
]	O
.	O

While	O
the	O
expression	O
patterns	O
in	O
clusters	O
CC4	O
,	O
CC5	O
,	O
CC8	O
,	O
and	O
CC9	O
match	O
the	O
previously	O
described	O
in	O
vitro	O
differences	O
between	O
WT	O
and	O
AP	S-Species
strains	O
[	O
10	O
]	O
,	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
(	O
e	O
.	O
g	O
.	O
,	O
downregulation	O
of	O
SpeB	S-Biological_Molecule
,	O
CAMP	S-Biological_Molecule
,	O
and	O
EndoS	S-Biological_Molecule
genes	O
;	O
upregulation	O
of	O
SpeA	S-Biological_Molecule
,	O
SIC	S-Biological_Molecule
,	O
and	O
capsule	O
genes	O
)	O
,	O
the	O
combined	O
comparative	O
analysis	O
of	O
in	O
vitro	O
and	O
in	O
vivo	O
samples	O
revealed	O
novel	O
expression	O
patterns	O
exemplified	O
by	O
CC6	O
and	O
CC10	O
.	O

For	O
example	O
,	O
the	O
expression	O
of	O
genes	O
in	O
the	O
SLS	O
and	O
Trx	O
operons	O
is	O
induced	O
in	O
vivo	O
only	O
in	O
WT	O
bacteria	O
,	O
but	O
is	O
mostly	O
repressed	O
in	O
AP	S-Species
bacteria	O
(	O
Fig	O
.	O
2	O
,	O
CC6	O
)	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Likewise	O
,	O
some	O
genes	O
are	O
only	O
induced	O
in	O
AP	S-Species
-	O
vivo	O
,	O
including	O
those	O
encoding	O
the	O
toxin	O
/	O
enzyme	O
streptokinase	O
and	O
a	O
RofA	S-Biological_Molecule
/	O
Nra	S-Biological_Molecule
-	O
like	O
transcriptional	O
regulator	O
(	O
Fig	O
.	O
2	O
,	O
CC10	O
)	O
.	O

Subsequent	O
to	O
the	O
coexpression	O
analysis	O
,	O
we	O
calculated	O
differential	O
expression	O
ratios	O
between	O
each	O
pair	O
of	O
conditions	O
(	O
Table	O
S2	O
)	O
at	O
different	O
statistical	O
significance	O
cutoffs	O
,	O
starting	O
by	O
the	O
commonly	O
used	O
significance	O
threshold	O
of	O
twofold	O
ratio	O
and	O
P	O
value	O
<	O
0	O
.	O
05	O
,	O
and	O
moving	O
to	O
thresholds	O
that	O
are	O
more	O
conservative	O
.	O

At	O
all	O
significance	O
cutoffs	O
,	O
the	O
fewest	O
observed	O
transcriptional	O
changes	O
were	O
those	O
differentiating	O
WT	O
and	O
AP	S-Species
bacteria	O
in	O
vitro	O
compared	O
to	O
other	O
pairs	O
of	O
conditions	O
.	O

Overall	O
,	O
at	O
the	O
least	O
conservative	O
statistical	O
threshold	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
the	O
transcription	O
of	O
557	O
(	O
23	O
.	O
9	O
%	O
)	O
out	O
of	O
2	O
,	O
329	O
genes	O
probed	O
in	O
the	O
microarrays	O
was	O
significantly	O
perturbed	O
(	O
up	O
or	O
down	O
,	O
at	O
one	O
or	O
more	O
conditions	O
,	O
Fig	O
.	O
S3	O
)	O
and	O
the	O
only	O
set	O
of	O
contiguous	O
genes	O
that	O
underwent	O
transcriptional	O
changes	O
at	O
all	O
tested	O
conditions	O
is	O
the	O
SpeB	S-Biological_Molecule
operon	O
gene	O
set	O
(	O
CC4	O
in	O
Fig	O
.	O
2	O
)	O
.	O

Inspired	O
by	O
the	O
recently	O
described	O
neighbor	O
clustering	O
method	O
for	O
microarray	O
analysis	O
[	O
41	O
]	O
,	O
we	O
also	O
mapped	O
the	O
significant	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
differential	O
expression	O
ratios	O
of	O
different	O
genes	O
to	O
their	O
chromosomal	O
loci	O
(	O
Fig	O
.	O
3	O
and	O
Fig	O
.	O
S4	O
)	O
to	O
allow	O
the	O
visualization	O
of	O
coexpressed	O
contiguous	O
genes	O
,	O
including	O
operons	O
.	O

This	O
mapping	O
highlighted	O
genes	O
that	O
might	O
otherwise	O
have	O
been	O
overlooked	O
by	O
the	O
CC	O
or	O
expression	O
ratio	O
methods	O
.	O

A	O
subsystem	O
is	O
a	O
part	O
of	O
a	O
genome	O
that	O
represents	O
a	O
functional	O
module	O
,	O
e	O
.	O
g	O
.	O
,	O
an	O
operon	O
,	O
a	O
cellular	O
pathway	O
,	O
a	O
regulon	O
,	O
or	O
a	O
complex	O
regulatory	O
network	O
[	O
43	O
]	O
.	O

Of	O
interest	O
,	O
among	O
the	O
genes	O
of	O
known	O
function	O
,	O
25	O
%	O
of	O
those	O
whose	O
transcription	O
was	O
modulated	O
as	O
a	O
consequence	O
of	O
the	O
covS	S-Biological_Molecule
mutation	O
are	O
virulence	O
-	O
related	O
and	O
another	O
25	O
%	O
are	O
related	O
to	O
carbohydrate	O
metabolism	O
pathways	O
,	O
which	O
are	O
connected	O
to	O
virulence	O
in	O
streptococci	S-Species
[	O
44	O
]	O
,	O
[	O
45	O
]	O
,	O
[	O
46	O
]	O
.	O

When	O
we	O
attempted	O
to	O
correlate	O
the	O
array	O
results	O
with	O
known	O
GAS	S-Species
regulons	O
,	O
some	O
differentially	O
expressed	O
gene	O
sets	O
could	O
be	O
fitted	O
into	O
previously	O
described	O
regulatory	O
networks	O
while	O
others	O
did	O
not	O
belong	O
to	O
any	O
such	O
networks	O
.	O

Alternatively	O
,	O
the	O
mutation	O
in	O
covS	S-Biological_Molecule
may	O
have	O
different	O
effects	O
on	O
CovR	S-Biological_Molecule
-	O
mediated	O
regulation	O
of	O
different	O
genes	O
[	O
26	O
]	O
.	O

In	O
fact	O
,	O
our	O
in	O
vivo	O
data	O
show	O
that	O
covR	S-Biological_Molecule
itself	O
is	O
downregulated	O
in	O
vivo	O
in	O
both	O
WT	O
and	O
AP	S-Species
strains	O
(	O
Fig	O
.	O
2	O
,	O
CC2	O
and	O
Table	O
S1	O
)	O
;	O
however	O
,	O
the	O
SLS	O
operon	O
is	O
upregulated	O
in	O
vivo	O
in	O
WT	O
bacteria	O
,	O
suggesting	O
that	O
its	O
regulation	O
is	O
not	O
solely	O
modulated	O
by	O
CovRS	S-Biological_Molecule
.	O

The	O
TrxRS	S-Biological_Molecule
system	O
reportedly	O
responds	O
to	O
a	O
yet	O
-	O
to	O
-	O
be	O
-	O
identified	O
extracellular	O
signal	O
while	O
TrxR	S-Biological_Molecule
itself	O
is	O
directly	O
regulated	O
by	O
CovR	S-Biological_Molecule
[	O
42	O
]	O
.	O

Inactivation	O
or	O
downregulation	O
of	O
one	O
regulator	O
may	O
eventually	O
perturb	O
the	O
entire	O
system	O
,	O
and	O
several	O
other	O
regulators	O
are	O
likely	O
to	O
become	O
engaged	O
in	O
compensatory	O
mechanisms	O
to	O
maintain	O
cellular	O
homeostasis	O
.	O

Discussion	O

Normally	O
,	O
capturing	O
such	O
evolutionary	O
events	O
in	O
real	O
time	O
is	O
difficult	O
,	O
both	O
because	O
multiple	O
sampling	O
of	O
the	O
bacteria	O
in	O
vivo	O
is	O
often	O
unfeasible	O
due	O
to	O
their	O
dissemination	O
,	O
and	O
because	O
the	O
fittest	O
members	O
of	O
the	O
community	O
usually	O
overtake	O
the	O
rest	O
of	O
the	O
population	O
rather	O
rapidly	O
,	O
thereby	O
hampering	O
the	O
ability	O
to	O
capture	O
dynamic	O
changes	O
associated	O
with	O
the	O
restructuring	O
of	O
the	O
bacterial	O
community	O
at	O
different	O
host	O
niches	O
.	O

In	O
vitro	O
,	O
the	O
growth	O
of	O
these	O
two	O
variants	O
of	O
the	O
M1T1	S-Species
bacteria	O
was	O
comparable	O
and	O
,	O
although	O
137	O
(	O
5	O
.	O
9	O
%	O
)	O
of	O
their	O
genes	O
were	O
differentially	O
expressed	O
(	O
Table	O
2	O
)	O
,	O
in	O
vitro	O
phenotypic	O
screening	O
revealed	O
negligible	O
differences	O
(	O
Table	O
1	O
)	O
.	O

Indeed	O
,	O
several	O
virulence	O
genes	O
were	O
among	O
the	O
137	O
in	O
vitro	O
differentially	O
expressed	O
genes	O
between	O
these	O
two	O
M1T1	S-Species
variants	O
.	O

Besides	O
metabolic	O
gene	O
sets	O
involved	O
in	O
trehalose	S-Chemical_Compound
and	O
ascorbate	S-Chemical_Compound
utilization	O
,	O
several	O
known	O
virulence	O
factors	O
were	O
downregulated	O
in	O
AP	S-Species
bacteria	O
,	O
and	O
these	O
included	O
the	O
SpeB	S-Biological_Molecule
operon	O
,	O
GRAB	S-Biological_Molecule
,	O
EndoS	S-Biological_Molecule
,	O
and	O
CAMP	O
factor	O
.	O

SpeB	S-Biological_Molecule
is	O
a	O
major	O
virulence	O
factor	O
in	O
GAS	S-Species
pathogenesis	O
and	O
its	O
expression	O
is	O
regulated	O
by	O
different	O
systems	O
[	O
40	O
]	O
,	O
[	O
56	O
]	O
,	O
[	O
57	O
]	O
,	O
[	O
58	O
]	O
,	O
including	O
the	O
CovRS	S-Biological_Molecule
system	O
[	O
20	O
]	O
,	O
[	O
53	O
]	O
.	O

Their	O
downregulation	O
in	O
AP	S-Species
is	O
thus	O
consistent	O
with	O
the	O
hypothesis	O
that	O
this	O
hypervirulent	O
variant	O
is	O
adapted	O
for	O
deep	O
infection	O
.	O

In	O
addition	O
,	O
the	O
downregulation	O
of	O
SpeB	S-Biological_Molecule
,	O
EndoS	S-Biological_Molecule
,	O
and	O
CAMP	O
is	O
in	O
agreement	O
with	O
our	O
previous	O
proteomic	O
results	O
[	O
12	O
]	O
as	O
well	O
as	O
other	O
published	O
transcriptional	O
analyses	O
[	O
13	O
]	O
,	O
[	O
27	O
]	O
.	O

As	O
both	O
bacterial	O
variants	O
were	O
subjected	O
to	O
the	O
host	O
environment	O
,	O
they	O
underwent	O
additional	O
changes	O
in	O
gene	O
expression	O
.	O

By	O
parsing	O
these	O
differentially	O
expressed	O
genes	O
into	O
operons	O
,	O
subsystems	O
,	O
and	O
functional	O
pathways	O
,	O
we	O
found	O
that	O
many	O
reflect	O
the	O
engagement	O
of	O
several	O
regulatory	O
networks	O
involved	O
in	O
metabolic	O
adaptation	O
and	O
immune	O
camouflage	O
or	O
evasion	O
of	O
host	O
defenses	O
.	O

Many	O
of	O
the	O
in	O
vivo	O
changes	O
that	O
both	O
the	O
WT	O
and	O
AP	S-Species
bacteria	O
underwent	O
are	O
suggestive	O
of	O
major	O
metabolic	O
reprogramming	O
associated	O
with	O
the	O
transition	O
from	O
a	O
saprophytic	O
lifestyle	O
in	O
the	O
carbohydrate	O
-	O
rich	O
laboratory	O
culture	O
medium	O
to	O
a	O
parasitic	O
lifestyle	O
in	O
the	O
vascularized	O
and	O
the	O
anaerobic	O
subcutaneous	O
environments	O
rich	O
in	O
peptides	O
,	O
amino	O
acids	O
,	O
nucleotides	O
,	O
and	O
different	O
types	O
of	O
complex	O
carbohydrates	O
.	O

The	O
downregulation	O
of	O
arginine	O
deiminase	O
,	O
a	O
streptococcal	O
immunogen	O
and	O
a	O
potential	O
vaccine	O
target	O
(	O
Henningham	O
et	O
al	O
.	O
,	O
submitted	O
)	O
,	O
is	O
also	O
suggestive	O
of	O
immune	O
evasion	O
.	O

Several	O
phage	O
genes	O
are	O
split	O
between	O
the	O
upregulated	O
and	O
downregulated	O
gene	O
clusters	O
;	O
this	O
may	O
indicate	O
a	O
stress	O
-	O
dependent	O
reprogramming	O
of	O
prophage	O
induction	O
and	O
gene	O
expression	O
that	O
needs	O
to	O
be	O
explored	O
in	O
future	O
studies	O
.	O

On	O
the	O
other	O
hand	O
,	O
genes	O
encoding	O
the	O
fibrinolytic	O
enzyme	O
streptokinase	O
,	O
Ska	S-Biological_Molecule
,	O
a	O
RofA	S-Biological_Molecule
-	O
like	O
transcriptional	O
regulator	O
,	O
several	O
cell	O
division	O
proteins	O
,	O
and	O
some	O
phage	O
proteins	O
were	O
only	O
upregulated	O
when	O
the	O
AP	S-Species
bacteria	O
sensed	O
the	O
in	O
vivo	O
environment	O
(	O
AP	S-Species
-	O
vivo	O
,	O
Fig	O
.	O
2	O
,	O
CC10	O
)	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrate	O
how	O
the	O
murine	S-Species
model	O
has	O
allowed	O
us	O
to	O
finely	O
dissect	O
two	O
classes	O
of	O
events	O
affecting	O
GAS	S-Species
sociomicrobiology	O
:	O
those	O
related	O
to	O
reversible	O
transcriptional	O
adaptation	O
and	O
those	O
irreversibly	O
caused	O
by	O
the	O
covS	S-Biological_Molecule
mutation	O
in	O
AP	S-Species
bacteria	O
.	O

Comparing	O
the	O
microarray	O
data	O
in	O
this	O
study	O
with	O
previously	O
published	O
work	O
provides	O
further	O
validation	O
of	O
these	O
results	O
.	O

For	O
example	O
,	O
the	O
in	O
vitro	O
microarray	O
results	O
are	O
consistent	O
with	O
our	O
previous	O
proteomic	O
studies	O
of	O
the	O
WT	O
and	O
AP	S-Species
secreted	O
bacterial	O
proteomes	O
[	O
12	O
]	O
as	O
well	O
as	O
with	O
other	O
recently	O
published	O
studies	O
of	O
the	O
in	O
vitro	O
transcriptome	O
of	O
closely	O
related	O
strains	O
[	O
13	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
.	O

It	O
also	O
allowed	O
us	O
to	O
dissect	O
changes	O
related	O
to	O
niche	O
adaptation	O
from	O
those	O
reflecting	O
the	O
selection	O
of	O
the	O
fittest	O
members	O
of	O
the	O
bacterial	O
community	O
when	O
faced	O
with	O
different	O
environments	O
and	O
conditions	O
.	O

The	O
use	O
of	O
multiple	O
microarray	O
analysis	O
strategies	O
and	O
the	O
integration	O
of	O
their	O
results	O
strengthened	O
this	O
study	O
since	O
each	O
strategy	O
has	O
advantages	O
and	O
disadvantages	O
.	O

For	O
example	O
,	O
coexpression	O
clustering	O
-	O
one	O
of	O
the	O
earliest	O
developed	O
microarray	O
analysis	O
tools	O
[	O
62	O
]	O
,	O
[	O
63	O
]	O
-	O
provides	O
an	O
overall	O
view	O
of	O
expression	O
patterns	O
of	O
different	O
genes	O
,	O
and	O
greatly	O
helps	O
dissect	O
and	O
demonstrate	O
the	O
effect	O
of	O
each	O
condition	O
on	O
the	O
overall	O
transcriptome	O
.	O

Besides	O
these	O
two	O
clustering	O
methods	O
,	O
expression	O
ratios	O
provided	O
pairwise	O
comparison	O
,	O
thereby	O
allowing	O
the	O
quantification	O
of	O
the	O
impact	O
of	O
each	O
individual	O
change	O
of	O
condition	O
on	O
overall	O
gene	O
expression	O
(	O
Table	O
2	O
)	O
as	O
well	O
as	O
on	O
specific	O
genes	O
of	O
interest	O
(	O
Table	O
3	O
)	O
.	O

However	O
,	O
the	O
use	O
of	O
ratios	O
alone	O
may	O
be	O
misleading	O
,	O
especially	O
when	O
they	O
are	O
calculated	O
between	O
two	O
transcripts	O
with	O
low	O
expression	O
levels	O
,	O
resulting	O
in	O
spurious	O
ratios	O
of	O
low	O
biological	O
significance	O
.	O

The	O
bigger	O
picture	O
:	O
niche	O
adaptation	O
and	O
the	O
evolution	O
of	O
hypervirulence	O
in	O
S	B-Species
.	I-Species
pyogenes	E-Species

However	O
,	O
many	O
of	O
the	O
genes	O
modulated	O
in	O
vivo	O
seem	O
to	O
be	O
involved	O
in	O
metabolic	O
reprogramming	O
and	O
stress	O
responses	O
rather	O
than	O
pathoadaptation	O
and	O
virulence	O
.	O

This	O
is	O
why	O
we	O
believe	O
that	O
transcriptional	O
reprogramming	O
by	O
environmental	O
adaptation	O
alone	O
was	O
insufficient	O
to	O
provide	O
WT	O
bacteria	O
with	O
an	O
in	O
vivo	O
survival	O
advantage	O
.	O

However	O
,	O
the	O
degree	O
of	O
AP	S-Species
invasiveness	O
might	O
vary	O
depending	O
on	O
the	O
route	O
of	O
infection	O
and	O
animal	O
model	O
[	O
15	O
]	O
.	O

It	O
is	O
noteworthy	O
that	O
SpeB	S-Biological_Molecule
expression	O
has	O
a	O
dominant	O
effect	O
,	O
since	O
even	O
if	O
secreted	O
in	O
low	O
amounts	O
by	O
a	O
minor	O
subpopulation	O
,	O
this	O
broad	O
-	O
spectrum	O
protease	O
would	O
still	O
be	O
able	O
to	O
degrade	O
,	O
fully	O
or	O
partially	O
,	O
many	O
GAS	S-Species
virulence	O
proteins	O
,	O
including	O
Sda1	S-Biological_Molecule
,	O
thereby	O
rendering	O
the	O
bacteria	O
vulnerable	O
to	O
different	O
effector	O
mechanisms	O
of	O
the	O
host	O
'	O
s	O
innate	O
immune	O
system	O
including	O
neutrophil	O
killing	O
[	O
14	O
]	O
,	O
[	O
67	O
]	O
,	O
[	O
68	O
]	O
.	O

Thus	O
,	O
a	O
complete	O
shutdown	O
of	O
proteolytically	O
active	O
SpeB	S-Biological_Molecule
is	O
essential	O
to	O
preserve	O
effective	O
extracellular	O
virulence	O
factors	O
[	O
15	O
]	O
.	O

However	O
,	O
the	O
CovRS	S-Biological_Molecule
system	O
is	O
a	O
major	O
player	O
,	O
among	O
these	O
regulators	O
,	O
in	O
driving	O
the	O
bacterial	O
adaptation	O
to	O
the	O
host	O
'	O
s	O
environment	O
and	O
regulating	O
virulence	O
directly	O
or	O
through	O
other	O
downstream	O
regulators	O
[	O
20	O
]	O
,	O
[	O
54	O
]	O
.	O

It	O
is	O
thus	O
counterintuitive	O
that	O
bacteria	O
lacking	O
the	O
important	O
environmental	O
sensor	O
,	O
CovS	S-Biological_Molecule
,	O
would	O
prevail	O
in	O
one	O
of	O
the	O
most	O
stressful	O
environments	O
.	O

However	O
,	O
losing	O
this	O
sensor	O
might	O
be	O
the	O
last	O
resort	O
for	O
these	O
bacteria	O
stranded	O
away	O
from	O
their	O
primary	O
niche	O
and	O
surrounded	O
by	O
hostile	O
immune	O
cells	O
and	O
proteins	O
.	O

Such	O
mutation	O
is	O
likely	O
detrimental	O
to	O
the	O
bacterial	O
long	O
-	O
term	O
survival	O
and	O
dissemination	O
via	O
colonization	O
of	O
new	O
hosts	O
[	O
71	O
]	O
,	O
as	O
they	O
need	O
a	O
WT	O
sensor	O
for	O
better	O
adaptability	O
[	O
72	O
]	O
(	O
e	O
.	O
g	O
.	O
,	O
in	O
less	O
hostile	O
niches	O
like	O
throat	O
or	O
saliva	O
[	O
26	O
]	O
)	O
.	O

An	O
intact	O
CovRS	S-Biological_Molecule
system	O
would	O
offer	O
the	O
bacteria	O
enough	O
versatility	O
to	O
turn	O
on	O
and	O
off	O
many	O
regulatory	O
networks	O
through	O
CovS	S-Biological_Molecule
signaling	O
.	O

(	O
4	O
)	O
We	O
also	O
show	O
that	O
the	O
impact	O
of	O
the	O
covS	S-Biological_Molecule
mutation	O
goes	O
beyond	O
the	O
defined	O
CovR	S-Biological_Molecule
regulon	O
.	O

This	O
finding	O
is	O
in	O
accordance	O
with	O
previous	O
observations	O
that	O
CovR	S-Biological_Molecule
and	O
CovS	S-Biological_Molecule
are	O
not	O
committed	O
to	O
each	O
other	O
,	O
as	O
CovR	S-Biological_Molecule
could	O
be	O
phosphorylated	O
in	O
the	O
absence	O
of	O
a	O
functional	O
CovS	S-Biological_Molecule
[	O
22	O
]	O
and	O
as	O
different	O
covS	S-Biological_Molecule
mutations	O
,	O
albeit	O
clustered	O
in	O
the	O
histidine	O
kinase	O
domain	O
,	O
might	O
have	O
different	O
transcriptional	O
effects	O
[	O
27	O
]	O
,	O
including	O
opposite	O
effects	O
on	O
different	O
members	O
of	O
the	O
CovR	S-Biological_Molecule
regulon	O
[	O
26	O
]	O
.	O

We	O
believe	O
that	O
our	O
results	O
offer	O
a	O
proof	O
of	O
principle	O
that	O
in	O
vivo	O
-	O
extracted	O
RNA	O
can	O
provide	O
transcriptional	O
profiles	O
that	O
better	O
reflect	O
the	O
complexity	O
of	O
heterogeneous	O
bacterial	O
communities	O
,	O
and	O
,	O
as	O
shown	O
in	O
this	O
study	O
,	O
can	O
provide	O
a	O
transcriptional	O
snapshot	O
of	O
a	O
bacterial	O
population	O
right	O
before	O
its	O
extinction	O
.	O

The	O
use	O
of	O
in	O
vivo	O
-	O
driven	O
RNA	O
in	O
understanding	O
virulence	O
has	O
been	O
appreciated	O
in	O
streptococcal	O
research	O
[	O
73	O
]	O
,	O
but	O
the	O
technique	O
has	O
not	O
previously	O
been	O
used	O
to	O
explain	O
the	O
switch	O
to	O
hypervirulent	O
,	O
invasive	O
phenotypes	O
or	O
to	O
dissect	O
heterogeneous	O
microbial	O
subpopulations	O
.	O

This	O
study	O
is	O
a	O
first	O
step	O
towards	O
exploring	O
the	O
sociomicrobiology	O
of	O
invasive	O
GAS	S-Species
in	O
vivo	O
.	O

Having	O
captured	O
snapshots	O
of	O
different	O
transcriptional	O
programs	O
within	O
the	O
same	O
bacterial	O
community	O
,	O
we	O
plan	O
to	O
follow	O
with	O
single	O
cell	O
studies	O
[	O
74	O
]	O
,	O
[	O
75	O
]	O
of	O
bacteria	O
associated	O
with	O
immune	O
cells	O
to	O
further	O
dissect	O
the	O
different	O
roles	O
played	O
by	O
members	O
of	O
the	O
same	O
bacterial	O
community	O
.	O

Inactivation	O
of	O
DNA	O
-	O
Binding	O
Response	O
Regulator	O
Sak189	S-Biological_Molecule
Abrogates	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
Antigen	E-Biological_Molecule
Expression	O
and	O
Affects	O
Virulence	O
of	O
Streptococcus	B-Species
agalactiae	E-Species

Background	O
Streptococcus	B-Species
agalactiae	E-Species
is	O
able	O
to	O
colonize	O
numerous	O
tissues	O
employing	O
different	O
mechanisms	O
of	O
gene	O
regulation	O
,	O
particularly	O
via	O
two	O
-	O
component	O
regulatory	O
systems	O
.	O

In	O
S	B-Species
.	I-Species
agalactiae	E-Species
genome	O
,	O
it	O
was	O
adjacent	O
to	O
the	O
bac	S-Biological_Molecule
gene	O
encoding	O
for	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
antigen	E-Biological_Molecule
,	O
an	O
important	O
virulence	O
factor	O
.	O

Methodology	O
/	O
Principal	O
Findings	O
In	O
this	O
study	O
,	O
the	O
sak188	S-Biological_Molecule
and	O
sak189	S-Biological_Molecule
genes	O
were	O
inactivated	O
,	O
and	O
the	O
functional	O
role	O
of	O
Sak188	S-Biological_Molecule
/	O
Sak189	S-Biological_Molecule
two	O
-	O
component	O
system	O
in	O
regulation	O
of	O
the	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
antigen	E-Biological_Molecule
expression	O
was	O
investigated	O
.	O

It	O
was	O
demonstrated	O
that	O
both	O
transcription	O
of	O
bac	S-Biological_Molecule
gene	O
and	O
expression	O
of	O
encoded	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
antigen	E-Biological_Molecule
were	O
controlled	O
by	O
Sak189	S-Biological_Molecule
response	O
regulator	O
,	O
but	O
not	O
Sak188	S-Biological_Molecule
histidine	O
kinase	O
.	O

It	O
was	O
also	O
found	O
that	O
the	O
regulation	O
occurred	O
at	O
transcriptional	O
level	O
.	O

Conclusions	O
/	O
Significance	O
Sak189	S-Biological_Molecule
response	O
regulator	O
is	O
necessary	O
for	O
activation	O
of	O
bac	S-Biological_Molecule
gene	O
transcription	O
.	O

Given	O
that	O
the	O
primary	O
functional	O
role	O
of	O
Sak188	S-Biological_Molecule
/	O
Sak189	S-Biological_Molecule
two	O
-	O
component	O
systems	O
is	O
a	O
control	O
of	O
bac	S-Biological_Molecule
gene	O
transcription	O
,	O
this	O
system	O
can	O
be	O
annotated	O
as	O
BgrR	S-Biological_Molecule
/	O
S	S-Biological_Molecule
(	O
bac	S-Biological_Molecule
gene	O
regulatory	O
system	O
)	O
.	O

Introduction	O

Streptococcus	B-Species
agalactiae	E-Species
(	O
group	B-Species
B	I-Species
streptococcus	E-Species
)	O
is	O
an	O
important	O
cause	O
of	O
neonatal	O
invasive	O
infections	O
and	O
variety	O
of	O
diseases	O
in	O
human	S-Species
and	O
animals	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

One	O
mechanism	O
for	O
adaptation	O
to	O
changing	O
environment	O
is	O
transcriptional	O
regulation	O
by	O
two	O
-	O
component	O
regulatory	O
systems	O
(	O
TCSs	O
)	O
,	O
a	O
family	O
of	O
systems	O
that	O
are	O
widely	O
distributed	O
among	O
many	O
bacterial	O
genera	O
[	O
3	O
]	O
.	O

These	O
regulatory	O
systems	O
comprise	O
two	O
proteins	O
,	O
sensor	O
histidine	O
kinase	O
,	O
HK	O
,	O
and	O
DNA	O
-	O
binding	O
response	O
regulator	O
,	O
RR	O
.	O

HK	O
is	O
a	O
sensor	O
protein	O
,	O
responding	O
to	O
the	O
environmental	O
changes	O
by	O
autophosphorylating	O
a	O
conserved	O
histidine	O
residue	O
.	O

Conformationally	O
modified	O
RR	O
molecule	O
functions	O
as	O
transcriptional	O
regulator	O
(	O
activator	O
or	O
repressor	O
)	O
by	O
binding	O
with	O
promoter	O
regions	O
of	O
the	O
genes	O
through	O
helix	O
-	O
turn	O
-	O
helix	O
(	O
HTH	O
)	O
motif	O
.	O

For	O
example	O
,	O
20	O
TCSs	O
have	O
been	O
identified	O
after	O
the	O
complete	O
genome	O
sequencing	O
in	O
the	O
strain	O
NEM316	S-Species
[	O
6	O
]	O
,	O
and	O
17	O
TCSs	O
-	O
in	O
the	O
strain	B-Species
2603	I-Species
V	I-Species
/	I-Species
R	E-Species
[	O
7	O
]	O
.	O

Inactivation	O
of	O
CovRS	S-Biological_Molecule
was	O
also	O
observed	O
at	O
phenotypic	O
level	O
:	O
the	O
mutant	O
strains	O
became	O
less	O
virulent	O
compared	O
to	O
the	O
parental	O
wild	O
-	O
type	O
strain	O
[	O
9	O
]	O
.	O

Transcriptome	O
analysis	O
revealed	O
the	O
CovRS	S-Biological_Molecule
core	O
-	O
regulon	O
which	O
consisted	O
of	O
39	O
genes	O
including	O
genes	O
of	O
the	O
stress	O
response	O
,	O
the	O
genes	O
important	O
for	O
adhesion	O
of	O
S	B-Species
.	I-Species
agalactiae	E-Species
to	O
the	O
host	O
cells	O
and	O
others	O
[	O
10	O
]	O
.	O

In	O
addition	O
,	O
inactivation	O
of	O
histidine	O
kinase	O
gene	O
rgfC	S-Biological_Molecule
resulted	O
in	O
increased	O
transcription	O
of	O
scpB	S-Biological_Molecule
gene	O
[	O
12	O
]	O
.	O

Recently	O
,	O
putative	O
two	O
-	O
component	O
regulatory	O
system	O
genes	O
encoding	O
for	O
sensor	O
histidine	O
kinase	O
(	O
sak188	S-Biological_Molecule
)	O
and	O
DNA	O
-	O
binding	O
response	O
regulator	O
(	O
sak189	S-Biological_Molecule
)	O
were	O
identified	O
in	O
S	B-Species
.	I-Species
agalactiae	I-Species
strains	I-Species
98	I-Species
-	I-Species
D60C	E-Species
and	O
A909	S-Species
[	O
13	O
]	O
,	O
[	O
14	O
]	O
.	O

This	O
surface	O
protein	O
has	O
capacity	O
to	O
bind	O
IgA	S-Biological_Molecule
and	O
factor	B-Biological_Molecule
H	E-Biological_Molecule
of	O
complement	O
,	O
and	O
it	O
is	O
supposed	O
to	O
be	O
an	O
important	O
virulence	O
factor	O
[	O
15	O
]	O
.	O

Sak188	S-Biological_Molecule
and	O
Sak189	S-Biological_Molecule
proteins	O
revealed	O
78	O
%	O
and	O
83	O
%	O
similarity	O
with	O
sensor	O
histidine	O
kinase	O
HK06	S-Biological_Molecule
and	O
DNA	O
-	O
binding	O
response	O
regulator	O
RR06	S-Biological_Molecule
of	O
S	B-Species
.	I-Species
pneumoniae	E-Species
strains	O
,	O
respectively	O
[	O
13	O
]	O
,	O
[	O
16	O
]	O
-	O
[	O
19	O
]	O
.	O

In	O
S	B-Species
.	I-Species
pneumoniae	E-Species
genome	O
,	O
the	O
hk06	S-Biological_Molecule
and	O
rr06	S-Biological_Molecule
genes	O
are	O
adjacent	O
to	O
cbpA	S-Biological_Molecule
gene	O
encoding	O
choline	S-Chemical_Compound
binding	O
protein	O
,	O
CbpA	S-Biological_Molecule
,	O
a	O
surface	O
-	O
exposed	O
protective	O
antigen	O
and	O
virulence	O
factor	O
of	O
S	B-Species
.	I-Species
pneumoniae	E-Species
[	O
20	O
]	O
,	O
[	O
21	O
]	O
.	O

In	O
addition	O
,	O
some	O
regions	O
of	O
CbpA	S-Biological_Molecule
protein	O
has	O
the	O
certain	O
similarity	O
with	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
antigen	E-Biological_Molecule
.	O

Given	O
the	O
certain	O
similarity	O
in	O
the	O
sequences	O
,	O
functions	O
and	O
relative	O
locations	O
of	O
Sak188	S-Biological_Molecule
/	O
Sak189	S-Biological_Molecule
and	O
HK06	S-Biological_Molecule
/	O
RR06	S-Biological_Molecule
,	O
and	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
antigen	E-Biological_Molecule
and	O
CbpA	S-Biological_Molecule
,	O
we	O
suggested	O
that	O
Sak188	S-Biological_Molecule
/	O
Sak189	S-Biological_Molecule
TCS	O
affected	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
antigen	E-Biological_Molecule
expression	O
and	O
virulent	O
properties	O
of	O
S	B-Species
.	I-Species
agalactiae	E-Species
in	O
the	O
same	O
manner	O
as	O
HK06	S-Biological_Molecule
/	O
RR06	S-Biological_Molecule
affected	O
CbpA	S-Biological_Molecule
in	O
S	B-Species
.	I-Species
pneumoniae	E-Species
.	O

Results	O

An	O
occurrence	O
of	O
bac	S-Biological_Molecule
gene	O
,	O
sak188	S-Biological_Molecule
,	O
sak189	S-Biological_Molecule
TCS	O
genes	O
and	O
erythromycin	S-Chemical_Compound
resistance	O
among	O
S	B-Species
.	I-Species
agalactiae	I-Species
strains	E-Species
A	O
total	O
of	O
239	O
S	B-Species
.	I-Species
agalactiae	E-Species
strains	O
isolated	O
from	O
human	S-Species
and	O
animals	O
were	O
studied	O
.	O

They	O
were	O
selected	O
for	O
further	O
study	O
.	O

PCR	O
analysis	O
of	O
the	O
bac	S-Biological_Molecule
gene	O
positive	O
strains	O
revealed	O
that	O
the	O
presence	O
of	O
bac	S-Biological_Molecule
gene	O
correlated	O
with	O
the	O
presence	O
of	O
sensor	O
histidine	O
kinase	O
gene	O
sak188	S-Biological_Molecule
and	O
DNA	O
-	O
binding	O
response	O
regulator	O
gene	O
sak189	S-Biological_Molecule
(	O
data	O
not	O
shown	O
)	O
.	O

Genomic	O
architecture	O
of	O
DNA	O
fragments	O
containing	O
sak188	S-Biological_Molecule
,	O
sak189	S-Biological_Molecule
and	O
bac	S-Biological_Molecule
genes	O
in	O
S	B-Species
.	I-Species
agalactiae	E-Species
[	O
13	O
]	O
,	O
[	O
14	O
]	O
,	O
and	O
rr06	S-Biological_Molecule
,	O
hk06	S-Biological_Molecule
and	O
cbpA	S-Biological_Molecule
genes	O
in	O
S	B-Species
.	I-Species
pneumoniae	E-Species
[	O
22	O
]	O
is	O
presented	O
in	O
the	O
Fig	O
.	O

1	O
.	O

Construction	O
and	O
characterization	O
of	O
mutant	O
strains	O

To	O
investigate	O
a	O
functional	O
role	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
Sak188	S-Biological_Molecule
/	O
Sak189	S-Biological_Molecule
in	O
S	B-Species
.	I-Species
agalactiae	E-Species
,	O
the	O
sak188	S-Biological_Molecule
and	O
sak189	S-Biological_Molecule
genes	O
were	O
inactivated	O
by	O
insertional	O
mutagenesis	O
(	O
Fig	O
.	O
2	O
)	O
.	O

PCR	O
products	O
were	O
cloned	O
into	O
pGEM	O
-	O
T	O
Easy	O
vector	O
(	O
Promega	O
,	O
USA	O
)	O
,	O
and	O
the	O
recombinant	O
plasmids	O
named	O
as	O
pGEM	O
-	O
Tsak188	S-Biological_Molecule
and	O
pGEM	O
-	O
Tsak189	S-Biological_Molecule
were	O
digested	O
with	O
EcoRI	S-Biological_Molecule
.	O

Subsequently	O
,	O
EcoRI	S-Biological_Molecule
fragments	O
were	O
cloned	O
into	O
suicide	O
vector	O
pVA891	O
-	O
2	O
,	O
and	O
the	O
recombinant	O
plasmids	O
named	O
as	O
pHK	O
and	O
pRR	O
,	O
respectively	O
,	O
were	O
used	O
to	O
transform	O
S	B-Species
.	I-Species
agalactiae	E-Species
strain	O
168	O
/	O
00	O
according	O
to	O
the	O
protocol	O
[	O
33	O
]	O
.	O

Construction	O
of	O
the	O
strains	O
was	O
confirmed	O
by	O
PCR	O
and	O
nucleotide	O
sequencing	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
size	O
,	O
shape	O
and	O
color	O
of	O
the	O
colonies	O
,	O
diameter	O
of	O
zone	O
of	O
hemolysis	O
,	O
morphology	O
of	O
the	O
cells	O
and	O
the	O
chain	O
length	O
were	O
similar	O
in	O
all	O
the	O
strains	O
.	O

At	O
the	O
same	O
time	O
the	O
growth	O
curves	O
of	O
mutant	O
strains	O
in	O
THB	O
slightly	O
differed	O
from	O
the	O
growth	O
curve	O
of	O
the	O
strain	O
168	O
/	O
00	O
(	O
data	O
not	O
shown	O
)	O
.	O

Two	O
time	O
points	O
(	O
2	O
hrs	O
and	O
5	O
hrs	O
)	O
corresponding	O
to	O
the	O
middle	O
-	O
exponential	O
and	O
post	O
-	O
exponential	O
phases	O
of	O
growth	O
,	O
respectively	O
,	O
were	O
selected	O
for	O
further	O
study	O
.	O

Effect	O
of	O
insertional	O
inactivation	O
on	O
expression	O
of	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
antigen	E-Biological_Molecule

Several	O
approaches	O
were	O
used	O
to	O
prepare	O
the	O
cell	O
lysates	O
of	O
the	O
wild	O
-	O
type	O
strain	O
168	O
/	O
00	O
and	O
mutant	O
strains	O
.	O

As	O
result	O
,	O
10	O
min	O
boiling	O
of	O
the	O
cells	O
in	O
2	B-Chemical_Compound
-	I-Chemical_Compound
mercaptoethanol	E-Chemical_Compound
(	O
10	O
%	O
,	O
w	O
/	O
w	O
)	O
was	O
found	O
to	O
be	O
most	O
effective	O
with	O
respect	O
to	O
higher	O
yield	O
and	O
quality	O
of	O
the	O
protein	O
bands	O
observed	O
after	O
SDS	O
-	O
PAGE	O
(	O
data	O
not	O
shown	O
)	O
.	O

SDS	O
-	O
PAGE	O
of	O
secreted	O
proteins	O
did	O
not	O
reveal	O
any	O
difference	O
among	O
the	O
wild	O
-	O
type	O
strain	O
and	O
mutant	O
strains	O
(	O
data	O
not	O
shown	O
)	O
.	O

Western	O
-	O
blotting	O
with	O
labeled	O
human	S-Species
IgA	S-Biological_Molecule
identified	O
this	O
protein	O
as	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
antigen	E-Biological_Molecule
(	O
Fig	O
.	O
3	O
)	O
.	O

Effect	O
of	O
insertional	O
inactivation	O
on	O
transcription	O
of	O
bac	S-Biological_Molecule
gene	O

As	O
result	O
,	O
transcription	O
of	O
bac	S-Biological_Molecule
gene	O
in	O
sak189	S-Biological_Molecule
/	O
sak188	S-Biological_Molecule
double	O
mutant	O
strain	O
was	O
17	O
-	O
fold	O
less	O
than	O
in	O
168	O
/	O
00	O
wild	O
-	O
type	O
strain	O
(	O
Fig	O
.	O
3	O
)	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
bac	S-Biological_Molecule
gene	O
transcription	O
level	O
in	O
sak188	S-Biological_Molecule
mutant	O
strain	O
was	O
almost	O
similar	O
to	O
that	O
in	O
the	O
wild	O
-	O
type	O
strain	O
that	O
confirmed	O
the	O
results	O
of	O
SDS	O
-	O
PAGE	O
and	O
western	O
-	O
blotting	O
.	O

Murine	S-Species
intraperitoneal	O
model	O
of	O
streptococcal	O
infection	O
was	O
developed	O
to	O
compare	O
the	O
virulent	O
properties	O
of	O
the	O
strains	O
under	O
study	O
.	O

Mice	S-Species
were	O
injected	O
with	O
0	O
.	O
5	O
ml	O
of	O
PBS	O
containing	O
108	O
CFUs	O
and	O
observed	O
for	O
10	O
days	O
.	O

As	O
seen	O
from	O
the	O
Fig	O
.	O

In	O
S	B-Species
.	I-Species
agalactiae	E-Species
,	O
a	O
total	O
of	O
21	O
TCSs	O
are	O
involved	O
in	O
the	O
regulatory	O
network	O
essential	O
for	O
successful	O
colonization	O
,	O
penetration	O
and	O
/	O
or	O
invasion	O
as	O
well	O
as	O
for	O
resistance	O
to	O
human	S-Species
immune	O
system	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
functional	O
role	O
of	O
Sak188	S-Biological_Molecule
/	O
Sak189	S-Biological_Molecule
two	O
-	O
component	O
system	O
in	O
regulation	O
of	O
the	O
expression	O
of	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
antigen	E-Biological_Molecule
,	O
an	O
important	O
virulence	O
factor	O
of	O
S	B-Species
.	I-Species
agalactiae	E-Species
.	O

It	O
was	O
also	O
found	O
that	O
regulation	O
occurred	O
at	O
transcriptional	O
level	O
.	O

Variety	O
of	O
publications	O
are	O
currently	O
available	O
regarding	O
the	O
occurrence	O
of	O
bac	S-Biological_Molecule
gene	O
among	O
S	B-Species
.	I-Species
agalactiae	E-Species
strains	O
as	O
well	O
as	O
genetic	O
polymorphism	O
of	O
bac	S-Biological_Molecule
gene	O
and	O
use	O
of	O
encoded	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
antigen	E-Biological_Molecule
as	O
a	O
vaccine	O
component	O
[	O
32	O
]	O
,	O
[	O
34	O
]	O
-	O
[	O
38	O
]	O
.	O

However	O
,	O
the	O
regulatory	O
mechanism	O
of	O
bac	S-Biological_Molecule
gene	O
expression	O
has	O
not	O
been	O
studied	O
.	O

Comparative	O
analysis	O
of	O
Sak188	S-Biological_Molecule
and	O
Sak189	S-Biological_Molecule
amino	O
acid	O
sequences	O
in	O
the	O
wild	O
-	O
type	O
strain	O
168	B-Species
/	I-Species
00	E-Species
and	O
deduced	O
protein	O
sequences	O
in	O
mutant	O
strains	O
predicted	O
the	O
replacement	O
of	O
95	O
amino	O
acids	O
at	O
the	O
C	O
-	O
terminal	O
end	O
of	O
Sak188	S-Biological_Molecule
protein	O
by	O
191	O
amino	O
acids	O
,	O
and	O
replacement	O
of	O
51	O
amino	O
acids	O
at	O
the	O
C	O
-	O
terminal	O
end	O
of	O
Sak189	S-Biological_Molecule
protein	O
by	O
15	O
amino	O
acids	O
(	O
Fig	O
.	O
5	O
)	O
.	O

Theoretically	O
,	O
in	O
both	O
sak188	S-Biological_Molecule
mutant	O
strain	O
and	O
sak189	S-Biological_Molecule
/	O
sak188	S-Biological_Molecule
double	O
mutant	O
strain	O
,	O
the	O
Sak188	S-Biological_Molecule
/	O
Sak189	S-Biological_Molecule
TCS	O
can	O
be	O
inactive	O
.	O

In	O
S	B-Species
.	I-Species
pneumoniae	E-Species
,	O
inactivation	O
of	O
the	O
response	O
regulator	O
RR06	S-Biological_Molecule
(	O
83	O
%	O
similarity	O
with	O
Sak189	S-Biological_Molecule
)	O
,	O
which	O
binds	O
promoter	O
region	O
of	O
cbpA	S-Biological_Molecule
,	O
repressed	O
transcription	O
of	O
the	O
cbpA	S-Biological_Molecule
gene	O
[	O
22	O
]	O
.	O

In	O
this	O
study	O
,	O
western	O
blotting	O
and	O
quantitative	O
RT	O
-	O
PCR	O
revealed	O
that	O
DNA	O
-	O
binding	O
response	O
regulator	O
Sak189	S-Biological_Molecule
is	O
necessary	O
for	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
antigen	E-Biological_Molecule
expression	O
suggesting	O
direct	O
binding	O
of	O
Sak189	S-Biological_Molecule
with	O
bac	S-Biological_Molecule
gene	O
promoter	O
.	O

This	O
is	O
not	O
surprising	O
given	O
the	O
high	O
similarity	O
in	O
the	O
sequences	O
,	O
functions	O
and	O
relative	O
locations	O
of	O
Sak188	S-Biological_Molecule
/	O
Sak189	S-Biological_Molecule
and	O
HK06	S-Biological_Molecule
/	O
RR06	S-Biological_Molecule
,	O
and	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
antigen	E-Biological_Molecule
and	O
CbpA	S-Biological_Molecule
(	O
Fig	O
.	O
1	O
)	O
.	O

In	O
this	O
study	O
,	O
both	O
sak188	S-Biological_Molecule
and	O
bac	S-Biological_Molecule
genes	O
located	O
downstream	O
the	O
sak189	S-Biological_Molecule
gene	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Thus	O
,	O
we	O
can	O
conclude	O
that	O
sak188	S-Biological_Molecule
and	O
bac	S-Biological_Molecule
gene	O
are	O
not	O
in	O
the	O
operon	O
,	O
and	O
repression	O
of	O
bac	S-Biological_Molecule
gene	O
transcription	O
in	O
sak189	S-Biological_Molecule
/	O
sak188	S-Biological_Molecule
double	O
mutant	O
strain	O
is	O
not	O
due	O
to	O
the	O
polar	O
effect	O
.	O

The	O
cross	O
-	O
talk	O
among	O
different	O
TCSs	O
has	O
been	O
described	O
for	O
many	O
bacterial	O
species	O
[	O
3	O
]	O
including	O
pathogenic	O
streptococci	S-Species
.	O

For	O
example	O
,	O
in	O
S	B-Species
.	I-Species
pneumoniae	E-Species
inactivation	O
of	O
histidine	O
kinase	O
HK06	S-Biological_Molecule
(	O
78	O
%	O
similarity	O
with	O
Sak188	S-Biological_Molecule
)	O
,	O
in	O
contrast	O
to	O
RR06	S-Biological_Molecule
(	O
83	O
%	O
similarity	O
with	O
Sak189	S-Biological_Molecule
)	O
,	O
did	O
not	O
repress	O
transcription	O
of	O
the	O
adjacent	O
cbpA	S-Biological_Molecule
gene	O
[	O
22	O
]	O
indicating	O
a	O
cross	O
-	O
talk	O
between	O
RR06	S-Biological_Molecule
and	O
noncognate	O
histidine	O
kinase	O
(	O
s	O
)	O
.	O

Intraperitoneal	O
infection	O
of	O
laboratory	O
mice	S-Species
demonstrated	O
that	O
Sak189	S-Biological_Molecule
DNA	O
-	O
binding	O
response	O
regulatory	O
protein	O
is	O
important	O
for	O
virulent	O
properties	O
of	O
S	B-Species
.	I-Species
agalactiae	E-Species
.	O

It	O
could	O
be	O
predicted	O
given	O
that	O
inactivation	O
of	O
other	O
S	B-Species
.	I-Species
agalactiae	E-Species
TCSs	O
(	O
CovS	S-Biological_Molecule
/	O
CovR	S-Biological_Molecule
,	O
DltR	S-Biological_Molecule
/	O
DltS	S-Biological_Molecule
,	O
RgfA	S-Biological_Molecule
/	O
RgfC	S-Biological_Molecule
)	O
resulted	O
in	O
the	O
changes	O
of	O
virulent	O
properties	O
,	O
however	O
,	O
in	O
all	O
these	O
studies	O
the	O
mutant	O
strains	O
became	O
less	O
virulent	O
compared	O
to	O
the	O
wild	O
-	O
type	O
strains	O
[	O
8	O
]	O
-	O
[	O
12	O
]	O
.	O

Thus	O
,	O
we	O
suggest	O
that	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
antigen	E-Biological_Molecule
located	O
on	O
the	O
bacterial	O
surface	O
can	O
interfere	O
with	O
the	O
disease	O
process	O
and	O
play	O
a	O
role	O
of	O
anti	O
-	O
virulent	O
factor	O
(	O
at	O
least	O
,	O
in	O
mice	S-Species
)	O
similarly	O
to	O
hyaluronate	O
lyase	O
of	O
S	B-Species
.	I-Species
pyogenes	E-Species
[	O
41	O
]	O
.	O

It	O
is	O
also	O
possible	O
that	O
bac	O
gene	O
encoding	O
for	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
antigen	E-Biological_Molecule
is	O
not	O
only	O
target	O
for	O
Sak188	S-Biological_Molecule
/	O
Sak189	S-Biological_Molecule
TCS	O
.	O

The	O
difference	O
among	O
the	O
growth	O
curves	O
of	O
the	O
wild	O
-	O
type	O
and	O
mutant	O
strains	O
(	O
data	O
not	O
shown	O
)	O
indicate	O
that	O
in	O
addition	O
to	O
bac	O
gene	O
,	O
some	O
metabolic	O
genes	O
can	O
be	O
controlled	O
by	O
Sak188	S-Biological_Molecule
/	O
Sak189	S-Biological_Molecule
TCS	O
.	O

This	O
suggestion	O
is	O
confirmed	O
by	O
the	O
numerous	O
studies	O
demonstrating	O
the	O
genome	O
-	O
wide	O
location	O
of	O
the	O
genes	O
affected	O
by	O
TCSs	O
[	O
10	O
]	O
,	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
,	O
and	O
set	O
of	O
the	O
genes	O
controlled	O
by	O
Sak188	S-Biological_Molecule
/	O
Sak189	S-Biological_Molecule
(	O
TCS	O
regulon	O
)	O
can	O
be	O
identified	O
using	O
microarray	O
technology	O
.	O

As	O
seen	O
from	O
the	O
data	O
of	O
this	O
study	O
,	O
transcription	O
of	O
bac	O
gene	O
and	O
expression	O
of	O
encoded	O
beta	O
-	O
antigen	O
are	O
the	O
primary	O
genotypic	O
/	O
phenotypic	O
properties	O
controlled	O
by	O
Sak188	S-Biological_Molecule
/	O
Sak189	S-Biological_Molecule
TCS	O
.	O

Therefore	O
,	O
it	O
is	O
reasonable	O
to	O
annotate	O
this	O
system	O
as	O
BgrR	S-Biological_Molecule
/	O
S	S-Biological_Molecule
(	O
bac	S-Biological_Molecule
gene	O
regulatory	O
system	O
)	O
,	O
and	O
DNA	O
-	O
binding	O
response	O
regulator	O
Sak189	S-Biological_Molecule
and	O
sensor	O
histidine	O
kinase	O
Sak188	S-Biological_Molecule
as	O
BgrR	S-Biological_Molecule
and	O
BgrS	S-Biological_Molecule
proteins	O
,	O
respectively	O
.	O

In	O
conclusion	O
,	O
the	O
data	O
presented	O
here	O
characterize	O
the	O
functional	O
role	O
of	O
S	B-Species
.	I-Species
agalactiae	E-Species
Sak188	S-Biological_Molecule
/	O
Sak189	S-Biological_Molecule
two	O
-	O
component	O
system	O
.	O

Inactivation	O
of	O
histidine	O
kinase	O
Sak188	S-Biological_Molecule
does	O
not	O
affect	O
transcription	O
of	O
bac	O
gene	O
and	O
expression	O
of	O
beta	B-Biological_Molecule
-	I-Biological_Molecule
antigen	E-Biological_Molecule
,	O
that	O
suggests	O
the	O
cross	O
-	O
talk	O
between	O
Sak189	S-Biological_Molecule
and	O
other	O
sensor	O
kinase	O
(	O
s	O
)	O
in	O
S	B-Species
.	I-Species
agalactiae	E-Species
.	O

Finally	O
,	O
Sak189	S-Biological_Molecule
,	O
but	O
not	O
Sak188	S-Biological_Molecule
,	O
controls	O
virulent	O
properties	O
of	O
S	B-Species
.	I-Species
agalactiae	E-Species
in	O
vivo	O
.	O
